PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jaskolka, MC; Kane, PM				Jaskolka, Michael C.; Kane, Patricia M.			Interaction between the yeast RAVE complex and Vph1-containing V-o sectors is a central glucose-sensitive interaction required for V-ATPase reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; vacuole; vacuolar acidification; yeast; organellar pH homeostasis; glucose signaling; protein-protein interaction; proton pump; rabconnectin-3; RAVE complex	H+-ATPASE; PH HOMEOSTASIS; VACUOLAR; SUBUNIT; GENE; ACIDIFICATION; PURIFICATION; INHIBITION; REGULATOR; ENCODES	The yeast vacuolar H+-ATPase (V-ATPase) of budding yeast (Saccharomyces cerevisiae) is regulated by reversible disassembly. Disassembly inhibits V-ATPase activity under low-glucose conditions by releasing peripheral V-1 subcomplexes from membrane-bound V-o subcomplexes. V-ATPase reassembly and reactivation requires intervention of the conserved regulator of H+-ATPase of vacuoles and endosomes (RAVE) complex, which binds to cytosolic V-1 subcomplexes and assists reassembly with integral membrane V-o complexes. Consistent with its role, the RAVE complex itself is reversibly recruited to the vacuolar membrane by glucose, but the requirements for its recruitment are not understood. We demonstrate here that RAVE recruitment to the membrane does not require an interaction with V-1. Glucose-dependent RAVE localization to the vacuolar membrane required only intact V-o complexes containing the Vph1 subunit, suggesting that the RAVE-V-o interaction is glucose-dependent. We identified a short conserved sequence in the center of the RAVE subunit Rav1 that is essential for the interaction with Vph1 in vivo and in vitro. Mutations in this region resulted in the temperature- and pH-dependent growth phenotype characteristic of rav? mutants. However, this region did not account for glucose sensitivity of the Rav1-Vph1 interaction. We quantitated glucose-dependent localization of a GFP-tagged RAVE subunit to the vacuolar membrane in several mutants previously implicated in altering V-ATPase assembly state or glucose-induced assembly. RAVE localization did not correlate with V-ATPase assembly levels reported previously in these mutants, highlighting both the catalytic nature of RAVE's role in V-ATPase assembly and the likelihood of glucose signaling to RAVE independently of V-1.	[Jaskolka, Michael C.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu		Jaskolka, Michael/0000-0003-2341-0750	National Institutes of Health [R01 GM127364]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 GM127364 (to P. M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Deprez MA, 2018, MICROB CELL, V5, P119, DOI 10.15698/mic2018.03.618; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Einhorn Z, 2012, J NEUROSCI, V32, P11144, DOI 10.1523/JNEUROSCI.1705-12.2012; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Henderson KA, 2014, ELIFE, V3, DOI 10.7554/eLife.03504; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Ho B, 2018, CELL SYST, V6, P192, DOI 10.1016/j.cels.2017.12.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kane PM, 1999, J BIOL CHEM, V274, P17275, DOI 10.1074/jbc.274.24.17275; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Liu Y, 2017, DIABETES, V66, P1521, DOI 10.2337/db16-0727; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; Merkulova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14827; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Sakisaka T, 2005, METHOD ENZYMOL, V403, P401, DOI 10.1016/S0076-6879(05)03035-1; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Sharma S, 2019, J BIOL CHEM, V294, P6439, DOI 10.1074/jbc.RA119.007577; Sherman F., 1982, METHODS YEAST GENETI; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; UMEMOTO N, 1991, J BIOL CHEM, V266, P24526; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wilms T, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006835; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001	41	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2259	2269		10.1074/jbc.RA119.011522	http://dx.doi.org/10.1074/jbc.RA119.011522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31941791	Green Published, hybrid			2022-12-26	WOS:000517330200010
J	Shin, NY; Yamazaki, H; Beniash, E; Yang, X; Margolis, SS; Pugach, MK; Simmer, JP; Margolis, HC				Shin, Nah-Young; Yamazaki, Hajime; Beniash, Elia; Yang, Xu; Margolis, Seth S.; Pugach, Megan K.; Simmer, James P.; Margolis, Henry C.			Amelogenin phosphorylation regulates tooth enamel formation by stabilizing a transient amorphous mineral precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomineralization; tooth; tooth development; extracellular matrix protein; phosphorylation; amelogenesis; amelogenin; dental enamel; knock-in mouse model	CALCIUM-PHOSPHATE FORMATION; OCTACALCIUM PHOSPHATE; MATRIX PROTEINS; FINE-STRUCTURE; MICE DISPLAY; AMELOBLASTIN; IMPERFECTA; DEFECTS; MMP20; CELL	Dental enamel comprises interwoven arrays of extremely long and narrow crystals of carbonated hydroxyapatite called enamel rods. Amelogenin (AMELX) is the predominant extracellular enamel matrix protein and plays an essential role in enamel formation (amelogenesis). Previously, we have demonstrated that full-length AMELX forms higher-order supramolecular assemblies that regulate ordered mineralization in vitro, as observed in enamel rods. Phosphorylation of the sole AMELX phosphorylation site (Ser-16) in vitro greatly enhances its capacity to stabilize amorphous calcium phosphate (ACP), the first mineral phase formed in developing enamel, and prevents apatitic crystal formation. To test our hypothesis that AMELX phosphorylation is critical for amelogenesis, we generated and characterized a hemizygous knockin (KI) mouse model with a phosphorylation-defective Ser-16 to Ala-16 substitution in AMELX. Using EM analysis, we demonstrate that in the absence of phosphorylated AMELX, KI enamel lacks enamel rods, the hallmark component of mammalian enamel, and, unlike WT enamel, appears to be composed of less organized arrays of shorter crystals oriented normal to the dentinoenamel junction. KI enamel also exhibited hypoplasia and numerous surface defects, whereas heterozygous enamel displayed highly variable mosaic structures with both KI and WT features. Importantly, ACP-to-apatitic crystal transformation occurred significantly faster in KI enamel. Secretory KI ameloblasts also lacked Tomes' processes, consistent with the absence of enamel rods, and underwent progressive cell pathology throughout enamel development. In conclusion, AMELX phosphorylation plays critical mechanistic roles in regulating ACP-phase transformation and enamel crystal growth, and in maintaining ameloblast integrity and function during amelogenesis.	[Shin, Nah-Young; Yamazaki, Hajime; Pugach, Megan K.; Margolis, Henry C.] Forsyth Inst, Cambridge, MA 02142 USA; [Shin, Nah-Young; Yamazaki, Hajime; Pugach, Megan K.; Margolis, Henry C.] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Yamazaki, Hajime; Beniash, Elia; Yang, Xu] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial Regenerat, Dept Oral Biol, Pittsburgh, PA 15213 USA; [Margolis, Henry C.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial Regenerat, Dept Periodont & Prevent Dent, Pittsburgh, PA 15213 USA; [Margolis, Seth S.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA; [Shin, Nah-Young] Boston Childrens Hosp, Dept Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Shin, Nah-Young] Harvard Med Sch, Dana Farber Canc Inst, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Margolis, HC (corresponding author), Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial Regenerat, Dept Periodont & Prevent Dent, Pittsburgh, PA 15213 USA.	hmargolis@pitt.edu		Simmer, James/0000-0002-7192-6105; Yamazaki, Hajime/0000-0002-5138-4142	National Institutes of Health NIDCR Grant R21-dental enamel formation [DE023425]; The Forsyth Institute; University of Pittsburgh School of Dental Medicine	National Institutes of Health NIDCR Grant R21-dental enamel formation; The Forsyth Institute; University of Pittsburgh School of Dental Medicine(University of Pittsburgh)	This work was supported by National Institutes of Health NIDCR Grant R21-dental enamel formation, through the use of knockout and DE023425 (to H. C. M.), The Forsyth Institute, and the University of Pittsburgh School of Dental Medicine. The authors declare that they have no conflicts of interest with the contents of this article.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aichmayer B, 2005, J STRUCT BIOL, V151, P239, DOI 10.1016/j.jsb.2005.06.007; Bajaj D, 2009, BIOMATERIALS, V30, P4037, DOI 10.1016/j.biomaterials.2009.04.017; Baldassarri M, 2008, J DENT RES, V87, P645, DOI 10.1177/154405910808700711; Bartlett JD, 1999, CRIT REV ORAL BIOL M, V10, P425, DOI 10.1177/10454411990100040101; Bartlett JD, 2011, CELLS TISSUES ORGANS, V194, P222, DOI 10.1159/000324205; Beniash E, 2005, J STRUCT BIOL, V149, P182, DOI 10.1016/j.jsb.2004.11.001; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Caterina JJ, 2002, J BIOL CHEM, V277, P49598, DOI 10.1074/jbc.M209100200; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Chan HC, 2010, J DENT RES, V89, P695, DOI 10.1177/0022034510365662; Connelly C, 2016, COLLOID SURFACE B, V148, P377, DOI 10.1016/j.colsurfb.2016.09.010; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Cui JX, 2017, ELIFE, V6, DOI 10.7554/eLife.23990; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; Fang PA, 2013, J STRUCT BIOL, V183, P250, DOI 10.1016/j.jsb.2013.05.011; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; FRANKLIN DL, 1991, J ANAT, V174, P103; Fukae M, 1998, CONNECT TISSUE RES, V39, P123, DOI 10.3109/03008209809023918; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gallon V, 2013, J STRUCT BIOL, V183, P239, DOI 10.1016/j.jsb.2013.03.014; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1; Hu JCC, 2008, J BIOL CHEM, V283, P10858, DOI 10.1074/jbc.M710565200; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Hu JCC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089303; Hu YY, 2016, MOL GENET GENOM MED, V4, P641, DOI 10.1002/mgg3.252; Hu YY, 2011, EUR J ORAL SCI, V119, P217, DOI 10.1111/j.1600-0722.2011.00859.x; KALLENBACH E, 1973, TISSUE CELL, V5, P501, DOI 10.1016/S0040-8166(73)80041-2; KALLENBACH E, 1977, AM J ANAT, V148, P479, DOI 10.1002/aja.1001480406; Kwak SY, 2016, J DENT RES, V95, P1511, DOI 10.1177/0022034516662814; Kwak SY, 2014, CONNECT TISSUE RES, V55, P21, DOI 10.3109/03008207.2014.923853; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Le Norcy E, 2011, J DENT RES, V90, P1091, DOI 10.1177/0022034511411301; Le Norcy E, 2011, EUR J ORAL SCI, V119, P97, DOI 10.1111/j.1600-0722.2011.00900.x; LEBLOND CP, 1979, J DENT RES, V58, P950, DOI 10.1177/00220345790580024901; Lignon G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00267; Ma P, 2016, J DENT RES, V95, P1408, DOI 10.1177/0022034516661513; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Margolis H. C., 2010, AMELOGENINS MULTIFAC, P133, DOI 10.2174/978160805171711001010133; Margolis HC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00339; Masica DL, 2011, J PHYS CHEM C, V115, P13775, DOI 10.1021/jp202965h; Mazumder P, 2016, J DENT RES, V95, P1042, DOI 10.1177/0022034516645389; Mazumder P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00274; Moradian-Oldak J, 2006, EUR J ORAL SCI, V114, P289, DOI 10.1111/j.1600-0722.2006.00285.x; Nagano T, 2009, J DENT RES, V88, P823, DOI 10.1177/0022034509342694; Nanci A, 2007, 10 CATES ORAL HISTOL; Nishikawa S, 2017, J ORAL BIOSCI, V59, P197, DOI 10.1016/j.job.2017.07.002; Ohyama Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27784; Paine CT, 1998, CONNECT TISSUE RES, V38, P257, DOI 10.3109/03008209809017046; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; Pugach MK, 2010, J DENT RES, V89, P165, DOI 10.1177/0022034509358392; Robinson C, 2007, J DENT RES, V86, P677, DOI 10.1177/154405910708600801; ROBINSON C, 1981, J CRYST GROWTH, V53, P160, DOI 10.1016/0022-0248(81)90062-2; Robinson C, 2003, CONNECT TISSUE RES, V44, P65, DOI 10.1080/03008200390152115; Robinson C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00405; Shin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086774; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Skobe Z, 2006, EUR J ORAL SCI, V114, P338, DOI 10.1111/j.1600-0722.2006.00305.x; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 2019, J ANAT, V235, P912, DOI 10.1111/joa.13053; Smith CEL, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00435; Tao JH, 2007, J PHYS CHEM B, V111, P13410, DOI 10.1021/jp0732918; Verdelis K, 2016, MATRIX BIOL, V52-54, P246, DOI 10.1016/j.matbio.2016.01.003; Wald T, 2017, P NATL ACAD SCI USA, V114, pE1641, DOI 10.1073/pnas.1615334114; Wang SK, 2013, J BONE MINER RES, V28, P2508, DOI 10.1002/jbmr.1990; Wang XF, 2012, J BIOL CHEM, V287, P35934, DOI 10.1074/jbc.M112.386862; WARSHAWSKY H, 1971, ANAT RECORD, V169, P585, DOI 10.1002/ar.1091690308; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Wiedemann-Bidlack FB, 2011, J STRUCT BIOL, V173, P250, DOI 10.1016/j.jsb.2010.11.006; WITKOP CJ, 1967, ORAL SURG ORAL MED O, V23, P174, DOI 10.1016/0030-4220(67)90092-8; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Xia Y, 2016, MATRIX BIOL, V52-54, P198, DOI 10.1016/j.matbio.2015.11.005; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P206, DOI 10.1111/j.1600-0722.2011.00866.x; Yamazaki H, 2019, J DENT RES, V98, P468, DOI 10.1177/0022034518823537; Yamazaki H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00450; Zalzal SF, 2008, MATRIX BIOL, V27, P352, DOI 10.1016/j.matbio.2008.01.003	85	26	27	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1943	1959		10.1074/jbc.RA119.010506	http://dx.doi.org/10.1074/jbc.RA119.010506			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919099	Green Published, hybrid			2022-12-26	WOS:000517128200014
J	Elyasi, M; Lai, H; Major, PW; Baker, SR; Amin, M				Elyasi, Maryam; Lai, Hollis; Major, Paul W.; Baker, Sarah R.; Amin, Maryam			Modeling the Theory of Planned Behaviour to predict adherence to preventive dental visits in preschool children	PLOS ONE			English	Article							ORAL-HEALTH STATUS; COHERENCE; PARENTS; SENSE; CARE	Objectives Dental caries is the most common chronic childhood disease that occurs in a continuum and can be prevented by children and their parents' adherence to recommended oral health behaviors. Theory-driven tools help practitioners to identify the causes for poor adherence and develop effective interventions. This study examined the Expanded Theory of Planned Behaviour (TPB) Model by adding the concept of Sense of Coherence (SOC) to predict parental adherence to preschooler's preventive dental visits. Methods Data regarding socio-economic demographics were collected from parents of children aged 2-6 years. Constructs of TPB including parental attitudes, subjective norms (SN), Perceived Behavioural Control (PBC), and intention to attend preventive dental visits for their preschoolers were collected by questionnaire, alongside parents' sense of coherence (SOC). Dental attendance was measured by asking if the child had a regular dental visit during the last year. Structural Equation Modeling Analysis (SEMA) was carried out to identify significant direct and indirect (mediated) pathways in the extended TPB model. Results Three hundred and seventy-eight mothers (mean age = 34.41 years, range 22-48) participated in the study. The mean age of children was 3.92 years, range: 2-6), and 75.9% had dental insurance. Results of the final model showed that predisposing factors (child's birthplace and mother's birthplace) significantly predicted enabling resources (family monthly income and child's dental insurance status); both predicted the TPB components (PBC, SN, and attitude). TPB components, in turn, predicted behavioural intention. However, contrary to expectation, intention did not significantly predict dental attendance in the past 12 months. Parent's SOC significantly predicted TPB components and dental attendance. Overall, 56% of the variance in dental attendance was explained by the expanded TPB model. Conclusions The expanded TPB model explained a great deal of variance in preschooler's dental attendance. These findings suggest that the expanded model could be used as the framework for designing interventions or strategies to enhance dental attendance among preschoolers; in particular, such strategies should focus specifically on enhancing parental SOC including empowerment.	[Elyasi, Maryam; Major, Paul W.] Univ Alberta, Sch Dent, Orthodont Grad Program, Edmonton, AB, Canada; [Lai, Hollis] Univ Alberta, Sch Dent, Edmonton, AB, Canada; [Baker, Sarah R.] Univ Sheffield, Acad Unit Oral Hlth Dent & Soc, Sheffield, S Yorkshire, England; [Amin, Maryam] Univ Alberta, Div Pediat Dent, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Sheffield; University of Alberta	Amin, M (corresponding author), Univ Alberta, Div Pediat Dent, Edmonton, AB, Canada.	maryam.amin@ualberta.ca	Lai, Hollis/AAE-3663-2022	Amin, Maryam/0000-0003-2249-5465	Canadian Institutes of Health Research (CIHR) [126751]; Fund for Dentistry, University of Alberta [(2015-03) 3]; Alpha Omega Foundation of Canada; Postdoctoral Education Research Grant [2015-16]; American Association of Orthodontics Foundation (AAOF), Resident Research Award 2017	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fund for Dentistry, University of Alberta; Alpha Omega Foundation of Canada; Postdoctoral Education Research Grant; American Association of Orthodontics Foundation (AAOF), Resident Research Award 2017	ME & MA received the following sources of funding for this study: 1. Canadian Institutes of Health Research (CIHR) grant (FRN: 126751) 2. Fund for Dentistry, University of Alberta (Project #: 2015-03) 3. Alpha Omega Foundation of Canada, Postdoctoral Education Research Grant 2015-16. 4. American Association of Orthodontics Foundation (AAOF), Resident Research Award 2017.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2010, BIOFEEDBACK SELF-REG, V17, P1, DOI [10.1016/0749-5978(91)90020-T, DOI 10.1016/0749-5978(91)90020-T]; American Academy of Pediatric Dentists, 2015, PEDIAT DENT S, V30, P22; Amin M, 2014, J CAN DENT ASSOC, V80; Anderson CN, 2012, HEALTH COMMUN, P1; Antonovsky A., 1987, UNRAVELING MYSTERY H; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Ashkenazi M, 2012, ODONTOLOGY, V100, P241, DOI 10.1007/s10266-011-0034-1; Badri P, 2014, J AM DENT ASSOC, V145, P817, DOI 10.14219/jada.2014.49; Brown T.A., 2014, CONFIRMATORY FACTOR; Buunk-Werkhoven YAB, 2011, COMMUNITY DENT ORAL, V39, P250, DOI 10.1111/j.1600-0528.2010.00589.x; Canadian Institute for Health Information, 2013, TREATM PREV DENT CAV; da Silva AN, 2011, COMMUNITY DENT ORAL, V39, P115, DOI 10.1111/j.1600-0528.2010.00576.x; Dumitrescu Alexandrina L, 2011, J Oral Sci, V53, P369; Elyasi M, PARENT S SENSE COHER, P23; Elyasi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133918; Freire MariadoCarmoMatias, 2002, Community Dent Health, V19, P24; Gomes MC, 2018, INFLUENCE SENSE COHE, P1973; Hallberg U, 2008, INT J PAEDIATR DENT, V18, P27, DOI 10.1111/j.1365-263X.2007.00867.x; Harris Rebecca, 2004, Community Dent Health, V21, P71; Holde GE, 2018, J CLIN PERIODONTOL, V45, P768, DOI 10.1111/jcpe.12906; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kirschstein RL, 2000, OR HLTH AM REP SURG; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Locker D, 1998, COMMUNITY DENT ORAL, V26, P177, DOI 10.1111/j.1600-0528.1998.tb01947.x; Luzzi L, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-93; Mark C, 2005, PREDICTING HLTH BEHA; Pakpour AH, 2012, PSYCHOL HEALTH MED, V17, P176, DOI 10.1080/13548506.2011.596551; Perazzo MF, 2017, INT J PAEDIATR DENT, V27, P334, DOI 10.1111/ipd.12266; Pierce KM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e82; Rich A, 2015, J BEHAV MED, V38, P673, DOI 10.1007/s10865-015-9644-3; Scheerman JFM, 2016, COMMUNITY DENT ORAL, V44, P331, DOI 10.1111/cdoe.12224; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Van den Branden S, 2013, COMMUNITY DENT HLTH, V30, P19, DOI 10.1922/CDH_2897Branden07; Weatherwax JA, 2015, INT J DENT HYG, V13, P49, DOI 10.1111/idh.12097; World Health Organisation, 2003, ADHERENCE LONG TERM; Yu SM, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e73	38	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227233	10.1371/journal.pone.0227233	http://dx.doi.org/10.1371/journal.pone.0227233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945098	gold, Green Accepted, Green Published			2022-12-26	WOS:000534370100025
J	Weyers, JJ; Gunaje, JJ; Van Biber, B; Martinson, A; Reinecke, H; Mahoney, WM; Schwartz, SM; Cox, TC; Murry, CE				Weyers, Jill J.; Gunaje, Jagadambika J.; Van Biber, Benjamin; Martinson, Amy; Reinecke, Hans; Mahoney, William M.; Schwartz, Stephen M.; Cox, Timothy C.; Murry, Charles E.			Sonic Hedgehog upregulation does not enhance the survival and engraftment of stem cell-derived cardiomyocytes in infarcted hearts	PLOS ONE			English	Article							SKELETAL-MUSCLE; CARDIAC REPAIR; GENE DELIVERY; GROWTH; ANGIOGENESIS; TRANSPLANTATION; PROLIFERATION; ACTIVATION; GENERATION; MATURATION	The engraftment of human stem cell-derived cardiomyocytes (hSC-CMs) is a promising treatment for remuscularizing the heart wall post-infarction, but it is plagued by low survival of transplanted cells. We hypothesize that this low survival rate is due to continued ischemia within the infarct, and that increasing the vascularization of the scar will ameliorate the ischemia and improve hSC-CM survival and engraftment. An adenovirus expressing the vascular growth factor Sonic Hedgehog (Shh) was injected into the infarcted myocardium of rats immediately after ischemia/reperfusion, four days prior to hSC-CM injection. By two weeks post-cell injection, Shh treatment had successfully increased capillary density outside the scar, but not within the scar. In addition, there was no change in vessel size or percent vascular volume when compared to cell injection alone. Micro-computed tomography revealed that Shh failed to increase the number and size of larger vessels. It also had no effect on graft size or heart function when compared to cell engraftment alone. Our data suggests that, when combined with the engraftment of hSC-CMs, expression of Shh within the infarct scar and surrounding myocardium is unable to increase vascularization of the infarct scar, and it does not improve survival or function of hSC-CM grafts.	[Weyers, Jill J.; Gunaje, Jagadambika J.; Van Biber, Benjamin; Martinson, Amy; Reinecke, Hans; Mahoney, William M.; Schwartz, Stephen M.; Murry, Charles E.] Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Weyers, Jill J.; Gunaje, Jagadambika J.; Van Biber, Benjamin; Martinson, Amy; Reinecke, Hans; Mahoney, William M.; Schwartz, Stephen M.; Murry, Charles E.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Cox, Timothy C.] Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA USA; [Cox, Timothy C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Weyers, Jill J.] Sunnybrook Res Inst, Dept Phys Sci, Toronto, ON, Canada; [Cox, Timothy C.] Univ Missouri, Dept Oral & Craniofacial Sci, Kansas City, MO 64110 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Missouri System; University of Missouri Kansas City	Murry, CE (corresponding author), Univ Washington, Dept Pathol, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.; Murry, CE (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.; Murry, CE (corresponding author), Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA.; Murry, CE (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	murry@uw.edu	Mahoney, William/GQB-0802-2022; Weyers, Jill/AGX-7536-2022	Weyers, Jill/0000-0003-2358-1162	National Institutes of Health (NIH) [P01 HL094374, R01 HL128362, R01 HL084642, U54 DK107979, P01 GM081619]; Foundation Leducq Transatlantic Network of Excellence Award; American Heart Association fellowships [12POST9330030, 14POST18320023]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq Transatlantic Network of Excellence Award; American Heart Association fellowships(American Heart Association)	These studies were supported by National Institutes of Health (NIH) grants P01 HL094374 to CEM, SMS and WMM; R01 HL128362, R01 HL084642, U54 DK107979, and P01 GM081619 to CEM; a grant from the Foundation Leducq Transatlantic Network of Excellence Award to CEM, and a gift from the Robert B. McMillen Foundation to CEM. JJW was supported by American Heart Association fellowships 12POST9330030 and 14POST18320023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2007, FASEB J, V21, P2735, DOI 10.1096/fj.07-8079com; Ahmed RPH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008576; ALROY J, 1987, HISTOCHEMISTRY, V86, P603, DOI 10.1007/BF00489554; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; CHRISTIE KN, 1989, J HISTOCHEM CYTOCHEM, V37, P1303, DOI 10.1177/37.8.2754256; Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001; Fernandes S, 2015, STEM CELL REP, V5, P753, DOI 10.1016/j.stemcr.2015.09.011; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HUGHES SM, 1993, DEV BIOL, V158, P183, DOI 10.1006/dbio.1993.1178; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; KASSEISLER A, 1993, P NATL ACAD SCI USA, V90, P11498, DOI 10.1073/pnas.90.24.11498; Kolpak A, 2005, J NEUROSCI, V25, P3432, DOI 10.1523/JNEUROSCI.4938-04.2005; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lavine KJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000343; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Liu YW, 2018, NAT BIOTECHNOL, V36, P597, DOI 10.1038/nbt.4162; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; McDevitt TC, 2005, J MOL CELL CARDIOL, V39, P865, DOI 10.1016/j.yjmcc.2005.09.007; Morrow D, 2009, ARTERIOSCL THROM VAS, V29, P1112, DOI 10.1161/ATVBAHA.109.186890; Palladino M, 2011, MOL THER, V19, P658, DOI 10.1038/mt.2010.292; Paulis L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07983; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Pola R, 2003, CIRCULATION, V108, P479, DOI 10.1161/01.CIR.0000080338.60981.FA; Renault MA, 2013, CIRC RES, V113, P1148, DOI 10.1161/CIRCRESAHA.113.301546; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Romagnuolo R, 2019, STEM CELL REP, V12, P967, DOI 10.1016/j.stemcr.2019.04.005; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Shiba Y, 2016, NATURE, V538, P388, DOI 10.1038/nature19815; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Straface G, 2009, J CELL MOL MED, V13, P2424, DOI 10.1111/j.1582-4934.2008.00440.x; Ueda K, 2010, J CLIN INVEST, V120, P2016, DOI 10.1172/JCI39896; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Weyers JJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000202; Weyers JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3740; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227780	10.1371/journal.pone.0227780	http://dx.doi.org/10.1371/journal.pone.0227780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945113	Green Published, gold			2022-12-26	WOS:000534370100064
J	Wootton, CI; Soukavong, M; Kidoikhammouan, S; Samountry, B; English, JSC; Mayfong, M				Wootton, Catriona, I; Soukavong, Mick; Kidoikhammouan, Sonexai; Samountry, Bounthome; English, John S. C.; Mayfong, Mayxay			Patch testing in Lao medical students	PLOS ONE			English	Article							RISK-FACTORS; ALLERGENS; CHINA	Background Dermatological services in Laos, South East Asia are limited to the capital and patch testing is currently not available, so no data exists regarding the common cutaneous allergens in this population. Objectives The aim of this study was to document positive patch tests in medical students without evidence of contact dermatitis in Laos. Patients/Materials/Methods One hundred and fifty medical students were patch tested using TRUE Test (R) panels 1 to 3 (35 allergens). Readings were taken at Days 2 and 4. Results Thirty-eight students (25.3%) had a positive reaction to at least one allergen, accounting for 52 reactions in total. The proportion of the students with positive patch test reading was significantly higher in the female [33/96 (34%)] than in the male [5/54 (9%)], p<0.001. The most common allergens were: nickel (10%), gold (6.6%), thiomersal (6.6%), cobalt dichloride (2%) and p-tert-Butylphenol formaldehyde resin (2%). Balsam of Peru (0.66%), black rubber mix (0.66%), Cl+Me-lsothiazolinone (0.66%), fragrance mix 1 (0.66%), quinolone mix (0.66%), methyldibromo glutaronitrile (0.66%), mercapto mix (0.66%), epoxy resin (0.66%), paraben mix (0.66%), thiuram (0.66%) and wool alcohols (0.66%) accounted for all of the other positive reactions. Conclusion This study represents the first documented patch test results in Lao medical students and in the adult Lao population. The results of this study will inform any future research into contact allergy in Laos and give an insight into the background level of contact sensitivity in this population.	[Wootton, Catriona, I; Mayfong, Mayxay] Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos; [Wootton, Catriona, I] Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford, England; [Soukavong, Mick; Kidoikhammouan, Sonexai; Samountry, Bounthome] Univ Hlth Sci, Fac Basic Sci, Viangchan, Laos; [English, John S. C.] Nottingham NHS Treatment Ctr, Nottingham, England; [Mayfong, Mayxay] Univ Hlth Sci, Inst Res & Educ Dev & Red, Minist Hlth, Vientiane, England; [Mayfong, Mayxay] Churchill Hosp, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford	Wootton, CI (corresponding author), Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Viangchan, Laos.; Wootton, CI (corresponding author), Oxford Univ Hosp NHS Fdn Trust, Churchill Hosp, Oxford, England.	ciwootton@aol.com			CIW - The Geoffrey Dowling Fellowship from the British Association of Dermatologists	CIW - The Geoffrey Dowling Fellowship from the British Association of Dermatologists	Funded by CIW - The Geoffrey Dowling Fellowship from the British Association of Dermatologists. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to the medical students who participated in this study. Thanks also go to the former President of the University of Health Sciences, Associate Professor Somchit Boupha who provided her invaluable advice for the study.	[Anonymous], LAO POP HOUS CENS 20; Boonchai W, 2014, ASIAN PAC J ALLERGY, V32, P60, DOI 10.12932/AP0326.32.1.2014; Brelthaupt A, 2008, DERMATITIS, V19, P275, DOI 10.2310/6620.2008.08028; Dararattanaroj W, 2017, ASIAN PAC J ALLERGY, V35, P27, DOI 10.12932/AP0757; Diepgen TL, 2016, BRIT J DERMATOL, V174, P319, DOI 10.1111/bjd.14167; Hamann CR, 2010, CONTACT DERMATITIS, V62, P232, DOI 10.1111/j.1600-0536.2010.01694.x; How K N, 2017, Med J Malaysia, V72, P113; Johnston GA, 2017, BRIT J DERMATOL, V176, P317, DOI 10.1111/bjd.15239; MOLLER H, 1994, CONTACT DERMATITIS, V31, P209, DOI 10.1111/j.1600-0536.1994.tb01989.x; Yin R, 2011, CONTACT DERMATITIS, V65, P28, DOI 10.1111/j.1600-0536.2010.01854.x	10	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0217192	10.1371/journal.pone.0217192	http://dx.doi.org/10.1371/journal.pone.0217192			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945067	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100002
J	Arevian, AC; Bone, D; Malandrakis, N; Martinez, VR; Wells, KB; Miklowitz, DJ; Narayanan, S				Arevian, Armen C.; Bone, Daniel; Malandrakis, Nikolaos; Martinez, Victor R.; Wells, Kenneth B.; Miklowitz, David J.; Narayanan, Shrikanth			Clinical state tracking in serious mental illness through computational analysis of speech	PLOS ONE			English	Article							DEPRESSION SEVERITY; SCHIZOPHRENIA; DISORDER; VARIABILITY; RELIABILITY; COMPLEXITY; BIOMARKERS; DISEASE; MARKERS	Individuals with serious mental illness experience changes in their clinical states over time that are difficult to assess and that result in increased disease burden and care utilization. It is not known if features derived from speech can serve as a transdiagnostic marker of these clinical states. This study evaluates the feasibility of collecting speech samples from people with serious mental illness and explores the potential utility for tracking changes in clinical state over time. Patients (n = 47) were recruited from a community-based mental health clinic with diagnoses of bipolar disorder, major depressive disorder, schizophrenia or schizoaffective disorder. Patients used an interactive voice response system for at least 4 months to provide speech samples. Clinic providers (n = 13) reviewed responses and provided global assessment ratings. We computed features of speech and used machine learning to create models of outcome measures trained using either population data or an individual's own data over time. The system was feasible to use, recording 1101 phone calls and 117 hours of speech. Most (92%) of the patients agreed that it was easy to use. The individually-trained models demonstrated the highest correlation with provider ratings (rho = 0.78, p<0.001). Population-level models demonstrated statistically significant correlations with provider global assessment ratings (rho = 0.44, p<0.001), future provider ratings (rho = 0.33, p<0.05), BASIS-24 summary score, depression sub score, and self-harm sub score (rho = 0.25,0.25, and 0.28 respectively; p<0.05), and the SF-12 mental health sub score (rho = 0.25, p<0.05), but not with other BASIS-24 or SF-12 sub scores. This study brings together longitudinal collection of objective behavioral markers along with a transdiagnostic, personalized approach for tracking of mental health clinical state in a community-based clinical setting.	[Arevian, Armen C.; Wells, Kenneth B.; Miklowitz, David J.] Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Bone, Daniel; Malandrakis, Nikolaos; Martinez, Victor R.; Narayanan, Shrikanth] Univ Southern Calif, Signal Anal & Interpretat Lab, Los Angeles, CA USA; [Wells, Kenneth B.] RAND Corp, Santa Monica, CA USA	University of California System; University of California Los Angeles; University of Southern California; RAND Corporation	Arevian, AC (corresponding author), Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	aarevian@mednet.ucla.edu	Miklowitz, David/AAE-3065-2022		NIMH [R01MH093676-02S1, R34MH117200, R21/R33MH097007, P30 MH082760-05S1]; California State Center of Excellence for Behavioral Health [SB 852]; NSF [CCF 1029373]; NIAA [R01AA018673]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California State Center of Excellence for Behavioral Health; NSF(National Science Foundation (NSF)); NIAA	AA, KW supported by NIMH P30 MH082760-05S1 and California State Center of Excellence for Behavioral Health SB 852. AA and DM supported by NIMH R01MH093676-02S1 and R34MH117200. DM supported by R21/R33MH097007. DB, NM, VM, SN supported by NSF CCF 1029373 and NIAA R01AA018673. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank: the patients and staff at the R.O.A.D.S. Foundation clinic where this study was conducted for their support; Joseph Mango, Catherine Wilkerson, Jennifer O'Hora for administrative support for the study; Chris German, Chi-Hong Tseng, Xinkai Zhou, and Sitaram Vangala for assistance in data analysis; and Bonnie Zima for her helpful comments on the manuscript.	[Anonymous], 1967, WRIGHT PATTERSON AIR; Arevian AC, 2018, ETHNICITY DIS, V24; Bedi G, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.30; Boersma Paul, 2006, PRAAT DOING PHONETIC; Bojanowski Piotr, 2017, T ASSOC COMPUT LING, V5, P135, DOI 10.1162/tacl_a_00051; Bone D, 2014, J SPEECH LANG HEAR R, V57, P1162, DOI 10.1044/2014_JSLHR-S-13-0062; Burns A, 2004, J NEUROL NEUROSUR PS, V75, P362, DOI 10.1136/jnnp.2003.023366; Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834; Chen Y, 2006, CURR PSYCHIATRY REV, V2, P431, DOI 10.2174/157340006778699729; Cohen AS, 2014, CURR OPIN PSYCHIATR, V27, P203, DOI 10.1097/YCO.0000000000000056; Cohn MA, 2004, PSYCHOL SCI, V15, P687, DOI 10.1111/j.0956-7976.2004.00741.x; Cummins N, 2015, SPEECH COMMUN, V75, P27, DOI 10.1016/j.specom.2015.09.003; Cummins N, 2015, SPEECH COMMUN, V71, P10, DOI 10.1016/j.specom.2015.03.004; Cummins N, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P3008; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Davis J, 2015, MOL PSYCHIATR, V20, P152, DOI 10.1038/mp.2014.139; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Eisen SV, 2006, J BEHAV HEALTH SER R, V33, P304, DOI 10.1007/s11414-006-9025-3; Elvevag B, 2007, SCHIZOPHR RES, V93, P304, DOI 10.1016/j.schres.2007.03.001; Elvevag B, 2016, AM J MED GENET B, V171, P904, DOI 10.1002/ajmg.b.32438; Emsley R, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-50; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Faurholt-Jepsen M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.123; Fears SC, 2014, JAMA PSYCHIAT, V71, P375, DOI 10.1001/jamapsychiatry.2013.4100; Fraser KC, 2019, COMPUT SPEECH LANG, V53, P121, DOI 10.1016/j.csl.2018.07.005; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; GOTTSCHALK A, 1995, ARCH GEN PSYCHIAT, V52, P947; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Harrison Y, 1997, SLEEP, V20, P871, DOI 10.1093/sleep/20.10.871; Hashim NW, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2016.06.006; Hedden S.L., 2015, HHS PUBLICATION; Holt TA, 2004, COMPLEXITY CLIN; Karam Z. N., 2014, INT CONF ACOUST SPEE, DOI 10.1109/ICASSP.2014.6854525; Kincaid J Peter, 1975, TECHNICAL REPORT; Lanata A, 2015, IEEE J BIOMED HEALTH, V19, P132, DOI 10.1109/JBHI.2014.2360711; Liu G-D, 2019, BRIEF REV ARTIFICIAL; Malandrakis N., 2015, 16 ANN C INT SPEECH; McInnes N, 2011, INFORM HEALTH SOC CA, V36, P173, DOI 10.3109/17538157.2010.542529; MCLAUGHLIN GH, 1969, J READING, V12, P639; Medicare Cf Services M, 2019, DUAL ELIGIBLE BENEFI; Muaremi A, 2014, INT S PERV COMP PAR; Mundt JC, 2007, J NEUROLINGUIST, V20, P50, DOI 10.1016/j.jneuroling.2006.04.001; Mundt JC, 2012, BIOL PSYCHIAT, V72, P580, DOI 10.1016/j.biopsych.2012.03.015; Musliner KL, 2016, JAMA PSYCHIAT, V73, P346, DOI 10.1001/jamapsychiatry.2015.3365; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Paulus MP, 2003, BIOL PSYCHIAT, V53, P3, DOI 10.1016/S0006-3223(02)01701-8; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Prechter HCBRP, PRIORI LONG VOIC PAT; Ringeval F, 2018, P 2018 AUD VIS EM CH; Rude SS, 2004, COGNITION EMOTION, V18, P1121, DOI 10.1080/02699930441000030; Schuller B. W., 1988, EMOTION AFFECT PERSO; Smith GN, 2011, PSYCHIAT SERV, V62, P411, DOI 10.1176/ps.62.4.pss6204_0411; Soderberg P, 2005, PSYCHIAT SERV, V56, P434, DOI 10.1176/appi.ps.56.4.434; Stange JP, 2018, BIPOLAR DISORD, V20, P285, DOI 10.1111/bdi.12637; Sugar CA, 1998, HEALTH SERV RES, V33, P911; Tamminga C, 2005, PHENOTYPE SCHIZOPHRE; Tamminga CA, 2005, MOL PSYCHIATR, V10, P27, DOI 10.1038/sj.mp.4001563; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Torous J, 2016, JAMA PSYCHIAT, V73, P3, DOI 10.1001/jamapsychiatry.2015.2622; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; Xiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143055; Zhao J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5692	62	19	19	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0225695	10.1371/journal.pone.0225695	http://dx.doi.org/10.1371/journal.pone.0225695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940347	Green Published, gold			2022-12-26	WOS:000534368000009
J	Hsu, CL; Chhiba, KD; Krier-Burris, R; Hosakoppal, S; Berdnikovs, S; Miller, ML; Bryce, PJ				Hsu, Chia-Lin; Chhiba, Krishan D.; Krier-Burris, Rebecca; Hosakoppal, Shweta; Berdnikovs, Sergejs; Miller, Mendy L.; Bryce, Paul J.			Allergic inflammation is initiated by IL-33-dependent crosstalk between mast cells and basophils	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; LUNG INFLAMMATION; IL-33 EXPRESSION; T-CELL; RECRUITMENT; CYTOKINE; RECEPTOR; GAMMA; ST2; ASTHMA	IgE-primed mast cells in peripheral tissues, including the skin, lung, and intestine, are key initiators of allergen-triggered edema and inflammation. Particularly in severe forms of allergy, this inflammation becomes strongly neutrophil dominated, and yet how mast cells coordinate this type of response is unknown. We and others have reported that activated mast cells-a hematopoietic cell type-can produce IL-33, a cytokine known to participate in allergic responses but generally considered as being of epithelial origin and driving Type 2 immune responses (e.g., ILC2 and eosinophil activation). Using models of skin anaphylaxis, our data reveal that mast cell-derived IL-33 also initiates neutrophilic inflammation. We demonstrate a cellular crosstalk mechanism whereby activated mast cells crosstalk to IL-33 receptor-bearing basophils, driving these basophils to adopt a unique response signature rich in neutrophil-associated molecules. We further establish that basophil expression of CXCL1 is necessary for IgE-driven neutrophilic inflammation. Our findings thus unearth a new mechanism by which mast cells initiate local inflammation after antigen triggering and might explain the complex inflammatory phenotypes observed in severe allergic diseases. Moreover, our findings (i) establish a functional link from IL-33 to neutrophilic inflammation that extends IL-33-mediated biology well beyond that of Type 2 immunity, and (ii) demonstrate the functional importance of hematopoietic cell-derived IL-33 in allergic pathogenesis.	[Hsu, Chia-Lin; Chhiba, Krishan D.; Krier-Burris, Rebecca; Hosakoppal, Shweta; Berdnikovs, Sergejs; Miller, Mendy L.; Bryce, Paul J.] Northwestern Univ, Dept Med, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA; [Bryce, Paul J.] Sanofi US, Immunol & Inflammat Therapeut Area, Cambridge, MA 02139 USA	Northwestern University; Feinberg School of Medicine; Sanofi-Aventis	Bryce, PJ (corresponding author), Northwestern Univ, Dept Med, Div Allergy Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.; Bryce, PJ (corresponding author), Sanofi US, Immunol & Inflammat Therapeut Area, Cambridge, MA 02139 USA.	paul.bryce@sanofi.com		Krier-Burris, Rebecca/0000-0001-9722-215X	US National Institutes of Health [R01AI105839, 2R01AI076456, R56AI092136]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US National Institutes of Health (R01AI105839, 2R01AI076456 and R56AI092136 to P.J.B.).	Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Baumann C, 2015, P NATL ACAD SCI USA, V112, P4056, DOI 10.1073/pnas.1418549112; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Caproni M, 2005, CLIN IMMUNOL, V114, P284, DOI 10.1016/j.clim.2004.10.007; Cayrol C, 2014, CURR OPIN IMMUNOL, V31, P31, DOI 10.1016/j.coi.2014.09.004; Chhiba KD, 2017, J IMMUNOL, V198, P4868, DOI 10.4049/jimmunol.1601825; Chiba N, 2015, J IMMUNOL, V194, P3840, DOI 10.4049/jimmunol.1402685; Cho KA, 2012, AM J PHYSIOL-LUNG C, V302, pL429, DOI 10.1152/ajplung.00252.2011; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Enoksson M, 2013, BLOOD, V121, P530, DOI 10.1182/blood-2012-05-434209; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Ganeshan K, 2013, J IMMUNOL, V190, P5731, DOI 10.4049/jimmunol.1203362; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Han GW, 2011, CLIN RHEUMATOL, V30, P1583, DOI 10.1007/s10067-011-1843-x; Han H, 2018, MUCOSAL IMMUNOL, V11, P394, DOI 10.1038/mi.2017.61; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hardman CS, 2013, EUR J IMMUNOL, V43, P488, DOI 10.1002/eji.201242863; Hsu CL, 2012, J IMMUNOL, V189, P3421, DOI 10.4049/jimmunol.1201224; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Imai Y, 2013, P NATL ACAD SCI USA, V110, P13921, DOI 10.1073/pnas.1307321110; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; Jin GH, 2012, J DERMATOL SCI, V67, P181, DOI 10.1016/j.jdermsci.2012.06.005; Jin LL, 2014, J IMMUNOL, V193, P3549, DOI 10.4049/jimmunol.1401138; Johnston LK, 2014, J IMMUNOL, V192, P2529, DOI 10.4049/jimmunol.1303026; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Marichal T, 2013, CANCER IMMUNOL RES, V1, P269, DOI 10.1158/2326-6066.CIR-13-0119; Meephansan J, 2012, J INVEST DERMATOL, V132, P2593, DOI 10.1038/jid.2012.185; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Roussel L, 2013, J ALLERGY CLIN IMMUN, V131, P913, DOI 10.1016/j.jaci.2012.10.019; Saglani S, 2013, J ALLERGY CLIN IMMUN, V132, P676, DOI 10.1016/j.jaci.2013.04.012; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider E, 2009, J IMMUNOL, V183, P3591, DOI 10.4049/jimmunol.0900328; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Tashiro H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157571; Tjota MY, 2014, J ALLERGY CLIN IMMUN, V134, P706, DOI 10.1016/j.jaci.2014.06.013; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Venturelli N, 2016, J ALLERGY CLIN IMMUN, V138, P1367, DOI 10.1016/j.jaci.2016.02.034; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Vukman KV., 2014, BIOPROTOC, V4, pe1053; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Xue LZ, 2014, J ALLERGY CLIN IMMUN, V133, P1184, DOI 10.1016/j.jaci.2013.10.056; Zhao WH, 2012, CYTOKINE, V58, P267, DOI 10.1016/j.cyto.2012.01.019	62	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226701	10.1371/journal.pone.0226701	http://dx.doi.org/10.1371/journal.pone.0226701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940364	Green Published, gold			2022-12-26	WOS:000534368000036
J	Yang, WL; Chi, YJ; Meng, YH; Chen, ZZ; Xiang, R; Yan, H; Yang, JC				Yang, Weili; Chi, Yujing; Meng, Yuhong; Chen, Zhenzhen; Xiang, Rui; Yan, Han; Yang, Jichun			FAM3A plays crucial roles in controlling PDX1 and insulin expressions in pancreatic beta cells	FASEB JOURNAL			English	Article						FAM3A; FOXA2; mitochondria; pancreatic beta cells; PDX1	MITOCHONDRIAL DYSFUNCTION; HEPATIC GLUCONEOGENESIS; FOXA2; GENE; SECRETION; DIFFERENTIATION; TRANSCRIPTION; MAFA; ATP; PROLIFERATION	So far, the mechanism that links mitochondrial dysfunction to PDX1 inhibition in the pathogenesis of pancreatic beta cell dysfunction under diabetic condition remains largely unclear. This study determined the role of mitochondrial protein FAM3A in regulating PDX1 expression in pancreatic beta cells using gain- and loss-of function methods in vitro and in vivo. Within pancreas, FAM3A is highly expressed in beta, alpha, delta, and pp cells of islets. Islet FAM3A expression was correlated with insulin expression under physiological and diabetic conditions. Mice with specific knockout of FAM3A in islet beta cells exhibited markedly blunted insulin secretion and glucose intolerance. FAM3A-deficient islets showed significant decrease in PDX1 expression, and insulin expression and secretion. FAM3A overexpression upregulated PDX1 and insulin expressions, and augmented insulin secretion in cultured islets and beta cells. Mechanistically, FAM3A enhanced ATP production to elevate cellular Ca2+ level and promote insulin secretion. Furthermore, FAM3A-induced ATP release activated CaM to function as a co-activator of FOXA2, stimulating PDX1 gene transcription. In conclusion, FAM3A plays crucial roles in controlling PDX1 and insulin expressions in pancreatic beta cells. Inhibition of FAM3A will trigger mitochondrial dysfunction to repress PDX1 and insulin expressions.	[Yang, Weili; Meng, Yuhong; Xiang, Rui; Yan, Han; Yang, Jichun] Peking Univ, Sch Basic Med Sci, Ctr Noncoding RNA Med,Dept Physiol & Pathophysiol, Hlth Sci Ctr,Key Lab Mol Cardiovasc Sci,Minist Ed, Beijing, Peoples R China; [Yang, Weili] Capital Med Univ, Beijing Tongren Hosp, Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China; [Chi, Yujing] Peking Univ, Peoples Hosp, Dept Cent Lab, Beijing, Peoples R China; [Chi, Yujing] Peking Univ, Peoples Hosp, Inst Clin Mol Biol, Beijing, Peoples R China; [Chen, Zhenzhen] Chinese Acad Med Sci & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Hypertens Ctr, Fuwai Hosp,State Key Lab Cardiovasc Dis, Beijing, Peoples R China	Peking University; Capital Medical University; Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Yang, JC (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Hlth Sci Ctr, Beijing 100191, Peoples R China.	yangj@bjmu.edu.cn		Chen, Zhenzhen/0000-0001-9919-3997; Xiang, Rui/0000-0002-1473-3235	National Key Research Program of China [2016YFC0903000/2017YFC0909600]; National Natural Science Foundation of China [81670748, 81471035, 81870551, 81670787]; Beijing Natural Science Foundation [7171006]; State Key Laboratory of Cardiovascular Disease Grant [2018fk-02]; Innovative Fund for Doctoral Students [89100226570405007]	National Key Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); State Key Laboratory of Cardiovascular Disease Grant; Innovative Fund for Doctoral Students	National Key Research Program of China, Grant/Award Number: 2016YFC0903000/2017YFC0909600; National Natural Science Foundation of China, Grant/Award Number: 81670748, 81471035, 81870551 and 81670787; Beijing Natural Science Foundation, Grant/Award Number: 7171006; State Key Laboratory of Cardiovascular Disease Grant, Grant/Award Number: 2018fk-02; Innovative Fund for Doctoral Students, Grant/Award Number: 89100226570405007	Abdul-Ghani MA, 2008, AM J PHYSIOL-ENDOC M, V295, pE678, DOI 10.1152/ajpendo.90287.2008; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Arnes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052026; Bastidas-Ponce A, 2017, MOL METAB, V6, P524, DOI 10.1016/j.molmet.2017.03.007; Bonnavion R, 2017, J PATHOL, V242, P90, DOI 10.1002/path.4885; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Cantley J, 2019, DIABETOLOGIA, V62, P99, DOI 10.1007/s00125-018-4743-7; Carobbio S, 2009, J BIOL CHEM, V284, P921, DOI 10.1074/jbc.M806295200; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chen ACH, 2017, CELL TISSUE RES, V368, P563, DOI 10.1007/s00441-017-2583-2; Chen ZZ, 2017, ONCOTARGET, V8, P49882, DOI 10.18632/oncotarget.17805; Chi YJ, 2017, ONCOTARGET, V8, P45862, DOI 10.18632/oncotarget.17578; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Choudhury AI, 2005, J CLIN INVEST, V115, P940; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Fogarty MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004633; Pacheco PAF, 2013, CURR DIABETES REV, V9, P228, DOI 10.2174/1573399811309030004; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gao N, 2010, MOL ENDOCRINOL, V24, P1594, DOI 10.1210/me.2009-0513; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Han SI, 2016, ACTA DIABETOL, V53, P651, DOI 10.1007/s00592-016-0853-1; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hoang M, 2019, ENDOCRINOLOGY, V160, P2825, DOI 10.1210/en.2018-00936; Hou WF, 1998, ANTISENSE NUCLEIC A, V8, P295, DOI 10.1089/oli.1.1998.8.295; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Jang I, 2019, ELIFE, V8, DOI 10.7554/eLife.44528; Jia S, 2014, J MOL CELL CARDIOL, V74, P173, DOI 10.1016/j.yjmcc.2014.05.011; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Kaviani M, 2016, CELL BIOL INT, V40, P1248, DOI 10.1002/cbin.10691; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Li XM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11740; Millership SJ, 2018, J CLIN INVEST, V128, P3369, DOI 10.1172/JCI120115; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ni QC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15755; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Osman MAA, 2019, J CELL MOL MED, V23, P4653, DOI 10.1111/jcmm.14216; Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qin Y, 2015, GENET MOL RES, V14, P8892, DOI 10.4238/2015.August.3.12; Richards-Williams C, 2008, PURINERG SIGNAL, V4, P393, DOI 10.1007/s11302-008-9126-y; Robert-Cooperman CE, 2010, DIABETES, V59, P2209, DOI 10.2337/db09-1552; Sargsyan E, 2016, BBA-MOL CELL BIOL L, V1861, P1151, DOI 10.1016/j.bbalip.2016.06.012; Song Q, 2016, NEUROCHEM INT, V94, P82, DOI 10.1016/j.neuint.2016.02.010; Song Q, 2015, CELL PHYSIOL BIOCHEM, V37, P1431, DOI 10.1159/000438512; Tamura Y, 2007, DIABETOLOGIA, V50, P131, DOI 10.1007/s00125-006-0467-1; Taylor R, 2013, DIABETIC MED, V30, P267, DOI 10.1111/dme.12039; Wang CJ, 2014, HEPATOLOGY, V59, P1779, DOI 10.1002/hep.26945; Wang CJ, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/515136; Wang HY, 2002, J BIOL CHEM, V277, P17564, DOI 10.1074/jbc.M111037200; Wang JP, 2018, DIABETES, V67, P581, DOI 10.2337/db17-0799; Wang YQ, 2019, DIABETES, V68, P1950, DOI 10.2337/db19-0166; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wu L, 2004, J BIOL CHEM, V279, P12126, DOI 10.1074/jbc.M307097200; Yang JC, 2004, J BIOL CHEM, V279, P53915, DOI 10.1074/jbc.M405309200; Yang JC, 2010, NUTR REV, V68, P270, DOI 10.1111/j.1753-4887.2010.00282.x; Yang JC, 2009, FEBS LETT, V583, P3009, DOI 10.1016/j.febslet.2009.08.008; Yang WL, 2017, DIABETES, V66, P1819, DOI 10.2337/db16-1172; Yang Z, 2011, ARCH MED SCI, V7, P665, DOI 10.5114/aoms.2011.24137; Yu X, 2018, MOL MED REP, V17, P7931, DOI 10.3892/mmr.2018.8813; Zhang XY, 2018, METABOLISM, V81, P71, DOI 10.1016/j.metabol.2017.12.001; Zhang Y, 2012, GASTROENTEROLOGY, V142, P1571, DOI 10.1053/j.gastro.2012.02.043; Zhou YL, 2013, BBA-GEN SUBJECTS, V1830, P4160, DOI 10.1016/j.bbagen.2013.03.029; Zhu Y, 2002, GENOMICS, V80, P144, DOI 10.1006/geno.2002.6816; Zhu YX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0694-z	70	5	5	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3915	3931		10.1096/fj.201902368RR	http://dx.doi.org/10.1096/fj.201902368RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944392	hybrid			2022-12-26	WOS:000507593700001
J	Rahman, MM; Zhang, C; Swe, KT; Rahman, MS; Islam, MR; Kamrujjaman, M; Sultana, P; Hassan, MZ; Alam, MS; Rahman, MM				Rahman, Md. Mahfuzur; Zhang, Cherri; Swe, Khin Thet; Rahman, Md. Shafiur; Islam, Md. Rashedul; Kamrujjaman, Md.; Sultana, Papia; Hassan, Md. Zakiul; Alam, Md. Shahinul; Rahman, Md. Mizanur			Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis	PLOS ONE			English	Article							PAYMENTS; COVERAGE; SEEKING; TRENDS	Background Because of the rapid increase of non-communicable diseases (NCDs) and high burden of healthcare-related financial issues in Bangladesh, there is a concern that out-of-pocket (OOP) payments related to illnesses may become a major burden on household. It is crucial to understand what are the major illnesses responsible for high OPP at the household level to help policymakers prioritize key areas of actions to protect the household from 100% financial hardship for seeking health care as part of universal health coverage. Objectives We first estimated the costs of illnesses among a population in urban Bangladesh, and then assessed the household financial burden associated with these illnesses. Method A cross-sectional survey of 1593 randomly selected households was carried out in Bangladesh (urban area of Rajshahi city), in 2011. Catastrophic expenditure was estimated at 40% threshold of household capacity to pay. We employed the Bayesian two-stage hurdle model and Bayesian logistic regression model to estimate age-adjusted average cost and the incidence of household financial catastrophe for each illness, respectively. Results Overall, approximately 45% of the population of Bangladesh had at least one episode of illness. The age-sex-adjusted average medical expenses and catastrophic health care expenditure among the households were TK 621 and 8%, respectively. Households spent the highest amount of money 7676.9 on paralysis followed by liver disease (TK 2695.4), injury (TK 2440.0), mental disease (TK 2258.0), and tumor (TK 2231.2). These diseases were also responsible for higher incidence of financial catastrophe. Our study showed that 24% of individuals who suffered typhoid incurred catastrophic expenditure followed by liver disease (12.3%), tumor (12.1%), heart disease (8.4%), injury (7.9%), mental disease (7.9%), cataract (7.1%), and paralysis (6.5%). Conclusion The study findings suggest that chronic illnesses were responsible for high costs and high catastrophic expenditures in Bangladesh. Effective risk pooling mechanism might reduce household financial burden related to illnesses. Chronic illness related to NCDs is the major cause of OOP. It is also important to consider prioritizing vulnerable population by subsidizing the high health care cost for some of the chronic illnesses.	[Rahman, Md. Mahfuzur; Zhang, Cherri; Rahman, Md. Shafiur; Islam, Md. Rashedul; Rahman, Md. Mizanur] Global Publ Hlth Res Fdn, Dhaka, Bangladesh; [Swe, Khin Thet; Rahman, Md. Shafiur; Islam, Md. Rashedul; Rahman, Md. Mizanur] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Kamrujjaman, Md.] Univ Dhaka, Dept Math, Dhaka, Bangladesh; [Sultana, Papia] Univ Rajshahi, Dept Stat, Rajshahi, Bangladesh; [Hassan, Md. Zakiul] Icddr b, Dhaka, Bangladesh; [Alam, Md. Shahinul] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh	University of Tokyo; University of Dhaka; University of Rajshahi; International Centre for Diarrhoeal Disease Research (ICDDR); Bangabandhu Sheikh Mujib Medical University (BSMMU)	Rahman, MM (corresponding author), Global Publ Hlth Res Fdn, Dhaka, Bangladesh.	mahfuz@gphrf.org	Sultana, Papia/GRS-6420-2022; Kamrujjaman/ABE-7558-2021; Islam, Rashedul/AAO-1177-2020	Kamrujjaman/0000-0002-4892-745X; Islam, Rashedul/0000-0003-3568-0870; Sultana, Papia/0000-0002-5917-238X; Rahman, Md. Mahfuzur/0000-0003-1018-8732; Alam, Shahinul/0000-0001-8053-0738; Zhang, Cherri/0000-0001-7059-4922				Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Hamid SA, 2011, J RISK INSUR, V78, P57, DOI 10.1111/j.1539-6975.2010.01402.x; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Ir P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010930; Joarder T, 2019, ADV PUBLIC HLTH, V2019; Kastor A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196106; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Ministry of Health and Family Welfare, 2018, BANGL NAT HLTH ACC 1; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; Pandey A, 2018, B WORLD HEALTH ORGAN, V96, P18, DOI 10.2471/BLT.17.191759; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; Rahman MS, 2018, LANCET GLOB HEALTH, V6, pE84, DOI 10.1016/s2214-109x(17)30413-8; Ruger JP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001294; Sarker AR, 2018, GLOB HEALTH RES POL, V3, DOI 10.1186/s41256-017-0056-5; Sarker AR, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-518; Smith R, 2012, SCIENCE, V337, P1501, DOI 10.1126/science.1222569; Steinhardt LC, 2009, HEALTH POLICY PLANN, V24, P1, DOI 10.1093/heapol/czn043; Swe KT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194564; Trogdon JG, 2008, HEALTH SERV RES, V43, P1442, DOI 10.1111/j.1475-6773.2007.00827.x; Xu K., 2005, DISTRIBUTION HLTH PA	24	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227565	10.1371/journal.pone.0227565	http://dx.doi.org/10.1371/journal.pone.0227565			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935266	Green Published, gold			2022-12-26	WOS:000534354100031
J	Romagnoli, CL; Pellegrino, KCM; Silva, NM; Brianesi, UA; Leao, SC; Rabello, MCD; Viana-Niero, C				Romagnoli, Camila Lopes; Machado Pellegrino, Katia Cristina; Silva, Natalia Maria; Brianesi, Urze Adomaitis; Leao, Sylvia Cardoso; da Silva Rabello, Michelle Christiane; Viana-Niero, Cristina			Diversity of Mycobacteriaceae from aquatic environment at the Sao Paulo Zoological Park Foundation in Brazil	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SP NOV.; GENUS MYCOBACTERIUM; SEQUENCE-ANALYSIS; WATER-TREATMENT; IDENTIFICATION; HSP65; CONFIDENCE; PHYLOGENY; NEOAURUM	We investigated the species diversity of Mycobacteriaceae in surface water samples from six environments at the zoological park in Sao Paulo, Brazil. Three hundred and eighty isolates were cultivated and identified by phenotypic characteristics (growth rate and pigmentation) and sequencing of hsp65, rpoB and 16S rRNA genes. The results revealed that almost 48% of the isolates could be identified at the species level; about 50% were classified at the genus level, and only less than 2% of the isolates showed an inconclusive identification. The isolates classified at the genus level and not identified were then evaluated by phylogenetic analyses using the same three concatenated target genes. The results allowed us to identify at the genus level some isolates that previously had inconclusive identification, and they also suggested the presence of putative candidate species within the sample, demonstrating that this zoological park is an important source of diversity.	[Romagnoli, Camila Lopes; Silva, Natalia Maria; Brianesi, Urze Adomaitis; Leao, Sylvia Cardoso; Viana-Niero, Cristina] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, SP, Brazil; [Machado Pellegrino, Katia Cristina] Univ Fed Sao Paulo, Dept Ecol & Biol Evolut, Diadema, SP, Brazil; [da Silva Rabello, Michelle Christiane] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Dept Imunol, Recife, PE, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz	Viana-Niero, C (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, SP, Brazil.	cristina.viana@unifesp.br	Leao, Sylvia/F-4431-2012	Leao, Sylvia/0000-0003-2083-0119	Sao Paulo Research Foundation (FAPESP) [CVN 2010/52641-1, UAB 2011/13140-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CVN 2010/52641-1 from the Sao Paulo Research Foundation (FAPESP). NMS and CLR were supported by fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001". UAB 2011/13140-0 Sao Paulo Research Foundation (FAPESP).	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Adekambi T, 2004, INT J SYST EVOL MICR, V54, P2095, DOI 10.1099/ijs.0.63094-0; Amha YM, 2017, ENVIRON SCI TECHNOL, V51, P3048, DOI 10.1021/acs.est.6b05580; Amrane S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49189-8; Ben Salah I, 2009, INT J SYST EVOL MICR, V59, P2803, DOI 10.1099/ijs.0.010637-0; Bicudo D.C., 2002, PARQUE ESTADUAL FONT; Brown-Elliott BA, 2010, J CLIN MICROBIOL, V48, P4377, DOI 10.1128/JCM.00853-10; Carvalho M do C, 2013, MANUAL CIANOBACTERIA; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Falkinham JO, 2015, CLIN CHEST MED, V36, P35, DOI 10.1016/j.ccm.2014.10.003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gentil Regina Célia, 2008, Hoehnea, V35, P265; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gupta RS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00067; Haig SJ, 2018, MBIO, V9, DOI [10.1128/mbio.02354-17, 10.1128/mBio.02354-17]; HEITKAMP MA, 1988, APPL ENVIRON MICROB, V54, P1612, DOI 10.1128/AEM.54.6.1612-1614.1988; HEITKAMP MA, 1988, APPL ENVIRON MICROB, V54, P2549, DOI 10.1128/AEM.54.10.2549-2555.1988; Hennessee CT, 2009, INT J SYST EVOL MICR, V59, P378, DOI 10.1099/ijs.0.65827-0; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051846; Kim SJ, 2015, APPL ENVIRON MICROB, V81, P4263, DOI 10.1128/AEM.00730-15; Kormas KA, 2010, ENVIRON MONIT ASSESS, V165, P27, DOI 10.1007/s10661-009-0924-7; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]; LEAO S. C, 2004, PRACTICAL HDB PHENOT; Lima JD, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0734-3; Makovcova J, 2015, ANTON LEEUW INT J G, V107, P1165, DOI 10.1007/s10482-015-0408-4; Makovcova J, 2014, J WATER HEALTH, V12, P254, DOI 10.2166/wh.2013.102; McNabb A, 2004, J CLIN MICROBIOL, V42, P3000, DOI 10.1128/JCM.42.7.3000-3011.2004; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Nogueira CL, 2015, INT J SYST EVOL MICR, V65, P4403, DOI 10.1099/ijsem.0.000590; Nogueira CL, 2015, INT J SYST EVOL MICR, V65, P2148, DOI 10.1099/ijs.0.000234; Oren A, 2018, INT J SYST EVOL MICR, V68, P3951, DOI 10.1099/ijsem.0.003063; Peng RH, 2014, METAB ENG, V26, P100, DOI 10.1016/j.ymben.2014.09.005; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Radomski N, 2010, APPL ENVIRON MICROB, V76, P3514, DOI 10.1128/AEM.02659-09; Rambaut A., 2007, TRACER V1 4; Rice E.W., 2012, STANDARD METHODS EXA; Rodriguez-Garcia A, 2016, J BIOTECHNOL, V224, P64, DOI 10.1016/j.jbiotec.2016.03.021; Roguet A, 2016, ANTON LEEUW INT J G, V109, P619, DOI 10.1007/s10482-016-0665-x; Sant'Anna C, 2012, I BOT NUCL PESQUI FI, V175, DOI [10.13140/2.1.4417.1208, DOI 10.13140/2.1.4417.1208]; Selvaraju SB, 2005, MOL CELL PROBE, V19, P93, DOI 10.1016/j.mcp.2004.09.007; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Stout LM, 2009, FEMS MICROBIOL ECOL, V70, P402, DOI 10.1111/j.1574-6941.2009.00780.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Teniola OD, 2005, INT J FOOD MICROBIOL, V105, P111, DOI 10.1016/j.ijfoodmicro.2005.05.004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tortoli E, 2017, INFECT GENET EVOL, V56, P19, DOI 10.1016/j.meegid.2017.10.013; Torvinen E, 2004, APPL ENVIRON MICROB, V70, P1973, DOI 10.1128/AEM.70.4.1973-1981.2004; Torvinen E, 2007, APPL ENVIRON MICROB, V73, P6201, DOI 10.1128/AEM.00828-07; van der Wielen PWJJ, 2013, APPL ENVIRON MICROB, V79, P6160, DOI 10.1128/AEM.01591-13; Wee WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152682; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	58	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227759	10.1371/journal.pone.0227759	http://dx.doi.org/10.1371/journal.pone.0227759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935265	gold, Green Published			2022-12-26	WOS:000534354100050
J	Snell, KRS; Jensen, RBE; Ortvad, TE; Willemoes, M; Thorup, K				Snell, Katherine R. S.; Jensen, Rie B. E.; Ortvad, Troels E.; Willemoes, Mikkel; Thorup, Kasper			Multiple fragmented habitat-patch use in an urban breeding passerine, the Short-toed Treecreeper	PLOS ONE			English	Article							GAP-CROSSING DECISIONS; RANGE SIZE; BIRDS; DISPERSAL; URBANIZATION; ENVIRONMENT; POPULATION; DIVERSITY; SONGBIRDS; BEHAVIOR	Individual responses of wild birds to fragmented habitat have rarely been studied, despite large-scale habitat fragmentation and biodiversity loss resulting from widespread urbanisation. We investigated the spatial ecology of the Short-toed Treecreeper Certhia brachydactyla, a tiny, resident, woodland passerine that has recently colonised city parks at the northern extent of its range. High resolution spatiotemporal movements of this obligate treeliving species were determined using radio telemetry within the urbanized matrix of city parks in Copenhagen, Denmark. We identified regular edge crossing behaviour, novel in woodland birds. While low numbers of individuals precluded a comprehensive characterisation of home range for this population, we were able to describe a consistent behaviour which has consequences for our understanding of animal movement in urban ecosystems. We report that treecreepers move freely, and apparently do so regularly, between isolated habitat patches. This behaviour is a possible driver of the range expansion in this species and may contribute to rapid dispersal capabilities in certain avian species, including Short-toed Treecreepers, into northern Europe. Alternatively, these behaviours might be common and/or provide an adaptive advantage for birds utilising matrix habitats, for example within urban ecosystems.	[Snell, Katherine R. S.; Jensen, Rie B. E.; Ortvad, Troels E.; Willemoes, Mikkel; Thorup, Kasper] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Copenhagen, Denmark	University of Copenhagen	Snell, KRS (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, Copenhagen, Denmark.	katherine.snell@snm.ku.dk	Snell, Katherine R S/B-9085-2015; Thorup, Kasper/A-4835-2013	Snell, Katherine R S/0000-0003-3720-4579; Thorup, Kasper/0000-0002-0320-0601	Danish Council for Independent Research [1323-00048B]; Danish National Research Foundation [DNRF96]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond)	The Danish Council for Independent Research supported the MATCH project (1323-00048B) and Danish National Research Foundation supported Center for Macroecology, Evolution and Climate (DNRF96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson SA, 2018, J AVIAN BIOL, V49, DOI 10.1111/jav.01555; Amlaner CJ, 2013, HDB BIOTELEMETRY RAD; Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Ausprey IJ, 2013, CONDOR, V115, P102, DOI 10.1525/cond.2013.110176; Baltensperger AP, 2013, POLAR BIOL, V36, P1587, DOI 10.1007/s00300-013-1376-7; BirdLife International, 2017, SPEC FACTSH CERTH BR; Bonlokke J., 2006, DANISH BIRD MIGRATIO; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CLAUSEN P, 1988, BRIT BIRDS, V81, P496; Clouet M, 2019, J ORNITHOL, V160, P27, DOI 10.1007/s10336-018-1605-5; Cox DTC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37669; Creegan HP, 2005, J APPL ECOL, V42, P678, DOI 10.1111/j.1365-2664.2005.01057.x; Crooks KR, 2001, CONSERV BIOL, V15, P159, DOI 10.1046/j.1523-1739.2001.99379.x; Davis R. A., 2013, Pacific Conservation Biology, V19, P110; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; del Hoyo J., 2008, HDB BIRDS WORLD; Delmore KE, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00003; Desrochers A, 1997, CONSERV BIOL, V11, P1204, DOI 10.1046/j.1523-1739.1997.96187.x; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Dybbro T., 2004, POLITIKENS STORE FUG; Eugster MJA, 2012, R J; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Ferenc M, 2014, URBAN ECOSYST, V17, P625, DOI 10.1007/s11252-013-0328-x; Fernandez-Juricic E, 2001, BIODIVERS CONSERV, V10, P2023, DOI 10.1023/A:1013133308987; Fernandez-Juricic E, 2000, CONSERV BIOL, V14, P513, DOI 10.1046/j.1523-1739.2000.98600.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Forman RTT, 2014, URBAN ECOLOGY: SCIENCE OF CITIES, P1; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Grell MB, 1998, FUGLENES DANMARK DAN; Gundersen Vegard, 2005, Urban Forestry & Urban Greening, V3, P189, DOI 10.1016/j.ufug.2005.03.001; HAAS CA, 1995, CONSERV BIOL, V9, P845, DOI 10.1046/j.1523-1739.1995.09040845.x; Hobson KA, 2019, TERR ECOL SER, V2, P1, DOI 10.1016/B978-0-12-814723-8.00001-5; Hodgson P, 2007, LANDSCAPE URBAN PLAN, V79, P266, DOI 10.1016/j.landurbplan.2006.02.012; Huntley B., 2007, CLIMATIC ATLAS EUROP; Jokimaki Jukka, 2000, Urban Ecosystems, V3, P21, DOI 10.1023/A:1009505418327; Kenward R.E., 2000, MANUAL WILDLIFE RADI; Ladin ZS, 2018, MOV ECOL, V6, DOI 10.1186/s40462-018-0132-6; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mannan RW, 2000, WILSON BULL, V112, P21, DOI 10.1676/0043-5643(2000)112[0021:HRCOMC]2.0.CO;2; Marzluff JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167829; Marzluff JM, 2017, IBIS, V159, P1, DOI 10.1111/ibi.12430; Matsuba M, 2016, URBAN FOR URBAN GREE, V18, P173, DOI 10.1016/j.ufug.2016.05.011; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Melles S, 2003, CONSERV ECOL, V7; Moore RP, 2008, ECOL LETT, V11, P960, DOI 10.1111/j.1461-0248.2008.01196.x; Morrison JL, 2016, URBAN ECOSYST, V19, P1373, DOI 10.1007/s11252-016-0554-0; OpenStreetMap contributors, 2017, PLAN DUMP 12 APR 201; Plummer KE, 2015, GLOBAL CHANGE BIOL, V21, P4353, DOI 10.1111/gcb.13070; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Rose E, 2006, IBIS, V148, P231, DOI 10.1111/j.1474-919x.2006.00499.x; Rutz C, 2006, ARDEA, V94, P185; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Scolozzi R, 2012, ENVIRON IMPACT ASSES, V36, P9, DOI 10.1016/j.eiar.2012.03.001; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sjoman H, 2012, URBAN FOR URBAN GREE, V11, P31, DOI 10.1016/j.ufug.2011.09.004; Strubbe D, 2011, IBIS, V153, P180, DOI 10.1111/j.1474-919X.2010.01074.x; Tremblay JA, 2017, J UNMANNED VEHICLE S, DOI [10.1139/juvs-2016-0019, DOI 10.1139/JUVS-2016-0019]; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Werner P, 2017, ADV 21ST CENT HUMAN, P131, DOI 10.1007/978-981-10-4113-6_7; Wilcove D.S., 1986, P237; Wildlife telemetry fr: SD Schemnitz, 1980, WILDLIFE MANAGEMENT, V4a, p5O7	65	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227731	10.1371/journal.pone.0227731	http://dx.doi.org/10.1371/journal.pone.0227731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935239	Green Published, gold, Green Submitted			2022-12-26	WOS:000534354100046
J	Wedekind, A; Rajan, G; Van Dun, B; Tavora-Vieira, D				Wedekind, Andre; Rajan, Gunesh; Van Dun, Bram; Tavora-Vieira, Dayse			Restoration of cortical symmetry and binaural function: Cortical auditory evoked responses in adult cochlear implant users with single sided deafness	PLOS ONE			English	Article							UNILATERAL DEAFNESS; HEARING-LOSS; POTENTIALS; CHILDREN; TINNITUS; RECOGNITION; DEPRIVATION; SENSITIVITY; PERCEPTION; OUTCOMES	Background Cochlear implantation for single-sided deafness (SSD) is the only treatment option with the potential to restore binaural hearing cues. Significant binaural benefit has been measured in adults by speech in noise and localisation tests, who receive a cochlear implant for SSD, however, little is known on the cortical changes that help provide this benefit. In the present study, detection of sound in the auditory cortex, speech testing and localisation was used to investigate the ability of a cochlear implant (CI) to restore auditory cortical latencies and improve binaural benefit in the adult SSD population. Methods Twenty-nine adults with acquired single-sided deafness who received a CI in adulthood were studied. Speech perception in noise was tested using the Bamford-Kowal-Bench speech-in-noise test, localisation ability was measured using the auditory speech sounds evaluation (AdE) localisation test and cortical auditory evoked responses, comparing N1-P2 latencies recorded from the normal hearing ear and cochlear implant were used to investigate the synchrony of the cortical pathway from the CI and normal hearing ear (NHe) with binaural hearing function. Results There was a significant improvement in speech perception in noise in all spatial configurations S0/N0 (Z =-3.066, p< 0.002), S0/NHE (Z =-4.031, p< 0.001), SCI/NHE (Z =-3.851, p< 0.001). Localization significantly improved when tested with the cochlear implant on (p< 0.001) with a shorter duration of deafness correlating to a greater improvement in localisation ability F(1:18) = 6.854; p = 0.017). There was no significant difference in N1-P2 latency recorded from the normal hearing ear and the CI. Conclusion Cortical auditory evoked response latencies recorded from the CI and NHe showed no significant difference, indicating that the detection of sound in the auditory cortex occurred simultaneously, providing the cortex with auditory information for binaural hearing.	[Wedekind, Andre; Rajan, Gunesh; Tavora-Vieira, Dayse] Univ Western Australia, Otolaryngol Head & Neck Surg, Sch Surg, Perth, WA, Australia; [Wedekind, Andre; Tavora-Vieira, Dayse] Fiona Stanley Hosp, Perth, WA, Australia; [Rajan, Gunesh] Luzerner Kantonsspital, Dept Otolaryngol Head & Neck Surg, Luzern, Switzerland; [Van Dun, Bram] Natl Acoust Labs, Sydney, NSW, Australia	University of Western Australia; Lucerne Cantonal Hospital; National Acoustic Laboratories	Wedekind, A (corresponding author), Univ Western Australia, Otolaryngol Head & Neck Surg, Sch Surg, Perth, WA, Australia.; Wedekind, A (corresponding author), Fiona Stanley Hosp, Perth, WA, Australia.	andre.wedekind@gmail.com		Tavora-Vieira, Dayse/0000-0001-6249-7268				Arndt S, 2017, HNO, V65, P98, DOI 10.1007/s00106-016-0297-5; Arndt S, 2011, OTOL NEUROTOL, V32, P39, DOI 10.1097/MAO.0b013e3181fcf271; Arsenault MD, 1999, J ACOUST SOC AM, V105, P1821, DOI 10.1121/1.426720; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; Blamey P, 1996, Audiol Neurootol, V1, P293; Boisvert I, 2012, NEUROREPORT, V23, P195, DOI 10.1097/WNR.0b013e32834fab4b; Boisvert I, 2011, EAR HEARING, V32, P758, DOI 10.1097/AUD.0b013e3182234c45; BRUGGE JF, 1988, HEARING RES, V34, P127, DOI 10.1016/0378-5955(88)90100-1; Buechner A, 2010, OTOL NEUROTOL, V31, P1381, DOI 10.1097/MAO.0b013e3181e3d353; Carter L, 2013, J AM ACAD AUDIOL, V24, P807, DOI 10.3766/jaaa.24.9.5; de Heyning PV, 2008, ANN OTO RHINOL LARYN, V117, P645, DOI 10.1177/000348940811700903; Dillon H, 2002, HEARING AIDS; Firszt JB, 2012, OTOL NEUROTOL, V33, P1339, DOI 10.1097/MAO.0b013e318268d52d; Francis HW, 2005, EAR HEARING, V26, p7S, DOI 10.1097/00003446-200508001-00003; Friedland DR, 2003, OTOL NEUROTOL, V24, P582, DOI 10.1097/00129492-200307000-00009; Friedmann DR, 2016, OTOL NEUROTOL, V37, pE154, DOI 10.1097/MAO.0000000000000951; Gilley PM, 2005, CLIN NEUROPHYSIOL, V116, P648, DOI 10.1016/j.clinph.2004.09.009; Golding M, 2009, DETECTION ADULT CORT; Grantham DW, 2007, EAR HEARING, V28, P524, DOI 10.1097/AUD.0b013e31806dc21a; Groenen PAP, 2001, SCAND AUDIOL, V30, P31, DOI 10.1080/010503901750069554; Han JH, 2016, CLIN NEUROPHYSIOL, V127, P1603, DOI 10.1016/j.clinph.2015.10.049; Hawley ML, 2004, J ACOUST SOC AM, V115, P833, DOI 10.1121/1.1639908; Kelly AS, 2005, CLIN NEUROPHYSIOL, V116, P1235, DOI 10.1016/j.clinph.2005.02.011; Kosaner J, 2018, INT J PEDIATR OTORHI, V108, P100, DOI 10.1016/j.ijporl.2018.02.033; Kral A, 2015, AUDIOL NEURO-OTOL, V20, P7, DOI 10.1159/000380742; Legris E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204402; Litovsky RY, 2018, HEARING RES; Palau EM, 2010, ACTA OTORRINOLAR ESP, V61, P405, DOI 10.1016/j.otorri.2010.07.001; Mertens G, 2017, EAR HEARING, V38, P117, DOI 10.1097/AUD.0000000000000359; Pantev C, 2006, CEREB CORTEX, V16, P31, DOI 10.1093/cercor/bhi081; Prejban DA, 2018, OTOL NEUROTOL, V39, pE803, DOI 10.1097/MAO.0000000000001963; Punte Andrea Kleine, 2011, Cochlear Implants Int, V12 Suppl 1, pS26, DOI 10.1179/146701011X13001035752336; Purdy SC, 2016, SEM HEAR; Rahne T, 2016, OTOL NEUROTOL, V37, pE332, DOI 10.1097/MAO.0000000000000971; Ramos A, 2012, ACTA OTORRINOLAR ESP, V63, P15, DOI 10.1016/j.otorri.2011.07.004; Sandmann P, 2015, CLIN NEUROPHYSIOL, V126, P594, DOI 10.1016/j.clinph.2014.06.029; Stelzig Yvonne, 2011, J Med Case Rep, V5, P343, DOI 10.1186/1752-1947-5-343; Tavora-Vieira D, 2019, OTOLOGY NEUROTOLOGY; Tavora-Vieira D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193081; Tavora-Vieira D, 2015, EAR HEARING, V36, pE93, DOI 10.1097/AUD.0000000000000130; Tavora-Vieira D, 2015, OTOL NEUROTOL, V36, P430, DOI 10.1097/MAO.0000000000000707; Tavora-Vieira D, 2015, OTOL NEUROTOL, V36, P235, DOI 10.1097/MAO.0000000000000677; Tavora-Vieira D, 2013, NEUROREPORT, V24, P724, DOI 10.1097/WNR.0b013e3283642a93; Timm L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045375; Tong YX, 2009, BRAIN RES, V1297, P80, DOI 10.1016/j.brainres.2009.07.089; Tremblay KL, 2009, CLIN NEUROPHYSIOL, V120, P128, DOI 10.1016/j.clinph.2008.10.005; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Vermeire K, 2009, AUDIOL NEURO-OTOL, V14, P163, DOI 10.1159/000171478	48	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227371	10.1371/journal.pone.0227371	http://dx.doi.org/10.1371/journal.pone.0227371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935234	gold, Green Published			2022-12-26	WOS:000534354100017
J	Bloch, K; Hornfeld, SH; Dar, S; Vanichkin, A; Gil-Ad, I; Vardi, P; Weizman, A				Bloch, Konstantin; Hornfeld, Shay Henry; Dar, Shira; Vanichkin, Alexey; Gil-Ad, Irit; Vardi, Pnina; Weizman, Abraham			Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia	PLOS ONE			English	Article							INTRANASAL INSULIN; BRAIN	Accumulating evidence suggests that Alzheimer's disease is associated with brain insulin resistance, as are some other types of dementia. Intranasal insulin administration has been suggested as a potential approach to overcoming brain insulin resistance and improving cognitive functions. Islet transplantation into the cranial subarachnoid cavity was used as an alternative route for insulin delivery into the brain. Recently, the authors showed the short-term beneficial cognitive effect of a small number of intracranially grafted islets in rats with cognitive dysfunction induced by intracerebroventricular administration of streptozotocin (icv-STZ). This was associated with continuous and safe insulin delivery to the rat brain. The current study investigated the long-term effect of intracranial grafting of islets on cognitive functioning in icv-STZ rats. Severe dementia, associated with obesity and cerebral amyloid-beta angiopathy, was induced in Lewis inbred rats by icv-STZ. Two months after icv-STZ, one hundred syngeneic islets were transplanted into the cranial subarachnoid space. Two and six months later, cognitive alterations were assessed by Morris water-maze tests. Islet graft survival was evaluated by immunohistochemical and biochemical assays. Improvement was found in spatial learning and memory of grafted rats as opposed to the sham-operated icv-STZ rats. The grafted islets showed intact morphology, intensive expression of insulin, glucagon and glucose transporter 2. Normoglycemic obesity and cerebral amyloid-beta angiopathy were found in both grafted and sham-operated icv-STZ rats. In conclusion, islet grafting into cranial subarachnoid space provides an efficient and safe approach for insulin delivery to the brain, leading to a long-term attenuation of icv-STZ-induced cognitive dysfunction.	[Bloch, Konstantin; Vardi, Pnina] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Diabet & Obes Res, Petah Tiqwa, Israel; [Hornfeld, Shay Henry; Dar, Shira; Gil-Ad, Irit; Weizman, Abraham] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Biol Psychiat, Petah Tiqwa, Israel; [Vanichkin, Alexey] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Transplantat, Petah Tiqwa, Israel; [Weizman, Abraham] Geha Mental Hlth Ctr, Res Unit, Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Bloch, K (corresponding author), Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, Lab Diabet & Obes Res, Petah Tiqwa, Israel.	kbloch@post.tau.ac.il	Weizman, Abraham/AAK-6450-2020	Weizman, Abraham/0000-0002-9765-8938; Bloch, Konstantin/0000-0002-2511-8342	Tel Aviv University [0601243032, 0601523471]	Tel Aviv University	This study was supported in part by grants (0601243032 and 0601523471) from Tel Aviv University (https://www.tau.ac.il/) to KB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Bloch F, 2016, CLIN CASE REP, V4, P376, DOI 10.1002/ccr3.530; Bloch K, 2019, TRANSPLANTATION, V103, pE137, DOI 10.1097/TP.0000000000002671; Bloch K, 2018, J ALZHEIMERS DIS, V65, P1445, DOI 10.3233/JAD-180623; Bloch K, 2017, J TISSUE ENG REGEN M, V11, P3263, DOI 10.1002/term.2235; Bloch K, 2017, J ALZHEIMERS DIS, V60, P121, DOI [10.3233/JAD-161289, 10.3233/jad-161289]; Bloch K, 2015, HORM BEHAV, V72, P1, DOI 10.1016/j.yhbeh.2015.04.019; Chen YX, 2014, EXP NEUROL, V261, P610, DOI 10.1016/j.expneurol.2014.06.004; Craft S, 2017, J ALZHEIMERS DIS, V57, P1325, DOI 10.3233/JAD-161256; DUELLI R, 1994, INT J DEV NEUROSCI, V12, P737, DOI 10.1016/0736-5748(94)90053-1; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Grieb P, 2016, MOL NEUROBIOL, V53, P1741, DOI 10.1007/s12035-015-9132-3; Jakel L, 2017, CLIN SCI, V131, P2469, DOI 10.1042/CS20170033; Mao YF, 2016, AGING CELL, V15, P893, DOI 10.1111/acel.12498; Rhea EM, 2019, EXP NEUROL, V313, P10, DOI 10.1016/j.expneurol.2018.11.007; Salkovic-Petrisic M, 2013, J NEURAL TRANSM, V120, P233, DOI 10.1007/s00702-012-0877-9; Salkovic-Petrisic M, 2011, J NEURAL TRANSM, V118, P765, DOI 10.1007/s00702-011-0651-4; Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027; Stoeckel Luke E, 2016, F1000Res, V5, P353, DOI 10.12688/f1000research.8300.1; Zhao QH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0098545, 10.1371/journal.pone.0095755]	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227879	10.1371/journal.pone.0227879	http://dx.doi.org/10.1371/journal.pone.0227879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929603	Green Published, gold			2022-12-26	WOS:000534352500081
J	Ibine, B; Ametepe, LS; Okere, M; Anto-Ocrah, M				Ibine, Bolade; Ametepe, Linda Sefakor; Okere, Maxfield; Anto-Ocrah, Martina			"I did not know it was a medical condition": Predictors, severity and help seeking behaviors of women with female sexual dysfunction in the Volta region of Ghana	PLOS ONE			English	Article							NATIONAL AMBULANCE SERVICE; QUALITY-OF-LIFE; MATERNAL MORTALITY; PREVALENCE; HEALTH; DOCTORS; IMPACT; GYNECOLOGY; BARRIERS; SLEEP	Objectives The study's main objective was to describe the prevalence and severity of female sexual dysfunction (FSD) amongst a group of Ghanaian women in the outpatient setting of the predominantly rural Volta region of Ghana. Additionally we determine the predictors of FSD severity and care seeking behaviors of women with the condition. Study design and setting This was a cross sectional study conducted in the outpatient setting of the Ho Teaching Hospital in the rural-savannah, agro-ecological zone of Volta Region, Ghana. Methods and procedures FSD was assessed using the Female Sexual Function Index (FSFI) questionnaire. FSD was defined with a cutoff of <= 23 so as not to under-estimate the prevalence in this conservative setting. FSFI score >23 was designated "no FSD". We further categorized women with FSD as having mild (FSFI Total score 18-23), moderate (FSFI Total score < 18 to > 10) or severe (FSFI Total score <= 10) FSD. Due to sample size restrictions, we combined the moderate and severe FSD groups in our analyses and defined "moderate/severe FSD" as an FSFI Total score < 18. Participants with FSD were further asked to indicate whether or not they sought help for their conditions, the reasons they sought help, and the types of help they sought. We used p<0.05 to determine statistical significance for all analyses and logistic regression models were used to determine crude and age-adjusted effect estimates. Results FSD Prevalence: Out of 407 women approached, 300 (83.8%) agreed and consented to participate in the study. The prevalence of FSD was 48.3% (n = 145). Compared to those without FSD, over a third of the FSD women resided in rural settings (37.90% vs 20.60%; p = 0.001) and tended to be multiparous, with a significantly greater proportion having at least three children (31.70% vs 18.10%; p = 0.033). FSD Severity: Over a quarter of the sample (27.6%, n = 40) met the cut-off for moderate to severe FSD. In age-adjusted models, lubrication disorder was associated with 45 times the odds of moderate/severe FSD (age-adj. OR: 45.38, 95% CI: 8.37, 246.00; p<0.001), pain with 17times the odds (age-adj. OR: 17.18, 95% CI: 4.50, 65.50; p<0.001) and satisfaction almost 5times the odds (age-adj. OR: 4.69, 95% CI: 1.09, 20.2; p = 0.04). Compared to those with 1-3 children, nulliparous women had 3.5 times higher odds of moderate/severe sexual dysfunction as well (age-adj. OR:3.51, 95% CI:1.37,8.98; p = 0.009). FSD-related Health Seeking Behaviors: Statistically significant predictors of FSD-related care seeking included having FSD of pain disorder (age-adj. OR: 5.91, 95% CI:1.29, 27.15; p = 0.02), having.4 children (age-adj. OR: 6.29, 95%CI: 1.53, 25.76; p = 0.01). Of those who sought help, seven in 10 sought formal help from a healthcare provider, with General Practitioners preferred over Gynecologist. About one in 3 (31.3%) who did not seek help indicated that they did not know their sexual dysfunction was a medical condition, over a quarter (28.9%) "thought it was normal" to have FSD, and interestingly, 14.1% did not think a medical provider would be able to provide them with assistance. Conclusions Sexual dysfunctions are prevalent yet taboo subjects in many countries, including Ghana. Awareness raising and efforts to feminize the physician workforce are necessary to meet the healthcare needs of vulnerable members of Ghanaian society.	[Ibine, Bolade; Ametepe, Linda Sefakor] Univ Hlth & Allied Sci, Obstet & Gynecol, Sch Med, Ho, Volta Region, Ghana; [Ibine, Bolade] Family Hlth Med Sch, Dept Obstet & Gynecol, Accra, Ghana; [Okere, Maxfield] Korle Bu Teaching Hosp, Dept Biostat, Accra, Greater Accra R, Ghana; [Anto-Ocrah, Martina] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14642 USA; [Anto-Ocrah, Martina] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Anto-Ocrah, Martina] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Anto-Ocrah, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14642 USA.; Anto-Ocrah, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA.; Anto-Ocrah, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA.	martina_anto-ocrah@urmc.rochester.edu	Ibine, Bolade/GRE-6505-2022; Ibine, Bolade/AAA-2637-2022	Ibine, Bolade/0000-0002-3230-1348; Anto-Ocrah, Martina/0000-0002-0368-2575				Abdulai T, BRIDGING INEQUITABLE; Adanu R M, 2012, Ghana Med J, V46, P58; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amalba A, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1234-y; Amidu N, 2014, INT J IMPOT RES, V26, P135, DOI 10.1038/ijir.2013.52; Amir H, 2018, J IMMIGR MINOR HEALT, V20, P51, DOI 10.1007/s10903-016-0522-z; Anarfi JK, 2011, SEX CULT, V15, P1, DOI 10.1007/s12119-010-9078-6; [Anonymous], 2014, Obstet Gynecol, V123, P384, DOI 10.1097/01.AOG.0000443278.06393.d6; [Anonymous], 2019, J HUIZEN MED NE 0502; [Anonymous], 2019, WORLD POPULATION REV; [Anonymous], 2018, ZINDZY GRACIA CURREN; [Anonymous], 2018, CIA WORLD FACTB; [Anonymous], JAMBA J DISASTER RIS; [Anonymous], 2018, WORLD POPULATION REV; [Anonymous], 2014, GUARDIAN; Anto-Ocrah M, 2019, BRAIN INJURY, V33, P1449, DOI 10.1080/02699052.2019.1644377; Association AP, 2013, HIGHL CHANG DSM 4 TR; Awoonor-Williams JK, 2015, GLOB PUBLIC HEALTH, V10, P1118, DOI 10.1080/17441692.2015.1027247; Bachmann G A, 1995, Int J Fertil Menopausal Stud, V40 Suppl 1, P16; Bachmann GA, 2004, MENOPAUSE, V11, P120, DOI 10.1097/01.GME.0000075502.60230.28; Baravilala W, GLOBAL BURDEN SURG D; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7; Bazzano AN, 2008, INT J GYNECOL OBSTET, V102, P91, DOI 10.1016/j.ijgo.2008.02.004; Breyer BN, 2010, J SEX MED, V7, P2391, DOI 10.1111/j.1743-6109.2010.01794.x; Buck KS, 2014, J PSYCHOSOM OBST GYN, V35, P1, DOI 10.3109/0167482X.2013.866646; Campbell J, 2013, B WORLD HEALTH ORGAN, V91, P853, DOI 10.2471/BLT.13.118729; Clinton Y, 2010, ACAD MED, V85, P1564, DOI 10.1097/ACM.0b013e3181f09112; Coelho G, 2015, J WOMENS HEALTH, V24, P958, DOI 10.1089/jwh.2015.5537; Cong JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155563; Development Initiatives, 2018, GHAN RUR SAV AR SUFF; Duarte-Guterman P, 2019, FRONT NEUROENDOCRIN, V53, DOI 10.1016/j.yfrne.2019.02.004; Eid Somaia Ragab, 2019, AM J NURSING RES, V7, P1; Feldhaus-Dahir Melissa, 2009, Urol Nurs, V29, P81; Fiaveh DY, 2019, SEXUALITIES, V22, P131, DOI 10.1177/1363460716677281; Flynn K.E., 2016, J SEX MED; French Fiona, 2006, J Health Organ Manag, V20, P163, DOI 10.1108/14777260610661556; Ghana Health Service, 2017, HLTH SECT GHAN FACTS; Ghana Health Service and Center for Health and Information Management subdivision of the Policy Planning Monitoring and Evaluation Division (PPMED) of the Ghana Health Service, 2016, HLTH SECT GHAN FACTS; Ghana Statistical Service, 2012, 2010 POP HOUS CENS S; Ghana Statistical Service, 2018, 2010 POP PROJ SEX; Glaziou Philippe, 2003, SAMPSIZE; Goldstein Erica, 2015, NOV 2015 PHYS HUM RI; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Gott M, 2003, FAM PRACT, V20, P690, DOI 10.1093/fampra/cmg612; Hedden L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-32; Heiman JR, 2002, J SEX RES, V39, P73, DOI 10.1080/00224490209552124; Imbeah Emelia P, 2015, J WOMENS HLTH ISSUES, V4; International Society for Sexual Medicine, WHY IS VAG LUBR IMP; Kacker S., 2015, INJURY; Khalesi ZB, 2018, AFR HEALTH SCI, V18, P227, DOI 10.4314/ahs.v18i2.5; Kingsberg SA, 2019, J WOMENS HEALTH, V28, P432, DOI 10.1089/jwh.2018.7352; Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846; Kyei-Nimakoh M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0503-x; Kyei-Nimakoh M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0840-0; Kyei-Nimakoh M, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0045-z; Lassey A T, 2013, Ghana Med J, V47, P87; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Levinson W, 2004, ANN INTERN MED, V141, P471, DOI 10.7326/0003-4819-141-6-200409210-00013; LEVY DR, 1985, PEDIATRICS, V75, P639; Makara-Studzinska MT, 2014, MENOPAUSE REV, V13, P203, DOI 10.5114/pm.2014.43827; Mark T, 2018, CONS U GLOB HLTH CUG; McAnulty Richard D, 2006, SEX SEXUALITY SEXUAL; McCool Megan E, 2016, Sex Med Rev, V4, P197, DOI 10.1016/j.sxmr.2016.03.002; Mohamed NA, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0283-y; Nappi RE, 2016, MATURITAS, V94, P87, DOI 10.1016/j.maturitas.2016.09.013; Nappi RE, 2009, MATURITAS, V63, P138, DOI 10.1016/j.maturitas.2009.03.021; Newell R, 2017, J PUBLIC HEALTH AFR, V8, P89, DOI 10.4081/jphia.2017.592; Newman-Nartey Merley A, 2019, Ghana Med J, V53, P13, DOI 10.4314/gmj.v53i1.3; Prairie BA, 2015, J WOMENS HEALTH, V24, P119, DOI 10.1089/jwh.2014.4798; Rahman S, 2018, SEX MED REV, V6, P535, DOI 10.1016/j.sxmr.2018.02.006; Remez L, MULTIPLE FACTORS INC; Roos AM, 2012, INT UROGYNECOL J, V23, P145, DOI 10.1007/s00192-011-1516-y; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Russo G, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0064-9; Safarinejad MR, 2006, INT J IMPOT RES, V18, P382, DOI 10.1038/sj.ijir.3901440; Sandfort TGM, 2004, ARCH SEX BEHAV, V33, P181, DOI 10.1023/B:ASEB.0000026618.16408.e0; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Seftel AD, 2012, J UROLOGY, V188, P1265, DOI 10.1016/j.juro.2012.06.115; Shields CG, 2019, J GEN INTERN MED, V34, P435, DOI 10.1007/s11606-018-4785-z; Shifren JL., SEXUAL DYSFUNCTION W; Sikder SS, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0832-1; Silver JK, 2019, HEALTH EQUITY, V3, P360, DOI 10.1089/heq.2019.0040; Simons JS, 2001, ARCH SEX BEHAV, V30, P177, DOI 10.1023/A:1002729318254; Smith LJ, 2007, J SEX MED, V4, P1247, DOI 10.1111/j.1743-6109.2007.00568.x; Smith NK, 2015, J SEX MED, V12, P985, DOI 10.1111/jsm.12824; Stallings Erika, 2019, BLACK PATIENTS BLACK; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Tansley G, 2016, PREHOSP EMERG CARE, V20, P768, DOI 10.3109/10903127.2016.1164775; Tau Menes, 2013, GHANAIAN MED DOCTORS; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Torres N., 2018, HARVARD BUS REV; UNICEF, 2013, GLANC GHAN STAT; West SL, 2004, ANN REV SEX RES, V15, P40; WHO, 2020, GLOB STRAT HUM RES H; World Health Organization, 2006, SEX REPR HLTH WORK D; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Zakariah A, 2017, PREHOSP DISASTER MED, V32, P83, DOI 10.1017/S1049023X16001151	98	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226404	10.1371/journal.pone.0226404	http://dx.doi.org/10.1371/journal.pone.0226404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929541	gold, Green Published			2022-12-26	WOS:000534352500012
J	Li, CY; Cao, X; Chi, M				Li, Chuanyun; Cao, Xia; Chi, Ming			Research on an evolutionary game model and simulation of a cluster innovation network based on fairness preference	PLOS ONE			English	Article							PROMOTES COOPERATION; ALLOCATION; INVESTMENT	The cluster innovation network is an important part of regional economic development. In addition, the fairness preference of internal innovators in the processes of investment and benefit distribution are particularly important for curbing "free riding" and other speculative behaviors and for creating a good cooperation environment. Therefore, taking a cluster innovation network constructed by the weighted evolutionary BBV model as the research subject, this paper constructs an evolutionary game model of a cluster innovation network based on a spatial public goods game and the theory of fairness preferences, which involves the processes of investment and payoff allocation. Using simulation analysis, this paper studies the evolution of innovators' cooperative behaviors and benefits in cluster innovation network under the conditions of a fairness preference and a return intensity. The results show that an increase in the weight coefficient, gain coefficient and degree of differentiation between the previous income and current investment can effectively promote improvements in the level of enterprise cooperation. Indeed, the greater the weight coefficient, the gain coefficient and the degree of differentiation are, the more substantial the improvement in the level of enterprise cooperation will be. Moreover, an improvement in the differentiation of the breadth and depth of enterprise cooperation has an inhibitory effect on enterprise cooperation. Furthermore, whereas increases in regulation and gain coefficients can effectively promote enterprise cooperation. However, the increase in the weight coefficient has a different effect on enterprise benefit in terms of the breadth and depth of cooperation. Finally, we hope to improve the overall cooperation level and cooperation income of the network by deeply understanding the fair preferences of innovators in the processes of investment and benefit distribution, which is helpful for promoting the evolution and development of cluster innovation networks.	[Li, Chuanyun; Cao, Xia] Harbin Engn Univ, Econ & Management Sch, Harbin, Peoples R China; [Chi, Ming] Jilin Univ, Sch Management, Changchun, Peoples R China	Harbin Engineering University; Jilin University	Cao, X (corresponding author), Harbin Engn Univ, Econ & Management Sch, Harbin, Peoples R China.	caoxia@hrbeu.edu.cn		chi, ming/0000-0002-6532-9371	National Natural Science Foundation of China [71473055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant No. 71473055).	Barrat A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228701; Botelho A, 2009, GAME ECON BEHAV, V67, P253, DOI 10.1016/j.geb.2008.11.013; Cao XB, 2010, PHYSICA A, V389, P1273, DOI 10.1016/j.physa.2009.11.044; Charness G, 2002, Q J ECON, P151, DOI [10.1162/003355302760193904, DOI 10.1162/003355302760193904]; Ding H, 2018, SOFT COMPUT, V22, P1287, DOI 10.1007/s00500-016-2415-4; Dugatkin LA, 1997, BIOSCIENCE, V47, P355, DOI 10.2307/1313150; Dutta P.K., 1993, EC THEOR, V3, P413, DOI 10.1007/BF01209694; Fan RG, 2017, PHYSICA A, V465, P454, DOI 10.1016/j.physa.2016.08.039; Huang K., 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0120317; Iammarino S, 2006, RES POLICY, V35, P1018, DOI 10.1016/j.respol.2006.05.004; Ichinose G, 2017, ARTIF LIFE, V23, P25, DOI 10.1162/ARTL_a_00220; Kamei K, 2017, ECON J, V127, P1069, DOI 10.1111/ecoj.12320; Kim J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09381; Lei CA, 2010, PHYSICA A, V389, P4708, DOI 10.1016/j.physa.2010.06.002; Li J, 2012, PHYSICA A, V391, P3924, DOI 10.1016/j.physa.2012.03.016; Liu JZ, 2018, CHAOS SOLITON FRACT, V109, P214, DOI 10.1016/j.chaos.2018.01.019; Melamed D, 2016, SOC NETWORKS, V45, P32, DOI 10.1016/j.socnet.2015.11.001; Meloni S, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170092; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Peng D, 2010, EUR PHYS J B, V73, P455, DOI 10.1140/epjb/e2010-00008-7; Pouder R, 1996, ACAD MANAGE REV, V21, P1192, DOI 10.2307/259168; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Stoop J, 2018, J ENVIRON ECON MANAG, V88, P300, DOI 10.1016/j.jeem.2017.12.007; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szolnoki A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.047102; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Tsai MH, 2012, SURGERY, V151, P490, DOI 10.1016/j.surg.2011.12.037; Vukov J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036133; Wang Q, 2018, PHYSICA A, V502, P570, DOI 10.1016/j.physa.2018.02.140; Wu ZX, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.037103; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zhang HF, 2012, PHYSICA A, V391, P2617, DOI 10.1016/j.physa.2011.12.005; Zhang HF, 2010, PHYSICA A, V389, P1099, DOI 10.1016/j.physa.2009.11.029; Zhang L, 2016, PROCEDIA ENGINEER, V138, P259, DOI 10.1016/j.proeng.2016.01.267; Zhang YC, 2017, KNOWL-BASED SYST, V136, P150, DOI 10.1016/j.knosys.2017.09.011	36	2	2	16	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226777	10.1371/journal.pone.0226777	http://dx.doi.org/10.1371/journal.pone.0226777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929550	Green Published, Green Accepted, gold			2022-12-26	WOS:000534352500019
J	Naunton, J; Harrison, C; Britt, H; Haines, T; Malliaras, P				Naunton, Josh; Harrison, Christopher; Britt, Helena; Haines, Terrence; Malliaras, Peter			General practice management of rotator cuff related shoulder pain: A reliance on ultrasound and injection guided care	PLOS ONE			English	Article							SUBACROMIAL DECOMPRESSION; PHYSIOTHERAPY; PREVALENCE; DISORDERS; REPAIR; TEARS; DIAGNOSIS; PATTERNS; SURGERY; DISEASE	Objective To describe general practitioner's (GP's) current management of rotator cuff related shoulder pain (RCRP) in Australia and identify if this is consistent with recommended care and best available evidence. The secondary aim was to determine if GP management of RCRP changed over time. Methods Data about management of RCRP by Australian GPs was extracted from the Bettering the Evaluation of Care of Health program database over its final five years (April 2011-March 2016). Patient and GP characteristics and encounter management data were extracted. Results are reported using descriptive statistics with point estimates and 95% confidence intervals. A secondary analysis over a 16 year period (2000-2016) examined management data for RCRP in four year periods. Results RCRP was the most common shoulder condition managed by GPs at 5.12 per 1,000 encounters; and at an estimated 732,000 times nationally in 2015-2016. Management rate was higher among male patients (5.5 per 1000 encounters c.f. 4.8 for female patients) and was highest in the 45-64 year old age group (8.6 per 1000). RCRP was most frequently managed with medications (54.7%), steroid injection (19.5%) followed by non-steroidal anti-inflammatory drugs (NSAIDs) (19.1%). Imaging was ordered for 43.4% (ultrasound 41.2% and x-ray 11.6%) of all RCRP presentations (new and returning). Over half (53.0%) of new RCRP presentations were referred for ultrasound imaging. In the 16 year period 2000-16 ultrasound imaging more than doubled from 19.1% to 41.9% of management occasions. In parallel, prescribed steroid injection increased from 9.8% to 19.7%. Conclusion The usual care provided by GPs for RCRP relies on the use of ultrasound and steroid injection. This is not consistent with recommended care and clinical guidelines that recommend these are delayed until after 6-12 weeks of NSAID medication, exercise and activity modification. There has been a significant increase in the rate of steroid injection and ultrasound imaging, which may be due in part to policy change.	[Naunton, Josh; Malliaras, Peter] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary & Allied Hlth Care, Physiotherapy Dept, Melbourne, Vic, Australia; [Harrison, Christopher] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Menzies Ctr Hlth Policy, Sydney, NSW, Australia; [Britt, Helena] Univ Sydney, Fac Med & Hlth, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Haines, Terrence] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary & Allied Hlth Care, Melbourne, Vic, Australia	Monash University; University of Sydney; University of Sydney; Monash University	Naunton, J (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary & Allied Hlth Care, Physiotherapy Dept, Melbourne, Vic, Australia.	joshua.naunton@monash.edu		Naunton, Josh/0000-0002-4019-8096; Harrison, Christopher/0000-0002-8769-6877	AbbVie Pty Ltd.; AstraZeneca Pty Ltd. (Australia); Australian Government Department of Health and Ageing; Australian Government Department of Veterans' Affairs; GlaxoSmithKline Australia Pty Ltd.; Merck, Sharpe and Dohme (Australia) Pty Ltd.; National Prescribing Service; Novartis Pharmaceuticals Australia Pty Ltd.; Pfizer Australia; Sanofi-Aventis Australia Pty Ltd.; CSL/Seqirus (Australia) Pty Ltd.; University of Sydney; Australian Government Research Training Program (RTP) Scholarship	AbbVie Pty Ltd.; AstraZeneca Pty Ltd. (Australia)(AstraZeneca); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Government Department of Veterans' Affairs(US Department of Veterans Affairs); GlaxoSmithKline Australia Pty Ltd.; Merck, Sharpe and Dohme (Australia) Pty Ltd.; National Prescribing Service; Novartis Pharmaceuticals Australia Pty Ltd.; Pfizer Australia(PfizerPfizer Australia); Sanofi-Aventis Australia Pty Ltd.(Sanofi-Aventis); CSL/Seqirus (Australia) Pty Ltd.; University of Sydney(University of Sydney); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors would like to acknowledge that between 2011 and 2016 BEACH was financially supported by a consortium of Government, Industry and non-Government organisations, namely: AbbVie Pty Ltd.; AstraZeneca Pty Ltd. (Australia); Australian Government Department of Health and Ageing; Australian Government Department of Veterans' Affairs; GlaxoSmithKline Australia Pty Ltd.; Merck, Sharpe and Dohme (Australia) Pty Ltd.; National Prescribing Service; Novartis Pharmaceuticals Australia Pty Ltd.; Pfizer Australia; Sanofi-Aventis Australia Pty Ltd.; CSL/Seqirus (Australia) Pty Ltd. Funding was provided through a research agreement with the University of Sydney which afforded complete research autonomy for the team conducting the BEACH program. Final decisions regarding research design, data collection and analysis, and reporting of findings remain with the principal investigators under the ethical supervision of the University of Sydney. JN is supported by an Australian Government Research Training Program (RTP) Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to thank the GP participants in the BEACH program and all members of the BEACH team; the Royal Australian College of General Practitioners (RACGP) and the Australian Medical Association (AMA) for their endorsement; and the Australian Government Department of Health for regularly supplying general practitioner random samples and national Medicare statistics. The authors would also like to acknowledge that between 2011 and 2016 BEACH was financially supported by a consortium of Government, Industry and non-Government organisations, namely: AbbVie Pty Ltd.; AstraZeneca Pty Ltd. (Australia); Australian Government Department of Health and Ageing; Australian Government Department of Veterans' Affairs; GlaxoSmithKline Australia Pty Ltd.; Merck, Sharpe and Dohme (Australia) Pty Ltd.; National Prescribing Service; Novartis Pharmaceuticals Australia Pty Ltd.; Pfizer Australia; Sanofi-Aventis Australia Pty Ltd.; CSL/Seqirus (Australia) Pty Ltd. Funding was provided through a research agreement with the University of Sydney which afforded complete research autonomy for the team conducting the BEACH program. Final decisions regarding research design, data collection and analysis, and reporting of findings remain with the principal investigators under the ethical supervision of the University of Sydney.	American Academy of Orthopaedic Surgeons, 2019, MAN ROT CUFF INJ CLI; American Board of Internal Medicine Foundation, 2019, CHOOS WIS HIST; Austin PC, 2002, J VASC SURG, V36, P194, DOI 10.1067/mva.2002.125015; Australian Bureau of Statistics, 2013, SOC IND AR; Australian Bureau of Statistics, 2018, AUSTR STAT GEOGR STA; Bloom JE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009147.pub2; Brand CA, 2014, ARTHRIT CARE RES, V66, P551, DOI 10.1002/acr.22197; British Orthopaedic Association, 2014, COMM GUID SUB SHOULD; Britt H, GEN PRACTICE ACTIVIT; Britt H, DECADE AUSTR GEN PRA, V37; Britt H, 2015, AUST FAM PHYSICIAN, V44, P411; Broadhurst Norman A, 2004, Aust Fam Physician, V33, P861; Buchbinder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061243; Choosing Wisely Australia, 2017, CHOOS WIS AUSTR BROA; Cole A, 2009, J RHEUMATOL, V36, P371, DOI 10.3899/jrheum.080349; Department of Human Services, 2019, MED AUSTR STAT ULTR; Department of Human Services, 2019, MED AUSTR STAT RAD E; Diercks R, 2014, ACTA ORTHOP, V85, P314, DOI 10.3109/17453674.2014.920991; Dingwall S, 2019, AUSTR HLTH REV; Dunn WR, 2016, J SHOULDER ELB SURG, V25, P1303, DOI 10.1016/j.jse.2016.04.030; Egerton T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011618; Family Medicine Research Centre, 2019, ICPC 2 PLUS DEM SYDN; Glazier RH, 1998, CAN MED ASSOC J, V158, P1037; Harrison C, 2011, AUST FAM PHYSICIAN, V40, P12; Harrison CM, 2011, MED J AUSTRALIA, V195, P192, DOI 10.5694/j.1326-5377.2011.tb03278.x; Hopman K, 2013, CLIN PRACTICE GUIDEL; Johol P, 2008, AUST FAM PHYSICIAN, V37, P263; Judge A, 2014, BONE JOINT J, V96B, P70, DOI 10.1302/0301-620X.96B1.32556; Klintberg IH, 2015, INT ORTHOP, V39, P715, DOI 10.1007/s00264-014-2639-9; Kukkonen J, 2015, J BONE JOINT SURG AM, V97A, P1729, DOI 10.2106/JBJS.N.01051; Kulkarni Rohit, 2015, Shoulder Elbow, V7, P135, DOI 10.1177/1758573215576456; Lewis J, 2016, MANUAL THER, V23, P57, DOI 10.1016/j.math.2016.03.009; Linsell L, 2006, RHEUMATOLOGY, V45, P215, DOI 10.1093/rheumatology/kei139; Littlewood C., 2019, PHYSIOTHERAPY PRACTI, V40, P87, DOI [10.3233/PPR-190129, DOI 10.3233/PPR-190129]; Littlewood C, 2013, SHOULDER ELB, V5, P256, DOI [10.1111/sae.12028, DOI 10.1111/SAE.12028]; Loebenberg Mark I, 2006, Bull Hosp Jt Dis, V63, P137; Mallows A, 2017, BRIT J SPORT MED, V51, P743, DOI 10.1136/bjsports-2016-096154; Mauro CS, 2012, J BONE JOINT SURG AM, V94A, P1492, DOI 10.2106/JBJS.J.01696; Moosmayer S, 2014, J BONE JOINT SURG AM, V96A, P1504, DOI 10.2106/JBJS.M.01393; NPS MedicineWise, 2018, NONTR SHOULD PAIN GE; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Oliva F, 2015, MLTJ-MUSCLE LIGAMENT, V5, P227, DOI 10.11138/mltj/2015.5.4.227; Ottenheijm RPG, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-154; Page MJ, 2016, COCHRANE DATABASE SY; Patel S, 2011, J EVAL CLIN PRACT, V17, P118, DOI 10.1111/j.1365-2753.2010.01377.x; Pope DP, 1997, ANN RHEUM DIS, V56, P308, DOI 10.1136/ard.56.5.308; Rechardt M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-165; Saltychev M, 2015, DISABIL REHABIL, V37, P1, DOI 10.3109/09638288.2014.907364; Slade SC, 2016, CLIN J PAIN, V32, P800, DOI 10.1097/AJP.0000000000000324; Storheim K, 2014, ANN RHEUM DIS, V73, P949, DOI 10.1136/annrheumdis-2014-205327; Teunis T, 2014, J SHOULDER ELB SURG, V23, P1913, DOI 10.1016/j.jse.2014.08.001; Thorpe A, 2016, ANZ J SURG, V86, P801, DOI 10.1111/ans.13691; Traeger AC, 2017, J PHYSIOTHER, V63, P63, DOI 10.1016/j.jphys.2017.02.003; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Vandvik PO, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l294; Vicenzino B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181631; WHO Collaborating Centre for Drug Statistics Methodology, 2016, AN THER CHEM ATC CLA; *WICC, 1998, ICPC 2 INT CLASS PRI; Yu E, 2010, ARTHROSCOPY, V26, pS142, DOI 10.1016/j.arthro.2010.02.029	59	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227688	10.1371/journal.pone.0227688	http://dx.doi.org/10.1371/journal.pone.0227688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929588	Green Published, gold			2022-12-26	WOS:000534352500061
J	Umeda, K; Nakamura, H; Fukuda, A; Yamaguchi, T; Matsumoto, Y; Motooka, D; Nakamura, S; Kawahara, R				Umeda, Kaoru; Nakamura, Hiromi; Fukuda, Akira; Yamaguchi, Takahiro; Matsumoto, Yuki; Motooka, Daisuke; Nakamura, Shota; Kawahara, Ryuji			Molecular characterization of bla(KHM-1) encoding plasmid in an Enterobacter hormaechei subsp. hoffmannii isolate from blood culture	PLOS ONE			English	Article							CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; SEQUENCE; GENE; IDENTIFICATION	KHM-1 was first reported in 1997 in Japan as a novel metallo-beta-lactamase mediated by Citrobacter freundii carrying pKHM-1 plasmid. There have been few reports in the clinical field since then. A bla(KHM-1)-positive Enterobacter hormaechei subsp. hoffmannii in E. cloacae complex, isolate OIPH-N069 was isolated from an inpatient blood culture in 2016. The isolate was characterized by whole-genome sequencing, comparative analysis of the bla(KHM-1) encoding plasmid, antimicrobial susceptibility tests, and bacterial conjugation. OIPH-N069 was classified into ST78 of E. cloacae complex, and was multidrug resistant because of the presence of antimicrobial resistance genes in addition to bla(KHM-1) on its chromosome and plasmids. bla(KHM-1) was located on 136,816 bp of the IncA/C-2 plasmid pN0691, which could be transferred to different bacterial species. The backbone structure, genetic arrangement of the class 1 integron cassette, and the bla(KHM-1) gene located downstream of the IncA/C-2 antibiotic resistance island, ARI-A, in pN069-1 and p(KHM-1) were identical. Horizontal gene transfer of the bla(CTX-M-2)-ISEcp1 resistance gene module only occurred with pN069-1. The study findings indicate not only the structural conservation of bla(KHM-1) encoding plasmids over time and across species, but also the risk of the spread of bla(KHM-1) encoding plasmids to other bacterial species and the accumulation of additional resistance genes.	[Umeda, Kaoru; Nakamura, Hiromi; Fukuda, Akira; Yamaguchi, Takahiro; Kawahara, Ryuji] Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan; [Matsumoto, Yuki; Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Res Inst Microbial Dis, Genome Informat Res Ctr, Osaka, Japan	Osaka Prefectural Institute of Public Health; Osaka University	Umeda, K (corresponding author), Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan.	kaor-umeda@iph.osaka.jp			Japan Society for the Promotion of Science (JSPS) [JP18K10040]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supproted by the Grantin-Aid for Scientific Research (KAKENHI) of Japan Society for the Promotion of Science (JSPS) under Grant No. JP18K10040 (RK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Annavajhala MK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00044; [Anonymous], 2015, M100S25 CLSI; Aoki K, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02091-17, 10.1128/aac.02091-17]; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Chavda KD, 2016, MBIO, V7, DOI 10.1128/mBio.02093-16; Dortet L, 2012, ANTIMICROB AGENTS CH, V56, P6437, DOI 10.1128/AAC.01395-12; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Harmer CJ, 2015, PLASMID, V80, P63, DOI 10.1016/j.plasmid.2015.04.003; Jin Y, 2017, EXP THER MED, V13, P1117, DOI 10.3892/etm.2017.4070; Kayama S, 2015, ANTIMICROB AGENTS CH, V59, P1356, DOI 10.1128/AAC.04759-14; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kudo H, 2019, J ANTIBIOT, V72, P79, DOI 10.1038/s41429-018-0113-4; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Moura A, 2009, BIOINFORMATICS, V25, P1096, DOI 10.1093/bioinformatics/btp105; National Institute of Infectious Diseases, 2016, PATH DET MAN DRUG RE; Papagiannitsis CC, 2016, INT J ANTIMICROB AG, V47, P158, DOI 10.1016/j.ijantimicag.2015.12.001; Sekiguchi J, 2008, ANTIMICROB AGENTS CH, V52, P4194, DOI 10.1128/AAC.01337-07; Sheu CC, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00080; Stoesser N, 2016, ANTIMICROB AGENTS CH, V60, P5068, DOI 10.1128/AAC.00840-16; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Sunagawa Y, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0184720, DOI 10.1371/JOURNAL.PONE.0184720]; Sutton Granger G, 2018, F1000Res, V7, P521, DOI 10.12688/f1000research.14566.1; Suzuki Y, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00391-19; Tanizawa Y, 2018, BIOINFORMATICS, V34, P1037, DOI 10.1093/bioinformatics/btx713; Usui M, 2012, JPN J INFECT DIS, V65, P252, DOI 10.7883/yoken.65.252; van Duin D, 2017, VIRULENCE, V8, P460, DOI 10.1080/21505594.2016.1222343; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227605	10.1371/journal.pone.0227605	http://dx.doi.org/10.1371/journal.pone.0227605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929575	Green Published, Green Submitted, gold			2022-12-26	WOS:000534352500050
J	Chang, NC; Hu, P; Chen, TH; Mao, CT; Hung, MJ; Yeh, CT; Hung, MY				Chang, Nen-Chung; Hu, Patrick; Chen, Tien-Hsing; Mao, Chun-Tai; Hung, Ming-Jui; Yeh, Chi-Tai; Hung, Ming-Yow			Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INSURANCE RESEARCH DATABASE; ASSOCIATION TASK-FORCE; ANTITHROMBOTIC THERAPY; CLINICAL-OUTCOMES; MANAGEMENT; THROMBOSIS; GUIDELINES; STROKE; PREDICTORS	Background Acute myocardial infarction (AMI) complicates the clinical management of atrial fibrillation (AF) because coronary stenting may influence subsequent antithrombotic therapy. We investigated the use of a bare-metal stent (BMS) or a drug-eluting stent (DES) and associated outcomes in patients with pre-existing AF and first AMI undergoing percutaneous coronary intervention. Methods and results Patient records in this population-based study were retrospectively collected from the Taiwan National Health Insurance Research Database. Using propensity score matching (PSM), we used 1:2 ratio stratification into a DES group of 436 and a BMS group of 785 patients from 2007 to 2011. The mean follow-up of matched cohorts was 1.7 years. After PSM, DESs were associated with lower rates of cardiovascular death (7.8%, hazard ratio [HR] 0.58, 95% confidence interval [CI] 0.39-0.86 and 10.1%, HR 0.64, 95% CI 0.45-0.90) and primary composite outcome (35.1%, HR 0.76, 95% CI 0.63-0.92 and 48.2%, HR 0.81, 95% CI 0.69-0.96) than BMSs within the first year and at the end of follow-up. Although the greatest benefit from DESs, irrespective of the first- and second- generation DESs, implantation was observed within the first year only, this benefit was not observed in patients with diabetes, chronic kidney disease, or dialysis. Conclusions Use of DESs in AMI patients with pre-existing AF is associated with significantly lower rates of cardiovascular death and primary composite outcome within the first year follow-up. However, the effect is not apparent in patients with diabetes, chronic kidney disease or dialysis.	[Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Hu, Patrick] Univ Calif Riverside, Riverside, CA 92521 USA; [Hu, Patrick] Riverside Med Clin, Dept Cardiol, Riverside, CA USA; [Chen, Tien-Hsing; Mao, Chun-Tai; Hung, Ming-Jui] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med & Community Med,Res Ctr,Div Cardiol, Keelung, Taiwan; [Yeh, Chi-Tai] Taipei Med Univ, Shuang Ho Hosp, Dept Med Res & Educ, New Taipei, Taiwan; [Yeh, Chi-Tai] Yuanpei Univ Med Technol, Dept Med Lab Sci & Biotechnol, Hsinchu, Taiwan; [Hung, Ming-Yow] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, New Taipei, Taiwan; [Hung, Ming-Yow] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; University of California System; University of California Riverside; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Hung, MY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Cardiol, New Taipei, Taiwan.; Hung, MY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	myhung6@ms77.hinet.net		Hung, Ming-Yow/0000-0002-6912-7523	National Science Council of Taiwan [MOST-108-2314-B-038-119-MY3]; Taipei Medical University-Shuang Ho Hospital [106TMU-SHH-06]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Shuang Ho Hospital	This work was supported by National Science Council of Taiwan grant to Ming-Yow Hung (MOST-108-2314-B-038-119-MY3); and Taipei Medical University-Shuang Ho Hospital (106TMU-SHH-06) to Ming-Yow Hung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Khdair D, 2012, CAN J CARDIOL, V28, P443, DOI 10.1016/j.cjca.2011.12.011; Angiolillo DJ, 2018, CIRCULATION, V138, P527, DOI 10.1161/CIRCULATIONAHA.118.034722; Angiolillo DJ, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.004395; Aoki J, 2009, CIRCULATION, V119, P687, DOI 10.1161/CIRCULATIONAHA.108.804203; Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954; Braun OO, 2015, THROMB RES, V135, P26, DOI 10.1016/j.thromres.2014.10.016; Cannon C. P., 2017, N ENGL J MED, DOI 10.1056/NEJMoa1708454; Chen DY, 2016, INT J CARDIOL, V215, P98, DOI 10.1016/j.ijcard.2016.04.014; Chen DY, 2016, CIRC J, V80, P363, DOI 10.1253/circj.CJ-15-0778; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; De Luca G, 2013, DIABETES CARE, V36, P1020, DOI 10.2337/dc12-1507; De Luca G, 2012, ARCH INTERN MED, V172, P611, DOI 10.1001/archinternmed.2012.758; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P1248, DOI 10.1016/j.jcin.2009.10.003; Faxon DP, 2011, CIRC-CARDIOVASC INTE, V4, P522, DOI 10.1161/CIRCINTERVENTIONS.111.965186; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Goto S, 2011, CIRC J, V75, P2598, DOI 10.1253/circj.CJ-11-0378; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hicks KA, 2010, STANDARDIZED DATA CO; Ho KW, 2013, CAN J CARDIOL, V29, P213, DOI 10.1016/j.cjca.2012.08.008; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Iijima R, 2013, INT J CARDIOL, V168, P2588, DOI 10.1016/j.ijcard.2013.03.046; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kikkert WJ, 2018, NETH HEART J, V26, P321, DOI 10.1007/s12471-018-1113-5; Kim C, 2007, CLIN CARDIOL, V30, P491, DOI 10.1002/clc.20000; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Lin LY, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018062; Lip GYH, 2014, EUR HEART J, V35, P3155, DOI 10.1093/eurheartj/ehu298; Mao CT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214417; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Potter BJ, 2018, CLIN CARDIOL, V41, P470, DOI 10.1002/clc.22898; Puurunen MK, 2014, THROMB RES, V133, P560, DOI 10.1016/j.thromres.2014.01.007; Russ MA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0500-y; Sambola A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147245; Shenoy C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015070; Soliman EZ, 2014, JAMA INTERN MED, V174, pE107, DOI 10.1001/jamainternmed.2013.11912; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Valgimigli M, 2015, J AM COLL CARDIOL, V65, P805, DOI 10.1016/j.jacc.2014.11.053; Varenne O, 2018, LANCET, V391, P41, DOI 10.1016/S0140-6736(17)32713-7; Violi F, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003347; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Zhang RY, 2006, CHINESE MED J-PEKING, V119, P1176, DOI 10.1097/00029330-200607020-00007	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227571	10.1371/journal.pone.0227571	http://dx.doi.org/10.1371/journal.pone.0227571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923246	Green Published, gold			2022-12-26	WOS:000534350000092
J	Perrault, DP; Lee, GK; Bouz, A; Sung, C; Yu, R; Pourmoussa, AJ; Park, SY; Kim, GH; Jiao, W; Patel, KM; Hong, YK; Wong, AK				Perrault, David P.; Lee, Gene K.; Bouz, Antoun; Sung, Cynthia; Yu, Roy; Pourmoussa, Austin J.; Park, Sun Young; Kim, Gene H.; Jiao, Wan; Patel, Ketan M.; Hong, Young-Kwon; Wong, Alex K.			Ischemia and reperfusion injury in superficial inferior epigastric artery-based vascularized lymph node flaps	PLOS ONE			English	Article							CANCER-RELATED LYMPHEDEMA; NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; SECONDARY; TRANSPLANTATION; OUTCOMES; PECAM-1	Vascularized lymph node transfer (VLNT) is a promising treatment modality for lymphedema; however, how lymphatic tissue responds to ischemia has not been well defined. This study investigates the cellular changes that occur in lymph nodes in response to ischemia and reperfusion. Lymph node containing superficial epigastric artery-based groin flaps were isolated in Prox-1 EGFP rats which permits real time identification of lymphatic tissue by green fluorescence during flap dissection. Flaps were subjected to ischemia for either 1, 2, 4, or 8 hours, by temporarily occluding the vascular pedicle. Flaps were harvested after 0 hours, 24 hours, or 5 days of reperfusion. Using EGFP signal guidance, lymph nodes were isolated from the flaps and tissue morphology, cell apoptosis, and inflammatory cytokines were quantified and analyzed via histology, immunostaining, and rtPCR. There was a significant increase in collagen deposition and tissue fibrosis in lymph nodes after 4 and 8 hours of ischemia compared to 1 and 2 hours, as assessed by picrosirius red staining. Cell apoptosis significantly increased after 4 hours of ischemia in all harvest times. In tissue subject to 4 hours of ischemia, longer reperfusion periods were associated with increased rates of CD3+ and CD45(+) cell apoptosis. rtPCR analysis demonstrated significantly increased expression of CXCL1/GRO-alpha with 2 hours of ischemia and increased PECAM-1 and TNF-alpha expression with 1 hour of ischemia. Significant cell death and changes in tissue morphology do not occur until after 4 hours of ischemia; however, analysis of inflammatory biomarkers suggests that ischemia reperfusion injury can occur with as little as 2 hours of ischemia.	[Perrault, David P.; Lee, Gene K.; Bouz, Antoun; Sung, Cynthia; Yu, Roy; Pourmoussa, Austin J.; Park, Sun Young; Jiao, Wan; Patel, Ketan M.; Hong, Young-Kwon; Wong, Alex K.] USC, Keck Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90007 USA; [Kim, Gene H.] USC, Keck Sch Med, Dept Pathol, Los Angeles, CA USA; [Kim, Gene H.] USC, Keck Sch Med, Dept Dermatol, Los Angeles, CA USA	University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital	Wong, AK (corresponding author), USC, Keck Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90007 USA.	Alex.Wong@med.usc.edu	Pourmoussa, Austin J/AAU-7230-2020; Park, Sun/GSD-9620-2022	Pourmoussa, Austin J/0000-0003-0488-0933; Yu, Roy/0000-0001-9787-5388; Bouz, Antoun/0000-0002-8793-2729	 [1K08HL13211001A1];  [5R01HL141857];  [5R01DK114645]	; ; 	Funded by Alex Wong -1K08HL13211001A1. Young Kwon Hong -5R01HL141857 & 5R01DK114645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita S, 2015, ANN PLAS SURG, V74, P573, DOI 10.1097/SAP.0000000000000513; Allen RJ, 2016, J SURG ONCOL, V113, P923, DOI 10.1002/jso.24170; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Basta MN, 2014, PLAST RECONSTR SURG, V133, P905, DOI 10.1097/PRS.0000000000000010; Benahmed F, 2012, CLIN IMMUNOL, V144, P109, DOI 10.1016/j.clim.2012.05.004; Bokhari Faraz Ahmed, 2014, J Ayub Med Coll Abbottabad, V26, P111; Cheng MH, 2014, PLAST RECONSTR SURG, V133, p192E, DOI 10.1097/01.prs.0000437257.78327.5b; Cormier JN, 2010, CANCER-AM CANCER SOC, V116, P5138, DOI 10.1002/cncr.25458; De Brucker B, 2016, PLAST RECONSTR SURG, V137, P1673, DOI 10.1097/PRS.0000000000002169; Dionyssiou D, 2016, BREAST CANCER RES TR, V156, P73, DOI 10.1007/s10549-016-3716-0; ECKERT P, 1991, ANN PLAS SURG, V26, P77, DOI 10.1097/00000637-199101000-00012; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Gurevitch J, 1996, J AM COLL CARDIOL, V28, P247, DOI 10.1016/0735-1097(96)00105-2; Hinrichs CS, 2004, ANN SURG ONCOL, V11, P573, DOI 10.1245/ASO.2004.04.017; Jung E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06031-3; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; KERRIGAN CL, 1982, PLAST RECONSTR SURG, V69, P986, DOI 10.1097/00006534-198206000-00014; Knight RJ, 1997, TRANSPLANTATION, V64, P1102, DOI 10.1097/00007890-199710270-00003; Losy J, 2005, FOLIA NEUROPATHOL, V43, P97; Maddahi A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-107; Nguyen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064368; Nourshargh S, 2006, J LEUKOCYTE BIOL, V80, P714, DOI 10.1189/jlb.1105645; Ozturk CN, 2016, J PLAST RECONSTR AES, V69, P1234, DOI 10.1016/j.bjps.2016.06.022; Patel KM, 2015, ANN SURG ONCOL, V22, P2424, DOI 10.1245/s10434-014-4276-3; Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9; Scaglioni MF, 2018, MICROSURG, V38, P222, DOI 10.1002/micr.30079; SHESOL BF, 1979, PLAST RECONSTR SURG, V63, P817, DOI 10.1097/00006534-197963060-00007; Siemionow M, 2004, MICROSURG, V24, P468, DOI 10.1002/micr.20060; Tinhofer IE, 2019, J SURG ONCOL; Tobbia D, 2009, PLAST RECONSTR SURG, V124, P777, DOI 10.1097/PRS.0b013e3181b03787; Turegun M, 1999, PLAST RECONSTR SURG, V104, P1033; Wang H, 2011, IRISH J MED SCI, V180, P483, DOI 10.1007/s11845-010-0644-6; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Yang CY, 2018, PLAST RECONSTR SURG, V142, P688, DOI 10.1097/PRS.0000000000004673; ZELT RG, 1986, PLAST RECONSTR SURG, V78, P498, DOI 10.1097/00006534-198610000-00011	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227599	10.1371/journal.pone.0227599	http://dx.doi.org/10.1371/journal.pone.0227599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923917	Green Published, gold			2022-12-26	WOS:000534350000099
J	Teixeira, CM; Silva, HT; de Moura, LAR; Proenca, HMD; de Marco, R; de Lima, MG; Cristelli, MP; Viana, LA; Felipe, CR; Pestana, JOM				Teixeira, Cinthia Montenegro; Silva Junior, Helio Tedesco; Ribeiro de Moura, Luiz Antonio; de Sousa Proenca, Henrique Machado; de Marco, Renato; de Lima, Maria Gerbase; Cristelli, Marina Pontello; Viana, Laila Almeida; Felipe, Claudia Rosso; Medina Pestana, Jose Osmar			Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ANTIBODY-MEDIATED REJECTION; PROGNOSTIC-FACTORS; GLOMERULOPATHY; CYCLOSPORINE; ALLOGRAFTS; RECIPIENTS	Introduction Thrombotic microangiopathy (TMA) in post-transplant setting has heterogeneous clinical manifestations. Methods We retrospectively studied data of 89 patients with post-transplant TMA, which was characterized by thrombi in at least one glomerulus and/or arteriole. Systemic TMA was defined by thrombocytopenia and microangiopathic anemia and early onset TMA, when occurred less than 90 days post transplant. Results The cumulative incidence was 0.93%. The majority of the recipients were young (mean age 39 years), female (52%) and Caucasian (48%) with primary kidney disease of unknown etiology (37%). Early TMA occurred in 51% of the patients and systemic TMA, in 25%. Underlying precipitating factors were: infection (54%), acute rejection (34%), calcineurin inhibitor toxicity (13%) and pregnancy (3%). 18% of the patients had several triggers. Glomerular TMA was observed in 50% of the biopsies and endothelial cell activation, in 61%. The 1-year patient survival was 97% and corresponding graft survival, 66%. Allograft survival was inferior when acute antibody mediated rejection (ABMR) occurred (with 41%; without 70%, p = 0.01), however no differences were determined by hemolysis, time of onset, thrombi location or endothelial cell activation. Conclusions Our results suggest that post-transplant TMA is a rare but severe condition, regardless of its clinical and histological presentation, mainly when associated to ABMR.	[Teixeira, Cinthia Montenegro; Silva Junior, Helio Tedesco; Cristelli, Marina Pontello; Viana, Laila Almeida; Felipe, Claudia Rosso; Medina Pestana, Jose Osmar] Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil; [Ribeiro de Moura, Luiz Antonio; de Sousa Proenca, Henrique Machado] Univ Fed Sao Paulo, Hosp Rim, Pathol Div, Sao Paulo, Brazil; [de Marco, Renato; de Lima, Maria Gerbase] AFIP, Immunogenet Inst, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Teixeira, CM (corresponding author), Univ Fed Sao Paulo, Nephrol Div, Sao Paulo, Brazil.	cinthiamt@gmail.com		Teixeira, Cinthia/0000-0002-7091-2617	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by CAPES "Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardalan MR, 2008, RENAL FAILURE, V30, P199, DOI 10.1080/08860220701810547; ARGYLE JC, 1990, PEDIATR NEPHROL, V4, P52, DOI 10.1007/BF00858440; Baid-Agrawal S, 2011, KIDNEY INT, V80, P879, DOI 10.1038/ki.2011.194; Banasik M, 2014, TRANSPL INT, V27, P1029, DOI 10.1111/tri.12371; Bayer G1, 2019, CLIN J AM SOC NEPHRO; Caires RA, 2012, TRANSPL P, V44, P2388, DOI 10.1016/j.transproceed.2012.07.039; Chiurchiu Carlos, 2002, Ann Transplant, V7, P28; CONITEC, 2018, EC TRAT HEM PAR NOT; CONITEC, 2018, EC TRAT SINDR HEM UR; Drachenberg CB, 2013, TRANSPLANTATION, V95, P1073, DOI 10.1097/TP.0b013e31827e6b45; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Gareau AJ, 2018, TRANSPL IMMUNOL, V46, P29, DOI 10.1016/j.trim.2017.12.001; Garg N, 2018, TRANSPLANT REV-ORLAN, V32, P58, DOI 10.1016/j.trre.2017.10.001; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Hollenbeck M, 1998, NEPHROL DIAL TRANSPL, V13, P76, DOI 10.1093/ndt/13.1.76; Karthikeyan V, 2003, AM J TRANSPLANT, V3, P1289, DOI 10.1046/j.1600-6143.2003.00222.x; Laszik ZG, 2015, HEPTINSTALLS PATHOLO, P753; Le Quintrec M, 2008, AM J TRANSPLANT, V8, P1694, DOI 10.1111/j.1600-6143.2008.02297.x; Le Quintrec M, 2013, AM J TRANSPLANT, V13, P663, DOI 10.1111/ajt.12077; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsumae T, 1996, CLIN NEPHROL, V45, P153; Meehan SM, 2011, CLIN J AM SOC NEPHRO, V6, P395, DOI 10.2215/CJN.05870710; Nadasdy T, 2014, CURR OPIN ORGAN TRAN, V19, P283, DOI 10.1097/MOT.0000000000000074; Nava F, 2014, TRANSPL P, V46, P2263, DOI 10.1016/j.transproceed.2014.07.062; Noris M, 2010, AM J TRANSPLANT, V10, P1517, DOI 10.1111/j.1600-6143.2010.03156.x; Reynolds JC, 2003, AM J KIDNEY DIS, V42, P1058, DOI 10.1016/j.ajkd.2003.07.008; Riedl M, 2014, SEMIN THROMB HEMOST, V40, P444, DOI 10.1055/s-0034-1376153; Satoskar AA, 2010, AM J TRANSPLANT, V10, P1804, DOI 10.1111/j.1600-6143.2010.03178.x; Schwimmer J, 2003, AM J KIDNEY DIS, V41, P471, DOI 10.1053/ajkd.2003.50058; Sreedharanunni S, 2014, TRANSPL INT, V27, P784, DOI 10.1111/tri.12331; Suarez MLG, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070919; Taniguchi M, 2013, AM J TRANSPLANT, V13, P2577, DOI 10.1111/ajt.12395; Tostivint I, 2002, NEPHROL DIAL TRANSPL, V17, P1228, DOI 10.1093/ndt/17.7.1228; Wu KY, 2016, CLIN TRANSPLANT, V30, P105, DOI 10.1111/ctr.12645; Yu XJ, 2014, SCI WORLD J, DOI 10.1155/2014/680502; Zarifian A, 1999, KIDNEY INT, V55, P2457, DOI 10.1046/j.1523-1755.1999.00492.x; Zuber J, 2019, J AM SOC NEPHROL, V30, P2449, DOI 10.1681/ASN.2019040331; Zuber J, 2011, NAT REV NEPHROL, V7, P23, DOI 10.1038/nrneph.2010.155	38	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227445	10.1371/journal.pone.0227445	http://dx.doi.org/10.1371/journal.pone.0227445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923282	gold, Green Published			2022-12-26	WOS:000534350000080
J	Zhao, DJ; Zhang, B; Zhao, Y; Sun, Q; Li, CJ; Wang, C				Zhao, Dongjie; Zhang, Bin; Zhao, Ying; Sun, Qun; Li, Chuanjun; Wang, Chong			Research on motion planning for an indoor spray arm based on an improved potential field method	PLOS ONE			English	Article							AUTOMATIC DETECTION; CROP ROWS; ROBOT; OPTIMIZATION; TIME	The target spraying effect of spray robots mainly depends on the control performance of the spraying arm during the processes of aiming and tracking. To further improve the robustness of the endpoint control and positioning accuracy of the spray arm, an improved potential field algorithm for the motion planning and control of the spray arm is proposed based on prophase research. The algorithm introduces a velocity potential field, visual field constraints and joint position limit constraints into the traditional artificial potential field method. The velocity potential field is used to ensure that the target state of the spraying arm is at the same velocity as the target crop (relative velocity) to achieve stable target tracking. The visual field constraints and joint position limit constraints are utilized to ensure the efficiency of the visual servo control and the movement of the spray arm. The algorithm can plan a feasible trajectory for the spraying arm in Cartesian space and image space, and use the speed controller to control the spraying arm movement along the trajectory for aiming and tracking. Simulation analysis shows that the algorithm can plan better motion trajectories than the servo controller based on image moments in previous studies. In addition, the experimental results show that the algorithm can effectively improve the robustness of targeting and tracking control for the spray robot.	[Zhao, Dongjie; Zhao, Ying; Sun, Qun; Wang, Chong] Liaocheng Univ, Sch Mech & Automot Engn, Liaocheng, Shandong, Peoples R China; [Zhang, Bin; Li, Chuanjun] China Agr Univ, Coll Engn, Beijing, Peoples R China	Liaocheng University; China Agricultural University	Zhao, DJ (corresponding author), Liaocheng Univ, Sch Mech & Automot Engn, Liaocheng, Shandong, Peoples R China.	zdj1977@126.com			National Natural Science Foundation of China [60703192]; Project of Shandong Province Higher Educational Science and Technology Program [KJ2018BBB032]; Doctoral Program Foundation of Institutions of Higher Education of China [20120008110046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shandong Province Higher Educational Science and Technology Program; Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work presented in this paper was carried out thanks to the support of the National Natural Science Foundation of China [grant number 60703192]; A Project of Shandong Province Higher Educational Science and Technology Program [grant number KJ2018BBB032]; and the Doctoral Program Foundation of Institutions of Higher Education of China [grant number 20120008110046]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2011, ROBOTICA, V29, P797, DOI 10.1017/S0263574710000767; Azzabi A, 2019, T I MEAS CONTROL, V41, P3132, DOI 10.1177/0142331218824393; Baizid K, 2015, ROBOT CIM-INT MANUF, V34, P140, DOI 10.1016/j.rcim.2014.12.003; Chen CT, 2011, ROBOT CIM-INT MANUF, V27, P72, DOI 10.1016/j.rcim.2010.06.012; Chen GL, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/1932812; De Momi E, 2016, FRONT ROBOT AI, V3, DOI 10.3389/frobt.2016.00034; Garcia-Santillan I, 2018, ADV INTELL SYST, V721, P355, DOI 10.1007/978-3-319-73450-7_34; Garcia-Santillan ID, 2017, BIOSYST ENG, V156, P61, DOI 10.1016/j.biosystemseng.2017.01.013; Hong SW, 2018, ATMOS ENVIRON, V175, P109, DOI 10.1016/j.atmosenv.2017.12.001; Hua CC, 2014, ROBOT CIM-INT MANUF, V30, P19, DOI 10.1016/j.rcim.2013.06.002; Kovacs B, 2016, ROBOT AUTON SYST, V82, P24, DOI 10.1016/j.robot.2016.04.007; Kumar PB, 2019, EXPERT SYST, V36, DOI 10.1111/exsy.12360; Li WY, 2018, J MATER SCI TECHNOL, V34, P440, DOI 10.1016/j.jmst.2017.09.015; Liu T, 2019, INT J PRECIS ENG MAN, V20, P1721, DOI 10.1007/s12541-019-00073-5; [刘雪美 Liu Xuemei], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P37; [卢翔 Lu Xiang], 2013, [机器人, Robot], V35, P218; Mezouar Y, 2002, IEEE T ROBOTIC AUTOM, V18, P534, DOI 10.1109/TRA.2002.802218; Ning Q, 2019, PHYS COMMUN-AMST, V35, DOI 10.1016/j.phycom.2019.100717; [邱白晶 Qiu Baijing], 2015, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V46, P59; Wang MM, 2015, ACTA ASTRONAUT, V112, P77, DOI 10.1016/j.actaastro.2015.03.008; Wang WS, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800484; Wen-Chung Chang, 2010, Proceedings of the SICE 2010 - 49th Annual Conference of the Society of Instrument and Control Engineers of Japan, P415; Xie L, 2019, OCEAN ENG, V184, P311, DOI 10.1016/j.oceaneng.2019.04.055; Xu Y., 2018, INT J ADV ROBOT SYST, V15, P1, DOI [10.1177/1729881418787075, DOI 10.1177/1729881418787075]; Yang CG, 2013, IEEE T CYBERNETICS, V43, P24, DOI 10.1109/TSMCB.2012.2198813; Zhang Q, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0247-z; [赵栋杰 Zhao Dongjie], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P22; Zhao SP, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112226	28	1	1	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226912	10.1371/journal.pone.0226912	http://dx.doi.org/10.1371/journal.pone.0226912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923217	Green Published, gold			2022-12-26	WOS:000534350000033
J	Lim, WW; Ng, B; Widjaja, A; Xie, C; Su, LP; Ko, N; Lim, SY; Kwek, XY; Lim, S; Cook, SA; Schafer, S				Lim, Wei-Wen; Ng, Benjamin; Widjaja, Anissa; Xie, Chen; Su, Liping; Ko, Nicole; Lim, Sze-Yun; Kwek, Xiu-Yi; Lim, Stella; Cook, Stuart Alexander; Schafer, Sebastian			Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; INTESTINAL INFLAMMATION; CELLS; IL-11; GALECTIN-3; CHEMOKINES; COLITIS; GP130	Interleukin 11 (IL11) is a profibrotic cytokine, secreted by myofibroblasts and damaged epithelial cells. Smooth muscle cells (SMCs) also secrete IL11 under pathological conditions and express the IL11 receptor. Here we examined the effects of SMC-specific, conditional expression of murine IL11 in a transgenic mouse (Il11(SMC)). Within days of transgene activation, Il11(SMC) mice developed loose stools and progressive bleeding and rectal prolapse, which was associated with a 65% mortality by two weeks. The bowel of Il11(SMC) mice was inflamed, fibrotic and had a thickened wall, which was accompanied by activation of ERK and STAT3. In other organs, including the heart, lung, liver, kidney and skin there was a phenotypic spectrum of fibro-inflammation, together with consistent ERK activation. To investigate further the importance of stromal-derived IL11 in the inflammatory bowel phenotype we used a second model with fibroblast-specific expression of IL11, the Il11(Fib) mouse. This additional model largely phenocopied the Il11(SMC) bowel phenotype. These data show that IL11 secretion from the stromal niche is sufficient to drive inflammatory bowel disease in mice. Given that IL11 expression in colonic stromal cells predicts anti-TNF therapy failure in patients with ulcerative colitis or Crohn's disease, we suggest IL11 as a therapeutic target for inflammatory bowel disease.	[Lim, Wei-Wen; Ng, Benjamin; Xie, Chen; Su, Liping; Lim, Sze-Yun; Kwek, Xiu-Yi; Cook, Stuart Alexander; Schafer, Sebastian] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Lim, Wei-Wen; Ng, Benjamin; Widjaja, Anissa; Ko, Nicole; Lim, Stella; Cook, Stuart Alexander; Schafer, Sebastian] Duke Natl Univ Singapore Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Cook, Stuart Alexander] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Cook, Stuart Alexander] MRC London Inst Med Sci, London, England	National Heart Centre Singapore; Imperial College London	Cook, SA; Schafer, S (corresponding author), Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore.; Cook, SA; Schafer, S (corresponding author), Duke Natl Univ Singapore Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore.; Cook, SA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Cook, SA (corresponding author), MRC London Inst Med Sci, London, England.	stuart.cook@singhealth.com; sebastian@duke-nus.edu.sg	Lim, Wei-Wen/AAC-7457-2019	Lim, Wei-Wen/0000-0003-0311-943X; Widjaja, Anissa/0000-0001-9404-7608	National Medical Research Council (NMRC) Singapore STaR awards [NMRC/STaR/0029/2017]; NMRC Central Grant; Goh Foundation; Tanoto Foundation; Fondation Leducq; Charles Toh Cardiovascular Fellowship; National Medical Research Council Young Individual Research Grant [MOH-OFYIRG18nov0003]; NMRC YIRG [NMRC/OFYIRG/0053/2017]; MRC [MC_U120085815] Funding Source: UKRI	National Medical Research Council (NMRC) Singapore STaR awards(National Medical Research Council, Singapore); NMRC Central Grant; Goh Foundation; Tanoto Foundation; Fondation Leducq(Leducq Foundation); Charles Toh Cardiovascular Fellowship; National Medical Research Council Young Individual Research Grant; NMRC YIRG; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by the National Medical Research Council (NMRC; https://www.nmrc.gov.sg/) Singapore STaR awards to S. A.C. (NMRC/STaR/0029/2017), the NMRC Central Grant to the NHCS, Goh Foundation, Tanoto Foundation and a grant from the Fondation Leducq. S.S. is supported by the Goh Foundation and Charles Toh Cardiovascular Fellowship and by the National Medical Research Council Young Individual Research Grant (MOH-OFYIRG18nov0003). A.A.W. is supported by the NMRC YIRG (NMRC/OFYIRG/0053/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arijs I, 2009, GUT, V58, P1612, DOI 10.1136/gut.2009.178665; Arijs I, 2010, INFLAMM BOWEL DIS, V16, P2090, DOI 10.1002/ibd.21301; Bandinelli F, 2012, CLIN EXP RHEUMATOL, V30, pS44; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Boerma M, 2007, CANCER RES, V67, P9501, DOI 10.1158/0008-5472.CAN-07-0810; Chen WQ, 2017, J CROHNS COLITIS, V11, P92, DOI 10.1093/ecco-jcc/jjw126; Collins SM, 1994, INFLAMM BOWEL DIS, P162, DOI [DOI 10.1007/978-94-009-0371-5_16, 10.1007/978-94-009-0371-5_16]; Cook SA, 2018, BIORXIV, P597, DOI [10.1101/336537, DOI 10.1101/336537]; Dahab GM, 2004, J GASTROEN HEPATOL, V19, P78, DOI 10.1111/j.1440-1746.2004.03183.x; de Bruyn JR, 2015, J CROHNS COLITIS, V9, P966, DOI 10.1093/ecco-jcc/jjv133; Denton CP, 2018, ANN RHEUM DIS, V77, P1362, DOI 10.1136/annrheumdis-2018-213031; DeRoche TC, 2014, GASTROENTEROL REP, V2, P178, DOI 10.1093/gastro/gou031; Diaz-Alvarez L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9247574; Diaz-Granados N, 2000, AM J PATHOL, V156, P2169, DOI 10.1016/S0002-9440(10)65087-0; Dong S, 1997, GLYCOCONJUGATE J, V14, P267, DOI 10.1023/A:1018554124545; Elias JA, 1997, AM J PHYSIOL-LUNG C, V273, pL648, DOI 10.1152/ajplung.1997.273.3.L648; Gibson DL, 2010, GASTROENTEROLOGY, V139, P1277, DOI 10.1053/j.gastro.2010.06.057; Grimm MC, 1996, J LEUKOCYTE BIOL, V59, P804, DOI 10.1002/jlb.59.6.804; Hasegawa M, 1998, J RHEUMATOL, V25, P308; Herrick AL, 2000, CURR OPIN RHEUMATOL, V12, P527, DOI 10.1097/00002281-200011000-00009; Jin BR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46252; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Kim H, 2007, CELL BIOL INT, V31, P655, DOI 10.1016/j.cellbi.2006.11.036; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Lakhan SE, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-37; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Mazzucchelli L, 1996, J PATHOL, V178, P201, DOI 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4; Minshall E, 2000, J ALLERGY CLIN IMMUN, V105, P232, DOI 10.1016/S0091-6749(00)90070-8; Orazi A, 1996, LAB INVEST, V75, P33; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qiu BS, 1996, DIGEST DIS SCI, V41, P1625, DOI 10.1007/BF02087911; Rossi JF, 2015, CLIN CANCER RES, V21, P1248, DOI 10.1158/1078-0432.CCR-14-2291; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Shea-Donohue T, 2012, NEUROGASTROENT MOTIL, V24, P802, DOI 10.1111/j.1365-2982.2012.01986.x; Shi XZ, 2005, AM J PHYSIOL-GASTR L, V289, pG274, DOI 10.1152/ajpgi.00512.2004; Shin JY, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw0790; Smillie C. S., 2018, BIORXIV, DOI [10.1101/455451, DOI 10.1101/455451]; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Sundblad V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00379; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Taki H, 1999, ATHEROSCLEROSIS, V144, P375, DOI 10.1016/S0021-9150(99)00009-X; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Widjaja A.A., 2019, REDEFINING INTERLEUK, DOI [10.1101/830018, DOI 10.1101/830018]; Widjaja AA, 2019, GASTROENTEROLOGY; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X	46	18	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227505	10.1371/journal.pone.0227505	http://dx.doi.org/10.1371/journal.pone.0227505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917819	Green Published, gold, Green Submitted			2022-12-26	WOS:000534341100021
J	Pang, HM; Wang, XD; Zhao, SQ; Xi, W; Lv, JL; Qin, JW; Zhao, Q; Che, YZ; Chen, LY; Li, SJ				Pang, Huimin; Wang, Xudong; Zhao, Shiqun; Xi, Wang; Lv, Jili; Qin, Jiwei; Zhao, Qing; Che, Yongzhe; Chen, Liangyi; Li, Shu Jie			Loss of the voltage-gated proton channel Hv1 decreases insulin secretion and leads to hyperglycemia and glucose intolerance in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin secretion; pancreatic islet; ?-cell; glucose metabolism; homeostasis; diabetes; Hv1; voltage-gated proton channel	BETA-CELL DYSFUNCTION; SUPEROXIDE-PRODUCTION; GRANULE DYNAMICS; INTRACELLULAR PH; EXOCYTOSIS; MECHANISMS; RELEASE; PROTEIN; MOUSE	Insulin secretion by pancreatic islet ?-cells is regulated by glucose levels and is accompanied by proton generation. The voltage-gated proton channel Hv1 is present in pancreatic ?-cells and extremely selective for protons. However, whether Hv1 is involved in insulin secretion is unclear. Here we demonstrate that Hv1 promotes insulin secretion of pancreatic ?-cells and glucose homeostasis. Hv1-deficient mice displayed hyperglycemia and glucose intolerance because of reduced insulin secretion but retained normal peripheral insulin sensitivity. Moreover, Hv1 loss contributed much more to severe glucose intolerance as the mice got older. Islets of Hv1-deficient and heterozygous mice were markedly deficient in glucose- and K+-induced insulin secretion. In perifusion assays, Hv1 deletion dramatically reduced the first and second phase of glucose-stimulated insulin secretion. Islet insulin and proinsulin content was reduced, and histological analysis of pancreas slices revealed an accompanying modest reduction of ?-cell mass in Hv1 knockout mice. EM observations also indicated a reduction in insulin granule size, but not granule number or granule docking, in Hv1-deficient mice. Mechanistically, Hv1 loss limited the capacity for glucose-induced membrane depolarization, accompanied by a reduced ability of glucose to raise Ca2+ levels in islets, as evidenced by decreased durations of individual calcium oscillations. Moreover, Hv1 expression was significantly reduced in pancreatic ?-cells from streptozotocin-induced diabetic mice, indicating that Hv1 deficiency is associated with ?-cell dysfunction and diabetes. We conclude that Hv1 regulates insulin secretion and glucose homeostasis through a mechanism that depends on intracellular Ca2+ levels and membrane depolarization.	[Pang, Huimin; Wang, Xudong; Xi, Wang; Lv, Jili; Qin, Jiwei; Zhao, Qing; Li, Shu Jie] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Dept Biophys,Sch Phys Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Zhao, Shiqun; Chen, Liangyi] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Che, Yongzhe] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Nankai University; Peking University; Nankai University	Chen, LY; Li, SJ (corresponding author), Nankai Univ, Minist Educ, Key Lab Bioact Mat, Dept Biophys,Sch Phys Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	lychen@pku.edu.cn; shujieli@nankai.edu.cn			National Natural Science Foundation of China [31271464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by National Natural Science Foundation of China Grant 31271464. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Barg S, 2001, J CELL SCI, V114, P2145; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CERASI E, 1975, DIABETOLOGIA, V11, P1, DOI 10.1007/BF00422811; CURRY DL, 1968, ENDOCRINOLOGY, V83, P572, DOI 10.1210/endo-83-3-572; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Gunawardana SC, 2002, DIABETES, V51, P105, DOI 10.2337/diabetes.51.1.105; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; HOSKER JP, 1989, METABOLISM, V38, P767, DOI 10.1016/0026-0495(89)90064-4; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LINDSTROM P, 1984, BIOCHEM J, V218, P887, DOI 10.1042/bj2180887; LINDSTROM P, 1986, BIOCHEM J, V239, P199, DOI 10.1042/bj2390199; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nunemaker CS, 2006, AM J PHYSIOL-ENDOC M, V290, pE523, DOI 10.1152/ajpendo.00392.2005; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; PACE CS, 1983, AM J PHYSIOL, V244, pE3, DOI 10.1152/ajpendo.1983.244.1.E3; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Qureshi FM, 2015, CELL CALCIUM, V57, P366, DOI 10.1016/j.ceca.2015.03.002; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; TAGUCHI N, 1995, ENDOCRINOLOGY, V136, P3942, DOI 10.1210/en.136.9.3942; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070550; Wang YF, 2012, J BIOL CHEM, V287, P13877, DOI 10.1074/jbc.M112.345280; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhao AZ, 2010, DIABETES, V59, P2522, DOI 10.2337/db09-1719; Zhao Q, 2015, BIOCHEM BIOPH RES CO, V468, P746, DOI 10.1016/j.bbrc.2015.11.027	40	6	6	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3601	3613		10.1074/jbc.RA119.010489	http://dx.doi.org/10.1074/jbc.RA119.010489			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31949049	hybrid, Green Published			2022-12-26	WOS:000527725300019
J	Chen, RK; Shimono, A; Aono, M; Nakajima, N; Ohsawa, R; Yoshioka, Y				Chen, Ruikun; Shimono, Ayako; Aono, Mitsuko; Nakajima, Nobuyoshi; Ohsawa, Ryo; Yoshioka, Yosuke			Genetic diversity and population structure of feral rapeseed (Brassica napus L.) in Japan	PLOS ONE			English	Article							OILSEED RAPE; PERSISTENCE; ENVIRONMENT; TRANSGENE; SOFTWARE; ESCAPE	Rapeseed (Brassica napus L.) is one of the most economically important oilseed crops worldwide. In Japan, it has been cultivated for more than a century and has formed many feral populations. The aim of this study was to elucidate the genetic diversity of feral rapeseeds by genotyping 537 individuals (among which 130 were determined to be genetically modified) sampled from various regions in Japan. Analysis of 30 microsatellite markers amplified 334 alleles and indicated moderate genetic diversity and high inbreeding (expected heterozygosity, 0.50; observed heterozygosity, 0.16; inbreeding coefficient within individuals, 0.68) within the feral populations. The Mantel test showed only an insignificant weak positive correlation between geographic distance and genetic distance. Analysis of molecular variance showed a greater genetic diversity among individuals than between populations. These results are in accordance with population structure assessed by using principal coordinate analysis and the program STRUCTURE, which showed that the 537 individuals could be assigned to 8 genetic clusters with very large genetic differences among individuals within the same geographic population, and that among feral individuals, many are closely related to rapeseed accessions in the NARO Genebank but some have unknown origins. These unique feral rapeseeds are likely to be affected by strong selection pressure. The results for genetically modified individuals also suggest that they have two different sources and have a considerable degree of diversity, which might be explained by hybridization with nearby individuals and separation of hybrid cultivars. The information obtained in this study could help improve the management of feral rapeseed plants in Japan.	[Chen, Ruikun] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Shimono, Ayako] Toho Univ, Fac Sci, Funabashi, Chiba, Japan; [Aono, Mitsuko; Nakajima, Nobuyoshi] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Ohsawa, Ryo; Yoshioka, Yosuke] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; Toho University; National Institute for Environmental Studies - Japan; University of Tsukuba	Yoshioka, Y (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yoshioka.yosuke.fw@u.tsukuba.ac.jp		Shimono, Ayako/0000-0001-5853-0475; Aono, Mitsuko/0000-0002-4452-8662	Ministry of Agriculture, Forestry and Fisheries of Japan [GRA-102]; University of Tsukuba	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); University of Tsukuba	This work was partly supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, GRA-102), and from the University of Tsukuba ("Sustainable Food Security Research Project"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Aono Mitsuko, 2011, GM Crops, V2, P201, DOI 10.4161/gmcr.2.3.18931; Bond JM, 2004, EUPHYTICA, V139, P173, DOI 10.1007/s10681-004-2781-3; Canola Council of Canada, 2019, CAN VAR SEL GUID; Chen RK, 2017, BREEDING SCI, P16192; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elling B, 2009, BASIC APPL ECOL, V10, P544, DOI 10.1016/j.baae.2009.01.005; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 2010, INTRO CONSERVATION G; Gilbert N., 2010, NATURE NEWS, DOI [10.1038/news.2010.393, DOI 10.1038/NEWS.2010.393]; Government of Canada, ARCHIVED GLYPH TOL C; Hoshikawa K., 1987, ORIGIN DIFFUSION DOM, P311; Katsuta K, 2005, BREEDING SCI, V65, P265; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu YB, 2010, PLANT SCI, V179, P459, DOI 10.1016/j.plantsci.2010.07.005; Malla S., 2015, AgBioForum, V18, P7; Ministry of finance Japan, TRAD STAT JAP; Mizuguti A, 2011, JARQ-JPN AGR RES Q, V45, P181, DOI 10.6090/jarq.45.181; Morrison MJ, 2016, CROP PASTURE SCI, V67, P245, DOI 10.1071/CP15348; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nishizawa Toru, 2010, GM Crops, V1, P143, DOI 10.4161/gmcr.1.3.12761; Pandolfo CE, 2018, ENVIRON SCI POLLUT R, V25, P6251, DOI 10.1007/s11356-017-0726-3; Pascher K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-63; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pivard S, 2008, J APPL ECOL, V45, P476, DOI 10.1111/j.1365-2664.2007.01358.x; Pritchard JK, 2000, GENETICS, V155, P945; Saji Hikaru, 2005, Environmental Biosafety Research, V4, P217, DOI 10.1051/ebr:2006003; Salisbury PA, 2016, CROP PASTURE SCI, V67, P266, DOI 10.1071/CP15262; SHIGA T., 1970, Japan Agricultural Research Quarterly, V5, P5; Shimizu Tokurou, 2011, BMC Res Notes, V4, P161, DOI 10.1186/1756-0500-4-161; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Statistics of Japan, 2008, CROP SURV PADD LAND; The Ministry of Agriculture Forestry and Fisheries of Japan, RES SURV GEN MOD PLA; The Ministry of Agriculture Forestry and Fisheries of Japan, CIRC SURR BUCKWH RAP; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227990	10.1371/journal.pone.0227990	http://dx.doi.org/10.1371/journal.pone.0227990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945118	Green Published, gold			2022-12-26	WOS:000534370100079
J	Jiang, SH; Dong, FY; Da, LT; Yang, XM; Wang, XX; Weng, JY; Feng, L; Zhu, LL; Zhang, YL; Zhang, ZG; Sun, YW; Li, J; Xu, MJ				Jiang, Shu-Heng; Dong, Fang-Yuan; Da, Lin-Tai; Yang, Xiao-Mei; Wang, Xiao-Xue; Weng, Jing-Yi; Feng, Lei; Zhu, Li-Li; Zhang, Yan-Li; Zhang, Zhi-Gang; Sun, Yong-Wei; Li, Jun; Xu, Min-Juan			Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2	FASEB JOURNAL			English	Article						chemosensitivity; hexokinase; pancreatic cancer; Streptomyces; Warburg effect	STREPTOMYCES XIAMENENSIS 318; METABOLIC REQUIREMENTS; 2-DEOXY-D-GLUCOSE; TUMORS	Mangrove-derived actinobacteria strains are well-known for producing novel secondary metabolites. The polycyclic tetramate macrolactam (PTM), ikarugamycin (IKA) isolated from Streptomyces xiamenensis 318, exhibits antiproliferative activities against pancreatic ductal adenocarcinoma (PDAC) in vitro. However, the protein target for bioactive IKA is unclear. In this study, whole transcriptome-based profiling revealed that the glycolysis pathway is significantly affected by IKA. Metabolomic studies demonstrated that IKA treatment induces a significant drop in glucose-6-phosphate and a slight increase in intracellular glucose level. Analysis of glucose consumption, lactate production, and the extracellular acidification rate confirmed the inhibitory role of IKA on the glycolytic flux in PDAC cells. Surface plasmon resonance (SPR) experiments and docking studies identified the key enzyme of glycolysis, hexokinase 2 (HK2), as a molecular target of IKA. Moreover, IKA reduced tumor size without overt cytotoxicity in mice with PDAC xenografts and increased chemotherapy response to gemcitabine in PDAC cells in vitro. Taken together, IKA can block glycolysis in pancreatic cancer by targeting HK2, which may be a potential drug candidate for PDAC treatment.	[Jiang, Shu-Heng; Da, Lin-Tai; Weng, Jing-Yi; Xu, Min-Juan] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Jiang, Shu-Heng; Yang, Xiao-Mei; Zhu, Li-Li; Zhang, Yan-Li; Zhang, Zhi-Gang; Li, Jun] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Dong, Fang-Yuan] Fudan Univ, Huadong Hosp, Shanghai Key Lab Clin Geriatr Med, Dept Gastroenterol, Shanghai, Peoples R China; [Wang, Xiao-Xue; Feng, Lei] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai, Peoples R China; [Sun, Yong-Wei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Biliary Pancreat Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xu, MJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.; Li, J (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	junli@shsci.org; minjuanxu@sjtu.edu.cn		Xu, Min-Juan/0000-0003-1768-208X	National Natural Science Foundation of China (NSFC) [81502382, 81473105]; National Natural Science Foundation of China; Shanghai Jiao Tong University; Fudan University;  [2019YFC0312501];  [19YF1445700];  [ZH2018ZDB08]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University; Fudan University; ; ; 	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81473105; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81502382; Research and Development, Grant/Award Number: 2019YFC0312501, 81502382, 19YF1445700 and ZH2018ZDB08; National Natural Science Foundation of China; Shanghai Jiao Tong University; Fudan University	Antosch J, 2014, ANGEW CHEM INT EDIT, V53, P3011, DOI 10.1002/anie.201310641; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Boeck S, 2017, LANCET, V390, P847, DOI 10.1016/S0140-6736(17)31806-8; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; Du Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10982; Elkin SR, 2016, TRAFFIC, V17, P1139, DOI 10.1111/tra.12425; Futamura Y, 2013, MOL BIOSYST, V9, P897, DOI 10.1039/c2mb25468a; Gandham SK, 2015, INT J NANOMED, V10, P4405, DOI 10.2147/IJN.S82818; Gordon-Dseagu VL, 2018, INT J EPIDEMIOL, V47, P427, DOI 10.1093/ije/dyx232; Habrook CJ, 2017, CANCER CELL, V31, P5, DOI 10.1016/j.ccell.2016.12.006; Hamanaka RB, 2012, J EXP MED, V209, P211, DOI 10.1084/jem.20120162; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HASUMI K, 1992, EUR J BIOCHEM, V205, P841, DOI 10.1111/j.1432-1033.1992.tb16848.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang SH, 2017, GASTROENTEROLOGY, V153, P277, DOI 10.1053/j.gastro.2017.03.008; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Lacret R, 2015, MAR DRUGS, V13, P128, DOI 10.3390/md13010128; Li W, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0530-4; Lin H, 2016, ACS MED CHEM LETT, V7, P217, DOI 10.1021/acsmedchemlett.5b00214; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nath K, 2016, BBA-REV CANCER, V1866, P151, DOI 10.1016/j.bbcan.2016.08.001; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Popescu R, 2011, MUTAT RES-FUND MOL M, V709-10, P60, DOI 10.1016/j.mrfmmm.2011.03.001; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Ros S, 2013, CANCER DISCOV, V3, P1105, DOI 10.1158/2159-8290.CD-13-0565; Salani B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02070; Schug ZT, 2016, CELL METAB, V23, P391, DOI 10.1016/j.cmet.2016.02.016; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xu MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18977; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yu HL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40689; Zhang GT, 2014, ANGEW CHEM INT EDIT, V53, P4840, DOI 10.1002/anie.201402078; Zhang XD, 2006, ANTICANCER RES, V26, P3561; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	42	12	12	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3943	3955		10.1096/fj.201901237R	http://dx.doi.org/10.1096/fj.201901237R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944405	Bronze			2022-12-26	WOS:000507596900001
J	Rivas, NA; Babayigit, A; Conings, B; Schwarz, T; Sturm, A; Manjon, AG; Cojocaru-Miredin, O; Gault, B; Renner, FU				Rivas, Nicolas Alfonso; Babayigit, Aslihan; Conings, Bert; Schwarz, Torsten; Sturm, Andreas; Manjon, Alba Garzon; Cojocaru-Miredin, Oana; Gault, Baptiste; Renner, Frank Uwe			Cryo-focused ion beam preparation of perovskite based solar cells for atom probe tomography	PLOS ONE			English	Article							DAMAGE	Focused-ion beam lift-out and annular milling is the most common method used for obtaining site specific specimens for atom probe tomography (APT) experiments and transmission electron microscopy. However, one of the main limitations of this technique comes from the structural damage as well as chemical degradation caused by the beam of high-energy ions. These aspects are especially critical in highly-sensitive specimens. In this regard, ion beam milling under cryogenic conditions has been an established technique for damage mitigation. Here, we implement a cryo-focused ion beam approach to prepare specimens for APT measurements from a quadruple cation perovskite-based solar cell device with 19.7% efficiency. As opposed to room temperature FIB milling we found that cryo-milling considerably improved APT results in terms of yield and composition measurement, i.e. halide loss, both related to less defects within the APT specimen. Based on our approach we discuss the prospects of reliable atom probe measurements of perovskite based solar cell materials. An insight into the field evaporation behavior of the organic-inorganic molecules that compose the perovskite material is also given with the aim of expanding the applicability of APT experiments towards nano-characterization of complex organo-metal materials.	[Rivas, Nicolas Alfonso; Babayigit, Aslihan; Conings, Bert; Renner, Frank Uwe] Hasselt Univ, Inst Mat Res IMO, Diepenbeek, Limburg, Belgium; [Rivas, Nicolas Alfonso; Babayigit, Aslihan; Conings, Bert] IMEC Vzw Div IMOMEC, Diepenbeek, Limburg, Belgium; [Rivas, Nicolas Alfonso; Schwarz, Torsten; Sturm, Andreas; Manjon, Alba Garzon; Gault, Baptiste] Max Planck Inst Eisenforsch GmbH, Dept Microstruct Phys & Alloy Design, Dusseldorf, North Rhein Wes, Germany; [Cojocaru-Miredin, Oana] Rhein Westfal TH Aachen, Inst Phys, Aachen, North Rhein Wes, Germany; [Gault, Baptiste] Imperial Coll, Royal Sch Mines, Dept Mat, London, England	Hasselt University; IMEC; Max Planck Society; RWTH Aachen University; Imperial College London	Rivas, NA (corresponding author), Hasselt Univ, Inst Mat Res IMO, Diepenbeek, Limburg, Belgium.; Rivas, NA (corresponding author), IMEC Vzw Div IMOMEC, Diepenbeek, Limburg, Belgium.; Rivas, NA (corresponding author), Max Planck Inst Eisenforsch GmbH, Dept Microstruct Phys & Alloy Design, Dusseldorf, North Rhein Wes, Germany.	nicolas.rivas@uhasselt.be	Manjón, Alba Garzón/AAF-3328-2021	Manjón, Alba Garzón/0000-0003-2954-1102; Rivas, Nicolas/0000-0003-0805-5543; Gault, Baptiste/0000-0002-4934-0458	German Research Foundation (DFG) [GA 2450/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	T.S. acknowledges the funding by the German Research Foundation (DFG) (Contract GA 2450/1-1).	[Anonymous], 2014, PEERJ, V2, pe447; Babayigit A, 2018, JOULE, V2, P1205, DOI 10.1016/j.joule.2018.06.009; Bassim ND, 2012, J MICROSC-OXFORD, V245, P288, DOI 10.1111/j.1365-2818.2011.03570.x; Chang YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08752-7; Choi P.-P., 2012, MICROSC TODAY, V20, P18, DOI DOI 10.1017/S1551929512000235; Conings B, 2016, ADV MATER, V28, P10701, DOI 10.1002/adma.201603747; Diercks DR, 2014, 2014 IEEE 40TH PHOTOVOLTAIC SPECIALIST CONFERENCE (PVSC), P85, DOI 10.1109/PVSC.2014.6925241; Duarte MJ, 2014, ACTA MATER, V71, P20, DOI 10.1016/j.actamat.2014.02.027; Gault B, 2012, ATOM PROBE MICROSCOP, Vxxiii; Gault B, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/3/033031; Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686; Greene ME, 2012, J MICROSC-OXFORD, V247, P288, DOI 10.1111/j.1365-2818.2012.03644.x; Greiwe GH, 2014, ULTRAMICROSCOPY, V141, P51, DOI 10.1016/j.ultramic.2014.03.007; Huheey JE, 1972, INORGANIC CHEM PRINC, Vxvi; Joester D., 2012, MICROSC TODAY, V20, P26, DOI [10.1017/S1551929512000260, DOI 10.1017/S1551929512000260]; Kelly TF, 2012, ANNU REV MATER RES, V42, P1, DOI 10.1146/annurev-matsci-070511-155007; Kelly TF, 2009, MRS BULL, V34, P744, DOI 10.1557/mrs2009.249; Kim S, 2011, ULTRAMICROSCOPY, V111, P191, DOI 10.1016/j.ultramic.2010.11.027; KINGHAM DR, 1982, SURF SCI, V116, P273, DOI 10.1016/0039-6028(82)90434-4; Kotulak NA, 2018, WORL CON PHOTOVOLT E, P0485, DOI 10.1109/PVSC.2018.8547348; Kubicki DJ, 2017, J AM CHEM SOC, V139, P14173, DOI 10.1021/jacs.7b07223; Larson T, 2013, PLACING THE SUSPECT BEHIND THE KEYBOARD: USING DIGITAL FORENSICS AND INVESTIGATIVE TECHNIQUES TO IDENTIFY CYBERCRIME SUSPECTS, pXVII; Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014; McCaffrey JP, 2001, ULTRAMICROSCOPY, V87, P97, DOI 10.1016/S0304-3991(00)00096-6; Medeiros JM, 2018, CURR OPIN MICROBIOL, V43, P62, DOI 10.1016/j.mib.2017.12.006; Muller M, 2011, ULTRAMICROSCOPY, V111, P487, DOI 10.1016/j.ultramic.2010.11.019; O Cojocaru-Miredin, 2011, 2011 37 IEEE PHOT SP; Prosa TJ, 2017, MICROSC MICROANAL, V23, P194, DOI 10.1017/S1431927616012642; Reese MO, 2018, NAT ENERGY, V3, P1002, DOI 10.1038/s41560-018-0258-1; Rigort A, 2015, ARCH BIOCHEM BIOPHYS, V581, P122, DOI 10.1016/j.abb.2015.02.009; Rothmann MU, 2018, ADV MATER, V30, DOI 10.1002/adma.201800629; Rusitzka KAK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36110-y; Saxey DW, 2011, ULTRAMICROSCOPY, V111, P473, DOI 10.1016/j.ultramic.2010.11.021; Schnorr K, 2014, FARADAY DISCUSS, V171, P41, DOI 10.1039/c4fd00031e; Shukla N, 2009, APPL SURF SCI, V256, P475, DOI 10.1016/j.apsusc.2009.07.024; SOMAYAJULU GR, 1960, J CHEM PHYS, V33, P1541, DOI 10.1063/1.1731440; Thompson K, 2007, ULTRAMICROSCOPY, V107, P131, DOI 10.1016/j.ultramic.2006.06.008; Villa E, 2014, BIOPHYS J, V106, p600A, DOI 10.1016/j.bpj.2013.11.3320; Volkert CA, 2007, MRS BULL, V32, P389, DOI 10.1557/mrs2007.62; Xiao ZG, 2015, NAT MATER, V14, P193, DOI [10.1038/nmat4150, 10.1038/NMAT4150]; Yuan HF, 2016, J PHYS CHEM LETT, V7, P561, DOI 10.1021/acs.jpclett.5b02828	41	19	19	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227920	10.1371/journal.pone.0227920	http://dx.doi.org/10.1371/journal.pone.0227920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KL0RY	31945119	Green Published, gold			2022-12-26	WOS:000513141500001
J	Truchetti, G; Otis, C; Brisville, AC; Beauchamp, G; Pang, D; Troncy, E				Truchetti, Geoffrey; Otis, Colombe; Brisville, Anne-Claire; Beauchamp, Guy; Pang, Daniel; Troncy, Eric			Management of veterinary anaesthesia in small animals: A survey of current practice in Quebec	PLOS ONE			English	Article							RISK-FACTORS; CONFIDENTIAL INQUIRY; POSTANESTHETIC HYPOTHERMIA; PAIN MANAGEMENT; PET OWNERS; DOGS; DEATH; COMPLICATIONS; GUIDELINES; MORTALITY	Objective To describe how small animal anaesthesia is performed in French-speaking Eastern Canada, and the variations between practices, in particular based on practice type, veterinarian gender and experience. Design Observational study, survey. Sample 156 respondents. Procedure A questionnaire was designed to assess current small animal anaesthesia practices in French-speaking Eastern Canada, mainly in the province of Quebec. The questionnaire was available through SurveyMonkey, and consisted of four parts: demographic information about the veterinarians surveyed, evaluation and management of anaesthetic risk, anaesthesia procedure, monitoring and safety. Gender, year of graduation, and type of practice were tested as potential risk factors. Chi-square exact test was used to study relations between each risk factor, and the effect of the selected risk factor on each response of the survey. For ordinal data, the Cochran-Mantel-Haenszel test was used to maximize power. Results Response rate over a period of 3 months was 20.85% (156 respondents). Overall, the way anaesthesia is performed by most respondents does not meet international guidelines, such as patient preparation and evaluation prior to anaesthesia, not using individualised protocols (for 41%), not obtaining intravenous access (12.4% use it for all their anaesthesia in cats, and 30.6% in dogs), lack of patient monitoring at certain intervals for 55% of the responses, and client prompted optional analgesia (for 29% of respondents). Some practices are more compliant than others. Among them, referral centres generally offer better care than general practices. Conclusions and clinical relevance The level of care in anaesthesia and analgesia in practices in French-speaking Eastern Canada is concerning, highlighting the need for more sustained continuing education.	[Truchetti, Geoffrey] Ctr Vet Rive Sud, Brossard, PQ, Canada; [Otis, Colombe; Beauchamp, Guy; Pang, Daniel; Troncy, Eric] Univ Montreal, Fac Vet Med, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ, Canada; [Brisville, Anne-Claire] Boehringer Ingelheim Anim Hlth, Bovine Unit, Burlington, ON, Canada	Universite de Montreal	Troncy, E (corresponding author), Univ Montreal, Fac Vet Med, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ, Canada.	eric.troncy@umontreal.ca	Troncy, Eric/J-6650-2013	Troncy, Eric/0000-0003-0209-5261; Pang, Daniel/0000-0002-6420-477X	Natural Sciences and Engineering Research Council (NSERC) of Canada [441651-2013, RDCPJ 491953-2016]; MITACS Canada Elevation postdoctoral scholarship [IT11643]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); MITACS Canada Elevation postdoctoral scholarship	There was not proprietary interest or funding directly provided for this project or to any of the authors. This work was indirectly supported (ET) by a Discovery grant (#441651-2013, supporting salaries) and a Collaborative Research and Development grant (#RDCPJ 491953-2016 supporting operations and salaries in partnership with ArthroLab Inc.) from the Natural Sciences and Engineering Research Council (NSERC) of Canada. CO is a recipient of a MITACS Canada Elevation postdoctoral scholarship (#IT11643). ACB received support in the form of salary from the Boehringer Ingelheim Animal Health, but she did participate in the survey outside of her regular tasks for the employer, which had in consequence no role in the present study. The authors got support from the company Dispomed Inc., i.e. to deliver the electronic survey to their clients, with the previous approval of the Ordre des me ' decins ve ' te ' rinaires du Que ' bec. The specific roles of all authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Veterinary Anesthesia and Analgesia, 2009, SMALL AN MON GUID; Association of American Veterinary Medical College, 2019, AAVMCS 2018 2019 ANN; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Bille C, 2012, VET ANAESTH ANALG, V39, P59, DOI 10.1111/j.1467-2995.2011.00686.x; Brodbelt DC, 2007, BRIT J ANAESTH, V99, P617, DOI 10.1093/bja/aem229; Brodbelt D.C., 2015, LUMB JONESVETERINARY, P11; Brodbelt DC, 2008, JAVMA-J AM VET MED A, V233, P1096, DOI 10.2460/javma.233.7.1096; Brodbelt DC, 2008, VET ANAESTH ANALG, V35, P365, DOI 10.1111/j.1467-2995.2008.00397.x; Brodbelt DC, 2006, VET REC, V158, P563, DOI 10.1136/vr.158.16.563; Carter JE, 2017, J AM ANIM HOSP ASSOC, V53, P206, DOI [10.5326/JAAHA-MS-6512, 10.5326/jaaha-ms-6512]; Clark WT, 2002, AUST VET J, V80, P37, DOI 10.1111/j.1751-0813.2002.tb12830.x; Clarke K. W., 1990, Journal of the Association of Veterinary Anaesthetists of Great Britain and Ireland, V17, P4; Duke-Novakovski T., 2016, BSAVA MANUAL CANINE; Dyson DH, 1998, J AM ANIM HOSP ASSOC, V34, P325, DOI 10.5326/15473317-34-4-325; Epstein M, 2015, J AM ANIM HOSP ASSOC, V51, P67, DOI 10.5326/JAAHA-MS-7331; Gaynor JS, 1999, J AM ANIM HOSP ASSOC, V35, P13, DOI 10.5326/15473317-35-1-13; Gil L, 2013, VET ANAESTH ANALG, V40, pE57, DOI 10.1111/vaa.12059; Hall LW, 2000, VET ANAESTHESIA; Hallqvist L, 2018, EUR J ANAESTH, V35, P273, DOI 10.1097/EJA.0000000000000735; Hallqvist L, 2016, EUR J ANAESTH, V33, P450, DOI 10.1097/EJA.0000000000000429; Hewson CJ, 2006, CAN VET J, V47, P453; Hosgood G, 2002, J VET EMERG CRIT CAR, V12, P9, DOI 10.1046/j.1534-6935.2002.00002.x; Hosgood G, 2007, J VET EMERG CRIT CAR, V8, P222, DOI DOI 10.1111/J.1476-4431.1998.TB00128.X; Iadarola MJ, 2018, PAIN, V159, P2105, DOI 10.1097/j.pain.0000000000001314; Joubert KE, 2007, J S AFR VET ASSOC, V78, P31; Mathews K, 2014, J SMALL ANIM PRACT, V55, pE10, DOI 10.1111/jsap.12200; Matthews NS, 2017, JAVMA-J AM VET MED A, V250, P655, DOI 10.2460/javma.250.6.655; Mckelvey D., 2003, VET ANAESTH ANALG; Oliver JAC, 2010, VET OPHTHALMOL, V13, P244, DOI 10.1111/j.1463-5224.2010.00793.x; Redondo JI, 2007, J VET MED A, V54, P470, DOI 10.1111/j.1439-0442.2007.00987.x; Redondo JI, 2012, VET REC, V171, P374, DOI 10.1136/vr.100476; Redondo JI, 2012, VET REC, V170, P206, DOI 10.1136/vr.100184; Robertson SA, 2018, J FELINE MED SURG, V20, P602, DOI [10.1177/1098612x18781391, 10.1177/1098612X18781391]; SAWYER DC, 1991, AM J VET RES, V52, P1826; SAWYER DC, 1987, J AM ANIM HOSP ASSOC, V23, P438; Seymour C, 2007, BSAVA MANUAL CANINE; Simon BT, 2018, VET SURG, V47, P277, DOI 10.1111/vsu.12753; Steagall PV, 2017, J SMALL ANIM PRACT, V58, P380, DOI 10.1111/jsap.12674; Wagner AE, 2003, J AM VET MED ASSOC, V223, P1426, DOI 10.2460/javma.2003.223.1426; Warne LN, 2018, AUST VET J, V96, P413, DOI 10.1111/avj.12762	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227204	10.1371/journal.pone.0227204	http://dx.doi.org/10.1371/journal.pone.0227204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945076	Green Published, gold			2022-12-26	WOS:000534370100024
J	Chapman, TB; Schoennagel, T; Veblen, TT; Rodman, KC				Chapman, Teresa B.; Schoennagel, Tania; Veblen, Thomas T.; Rodman, Kyle C.			Still standing: Recent patterns of post-fire conifer refugia in ponderosa pine-dominated forests of the Colorado Front Range	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; WESTERN UNITED-STATES; CLIMATE-CHANGE; FIRE SEVERITY; BURN SEVERITY; SPATIAL-PATTERNS; WILDFIRE; REGENERATION; REGIMES; RESILIENCE	Forested fire refugia (trees that survive fires) are important disturbance legacies that provide seed sources for post-fire regeneration. Conifer regeneration has been limited following some recent western fires, particularly in ponderosa pine (Pinus ponderosa) forests. However, the extent, characteristics, and predictability of ponderosa pine fire refugia are largely unknown. Within 23 fires in ponderosa pine-dominated forests of the Colorado Front Range (1996-2013), we evaluated the spatial characteristics and predictability of refugia: first using Monitoring Trends in Burn Severity (MTBS) burn severity metrics, then using land-scape variables (topography, weather, anthropogenic factors, and pre-fire forest cover). Using 1-m resolution aerial imagery, we created a binary variable of post-fire conifer presence ('Conifer Refugia') and absence ('Conifer Absence') within 30-m grid cells. We found that maximum patch size of Conifer Absence was positively correlated with fire size, and 38% of the burned area was >= 50m from a conifer seed source, revealing a management challenge as fire sizes increase with warming further limiting conifer recovery. In predicting Conifer Refugia with two MTBS-produced databases, thematic burn severity classes (TBSC) and continuous Relative differenced Normalized Burn Ratio (RdNBR) values, Conifer Absence was high in previously forested areas of Low and Moderate burn severity classes in TBSC. RdNBR more accurately identified post-fire conifer survivorship. In predicting Conifer Refugia with landscape variables, Conifer Refugia were less likely during burn days with high maximum temperatures: while Conifer Refugia were more likely on moister soils and closer to higher order streams, homes, and roads; and on less rugged, valley topography. Importantly, pre-fire forest canopy cover was not strongly associated with Conifer Refugia. This study further informs forest management by mapping post-fire patches lacking conifer seed sources, validating the use of RdNBR for fire refugia, and detecting abiotic and topographic variables that may promote conifer refugia.	[Chapman, Teresa B.] Nature Conservancy, Boulder, CO 80302 USA; [Chapman, Teresa B.; Schoennagel, Tania; Veblen, Thomas T.; Rodman, Kyle C.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Schoennagel, Tania] Univ Colorado, Inst Arctic & Alpine Res INSTAAR, Boulder, CO 80309 USA	Nature Conservancy; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chapman, TB (corresponding author), Nature Conservancy, Boulder, CO 80302 USA.; Chapman, TB (corresponding author), Univ Colorado, Dept Geog, Boulder, CO 80309 USA.	tchapman@tnc.org		Chapman, Teresa/0000-0003-3021-1231	U.S. National Science Foundation [1030845]; Australian Research Council [DP170101288]; Joint Fire Science Program Graduate Research Innovation Award [17-2-01-4 KR]	U.S. National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Joint Fire Science Program Graduate Research Innovation Award	This work was funded by the U.S. National Science Foundation Award No. 1030845 to TBC and TTV (www.nsf.gov), Australian Research Council Award DP170101288 to TTV (www.arc.gov.au), and Joint Fire Science Program Graduate Research Innovation Award 17-2-01-4 KR and TTV (www.firescience.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2017, INT J WILDLAND FIRE, V26, P269, DOI [10.1071/wf16165, 10.1071/WF16165]; Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Abella SR, 2013, FOREST ECOL MANAG, V310, P632, DOI 10.1016/j.foreco.2013.09.022; Abella SR, 2009, CAN J FOREST RES, V39, P2391, DOI 10.1139/X09-146; Addington RN, 2018, RMRSGTR373 DEP AGR F; Baker WL, 2015, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00088; Barbero R, 2015, INT J WILDLAND FIRE, V24, P892, DOI 10.1071/WF15083; Battaglia MA, 2018, FOREST ECOL MANAG, V422, P147, DOI 10.1016/j.foreco.2018.04.010; Birch DS, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00213.1; Bonnet VH, 2005, CAN J FOREST RES, V35, P37, DOI 10.1139/x04-157; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown PM, 2015, CAN J FOREST RES, V45, P1462, DOI 10.1139/cjfr-2014-0387; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Caggiano MD, 2017, FRONT RANG ROUND TAB; Caggiano MD, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00174; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Camp A, 1997, FOREST ECOL MANAG, V95, P63, DOI 10.1016/S0378-1127(97)00006-6; Cansler CA, 2014, ECOL APPL, V24, P1037, DOI 10.1890/13-1077.1; Chambers ME, 2016, FOREST ECOL MANAG, V378, P57, DOI 10.1016/j.foreco.2016.07.001; Chaney NW, 2016, GEODERMA, V274, P54, DOI 10.1016/j.geoderma.2016.03.025; Collins L, 2019, GLOBAL CHANGE BIOL, V25, P3829, DOI 10.1111/gcb.14735; Coop JD, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2809; Davis KT, 2019, P NATL ACAD SCI USA, V116, P6193, DOI 10.1073/pnas.1815107116; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; DeRose RJ, 2014, FOREST SCI, V60, P1205, DOI 10.5849/forsci.13-507; Dillon GK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00271.1; Donchyts G, 2016, GLOBAL 30M HEIGHT NE, DOI [10.13140/RG.2.1.3956.8880, DOI 10.13140/RG.2.1.3956.8880]; Donnegan JA, 2001, CAN J FOREST RES, V31, P1526, DOI 10.1139/cjfr-31-9-1526; Dwire KA, 2003, FOREST ECOL MANAG, V178, P61, DOI 10.1016/S0378-1127(03)00053-7; Eidenshink J., 2007, FIRE ECOL, V3, P3, DOI [DOI 10.4996/FIREECOLOGY.0301003, 10.4996/fireecology.0301003]; Fornwalt PJ, 2016, FIRE ECOL, V12, P117, DOI 10.4996/fireecology.1203117; Gartner MH, 2012, INT J WILDLAND FIRE, V21, P562, DOI 10.1071/WF10103; Graham R, 2012, 289 RMRSGTR FORT COL, P289, DOI [10.2737/RMRS-GTR-289, DOI 10.2737/RMRS-GTR-289]; Haffey C, 2018, FIRE ECOL, V14, DOI 10.4996/fireecology.140114316; Haire SL, 2010, LANDSCAPE ECOL, V25, P1055, DOI 10.1007/s10980-010-9480-3; Halofsky JE, 2018, FOREST ECOL MANAG, V421, P84, DOI 10.1016/j.foreco.2018.02.037; Holsinger L, 2016, FOREST ECOL MANAG, V380, P59, DOI 10.1016/j.foreco.2016.08.035; Huckaby LS, 2000, US FOR SERV RMRS-P, P19; Hurteau MD, 2016, ECOL APPL, V26, P382, DOI 10.1890/15-0337; Johnstone JF, 2016, FRONT ECOL ENVIRON, V14, P369, DOI 10.1002/fee.1311; Kaufmann M.R., 2006, HIST FIRE REGIMES PO, DOI 10.13140/RG.2.1.3834.1521; Kaufmann MR, 2016, SRFSN PUBL; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Keith RP, 2010, J VEG SCI, V21, P488, DOI 10.1111/j.1654-1103.2009.01156.x; Kemp KB, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2568; Kemp KB, 2016, LANDSCAPE ECOL, V31, P619, DOI 10.1007/s10980-015-0268-3; Kennedy MC, 2014, FOREST ECOL MANAG, V318, P122, DOI 10.1016/j.foreco.2014.01.014; Keyser AR, 2019, FOREST ECOL MANAG, V432, P694, DOI 10.1016/j.foreco.2018.09.027; Kolden CA, 2015, INT J WILDLAND FIRE; Korb JE, 2019, FOREST ECOL MANAG, V454, DOI 10.1016/j.foreco.2019.117663; Krawchuk MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1632; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Lukas J., 2014, CLIMATE CHANGE COLOR; Lutz JA, 2018, GLOBAL ECOL BIOGEOGR, V27, P849, DOI 10.1111/geb.12747; Malone SL, 2018, FORESTS, V9, DOI 10.3390/f9010045; Marr JW, 1961, U COLORADO STUDIES S, V8, P134; Matonis MS, 2018, FOREST ECOL MANAG, V411, P120, DOI 10.1016/j.foreco.2018.01.019; Mccauley LA, 2019, ECOL APPL, V29, DOI 10.1002/eap.1979; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; McGuire CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044370; Meddens AJH, 2018, BIOSCIENCE, V68, P944, DOI 10.1093/biosci/biy103; Meddens AJH, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2029; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Miller JD, 2007, REMOTE SENS ENVIRON, V109, P66, DOI 10.1016/j.rse.2006.12.006; Odion DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087852; Owen SM, 2017, FOREST ECOL MANAG, V405, P134, DOI 10.1016/j.foreco.2017.09.005; PEET RK, 1981, VEGETATIO, V45, P3; Pettit NE, 2007, ECOSYSTEMS, V10, P673, DOI 10.1007/s10021-007-9048-5; Picotte JJ, 2016, INT J WILDLAND FIRE, V25, P413, DOI 10.1071/WF15039; Porter AAB, 2019, THESIS; Puhlick JJ, 2012, FOREST ECOL MANAG, V264, P10, DOI 10.1016/j.foreco.2011.10.002; R Core Team, 2021, R LANGUAGE ENV STAT; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Rice JR, 2018, RMRSGTR376 FORT COLL, V376; Rodman KC, 2020, ECOL APPL, V30, DOI 10.1002/eap.2001; Rodman KC, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2594; ROMME WH, 2003, HAYMAN FIRE CASE STU, P181; Rother MT, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1594; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Scheffer M, 2015, ANNU REV ECOL EVOL S, V46, P145, DOI 10.1146/annurev-ecolsys-112414-054242; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schoennagel T, 2011, ECOL APPL, V21, P2210, DOI 10.1890/10-1222.1; Sherriff RL, 2007, ECOSYSTEMS, V10, P311, DOI 10.1007/s10021-007-9022-2; Sherriff RL, 2006, J VEG SCI, V17, P705, DOI 10.1111/j.1654-1103.2006.tb02494.x; Sherriff RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106971; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Stevens-Rumann CS, 2019, FIRE ECOL, V15, DOI 10.1186/s42408-019-0032-1; Stevens-Rumann CS, 2018, ECOL LETT, V21, P243, DOI 10.1111/ele.12889; Tepley AJ, 2018, J ECOL, V106, P1925, DOI 10.1111/1365-2745.12950; Theobald DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143619; Therneau T, 2015, PACKAGERPART; Vander Wall SB, 2008, ECOLOGY, V89, P1837, DOI 10.1890/07-0409.1; Veblen T.T., 2005, HIST RANGE VARIABILI; Veblen TT, 2000, ECOL APPL, V10, P1178, DOI 10.1890/1051-0761(2000)010[1178:CAHIOF]2.0.CO;2; Walker RB, 2019, FORESTS, V10, DOI 10.3390/f10090782; Walker RB, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2182; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Whitman E, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2128; Wilkin KM, 2016, FORESTS, V7, DOI 10.3390/f7040077; Ziegler JP, 2017, FORESTS, V8, DOI 10.3390/f8100391	101	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226926	10.1371/journal.pone.0226926	http://dx.doi.org/10.1371/journal.pone.0226926			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940320	Green Published, gold			2022-12-26	WOS:000534368000049
J	Lahmann, AL; Bongiovanni, D; Berkefeld, A; Kettern, M; Martinez, L; Okrojek, R; Hoppmann, P; Laugwitz, KL; Mayr, P; Cassese, S; Byrne, R; Kutner, S; Xhepal, E; Schunkert, H; Kastrati, A; Joner, M				Lahmann, Anna Lena; Bongiovanni, Dario; Berkefeld, Anna; Kettern, Maximilian; Martinez, Lucas; Okrojek, Rainer; Hoppmann, Petra; Laugwitz, Karl-Ludwig; Mayr, Patrick; Cassese, Salvatore; Byrne, Robert; Kutner, Sebastian; Xhepal, Erion; Schunkert, Heribert; Kastrati, Adnan; Joner, Michael			Predicting factors for long-term survival in patients with out-of-hospital cardiac arrest - A propensity score-matched analysis	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; MYOCARDIAL-INFARCTION; COMATOSE SURVIVORS; OUTCOMES; CATHETERIZATION; CARE; ASSOCIATION; IMPACT; HEART; LIFE	Background Out-of-hospital cardiac arrest (OHCA) is one of the leading causes of death worldwide, with acute coronary syndromes accounting for most of the cases. While the benefit of early revascularization has been clearly demonstrated in patients with ST-segment-elevation myocardial infarction (STEMI), diagnostic pathways remain unclear in the absence of STEMI. We aimed to characterize OHCA patients presenting to 2 tertiary cardiology centers and identify predicting factors associated with survival. Methods We retrospectively analyzed 519 patients after OHCA from February 2003 to December 2017 at 2 centers in Munich, Germany. Patients undergoing immediate coronary angiography (CAG) were compared to those without. Multivariate regression analysis and inverse probability treatment weighting (IPTW) were performed to identify predictors for improved outcome in a matched population. Results Immediate CAG was performed in 385 (74.1%) patients after OHCA with presumed cardiac cause of arrest. As a result of multivariate analysis after propensity score matching, we found that immediate CAG, return of spontaneous circulation (ROSC) at admission, witnessed arrest and former smoking were associated with improved 30-days-survival [(OR, 0.46; 95% CI, 0.26-0.84), (OR, 0.21; 95% CI, 0.10-0.45), (OR, 0.50; 95% CI, 0.26-0.97), (OR, 0.43; 95% CI, 0.23-0.81)], and 1-year-survival [(OR, 0.39; 95% CI, 0.19-0.82), (OR, 0.29; 95% CI, 0.12-0.7), (OR, 0.43; 95% CI, 0.2-1.00), (OR, 0.3; 95% CI, 0.14-0.63)]. Conclusions In our study, immediate CAG, ROSC at admission, witnessed arrest and former smoking were independent predictors of survival in cardiac arrest survivors. Improvement in prehospital management including bystander CPR and best practice post-resuscitation care with optimized triage of patients to an early invasive strategy may help ameliorate overall outcome of this critically-ill patient population.	[Lahmann, Anna Lena; Kettern, Maximilian; Martinez, Lucas; Cassese, Salvatore; Byrne, Robert; Kutner, Sebastian; Xhepal, Erion; Schunkert, Heribert; Kastrati, Adnan; Joner, Michael] Tech Univ Munich, German Heart Ctr Munich, Dept Cardiol, Munich, Germany; [Bongiovanni, Dario; Berkefeld, Anna; Okrojek, Rainer; Hoppmann, Petra; Laugwitz, Karl-Ludwig] Tech Univ Munich, Dept Cardiol, Klinikum Rechts Isar, Munich, Germany; [Laugwitz, Karl-Ludwig; Schunkert, Heribert; Kastrati, Adnan; Joner, Michael] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Mayr, Patrick] Tech Univ Munich, German Heart Ctr Munich, Dept Anesthesiol, Munich, Germany	German Heart Centre Munich; Technical University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; German Heart Centre Munich; Technical University of Munich	Lahmann, AL (corresponding author), Tech Univ Munich, German Heart Ctr Munich, Dept Cardiol, Munich, Germany.	annalena@lahmann.at	Bongiovanni, Dario/AAB-9161-2021; Mayr, N. Patrick/C-7389-2017; Xhepa, Erion/N-4435-2016; Joner, Michael/AAR-1229-2021; Xhepa, Erion/GQA-5562-2022	Bongiovanni, Dario/0000-0002-4162-1482; Mayr, N. Patrick/0000-0002-3549-3007; Xhepa, Erion/0000-0002-0728-2819; 				ABRAMSON NS, 1988, CRIT CARE MED, V16, P1053, DOI 10.1097/00003246-198810000-00019; Adrie C, 2006, EUR HEART J, V27, P2840, DOI 10.1093/eurheartj/ehl335; Anyfantakis ZA, 2009, AM HEART J, V157, P312, DOI 10.1016/j.ahj.2008.09.016; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Blom MT, 2014, CIRCULATION, V130, P1868, DOI 10.1161/CIRCULATIONAHA.114.010905; Bunch TJ, 2003, NEW ENGL J MED, V348, P2626, DOI 10.1056/NEJMoa023053; Camuglia AC, 2014, RESUSCITATION, V85, P1533, DOI 10.1016/j.resuscitation.2014.08.025; Dumas F, 2010, CIRC-CARDIOVASC INTE, V3, P200, DOI 10.1161/CIRCINTERVENTIONS.109.913665; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; GRUBB NR, 1995, LANCET, V346, P417, DOI 10.1016/S0140-6736(95)92784-0; Gupta T, 2014, AM J CARDIOL, V114, P169, DOI 10.1016/j.amjcard.2014.04.021; Hollenbeck RD, 2014, RESUSCITATION, V85, P88, DOI 10.1016/j.resuscitation.2013.07.027; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Kern KB, 2015, JACC-CARDIOVASC INTE, V8, P1031, DOI 10.1016/j.jcin.2015.02.021; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Rittenberger JC, 2011, RESUSCITATION, V82, P1036, DOI 10.1016/j.resuscitation.2011.03.034; Roberts Alexandra, 2014, Nat Rev Cardiol, V11, P374, DOI 10.1038/nrcardio.2014.73; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Soholm H, 2015, CIRC-CARDIOVASC QUAL, V8, P268, DOI 10.1161/CIRCOUTCOMES.115.001767; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stiell I, 2003, CIRCULATION, V108, P1939, DOI 10.1161/01.CIR.0000095028.95929.B0; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Strote JA, 2012, AM J CARDIOL, V109, P451, DOI 10.1016/j.amjcard.2011.09.036; Wibrandt I, 2015, BMC EMERG MED, V15, DOI 10.1186/s12873-015-0028-3; Zanuttini D, 2012, AM J CARDIOL, V110, P1723, DOI 10.1016/j.amjcard.2012.08.006	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0218634	10.1371/journal.pone.0218634	http://dx.doi.org/10.1371/journal.pone.0218634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940337	Green Submitted, Green Published, gold			2022-12-26	WOS:000534368000001
J	Krackhardt, F; Waliszewski, M; Ahmad, WAW; Kocka, V; Tousek, P; Janek, B; Trencan, M; Krajci, P; Lozano, F; Garcia-San Roman, K; Irurueta, IO; del Blanco, BG; Wachowiak, L; del Olmo, VV; Nofrerias, EF; Jeong, MH; Jung, BC; Han, KR; Piot, C; Sebagh, L; Rischner, J; Pansieri, M; Leschke, M; Ahn, TH				Krackhardt, Florian; Waliszewski, Matthias; Ahmad, Wan Azman Wan; Kocka, Viktor; Tousek, Petr; Janek, Bronislav; Trencan, Milan; Krajci, Peter; Lozano, Fernando; Garcia-San Roman, Koldobika; Otaegui Irurueta, Imanol; Garcia del Blanco, Bruno; Wachowiak, Lucie; Vilalta del Olmo, Victoria; Fernandez Nofrerias, Eduard; Jeong, Myung Ho; Jung, Byung-Chun; Han, Kyu-Rock; Piot, Christophe; Sebagh, Laurent; Rischner, Jerome; Pansieri, Michel; Leschke, Matthias; Ahn, Tae Hoon			Polymer-free sirolimus-eluting stent use in Europe and Asia: Ethnic differences in demographics and clinical outcomes	PLOS ONE			English	Article							STRUT BARE METAL; TRIALS	Background The objective of this study was to assess regional and ethnic differences in an unselected patient population treated with polymer-free sirolimus-eluting stents (PF-SES) in Asia and Europe. Methods Two all-comers observational studies based on the same protocol (ClinicalTrials.gov Identifiers: NCT02629575 and NCT02905214) were combined for data analysis to assure sufficient statistical power. The primary endpoint was the accumulated target lesion revascularization (TLR) rate at 9-12 months. Results Of the total population of 7243 patients, 44.0% (3186) were recruited in the Mediterranean region and 32.0% (2317) in central Europe. The most prominent Asian region was South Korea (17.6%, 1274) followed by Malaysia (5.7%, 413). Major cardiovascular risk factors varied significantly across regions. The overall rates for accumulated TLR and MACE were low with 2.2% (140/6374) and 4.4% (279/6374), respectively. In ACS patients, there were no differences in terms of MACE, TLR, MI and accumulated mortality between the investigated regions. Moreover, dual antiplatelet therapy (DAPT) regimens were substantially longer in Asian countries even in patients with stable coronary artery disease as compared to those in Europe. Conclusions PF-SES angioplasty is associated with low clinical event rates in all regions. Further reductions in clinical event rates seem to be associated with longer DAPT regimens.	[Krackhardt, Florian; Waliszewski, Matthias] Charite Univ Med Berlin, Dept Internal Med & Cardiol, Campus Virchow, Berlin, Germany; [Waliszewski, Matthias] B Braun Melsungen AG, Med Sci Affairs, Berlin, Germany; [Ahmad, Wan Azman Wan] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Kocka, Viktor; Tousek, Petr] Univ Hosp Kralovske Vinohrady Prague, Prague, Czech Republic; [Janek, Bronislav] IKEM Prague, Prague, Czech Republic; [Trencan, Milan; Krajci, Peter] SUSCCH As, Banska Bystrica, Slovakia; [Lozano, Fernando] Hosp Gen Univ Ciudad Real, Ciudad Real, Spain; [Garcia-San Roman, Koldobika] Hosp Univ Cruces, Bilbao, Spain; [Otaegui Irurueta, Imanol; Garcia del Blanco, Bruno] Hosp Univ Vail Hebron, Barcelona, Spain; [Wachowiak, Lucie] B Braun France, Med Sci Affairs, St Cloud, France; [Vilalta del Olmo, Victoria; Fernandez Nofrerias, Eduard] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Jeong, Myung Ho] Chonnam Natl Univ, Gwangju, South Korea; [Jung, Byung-Chun] Daegu Fatima Hosp, Daegu, South Korea; [Han, Kyu-Rock] Kangdong Sacred Heart Hosp, Kangdong, South Korea; [Piot, Christophe] Clin Millenaire, Montpellier, France; [Sebagh, Laurent] Clin Turin, Paris, France; [Rischner, Jerome] Hop Albert Schweitzer, Colmar, France; [Pansieri, Michel] Ctr Hosp Avignon, Avignon, France; [Leschke, Matthias] Stadt Kliniken Esslingen, Esslingen, Germany; [Ahn, Tae Hoon] Gachon Univ, Gil Med Ctr, Incheon, South Korea	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; B Braun Melsungen; Universiti Malaya; University Hospital Vinohrady; Hospital Universitario Cruces; Hospital Universitari Vall d'Hebron; Hospital Germans Trias i Pujol; Chonnam National University; Daegu Fatima Hospital; Gachon University	Krackhardt, F (corresponding author), Charite Univ Med Berlin, Dept Internal Med & Cardiol, Campus Virchow, Berlin, Germany.	Florian.Krackhardt@charite.de	Fernandez Nofrerias, Eduard/AAO-3956-2021; 안, 태훈/GON-9067-2022	Fernandez Nofrerias, Eduard/0000-0003-2219-921X; 안, 태훈/0000-0003-1544-1784; Garcia del Blanco, Bruno/0000-0002-4527-1600; Krackhardt, Florian/0000-0001-5965-8817; Piot, Christophe/0000-0001-7497-0294; Vilalta, Victoria/0000-0003-1767-5963; Waliszewski, Matthias/0000-0002-8689-4505; Jeong, Myung Ho/0000-0003-2424-810X				Ananthakrishna R, 2018, CATHETER CARDIO INTE, V92, P1097, DOI 10.1002/ccd.27577; Bae JS, 2018, CURR VASC PHARMACOL, V16, P459, DOI 10.2174/1570161116666180117103238; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Hickman PE, 2015, CRIT REV CL LAB SCI, V52, P28, DOI 10.3109/10408363.2014.972497; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Inohara T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128252; Jensen LO, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003610; Klomp M, 2012, CORONARY ARTERY DIS, V23, P271, DOI 10.1097/MCA.0b013e328351aaed; Krackhardt F, 2018, CATHETER CARDIO INTE, V91, P1221, DOI 10.1002/ccd.27306; Krackhardt F, 2017, OPEN HEART, V4, DOI 10.1136/openhrt-2017-000592; Leschke M, 2016, CATHETER CARDIO INTE, V88, P358, DOI 10.1002/ccd.26261; Leschke Matthias, 2012, Indian Heart J, V64, P453, DOI 10.1016/j.ihj.2012.08.002; Mehran R, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.118.006918; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Pepe M, 2019, AM J CARDIOL, V124, P1518, DOI 10.1016/j.amjcard.2019.08.015; Pepe M, 2019, AM J CARDIOL, V124, P195, DOI 10.1016/j.amjcard.2019.04.015; Reddon H, 2018, OBES REV, V19, P1525, DOI 10.1111/obr.12742; Sperling C, 2019, THER ADV CARDIO DIS, V13, DOI 10.1177/1753944719826335; Tong JL, 2016, J GERIATR CARDIOL, V13, P830, DOI 10.11909/j.issn.1671-5411.2016.10.001; van Oeffelen AAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136415; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Wohrle J, 2012, J AM COLL CARDIOL, V60, P1733, DOI 10.1016/j.jacc.2012.07.040; Yeh RW, 2017, JACC-CARDIOVASC INTE, V10, P247, DOI 10.1016/j.jcin.2016.11.004	23	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226606	10.1371/journal.pone.0226606	http://dx.doi.org/10.1371/journal.pone.0226606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929543	gold, Green Published, Green Submitted			2022-12-26	WOS:000534352500017
J	Sarabi-Jamab, A; Araabi, BN				Sarabi-Jamab, Atiye; Araabi, Babak N.			An information-based approach to handle various types of uncertainty in fuzzy bodies of evidence	PLOS ONE			English	Article							DEMPSTER-SHAFER THEORY; DATA FUSION; BELIEF; ENTROPY; PROBABILITIES; INFERENCE; DISTANCES; CONFLICT	Fuzzy evidence theory, or fuzzy Dempster-Shafer Theory captures all three types of uncertainty, i.e. fuzziness, non-specificity, and conflict, which are usually contained in a piece of information within one framework. Therefore, it is known as one of the most promising approaches for practical applications. Quantifying the difference between two fuzzy bodies of evidence becomes important when this framework is used in applications. This work is motivated by the fact that while dissimilarity measures have been surveyed in the fields of evidence theory and fuzzy set theory, no comprehensive survey is yet available for fuzzy evidence theory. We proposed a modification to a set of the most discriminative dissimilarity measures (smDDM)-as the minimum set of dissimilarity with the maximal power of discrimination in evidence theory- to handle all types of uncertainty in fuzzy evidence theory. The generalized smDDM (FsmDDM) together with the one previously introduced as fuzzy measures make up a set of measures that is comprehensive enough to collectively address all aspects of information conveyed by the fuzzy bodies of evidence. Experimental results are presented to validate the method and to show the efficiency of the proposed method.	[Sarabi-Jamab, Atiye] Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran; [Araabi, Babak N.] Univ Tehran, Control & Intelligent Proc Ctr Excellence, Sch Elect & Comp Engn, Tehran, Iran	University of Tehran	Sarabi-Jamab, A (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci, Tehran, Iran.	a.sarabi@ipm.ir						Bloch I, 1999, PATTERN RECOGN, V32, P1873, DOI 10.1016/S0031-3203(99)00011-4; Burkov A., 2011, DECIS SUPPORT SYST, P453; DECAMPOS LM, 1990, FUZZY SET SYST, V35, P57, DOI 10.1016/0165-0114(90)90018-2; DELUCA A, 1972, INFORM CONTROL, V20, P301, DOI 10.1016/S0019-9958(72)90199-4; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng X., 2019, INT J FUZZY SYST; Deng Y, 2011, EXPERT SYST APPL, V38, P15438, DOI 10.1016/j.eswa.2011.06.018; Denoeux T, 2004, IEEE T SYST MAN CY B, V34, P95, DOI 10.1109/TSMCB.2002.806496; Denoeux T, 2019, INT J APPROX REASON, V109, P87, DOI 10.1016/j.ijar.2019.03.009; EBANKS BR, 1983, J MATH ANAL APPL, V94, P24, DOI 10.1016/0022-247X(83)90003-3; George T, 1996, INT J GEN SYST, V24, P407, DOI 10.1080/03081079608945130; Guo HW, 2006, IEEE T SYST MAN CY B, V36, P970, DOI 10.1109/TSMCB.2006.872269; GUPTA P, 2014, INT J STAT MATH, V10, P47; HOHLE U, 1987, J MATH ANAL APPL, V127, P346, DOI 10.1016/0022-247X(87)90114-4; Hwang CM, 2007, INT J INTELL SYST, V22, P1215, DOI 10.1002/int.20246; ISHIZUKA M, 1982, INFORM SCIENCES, V28, P179, DOI 10.1016/0020-0255(82)90047-0; Jousselme AL, 2012, INT J APPROX REASON, V53, P118, DOI 10.1016/j.ijar.2011.07.006; Kapur JN., 1997, MEASURES FUZZY INFOR; Kaufmann A., 1975, INTRO THEORY FUZZY S, VVolume 2; Liu WR, 2006, ARTIF INTELL, V170, P909, DOI 10.1016/j.artint.2006.05.002; Liu Zhiquan, 2017, IEEE T FUZZY SYST, V99, P1, DOI [DOI 10.1080/00207160.2017.1290434, DOI 10.1109/DASC.2017.8102134]; Liu ZW, 2019, INT J PROD RES, V57, P7104, DOI 10.1080/00207543.2019.1577566; Lucas C, 1999, IEEE T FUZZY SYST, V7, P255, DOI 10.1109/91.771083; Martin A., CONFLICT MEASURE DIS, P1003; OGAWA H, 1985, INT J MAN MACH STUD, V22, P295, DOI 10.1016/S0020-7373(85)80005-5; PAL NR, 1993, INT J APPROX REASON, V8, P1, DOI 10.1016/S0888-613X(05)80003-9; Parkash O, 2008, INFORM SCIENCES, V178, P2389, DOI 10.1016/j.ins.2007.12.003; Petit-Renaud S, 2004, INT J APPROX REASON, V35, P1, DOI 10.1016/S0888-613X(03)00056-2; Sarabi-Jamab A., 2013, KNOWLEDGE BASED SYST, V54; Sarabi-Jamab A, 2018, INFORM SCIENCES, V448, P233, DOI 10.1016/j.ins.2018.03.001; Sarabi-Jamab A, 2016, INT J UNCERTAIN FUZZ, V24, P503, DOI 10.1142/S0218488516500252; Sarabi-Jamab A, 2011, J CONTROL SCI ENG, V2011, DOI 10.1155/2011/121320; Shafer G.A., 1976, MATH THEORY EVIDENCE; SMETS P, 1981, INFORM SCIENCES, V25, P1, DOI 10.1016/0020-0255(81)90008-6; TESSEM B, 1993, ARTIF INTELL, V61, P315, DOI 10.1016/0004-3702(93)90072-J; Wen CL, 2008, LECT NOTES COMPUT SC, V5264, P506; Xiao FY, 2019, INFORM FUSION, V46, P23, DOI 10.1016/j.inffus.2018.04.003; YAGER RR, 1982, INFORM SCIENCES, V28, P45, DOI 10.1016/0020-0255(82)90031-7; YAGER RR, 1995, IEEE T SYST MAN CYB, V25, P1221, DOI 10.1109/21.398683; YAGER RR, 1983, INT J GEN SYST, V9, P249, DOI 10.1080/03081078308960825; Yang MS, 2003, INT J INTELL SYST, V18, P925, DOI 10.1002/int.10126; YEN J, 1990, IEEE T SYST MAN CYB, V20, P559, DOI 10.1109/21.57269; Zadeh L.A, 1996, FUZZY SETS FUZZY LOG, DOI DOI 10.1142/9789814261302_0022; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; Zadeh LA, 1997, FUZZY SET SYST, V90, P111, DOI 10.1016/S0165-0114(97)00077-8; Zhu H, 2006, SOFT COMPUT, V10, P1169, DOI 10.1007/s00500-005-0039-1	46	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227495	10.1371/journal.pone.0227495	http://dx.doi.org/10.1371/journal.pone.0227495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929579	Green Published, Green Submitted, gold			2022-12-26	WOS:000534352500041
J	Lund, A; Nordrehaug, JE; Slettom, G; Solvang, SEH; Pedersen, EKR; Midttun, O; Ulvik, A; Ueland, PM; Nygard, O; Giil, LM				Lund, Anders; Nordrehaug, Jan Erik; Slettom, Grete; Solvang, Stein-Erik Hafstad; Pedersen, Eva Kristine Ringdal; Midttun, Oivind; Ulvik, Arve; Ueland, Per Magne; Nygard, Ottar; Giil, Lasse Melvaer			Plasma kynurenines and prognosis in patients with heart failure	PLOS ONE			English	Article							INTERFERON-GAMMA; VITAMIN STATUS; INFLAMMATION; PATHWAY; BIOMARKERS; APOPTOSIS; 3-HYDROXYKYNURENINE; ASSOCIATION; METABOLISM; ACTIVATION	Background Metabolites of the kynurenine pathway (mKP) relate to important aspects of heart failure pathophysiology, such as inflammation, energy-homeostasis, apoptosis, and oxidative stress. We aimed to investigate whether mKP predict mortality in patients with heart failure. Methods The study included 202 patients with heart failure (73.8% with coronary artery disease (CAD)), propensity score matched to 384 controls without heart disease, and 807 controls with CAD (71%). All underwent coronary angiography and ventriculography at baseline. Plasma mKP, pyridoxal 5'phosphate (PLP) and CRP were measured at baseline. Case-control differences were assessed by logistic regression and survival by Cox regression, adjusted for age, gender, smoking, diabetes, ejection fraction, PLP, eGFR and CRP. Effect measures are reported per standard deviation increments. Results Higher plasma levels of kynurenine, 3- hydroxykynurenine (HK), quinolinic acid (QA), the kynurenine-tryptophan-ratio (KTR) and the ratio of HK to xanthurenic acid (HK/XA) were detected in heart failure compared to both control groups. The mortality rate per 1000 person-years was 55.5 in patients with heart failure, 14.6 in controls without heart disease and 22.2 in CAD controls. QA [HR 1.80, p = 0.013], HK [HR 1.77, p = 0.005], HK/XA [HR 1.67, p < 0.001] and KTR [HR 1.55, p = 0.009] were associated with increased mortality in patients with heart failure, while XA [HR 0.68-0.80, p = 0.013-0.037] were associated with lower mortality in all groups. HK and HK/XA had weak associations with increased mortality in CAD-controls. Conclusion Elevated plasma levels of mKP and metabolite ratios are associated with increased mortality, independent of CAD, in patients with heart failure.	[Lund, Anders; Nordrehaug, Jan Erik; Slettom, Grete; Solvang, Stein-Erik Hafstad; Pedersen, Eva Kristine Ringdal; Ueland, Per Magne; Nygard, Ottar; Giil, Lasse Melvaer] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Nordrehaug, Jan Erik] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Slettom, Grete; Pedersen, Eva Kristine Ringdal; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Solvang, Stein-Erik Hafstad; Giil, Lasse Melvaer] Haraldsplass Deaconess Hosp, Dept Internal Med, Bergen, Norway; [Midttun, Oivind; Ulvik, Arve] Bevital AS, Bergen, Norway; [Ueland, Per Magne] Haukeland Hosp, Lab Clin Biochem, Bergen, Norway	University of Bergen; Stavanger University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Lund, A (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	lund.anders88@gmail.com	Ueland, Per M/C-7340-2013	Lund, Anders/0000-0002-9183-4814; Giil, Lasse Melvaer/0000-0003-3520-7530; Ueland, Per Magne/0000-0002-1903-0571	Western Norway Regional Health Authority [912072]	Western Norway Regional Health Authority	This work was supported by the Western Norway Regional Health Authority [grant number 912072]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One or more of the authors are employed by a commercial company, Bevital AS. Bevital AS is owned by a non-profit organization and did not play a role in this study.	Anand IS, 2005, CIRCULATION, V112, P1428, DOI 10.1161/CIRCULATIONAHA.104.508465; Aquilani R, 2003, J AM COLL CARDIOL, V42, P1218, DOI 10.1016/S0735-1097(03)00946-X; Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Aziz N, 2016, CYTOKINE, V84, P17, DOI 10.1016/j.cyto.2016.05.010; Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Ezekowitz J, 2004, J AM COLL CARDIOL, V44, P1587, DOI 10.1016/j.jacc.2004.06.072; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Han Q, 2010, CELL MOL LIFE SCI, V67, P353, DOI 10.1007/s00018-009-0166-4; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Hulsmans M, 2016, J MOL CELL CARDIOL, V93, P149, DOI 10.1016/j.yjmcc.2015.11.015; Jones SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131389; Konishi M, 2017, CIRC J, V81, P52, DOI 10.1253/circj.CJ-16-0791; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Levick S, 2014, HEART FAIL REV, V19, P227, DOI 10.1007/s10741-013-9393-8; Mailankot M, 2010, INT J BIOCHEM CELL B, V42, P1446, DOI 10.1016/j.biocel.2010.04.014; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Midttun O, 2014, J NUTR, V144, P784, DOI 10.3945/jn.113.189738; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Minovic I, 2017, AM J CLIN NUTR, V106, P1366, DOI 10.3945/ajcn.117.164012; Ocampo JR, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/646909; Parry HM, 2015, CIRC-HEART FAIL, V8, P236, DOI 10.1161/CIRCHEARTFAILURE.113.000920; Pawlak K, 2009, ATHEROSCLEROSIS, V204, P309, DOI 10.1016/j.atherosclerosis.2008.08.014; Pedersen AG, 2015, TIDSSKR NORSKE LAEGE, V135, P768, DOI 10.4045/tidsskr.14.1065; Pedersen ER, 2015, ARTERIOSCL THROM VAS, V35, P455, DOI 10.1161/ATVBAHA.114.304674; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sawyer DB, 2011, AM J MED SCI, V342, P120, DOI 10.1097/MAJ.0b013e3182249fcd; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Seccareccia F, 2003, EUR J EPIDEMIOL, V18, P487, DOI 10.1023/A:1024672522802; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Theofylaktopoulou D, 2013, CLIN EXP IMMUNOL, V173, P121, DOI 10.1111/cei.12092; Theofylaktopoulou D, 2014, BRIT J NUTR, V112, P1065, DOI 10.1017/S0007114514001858; Ueland PM, 2017, MOL ASPECTS MED, V53, P10, DOI 10.1016/j.mam.2016.08.001; Ulvik A, 2013, AM J CLIN NUTR, V98, P934, DOI 10.3945/ajcn.113.064998; Wang QX, 2015, FRONT BIOSCI-LANDMRK, V20, P1116, DOI 10.2741/4363; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wei HF, 2000, J NEUROCHEM, V75, P81, DOI 10.1046/j.1471-4159.2000.0750081.x; Young SN, 2013, J PSYCHIATR NEUROSCI, V38, P294, DOI 10.1503/jpn.120209; Zhang YY, 2017, EUR J HEART FAIL, V19, P1379, DOI 10.1002/ejhf.942; Zuo H, 2016, AM J EPIDEMIOL, V183, P249, DOI 10.1093/aje/kwv242; Zuo H, 2014, CANCER-AM CANCER SOC, V120, P3370, DOI 10.1002/cncr.28869	43	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227365	10.1371/journal.pone.0227365	http://dx.doi.org/10.1371/journal.pone.0227365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923223	Green Published, gold			2022-12-26	WOS:000534350000071
J	Paquin, C; Cote, SM; Tremblay, RE; Seguin, JR; Boivin, M; Herba, CM				Paquin, Chantal; Cote, Sylvana M.; Tremblay, Richard E.; Seguin, Jean R.; Boivin, Michel; Herba, Catherine M.			Maternal depressive symptoms and children's cognitive development: Does early childcare and child's sex matter?	PLOS ONE			English	Article							SCHOOL READINESS; ACADEMIC-ACHIEVEMENT; SOCIOEMOTIONAL DEVELOPMENT; POSTPARTUM DEPRESSION; POSTNATAL DEPRESSION; MIDDLE CHILDHOOD; AGE 16; OUTCOMES; PERFORMANCE; ADJUSTMENT	Background Maternal depressive symptoms (MDS) have been associated with poorer child cognitive development. Some studies have shown that childcare attendance moderates associations between MDS and child behavior problems, but we do not know if this is the case for children's cognitive development. Furthermore, few studies have evaluated whether associations between MDS and child cognitive development differ for boys and girls at school entry. Methods This study used data from a population-based cohort study (n = 1364) comprising well-validated measures of children's cognitive development including academic readiness and language development in kindergarten and reading and mathematics achievement in first grade. Information on MDS was collected repeatedly from the child's age of 5 months to 5 years and on childcare from 5 months to 4.5 years. Moderation analyses were conducted to evaluate the differential associations of MDS with children's outcomes depending on the type of childcare attended and the child's sex. Results Childcare type or child's sex did not moderate associations between MDS and children's cognitive outcomes except for MDS being associated with lower scores on reading achievement in first grade for girls with a very small effect size (sr(2) =.003). Childcare attendance was associated with higher scores for children's cognitive development, however these associations disappeared after adjusting for covariates including child, mother and family characteristics. Regardless of MDS and childcare type, boys had, even after adjusting for covariates, lower scores on academic readiness (sr(2) =.029) and higher scores on mathematics achievement (sr(2) =.004). Conclusions Children's cognitive development at school entry was more strongly associated with maternal education, children's age in kindergarten and number of months of schooling in first grade than MDS. Contrary to associations between MDS and child behavior problems, childcare attendance did not moderate associations between MDS and children's cognitive development at school entry.	[Paquin, Chantal; Herba, Catherine M.] Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada; [Paquin, Chantal; Cote, Sylvana M.; Tremblay, Richard E.; Seguin, Jean R.; Herba, Catherine M.] Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ, Canada; [Cote, Sylvana M.] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Cote, Sylvana M.] Univ Bordeaux, INSERM U1219, Bordeaux Populat Hlth Unit BPH, Bordeaux, France; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Tremblay, Richard E.] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [Herba, Catherine M.] Univ Montreal, Dept Psychiat & Addictol, Montreal, PQ, Canada; [Boivin, Michel] Laval Univ, Sch Psychol, Quebec City, PQ, Canada	University of Quebec; University of Quebec Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universite de Montreal; Universite de Montreal; University College Dublin; Universite de Montreal; Laval University	Herba, CM (corresponding author), Univ Quebec Montreal, Dept Psychol, Montreal, PQ, Canada.; Herba, CM (corresponding author), Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ, Canada.; Herba, CM (corresponding author), Univ Montreal, Dept Psychiat & Addictol, Montreal, PQ, Canada.	herba.catherine@uqam.ca	Côté, Sylvana M./T-4600-2019; Séguin, Jean R./B-5349-2008	Côté, Sylvana M./0000-0001-7944-0647; Séguin, Jean R./0000-0003-3359-6202	Fond de Recherche du Quebec Sante (FRQS); Social Sciences and Humanities Research Council (SSHRC) [4122000-1003, 839-2000-1008, 412-94-0016]; Fonds pour la formation des chercheurs et l'aide a la recherche (FCAR) [EC-0307]; Fonds Monique Gaumond pour la recherche en maladies affectives; Quebec provincial government's ministere de la Famille and ministere de l'E ducation et de l'Enseignement superieur; Lucie and Andre Chagnon Foundation; Institut de la statistique du Quebec; Institut de recherche Robert-Sauveen santeet en securitedu travail (IRSST); Centre hospitalier universitaire Sainte-Justine Research Center; Ministere de la Santeet des Services sociaux du Quebec	Fond de Recherche du Quebec Sante (FRQS); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Fonds pour la formation des chercheurs et l'aide a la recherche (FCAR); Fonds Monique Gaumond pour la recherche en maladies affectives; Quebec provincial government's ministere de la Famille and ministere de l'E ducation et de l'Enseignement superieur; Lucie and Andre Chagnon Foundation; Institut de la statistique du Quebec(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut de recherche Robert-Sauveen santeet en securitedu travail (IRSST); Centre hospitalier universitaire Sainte-Justine Research Center; Ministere de la Santeet des Services sociaux du Quebec	The Fond de Recherche du Quebec Sante (FRQS; http://www.frqsc.gouv.qc.ca/) supported this work through a salary award granted to CMH and a doctoral training award granted to CP. This work was also supported through grants (4122000-1003, 839-2000-1008) from the Social Sciences and Humanities Research Council (SSHRC; http://www.sshrc-crsh.gc.ca/) to RET, MB, and JRS, grant 412-94-0016 from the Social Sciences and Humanities Research Council (SSHRC; http://www.sshrc-crsh.gc.ca/) to RET, and grant EC-0307 from Fonds pour la formation des chercheurs et l'aide a la recherche (FCAR; http://www.frqsc.gouv.qc.ca/) to RET. JRS is supported by the Fonds Monique Gaumond pour la recherche en maladies affectives. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The larger Quebec Longitudinal Study of Child Development (QLSCD) was also supported by funding from the Quebec provincial government's ministere de la Famille and ministere de l'E ducation et de l'Enseignement superieur, the Lucie and Andre Chagnon Foundation, the Institut de la statistique du Quebec, the Institut de recherche Robert-Sauveen santeet en securitedu travail (IRSST), the Centre hospitalier universitaire Sainte-Justine Research Center and the Ministere de la Santeet des Services sociaux du Quebec.	Ahun MN, 2019, ARCH WOMEN MENT HLTH, V22, P15, DOI 10.1007/s00737-018-0870-x; Ahun MN, 2017, J PEDIATR-US, V190, P251, DOI 10.1016/j.jpeds.2017.07.007; Al-Hendawi M, 2013, EDUC REV, V65, P177, DOI 10.1080/00131911.2011.648371; [Anonymous], 1995, OV SURV INSTR 1994 9; Antoniou EE, 2013, J DEV ORIG HLTH DIS, V4, P513, DOI 10.1017/S2040174413000287; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; Berry D, 2016, EARLY CHILD RES Q, V34, P115, DOI 10.1016/j.ecresq.2015.09.003; Beswick J. F., 2005, EDUCATION, V126, P116; BISANZ J, 1995, DEV PSYCHOL, V31, P221, DOI 10.1037/0012-1649.31.2.221; Boivin M, 2005, J CHILD PSYCHOL PSYC, V46, P612, DOI 10.1111/j.1469-7610.2004.00375.x; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CAHAN S, 1987, AM EDUC RES J, V24, P1, DOI 10.3102/00028312024001001; Campbell SB, 2007, DEV PSYCHOL, V43, P1202, DOI 10.1037/0012-1649.43.5.1202; CHEW AL, 1984, EDUC PSYCHOL MEAS, V44, P987, DOI 10.1177/0013164484444022; Cohen J.E., 1988, STAT POWER ANAL BEHA; Comaskey B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177065; Conners-Burrow NA, 2014, J PEDIATR HEALTH CAR, V28, P404, DOI 10.1016/j.pedhc.2013.12.005; Cote SM, 2013, CHILD DEV, V84, P1191, DOI 10.1111/cdev.12049; COX AD, 1987, J CHILD PSYCHOL PSYC, V28, P917, DOI 10.1111/j.1469-7610.1987.tb00679.x; Cunningham A, 2011, J EXP CHILD PSYCHOL, V109, P248, DOI 10.1016/j.jecp.2010.12.005; Desrosiers H, 2001, 12 I STAT QUEB; Dollaghan CA, 1999, J SPEECH LANG HEAR R, V42, P1432, DOI 10.1044/jslhr.4206.1432; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Duncan GJ, 2006, EVALUATION REV, V30, P611, DOI 10.1177/0193841X06291530; Dunn L, 1981, PPVT R MANUAL; Dunn L. M., 1993, MANUAL ECHELLE VOCAB; Edwards C.P., 2008, PARENT ENGAGEMENT SC; Farrant BM, 2013, FIRST LANG, V33, P280, DOI 10.1177/0142723713487617; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Geoffroy MC, 2012, CAN J PUBLIC HEALTH, V103, P76, DOI 10.1007/BF03404073; Geoffroy MC, 2010, J CHILD PSYCHOL PSYC, V51, P1359, DOI 10.1111/j.1469-7610.2010.02316.x; Gersten R, 2005, J LEARN DISABIL-US, V38, P293, DOI 10.1177/00222194050380040301; Giles LC, 2011, PEDIATRICS, V128, pE78, DOI 10.1542/peds.2010-3119; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Gueron-Sela N, 2018, DEV PSYCHOL, V54, P71, DOI 10.1037/dev0000389; Hayes AF, 2017, COMMUN METHODS MEAS, V11, P1, DOI 10.1080/19312458.2016.1271116; Herba CM, 2013, JAMA PSYCHIAT, V70, P830, DOI 10.1001/jamapsychiatry.2013.1361; Heyder A, 2015, SOC PSYCHOL EDUC, V18, P467, DOI 10.1007/s11218-015-9303-0; Hill NE, 2001, J EDUC PSYCHOL, V93, P686, DOI 10.1037//0022-0663.93.4.686; Horta BL, 2015, ACTA PAEDIATR, V104, P14, DOI 10.1111/apa.13139; Hotz V, 2015, J POPUL ECON, V28, P911, DOI 10.1007/s00148-015-0542-3; Hughes C, 2013, J CHILD PSYCHOL PSYC, V54, P169, DOI 10.1111/jcpp.12014; Japel C., 2005, CHOICES, V11, P5; Jenkins JM, 2008, J AM ACAD CHILD PSY, V47, P399, DOI 10.1097/CHI.0b013e31816407db; Kaufman AS, BATTERIE EXAMEN PSYC; Kaufman N.L., 1983, K ABC KAUFMAN ASSESS; Kersten-Alvarez LE, 2012, CHILD PSYCHIAT HUM D, V43, P201, DOI 10.1007/s10578-011-0257-y; Kiernan KE, 2008, BRIT J SOCIOL, V59, P783, DOI 10.1111/j.1468-4446.2008.00219.x; Lanes A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-302; Laurin JC, 2015, PEDIATRICS, V136, P1112, DOI 10.1542/peds.2015-0419; Lee LC, 2006, J EPIDEMIOL COMMUN H, V60, P305, DOI 10.1136/jech.2005.040956; Letourneau NL, 2013, J PEDIATR NURS, V28, P223, DOI 10.1016/j.pedn.2012.07.014; Liu Y, 2017, PSYCHOL MED, V47, P680, DOI 10.1017/S003329171600283X; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Luyten H, 2017, SCH EFF SCH IMPROV, V28, P374, DOI 10.1080/09243453.2017.1297312; Mensah FK, 2010, SOC PSYCH PSYCH EPID, V45, P1023, DOI 10.1007/s00127-009-0137-y; Milgrom J, 2019, J DEV ORIG HLTH DIS, V10, P221, DOI 10.1017/S2040174418000739; Murray L, 1996, J CHILD PSYCHOL PSYC, V37, P927, DOI 10.1111/j.1469-7610.1996.tb01490.x; Murray L, 2010, J CHILD PSYCHOL PSYC, V51, P1150, DOI 10.1111/j.1469-7610.2010.02259.x; Naicker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033422; *NICHD EARL CHILD, 2006, AM PSYCHOL, V0061; Okamoto Y, 1996, MONOGR SOC RES CHILD, V61, P27, DOI 10.1111/j.1540-5834.1996.tb00536.x; Paulson JF, 2006, PEDIATRICS, V118, P659, DOI 10.1542/peds.2005-2948; Pearson RM, 2016, J CHILD PSYCHOL PSYC, V57, P491, DOI 10.1111/jcpp.12483; Poulin Christiane, 2005, Chronic Dis Can, V26, P65; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richards M, 2001, BRIT MED J, V322, P199, DOI 10.1136/bmj.322.7280.199; Rigby E, 2007, J POLICY ANAL MANAG, V26, P887, DOI 10.1002/pam.20290; Romano E, 2010, DEV PSYCHOL, V46, P995, DOI 10.1037/a0018880; Sabol TJ, 2012, CHILD DEV, V83, P282, DOI 10.1111/j.1467-8624.2011.01678.x; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Shen HY, 2016, JAMA PSYCHIAT, V73, P239, DOI 10.1001/jamapsychiatry.2015.2917; Sinclair D, 1998, BRIT J PSYCHIAT, V172, P58, DOI 10.1192/bjp.172.1.58; Sohr-Preston SL, 2006, CLIN CHILD FAM PSYCH, V9, P65, DOI 10.1007/s10567-006-0004-2; Stein A, 2008, CHILD CARE HLTH DEV, V34, P603, DOI 10.1111/j.1365-2214.2008.00837.x; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Van der Ende J, 2016, DEV PSYCHOPATHOL, V28, P855, DOI 10.1017/S0954579416000353; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Venet M, 2003, REV PSYCHOEDUCATION; Veronneau MH, 2010, DEV PSYCHOL, V46, P773, DOI 10.1037/a0019816; Vilagut G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155431; Votruba-Drzal E, 2013, J EDUC PSYCHOL, V105, P821, DOI 10.1037/a0032951; Warner R.M., 2012, APPL STAT BIVARIATE; Westerlund M, 2008, CHILD CARE HLTH DEV, V34, P257, DOI 10.1111/j.1365-2214.2007.00801.x	87	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227179	10.1371/journal.pone.0227179	http://dx.doi.org/10.1371/journal.pone.0227179			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923279	Green Published, gold			2022-12-26	WOS:000534350000051
J	Salam, T; Duhig, A; Patel, AA; Cameron, A; Voelker, J; Bookhart, B; Coleman, CI				Salam, Tabassum; Duhig, Amy; Patel, Aarti A.; Cameron, Ann; Voelker, Jennifer; Bookhart, Brahim; Coleman, Craig I.			Physicians' perspectives regarding non-medical switching of prescription medications: Results of an internet e-survey	PLOS ONE			English	Article							CARE	Background Physicians are in an ideal position to describe the impact of medication non-medical switching (switching commonly due to formulary changes by insurer for reasons unrelated to patient health) on their practice dynamics and patient care. We sought to examine physicians' openness to requests for non-medical switching and their experiences and opinions regarding the impact of non-medical switching on their practice, staff and patients. Methods An online survey of randomly-sampled physicians spending >= 10% of time providing patient care and having received >= 1 non-medical switch request during the prior 12-months. The impact of non-medical switching on clinical decision-making process; professional experience with clinical practice, patient-physician relationship, insurance process; and perceived impact on practice, staff and patients were assessed. Weighted percent responses were calculated. Results We sampled 1,010 physicians (response rate = 55.5%). Many responded being frequently not amenable (26.0%) or had reservations (41.8%) to non-medical switch requests; with > 50% indicating patient stability on current therapy and suboptimal alternatives as factors frequently influencing amenability. Physicians agreed non-medical switching can create ethical concerns (clinical judgement, autonomy, ability to treat per guidelines; 74.8%, 82.3%, 53.5%, respectively), while forcing them to take responsibility for insurers' decisions (81.1%) and diverting their clinical time (84.3%). Most indicated non-medical switching increased practice burden (administrative, non-billable interactions, additional staffing, non-office patient contact, calls to/from the pharmacy; 85.0%, 72.5%, 62.2%, 64.2%, 69.5%, respectively). Physicians felt insurer processes discouraged non-medical switch challenges (76.7%) and required inconvenient lengths-of-time (76.1%) speaking to insurer representatives without proper expertise (62.0%). They believed non-medical switching negatively impacted aspects of care (effectiveness, side-effects, medication adherence and abandonment, out-of-pocket costs, medication errors; 46.5%, 53.2%, 50.6%, 49.4%, 59.6%, 54.5%, respectively). Conclusions Physicians were frequently not amenable or had reservations regarding non-medical switching. They noted ethical concerns due to non-medical switching. Most felt non-medical switches burdened their practice and negatively impacted care.	[Salam, Tabassum] Amer Coll Physicians, Med Educ, Philadelphia, PA USA; [Duhig, Amy; Cameron, Ann] Xcenda, Consulting Serv, Palm Harbor, FL USA; [Patel, Aarti A.; Voelker, Jennifer; Bookhart, Brahim] Janssen Sci Affairs LLC, Titusville, NJ USA; [Coleman, Craig I.] Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA; [Coleman, Craig I.] Hartford Hosp, Evidence Based Practice Ctr, Hartford, CT 06115 USA	American College of Physicians; AmerisourceBergen Corporation; Xcenda, LLC; Johnson & Johnson; Janssen Pharmaceuticals; University of Connecticut; Hartford Hospital	Coleman, CI (corresponding author), Univ Connecticut, Sch Pharm, Storrs, CT 06269 USA.; Coleman, CI (corresponding author), Hartford Hosp, Evidence Based Practice Ctr, Hartford, CT 06115 USA.	craig.coleman@hhchealth.org		Coleman, Craig/0000-0003-4868-7158	Janssen Scientific Affairs, Inc	Janssen Scientific Affairs, Inc	Financial support for this research was provided by Janssen Scientific Affairs, Inc, to Xcenda, a health economics consultancy providing services to the life science industry. In their role as coauthors, Drs Patel, Voelker and Mr. Bookhart of the funding body contributed to design and conduct of the study; management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Allery LA, 2016, EDUC PRIM CARE, V27, P234, DOI 10.1080/14739879.2016.1175914; American Medical Association, H125991 AM MED ASS; American Medical Association, 2017, PRIOR AUTH UT MAN RE; [Anonymous], 2018, SPECIAL COMMISSION S; [Anonymous], 2018, CRIS HLTH CAR CALL A; [Anonymous], 2019, PROFESSIONALLY ACTIV; [Anonymous], 2017, RES REPORT; [Anonymous], PAT PAP; [Anonymous], 2018, PUTT PROF PAT PROV P; [Anonymous], NUMB PRACT PRIM CAR; Association AM, 2019, AMA PRIOR AUTH PA PH; Association of American Medical Colleges, 2018, 2018 PHYS SPEC DAT R; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Centers for Medicare and Medicaid Services, PAT PAP; Consumer Reports National Research Center, 2015, SURPRISE MEDICAL BIL; Dalen JE, 2017, AM J MED, V130, P766, DOI 10.1016/j.amjmed.2017.01.026; *DOCT PAT RIGHTS P, 2017, NOT WHAT DOCT ORD BA; Erickson SM, 2017, ANN INTERN MED, V166, P659, DOI 10.7326/M16-2697; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Gray T, 2005, PHARMACOTHERAPY, V25, P1666, DOI 10.1592/phco.2005.25.11.1666; Han S, 2019, ANN INTERN MED, V170, P784, DOI 10.7326/M18-1422; HOLT D, 1979, J ROY STAT SOC A STA, V142, P33, DOI 10.2307/2344652; Nguyen E, 2016, CURR MED RES OPIN, V32, P1281, DOI 10.1185/03007995.2016.1170673; Nickel WK, 2018, ANN INTERN MED, V169, P796, DOI 10.7326/M18-0018; Phillips AW, 2016, MED TEACH, V38, P217, DOI 10.3109/0142159X.2015.1105945; Young A, 2017, J MED REGUL, V103, P7, DOI 10.30770/2572-1852-103.2.7	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0225867	10.1371/journal.pone.0225867	http://dx.doi.org/10.1371/journal.pone.0225867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923201	gold, Green Published			2022-12-26	WOS:000534350000010
J	Su, QT; Bouteau, A; Cardenas, J; Uthra, B; Wang, YY; Smitherman, C; Gu, JH; Igyarto, BZ				Su, Qingtai; Bouteau, Aurelie; Cardenas, Jacob; Uthra, Balaji; Wang, Yuanyaun; Smitherman, Cynthia; Gu, Jinghua; Igyarto, Botond Z.			Brief communication: Long-term absence of Langerhans cells alters the gene expression profile of keratinocytes and dendritic epidermal T cells	PLOS ONE			English	Article							ANTIGEN	Tissue-resident and infiltrating immune cells are continuously exposed to molecules derived from the local cells that often come in form of secreted factors, such as cytokines. These factors are known to impact the immune cells' biology. However, very little is known about whether the tissue resident immune cells in return also affect the local environment. In this study, with the help of RNA-sequencing, we show for the first time that long-term absence of epidermal resident Langerhans cells led to significant gene expression changes in the local keratinocytes and resident dendritic epidermal T cells. Thus, immune cells might play an active role in maintaining tissue homeostasis, which should be taken in consideration at data interpretation.	[Su, Qingtai; Bouteau, Aurelie; Igyarto, Botond Z.] Baylor Inst Immunol Res, Baylor Scott & White Res Inst, Dallas, TX 75204 USA; [Bouteau, Aurelie] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA; [Cardenas, Jacob; Uthra, Balaji; Wang, Yuanyaun; Smitherman, Cynthia; Gu, Jinghua] Baylor Scott & White Res Inst, Dallas, TX USA; [Igyarto, Botond Z.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; Baylor University; Baylor Health Care System; Baylor University Medical Center; Jefferson University	Igyarto, BZ (corresponding author), Baylor Inst Immunol Res, Baylor Scott & White Res Inst, Dallas, TX 75204 USA.; Igyarto, BZ (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	botond.igyarto@jefferson.edu	Gu, Jinghua/AAX-6302-2021	Bouteau, Aurelie/0000-0003-0186-8816; Igyarto, Botond/0000-0002-9770-800X	Baylor Scott & White Health Foundation	Baylor Scott & White Health Foundation	B.Z.I. The Baylor Scott & White Health Foundation supported this work.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2015, BABRAHAM BIOINFORMAT; [Anonymous], 2016, BIORXIV, DOI [DOI 10.1101/060012, 10.1101/060012]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Boulais N, 2008, EUR J DERMATOL, V18, P119, DOI 10.1684/ejd.2008.0348; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Clausen BE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00534; Clayton K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01676; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Han NR, 2014, J INVEST DERMATOL, V134, P2521, DOI 10.1038/jid.2014.198; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Igyarto BZ, 2009, J IMMUNOL, V183, P5085, DOI 10.4049/jimmunol.0901884; Kang J, 2015, ANNU REV IMMUNOL, V33, P505, DOI 10.1146/annurev-immunol-032414-112025; Kaplan DH, 2017, NAT IMMUNOL, V18, P1068, DOI 10.1038/ni.3815; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kashem Sakeen W, 2018, Curr Protoc Immunol, V121, pe45, DOI 10.1002/cpim.45; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee HJ, 2019, J INVEST DERMATOL, V139, P1182, DOI 10.1016/j.jid.2018.10.036; Lewis JM, 2015, J INVEST DERMATOL, V135, P2824, DOI 10.1038/jid.2015.207; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Obhrai JS, 2008, J INVEST DERMATOL, V128, P1950, DOI 10.1038/jid.2008.52; Pakalniskyte D, 2017, ADV IMMUNOL, DOI [10.1016/bs.ai.2017.01.003, DOI 10.1016/BS.AI.2017.01.002]; Romani N, 2003, APMIS, V111, P725, DOI 10.1034/j.1600-0463.2003.11107805.x; Shipman WD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9527; Skaper SD, 2017, IMMUNOLOGY, V151, P1, DOI 10.1111/imm.12717; Su QT, 2019, J INVEST DERMATOL, V139, P2313, DOI 10.1016/j.jid.2019.05.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taveirne S, 2011, J LEUKOCYTE BIOL, V90, P61, DOI 10.1189/jlb.1010581	39	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0223397	10.1371/journal.pone.0223397	http://dx.doi.org/10.1371/journal.pone.0223397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923202	Green Published, gold, Green Submitted			2022-12-26	WOS:000534350000006
J	Yamamoto, M; Takada, H; Ishizuka, S; Kitamura, K; Jeong, J; Sato, M; Hinata, N; Abe, S				Yamamoto, Masahito; Takada, Hiromasa; Ishizuka, Satoshi; Kitamura, Kei; Jeong, Juhee; Sato, Masaki; Hinata, Nobuyuki; Abe, Shinichi			Morphological association between the muscles and bones in the craniofacial region	PLOS ONE			English	Article							NEURAL CREST; TISSUE; EXPRESSION; DEMETHYLATION; CARTILAGE; MESODERM; ORIGINS; ABSENCE; TENDON; MICE	The strains of inbred laboratory mice are isogenic and homogeneous for over 98.6% of their genomes. However, geometric morphometric studies have demonstrated clear differences among the skull shapes of various mice strains. The question now arises: why are skull shapes different among the mice strains? Epigenetic processes, such as morphological interaction between the muscles and bones, may cause differences in the skull shapes among various mice strains. To test these predictions, the objective of this study is to examine the morphological association between a specific part of the skull and its adjacent muscle. We examined C57BL6J, BALB/cA, and ICR mice on embryonic days (E) 12.5 and 16.5 as well as on postnatal days (P) 0, 10, and 90. As a result, we found morphological differences between C57BL6J and BALB/cA mice with respect to the inferior spine of the hypophyseal cartilage or basisphenoid (SP) and the tensor veli palatini muscle (TVP) during the prenatal and postnatal periods. There was a morphological correlation between the SP and the TVP in the C57BL6J, BALB/cA, and ICR mice during E15 and P0. However, there were not correlation between the TVP and the SP during P10. After discectomy, bone deformation was associated with a change in the shape of the adjacent muscle. Therefore, epigenetic modifications linked to the interaction between the muscles and bones might occur easily during the prenatal period, and inflammation seems to allow epigenetic modifications between the two to occur.	[Yamamoto, Masahito; Takada, Hiromasa; Ishizuka, Satoshi; Abe, Shinichi] Tokyo Dent Coll, Dept Anat, Tokyo, Japan; [Yamamoto, Masahito; Ishizuka, Satoshi; Kitamura, Kei; Sato, Masaki; Abe, Shinichi] Tokyo Dent Coll, Res Branding Project, Tokyo, Japan; [Kitamura, Kei] Tokyo Dent Coll, Dept Histol & Dev Biol, Tokyo, Japan; [Jeong, Juhee] New York Univ, Dept Basic Sci & Craniofacial Biol, Coll Dent, New York, NY USA; [Sato, Masaki] Tokyo Dent Coll, Lab Biol, Tokyo, Japan; [Hinata, Nobuyuki] Kobe Univ, Grad Sch Med, Dept Urol, Kobe, Hyogo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College; New York University; Tokyo Dental College; Kobe University	Abe, S (corresponding author), Tokyo Dent Coll, Dept Anat, Tokyo, Japan.; Abe, S (corresponding author), Tokyo Dent Coll, Res Branding Project, Tokyo, Japan.	abesh@tdc.ac.jp	Hinata, Nobuyuki/AAQ-8687-2020	Hinata, Nobuyuki/0000-0001-7014-6812; Abe, Shinichi/0000-0003-4632-9736	Ministry of Education, Culture, Sports, Science and Technology, Japan [90733767, JP18K17180]; MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in Aid for Scientific Research (nos. 90733767: M. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and was a This study was supported by a Grant-in Aid for Scientific Research (nos. JP18K17180: M. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and was supported by the Private University Research Branding Project from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. supported by the Private University Research Branding Project from MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2010, J ANAT, V217, P167, DOI 10.1111/j.1469-7580.2010.01246.x; Alias L, 2019, BONE, V120, P523, DOI 10.1016/j.bone.2018.10.004; Balanta-Melo J, 2019, TOXINS, V11, DOI 10.3390/toxins11020084; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Brakefield PM, 2011, PHILOS T R SOC B, V366, P2069, DOI 10.1098/rstb.2011.0007; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Carlson BM, 2014, EUR J TRANSL MYOL, V24, P5, DOI 10.4081/ejtm.2014.3293; Chen JW, 2014, DEVELOPMENT, V141, P2035, DOI 10.1242/dev.104067; Cohen WA, 2014, J ORAL PATHOL MED, V43, P162, DOI 10.1111/jop.12113; Conith AJ, 2019, GENESIS, V57, DOI 10.1002/dvg.23263; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; Glastad KM, 2019, ANNU REV ENTOMOL, V64, P185, DOI 10.1146/annurev-ento-011118-111914; Gomez C, 2007, J ANAT, V210, P259, DOI 10.1111/j.1469-7580.2007.00698.x; Hallgrimsson B, 2004, J ANAT, V205, P501, DOI 10.1111/j.0021-8782.2004.00356.x; Hirouchi H, 2018, ARCH ORAL BIOL, V89, P84, DOI 10.1016/j.archoralbio.2017.12.027; Inoue M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40463-3; Kawakami M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-73; Kikuchi R, 2014, J HARD TISSUE BIOL, V23, P225, DOI 10.2485/jhtb.23.225; Kishi A, 2012, ANAT SCI INT, V87, P126, DOI 10.1007/s12565-012-0132-3; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; MOORE W. J., 1965, J ZOOL PROC ZOOL SOC LONDON, V146, P123; Moresi V, 2015, BBA-GENE REGUL MECH, V1849, P309, DOI 10.1016/j.bbagrm.2015.01.002; Nara M, 2017, ARCH ORAL BIOL, V82, P71, DOI 10.1016/j.archoralbio.2017.06.001; Noble D, 2015, J EXP BIOL, V218, P816, DOI 10.1242/jeb.120071; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Nowlan NC, 2010, BONE, V46, P1275, DOI 10.1016/j.bone.2009.11.026; Olsson L, 2001, DEV BIOL, V237, P354, DOI 10.1006/dbio.2001.0377; Purcell P, 2012, J DENT RES, V91, P387, DOI 10.1177/0022034512438401; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Rot-Nikcevic I, 2007, HISTOL HISTOPATHOL, V22, P51, DOI 10.14670/HH-22.51; Rot-Nikcevic I, 2006, DEV GENES EVOL, V216, P1, DOI 10.1007/s00427-005-0024-9; Sakai T, 2005, MAMM GENOME, V16, P11, DOI 10.1007/s00344-004-3013-9; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Scarpa S, 1996, CELL GROWTH DIFFER, V7, P1051; Sella-Tunis T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24293-3; Sharir A, 2011, DEVELOPMENT, V138, P3247, DOI 10.1242/dev.063768; Spassov A, 2017, J ANAT, V231, P736, DOI 10.1111/joa.12664; Standling S, 2005, GRAYS ANATOMY, V39th, P684; Thompson KD, 2017, ZOOLOGY, V124, P51, DOI 10.1016/j.zool.2017.01.002; Verschueren S, 2013, OSTEOPOROSIS INT, V24, P87, DOI 10.1007/s00198-012-2057-z; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Wang RF, 2017, CURR STEM CELL RES T, V12, P442, DOI 10.2174/1574888X11666161226145432; WEIJS WA, 1986, AM J PHYS ANTHROPOL, V70, P423, DOI 10.1002/ajpa.1330700403; Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134; Xu L, 2009, OSTEOARTHR CARTILAGE, V17, P917, DOI 10.1016/j.joca.2009.01.002; Yamamoto M, 2017, ANAT SCI INT, V92, P364, DOI 10.1007/s12565-016-0340-3; Yamamoto M, 2014, ARCH ORAL BIOL, V59, P871, DOI 10.1016/j.archoralbio.2014.03.011; Zernicka E, 2002, J APPL PHYSIOL, V92, P535, DOI 10.1152/japplphysiol.00820.2001; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	50	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227301	10.1371/journal.pone.0227301	http://dx.doi.org/10.1371/journal.pone.0227301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923241	Green Published, gold			2022-12-26	WOS:000534350000065
J	Miao, R; Badger, TC; Groesch, K; Diaz-Sylvester, PL; Wilson, T; Ghareeb, A; Martin, JA; Cregger, M; Welge, M; Bushell, C; Auvil, L; Zhu, RQ; Brard, L; Braundmeier-Fleming, A				Miao, Ruizhong; Badger, Taylor C.; Groesch, Kathleen; Diaz-Sylvester, Paula L.; Wilson, Teresa; Ghareeb, Allen; Martin, Jongjin Anne; Cregger, Melissa; Welge, Michael; Bushell, Colleen; Auvil, Loretta; Zhu, Ruoqing; Brard, Laurent; Braundmeier-Fleming, Andrea			Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer	PLOS ONE			English	Article							REGRESSION SHRINKAGE; GUT MICROBIOTA; BIOMARKERS; CA-125; SERUM; FLUID; HE-4; CULDOCENTESIS; PREDICTION; CARCINOMA	Epithelial ovarian cancer (OC) is the most deadly cancer of the female reproductive system. To date, there is no effective screening method for early detection of OC and current diagnostic armamentarium may include sonographic grading of the tumor and analyzing serum levels of tumor markers, Cancer Antigen 125 (CA-125) and Human epididymis protein 4 (HE4). Microorganisms (bacterial, archaeal, and fungal cells) residing in mucosal tissues including the gastrointestinal and urogenital tracts can be altered by different disease states, and these shifts in microbial dynamics may help to diagnose disease states. We hypothesized that the peritoneal microbial environment was altered in patients with OC and that inclusion of selected peritoneal microbial features with current clinical features into prediction analyses will improve detection accuracy of patients with OC. Blood and peritoneal fluid were collected from consented patients that had sonography confirmed adnexal masses and were being seen at SIU School of Medicine Simmons Cancer Institute. Blood was processed and serum HE4 and CA-125 were measured. Peritoneal fluid was collected at the time of surgery and processed for Next Generation Sequencing (NGS) using 16S V4 exon bacterial primers and bioinformatics analyses. We found that patients with OC had a unique peritoneal microbial profile compared to patients with a benign mass. Using ensemble modeling and machine learning pathways, we identified 18 microbial features that were highly specific to OC pathology. Prediction analyses confirmed that inclusion of microbial features with serum tumor marker levels and control features (patient age and BMI) improved diagnostic accuracy compared to currently used models. We conclude that OC pathogenesis alters the peritoneal microbial environment and that these unique microbial features are important for accurate diagnosis of OC. Our study warrants further analyses of the importance of microbial features in regards to oncological diagnostics and possible prognostic and interventional medicine.	[Miao, Ruizhong] Univ Virginia, Dept Stat, Charlottesville, VA USA; [Badger, Taylor C.; Braundmeier-Fleming, Andrea] SIU Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA; [Groesch, Kathleen; Diaz-Sylvester, Paula L.; Wilson, Teresa; Ghareeb, Allen] SIU Sch Med, Clin Res Ctr, Springfield, IL USA; [Groesch, Kathleen; Diaz-Sylvester, Paula L.; Wilson, Teresa; Ghareeb, Allen; Martin, Jongjin Anne; Brard, Laurent; Braundmeier-Fleming, Andrea] SIU Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA; [Cregger, Melissa] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Cregger, Melissa] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Welge, Michael; Auvil, Loretta] Univ Illinois, Natl Ctr Supercomp Applicat, Champaign, IL USA; [Bushell, Colleen] Univ Illinois, Inst Appl Res, Champaign, IL USA; [Zhu, Ruoqing] Univ Illinois, Dept Stat, Champaign, IL 61820 USA; [Brard, Laurent; Braundmeier-Fleming, Andrea] Simmons Canc Inst SIU, Springfield, IL 62702 USA	University of Virginia; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Braundmeier-Fleming, A (corresponding author), SIU Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA.; Braundmeier-Fleming, A (corresponding author), SIU Sch Med, Dept Obstet & Gynecol, Springfield, IL 62702 USA.; Braundmeier-Fleming, A (corresponding author), Simmons Canc Inst SIU, Springfield, IL 62702 USA.	abraundmeier88@siumed.edu	Ghareeb, Allen/AAM-8996-2020; Braundmeier-Fleming, Andrea/AAQ-4014-2020	Braundmeier-Fleming, Andrea/0000-0001-7136-9567; Diaz-Sylvester, Paula/0000-0002-1531-1958; Badger, Taylor/0000-0002-8398-7677	Laboratory Directed Research and Development Program, of Oak Ridge National Laboratory; U.S. Department of Energy [DEAC05-00OR22725]; Simmons Cancer Institute at Southern Illinois University School of Medicine; Lyceum Foundation	Laboratory Directed Research and Development Program, of Oak Ridge National Laboratory; U.S. Department of Energy(United States Department of Energy (DOE)); Simmons Cancer Institute at Southern Illinois University School of Medicine; Lyceum Foundation	This research was supported by the Laboratory Directed Research and Development Program, of Oak Ridge National Laboratory awarded to ABF, LB and MC. This program is managed by UT-Battelle, LLC, for the U.S. Department of Energy. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. Department of Energy under contract DEAC05-00OR22725. Funding was also provided by the Simmons Cancer Institute at Southern Illinois University School of Medicine through the Team Science Grant (TSG) awarded to ABF and LB and through the Lyceum Foundation Fellowship awarded to ABF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa CWJ, 2014, INT J ENV RES PUB HE, V11, P6979, DOI 10.3390/ijerph110706979; Aguilera O, 1998, FEMS IMMUNOL MED MIC, V21, P29, DOI 10.1016/S0928-8244(98)00030-3; Ai LY, 2017, ONCOTARGET, V8, P9546, DOI 10.18632/oncotarget.14488; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P201; Andersen MR, 2010, GYNECOL ONCOL, V116, P378, DOI 10.1016/j.ygyno.2009.10.087; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Bellia A, 2016, ARCH GYNECOL OBSTET, V294, P615, DOI 10.1007/s00404-016-4087-9; Bhatt AP, 2017, CA-CANCER J CLIN, V67, P327, DOI 10.3322/caac.21398; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borre YE, 2014, ADV EXP MED BIOL, V817, P373, DOI 10.1007/978-1-4939-0897-4_17; Bottoni P, 2015, ADV EXP MED BIOL, V867, P229, DOI 10.1007/978-94-017-7215-0_14; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burns MB, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007376; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Champer M, 2018, BJOG-INT J OBSTET GY, V125, P309, DOI 10.1111/1471-0528.14631; Chase D, 2015, GYNECOL ONCOL, V138, P190, DOI 10.1016/j.ygyno.2015.04.036; Chen PC, 1998, AM J ROENTGENOL, V170, P1299, DOI 10.2214/ajr.170.5.9574606; Chudecka-Glaz A, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-22; Del Chierico F, 2014, INT J MOL SCI, V15, P11678, DOI 10.3390/ijms150711678; Duarte SMB, 2018, NUTR METAB CARDIOVAS, V28, P369, DOI 10.1016/j.numecd.2017.10.014; Duffy MJ, 2015, ADV EXP MED BIOL, V867, P27, DOI 10.1007/978-94-017-7215-0_3; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farolfi A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102569; Fowler JR, 2019, CULDOCENTESIS; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Giampaolino P, 2019, MINERVA MED, V110, P279, DOI 10.23736/S0026-4806.19.06086-5; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goker M, 2011, STAND GENOMIC SCI, V4, P200, DOI 10.4056/sigs.1714269; Golob JL, 2017, CLIN INFECT DIS, V65, P1984, DOI 10.1093/cid/cix699; Gomez-Arango LF, 2016, HYPERTENSION, V68, P974, DOI 10.1161/HYPERTENSIONAHA.116.07910; Granato T, 2015, CLIN CHIM ACTA, V446, P147, DOI 10.1016/j.cca.2015.03.047; Green MA, 2018, PROG PHOTOVOLTAICS, V26, P427, DOI 10.1002/pip.3040; Gregory JC, 2015, J BIOL CHEM, V290, P5647, DOI 10.1074/jbc.M114.618249; GRILLO D, 1966, OBSTET GYNECOL, V28, P346; Grossman DC, 2018, JAMA-J AM MED ASSOC, V319, P588, DOI 10.1001/jama.2017.21926; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; HUNTER VJ, 1990, GYNECOL ONCOL, V36, P161, DOI 10.1016/0090-8258(90)90165-H; Jamain B, 1969, Gynecol Obstet (Paris), V68, P73; Javurek AB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23027; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kamal R, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170571; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Lukens JR, 2014, NATURE, V516, P246, DOI 10.1038/nature13788; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McMurdie PJ, 2012, BIOCOMPUT-PAC SYM, P235; Mert I, 2018, J OBSTET GYNAECOL RE, V44, P1693, DOI 10.1111/jog.13701; Minig L, 2016, J MINIM INVAS GYN, V23, P309, DOI 10.1016/j.jmig.2015.10.014; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Mukherjee S, 2018, J NUTR BIOCHEM, V61, P111, DOI 10.1016/j.jnutbio.2018.07.010; Naftali T, 2016, INFLAMM BOWEL DIS, V22, P293, DOI 10.1097/MIB.0000000000000662; Nakamura M, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1593811; National Cancer Institute, 2019, CANC STAT FACTS OV C; Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012179; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Partheen K, 2011, J GYNECOL ONCOL, V22, P244, DOI 10.3802/jgo.2011.22.4.244; Paul B, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0144-7; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308; R Team C, 2012, TEAM RDC R LANG ENV; ROBERTS MR, 1982, ANN EMERG MED, V11, P556, DOI 10.1016/S0196-0644(82)80431-9; ROMERO R, 1985, OBSTET GYNECOL, V65, P519; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189; Shetty M, 2019, SEMIN ULTRASOUND CT, V40, P302, DOI 10.1053/j.sult.2019.04.002; Skripnikova E., 2017, AM J PHYSIOL-REG I, V312, pR412; Spasova DS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00318; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szubert M, 2012, ARCH MED SCI, V8, P504, DOI 10.5114/aoms.2012.29407; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Gorp T, 2011, BRIT J CANCER, V104, P863, DOI 10.1038/sj.bjc.6606092; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Wu S, 2018, MOLECULES, V23, DOI [10.3390/molecules23123213, DOI 10.3390/M0LECULES23123213]; Wu YY, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22833; Yip P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029533; Zandi Z, 2019, EUR J PHARMACOL, V853, P256, DOI 10.1016/j.ejphar.2019.03.046; Zhou YH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00579	89	15	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227707	10.1371/journal.pone.0227707	http://dx.doi.org/10.1371/journal.pone.0227707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KF6TG	31917801	Green Published, gold			2022-12-26	WOS:000509372400001
J	Salehzadeh, H; Maleki, A; Rezaee, R; Shahmoradi, B; Ponnet, K				Salehzadeh, Hamzeh; Maleki, Afshin; Rezaee, Reza; Shahmoradi, Behzad; Ponnet, Koen			The nitrate content of fresh and cooked vegetables and their health-related risks	PLOS ONE			English	Article							NITRITE CONTENT; ACCUMULATION; PRODUCTS; IMPACT	Background Vegetables are the most important source of nitrates in the human diet. During various processes in the body, nitrates are converted into nitrites, which causes various diseases, such as blue baby syndrome and cancer. This study aimed to determine the concentration of nitrates in several vegetable farms in Sanandaj city and to evaluate their health-related risks. Methods This descriptive cross-sectional study was conducted from October 2017 to July 2018. A total of 90 samples were taken from nine farms. Soil and water sampling was also carried out. All stages of sample preparation and extraction were carried out according to Food Standards 2-16721, and the nitrate measurements were performed using ion chromatography (Compact IC Plus 882 Model, Metrohm, Switzerland). A health risk assessment was performed using the non-carcinogenic risk assessment. Results This study's results showed that the nitrate concertation in all vegetables was less than National Iranian Vegetable Nitrate Standard. Nitrate levels in leafy vegetables were higher than in root vegetables, and the root vegetables levels were higher than those in Fruit vegetable. The nitrate level in vegetables in autumn was higher than in spring. The cooking process reduced the raw vegetables' nitrate content from 4.094% to 13.407%, while the frying process increased the vegetables' nitrate content from 12.46% to 29.93%. The highest health risk level in raw, cooked and fried vegetables was parsley, parsley and beet leaves, respectively, and the lowest in all categories was tomatoes. Generally, the highest health risk was related to fried beet leaves, and the lowest was raw tomatoes. In addition, each of the abovementioned relationships between vegetables' nitrate levels and the harvest season, type of processing procedure and type of vegetables was significant (p < 0.05). The irrigation water's nitrate concentration in all fields was between 12.36 and 33.14 mg/l. The soil contained nitrate levels of between 4.35 and 9.7 mg/kg. Conclusion Based on this study, we can conclude that the amount of nitrates in raw vegetables was lower than the standard limit's level and that this level does not cause health problems for consumers.	[Salehzadeh, Hamzeh] Kurdistan Univ Med Sci, Student Res Comm, Sanandaj, Iran; [Maleki, Afshin; Rezaee, Reza; Shahmoradi, Behzad] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Environm Hlth Res Ctr, Sanandaj, Iran; [Ponnet, Koen] Univ Ghent, Mict, IMEC, Fac Social Sci, Ghent, Belgium	Kurdistan University of Medical Sciences; Kurdistan University of Medical Sciences; Ghent University; IMEC	Maleki, A (corresponding author), Kurdistan Univ Med Sci, Res Inst Hlth Dev, Environm Hlth Res Ctr, Sanandaj, Iran.	malaki@muk.ac.ir	Ponnet, Koen/K-9389-2017; Shahmoradi, Behzad/G-5625-2015	Ponnet, Koen/0000-0002-6911-7632; Shahmoradi, Behzad/0000-0002-2120-4518; Maleki, Afshin/0000-0001-8261-8717	Kurdistan University of Medical Sciences and Environmental Health Research Center [IR.MUK.REC.1396/96]	Kurdistan University of Medical Sciences and Environmental Health Research Center	This study was extracted from a Master dissertation work which was approved by Kurdistan University of Medical Sciences and Environmental Health Research Center with the file number IR.MUK.REC.1396/96.	Ayaz A., 2007, Journal of Food Technology, V5, P177; BAKR TMA, 1986, FOOD CHEM, V19, P265; BEDNAR C, 1994, PLANT FOOD HUM NUTR, V45, P71, DOI 10.1007/BF01091231; Bell R, 1997, LONG RANGE PLANN, V30, P853, DOI 10.1016/S0024-6301(97)00071-X; Bill H, COMMUNICATION; BLOMZANDSTRA M, 1989, ANN APPL BIOL, V115, P553, DOI 10.1111/j.1744-7348.1989.tb06577.x; Boroujerdnia M, 2007, ASIAN J PLANT SCI; Boroujerdnia Maryam, 2007, Asian Journal of Plant Sciences, V6, P550; Cammack R, 1999, BBA-BIOENERGETICS, V1411, P475, DOI 10.1016/S0005-2728(99)00033-X; Chetty AA, 2009, FOOD CHEM, V116, P561, DOI 10.1016/j.foodchem.2009.03.006; Chou SS, 2003, J FOOD DRUG ANAL, V11, P233; Dich J, 1996, DIETARY INTAKES NITR; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.689; Farahani S. S., 2017, Journal of the Saudi Society of Agricultural Sciences, V16, P265, DOI 10.1016/j.jssas.2015.09.001; Fytianos K, 1999, B ENVIRON CONTAM TOX, V62, P187, DOI 10.1007/s001289900858; Gholami A, 2013, STUDY NITRATE CONTAM; Gorenjak AH, 2013, ACTA ALIMENT HUNG, V42, P158, DOI 10.1556/AAlim.42.2013.2.4; Gruszecka-Kosowska A, 2017, HUM ECOL RISK ASSESS, V23, P727, DOI 10.1080/10807039.2016.1277414; hanafi hatami, 2013, SEPEHR GEOGRAPHICAL, V22, P24; Hill M.J., 1996, NITRATES NITRITES FO; Hord NG, 2009, AM J CLIN NUTR, V90, P1, DOI 10.3945/ajcn.2008.27131; Hsu J, 2009, FOOD CHEM, V115, P334, DOI 10.1016/j.foodchem.2008.11.081; HuarteMendicoa JC, 1997, FOOD CHEM, V58, P39, DOI 10.1016/S0308-8146(96)00193-8; Jafari R, 2001, NITRATE NITRITE CONC; Khoshtinat K.H., 2009, J FOOD SCI TECHNOLOG, V10, P63; Mehrabi Z, 2017, JWSS ISFAHAN U TECHN, V21, P1; Merusi C, 2010, FOOD CHEM, V120, P615, DOI 10.1016/j.foodchem.2009.10.035; Molina V, 2011, HLTH RISK ASSESSMENT; PATE JS, 1980, ANNU REV PLANT PHYS, V31, P313, DOI 10.1146/annurev.pp.31.060180.001525; Pavlou GC, 2007, SCI HORTIC-AMSTERDAM, V111, P319, DOI 10.1016/j.scienta.2006.11.003; Pirsaheb M, 2012, NITRITE NITRATE CONT; Pourmoghim M., 2010, Iranian Journal of Nutrition Sciences & Food Technology, V5, P63; Prasad S, 2008, FOOD CHEM, V106, P772, DOI 10.1016/j.foodchem.2007.06.005; Pretty JN, 2000, AGR SYST, V65, P113, DOI 10.1016/S0308-521X(00)00031-7; RAHMANI HR, 2006, INVESTIGATION NITRAT; RAMACHANDRAN A, 2005, SEASONAL CHANGES TIS; Sadeghi E, 2013, IRAN J NUTR SCI FOOD, V8, P201; Sadeghi E, 2015, IRAN J HLTH ENV, V7, P491; Santamaria P, 2006, J SCI FOOD AGR, V86, P10, DOI 10.1002/jsfa.2351; Shahbazzadegan S., 2010, J ARDEBIL U MED SCI, V10, P38; Shahlaei Ahmad, 2007, Asian Journal of Plant Sciences, V6, P1197; Shokatyari S, 2013, MAT ENERGY, V13, P737; Suh Junghyuck, 2013, Journal of Applied Biological Chemistry, V56, P205, DOI 10.3839/jabc.2013.033; Tabande L., 2018, Iranian Journal of Soil Research, V32, P189; Tabande L., 2016, IRAN J HLTH ENV, V9, P41; Tamme T, 2006, FOOD ADDIT CONTAM A, V23, P355, DOI 10.1080/02652030500482363; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; Williams GM, 2016, CRIT REV TOXICOL, V46, P3, DOI 10.1080/10408444.2016.1214677; Wood RS, 2006, POLICY STUD J, V34, P1, DOI 10.1111/j.1541-0072.2006.00153.x	49	36	37	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227551	10.1371/journal.pone.0227551	http://dx.doi.org/10.1371/journal.pone.0227551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917821	Green Published, gold			2022-12-26	WOS:000534341100025
J	Pirozzi, C; Lama, A; Annunziata, C; Cavaliere, G; De Caro, C; Citraro, R; Russo, E; Tallarico, M; Iannone, M; Ferrante, MC; Mollica, MP; Raso, GM; De Sarro, G; Calignano, A; Meli, R				Pirozzi, Claudio; Lama, Adriano; Annunziata, Chiara; Cavaliere, Gina; De Caro, Carmen; Citraro, Rita; Russo, Emilio; Tallarico, Martina; Iannone, Michelangelo; Ferrante, Maria Carmela; Mollica, Maria Pina; Mattace Raso, Giuseppina; De Sarro, Giovambattista; Calignano, Antonio; Meli, Rosaria			Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence	FASEB JOURNAL			English	Article						antiepileptic drug; hepatotoxicity; lipid metabolism; mitochondrial dysfunction; oxidative stress; short-chain fatty acid	ACTIVATED RECEPTOR-ALPHA; SPIKE-WAVE DISCHARGES; SODIUM VALPROATE; OXIDATIVE STRESS; ABSENCE EPILEPSY; ANTIEPILEPTIC DRUGS; ACID-METABOLISM; WAG/RIJ; TOXICITY; HEPATOTOXICITY	Sodium valproate (VPA), an antiepileptic drug, may cause dose- and time-dependent hepatotoxicity. However, its iatrogenic molecular mechanism and the rescue therapy are disregarded. Recently, it has been demonstrated that sodium butyrate (NaB) reduces hepatic steatosis, improving respiratory capacity and mitochondrial dysfunction in obese mice. Here, we investigated the protective effect of NaB in counteracting VPA-induced hepatotoxicity using in vitro and in vivo models. Human HepG2 cells and primary rat hepatocytes were exposed to high VPA concentration and treated with NaB. Mitochondrial function, lipid metabolism, and oxidative stress were evaluated, using Seahorse analyzer, spectrophotometric, and biochemical determinations. Liver protection by NaB was also evaluated in VPA-treated epileptic WAG/Rij rats, receiving NaB for 6 months. NaB prevented VPA toxicity, limiting cell oxidative and mitochondrial damage (ROS, malondialdehyde, SOD activity, mitochondrial bioenergetics), and restoring fatty acid oxidation (peroxisome proliferator-activated receptor alpha expression and carnitine palmitoyl-transferase activity) in HepG2 cells, primary hepatocytes, and isolated mitochondria. In vivo, NaB confirmed its activity normalizing hepatic biomarkers, fatty acid metabolism, and reducing inflammation and fibrosis induced by VPA. These data support the protective potential of NaB on VPA-induced liver injury, indicating it as valid therapeutic approach in counteracting this common side effect due to VPA chronic treatment.	[Pirozzi, Claudio; Lama, Adriano; Annunziata, Chiara; Mattace Raso, Giuseppina; Calignano, Antonio; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy; [Cavaliere, Gina; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, Naples, Italy; [De Caro, Carmen; Citraro, Rita; Russo, Emilio; De Sarro, Giovambattista] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy; [Tallarico, Martina; Iannone, Michelangelo] CNR, Inst Neurol Sci, Pharmacol Sect, Catanzaro, Italy; [Ferrante, Maria Carmela] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Magna Graecia University of Catanzaro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Neurologiche (ISN-CNR); University of Naples Federico II	Raso, GM; Meli, R (corresponding author), Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy.	mattace@unina.it; meli@unina.it	Lama, Adriano/AAC-1964-2020; Tallarico, Martina/AAC-5167-2022; Pirozzi, Claudio/S-2760-2016; Russo, Emilio/G-5241-2010; De, Carmen/AAH-2150-2019	Lama, Adriano/0000-0002-5816-1400; Russo, Emilio/0000-0002-1279-8123; Mollica, Maria Pina/0000-0003-2726-7779; Mattace Raso, Giuseppina/0000-0002-5254-139X; Pirozzi, Claudio/0000-0002-3409-5744; Annunziata, Chiara/0000-0003-2784-8004; DE CARO, Carmen/0000-0003-3549-5958	Italian Ministry of Research (MIUR) [2015XSZ9A2]	Italian Ministry of Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research project was partially financed by the Italian Ministry of Research (MIUR; prot. 2015XSZ9A2)	Aires CCP, 2010, BIOCHEM PHARMACOL, V79, P792, DOI 10.1016/j.bcp.2009.10.011; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Bai XP, 2017, TOXICOL APPL PHARM, V324, P12, DOI 10.1016/j.taap.2017.03.022; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Behrends V, 2019, ARCH TOXICOL, V93, P341, DOI 10.1007/s00204-018-2371-0; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Garcia-Canaveras JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27239; Chang TKH, 2006, DRUG METAB REV, V38, P627, DOI 10.1080/03602530600959433; Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016; Church RJ, 2019, HEPATOLOGY, V69, P760, DOI 10.1002/hep.29802; Citraro R, 2020, MOL NEUROBIOL, V57, P408, DOI 10.1007/s12035-019-01712-8; Citraro R, 2017, CURR PHARM DESIGN, V23, P5546, DOI 10.2174/1381612823666171024130001; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gayam V, 2018, J COMMUNITY HOSP INT, V8, P311, DOI 10.1080/20009666.2018.1514933; Gong Y, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-44; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Ikura Y, 2010, HEPATOLOGY, V51, P2227, DOI 10.1002/hep.23688; Jafarian I, 2013, TOXICOL MECH METHOD, V23, P617, DOI 10.3109/15376516.2013.821567; Ji QLL, 2010, TOXICOL IN VITRO, V24, P1086, DOI 10.1016/j.tiv.2010.03.014; Kiang TKL, 2010, TOXICOL SCI, V118, P501, DOI 10.1093/toxsci/kfq294; Kim SM, 2017, ONCOTARGET, V8, P46273, DOI 10.18632/oncotarget.17695; Komulainen T, 2015, TOXICOLOGY, V331, P47, DOI 10.1016/j.tox.2015.03.001; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kovacs Z, 2014, BRAIN RES BULL, V104, P7, DOI 10.1016/j.brainresbull.2014.03.003; Kovacs Z, 2011, BRAIN RES BULL, V85, P410, DOI 10.1016/j.brainresbull.2011.05.003; Lama A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41295-x; Lama A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600418; Lee MS, 2009, ARCH PHARM RES, V32, P1029, DOI 10.1007/s12272-009-1708-x; Leo A, 2017, NEUROTHERAPEUTICS, V14, P1134, DOI 10.1007/s13311-017-0550-y; LEWIS JH, 1982, HEPATOLOGY, V2, P870, DOI 10.1002/hep.1840020622; Lheureux PER, 2005, CRIT CARE, V9, P431, DOI 10.1186/cc3742; Lheureux PER, 2009, CLIN TOXICOL, V47, P101, DOI 10.1080/15563650902752376; Li SS, 2018, MOL MED REP, V18, P799, DOI 10.3892/mmr.2018.9048; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Luef G, 2009, EPILEPSY RES, V86, P42, DOI 10.1016/j.eplepsyres.2009.04.004; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Mancuso M, 2012, EXPERT OPIN PHARMACO, V13, P527, DOI 10.1517/14656566.2012.657177; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Ong MMK, 2006, FREE RADICAL BIO MED, V40, P420, DOI 10.1016/j.freeradbiomed.2005.08.038; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; POWELLJACKSON PR, 1984, GUT, V25, P673, DOI 10.1136/gut.25.6.673; Rabinowich L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168905; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Raso GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068626; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Roma-Giannikou E, 1999, CELL MOL LIFE SCI, V56, P363, DOI 10.1007/s000180050437; Ruoss M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020347; Russo E, 2008, EPILEPSY BEHAV, V13, P295, DOI 10.1016/j.yebeh.2008.04.018; Russo E, 2016, NEUROSCI BIOBEHAV R, V71, P388, DOI 10.1016/j.neubiorev.2016.09.017; Russo E, 2014, BRAIN BEHAV IMMUN, V42, P157, DOI 10.1016/j.bbi.2014.06.016; Russo E, 2013, PHARMACOL RES, V70, P1, DOI 10.1016/j.phrs.2012.12.002; Russo R, 2016, PHARMACOL RES, V103, P279, DOI 10.1016/j.phrs.2015.11.026; Sato K, 2005, VIRCHOWS ARCH, V447, P996, DOI 10.1007/s00428-005-0042-z; Schmid MM, 2013, PHARMACOPSYCHIATRY, V46, P63, DOI 10.1055/s-0032-1323671; Schumacher JD, 2015, TOXICOL APPL PHARM, V289, P40, DOI 10.1016/j.taap.2015.08.022; Shen Ling, 2012, J Vis Exp, DOI 10.3791/3917; Silva MFB, 2008, J INHERIT METAB DIS, V31, P205, DOI 10.1007/s10545-008-0841-x; Silva MFB, 2001, ANAL BIOCHEM, V290, P60, DOI 10.1006/abio.2000.4947; Szyf M, 2015, EUR NEUROPSYCHOPHARM, V25, P682, DOI 10.1016/j.euroneuro.2014.01.009; TAKEUCHI T, 1988, NEUROPEDIATRICS, V19, P158, DOI 10.1055/s-2008-1052421; Taniura H, 2006, HISTOL HISTOPATHOL, V21, P785, DOI 10.14670/HH-21.785; Tham NTT, 2019, J VET SCI, V20, P34, DOI 10.4142/jvs.2019.20.1.34; Tolosa L, 2018, ARCH TOXICOL, V92, P383, DOI 10.1007/s00204-017-2036-4; Tong V, 2005, TOXICOL SCI, V86, P436, DOI 10.1093/toxsci/kfi185; Tong V, 2005, TOXICOL SCI, V86, P427, DOI 10.1093/toxsci/kfi184; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; van Breda SGJ, 2018, TOXICOLOGY, V393, P160, DOI 10.1016/j.tox.2017.11.013; van Luijtelaar G, 2012, INT J PSYCHOPHYSIOL, V85, P49, DOI 10.1016/j.ijpsycho.2011.09.010; van Rijn CM, 2004, EPILEPSY RES, V59, P181, DOI 10.1016/j.eplepsyres.2004.04.003; Vidaurre J, 2017, PEDIATR NEUROL, V77, P23, DOI 10.1016/j.pediatrneurol.2017.09.013; Vitins AP, 2014, ARCH TOXICOL, V88, P1573, DOI 10.1007/s00204-014-1211-0; Wang W, 2012, HUM EXP TOXICOL, V31, P1092, DOI 10.1177/0960327112444477; Wu JL, 2017, IMMUNOL LETT, V190, P169, DOI 10.1016/j.imlet.2017.08.005; Zhou D, 2017, WORLD J GASTROENTERO, V23, P60, DOI 10.3748/wjg.v23.i1.60	77	24	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					676	690		10.1096/fj.201900927RR	http://dx.doi.org/10.1096/fj.201900927RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914696				2022-12-26	WOS:000507308900047
J	Rymut, N; Heinz, J; Sadhu, S; Hosseini, Z; Riley, CO; Marinello, M; Maloney, J; MacNamara, KC; Spite, M; Fredman, G				Rymut, Nicholas; Heinz, Justin; Sadhu, Sudeshna; Hosseini, Zeinab; Riley, Colin O.; Marinello, Michael; Maloney, Jackson; MacNamara, Katherine C.; Spite, Matthew; Fredman, Gabrielle			Resolvin D1 promotes efferocytosis in aging by limiting senescent cell-induced MerTK cleavage	FASEB JOURNAL			English	Article						efferocytosis; inflammation-resolution; MerTK; resolvin; SASP	APOPTOTIC CELLS; PLAQUE NECROSIS; RESOLUTION; INFLAMMATION; MACROPHAGES; CLEARANCE; RECEPTOR; REDUCTION; LIPOXIN	Inflammation-resolution is mediated by the balance between specialized pro-resolving mediators (SPMs) like resolvin D1 (RvD1) and pro-inflammatory factors, like leukotriene B-4 (LTB4). A key cellular process of inflammation-resolution is efferocytosis. Aging is associated with defective inflammation-resolution and the accumulation of pro-inflammatory senescent cells (SCs). Therefore, understanding mechanism(s) that underpin this impairment is a critical gap. Here, using a model of hind limb ischemia-reperfusion (I/R) remote lung injury, we present evidence that aging is associated with heightened inflammation, impaired SPM:LT ratio, defective efferocytosis, and a decrease in MerTK levels in injured lungs. Treatment with RvD1 mitigated I/R lung injury in aging, promoted efferocytosis, and prevented the decrease of MerTK in injured lungs from old mice. Old MerTK cleavage-resistant mice (MerTK(CR)) exhibited less neutrophils or polymorpho nuclear cells infiltration and had improved efferocytosis compared with old WT controls. Mechanistically, macrophages that were treated with conditioned media (CM) from senescent cells had increased MerTK cleavage, impaired efferocytosis, and a defective RvD1:LTB4 ratio. Macrophages from MerTK(CR) mice were resistant to CM-induced efferocytosis defects and had an improved RvD1:LTB4 ratio. RvD1-stimulated macrophages prevented CM-induced MerTK cleavage and promoted efferocytosis. Together, these data suggest a new mechanism and a potential therapy to promote inflammation-resolution and efferocytosis in aging.	[Rymut, Nicholas; Heinz, Justin; Sadhu, Sudeshna; Hosseini, Zeinab; Marinello, Michael; Fredman, Gabrielle] Albany Med Coll, Dept Mol & Cellular Physiol, ME403, Albany, NY 12208 USA; [Riley, Colin O.; Spite, Matthew] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA; [Riley, Colin O.; Spite, Matthew] Harvard Med Sch, Boston, MA 02115 USA; [Maloney, Jackson; MacNamara, Katherine C.] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Albany Medical College	Fredman, G (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, ME403, Albany, NY 12208 USA.	fredmag@amc.edu			American Federation for Aging (AFAR) Research grant [A16034]; NIH [HL119587, HL141127, HL106173, GM095467, GM105949]	American Federation for Aging (AFAR) Research grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an American Federation for Aging (AFAR) Research grant A16034 (GF), NIH grants HL119587 (GF), HL141127 (GF), HL106173 (MS), GM095467 (MS; Core B), and GM105949 (KCM)	Aprahamian T, 2008, CLIN EXP IMMUNOL, V152, P448, DOI 10.1111/j.1365-2249.2008.03658.x; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313; Cai B, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3721; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Campisi J, 2014, INTERD T GERONT GERI, V39, P45, DOI 10.1159/000358899; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; DeBerge M, 2017, CIRC RES, V121, P930, DOI 10.1161/CIRCRESAHA.117.311327; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Fredman G, 2010, ARTERIOSCL THROM VAS, V30, P2005, DOI 10.1161/ATVBAHA.110.209908; Frisch BJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124213; Gangemi S, 2005, EXP GERONTOL, V40, P612, DOI 10.1016/j.exger.2005.04.004; HIGASHIMOTO Y, 1993, MECH AGEING DEV, V69, P207, DOI 10.1016/0047-6374(93)90024-L; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Kline KA, 2016, CURR OPIN MICROBIOL, V29, P63, DOI 10.1016/j.mib.2015.11.003; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Linehan E, 2014, AGING CELL, V13, P699, DOI 10.1111/acel.12223; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; McPhillips K, 2007, J IMMUNOL, V178, P8117, DOI 10.4049/jimmunol.178.12.8117; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; Rodier Francis, 2013, Methods Mol Biol, V965, P165, DOI 10.1007/978-1-62703-239-1_10; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SEEKAMP A, 1993, AGENT ACTION SUPPL, V41, P137; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shinohara M, 2014, AM J PHYSIOL-LUNG C, V307, pL746, DOI 10.1152/ajplung.00166.2014; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Whittington RA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01464; Wong CK, 2017, J IMMUNOL, V199, P1060, DOI 10.4049/jimmunol.1700397; Wongrakpanich S, 2018, AGING DIS, V9, P143, DOI 10.14336/AD.2017.0306; Yang B, 2016, BR J ANAESTH S2, V117, pii32	42	32	32	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					597	609		10.1096/fj.201902126R	http://dx.doi.org/10.1096/fj.201902126R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914705	Green Accepted, Bronze			2022-12-26	WOS:000507308900041
J	Su, H; Ye, C; Lei, CT; Tang, H; Zeng, JY; Yi, F; Zhang, C				Su, Hua; Ye, Chen; Lei, Chun-Tao; Tang, Hui; Zeng, Jie-Yu; Yi, Fan; Zhang, Chun			Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure	FASEB JOURNAL			English	Article						cell cycle; integrin beta 8; MDM2 membrane translocation; p53; TGF-beta 1	ACUTE-RENAL-FAILURE; FIBROSIS; ACTIVATION; BINDING; REPAIR; CELLS; BETA	Acute kidney injury (AKI) is the leading cause of renal failure, and quite a few patients will advance to chronic kidney disease (CKD) in the long term. Here, we explore the roles and mechanisms of tubular epithelial cells (TECs) during repeated cisplatin (CP) induced AKI to CKD transition (AKI-CKD). Previously, we reported that murine double minute 2 (MDM2), an E3-ubiquitin ligase, is involved in tubulointerstitial fibrosis. However, whether tubular MDM2 is implicated in AKI-CKD is undefined. Currently, we confirmed that during AKI-CKD, MDM2 shifts from nucleus to cell membrane in TECs both in vivo and in vitro. Whereas regulating MDM2 distribution chemically or genetically has a prominent impact on tubular disorders. And then we investigated the mechanisms of the above findings. First, in the nucleus, repeated CP administration leads to MDM2 reduction with escalated p53 and cell cycle G2/M arrest. On the other hand, multiple CP treatment increases the level of membranous MDM2 with ensuing integrin beta 8 degradation and TGF-beta 1 activation. More interestingly, anchoring MDM2 on cell membranes can mimic the reduction of integrin beta 8 arousing by repeated CP exposure. Collectively, our findings provided the evidence that tubular MDM2 subcellular shuttling is involved in AKI-CKD through p53-G2/M arrest and integrin beta 8 mediated TGF-beta 1 activation.	[Su, Hua; Ye, Chen; Lei, Chun-Tao; Tang, Hui; Zeng, Jie-Yu; Zhang, Chun] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nephrol, Union Hosp, Wuhan 430022, Hubei, Peoples R China; [Yi, Fan] Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, Key Lab Infect & Immun Shandong Prov, Jinan, Peoples R China	Huazhong University of Science & Technology; Shandong University	Zhang, C (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Nephrol, Union Hosp, Wuhan 430022, Hubei, Peoples R China.	drzhangchun@hust.edu.cn			Program for HUST Academic Frontier Youth Team [2017QYTD20]; National Natural Science Foundation of China [81570671, 81873602, 81770711]	Program for HUST Academic Frontier Youth Team; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Program for HUST Academic Frontier Youth Team, Grant/Award Number: 2017QYTD20; National Natural Science Foundation of China, Grant/Award Number: 81570671, 81873602 and 81770711	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Jadot I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183604; Jiang CM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36698; Khan S, 2011, AM J PATHOL, V178, P609, DOI 10.1016/j.ajpath.2010.10.031; Lakhe-Reddy S, 2006, J BIOL CHEM, V281, P19688, DOI 10.1074/jbc.M601110200; Le Clef N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152153; Lei CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10927-5; Little MH, 2017, J AM SOC NEPHROL, V28, P34, DOI 10.1681/ASN.2016070748; MOYLE M, 1991, J BIOL CHEM, V266, P19650; Mulay SR, 2016, AM J PATHOL, V186, P1442, DOI 10.1016/j.ajpath.2016.01.017; Mulay SR, 2013, J PATHOL, V230, P322, DOI 10.1002/path.4193; Mulay SR, 2012, KIDNEY INT, V81, P1199, DOI 10.1038/ki.2011.482; Murugan R, 2011, NAT REV NEPHROL, V7, P209, DOI 10.1038/nrneph.2011.13; Sarafraz-Yazdi E, 2010, P NATL ACAD SCI USA, V107, P1918, DOI 10.1073/pnas.0909364107; Sharp CN, 2016, AM J PHYSIOL-RENAL, V310, pF560, DOI 10.1152/ajprenal.00512.2015; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Strous G J, 2001, Sci STKE, V2001, ppe41, DOI 10.1126/stke.2001.110.pe41; Tang H, 2017, J CELL MOL MED, V21, P3435, DOI 10.1111/jcmm.13253; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Wang SM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026245; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ye C, 2017, AM J PHYSIOL-RENAL, V312, pF760, DOI 10.1152/ajprenal.00528.2016	35	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1620	1636		10.1096/fj.201901412R	http://dx.doi.org/10.1096/fj.201901412R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914692	Bronze			2022-12-26	WOS:000507308900107
J	El-Ansary, A; Hassan, WM; Daghestani, M; Al-Ayadhi, L; Ben Bacha, A				El-Ansary, Afaf; Hassan, Wail M.; Daghestani, Maha; Al-Ayadhi, Laila; Ben Bacha, Abir			Preliminary evaluation of a novel nine-biomarker profile for the prediction of autism spectrum disorder	PLOS ONE			English	Article							EARLY INTERVENTION; OXIDATIVE STRESS; CHILDREN; CREATINE; DYSFUNCTION; BIOMARKERS; CELLS	Background Autism spectrum disorder (ASD) is a complex group of heterogeneous neurodevelopmental disorders the prevalence of which has been in the rise in the past decade. In an attempt to better target the basic causes of ASD for diagnosis and treatment, efforts to identify reliable biomarkers related to the body's metabolism are increasing. Despite an increase in identifying biomarkers in ASD, there are none so far with enough evidence to be used in routine clinical examination, unless medical illness is suspected. Promising biomarkers include those of mitochondrial dysfunction, oxidative stress, energy metabolism, and apoptosis. Methods and participants Sodium (Na+), Potassium (K+), glutathione (GSH), glutathione-s-transferase (GST), Creatine kinase (CK), lactate dehydrogenase (LDH), Coenzyme Q10, and melatonin (MLTN) were evaluated in 13 participants with ASD and 24 age-matched healthy controls. Additionally, five ratios, which include Na+/K+, GSH:GST, CK:Cas7, CoQ10: Cas 7, and Cas7: MLTN, were tested to measure their predictive values in discriminating between autistic individuals and controls. These markers, either in absolute values, as five ratios, or combined (9 markers + 5 ratios) were subjected to a principal component analysis and multidimensional scaling (MDS), and hierarchical clustering, which are helpful statistical tools in the field of biomarkers. Results Our data demonstrated that both PCA and MDS analysis were effective in separating autistic from control subjects completely. This was also confirmed through the use of hierarchical clustering, which showed complete separation of the autistic and control groups based on nine biomarkers, five biomarker ratios, or a combined profile. Excellent predictive value of the measured profile was obtained using the receiver operating characteristics analysis, which showed an area under the curve of 1. Conclusion The availability of an improved predictive profile, represented by nine biomarkers plus the five ratios, inter-related different etiological mechanisms in ASD and would be valuable in providing greater recognition of the altered biological pathways in ASD. Our predictive profile could be used for the diagnosis and intervention of ASD.	[El-Ansary, Afaf; Daghestani, Maha] King Saud Univ, Ctr Female Sci & Med Coll, Natl Res Ctr, Riyadh, Saudi Arabia; [El-Ansary, Afaf] Natl Res Ctr, Therapeut Chem Dept, Cairo, Egypt; [El-Ansary, Afaf; Al-Ayadhi, Laila] King Saud Univ, Autism Res & Treatment Ctr, Riyadh, Saudi Arabia; [Hassan, Wail M.] Univ Missouri, Sch Med, Dept Biomed Sci, Kansas City, MO 64108 USA; [Daghestani, Maha] King Saud Univ, Sci Coll, Zool Dept, Riyadh, Saudi Arabia; [Al-Ayadhi, Laila] King Saud Univ, Fac Med, Dept Physiol, Riyadh, Saudi Arabia; [Ben Bacha, Abir] King Saud Univ, Sci Coll, Biochem Dept, Riyadh, Saudi Arabia; [Ben Bacha, Abir] Univ Sfax, Fac Sci Sfax, Lab Plant Biotechnol Appl Crop Improvement, Sfax, Tunisia	King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Saud University; University of Missouri System; University of Missouri Kansas City; King Saud University; King Saud University; King Saud University; Universite de Sfax; Faculty of Sciences Sfax	El-Ansary, A (corresponding author), King Saud Univ, Ctr Female Sci & Med Coll, Natl Res Ctr, Riyadh, Saudi Arabia.; El-Ansary, A (corresponding author), Natl Res Ctr, Therapeut Chem Dept, Cairo, Egypt.; El-Ansary, A (corresponding author), King Saud Univ, Autism Res & Treatment Ctr, Riyadh, Saudi Arabia.	elansary@ksu.edu.sa	bacha, Abir ben/AFM-1328-2022; Hassan, Wail/R-5045-2019	Hassan, Wail/0000-0002-2960-3927; Ben Bacha, Abir/0000-0001-6372-7483	National Plan for Science Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology [08-MED 510-02]	National Plan for Science Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology	This work was supported by 08-MED 510-02 to LA, National Plan for Science Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, https://www.kacst.edu.sa/eng/Pages/default.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by the National Plan for Science Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award number: 08-MED 510-02.	AMADOR E, 1963, CLIN CHEM, V9, P391; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baio J, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6706a1; Barderas MG, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/790132; Beger RD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1094-6; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Braam W, 2013, J INTELL DISABIL RES, V57, P993, DOI 10.1111/j.1365-2788.2012.01595.x; Castora FJ, 2019, PROG NEURO-PSYCHOPH, V92, P83, DOI 10.1016/j.pnpbp.2018.12.015; Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x; Chen CP, 2019, COMPUT SPEECH LANG, V56, P17, DOI 10.1016/j.csl.2018.12.003; Cornelius N, 2017, MITOCHONDRION, V34, P103, DOI 10.1016/j.mito.2017.03.001; Dawson G, 2010, CURR OPIN NEUROL, V23, P95, DOI 10.1097/WCO.0b013e3283377644; El-Ansary A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164153; El-Ansary A, 2016, DATA BRIEF, V7, P111, DOI 10.1016/j.dib.2016.02.025; El-Ansary A, 2010, CLIN BIOCHEM, V43, P63, DOI 10.1016/j.clinbiochem.2009.09.008; Faber S, 2019, FREE RADICAL BIO MED, V134, P666, DOI 10.1016/j.freeradbiomed.2019.02.009; Fontil L, 2019, RES DEV DISABIL, V88, P30, DOI 10.1016/j.ridd.2019.02.006; Ford TC, 2019, PROG NEURO-PSYCHOPH, V88, P235, DOI 10.1016/j.pnpbp.2018.07.024; Fraguas D, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2018-3218; Gabis LV, 2020, NEUROPROTECTION IN AUTISM, SCHIZOPHRENIA AND ALZHEIMER'S DISEASE, P79, DOI 10.1016/B978-0-12-814037-6.00004-5; Goyal N, 2016, SCAND J IMMUNOL, V83, P338, DOI 10.1111/sji.12424; Guglielmi L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00034; Hassan WM, 2018, J MOL NEUROSCI, V66, P85, DOI 10.1007/s12031-018-1136-9; Heuer LS, 2019, BIOL PSYCHIAT, V86, P255, DOI 10.1016/j.biopsych.2019.04.037; Nguyen HTN, 2018, BIOCHEM BIOPHYS REP, V16, P24, DOI 10.1016/j.bbrep.2018.09.004; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Kerns CM, 2014, J AUTISM DEV DISORD, V44, P2851, DOI 10.1007/s10803-014-2141-7; Khemakhem AM, 2017, METAB BRAIN DIS, V32, P1983, DOI 10.1007/s11011-017-0085-2; Kintz P, 1999, J ANAL TOXICOL, V23, P352, DOI 10.1093/jat/23.5.352; Lasheras I, 2020, ASIAN J PSYCHIATR, V47, DOI 10.1016/j.ajp.2019.101874; Lukmanji S, 2019, EPILEPSY BEHAV, V98, P238, DOI 10.1016/j.yebeh.2019.07.037; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; Mari M, 2013, BBA-GEN SUBJECTS, V1830, P3317, DOI 10.1016/j.bbagen.2012.10.018; Mierau SB, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104544; O'Neill J, 2019, BIOL PSYCHIAT; Ostojic SM, 2018, MED HYPOTHESES, V113, P52, DOI 10.1016/j.mehy.2018.02.022; Park JC, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101690; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; Preeti K, 2017, ASIAN J PSYCHIATR, V25, P13, DOI 10.1016/j.ajp.2016.07.021; Randall M, 2018, COCHRANE DB SYST REV, P1, DOI 10.1002/14651858.CD009044.pub2; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schumann G, 2002, CLIN CHEM LAB MED, V40, P635, DOI 10.1515/CCLM.2002.110; Shoffner J, 2010, J CHILD NEUROL, V25, P429, DOI 10.1177/0883073809342128; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; WACKER WEC, 1956, NEW ENGL J MED, V255, P449, DOI 10.1056/NEJM195609062551001; Xu G, 2018, JAMA-J AM MED ASSOC, V319, P505, DOI 10.1001/jama.2018.0022	46	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227626	10.1371/journal.pone.0227626	http://dx.doi.org/10.1371/journal.pone.0227626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945130	gold, Green Published			2022-12-26	WOS:000534370100048
J	Zhou, YX; Qiu, LY; Wang, HY; Chen, XM				Zhou, Yuxin; Qiu, Liyan; Wang, Haiying; Chen, Xuanmao			Induction of activity synchronization among primed hippocampal neurons out of random dynamics is key for trace memory formation and retrieval	FASEB JOURNAL			English	Article						calcium imaging in freely behaving animals; declarative memory; GCaMP6; memory consolidation; right-skewed lognormal distribution; synaptic plasticity	BIDIRECTIONAL SYNAPTIC PLASTICITY; TIMING-DEPENDENT PLASTICITY; IN-VIVO; ADENYLYL CYCLASES; CALCIUM SIGNALS; BRAIN; EXCITABILITY; AMYGDALA; CREB; ORGANIZATION	Memory is thought to be encoded by sparsely distributed neuronal ensembles in memory-related regions. However, it is unclear how memory-eligible neurons react during learning to encode trace fear memory and how they retrieve a memory. We implemented a fiber-optic confocal fluorescence endomicroscope to directly visualize calcium dynamics of hippocampal CA1 neurons in freely behaving mice subjected to trace fear conditioning. Here we report that the overall activity levels of CA1 neurons showed a right-skewed lognormal distribution, with a small portion of highly active neurons (termed Primed Neurons) filling the long-tail. Repetitive training induced Primed Neurons to shift from random activity to well-tuned synchronization. The emergence of activity synchronization coincided with the appearance of mouse freezing behaviors. In recall, a partial synchronization among the same subset of Primed Neurons was induced from random dynamics, which also coincided with mouse freezing behaviors. Additionally, training-induced synchronization facilitated robust calcium entry into Primed Neurons. In contrast, most CA1 neurons did not respond to tone and foot shock throughout the training and recall cycles. In conclusion, Primed Neurons are preferably recruited to encode trace fear memory and induction of activity synchronization among Primed Neurons out of random dynamics is critical for trace memory formation and retrieval.	[Zhou, Yuxin; Qiu, Liyan; Chen, Xuanmao] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Wang, Haiying] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	University System Of New Hampshire; University of New Hampshire; University of Connecticut	Chen, XM (corresponding author), Univ New Hampshire, Coll Life Sci & Agr, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	Xuanmao.Chen@unh.edu		Chen, Xuanmao/0000-0002-0057-8510	National Institutes of Health [MH105746, AG054729, GM113131-7006]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: MH105746, AG054729 and GM113131-7006	AIKA Y, 1994, EXP BRAIN RES, V99, P267; Andersen P., 2007, HIPPOCAMPUS BOOK; Asok A, 2019, TRENDS NEUROSCI, V42, P14, DOI 10.1016/j.tins.2018.10.005; Bakkum DJ, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00193; Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Buonomano DV, 2009, NEURON, V63, P423, DOI 10.1016/j.neuron.2009.08.003; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Chen CP, 2006, BIOSYSTEMS, V85, P137, DOI 10.1016/j.biosystems.2005.12.006; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XM, 2016, BIOL PSYCHIAT, V80, P836, DOI 10.1016/j.biopsych.2015.12.012; Chen XM, 2015, J NEUROSCI, V35, P339, DOI 10.1523/JNEUROSCI.2478-14.2015; Clark RE, 2002, TRENDS COGN SCI, V6, P524, DOI 10.1016/S1364-6613(02)02041-7; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Frankland PW, 2015, NEUROPSYCHOPHARMACOL, V40, P243, DOI 10.1038/npp.2014.234; Ghandour K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10683-2; Golomb D, 2006, J NEUROPHYSIOL, V95, P1049, DOI 10.1152/jn.00932.2005; Gore BB, 2014, LEARN MEMORY, V21, P575, DOI 10.1101/lm.036079.114; Gorski JA, 2002, J NEUROSCI, V22, P6309; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kim J, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00044; Kochli DE, 2015, LEARN MEMORY, V22, P92, DOI 10.1101/lm.034918.114; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Le Duigou C, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00262; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; Mizuseki K, 2013, CELL REP, V4, P1010, DOI 10.1016/j.celrep.2013.07.039; Pang KKL, 2019, P NATL ACAD SCI USA, V116, P5737, DOI 10.1073/pnas.1817643116; Park S, 2016, NEUROPSYCHOPHARMACOL, V41, P2987, DOI 10.1038/npp.2016.73; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Roy DS, 2017, CELL, V170, P1000, DOI 10.1016/j.cell.2017.07.013; Russell JT, 2011, BRIT J PHARMACOL, V163, P1605, DOI 10.1111/j.1476-5381.2010.00988.x; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schultz SR., 2007, SCHOLARPEDIA, V2, P2046, DOI 10.4249/scholarpedia.2046; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Semon R.W., 1921, THE MNEME; Song CH, 2015, J NEUROSCI, V35, P13511, DOI 10.1523/JNEUROSCI.2329-15.2015; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tanaka KZ, 2018, SCIENCE, V361, P392, DOI 10.1126/science.aat5397; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tonegawa S, 2018, NAT REV NEUROSCI, V19, P485, DOI 10.1038/s41583-018-0031-2; Tonegawa S, 2015, CURR OPIN NEUROBIOL, V35, P101, DOI 10.1016/j.conb.2015.07.009; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; Vincent P, 2006, EMBO REP, V7, P1154, DOI 10.1038/sj.embor.7400801; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Wang HB, 2012, REV NEUROSCIENCE, V23, P67, DOI 10.1515/revneuro-2011-0063; Wang ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00697-5; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yada Y, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00028; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Yang SG, 2014, P NATL ACAD SCI USA, V111, P12919, DOI 10.1073/pnas.1405468111; Yang WJ, 2017, NAT METHODS, V14, P349, DOI 10.1038/nmeth.4230; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Zhang L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219152; Zhang M, 2011, J NEUROSCI, V31, P10174, DOI 10.1523/JNEUROSCI.0009-11.2011; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	69	6	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3658	3676		10.1096/fj.201902274R	http://dx.doi.org/10.1096/fj.201902274R		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944374	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000507592600001
J	Abed, S; Behiry, AAMR; Ahmad, I				Abed, Sa'ed; Behiry, Ali A. M. R.; Ahmad, Imtiaz			Error metrics determination in functionally approximated circuits using SAT solvers	PLOS ONE			English	Article							DESIGN	Approximate computing is an emerging design paradigm that offers trade-offs between output accuracy and computation efforts by exploiting some applications' intrinsic error resiliency. Computation of error metrics is of paramount importance in approximate circuits to measure the degree of approximation. Most of the existing techniques for evaluating error metrics apply simulations which may not be effective for evaluation of large complex designs because of an immense increase in simulation runtime and a decrease in accuracy. To address these deficiencies, we present a novel methodology that employs SAT (Boolean satisfiability) solvers for fast and accurate determination of error metrics specifically for the calculation of an average-case error and the maximum error rate in functionally approximated circuits. The proposed approach identifies the set of all errors producing assignments to gauge the quality of approximate circuits for real-life applications. Additionally, the proposed approach provides a test generation method to facilitate design choices, and acts as an important guide to debug the approximate circuits to discover and locate the errors. The effectiveness of the approach is demonstrated by evaluating the error metrics of several benchmark-approximated adders of different sizes. Experimental results on benchmark circuits show that the proposed SAT-based methodology accurately determines the maximum error rate and an average-case error within acceptable CPU execution time in one go, and further provides a log of error-generating input assignments.	[Abed, Sa'ed; Behiry, Ali A. M. R.; Ahmad, Imtiaz] Kuwait Univ, Comp Engn Dept, Coll Engn & Petr, Kuwait, Kuwait	Kuwait University	Abed, S (corresponding author), Kuwait Univ, Comp Engn Dept, Coll Engn & Petr, Kuwait, Kuwait.	s.abed@ku.edu.kw	, Sa'ed/F-9567-2015	, Sa'ed/0000-0003-1849-9316; Rady, Ali/0000-0002-3458-0686				Afonso J, 2017, DES AUT TEST EUROPE, P824, DOI 10.23919/DATE.2017.7927102; Akbari O, 2018, IEEE T CIRCUITS-II, V65, P1089, DOI 10.1109/TCSII.2016.2633307; Akhtar Y, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY (CIT), P10, DOI 10.1109/CIT.2016.89; [Anonymous], 2018, [No title captured], DOI [10.1109/ISCAS.2018.8351273, DOI 10.1109/ISCAS.2018.8351273]; Berkeley Logic Synthesis and Verification Group, 2019, ABC SYSTEM SEQUENTIA; Cabodi G, 2002, DES AUT CON, P117, DOI 10.1109/DAC.2002.1012605; Chandrasekharan A, 2018, ASIA S PACIF DES AUT, P239; Chandru AA, 2016, ADV INTELL SYST, V397, P1, DOI 10.1007/978-81-322-2671-0_1; Chippa V., 2013, P 50 ACM EDAC IEEE D, P1, DOI [10.1145/2463209.2488873, DOI 10.1145/2463209.2488873]; Choudhury MR, 2013, IEEE T COMPUT AID D, V32, P1163, DOI 10.1109/TCAD.2013.2250581; Dal Bem V, 2017, IEEE T EMERG TOP COM, V5, P247, DOI 10.1109/TETC.2016.2644381; Froehlich S, 2019, DES AUT TEST EUROPE, P284, DOI 10.23919/DATE.2019.8715138; Gebregiorgis A, 2019, DES AUT TEST EUROPE, P1028, DOI 10.23919/DATE.2019.8714898; Han J, 2013, EUROSURVEILLANCE, V18, P6; Holik L., 2016, 2 WORKSHOP APPROXIMA, P1; Huang JW, 2012, DES AUT CON, P504; Jiang HL, 2016, IEEE INT SYMP NANO, P191, DOI 10.1145/2950067.2950068; Keszocze O, 2018, INFORM PROCESS LETT, V139, P1, DOI 10.1016/j.ipl.2018.06.010; Lingamneni A, 2011, DES AUT TEST EUROPE, P764; Mazahir S, 2017, IEEE T COMPUT, V66, P1982, DOI 10.1109/TC.2017.2709542; Mazahir S, 2017, IEEE T COMPUT, V66, P515, DOI 10.1109/TC.2016.2605382; MITTAL S, 2016, ACM COMPUT SURV, V48, DOI DOI 10.1145/2893356; Momeni A, 2015, IEEE T COMPUT, V64, P984, DOI 10.1109/TC.2014.2308214; Qureshi A, 2019, IEEE T COMPUT AID D, V38, P177, DOI 10.1109/TCAD.2018.2803622; Schlachter J, 2017, IEEE T VLSI SYST, V25, P1694, DOI 10.1109/TVLSI.2017.2657799; Shafique M, 2015, DES AUT CON, DOI 10.1145/2744769.2744778; Soeken M, 2016, ASIA S PACIF DES AUT, P474, DOI 10.1109/ASPDAC.2016.7428057; Toda Takahisa, 2016, J EXPT ALGORITHMICS, V21, P1, DOI [DOI 10.1145/2975585, 10.1145/2975585]; Venkatesan R, 2011, ICCAD-IEEE ACM INT, P667, DOI 10.1109/ICCAD.2011.6105401; Wolf C, 2016, YOSYS OPEN SYNTHESIS; Wu Y, 2017, ARXIV170303522; Yu CX, 2016, IEEE COMP SOC ANN, P152, DOI 10.1109/ISVLSI.2016.85	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227745	10.1371/journal.pone.0227745	http://dx.doi.org/10.1371/journal.pone.0227745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935260	Green Published, gold			2022-12-26	WOS:000534354100049
J	Vennemann, B; Obrist, D; Rosgen, T				Vennemann, Bernhard; Obrist, Dominik; Rosgen, Thomas			A smartphone-enabled wireless and batteryless implantable blood flow sensor for remote monitoring of prosthetic heart valve function	PLOS ONE			English	Article							DESIGN; MAGNETS	Aortic valve disease is one of the leading forms of complications in the cardiovascular system. The failing native aortic valve is routinely surgically replaced with a bioprosthesis. However, insufficient durability of bioprosthetic heart valves often requires reintervention. Valve degradation can be assessed by an analysis of the blood flow characteristics downstream of the valve. This is cost and labor intensive using clinical methodologies and is performed infrequently. The integration of consumer smartphones and implantable blood flow sensors into the data acquisition chain facilitates remote management of patients that is not limited by access to clinical facilities. This article describes the characteristics of an implantable magnetic blood flow sensor which was optimized for small size and low power consumption to allow for batteryless operation. The data is wirelessly transmitted to the patient's smartphone for in-depth processing. Tests using three different experimental setups confirmed that wireless and batteryless blood flow recording using a magnetic flow meter technique is feasible and that the sensor system is capable of monitoring the characteristic flow downstream of the valve.	[Vennemann, Bernhard; Rosgen, Thomas] Swiss Fed Inst Technol, Inst Fluid Dynam, Zurich, Switzerland; [Vennemann, Bernhard; Obrist, Dominik] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern	Vennemann, B (corresponding author), Swiss Fed Inst Technol, Inst Fluid Dynam, Zurich, Switzerland.; Vennemann, B (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland.	bvennema@ethz.ch	Obrist, Dominik/AAT-3254-2020	Obrist, Dominik/0000-0002-6062-9076				Boutry CM, 2019, NAT BIOMED ENG, V3, P47, DOI 10.1038/s41551-018-0336-5; Cannata JM, 2012, J ULTRAS MED, V31, P1795, DOI 10.7863/jum.2012.31.11.1795; Cheong JH, 2012, IEEE T BIO-MED ENG, V59, P2466, DOI 10.1109/TBME.2012.2203131; Furlani E. P., 2001, PERMANENT MAGNET ELE; GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709; HALBACH K, 1980, NUCL INSTRUM METHODS, V169, P1, DOI 10.1016/0029-554X(80)90094-4; Head SJ, 2017, EUR HEART J, V38, P2183, DOI 10.1093/eurheartj/ehx141; Kolin A., 1937, AM J PHYSIOL, V119, P355; Locke SE, 2004, COMPUT CARDIOL, V31, P713; MALLINSON JC, 1973, IEEE T MAGN, VMAG9, P678, DOI 10.1109/TMAG.1973.1067714; Mills CJ., 1972, MEASUREMENT PULSATIL; Nishimura RA, 2002, CIRCULATION, V106, P770, DOI 10.1161/01.CIR.0000027621.26167.5E; Raich H, 2004, CONCEPT MAGN RESON B, V23B, P16, DOI 10.1002/cmr.b.20018; Rothfuss MA, 2016, IEEE J TRANSL ENG HE, V4; Schwan H. P, 1983, ANN HEMATOL, V46, P185, DOI DOI 10.1007/BF00320638; Shercliff J. A., 1962, THEORY ELECTROMAGNET; Steeves CA, 2007, J MATER SCI-MATER M, V18, P25, DOI 10.1007/s10856-006-0659-8; Steve Majerus J A, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P2989, DOI 10.1109/EMBC.2018.8512997; Tang SC, 2014, IEEE INT ULTRA SYM, P1622, DOI 10.1109/ULTSYM.2014.0402; Unadkat J, 2014, PLAST RECONSTR SURG, V134, P57, DOI DOI 10.1097/01.PRS.0000455398.99175.A6; Unadkat JV, 2015, PLAST RECONSTR SURG, V136, P199, DOI 10.1097/PRS.0000000000001372; Vennemann B., 2019, WIRELESS BLOOD FLOW; Vennemann B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222983; Vennemann B, 2018, ASAIO J, V64, P651, DOI 10.1097/MAT.0000000000000687; Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9; Vilkomerson D, 2005, IEEE ULTR S, P461; Vilkomerson D, 2008, PROC SPIE, V6920, DOI 10.1117/12.772845; Wetterer E, 1938, Z BIOL-MUNICH, V99, P158; Windt CW, 2011, J MAGN RESON, V208, P27, DOI 10.1016/j.jmr.2010.09.020; Woodcock JP, 1975, THEORY PRACTICE BLOO; Xue RF, 2011, INT SYM INT CIR ISIC; ZIJLSTRA H, 1985, PHILIPS J RES, V40, P259	32	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227372	10.1371/journal.pone.0227372	http://dx.doi.org/10.1371/journal.pone.0227372			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935231	Green Published, gold			2022-12-26	WOS:000534354100018
J	Silva, MF; Pereira, G; Carneiro, C; Hemphill, A; Mateus, L; Lopes-da-Costa, L; Silva, E				Silva, Marta Filipa; Pereira, Goncalo; Carneiro, Carla; Hemphill, Andrew; Mateus, Luisa; Lopes-da-Costa, Luis; Silva, Elisabete			Campylobacter portucalensis sp. nov., a new species of Campylobacter isolated from the preputial mucosa of bulls	PLOS ONE			English	Article							EFFLUX PUMP; JEJUNI; IDENTIFICATION; COLONIZATION; CMEABC; CATTLE; GENE; INTERNALIZATION; RESISTANCE; VIRULENCE	A new species of the Campylobacter genus is described, isolated from the preputial mucosa of bulls (Bos taurus). The five isolates obtained exhibit characteristics of Campylobacter, being Gram-negative non-motile straight rods, oxidase positive, catalase negative and microaerophilic. Phenotypic characteristics and nucleotide sequence analysis of 16S rRNA and hsp60 genes demonstrated that these isolates belong to a novel species within the genus Campylobacter. Based on hsp60 gene phylogenetic analysis, the most related species are C. ureolyticus, C. blaseri and C. corcagiensis. The whole genome sequence analysis of isolate FMV-PI01 revealed that the average nucleotide identity with other Campylobacter species was less than 75%, which is far below the cut-off for isolates of the same species. However, whole genome sequence analysis identified coding sequences highly homologous with other Campylobacter spp. These included several virulence factor coding genes related with host cell adhesion and invasion, transporters involved in resistance to antimicrobials, and a type IV secretion system (T4SS), containing virB2-virB11/virD4 genes, highly homologous to the C. fetus subsp. venerealis. The genomic G+C content of isolate FMV-PI01 was 28.3%, which is one of the lowest values reported for species of the genus Campylobacter. For this species the name Campylobacter portucalensis sp. nov. is proposed, with FMV-PI01 (= LMG 31504, = CCUG 73856) as the type strain.	[Silva, Marta Filipa; Pereira, Goncalo; Carneiro, Carla; Mateus, Luisa; Lopes-da-Costa, Luis; Silva, Elisabete] Univ Lisbon, CIISA Ctr Invest Interdisciplinar Sanidade Anim, Fac Med Vet, Lisbon, Portugal; [Hemphill, Andrew] Univ Bern, Inst Parasitol, Vetsuisse Fac, Bern, Switzerland	Universidade de Lisboa; University of Bern	Silva, E (corresponding author), Univ Lisbon, CIISA Ctr Invest Interdisciplinar Sanidade Anim, Fac Med Vet, Lisbon, Portugal.	elisabetesilva@fmv.ulisboa.pt	Silva, Maria elisabete T:S./K-3678-2017; Mateus, Luísa/AAH-8643-2021; Pereira, Gonçalo/AAX-2196-2020	Silva, Maria elisabete T:S./0000-0002-2332-7642; Pereira, Gonçalo/0000-0003-3533-6893; Mateus, Luisa/0000-0002-8304-9920; Lopes-da-Costa, Luis/0000-0001-5165-3034; Hemphill, Andrew/0000-0002-0622-2128	Fundacao para a Ciencia e a Tecnologia (FCT) [02/SAICT/2017, 030145, SFRH/BD/125657/2016, SFRH/BD/130923/2017, DL 57/2016/CP1438/CT0001]; Fundo Europeu de Desenvolvimento Regional (FEDER); Centro de Investigacao Interdisciplinar em Sanidade Animal - FCT [UID/CVT/00276/2019]; Swiss National Science Foundation [310030_184662]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Centro de Investigacao Interdisciplinar em Sanidade Animal - FCT; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by Fundacao para a Ciencia e a Tecnologia (FCT - www.fct.pt), under the 02/SAICT/2017, project no. 030145, cofunded by Fundo Europeu de Desenvolvimento Regional (FEDER). In addition, the study was funded by Centro de Investigacao Interdisciplinar em Sanidade Animal (http://ciisa.fmv.ulisboa.pt/en/) (Project UID/CVT/00276/2019, funded by FCT). Marta Silva and Goncalo Pereira are PhD students supported by grants from FCT, SFRH/BD/125657/2016 and SFRH/BD/130923/2017, respectively. Andrew Hemphill is funded by the Swiss National Science Foundation grant No. 310030_184662. Elisabete Silva is funded by FCT (DL 57/2016/CP1438/CT0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2012, GENE, V508, P145, DOI 10.1016/j.gene.2012.07.070; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Basto AP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01031-17, 10.1128/aac.01031-17]; Caceres A, 2017, INT J SYST EVOL MICR, V67, P1643, DOI 10.1099/ijsem.0.001822; Chaban B, 2013, AM J VET RES, V74, P1066, DOI 10.2460/ajvr.74.8.1066; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Couvin D, 2018, NUCLEIC ACIDS RES, V46, pW246, DOI 10.1093/nar/gky425; Debruyne L, 2010, INT J SYST EVOL MICR, V60, P1870, DOI 10.1099/ijs.0.013748-0; Debruyne L, 2010, INT J SYST EVOL MICR, V60, P815, DOI 10.1099/ijs.0.011056-0; Foster G, 2004, INT J SYST EVOL MICR, V54, P2369, DOI 10.1099/ijs.0.63147-0; Gibreel A, 2007, ANTIMICROB AGENTS CH, V51, P3212, DOI 10.1128/AAC.01592-06; Gilber MJ, 2018, INT J SYST EVOL MICR, V68, P1787, DOI 10.1099/ijsem.0.002742; Gilbert MJ, 2017, INT J SYST EVOL MICR, V67, P1961, DOI 10.1099/ijsem.0.001894; Gilbert MJ, 2015, INT J SYST EVOL MICR, V65, P975, DOI 10.1099/ijs.0.000048; Golz G, 2014, INT J MED MICROBIOL, V304, P817, DOI 10.1016/j.ijmm.2014.08.015; Gorkiewicz G, 2003, J CLIN MICROBIOL, V41, P2537, DOI 10.1128/JCM.41.6.2537-2546.2003; Gorkiewicz G, 2010, J BACTERIOL, V192, P502, DOI 10.1128/JB.00803-09; Guo BQ, 2010, FOODBORNE PATHOG DIS, V7, P77, DOI 10.1089/fpd.2009.0354; Hakkinen M, 2007, APPL ENVIRON MICROB, V73, P3232, DOI 10.1128/AEM.02579-06; Hemphill A, 2004, MICROSC MICROANAL, V10, P602, DOI 10.1017/S1431927604040930; Hemphill Andrew, 1997, P227; Inglis GD, 2007, INT J SYST EVOL MICR, V57, P2636, DOI 10.1099/ijs.0.65061-0; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P5145, DOI 10.1128/AEM.71.9.5145-5153.2005; Iraola G, 2014, GENOME BIOL EVOL, V6, P2392, DOI 10.1093/gbe/evu195; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Karenlampi RI, 2004, J CLIN MICROBIOL, V42, P5731, DOI 10.1128/JCM.42.12.5731-5738.2004; Kienesberger S, 2011, J BACTERIOL, V193, P744, DOI 10.1128/JB.00798-10; Konkel ME, 1999, MOL MICROBIOL, V32, P691, DOI 10.1046/j.1365-2958.1999.01376.x; Konkel ME, 1999, ADV EXP MED BIOL, V473, P215; Koziel M, 2014, INT J SYST EVOL MICR, V64, P2878, DOI 10.1099/ijs.0.063867-0; Koziel M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-14; Krause-Gruszczynska M, 2007, FEMS MICROBIOL LETT, V274, P9, DOI 10.1111/j.1574-6968.2007.00802.x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lastovica A.J., 2014, PROKARYOTES, P307, DOI DOI 10.1007/978-3-642-39044-9_274; Lawson AJ, 2001, INT J SYST EVOL MICR, V51, P651, DOI 10.1099/00207713-51-2-651; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Logan JMJ, 2000, INT J SYST EVOL MICR, V50, P865, DOI 10.1099/00207713-50-2-865; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Mann S, 2010, GENOMICS, V95, P7, DOI 10.1016/j.ygeno.2009.09.002; Michi AN, 2016, THERIOGENOLOGY, V85, P781, DOI 10.1016/j.theriogenology.2015.10.037; Monke HJ, 2002, J VET DIAGN INVEST, V14, P35, DOI 10.1177/104063870201400107; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; ON SLW, 1991, J CLIN MICROBIOL, V29, P1785, DOI 10.1128/JCM.29.9.1785-1788.1991; ON SLW, 1991, J CLIN MICROBIOL, V29, P923, DOI 10.1128/JCM.29.5.923-926.1991; On SLW, 2017, INT J SYST EVOL MICR, V67, P5296, DOI 10.1099/ijsem.0.002255; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Piccirillo A, 2016, INT J SYST EVOL MICR, V66, P3468, DOI 10.1099/ijsem.0.001219; Public Health England, UK STAND MICR INV MO; Quinn PJ, 2011, VET MICROBIOLOGY MIC, P357; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rossi M, 2009, INT J SYST EVOL MICR, V59, P2364, DOI 10.1099/ijs.0.007419-0; Sahin O, 2017, ANNU REV ANIM BIOSCI, V5, P21, DOI 10.1146/annurev-animal-022516-022826; Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0; Shinha T, 2015, EMERG INFECT DIS, V21, P1084, DOI 10.3201/eid2106.142043; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Van TTH, 2016, INT J SYST EVOL MICR, V66, P4518, DOI 10.1099/ijsem.0.001383; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vandamme P, 2010, INT J SYST EVOL MICR, V60, P2016, DOI 10.1099/ijs.0.017152-0; Vandamme P, 2005, BERGEYS MANUAL SYSTE, V2, P1147; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Westra ER, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0101; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zanoni RG, 2009, INT J SYST EVOL MICR, V59, P1666, DOI 10.1099/ijs.0.007286-0; Ziprin RL, 1999, AVIAN DIS, V43, P586, DOI 10.2307/1592660	67	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227500	10.1371/journal.pone.0227500	http://dx.doi.org/10.1371/journal.pone.0227500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923228	gold, Green Published			2022-12-26	WOS:000534350000087
J	Tietel, Z; Srivastava, S; Fait, A; Tel-Zur, N; Carmi, N; Raveh, E				Tietel, Zipora; Srivastava, Snehil; Fait, Aaron; Tel-Zur, Noemi; Carmi, Nir; Raveh, Eran			Impact of scion/rootstock reciprocal effects on metabolomics of fruit juice and phloem sap in grafted Citrus reticulata	PLOS ONE			English	Article							ROOTSTOCK; SCION; QUALITY; WATER; METABOANALYST; COMBINATIONS; POMELO	Background Rootstock has a significant impact on plant growth and development, including fruit maturation. However, the existence of mutual interaction between scion and rootstock is often neglected. To explore the origin of different fruit quality traits in citrus, we studied the effect of rootstock and the reciprocal interaction between scion and rootstock of nine combinations; three mandarin varieties grafted on three different rootstocks. We analyzed the metabolic profile of juice via gas and liquid chromatography-mass spectrometry (GC-MS and LCMS, respectively). Additionally, we profiled phloem sap composition in the scion and the rootstock. Quality traits of fruit and their physio-chemical characteristics were also evaluated. Results For all three cultivars, rootstock was found to affect fruit yield and biochemical fruit quality parameters (sugar and acidity) in interactions with the scions. In mandarin juice, eight of 48 compounds (two primary and six secondary) were related directly to the rootstock, and another seven (one primary and six secondary) were interactively affected by scion and rootstock. In scion and rootstock sap, six and 14 of 53 and 55 primary metabolites, respectively, were directly affected by the rootstock, while 42 and 33 were affected by rootstock interactively with scion, respectively. Conclusion In this work, we show for the first time a reciprocal effect between rootstock and scion. Based on our results, the scion and rootstock interaction might be organ, distance or time dependent.	[Tietel, Zipora; Carmi, Nir; Raveh, Eran] Agr Res Org, Gilat Res Ctr, Gilat, Israel; [Srivastava, Snehil; Fait, Aaron; Tel-Zur, Noemi] Ben Gurionn Univ Negev BGU, J Blaustein Inst Desert Res, French Associates Inst Agr & Biotechnol Drylands, Sede Boger Campus, Sede Boqer, Israel	Ben Gurion University	Raveh, E (corresponding author), Agr Res Org, Gilat Res Ctr, Gilat, Israel.	eran@volcani.agri.gov.il	Fait, Aaron/M-2869-2015	Fait, Aaron/0000-0002-9073-8441; Raveh, Eran/0000-0001-7488-9197				Batushansky A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00785; Benjamin G, 2013, J AGR FOOD CHEM, V61, P11286, DOI 10.1021/jf402892p; Martinez-Ballesta MC, 2010, SCI HORTIC-AMSTERDAM, V127, P112, DOI 10.1016/j.scienta.2010.08.002; Castle WS, 2010, HORTSCIENCE, V45, P11, DOI 10.21273/HORTSCI.45.1.11; Davies F.S., 1994, CITRUS, P30; DeBolt S, 2006, P NATL ACAD SCI USA, V103, P5608, DOI 10.1073/pnas.0510864103; Dinant S, 2010, CR BIOL, V333, P504, DOI 10.1016/j.crvi.2010.03.008; Doerfler H, 2013, METABOLOMICS, V9, P564, DOI 10.1007/s11306-012-0470-0; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Ghosh S, 2012, BIOTECHNOL ADV, V30, P1425, DOI 10.1016/j.biotechadv.2012.03.001; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; Goldenberg L, 2014, J AGR FOOD CHEM, V62, P4938, DOI 10.1021/jf5002414; Goncalves B, 2006, TREE PHYSIOL, V26, P93, DOI 10.1093/treephys/26.1.93; Gonqalves B, 2003, J HORTIC SCI BIOTECH, V78, P667; Gregory PJ, 2013, J EXP BOT, V64, P1209, DOI 10.1093/jxb/ers385; Grosser JW, 2004, J AM SOC HORTIC SCI, V129, P530, DOI 10.21273/JASHS.129.4.0530; Hanana M, 2015, PLANT PHYSIOL BIOCH, V3; Hasegawa S., 2000, Conference Digest. 2000 International Quantum Electronics Conference (Cat. No.00TH8504), DOI 10.1109/IQEC.2000.907914; Hijaz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101830; Hochberg U, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-184; Jia WS, 2008, PLANT SIGNAL BEHAV, V3, P772, DOI 10.4161/psb.3.10.6294; Keller M, 2001, AUST J GRAPE WINE R, V7, P12, DOI 10.1111/j.1755-0238.2001.tb00188.x; Koepke T, 2013, PLANT CELL REP, V32, P1321, DOI 10.1007/s00299-013-1471-9; Komor E, 1996, J EXP BOT, V47, P1155, DOI 10.1093/jxb/47.Special_Issue.1155; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Manners GD, 2007, J AGR FOOD CHEM, V55, P8285, DOI 10.1021/jf071797h; NAOR A, 1995, J AM SOC HORTIC SCI, V120, P577, DOI 10.21273/JASHS.120.4.577; Neilsen G, 1996, HORTSCIENCE, V31, P1169, DOI 10.21273/HORTSCI.31.7.1169; Pal M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31297-6; Ramin Ali-Akbar, 2005, Fruits, V60, P311, DOI 10.1051/fruits:2005037; Raveh E, 2005, SCI HORTIC-AMSTERDAM, V103, P317, DOI 10.1016/j.scienta.2004.06.007; Raveh E, 2011, ISR J PLANT SCI, V59, P177, DOI 10.1560/IJPS.59.2-4.177; Raveh E, 2009, J SCI FOOD AGR, V89, P1825, DOI 10.1002/jsfa.3639; Rennie EA, 2009, P NATL ACAD SCI USA, V106, P14162, DOI 10.1073/pnas.0902279106; RUHL EH, 1989, AUST J EXP AGR, V29, P133, DOI 10.1071/EA9890133; SCHMITT ER, 1989, SCI HORTIC-AMSTERDAM, V39, P189, DOI 10.1016/0304-4238(89)90132-5; Shackel K. A., 1997, HortTechnology, V7, P23; Tohge T, 2014, J EXP BOT, V65, P4599, DOI 10.1093/jxb/ert443; Vazifeshenas M, 2009, FRUITS, V64, P343, DOI 10.1051/fruits/2009030; Wallis CM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00502; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhao CY, 2020, CRIT REV FOOD SCI, V60, P566, DOI 10.1080/10408398.2018.1544885	45	24	25	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227192	10.1371/journal.pone.0227192	http://dx.doi.org/10.1371/journal.pone.0227192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923191	Green Published, gold			2022-12-26	WOS:000534350000053
J	Eaton, M; Davies, AH; Devine, J; Zhao, X; Simmons, DG; Mariusdottir, E; Natale, DRC; Matyas, JR; Bering, EA; Workentine, ML; Hallgrimsson, B; Cross, JC				Eaton, Malcolm; Davies, Alastair H.; Devine, Jay; Zhao, Xiang; Simmons, David G.; Mariusdottir, Elin; Natale, David R. C.; Matyas, John R.; Bering, Elizabeth A.; Workentine, Matthew L.; Hallgrimsson, Benedikt; Cross, James C.			Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction	PLOS ONE			English	Article							FETAL-GROWTH; RESOURCE-ALLOCATION; TROPHOBLAST CELLS; GLYCOGEN CELLS; PROTEIN; MORPHOLOGY; PHENOTYPE; TRANSPORT; DIFFERENTIATION; EXPRESSION	The major milestones in mouse placental development are well described, but our understanding is limited to how the placenta can adapt to damage or changes in the environment. By using stereology and expression of cell cycle markers, we found that the placenta grows under normal conditions not just by hyperplasia of trophoblast cells but also through extensive polyploidy and cell hypertrophy. In response to feeding a low protein diet to mothers prior to and during pregnancy, to mimic chronic malnutrition, we found that this normal program was altered and that it was influenced by the sex of the conceptus. Male fetuses showed intrauterine growth restriction (IUGR) by embryonic day (E) 18.5, just before term, whereas female fetuses showed IUGR as early as E16.5. This difference was correlated with differences in the size of the labyrinth layer of the placenta, the site of nutrient and gas exchange. Functional changes were implied based on up-regulation of nutrient transporter genes. The junctional zone was also affected, with a reduction in both glycogen trophoblast and spongiotrophoblast cells. These changes were associated with increased expression of Phlda2 and reduced expression of Egfr. Polyploidy, which results from endoreduplication, is a normal feature of trophoblast giant cells (TGC) but also spongiotrophoblast cells. Ploidy was increased in sinusoidal-TGCs and spongiotrophoblast cells, but not parietal-TGCs, in low protein placentas. These results indicate that the placenta undergoes a range of changes in development and function in response to poor maternal diet, many of which we interpret are aimed at mitigating the impacts on fetal and maternal health.	[Eaton, Malcolm; Zhao, Xiang; Bering, Elizabeth A.; Cross, James C.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Davies, Alastair H.; Zhao, Xiang; Simmons, David G.; Mariusdottir, Elin; Natale, David R. C.; Matyas, John R.; Cross, James C.] Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada; [Devine, Jay; Hallgrimsson, Benedikt] Univ Calgary, Dept Anat & Cell Biol, Cumming Sch Med, Calgary, AB, Canada; [Workentine, Matthew L.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Cross, JC (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.; Cross, JC (corresponding author), Univ Calgary, Dept Comparat Biol & Expt Med, Fac Vet Med, Calgary, AB, Canada.	jcross@ucalgary.ca	Simmons, David G/C-5983-2009; Cross, James/F-4814-2011	Simmons, David G/0000-0002-4115-9371; Cross, James/0000-0003-0956-9378	Canadian Institutes for Health Research [MOP-136900]; Alberta Innovates Health Solutions	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions	The work was funded by grants from the Canadian Institutes for Health Research (to JCC, grant MOP-136900) and Alberta Innovates Health Solutions (to JCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Barbeito-Andres J, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.204651; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bouillot S, 2006, PLACENTA, V27, P882, DOI 10.1016/j.placenta.2005.09.009; Chen PY, 2013, PHYSIOL GENOMICS, V45, P565, DOI 10.1152/physiolgenomics.00034.2013; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2011, J PHYSIOL-LONDON, V589, P3659, DOI 10.1113/jphysiol.2011.208629; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2006, DEV DYNAM, V235, P3280, DOI 10.1002/dvdy.20981; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Coan PM, 2005, J ANAT, V207, P783, DOI 10.1111/j.1469-7580.2005.00488.x; Constancia M, 2002, NAT LETT, V417; Cross JC, 2016, REPROD FERT DEVELOP, V28, P75, DOI 10.1071/RD15342; Cross JC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004330; Cuffe JSM, 2014, J PHYSIOL-LONDON, V592, P3127, DOI 10.1113/jphysiol.2014.272856; Dackor J, 2007, PLACENTA, V28, P1211, DOI 10.1016/j.placenta.2007.07.005; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Fowden AL, 2012, PLACENTA, V33, pE11, DOI 10.1016/j.placenta.2012.05.002; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gaccioli F, 2013, J DEV ORIG HLTH DIS, V4, P101, DOI 10.1017/S2040174412000529; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Gao Haijun, 2012, Front Biosci (Elite Ed), V4, P1434; Gasperowicz M, 2013, DEV BIOL, V382, P1, DOI 10.1016/j.ydbio.2013.08.005; Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hannibal RL, 2016, CURR BIOL, V26, P230, DOI 10.1016/j.cub.2015.11.060; Hannibal RL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004290; Hayakawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23832-2; Hendzel MJ, 1997, CHROMOSOMA, V106; Higgins JS, 2016, J PHYSIOL-LONDON, V594, P1341, DOI 10.1113/JP271057; Ishikawa H, 2003, BIOL REPROD, V69, P483, DOI 10.1095/biolreprod.102.012641; JOHANSSON S, 1993, ANAT EMBRYOL, V187, P409; Jones HN, 2007, PLACENTA, V28, P763, DOI 10.1016/j.placenta.2007.05.002; Langley-Evans SC, 1997, FETAL EXPOSURE LOW P, V127; MacAuley A, 1998, MOL BIOL CELL, V9, P795, DOI 10.1091/mbc.9.4.795; Mao J, 2010, P NATL ACAD SCI USA, V107, P5557, DOI 10.1073/pnas.1000440107; Mayhew TM, 2009, J ANAT, V215, P77, DOI 10.1111/j.1469-7580.2008.00994.x; Mayhew TM, 2001, PLACENTA, V22, P628, DOI 10.1053/plac.2001.0700; Morrison JL, 2008, CLIN EXP PHARMACOL P, V35, P730, DOI 10.1111/j.1440-1681.2008.04975.x; Outhwaite JE, 2015, PLACENTA, V36, P951, DOI 10.1016/j.placenta.2015.05.013; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; Prada JA, 1998, EUR J CLIN NUTR, V52, pS21; Rai A, 2015, DEV BIOL, V398, P110, DOI 10.1016/j.ydbio.2014.11.023; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rebelato HJ, 2013, J MOL HISTOL, V44, P629, DOI 10.1007/s10735-013-9522-7; Romo Agustin, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P332; Rosenfeld CS, 2015, ENDOCRINOLOGY, V156, P3422, DOI 10.1210/en.2015-1227; Sawa H, 1997, J HISTOCHEMISTRY CYT, V45; Schulz LC, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.103218; Sferruzzi-Perri AN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00033; Sferruzzi-Perri AN, 2018, PLACENTA, V64, pS16, DOI 10.1016/j.placenta.2018.01.005; Sferruzzi-Perri AN, 2011, ENDOCRINOLOGY, V152; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Simmons DG, 2007, DEV BIOL, V304, P567, DOI 10.1016/j.ydbio.2007.01.009; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Soares MJ, 2007, TRENDS ENDOCRIN MET, V18, P114, DOI 10.1016/j.tem.2007.02.005; Strakovsky RS, 2010, J NUTR, V140, P2116, DOI 10.3945/jn.110.127803; Tunster SJ, 2010, MOL CELL BIOL, V30, P295, DOI 10.1128/MCB.00662-09; Waddell BJ, 2000, BIOL REPROD, V63, P1913, DOI 10.1095/biolreprod63.6.1913; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Watson ED, 2007, DEVELOPMENT, V134, P1809, DOI 10.1242/dev.02843; Yi L, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1419-z; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zybina E V, 1975, CELL TISS RES, V60; Zybina EV, 2008, MICRON, V39, P593, DOI 10.1016/j.micron.2007.05.006	72	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0226735	10.1371/journal.pone.0226735	http://dx.doi.org/10.1371/journal.pone.0226735			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917811	Green Published, gold			2022-12-26	WOS:000534341100009
J	Parbhakar, KK; Rosella, LC; Singhal, S; Quinonez, CR				Parbhakar, Kamini Kaura; Rosella, Laura C.; Singhal, Sonica; Quinonez, Carlos R.			Risk of complications among diabetics self-reporting oral health status in Canada: A population-based cohort study	PLOS ONE			English	Article							GLOBAL BURDEN; CARE COSTS; PERIODONTITIS; ASSOCIATION; DISEASES; IMPACT	Background Periodontitis has been associated with diabetes and poor health. While clear associations have been identified for the diabetes-oral health link, less is known about the implications of poor oral health status for incident complications of diabetes. This study investigated the risk of diabetes complications associated with self-reported "poor to fair" and "good to excellent" oral health among diabetics living in Ontario, Canada. Methods This was a cohort study of diabetics who took part in the Canadian Community Health Survey (2003 and 2007-08). Self-reported oral health was linked to electronic health records held at the Institute for Clinical Evaluative Sciences. Participants aged 40 years and over, who self-reported oral health status in linked databases were included (N = 5,183). Cox proportional hazard models were constructed to determine the risk of diabetes complications. Participants who did not experience any complications were censored. Models were adjusted for age and sex, followed by social characteristics and behavioural factors. The population attributable risk of diabetes complications was calculated using fully adjusted hazard ratios. Results Diabetes complications differed by self-reported oral health; 35% of the total sample experienced a complication and 34% of those reporting "good to excellent" oral health (n = 4090) experienced a complication in comparison to 38% of those with "fair to poor" oral health (n = 1093). For those reporting "poor to fair" oral health, the hazard of a diabetes complication was 30% greater (HR 1.29; 95% CI: 1.03, 1.61) than those reporting "good to excellent" oral health. The population level risk of complications attributable to oral health was 5.2% (95% CI: 0.67, 8.74). Conclusions Our findings indicate that reporting "poor to fair" oral health status may be attributed to health complications among diabetics, after adjusting for a wide range of confounders. This has important public health implications for diabetics in Ontario, Canada.	[Parbhakar, Kamini Kaura; Singhal, Sonica; Quinonez, Carlos R.] Univ Toronto, Dent Publ Hlth, Fac Dent, Toronto, ON, Canada; [Rosella, Laura C.; Quinonez, Carlos R.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Rosella, Laura C.; Quinonez, Carlos R.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Singhal, Sonica; Quinonez, Carlos R.] Publ Hlth Ontario Toronto, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Parbhakar, KK (corresponding author), Univ Toronto, Dent Publ Hlth, Fac Dent, Toronto, ON, Canada.	kamini.kaura@utoronto.ca			Canadian Foundation of Dental Hygiene Research and Education; University of Toronto; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Foundation of Dental Hygiene Research and Education; University of Toronto(University of Toronto); Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a grant and scholarship awarded to KKP. The grant was received from the Canadian Foundation of Dental Hygiene Research and Education. The David Locker Graduate Scholarship in Dental Public Health was received from the University of Toronto. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The funders were not involved with the design or conduct of the study; collection, management, analysis or interpretation of the data; preparation, review or approval of the manuscript; or decision to submit the manuscript for publication.	Albert DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-103; [Anonymous], 2010, SUMMARY REPORT FINDI; Benyamini Y, 2011, HLTH ILLNESS PERCEPT; Bilandzic A, 2017, HEALTH PROMOT CHRON, V37, P49, DOI 10.24095/hpcdp.37.2.03; Booth G, 2012, REGIONAL MEASURES DI; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Canadian Community Health Survey (CCHS), 2005, CANADIAN COMMUNITY H; Canadian Diabetes Association, 2018, CHART BACKGROUNDERDI; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1111/jcpe.12077, 10.1902/jop.2013.1340011]; Chee B, 2013, INT J EVIDENCE BASED; Daudt LD, 2018, BRAZ ORAL RES, V32, DOI 10.1590/1807-3107bor-2018.vol32.0035; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; Diabetes Canada, DIAB CAN; Elangovan Satheesh, 2014, Clin Diabetes, V32, P188, DOI 10.2337/diaclin.32.4.188; Farmer J, 2017, J PUBLIC HEALTH DENT, V77, P295, DOI 10.1111/jphd.12205; Gatehouse Jonathon, 2019, CBC NEWS; Glazier RH., 2012, COMP PRIMARY CARE MO; Gonzalez-Guarda Rosa M., 2006, GRAND ROUNDS ORAL SY, V2, P36; Hajishengallis G, 2014, MOL ORAL MICROBIOL; Hasturk H, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00118; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Hux JE, DIABETES ONTARIO DET; Jeffcoat MK, 2014, AM J PREV MED, V47, P166, DOI 10.1016/j.amepre.2014.04.001; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kebede TG, 2018, DIABETES METAB, V44, P243, DOI 10.1016/j.diabet.2017.11.003; Lo Ma TE, 2015, END ABSTR, V37; Maxey H, 2017, INTEGRATION ORAL HLT; MOUTSOPOULOS NM, 2006, ANN NY ACAD SCI, V1088, P251, DOI [10.1196/annats.1366.032, DOI 10.1196/ANNATS.1366.032]; Nasseh K, 2017, HEALTH ECON, V26, P519, DOI 10.1002/hec.3316; Public Health Agency of Canada, 2011, DIAB CAN FACTS FIG P; Pumerantz AS, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000413; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salvi GE, 2005, J CLIN PERIODONTOL, V32, P310, DOI 10.1111/j.1600-051X.2005.00682.x; Sardarinia M, 2016, RISK FACTORS INCIDEN; Sharma P, 2016, J CLIN PERIODONTOL, V43, P104, DOI 10.1111/jcpe.12502; Shearer DM, 2017, J CLIN PERIODONTOL, V44, P22, DOI 10.1111/jcpe.12641; Simpson TC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004714.pub3; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X; Taylor GW, 2008, ORAL DIS, V14, P191, DOI 10.1111/j.1601-0825.2008.01442.x; Thomas S, 2009, STAT CAN HLTH REP, V20, P55; Tonetti MS, 2017, J CLIN PERIODONTOL, V44, P456, DOI 10.1111/jcpe.12732; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Tsakos G, 2013, J EPIDEMIOL COMMUN H, V67, P381, DOI 10.1136/jech-2013-202481; Watt RG, 2012, COMMUNITY DENT ORAL, V40, P289, DOI 10.1111/j.1600-0528.2012.00680.x; Wellappuli N C, 2018, JDR Clin Trans Res, V3, P65, DOI 10.1177/2380084417742120; Wiener RC, 2018, ADV PUBLIC HEAL, V2018, P1; Zuk A, 2017, J CLIN PERIODONTOL, V44, P132, DOI 10.1111/jcpe.12684	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0218056	10.1371/journal.pone.0218056	http://dx.doi.org/10.1371/journal.pone.0218056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917813	gold, Green Published, Green Submitted			2022-12-26	WOS:000534341100001
J	Annunziata, C; Lama, A; Pirozzi, C; Cavaliere, G; Trinchese, G; Di Guida, F; Izzo, AN; Cimmino, F; Paciello, O; De Biase, D; Murru, E; Banni, S; Calignano, A; Mollica, MP; Raso, GM; Meli, R				Annunziata, Chiara; Lama, Adriano; Pirozzi, Claudio; Cavaliere, Gina; Trinchese, Giovanna; Di Guida, Francesca; Nitrato Izzo, Allegra; Cimmino, Fabiano; Paciello, Orlando; De Biase, Davide; Murru, Elisabetta; Banni, Sebastiano; Calignano, Antonio; Mollica, Maria Pina; Mattace Raso, Giuseppina; Meli, Rosaria			Palmitoylethanolamide counteracts hepatic metabolic inflexibility modulating mitochondrial function and efficiency in diet-induced obese mice	FASEB JOURNAL			English	Article						adenosine monophosphate-activated protein kinase (AMPK); high-fat diet; metabolic flexibility; mitochondrial dysfunction; oxidative stress; peroxisome proliferator-activated receptor (PPAR)-alpha	ACTIVATED PROTEIN-KINASE; IMPROVES INSULIN SENSITIVITY; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; IN-VITRO; FLEXIBILITY; AMPK; OVEREXPRESSION; INFLAMMATION; RESISTANCE	Peroxisome proliferator-activated receptor (PPAR)-alpha activation controls hepatic lipid homeostasis, stimulating fatty acid oxidation, and adapting the metabolic response to lipid overload and storage. Here, we investigate the effect of palmitoylethanolamide (PEA), an endogenous PPAR-alpha ligand, in counteracting hepatic metabolic inflexibility and mitochondrial dysfunction induced by high-fat diet (HFD) in mice. Long-term PEA administration (30 mg/kg/die per os) in HFD mice limited hepatic lipid accumulation, increased energy expenditure, and markedly reduced insulin resistance. In isolated liver mitochondria, we have demonstrated PEA capability to modulate mitochondrial oxidative capacity and energy efficiency, leading to the reduction of intracellular lipid accumulation and oxidative stress. Moreover, we have evaluated the effect of PEA on mitochondrial bioenergetics of palmitate-challenged HepG2 cells, using Seahorse analyzer. In vitro data showed that PEA recovered mitochondrial dysfunction and reduced lipid accumulation in insulin-resistant HepG2 cells, increasing fatty acid oxidation. Mechanistic studies showed that PEA effect on lipid metabolism was limited by AMP-activated protein kinase (AMPK) inhibition, providing evidence for a pivotal role of AMPK in PEA-induced adaptive metabolic setting. All these findings identify PEA as a modulator of hepatic lipid and glucose homeostasis, limiting metabolic inflexibility induced by nutrient overload.	[Annunziata, Chiara; Lama, Adriano; Pirozzi, Claudio; Di Guida, Francesca; Nitrato Izzo, Allegra; Calignano, Antonio; Mattace Raso, Giuseppina; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Cavaliere, Gina; Trinchese, Giovanna; Cimmino, Fabiano; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, I-80126 Naples, Italy; [Paciello, Orlando; De Biase, Davide] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Murru, Elisabetta; Banni, Sebastiano] Univ Cagliari, Cittadella Univ Monserrato, Dept Biomed Sci, Cagliari, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Cagliari	Mollica, MP (corresponding author), Univ Naples Federico II, Dept Biol, Complesso Univ Monte St Angelo, I-80126 Naples, Italy.	mariapia.mollica@unina.it	Pirozzi, Claudio/S-2760-2016; Murru, Elisabetta/AAW-4909-2021; Giovanna, Trinchese/AAC-5995-2022; CIMMINO, FABIANO/AIA-1152-2022; Lama, Adriano/AAC-1964-2020	Giovanna, Trinchese/0000-0002-4096-6876; CIMMINO, FABIANO/0000-0001-5239-4329; Lama, Adriano/0000-0002-5816-1400; Mattace Raso, Giuseppina/0000-0002-5254-139X; Annunziata, Chiara/0000-0003-2784-8004; Mollica, Maria Pina/0000-0003-2726-7779; Murru, Maria Elisabetta/0000-0002-7394-5780; Pirozzi, Claudio/0000-0002-3409-5744				Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; Battaglia GM, 2012, AM J PHYSIOL-ENDOC M, V303, pE1440, DOI 10.1152/ajpendo.00355.2012; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bergamo P, 2007, FREE RADICAL BIO MED, V43, P71, DOI 10.1016/j.freeradbiomed.2007.03.023; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Carta G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00902; Cavaliere G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149033; D'Agostino G, 2015, MOL METAB, V4, P528, DOI 10.1016/j.molmet.2015.04.005; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dominguez JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006790; Fanelli F, 2018, MOL METAB, V14, P82, DOI 10.1016/j.molmet.2018.06.002; Ferrante MC, 2014, TOXICOL APPL PHARM, V279, P401, DOI 10.1016/j.taap.2014.06.016; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Franko A, 2016, DIABETES, V65, P2540, DOI 10.2337/db15-1670; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gross B, 2017, NAT REV ENDOCRINOL, V13, P36, DOI 10.1038/nrendo.2016.135; Harriman G, 2016, P NATL ACAD SCI USA, V113, pE1796, DOI 10.1073/pnas.1520686113; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kanuri G, 2013, INT J MOL SCI, V14, P11963, DOI 10.3390/ijms140611963; Khan RS, 2019, HEPATOLOGY, V70, P711, DOI 10.1002/hep.30429; Kim K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071522; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Konrad D, 2014, PHYSIOLOGY, V29, P304, DOI 10.1152/physiol.00014.2014; Lama A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41295-x; Lama A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600418; Lihn AS, 2008, MOL CELL ENDOCRINOL, V292, P36, DOI 10.1016/j.mce.2008.06.004; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Meli R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00177; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Oriente F, 2013, DIABETOLOGIA, V56, P2713, DOI 10.1007/s00125-013-3053-3; Petrosino S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00249; Petrosino S, 2017, BRIT J PHARMACOL, V174, P1349, DOI 10.1111/bph.13580; Piscitelli F, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-51; Raso GM, 2014, ENDOCRINOLOGY, V155, P1291, DOI 10.1210/en.2013-1823; Raso GM, 2014, PHARMACOL RES, V86, P32, DOI 10.1016/j.phrs.2014.05.006; Russo R, 2018, CURR MED CHEM, V25, P3930, DOI 10.2174/0929867324666170216113756; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Seo E, 2009, KOREAN J PHYSIOL PHA, V13, P449, DOI 10.4196/kjpp.2009.13.6.449; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011; Theurey P, 2017, TRENDS ENDOCRIN MET, V28, P32, DOI 10.1016/j.tem.2016.09.002; Wallenius K, 2013, PPAR RES, V2013, DOI 10.1155/2013/305347; Wu D, 2014, INT J MOL MED, V34, P1706, DOI 10.3892/ijmm.2014.1942; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhang HA, 2016, BIOCHEM BIOPH RES CO, V474, P364, DOI 10.1016/j.bbrc.2016.04.111	61	20	20	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					350	364		10.1096/fj.201901510RR	http://dx.doi.org/10.1096/fj.201901510RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914699	Green Published			2022-12-26	WOS:000507308900025
J	Arnaud, AP; Rome, V; Richard, M; Formal, M; David-Le Gall, S; Boudry, G				Arnaud, Alexis Pierre; Rome, Veronique; Richard, Marion; Formal, Michele; David-Le Gall, Sandrine; Boudry, Gaelle			Post-natal co-development of the microbiota and gut barrier function follows different paths in the small and large intestine in piglets	FASEB JOURNAL			English	Article						intestinal permeability; neonate; short-chain fatty acid; toll-like receptors	GERM-FREE; MILK; INFLAMMATION; EXPRESSION; SECRETION; PROFILES; GRADIENT; VIRUSES; HEALTH; MODEL	Gut microbiota and intestinal barrier co-develop after birth, establishing a homeostatic state whereby mucosal cells cohabit with commensal bacteria. We hypothesized that this post-natal co-development follows different timings depending on the intestinal site considered. Jejunal, ileal, and colonic luminal contents and mucosa were sampled in suckling piglets at post-natal day (PND) 0, 2, 7, 14, and 28. Jejunal, ileal, and colonic luminal microbiota (evaluated by 16S DNA sequencing followed by beta-diversity analysis) clustered at PND2 but colonic microbiota diverge afterwards (P < .05). Mucosal permeability, evaluated in Ussing chambers, increased with age in the jejunum and ileum (P < .05) but not the colon. Expression of pattern recognition receptor (PRR) exhibited different patterns (gradual or sharp increase, decrease, or no change with age, P < .05) depending on PRR and intestinal site considered. Principal component analysis of mucosa data revealed clear clustering of colonic samples, irrespective of the age and clustering of jejunal and ileal samples, with gradual changes with age. Correlation analysis highlighted three families correlating with mucosal parameters: Enterobacteriaceae in the jejunum, Peptostreptococcaceae in the ileum, and Micrococcaceae in the colon. In conclusion, small and large intestine display close microbiota composition early in life but distinct mucosal phenotype and follow very different post-natal development.	[Arnaud, Alexis Pierre; Rome, Veronique; Richard, Marion; Formal, Michele; David-Le Gall, Sandrine; Boudry, Gaelle] Univ Rennes, INSERM, INRA, Inst NuMeCan, St Gilles, France; [Arnaud, Alexis Pierre] Univ Rennes 1, CHU Rennes, Serv Chirurg Pediat, Rennes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes; Universite de Rennes	Boudry, G (corresponding author), Univ Rennes 1, INRA, INSERM, Inst NuMeCan, F-35590 St Gilles, France.	Gaelle.Boudry@inra.fr	Arnaud, Alexis/AGT-6845-2022; Boudry, Gaelle/ABG-8836-2020	Arnaud, Alexis/0000-0003-4378-3570; Boudry, Gaelle/0000-0002-5287-571X; LE GALL-DAVID, Sandrine/0000-0001-5493-3429				Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Bhattarai Y, 2016, METHODS MOL BIOL, V1438, P123, DOI 10.1007/978-1-4939-3661-8_8; Boudry G, 2008, J PHYSIOL PHARMACOL, V59, P543; Buddington RK, 2011, J ANIM SCI, V89, P1506, DOI 10.2527/jas.2010-3705; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; Chen L, 2018, PEERJ, V6, DOI 10.7717/peerj.4600; Chen NH, 2017, IUBMB LIFE, V69, P297, DOI 10.1002/iub.1625; Chen X, 2018, ANAEROBE, V49, P30, DOI 10.1016/j.anaerobe.2017.12.002; Choteau L, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0158-0; Desaldeleer C, 2014, J NUTR BIOCHEM, V25, P1090, DOI 10.1016/j.jnutbio.2014.05.014; DUCKER DA, 1980, GUT, V21, P133, DOI 10.1136/gut.21.2.133; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Gebbers JO, 2004, ANN NY ACAD SCI, V1029, P337, DOI 10.1196/annals.1309.015; Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039; Gourbeyre P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12225; Alvarez-Mercado AI, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030068; Kerr CA, 2015, CRIT REV MICROBIOL, V41, P326, DOI 10.3109/1040841X.2013.837863; KLOBASA F, 1987, J ANIM SCI, V64, P1458, DOI 10.2527/jas1987.6451458x; Kraiczy J, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7242415; Kraiczy J, 2019, GUT, V68, P49, DOI 10.1136/gutjnl-2017-314817; Le Bourgot C, 2019, FASEB J, V33, P301, DOI 10.1096/fj.201800108R; Le Bourgot C, 2017, BRIT J NUTR, V117, P83, DOI 10.1017/S0007114516004268; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Li N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01798; Liu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40235-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Maradiaga N, 2018, MICROB PATHOGENESIS, V121, P27, DOI 10.1016/j.micpath.2018.05.007; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Pacheco AR, 2015, ANNU REV ANIM BIOSCI, V3, P419, DOI 10.1146/annurev-animal-022114-111112; Price AE, 2018, IMMUNITY, V49, P560, DOI 10.1016/j.immuni.2018.07.016; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reid CJ, 1998, GUT, V42, P220, DOI 10.1136/gut.42.2.220; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rokhsefat S, 2016, DIGEST DIS SCI, V61, P1473, DOI 10.1007/s10620-016-4032-6; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Salcedo J, 2016, J DAIRY SCI, V99, P7733, DOI 10.3168/jds.2016-10966; Shulman RJ, 1998, PEDIATR RES, V44, P519, DOI 10.1203/00006450-199810000-00009; Smirnov KS, 2016, INT J MED MICROBIOL, V306, P266, DOI 10.1016/j.ijmm.2016.03.006; Sun J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29093-3; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Walker RW, 2017, PEDIATR OBES, V12, P3, DOI 10.1111/ijpo.12217; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009	51	12	12	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1430	1446		10.1096/fj.201902514R	http://dx.doi.org/10.1096/fj.201902514R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914707	Bronze			2022-12-26	WOS:000507308900095
J	Sochaj-Gregorczyk, A; Ksiazek, M; Waligorska, I; Straczek, A; Benedyk, M; Mizgalska, D; Thogersen, IB; Enghild, JJ; Potempa, J				Sochaj-Gregorczyk, Alicja; Ksiazek, Miroslaw; Waligorska, Irena; Straczek, Anna; Benedyk, Malgorzata; Mizgalska, Danuta; Thogersen, Ida B.; Enghild, Jan J.; Potempa, Jan			Plasmin inhibition by bacterial serpin: Implications in gum disease	FASEB JOURNAL			English	Article						fibrinolysis; plasmin; periodontitis; serpin; Tannerella forsythia	STAPHYLOCOCCUS-AUREUS; TANNERELLA-FORSYTHIA; PERIODONTAL-DISEASE; DEFICIENCY; COMPLEX; RANGE; MODEL; UPA	Tannerella forsythia is a periodontopathogen that expresses miropin, a protease inhibitor in the serpin superfamily. In this study, we show that miropin is also a specific and efficient inhibitor of plasmin; thus, it represents the first proteinaceous plasmin inhibitor of prokaryotic origin described to date. Miropin inhibits plasmin through the formation of a stable covalent complex triggered by cleavage of the Lys(368)-Thr(369) (P2-P1) reactive site bond with a stoichiometry of inhibition of 3.8 and an association rate constant (k(ass)) of 3.3 x 10(5) M(-1)s(-1). The inhibition of the fibrinolytic activity of plasmin was nearly as effective as that exerted by alpha(2)-antiplasmin. Miropin also acted in vivo by reducing blood loss in a mice tail bleeding assay. Importantly, intact T. forsythia cells or outer membrane vesicles, both of which carry surface-associated miropin, strongly inhibited plasmin. In intact bacterial cells, the antiplasmin activity of miropin protects envelope proteins from plasmin-mediated degradation. In summary, in the environment of periodontal pockets, which are bathed in gingival crevicular fluid consisting of 70% of blood plasma, an abundance of T. forsythia in the bacterial biofilm can cause local inhibition of fibrinolysis, which could have possible deleterious effects on the tooth-supporting structures of the periodontium.	[Sochaj-Gregorczyk, Alicja; Ksiazek, Miroslaw] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Ksiazek, Miroslaw; Waligorska, Irena; Straczek, Anna; Benedyk, Malgorzata; Mizgalska, Danuta; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland; [Ksiazek, Miroslaw; Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Jagiellonian University; Jagiellonian University; University of Louisville; Aarhus University	Ksiazek, M (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	ksiazek.miroslaw@gmail.com	Potempa, Jan/AAA-6850-2021		National Science Center (Krakow, Poland) [UMO-2015/17/B/NZ1/00666, UMO-2016/21/B/NZ1/00292]; NIH/NIDCR [R21DE026280]; Ministry of Science and Higher Education [1306/MOB/IV/2015/0]	National Science Center (Krakow, Poland)(National Science Centre, Poland); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	National Science Center (Krakow, Poland), Grant/Award Number: UMO-2015/17/B/NZ1/00666 and UMO-2016/21/B/NZ1/00292; NIH/NIDCR, Grant/Award Number: R21DE026280; Ministry of Science and Higher Education, Grant/Award Number: 1306/MOB/IV/2015/0	Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Benedyk M, 2016, J INNATE IMMUN, V8, P185, DOI 10.1159/000441724; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Celkan T, 2017, J THROMB THROMBOLYS, V43, P132, DOI 10.1007/s11239-016-1416-6; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Collen D, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P24; Cortes-Vieyra R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1396106; Darenfed H, 1999, INFECT IMMUN, V67, P6439; DeCarlo AA, 2007, J PERIODONTAL RES, V42, P305, DOI 10.1111/j.1600-0765.2006.00949.x; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Eckert M, 2018, MOL ORAL MICROBIOL, V33, P240, DOI 10.1111/omi.12220; Friedrich V, 2015, MOL ORAL MICROBIOL, V30, P451, DOI 10.1111/omi.12104; Goulas T, 2017, J BIOL CHEM, V292, P10883, DOI 10.1074/jbc.M117.786533; Guo YZ, 2008, ARTHRITIS RHEUM, V58, P764, DOI 10.1002/art.23263; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hienz SA, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/615486; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Imamura T, 2001, J BIOL CHEM, V276, P18984, DOI 10.1074/jbc.M006760200; Ioannidou E, 2011, J DENT RES, V90, P1411, DOI 10.1177/0022034511423394; Kanno Y, 2016, INT J BIOL SCI, V12, P63, DOI 10.7150/ijbs.12690; Khoshhal K, 2003, J PEDIATR ORTHOPED, V23, P661, DOI 10.1097/01241398-200309000-00017; Krafts KP, 2010, ORGANOGENESIS, V6, P225, DOI 10.4161/org.6.4.12555; Ksiazek M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00312; Ksiazek M, 2015, J BIOL CHEM, V290, P658, DOI 10.1074/jbc.M114.601716; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lam RS, 2015, IMMUNOL CELL BIOL, V93, P705, DOI 10.1038/icb.2015.25; Lasica AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37708; Liesenborghs L, 2018, J THROMB HAEMOST, V16, P441, DOI 10.1111/jth.13928; Nazir Muhammad Ashraf, 2017, Int J Health Sci (Qassim), V11, P72; Neilands J, 2016, ARCH ORAL BIOL, V70, P1, DOI 10.1016/j.archoralbio.2016.05.016; Peetermans M, 2016, CRIT REV MICROBIOL, V42, P866, DOI 10.3109/1040841X.2015.1080214; Persson RE, 2003, J CLIN PERIODONTOL, V30, P207, DOI 10.1034/j.1600-051X.2003.00237.x; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scully C, 2001, ORAL SURG ORAL MED O, V91, P334, DOI 10.1067/moe.2001.112158; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Srinivas SK, 2012, J WOMENS HEALTH, V21, P121, DOI 10.1089/jwh.2011.3023; Sulniute R, 2011, AM J PATHOL, V179, P819, DOI 10.1016/j.ajpath.2011.05.003; Suzuki J, 2010, EXPERT OPIN THER TAR, V14, P1023, DOI 10.1517/14728222.2010.511616; Tefs K, 2006, BLOOD, V108, P3021, DOI 10.1182/blood-2006-04-017350; UETE T, 1975, CLIN CHEM, V21, P1632; Ulisse S, 2011, ENCY CANC, P2904; Vieira ML, 2016, CRIT REV MICROBIOL, V42, P573, DOI 10.3109/1040841X.2014.972336; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; Waschulewski IK, 2016, ARCH ORAL BIOL, V72, P75, DOI 10.1016/j.archoralbio.2016.07.013; Zeng XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046508	49	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					619	630		10.1096/fj.201901490RR	http://dx.doi.org/10.1096/fj.201901490RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914706	Green Accepted			2022-12-26	WOS:000507308900043
J	Omsland, M; Andresen, V; Gullaksen, SE; Ayuda-Duran, P; Popa, M; Hovland, R; Brendehaug, A; Enserink, J; McCormack, E; Gjertsen, BT				Omsland, Maria; Andresen, Viheke; Gullaksen, Stein-Erik; Ayuda-Duran, Pilar; Popa, Mihacla; Hovland, Randi; Brendehaug, Atle; Enserink, Jorrit; McCormack, Emmet; Gjertsen, Bjorn Tore			Tyrosine kinase inhibitors and interferon-alpha increase tunneling nanotube (TNT) formation and cell adhesion in chronic myeloid leukemia (CML) cell lines	FASEB JOURNAL			English	Article						cell adhesion; chronic myeloid leukemia; interferon-alpha; tunneling nanotubes; tyrosine kinase inhibitors	CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW MICROENVIRONMENT; INTEGRIN-MEDIATED ADHESION; BCR-ABL EXPRESSION; MEMBRANE NANOTUBES; PROGENITOR CELLS; VALPROIC ACID; CUTTING EDGE; STEM-CELLS; T-CELLS	Chronic myeloid leukemia (CML) is a stem cell disease of the bone marrow where mechanisms of inter-leukemic communication and cell-to-cell interactions are proposed to be important for optimal therapy response. Tunneling nanotubes (TNTs) are novel intercellular communication structures transporting different cargos with potential implications in therapy resistance. Here, we have investigated TNTs in CML cells and following treatment with the highly effective CML therapeutics tyrosine kinase inhibitors (TKIs) and interferon-alpha (IFN alpha). CML cells from chronic phase CML patients as well as the blast crisis phase cell lines, Kcl-22 and K562, formed few or no TNTs. Treatment with imatinib increased TNT formation in both Kcl-22 and K562 cells, while nilotinib or IFN alpha increased TNTs in Kcl-22 cells only where the TNT increase was associated with adherence to fibronectin-coated surfaces, altered morphology, and reduced movement involving beta 1integrin. Ex vivo treated cells from chronic phase CML patients showed limited changes in TNT formation similarly to bone marrow cells from healthy individuals. Interestingly, in vivo nilotinib treatment in a Kcl-22 subcutaneous mouse model resulted in morphological changes and TNT-like structures in the tumor-derived Kcl-22 cells. Our results demonstrate that CML cells express low levels of TNTs, but CML therapeutics increase TNT formation in designated cell models indicating TNT functionality in bone marrow derived malignancies and their microenvironment.	[Omsland, Maria; Andresen, Viheke; Gullaksen, Stein-Erik; McCormack, Emmet; Gjertsen, Bjorn Tore] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, N-5021 Bergen, Norway; [Omsland, Maria] NCI, Anim Models & Retroviral Vaccines Sect, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Andresen, Viheke; Gullaksen, Stein-Erik; Popa, Mihacla; Gjertsen, Bjorn Tore] Haukeland Hosp, Dept Internal Med, Hematol Sect, Bergen, Norway; [Ayuda-Duran, Pilar; Enserink, Jorrit] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway; [Popa, Mihacla] KinN Therapeut, Bergen, Norway; [Hovland, Randi; Brendehaug, Atle] Haukeland Hosp, Dept Med Genet, Bergen, Norway	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital	Gjertsen, BT (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, N-5021 Bergen, Norway.	bjorn.gjertsen@uib.no	Ayuda-Durán, Pilar/ABA-2373-2020; Gjertsen, Bjorn T/O-1542-2015; Gjertsen, Bjørn T/AAP-3281-2020; Ayuda-Durán, Pilar/AAR-6755-2021; Cormack, Emmet Mc/D-2922-2012; Gullaksen, Stein-Erik/AAD-4344-2021	Ayuda-Durán, Pilar/0000-0002-9799-3680; Gjertsen, Bjorn T/0000-0001-9358-9704; Gjertsen, Bjørn T/0000-0001-9358-9704; Ayuda-Durán, Pilar/0000-0002-9799-3680; Cormack, Emmet Mc/0000-0002-7621-4625; 	University of Bergen; Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; Melzer Hoyskolefond; Bergen Forskningsstiftelse (Bergen Research Foundation); Trond Mohn Foundation; Helse Bergen HF [911809, 911852, 912171, 240222]; Norwegian Research Council of Norway through its Centers of excellence funding scheme [223250, 262652]; Norwegian Research Council [294916]; Helse Vest RHF; Norwegian Cancer Society [205729, 182524]	University of Bergen; Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Melzer Hoyskolefond; Bergen Forskningsstiftelse (Bergen Research Foundation); Trond Mohn Foundation; Helse Bergen HF; Norwegian Research Council of Norway through its Centers of excellence funding scheme; Norwegian Research Council(Research Council of NorwayEuropean Commission); Helse Vest RHF; Norwegian Cancer Society(Norwegian Cancer Society)	University of Bergen; Intramural Research Program of the National Institutes of Health; National Cancer Institute; Center for Cancer Research; Norwegian Cancer Society with Solveig & Ole Lunds Legacy and Oyvinn Molbach-Petersens Fond for Clinical Research (BTG); Melzer Hoyskolefond (BTG); Bergen Forskningsstiftelse (Bergen Research Foundation); Trond Mohn Foundation (VA); Helse Vest RHF; Helse Bergen HF, Grant/Award Number: 911809, 911852, 912171 and 240222; Norwegian Cancer Society, Grant/Award Number: 205729 and 182524; Norwegian Research Council of Norway through its Centers of excellence funding scheme, Grant/Award Number: 223250 and 262652; Norwegian Research Council, Grant/Award Number: 294916	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Andresen V, 2013, CELL DEATH DIFFER, V20, P1124, DOI 10.1038/cdd.2013.61; Apperley JF, 2015, LANCET, V385, P1447, DOI 10.1016/S0140-6736(13)62120-0; Barnes DJ, 2005, CANCER RES, V65, P8912, DOI 10.1158/0008-5472.CAN-05-0076; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; BHATIA R, 1995, BLOOD, V85, P3636, DOI 10.1182/blood.V85.12.3636.bloodjournal85123636; Bhatia R, 1998, LEUKEMIA LYMPHOMA, V28, P241, DOI 10.3109/10428199809092680; Bhatia R, 1998, BLOOD, V91, P3414, DOI 10.1182/blood.V91.9.3414.3414_3414_3422; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Bruck O, 2018, LEUKEMIA, V32, P1643, DOI 10.1038/s41375-018-0175-0; Bruserud O, 2001, STEM CELLS, V19, P1, DOI 10.1634/stemcells.19-1-1; Burt R, 2019, BLOOD, V134, P1415, DOI 10.1182/blood.2019001398; Caponetti GC, 2019, SEMIN HEMATOL, V56, P7, DOI 10.1053/j.seminhematol.2018.05.004; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; Delannoy A, 1997, J NATL CANCER I, V89, P1616; Desir S, 2019, CANCERS, V11, DOI 10.3390/cancers11070892; Desir S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27649-x; DOWDING C, 1993, LEUKEMIA LYMPHOMA, V11, P185, DOI 10.3109/10428199309047884; DOWDING C, 1991, BLOOD, V78, P499; Duarte D, 2018, BLOOD, V131, P1507, DOI 10.1182/blood-2017-12-784132; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Eiring AM, 2015, LEUKEMIA, V29, P586, DOI 10.1038/leu.2014.245; Forthun RB, 2019, J CANCER RES CLIN, V145, P1729, DOI 10.1007/s00432-019-02931-1; GORDON MY, 1987, NATURE, V328, P342, DOI 10.1038/328342a0; Gousset K, 2013, J CELL SCI, V126, P4424, DOI 10.1242/jcs.129239; Gratwohl A, 2003, LEUKEMIA, V17, P941, DOI 10.1038/sj.leu.2402896; Griessinger E, 2017, TRENDS CANCER, V3, P828, DOI 10.1016/j.trecan.2017.10.003; Gullaksen SE, 2017, HAEMATOLOGICA, V102, P1361, DOI 10.3324/haematol.2017.167080; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Hanna SJ, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223321; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hehlmann R, 2012, BLOOD, V120, P737, DOI 10.1182/blood-2012-03-380147; Hjorth-Hansen H, 2016, LEUKEMIA, V30, P1853, DOI 10.1038/leu.2016.121; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Houshmand M, 2019, LEUKEMIA, V33, P1543, DOI 10.1038/s41375-019-0490-0; Hurley A, 2013, J INFECT DIS, V207, P638, DOI 10.1093/infdis/jis730; Jabbour E, 2018, AM J HEMATOL, V93, P442, DOI 10.1002/ajh.25011; Jash E, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0281-7; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Kolba MD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2045-8; Krause DS, 2015, HAEMATOLOGICA, V100, P1376, DOI 10.3324/haematol.2014.113852; Kretschmer A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44346-5; Kumar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10373-3; LEE JC, 1982, J IMMUNOL, V128, P2393; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Lundell BI, 1996, BLOOD, V87, P2450, DOI 10.1182/blood.V87.6.2450.bloodjournal8762450; Matula Z, 2016, STEM CELLS DEV, V25, P1818, DOI 10.1089/scd.2016.0086; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; McCormack E, 2013, BLOOD, V121, pE34, DOI 10.1182/blood-2012-05-429555; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Mitchell R, 2018, JNCI-J NATL CANCER I, V110, P467, DOI 10.1093/jnci/djx236; Mittal R, 2019, J CELL PHYSIOL, V234, P1130, DOI 10.1002/jcp.27072; Obr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107367; Omsland M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29391-w; Omsland M, 2017, ONCOTARGET, V8, P7946, DOI 10.18632/oncotarget.13853; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Osteikoetxea-Molnar A, 2016, CELL MOL LIFE SCI, V73, P4531, DOI 10.1007/s00018-016-2233-y; Panasiuk M, 2018, J VIROL, V92, DOI [10.1128/jvi.00090-18, 10.1128/JVI.00090-18]; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Pemovska T, 2015, NATURE, V519, P102, DOI 10.1038/nature14119; Perrotti D, 2017, CURR DRUG TARGETS, V18, P377, DOI 10.2174/1389450117666160615074120; Pietarinen PO, 2017, ONCOTARGET, V8, P22606, DOI 10.18632/oncotarget.15146; Podszywalow-Bartnicka P, 2016, ONCOTARGET, V7, P79692, DOI 10.18632/oncotarget.12941; Polak R, 2015, BLOOD, V126, P2404, DOI 10.1182/blood-2015-03-634238; Radich JP, 2018, J NATL COMPR CANC NE, V16, P1108, DOI 10.6004/jnccn.2018.0071; Rainy N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.245; Reichert D, 2016, EXP HEMATOL, V44, P1092, DOI 10.1016/j.exphem.2016.07.006; Reikvam H, 2018, CASE REP HEMATOL, V2018, DOI 10.1155/2018/2045985; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Seyed-Razavi Y, 2013, IMMUNOL CELL BIOL, V91, P89, DOI 10.1038/icb.2012.52; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Silden E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056276; Simonsson B, 2011, BLOOD, V118, P3228, DOI 10.1182/blood-2011-02-336685; Souriant S, 2019, CELL REP, V26, P3586, DOI 10.1016/j.celrep.2019.02.091; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Talpaz M, 2013, LEUKEMIA, V27, P803, DOI 10.1038/leu.2012.313; TALPAZ M, 1987, BLOOD, V69, P1280; TALPAZ M, 1986, NEW ENGL J MED, V314, P1065, DOI 10.1056/NEJM198604243141701; Valent P, 2019, SEMIN CANC BIOL; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Verfaillie CM, 1998, J LAB CLIN MED, V131, P163, DOI 10.1016/S0022-2143(98)90159-7; VERFAILLIE CM, 1992, J CLIN INVEST, V90, P1232, DOI 10.1172/JCI115985; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2008, MOL CANCER THER, V7, P1121, DOI 10.1158/1535-7163.MCT-07-2331; Wertheim JA, 2003, BLOOD, V102, P2220, DOI 10.1182/blood-2003-01-0062; Zaccard CR, 2016, J LEUKOCYTE BIOL, V100, P81, DOI 10.1189/jlb.4VMR0915-395R; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	96	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3773	3791		10.1096/fj.201802061RR	http://dx.doi.org/10.1096/fj.201802061RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31945226	Green Published, hybrid			2022-12-26	WOS:000507597400001
J	Pinoli, P; Stamoulakatou, E; Nguyen, AP; Martinez, MR; Ceri, S				Pinoli, Pietro; Stamoulakatou, Eirini; An-Phi Nguyen; Martinez, Maria Rodriguez; Ceri, Stefano			Pan-cancer analysis of somatic mutations and epigenetic alterations in insulated neighbourhood boundaries	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; BINDING-SITES; ENHANCER-BLOCKING; CTCF; CHROMATIN; GENOME; LANDSCAPE; METHYLATION; IDENTIFICATION; ORGANIZATION	Recent evidence shows that the disruption of constitutive insulated neighbourhoods might lead to oncogene dysregulation. We present here a systematic pan-cancer characterisation of the associations between constitutive boundaries and genome alterations in cancer. Specifically, we investigate the enrichment of somatic mutation, abnormal methylation, and copy number alteration events in the proximity of CTCF bindings overlapping with topological boundaries (junctions) in 26 cancer types. Focusing on CTCF motifs that are both inboundary (overlapping with junctions) and active (overlapping with peaks of CTCF expression), we find a significant enrichment of somatic mutations in several cancer types. Furthermore, mutated junctions are significantly conserved across cancer types, and we also observe a positive selection of transversions rather than transitions in many cancer types. We also analyzed the mutational signature found on the different classes of CTCF motifs, finding some signatures (such as SBS26) to have a higher weight within in-boundary than off-bounday motifs. Regarding methylation, we find a significant number of over-methylated active in-boundary CTCF motifs in several cancer types; similarly to somatic-mutated junctions, they also have a significant conservation across cancer types. Finally, in several cancer types we observe that copy number alterations tend to overlap with active junctions more often than in matched normal samples. While several articles have recently reported a mutational enrichment at CTCF binding sites for specific cancer types, our analysis is pancancer and investigates abnormal methylation and copy number alterations in addition to somatic mutations. Our method is fully replicable and suggests several follow-up tumour-specific analyses.	[Pinoli, Pietro; Stamoulakatou, Eirini; Ceri, Stefano] Politecn Milan, DEIB, Milan, Italy; [An-Phi Nguyen; Martinez, Maria Rodriguez] IBM Res Zurich, Ruschlikon, Switzerland	Polytechnic University of Milan; International Business Machines (IBM)	Pinoli, P (corresponding author), Politecn Milan, DEIB, Milan, Italy.	pietro.pinoli@polimi.it	PINOLI, PIETRO/AFU-7318-2022	PINOLI, PIETRO/0000-0001-9786-2851	ERC [693174 GeCo]; European Union [668858]	ERC(European Research Council (ERC)European Commission); European Union(European Commission)	SC, PP, ES are supported by the ERC Advanced Grant 693174 GeCo (Data-Driven Genomic Computing); MRM and AN by European Union's Horizon 2020 research and innovation programme under grant agreement No 668858.	Alexandrov LB, 2019, BMC BIOINFORMATICS, V4, P152; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bastaki F, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0429-0; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Corces MR, 2016, CURR OPIN GENET DEV, V36, P1, DOI 10.1016/j.gde.2016.01.002; Dixon JR, 2016, MOL CELL, V62, P668, DOI 10.1016/j.molcel.2016.05.018; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Gonzalez-Perez A, 2019, CELL, V177, P101, DOI 10.1016/j.cell.2019.02.051; Graham NA, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167159; Gregor A, 2013, AM J HUM GENET, V93, P124, DOI 10.1016/j.ajhg.2013.05.007; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Guo C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3785-4; Guo YA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03828-2; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hou CH, 2008, P NATL ACAD SCI USA, V105, P20398, DOI 10.1073/pnas.0808506106; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Jose CC, 2014, P NATL ACAD SCI USA, V111, P14631, DOI 10.1073/pnas.1406923111; Kaiser VB, 2017, F1000RES, V6, pF1000; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Krijger PHL, 2016, NAT REV MOL CELL BIO, V17, P771, DOI 10.1038/nrm.2016.138; Kruger S, 2018, BIORXIV; Laddha SV, 2014, MOL CANCER RES, V12, P485, DOI 10.1158/1541-7786.MCR-13-0614; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu EMW, 2019, CELL SYST, V8, P446, DOI 10.1016/j.cels.2019.04.001; Masseroli M, 2015, BIOINFORMATICS, V31, P1881, DOI 10.1093/bioinformatics/btv048; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Pages H, 2019, BIOSTRINGS EFFICIENT; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Poulos RC, 2016, CELL REP, V17, P2865, DOI 10.1016/j.celrep.2016.11.055; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Song Sang-Hyun, 2017, Genomics & Informatics, V15, P114, DOI 10.5808/GI.2017.15.4.114; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taberlay PC, 2016, GENOME RES, V26, P719, DOI 10.1101/gr.201517.115; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Valton AL, 2016, CURR OPIN GENET DEV, V36, P34, DOI 10.1016/j.gde.2016.03.008; Walker BA, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.13; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Weischenfeldt J, 2017, NAT GENET, V49, P65, DOI 10.1038/ng.3722; Yang JK, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1572-4; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	54	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227180	10.1371/journal.pone.0227180	http://dx.doi.org/10.1371/journal.pone.0227180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945090	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100022
J	Asano, K; Nakajima, Y; Mukai, K; Urai, T; Okuwa, M; Sugama, J; Konya, C; Nakatani, T				Asano, Kimi; Nakajima, Yukari; Mukai, Kanae; Urai, Tamae; Okuwa, Mayumi; Sugama, Junko; Konya, Chizuko; Nakatani, Toshio			Pre-collecting lymphatic vessels form detours following obstruction of lymphatic flow and function as collecting lymphatic vessels	PLOS ONE			English	Article							UPPER-LIMB; MR LYMPHANGIOGRAPHY; NODE DISSECTION; LYMPHOSCINTIGRAPHY; LYMPHEDEMA; LYMPHADENECTOMY; ANASTOMOSIS; MATURATION	Background Previously, we showed that lymphatic vessels (LVs) formed detours after lymphatic obstruction, contributing to preventing lymphedema. In this study, we developed detours using lymphatic ligation in mice and we identified the detours histologically. Methods and results Under anesthesia, both hindlimbs in mice were subcutaneously injected with Evans blue dye to detect LVs. We tied the right collecting LV on the abdomen that passes through the inguinal lymph node (LN) at two points. The right and left sides comprised the operation and sham operation sides, respectively. Lymphography was performed to investigate the lymph flow after lymphatic ligation until day 30, using a near-infrared fluorescence imaging system. Anti-podoplanin antibody and 5-ethynyl-2'-deoxyuridine (EdU) were used to detect LVs and lymphangiogenesis. Within 30 days, detours had developed in 62.5% of the mice. Detours observed between two ligation sites were enlarged and irregular in shape. Podoplanin(+) LVs, which were located in the subcutaneous tissue of the upper panniculus carnosus muscle, connected to collecting LVs at the upper portion from the cranial ligation site and at the lower portion from the caudal ligation site. EdU(+) cells were not observed in these detours. The sham operation side showed normal lymph flow and did not show enlarged pre-collecting LVs until day 30. Conclusions Detours after lymphatic ligation were formed not by lymphangiogenesis but through an enlargement of pre-collecting LVs that functioned as collecting LVs after lymphatic ligation. Further studies are required to explore the developmental mechanism of the lymphatic detour for treatment and effective care of lymphedema in humans.	[Asano, Kimi] Kanazawa Univ, Grad Sch Med Sci, Grad Course Nursing Sci, Div Hlth Sci,Dept Clin Nursing, Kanazawa, Ishikawa, Japan; [Asano, Kimi] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa, Japan; [Nakajima, Yukari; Mukai, Kanae; Okuwa, Mayumi; Nakatani, Toshio] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Urai, Tamae] Toyama Prefectural Univ, Fac Nursing, Toyama, Japan; [Sugama, Junko] Kanazawa Univ, Inst Frontier Sci Initiat, Adv Hlth Care Sci Res Unit, Innovat Integrated Biores Core, Kanazawa, Ishikawa, Japan; [Konya, Chizuko] Ishikawa Prefectural Nursing Univ, Fac Nursing, Kahoku, Ishikawa, Japan	Kanazawa University; Kanazawa Medical University; Kanazawa University; Toyama Prefectural University; Kanazawa University	Nakatani, T (corresponding author), Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.	nakatosi@staff.kanazawa-u.ac.jp			JSPS KAKENHI [18H03072, 16K11931]; Yasuda Medical Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yasuda Medical Foundation	This work was funded by JSPS KAKENHI Grant Number 18H03072 to T N and 16K11931 to KA, https://www.jsps.go.jp/; and The Yasuda Medical Foundation to YN, http://www.yasuda-mf.or.jp/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE R, 1976, TOHOKU J EXP MED, V118, P163, DOI 10.1620/tjem.118.163; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; [Anonymous], 2016, LYMPHOLOGY, V49, P170; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Bouta EM, 2014, J PHYSIOL-LONDON, V592, P1213, DOI 10.1113/jphysiol.2013.266700; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Ikomi F, 2006, MICROCIRCULATION, V13, P365, DOI 10.1080/10739680600745810; Komatsu E, 2017, LYMPHAT RES BIOL, V15, P32, DOI 10.1089/lrb.2016.0026; Kretz O, 2012, FOLDIS TXB LYMPHOLOG, P120; Kwon S, 2016, BIOMED OPT EXPRESS, V7, P1100, DOI 10.1364/BOE.7.001100; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; Lohrmann C, 2006, AM J ROENTGENOL, V187, P556, DOI 10.2214/AJR.05.1750; Lonza, 2018, CERT AN, P1; Lu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050319; Maegawa J, 2010, MICROSURG, V30, P437, DOI 10.1002/micr.20772; Mikami T, 2011, LYMPHOLOGY, V44, P155; Moshiri M, 2002, AM J ROENTGENOL, V178, P405, DOI 10.2214/ajr.178.2.1780405; Nakajima Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25383-y; Neligan PC, 2017, J SURG ONCOL, V115, P18, DOI 10.1002/jso.24337; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Pecking AP, 2008, LYMPHOLOGY, V41, P1; Sacchi G, 1997, ANAT REC, V247, P53, DOI 10.1002/(SICI)1097-0185(199701)247:1<53::AID-AR8>3.0.CO;2-G; Sarri AJ, 2017, BREAST CANCER-TARGET, V9, P279, DOI 10.2147/BCTT.S131407; Shimamura K, 2009, WOUND REPAIR REGEN, V17, P598, DOI 10.1111/j.1524-475X.2009.00512.x; Suami H, 2007, PLAST RECONSTR SURG, V120, P982, DOI 10.1097/01.prs.0000277995.25009.3e; Suami H, 2016, J PLAST RECONSTR AES, V69, P723, DOI 10.1016/j.bjps.2016.01.002; Suami H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069222; Szuba A, 2016, LYMPHOLOGY, V49, P44; Taghian NR, 2014, CRIT REV ONCOL HEMAT, V92, P227, DOI 10.1016/j.critrevonc.2014.06.004; Takeno Y, 2017, LYMPHOLOGY, V50, P131; Takeno Y, 2013, LYMPHOLOGY, V46, P12; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Yamaji Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23693-9	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227814	10.1371/journal.pone.0227814	http://dx.doi.org/10.1371/journal.pone.0227814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940420	Green Published, gold			2022-12-26	WOS:000534368000100
J	Breusing, C; Franke, M; Young, CR				Breusing, Corinna; Franke, Maximilian; Young, Curtis Robert			Intra-host symbiont diversity in eastern Pacific cold seep tubeworms identified by the 16S-V6 region, but undetected by the 16S-V4 region	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; VESTIMENTIFERAN TUBEWORMS; POPULATION-STRUCTURE; RIFTIA-PACHYPTILA; ENDOSYMBIONTS; BACTERIA; ANNELIDA; TROPHOSOME; PHYLOGENY; TUBE	Vestimentiferan tubeworms are key taxa in deep-sea chemosynthetic habitats worldwide. As adults they obtain their nutrition through their sulfide-oxidizing bacterial endosymbionts, which are acquired from the environment. Although horizontal transmission should favor infections by various symbiotic microbes, the current paradigm holds that every tubeworm harbors only one endosymbiotic 16S rRNA phylotype. Although previous studies based on traditional Sanger sequencing have questioned these findings, population level high-throughput analyses of the symbiont 16S diversity are still missing. To get further insights into the symbiont genetic variation and uncover hitherto hidden diversity we applied state-of-the-art 16S-V4 amplicon sequencing to populations of the co-occurring tubeworm species Lamellibrachia barhami and Escarpia spicata that were collected during E/V Nautilus and R/V Western Flyer cruises to cold seeps in the eastern Pacific Ocean. In agreement with earlier work our sequence data indicated that L. barhami and E. spicata share one monomorphic symbiont phylotype. However, complementary CARD-FISH analyses targeting the 16S-V6 region implied the existence of an additional phylotype in L. barhami. Our results suggest that the V4 region might not be sufficiently variable to investigate diversity in the intra-host symbiont population at least in the analyzed sample set. This is an important finding given that this region has become the standard molecular marker for high-throughput microbiome analyses. Further metagenomic research will be necessary to solve these issues and to uncover symbiont diversity that is hidden below the 16S rRNA level.	[Breusing, Corinna] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Breusing, Corinna; Young, Curtis Robert] Natl Oceanog Ctr, Southampton, Hants, England; [Franke, Maximilian] Max Planck Inst Marine Microbiol, Bremen, Germany; [Breusing, Corinna] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Monterey Bay Aquarium Research Institute; NERC National Oceanography Centre; Max Planck Society; University of Rhode Island	Breusing, C (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.; Breusing, C (corresponding author), Natl Oceanog Ctr, Southampton, Hants, England.; Breusing, C (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	corinnabreusing@gmail.com		Franke, Maximilian/0000-0002-1930-1036; Breusing, Corinna/0000-0001-6845-0188	David and Lucile Packard Foundation; German Research Foundation [BR 5488/1-1]; UK Natural Environment Research Council [NE/N006496/1, NE/R015953/1]; NOAA-OER [NA15OAR0110220]; Max Planck Society; DFG Cluster of Excellence 'The Ocean in the Earth System' at MARUM (University of Bremen); NERC [noc010009, NE/N006496/1] Funding Source: UKRI	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); German Research Foundation(German Research Foundation (DFG)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NOAA-OER; Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG Cluster of Excellence 'The Ocean in the Earth System' at MARUM (University of Bremen); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded through grants of the David and Lucile Packard Foundation (to MBARI) and the German Research Foundation (grant number BR 5488/1-1 to C.B.). C.R.Y was supported by UK Natural Environment Research Council funding Calibrating eDNA Tools for Biodiversity Monitoring in the Ocean (grant number NE/N006496/1) and National Capability funding to the National Oceanography Centre, as part of the Climate Linked Atlantic Section Science (CLASS) programme (grant number NE/R015953/1). The Ocean Exploration Trust's Nautilus Exploration Program, Cruise NA090, was funded through NOAA-OER (grant number NA15OAR0110220). The work by M.F. was funded by the Max Planck Society and the DFG Cluster of Excellence 'The Ocean in the Earth System' at MARUM (University of Bremen).	Andrews S., 2010, FASTQC QUALITY CONTR; Boetius A, 2005, PLOS BIOL, V3, P375, DOI 10.1371/journal.pbio.0030102; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Breusing C, 2015, CONSERV GENET, V16, P1415, DOI 10.1007/s10592-015-0750-0; Bright M, 2003, INVERTEBR BIOL, V122, P347; Bright M, 2010, OCEANOGR MAR BIOL, V48, P213; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Cordes EE, 2005, PLOS BIOL, V3, P497, DOI 10.1371/journal.pbio.0030077; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; DANDO PR, 1992, NATURE, V356, P667, DOI 10.1038/356667a0; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eren AM, 2013, METHODS ECOL EVOL, V4, P1111, DOI 10.1111/2041-210X.12114; Fauvart M, 2008, FEMS MICROBIOL LETT, V285, P1, DOI 10.1111/j.1574-6968.2008.01254.x; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gambi M. C., 2011, MAR BIODIVERS REC, V4, pe24, DOI DOI 10.1017/S1755267211000261; Gardebrecht A, 2012, ISME J, V6, P766, DOI 10.1038/ismej.2011.137; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Halanych KM, 2005, HYDROBIOLOGIA, V535, P297, DOI 10.1007/s10750-004-1437-6; Hughes DJ, 2009, MAR BIODIVERS REC, V1, pe21; Ikuta T, 2016, ISME J, V10, P990, DOI 10.1038/ismej.2015.176; Johnson SB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-21; Klose Julia, 2015, Proc Natl Acad Sci U S A, V112, P11300, DOI 10.1073/pnas.1501160112; Li YN, 2018, ISME J, V12, P2785, DOI 10.1038/s41396-018-0220-z; McMullin ER, 2003, SYMBIOSIS, V34, P1; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Nyholm SV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038267; Perez M, 2016, APPL ENVIRON MICROB, V82, P5197, DOI 10.1128/AEM.00953-16; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Reveillaud J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0411-x; Salathe RM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-189; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Southward EC, 2005, HYDROBIOLOGIA, V535, P227, DOI 10.1007/s10750-004-4401-6; STEEDMAN HF, 1957, NATURE, V179, P1345, DOI 10.1038/1791345a0; Thiel V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00423; Verna C, 2010, ENVIRON MICROBIOL, V12, P2355, DOI 10.1111/j.1462-2920.2010.02299.x; Vrijenhoek RC, 2007, BIOL BULL-US, V212, P180, DOI 10.2307/25066600; Vrijenhoek RC, 2010, TOP GEOBIOL, V33, P15, DOI 10.1007/978-90-481-9572-5_2; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Yang Y, 2020, ISME J, V14, P135, DOI 10.1038/s41396-019-0520-y; Zimmermann J, 2014, ENVIRON MICROBIOL, V16, P3638, DOI 10.1111/1462-2920.12427	45	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227053	10.1371/journal.pone.0227053	http://dx.doi.org/10.1371/journal.pone.0227053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940381	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000534368000057
J	Park, VY; Han, K; Kim, HJ; Lee, E; Youk, JH; Kim, EK; Moon, HJ; Yoon, JH; Kwak, JY				Park, Vivian Y.; Han, Kyunghwa; Kim, Hye Jung; Lee, Eunjung; Youk, Ji Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Kwak, Jin Young			Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma	PLOS ONE			English	Article							PREOPERATIVE DIAGNOSIS; PROGNOSTIC-FACTORS; TEXTURE ANALYSIS; NODULES; CANCER; ULTRASOUND; MALIGNANCY; GUIDELINES; BENIGN; KOREA	Purpose Preoperative neck ultrasound (US) for lateral cervical lymph nodes is recommended for all patients undergoing thyroidectomy for thyroid malignancy, but it is operator dependent. We aimed to develop a radiomics signature using US images of the primary tumor to preoperatively predict lateral lymph node metastasis (LNM) in patients with conventional papillary thyroid carcinoma (cPTC). Methods Four hundred consecutive cPTC patients from January 2004 to February 2006 were enrolled as the training cohort, and 368 consecutive cPTC patients from March 2006 to February 2007 served as the validation cohort. A radiomics signature, which consisted of 14 selected features, was generated by the least absolute shrinkage and selection operator (LASSO) regression model in the training cohort. The discriminating performance of the radiomics signature was assessed in the validation cohort with the area under the receiver operating characteristic curve (AUC). Results The radiomics signature was significantly associated with lateral cervical lymph node status (p < 0.001). The AUC of its performance in discriminating metastatic and non-metastatic lateral cervical lymph nodes was 0.710 (95% CI: 0.649-0.770) in the training cohort and was 0.621 (95% CI: 0.560-0.682) in the validation cohort. Conclusions The present study showed that US radiomic features of the primary tumor were associated with lateral cervical lymph node status. Although their discriminatory performance was slightly lower in the validation cohort, our study shows that US radiomic features of the primary tumor alone have the potential to predict lateral LNM.	[Park, Vivian Y.; Han, Kyunghwa; Kim, Eun-Kyung; Moon, Hee Jung; Yoon, Jung Hyun; Kwak, Jin Young] Yonsei Univ, Severance Hosp, Res Inst Radiol Sci, Dept Radiol,Coll Med, Seoul, South Korea; [Kim, Hye Jung] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Radiol, Daegu, South Korea; [Lee, Eunjung] Yonsei Univ, Dept Computat Sci & Engn, Seoul, South Korea; [Youk, Ji Hyun] Yonsei Univ, Gangnam Severance Hosp, Res Inst Radiol Sci, Dept Radiol,Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Kyungpook National University; Yonsei University; Yonsei University; Yonsei University Health System	Kwak, JY (corresponding author), Yonsei Univ, Severance Hosp, Res Inst Radiol Sci, Dept Radiol,Coll Med, Seoul, South Korea.	docjin@yuhs.ac	; Kim, Eun-Kyung/E-5211-2017	Moon, Hee Jung/0000-0002-5643-5885; Kim, Eun-Kyung/0000-0002-3368-5013; Yoon, Jung Hyun/0000-0002-2100-3513; Lee, Eunjung/0000-0001-9989-3555; Park, Vivian/0000-0002-5135-4058; Kwak, Jin Young/0000-0002-6212-1495	Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education [2016R1D1A1B03930375]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1A2C1002375]	Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education; National Research Foundation of Korea (NRF) - Korea government (MSIT)	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) by the Ministry of Education (2016R1D1A1B03930375) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2019R1A2C1002375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2016, THYROID, V26, P1535, DOI 10.1089/thy.2016.0075; Bhatia KSS, 2016, ULTRASOUND MED BIOL, V42, P1671, DOI 10.1016/j.ultrasmedbio.2016.01.013; Chen SJ, 2010, ULTRASOUND MED BIOL, V36, P2018, DOI 10.1016/j.ultrasmedbio.2010.08.019; Cho BY, 2013, THYROID, V23, P797, DOI 10.1089/thy.2012.0329; Cho E, 2018, AM J SURG, V216, P562, DOI 10.1016/j.amjsurg.2017.12.006; Gillies RJ, 2015, RADIOLOGY, DOI DOI 10.1148/RADIOL.2015151169; Grani G, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001129; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Huang YQ, 2016, J CLIN ONCOL, V34, P2157, DOI 10.1200/JCO.2015.65.9128; Ito Y, 2005, WORLD J SURG, V29, P917, DOI 10.1007/s00268-005-7789-x; Kim H, 2017, THYROID, V27, P908, DOI 10.1089/thy.2016.0648; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176103; Kim SY, 2015, AM J ROENTGENOL, V205, pW343, DOI 10.2214/AJR.14.13825; Kwak JY, 2009, ANN SURG ONCOL, V16, P1348, DOI 10.1245/s10434-009-0384-x; Lee JH, 2018, THYROID, V28, P1332, DOI 10.1089/thy.2018.0082; Lee SH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22981-8; Liang JY, 2018, THYROID, V28, P1024, DOI 10.1089/thy.2017.0525; Liu TT, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819831713; Liu TT, 2018, INT J COMPUT ASS RAD, V13, P1617, DOI 10.1007/s11548-018-1796-5; Londero SC, 2015, THYROID, V25, P78, DOI 10.1089/thy.2014.0294; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Moon HJ, 2012, ULTRASOUND MED BIOL, V38, P568, DOI 10.1016/j.ultrasmedbio.2012.01.002; Moon HJ, 2011, AM J ROENTGENOL, V197, pW324, DOI 10.2214/AJR.10.5576; Nam SJ, 2016, J ULTRAS MED, V35, P775, DOI 10.7863/ultra.15.05055; Park VY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004292; Qu JR, 2019, EUR RADIOL, V29, P906, DOI 10.1007/s00330-018-5583-z; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Suh CH, 2017, AM J NEURORADIOL, V38, P154, DOI 10.3174/ajnr.A4967; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wu LM, 2012, EUR J RADIOL, V81, P1798, DOI 10.1016/j.ejrad.2011.04.028; Wu SX, 2017, CLIN CANCER RES, V23, P6904, DOI 10.1158/1078-0432.CCR-17-1510; Zhang B, 2017, CLIN CANCER RES, V23, P4259, DOI 10.1158/1078-0432.CCR-16-2910	32	18	20	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227315	10.1371/journal.pone.0227315	http://dx.doi.org/10.1371/journal.pone.0227315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940386	Green Published, gold			2022-12-26	WOS:000534368000066
J	Skoracki, M; Sikora, B; Jerzak, L; Hromada, M				Skoracki, Maciej; Sikora, Bozena; Jerzak, Leszek; Hromada, Martin			Tanopicobia gen. nov., a new genus of quill mites, its phylogenetic placement in the subfamily Picobiinae (Acariformes: Syringophilidae) and picobiine relationships with avian hosts	PLOS ONE			English	Article							BIRDS; PROSTIGMATA; ACARI; PARASITES; AVES; TREE; JOHNSTON; KETHLEY; WORLD; TAXA	A new monotypic genus Tanopicobia gen. nov. is established for a new species Tanopicobia trachyphoni sp. nov., parasitizing Trachyphonus erythrocephalus Cabanis, 1878 (Piciformes: Lybiidae) from Tanzania. In phylogenetic analyses based on morphological data and constructed using the maximum parsimony approach, this taxon falls within the subfamily Picobiinae Johnston and Kethley, 1973 in the Neopicobia-species-group as closely related to the genus Pipicobia Glowska and Schmidt, 2014. Tanopicobia differs from Pipicobia by the following features in females: genital setae absent; setae ye are situated far and posteromedial to the level of setal bases vi; setae 3a are thick and knobbed. Additionally, a new generic key for subfamily Picobiinae is constructed and general host-parasite ecological and phylogenetic relationships are discussed. Picobiines are present in several lineages of neoavian birds, from basal Galloanseres to terminal Telluraves, which are infested by 70 (89.7% of all) species of these ectoparasites.	[Skoracki, Maciej; Sikora, Bozena] Adam Mickiewicz Univ, Fac Biol, Dept Anim Morphol, Poznan, Poland; [Skoracki, Maciej; Hromada, Martin] Univ Presov, Fac Humanities & Nat Sci, Dept Ecol, Lab & Museum Evolutionary Ecol, Presov, Slovakia; [Jerzak, Leszek; Hromada, Martin] Univ Zielona Gera, Fac Biol Sci, Zielona Gera, Poland	Adam Mickiewicz University; University of Presov	Hromada, M (corresponding author), Univ Presov, Fac Humanities & Nat Sci, Dept Ecol, Lab & Museum Evolutionary Ecol, Presov, Slovakia.; Hromada, M (corresponding author), Univ Zielona Gera, Fac Biol Sci, Zielona Gera, Poland.	hromada.martin@gmail.com	Hromada, Martin/I-7409-2019	Hromada, Martin/0000-0002-5626-1205; Jerzak, Leszek/0000-0001-5332-279X; Skoracki, Maciej/0000-0001-7416-3580	Polish National Science Centre [NCN 2014/15/B/NZ8/00208]; Slovak Research and Development Agency [APVV-16-0411]; Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0977/16]; Research agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic for the Structural Funds of EU [ITMS26110230119]	Polish National Science Centre; Slovak Research and Development Agency(Slovak Research and Development Agency); Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic; Research agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic for the Structural Funds of EU	MS and BS were supported by Polish National Science Centre (https://www.ncn.gov.pl/? language=en), project NCN 2014/15/B/NZ8/00208. MH and MS were supported by Slovak Research and Development Agency (https://www.apvv.sk/? lang=en) under the contract No. APVV-16-0411; Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic (https://www.minedu.sk/vedecka-grantova-agenturamsvvas-sr-a-sav-vega/) VEGA 1/0977/16. MH was supported by Research agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic for the Structural Funds of EU, project ITMS26110230119 (http://www.vyskumnaagentura.sk/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo A, 2015, ADV PARASIT, V90, P349, DOI 10.1016/bs.apar.2015.03.003; Brazeau MD, 2011, BIOL J LINN SOC, V104, P489, DOI 10.1111/j.1095-8312.2011.01755.x; Casto S.D., 1977, Southwestern Naturalist, V22, P169; Claramunt S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501005; Clements J.F., 2018, EBIRD CLEMENTS CHECK; CRACRAFT J, 1981, AUK, V98, P681; Dittmar K, 2012, BLACKW COMPANION ANT, P170; Dittmar K, 2009, J PARASITOL, V95, P365, DOI 10.1645/GE-1676.1; Dormann C.F., 2008, R NEWS, V8, P8; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Ericson PGP, 2012, J BIOGEOGR, V39, P813, DOI 10.1111/j.1365-2699.2011.02650.x; Fain A., 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Entomologie, V70, P33; Field D. J., 2019, PEERJ PREPR, V7, DOI DOI 10.7287/PEERJ.PREPRINTS.27521V1; Glowska E, 2014, ZOOTAXA, V3861, P193, DOI 10.11646/zootaxa.3861.2.7; Grandjean F., 1939, Bulletin de la Societe Zoologique de France, V64, P273; Grandjean F., 1944, Archives des Sciences Physiques et Naturelles Geneve, V26, P103; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Houde P, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070108; Hromada M, 2016, SYST APPL ACAROL-UK, V21, P528, DOI 10.11158/saa.21.4.11; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kethley J., 1990, P667; Kethley J. B., 1970, Contr. Am. ent. Inst., V5, P1; Kimball RT, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070109; Kimball RT, 2013, MOL PHYLOGENET EVOL, V69, P1021, DOI 10.1016/j.ympev.2013.05.029; Klimovicova M., 2015, FOLIA OECOLOGICA, V7, P98; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; MACLEAN G. L., 1967, J ORNITHOL, V108, P203, DOI 10.1007/BF01671410; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; Mikula P, 2016, MAMMAL REV, V46, P160, DOI 10.1111/mam.12060; Mironov S.V., 2009, P ZOOLOGICAL I RUSSI, V313, P97; Moller AP, 2015, OECOLOGIA, V178, P943, DOI 10.1007/s00442-015-3268-8; Mooi RD, 2010, ZOOTAXA, P26; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Nixon KC., 1999, WINCLADA; Page R. D. M., 2001, NDE NEXUS DATA EDITO; Page RDM, 1988, TREEVIEW; Payevsky V. A., 2014, BIOL B REV, V4, P143, DOI DOI 10.1134/S2079086414020054; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rambaut A., 2018, FIGTREE V1 4 4 I EVO; Reddy S, 2017, SYST BIOL, V66, P857, DOI 10.1093/sysbio/syx041; Skoracki M, 2004, ACTA PARASITOL, V49, P348; Skoracki M., 2012, Acarina, V20, P67; Skoracki M, 2001, FOLIA PARASIT, V48, P154, DOI 10.14411/fp.2001.024; Skoracki M, 2018, J MED ENTOMOL, V55, P1464, DOI 10.1093/jme/tjy106; Skoracki M, 2016, ZOOTAXA, V4113, P1, DOI 10.11646/zootaxa.4113.1.1; Skoracki M, 2010, ZOOTAXA, P1; Skoracki M, 2011, ZOOTAXA, P1; Skoracki M, 2014, SYST PARASITOL, V87, P99, DOI 10.1007/s11230-013-9460-5; Skoracki M, 2013, EUR J ENTOMOL, V110, P663, DOI 10.14411/eje.2013.090; Strong EE, 1999, CLADISTICS, V15, P363, DOI 10.1111/j.1096-0031.1999.tb00272.x; Suh A, 2016, ZOOL SCR, V45, P50, DOI 10.1111/zsc.12213; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wang N, 2012, MOL BIOL EVOL, V29, P737, DOI 10.1093/molbev/msr230; Yuri Tamaki, 2013, Biology - Basel, V2, P419, DOI 10.3390/biology2010419; Zmudzinski M, 2018, UPDATED CHECK LIST F	58	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0225982	10.1371/journal.pone.0225982	http://dx.doi.org/10.1371/journal.pone.0225982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940314	gold, Green Published			2022-12-26	WOS:000534368000014
J	Vidal, E; Fernandez-Borges, N; Erana, H; Parra, B; Pintado, B; Sanchez-Martin, MA; Charco, JM; Ordonez, M; Perez-Castro, MA; Pumarola, M; Mathiason, CK; Mayoral, T; Castilla, J				Vidal, Enric; Fernandez-Borges, Natalia; Erana, Hasier; Parra, Beatriz; Pintado, Belen; Sanchez-Martin, Manuel A.; Charco, Jorge M.; Ordonez, Montserrat; Perez-Castro, Miguel A.; Pumarola, Marti; Mathiason, Candace K.; Mayoral, Tomas; Castilla, Joaquin			Dogs are resistant to prion infection, due to the presence of asparagine at position 163 of their prion protein	FASEB JOURNAL			English	Article						canids; canine; dog; interspecies transmission; prion infection; prion susceptibility; scrapie; transgenic mouse models; transmission barrier; transmissible spongiform encephalopathy	BOVINE SPONGIFORM ENCEPHALOPATHY; BSE; SCRAPIE; DISEASE; TRANSMISSION; AGENT; CATS; DEGENERATION; REPLICATION; PRPRES	Unlike other species, prion disease has never been described in dogs even though they were similarly exposed to the bovine spongiform encephalopathy (BSE) agent. This resistance prompted a thorough analysis of the canine PRNP gene and the presence of a negatively charged amino acid residue in position 163 was readily identified as potentially fundamental as it differed from all known susceptible species. In the present study, the first transgenic mouse model expressing dog prion protein (PrP) was generated and challenged intracerebrally with a panel of prion isolates, none of which could infect them. The brains of these mice were subjected to in vitro prion amplification and failed to find even minimal amounts of misfolded prions providing definitive experimental evidence that dogs are resistant to prion disease. Subsequently, a second transgenic model was generated in which aspartic acid in position 163 was substituted for asparagine (the most common in prion susceptible species) resulting in susceptibility to BSE-derived isolates. These findings strongly support the hypothesis that the amino acid residue at position 163 of canine cellular prion protein (PrP (c)) is a major determinant of the exceptional resistance of the canidae family to prion infection and establish this as a promising therapeutic target for prion diseases.	[Vidal, Enric; Ordonez, Montserrat] Univ Autonoma Barcelona, IRTA, Ctr Recerca Sanit Anim, CReSA, Barcelona, Spain; [Fernandez-Borges, Natalia; Erana, Hasier; Charco, Jorge M.; Perez-Castro, Miguel A.; Castilla, Joaquin] CIC BioGUNE, Parque Tecnol Bizkaia, Derio 48160, Bizkaia, Spain; [Parra, Beatriz; Mayoral, Tomas] LCV, Madrid, Spain; [Pintado, Belen] Ctr Nacl Biotecnol, Madrid, Spain; [Sanchez-Martin, Manuel A.] Univ Salamanca, Serv Transgenesis, Nucleus, Salamanca, Spain; [Sanchez-Martin, Manuel A.] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain; [Pumarola, Marti] UAB, Fac Vet, Dept Med & Cirurgia Anim, Barcelona, Spain; [Mathiason, Candace K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Castilla, Joaquin] Ikerbasque, Basque Fdn Sci, Bilbao, Spain	Autonomous University of Barcelona; IRTA; CIC bioGUNE; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Autonomous University of Barcelona; Colorado State University; Basque Foundation for Science	Castilla, J (corresponding author), CIC BioGUNE, Parque Tecnol Bizkaia, Derio 48160, Bizkaia, Spain.	castilla@joaquincastilla.com	Castilla, Joaquín/J-8414-2019; Pérez-Castro, Miguel A./AGW-9540-2022; Fernández-Borges, Natalia/H-1875-2012; Sanchez-Martin, Manuel/N-5327-2016; Vidal, Enric/P-2901-2019; Vidal, Enric/I-1679-2014	Castilla, Joaquín/0000-0002-2216-1361; Pérez-Castro, Miguel A./0000-0003-2850-3470; Sanchez-Martin, Manuel/0000-0001-8370-1336; Vidal, Enric/0000-0002-4965-3286; Vidal, Enric/0000-0002-4965-3286; Pumarola Batlle, Marti/0000-0002-0935-7941; M. Charco, Jorge/0000-0003-3476-1855	Ikerbasque foundation	Ikerbasque foundation	The authors would like to thank the following for their support: Ikerbasque foundation, vivarium, and maintenance from CIC bioGUNE and Patricia Pineiro for technical support. Sierra Espinar, Marta Valle, and Mariano Moreno for technical support, and IRTA-CReSA's biocontainment unit staff for care and maintenance of the animals. Olivier Andreoletti, Jean Jewell, and Fabrizio Tagliavini for the sheep-BSE, CWD, and BSE-L brain tissue samples, respectively. Glenn Telling and Jifeng Bian for the plasmid phgPrP-MCS. Dr. Mark P. Dagleish (Moredun Research Institute) for useful discussion and advice.	ALDHOUS P, 1990, NATURE, V345, P194; Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Benestad SL, 2008, VET RES, V39, DOI 10.1051/vetres:2007056; Bian JF, 2017, P NATL ACAD SCI USA, V114, P1141, DOI 10.1073/pnas.1611891114; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, FEBS LETT, V579, P6237, DOI 10.1016/j.febslet.2005.09.099; Castilla J, 2004, J NEUROSCI, V24, P5063, DOI 10.1523/JNEUROSCI.5400-03.2004; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; David M, 2012, OR 09 CANINE SPONGIF; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Erana H, 2017, J VIROL, V91, DOI 10.1128/JVI.01543-17; Espinosa JC, 2009, EMERG INFECT DIS, V15, P1214, DOI 10.3201/eid1508.081218; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Fernandez-Borges N, 2018, PRION, V2018, P1; Fernandez-Borges N, 2018, ACTA NEUROPATHOL, V135, P179, DOI 10.1007/s00401-017-1782-y; Fernandez-Borges N, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006716; Fernandez-Borges N, 2012, PRION, V6, DOI 10.4161/pri.22057; FRASER H, 1994, VET REC, V134, P449, DOI 10.1136/vr.134.17.449; GOURMELON P, 1987, BRAIN RES, V411, P391, DOI 10.1016/0006-8993(87)91093-6; Greenwood AD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-44; Hedman C, 2016, VET RES, V47, DOI 10.1186/s13567-015-0295-8; Kortz GD, 1997, VET PATHOL, V34, P296, DOI 10.1177/030098589703400405; Leclerc E, 2003, J MOL BIOL, V326, P475, DOI 10.1016/S0022-2836(02)01365-7; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2013, J VIROL, V87, P1947, DOI 10.1128/JVI.02592-12; Otero A, 2017, MOL NEUROBIOL, V2017, P1; Otero A, 2019, MOL NEUROBIOL, V55, P6182; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Piccardo P, 2012, J COMP PATHOL, V147, P84, DOI 10.1016/j.jcpa.2011.09.004; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Sanchez-Garcia J, 2016, NEUROBIOL DIS, V95, P204, DOI 10.1016/j.nbd.2016.07.025; Sanchez-Garcia J, 2018, NEUROBIOL DIS, V119, P1, DOI 10.1016/j.nbd.2018.07.011; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Sigurdson CJ, 2003, BRIT MED BULL, V66, P199, DOI 10.1093/bmb/66.1.199; Siso S, 2004, VET REC, V155, P524, DOI 10.1136/vr.155.17.524; Stewart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050623; Torres JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089722; Vidal E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004977; Vidal E, 2013, PRION, V7, P443, DOI 10.4161/pri.27014; Vidal E, 2013, J NEUROSCI, V33, P7778, DOI 10.1523/JNEUROSCI.0244-13.2013; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Windl Otto, 2012, Subcell Biochem, V65, P497, DOI 10.1007/978-94-007-5416-4_18; WYATT JM, 1991, VET REC, V129, P233, DOI 10.1136/vr.129.11.233; Zanusso G, 1998, LANCET, V352, P1116, DOI 10.1016/S0140-6736(05)79756-7	52	16	16	2	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3969	3982		10.1096/fj.201902646R	http://dx.doi.org/10.1096/fj.201902646R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944411	Green Published			2022-12-26	WOS:000507590900001
J	Yuan, Q; Tan, TH; Wang, PZ; Devi, F; Ong, HL; Abdin, E; Harish, M; Goveas, R; Ng, L; Chong, SA; Subramaniam, M				Yuan, Qi; Tan, Tee Hng; Wang, Peizhi; Devi, Fiona; Ong, Hui Lin; Abdin, Edimansyah; Harish, Magadi; Goveas, Richard; Ng, Li Ling; Chong, Siow Ann; Subramaniam, Mythily			Staging dementia based on caregiver reported patient symptoms: Implications from a latent class analysis	PLOS ONE			English	Article							INSTRUMENTAL ACTIVITIES; PEOPLE; MODEL; PREVALENCE; VALIDATION; DEPRESSION; SCALE	Background Tailoring interventions to the needs of caregivers is an important feature of successful caregiver support programs. To improve cost-effectiveness, group tailoring based on the stage of dementia could be a good alternative. However, existing staging strategies mostly depend on trained professionals. Objective This study aims to stage dementia based on caregiver reported symptoms of persons with dementia. Methods Latent class analysis was used. The classes derived were then mapped with disease duration to define the stages. Logistic regression with receiver operating characteristic curve was used to generate the optimal cut-offs. Results Latent class analysis suggested a 4-class solution, these four classes were named as early (25.9%), mild (25.2%), moderate (16.7%) and severe stage (32.3%). The stages based on the cut-offs generated achieved an overall accuracy of 90.8% compared to stages derived from latent class analysis. Conclusion The current study confirmed that caregiver reported patient symptoms could be used to classify persons with dementia into different stages. The new staging strategy is a good complement of existing dementia clinical assessment tools in terms of better supporting informal caregivers.	[Yuan, Qi; Tan, Tee Hng; Wang, Peizhi; Devi, Fiona; Ong, Hui Lin; Abdin, Edimansyah; Chong, Siow Ann; Subramaniam, Mythily] Inst Mental Hlth, Res Div, Singapore, Singapore; [Harish, Magadi; Goveas, Richard] Inst Mental Hlth, Dept Geriatr Psychiat, Singapore, Singapore; [Ng, Li Ling] Changi Gen Hosp, Dept Psychol Med, Singapore, Singapore; [Subramaniam, Mythily] Lee Kong Chian Sch Med, Neurosci & Mental Hlth, Singapore, Singapore	Changi General Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yuan, Q (corresponding author), Inst Mental Hlth, Res Div, Singapore, Singapore.	Qi_YUAN@imh.com.sg	; Abdin, Edimansyah/E-6451-2011	YUAN, Qi/0000-0002-5271-6954; Abdin, Edimansyah/0000-0002-1016-3298	Singapore Ministry of Health's National Medical Research Council under the Center Grant Programme [NMRC/CG/004/2013]; Institute of Mental Health Bridging Fund (CRC) [5452016]	Singapore Ministry of Health's National Medical Research Council under the Center Grant Programme; Institute of Mental Health Bridging Fund (CRC)	The study is funded by the Singapore Ministry of Health's National Medical Research Council under the Center Grant Programme (Grant No.: NMRC/CG/004/2013) and the Institute of Mental Health Bridging Fund (CRC ref No.: 5452016). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; Alzheimer's Disease International, 2016, WORLD ALZHEIMER REPO; Aminzadeh F, 2007, AGING MENT HEALTH, V11, P281, DOI 10.1080/13607860600963695; Autio T, 2018, SCAND J CARING SCI, V32, P45, DOI 10.1111/scs.12452; Bakar o, 2017, ARCH NEUROPSYCHIATRY, V54, P82, DOI DOI 10.5152/NPA.2017.11304; Bass DM, 2012, AM J GERIAT PSYCHIAT, V20, P239, DOI 10.1097/JGP.0b013e31824108ca; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Davis WA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194417; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Givens JL, 2014, AM J GERIAT PSYCHIAT, V22, P481, DOI 10.1016/j.jagp.2012.08.010; Haro JM, 2014, J NUTR HEALTH AGING, V18, P677, DOI [10.1007/s12603-014-0500-x, 10.1007/s12603-014-0036-0]; Hopwood J, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9548; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jaimes FA, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-23; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; LAWTON MP, 1991, J GERONTOL, V46, pP181, DOI 10.1093/geronj/46.4.P181; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Mittelman MS, 2008, AM J GERIAT PSYCHIAT, V16, P893, DOI 10.1097/JGP.0b013e3181898095; Mole L, 2018, HEALTH SOC CARE COMM, V26, pE485, DOI 10.1111/hsc.12540; Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726; Ostbye T, 2013, J GERONTOL B-PSYCHOL; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pozzebon M, 2016, INT PSYCHOGERIATR, V28, P537, DOI 10.1017/S1041610215002239; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reisberg B., 2011, PRINCIPLES PRACTICE, V3rd ed., P162, DOI DOI 10.1002/9780470669600; Rockwood K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2461; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Sien NY., 2014, SINGAPORE FAM PHYS, V40, P26; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Ulbricht CM, 2015, J AFFECT DISORDERS, V188, P270, DOI 10.1016/j.jad.2015.08.039; van Wijngaarden E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198034; Wartberg L, 2017, COMPUT HUM BEHAV, V67, P233, DOI 10.1016/j.chb.2016.10.029; Whitlatch CJ, 2018, GERONTOLOGIST, V58, pS58, DOI 10.1093/geront/gnx162; World Health Organization, FACT SHEET DEM 2017; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Xie F, 2006, OSTEOARTHR CARTILAGE, V14, P1098, DOI 10.1016/j.joca.2006.05.005; Xu JF, 2017, LANCET, V390, pS47, DOI 10.1016/S0140-6736(17)33185-9; Ying JB, 2019, DEMENT GERIATR COGN, V47, P323, DOI 10.1159/000500940; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou M, 2018, PHARMACOECONOMICS, V36, P175, DOI 10.1007/s40273-017-0575-4	47	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227857	10.1371/journal.pone.0227857	http://dx.doi.org/10.1371/journal.pone.0227857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940419	Green Published, gold			2022-12-26	WOS:000534368000104
J	Ballegaard, V; Pedersen, KK; Braendstrup, P; Kirkby, N; Stryhn, A; Ryder, LP; Gerstoft, J; Nielsen, SD				Ballegaard, Vibe; Pedersen, Karin Kaereby; Braendstrup, Peter; Kirkby, Nikolai; Stryhn, Anette; Ryder, Lars P.; Gerstoft, Jan; Nielsen, Susanne Dam			Cytomegalovirus-specific CD8+T-cell responses are associated with arterial blood pressure in people living with HIV	PLOS ONE			English	Article							IMMUNOGLOBULIN-G ANTIBODY; T-CELL-ACTIVATION; INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; PULSE PRESSURE; HEART-DISEASE; HYPERTENSION	People living with HIV (PLHIV) are at increased risk for cardiovascular disease (CVD), and immunity against cytomegalovirus (CMV) may be a contributing factor. We hypothesized that enhanced T-cell responses against CMV and CMV-IgG antibody-levels are associated with higher arterial blood pressure in PLHIV. We assessed serum CMV-IgG, systolic- (SBP) and diastolic- (DBP) blood pressure, pulse pressure (PP), traditional risk factors, activated CD8+ T-cells (CD38+HLA-DR+), senescent CD8+ T-cells (CD28-CD57+) and interleukin-6 (IL-6) in 60 PLHIV and 31 HIV-uninfected controls matched on age, gender, education and comorbidity. In PLHIV, expression of interleukin-2, tumor necrosis factor-a and interferon-gamma was measured by intracellular-cytokine-staining after stimulation of T-cells with CMV-pp65 and CMV-gB. Associations between CMV-specific immune responses and hypertension, SBP, DBP or PP were assessed by multivariate logistic and linear regression models adjusted for appropriate confounders. The median age of PLHIV was 47 years and 90% were male. Prevalence of hypertension in PLHIV was 37% compared to 55% of HIV-uninfected controls. CMV-specific CD8+ T-cell responses were independently associated with higher PP (CMV-pp65; beta = 2.29, p = 0.001, CMV-gB; beta = 2.42, p = 0.001) in PLHIV. No significant differences were found with regard to individual measures of SBP and DBP. A possible weak association was found between CMV-IgG and hypertension (beta = 1.33, p = 0.049) after adjustment for age, smoking and LDL-cholesterol. HIV-related factors, IL-6, CD8+ Tcell activation or CD8+ T-cell senescence did not mediate the associations, and no associations were found between CMV-specific CD4+ T-cell responses and blood pressure in PLHIV. In conclusion, increased arterial blood pressure in PLHIV may be affected by heightened CMV-specific CD8+ T-cell responses.	[Ballegaard, Vibe; Pedersen, Karin Kaereby; Gerstoft, Jan; Nielsen, Susanne Dam] Univ Hosp Copenhagen, Rigshosp, Viroimmunol Res Unit, Dept Infect Dis, Copenhagen, Denmark; [Ballegaard, Vibe; Braendstrup, Peter; Ryder, Lars P.] Univ Hosp Copenhagen, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Braendstrup, Peter; Stryhn, Anette] Univ Copenhagen, Dept Immunol & Microbiol, Copenhagen, Denmark; [Braendstrup, Peter] Herlev Univ Hosp, Dept Hematol, Herlev, Denmark; [Kirkby, Nikolai] Univ Hosp Copenhagen, Rigshosp, Dept Med Microbiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Nielsen, SD (corresponding author), Univ Hosp Copenhagen, Rigshosp, Viroimmunol Res Unit, Dept Infect Dis, Copenhagen, Denmark.	sdn@dadlnet.dk	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Stryhn, Anette/0000-0002-4581-3553; Nielsen, Susanne Dam/0000-0001-6391-7455; Braendstrup, Peter/0000-0003-3360-7725	University of Copenhagen (Faculty of Health and Medical Sciences); Danish Council for Independent Research, Snedkermester Sophus Jakobsens Legat; AP Moller Foundation; Novo Nordisk foundation; University of Copenhagen Rigshospitalet, Research Council	University of Copenhagen (Faculty of Health and Medical Sciences); Danish Council for Independent Research, Snedkermester Sophus Jakobsens Legat; AP Moller Foundation; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); University of Copenhagen Rigshospitalet, Research Council	This work was supported by University of Copenhagen (Faculty of Health and Medical Sciences), the Danish Council for Independent Research, Snedkermester Sophus Jakobsens Legat, the AP Moller Foundation, The Novo Nordisk foundation and the University of Copenhagen Rigshospitalet, Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate D, 2013, J CLIN MICROBIOL, V51, P2501, DOI 10.1128/JCM.00563-13; Baekken M, 2008, J HYPERTENS, V26, P2126, DOI 10.1097/HJH.0b013e32830ef5fb; Bajwa M, 2016, J INFECT DIS, V214, P1430, DOI 10.1093/infdis/jiw371; Ballegaard V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21347-4; Ballegaard V, 2017, JAIDS-J ACQ IMM DEF, V74, pE104, DOI 10.1097/qai.0000000000001191; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bolovan-Fritts CA, 2008, BLOOD, V111, P175, DOI 10.1182/blood-2007-08-107730; Bolovan-Fritts CA, 2007, BLOOD, V110, P1857, DOI 10.1182/blood-2007-03-078881; Braendstrup P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094892; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; De Socio GV, 2014, AM J HYPERTENS, V27, P222, DOI 10.1093/ajh/hpt182; Delforge ML, 2015, J CLIN VIROL, V72, P42, DOI 10.1016/j.jcv.2015.09.002; Firth C, 2016, QJM-INT J MED, V109, P595, DOI 10.1093/qjmed/hcw026; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Freeman ML, 2016, CURR HIV-AIDS REP, V13, P10, DOI 10.1007/s11904-016-0297-9; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Gelpi M, 2018, CLIN INFECT DIS, V67, P579, DOI 10.1093/cid/ciy146; Gianella S, 2016, J INFECT DIS, V214, pS67, DOI 10.1093/infdis/jiw217; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Gkrania-Klotsas E, 2013, CLIN INFECT DIS, V56, P1421, DOI 10.1093/cid/cit083; Gkrania-Klotsas E, 2012, J INFECT DIS, V206, P1897, DOI 10.1093/infdis/jis620; Haarala A, 2012, CLIN EXP IMMUNOL, V167, P309, DOI 10.1111/j.1365-2249.2011.04513.x; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Jacobson MA, 2006, J CLIN VIROL, V35, P332, DOI 10.1016/j.jcv.2005.09.019; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; KANNEL WB, 1981, JAMA-J AM MED ASSOC, V245, P1225, DOI 10.1001/jama.245.12.1225; Kaplan RC, 2011, ATHEROSCLEROSIS, V217, P207, DOI 10.1016/j.atherosclerosis.2011.03.011; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Karim R, 2014, JAIDS-J ACQ IMM DEF, V67, P349, DOI 10.1097/QAI.0000000000000311; Kooij KW, 2016, JAIDS-J ACQ IMM DEF, V73, P55, DOI 10.1097/QAI.0000000000001024; Lachmann R, 2012, J VIROL, V86, P1001, DOI 10.1128/JVI.00873-11; Legarth RA, 2016, JAIDS-J ACQ IMM DEF, V71, P213, DOI 10.1097/QAI.0000000000000825; Li HF, 2014, J INFECT DIS, V210, P400, DOI 10.1093/infdis/jiu093; Li X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180217; Lichtner M, 2012, J INT AIDS SOC, V15, P21, DOI 10.7448/IAS.15.6.18197; Loeth N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031420; Maecker HT, 2004, HUM IMMUNOL, V65, P493, DOI 10.1016/j.humimm.2004.02.004; Manner IW, 2013, J CLIN HYPERTENS, V15, P101, DOI 10.1111/jch.12029; Masia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064327; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Pachnio A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005832; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Pedersen KK, 2015, JAIDS-J ACQ IMM DEF, V70, P16, DOI 10.1097/QAI.0000000000000697; Pedersen KK, 2014, JAIDS-J ACQ IMM DEF, V67, P370, DOI 10.1097/QAI.0000000000000339; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V64, P425, DOI 10.1097/QAI.0b013e31829f919d; Pedersen KK, 2013, JAIDS-J ACQ IMM DEF, V63, P272, DOI 10.1097/QAI.0b013e318289bced; Pedersen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051132; Rasmussen LD, 2015, LANCET HIV, V2, pE288, DOI 10.1016/S2352-3018(15)00077-6; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Shirwany NA, 2010, ACTA PHARMACOL SIN, V31, P1267, DOI 10.1038/aps.2010.123; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stone SF, 2005, AIDS, V19, P555, DOI 10.1097/01.aids.0000163931.68907.7e; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Terrazzini N, 2014, J INFECT DIS, V209, P1382, DOI 10.1093/infdis/jit576; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang HR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005025; WHO, 2008, WORLD HEAL ORGAN, P8, DOI DOI 10.1038/EJCN.2009.139; Youn Jong-Chan, 2018, Clin Hypertens, V24, P5, DOI 10.1186/s40885-018-0090-8; Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689; Yu HT, 2017, J AM HEART ASSOC, V6, DOI [10.1161/JAHA.117.006535, 10.1161/jaha.117.006535]	66	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226182	10.1371/journal.pone.0226182	http://dx.doi.org/10.1371/journal.pone.0226182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929537	Green Submitted, gold, Green Published			2022-12-26	WOS:000534352500008
J	Chen, CD; Li, YX; Chen, AK; Rudy, MA; Nasse, JS; Zeldich, E; Polanco, TJ; Abraham, CR				Chen, Ci-Di; Li, Yuexuan; Chen, Arthur K.; Rudy, Melissa A.; Nasse, Jason S.; Zeldich, Ella; Polanco, Taryn J.; Abraham, Carmela R.			Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; FUNCTIONAL VARIANT; GENE; HORMONE; ASSOCIATION; CHANNEL; MICE	Klotho is an age-extending, cognition-enhancing protein found to be down-regulated in aged mammals when age-related diseases start to appear. Low levels of Klotho occur in neurodegenerative diseases, kidney disease and many cancers. Many normal and pathologic processes involve the proteolytic shedding of membrane proteins. Transmembrane (TM) Klotho contains two homologous domains, KL1 and KL2 with homology to glycosidases. After shedding by ADAM 10 and 17, a shed Klotho isoform is released into serum and urine by the kidney, and into the CSF by the choroid plexus. We previously reported that human Klotho contains two major cleavage sites. However, the exact cleavage site responsible for the cleavage between the KL1 and KL2 domains remains unknown for the human Klotho, and both sites are unknown for mouse Klotho. In this study, we aimed to identify the cleavage sites leading to the shed forms of human and mouse Klotho. Mutations in the region close to the TM domain of mouse Klotho result in the reduced shedding of the 130 kD (KL1 +KL2) and 70 kD (KL1) fragments, suggesting that the cleavage site lies within the mutated region. We further identified the cleavage sites responsible for the cleavage between KL1 and KL2 of human and mouse Klotho. Moreover, mutated Klotho proteins have similar subcellular localization patterns as wild type Klotho. Finally, in an FGF23 functional assay, all Klotho mutants with a nine amino acid deletion can also function as an FGFR1 co-receptor for FGF23 signaling, however, the signaling activity was greatly reduced. The study provides new and important information on Klotho shedding, and paves the way for studies aimed to distinguish between the distinct roles of the various isoforms of Klotho.	[Chen, Ci-Di; Li, Yuexuan; Chen, Arthur K.; Rudy, Melissa A.; Nasse, Jason S.; Zeldich, Ella; Polanco, Taryn J.; Abraham, Carmela R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Abraham, Carmela R.] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University; Boston University	Abraham, CR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.; Abraham, CR (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	cabraham@bu.edu		Rudy, Melissa/0000-0003-0165-5669; Abraham, Carmela/0000-0002-6649-1960	NIH-NIA [R56 AG051638]; Affinity Research Collaborative grant from the Boston Medical Center Evans Foundation	NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Affinity Research Collaborative grant from the Boston Medical Center Evans Foundation	This study was supported in part by an NIH-NIA grant R56 AG051638 to CRA and by an Affinity Research Collaborative grant from the Boston Medical Center Evans Foundation to CRA. https://www.bumc.bu.edu/evanscenteribr/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abraham CR, 2016, VITAM HORM, V101, P215, DOI 10.1016/bs.vh.2016.02.004; Aleagha MSE, 2015, J NEUROIMMUNOL, V281, P5, DOI 10.1016/j.jneuroim.2015.02.004; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Baluchnejadmojarad T, 2017, EXP GERONTOL, V100, P70, DOI 10.1016/j.exger.2017.10.023; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Brobey RK, 2015, PLOS ONE, V10, P1; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Chen CD, 2014, BIOCHEMISTRY-US, V53, P5579, DOI 10.1021/bi500409n; Chen CD, 2013, J NEUROSCI, V33, P1927, DOI 10.1523/JNEUROSCI.2080-12.2013; Chen GZ, 2018, NATURE, V553, P461, DOI 10.1038/nature25451; Cheng MF, 2015, ACTA NEUROBIOL EXP, V75, P60; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Duce JA, 2008, GLIA, V56, P106, DOI 10.1002/glia.20593; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Krajisnik T, 2007, J ENDOCRINOL, V195, P125, DOI 10.1677/JOE-07-0267; Kuro-O M, 2012, CURR OPIN NEPHROL HY, V21, P362, DOI 10.1097/MNH.0b013e32835422ad; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2009, MOL CELL ENDOCRINOL, V299, P72, DOI 10.1016/j.mce.2008.10.052; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Masso A, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.211; Masso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143623; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Semba RD, 2014, NEUROSCI LETT, V558, P37, DOI 10.1016/j.neulet.2013.10.058; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Xin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep07645; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yokoyama JS, 2015, ANN CLIN TRANSL NEUR, V2, P215, DOI 10.1002/acn3.161; Zeldich E, 2015, J MOL NEUROSCI, V57, P185, DOI 10.1007/s12031-015-0598-2; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321	37	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226382	10.1371/journal.pone.0226382	http://dx.doi.org/10.1371/journal.pone.0226382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929539	Green Submitted, Green Published, gold			2022-12-26	WOS:000534352500011
J	Ferreira, PMA; Andrade, BO; Podgaiski, LR; Dias, AC; Pillar, VD; Overbeck, GE; Mendonca, MDS; Boldrini, II				Ferreira, Pedro M. A.; Andrade, Bianca O.; Podgaiski, Luciana R.; Dias, Amanda C.; Pillar, Valerio D.; Overbeck, Gerhard E.; Mendonca, Milton de S., Jr.; Boldrini, Ilsi I.			Long-term ecological research in southern Brazil grasslands: Effects of grazing exclusion and deferred grazing on plant and arthropod communities	PLOS ONE			English	Article							LARGE HERBIVORES; FLORISTIC COMPOSITION; TRAIT-CONVERGENCE; SPECIES RICHNESS; LATE QUATERNARY; DIVERSITY; VEGETATION; DYNAMICS; CONSERVATION; DISTURBANCE	Grazing exclusion may lead to biodiversity loss and homogenization of naturally heterogeneous and species-rich grassland ecosystems, and these effects may cascade to higher trophic levels and ecosystem properties. Although grazing exclusion has been studied elsewhere, the consequences of alleviating the disturbance regime in grassland ecosystems remain unclear. In this paper, we present results of the first five years of an experiment in native grasslands of southern Brazil. Using a randomized block experimental design, we examined the effects of three grazing treatments on plant and arthropod communities: (i) deferred grazing (i.e., intermittent grazing), (ii) grazing exclusion and (iii) a control under traditional continuous grazing, which were applied to 70 x 70 m experimental plots, in six regionally distributed blocks. We evaluated plant community responses regarding taxonomic and functional diversity (life-forms) in separate spatial components: alpha (1 x 1 m subplots), beta, and gamma (70 x 70 m plots), as well as the cascading effects on arthropod high-taxa. By estimating effect sizes (treatments vs. control) by bootstrap resampling, both deferred grazing and grazing exclusion mostly increased vegetation height, plant biomass and standing dead biomass. The effect of grazing exclusion on plant taxonomic diversity was negative. Conversely, deferred grazing increased plant taxonomic diversity, but both treatments reduced plant functional diversity. Reduced grazing pressure in both treatments promoted the break of dominance by prostrate species, followed by fast homogenization of vegetation structure towards dominance of ligneous and erect species. These changes in the plant community led to increases in high-taxa richness and abundance of vegetation-dwelling arthropod groups under both treatments, but had no detectable effects on epigeic arthropods. Our results indicate that decision-making regarding the conservation of southern Brazil grasslands should include both intensive and alleviated levels of grazing management, but not complete grazing exclusion, to maximize conservation results when considering plant and arthropod communities.	[Ferreira, Pedro M. A.] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Ecol & Evolucao Biodiversidade, Porto Alegre, RS, Brazil; [Andrade, Bianca O.; Overbeck, Gerhard E.; Boldrini, Ilsi I.] Univ Fed Rio Grande do Sul, Dept Bot, Porto Alegre, RS, Brazil; [Andrade, Bianca O.] Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil; [Podgaiski, Luciana R.; Pillar, Valerio D.; Overbeck, Gerhard E.; Mendonca, Milton de S., Jr.] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Dias, Amanda C.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; University of Nebraska System; University of Nebraska Lincoln	Ferreira, PMA (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Ecol & Evolucao Biodiversidade, Porto Alegre, RS, Brazil.	pedro.abreu@pucrs.br	Podgaiski, Luciana Regina/D-4241-2013; Andrade, Bianca Ott/M-4030-2017; Mendonça, Milton/AIE-5944-2022; Pillar, Valerio/B-9872-2008; Ferreira, Pedro/HDO-1346-2022; Ferreira, Pedro Maria Abreu/K-4323-2013; de Souza Mendonca, Milton/J-6479-2012; Overbeck, Gerhard/D-8695-2013	Podgaiski, Luciana Regina/0000-0001-8020-2312; Andrade, Bianca Ott/0000-0003-2945-1510; Pillar, Valerio/0000-0001-6408-2891; Ferreira, Pedro Maria Abreu/0000-0002-4088-4571; de Souza Mendonca, Milton/0000-0001-5272-5124; Overbeck, Gerhard/0000-0002-8716-5136	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; CNPq [558282/2009-1, 403750/2012-1, 441570/2016-0]; FAPERGS [003122-2551/12-7, 16/2551-0000102-2]; CAPES [23038.000452/2017-16]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	P.M.A.F. and B.O.A. received scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. This work is part of a long-term research (PELD) project funded to V.D.P. by CNPq (grants 558282/2009-1, 403750/2012-1, 441570/2016-0), FAPERGS (grants 003122-2551/12-7, 16/2551-0000102-2) and CAPES (23038.000452/2017-16). URL of funder website: https://www.capes.gov.br/.Funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all farm owners that kindly allowed this work to be carried out in their properties, and all local environmental authorities that allowed research in protected areas and helped us during fieldwork. We thank Fernando Quadros for suggestions on the experimental design and setting of the deferred grazing management regime, and Eduardo Velez for helping with the selection of the first experimental sites. The grazing experiment was maintained with the help of MarianaAvila, Julio Azambuja, Augusto Fernandes, Rodrigo Fagundes, and Jonathas Milano. P.M.A.F. and B.O.A. received scholarships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001. This work is part of a long-term research (PELD) project funded to V.D.P. by CNPq (grants 558282/2009-1, 403750/2012-1, 441570/2016-0), FAPERGS (grants 003122-2551/12-7, 16/2551-0000102-2) and CAPES (23038.000452/2017-16).	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Altesor A, 2005, PLANT ECOL, V179, P83, DOI 10.1007/s11258-004-5800-5; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Andrade BO, 2015, NAT CONSERVACAO, V13, P95, DOI 10.1016/j.ncon.2015.08.002; ANDRADE BO, 2016, OECOL AUST, V20, P37, DOI DOI 10.4257/oeco.2016.2002.04; [Anonymous], 1997, CAMPOS RIO GRANDE CA; [Anonymous], 2001, PLANT STRATEGIES VEG; Bakker ES, 2004, OECOLOGIA, V138, P91, DOI 10.1007/s00442-003-1402-5; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Behling H., 2008, GRASSLANDS ECOLOGY M, P99; Behling H, 2007, PHILOS T R SOC B, V362, P243, DOI 10.1098/rstb.2006.1984; Berman TS, 2018, AGR ECOSYST ENVIRON, V261, P45, DOI 10.1016/j.agee.2018.03.019; Boavista LD, 2019, APPL VEG SCI, V22, P326, DOI 10.1111/avsc.12432; Boldirini II, 1996, ACTA BOT BRASILICA S, V1100, P3750; Boldrini I. I., 2009, BIODIVERSIDADE CAMPO, P39; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; CHANETON EJ, 1991, VEGETATIO, V93, P143, DOI 10.1007/BF00033208; Chapin F.S., 1993, SCALING PHYSL PROCES, P287; Cingolani AM, 2003, J VEG SCI, V14, P223, DOI 10.1111/j.1654-1103.2003.tb02147.x; COLLINS SL, 1995, ECOLOGY, V76, P486, DOI 10.2307/1941207; Cruz P, 2010, RANGELAND ECOL MANAG, V63, P350, DOI 10.2111/08-016.1; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; de Quadros FLF, 2006, REUN ANU SOC BRAS ZO, V43; Dennis P, 2008, J APPL ECOL, V45, P279, DOI 10.1111/j.1365-2664.2007.01378.x; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Drose W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215310; Ebeling A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106529; Efron B., 1992, BREAKTHROUGHS STAT, P569, DOI DOI 10.1007/978-1-4612-4380-9_41; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Evans DM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00316.1; Farrell KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129823; Fedrigo JK, 2018, RESTOR ECOL, V26, P677, DOI 10.1111/rec.12635; Fernandez G, 2019, J VEG SCI, V30, P203, DOI 10.1111/jvs.12715; Fidelis A, 2014, FLORA, V209, P110, DOI 10.1016/j.flora.2013.12.003; Forgiarini C, 2017, FLORA, V234, P119, DOI 10.1016/j.flora.2017.07.008; Frank DA, 2005, OECOLOGIA, V143, P629, DOI 10.1007/s00442-005-0019-2; FRANK DA, 1993, OECOLOGIA, V96, P157, DOI 10.1007/BF00317727; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Guido A, 2017, PERSPECT ECOL CONSER, V15, P52, DOI 10.1016/j.pecon.2016.11.002; Hedges L. V., 1981, J ED STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Honda EA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0313; Jaurena M, 2012, CHIL J AGR RES, V72, P541, DOI 10.4067/S0718-58392012000400013; Joern A, 2013, ANNU REV ENTOMOL, V58, P19, DOI 10.1146/annurev-ento-120811-153540; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kirby KN, 2013, BEHAV RES METHODS, V45, P905, DOI 10.3758/s13428-013-0330-5; Knapp AK, 1998, GRASSLAND DYNAMICSLO; Lezama F, 2014, J VEG SCI, V25, P8, DOI 10.1111/jvs.12053; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; MacFadden BJ, 1997, TRENDS ECOL EVOL, V12, P182, DOI 10.1016/S0169-5347(97)01049-5; MacFadden BJ, 2005, QUATERNARY RES, V64, P113, DOI 10.1016/j.yqres.2005.05.003; MCINTYRE S, 1995, J ECOL, V83, P31, DOI 10.2307/2261148; McIntyre Sue, 2005, Ecological Management & Restoration, V6, P43, DOI 10.1111/j.1442-8903.2005.00218.x; McIvor JG, 2005, AUSTRAL ECOL, V30, P445, DOI 10.1111/j.1442-9993.2005.01488.x; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Meyer ST, 2019, AGR ECOSYST ENVIRON, V270, P84, DOI 10.1016/j.agee.2018.10.015; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Oesterheld M., 1999, V16, P287; Oliveira J. M., 2004, Community Ecology, V5, P197, DOI 10.1556/ComEc.5.2004.2.8; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Overbeck GE, 2015, DIVERS DISTRIB, V21, P1455, DOI 10.1111/ddi.12380; Overbeck GF, 2005, J VEG SCI, V16, P655, DOI 10.1111/j.1654-1103.2005.tb02408.x; PATTA PILLAR V. DE, 2009, CAMPOS SULINOS CONSE; Pausas JG, 2018, NEW PHYTOL, V217, P1435, DOI 10.1111/nph.14982; Picket S. T. A, 1985, ECOLOGY NATURAL DIST; Pillar V.D., 1997, COENOSES, V12, P301, DOI 10.1007/978-3-0348-8722-9_17; Pillar VD, 2009, J VEG SCI, V20, P334, DOI 10.1111/j.1654-1103.2009.05666.x; Pillar VD, 2010, NAT CONSERVACAO, V8, P84; Podani J, 1999, TAXON, V48, P331, DOI 10.2307/1224438; Podgaiski LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060207; Podgaiski LR, 2018, INSECT CONSERV DIVER, V11, P204, DOI 10.1111/icad.12269; Pucheta E., 1998, Revista de la Facultad de Agronomia (La Plata), V103, P77; Pucheta E, 1998, ACTA OECOL, V19, P97, DOI 10.1016/S1146-609X(98)80013-1; Ramula S, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2667; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Rodriguez C, 2003, J VEG SCI, V14, P433, DOI 10.1111/j.1654-1103.2003.tb02169.x; Schowalter TD, 2018, BASIC APPL ECOL, V26, P1, DOI 10.1016/j.baae.2017.09.011; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Simons NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107033; Soriano A., 1992, NATURAL GRASSLANDS I, P367; Staude IR, 2018, J APPL ECOL, V55, P1241, DOI 10.1111/1365-2664.13067; Suhs RB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206805; Susaana J.F, 2009, CAMPOS SULINOS CONSE, P331; Thomas PA, 2019, ACTA BOT BRASILICA S; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; Tothill JC, 1992, TROP AGRON TECH MEMO; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Turner MG, 2003, BIOSCIENCE, V53, P46, DOI 10.1641/0006-3568(2003)053[0046:DDAERT]2.0.CO;2; van Klink R, 2015, BIOL REV, V90, P347, DOI 10.1111/brv.12113; Veldman JW, 2015, FRONT ECOL ENVIRON, V13, P154, DOI 10.1890/140270; Vaieretti MV, 2010, AUSTRAL ECOL, V35, P935, DOI 10.1111/j.1442-9993.2009.02105.x; WILLIAMS PH, 1994, BIOL CONSERV, V67, P211, DOI 10.1016/0006-3207(94)90612-2; Zhu H, 2015, AGR ECOSYST ENVIRON, V212, P245, DOI 10.1016/j.agee.2015.07.008	99	28	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227706	10.1371/journal.pone.0227706	http://dx.doi.org/10.1371/journal.pone.0227706			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931512	Green Published, gold			2022-12-26	WOS:000534352500063
J	Sharpe, RM; Gustafson, L; Hewitt, S; Kilian, B; Crabb, J; Hendrickson, C; Jiwan, D; Andrews, P; Dhingra, A				Sharpe, Richard M.; Gustafson, Luke; Hewitt, Seanna; Kilian, Benjamin; Crabb, James; Hendrickson, Christopher; Jiwan, Derick; Andrews, Preston; Dhingra, Amit			Concomitant phytonutrient and transcriptome analysis of mature fruit and leaf tissues of tomato (Solanum lycopersicum L. cv. Oregon Spring) grown using organic and conventional fertilizer	PLOS ONE			English	Article							PHOSPHATE DEFICIENCY; CAROTENOID BIOSYNTHESIS; PROVIDES INSIGHTS; OVER-EXPRESSION; VITAMIN-C; ARABIDOPSIS; PLANT; ASCORBATE; PATHWAY; STRESS	Enhanced levels of antioxidants, phenolic compounds, carotenoids and vitamin C have been reported for several crops grown under organic fertilizer, albeit with yield penalties. As organic agricultural practices continue to grow and find favor it is critical to gain an understanding of the molecular underpinnings of the factors that limit the yields in organically farmed crops. Concomitant phytochemical and transcriptomic analysis was performed on mature fruit and leaf tissues derived from Solanum lycopersicum L. 'Oregon Spring' grown under organic and conventional fertilizer conditions to evaluate the following hypotheses. 1. Organic soil fertilizer management results in greater allocation of photosynthetically derived resources to the synthesis of secondary metabolites than to plant growth, and 2. Genes involved in changes in the accumulation of phytonutrients under organic fertilizer regime will exhibit differential expression, and that the growth under different fertilizer treatments will elicit a differential response from the tomato genome. Both these hypotheses were supported, suggesting an adjustment of the metabolic and genomic activity of the plant in response to different fertilizers. Organic fertilizer treatment showed an activation of photoinhibitory processes through differential activation of nitrogen transport and assimilation genes resulting in higher accumulation of phytonutrients. This information can be used to identify alleles for breeding crops that allow for efficient utilization of organic inputs.	[Sharpe, Richard M.; Gustafson, Luke; Hewitt, Seanna; Kilian, Benjamin; Crabb, James; Hendrickson, Christopher; Jiwan, Derick; Andrews, Preston; Dhingra, Amit] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Sharpe, Richard M.; Hewitt, Seanna; Kilian, Benjamin; Jiwan, Derick; Dhingra, Amit] Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA; [Gustafson, Luke] Univ Maryland Extens, Bel Alton, MD USA; [Kilian, Benjamin] Liberty Univ, Lynchburg, VA USA; [Hendrickson, Christopher] Natl Univ, Dept Math & Nat Sci, La Jolla, CA USA; [Jiwan, Derick] Hazel Technol, Chicago, IL USA	Washington State University; Washington State University; Liberty University	Dhingra, A (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.; Dhingra, A (corresponding author), Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA.	adhingra@wsu.edu	Dhingra, Amit/AAX-9566-2020	Dhingra, Amit/0000-0002-4464-2502; Sharpe, Richard/0000-0002-8513-4862	CSANR BIOAg grant; USDA National Institute of Food and Agriculture, Hatch project [WNP00011]; NIH/NIGMS [T32-GM008336]	CSANR BIOAg grant; USDA National Institute of Food and Agriculture, Hatch project; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by CSANR BIOAg grant to PA and AD, and by the USDA National Institute of Food and Agriculture, Hatch project WNP00011 to AD. SLH and BRK acknowledge the support of NIH/NIGMS through institutional training grant award T32-GM008336. The contents of the publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS or NIH. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amorati R, 2015, FREE RADICAL RES, V49, P633, DOI 10.3109/10715762.2014.996146; Apel W, 2009, PLANT PHYSIOL, V151, P59, DOI 10.1104/pp.109.140533; Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c; Aune JB, 2012, CONVENTIONAL ORGANIC, P149; Baranski M, 2014, BRIT J NUTR, V112, P794, DOI 10.1017/S0007114514001366; Bellieny-Rabelo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep36009; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Buchanan B., 2005, BIOCH MOL BIOL PLANT; Bulley S, 2012, PLANT BIOTECHNOL J, V10, P390, DOI 10.1111/j.1467-7652.2011.00668.x; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Caffarri S, 2014, CURR PROTEIN PEPT SC, V15, P296, DOI 10.2174/1389203715666140327102218; CHOI K, 1995, T ASAE, V38, P171, DOI 10.13031/2013.27827; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Connor DJ, 2008, FIELD CROP RES, V106, P187, DOI 10.1016/j.fcr.2007.11.010; Dangour AD, 2009, AM J CLIN NUTR, V90, P680, DOI 10.3945/ajcn.2009.28041; Desjardins Y, 2015, P INT S INNOVATION I; Esser C, 2014, MOL BIOL EVOL, V31, P1089, DOI 10.1093/molbev/msu041; Feng K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01279; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Galpaz N, 2006, PLANT CELL, V18, P1947, DOI 10.1105/tpc.105.039966; Gautier H, 2009, ANN BOT-LONDON, V103, P495, DOI 10.1093/aob/mcn233; Gilsenan C, 2012, J CULIN SCI TECHNOL, V10, P154, DOI 10.1080/15428052.2012.679232; Giorio G, 2013, METAB ENG, V20, P167, DOI 10.1016/j.ymben.2013.10.007; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Gururani MA, 2015, MOL PLANT, V8, P1304, DOI 10.1016/j.molp.2015.05.005; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hewitt S, 2017, COMPUT STRUCT BIOTEC, V15, P290, DOI 10.1016/j.csbj.2017.03.002; Hoff MLM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169366; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Hu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126012; Igamberdiev AU, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01042; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Jimenez A, 2002, PLANTA, V214, P751, DOI 10.1007/s004250100667; Kiiski H, 2000, ULLMANNS ENCY IND CH; Kravchenko AN, 2017, P NATL ACAD SCI USA, V114, P926, DOI 10.1073/pnas.1612311114; Lindahl M, 2000, PLANT CELL, V12, P419, DOI 10.1105/tpc.12.3.419; LORIMER GH, 1981, ANNU REV PLANT PHYS, V32, P349, DOI 10.1146/annurev.pp.32.060181.002025; MAGALHAES JR, 1984, J PLANT NUTR, V7, P1477, DOI 10.1080/01904168409363295; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Massot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084474; Matas AJ, 2011, PLANT CELL, V23, P3893, DOI 10.1105/tpc.111.091173; Mellidou I, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00050; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01410-w; NAGATA M, 1992, J JPN SOC FOOD SCI, V39, P925; NEUBAUER C, 1992, PLANT PHYSIOL, V99, P1354, DOI 10.1104/pp.99.4.1354; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Oliveira AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056354; Ono F, 2000, PLANT BIOLOGY, V2, P17, DOI 10.1055/s-2000-297; Peck GM, 2006, HORTSCIENCE, V41, P99, DOI 10.21273/HORTSCI.41.1.99; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; POIRIER Y, 1991, PLANT PHYSIOL, V97, P1087, DOI 10.1104/pp.97.3.1087; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Reganold JP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.221, 10.1038/nplants.2015.221]; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Remans T, 2006, PLANT PHYSIOL, V140, P909, DOI 10.1104/pp.105.075721; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Schjoerring JK, 2002, J EXP BOT, V53, P883, DOI 10.1093/jexbot/53.370.883; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; Tegeder M, 2010, MOL PLANT, V3, P997, DOI 10.1093/mp/ssq047; Tenea GN, 2012, J AGR FOOD CHEM, V60, P10970, DOI 10.1021/jf302705p; van Bueren ETL, 2011, NJAS-WAGEN J LIFE SC, V58, P193, DOI 10.1016/j.njas.2010.04.001; van Dijk JP, 2012, J AGR FOOD CHEM, V60, P2090, DOI 10.1021/jf204696w; van Dijk JP, 2009, J AGR FOOD CHEM, V57, P1612, DOI 10.1021/jf802815d; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Zhang CS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01425; Zhang SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23173; Zushi K, 2009, SCI HORTIC-AMSTERDAM, V122, P362, DOI 10.1016/j.scienta.2009.06.001	85	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227429	10.1371/journal.pone.0227429	http://dx.doi.org/10.1371/journal.pone.0227429			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931517	Green Published, gold, Green Submitted			2022-12-26	WOS:000534352500038
J	Yu, LY; Ding, K; Luo, LF; Yu, ZW				Yu, Lingyan; Ding, Kai; Luo, Lifang; Yu, Zhenwei			Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017	PLOS ONE			English	Article							BETA-ADRENERGIC ANTAGONISTS; OPEN-ANGLE GLAUCOMA; PROSTAGLANDIN; PREVALENCE; ANALOGS	Objective To evaluate the prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017. Methods A descriptive analysis using pharmacy prescription data was conducted. Outpatient prescription data was extracted from the Hospital Prescription Analysis Cooperative Project. Prescribing patterns, trends of visits, and corresponding expenditures for glaucoma medications were analyzed. Results A total of 84297 ambulatory prescriptions were included in the current study. Visits by glaucoma patients increased from 13808 in 2013 to 20060 in 2017. Over the same period, the yearly expenditure for glaucoma drugs increased from 2.33 million to 3.95 million Chinese Yuan (CNY). Among all the six classes of glaucoma drugs (prostaglandin analogues, carbonic anhydrase inhibitors, alpha-receptor agonists, beta-receptor antagonists, cholinergic agonists and fixed combinations), beta-receptor antagonists were the most commonly prescribed in 2013, accounting for 34.3% of patients, but gradually decreased to 27.1% in 2017. Prostaglandin analogues became the most frequently prescribed drugs in 2017, accounting for 30.2% of the visits. Prostaglandin analogues are the most expensive and yielded a total expenditure of 2.34 million CNY in 2017, followed by carbonic anhydrase inhibitors, alpha-receptor agonists, beta-receptor antagonists, fixed combinations, and cholinergic agonists. Combination therapy became increasingly prescribed in 2017. Conclusion Glaucoma prescribing practices exhibited substantial changes over the study period. The number of glaucoma prescriptions continuously increased from 2013 to 2017, leading to increased prescription costs. These findings implied a similar trend observed in previous studies, as well as recommendations in the appropriate guidelines.	[Yu, Lingyan; Ding, Kai; Luo, Lifang] Zhejiang Univ, Dept Pharm, Affiliated Hosp 2, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Yu, Zhenwei] Zhejiang Univ, Dept Pharm, Sir Run Run Shaw Hosp, Coll Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, ZW (corresponding author), Zhejiang Univ, Dept Pharm, Sir Run Run Shaw Hosp, Coll Med, Hangzhou, Zhejiang, Peoples R China.	yzw_srrsh@zju.edu.cn		YU, Zhenwei/0000-0002-3776-2290	Zhejiang Provincial Natural Science Foundation [LY18H310005]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work is funded by Zhejiang Provincial Natural Science Foundation (ZWY, LY18H310005,http://www.zjnsf.gov.cn).The funder plays no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland MV, 2013, ANN INTERN MED, V158, P271, DOI 10.7326/0003-4819-158-4-201302190-00008; Bucolo C, 2015, CURR PHARM DESIGN, V21, P4673, DOI 10.2174/1381612821666150909095553; Conlon R, 2017, CAN J OPHTHALMOL, V52, P114, DOI 10.1016/j.jcjo.2016.07.013; Connor AJ, 2014, EYE, V28, P863, DOI 10.1038/eye.2014.114; Fajgenbaum M, 2017, ADV THER, V34, P2033, DOI 10.1007/s12325-017-0593-9; Goldberg I, 2001, J GLAUCOMA, V10, P414, DOI 10.1097/00061198-200110000-00010; Gupta D, 2016, AM FAM PHYSICIAN, V93, P668; Han G, 2015, THER CLIN RISK MANAG, V11, P201, DOI 10.2147/TCRM.S76636; Heng JS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010429; Levkovitch-Verbin H, 2014, AM J OPHTHALMOL, V158, P402, DOI 10.1016/j.ajo.2014.04.026; Li SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096852; Liebmann Jeffrey M, 2017, Am J Manag Care, V23, pS279; Mansberger SL, 2007, ARCH OPHTHALMOL-CHIC, V125, P454, DOI 10.1001/archopht.125.4.454; Musch DC, 1999, OPHTHALMOLOGY, V106, P653, DOI 10.1016/S0161-6420(99)90147-1; National Institute for Health and Care Excellence, 2017, GLAUCOMA DIAGNOSIS M; Perry CM, 2003, DRUG AGING, V20, P597, DOI 10.2165/00002512-200320080-00005; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rotchford AP, 2020, BRIT J OPHTHALMOL, V104, P381, DOI 10.1136/bjophthalmol-2019-314206; Sakamoto M, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/7642049; Sambhara D, 2014, THER ADV CHRONIC DIS, V5, P30, DOI 10.1177/2040622313511286; Schehlein EM, 2017, CURR OPIN OPHTHALMOL, V28, P161, DOI 10.1097/ICU.0000000000000346; Song PG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020705; Song WL, 2011, OPHTHALMOLOGY, V118, P1982, DOI 10.1016/j.ophtha.2011.02.050; Tanna AP, 2010, ARCH OPHTHALMOL-CHIC, V128, P825, DOI 10.1001/archophthalmol.2010.131; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yu A, 2013, KLIN MONATSBL AUGENH, V230, P127, DOI 10.1055/s-0032-1327946; Yu LY, 2019, INT CLIN PSYCHOPHARM, V34, P312, DOI 10.1097/YIC.0000000000000278	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227595	10.1371/journal.pone.0227595	http://dx.doi.org/10.1371/journal.pone.0227595			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929565	Green Published, gold			2022-12-26	WOS:000534352500048
J	Anderson, JG; Kol, A; Bizikova, P; Stapelton, BP; Ford, K; Villarreal, A; Jimenez, RJ; Vasilatis, D; Murphy, BG				Anderson, J. G.; Kol, A.; Bizikova, P.; Stapelton, B. P.; Ford, K.; Villarreal, A.; Jimenez, R. J.; Vasilatis, D.; Murphy, B. G.			Immunopathogenesis of canine chronic ulcerative stomatitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; ORAL LICHEN-PLANUS; PERIODONTAL-DISEASE; TH17 CELLS; EXPRESSION; DOGS; PREVALENCE; CYTOKINE; ADULTS	Canine Chronic Ulcerative Stomatitis is a spontaneously occurring inflammatory disease of the oral mucosa. An immune-mediated pathogenesis is suspected though not yet proven. We have recently reported on the clinical and histologic features, and identification of select leukocyte cell populations within the lesion. A clinical and histologic similarity to oral lichen planus of people was proposed. In the present study, these initial observations are extended by examining lesions from 24 dogs with clinical evidence of chronic ulcerative stomatitis. Because dogs with chronic ulcerative stomatitis often have concurrent periodontal disease, we wondered if dental plaque/biofilm may be a common instigator of inflammation in both lesions. We hypothesized that dogs with chronic ulcerative stomatitis would exhibit a spectrum of pathologic changes and phenotype of infiltrating leukocytes that would inform lesion pathogenesis and that these changes would differ from inflammatory phenotypes in periodontitis. Previously we identified chronic ulcerative stomatitis lesions to be rich in FoxP3+ and IL17+ cells. As such, we suspect that these leukocytes play an important role in lesion pathogenesis. The current study confirms the presence of moderate to large numbers of FoxP3+ T cells and IL17+ cells in all ulcerative stomatitis lesions using confocal immunofluorescence. Interestingly, the majority of IL17+ cells were determined to be non-T cells and IL17+ cell frequencies were negatively correlated with severity on the clinical scoring system. Three histologic subtypes of ulcerative stomatitis were determined; lichenoid, deep stomatitis and granulomatous. Periodontitis lesions, like stomatitis lesions, were B cell and plasma cell rich, but otherwise differed from the stomatitis lesions. Direct immunofluorescence results did not support an autoantibody-mediated autoimmune disease process. This investigation contributes to the body of literature regarding leukocyte involvement in canine idiopathic inflammatory disease pathogenesis.	[Anderson, J. G.] Sacramento Vet Dent Serv, Rancho Cordova, CA 95670 USA; [Kol, A.; Villarreal, A.; Jimenez, R. J.; Vasilatis, D.; Murphy, B. G.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bizikova, P.] NC State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Stapelton, B. P.; Ford, K.] Barrington Anim Hosp, Barrington, IL USA	University of California System; University of California Davis; University of North Carolina; North Carolina State University	Anderson, JG (corresponding author), Sacramento Vet Dent Serv, Rancho Cordova, CA 95670 USA.	jgadvm@gmail.com		Kol, Amir/0000-0003-2324-6962; Anderson, Jamie/0000-0002-6065-2516	Waltham Foundation [TC 03102016]	Waltham Foundation	This study was supported by grant number The Waltham Foundation, TC 03102016, The Waltham Foundation - https://www.waltham.com/grants-awards/, to JGA, BGM, AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2015, J IMMUNOL, V195, P1427, DOI 10.4049/jimmunol.1500496; Abusleme L, 2017, ORAL DIS, V23, P854, DOI 10.1111/odi.12598; Akitsu A, 2018, IMMUNOLOGY, V155, P418, DOI 10.1111/imm.12993; Anderson JG, 2017, VET PATHOL, V54, P511, DOI 10.1177/0300985816688754; Bellows J, 2019, AAHA DENT CARE GUIDL; Biller BJ, 2007, VET IMMUNOL IMMUNOP, V116, P69, DOI 10.1016/j.vetimm.2006.12.002; Buajeeb W, 2015, J CLIN DIAGN RES, V9, pZC34, DOI 10.7860/JCDR/2015/13510.6312; Chellappa S, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1102828; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dutzan N, 2016, MUCOSAL IMMUNOL, V9, P1163, DOI 10.1038/mi.2015.136; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2016, PERIODONTOL 2000, V72, P76, DOI 10.1111/prd.12145; Firth FA, 2015, ARCH DERMATOL RES, V307, P333, DOI 10.1007/s00403-015-1540-8; Gaffen SL, 2008, J DENT RES, V87, P817, DOI 10.1177/154405910808700908; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2013, TRENDS IMMUNOL, V34, P1, DOI 10.1016/j.it.2012.08.003; Harvey CE, 2005, VET CLIN N AM-SMALL, V35, P819, DOI 10.1016/j.cvsm.2005.03.002; Javvadi LR, 2016, PATHOLOGY, V48, P564, DOI 10.1016/j.pathol.2016.06.002; Jubala CM, 2005, VET PATHOL, V42, P468, DOI 10.1354/vp.42-4-468; Junginger J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-23; Kato Y, 2013, J COMP PATHOL, V148, P188, DOI 10.1016/j.jcpa.2012.06.009; Keller SM, 2013, VET PATHOL, V50, P281, DOI 10.1177/0300985812451625; Kol A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148568; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lei L, 2014, MOL MED REP, V9, P928, DOI 10.3892/mmr.2014.1919; Lionakis MS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019638; Maeda S, 2016, VET PATHOL, V53, P102, DOI 10.1177/0300985815591081; Mailer RKW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00530; MOORE PF, 1992, TISSUE ANTIGENS, V40, P75, DOI 10.1111/j.1399-0039.1992.tb01963.x; Moutsopoulos NM, 2017, NEW ENGL J MED, V376, P1141, DOI 10.1056/NEJMoa1612197; Moutsopoulos NM, 2012, J AUTOIMMUN, V39, P294, DOI 10.1016/j.jaut.2012.03.003; Noland EL, 2018, VET PATHOL, V55, P802, DOI 10.1177/0300985818789474; Ohlrich EJ, 2009, AUST DENT J, V54, pS2, DOI 10.1111/j.1834-7819.2009.01139.x; Papotto PH, 2018, J AUTOIMMUN, V87, P26, DOI 10.1016/j.jaut.2017.11.006; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; Ramirez-Velazquez C, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-23; Ramos-Vara JA, 2007, VET PATHOL, V44, P875, DOI 10.1354/vp.44-6-875; Stilwell JM, 2018, VET PATHOL, V55, P517, DOI 10.1177/0300985818759770; Sueiro FAR, 2004, J COMP PATHOL, V131, P207, DOI 10.1016/j.jcpa.2004.04.002; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Wagner A, 2018, VET IMMUNOL IMMUNOP, V197, P49, DOI 10.1016/j.vetimm.2018.01.011; Zenobia C, 2015, PERIODONTOL 2000, V69, P142, DOI 10.1111/prd.12083; Zhou LL, 2016, INFLAMMATION, V39, P1205, DOI 10.1007/s10753-016-0356-9	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227386	10.1371/journal.pone.0227386	http://dx.doi.org/10.1371/journal.pone.0227386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923271	Green Published, gold			2022-12-26	WOS:000534350000073
J	Chien, KH; Huang, KH; Chung, CH; Hsieh, YH; Liang, CM; Chang, YH; Weng, TH; Chien, WC				Chien, Ke-Hung; Huang, Ke-Hao; Chung, Chi-Hsiang; Hsieh, Yun-Hsiu; Liang, Chang-Min; Chang, Yu-Hua; Weng, Tzu-Heng; Chien, Wu-Chien			The impact of diabetes mellitus medication on the incidence of endogenous endophthalmitis	PLOS ONE			English	Article							BACTERIAL ENDOPHTHALMITIS; KLEBSIELLA-PNEUMONIAE; CLINICAL-FEATURES; RISK-FACTORS; EXPERIENCE; ABSCESS	Purpose This study aimed to evaluate the relationship between diabetic mellitus (DM) treatment and the incidence rate of endogenous endophthalmitis (EE). Design This study used a matched cohort design. We utilized the Longitudinal Health Insurance Database to identify outpatients and inpatients who were diagnosed with DM and treated with medication from 2000 to 2010. Methods Several factors and different DM medications were also investigated. The influence of DM medication on the incidence of EE was examined by using Cox proportional hazards regression models, and the hazard ratios and 95% confidence intervals were determined. Results The cumulative incidence of EE was lower in DM patients treated with medication than in subjects in the control group (P = 0.002). The adjusted hazard ratio (AHR) was 0.47-fold lower in the treatment group than in the control group (P = 0.004). With respect to DM medication, single-agent therapy with insulin, metformin, gliclazide, glimepiride, or repaglinide and combination therapy with glimepiride/metformin or repaglinide/metformin were associated with decreased AHRs (0.257-0.544, all P<0.05). Conclusions Diabetic patients treated with medication had lower AHRs than those in the control group. Further stratification indicated that liver abscess, liver disease DM patients who were treated with medication had a lower risk of developing EE. Several specific DM medications may decrease the incidence of EE.	[Chien, Ke-Hung; Huang, Ke-Hao; Hsieh, Yun-Hsiu; Liang, Chang-Min; Weng, Tzu-Heng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chien, Ke-Hung] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan; [Huang, Ke-Hao] Natl Def Med Ctr, Triserv Gen Hosp, Songshan Branch, Dept Ophthalmol, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc TI, Taipei, Taiwan; [Chang, Yu-Hua] Natl Def Med Ctr, Triserv Gen Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Weng, TH (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	aheng7435@gmail.com; chienwu@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021		Tri-Service General Hospital Research Foundation [TSGHC107-004, TSGH-C107-090]; Ministry of National Defense Medical Affairs Bureau [MAB-108-049]	Tri-Service General Hospital Research Foundation; Ministry of National Defense Medical Affairs Bureau	This study was supported by grants from the Tri-Service General Hospital Research Foundation (TSGHC107-004 and TSGH-C107-090) and the Ministry of National Defense Medical Affairs Bureau (MAB-108-049). The sponsors had no roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Arevalo J Fernando, 2010, Int Ophthalmol Clin, V50, P173, DOI 10.1097/IIO.0b013e3181d26dfc; Binder MI, 2003, MEDICINE, V82, P97, DOI 10.1097/00005792-200303000-00004; Cecilia OM, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/8562408; Coburn PS, 2012, INVEST OPHTH VIS SCI, V53, P7426, DOI 10.1167/iovs.12-10661; Doft Bernard H, 2002, Curr Opin Ophthalmol, V13, P147, DOI 10.1097/00055735-200206000-00003; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; El-Mollayess Georges M, 2012, ISRN Ophthalmol, V2012, P456209, DOI 10.5402/2012/456209; FRANK RN, 1985, ARCH OPHTHALMOL-CHIC, V103, P1303; FRIEND J, 1982, OPHTHALMIC RES, V14, P269, DOI 10.1159/000265202; Gupta Amit, 2003, Indian Journal of Ophthalmology, V51, P139; HAN SHB, 1995, WESTERN J MED, V162, P220; Jackson TL, 2014, SURV OPHTHALMOL, V59, P627, DOI 10.1016/j.survophthal.2014.06.002; Jackson TL, 2003, SURV OPHTHALMOL, V48, P403, DOI 10.1016/S0039-6257(03)00054-7; KATTAN HM, 1991, OPHTHALMOLOGY, V98, P227; Keswani Tulsi, 2006, Indian J Med Sci, V60, P454; Leibovitch I, 2005, SCAND J INFECT DIS, V37, P184, DOI 10.1080/00365540410020965; Madu A A, 1995, Curr Opin Ophthalmol, V6, P88, DOI 10.1097/00055735-199512000-00015; MAY DR, 1976, AM J OPHTHALMOL, V81, P520, DOI 10.1016/0002-9394(76)90314-7; MICHELSON JB, 1987, INT OPHTHALMOL CLIN, V27, P120, DOI 10.1097/00004397-198702720-00009; MOWAT AG, 1971, NEW ENGL J MED, V284, P621, DOI 10.1056/NEJM197103252841201; OKADA AA, 1994, OPHTHALMOLOGY, V101, P832; SAINI JS, 1995, CAN J OPHTHALMOL, V30, P142; Schiedler V, 2004, AM J OPHTHALMOL, V137, P725, DOI 10.1016/j.ajo.2003.11.013; Sheu Shwu Jiuan, 2017, Korean J Ophthalmol, V31, P283, DOI 10.3341/kjo.2017.0036; Sheu SJ, 2011, RETINA-J RET VIT DIS, V31, P2026, DOI 10.1097/IAE.0b013e31820d3f9e; Vaziri K, 2015, AM J OPHTHALMOL, V159, P498, DOI 10.1016/j.ajo.2014.11.032; Weishaar PD, 1998, OPHTHALMOLOGY, V105, P57, DOI 10.1016/S0161-6420(98)71225-3; Weng TH, 2018, INVEST OPHTH VIS SCI, V59, P2487, DOI 10.1167/iovs.18-23783; Wong JS, 2000, OPHTHALMOLOGY, V107, P1483, DOI 10.1016/S0161-6420(00)00216-5; Xu HZ, 2011, INVEST OPHTH VIS SCI, V52, P2160, DOI 10.1167/iovs.10-6518; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu KP, 2011, INVEST OPHTH VIS SCI, V52, P3301, DOI 10.1167/iovs.10-5670; Zhang CH, 2014, DISCOV MED, V18, P105; Zhang H, 2010, OCUL IMMUNOL INFLAMM, V18, P133, DOI 10.3109/09273940903494717	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227442	10.1371/journal.pone.0227442	http://dx.doi.org/10.1371/journal.pone.0227442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923190	gold, Green Published			2022-12-26	WOS:000534350000078
J	Kwak, YH; Kwak, DK; Kim, NY; Kim, YJ; Lim, JS; Yoo, JH				Kwak, Yoon Hae; Kwak, Dae-Kyung; Kim, Nan Young; Kim, Yun Joong; Lim, Jeong Seop; Yoo, Je-Hyun			Significant changes in synovial fluid microRNAs after high tibial osteotomy in medial compartmental knee osteoarthritis: Identification of potential prognostic biomarkers	PLOS ONE			English	Article							CARTILAGE REGENERATION; CANCER; DYSREGULATION; EXPRESSION	High tibial osteotomy (HTO) is a well-established treatment for medial compartmental knee osteoarthritis. Several microRNAs (miRNAs) are involved in osteoarthritis progression and are useful as osteoarthritis-related biomarkers. In this prospective study, we investigated differentially expressed microRNAs in the synovial fluid (SF) before and after HTO in patients with medial compartmental knee osteoarthritis to identify microRNAs that can be used as prognostic biomarkers. We used miRNA-PCR arrays to screen for miRNAs in SF samples obtained preoperatively and 6 months postoperatively from 6 patients with medial compartmental knee osteoarthritis who were treated with medial open wedge HTO. Differentially expressed miRNAs identified in the profiling stage were validated by real-time quantitative PCR in 22 other patients who had also been treated with HTO. All patients radiographically corresponded to Kellgren-Lawrence grade II or III with medial compartmental osteoarthritis. These patients were clinically assessed using a visual analogue scale and Western Ontario McMaster Universities scores. Mechanical axis changes were measured on standing anteroposterior radiographs of the lower limbs assessed preoperatively and at 6 months postoperatively. Among 84 miRNAs known to be involved in the inflammatory process, 14 were expressed in all SF specimens and 3 (miR-30a-5p, miR-29a-3p, and miR-30c-5p) were differentially expressed in the profiling stage. These 3 miRNAs, as well as 4 other miRNAs (miR-378a-5p, miR-140-3p, miR-23a-3p, miR-27b-3p), are related to osteoarthritis progression. These results were validated in the SF from 22 patients. Clinical and radiological outcomes improved after HTO in all patients, and only 2 miRNAs (miR-30c-5p and miR-23a3p) were significantly differentially expressed between preoperative and postoperative 6-month SF samples (p = 0.006 and 0.007, respectively). Of these two miRNAs, miR-30c-5p correlated with postoperative pain relief. This study provides potential prognostic miRNAs after HTO and further investigations should be considered to determine clinical implications of these miRNAs.	[Kwak, Yoon Hae] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kwak, Dae-Kyung; Lim, Jeong Seop; Yoo, Je-Hyun] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Orthopaed Surg, Anyang, South Korea; [Kim, Nan Young; Kim, Yun Joong] Hallym Univ, Med Ctr, Hallym Inst Translat Genom & Bioinformat, Anyang, South Korea; [Kim, Yun Joong] Hallym Univ, Ilsong Inst Life Sci, Anyang, South Korea; [Kim, Yun Joong] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Neurol, Anyang, South Korea	Yonsei University; Yonsei University Health System; Hallym University; Hallym University; Hallym University; Hallym University	Yoo, JH (corresponding author), Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Orthopaed Surg, Anyang, South Korea.	oships@hallym.ac.kr	; Kim, Yun Joong/E-7117-2015	Kwak, Yoon Hae/0000-0002-0596-1228; Kim, Yun Joong/0000-0002-2956-1552	National Research Foundation of Korea [NRF2015R1D1A1A01060157]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a Grant from National Research Foundation of Korea (NRF2015R1D1A1A01060157; https://ernd.nrf.re.kr).	Beyer C, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204698; Bignotti E, 2016, J CELL MOL MED, V20, P2341, DOI 10.1111/jcmm.12927; Birmingham TB, 2017, OSTEOARTHR CARTILAGE, V25, P1999, DOI 10.1016/j.joca.2017.08.017; Cao JM, 2017, BIOMED PHARMACOTHER, V93, P554, DOI 10.1016/j.biopha.2017.06.084; Caserta S, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01977; Caserta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28006; Ceolotto G, 2017, CARDIOVASC RES, V113, P1627, DOI 10.1093/cvr/cvx157; Cong L, 2017, OSTEOARTHR CARTILAGE, V25, P1362, DOI 10.1016/j.joca.2017.03.012; Dong J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13104-w; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fredsoe J., 2017, EUR UROL FOCUS, V4569, P30066; Huang JX, 2014, MOD RHEUMATOL, V24, P331, DOI 10.3109/14397595.2013.854077; Jung WH, 2014, ARTHROSCOPY, V30, P72, DOI 10.1016/j.arthro.2013.10.008; Jung WH, 2013, ARTHROSCOPY, V29, P1063, DOI 10.1016/j.arthro.2013.02.020; Kanamiya T, 2002, ARTHROSCOPY, V18, P725, DOI 10.1053/jars.2002.35258; Kersten P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099485; Kung LHW, 2018, ARTHRITIS RHEUMATOL, V70, P383, DOI 10.1002/art.40378; Le LTT, 2016, J MOL MED, V94, P583, DOI 10.1007/s00109-015-1374-z; Li YH, 2016, OSTEOARTHR CARTILAGE, V24, P1577, DOI 10.1016/j.joca.2016.04.019; Liu YC, 2017, DIGEST DIS SCI, V62, P3040, DOI 10.1007/s10620-017-4763-z; Lv Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504208; Lyng MB, 2016, MOL ONCOL, V10, P1621, DOI 10.1016/j.molonc.2016.10.004; Maciejak A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28118-1; MORELAND JR, 1987, J BONE JOINT SURG AM, V69A, P745, DOI 10.2106/00004623-198769050-00016; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Niemeyer P, 2010, ARTHROSCOPY, V26, P1607, DOI 10.1016/j.arthro.2010.05.006; Nugent M, 2016, OSTEOARTHR CARTILAGE, V24, P573, DOI 10.1016/j.joca.2015.10.018; Prajzlerova K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185323; Prodromos Chadwick C, 2015, Instr Course Lect, V64, P555; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Ruangsomboon P, 2017, INT ORTHOP, V41, P2045, DOI 10.1007/s00264-017-3517-z; Shen P F, 2017, Zhonghua Yi Xue Za Zhi, V97, P3079, DOI 10.3760/cma.j.issn.0376-2491.2017.39.008; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Song J, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-31; Spahn G, 2013, KNEE SURG SPORT TR A, V21, P1553, DOI 10.1007/s00167-012-2169-1; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Vilahur G, 2017, CARDIOVASC RES, V113, P1536, DOI 10.1093/cvr/cvx194; Yang RJ, 2018, MED SCI MONITOR, V24, P863, DOI 10.12659/MSM.908110; Yin CM, 2017, BONE JOINT RES, V6, P612, DOI 10.1302/2046-3758.611.BJR-2017-0090.R1; Zhang M., 2017, J ARTHRITIS, V6; Zhu JJ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0591-1	41	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227596	10.1371/journal.pone.0227596	http://dx.doi.org/10.1371/journal.pone.0227596			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923920	Green Published, gold			2022-12-26	WOS:000534350000098
J	Moore-Jones, G; Arduser, F; Durr, S; Brawand, SG; Steiner, A; Zanolari, P; Ryser-Degiorgis, MP				Moore-Jones, Gaia; Ardueser, Flurin; Duerr, Salome; Brawand, Stefanie Gobeli; Steiner, Adrian; Zanolari, Patrik; Ryser-Degiorgis, Marie-Pierre			Identifying maintenance hosts for infection with Dichelobacter nodosus in free-ranging wild ruminants in Switzerland: A prevalence study	PLOS ONE			English	Article							ELK CERVUS-ELAPHUS; DIGITAL DERMATITIS; FOOT ROT; FUSOBACTERIUM-NECROPHORUM; ACTIVITY PATTERNS; ALPINE IBEX; SHEEP; WASHINGTON; MUSIMON; CATTLE	Footrot is a worldwide economically important, painful, contagious bacterial foot disease of domestic and wild ungulates caused by Dichelobacter nodosus. Benign and virulent strains have been identified in sheep presenting with mild and severe lesions, respectively. However, in Alpine ibex (Capra ibex ibex), both strains have been associated with severe lesions. Because the disease is widespread throughout sheep flocks in Switzerland, a nationwide footrot control program for sheep focusing on virulent strains shall soon be implemented. The aim of this cross-sectional study was to estimate the nationwide prevalence of both strain groups of D. nodosus in four wild indigenous ruminant species and to identify potential susceptible wildlife maintenance hosts that could be a reinfection source for domestic sheep. During two years (2017-2018), interdigital swabs of 1,821 wild indigenous ruminant species (Alpine ibex, Alpine chamois (Rupicapra rupicapra), roe deer (Capreolus capreolus), red deer (Cervus elaphus)) were analysed by Real-Time PCR. Furthermore, observed interspecies interactions were documented for each sample. Overall, we report a low prevalence of D. nodosus in all four indigenous wild ruminants, for both benign (1.97%, N = 36, of which 31 red deer) and virulent (0.05%, N = 1 ibex) strains. Footrot lesions were documented in one ibex with virulent strains, and in one ibex with benign strains. Interspecific interactions involving domestic livestock occurred mainly with cattle and sheep. In conclusion, the data suggest that wild ungulates are likely irrelevant for the maintenance and spread of D. nodosus. Furthermore, we add evidence that both D. nodosus strain types can be associated with severe disease in Alpine ibex. These data are crucial for the upcoming nationwide control program and reveal that wild ruminants should not be considered as a threat to footrot control in sheep in this context.	[Moore-Jones, Gaia; Ryser-Degiorgis, Marie-Pierre] Univ Bern, Ctr Fish & Wildlife Hlth, Vetsuisse Fac, Bern, Switzerland; [Ardueser, Flurin; Steiner, Adrian; Zanolari, Patrik] Univ Bern, Clin Ruminants, Vetsuisse Fac, Bern, Switzerland; [Duerr, Salome] Univ Bern, Vet Publ Hlth Inst, Vetsuisse Fac, Liebefeld, Switzerland; [Brawand, Stefanie Gobeli] Univ Bern, Inst Vet Bacteriol, Vetsuisse Fac, Bern, Switzerland; [Brawand, Stefanie Gobeli] Fed Food Safety & Vet Off FSVO, Bern, Switzerland	University of Bern; University of Bern; University of Bern; University of Bern	Ryser-Degiorgis, MP (corresponding author), Univ Bern, Ctr Fish & Wildlife Hlth, Vetsuisse Fac, Bern, Switzerland.	marie-pierre.ryser@vetsuisse.unibe.ch	Dürr, Salome/AAS-9109-2020; Steiner, Adrian/AAD-6814-2022; Durr, Salome/C-1343-2014	Steiner, Adrian/0000-0003-2415-3768; Durr, Salome/0000-0002-7321-5980	Swiss Federal Food Safety and Veterinary Office; canton of Fribourg [1.17.05]; canton of Grisons [1.17.05]; canton of Ticino [1.17.05]; canton of Schwyz [1.17.05]; canton of Nidwalden [1.17.05]	Swiss Federal Food Safety and Veterinary Office; canton of Fribourg; canton of Grisons; canton of Ticino; canton of Schwyz; canton of Nidwalden	This study was financially supported by a grant of the Swiss Federal Food Safety and Veterinary Office (www.blv.admin.ch) together with the hunting authorities of the cantons of Fribourg, Grisons, Ticino, Schwyz and Nidwalden to MPRD and PZ (principal investigators), SD, SG, AS (grant Nr. 1.17.05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Andersen R., 1998, EUROPEAN ROE DEER BI; [Anonymous], 2016, JUBB KENNEDY PALMERS, V1; Arduser F, 2020, PREV VET MED, V178, DOI 10.1016/j.prevetmed.2019.05.001; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Baumann M, 2012, JAGEN SCHWEIZ WEG JA; Belloy L, 2007, J WILDLIFE DIS, V43, P82, DOI 10.7589/0090-3558-43.1.82; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; CEDERLUND G, 1989, HOLARCTIC ECOL, V12, P39; Clegg SR, 2015, J CLIN MICROBIOL, V53, P88, DOI 10.1128/JCM.02276-14; Deletraz C., 2002, THESIS; EGERTON JR, 1971, J COMP PATHOL, V81, P179, DOI 10.1016/0021-9975(71)90091-0; Frosth S, 2015, VET MICROBIOL, V179, P82, DOI 10.1016/j.vetmic.2015.02.034; Gelormini G, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0972-0; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; Godfroid J., 2018, VET SCI, V5; Gortazar C, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2014.00027; Greber D, 2018, J VET DIAGN INVEST, V30, P205, DOI 10.1177/1040638717733508; Green LE, 2008, VET J, V175, P173, DOI 10.1016/j.tvjl.2007.01.014; Han S, 2019, VET PATHOL, V56, P118, DOI 10.1177/0300985818798108; Han SS, 2014, J WILDLIFE DIS, V50, P259, DOI 10.7589/2013-07-163; Handeland K, 2010, J COMP PATHOL, V143, P29, DOI 10.1016/j.jcpa.2009.12.018; Kennan RM, 2011, VET MICROBIOL, V153, P59, DOI 10.1016/j.vetmic.2011.04.005; Klitgaard K, 2008, J CLIN MICROBIOL, V46, P3012, DOI 10.1128/JCM.00670-08; Knappe-Poindecker M, 2014, VET MICROBIOL, V170, P375, DOI 10.1016/j.vetmic.2014.02.044; Locher I, 2015, SMALL RUMINANT RES, V132, P128, DOI 10.1016/j.smallrumres.2015.10.021; Martin C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-70; Meile P, 2003, STEINBOCK BIOL JAGD; Nielsen MW, 2016, VET MICROBIOL, V186, P139, DOI 10.1016/j.vetmic.2016.03.003; Niggeler A, 2017, ANIM GENET, V48, P712, DOI 10.1111/age.12614; Olsen SC, 2011, CLIN VACCINE IMMUNOL, V18, P2075, DOI 10.1128/CVI.05383-11; Reimoser F, 2015, ROTHIRSCH RATIKON DR; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Rogdo T, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-19; Ryser-Degiorgis M-P, 2002, HYSTRIX INT J MAMM, V13; Ryser-Degiorgis MP, 2009, VET MICROBIOL, V134, P368, DOI 10.1016/j.vetmic.2008.08.005; Sonnenburg J, 2017, BMC VET RES, V13, DOI 10.1186/s12917-016-0935-x; Stauble A, 2014, VET MICROBIOL, V168, P177, DOI 10.1016/j.vetmic.2013.11.013; Stewart D., 1993, OVINE FOOTROT CLIN D; Volmer K, 2008, EUR J WILDLIFE RES, V54, P657, DOI 10.1007/s10344-008-0192-9; Wimmershoff J, 2015, SCHWEIZ ARCH TIERH, V157, P277, DOI 10.17236/sat00021; Witcomb LA, 2014, PREV VET MED, V115, P48, DOI 10.1016/j.prevetmed.2014.03.004; Zingg D, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00070; Zuba Jeffery R., 2012, P619	44	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0219805	10.1371/journal.pone.0219805	http://dx.doi.org/10.1371/journal.pone.0219805			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917824	gold, Green Submitted, Green Published			2022-12-26	WOS:000534341100003
J	Nagel, A; Dimitrakopoulou, E; Teig, N; Kern, P; Lucke, T; Michna, D; Korn, K; Steininger, P; Shahada, K; Neumann, K; Ueberla, K				Nagel, Angela; Dimitrakopoulou, Emmanouela; Teig, Norbert; Kern, Peter; Luecke, Thomas; Michna, Dariusz; Korn, Klaus; Steininger, Philipp; Shahada, Khalid; Neumann, Katrin; Ueberla, Klaus			Characterization of a universal screening approach for congenital CMV infection based on a highly-sensitive, quantitative, multiplex real-time PCR assay	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CYTOMEGALOVIRUS-INFECTION; SALIVA; URINE; DNA	The majority of congenital cytomegalovirus (cCMV) infections are asymptomatic at birth and therefore not diagnosed. Approximately 10-15% of these infants develop late-onset hearing loss and other developmental disorders. Implementation of a universal screening approach at birth may allow early initiation of symptomatic interventions due to a closer follow-up of infants at risk and offers the opportunity to consider treatment of late-onset disease. Realtime PCR assays for the detection of CMV DNA in buccal swab samples demonstrated feasibility and good clinical sensitivity in comparison to a rapid culture screening assay. Because most cCMV infections remain asymptomatic, a universal screening assay that stratifies CMV infected infants according to low and high risk of late-onset cCMV disease could limit the parental anxiety and reduce follow-up costs. We therefore developed and characterized a screening algorithm based on a highly-sensitive quantitative real-time PCR assay that is compatible with centralized testing of samples from universal screening and allows to determine CMV DNA load of saliva samples either as International Units (IU)/ml saliva or IU/10(5) cell equivalents. 18 of 34 saliva samples of newborns that tested positively by the screening algorithm were confirmed by detection of CMV DNA in blood and/or urine samples obtained during the first weeks of life. All screening samples that could not be confirmed had viral loads of < 2.3x10(5) IU/ml saliva (median: 6.8x10(3)) or 1.3x10(5) IU/10(5) cell equivalents (median: 4.0x10(2)). The viral load of screening samples with confirmed cCMV infection ranged from 7.5x10(2) to 8.2x10(9) IU/ml saliva (median: 9.3x10(7)) or 1.5x10(2) to 5.6x10(10) IU/10(5) cell equivalents (median: 3.5x10(6)). Clinical follow-up of these newborns with confirmed cCMV infection should reveal whether the risk of late-onset cCMV disease correlates with CMV DNA load in early life saliva samples and whether a cut-off can be defined identifying cCMV infected infants with or without risk for late-onset cCMV disease.	[Nagel, Angela; Korn, Klaus; Steininger, Philipp; Ueberla, Klaus] Univ Hosp Erlangen, Inst Clin & Mol Virol, Erlangen, Germany; [Dimitrakopoulou, Emmanouela; Neumann, Katrin] Ruhr Univ Bochum, St Elisabeth Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Phoniatr & Pediat Audiol, Bochum, Germany; [Teig, Norbert; Luecke, Thomas] Ruhr Univ Bochum, St Josef Hosp, Dept Pediat, Bochum, Germany; [Kern, Peter] Ruhr Univ Bochum, St Elisabeth Hosp, Dept Gynecol, Bochum, Germany; [Michna, Dariusz] Elisabeth Hosp Essen, Dept Pediat, Essen, Germany; [Shahada, Khalid] Hamad Med Corp, Audiol & Balance Ctr, Doha, Qatar	University of Erlangen Nuremberg; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Hamad Medical Corporation	Nagel, A (corresponding author), Univ Hosp Erlangen, Inst Clin & Mol Virol, Erlangen, Germany.	angela.nagel@uk-erlangen.de	Kern, Peter/AAX-7899-2020		National Priorities Research Program of the Qatar National Research Fund (QNRF) [NPRP 7-1845-3-480]	National Priorities Research Program of the Qatar National Research Fund (QNRF)	Financial support for the study was provided by the National Priorities Research Program (https://www.qnrf.org/en-us/Funding/Research-Programs/National-Priorities-Research Program-NPRP) of the Qatar National Research Fund (QNRF) with grant number NPRP 7-1845-3-480 to KN, KU and KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; Barkai G, 2014, J CLIN VIROL, V60, P361, DOI 10.1016/j.jcv.2014.04.024; Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561; Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423; Cannas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006985; Cannon MJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0569-1; Cannon MJ, 2014, REV MED VIROL, V24, P291, DOI 10.1002/rmv.1790; Cannon MJ, 2011, REV MED VIROL, V21, P240, DOI 10.1002/rmv.695; Carvalho-Queiroz C, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00093; Cardoso ESD, 2015, REV SOC BRAS MED TRO, V48, P206, DOI 10.1590/0037-8682-0200-2014; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Eventov-Friedman S, 2019, J INFECT DIS; Exler S, 2019, J CLIN VIROL, V117, P33, DOI 10.1016/j.jcv.2019.05.015; Fernandez-Soto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061703; Fowler KB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2128; Gantt S, 2017, J VIROL, V91; Gantt S, 2016, JAMA PEDIATR, V170, P1173, DOI 10.1001/jamapediatrics.2016.2016; Kadambari S, 2015, EUR J PEDIATR, V174, P1117, DOI 10.1007/s00431-015-2506-8; Kohmer N, 2019, J CLIN VIROL, V115, P32, DOI 10.1016/j.jcv.2019.03.017; Korn K, 2012, INFECTION, V40, P181, DOI 10.1007/s15010-012-0249-2; Koyano S, 2013, ARCH DIS CHILD-FETAL, V98, pF182, DOI 10.1136/archdischild-2012-302230; Leruez-Ville M, 2017, CLIN INFECT DIS, V65, P398, DOI 10.1093/cid/cix337; Marsico C, 2019, J INFECT DIS, V219, P1398, DOI 10.1093/infdis/jiy695; Marsico C, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0358-8; Pinninti SG, 2015, PEDIATR INFECT DIS J, V34, P536, DOI 10.1097/INF.0000000000000609; Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3; Retzler J, 2018, ARCH DIS CHILD; Ronchi A, 2017, EXPERT REV ANTI-INFE, V15, P417, DOI 10.1080/14787210.2017.1303377; Ross SA, 2018, J INFECT DIS, V217, P1612, DOI 10.1093/infdis/jiy057; Ross SA, 2017, J PEDIATR-US, V184, P57, DOI 10.1016/j.jpeds.2017.01.047; Vives-Onos I, 2019, PEDIATR INFECT DIS J, V38, P520, DOI 10.1097/INF.0000000000002144; Voigt S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv193; Xu AQ, 2018, J PEDIAT INF DIS SOC, V7, pE160, DOI 10.1093/jpids/piy048; Yamamoto AY, 2006, J CLIN VIROL, V36, P228, DOI 10.1016/j.jcv.2006.03.011	34	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227143	10.1371/journal.pone.0227143	http://dx.doi.org/10.1371/journal.pone.0227143			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917817	Green Published, gold			2022-12-26	WOS:000534341100015
J	Park, JE; Brand, DD; Rosloniec, EF; Yi, AK; Stuart, JM; Kang, AH; Myers, LK				Park, Jeoung-Eun; Brand, David D.; Rosloniec, Edward F.; Yi, Ae-Kyung; Stuart, John M.; Kang, Andrew H.; Myers, Linda K.			Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; receptor; autoimmunity; collagen; inflammation; CD305; kinase signaling; leukocyte-associated immunoglobulin-like receptor 1; rheumatoid arthritis	IG-LIKE RECEPTOR-1; LAIR-1; COLLAGENS; INITIATION; TYROSINE; KINASES; DOMAIN	Multiple observations implicate T-cell dysregulation as a central event in the pathogenesis of rheumatoid arthritis. Here, we investigated mechanisms for suppressing T-cell activation via the inhibitory receptor leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1). To determine how LAIR-1 affects T-cell receptor (TCR) signaling, we compared 1) T cells from LAIR-1?sufficient and ?deficient mice, 2) Jurkat cells expressing either LAIR-1 mutants or C-terminal Src kinase (CSK) mutants, and 3) T cells from mice that contain a CSK transgene susceptible to chemical inhibition. Our results indicated that LAIR-1 engagement by collagen or by complement C1q (C1Q, which contains a collagen-like domain) inhibits TCR signaling by decreasing the phosphorylation of key components in the canonical T-cell signaling pathway, including LCK proto-oncogene SRC family tyrosine kinase (LCK), LYN proto-oncogene SRC family tyrosine kinase (LYN), ? chain of T-cell receptor?associated protein kinase 70 (ZAP-70), and three mitogen-activated protein kinases (extracellular signal?regulated kinase, c-Jun N-terminal kinase 1/2, and p38). The intracellular region of LAIR-1 contains two immunoreceptor tyrosine-based inhibition motifs that are both phosphorylated by LAIR-1 activation, and immunoprecipitation experiments revealed that Tyr-251 in LAIR-1 binds CSK. Using CRISPR/Cas9-mediated genome editing, we demonstrate that CSK is essential for the LAIR-1?induced inhibition of the human TCR signal transduction. T cells from mice that expressed a PP1 analog?sensitive form of CSK (CskAS) corroborated these findings, and we also found that Tyr-251 is critical for LAIR-1's inhibitory function. We propose that LAIR-1 activation may be a strategy for controlling inflammation and may offer a potential therapeutic approach for managing autoimmune diseases.	[Park, Jeoung-Eun; Brand, David D.; Rosloniec, Edward F.; Stuart, John M.; Kang, Andrew H.; Myers, Linda K.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA; [Brand, David D.; Yi, Ae-Kyung] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol Biochem, Memphis, TN 38163 USA; [Brand, David D.; Rosloniec, Edward F.; Stuart, John M.; Kang, Andrew H.] Vet Affairs Med Ctr, Res Serv, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Myers, LK (corresponding author), Div Rheumatol, 956 Court Ave,Rm G326, Memphis, TN 38163 USA.	lmyers@uthsc.edu		Brand, David/0000-0002-9260-7963	U.S. Public Health Service [AR064825, AR069010, AR064723]; Department of Veterans Affairs; Arthritis Foundation	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Veterans Affairs(US Department of Veterans Affairs); Arthritis Foundation	This work was supported, in part, by U.S. Public Health Service Grants AR064825, AR069010, and AR064723 and program-directed funds from the Department of Veterans Affairs and the Arthritis Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agashe VV, 2018, J IMMUNOL, V201, P772, DOI 10.4049/jimmunol.1701753; Boraschi-Diaz I, 2018, BONE, V117, P23, DOI 10.1016/j.bone.2018.09.006; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; Heyeck SD, 1997, J BIOL CHEM, V272, P25401, DOI 10.1074/jbc.272.40.25401; Jin JY, 2018, CELL IMMUNOL, V331, P78, DOI 10.1016/j.cellimm.2018.05.011; Kim S, 2017, J IMMUNOL, V199, P2692, DOI 10.4049/jimmunol.1700271; Kim YI, 2008, J BIOL CHEM, V283, P15258, DOI 10.1074/jbc.M709549200; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lebbink RJ, 2009, MATRIX BIOL, V28, P202, DOI 10.1016/j.matbio.2009.03.005; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Maasho K, 2005, MOL IMMUNOL, V42, P1521, DOI 10.1016/j.molimm.2005.01.004; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Otahal P, 2011, BBA-MOL CELL RES, V1813, P367, DOI 10.1016/j.bbamcr.2010.12.003; Pritchard NR, 2003, IMMUNOLOGY, V108, P263, DOI 10.1046/j.1365-2567.2003.01592.x; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Schoenborn JR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001893; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Son M, 2014, MOL MED, V20, P559, DOI 10.2119/molmed.2014.00185; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Tan YX, 2014, NAT IMMUNOL, V15, P186, DOI 10.1038/ni.2772; Tang B, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4433; Tang XB, 2012, J IMMUNOL, V188, P548, DOI 10.4049/jimmunol.1102044; Verbrugge A, 2006, EUR J IMMUNOL, V36, P190, DOI 10.1002/eji.200535226; Zhang Y, 2014, CELL IMMUNOL, V287, P46, DOI 10.1016/j.cellimm.2013.12.005	31	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2239	2247		10.1074/jbc.RA119.011150	http://dx.doi.org/10.1074/jbc.RA119.011150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31932281	Green Published, hybrid			2022-12-26	WOS:000517330200008
J	Sarkar, SK; Foo, ACY; Matyas, A; Asikhia, I; Kosenko, T; Goto, NK; Vergara-Jaque, A; Lagace, TA				Sarkar, Samantha K.; Foo, Alexander C. Y.; Matyas, Angela; Asikhia, Ikhuosho; Kosenko, Tanja; Goto, Natalie K.; Vergara-Jaque, Ariela; Lagace, Thomas A.			A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proprotein convertase subtilisin; kexin type 9 (PCSK9); low-density lipoprotein (LDL); lipoprotein metabolism; intrinsically disordered protein; conformational change; computer modeling; lipid metabolism; allosteric regulation; allostery; familial hypercholesterolemia; cholesterol regulation	SUBTILISIN/KEXIN TYPE 9; PROTEIN-STRUCTURE PREDICTION; OF-FUNCTION MUTATIONS; C-TERMINAL DOMAIN; LDL RECEPTOR; TRANSCRIPTIONAL ACTIVATION; SECONDARY STRUCTURE; CHOLESTEROL LEVELS; MOLECULAR-BASIS; HUMAN PLASMA	Proprotein convertase subtilisin/kexin type-9 (PCSK9) is a ligand of low-density lipoprotein (LDL) receptor (LDLR) that promotes LDLR degradation in late endosomes/lysosomes. In human plasma, 30?40% of PCSK9 is bound to LDL particles; however, the physiological significance of this interaction remains unknown. LDL binding in vitro requires a disordered N-terminal region in PCSK9's prodomain. Here, we report that peptides corresponding to a predicted amphipathic ?-helix in the prodomain N terminus adopt helical structure in a membrane-mimetic environment. This effect was greatly enhanced by an R46L substitution representing an atheroprotective PCSK9 loss-of-function mutation. A helix-disrupting proline substitution within the putative ?-helical motif in full-length PCSK9 lowered LDL binding affinity >5-fold. Modeling studies suggested that the transient ?-helix aligns multiple polar residues to interact with positively charged residues in the C-terminal domain. Gain-of-function PCSK9 mutations associated with familial hypercholesterolemia (FH) and clustered at the predicted interdomain interface (R469W, R496W, and F515L) inhibited LDL binding, which was completely abolished in the case of the R496W variant. These findings shed light on allosteric conformational changes in PCSK9 required for high-affinity binding to LDL particles. Moreover, the initial identification of FH-associated mutations that diminish PCSK9's ability to bind LDL reported here supports the notion that PCSK9-LDL association in the circulation inhibits PCSK9 activity.	[Sarkar, Samantha K.; Matyas, Angela; Asikhia, Ikhuosho; Kosenko, Tanja; Lagace, Thomas A.] Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, Ottawa, ON K1Y 4W7, Canada; [Foo, Alexander C. Y.; Goto, Natalie K.] Univ Ottawa, Fac Sci, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada; [Vergara-Jaque, Ariela] Univ Talca, Ctr Bioinformat & Mol Simulat, Talca 3460000, Chile; [Vergara-Jaque, Ariela] Millennium Nucleus Ion Channel Associated Dis MiN, Talca 3460000, Chile	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Universidad de Talca	Lagace, TA (corresponding author), Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, 40 Ruskin St,Rm H-4213, Ottawa, ON K1N 6N5, Canada.	tlagace@ottawaheart.ca	Vergara-Jaque, Ariela/AAJ-1645-2020; Goto, Natalie/AAO-7979-2020	Vergara-Jaque, Ariela/0000-0002-1236-013X; Goto, Natalie/0000-0003-4877-4884; Lagace, Thomas/0000-0002-6946-4212; Foo, Alexander/0000-0002-4331-2085	Heart and Stroke Foundation of Canada [G-15-0009352]; Canadian Institutes of Health Research (CIHR) [391063]; Pfizer ASPIRE Program; FONDECYT Research Initiation Grant [11170223]; Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile)	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pfizer ASPIRE Program; FONDECYT Research Initiation Grant; Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile)	This work was supported in part by Heart and Stroke Foundation of Canada Grant G-15-0009352, Canadian Institutes of Health Research (CIHR) Grant 391063, and the Pfizer ASPIRE Program (to T. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by FONDECYT Research Initiation Grant 11170223. The Millennium Nucleus of Ion Channels-Associated Diseases (MiNICAD) is a Millennium Nucleus supported by the Iniciativa Cientifica Milenio of the Ministry of Economy, Development, and Tourism (Chile).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Ahrens JB, 2017, CELL MOL LIFE SCI, V74, P3163, DOI 10.1007/s00018-017-2559-0; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Chorba JS, 2018, J BIOL CHEM, V293, P1875, DOI 10.1074/jbc.RA117.000754; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; El Khoury P, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0684-8; Fasano T, 2009, ATHEROSCLEROSIS, V203, P166, DOI 10.1016/j.atherosclerosis.2008.10.027; Fazio S, 2017, J CLIN ENDOCR METAB, V102, P3340, DOI 10.1210/jc.2016-4043; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Galvan AM, 2019, J LIPID RES, V60, P71, DOI 10.1194/jlr.M087189; Geschwindner S, 2015, PROTEIN ENG DES SEL, V28, P117, DOI 10.1093/protein/gzv008; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Graham JM, 1996, ATHEROSCLEROSIS, V124, P125, DOI 10.1016/0021-9150(96)05797-8; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Gustafsen C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00568-7; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Hopkins PN, 2015, CIRC-CARDIOVASC GENE, V8, P823, DOI 10.1161/CIRCGENETICS.115.001129; Hori M, 2015, J CLIN ENDOCR METAB, V100, pE41, DOI 10.1210/jc.2014-3066; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaya E, 2017, ANATOL J CARDIOL, V18, P266, DOI 10.14744/AnatolJCardiol.2017.7654; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Konrat R, 2009, CELL MOL LIFE SCI, V66, P3625, DOI 10.1007/s00018-009-0117-0; Kosenko T, 2013, J BIOL CHEM, V288, P8279, DOI 10.1074/jbc.M112.421370; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Krois AS, 2016, P NATL ACAD SCI USA, V113, pE1853, DOI 10.1073/pnas.1602487113; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; MacRaild CA, 2004, BIOCHEMISTRY-US, V43, P8084, DOI 10.1021/bi049817l; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Millard CJ, 2014, STRUCTURE, V22, P1571, DOI 10.1016/j.str.2014.08.023; Nguyen MA, 2014, J LIPID RES, V55, P266, DOI 10.1194/jlr.M044156; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Romagnuolo R, 2015, J BIOL CHEM, V290, P11649, DOI 10.1074/jbc.M114.611988; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUMSEY SC, 1992, J LIPID RES, V33, P1551; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Schiele F, 2014, J MOL BIOL, V426, P843, DOI 10.1016/j.jmb.2013.11.011; SEGREST JP, 1992, J LIPID RES, V33, P141; Seidah NG, 2019, J MOL BIOL, V431, P904, DOI 10.1016/j.jmb.2019.01.015; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Stein EA, 2014, ANNU REV MED, V65, P417, DOI 10.1146/annurev-med-022613-090402; Stein EA, 2013, CIRCULATION, V127, P2372, DOI 10.1161/CIRCULATIONAHA.113.003360; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Tavori H, 2015, ATHEROSCLEROSIS, V238, P264, DOI 10.1016/j.atherosclerosis.2014.12.017; Tavori H, 2013, CIRCULATION, V127, P2403, DOI 10.1161/CIRCULATIONAHA.113.001592; Tompa P, 2014, MOL CELL, V55, P161, DOI 10.1016/j.molcel.2014.05.032; Ultsch M, 2019, J MOL BIOL, V431, P885, DOI 10.1016/j.jmb.2018.11.025; Verbeek R, 2017, ARTERIOSCL THROM VAS, V37, P43, DOI 10.1161/ATVBAHA.116.307995; Wierod L, 2016, MOL GENET METAB REP, V9, P86, DOI 10.1016/j.ymgmr.2016.11.003; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	76	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2285	2298		10.1074/jbc.RA119.010221	http://dx.doi.org/10.1074/jbc.RA119.010221			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31949048	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000517330200012
J	Getachew, B; Liabsuetrakul, T; Virani, S; Gebrehiwot, Y				Getachew, Biniam; Liabsuetrakul, Tippawan; Virani, Shama; Gebrehiwot, Yirgu			Age, period and cohort analysis of age-specific maternal mortality trend in Ethiopia: A secondary analysis	PLOS ONE			English	Article							PERINATAL MORTALITIES; SYSTEMATIC ANALYSIS; NATIONAL LEVELS; REASONS	Background Maternal mortality (MM) was persistently high for several decades in Ethiopia though it has declined in recent years. The roles of time-varying elements in this decrease are unknown. Analyzing MM with age-period-cohort analysis will provide evidence to policymakers to redirect resources towards vulnerable age groups. The aim of this analysis was to determine the role of age effect, period effect and birth cohort effect on the trend of age-specific maternal mortality in Ethiopia. Methods Age-period-cohort (APC) analysis was applied to examine the effect of age, period and birth cohort on MM in Ethiopia using data from the Ethiopian Demographic and Health Survey (EDHS) from years 2000, 2005, 2011 and 2016. Age-specific maternal mortality rates were calculated using standardized maternal death compared to age-specific population per 100,000 woman-years of exposure and the trend was analyzed. Result In most age groups, the MM rate decreased in 2015 compared with the previous years except for older women. According to the APC analysis, the age-cohort effect explains the MM rate better than age-period effect. The period effect shows the risk ratio of MM after 2005 decreased compared with before. The cohort effect illustrates women born after 1980 has lower risk ratio compared with the older one. Conclusion Maternal mortality in Ethiopia declined overall in recent years. However, certain age groups still face high maternal mortality rates. A national policy on MM reduction interventions for the identified high-risk age groups is required.	[Getachew, Biniam; Liabsuetrakul, Tippawan; Virani, Shama] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand; [Virani, Shama] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Gebrehiwot, Yirgu] Addis Ababa Univ, Obstet & Gynecol Dept, Addis Ababa, Ethiopia	Prince of Songkla University; University of Michigan System; University of Michigan; Addis Ababa University	Getachew, B (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand.	biniongech@gmail.com	Getachew, Biniam/X-7253-2019; Virani, Shama/AAX-3943-2020	Getachew, Biniam/0000-0002-5296-6611; Virani, Shama/0000-0002-1163-432X	Higher Education Research Promotion; Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission	Higher Education Research Promotion; Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission	This study was part of the thesis of the first author for fulfilling the requirements of the doctoral degree in Epidemiology at Prince of Songkla University under scholarship supported by the Higher Education Research Promotion and the Thailand's Education Hub for Southern Region of ASEAN Countries Project Office of the Higher Education Commission. The authors would like to thank Dr. Hutcha Sriplung for scientific comment in the methodology. In addition, we would like to acknowledge measure DHS for granting access to Ethiopian DHS 2000, 2005, 2011 and 2016 data.	Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P15, DOI 10.4314/ejhs.v24i0.3S; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P119, DOI 10.4314/ejhs.v24i0.11S; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P137, DOI 10.4314/ejhs.v24i0.12S; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P3, DOI 10.4314/ejhs.v24i0.2S; Blanc AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059864; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency (CSA)[Ethiopia] and ICF, 2016, ETH DEN HLTH SURV 20; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Central Statistics Agency (CSA) [Ethiopia] and ORC Macro, 2001, ETH DEM HLTH SURV 20; Federal Ministry of Health, 2010, IMPL MAN HEALTHC FIN; Godefay H, 2016, J GLOB HEALTH, V6, P1; Graham W., 1987, Health Policy and Planning, V2, P323, DOI 10.1093/heapol/2.4.323; Holford T R, 1992, Stat Methods Med Res, V1, P317, DOI 10.1177/096228029200100306; Holford TR, 2006, STAT MED, V25, P977, DOI 10.1002/sim.2253; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; Jain AK, 2011, STUD FAMILY PLANN, V42, P247, DOI 10.1111/j.1728-4465.2011.00288.x; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mgawadere F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1084-8; Nations United, 2015, MILL DEV GOALS REP 2; R Development Core Team, 2017, R LANG ENV STAT COMP; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wilmoth J, 2009, B WORLD HEALTH ORGAN, V87, P256, DOI 10.2471/BLT.07.048280; Workie NW, 2013, HLTH EXTENSION PROGR; Yifru Berhan, 2014, Ethiopian Journal of Health Sciences, V24, P105	27	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0224220	10.1371/journal.pone.0224220	http://dx.doi.org/10.1371/journal.pone.0224220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945060	Green Published, gold			2022-12-26	WOS:000534370100008
J	Haglin, L; Tornkvist, B; Backman, L				Haglin, Lena; Tornkvist, Birgitta; Backman, Lennart			Obesity, smoking habits, and serum phosphate levels predicts mortality after life-style intervention	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE; RISK; HYPOPHOSPHATEMIA; ASSOCIATION; ADIPOSITY; ADULTS; SEX	Background Life-style interventions, including smoking cessation and weight control are of importance for managing future escalating prevalence of obesity. Smoking habits and obesity have jointly great impact on mortality, however mechanisms behind the effect and variables involved in the obesity paradox is still unknown. Objectives This study examines risk factors for all-cause, cardiovascular, and cancer mortality in males and females with high cardiovascular risk, mediated by smoking habits, body mass index (BMI, kg/m(2)), and serum phosphate (S-P) levels. Methods Patients were admitted to the Vindeln Patient Education Center in groups of 30 for a fou-rweek residential comprehensive program (114 hours) focusing on smoking cessation, stress reduction, food preferences and selections, and physical exercise. The follow-up, in years from 1984 to 2014 corresponds to 30 years. This study included 2,504 patients (1,408 females and 1,096 males). Cox regression analysis was used to assess mortality risk associated with smoking habits, low and high BMI, and low and high S-P levels. Results High BMI (> 34,2 kg/m(2)), current smoking, type 2 diabetes mellitus (T2DM), high serum calcium (S-Ca), mmol/L and high systolic blood pressure (SBP, mmHg) were associated with all-cause mortality irrespective of sex. Former and current smoking females had a high all-cause mortality (adjusted hazard ratio [HR] 1.581; 95% CI 1.108-2.256, adjusted hazard ratio [HR] 1.935; 95% CI 1.461-2.562, respectively) while current smoking and high BMI increased risk for cardiovascular mortality (adjusted hazard ratio [HR] 3.505; 95% CI 2.1405.740 and [HR] 1.536; 95% CI 1.058-2.231, respectively). Neither low nor high levels of S-P predicted all-cause, cardiovascular disease (CVD) and cancer mortality in males or females while low levels of S-P predicted all-cause mortality in smokers (adjusted hazard ratio [HR] 1.713; 95% CI 1.211-2.424). In non-smokers, low BMI (<27.6 kg/m(2)) was protecting and high BMI a risk for all-cause mortality. In males, ischemic heart disease (IHD), and low serum albumin (S-Alb) were associated with all-cause mortality. In females, an interaction between high BMI and smoking (HbmiSM) decreased the cardiovascular mortality (adjusted hazard ratio [HR] 0.410; 95% CI 0.179-0.937, respectively). Conclusions High BMI and current smoking were associated with all-cause mortality in both males and females in the present high cardiovascular-risk cohort. In current smokers and non-smokers, T2DM and high S-Ca were associated with an increase in all-cause mortality, while low S-P was associated with all-cause mortality in smokers. Interaction between high BMI and smoking contribute to the obesity paradox by being protective for cardiovascular mortality in females.	[Haglin, Lena; Tornkvist, Birgitta; Backman, Lennart] Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden	Umea University	Haglin, L (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Family Med, Umea, Sweden.	Lena.haglin@umu.se			County Counsil of West Bothnia	County Counsil of West Bothnia	The study was funded by the County Counsil of West Bothnia The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027; Badrick E, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000369; Borrell LN, 2014, ANN EPIDEMIOL, V24, P484, DOI 10.1016/j.annepidem.2014.02.016; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Broman M, 2017, ANESTH ANALG, V124, P1897, DOI 10.1213/ANE.0000000000002077; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Campos-Obando N, 2018, EUR J EPIDEMIOL, V33, P859, DOI 10.1007/s10654-018-0407-7; Cao BC, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0092-2; Cheungpasitporn Wisit, 2018, Hosp Pract (1995), V46, P121, DOI 10.1080/21548331.2018.1483172; FISHER J, 1983, CHEST, V83, P504, DOI 10.1378/chest.83.3.504; Freedman DM, 2006, AM J PREV MED, V31, P355, DOI 10.1016/j.amepre.2006.07.022; Haglin L, 2007, ACTA DIABETOL, V44, P138, DOI 10.1007/s00592-007-0254-6; Haglin L, 2001, EUR J CLIN NUTR, V55, P493, DOI 10.1038/sj.ejcn.1601209; Haglin L, 2011, EUR J CARDIOV PREV R, V18, P79, DOI 10.1097/HJR.0b013e32833a65cc; Haglin LM, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-39; Haider DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133426; Hoffmann M, 2008, J CLIN PATHOL, V61, P1104, DOI 10.1136/jcp.2007.054940; JANGHORBANI M, 1993, INT J EPIDEMIOL, V22, P1056, DOI 10.1093/ije/22.6.1056; Kagansky N, 2005, J INTERN MED, V257, P461, DOI 10.1111/j.1365-2796.2005.01457.x; Kim NH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139924; Klatsky Arthur L, 2017, Perm J, V21, P16, DOI 10.7812/TPP/16-142; Koster A, 2008, AM J CLIN NUTR, V88, P1206, DOI 10.3945/ajcn.2008.26298; LINDGARDE F, 1977, ACTA MED SCAND, V202, P307; Ma JM, 2013, PREV MED, V56, P178, DOI 10.1016/j.ypmed.2012.12.012; Narumi T, 2014, EXCLI J, V13, P516; Nikolakaros G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00206; Nyholm M, 2005, SCAND J PUBLIC HEALT, V33, P478, DOI 10.1080/14034940510006102; Siahpush M, 2014, TOB CONTROL, V23, P395, DOI 10.1136/tobaccocontrol-2012-050912; Soley-Bori M., 2013, KEY ASSUMPTIONS METH; Stokes A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009232; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Vaidyanathan Duraiswamy, 2000, Indian Journal of Physiology and Pharmacology, V44, P225; Yoo KD, 2016, AM J KIDNEY DIS, V67, P79, DOI 10.1053/j.ajkd.2015.06.027	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227692	10.1371/journal.pone.0227692	http://dx.doi.org/10.1371/journal.pone.0227692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945095	Green Published, gold			2022-12-26	WOS:000534370100054
J	Marangoni, A; Ceccarani, C; Camboni, T; Consolandi, C; Foschi, C; Salvo, M; Gaspari, V; D'Antuono, A; Belletti, M; Re, MC; Severgnini, M				Marangoni, Antonella; Ceccarani, Camilla; Camboni, Tania; Consolandi, Clarissa; Foschi, Claudio; Salvo, Melissa; Gaspari, Valeria; D'Antuono, Antonietta; Belletti, Matteo; Re, Maria Carla; Severgnini, Marco			Pharyngeal microbiome alterations during Neisseria gonorrhoeae infection	PLOS ONE			English	Article							MENINGITIDIS; ACID; MEN; SEX	Pharyngeal gonorrhoea is a common sexually transmitted infection among 'men having sex with other men' (MSM). Neisseria gonorrhoeae (NG) pharyngeal infections are usually characterized by the absence of symptoms, acting as an important reservoir for their further spread. To the best of our knowledge, no information about the composition of the pharyngeal microbiome during an ongoing NG infection is currently available. Therefore, in this study, we characterized the pharyngeal bacterial community profiles associated with NG infection in a well-selected cohort of HIV-negative MSM reporting unsafe oral intercourse. A total of 70 pharyngeal swabs were considered, comparing non-infected subjects (n = 45) versus patients with pharyngeal gonorrhoea (n = 25) whose microbiota composition was analyzed from pharyngeal swabs through sequencing of hypervariable V3-V4 regions of the 16S rRNA gene. The pharyngeal microbiome of all subjects was dominated by Prevotellaceae, Veillonellaceae and Streptococcaceae families. Patients with pharyngeal gonorrhoea harboured a pharyngeal microbiome quite similar to negative subjects. Nevertheless, when looking to less-represented bacterial species (relative abundance approximately 1% or less), an imbalance between aerobe and anaerobe microorganisms was observed in NGinfected patients. In particular, the pharyngeal microbiome of NG-positive individuals was richer in several anaerobes (e.g. Treponema, Parvimonas, Peptococcus, Catonella, Filifactor) and poorer in various aerobe genera (i.e. Pseudomonas, Escherichia), compared to non-infected controls. No significant differences were noticed in the distribution of commensal Neisseria species of the oropharynx between NG-positive and negative subjects. Metabolic variations induced by changes in the microbiome abundance were assessed by a functional prediction of the bacterial metabolic pathways: a more abundant involvement of D-glutamine and D-glutamate metabolism, carbohydrate metabolism, as well as a greater activation of the energy metabolism was observed in patients with pharyngeal gonorrhoea compared to non-infected individuals. Information about the bacterial composition of the pharyngeal microbiome in case of gonorrhoea could shed light on the pathogenesis of the infection and open new perspectives for the prevention and control of this condition.	[Marangoni, Antonella; Foschi, Claudio; Salvo, Melissa; Re, Maria Carla] Univ Bologna, DIMES, Microbiol, Bologna, Italy; [Ceccarani, Camilla; Camboni, Tania; Consolandi, Clarissa; Severgnini, Marco] CNR, Inst Biomed Technol, Milan, Italy; [Ceccarani, Camilla] Univ Milan, Dept Hlth Sci, Milan, Italy; [Gaspari, Valeria; D'Antuono, Antonietta; Belletti, Matteo] St Orsola Malpighi Hosp, Dermatol, Bologna, Italy	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Foschi, C (corresponding author), Univ Bologna, DIMES, Microbiol, Bologna, Italy.	claudio.foschi2@unibo.it	Foschi, Claudio/A-7299-2016	Foschi, Claudio/0000-0001-7253-8799				Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Catenazzi MCE, 2014, MOL MICROBIOL, V93, P346, DOI 10.1111/mmi.12664; Ceccarani C, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00358; Ceccarani C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50410-x; Chan Philip A, 2016, Infect Dis Obstet Gynecol, V2016, P5758387, DOI 10.1155/2016/5758387; Chow EPF, 2017, SEX TRANSM DIS, V44, P593, DOI [10.1097/OLQ.0000000000000654, 10.1097/olq.0000000000000654]; Deasy AM, 2015, CLIN INFECT DIS, V60, P1512, DOI 10.1093/cid/civ098; Donati C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.70, 10.1038/nmicrobiol.2016.70]; Dong HV, 2020, CLIN INFECT DIS, V70, P1169, DOI 10.1093/cid/ciz365; Exley RM, 2005, INFECT IMMUN, V73, P5762, DOI 10.1128/IAI.73.9.5762-5766.2005; Gaspari V, 2019, INT J STD AIDS, V2; Householder TC, 1999, J BACTERIOL, V181, P541, DOI 10.1128/JB.181.2.541-551.1999; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Laver JR, 2015, ADV MICROB PHYSIOL, V66, P323, DOI 10.1016/bs.ampbs.2015.05.001; LAW DJ, 1978, ANTIMICROB AGENTS CH, V13, P473, DOI 10.1128/AAC.13.3.473; Marangoni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120979; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mellies J, 1997, MOL GEN GENET, V255, P285, DOI 10.1007/s004380050499; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254; Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184; Quillin SJ, 2018, NAT REV MICROBIOL, V16, P226, DOI 10.1038/nrmicro.2017.169; Regan DG, 2018, LANCET INFECT DIS, V18, P1175, DOI 10.1016/S1473-3099(18)30610-8; Reinton N, 2013, SEX HEALTH, V10, P199, DOI 10.1071/SH12092; Schielke S, 2010, MED MICROBIOL IMMUN, V199, P185, DOI 10.1007/s00430-010-0150-5; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Walker S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164033; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weyand NJ, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx031	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227985	10.1371/journal.pone.0227985	http://dx.doi.org/10.1371/journal.pone.0227985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945133	gold, Green Published, Green Submitted			2022-12-26	WOS:000534370100078
J	Accinelli, RA; Leon-Abarca, JA				Alfonso Accinelli, Roberto; Alonso Leon-Abarca, Juan			Age and altitude of residence determine anemia prevalence in Peruvian 6 to 35 months old children	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; IRON-DEFICIENCY; ERYTHROPOIETIN; DEATH; VALUES; ADAPTATION; COMMUNITY; NORTHERN; WEIGHT; STATES	Background A Demographic and Family Health Survey (ENDES, for Encuesta Demografica y de Salud Familiar in Spanish) is carried out annually in Peru. Based on it, the anemia prevalence was 43.6% in 2016 and 43.8% in 2017 using the WHO cutoff value of 11 g/dL and the altitude-correction equation. Objective To assess factors contributing to anemia and to determine its prevalence in Peruvian children 6 to 35 months old. Methods We used the MEASURE DHS-based ENDES survey to obtain representative data for11364 children from 6 to 35 months old on hemoglobin and health determinants. To evaluate normal hemoglobin levels, we used the original WHO criterion of the 5th percentile in children without chronic malnutrition and then applied it to the overall population. Relationships between hemoglobin and altitude levels, usage of cleaning methods to sanitize water safe to drink, usage of solid fuels and poverty status were tested using methodology for complex survey data. Percentile curves were made for altitude intervals by plotting hemoglobin compared to age. The new anemia rates are presented in graphs by Peruvian political regions according to the degree of public health significance. Results Hemoglobin increased as age and altitude of residence increased. Using the 5th percentile, anemia prevalence was 7.3% in 2016 and 2017. Children from low altitudes had higher anemia prevalence (8.5%) than those from high altitudes (1.2%, p<0.0001). In the rainforest area of Peru, anemia prevalence was highest (13.5%), while in the highlands it was lowest 3.3%, p<0.0001). With access to safe drinking water and without chronic malnutrition, anemia rates could be reduced in the rainforest by 45% and 33%, respectively. Conclusion Anemia prevalence in Peruvian children from 6 to 35 months old was 7.3% in 2016 and 2017.	[Alfonso Accinelli, Roberto; Alonso Leon-Abarca, Juan] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru; [Alfonso Accinelli, Roberto; Alonso Leon-Abarca, Juan] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Alfonso Accinelli, Roberto] Hosp Cayetano Heredia, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Accinelli, RA (corresponding author), Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru.; Accinelli, RA (corresponding author), Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru.; Accinelli, RA (corresponding author), Hosp Cayetano Heredia, Lima, Peru.	roberto.accinelli@upch.pe		Accinelli, Roberto/0000-0002-9773-8778; Leon-Abarca, Juan Alonso/0000-0001-6018-5666	Peruvian Ministry of Economy	Peruvian Ministry of Economy	This study was self-funded. ENDES survey was funded by the Peruvian Ministry of Economy. The Facultad de Medicina Alberto Hurtado de la Universidad Peruana Cayetano Heredia support the publication of this paper in PLOS ONE journal.	Accinelli RA, 2017, ENVIRON RES, V158, P431, DOI 10.1016/j.envres.2017.06.032; ADAMSON JW, 1994, SEMIN ONCOL, V21, P9; Alaofe H, 2017, PUBLIC HEALTH NUTR, V20, P1203, DOI 10.1017/S1368980016003608; [Anonymous], 2007, ASS IR STAT POP REP; [Anonymous], 2013, 61107B US DEP TRANSP; [Anonymous], 2011, ETHIOPIA DEMOGRAPHIC, P452; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beutler E, 2003, BRIT J HAEMATOL, V120, P887, DOI 10.1046/j.1365-2141.2003.04215.x; Bigham AW, 2014, GENE DEV, V28, P2189, DOI 10.1101/gad.250167.114; Bigham AW, 2014, PHYSIOL GENOMICS, V46, P687, DOI 10.1152/physiolgenomics.00063.2014; Brotanek JM, 2008, ARCH PEDIAT ADOL MED, V162, P374, DOI 10.1001/archpedi.162.4.374; Cabada MM, 2014, PATHOG GLOB HEALTH, V108, P200, DOI 10.1179/2047773214Y.0000000142; Centers for Disease Control, 1994, ENH PED NUTR SURV SY; Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V47, P13; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Chowdhury SD, 2013, HOMO, V64, P215, DOI 10.1016/j.jchb.2013.03.006; Cook JD, 2005, BLOOD, V106, P1441, DOI 10.1182/blood-2004-12-4782; Crawford JE, 2017, AM J HUM GENET, V101, P752, DOI 10.1016/j.ajhg.2017.09.023; Croft TN, 2018, GUIDE DHS STAT; DALLMAN PR, 1984, AM J CLIN NUTR, V39, P437, DOI 10.1093/ajcn/39.3.437; Daugas E, 2001, CELL DEATH DIFFER, V8, P1131, DOI 10.1038/sj.cdd.4400953; de Benoist B, 2008, WHO GLOBAL DATABASE; DELEEUW NKM, 1966, MEDICINE, V45, P291, DOI 10.1097/00005792-196607000-00002; Department of the Army. Military Mountaineering, 2002, MIL MOUNT; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Din ZU, 2018, NUTR HOSP, V35, P1145, DOI 10.20960/nh.1685; Direccion General de Epidemiologia Ministerio de Salud del Peru, NUM EP DIARR AG PER; Donahue Angel M, 2017, FOOD NUTR BULL, V38, P554, DOI 10.1177/0379572117723134; Dufour DL, 2016, ANN HUM BIOL, V43, P330, DOI 10.1080/03014460.2016.1196245; Earl RO, 1993, IRON DEFICIENCY ANEM; Gonzales Gustavo F, 2017, Rev. perú. med. exp. salud publica, V34, P699, DOI 10.17843/rpmesp.2017.344.3208; Gonzales GF, 2018, AM J HEMATOL, V93, pE12, DOI 10.1002/ajh.24932; Gonzales Gustavo F, 2015, Rev. perú. med. exp. salud publica, V32, P198; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; HARRELL FE, 1982, BIOMETRIKA, V69, P635; HURTADO A, 1945, ARCH INTERN MED, V75, P284, DOI 10.1001/archinte.1945.00210290007002; Instituto Nacional de Estadistica e Informatica, 2018, ENC DEM SAL FAM ENDE; Instituto Nacional de Estadistica e Informatica, 2018, PER FORM ACC AG SAN; Instituto Nacional de Estadistica e Informatica, 2018, INF PERU IND RES PRO; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; Kawo KN, 2018, ANEMIA, V2018, DOI 10.1155/2018/3087354; KILPATRICK G, 1961, BRIT MED J, V1, P778, DOI 10.1136/bmj.1.5228.778; Kimura T, 2000, EXP HEMATOL, V28, P635, DOI 10.1016/S0301-472X(00)00156-9; Koller O, 1982, Obstet Gynecol Surv, V37, P649, DOI 10.1097/00006254-198211000-00001; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; Kumar T, 2017, CLIN NUTR, V36, P986, DOI 10.1016/j.clnu.2016.07.002; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Ministerio de Economia y Finanzas, 2016, INF CUMPL MET IND PR; Ministerio de Salud, SAL SIT SAL CAS SEG; Ministerio de Salud (MINSA), 2016, GUIA TECN GUIA PRACT; Monge MC, 1928, ANALES FACULTAD MED, V14, P1; Munares-Garcia Oscar, 2014, Rev Peru Med Exp Salud Publica, V31, P501; National Institute of Statistics of Rwanda (NISR) [Rwanda]; Ministry of Health (MOH) [Rwanda]; and ICF International, 2015, RWAND DEM HLTH SURV; NATVIG K, 1966, ACTA MED SCAND, V180, P613; Ncogo P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176613; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nguyen PH, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001010; Ocas-Cordova S, 2018, HIGH ALT MED BIOL, V19, P398, DOI 10.1089/ham.2018.0032; Orkin SH, 1999, NATURE, V401, P433, DOI 10.1038/46699; Polenakovic M, 1996, J AM SOC NEPHROL, V7, P1178; Pullum T, 2017, 18 DHS ICF, V18; Rademaker K, 2014, SCIENCE, V346, P466, DOI 10.1126/science.1258260; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Rishi G, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150014; Robins EB, 2007, AM J HEMATOL, V82, P611, DOI 10.1002/ajh.20848; Rutstein S.O., 2004, DHS WEALTH INDEX, V6; Sarna K, 2018, AM J HEMATOL, V93, pE229, DOI 10.1002/ajh.25194; STURGEON P, 1959, BRIT J HAEMATOL, V5, P31, DOI 10.1111/j.1365-2141.1959.tb04011.x; Tang F, 2019, HIGH ALT MED BIOL, V20, P112, DOI 10.1089/ham.2017.0159; United Nations International Children's Emergency Fund United Nations University World Health Organization, 2001, IRON DEFICIENCY ANAE; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489; WHO, 2017, NUTR AN TOOLS EFF PR; WHO Scientific Group on Nutritional Anaemias World Health Organization, 1968, TECH REP SER, V405; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 1959, WHO TECHN REP SER, P4; World Health Organization, 2015, GLOB PREV AN 2011; World Health Organization, 1995, PHYS STAT US INT ANT; YIP R, 1984, AM J CLIN NUTR, V39, P427, DOI 10.1093/ajcn/39.3.427; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	81	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226846	10.1371/journal.pone.0226846	http://dx.doi.org/10.1371/journal.pone.0226846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940318	Green Published, gold			2022-12-26	WOS:000534368000046
J	James, L; Davies, TGE; Lim, KS; Reynolds, A				James, Laura; Davies, T. G. Emyr; Lim, Ka S.; Reynolds, Andrew			Do bumblebees have signatures? Demonstrating the existence of a speed-curvature power law in Bombus terrestris locomotion patterns	PLOS ONE			English	Article							MINIMUM-JERK; MOVEMENT; VELOCITY; MECHANICS; ORIGINS	We report the discovery that Bombus terrestris audax (Buff-tailed bumblebee) locomotor trajectories adhere to a speed-curvature power law relationship which has previously been found in humans, non-human primates and Drosophila larval trajectories. No previous study has reported such a finding in adult insect locomotion. We used behavioural tracking to study walking Bombus terrestris in an arena under different training environments. Trajectories analysed from this tracking show the speed-curvature power law holds robustly at the population level, displaying an exponent close to two-thirds. This exponent corroborates previous findings in human movement patterns, but differs from the three-quarter exponent reported for Drosophila larval locomotion. There are conflicting hypotheses for the principal origin of these speed-curvature laws, ranging from the role of central planning to kinematic and muscular skeletal constraints. Our findings substantiate the latter idea that dynamic power-law effects are robust, differing only through kinematic constraints due to locomotive method. Our research supports the notion that these laws are present in a greater range of species than previously thought, even in the bumblebee. Such power laws may provide optimal behavioural templates for organisms, delivering a potential analytical tool to study deviations from this template. Our results suggest that curvature and angular speed are constrained geometrically, and independently of the muscles and nerves of the performing body.	[James, Laura; Davies, T. G. Emyr; Lim, Ka S.; Reynolds, Andrew] Rothamsted Res, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	James, L (corresponding author), Rothamsted Res, Harpenden, Herts, England.	Laura.james@rothamsted.ac.uk	Davies, Thomas G. Emyr/C-2795-2017	Davies, Thomas G. Emyr/0000-0002-9452-2947; James, Laura/0000-0003-4991-2433	Biotechnology and Biological Sciences Research Council (BBSRC); University of Nottingham; Biotechnology and Biological Sciences Research Council's (BBSRC) Industrial Strategy Challenge Fund [BBS/OS/CP/000001]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; Biotechnology and Biological Sciences Research Council's (BBSRC) Industrial Strategy Challenge Fund	This work was supported as part of L.J. Doctoral Training Partnership PhD project at Rothamsted Research funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (https://bbsrc.ukri.org/) and the University of Nottingham (https://www.nottingham.ac.uk/).T.G.E.D., K.S.L. and A.R. receive grant aided support from the Biotechnology and Biological Sciences Research Council's (BBSRC) Industrial Strategy Challenge Fund (BBS/OS/CP/000001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball P, 2013, NATURE, V494, P32, DOI 10.1038/494032a; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Catavitello G, 2016, EXP BRAIN RES, V234, P1649, DOI 10.1007/s00221-016-4569-9; deSperati C, 1997, J NEUROSCI, V17, P3932; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gribble PL, 1996, J NEUROPHYSIOL, V76, P2853, DOI 10.1152/jn.1996.76.5.2853; Huh D, 2015, P NATL ACAD SCI USA, V112, pE3950, DOI 10.1073/pnas.1510208112; Inger R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098631; Ivanenko YP, 2002, NEUROREPORT, V13, P1171, DOI 10.1097/00001756-200207020-00020; Kuroda S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0205; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Maoz U, 2006, ADV NEURAL INFORM PR, V18, P851; Marken RS, 2017, EXP BRAIN RES, V235, P1835, DOI 10.1007/s00221-017-4939-y; MASSEY JT, 1992, EXP BRAIN RES, V88, P685; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Ofstad TA, 2011, NATURE, V474, P204, DOI 10.1038/nature10131; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; Reynolds AM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150085; Reynolds A, 2015, PHYS LIFE REV, V14, P59, DOI 10.1016/j.plrev.2015.03.002; Reynolds AM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0392; Schaal S, 2001, EXP BRAIN RES, V136, P60, DOI 10.1007/s002210000505; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Smaira AD, 2012, REV BRAS ENSINO FIS, V34; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Spanos A, 2007, PHILOS SCI, V74, P1046, DOI 10.1086/525643; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Tanaka Y, 2012, J R SOC INTERFACE, V9, P222, DOI 10.1098/rsif.2011.0339; Thompson DaW, 1992, GROWTH FORM, DOI [10.1017/CBO9781107325852, DOI 10.1017/CBO9781107325852]; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1997, PHYS REV E, V55, P845, DOI 10.1103/PhysRevE.55.845; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; VIVIANI P, 1995, J EXP PSYCHOL HUMAN, V21, P32, DOI 10.1037/0096-1523.21.1.32; WANN J, 1988, J EXP PSYCHOL HUMAN, V14, P622, DOI 10.1037/0096-1523.14.4.622; Zago M, 2018, EXP BRAIN RES, V236, P69, DOI 10.1007/s00221-017-5108-z; Zago M, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0597	38	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226393	10.1371/journal.pone.0226393	http://dx.doi.org/10.1371/journal.pone.0226393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940358	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000030
J	Fujishima, MAT; Sa, DMC; Lima, CMD; Bittencourt, JPAHM; Pereira, WLA; Muribeca, ADB; Silva, CYYE; da Silva, MN; de Sousa, FFO; dos Santos, CBR; da Silva, JO				Teles Fujishima, Mayara Amoras; Cunha Sa, Dayse Maria; de Sousa Lima, Carolina Miranda; Bittencourt, Jose Prime Adolfo H. M.; Assuncao Pereira, Washington Luiz; Barbosa Muribeca, Abraao de Jesus; Yoshioka e Silva, Consuelo Yumiko; da Silva, Milton Nascimento; Oliveira de Sousa, Francisco Fabio; dos Santos, Cleydson B. R.; da Silva, Jocivania Oliveira			Chemical profiling of Curatella americana Linn leaves by UPLC-HRMS and its wound healing activity in mice	PLOS ONE			English	Article							MEDICINAL-PLANTS; HUMAN SKIN; IN-VITRO; INFLAMMATION; EXTRACTS; ANTIOXIDANTS; MECHANISMS; QUERCETIN; CHEMISTRY; CATECHIN	Based on ethnopharmacological studies, a lot of plants, as well as its compounds, have been investigated for the potential use as wound healing agents. In Brazil, Curatella americana is traditionally used by local people to treat wounds, ulcers and inflammations. However, to the best of our knowledge, its traditional use in the treatment of wounds has not been validated by a scientific study. Here, some compounds, many of them flavonoids, were identified in the hydroethanolic extract from the leaves of C. americana (HECA) by LC-HRMS and LC-MS/MS. Besides that, solutions containing different concentrations of HECA and a gel produced with this extract were evaluated for its antimicrobial, coagulant and wound healing activities on an excision mouse wound model as well as its acute dermal safety. A total of thirteen compounds were identified in HECA, mainly quercetin, kaempferol and glucoside derivatives of both, besides catechin and epicatechin known as wound healing agents. The group treated with 1% of HECA exhibited highest wound healing activity and best rate of wound contraction confirmed by histopathology results. The present study provides scientific evidence of, this extract (HECA) possess remarkable wound healing activity, thereby, supporting the traditional use.	[Teles Fujishima, Mayara Amoras; Cunha Sa, Dayse Maria; de Sousa Lima, Carolina Miranda; Bittencourt, Jose Prime Adolfo H. M.; Oliveira de Sousa, Francisco Fabio; dos Santos, Cleydson B. R.; da Silva, Jocivania Oliveira] Univ Fed Amapa, Postgrad Program Pharmaceut Innovat, Macapa, AP, Brazil; [Teles Fujishima, Mayara Amoras; Cunha Sa, Dayse Maria; de Sousa Lima, Carolina Miranda; da Silva, Jocivania Oliveira] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Toxicol, Macapa, AP, Brazil; [Teles Fujishima, Mayara Amoras; Bittencourt, Jose Prime Adolfo H. M.; dos Santos, Cleydson B. R.] Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, Macapa, AP, Brazil; [Assuncao Pereira, Washington Luiz] Fed Rural Univ Amazonia, Inst Anim Prod, Lab Anim Pathol, Belem, Para, Brazil; [Barbosa Muribeca, Abraao de Jesus; Yoshioka e Silva, Consuelo Yumiko; da Silva, Milton Nascimento] Fed Univ Para, Dept Chem, Lab Liquid Chromatog, Belem, Para, Brazil	Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa; Universidade Federal Rural da Amazonia (UFRA); Universidade Federal do Para	Fujishima, MAT (corresponding author), Univ Fed Amapa, Postgrad Program Pharmaceut Innovat, Macapa, AP, Brazil.; Fujishima, MAT (corresponding author), Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Toxicol, Macapa, AP, Brazil.; Fujishima, MAT (corresponding author), Univ Fed Amapa, Dept Biol & Hlth Sci, Lab Modeling & Computat Chem, Macapa, AP, Brazil.	mayarafuji@hotmail.com	de Sousa, Francisco Fábio Oliveira/O-7585-2019; Dos Santos, Cleydson Breno Rodrigues/G-5744-2015; PEREIRA, WASHINGTON/AAG-9373-2021	de Sousa, Francisco Fábio Oliveira/0000-0002-7366-1622; Dos Santos, Cleydson Breno Rodrigues/0000-0001-9878-6256; 	Postgraduate Program of Pharmaceutical Innovation	Postgraduate Program of Pharmaceutical Innovation	This study was supported by the Postgraduate Program of Pharmaceutical Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyare C, 2016, J ETHNOPHARMACOL, V177, P85, DOI 10.1016/j.jep.2015.11.008; Ahmed OM, 2018, BIOMED PHARMACOTHER, V101, P58, DOI 10.1016/j.biopha.2018.02.040; Alexandre-Moreira MS, 1999, J ETHNOPHARMACOL, V67, P171, DOI 10.1016/S0378-8741(99)00009-4; Barros ASA, 2017, BIOMED PHARMACOTHER, V96, P182, DOI 10.1016/j.biopha.2017.09.142; Amaral DD, 2016, BRAZ J BIOSC, V14, P257; Anchisi C, 2001, FARMACO, V56, P427, DOI 10.1016/S0014-827X(01)01055-2; [Anonymous], 2004, COSM PROD STAB GUID, V1; [Anonymous], 2010, BRAZ PHARM, V1, P546; [Anonymous], 2012, NAT FORM BRAZ PHARM; Baillon H, 1871, NATURAL HIST PLANTS, P1827; Barbosa Reinaldo Imbrozio, 2005, Acta Bot. Bras., V19, P323, DOI 10.1590/S0102-33062005000200015; Cabral MS, 2015, THESIS; Canuto J. Z., 2011, FILOGEOGRAFIA CURATE; Corrêa Nágila Maluf, 2005, Rev. Bras. Cienc. Farm., V41, P73, DOI 10.1590/S1516-93322005000100008; Costa ES, 2008, PHYTOTHER RES, V22, P705, DOI 10.1002/ptr.2397; de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026; de Toledo CEM, 2011, J ETHNOPHARMACOL, V133, P420, DOI 10.1016/j.jep.2010.10.021; ELAZIZI MM, 1980, J PHARM SCI, V69, P360, DOI 10.1002/jps.2600690333; Fernandez ML, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0396-1; FORM DM, 1983, P SOC EXP BIOL MED, V172, P214; Futagami A, 2002, LAB INVEST, V82, P1503, DOI 10.1097/01.LAB.0000035024.75914.39; Ghosh PK, 2013, J PHARM PHARM SCI, V16, P760, DOI 10.18433/J3831V; Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0; Guerrero MF, 2002, J ETHNOPHARMACOL, V80, P37, DOI 10.1016/S0378-8741(01)00420-2; GURNI AA, 1981, BIOCHEM SYST ECOL, V9, P109, DOI 10.1016/0305-1978(81)90028-4; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Hiruma-Lima CA, 2009, J ETHNOPHARMACOL, V121, P425, DOI 10.1016/j.jep.2008.10.017; Iwasaki Y, 2004, J GASTROENTEROL, V39, P831, DOI 10.1007/s00535-004-1399-5; Jeong WS, 2004, PHARM BIOL, V42, P84, DOI 10.3109/13880200490893500; Kant V, 2014, ACTA HISTOCHEM, V116, P5, DOI 10.1016/j.acthis.2013.04.010; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; KING D J, 1989, Reviews on Environmental Health, V8, P3; Kumara B, 2007, J ETHNOPHARMACOL, V114, P103, DOI 10.1016/j.jep.2007.08.010; Parente LML, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/375671; Leonardi GR, 2002, BRAS DERMATOL, V77, P563, DOI DOI 10.1590/S0365-05962002000500006; Lima C, 2014, J PHARMACOGN PHYTOCH, V3, P181; Lobmann R, 2005, DIABETES CARE, V28, P461, DOI 10.2337/diacare.28.2.461; Lopes TRM, 2014, BIOL, DOI [10.3109/13880209.2014.948634, DOI 10.3109/13880209.2014.948634]; Mandelbaum Samuel Henrique, 2003, An. Bras. Dermatol., V78, P393, DOI 10.1590/S0365-05962003000400002; Mercer PF, 2013, BBA-MOL BASIS DIS, V1832, P1018, DOI 10.1016/j.bbadis.2012.12.013; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Moura LD, 2014, MAR DRUGS, V12, P2471, DOI 10.3390/md12052471; Mulisa E, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0878-y; NCCLS, 2006, METH DIL ANT SUSC TE; Negrao R, 2013, J NUTR BIOCHEM, V24, P435, DOI 10.1016/j.jnutbio.2011.12.011; OECD, 2017, OECD GUIDELINES TEST, DOI [10.1787/9789264070585-en, DOI 10.1787/9789264070585-EN]; Lopes RHO, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9681425; Ousey K, 2016, J WOUND CARE, V25, P122, DOI 10.12968/jowc.2016.25.3.122; Pamplona S, 2015, MOLECULES, V20, P18777, DOI 10.3390/molecules201018777; Panchatcharam M, 2006, MOL CELL BIOCHEM, V290, P87, DOI 10.1007/s11010-006-9170-2; Ratter J. A., 2003, Edinburgh Journal of Botany, V60, P57, DOI 10.1017/S0960428603000064; Rhodes LE, 2013, BRIT J NUTR, V110, P891, DOI 10.1017/S0007114512006071; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shrivastava R, 2011, DIABETES RES CLIN PR, V92, P92, DOI 10.1016/j.diabres.2010.12.021; Singer AJ, 2008, NEW ENGL J MED, V359, P1037, DOI 10.1056/NEJMra0707253; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Souza CD, 2006, ACTA BOT BRAS, V20, P135, DOI DOI 10.1590/S0102-33062006000100013; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Suriyamoorthy S, 2012, REV BRAS FARMACOGN, V22, P1338, DOI 10.1590/S0102-695X2012005000121; Swamy HMK, 2007, J ETHNOPHARMACOL, V109, P529, DOI 10.1016/j.jep.2006.09.003; Talekar YP, 2017, J AYURVEDA INTEGR ME, V8, P73, DOI 10.1016/j.jaim.2016.11.007; Fujishima MAT, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11030072; Tsuruya M, 2014, APPL BIOCHEM BIOTECH, V174, P2223, DOI 10.1007/s12010-014-1124-7; Tulio AZ, 2014, FOOD CHEM, V157, P540, DOI 10.1016/j.foodchem.2014.02.047; Vila Verde GM, 2003, VER BRAS FARMACOG, V13, P64, DOI [10.1590/S0102-695X200300024, DOI 10.1590/S0102-695X200300024]; Villarroel Daniel, 2010, Ecología en Bolivia, V45, P116; World Health Organization (WHO), 2007, WHO GUID ASS QUAL HE; Yoon JJ, 2010, BIOCHEM BIOPH RES CO, V391, P96, DOI 10.1016/j.bbrc.2009.11.009; Zielins ER, 2015, EXPERT OPIN EMERG DR, V20, P235, DOI 10.1517/14728214.2015.1018176	72	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0225514	10.1371/journal.pone.0225514	http://dx.doi.org/10.1371/journal.pone.0225514			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929529	Green Published, gold			2022-12-26	WOS:000534352500004
J	Kwak, DE; Ko, T; Koh, HS; Ji, YW; Shin, J; Kim, K; Kim, HY; Lee, HK; Kim, Y				Kwak, Da Eun; Ko, Taeho; Koh, Han Seok; Ji, Yong Woo; Shin, Jisu; Kim, Kyeonghwan; Kim, Hye Yun; Lee, Hyung-Keun; Kim, YoungSoo			Alterations of aqueous humor A beta levels in A beta-infused and transgenic mouse models of Alzheimer disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; CLEARANCE; PLASMA; BRAIN; BIOMARKERS; GLAUCOMA; PEPTIDE; LENSES; TAU	Alzheimer's disease (AD) is an ageing-related neurodegenerative disease characterized and diagnosed by deposition of insoluble amyloid-beta (A ss) plaques in the brain. The plaque accumulation in the brain directly affects reduced levels of A beta in cerebrospinal fluid (CSF) and blood, as A beta can freely transport the blood-brain barrier, and clinical investigations have suggested these two biofluids as promising samples for in vitro diagnosis. Given that the human eye structurally resembles the brain and A beta accumulation often observed in the ocular region of AD patients, in this study, we examined aqueous humor A beta as another possible surrogate biomarker. First, using the acute A beta- infused AD mouse model by injecting A beta to the CSF in intracerebroventricular region of normal ICR mice, we investigated whether A beta concentration in the aqueous humor in AD models is positively correlated with the concentration in the CSF. Then, we examined the correlation of aqueous humor A beta levels with increased plaque deposition in the brain and reduced A beta levels in both CSF and blood in adult and aged 5XFAD Alzheimer transgenic mice. Collectively, the synthetic A beta injected into CSF immediately migrate to the aqueous humor, however, the age-dependently reducing pattern of A beta levels in CSF and blood was not observed in the aqueous humor.	[Kwak, Da Eun; Ko, Taeho; Shin, Jisu; Kim, Kyeonghwan; Kim, Hye Yun; Kim, YoungSoo] Yonsei Univ, Dept Pharm, Incheon, South Korea; [Kwak, Da Eun; Shin, Jisu; Kim, Kyeonghwan; Kim, Hye Yun; Kim, YoungSoo] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Incheon, South Korea; [Ko, Taeho; Kim, YoungSoo] Yonsei Univ, Ind Pharmaceut Sci, Incheon, South Korea; [Koh, Han Seok; Ji, Yong Woo; Lee, Hyung-Keun] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea; [Ji, Yong Woo] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Ophthalmol, Goyang, South Korea; [Kim, YoungSoo] Yonsei Univ, Integrated Sci & Engn Div, Incheon, South Korea; [Koh, Han Seok] Biorchestra, Daejeon, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; National Health Insurance Service; NHIS Ilsan Hospital; Yonsei University	Kim, Y (corresponding author), Yonsei Univ, Dept Pharm, Incheon, South Korea.; Kim, Y (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Incheon, South Korea.; Kim, Y (corresponding author), Yonsei Univ, Ind Pharmaceut Sci, Incheon, South Korea.; Lee, HK (corresponding author), Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol, Seoul, South Korea.; Kim, Y (corresponding author), Yonsei Univ, Integrated Sci & Engn Div, Incheon, South Korea.	shadik@yuhs.ac; y.kim@yonsei.ac.kr	Kim, YoungSoo/AAO-1970-2020	Kim, YoungSoo/0000-0001-5029-7082; Ji, Yong Woo/0000-0002-7211-6278; Kim, Hye Yun/0000-0003-3757-5652	National Research Foundation [NRF-2018R1A6A1A03023718, 2018R1D1A1B0704885, NRF-2018M3C7A1021858]; Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C1159]	National Research Foundation; Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This work was supported partially by National Research Foundation (Basic Science Research Program NRF-2018R1A6A1A03023718 and 2018R1D1A1B0704885 and Original Technology Research Program for Brain Science NRF-2018M3C7A1021858) and partially by the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by Ministry of Health & Welfare, Republic of Korea (HI18C1159).	Bayer AU, 2002, AM J OPHTHALMOL, V133, P135, DOI 10.1016/S0002-9394(01)01196-5; Bibl M, 2012, ELECTROPHORESIS, V33, P445, DOI 10.1002/elps.201100455; Blennow K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00345, 10.3389/fnins.2015.00345]; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Carandini T, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0543-7; Cho SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20185; Cho SM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06777; Chowdhury UR, 2010, INVEST OPHTH VIS SCI, V51, P4921, DOI 10.1167/iovs.10-5531; Colligris P, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/8538573; Danesh-Meyer Helen V, 2015, J Neuroophthalmol, V35 Suppl 1, pS22, DOI 10.1097/WNO.0000000000000293; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Donohue MC, 2015, ALZHEIMERS DEMENT, V11, P1069, DOI 10.1016/j.jalz.2014.07.156; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; Evans RW, 1998, NEUROL CLIN, V16, P83, DOI 10.1016/S0733-8619(05)70368-6; Fortmann SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24197-2; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Hampel H, 2004, MOL PSYCHIATR, V9, P705, DOI 10.1038/sj.mp.4001473; Hart NJ, 2016, ACTA NEUROPATHOL, V132, P767, DOI 10.1007/s00401-016-1613-6; Hillen H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01154; Jack CR, 2013, ACTA NEUROPATHOL, V126, P643, DOI 10.1007/s00401-013-1185-7; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Kanekiyo T, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00093; Kim HY, 2016, JOVE-J VIS EXP, DOI 10.3791/53308; Koronyo Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93621; Koronyo Y, 2012, NEURODEGENER DIS, V10, P285, DOI 10.1159/000335154; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; La Morgia C, 2016, ANN NEUROL, V79, P90, DOI 10.1002/ana.24548; Lashley T, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.031781; Lee JC, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0250-2; Lewczuk P, 2004, BIOL PSYCHIAT, V55, P524, DOI 10.1016/j.biopsych.2003.10.014; Lewczuk P, 2018, WORLD J BIOL PSYCHIA, V19, P244, DOI 10.1080/15622975.2017.1375556; Lim JKH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00536; Liu L., 2008, J VIS EXP; Liu P, 2018, P NATL ACAD SCI USA, V115, P9032, DOI 10.1073/pnas.1807982115; Lovheim H, 2017, ALZHEIMERS DEMENT, V13, P778, DOI 10.1016/j.jalz.2016.12.004; Mancino R, 2018, CURR NEUROPHARMACOL, V16, P971, DOI 10.2174/1570159X16666171206144045; Mansouri K, 2013, GRAEF ARCH CLIN EXP, V251, P2609, DOI 10.1007/s00417-013-2464-7; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Muller EG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221365; Niemantsverdriet E, 2017, ACTA NEUROL BELG, V117, P591, DOI 10.1007/s13760-017-0816-5; Parnell Miles, 2012, Int J Alzheimers Dis, V2012, P786494, DOI 10.1155/2012/786494; Perumal N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172481; Ratnayaka JA, 2015, EYE, V29, P1013, DOI 10.1038/eye.2015.100; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Silverberg N, 2018, ALZHEIMERS DEMENT, V14, P576, DOI 10.1016/j.jalz.2018.03.004; Takeda S, 2010, MOL BIOSYST, V6, P1760, DOI 10.1039/c003148h; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Teunissen CE, 2018, J ALZHEIMERS DIS, V62, P1857, DOI 10.3233/JAD-170784; Thompson J, 2015, PRIMARY CARE, V42, P409, DOI 10.1016/j.pop.2015.05.012; Tsolaki F, 2011, CLIN OPHTHALMOL, V5, P887, DOI 10.2147/OPTH.S22485; Wostyn P, 2019, ALZHEIMERS DEMENT, V15, P600, DOI 10.1016/j.jalz.2018.12.012	56	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227618	10.1371/journal.pone.0227618	http://dx.doi.org/10.1371/journal.pone.0227618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923257	gold, Green Published			2022-12-26	WOS:000534350000101
J	Chambers, ED; White, A; Vang, A; Wang, ZK; Ayala, A; Weng, TT; Blackburn, M; Choudhary, G; Rounds, S; Lu, Q				Chambers, Eboni D.; White, Alexis; Vang, Alexander; Wang, Zhengke; Ayala, Alfred; Weng, Tingting; Blackburn, Michael; Choudhary, Gaurav; Rounds, Sharon; Lu, Qing			Blockade of equilibrative nucleoside transporter 1/2 protects against Pseudomonas aeruginosa-induced acute lung injury and NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						acute lung injury; equilibrative nucleoside transporters; NLRP3 inflammasome; pneumonia; Pseudomonas aeruginosa	ADENOSINE-DEAMINASE DEFICIENCY; RESPIRATORY-DISTRESS-SYNDROME; EXTRACELLULAR ADENOSINE; INTERNATIONAL UNION; BARRIER DYSFUNCTION; PULMONARY; RECEPTORS; PNEUMONIA; CLASSIFICATION; EPIDEMIOLOGY	Pseudomonas aeruginosa infections are increasingly multidrug resistant and cause healthcare-associated pneumonia, a major risk factor for acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Adenosine is a signaling nucleoside with potential opposing effects; adenosine can either protect against acute lung injury via adenosine receptors or cause lung injury via adenosine receptors or equilibrative nucleoside transporter (ENT)-dependent intracellular adenosine uptake. We hypothesized that blockade of intracellular adenosine uptake by inhibition of ENT1/2 would increase adenosine receptor signaling and protect against P. aeruginosa-induced acute lung injury. We observed that P. aeruginosa (strain: PA103) infection induced acute lung injury in C57BL/6 mice in a dose- and time-dependent manner. Using ENT1/2 pharmacological inhibitor, nitrobenzylthioinosine (NBTI), and ENT1-null mice, we demonstrated that ENT blockade elevated lung adenosine levels and significantly attenuated P. aeruginosa-induced acute lung injury, as assessed by lung wet-to-dry weight ratio, BAL protein levels, BAL inflammatory cell counts, pro-inflammatory cytokines, and pulmonary function (total lung volume, static lung compliance, tissue damping, and tissue elastance). Using both agonists and antagonists directed against adenosine receptors A(2A)R and A(2B)R, we further demonstrated that ENT1/2 blockade protected against P. aeruginosa -induced acute lung injury via activation of A(2A)R and A(2B)R. Additionally, ENT1/2 chemical inhibition and ENT1 knockout prevented P. aeruginosa-induced lung NLRP3 inflammasome activation. Finally, inhibition of inflammasome prevented P. aeruginosa-induced acute lung injury. Our results suggest that targeting ENT1/2 and NLRP3 inflammasome may be novel strategies for prevention and treatment of P. aeruginosa-induced pneumonia and subsequent ARDS.	[Chambers, Eboni D.; White, Alexis; Vang, Alexander; Wang, Zhengke; Choudhary, Gaurav; Rounds, Sharon; Lu, Qing] Brown Univ, Alpert Med Sch, Providence Vet Affairs Med Ctr, Vasc Res Lab, Providence, RI 02912 USA; [Ayala, Alfred] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Div Surg Res, Providence, RI 02903 USA; [Weng, Tingting; Blackburn, Michael] Univ Texas Houston, Sch Med, Dept Biochem, Houston, TX USA; [Weng, Tingting; Blackburn, Michael] Univ Texas Houston, Sch Med, Dept Mol Biol, Houston, TX USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Lu, Q (corresponding author), Providence VA Med Ctr, Res Serv, 830 Chalkstone Ave, Providence, RI 02908 USA.	Qing_Lu@brown.edu	Rounds, Sharon/AAF-7380-2020; Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL130230, HL128661]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [P20 GM103652, R35GM118097]; NIH [AR073284]; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS) [T32 ES007272]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL130230 and HL128661; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20 GM103652 and R35GM118097; NIH, Grant/Award Number: AR073284; HHS | NIH | National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: T32 ES007272	Aggarwal NR, 2013, AM J RESP CELL MOL, V48, P635, DOI 10.1165/rcmb.2012-0351OC; Alfaro TM, 2017, PULM PHARMACOL THER, V45, P90, DOI 10.1016/j.pupt.2017.04.009; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Archer RGE, 2004, BRIT J PHARMACOL, V143, P202, DOI 10.1038/sj.bjp.0705921; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 1999, MOL MED TODAY, V5, P216, DOI 10.1016/S1357-4310(99)01459-8; Barletta KE, 2012, ARTERIOSCL THROM VAS, V32, P856, DOI 10.1161/ATVBAHA.111.226845; Baron L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.576; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Borgas D, 2016, AM J RESP CELL MOL, V54, P683, DOI 10.1165/rcmb.2015-0149OC; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; de Zoete MR, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016287; Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2013, FASEB J, V27, P3078, DOI 10.1096/fj.13-228551; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Fukumoto J, 2013, AM J PHYSIOL-CELL PH, V305, pC182, DOI 10.1152/ajpcell.00086.2013; Furuta GT, 2014, ANN ALLERG ASTHMA IM, V113, P3, DOI 10.1016/j.anai.2014.04.002; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Ibrahim EH, 2000, CHEST, V117, P1434, DOI 10.1378/chest.117.5.1434; Jin LL, 2017, J IMMUNOL, V198, P1253, DOI 10.4049/jimmunol.1601745; KOLLER DY, 1994, THORAX, V49, P496, DOI 10.1136/thx.49.5.496; Kumar VS, 2014, JOVE-J VIS EXP, DOI 10.3791/52044; Linch SN, 2009, INFECT IMMUN, V77, P4976, DOI 10.1128/IAI.00306-09; Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010; Longhi MS, 2013, J MOL MED, V91, P165, DOI 10.1007/s00109-012-0991-z; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Lu Q, 2013, AM J PHYSIOL-LUNG C, V304, pL361, DOI 10.1152/ajplung.00161.2012; Lu Q, 2012, AM J RESP CELL MOL, V47, P604, DOI 10.1165/rcmb.2012-0012OC; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Lu Q, 2010, AM J PHYSIOL-LUNG C, V298, pL755, DOI 10.1152/ajplung.00330.2009; Meduri GU, 1998, AM J RESP CRIT CARE, V158, P870, DOI 10.1164/ajrccm.158.3.9706112; Morote-Garcia JC, 2013, AM J RESP CELL MOL, V49, P296, DOI 10.1165/rcmb.2012-0457OC; Ramirez-Estrada S, 2016, INFECT DRUG RESIST, V9, P7, DOI 10.2147/IDR.S50669; Schultz MJ, 2003, INFECT IMMUN, V71, P1630, DOI 10.1128/IAI.71.4.1630-1634.2003; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; US Department of Health and Human Services Centers for Disease Control and Prevention., 2013, ANT RES THREATS US; Villar J, 2016, CURR OPIN CRIT CARE, V22, P1, DOI 10.1097/MCC.0000000000000266; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Wilson CN, 2002, J ENDOTOXIN RES, V8, P263, DOI 10.1179/096805102125000470; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093	57	16	17	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1516	1531		10.1096/fj.201902286R	http://dx.doi.org/10.1096/fj.201902286R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914698	Green Accepted, Bronze			2022-12-26	WOS:000507308900100
J	Chen, PH; Chen, YT; Chu, TY; Ma, TH; Wu, MH; Lin, HH; Chang, YS; Tan, BCM; Lo, SJ				Chen, Po-Hsiang; Chen, Yi-Tung; Chu, Tai-Ying; Ma, Tian-Hsiang; Wu, Mei-Hsuan; Lin, Hsi-Hsien; Chang, Yu-Sun; Tan, Bertrand Chin-Ming; Lo, Szecheng J.			Nucleolar control by a non-apoptotic p53-caspases-deubiquitinylase axis promotes resistance to bacterial infection	FASEB JOURNAL			English	Article						bacterial resistance; caspases; deubiquitinylase; fibrillarin; nucleolus; p53	PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; RIBOSOMAL-RNA; TRANSLATIONAL INHIBITION; C-ELEGANS; P53; ACTIVATION; CANCER; DISRUPTION; CASPASES	The nucleolus is best known for its cellular role in regulating ribosome production and growth. More recently, an unanticipated role for the nucleolus in innate immunity has recently emerged whereby downregulation of fibrillarin and nucleolar contraction confers pathogen resistance across taxa. The mechanism of this downregulation, however, remains obscure. Here we report that rather than fibrillarin itself being the proximal factor in this pathway, the key player is a fibrillarin-stabilizing deubiquitinylase USP-33. This was discovered by a candidate-gene search of Caenorhabditis elegans in which CED-3 caspase was revealed to execute targeted cleavage of USP-33, thus destabilizing fibrillarin. We also showed that cep-1 and ced-3 mutant worms altered nucleolar size and decreased antimicrobial peptide gene, spp-1, expression rendering susceptibility to bacterial infection. These phenotypes were reversed by usp-33 knockdown, thus linking the CEP-1-CED-3-USP-33 pathway with nucleolar control and resistance to bacterial infection in worms. Parallel experiments with the human analogs of caspases and USP36 revealed similar roles in coordinating these two processes. In summary, our work outlined a conserved cascade that connects cell death signaling to nucleolar control and innate immune response.	[Chen, Po-Hsiang; Chen, Yi-Tung; Wu, Mei-Hsuan; Tan, Bertrand Chin-Ming; Lo, Szecheng J.] Chang Gung Univ, Dept Biomed Sci, Coll Med, Taoyuan, Taiwan; [Chen, Po-Hsiang; Lin, Hsi-Hsien; Chang, Yu-Sun; Tan, Bertrand Chin-Ming; Lo, Szecheng J.] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan; [Chu, Tai-Ying; Lin, Hsi-Hsien] Chang Gung Univ, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Ma, Tian-Hsiang; Chang, Yu-Sun; Tan, Bertrand Chin-Ming] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Dept Neurosurg, Lin Kou Med Ctr, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chang, YS; Tan, BCM; Lo, SJ (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan.	ysc@mail.cgu.edu.tw; btan@mail.cgu.edu.tw; losj@mail.cgu.edu.tw	LIN, Hsi-Hsien/N-1488-2015	Chen, Yi-Tung/0000-0001-9715-648X; Chu, Tang-Yuan/0000-0003-2717-2681	Ministry of Science and Technology, Taiwan (MOST) [MOST105-2314-B-182-061-MY4]; Chang Gung Memorial Hospital (CGMH) [BMRP742]; Ministry of Education (MOE) [EMRPD1C0051]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (CGMH)(Chang Gung Memorial Hospital); Ministry of Education (MOE)(Ministry of Education, Singapore)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST104-2320-B-182-029-MY3; Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST105-2314-B-182-061-MY4; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: CMRPD1F0442; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: CMRPD1H0021; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: BMRP960; Chang Gung Memorial Hospital (CGMH), Grant/Award Number: BMRP742; Ministry of Education (MOE), Grant/Award Number: EMRPD1C0051	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Bastide A, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0044-8; BRENNER S, 1974, GENETICS, V77, P71; Buchwalter A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00322-z; Chen LD, 2015, ONCOTARGET, V6, P10207, DOI 10.18632/oncotarget.3504; Cmarko D, 2008, HISTOL HISTOPATHOL, V23, P1291, DOI 10.14670/HH-23.1291; Conradt B, 2016, GENETICS, V203, P1533, DOI 10.1534/genetics.115.186247; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Genuth NR, 2018, MOL CELL, V71, P364, DOI 10.1016/j.molcel.2018.07.018; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Hollville E, 2018, SEMIN CELL DEV BIOL, V82, P127, DOI 10.1016/j.semcdb.2017.11.037; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Khajuria RK, 2018, CELL, V173, P90, DOI 10.1016/j.cell.2018.02.036; Kumar S, 2015, LEUKEMIA LYMPHOMA, V56, P1846, DOI 10.3109/10428194.2014.974042; Labed SA, 2018, IMMUNITY, V48, P963, DOI 10.1016/j.immuni.2018.04.017; Lee CC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.114; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; McIlwain DR, 2015, CSH PERSPECT BIOL, V7; Mello SS, 2018, CURR OPIN CELL BIOL, V51, P65, DOI 10.1016/j.ceb.2017.11.005; Menon Vijay, 2014, Subcell Biochem, V85, P321, DOI 10.1007/978-94-017-9211-0_17; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nakajima YI, 2017, CELL DEATH DIFFER, V24, P1422, DOI 10.1038/cdd.2017.36; Nicholson SA, 2001, CANCER RES, V61, P5636; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Park SY, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.52; Parrales A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00288; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; PERRY RP, 1968, J CELL PHYSIOL, V72, P235, DOI 10.1002/jcp.1040720311; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Pinan-Lucarre B, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001331; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Raska I, 2006, CURR OPIN CELL BIOL, V18, P325, DOI 10.1016/j.ceb.2006.04.008; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Shaham S, 1998, J BIOL CHEM, V273, P35109, DOI 10.1074/jbc.273.52.35109; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Sun XX, 2015, CELL CYCLE, V14, P3786, DOI 10.1080/15384101.2015.1093713; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Tiku V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06051-1; Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tsai RYL, 2014, FASEB J, V28, P3290, DOI 10.1096/fj.14-254680; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Uppaluri S, 2016, CELL REP, V17, P345, DOI 10.1016/j.celrep.2016.09.007; Wang P, 2007, P NATL ACAD SCI USA, V104, P4054, DOI 10.1073/pnas.0700020104; Weaver BP, 2014, ELIFE, V3, DOI 10.7554/eLife.04265; Wu YC, 2000, GENE DEV, V14, P536; Xue D, 1996, GENE DEV, V10, P1073, DOI 10.1101/gad.10.9.1073; Yang K, 2018, CELL STRESS, V2, P125, DOI 10.15698/cst2018.06.139; Yang K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13599; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Yi YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005580; Yu H, 2015, BIOCHEM J, V470, P145, DOI 10.1042/BJ20150563; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	68	1	1	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1107	1121		10.1096/fj.201901959R	http://dx.doi.org/10.1096/fj.201901959R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914708	hybrid			2022-12-26	WOS:000507308900075
J	Schilperoort, M; Bravenboer, N; Lim, J; Mletzko, K; Busse, B; van Ruijven, L; Kroon, J; Rensen, PCN; Kooijman, S; Winter, EM				Schilperoort, Maaike; Bravenboer, Nathalie; Lim, Joann; Mletzko, Kathrin; Busse, Bjoern; van Ruijven, Leo; Kroon, Jan; Rensen, Patrick C. N.; Kooijman, Sander; Winter, Elizabeth M.			Circadian disruption by shifting the light-dark cycle negatively affects bone health in mice	FASEB JOURNAL			English	Article						bone mineralization; bone structure; bone turnover; circadian rhythm; clock genes	TURNOVER MARKERS; GENE-EXPRESSION; CLOCK; WORK; MINERALIZATION; RESORPTION; RHYTHMS; MOUSE; STRENGTH; SKELETAL	The past decade, it has become evident that circadian rhythms within metabolically active tissues are very important for physical health. However, although shift work has also been associated with an increased risk of fractures, circadian rhythmicity has not yet been extensively studied in bone. Here, we investigated which genes are rhythmically expressed in bone, and whether circadian disruption by shifts in light-dark cycle affects bone turnover and structure in mice. Our results demonstrate diurnal expression patterns of clock genes (Rev-erb alpha, Bmal1, Per1, Per2, Cry1, Clock), as well as genes involved in osteoclastogenesis, osteoclast proliferation and function (Rankl, Opg, Ctsk), and osteocyte function (c-Fos) in bone. Weekly alternating light-dark cycles disrupted rhythmic clock gene expression in bone and caused a reduction in plasma levels of procollagen type 1 amino-terminal propeptide (P1NP) and tartrate-resistant acidic phosphatase (TRAP), suggestive of a reduced bone turnover. These effects coincided with an altered trabecular bone structure and increased cortical mineralization after 15 weeks of light-dark cycles, which may negatively affect bone strength in the long term. Collectively, these results show that a physiological circadian rhythm is important to maintain bone health, which stresses the importance of further investigating the association between shift work and skeletal disorders.	[Schilperoort, Maaike; Bravenboer, Nathalie; Lim, Joann; Kroon, Jan; Rensen, Patrick C. N.; Kooijman, Sander; Winter, Elizabeth M.] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Postal Zone 9600, NL-2300 RC Leiden, Netherlands; [Schilperoort, Maaike; Lim, Joann; Kroon, Jan; Rensen, Patrick C. N.; Kooijman, Sander; Winter, Elizabeth M.] Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Bravenboer, Nathalie; Winter, Elizabeth M.] Leiden Univ, Med Ctr, Ctr Bone Qual, Dept Med, Leiden, Netherlands; [Bravenboer, Nathalie] Vrije Univ Amsterdam, Amsterdam Movement Sci, Dept Clin Chem, Amsterdam, Netherlands; [Mletzko, Kathrin; Busse, Bjoern] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech IOBM, Hamburg, Germany; [van Ruijven, Leo] Acad Ctr Dent Amsterdam ACTA, Dept Funct Anat, Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Winter, EM (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Postal Zone 9600, NL-2300 RC Leiden, Netherlands.; Winter, EM (corresponding author), Leiden Univ, Med Ctr, Ctr Bone Qual, Postal Zone 9600, NL-2300 RC Leiden, Netherlands.	e.m.winter@lumc.nl	Kooijman, Sander/S-3857-2016; Schilperoort, Maaike/AAM-3846-2021; Winter, Elizabeth M./ABI-7501-2020; Rensen, Patrick C.N./D-7176-2018	Kooijman, Sander/0000-0002-0014-5571; Winter, Elizabeth M./0000-0002-0119-1588; Rensen, Patrick C.N./0000-0002-8455-4988; Busse, Bjorn/0000-0002-3099-8073	Leiden University Fund / Elise Mathilde Fund; Board of Directors of Leiden University Medical Center; Dutch Heart Foundation [2017T016]; European Foundation for the Study of Diabetes [RS FS 2016_3]	Leiden University Fund / Elise Mathilde Fund; Board of Directors of Leiden University Medical Center; Dutch Heart Foundation(Netherlands Heart Foundation); European Foundation for the Study of Diabetes	This work was supported by a personal grant of the Leiden University Fund / Elise Mathilde Fund to EMW and by a personal grants from the Board of Directors of Leiden University Medical Center to MS. Additionally, this work was supported by the Dutch Heart Foundation (grant 2017T016 to SK) and the European Foundation for the Study of Diabetes (grant RS FS 2016_3 to SK). We thank Natasha Appelman-Dijkstra (Division of Endocrinology, Department of Medicine, Center for Bone Quality, LUMC, Leiden, the Netherlands) for her valuable support and constructive recommendations. We thank Lianne van der Wee-Pals, Hetty Sips, Trea Streefland, Cheraine Bouten, Isabel Mol and Chris van der Bent (Division of Endocrinology, Department of Medicine, LUMC, Leiden, The Netherlands), and Huib van Essen (Department of Clinical Chemistry, Amsterdam University Medical Center, Amsterdam, The Netherlands) for their excellent technical assistance.	Alswat Khaled A, 2017, J Clin Med Res, V9, P382, DOI 10.14740/jocmr2970w; Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; Aoyama S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00063; Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98; Brennan TA, 2014, DIS MODEL MECH, V7, P583, DOI 10.1242/dmm.014928; Burr DB, 2014, BASIC AND APPLIED BONE BIOLOGY, P3, DOI 10.1016/B978-0-12-416015-6.00001-0; CURREY JD, 1984, PHILOS T ROY SOC B, V304, P509, DOI 10.1098/rstb.1984.0042; Fehrendt H, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/318924; Feskanich D, 2009, OSTEOPOROSIS INT, V20, P537, DOI 10.1007/s00198-008-0729-5; Follet H, 2004, BONE, V34, P783, DOI 10.1016/j.bone.2003.12.012; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fujihara Y, 2014, BONE, V61, P1, DOI 10.1016/j.bone.2013.12.026; Greenblatt MB, 2017, CLIN CHEM, V63, P464, DOI 10.1373/clinchem.2016.259085; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hirai T, 2014, J CELL SCI, V127, P3711, DOI 10.1242/jcs.148148; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V217, P264, DOI 10.1006/bbrc.1995.2773; Johannesdottir F, 2017, BONE, V105, P93, DOI 10.1016/j.bone.2017.07.023; Kiehn JT, 2017, COMPR PHYSIOL, V7, P383, DOI 10.1002/cphy.c160017; Kivell TL, 2016, J ANAT, V228, P569, DOI 10.1111/joa.12446; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Komoto S, 2012, CHRONOBIOL INT, V29, P66, DOI 10.3109/07420528.2011.636496; Koorneef LL, 2018, ENDOCRINOLOGY, V159, P3925, DOI 10.1210/en.2018-00671; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mohamed AM, 2008, MALAYS J MED SCI, V15, P4; Mukherji A, 2019, J HEPATOL, V71, P200, DOI 10.1016/j.jhep.2019.03.020; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; Pouresmaeili F, 2018, THER CLIN RISK MANAG, V14, P2029, DOI 10.2147/TCRM.S138000; Quevedo I, 2010, J CLIN DENSITOM, V13, P467, DOI 10.1016/j.jocd.2010.07.004; Redmond J, 2016, J CLIN ENDOCR METAB, V101, P3222, DOI 10.1210/jc.2016-1183; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Rouhi G, 2004, FORMA, V19, P165, DOI [10.1016/j.ijengsci.2006.02.001, DOI 10.1016/J.IJENGSCI.2006.02.001]; Samsa WE, 2016, BONE, V84, P194, DOI 10.1016/j.bone.2016.01.006; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Schilperoort M, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12614; Sozen T, 2017, EUR J RHEUMATOL, V4, P46, DOI 10.5152/eurjrheum.2016.048; Sun M, 2018, OBES REV, V19, P28, DOI 10.1111/obr.12621; Swanson CM, 2017, J CLIN ENDOCR METAB, V102, P3722, DOI 10.1210/jc.2017-01147; Takarada T, 2017, J BONE MINER RES, V32, P872, DOI 10.1002/jbmr.3053; Tobias JH, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00020; Torquati L, 2018, SCAND J WORK ENV HEA, V44, P229, DOI 10.5271/sjweh.3700; Tsao YT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010159; van't Hof RJ, 2017, BONE, V99, P69, DOI 10.1016/j.bone.2017.03.051; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y; Xu C, 2016, J BONE MINER RES, V31, P1344, DOI 10.1002/jbmr.2803; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yuan GS, 2017, J BONE MINER RES, V32, P861, DOI 10.1002/jbmr.3046; Zimmermann EA, 2019, J BONE MINER RES, V34, P1461, DOI 10.1002/jbmr.3730	55	13	18	5	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1052	1064		10.1096/fj.201901929R	http://dx.doi.org/10.1096/fj.201901929R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914701	hybrid, Green Published			2022-12-26	WOS:000507308900071
J	Wang, L; Cheng, N; Wang, P; Li, J; Jia, AN; Li, WY; Zhang, N; Yin, YX; Tong, L; Wei, Q; Liu, GW; Li, ZM; Luo, J				Wang, Lu; Cheng, Na; Wang, Ping; Li, Jing; Jia, Anna; Li, Wenying; Zhang, Nan; Yin, Yanxia; Tong, Li; Wei, Qun; Liu, Guangwei; Li, Zhimei; Luo, Jing			A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcineurin; NFAT transcription factor; enzyme inhibitor; cytokine; cellular immune response	ACTIVATED T-CELLS; NUCLEAR FACTOR; AIRWAY INFLAMMATION; GENE-EXPRESSION; CYCLOSPORINE-A; INHIBITION; PHOSPHATASE; IDENTIFICATION; CALCIUM; PATHWAY	The calcineurin/nuclear factor of activated T cell (CN/NFAT) signaling pathway plays a critical role in the immune response. Therefore, inhibition of the CN/NFAT pathway is an important target for inflammatory disease. The conserved PXIXIT and LXVP motifs of CN substrates and targeting proteins have been recognized. Based on the affinity ability and inhibitory effect of these docking sequences on CN, we designed a bioactive peptide (named pep3) against the CN/NFAT interaction, which has two binding sites derived from the RCAN1-PXIXIT motif and the NFATc1-LXVP motif. The shortest linker between the two binding sites in pep3 is derived from A238L, a physiological binding partner of CN. Microscale thermophoresis revealed that pep3 has two docking sites on CN. Pep3 also has the most potent inhibitory effect on CN. It is suggested that pep3 contains an NFATc1-LXVP?substrate recognition motif and RCAN1-PXIXIT?mediated anchoring to CN. Expression of this peptide significantly suppresses CN/NFAT signaling. Cell-permeable 11-arginine?modified pep3 (11R-pep3) blocks the NFAT downstream signaling pathway. Intranasal administration of the 11R-pep3 peptide inhibits airway inflammation in an ovalbumin-induced asthma model. Our results suggest that pep3 is promising as an immunosuppressive agent and can be used in topical remedies.	[Wang, Lu; Cheng, Na; Wang, Ping; Li, Jing; Jia, Anna; Li, Wenying; Zhang, Nan; Yin, Yanxia; Tong, Li; Wei, Qun; Liu, Guangwei; Luo, Jing] Beijing Normal Univ, Key Lab Cell Proliferat & Regulat Biol, Gene Engn & Biotechnol Beijing Key Lab, Dept Biochem & Mol Biol,Minist Educ,Coll Life Sci, Beijing 100875, Peoples R China; [Li, Zhimei] Capital Med Univ, China Natl Clin Res Ctr Neurol Dis, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China; [Li, Jing] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60635 USA	Beijing Normal University; Capital Medical University; University of Chicago	Li, ZM (corresponding author), Capital Med Univ, China Natl Clin Res Ctr Neurol Dis, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China.; Luo, J (corresponding author), Beijing Normal Univ, Dept Biochem & Mol Biol, Gene Engn & Biotechnol Beijing Key Lab, 19 Xinjiekouwaidajie, Beijing 100875, Peoples R China.	lizm1211@163.com; luojing@bnu.edu.cn		LI, Jing/0000-0003-3277-6818	National Nature Science Foundation of China [81373389, 31700695]; research fund for China Association Against Epilepsy-UCB program [2017010]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); research fund for China Association Against Epilepsy-UCB program	This work was supported by National Nature Science Foundation of China Project Grants 81373389 (to J. L.) and 31700695 (to Y. Y.) and the research fund for China Association Against Epilepsy-UCB program 2017010. The authors declare that they have no conflicts of interest with the contents of this article.	Abrams CC, 2008, VIROLOGY, V374, P477, DOI 10.1016/j.virol.2008.01.005; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Aubareda A, 2006, CELL SIGNAL, V18, P1430, DOI 10.1016/j.cellsig.2005.11.006; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; Mulero MC, 2010, ANAL BIOCHEM, V398, P99, DOI 10.1016/j.ab.2009.10.045; Choi JM, 2012, IMMUNOL LETT, V143, P170, DOI 10.1016/j.imlet.2012.01.016; FUKUDA T, 1995, ANN ALLERG ASTHMA IM, V75, P65; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Grigoriu S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001492; Li CX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14275; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu J, 2001, J IMMUNOL, V167, P2677, DOI 10.4049/jimmunol.167.5.2677; Lunding LP, 2015, J IMMUNOL, V194, P5615, DOI 10.4049/jimmunol.1402529; Luo J, 2008, BRAIN RES BULL, V76, P464, DOI 10.1016/j.brainresbull.2007.12.005; Luo J, 2014, HUM MOL GENET, V23, P6567, DOI 10.1093/hmg/ddu377; Ma B, 2015, J NEUROSCI, V35, P10799, DOI 10.1523/JNEUROSCI.2455-14.2015; Ma YP, 2015, INT J BIOL MACROMOL, V72, P254, DOI 10.1016/j.ijbiomac.2014.08.042; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Martinez-Martineza S, 2009, P NATL ACAD SCI USA, V106, P6117, DOI 10.1073/pnas.0812544106; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mehta S, 2009, MOL CELL BIOL, V29, P2777, DOI 10.1128/MCB.01197-08; Mulero MC, 2009, J BIOL CHEM, V284, P9394, DOI 10.1074/jbc.M805889200; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02934-3; Rao A, 2009, NAT IMMUNOL, V10, P3, DOI 10.1038/ni0109-3; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Roh SS, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/781425; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Slupe AM, 2013, J BIOL CHEM, V288, P12353, DOI 10.1074/jbc.M113.459677; Song RW, 2017, BIOCHIMIE, V142, P158, DOI 10.1016/j.biochi.2017.09.002; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Wei Q, 1997, BIOCHEM MOL BIOL INT, V41, P169; WEI Q, 1988, J BIOL CHEM, V263, P19541; Zhao YN, 2016, BIOCHIMIE, V127, P50, DOI 10.1016/j.biochi.2016.04.011	36	9	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2760	2770		10.1074/jbc.RA119.010254	http://dx.doi.org/10.1074/jbc.RA119.010254			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31941790	Green Published, hybrid			2022-12-26	WOS:000519969100020
J	Mupere, E; Babikako, HM; Okaba-Kayom, V; Mutyaba, RB; Mwisaka, MN; Tenywa, E; Lula, A; Aceng, JR; Mpanga-Kaggwa, F; Matseketse, D; Aga, E				Mupere, Ezekiel; Babikako, Harriet M.; Okaba-Kayom, Violet; Mutyaba, Robert B.; Mwisaka, Milton Nasiero; Tenywa, Emmanuel; Lula, Albert; Aceng, Jane Ruth; Mpanga-Kaggwa, Flavia; Matseketse, David; Aga, Eresso			Family Health Days program contributions in vaccination of unreached and under-immunized children during routine vaccinations in Uganda	PLOS ONE			English	Article							STRATEGY	Background We explored the contributions of the Family Health Days (FHDs) concept, which was developed by the Uganda Ministry of Health (MOH) and UNICEF as a supplementary quarterly outreach program in addition to strengthening the routine expanded program for immunization (EPI), with the aim to increase coverage, through improved access to the unimmunized or unreached and under-immunized children under 5 years. Method A cross-sectional descriptive study of the Uganda MOH, Health Management Information Systems (HMIS) and UNICEF in house FHDs data was conducted covering six quarterly implementations of the program between April 2012 and December 2013. The FHDs program was implemented in 31 priority districts with low routine vaccination coverage from seven sub-regions in Uganda in a phased manner using places of worship for service delivery. Results During the six rounds of FHDs in the 31 districts, a total of 178,709 and 191,223 children received measles and Diphtheria-Pertussis-Tetanus (DPT3) vaccinations, respectively. The FHDs' contributions were 126% and 144% for measles and 103% and 122% for DPT3 in 2012 and 2013, respectively of the estimated unreached annual target populations. All implementing sub-regions after two rounds in 2012 attained over and above the desired target for DPT3 (85%) and measles (90%). The same was true in 2013 after four rounds, except for Karamoja and West Nile sub-regions, where in some districts a substantial proportion of children remained unimmunized. The administrative data for both DPT3 and measles immunization showed prominent and noticeable increase in coverage trend in FHDS regions for the months when the program was implemented. Conclusion The FHDs program improved vaccination equity by reaching the unreached and hard-to-reach children and bridging the gap in immunization coverage, and fast tracking the achievement of targets recommended by the Global Vaccine Action Plan (GVAP) for measles and DPT3 (85% and 90% respectively) in implementing sub-regions and districts. The FHDs is an innovative program to supplement routine immunizations designed to reach the unreached and under immunized children.	[Mupere, Ezekiel; Okaba-Kayom, Violet] Makerere Univ, Dept Paediat, Kampala, Uganda; [Mupere, Ezekiel; Okaba-Kayom, Violet] Makerere Univ, Child Hlth Coll Hlth Sci, Kampala, Uganda; [Mupere, Ezekiel; Babikako, Harriet M.] Child & Family Fdn Uganda, Res & Data Syst Ctr, Kampala, Uganda; [Babikako, Harriet M.] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Mutyaba, Robert B.] RBMTM Syst Consult Ltd, Informat Syst & Programming, Kampala, Uganda; [Mwisaka, Milton Nasiero] Minist Hlth, Jinja Reg Referral Hosp, Social Work Unit, Jinja, Uganda; [Tenywa, Emmanuel] Minist Hlth, Jinja Reg Referral Hosp, Paediat, Jinja, Uganda; [Lula, Albert] Minist Hlth, Nutr Unit, Kampala, Uganda; [Aceng, Jane Ruth] Minist Hlth, Kampala, Uganda; [Mpanga-Kaggwa, Flavia; Matseketse, David] UNICEF Uganda Country Off, Kampala, Uganda; [Aga, Eresso] UNICEF Jordan Country Off, Amman, Jordan	Makerere University; Makerere University; Makerere University	Mupere, E (corresponding author), Makerere Univ, Dept Paediat, Kampala, Uganda.; Mupere, E (corresponding author), Makerere Univ, Child Hlth Coll Hlth Sci, Kampala, Uganda.; Mupere, E (corresponding author), Child & Family Fdn Uganda, Res & Data Syst Ctr, Kampala, Uganda.	mupez@yahoo.com		Mupere, Ezekiel/0000-0002-8746-9009	UNICEF Uganda [43149306]	UNICEF Uganda	UNICEF Uganda provided operational funds that supported the study field activities through contracting of Child and Family Foundation Uganda (CFU), a non-government organization under contract number 43149306 but UNICEF Uganda did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. CFU paid field supervision expenses to EM, HMB, VKO, RBM, MNM, and ET in the conduct of the study. Robert B. Mutyaba was affiliated to RBMTM Systems, a commercial company but RBMTM Systems had no role in the funding and conduct of the study.; The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of UNICEF on Family Health Days (FHDs) in Uganda. We are grateful to UNICEF staff Uganda at both Kampala and Zonal offices; Ministry of Health; District Health Teams in FHDs implementing districts; and Faith-based Organization partners and staff who participated in a series of consultative meetings and interviews; and all field participants who contributed information through interviews and discussions.	Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; [Anonymous], 2012, UG DEM HLTH SURV 201; Babirye JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-723; Banerjee K, 2007, COMPREHENSIVE EVALUA; DeHaven MJ, 2004, AM J PUBLIC HEALTH, V94, P1030, DOI 10.2105/AJPH.94.6.1030; GAVI, 2012, OR GAVI; Government of Uganda, 2007, IMM PRACT UG MAN OP; Kamara L, 2013, HEALTH POLICY PLANN, V28, P11, DOI 10.1093/heapol/czs020; LaFond A, 2015, HEALTH POLICY PLANN, V30, P298, DOI 10.1093/heapol/czu011; Nshimirimana D, 2013, J VACCINES IMMUN, V1, P6; Nuwaha F, 2000, E AFR MED J, V77, P66; Okwo-Bele JM, 2011, VACCINE, V29, pD74, DOI 10.1016/j.vaccine.2012.01.080; Olivier, 2014, LOCAL FAITH COMMUNIT; Palmer AC, 2013, FOOD NUTR BULL, V34, P412, DOI 10.1177/156482651303400406; Ryman T, 2010, J PUBLIC HEALTH-UK, V32, P18, DOI 10.1093/pubmed/fdp048; Shen AK, 2014, GLOB HEALTH-SCI PRAC, V2, P381, DOI 10.9745/GHSP-D-14-00137; UNICEF, 2012, COMB ANT RUM LESS LE; WHO UNICEF, 2012, UGANDA NAT EXP PROGR; World Health Organization, 2009, EP UN CHILD FIND PEE; World Health Organization, 2008, AFRO RED GUID IMPL R	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0218239	10.1371/journal.pone.0218239	http://dx.doi.org/10.1371/journal.pone.0218239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951608	Green Published, gold			2022-12-26	WOS:000534370500001
J	Funeshima, N; Tanikawa, N; Yaginuma, H; Watanabe, H; Iwata, H; Kuwayama, T; Hamano, S; Shirasuna, K				Funeshima, Natsumi; Tanikawa, Nao; Yaginuma, Hikari; Watanabe, Hiroyuki; Iwata, Hisataka; Kuwayama, Takehito; Hamano, Seizo; Shirasuna, Koumei			Adverse reproductive effects of S100A9 on bovine sperm and early embryonic development in vitro	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; FERTILIZATION; ENDOMETRIUM; TIME; IMPLANTATION; EXPRESSION; PROTEINS; IMPROVES; OOCYTES; GAMETE	The phenomenon of aging arises from multiple, complex interactions causing dysfunction in cells and organs. In particular, fertility drastically decreases with age. Previously, we have demonstrated that the functional characteristics of the bovine oviduct and uterus change with the age-dependent upregulation of inflammation and noted that S100A9 triggers inflammatory responses in oviduct epithelial cells. In the present study, we investigated the hypothesis that S100A9 affects reproductive events to aspect such as sperm function, fertilization, and the development of the embryo in cows. To investigate the effect of S100A9 on bovine sperm, we incubated sperms in vitro with S100A9 for 5 h and observed significantly decreased sperm motility and viability. During in vitro fertilization, S100A9 treatment for 5 h did not affect the rate of fertilization, time of first division of embryos, or embryo development to blastocyst stage. Treatment of 2-cell stage embryos with S100A9 for 5 h significantly reduced the proportion of cells undergoing normal division (4-8 cell embryos) and embryo development to the blastocyst stage. In experiment involving 24 h treatment of 2-cell embryos, the development of all embryos stopped at the 2-cell stage in the S100A9-treated group. In blastocyst-stage embryos, S100A9 treatment significantly stimulated the expression of endoplasmic reticulum (ER) and the mRNA expression of ER stress markers, and activated caspase-3 with subsequent nuclear fragmentation. Pre-treatment with an ER stress inhibitor significantly suppressed caspase-3 activation by the S100A9 treatment, suggesting that S100A9 induces blastocyst dysfunction by apoptosis (via caspase-3 activation) depending on ER stress. These results indicate that direct exposure to S100A9 exerted adverse effects on sperm function and embryo development. These findings suggest that excessive dose of S100A9 may have an adverse effect to the reproductive machinery by inducing inflammation and tissue dysfunction.	[Funeshima, Natsumi; Tanikawa, Nao; Iwata, Hisataka; Kuwayama, Takehito; Shirasuna, Koumei] Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa, Japan; [Yaginuma, Hikari; Hamano, Seizo] Livestock Improvement Assoc Japan Inc, Anim Biotechnol Ctr, Tokyo, Japan; [Watanabe, Hiroyuki] Obihiro Univ Agr & Vet Med, Dept Life & Food Sci, Obihiro, Hokkaido, Japan; [Hamano, Seizo] Livestock Improvement Assoc Japan Inc, Maebashi Inst Anim Sci, Gunma, Japan	Tokyo University of Agriculture; Obihiro University of Agriculture & Veterinary Medicine	Shirasuna, K (corresponding author), Tokyo Univ Agr, Dept Anim Sci, Atsugi, Kanagawa, Japan.	ks205312@nodai.ac.jp			Japan Association for 394 Livestock New Technology and Livestock Promotional Funds of the Japan Racing Association	Japan Association for 394 Livestock New Technology and Livestock Promotional Funds of the Japan Racing Association	This study was supported by Japan Association for 394 Livestock New Technology and Livestock Promotional Funds of the Japan Racing Association (K.S.). Additional support was provided by the Livestock Improvement Association of Japan Inc (in the form of salaries to H.Y. and S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakri NM, 2016, SAUDI J BIOL SCI, V23, pS50, DOI 10.1016/j.sjbs.2015.10.023; Barabe F, 2015, BLOOD, V126; Basar M, 2014, FERTIL STERIL, V102, P1777, DOI 10.1016/j.fertnstert.2014.09.004; Bungum M, 2006, HUM REPROD, V21, P518, DOI 10.1093/humrep/dei350; Diskin MG, 2006, ANIM REPROD SCI, V96, P297, DOI 10.1016/j.anireprosci.2006.08.008; Funeshima N, 2019, J REPROD DEVELOP, V65, P443, DOI 10.1262/jrd.2019-026; Gianaroli L, 1996, HUM REPROD, V11, P166; Gu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070112; HAMANO S, 1993, THERIOGENOLOGY, V39, P703, DOI 10.1016/0093-691X(93)90255-4; Hu H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03083; Ibrahim M, 2016, THERIOGENOLOGY, V86, P2040, DOI 10.1016/j.theriogenology.2016.06.022; Ibrahim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119388; Kim JK, 2016, ANTICANCER RES, V36, P2281; Kostakis ID, 2010, EUR J OBSTET GYN R B, V151, P3, DOI 10.1016/j.ejogrb.2010.03.006; Koy M, 2013, VET IMMUNOL IMMUNOP, V155, P162, DOI 10.1016/j.vetimm.2013.07.002; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lin T, 2015, REPROD BIOL, V15, P101, DOI 10.1016/j.repbio.2015.01.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malhi PS, 2007, REPRODUCTION, V134, P233, DOI 10.1530/REP-07-0021; Meldrum DR, 2016, FERTIL STERIL, V105, P548, DOI 10.1016/j.fertnstert.2016.01.013; Nair RR, 2013, PLACENTA, V34, P824, DOI 10.1016/j.placenta.2013.06.307; Nair RR, 2015, AM J REPROD IMMUNOL, V73, P91, DOI 10.1111/aji.12318; Nakamura Y, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13163; Nelson SM, 2013, HUM REPROD UPDATE, V19, P67, DOI 10.1093/humupd/dms043; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Shimada M, 2013, AM J REPROD IMMUNOL, V69, P168, DOI 10.1111/aji.12024; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Swangchan-Uthai T, 2013, REPRODUCTION, V145, P527, DOI 10.1530/REP-12-0513; Swangchan-Uthai T, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102376; Swindell WR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01215; Takeo S, 2017, REPROD FERT DEVELOP, V29, P759, DOI 10.1071/RD15228; Tanaka H, 2016, MOL REPROD DEV, V83, P815, DOI 10.1002/mrd.22693; Tanikawa N, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0284-z; Tong L, 2014, OCUL SURF, V12, P23, DOI 10.1016/j.jtos.2013.10.001; Ulbrich SE, 2010, THERIOGENOLOGY, V73, P802, DOI 10.1016/j.theriogenology.2009.09.036; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Wilding M, 2015, FERTIL STERIL, V103, P1397, DOI 10.1016/j.fertnstert.2015.03.034; Yaginuma H, 2019, J REPROD DEVELOP, V65, P223, DOI 10.1262/jrd.2018-121; Yoisungnern T, 2016, TOXICOL IND HEALTH, V32, P1700, DOI 10.1177/0748233715579805; Zhao LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186727	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227885	10.1371/journal.pone.0227885	http://dx.doi.org/10.1371/journal.pone.0227885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945120	Green Published, gold			2022-12-26	WOS:000534370100070
J	Khan, N; Halcrow, PW; Lakpa, KL; Afghah, Z; Miller, NM; Dowdy, SF; Geiger, JD; Chen, XS				Khan, Nabab; Halcrow, Peter W.; Lakpa, Koffi L.; Afghah, Zahra; Miller, Nicole M.; Dowdy, Steven F.; Geiger, Jonathan D.; Chen, Xuesong			Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation	FASEB JOURNAL			English	Article						HIV-1 LTR transactivation; HIV-1 Tat; Tat endolysosome escape; two-pore channels	LYSOSOMAL MEMBRANE PERMEABILIZATION; ARGININE-RICH PEPTIDES; CENTRAL-NERVOUS-SYSTEM; CELLULAR UPTAKE; ANTIRETROVIRAL THERAPY; CALCIUM DYSREGULATION; MOLECULAR-MECHANISMS; ENTERS CELLS; VIRUS; PROTEIN	HIV-1 Tat is essential for HIV-1 replication and appears to play an important role in the pathogenesis of HIV-associated neurological complications. Secreted from infected or transfected cells, Tat has the extraordinary ability to cross the plasma membrane. In the brain, Tat can be taken up by CNS cells via receptor-mediated endocytosis. Following endocytosis and its internalization into endolysosomes, Tat must be released in order for it to activate the HIV-1 LTR promoter and facilitate HIV-1 viral replication in the nucleus. However, the underlying mechanisms whereby Tat escapes endolysosomes remain unclear. Because Tat disrupts intracellular calcium homeostasis, we investigated the involvement of calcium in Tat endolysosome escape and subsequent LTR transactivation. We demonstrated that chelating endolysosome calcium with high-affinity rhodamine-dextran or chelating cytosolic calcium with BAPTA-AM attenuated Tat endolysosome escape and LTR transactivation. Significantly, we demonstrated that pharmacologically blocking and knocking down the endolysosome-resident two-pore channels (TPCs) attenuated Tat endolysosome escape and LTR transactivation. This calcium-mediated effect appears to be selective for TPCs because knocking down TRPML1 calcium channels was without effect. Our findings suggest that calcium released from TPCs is involved in Tat endolysosome escape and subsequent LTR transactivation. TPCs might represent a novel therapeutic target against HIV-1 infection and HIV-associated neurological complications.	[Khan, Nabab; Halcrow, Peter W.; Lakpa, Koffi L.; Afghah, Zahra; Miller, Nicole M.; Geiger, Jonathan D.; Chen, Xuesong] Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 504 Hamline St, Grand Forks, ND 58203 USA; [Dowdy, Steven F.] UCSD, Dept Cellular & Mol Med, Sch Med, La Jolla, CA USA	University of North Dakota Grand Forks; University of California System; University of California San Diego	Chen, XS (corresponding author), Univ North Dakota, Dept Biomed Sci, Sch Med & Hlth Sci, 504 Hamline St, Grand Forks, ND 58203 USA.	xuesong.chen@und.edu			HHS \ NIH \ National Institute of Mental Health (NIMH) [R01MH100972, R01MH105329]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS065957]; HHS \ NIH \ National Institute on Drug Abuse (NIDA) [R01DA032444]	HHS \ NIH \ National Institute of Mental Health (NIMH); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ National Institute on Drug Abuse (NIDA)	HHS vertical bar NIH vertical bar National Institute of Mental Health (NIMH), Grant/Award Number: R01MH100972 and R01MH105329; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS065957; HHS vertical bar NIH vertical bar National Institute on Drug Abuse (NIDA), Grant/Award Number: R01DA032444	Agostini S, 2017, EBIOMEDICINE, V21, P170, DOI 10.1016/j.ebiom.2017.06.011; Aits S, 2015, AUTOPHAGY, V11, P1408, DOI 10.1080/15548627.2015.1063871; Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Castonguay J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10607-4; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chauhan A, 2015, MICROB PATHOGENESIS, V78, P1, DOI 10.1016/j.micpath.2014.11.003; Chauhan A, 2014, VIROLOGY, V456, P1, DOI 10.1016/j.virol.2014.03.002; Cheng JJ, 2006, J MED CHEM, V49, P6522, DOI 10.1021/jm060736s; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Christensen KA, 2002, J CELL SCI, V115, P599; Churchill MJ, 2006, J NEUROVIROL, V12, P146, DOI 10.1080/13550280600748946; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Clark E, 2017, ONCOTARGET, V8, P27569, DOI 10.18632/oncotarget.15174; Cossart P, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016972; Datta G, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00329; de Duve C, 2005, NAT CELL BIOL, V7, P847, DOI 10.1038/ncb0905-847; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ellis RJ, 2010, ARCH NEUROL-CHICAGO, V67, P552, DOI 10.1001/archneurol.2010.76; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Gaskill PJ, 2017, NEUROBIOL DIS, V105, P51, DOI 10.1016/j.nbd.2017.04.015; Glogau R, 2012, J DRUGS DERMATOL, V11, P38; Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grim CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01587; Gunaratne GS, 2018, CELL CALCIUM, V75, P30, DOI 10.1016/j.ceca.2018.08.003; Haughey NJ, 1999, J NEUROCHEM, V73, P1363, DOI 10.1046/j.1471-4159.1999.0731363.x; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hu XT, 2016, CURR DRUG TARGETS, V17, P4, DOI 10.2174/1389450116666150531162212; Hui L, 2015, CELL CALCIUM, V58, P617, DOI 10.1016/j.ceca.2015.10.001; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khan N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48777-y; Khan N, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1129-1; Kintzer AF, 2018, FEBS J, V285, P233, DOI 10.1111/febs.14154; KOLSON DL, 1994, J GEN VIROL, V75, P1927, DOI 10.1099/0022-1317-75-8-1927; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Lagostena L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43900; Li GH, 2012, FASEB J, V26, P2824, DOI 10.1096/fj.11-203315; Li SH, 2015, 2015 INTERNATIONAL CONFERENCE ON OPTOELECTRONICS AND MICROELECTRONICS (ICOM), P47, DOI 10.1109/ICoOM.2015.7398767; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2016, J CELL BIOL, V212, P755, DOI 10.1083/jcb.201603037; Lonn P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32301; Lonn P, 2015, EXPERT OPIN DRUG DEL, V12, P1627, DOI 10.1517/17425247.2015.1046431; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marban C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00397; Marceau F, 2012, TOXICOL APPL PHARM, V259, P1, DOI 10.1016/j.taap.2011.12.004; Marchant JS, 2015, BIOCHEM SOC T, V43, P434, DOI 10.1042/BST20140303; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2013, MOL BIOSYST, V9, P855, DOI 10.1039/c2mb25467k; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Norman JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003731; Peng F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034646; Rahman T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005450; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; Ruas Margarida, 2015, Messenger (Los Angel), V4, P4; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Sakurai Yasuteru, 2015, Virus (Nagoya), V65, P71, DOI 10.2222/jsv.65.71; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; SLICE LW, 1992, BIOCHEMISTRY-US, V31, P12062, DOI 10.1021/bi00163a014; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Staring J, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216259; Sterea AM, 2018, CELL CALCIUM, V72, P91, DOI 10.1016/j.ceca.2018.02.006; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vijaykumar TS, 2008, VIROLOGY, V381, P1, DOI 10.1016/j.virol.2008.07.039; Vives E, 2003, J MOL RECOGNIT, V16, P265, DOI 10.1002/jmr.636; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Wenzel ED, 2017, J NEUROIMMUNE PHARM, V12, P492, DOI 10.1007/s11481-017-9739-4; Wolfram J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14221-2; Wong VKW, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00351; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xiong J, 2016, SCI CHINA LIFE SCI, V59, P777, DOI 10.1007/s11427-016-5090-x; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; Zhang XH, 2003, J GENE MED, V5, P209, DOI 10.1002/jgm.340; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938; Zhong XZ, 2017, CELL CALCIUM, V64, P20, DOI 10.1016/j.ceca.2016.12.001; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	108	24	24	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4147	4162		10.1096/fj.201902534R	http://dx.doi.org/10.1096/fj.201902534R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950548	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000507915900001
J	Kim, JH; Kim, HY; Lee, DH				Kim, Jun-Ho; Kim, Hoon-Young; Lee, Dae-Hee			Opening gap width influences distal tibial rotation below the osteotomy site following open wedge high tibial osteotomy	PLOS ONE			English	Article							SLOPE; KNEE; ANTERIOR	Purpose Although rotation of the distal portion of the tibia below the osteotomy site is considered an inevitable change in the axial plane in open wedge high tibial osteotomy (HTO), several studies on this issue have shown contradictory results. The purpose of this study was, therefore, to determine the direction and amount of distal tibial rotation following open wedge HTO using a three-dimensional reconstructed model. Methods This study involved 41 patients (42 knees) undergoing open wedge HTO for primary medial osteoarthritis. Distal tibial rotation was measured on the overlaid tibial plateau of a preoperative and postoperative 3-dimensional reconstructed model based on computed tomography. Results The mean distal tibial external rotation was 2.7 degrees +/- 2.3 degrees (range, -0.9 degrees to 9.9 degrees), and the opening gap was larger in the group with > 3 degrees distal tibial rotation than in the group with. 3 degrees distal tibial rotation (11.4 mm vs. 9.6 mm, P = 0.027). Multiple regression analysis showed that the opening gap was the only predictor of distal tibial rotation. On receiver operating characteristics analysis, an opening gap of 10mm was found to be the optimal cutoff value for achieving greater than 3 degrees of distal tibial rotation. Conclusions Following medial opening wedge HTO, the distal tibial portion below the osteotomy site rotated approximately 3 degrees externally. The magnitude of the external rotation of the distal tibia was affected by the opening gap width.	[Kim, Jun-Ho; Kim, Hoon-Young; Lee, Dae-Hee] Sungkyunkwan Univ, Samsung Med Ctr, Dept Orthopaed Surg, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, DH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Orthopaed Surg, Sch Med, Seoul, South Korea.	eoak22@empal.com		Lee, Dae-Hee/0000-0003-3147-8763				Ahn GY, 2018, CLIN ORTHOP SURG, V10, P413, DOI 10.4055/cios.2018.10.4.413; Akagi M, 2004, CLIN ORTHOP RELAT R, P213, DOI 10.1097/01.blo.0000118442.93383.16; Baumgarten Keith M, 2007, HSS J, V3, P155, DOI 10.1007/s11420-007-9046-3; Briem K, 2007, J ORTHOP RES, V25, P311, DOI 10.1002/jor.20326; Gaasbeek RDA, 2005, KNEE SURG SPORT TR A, V13, P689, DOI 10.1007/s00167-004-0599-0; Han SB, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1066-z; Hinterwimmer S, 2016, INT ORTHOP, V40, P1849, DOI 10.1007/s00264-015-3100-4; Jacobi M, 2015, KNEE SURG SPORT TR A, V23, P2762, DOI 10.1007/s00167-014-3100-8; Jang KM, 2016, J ARTHROPLASTY, V31, P59, DOI 10.1016/j.arth.2015.08.010; Kendoff D, 2008, KNEE SURG SPORT TR A, V16, P904, DOI 10.1007/s00167-008-0567-1; Kobayashi H, 2017, KNEE; Lee BH, 2017, KNEE, V24, P362, DOI 10.1016/j.knee.2016.11.010; Lee DH, 2016, KNEE SURG SPORT TR A, V24, P3704, DOI 10.1007/s00167-015-3682-9; Lee DW, 2019, CLIN ORTHOP SURG, V11, P60, DOI 10.4055/cios.2019.11.1.60; Lee O-Sung, 2019, Knee Surg Relat Res, V31, P126, DOI 10.5792/ksrr.18.034; Lind-Hansen TB, 2016, J KNEE SURG, V29, P664, DOI 10.1055/s-0036-1571802; Moon SW, 2015, ARTHROSCOPY, V31, P1128, DOI 10.1016/j.arthro.2015.01.009; Nakamura R, 2015, BONE JOINT J, V97B, P1226, DOI 10.1302/0301-620X.97B9.34949; Nha Kyung Wook, 2019, Knee Surg Relat Res, V31, P81, DOI 10.5792/ksrr.17.090; Nha KW, 2016, AM J SPORT MED, V44, P3006, DOI 10.1177/0363546515626172; Noyes FR, 2005, AM J SPORT MED, V33, P378, DOI 10.1177/0363546504269034; Ogawa H, 2017, BONE JOINT J, V99B, P887, DOI 10.1302/0301-620X.99B7.BJJ-2016-0927.R1; Shon Oog-Jin, 2017, Knee Surg Relat Res, V29, P288, DOI 10.5792/ksrr.16.057; Suero EM, 2017, KNEE SURG SPORT TR A, V25, P299, DOI 10.1007/s00167-015-3553-4; Yazdi H, 2016, KNEE SURG SPORT TR A, V24, P79, DOI 10.1007/s00167-014-3321-x	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227969	10.1371/journal.pone.0227969	http://dx.doi.org/10.1371/journal.pone.0227969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945112	Green Published, gold			2022-12-26	WOS:000534370100076
J	Moyo, S; Jacobs, DS				Moyo, Sydney; Jacobs, David S.			Faecal analyses and alimentary tracers reveal the foraging ecology of two sympatric bats	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; SPECIES MYOTIS-MYOTIS; ISOTOPE MIXING MODELS; STABLE-ISOTOPE; INSECTIVOROUS BAT; HABITAT SELECTION; PREY SELECTION; NICHE DIFFERENTIATION; PRIOR INFORMATION; FOOD WEBS	We used three complementary methods to assess the diet of two insectivorous bat species: one an obligate aerial hunter, Miniopterus natalensis, and the other Myotis tricolor whose morphology and taxonomic affiliation to other trawling bats suggests it may be a trawler (capturing insects from the water surface with its feet and tail). We used visual inspection, stable isotope values and fatty acid profiles of insect fragments in bat faeces sampled across five sites to determine the contribution of aquatic and terrestrial arthropods to the diets of the two species. The niche widths of M. tricolor were generally wider than those of Miniopterus natalensis but with much overlap, both taking aquatic and terrestrial insects, albeit in different proportions. The diet of M. tricolor had high proportions of fatty acids (20:5.3 and 22:6.3) that are only obtainable from aquatic insects. Furthermore, the diet of M. tricolor had higher proportions of water striders (Gerridae) and whirligig beetles (Gyrinidae), insects obtainable via trawling, than Miniopterus natalensis. These results suggest both species are flexible in their consumption of prey but that M. tricolor may use both aerial hawking and trawling, or at least gleaning, to take insects from water surfaces. The resultant spatial segregation may sufficiently differentiate the niches of the two species, allowing them to co-exist. Furthermore, our results emphasize that using a combination of methods to analyse diets of cryptic animals yields greater insights into animal foraging ecology than any of them on their own.	[Moyo, Sydney; Jacobs, David S.] Univ Cape Town, Dept Biol Sci, Rondebosch, South Africa	University of Cape Town	Jacobs, DS (corresponding author), Univ Cape Town, Dept Biol Sci, Rondebosch, South Africa.	David.Jacobs@uct.ac.za	Jacobs, David/L-9118-2013	Jacobs, David/0000-0002-3243-8571; Moyo, Sydney/0000-0002-9286-6578	SARCHI Research Chair in Animal Evolution & Systematics as part of the South African Research Chair Initiative of the Department of Science and Technology [GUN 64798]	SARCHI Research Chair in Animal Evolution & Systematics as part of the South African Research Chair Initiative of the Department of Science and Technology	This research was funded by a Grant to DSJ (GUN 64798; SARCHI Research Chair in Animal Evolution & Systematics) as part of the South African Research Chair Initiative of the Department of Science and Technology, administered by the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank David Wechuli, Tshifhiwa Netshongolwe, Nikita Finger, Victor Mutavhatsindi, Allen Tshautshau, Robert Barclay for field assistance. We also thank Professor Judith Sealy and Ian Newton, Department of Archaeology, University of Cape Town for assistance with stable isotope analysis. We also extend gratitude to Chris Smith (Battery Centre, Plumstead, South Africa) for loaning us his batteries to run the light traps. Additionally, we thank the staff (Mr L Mokwena and MrsWKuhn) of the Central Analytical Services Mass Spectrometry Unit (Stellenbosch University) for allowing us to use their mass spectrometers. This research was funded by a Grant to DSJ (GUN 64798; SARCHI Research Chair in Animal Evolution & Systematics) as part of the South African Research Chair Initiative of the Department of Science and Technology, administered by the National Research Foundation of South Africa.	Abrantes K, 2008, ESTUAR COAST SHELF S, V80, P401, DOI 10.1016/j.ecss.2008.09.009; Aizpurua O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080163; Akasaka T, 2009, BIOL CONSERV, V142, P1302, DOI 10.1016/j.biocon.2009.01.028; Almenar D, 2008, J ZOOL, V274, P340, DOI 10.1111/j.1469-7998.2007.00390.x; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; [Anonymous], 2018, LANG ENV STAT COMP; Antonio ES, 2014, MAR ECOL PROG SER, V504, P193, DOI 10.3354/meps10761; Arlettaz R, 1997, J ZOOL, V242, P45, DOI 10.1111/j.1469-7998.1997.tb02928.x; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Ballinger A, 2006, MAR FRESHWATER RES, V57, P15, DOI 10.1071/MF05154; Boersma KS, 2014, SOUTHWEST NAT, V59, P301, DOI 10.1894/N09-FRG-07.1; BOGDANOWICZ W, 1990, J MAMMAL, V71, P205, DOI 10.2307/1382169; Brunet-Rossinni Anja K., 2009, P315; Catenazzi A, 2007, OIKOS, V116, P75, DOI 10.1111/j.2006.0030-1299.15230.x; Chari LD, 2018, ECOL ENTOMOL, V43, P1, DOI 10.1111/een.12458; Chari LD, 2018, ECOL ENTOMOL, V43, P15, DOI 10.1111/een.12459; Ciechanowski M, 2017, J MAMMAL, V98, P232, DOI 10.1093/jmammal/gyw108; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Denzinger A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00164; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Dietz C, 2007, HDB FLEDERMAUSE EURO, DOI [10.1016/j.mambio.2007.10.005, DOI 10.1016/J.MAMBIO.2007.10.005]; Falk B, 2014, J EXP BIOL, V217, P4356, DOI 10.1242/jeb.114132; Fenton MB, 2003, WILDLIFE SOC B, V31, P6; Fenton MB, 2002, CAN J ZOOL, V80, P1004, DOI 10.1139/Z02-083; Fontaneto D, 2011, ECOL FOOD NUTR, V50, P351, DOI 10.1080/03670244.2011.586316; Geberl C, 2015, P NATL ACAD SCI USA, V112, P4122, DOI 10.1073/pnas.1424457112; Gladyshev MI, 2013, PROSTAG OTH LIPID M, V107, P117, DOI 10.1016/j.prostaglandins.2013.03.002; Hatch KA, 2011, URSUS, V22, P133, DOI 10.2192/URSUS-D-10-00034.1; Hillen J, 2011, ANN ZOOL FENN, V48, P180, DOI 10.5735/086.048.0306; HUTCHINSON GE, 1981, BIOSCIENCE, V31, P495, DOI 10.2307/1308491; Indarti E, 2005, J FOOD COMPOS ANAL, V18, P161, DOI 10.1016/j.jfca.2003.12.007; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jacobs DS, 2009, J MAMMAL, V90, P879, DOI 10.1644/08-MAMM-A-235.1; Jacobs DS, 1999, ACTA CHIROPTEROL, V1, P93; JONES G, 1991, J ZOOL, V225, P393, DOI 10.1111/j.1469-7998.1991.tb03824.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kleynhans CJ, 2013, EC CROC RIV CA UNPUB, P126; Koussoroplis AM, 2008, LIPIDS, V43, P461, DOI 10.1007/s11745-008-3166-5; Kruger F, 2014, MOL ECOL, V23, P3657, DOI 10.1111/mec.12512; Kunz T.H., 2009, ECOLOGICAL BEHAV MET; Lacki MJ, 2007, BATS FORESTS CONSERV, P293; Lam MMY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083452; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; Levin E, 2006, MAMM BIOL, V71, P139, DOI 10.1016/j.mambio.2006.01.002; MACKEY RL, 1989, CAN J ZOOL, V67, P1167, DOI 10.1139/z89-168; Mason MK, 2010, ACTA CHIROPTEROL, V12, P161, DOI 10.3161/150811010X504662; McCulloch GA, 2009, MOL ECOL, V18, P4073, DOI 10.1111/j.1365-294X.2009.04337.x; McDonald JT, 1990, S AFR J WILDL RES 24, P20; Mcnab BK, 2018, COMP BIOCHEM PHYS A, V223, P18, DOI 10.1016/j.cbpa.2018.05.001; Miller-Butterworth CM, 2005, J MAMMAL, V86, P1121, DOI 10.1644/05-MAMM-A-021R1.1; Monadjem A, 2017, IUCN RED LIST THREAT, DOI [10.1038/536143a, DOI 10.1038/536143A]; Montanari S, 2017, PEERJ, V5, DOI 10.7717/peerj.3436; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Moyo S, 2018, HYDROBIOLOGIA, V806, P139, DOI 10.1007/s10750-017-3347-4; Neumann Frank H., 2015, Transactions of the Royal Society of South Africa, V70, P195, DOI 10.1080/0035919X.2015.1072859; Newsome SD, 2007, P NATL ACAD SCI USA, V104, P9709, DOI 10.1073/pnas.0610986104; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Orr TJ, 2016, J MAMMAL, V97, P1578, DOI 10.1093/jmammal/gyw122; Painter ML, 2009, CAN J ZOOL, V87, P865, DOI 10.1139/Z09-075; Papadatou E, 2008, J MAMMAL, V89, P503, DOI 10.1644/07-MAMM-A-163R1.1; Pease AA, 2019, FOOD WEBS, V18, DOI 10.1016/j.fooweb.2019.e00113; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Phillipsen IC, 2015, MOL ECOL, V24, P54, DOI 10.1111/mec.13003; Phillipsen IC, 2013, ECOGRAPHY, V36, P731, DOI 10.1111/j.1600-0587.2012.00002.x; Pitt KA, 2009, HYDROBIOLOGIA, V616, P133, DOI 10.1007/s10750-008-9584-9; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; RABINOWITZ AR, 1982, ACTA THERIOL, V27, P283, DOI 10.4098/AT.arch.82-25; Rundio DE, 2012, ECOL RES, V27, P539, DOI 10.1007/s11284-011-0920-6; Salvarina I, 2016, MAMMAL REV, V46, P131, DOI 10.1111/mam.12059; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; Schoeman MC, 2011, OECOLOGIA, V166, P493, DOI 10.1007/s00442-010-1854-3; Schoeman MC, 2003, OECOLOGIA, V134, P154, DOI 10.1007/s00442-002-1107-1; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Siemers BM, 2001, J EXP BIOL, V204, P3843; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; STAFFORD A, 2010, HYSTRIX, P29, DOI DOI 10.4404/HYSTRIX-22.1-4524; Stock B, 2013, MIXSIAR GUI USER MAN, DOI [10.5281/zenodo, DOI 10.5281/ZENODO]; Stoffberg S, 2004, CAN J ZOOL, V82, P1854, DOI 10.1139/Z04-172; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Todd VLG, 2007, J ZOOL, V273, P106, DOI 10.1111/j.1469-7998.2007.00306.x; Tsyrlin E, 2002, WATERBUG BOOK GUIDE; Vesterinen EJ, 2016, MOL ECOL, V25, P1581, DOI 10.1111/mec.13564; Voigt CC, 2015, METHODS ECOL EVOL, V6, P1332, DOI 10.1111/2041-210X.12414; Vollmer Michael, 2011, Physics Education, V46, P191, DOI 10.1088/0031-9120/46/2/007; VONFRENCKELL B, 1987, CAN J ZOOL, V65, P219, DOI 10.1139/z87-035; Ward EJ, 2010, ENVIRON SCI TECHNOL, V44, P4645, DOI 10.1021/es100053v; Whitaker J.O. Jr, 1988, P171; Whitaker JO, 2004, J MAMMAL, V85, P460, DOI 10.1644/1545-1542(2004)085<0460:PSIATZ>2.0.CO;2; Torres-Flores JW, 2018, ACTA CHIROPTEROL, V20, P343, DOI 10.3161/15081109ACC2018.20.2.006; Zettel H., 2014, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V116, P13	94	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227743	10.1371/journal.pone.0227743	http://dx.doi.org/10.1371/journal.pone.0227743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945139	gold, Green Published			2022-12-26	WOS:000534370100059
J	Oermann, MH; Krusmark, MA; Kardong-Edgren, S; Jastrzembski, TS; Gluck, KA				Oermann, Marilyn H.; Krusmark, Michael A.; Kardong-Edgren, Suzan; Jastrzembski, Tiffany S.; Gluck, Kevin A.			Training interval in cardiopulmonary resuscitation	PLOS ONE			English	Article							CARDIAC-ARREST; CPR; PSYCHOMOTOR; RETENTION; QUALITY; SKILLS	Aim Although evidence supports brief, frequent CPR training, optimal training intervals have not been established. The purpose of this study was to compare nursing students' CPR skills (compressions and ventilations) with 4 different spaced training intervals: daily, weekly, monthly, and quarterly, each for 4 times in a row. Methods Participants were nursing students (n = 475) in the first year of their prelicensure program in 10 schools of nursing across the United States. They were randomly assigned into the 4 training intervals in each of the schools. Students were trained in CPR on a Laerdal Resusci Anne adult manikin on the Resuscitation Quality Improvement (RQI) mobile simulation station. The outcome measures were quality of compressions and ventilations as measured by the RQI program. Results Although students were all certified in Basic Life Support prior to the study, they were not able to adequately perform compressions and ventilations at pretest. Overall compression scores improved from sessions 1 to 4 in all training intervals (all p < .001), but shorter intervals (daily training) resulted in larger increases in compression scores by session 4. There were similar findings for ventilation skills, but at session 4, both daily and weekly intervals led to better skill performance. Conclusion For students and other novices learning to perform CPR, the opportunity to train on consecutive days or weeks may be beneficial: if learners are aware of specific errors in performance, it may be easier for them to correct performance and refine skills when there is less time in between practice sessions.	[Oermann, Marilyn H.] Duke Univ, Sch Nursing, Durham, NC 27708 USA; [Krusmark, Michael A.] L3 Technol Air Force Res Lab, Wright Patterson AFB, OH USA; [Kardong-Edgren, Suzan] Ctr Med Simulat, Boston, MA USA; [Jastrzembski, Tiffany S.; Gluck, Kevin A.] Air Force Res Lab, Airman Syst Directorate, Human Performance Wing 711, Wright Patterson AFB, OH USA	Duke University; L3Harris Technologies; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Oermann, MH (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27708 USA.	marilyn.oermann@duke.edu		Oermann, Marilyn/0000-0002-4534-8962; Kardong-Edgren, Suzan (Suzie)/0000-0002-5794-4075	National League for Nursing; Laerdal Medical Corporation; Air Force Research Laboratory	National League for Nursing; Laerdal Medical Corporation; Air Force Research Laboratory	Funding was provided to MHO by the National League for Nursing with funding it received from Laerdal Medical Corporation. Additional funding was provided by the Air Force Research Laboratory for the participation of MAK, TSJ, and KAG. Laerdal Medical Corporation supplied the RQI mobile simulation stations and program for the study at no cost to the schools of nursing that served as training sites. The National League for Nursing and Laerdal Medical Corporation were not involved in the collection, analysis, and interpretation of the data; in writing the manuscript; nor in the decision to submit the manuscript for publication. The investigators had sole responsibility for implementing the study, collecting and analyzing the data, and writing the manuscript. There were no restrictions by the National League for Nursing or Laerdal Medical Corporation on the statistical analysis or publication of the findings.	Anderson R, 2019, RESUSCITATION, V135, P153, DOI 10.1016/j.resuscitation.2018.10.033; Bhanji F, 2015, CIRCULATION, V132, pS561, DOI 10.1161/CIR.0000000000000268; Cheng A, 2018, CIRCULATION, V138, pE82, DOI 10.1161/CIR.0000000000000583; Cheng A, 2015, JAMA PEDIATR, V169, P137, DOI 10.1001/jamapediatrics.2014.2616; Christenson J, 2009, CIRCULATION, V120, P1241, DOI 10.1161/CIRCULATIONAHA.109.852202; Core TR, 2019, R LANG ENV STAT COMP; Cortegiani A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1740-z; Cortegiani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169591; Dudzik LR, 2019, JT COMM J QUAL PATIE, V45, P789, DOI 10.1016/j.jcjq.2019.08.010; Gluck KA, 2008, P 30 ANN M COGN SCI; Greif R, 2015, RESUSCITATION, V95, P288, DOI 10.1016/j.resuscitation.2015.07.032; Harris J., 2009, P 9 INT C COGNITIVE; Idris AH, 2015, CRIT CARE MED, V43, P840, DOI 10.1097/CCM.0000000000000824; Kardong-Edgren S, 2019, J CONTIN EDUC NURS, V50, P257, DOI 10.3928/00220124-20190516-05; Kardong-Edgren S, 2012, J NURSES PROF DEV, V28, P9, DOI 10.1097/NND.0b013e318240a6ad; Kleinman ME, 2018, CIRCULATION, V137, pE802, DOI 10.1161/CIR.0000000000000561; Kyllonen P., 2000, TRAINING RETRAINING, P525; Laerdal, 2015, CPR SCOR EXPL; Larribau R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204169; Lin YQ, 2018, RESUSCITATION, V130, P6, DOI 10.1016/j.resuscitation.2018.06.025; Mancini ME, 2010, CIRCULATION, V122, P8539, DOI 10.1161/CIRCULATIONAHA.110.971143; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Niles DE, 2017, SIMUL HEALTHC, V12, P213, DOI 10.1097/SIH.0000000000000228; Oermann MH, 2016, J CONTIN EDUC NURS, V47, P278, DOI 10.3928/00220124-20160518-10; Oermann MH, 2011, RESUSCITATION, V82, P447, DOI 10.1016/j.resuscitation.2010.11.022; Riggs M, 2019, RESUSCITATION, V138, P259, DOI 10.1016/j.resuscitation.2019.03.019; Saad R, 2019, SIMUL HEALTHC, V14, P351, DOI 10.1097/SIH.0000000000000383; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; Sutton RM, 2013, RESUSCITATION, V84, P1680, DOI 10.1016/j.resuscitation.2013.07.029; Sutton RM, 2011, PEDIATRICS, V128, pE145, DOI 10.1542/peds.2010-2105; Talikowska M, 2015, RESUSCITATION, V96, P66, DOI 10.1016/j.resuscitation.2015.07.036; Wolfe H, 2014, CRIT CARE MED, V42, P1688, DOI 10.1097/CCM.0000000000000327; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012	33	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0226736	10.1371/journal.pone.0226786	http://dx.doi.org/10.1371/journal.pone.0226786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945074	Green Published, gold			2022-12-26	WOS:000534370100015
J	Zhang, Q; Liu, N; Bai, JJ; Zhou, Q; Mao, J; Xu, L; Liu, J; Wei, HB; Ren, CC; Wu, XY; Wang, M; Zhao, B; Cong, YS				Zhang, Qian; Liu, Ning; Bai, Junjie; Zhou, Qi; Mao, Jian; Xu, Lu; Liu, Jiang; Wei, Haibin; Ren, Chengcheng; Wu, Xiaoying; Wang, Miao; Zhao, Bin; Cong, Yu-Sheng			Human telomerase reverse transcriptase is a novel target of Hippo-YAP pathway	FASEB JOURNAL			English	Article						Hippo pathway; hTERT; TEAD; telomere; YAP	ORGAN SIZE; BINDING; ROLES; CELLS; TAZ	Telomerase plays a pivotal role in tumorigenesis by maintaining telomere homeostasis, a hallmark of cancer. However, the mechanisms by which telomerase is reactivated or upregulated during tumorigenesis remain incompletely understood. Here, we report that the Hippo pathway effector Yes-associated protein (YAP) regulates the expression of human telomerase reverse transcriptase (hTERT). Ectopic expression or physiological activation of YAP increases hTERT expression, whereas knockdown of YAP decreases the expression of hTERT. YAP binds to the hTERT promoter through interaction with the TEA domain family transcription factors and activates hTERT transcription. Furthermore, sustained YAP hyperactivation promotes telomerase activity and extends telomere length, with increased hTERT expression. In addition, we show that hTERT expression is positively correlated with YAP activation in human liver cancer tissues. Together, our results demonstrate that YAP promotes hTERT expression, which could contribute to tumor progression.	[Zhang, Qian; Bai, Junjie; Mao, Jian; Xu, Lu; Liu, Jiang; Ren, Chengcheng; Wu, Xiaoying; Wang, Miao; Cong, Yu-Sheng] Hangzhou Normal Univ, Inst Aging Res, Key Lab Aging & Canc Biol Zhejiang Prov, Sch Med, 2318 Yuhangtang Rd, Hangzhou, Zhejiang, Peoples R China; [Liu, Ning] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Zhou, Qi; Zhao, Bin] Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Qi; Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Life Sci Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Wei, Haibin] Zhejiang Canc Hosp, Zhejiang Canc Res Inst, Hangzhou, Peoples R China	Hangzhou Normal University; Shanghai Ocean University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital	Cong, YS (corresponding author), Hangzhou Normal Univ, Inst Aging Res, Key Lab Aging & Canc Biol Zhejiang Prov, Sch Med, 2318 Yuhangtang Rd, Hangzhou, Zhejiang, Peoples R China.; Zhao, B (corresponding author), Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.; Zhao, B (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Life Sci Inst, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	binzhao@zju.cdu.cn; yscong@hznu.edu.cn	Mao, Jianhua/GOK-2713-2022	Liu, Ning/0000-0002-7009-9187	National Natural Science Foundation of China [31571409, 31730020, 31801155]; Major Science and Technology Innovation Program of Hangzhou, Science and Technology Bureau of Hangzhou [20182014B01]; National Key R&D Program of China, Ministry of Science and Technology of China [2017YFA0504502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Innovation Program of Hangzhou, Science and Technology Bureau of Hangzhou; National Key R&D Program of China, Ministry of Science and Technology of China	National Natural Science Foundation of China, Grant/Award Number: 31571409, 31730020 and 31801155; Major Science and Technology Innovation Program of Hangzhou, Science and Technology Bureau of Hangzhou, Grant/Award Number: 20182014B01; National Key R&D Program of China, Ministry of Science and Technology of China, Grant/Award Number: 2017YFA0504502	Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Colebatch AJ, 2019, J CLIN PATHOL, V72, P281, DOI 10.1136/jclinpath-2018-205653; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Ding DQ, 2013, FASEB J, V27, P4375, DOI 10.1096/fj.13-230904; Ding DQ, 2013, FEBS J, V280, P3205, DOI 10.1111/febs.12258; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Jiang SW, 2000, DNA CELL BIOL, V19, P507, DOI 10.1089/10445490050128430; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Liu H, 2018, EMBO REP, V19, DOI 10.15252/embr.201745180; Liu N, 2016, NUCLEIC ACIDS RES, V44, P8693, DOI 10.1093/nar/gkw549; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Low KC, 2013, TRENDS BIOCHEM SCI, V38, P426, DOI 10.1016/j.tibs.2013.07.001; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park JH, 2018, MOL CELLS, V41, P83, DOI 10.14348/molcells.2018.2242; Rausch V, 2019, CURR BIOL, V29, P242, DOI 10.1016/j.cub.2018.11.066; Reddy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073763; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Wong MS, 2014, TRENDS GENET, V30, P430, DOI 10.1016/j.tig.2014.07.006; Wright WE, 1996, DEV GENET, V18, P173; Wyatt HDM, 2010, NUCLEIC ACIDS RES, V38, P5609, DOI 10.1093/nar/gkq370; Xu LF, 2013, ANNU REV PATHOL-MECH, V8, P49, DOI 10.1146/annurev-pathol-020712-164030; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan XT, 2019, ONCOGENE, V38, P6172, DOI 10.1038/s41388-019-0872-9; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep19852; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou JZ, 2014, AGING CELL, V13, P197, DOI 10.1111/acel.12161; Zuo QP, 2011, EUR J PHARMACOL, V672, P113, DOI 10.1016/j.ejphar.2011.09.187	44	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4178	4188		10.1096/fj.201902147R	http://dx.doi.org/10.1096/fj.201902147R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950551	hybrid			2022-12-26	WOS:000507916800001
J	Dakin, CJ; Kumar, P; Forbes, PA; Peters, A; Day, BL				Dakin, Christopher J.; Kumar, Prateek; Forbes, Patrick A.; Peters, Amy; Day, Brian L.			Variance based weighting of multisensory head rotation signals for verticality perception	PLOS ONE			English	Article							VESTIBULOOCULAR REFLEX; SPATIAL ORIENTATION; SENSORY AMBIGUITIES; ECCENTRIC ROTATION; INTERNAL-MODELS; SQUIRREL-MONKEY; INERTIAL MOTION; GRAVITY; HUMANS; CUES	We tested the hypothesis that the brain uses a variance-based weighting of multisensory cues to estimate head rotation to perceive which way is up. The hypothesis predicts that the known bias in perceived vertical, which occurs when the visual environment is rotated in a vertical-plane, will be reduced by the addition of visual noise. Ten healthy participants sat head-fixed in front of a vertical screen presenting an annulus filled with coloured dots, which could rotate clockwise or counter-clockwise at six angular velocities (1, 2, 4, 6, 8, 16 degrees/s) and with six levels of noise (0, 25, 50, 60, 75, 80%). Participants were required to keep a central bar vertical by rotating a hand-held dial. Continuous adjustments of the bar were required to counteract low-amplitude low-frequency noise that was added to the bar's angular position. During visual rotation, the bias in verticality perception increased over time to reach an asymptotic value. Increases in visual rotation velocity significantly increased this bias, while the addition of visual noise significantly reduced it, but did not affect perception of visual rotation velocity. The biasing phenomena were reproduced by a model that uses a multisensory variance-weighted estimate of head rotation velocity combined with a gravito-inertial acceleration signal (GIA) from the vestibular otoliths. The time-dependent asymptotic behaviour depends on internal feedback loops that act to pull the brain's estimate of gravity direction towards the GIA signal. The model's prediction of our experimental data furthers our understanding of the neural processes underlying human verticality perception.	[Dakin, Christopher J.; Kumar, Prateek; Peters, Amy; Day, Brian L.] UCL, Inst Neurol, London, England; [Forbes, Patrick A.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Dakin, Christopher J.] Utah State Univ, Dept Kinesiol & Hlth Sci, Logan, UT 84322 USA	University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Utah System of Higher Education; Utah State University	Dakin, CJ (corresponding author), UCL, Inst Neurol, London, England.; Dakin, CJ (corresponding author), Utah State Univ, Dept Kinesiol & Hlth Sci, Logan, UT 84322 USA.	chris.dakin@usu.edu	Forbes, Patrick/GZH-1852-2022	Forbes, Patrick/0000-0002-0230-9971	Canadian Institutes for Health Research Post-Doctoral Fellowship; Netherlands Organization for Scientific Research: NWO [016]	Canadian Institutes for Health Research Post-Doctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Netherlands Organization for Scientific Research: NWO(Netherlands Organization for Scientific Research (NWO))	CJD received financial support from a Canadian Institutes for Health Research Post-Doctoral Fellowship (http://www.cihr-irsc.gc.ca/e/193.html) and PAF received financial support from the Netherlands Organization for Scientific Research: NWO #016. Veni. 188.049 (https://www.nwo.nl/en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dakin CJ, 2018, CURR BIOL, V28, P3589, DOI 10.1016/j.cub.2018.09.049; DeAngelis G. C, 2012, NEURAL BASES MULTISE; DICHGANS J, 1972, SCIENCE, V178, P1217, DOI 10.1126/science.178.4066.1217; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; GLASAUER S, 1992, ANN NY ACAD SCI, V656, P847, DOI 10.1111/j.1749-6632.1992.tb25272.x; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Green AM, 2010, EXP BRAIN RES, V200, P197, DOI 10.1007/s00221-009-2054-4; Greenlee MW, 2016, MULTISENS RES, V29, P525, DOI 10.1163/22134808-00002527; Held R, 1974, VISION RES, V15, P357; Jurgens R, 2006, EXP BRAIN RES, V174, P528, DOI 10.1007/s00221-006-0486-7; Kleiner M, 2007, PERCEPTION, V36, P14; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kobayashi H, 2002, AURIS NASUS LARYNX, V29, P325, DOI 10.1016/S0385-8146(02)00058-5; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; Laurens J, 2013, NEURON, V80, P1508, DOI 10.1016/j.neuron.2013.09.029; Laurens J, 2013, NAT NEUROSCI, V16, P1701, DOI 10.1038/nn.3530; Laurens J, 2011, J VESTIBUL RES-EQUIL, V21, P251, DOI 10.3233/VES-2011-0425; Laurens J, 2008, SPRINGER TRAC ADV RO, V46, P279; Laurens J, 2011, EXP BRAIN RES, V210, P407, DOI 10.1007/s00221-011-2568-4; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; MacNeilage PR, 2018, CURR BIOL, V28, pR1296, DOI 10.1016/j.cub.2018.09.053; Merfeld D M, 1993, J Vestib Res, V3, P141; Merfeld D.M., 1997, 3 DIMENSIONAL KINEMA, P387; MERFELD DM, 1995, EXP BRAIN RES, V106, P111; MERFELD DM, 1995, EXP BRAIN RES, V106, P123; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Merfeld DM, 1990, THESIS; Niehof N, 2019, J NEUROPHYSIOL, V122, P788, DOI 10.1152/jn.00083.2019; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; R Core Team, 2021, R LANGUAGE ENV STAT; RAPHAN T, 1979, EXP BRAIN RES, V35, P229; ter Horst AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145015; Zupan LH, 2003, J NEUROPHYSIOL, V89, P390, DOI 10.1152/jn.00513.2001; Zupan LH, 2002, BIOL CYBERN, V86, P209, DOI 10.1007/s00422-001-0290-1	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227040	10.1371/journal.pone.0227040	http://dx.doi.org/10.1371/journal.pone.0227040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940387	Green Published, gold			2022-12-26	WOS:000534368000056
J	Fisler, M; Cremiere, C; Darlu, P; Lecointre, G				Fisler, Marie; Cremiere, Cedric; Darlu, Pierre; Lecointre, Guillaume			The treeness of the tree of historical trees of life	PLOS ONE			English	Article							EVOLUTION; SUPPORT	This paper compares and categorizes historical ideas about trees showing relationships among biological entities. The hierarchical structure of a tree is used to test the global consistency of similarities among these ideas; in other words we assess the "treeness" of the tree of historical trees. The collected data are figures and ideas about trees showing relationships among biological entities published or drawn by naturalists from 1555 to 2012. They are coded into a matrix of 235 historical trees and 141 descriptive attributes. From the most parsimonious "tree" of historical trees, treeness is measured by consistency index, retention index and homoplasy excess ratio. This tree is used to create sets or categories of trees, or to study the circulation of ideas. From an unrooted network of historical trees, treeness is measured by the delta-score. This unrooted network is used to measure and visualize treeness. The two approaches show a rather good treeness of the data, with respectively a retention idex of 0.83 and homoplasy excess ratio of 0.74, on one hand, and a delta-score of 0.26 on the other hand. It is interpreted as due to vertical transmission, i.e. an inheritance of shared ideas about biological trees among authors. This tree of trees is then used to test categories previously made. For instance, cladists and gradists are "paraphyletic". The branches of this tree of trees suggest new categories of tree-thinkers that could have been overlooked by historians or systematists.	[Fisler, Marie; Lecointre, Guillaume] Museum Natl Hist Nat, Dept Origines & Evolut, Inst Systemat Evolut & Biodiversite, UMR 7205,CNRS,EPHE, Paris, France; [Cremiere, Cedric] Musee Hist Nat Havre, Pl Vieux Marche, Le Havre, France; [Darlu, Pierre] Museum Natl Hist Nat, Dept Hommes Nat & Soc, Ecoanthropol & Ethnobiol, UMR 7206,CNRS,UPD, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Lecointre, G (corresponding author), Museum Natl Hist Nat, Dept Origines & Evolut, Inst Systemat Evolut & Biodiversite, UMR 7205,CNRS,EPHE, Paris, France.	guillaume.lecointre@mnhn.fr			LABEX (Laboratoire d'excellence) BCDIV; ARN	LABEX (Laboratoire d'excellence) BCDIV; ARN	This work was supported by public funds through the LABEX (Laboratoire d'excellence) BCDIV under the project name "Metaphore de l'arbre dans l'histoire des sciences naturelles" (2014) to MF and GL (https://labex-bcdiv.mnhn.fr/projetmission/metaphore-larbre-dans-lhistoiresciences-naturelles).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present project has been supported by Pr. Evelyne Heyer and Pr. Philippe Grandcolas, directors of the units UMR 7206 and UMR 7205 respectively, for a successful application to the " Laboratoire d'Excellence BCDiv" led by Jean-Denis Vigne. We also thank support from the ARN project " Anthropos " led by Delphine Kolesnik, Ecole Normale Superieure de Lyon. We warmly thank Giulio Barsanti, Pascal Charbonnat, Claude Dupuis, Pascal Duris, Sarah Franceschelli, Jean Gayon, Alice Michel-Salzat, Michel Morange, Armand de Ricqles, Ste ' phane Schmitt, Rene Zaragueta-y-Bagils for helpful comments and discussions. We thank Eglantine Lemense for help on the manuscript. We thank the Societe Francaise de Systematique by which this work has been awarded " Prix Jacques Lebbe "	[Anonymous], 1853, ALLGEMEINE MONATSSCH; ARCHIE JW, 1990, SYST ZOOL, V39, P169, DOI 10.2307/2992454; ARCHIE JW, 1989, SYST ZOOL, V38, P239, DOI 10.2307/2992285; Barsanti Giulio, 1992, SCALA MAPPA ALBERO I; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Brower AVZ, 2014, CLADISTICS, V30, P330, DOI 10.1111/cla.12050; BROWN S, 2014, P R SOC B, V281, P2013; Browne J, 1985, JUST ORIGIN AR WALLA, P96; Buican D, 1997, EVOLUTION THEORIES E; CARPENTER J M, 1987, Cladistics, V3, P363, DOI 10.1111/j.1096-0031.1987.tb00899.x; Charbonnat P, 2014, APPARENTER PENSEE VE; CHRISTOFFERSEN ML, 1995, SYST BIOL, V44, P440, DOI 10.2307/2413605; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Currie TE, 2010, PHILOS T R SOC B, V365, P3903, DOI 10.1098/rstb.2010.0014; DARLU P, 1993, RECONSTRUCTION PHYLO; Darlu P., 2019, RECONSTRUCTION PHYLO; de Bonis Louis, 2006, Annales de Paleontologie, V92, P205, DOI 10.1016/j.annpal.2006.03.010; De Quatrefages A, 1870, DARWIN SES PRECURSEU, P42; Diderot D., 1751, ENCYCLOP DIE DICT RA, V9; DUPUIS C, 1984, ANNU REV ECOL SYST, V15, P1; Dupuis C, 1978, CAHIER NATURALISTES, V341, P1; Dupuis C, 1986, ORDRE DIVERSITE VIVA, P215; Dupuis C, 1992, CAHIER NATURALISTES, V482, P29; Ebach MC, 2008, BIOL PHILOS, V23, P153, DOI 10.1007/s10539-007-9069-7; Fisler M, 2014, APPARENTER PENSEE, P103; Fisler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068814; Gaudant M, 1971, THEORIES CLASSIQUES; Gjelsvik A, 1981, THEORY THIN WALLED B, DOI DOI 10.1115/1.3162198; Gontier N., 2011, EVOL ED OUTREACH, V4, P515, DOI DOI 10.1007/S12052-011-0355-0; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Grimoult C, 2003, HIST HIST SCI HIST E; Grimoult C., 2000, HIST EVOLUTIONNISME; Grimoult C, 2001, EVOLUTION BIOL FRANC; GrimouLt C., 1998, EVOLUTIONNISME FIXIS; Heggarty P, 2010, PHILOS T R SOC B, V365, P3829, DOI 10.1098/rstb.2010.0099; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Holland BR, 2002, MOL BIOL EVOL, V19, P2051, DOI 10.1093/oxfordjournals.molbev.a004030; Hull, 2010, SCI PROCESS EVOLUTIO; Hurles ME, 2003, TRENDS ECOL EVOL, V18, P531, DOI 10.1016/S0169-5347(03)00245-3; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Le Bomin S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151570; Mayr E, 1986, ORDRE DIVERSITE VIVA, P143; Nakhleh L, 2005, T PHILOL SOC, V103, P171, DOI 10.1111/j.1467-968X.2005.00149.x; Nunn CL, 2010, PHILOS T R SOC B, V365, P3807, DOI 10.1098/rstb.2010.0009; OHARA RJ, 1991, BIOL PHILOS, V6, P255, DOI 10.1007/BF02426840; OHARA RJ, 1987, AM ZOOL, V27, pA107; Pietsch T. W., 2012, TREES LIFE VISUAL HI; Ragan MA, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-43; Roger Jacques, 1989, BUFFON PHILOS JARDIN; SCHUH RT, 2000, BIOL SYSTEMATICS PRI; TASSY P, 1991, ARBRE REMONTER TEMPS; Tassy PE, 2007, EMERGENCE REDUCTIONS, V2, P289	54	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226567	10.1371/journal.pone.0226567	http://dx.doi.org/10.1371/journal.pone.0226567			79	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940355	Green Published, gold			2022-12-26	WOS:000534368000033
J	Roy, S; Yuzefpolskaya, M; Nandakumar, R; Colombo, PC; Demmer, RT				Roy, Sumith; Yuzefpolskaya, Melana; Nandakumar, Renu; Colombo, Paolo C.; Demmer, Ryan T.			Plasma Trimethylamine-N-oxide and impaired glucose regulation: Results from The Oral Infections, Glucose Intolerance and Insulin Resistance Study (ORIGINS)	PLOS ONE			English	Article							SYSTEMIC INFLAMMATION; RISK; METABOLISM; PHOSPHATIDYLCHOLINE; MICROBIOME	Trimethylamine-N-oxide (TMAO)-a gut-microbiota metabolite-is a biomarker of cardiometabolic risk. No studies have investigated TMAO as an early biomarker of longitudinal glucose increase or prevalent impaired glucose regulation. In a longitudinal cohort study, 300 diabetes-free men and women (77%) aged 20-55 years (mean = 34 +/- 10) were enrolled at baseline and re-examined at 2-years to investigate the association between TMAO and biomarkers of diabetes risk. Plasma TMAO was measured using Ultra Performance Liquid Chromatography-Mass Spectrometry. After an overnight fast, FPG was measured longitudinally, HbA1C and insulin were measured only at baseline. Insulin resistance was defined using HOMA-IR. Multivariable generalized linear models regressed; i) FPG change (year 2 minus baseline) on baseline TMAO tertiles; and ii) HOMA-IR and HbA1c on TMAO tertiles. Multivariable relative risk regressions modeled prevalent prediabetes across TMAO tertiles. Mean values of 2-year longitudinal FPG +/- SE across tertiles of TMAO were 86.6 +/- 0.9, 86.7 +/- 0.9, 86.4 +/- 0.9 (p = 0.98). Trends were null for FPG, HbA1c, HOMA-IR, cross-sectionally. The prevalence ratio of prediabetes among participants in 2nd and 3rd TMAO tertiles (vs. the 1st) were 1.94 [95%CI 1.09-3.48] and 1.41 [95%CI: 0.76-2.61]. TMAO levels are associated with increased prevalence of prediabetes in a nonlinear fashion but not with insulin resistance or longitudinal FPG change.	[Roy, Sumith; Demmer, Ryan T.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Yuzefpolskaya, Melana; Colombo, Paolo C.] Columbia Univ, Dept Med, Div Cardiol, New York Presbyterian Hosp, New York, NY USA; [Nandakumar, Renu] Columbia Univ, Med Ctr, Irving Inst Clin & Translat Res, New York, NY USA; [Demmer, Ryan T.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; University of Minnesota System; University of Minnesota Twin Cities	Demmer, RT (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.; Demmer, RT (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	demm0009@umn.edu		Roy, Sumith/0000-0002-8887-9835; Demmer, Ryan/0000-0003-3429-0379	NIH [R00 DE018739, R21 DE022422, R01 DK 102932]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001873]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by NIH grants R00 DE018739, R21 DE022422 and R01 DK 102932 to Dr. Demmer. This publication was also supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1TR001873. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following individuals for their invaluable contributions to this research: the 1199 SEIU, HS-3/SSA Area leadership including Ms. Consuelo Mclaughin, Mr. Bennett Batista, Mr. Victor Rivera; Ms. Romanita Celenti for her efforts in performing phlebotomy and processing and analyzing plaque samples; Ms. Aleksandra Zuk and Garazi Zulaika for their leadership and excellent program coordination; Drs. Nidhi Arora, Ashwata Pokherel, Publio Silfa & Thomas Spinell for their skilled examinations and essential participant engagement. We are also profoundly grateful to the ORIGINS participants, for their participation in this research.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Dambrova M, 2016, EXP CLIN ENDOCR DIAB, V124, P251, DOI 10.1055/s-0035-1569330; Demmer RT, 2015, J DENT RES, V94, p201S, DOI 10.1177/0022034515590369; Demmer RT, 2017, J CLIN PERIODONTOL, V44, P255, DOI 10.1111/jcpe.12664; Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072; Gao X, 2014, J BIOSCI BIOENG, V118, P476, DOI 10.1016/j.jbiosc.2014.03.001; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lever M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114969; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Meyer KA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003970; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Papandreou C, 2018, AM J CLIN NUTR, V108, P163, DOI 10.1093/ajcn/nqy058; Shan ZL, 2017, AM J CLIN NUTR, V106, P888, DOI 10.3945/ajcn.117.157107; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2014, J AM COLL CARDIOL, V64, P1908, DOI 10.1016/j.jacc.2014.02.617; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Thai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092441; Wang ZN, 2014, ANAL BIOCHEM, V455, P35, DOI 10.1016/j.ab.2014.03.016; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	24	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227482	10.1371/journal.pone.0227482	http://dx.doi.org/10.1371/journal.pone.0227482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940332	gold, Green Published			2022-12-26	WOS:000534368000076
J	Villa, P; Soriano, S; Pollarolo, L; Smriglio, C; Gaeta, M; D'Orazio, M; Conforti, J; Tozzi, C				Villa, Paola; Soriano, Sylvain; Pollarolo, Luca; Smriglio, Carlo; Gaeta, Mario; D'Orazio, Massimo; Conforti, Jacopo; Tozzi, Carlo			Neandertals on the beach: Use of marine resources at Grotta dei Moscerini (Latium, Italy)	PLOS ONE			English	Article							CALLISTA-CHIONE; SHELL TOOLS; CAMPANIAN IGNIMBRITE; HOMO-ERECTUS; MIDDLE; EXPLOITATION; ISCHIA; SEA; GEOCHEMISTRY; TECHNOLOGY	Excavated in 1949, Grotta dei Moscerini, dated MIS 5 to early MIS 4, is one of two Italian Neandertal sites with a large assemblage of retouched shells (n = 171) from 21 layers. The other occurrence is from the broadly contemporaneous layer L of Grotta del Cavallo in southern Italy (n = 126). Eight other Mousterian sites in Italy and one in Greece also have shell tools but in a very small number. The shell tools are made on valves of the smooth clam Callista chione. The general idea that the valves of Callista chione were collected by Neandertals on the beach after the death of the mollusk is incomplete. At Moscerini 23.9% of the specimens were gathered directly from the sea floor as live animals by skin diving Neandertals. Archaeological data from sites in Italy, France and Spain confirm that shell fishing and fresh water fishing was a common activity of Neandertals, as indicated by anatomical studies recently published by E. Trinkaus. Lithic analysis provides data to show the relation between stone tools and shell tools. Several layers contain pumices derived from volcanic eruptions in the Ischia Island or the Campi Flegrei (prior to the Campanian Ignimbrite mega-eruption). Their rounded edges indicate that they were transported by sea currents to the beach at the base of the Moscerini sequence. Their presence in the occupation layers above the beach is discussed. The most plausible hypothesis is that they were collected by Neandertals. Incontrovertible evidence that Neandertals collected pumices is provided by a cave in Liguria. Use of pumices as abraders is well documented in the Upper Paleolithic. We prove that the exploitation of submerged aquatic resources and the collection of pumices common in the Upper Paleolithic were part of Neandertal behavior well before the arrival of modern humans in Western Europe.	[Villa, Paola] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Villa, Paola] Ist Italiano Paleontol Umana, Rome, Italy; [Villa, Paola; Pollarolo, Luca] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Soriano, Sylvain] Univ Paris Nanterre, Maison Archeol & Ethnol, CNRS, ArScAn,AnTET, Nanterre, France; [Pollarolo, Luca] Univ Geneva, Lab Archeol & Peuplement Afr, Geneva, Switzerland; [Smriglio, Carlo] Univ Roma, Dipartimento Sci, Rome, Italy; [Gaeta, Mario] Univ Roma La Sapienza, Dipartimento Sci Terra, Rome, Italy; [D'Orazio, Massimo] Univ Pisa, Dipartimento Sci Terra, Pisa, Italy; [Conforti, Jacopo; Tozzi, Carlo] Univ Pisa, Dipartimento Civilta & Forme Sapere, Pisa, Italy	University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); University of Geneva; Sapienza University Rome; University of Rome Tor Vergata; Sapienza University Rome; University of Pisa; University of Pisa	Villa, P (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.; Villa, P (corresponding author), Ist Italiano Paleontol Umana, Rome, Italy.; Villa, P (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	villap@colorado.edu		Soriano, Sylvain/0000-0002-4288-9763; Villa, Paola/0000-0002-9831-5443; POLLAROLO, LUCA/0000-0001-9449-5937	National Science Foundation [1118143]; BCS Archaeology	National Science Foundation(National Science Foundation (NSF)); BCS Archaeology	National Science Foundation Grant 1118143, BCS Archaeology, to PV (PI) and SS (coPI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Italian Institute of Human Paleontology, the Pigorini National Museum of Prehistory and Ethnography in Rome and the Zoology Museum in Rome for access to the Moscerini collections and facilities during the analysis. Fabio Parenti, then President of the Italian Institute of Human Paleontology, and Luciano Bruni very graciously allowed us full access to the Moscerini assemblage and its transport from the town of Anagni to the Zoology Museum in Rome, keep it there for the duration of the study and allowing us to make photos of lithics and shells. We thank Stefano Grimaldi, the new President of the Italian Institute of Human Paleontology for granting Fabrizio Marra permission to sample some pumices from various Moscerini levels for dating by 40Argon/39 Argon dating and for composition analysis by Mario Gaeta. We are grateful to the late Aldo G. Segre for providing field drawings and stratigraphic information on Moscerini. We thank the Director of the Pigorini Museum and Mario Mineo for permission to take photos of the materials and allowing us to use the skills of Fabio Naccari for photography. We are grateful to Mario Amore of the Pigorini Museum and Barbara Saracino of the Italian Institute of Human Paleontology for their help in accessing materials in Rome and in Anagni. We thank the Soprintendenza Archeologia, Belle Arti e Paesaggio della Liguria, the Superintendent Vincenzo Tine ', Nico Radi and Marta Conventi for permission to sample the pumice from Santa Lucia cave for analysis by Massimo D'Orazio. Two reviewers provided very valuable comments.	Adovasio JM, 1996, ANTIQUITY, V70, P526, DOI 10.1017/S0003598X0008368X; Ashton NM., 1991, LITHICS, V12, P1; Averbouh A., 1995, FICHES TYPOLOGIQUES, P83; Baeta M, 2014, OCEAN COAST MANAGE, V93, P15, DOI 10.1016/j.ocecoaman.2014.03.001; Bailey GN, 2008, QUATERNARY SCI REV, V27, P2153, DOI 10.1016/j.quascirev.2008.08.012; Bathrellos GD, 2009, CENT EUR J GEOSCI, V1, P19, DOI 10.2478/v10085-009-0006-7; Bocherens H, 2014, QUATERN INT, V339, P112, DOI 10.1016/j.quaint.2013.06.026; Borzatti von Lowenstern E., 1967, RIV SCI PREIST, V22, P205; Breuil H, 1955, COMPTED RENDUS SEANC, V99, P194, DOI [10.3406/crai.1955.10431, DOI 10.3406/CRAI.1955.10431]; Cassoli P.F., 1997, PALEOLITICO CASTELCI, V5; Choi K, 2007, J ARCHAEOL SCI, V34, P48, DOI 10.1016/j.jas.2006.03.013; Civetta L, 1997, J VOLCANOL GEOTH RES, V75, P183, DOI 10.1016/S0377-0273(96)00027-3; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Conard NJ, 2012, QUATERN INT, V247, P236, DOI 10.1016/j.quaint.2011.05.043; Cortes-Sanchez M, 2019, QUATERNARY SCI REV, V217, P284, DOI 10.1016/j.quascirev.2019.02.007; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; CRISCI GM, 1989, CHEM GEOL, V78, P15, DOI 10.1016/0009-2541(89)90049-1; Cristiani E., 2005, HOOVES HORNS MOLLUSC, P319; Cuenca-Solana D, 2016, J ARCHAEOL SCI, V74, P135, DOI 10.1016/j.jas.2016.07.018; Cuenca-Solana D, 2015, J ISL COAST ARCHAEOL, V10, P52, DOI 10.1080/15564894.2014.934491; Cuenca-Solana D, 2013, CURR ANTHROPOL, V54, P370, DOI 10.1086/670325; Dachary M, 2012, PALEO, V23, P315; Dantoni G, 2007, ANTHROPOLOGIE, V111, P346, DOI [10.1016/j.anthro.2007.04.001, DOI 10.1016/J.ANTHRO.2007.04.001]; Dantoni G, 1980, STUDI ECOLOGIA QUATE, V2, P67; Degano I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213473; Douka K, 2012, J WORLD PREHIST, V25, P45, DOI 10.1007/s10963-012-9056-z; Ezgeta-Balic D, 2011, HELGOLAND MAR RES, V65, P457, DOI 10.1007/s10152-010-0235-y; Gaspar MB, 2001, HYDROBIOLOGIA, V465, P153, DOI 10.1023/A:1014587212528; Giaccio B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45940; Giaccio B, 2017, QUATERNARY SCI REV, V158, P211, DOI 10.1016/j.quascirev.2017.01.004; Glover EA, 2010, J MOLLUS STUD, V76, P157, DOI 10.1093/mollus/eyp054; Gravina B, 2015, J HUM EVOL, V84, P83, DOI 10.1016/j.jhevol.2015.04.005; Hardy BL, 2013, QUATERNARY SCI REV, V82, P23, DOI 10.1016/j.quascirev.2013.09.028; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Hoffman JS, 2017, SCIENCE, V355, P276, DOI 10.1126/science.aai8464; Jaubert, 2008, SOC PALEOLITHIQUE GR, P83; Joordens JCA, 2015, NATURE, V518, P228, DOI 10.1038/nature13962; KELLY PA, 1983, GEOGRAPHY, V68, P25; Klein RG, 2016, J ANTHROPOL ARCHAEOL, V44, P198, DOI 10.1016/j.jaa.2016.07.008; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; LAWN BR, 1975, J MATER SCI, V10, P113, DOI 10.1007/BF00541038; Le Maitre R. W., 2005, IGNEOUS ROCKS CLASSI; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; Marean CW, 2014, J HUM EVOL, V77, P17, DOI 10.1016/j.jhevol.2014.02.025; Marra F, 2019, QUATERN INT, V525, P54, DOI 10.1016/j.quaint.2019.09.001; Moncel MH, 2012, J HUM EVOL, V63, P653, DOI 10.1016/j.jhevol.2012.08.001; Oxilia M., 1974, ATT 16 RIUN SCI I IT, P84; Pappalardo L, 1999, J VOLCANOL GEOTH RES, V91, P141, DOI 10.1016/S0377-0273(99)00033-5; Parsons K.M., 1991, P22; Peresani M, 2015, QUATERN INT, V361, P238, DOI 10.1016/j.quaint.2014.10.058; POLI S, 1987, CONTRIB MINERAL PETR, V95, P322, DOI 10.1007/BF00371846; Porraz G., 2002, PREHISTOIRES MEDITER, V10-11, P27; Prieur A., 2005, Paleorient, V31, P158, DOI 10.3406/paleo.2005.4794; Romagnoli F., 2014, J ARCHAEOL METHOD TH, V22, P1007; Romagnoli F, 2017, QUATERN INT, V427, P216, DOI 10.1016/j.quaint.2015.11.021; Romagnoli F, 2016, QUATERN INT, V407, P29, DOI 10.1016/j.quaint.2015.07.034; Romagnoli F, 2015, QUATERN INT, V361, P200, DOI 10.1016/j.quaint.2014.07.033; Schwarcz H.P, 1991, QUATERNARIA NOVA, V1, P51; Soriano S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186082; Stiner M.C., 1994, HONOR THIEVES ZOOARC; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Szabo K, 2007, CURR ANTHROPOL, V48, P701, DOI 10.1086/520131; Tixier J., 1999, PALEO, V11, P135, DOI DOI 10.3406/PAL.1999.1174; Tomlinson EL, 2014, J VOLCANOL GEOTH RES, V287, P22, DOI 10.1016/j.jvolgeores.2014.09.006; Tozzi C, 1962, RIV STDI LIGURI, VXXVI, P221; Tozzi C., 1970, RIV SCI PREISTORICHE, VXXV, P3; Trinkaus E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220464; Turolla E., 2007, ATLANTE BIVALVI MERC; Vaquero M, 2015, QUATERN INT, V361, P212, DOI 10.1016/j.quaint.2014.05.055; Vasconcelos P, 2011, ICES J MAR SCI, V68, P32, DOI 10.1093/icesjms/fsq149; Verhaegen M., 2013, Human Evolution, V28, P237; Verhaegen M, 2011, HOMO, V62, P237, DOI 10.1016/j.jchb.2011.06.002; Vicino G., 1974, ATT 16 RIUN SCI I IT, P75; Vigie B., 1986, Bulletin du Museum d'Histoire Naturelle de Marseille, V46, P51; Villa P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160516; Vitagliano S., 1984, ATT 24 RIUN SCI I IT, P155; Zanchetta G, 2018, QUATERNARY SCI REV, V182, P65, DOI 10.1016/j.quascirev.2017.12.014	78	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226690	10.1371/journal.pone.0226690	http://dx.doi.org/10.1371/journal.pone.0226690			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940356	Green Published, gold, Green Submitted			2022-12-26	WOS:000534368000035
J	Alballa, M; Aplop, F; Butler, G				Alballa, Munira; Aplop, Faizah; Butler, Gregory			TranCEP: Predicting the substrate class of transmembrane transport proteins using compositional, evolutionary, and positional information	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CLASSIFICATION DATABASE; MEMBRANE TRANSPORTERS; TOPOLOGY PREDICTION; WEB SERVER; GENOME; ANNOTATION; NETWORKS; TCDB	Transporters mediate the movement of compounds across the membranes that separate the cell from its environment and across the inner membranes surrounding cellular compartments. It is estimated that one third of a proteome consists of membrane proteins, and many of these are transport proteins. Given the increase in the number of genomes being sequenced, there is a need for computational tools that predict the substrates that are transported by the transmembrane transport proteins. In this paper, we present TranCEP, a predictor of the type of substrate transported by a transmembrane transport protein. TranCEP combines the traditional use of the amino acid composition of the protein, with evolutionary information captured in a multiple sequence alignment (MSA), and restriction to important positions of the alignment that play a role in determining the specificity of the protein. Our experimental results show that TranCEP significantly outperforms the state-of-the-art predictors. The results quantify the contribution made by each type of information used.	[Alballa, Munira; Butler, Gregory] Concordia Univ, Dept Comp Sci & Software Engn, Montreal, PQ, Canada; [Alballa, Munira] King Saud Univ, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Aplop, Faizah] Univ Malaysia Terengganu, Sch Informat & Appl Math, Terengganu, Malaysia; [Butler, Gregory] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada	Concordia University - Canada; King Saud University; Universiti Malaysia Terengganu; Concordia University - Canada	Butler, G (corresponding author), Concordia Univ, Dept Comp Sci & Software Engn, Montreal, PQ, Canada.; Butler, G (corresponding author), Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada.	gregory.butler@concordia.ca	aplop, faizah/CAJ-4872-2022	aplop, faizah/0000-0002-2473-7846; Butler, Gregory/0000-0002-6938-0879				Aplop F., 2017, ARPN J ENG APPL SCI, V12; Aplop F., 2016, COMPUTATIONAL APPROA; Barghash A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-343; Bekkar M., 2013, J INF ENG APPL, DOI [10.5121/ijdkp.2013.3402, DOI 10.5121/IJDKP.2013.3402]; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bhat B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13083-y; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Buehler L., 2015, STRUCTURE MEMBRANE P; Busch Wolfgang, 2003, Methods Mol Biol, V227, P21, DOI 10.1385/1-59259-387-9:21; Butt AH, 2017, J MEMBRANE BIOL, V250, P55, DOI 10.1007/s00232-016-9937-7; Chakraborty A, 2015, BRIEF BIOINFORM, V16, P71, DOI 10.1093/bib/bbt092; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Chen SA, 2011, BIOINFORMATICS, V27, P2062, DOI 10.1093/bioinformatics/btr340; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Dias O, 2017, IEEE ACM T COMPUT BI, V14, P443, DOI 10.1109/TCBB.2016.2527647; Dias O, 2015, NUCLEIC ACIDS RES, V43, P3899, DOI 10.1093/nar/gkv294; Ding Z., 2011, DIVERSIFIED ENSEMBLE; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Floden EW, 2016, NUCLEIC ACIDS RES, V44, pW339, DOI 10.1093/nar/gkw300; Gorodkin J, 2004, COMPUT BIOL CHEM, V28, P367, DOI 10.1016/j.compbiolchem.2004.09.006; Gromiha MM, 2014, BRIEF BIOINFORM, V15, P155, DOI 10.1093/bib/bbt015; Gromiha MM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-135; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Kwak SG, 2017, KOREAN J ANESTHESIOL, V70, P144, DOI 10.4097/kjae.2017.70.2.144; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee TJ, 2008, BIOINFORMATICS, V24, pI259, DOI 10.1093/bioinformatics/btn180; Li HQ, 2008, BIOINFORMATICS, V24, P1129, DOI 10.1093/bioinformatics/btn099; Li HQ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-418; Li LQ, 2016, IEEE ACM T COMPUT BI, V13, P947, DOI 10.1109/TCBB.2015.2495140; Lin HH, 2006, PROTEINS, V62, P218, DOI 10.1002/prot.20605; Liou YF, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S6; Loira N, 2015, J BIOINF COMPUT BIOL, V13, DOI 10.1142/S0219720015500067; Loira N, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-35; Manning C, 2010, NAT LANG ENG, V16, P280; Mishra NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100278; Ou YY, 2010, PROTEINS, V78, P1789, DOI 10.1002/prot.22694; Paparoditis P, 2014, BBA-BIOMEMBRANES, V1838, P193, DOI 10.1016/j.bbamem.2013.08.007; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Sahoo S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00091; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Schaadt NS, 2012, BIOPOLYMERS, V97, P558, DOI 10.1002/bip.22043; Schaadt NS, 2010, J CHEM INF MODEL, V50, P1899, DOI 10.1021/ci100243m; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsirigos KD, 2016, BIOINFORMATICS, V32, P665, DOI 10.1093/bioinformatics/btw444; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Weiss GM, 2003, J ARTIF INTELL RES, V19, P315, DOI 10.1613/jair.1199	58	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227683	10.1371/journal.pone.0227683	http://dx.doi.org/10.1371/journal.pone.0227683			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935244	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000534354100042
J	Crespo-Moral, M; Garcia-Posadas, L; Lopez-Garcia, A; Diebold, Y				Crespo-Moral, Mario; Garcia-Posadas, Laura; Lopez-Garcia, Antonio; Diebold, Yolanda			Histological and immunohistochemical characterization of the porcine ocular surface	PLOS ONE			English	Article							IN-VITRO MODEL; LYMPHOID-TISSUE; CELL-LINE; CONJUNCTIVA; DELIVERY; PIG; EYE; CULTURES; LIMBAL	The ocular surface of the white domestic pig (Sus scrofa domestica) is used as a helpful model of the human ocular surface; however, a complete histological description has yet to be published. In this work, we studied porcine eyeballs with intact eyelids to describe and characterize the different structures that form the ocular surface, including the cornea and conjunctiva that covers the bulbar sclera, tarsi, and the nictitating membrane. We determined the distribution of goblet cells of different types over the conjunctiva and analyzed the conjunctival-associated lymphoid tissue (CALT). Porcine eyeballs were obtained from a local slaughterhouse, fixed, processed, and embedded in paraffin blocks. Tissue sections (4 mu m) were stained with hematoxylin/eosin, Alcian blue/Periodic Acid Schiff, and Giemsa. Slides were also stained with lectins from Arachis hypogaea (PNA) and Helix pomatia (HPA) agglutinins and immunostained with rabbit anti-CD3. We found that the porcine cornea was composed of 6-8 epithelial cell layers, stroma, Descemet's membrane, and an endothelial monolayer. The total corneal thickness was 1131.0 +/- 87.5 mu m (mean +/- standard error of the mean) in the center and increased to 1496.9 +/- 138.2 mu m at the limbus. The goblet cell density was 71.25 +/- 12.29 cells/mm, ranging from the highest density (113.04 +/- 37.21 cells/mm) in the lower palpebral conjunctiva to the lowest density (12.69 +/- 4.29 cells/mm) in the bulbar conjunctiva. The CALT was distributed in the form of intraepithelial lymphocytes and subepithelial diffuse lymphoid tissue. Lenticular-shaped lymphoid follicles, about 8 per histological section, were also present within the conjunctival areas. In conclusion, we demonstrated that the analyzed porcine ocular structures are similar to those of humans, confirming the potential usefulness of pig eyes to study ocular surface physiology and pathophysiology.	[Crespo-Moral, Mario; Garcia-Posadas, Laura; Lopez-Garcia, Antonio; Diebold, Yolanda] Univ Valladolid, IOBA, Ocular Surface Grp, Valladolid, Spain; [Lopez-Garcia, Antonio; Diebold, Yolanda] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Valladolid, Spain	Universidad de Valladolid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Diebold, Y (corresponding author), Univ Valladolid, IOBA, Ocular Surface Grp, Valladolid, Spain.; Diebold, Y (corresponding author), Biomed Res Networking Ctr Bioengn Biomat & Nanome, Valladolid, Spain.	yol@ioba.med.uva.es	García-Posadas, Laura/P-9962-2018; Diebold, Yolanda/A-9087-2016	García-Posadas, Laura/0000-0001-9921-8541; Diebold, Yolanda/0000-0003-2990-9368; Crespo-Moral, Mario/0000-0001-6624-3943	Spanish Ministry of Economy and Competitiveness [MAT2013-47501-C2-1-R]; European Regional Development Fund [MAT2013-47501-C2-1-R, RTI2018-094071-B-C21]; Spanish Ministry of Science, Innovation and Universities [RTI2018-094071-B-C21]; Postdoctoral contrats 2017 call (University of Valladolid), Regional JCyL Scholarship/European Social Fund Program ORDEN [EDU/128/2015]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); Spanish Ministry of Science, Innovation and Universities(Spanish Government); Postdoctoral contrats 2017 call (University of Valladolid), Regional JCyL Scholarship/European Social Fund Program ORDEN	YD, MAT2013-47501-C2-1-R (Spanish Ministry of Economy and Competitiveness and European Regional Development Fund) http://www.mineco.gob.es/and https://ec.europa.eu/regional_policy/en/funding/erdf/YD and LGP, RTI2018-094071-B-C21 (Spanish Ministry of Science, Innovation and Universities and European Regional Development Fund) http://www.ciencia.gob.es/portal/site/MICINN/and https://ec.europa.eu/regional_policy/en/funding/erdf/LGP, Postdoctoral contrats 2017 call (University of Valladolid) http://www.uva.es/export/sites/uva/MCM, Regional JCyL Scholarship/European Social Fund Program ORDEN EDU/128/2015 (Regional JCyL and European Social Fund) https://www.jcyl.es/and https://ec.europa.eu/esf/home.jsp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnifili L, 2014, INVEST OPHTH VIS SCI, V55, P5254, DOI 10.1167/iovs.14-14365; Alvarez-Trabado J, 2018, INT J PHARMACEUT, V546, P20, DOI 10.1016/j.ijpharm.2018.05.015; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Arends G, 2004, ANN ANAT, V186, P195, DOI 10.1016/S0940-9602(04)80002-5; Bron AJ, 1998, ADV EXP MED BIOL, V438, P281; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chodosh J, 1998, DEV COMP IMMUNOL, V22, P621, DOI 10.1016/S0145-305X(98)00022-6; Dartt D a, 2014, CURR OPIN ALLERGY CL, V14, P1; Dartt DA, 2004, EXP EYE RES, V78, P173, DOI 10.1016/j.exer.2003.10.005; Dartt DA, 2006, DUANES FDN CLIN OPHT, V2; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Diebold Y, 2003, INVEST OPHTH VIS SCI, V44, P4263, DOI 10.1167/iovs.03-0560; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Fine BS, 1979, OCULAR HISTOLOGY, V2nd; Funke S, 2017, MOL NEUROBIOL, V54, P7262, DOI 10.1007/s12035-016-0172-0; Garcia-Posadas L, 2016, EYE CONTACT LENS, V42, P83, DOI 10.1097/ICL.0000000000000158; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gipson IK, 2016, PROG RETIN EYE RES, V54, P49, DOI 10.1016/j.preteyeres.2016.04.005; Hendrickson A, 2002, EXP EYE RES, V74, P435, DOI 10.1006/exer.2002.1181; Henker R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074046; Hodges RR, 2013, EXP EYE RES, V117, P62, DOI 10.1016/j.exer.2013.07.027; Horbach SPJM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186281; KAHN CR, 1993, INVEST OPHTH VIS SCI, V34, P3429; KAWANO K, 1988, EXP EYE RES, V47, P43, DOI 10.1016/0014-4835(88)90022-X; Kessing SV, 1968, ACTA OPHTHALMOL S95; Knop E, 2005, J ANAT, V206, P271, DOI 10.1111/j.1469-7580.2005.00394.x; Knop N, 2000, INVEST OPHTH VIS SCI, V41, P1270; Lorget F, 2016, MOL PHARMACEUT, V13, P2891, DOI 10.1021/acs.molpharmaceut.5b00731; Menduni F, 2018, CONTACT LENS ANTERIO, V41, P13, DOI 10.1016/j.clae.2017.09.003; Merindano M.D., 2002, EUR J ANAT, V6, P133; Nautscher N, 2016, VET OPHTHALMOL, V19, P297, DOI 10.1111/vop.12298; Notara M, 2011, TISSUE ENG PT A, V17, P741, DOI [10.1089/ten.tea.2010.0343, 10.1089/ten.TEA.2010.0343]; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Piehl M, 2010, TOXICOL IN VITRO, V24, P231, DOI 10.1016/j.tiv.2009.08.033; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Seftalioglu A, 1993, MED J ISLAM WORLD AC, V6, P46; Soriano-Romani L, 2018, EXP EYE RES, V167, P118, DOI 10.1016/j.exer.2017.12.002; Stern ME, 1998, CORNEA, V17, P584, DOI 10.1097/00003226-199811000-00002; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; WOTHERSPOON AC, 1994, J PATHOL, V174, P33, DOI 10.1002/path.1711740106	42	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227732	10.1371/journal.pone.0227732	http://dx.doi.org/10.1371/journal.pone.0227732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929592	Green Published, gold			2022-12-26	WOS:000534352500066
J	Vidal, D; Mocho, P; Paramo, A; Sanz, JL; Ortega, F				Vidal, Daniel; Mocho, Pedro; Paramo, Adrian; Luis Sanz, Jose; Ortega, Francisco			Ontogenetic similarities between giraffe and sauropod neck osteological mobility	PLOS ONE			English	Article							OPISTHOTONIC-POSTURE; EARLY EVOLUTION; DINOSAURS; HETEROCHRONY; HEAD; RIBS	The functional morphology of sauropod dinosaur long necks has been studied extensively, with virtual approaches yielding results that are difficult to obtain with actual fossils, due to their extreme fragility and size. However, analyses on virtual fossils have been questioned on several of their premises, such as the ability to accurately reconstruct intervertebral tissue with only skeletal data; or whether zygapophyseal overlap can be used to determine the limits of range of motion, since some extreme neck poses in extant giraffes have been claimed not to retain any zygapophyseal overlap. We compared articulation and range of motion in extant giraffes with the exceptionally well-preserved and complete basally branching eusauropod Spinophorosaurus nigerensis from the Middle (?) Jurassic of Niger, under the same virtual paleontology protocols. We examined the articulation and range of motion on grown and young specimens of both Spinophorosaurus and giraffes in order to record any potential changes during ontogeny. Also, the postures of virtual giraffes were compared with previously published data from living animals in the wild. Our analyses show that: (i) articulation of virtual bones in osteologically neutral pose (ONP) does enable accurate prediction of the amount of inter-vertebral space in giraffes and, roughly, in Spinophorosaurus; (ii) even the most extreme neck postures attained by living giraffes in the wild do not require to disarticulate cervical vertebrae; (iii) both living giraffes and Spinophorosaurus have large intervertebral spaces between their cervical centra in early ontogenetical stages, which decrease as ontogeny advances; and (iv) that grown specimens have a greater osteological range of motion in living giraffes and Spinophorosaurus.	[Vidal, Daniel; Mocho, Pedro; Ortega, Francisco] UNED, Fac Ciencias, Grp Biol Evolut, Madrid, Spain; [Mocho, Pedro] Univ Lisbon, Inst Dom Luiz, Bloco C6,38 Piso,Sale 6-3-57, Lisbon, Portugal; [Mocho, Pedro] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA; [Paramo, Adrian; Luis Sanz, Jose] Univ Autonoma Madrid, Fac Ciencias, Unidad Paleontol, Calle Darwin, Madrid, Spain; [Luis Sanz, Jose] Real Acad Espanola Ciencias Exactas Fisicas & Nat, Calle Valverde, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Universidade de Lisboa; Autonomous University of Madrid	Vidal, D (corresponding author), UNED, Fac Ciencias, Grp Biol Evolut, Madrid, Spain.	eoalulavis@gmail.com	Blázquez, Adrián Páramo/D-3227-2018; Vidal, Daniel/T-1730-2019; Ortega, Francisco/K-3255-2015; Vidal, Daniel C/G-6174-2016; Mocho, Pedro/A-4215-2019; Ortega, Francisco/B-5760-2009	Blázquez, Adrián Páramo/0000-0002-7746-5493; Vidal, Daniel/0000-0002-6054-1357; Ortega, Francisco/0000-0002-7431-354X; Vidal, Daniel C/0000-0002-6054-1357; Mocho, Pedro/0000-0002-3348-5572; Ortega, Francisco/0000-0002-7431-354X; Sanz, Jose Luis/0000-0002-5214-5725	Spanish Ministerio de Economia y Competitividad (MINECO) [CGL2015-68363-P]; predoctoral FPI UNED [0531174813 Y0SC001170]; FCT/MCTES for one CEEC Individual contract [CEECIND/00726/2017]	Spanish Ministerio de Economia y Competitividad (MINECO); predoctoral FPI UNED; FCT/MCTES for one CEEC Individual contract	Research was supported by the project CGL2015-68363-P of the Spanish Ministerio de Economia y Competitividad (MINECO). DV's research is funded by a predoctoral FPI UNED Grant (Ref. 0531174813 Y0SC001170). PM's research is funded by FCT/MCTES for one CEEC Individual contract (CEECIND/00726/2017).	Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Cambra-Moo O, 2006, BIOESTRATINOMIA FOSI; Carabajal AP, 2014, J VERTEBR PALEONTOL, V34, P870, DOI 10.1080/02724634.2014.838174; Christian Andreas, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V5, P271; Christian Andreas, 2007, Fossil Record, V10, P38; Christian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071172; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Dagg A. I., 1962, Journal of Mammalogy, V43, P88, DOI 10.2307/1376883; DAGG A I, 1971, Mammalian Species, V5, P1; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; Fronimos JA, 2017, AMEGHINIANA, V54, P36, DOI 10.5710/AMGH.05.09.2016.3009; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Hillis DM, 2011, PRINCIPLES LIFE; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Horwich R.H., 1983, Zoo Biology, V2, P105, DOI 10.1002/zoo.1430020204; Ikejiri T., 2004, ANATOMY CAMARASAURUS; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Jentgen-Ceschino B, 2019, 17 EAVP PROGR, P51; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; MALLISON H, 2010, PALAEONTOL ELECTRON, V13; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Mallison Heinrich, 2011, P237; Mallison H, 2010, SWISS J GEOSCI, V103, P211, DOI 10.1007/s00015-010-0024-2; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Marsh O. C., 1883, American Journal of Science, Vxxvi, P81; Martin J, 1987, 4 S MES TERR EC, P154; Martin John, 1998, Oryctos, V1, P113; McNamara Kenneth J., 2012, Evolution Education and Outreach, V5, P203; Mocho P., 2013, 6 INT S DIN PAL THEI, P89; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Paramo A, 2012, FUNDAMENTAL, P177; Paul GS, 2017, ANAT REC, V300, P1802, DOI 10.1002/ar.23617; Paul GS., 2000, SCI AM BOOK DINOSAUR, P78; Persons WS, 2012, ACTA GEOL SIN-ENGL, V86, P1402, DOI 10.1111/1755-6724.12009; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P119, DOI 10.1007/s12549-011-0068-y; Reiss S, 2014, PALAEONTOL ELECTRON, V17; Remes K, 2007, EVOLUTION PECTORAL G, DOI [10.1002/ajpa.1330170113, DOI 10.1002/AJPA.1330170113]; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Seeber Peter A., 2012, BMC Research Notes, V5, P650, DOI 10.1186/1756-0500-5-650; Seeber PA, 2012, AFR J ECOL, V50, P247, DOI 10.1111/j.1365-2028.2011.01314.x; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Solounias N, 1999, J ZOOL, V247, P257, DOI 10.1111/j.1469-7998.1999.tb00989.x; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, LIFE O PAST, P212; Stevens KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078572; Stevens Kent A., 2002, Senckenbergiana Lethaea, V82, P23; Taylor MP, 2014, PEERJ, V2, DOI 10.7717/peerj.712; Taylor MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078214; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Taylor MP, 2016, PEERJ PREPR, V4, pe67v2; Taylor MP, 2015, PEERJ, P1, DOI DOI 10.7287/PEERJ.PREPRINTS.1418V1; TSCHANZ K, 1988, PALAEONTOLOGY, V31, P997; Tschopp E, 2013, J ANAT, V222, P321, DOI 10.1111/joa.12012; Whitlock JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018304; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; Young CC, 1972, I VERTEBRATE PALEO A, VI, P1; YOUNG TP, 1991, ETHOLOGY, V87, P79; Zhang Y, 1988, MIDDLE JURASSIC DINO, V1, P1	63	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227537	10.1371/journal.pone.0227537	http://dx.doi.org/10.1371/journal.pone.0227537			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929581	Green Published, gold			2022-12-26	WOS:000534352500043
J	Gupta, NJ; Khare, A				Gupta, Neelu Jain; Khare, Akansha			Disruption in daily eating-fasting and activity-rest cycles in Indian adolescents attending school	PLOS ONE			English	Article							FOOD-CONSUMPTION; MEAL FREQUENCY; MENTAL-HEALTH; SLEEP; TIME; METABOLISM; TRANSITION; NUTRITION; HABITS; TRIAL	A lifestyle with erratic eating patterns and habits predisposes youngsters to obesity. Through a two-phase feasibility study among Indian students living in the Delhi area, we longitudinally examined the following: (1) the daily eating-fasting cycles of students (N = 34) in school and college using smartphones as they transition from high school (aged 13-15 years; nIX = 13) to higher secondary school (HSSS; 16-18 years; nXII = 9) to their first year (FY) of college (18-19 years; nFC = 12); and (2) daily activity-rest cycles and light-dark exposure of 31 higher secondary school students (HSSS) using actigraphy. In phase 1, students' food data were analyzed for temporal details of eating events and observable differences in diet composition, such as an energy-dense diet (fast food (FF)), as confounding factors of circadian health. Overall, the mean eating duration in high school, higher secondary and FY college students ranged from 14.1 to 16.2h. HSSS exhibited the shortest night fasting. Although FY college students exhibited the highest fast food percentage (FF%), a positive correlation between body mass index (BMI) and FF% was observed only among HSSS. Furthermore, the body weight of HSSS was significantly higher, indicating that FF, untimely eating and reduced night fasting were important obesity-associated factors in adolescents. Reduced night fasting duration was also related to shorter sleep in HSSS. Therefore, food data were supplemented with wrist actigraphy, i.e., activity-rest data, in HSSS. Actigraphy externally validated the increased obesogenic consequences of deregulated eating rhythms in HSSS. CamNtech motion watches were used to assess the relationship between disturbed activity cycles of HSSS and other circadian clock-related rhythms, such as sleep. Less than 50% of Indian HSSS slept 6 hours or more per night. Seven of 31 students remained awake throughout the night, during which they had more than 20% of their daily light exposure. Three nonparametric circadian rhythm analysis (NPCRA) variables revealed circadian disruption of activity in HSSS. The present study suggests that inappropriate timing and quality of food and sleep disturbances are important determinants of circadian disruptions in adolescents attending school.	[Gupta, Neelu Jain; Khare, Akansha] Chaudhary Charan Singh Univ, Dept Zool, Meerut, UP, India	Chaudhary Charan Singh University	Gupta, NJ (corresponding author), Chaudhary Charan Singh Univ, Dept Zool, Meerut, UP, India.	drneelujgupta@hotmail.com	Gupta, Neelu Jain/I-9900-2014; Gupta, Neelu Jain/AAF-6721-2020	Gupta, Neelu Jain/0000-0003-4885-1827; Khare, Akansha/0000-0002-6129-4669				Alhussain MH, 2016, AM J CLIN NUTR, V104, P21, DOI 10.3945/ajcn.115.125401; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Borraccino A, 2016, EUR J PUBLIC HEALTH, V26, P650, DOI 10.1093/eurpub/ckw056; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Brand S, 2011, INT J GEN MED, V4, P425, DOI 10.2147/IJGM.S11557; BUDNICK LD, 1995, AM J IND MED, V27, P771, DOI 10.1002/ajim.4700270602; Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004; Cressey D, 2010, NATURE, V464, P19, DOI 10.1038/464019a; Dashti HS, 2019, ADV NUTR, V10, P606, DOI 10.1093/advances/nmy131; Depner CM, 2018, P NATL ACAD SCI USA, V115, pE5390, DOI 10.1073/pnas.1714813115; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Ekblom O, 2012, J PHYS ACT HEALTH, V9, P389, DOI 10.1123/jpah.9.3.389; Evans D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01482; Faizi N, 2015, S AFR J CHILD HEALTH, V9, P18, DOI 10.7196/SAJCH.777; Fredriksen K, 2004, CHILD DEV, V75, P84, DOI 10.1111/j.1467-8624.2004.00655.x; Gabel Kelsey, 2018, Nutr Healthy Aging, V4, P345, DOI 10.3233/NHA-170036; Gill S, 2015, CELL METAB, V22, P789, DOI 10.1016/j.cmet.2015.09.005; Golem DL, 2014, ADV NUTR, V5, P742, DOI 10.3945/an.114.006809; Goncalves BSB, 2014, SLEEP SCI, V7, P158, DOI 10.1016/j.slsci.2014.09.013; Gupta NJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172852; Hagenauer MH, 2012, FRONT NEUROENDOCRIN, V33, P211, DOI 10.1016/j.yfrne.2012.04.003; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hernandez LM, 2006, GENES BEHAV SOCIAL E, P8; Huang YL, 2002, PHYSIOL BEHAV, V76, P597, DOI 10.1016/S0031-9384(02)00733-3; Isakson K, 1999, J YOUTH ADOLESCENCE, V28, P1, DOI 10.1023/A:1021616407189; Kahleova H, 2017, J NUTR, V147, P1722, DOI 10.3945/jn.116.244749; Kinsey AW, 2015, NUTRIENTS, V7, P2648, DOI 10.3390/nu7042648; Logan RW, 2019, NAT REV NEUROSCI, V20, P49, DOI 10.1038/s41583-018-0088-y; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lopes RD, 2013, SCI WORLD J, DOI 10.1155/2013/153839; Lushington K, 2015, INT J MENT HEALTH, V44, P139, DOI 10.1080/00207411.2015.1009788; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Rodrigues PRM, 2017, NUTRITION, V42, P114, DOI 10.1016/j.nut.2017.03.011; Moore M, 2011, SLEEP MED, V12, P239, DOI 10.1016/j.sleep.2010.07.020; Nielsen L, 2017, INT J EDUC RES, V83, P65, DOI 10.1016/j.ijer.2017.01.011; Owens J, 2014, PEDIATRICS, V134, pE921, DOI 10.1542/peds.2014-1696; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; ROZA AM, 1984, AM J CLIN NUTR, V40, P168, DOI 10.1093/ajcn/40.1.168; Takahashi M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111763; Wirz-Justice A., 2007, MEDICOGRAPHIA, V29, P84, DOI DOI 10.13078/jksrs09013; WITTING W, 1990, BIOL PSYCHIAT, V27, P563, DOI 10.1016/0006-3223(90)90523-5; Yoshida J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6262-3; ZEHRING WA, 1984, CELL, V39, P369, DOI 10.1016/0092-8674(84)90015-1	43	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227002	10.1371/journal.pone.0227002	http://dx.doi.org/10.1371/journal.pone.0227002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923256	Green Published, gold			2022-12-26	WOS:000534350000038
J	Patel, V; Spouge, JL				Patel, Vruj; Spouge, John L.			Estimating the basic reproduction number of a pathogen in a single host when only a single founder successfully infects	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; TRANSMISSION; HIV-1; DYNAMICS; RISK	If viruses or other pathogens infect a single host, the outcome of infection may depend on the initial basic reproduction number R0, the expected number of host cells infected by a single infected cell. This article shows that sometimes, phylogenetic models can estimate the initial R0, using only sequences sampled from the pathogenic population during its exponential growth or shortly thereafter. When evaluated by simulations mimicking the bursting viral reproduction of HIV and simultaneous sampling of HIV gp120 sequences during early viremia, the estimated R0 displayed useful accuracies in achievable experimental designs. Estimates of R0 have several potential applications to investigators interested in the progress of infection in single hosts, including: (1) timing a pathogen's movement through different microenvironments; (2) timing the change points in a pathogen's mode of spread (e.g., timing the change from cell-free spread to cell-to-cell spread, or vice versa, in an HIV infection); (3) quantifying the impact different initial microenvironments have on pathogens (e.g., in mucosal challenge with HIV, quantifying the impact that the presence or absence of mucosal infection has on R0); (4) quantifying subtle changes in infectability in therapeutic trials (either human or animal), even when therapies do not produce total sterilizing immunity; and (5) providing a variable predictive of the clinical efficacy of prophylactic therapies.	[Patel, Vruj; Spouge, John L.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Spouge, JL (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	spouge@nih.gov		Spouge, John/0000-0001-6207-1419	Intramural Research Program of the NIH	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Intramural Research Program of the NIH, National Library of Medicine.We thank three anonymous referees for useful suggestions and Drs. Junyong Park, DoHwan Park, Anthony DeVico, and George Lewis for useful conversations.	Athreya K.B., 2004, BRANCHING PROCESSES; BELLMAN R, 1948, P NATL ACAD SCI USA, V34, P601, DOI 10.1073/pnas.34.12.601; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Delwart E, 2002, AIDS, V16, P189, DOI 10.1097/00002030-200201250-00007; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Fidler S, 2013, NEW ENGL J MED, V368, P207, DOI 10.1056/NEJMoa1110039; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Gordon SN, 2016, J IMMUNOL, V197, P2726, DOI 10.4049/jimmunol.1600674; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1969, GENETICS, V61, P893; KNUTH DE, 1992, AM MATH MON, V99, P403, DOI 10.2307/2325085; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Kosaka PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171899; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Love TMT, 2016, BIOINFORMATICS, V32, P1308, DOI 10.1093/bioinformatics/btv749; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; McElroy Kerensa, 2014, Microb Inform Exp, V4, P1, DOI 10.1186/2042-5783-4-1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nolen TL, 2015, STAT MED, V34, P1981, DOI 10.1002/sim.6462; Park SY, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0269-6; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SPOUGE JL, 1994, J VIROL, V68, P1782, DOI 10.1128/JVI.68.3.1782-1789.1994; Spouge JL, 2019, THEOR POPUL BIOL, V12, P30151; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Strbo N, 2013, J IMMUNOL, V190, P2495, DOI 10.4049/jimmunol.1202655; Wakeley J., 2009, COALESCENT THEORY; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Zhang CW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004179	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227127	10.1371/journal.pone.0227127	http://dx.doi.org/10.1371/journal.pone.0227127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923263	gold, Green Published			2022-12-26	WOS:000534350000044
J	Playford, RJ; Marchbank, T				Playford, Raymond J.; Marchbank, Tania			Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION; ORGAN; RECEPTOR; MODEL	Intestinal ischemia/reperfusion (I/R) injury occurs during transplantation, mesenteric arterial occlusion, trauma and shock, causing systemic inflammation, multiple organ dysfunction and high mortality. Pancreatic secretory trypsin inhibitor (PSTI), a serine protease inhibitor expressed in gut mucosa may function as a mucosal protective/repair peptide. We examined whether PSTI affected mesenteric I/R-induced injury. Hypoxia/normoxia (H/N) caused 50% drop in cell viability of AGS, RIE1 and Caco-2 cells but PSTI (10 mu g/ml) given prior- or during-hypoxic period improved survival by 50% (p< 0.01). Similarly, Caco-2 monolayers exposed to H/N had 300% increase in transepithelial permeability, PSTI truncated this by 50% (p< 0.01). Mice underwent mesenteric I/R by clamping jejunum, causing severe mucosal injury, increased apoptotic markers and 3-fold increases in plasma IL-6, IL1 beta, TNF alpha, and tissue lipid peroxidation (MDA) and inflammatory infiltration (MPO) levels. Lungs showed similar significant injury and inflammatory infiltrate markers. Smaller increases in MDA and MPO were seen in kidney & liver. PSTI (20 mg/kg) reduced all injury markers by 50-80% (p<0.01). In vitro and in vivo studies showed PSTI reduced pro-apoptotic Caspase 3, 9 and Baxa levels, normalised Bcl2 and caused additional increases in HIF1 alpha, VEGF and Hsp70 above rises caused by I/R alone (all p< 0.01). PSTI also prevented reduction of tight junction molecules ZO1 and Claudin1 (all p<0.01) but did not affect increased ICAM-1 caused by I/R in gut or lung. PSTI may be a useful clinical target to prevent I/R injury.	[Playford, Raymond J.] Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England; [Playford, Raymond J.] Plymouth Univ, Peninsula Sch Dent, Plymouth, Devon, England; [Marchbank, Tania] Queen Mary Univ London, Barts & London Sch Med, Blizard Inst, Ctr Immunobiol, London, England	University of Plymouth; University of Plymouth; University of London; Queen Mary University London	Marchbank, T (corresponding author), Queen Mary Univ London, Barts & London Sch Med, Blizard Inst, Ctr Immunobiol, London, England.	t.marchbank@qmul.ac.uk		Marchbank, Tania/0000-0003-2076-9098; Playford, Raymond/0000-0003-1235-8504	Pantheryx Inc, Boulder, Co. USA	Pantheryx Inc, Boulder, Co. USA	RP and TM received funding for partial salary costs and consumables from Pantheryx Inc, Boulder, Co. USA (https://pantheryx.com/), with the remainder from internal sources. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANCO SC, 1983, CANCER RES, V43, P1703; Berlanga J, 2002, AM J PATHOL, V161, P373, DOI 10.1016/S0002-9440(10)64192-2; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Corcos O, 2013, BEST PRACT RES CL GA, V27, P709, DOI 10.1016/j.bpg.2013.08.006; Cummins EP, 2016, MOL ASPECTS MED, V47-48, P24, DOI 10.1016/j.mam.2015.12.004; Davison G, 2016, AM J CLIN NUTR, V104, P526, DOI 10.3945/ajcn.116.134403; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Fishman JE, 2014, ANN SURG, V260, P1112, DOI 10.1097/SLA.0000000000000631; FitzGerald AJ, 2004, PEPTIDES, V25, P793, DOI 10.1016/j.peptides.2003.12.022; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Gonzalez LM, 2015, AM J PHYSIOL-GASTR L, V308, pG63, DOI 10.1152/ajpgi.00112.2013; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; KAZAL LA, 1948, J AM CHEM SOC, V70, P3034, DOI 10.1021/ja01189a060; Kikuchi K, 1996, Rinsho Byori, V44, P579; Klingensmith NJ, 2016, CRIT CARE CLIN, V32, P203, DOI 10.1016/j.ccc.2015.11.004; Koksel O, 2005, PHARMACOL RES, V51, P453, DOI 10.1016/j.phrs.2004.11.007; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Marchbank T, 1998, DIGESTION, V59, P167, DOI 10.1159/000007485; Marchbank T, 1996, AM J PATHOL, V148, P715; Marchbank T, 2007, AM J PATHOL, V171, P1462, DOI 10.2353/ajpath.2007.070192; Marchbank T, 2013, AM J PHYSIOL-RENAL, V305, pF382, DOI 10.1152/ajprenal.00357.2012; MARSHALL NJ, 1995, GROWTH REGULAT, V5, P69; MOORE EE, 1994, J TRAUMA, V37, P881, DOI 10.1097/00005373-199412000-00002; Moore EE, 2010, AM J SURG, V200, P681, DOI 10.1016/j.amjsurg.2010.05.010; Moraes LB, 2008, J TRAUMA, V64, P1196, DOI 10.1097/TA.0b013e31816c5ca6; Nankervis CA, 2008, SEMIN PERINATOL, V32, P83, DOI 10.1053/j.semperi.2008.01.003; NIINOBU T, 1990, J EXP MED, V172, P1133, DOI 10.1084/jem.172.4.1133; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; PLAYFORD RJ, 1995, AM J PATHOL, V146, P310; Rokutan K, 2000, J GASTROEN HEPATOL, V15, pD12, DOI 10.1046/j.1440-1746.2000.02144.x; Sastry P, 2014, INTERACT CARDIOV TH, V19, P419, DOI 10.1093/icvts/ivu139; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Zhao H, 1985, J APPL PHYSIOL, V93, P338	37	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227059	10.1371/journal.pone.0227059	http://dx.doi.org/10.1371/journal.pone.0227059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923181	Green Published, gold			2022-12-26	WOS:000534350000040
J	Rojas, E; Martinez-Pacheco, M; Rodriguez-Sastre, MA; Ramos-Espinosa, P; Valverde, M				Rojas, Emilio; Martinez-Pacheco, Monica; Alexandra Rodriguez-Sastre, Maria; Ramos-Espinosa, Paulina; Valverde, Mahara			Post-transcriptional regulation of Rad51c by miR-222 contributes cellular transformation	PLOS ONE			English	Article							OVARIAN-CANCER; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; GENE-EXPRESSION; METAL MIXTURE; MICRORNAS; REPAIR; SENSITIVITY; CARCINOMA; CISPLATIN	DNA repair inhibition has been described as an essential event leading to the initiation of carcinogenesis. In a previous study, we observed that the exposure to metal mixture induces changes in the miR-nome of the cells that was correlated with the sub-expression of mRNA involved in processes and diseases associated with metal exposure. From this analysis, one of the miRNAs that shows changes in its expression is miR-222, which is over-expressed in various cancers associated with exposure to metals. In silico studies showed that a possible target for the microRNA-222 could be Rad 51c, a gene involved in the double-stranded DNA repair. We could appreciate that up-regulation of miR-222 reduces the expression both gene and as a protein expression of Rad51c by RT-PCR and immunoblot, respectively. A luciferase assay was performed to validate Rad51c as miR-222 target. Neutral comet assay was performed in order to evaluate DNA double-strand breaks under experimental conditions. Here, we demonstrate that miR-222 up-regulation, directly regulates Rad51c expression negatively, and impairs homologous recombination of double-strand break DNA repair during the initiation stage of cell transformation. This inhibition triggers morphological transformation in a two-stage Balb/c 3T3 cell assay, suggesting that this small RNA acts as an initiator of the carcinogenesis process.	[Rojas, Emilio; Alexandra Rodriguez-Sastre, Maria; Ramos-Espinosa, Paulina; Valverde, Mahara] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City, DF, Mexico; [Martinez-Pacheco, Monica] UNAM, Ctr Genom Sci, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rojas, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City, DF, Mexico.	emilior@biomedicas.unam.mx	; Valverde, Mahara/H-5573-2019	Martinez-Pacheco, Monica/0000-0002-8823-8907; Rodriguez sastre, Maria Alexandra/0000-0002-3946-0675; Valverde, Mahara/0000-0001-6975-1185	Consejo Nacional de Ciencia y Tecnologia Mexico [152473, 229336]; PAPIIT-UNAM [IN214310, 207815]	Consejo Nacional de Ciencia y Tecnologia Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was partially supported by Consejo Nacional de Ciencia y Tecnologia Mexico 152473 grant, PAPIIT-UNAM grants IN214310 and 207815. MPMA was recipient of Consejo Nacional de Ciencia y Tecnologia Mexico Ph D scholarship 229336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; *ATSDR, 2004, INT PROF ARS CADM CH, P160; Bailey J, 2013, MILIT STRAT OPERAT, P5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cerbinskaite A, 2012, CANCER TREAT REV, V38, P89, DOI 10.1016/j.ctrv.2011.04.015; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Dias F, 2013, PHARMACOGENOMICS, V14, P1793, DOI 10.2217/pgs.13.184; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Elamin BK, 2011, MUTAT RES-FUND MOL M, V717, P67, DOI 10.1016/j.mrfmmm.2011.03.015; Gasparini P, 2014, P NATL ACAD SCI USA, V111, P4536, DOI 10.1073/pnas.1402604111; Goodson WH, 2015, CARCINOGENESIS, V36, pS254, DOI 10.1093/carcin/bgv039; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegre SA, 2013, DNA REPAIR, V12, P80, DOI 10.1016/j.dnarep.2012.10.007; Hernandez-Franco P, 2011, BIOMETALS, V24, P951, DOI 10.1007/s10534-011-9453-2; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Huang JW, 2013, MOL CANCER RES, V11, P1564, DOI 10.1158/1541-7786.MCR-13-0292; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WP, 2012, FAM CANCER, V11, P381, DOI 10.1007/s10689-012-9523-9; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; MARTAMPIACUTEN SA, 2011, OXID MED CELL LONGEV, V2011, DOI DOI 10.1155/2011/935160; Martinez-Pacheco M, 2014, GENE, V533, P508, DOI 10.1016/j.gene.2013.09.049; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Natarajan Venkateswaran, 2016, Noncoding RNA Res, V1, P64, DOI 10.1016/j.ncrna.2016.10.002; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nejad C, 2017, RNA, V45, P11371; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olive PL, 1999, INT J RADIAT BIOL, V75, P395, DOI 10.1080/095530099140311; Pelttari LM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-552; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Puerta-Gil P, 2012, AM J PATHOL, V180, P1808, DOI 10.1016/j.ajpath.2012.01.034; Rodriguez-Sastre MA, 2014, MUTAGENESIS, V29, P251, DOI 10.1093/mutage/geu013; Rojas E, 1999, J CHROMATOGR B, V722, P225, DOI 10.1016/S0378-4347(98)00313-2; Scheckenbach K, 2014, ORAL ONCOL, V50, P196, DOI 10.1016/j.oraloncology.2013.11.007; Song LB, 2012, J MOL CELL BIOL, V4, P108, DOI 10.1093/jmcb/mjr046; Sun CY, 2013, JNCI-J NATL CANCER I, V105, P1750, DOI 10.1093/jnci/djt302; Tessitore A, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/820248; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsuchiya T, 1997, INT J CANCER, V73, P271, DOI 10.1002/(SICI)1097-0215(19971009)73:2<271::AID-IJC18>3.3.CO;2-S; Valeri N, 2010, P NATL ACAD SCI USA, V107, P21098, DOI 10.1073/pnas.1015541107; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xie QH, 2011, BIOCHEM BIOPH RES CO, V410, P440, DOI 10.1016/j.bbrc.2011.05.153; Xu KW, 2014, ONCOTARGETS THER, V7, DOI 10.2147/OTT.S59364; YAMASAKI H, 1985, CANCER RES, V45, P2395; Yu F, 2017, NUCLEIC ACIDS RES, V45, P11371, DOI 10.1093/nar/gkx788; Zhong ZW, 2013, TUMOR BIOL, V34, P1959, DOI 10.1007/s13277-013-0741-z	59	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0221681	10.1371/journal.pone.0221681	http://dx.doi.org/10.1371/journal.pone.0221681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923208	Green Published, gold			2022-12-26	WOS:000534350000005
J	Vinnikov, D; Tulekov, Z; Raushanova, A				Vinnikov, Denis; Tulekov, Zhangir; Raushanova, Aizhan			Occupational exposure to particulate matter from air pollution in the outdoor workplaces in Almaty during the cold season	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ASSESSING PERSONAL EXPOSURE; HOSPITAL ADMISSIONS; CITIES; PANEL; PM10	Background A large fraction of population in Almaty and other Kazakhstan cities is employed in the outdoor jobs and likely exposed to high levels of particulate matter (PM) during the cold season. The magnitude of such occupational exposure remains unknown; therefore, the aim was to quantify the levels of exposure to PM10 in the outdoor workplaces in Almaty in order to guide future interventions of primary prevention. Methods Outdoor security non-smoking guards (N = 12) wore TSI DustTrack AM520 aerosol monitors with a 10-mu m impactor for 8 hours of outdoor shift. Ten samples (k = 10) from each worker were obtained for the cold season (November-March) from various locations across Almaty. Total sampling time was 57600 minutes. We compared normalized time-weighted average (TWA) concentrations for 8-hour shifts within and between workers using analysis of variance (ANOVA) and assessed compliance with environmental exposure limit (EEL) (0.060 mg/m(3)) via exceedance (gamma) and probability of overexposure (theta). Results PM10 TWA ranged from 0.050 to 2.075 mg/m(3) with the geometric mean 0.366 and median 0.352 mg/m(3). PM10 TWA distribution was left-skewed with large variation. The fold-range of within-person variability, containing 95% of the exposure concentration (R-w(0.95)) was 13, whereas between-person fold-range (R-b(0.95)) was 3. However, between-person variance exceeded the one within with F-ratio 2.797 (p = 0.003) with statistical power 97% at a = 0.05. Only two of 120 samples had TWA below EEL, yielding gamma = 0.995 and theta = 1. Conclusions Outdoor workers in polluted cities like Almaty are exposed to very high levels of PM10 during the cold season. Urgent action should be taken to regulate such occupational exposure and to raise awareness of workers and employers on hazards associated with it.	[Vinnikov, Denis; Tulekov, Zhangir; Raushanova, Aizhan] al Farabi Kazakh Natl Univ, Sch Publ Hlth, Alma Ata, Kazakhstan; [Vinnikov, Denis] Natl Res Tomsk State Univ, Tomsk, Russia; [Vinnikov, Denis] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia	Al-Farabi Kazakh National University; Kazakhstan Medical University "KSPH"; Tomsk State University; Peoples Friendship University of Russia	Vinnikov, D (corresponding author), al Farabi Kazakh Natl Univ, Sch Publ Hlth, Alma Ata, Kazakhstan.; Vinnikov, D (corresponding author), Natl Res Tomsk State Univ, Tomsk, Russia.; Vinnikov, D (corresponding author), RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia.	denisvinnikov@mail.ru	Vinnikov, Denis/A-5908-2011	Vinnikov, Denis/0000-0003-0991-6237; Raushanova, Aizhan/0000-0003-4584-885X	Tomsk State University competitiveness improvement programme	Tomsk State University competitiveness improvement programme	This research was partially supported by grant from "The Tomsk State University competitiveness improvement programme". There was no additional external funding received for this study.	Ab Manan N, 2018, ANN GLOB HEALTH, V84, P670, DOI 10.29024/aogh.2376; Rodriguez-Villamizar LA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081610; Assimakopoulos VD, 2018, SCI TOTAL ENVIRON, V636, P1303, DOI 10.1016/j.scitotenv.2018.04.249; Ba AN, 2019, ENVIRON POLLUT, V248, P397, DOI 10.1016/j.envpol.2019.02.042; Blanc RD, 2007, INT J TUBERC LUNG D, V11, P251; Bloemsma LD, 2016, ENVIRON RES, V151, P458, DOI 10.1016/j.envres.2016.08.018; Feng W, 2019, SCI TOTAL ENVIRON, V657, P213, DOI 10.1016/j.scitotenv.2018.12.066; Guak S, 2018, ENVIRON SCI POLLUT R, P1; Hassanvand MS, 2017, ENVIRON POLLUT, V223, P695, DOI 10.1016/j.envpol.2017.02.005; Hinwood A, 2014, CHEMOSPHERE, V108, P125, DOI 10.1016/j.chemosphere.2014.02.071; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Li JH, 2016, INT J CHRONIC OBSTR, V11, P3079, DOI 10.2147/COPD.S122282; Liu CC, 2019, ENVIRON POLLUT, V245, P419, DOI 10.1016/j.envpol.2018.10.120; Luo LS, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102160; Maji KJ, 2017, ENVIRON SCI POLLUT R, V24, P11559, DOI 10.1007/s11356-017-8575-7; Michikawa T, 2014, SCI TOTAL ENVIRON, V466, P673, DOI 10.1016/j.scitotenv.2013.07.084; Nkosi V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3950-8; Rappaport S. M., 2008, QUANTITATIVE EXPOSUR; Sanyal S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112487; Sarigiannis DA, 2014, SCI TOTAL ENVIRON, V493, P795, DOI 10.1016/j.scitotenv.2014.06.055; Scapellato ML, 2009, INT J HYG ENVIR HEAL, V212, P626, DOI 10.1016/j.ijheh.2009.06.001; Tian YH, 2018, ENVIRON POLLUT, V242, P1042, DOI 10.1016/j.envpol.2018.07.116; Vinnikov D, 2017, AM J IND MED, V60, P1049, DOI 10.1002/ajim.22776; Wang SS, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0958-x; Zhu XJ, 2019, SCI TOTAL ENVIRON, V656, P90, DOI 10.1016/j.scitotenv.2018.11.240	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227447	10.1371/journal.pone.0227447	http://dx.doi.org/10.1371/journal.pone.0227447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923254	gold, Green Published			2022-12-26	WOS:000534350000081
J	Woo, YS; Yoon, BH; Song, JH; Seo, JS; Nam, B; Lee, K; Lee, J; Jung, YE; Kim, MD; Lee, JG; Wang, SM; Kwon, YJ; Bahk, WM				Woo, Young Sup; Yoon, Bo-Hyun; Song, Jye-Heon; Seo, Jeong Seok; Nam, Beomwoo; Lee, Kwanghun; Lee, Jonghun; Jung, Young-Eun; Kim, Moon-Doo; Lee, Jung Goo; Wang, Sheng-Min; Kwon, Young-Joon; Bahk, Won-Myong			Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study	PLOS ONE			English	Article							KOREAN MEDICATION ALGORITHM; PREDOMINANT POLARITY; PROPHYLACTIC LITHIUM; MAINTENANCE; DIVALPROEX; EFFICACY; CARBAMAZEPINE; PREDICTORS; PREVENTION; PLACEBO	Background Although mood stabilizers such as lithium (LIT), valproate (VAL), and lamotrigine (LMT) appear to be efficacious treatments for bipolar disorder (BD) in research settings, the long-term response to these mood stabilizers in clinical practice is highly variable among individuals. Thus, the present study examined the characteristics associated with good or insufficient responses to long-term treatment with LIT, VAL, or LMT for BD. Methods This study retrospectively analyzed the medical records of patients who visited an outpatient clinic with a diagnosis of BD I or II. Data from patients who were treated with one of three mood stabilizing medications (LIT, VAL, or LMT) for more than 6 months were selected, and the long-term treatment responses were evaluated using the Alda scale. For the purposes of this study, two response categories were formed: insufficient response (ISR), including non-response or poor response (Alda total score. 6), and good response (GR; Alda total score. 7). Results Of the 645 patients included in the present study, 172 were prescribed LIT, 320 were prescribed VAL, and 153 were prescribed LMT for at least 6 months. A binary logistic regression analysis revealed that a diagnosis of BD II (odds ratio [OR], 8.868; 95% confidence interval [CI], 1.123-70.046; p = 0.038), comorbid alcohol/substance use disorder (OR, 4.238; 95% CI, 1.154-15.566; p = 0.030), and a history of mixed episodes (OR, 4.363; 95% CI, 1.191-15.985; p = 0.026) were significant predictors of LIT-ISR. Additionally, a depressive-predominant polarity significantly predicted LMT-GR (OR, 8.586; 95% CI, 2.767-26.644; p < 0.001). Conclusion The present findings demonstrated that patients with a diagnosis of BD II, a comorbid alcohol/substance problem, or a history of mixed episodes were not likely to respond to LIT treatment. Additionally, LMT might be a better treatment choice for patients with a depressive-predominant polarity.	[Woo, Young Sup; Wang, Sheng-Min; Bahk, Won-Myong] Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul, South Korea; [Yoon, Bo-Hyun; Song, Jye-Heon] Naju Natl Hosp, Dept Psychiat, Naju, South Korea; [Seo, Jeong Seok; Nam, Beomwoo] Konkuk Univ, Sch Med, Dept Psychiat, Chungju, South Korea; [Lee, Kwanghun] Dongguk Univ, Coll Med, Dept Psychiat, Gyeongju, South Korea; [Lee, Jonghun] Catholic Univ Daegu, Sch Med, Dept Psychiat, Daegu, South Korea; [Jung, Young-Eun; Kim, Moon-Doo] Jeju Natl Univ, Sch Med, Dept Psychiat, Jeju, South Korea; [Lee, Jung Goo] Inje Univ, Paik Inst Clin Res, Coll Med, Dept Psychiat,Haeundae Paik Hosp, Busan, South Korea; [Lee, Jung Goo] Inje Univ, Grad Sch, Dept Hlth Sci & Technol, Busan, South Korea; [Kwon, Young-Joon] Soonchunhyang Univ, Coll Med, Dept Psychiat, Cheonan, South Korea	Catholic University of Korea; Konkuk University; Konkuk University Medical Center; Dongguk University; Catholic University of Daegu; Jeju National University; Inje University; Inje University; Soonchunhyang University	Bahk, WM (corresponding author), Catholic Univ Korea, Coll Med, Dept Psychiat, Seoul, South Korea.	wmbahk@catholic.ac.kr	SEO, JEONG SEOK/AAM-7739-2021; SEO, JEONG SEOK/GRR-2157-2022					Alda M, 2018, NEUROSCI LETT, V669, P3, DOI 10.1016/j.neulet.2017.12.005; Backlund L, 2009, EUR PSYCHIAT, V24, P171, DOI 10.1016/j.eurpsy.2008.12.009; Bai YM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1143-8; Belizario GO, 2018, J AFFECT DISORDERS, V241, P37, DOI 10.1016/j.jad.2018.07.086; Berk M, 2014, BIPOLAR DISORD, V16, P471, DOI 10.1111/bdi.12099; Brady KT, 2002, DRUG ALCOHOL DEPEN, V67, P323, DOI 10.1016/S0376-8716(02)00105-9; CALABRESE JR, 1990, AM J PSYCHIAT, V147, P431; Calkin CV, 2015, BRIT J PSYCHIAT, V206, P52, DOI 10.1192/bjp.bp.114.152850; Carvalho AF, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu079; Cipriani A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3646; Colom F, 2006, J AFFECT DISORDERS, V93, P13, DOI 10.1016/j.jad.2006.01.032; Dell'Osso B, 2009, NEUROPSYCH DIS TREAT, V5, P399; Fornaro M, 2018, PSYCHIAT RES, V269, P658, DOI 10.1016/j.psychres.2018.08.034; Fountoulakis KN, 2017, INT J NEUROPSYCHOPH, V20, P180, DOI 10.1093/ijnp/pyw109; Fountoulakis KN, 2017, INT J NEUROPSYCHOPH, V20, P121, DOI 10.1093/ijnp/pyw100; Geoffroy Pierre Alexis, 2014, Front Biosci (Elite Ed), V6, P120; Goodwin GM, 2016, J PSYCHOPHARMACOL, V30, P495, DOI 10.1177/0269881116636545; Grof P, 2002, J CLIN PSYCHIAT, V63, P942, DOI 10.4088/JCP.v63n1013; Grunze H, 2013, WORLD J BIOL PSYCHIA, V14, P154, DOI 10.3109/15622975.2013.770551; Gyulai L, 2003, NEUROPSYCHOPHARMACOL, V28, P1374, DOI 10.1038/sj.npp.1300190; Hartong EGTM, 2003, J CLIN PSYCHIAT, V64, P144, DOI 10.4088/JCP.v64n0206; Hayes JF, 2015, ACTA PSYCHIAT SCAND, V131, P417, DOI 10.1111/acps.12408; Jeong JH, 2019, CLIN PSYCHOPHARM NEU, V17, P155, DOI 10.9758/cpn.2019.17.2.155; Judd LL, 2003, INT J NEUROPSYCHOPH, V6, P127, DOI 10.1017/S1461145703003341; Kato T, 2000, INT J NEUROPSYCHOPH, V3, P83, DOI 10.1017/S1461145799001674; Ketter TA, 2002, J CLIN PSYCHIAT, V63, P146, DOI 10.4088/JCP.v63n0210; Kleindienst N, 2005, BIPOLAR DISORD, V7, P404, DOI 10.1111/j.1399-5618.2005.00244.x; Lewandowski KE, 2011, PSYCHOL MED, V41, P225, DOI 10.1017/S0033291710001042; Magalhaes PV, 2012, AUST NZ J PSYCHIAT, V46, P1058, DOI 10.1177/0004867412460593; Nivoli AMA, 2013, EUR NEUROPSYCHOPHARM, V23, P263, DOI 10.1016/j.euroneuro.2012.07.015; OKUMA T, 1993, NEUROPSYCHOBIOLOGY, V27, P138, DOI 10.1159/000118969; Popovic D, 2012, EUR NEUROPSYCHOPHARM, V22, P339, DOI 10.1016/j.euroneuro.2011.09.008; Post RM, 2016, COMPR PSYCHIAT, V66, P146, DOI 10.1016/j.comppsych.2016.01.009; Rosa AR, 2012, ACTA PSYCHIAT SCAND, V125, P335, DOI 10.1111/j.1600-0447.2011.01830.x; Rybakowski JK, 2014, ACS CHEM NEUROSCI, V5, P413, DOI 10.1021/cn5000277; Salloum IM, 2005, ARCH GEN PSYCHIAT, V62, P37, DOI 10.1001/archpsyc.62.1.37; Sentissi O, 2019, J AFFECT DISORDERS, V250, P43, DOI 10.1016/j.jad.2019.02.053; Sportiche S, 2017, AUST NZ J PSYCHIAT, V51, P524, DOI 10.1177/0004867416664794; Steardo L, 2019, J AFFECT DISORDERS, V245, P174, DOI 10.1016/j.jad.2018.10.360; Suppes T, 2005, J AFFECT DISORDERS, V89, P69, DOI 10.1016/j.jad.2005.07.011; Swann AC, 2002, NEUROPSYCHOPHARMACOL, V26, P530, DOI 10.1016/S0893-133X(01)00390-6; Tighe SK, 2011, THER ADV CHRONIC DIS, V2, P209, DOI 10.1177/2040622311399173; Tondo L, 2001, BRIT J PSYCHIAT, V178, pS184, DOI 10.1192/bjp.178.41.s184; Vinberg M, 2017, J AFFECT DISORDERS, V208, P521, DOI 10.1016/j.jad.2016.10.031; Woo YS, 2018, CLIN PSYCHOPHARM NEU, V16, P434, DOI 10.9758/cpn.2018.16.4.434; Yatham LN, 2018, BIPOLAR DISORD, V20, P97, DOI 10.1111/bdi.12609; Yazici O, 1999, J AFFECT DISORDERS, V55, P133, DOI 10.1016/S0165-0327(98)00216-X	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227217	10.1371/journal.pone.0227217	http://dx.doi.org/10.1371/journal.pone.0227217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923220	Green Published, gold			2022-12-26	WOS:000534350000057
J	Shao, LN; Zhang, ST; Wang, N; Yu, WJ; Chen, M; Xiao, N; Duan, Y; Pan, LZ; Song, WQ; Xia, YX; Zhang, L; Qi, N; Liu, M; Zhou, SH				Shao, Lin-Nan; Zhang, Shu-Ting; Wang, Ni; Yu, Wei-Jian; Chen, Mei; Xiao, Nan; Duan, Ying; Pan, Ling-Zi; Song, Wen-Qian; Xia, Yue-Xin; Zhang, Li; Qi, Ning; Liu, Ming; Zhou, Shi-Hang			Platelet indices significantly correlate with liver fibrosis in HCV-infected patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; COUNT; PATHOGENESIS; PROGRESSION; SEVERITY	Aim A total of 241 patients with chronic HCV infection were recruited to investigate the association between liver fibrosis and PLT counts, as well as with MPV, PDW and P-LCR indices. Methods The determination of PLT indices was carried out using a Sysmex XT-1800i automated hematology analyzer. Serological tests for HA, LN, C-IV and PIIINP were performed in 210 patients. The liver stiffness was measured in 69 patients by transient elastography (FibroScan). Results The analysis showed that the four serum fibrosis markers were negatively correlated with PLT counts, but positively correlated with the MPV, PDW and P-LCR values. Moreover, a similar pattern was found after analyzing the FibroScan measurements, which were negatively correlated with PLT counts, but positively correlated with MPV, PDW and P-LCR values. We subdivided the HCV-infected patients into mild and advanced fibrosis groups. The PLT counts were significantly decreased and the MPV, PDW and P-LCR values were significantly increased in the advanced fibrosis group when compared with the mild fibrosis group. Conclusions Our results demonstrate that not only the PLT counts but also the MPV, PDW and P-LCR indices significantly correlate with liver fibrosis in HCV-infected patients. Therefore, these indices may be useful laboratory measures for evaluating liver fibrosis progression.	[Shao, Lin-Nan; Zhang, Shu-Ting; Wang, Ni; Yu, Wei-Jian; Chen, Mei; Xiao, Nan; Duan, Ying; Pan, Ling-Zi; Song, Wen-Qian; Xia, Yue-Xin; Zhang, Li; Qi, Ning; Zhou, Shi-Hang] Dalian Blood Ctr, Dalian, Liaoning, Peoples R China; [Liu, Ming] Dalian Med Univ, Dept Cell Biol, Dalian, Liaoning, Peoples R China	Dalian Medical University	Zhou, SH (corresponding author), Dalian Blood Ctr, Dalian, Liaoning, Peoples R China.; Liu, M (corresponding author), Dalian Med Univ, Dept Cell Biol, Dalian, Liaoning, Peoples R China.	liuminglinxi@163.com; zshsail@163.com			Dalian Municipal Youth Science and Technology Star grant from the Dalian Municipal Science and Technology Bureau, Dalian, China [2017RQ170]	Dalian Municipal Youth Science and Technology Star grant from the Dalian Municipal Science and Technology Bureau, Dalian, China	This research was supported by Dalian Municipal Youth Science and Technology Star grant (2017RQ170) from the Dalian Municipal Science and Technology Bureau, Dalian, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ASTER RH, 1966, J CLIN INVEST, V45, P645, DOI 10.1172/JCI105380; Baranova A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-91; Beyazit Y, 2012, CLIN RES HEPATOL GAS, V36, P162, DOI 10.1016/j.clinre.2011.10.003; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Gupta P, 2019, PATHOG GLOB HEALTH, V113, P86, DOI 10.1080/20477724.2019.1600855; Heller T, 2005, SEMIN LIVER DIS, V25, P7, DOI 10.1055/s-2005-864778; Hernandez F, 1998, ACTA HAEMATOL-BASEL, V99, P217, DOI 10.1159/000040842; Irshad M, 2013, WORLD J GASTROENTERO, V19, P7896, DOI 10.3748/wjg.v19.i44.7896; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Kawasaki T, 1999, AM J GASTROENTEROL, V94, P1918; Lv LT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35705-9; Matsumura H, 2000, J VIRAL HEPATITIS, V7, P268; Nagamine T, 1996, J HEPATOL, V24, P135, DOI 10.1016/S0168-8278(96)80021-3; Nitta Y, 2009, HEPATOL RES, V39, P675, DOI 10.1111/j.1872-034X.2009.00500.x; Oh S, 2001, Curr Gastroenterol Rep, V3, P12, DOI 10.1007/s11894-001-0035-2; Pawlotsky JM, 1995, J HEPATOL, V23, P635, DOI 10.1016/0168-8278(95)80027-1; Pohl A, 2001, AM J GASTROENTEROL, V96, P3142, DOI 10.1111/j.1572-0241.2001.05268.x; Purnak T, 2013, CLIN RES HEPATOL GAS, V37, P41, DOI 10.1016/j.clinre.2012.03.035; Taniguchi H, 2006, J GASTROEN HEPATOL, V21, P281, DOI 10.1111/j.1440-1746.2006.04201.x; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Wu M, 2019, PLATELETS, V27, P1, DOI [10.1080/09537104.2019.1581921, DOI 10.1159/000501959]; Wu YY, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5504-9; Yoneda M, 2011, J GASTROENTEROL, V46, P1300, DOI 10.1007/s00535-011-0436-4; Zeng MD, 2005, HEPATOLOGY, V42, P1437, DOI 10.1002/hep.20960; Zhou K, 2010, J GASTROEN HEPATOL, V25, P1569, DOI 10.1111/j.1440-1746.2010.06383.x	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227544	10.1371/journal.pone.0227544	http://dx.doi.org/10.1371/journal.pone.0227544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917827	gold, Green Published			2022-12-26	WOS:000534341100024
J	Tsai, JP; Jan, YT; Yun, CH; Sung, KT; Liu, CC; Kuo, JY; Hung, CL; Wu, TH; Lin, JL; Hou, CJY; Yeh, HI; Bezerra, HG; So, A				Tsai, Jui-Peng; Jan, Ya-Ting; Yun, Chun-Ho; Sung, Kuo-Tzu; Liu, Chuan-Chuan; Kuo, Jen-Yuan; Hung, Chung-Lieh; Wu, Tung-Hsin; Lin, Jiun-Lu; Hou, Charles Jia-Yin; Yeh, Hung-I; Bezerra, Hiram G.; So, Aaron			Associations of cigarette smoking and burden of thoracic aortic calcification in asymptomatic individuals: A dose-response relationship	PLOS ONE			English	Article							RISK-FACTORS; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; COMPUTED-TOMOGRAPHY; HEART-DISEASE; CALCIUM SCORE; MORTALITY; DENSITY; STROKE; CESSATION	Smoking is known as a powerful predictor of pathological coronary atherosclerosis. Thoracic aortic calcification (TAC), an alternative marker for pathological atherosclerosis, has also been shown to be associated unfavorable cardiovascular outcomes. We aimed to investigate the dose-response relationship between cigarette use and calcification burden in subjects free from clinical symptoms. Among 3109 patients enrolled in this analysis, we categorized study participants according to smoking exposure pattern as: non-smokers, exsmokers and current smokers. Smoking dose (cigarette/day), duration (years) and pack-years were semi-quantified as smoking dose exposure variables. Thoracic aortic calcification burden (including TAC score, plaque volume and plaque density) were determined and related to smoking dose and pattern information. TAC burdens (including TAC score, plaque volume and density) were highest in current smoker compared to non-smoker group, with ex-smoker showing TAC burdens in-between (all ANOVA p<0.05). Linear regression models consistently demonstrated that TAC burdens as continuous variables were independently higher in a dose-dependent manner with smoking exposure, particularly in high-dose (> 10 cigarettes/day) and the long-duration (> 3 years) smokers, even after adjusting for baseline demographic differences (all p< 0.05). By logistic regression, subjects who never smoke consistently demonstrated reduced risk of TAC existence (adjusted OR: 0.65 [95% CI: 0.48-0.86], P = 0.003) in contrary to those current smokers (adjusted OR: 1.47 [95% CI: 1.10-1.89], P = 0.009). A dose-response relationship between active cigarette use and TAC burden was observed, with those who never exposed to smoking or quitted demonstrating partial protective effects. Our data provided imaging-based evidence about the potential deleterious biological hazards of long-term and high-dose cigarette consumption.	[Tsai, Jui-Peng; Jan, Ya-Ting; Sung, Kuo-Tzu; Wu, Tung-Hsin] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Tsai, Jui-Peng; Jan, Ya-Ting; Sung, Kuo-Tzu; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin] MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Tsai, Jui-Peng; Jan, Ya-Ting; Yun, Chun-Ho; Sung, Kuo-Tzu; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Med Coll, Dept Med, Taipei, Taiwan; [Tsai, Jui-Peng; Jan, Ya-Ting; Yun, Chun-Ho] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Yun, Chun-Ho] MacKay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Liu, Chuan-Chuan; Hung, Chung-Lieh] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei, Taiwan; [Liu, Chuan-Chuan] MacKay Mem Hosp, Hlth Evaluat Ctr, Taipei, Taiwan; [Liu, Chuan-Chuan] Yuanpei Univ Sci & Technol, Dept Med Technol, Hsinchu, Taiwan; [Lin, Jiun-Lu] MacKay Mem Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Bezerra, Hiram G.] Univ Hosp Case Med Ctr, Cardiovasc Dept, Cleveland, OH USA; [So, Aaron] Lawson Hlth Res Inst, Imaging Program, London, ON, Canada; [So, Aaron] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Western University (University of Western Ontario); Western University (University of Western Ontario)	Wu, TH (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.; Hung, CL (corresponding author), MacKay Mem Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Med Coll, Dept Med, Taipei, Taiwan.; Hung, CL (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Hlth Care Org Adm, Taipei, Taiwan.	jotaro3791@gmail.com; tung@ym.edu.tw	Kuo, Jen-Yuan/AAX-5448-2021	Lin, Jiun-Lu/0000-0001-5709-4114; Hung, Chung-Lieh/0000-0002-2858-3493				Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; AUERBACH O, 1965, NEW ENGL J MED, V273, P775, DOI 10.1056/NEJM196510072731501; Bellasi A, 2016, ATHEROSCLEROSIS, V250, P166, DOI 10.1016/j.atherosclerosis.2016.03.034; Bhat VM, 2008, STROKE, V39, P2439, DOI 10.1161/STROKEAHA.107.510073; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Criqui MH, 2014, JAMA-J AM MED ASSOC, V311, P271, DOI 10.1001/jama.2013.282535; Ding D, 2009, TOB CONTROL, V18, P354, DOI 10.1136/tc.2008.026112; Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215; Forbang NI, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005138; Forbang NI, 2016, ATHEROSCLEROSIS, V255, P54, DOI 10.1016/j.atherosclerosis.2016.10.036; Hisamatsu T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003738; Hou ZH, 2012, JACC-CARDIOVASC IMAG, V5, P990, DOI 10.1016/j.jcmg.2012.06.006; Hughes-Austin JM, 2014, VASC MED; Jiang CQ, 2009, ATHEROSCLEROSIS, V202, P529, DOI 10.1016/j.atherosclerosis.2008.03.004; Jockel KH, 2009, ATHEROSCLEROSIS, V203, P221, DOI 10.1016/j.atherosclerosis.2008.05.041; Jones MR, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002965; Kalsch H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005093; Kalsch H, 2013, INT J CARDIOVAS IMAG, V29, P207, DOI 10.1007/s10554-012-0051-3; Kim JA, 2013, INT J CARDIOVAS IMAG, V29, P21, DOI 10.1007/s10554-013-0224-8; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Nicoll R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091481; Okwuosa TM, 2011, J AM COLL CARDIOL, V57, P1838, DOI 10.1016/j.jacc.2010.11.053; Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Poredos P, 1999, ANGIOLOGY, V50, P201, DOI 10.1177/000331979905000304; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Salahuddin S, 2012, GLOB HEART, V7, P113, DOI 10.1016/j.gheart.2012.05.003; Tanne D, 2007, INT J CARDIOL, V120, P32, DOI 10.1016/j.ijcard.2006.08.010; Ueshima H, 2004, STROKE, V35, P1836, DOI 10.1161/01.STR.0000131747.84423.74; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227680	10.1371/journal.pone.0227680	http://dx.doi.org/10.1371/journal.pone.0227680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917812	Green Published, gold			2022-12-26	WOS:000534341100032
J	Srivastava, RK; Moliner, A; Lee, ES; Nickles, E; Sim, E; Liu, C; Schwarz, H; Ibanez, CF				Srivastava, Raj Kamal; Moliner, Annalena; Lee, Ee-Soo; Nickles, Emily; Sim, Eunice; Liu, Chang; Schwarz, Herbert; Ibanez, Carlos F.			CD137 negatively affects ?browning? of white adipose tissue during cold exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue metabolism; adipocyte; adipogenesis; adipose tissue; adipokine; beige adipocyte; brite adipocyte; thermogenesis; UCP1	BEIGE; ADIPOCYTES; DISTINCT; MOUSE; CELL	Prolonged cold exposure stimulates the formation of brownlike adipocytes expressing UCP1 (uncoupling-protein-1) in subcutaneous white adipose tissue which, together with classical brown adipose tissue, contributes to maintaining body temperature in mammals through nonshivering thermogenesis. The mechanisms that regulate the formation of these cells, alternatively called beige or brite adipocytes, are incompletely understood. Here we report that mice lacking CD137, a cell surface protein used in several studies as a marker for beige adipocytes, showed elevated levels of thermogenic markers, including UCP1, increased numbers of beige adipocyte precursors, and expanded UCP1-expressing cell clusters in inguinal white adipose tissue after chronic cold exposure. CD137 knockout mice also showed enhanced cold resistance. These results indicate that CD137 functions as a negative regulator of ?browning? in white adipose tissue and call into question the use of this protein as a functional marker for beige adipocytes.	[Srivastava, Raj Kamal; Lee, Ee-Soo; Nickles, Emily; Sim, Eunice; Liu, Chang; Schwarz, Herbert; Ibanez, Carlos F.] Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore; [Srivastava, Raj Kamal; Moliner, Annalena; Lee, Ee-Soo; Nickles, Emily; Sim, Eunice; Liu, Chang; Schwarz, Herbert; Ibanez, Carlos F.] Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore; [Moliner, Annalena; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Ibanez, Carlos F.] Stellenbosch Univ, Stellenbosch Inst Adv Study, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa; [Srivastava, Raj Kamal] Indira Gandhi Natl Tribal Univ, Amarkantak, India	National University of Singapore; National University of Singapore; Karolinska Institutet; Stellenbosch University; Indira Gandhi National Tribal University	Ibanez, CF (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore 117597, Singapore.; Ibanez, CF (corresponding author), Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore.; Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.; Ibanez, CF (corresponding author), Stellenbosch Univ, Stellenbosch Inst Adv Study, Wallenberg Res Ctr, ZA-7600 Stellenbosch, South Africa.	phscfi@nus.edu.sg	Srivastava, Raj Kamal/G-4853-2011	Srivastava, Raj Kamal/0000-0001-9328-146X; Sim, Eunice/0000-0002-0955-8807	Singapore National Medical Research Council [NMRC/CBRG/0107/2016, NMRC/BnB/018b/2015]; National University of Singapore; Swedish Research Council (Vetenskapsradet) [2016-01538]	Singapore National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	This work was supported by Singapore National Medical Research Council Grants NMRC/CBRG/0107/2016 (to C. F. I.) and NMRC/BnB/018b/2015 (to H. S.), National University of Singapore Aspiration Fund Partner (to C. F. I.), and Swedish Research Council (Vetenskapsradet) Grant 2016-01538 (to C. F. I.). The authors declare that they have no conflicts of interest with the contents of this article.	de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Dharmadhikari B, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1113367; Garcia RA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0081-2; Guo TQ, 2014, ELIFE, V3, DOI 10.7554/eLife.03245; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Igarashi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32803-6; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Kim CS, 2011, DIABETES, V60, P3159, DOI 10.2337/db10-1805; Kim CS, 2010, ENDOCRINOLOGY, V151, P4725, DOI 10.1210/en.2010-0346; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sanchez-Gurmaches J, 2016, TRENDS CELL BIOL, V26, P313, DOI 10.1016/j.tcb.2016.01.004; SCHWARZ H, 1995, BLOOD, V85, P1043, DOI 10.1182/blood.V85.4.1043.bloodjournal8541043; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Thum E, 2009, FRONT BIOSCI-LANDMRK, V14, P4173, DOI 10.2741/3521; Ussar S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008490; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	21	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2034	2042		10.1074/jbc.AC119.011795	http://dx.doi.org/10.1074/jbc.AC119.011795			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919095	Green Published, hybrid			2022-12-26	WOS:000517128200021
J	Bhatti, G; Romero, R; Rice, GE; Fitzgerald, W; Pacora, P; Gomez-Lopez, N; Kavdia, M; Tarca, AL; Margolis, L				Bhatti, Gaurav; Romero, Roberto; Rice, Gregory Edward; Fitzgerald, Wendy; Pacora, Percy; Gomez-Lopez, Nardhy; Kavdia, Mahendra; Tarca, Adi L.; Margolis, Leonid			Compartmentalized profiling of amniotic fluid cytokines in women with preterm labor	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BLOOD-CELL COUNT; INTRAAMNIOTIC INFECTION; MICROBIAL INVASION; EXTRACELLULAR VESICLES; CLINICAL CHORIOAMNIONITIS; PREMATURE RUPTURE; HUMAN-PREGNANCY; HISTOLOGIC CHORIOAMNIONITIS; INDUCED INFLAMMATION	Objective Amniotic fluid cytokines have been implicated in the mechanisms of preterm labor and birth. Cytokines can be packaged within or on the surface of extracellular vesicles. The main aim of this study was to test whether the protein abundance internal to and on the surface of extracellular vesicles changes in the presence of sterile intra-amniotic inflammation and proven intra-amniotic infection in women with preterm labor as compared to the women with preterm labor without either intra-amniotic inflammation or proven intra-amniotic infection. Study design Women who had an episode of preterm labor and underwent an amniocentesis for the diagnosis of intra-amniotic infection or intra-amniotic inflammation were classified into three groups: 1) preterm labor without either intra-amniotic inflammation or proven intra-amniotic infection, 2) preterm labor with sterile intra-amniotic inflammation, and 3) preterm labor with intra-amniotic infection. The concentrations of 38 proteins were determined on the extracellular vesicle surface, within the vesicles, and in the soluble fraction of amniotic fluid. Results 1) Intra-amniotic inflammation, regardless of detected microbes, was associated with an increased abundance of amniotic fluid cytokines on the extracellular vesicle surface, within vesicles, and in the soluble fraction. These changes were most prominent in women with proven intra-amniotic infection. 2) Cytokine changes on the surface of extracellular vesicles were correlated with those determined in the soluble fraction; yet the magnitude of the increase was significantly different between these compartments. 3) The performance of prediction models of early preterm delivery based on measurements on the extracellular vesicle surface was equivalent to those based on the soluble fraction. Conclusions Differential packaging of amniotic fluid cytokines in extracellular vesicles during preterm labor with sterile intra-amniotic inflammation or proven intra-amniotic infection is reported herein for the first time. The current study provides insights into the biology of the intra-amniotic fluid ad may aid in the development of biomarkers for obstetrical disease.	[Bhatti, Gaurav; Romero, Roberto; Pacora, Percy; Gomez-Lopez, Nardhy; Tarca, Adi L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Obstet & Maternal Fetal Med, Div Intramural Res,NIH,USDA, Bethesda, MD 20892 USA; [Bhatti, Gaurav; Kavdia, Mahendra] Wayne State Univ, Coll Engn, Dept Biomed Engn, Detroit, MI USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Romero, Roberto] Detroit Med Ctr, Detroit, MI 48201 USA; [Romero, Roberto] Florida Int Univ, Dept Obstet & Gynecol, Miami, FL 33199 USA; [Rice, Gregory Edward] Univ Queensland, Ctr Clin Res, Herston, Qld, Australia; [Fitzgerald, Wendy; Margolis, Leonid] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Intercellular Interact, NIH, USDA, Bethesda, MD USA; [Pacora, Percy; Gomez-Lopez, Nardhy; Tarca, Adi L.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Gomez-Lopez, Nardhy] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Coll Engn, Detroit, MI 48202 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Department of Agriculture (USDA); Wayne State University; University of Michigan System; University of Michigan; Michigan State University; Wayne State University; Detroit Medical Center; State University System of Florida; Florida International University; University of Queensland; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Department of Agriculture (USDA); Wayne State University; Wayne State University; Wayne State University	Romero, R; Tarca, AL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Obstet & Maternal Fetal Med, Div Intramural Res,NIH,USDA, Bethesda, MD 20892 USA.; Romero, R (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Romero, R (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.; Romero, R (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA.; Romero, R (corresponding author), Detroit Med Ctr, Detroit, MI 48201 USA.; Romero, R (corresponding author), Florida Int Univ, Dept Obstet & Gynecol, Miami, FL 33199 USA.; Rice, GE (corresponding author), Univ Queensland, Ctr Clin Res, Herston, Qld, Australia.; Tarca, AL (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA.; Tarca, AL (corresponding author), Wayne State Univ, Dept Comp Sci, Coll Engn, Detroit, MI 48202 USA.	prbchiefstaff@med.wayne.edu; g.rice@uq.edu.au; atarca@med.wayne.edu	Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121; bhatti, gaurav/0000-0002-8557-3347; Tarca, Adi Laurentiu/0000-0003-1712-7588	Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and; NICHD/NIH/DHHS [HHSN275201300006C]; Wayne State University Perinatal Research Initiative	Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and; NICHD/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wayne State University Perinatal Research Initiative	This research was supported, in part, by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with Federal funds from NICHD/NIH/DHHS under Contract No. HHSN275201300006C. Dr. Romero has contributed to this work as part of his official duties as an employee of the United States Federal Government. NG-L and ALT are supported by the Wayne State University Perinatal Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander M, 2017, J IMMUNOL, V199, P3559, DOI 10.4049/jimmunol.1700904; ALLBERT JR, 1994, J SOC GYNECOL INVEST, V1, P264, DOI 10.1177/107155769400100404; Allen-Daniels MJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.032; American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics, 2003, Obstet Gynecol, V102, P1445; [Anonymous], 2019, R LANG ENV STAT COMP; Arzt E, 1996, NEUROIMMUNOMODULAT, V3, P28, DOI 10.1159/000097224; Asea A, 2008, J REPROD IMMUNOL, V79, P12, DOI 10.1016/j.jri.2008.06.001; Balbi C, 2017, STEM CELL TRANSL MED, V6, P1340, DOI 10.1002/sctm.16-0297; BARTLETT MS, 1947, BIOMETRICS, V3, P39, DOI 10.2307/3001536; Bastek JA, 2011, CLIN PERINATOL, V38, P385, DOI 10.1016/j.clp.2011.06.003; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beretti F, 2018, BIOFACTORS, V44, P158, DOI 10.1002/biof.1407; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bretz NP, 2013, J BIOL CHEM, V288, P36691, DOI 10.1074/jbc.M113.512806; Buhimschi IA, 2007, AM J OBSTET GYNECOL, V197, pS11, DOI 10.1016/j.ajog.2007.10.026; Burdet J, 2014, CURR PHARM DESIGN, V20, P4741, DOI 10.2174/1381612820666140130202224; Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; Catov JM, 2007, AM J EPIDEMIOL, V166, P1312, DOI 10.1093/aje/kwm273; CHAIM W, 1992, ARCH GYNECOL OBSTET, V251, P9, DOI 10.1007/BF02718273; Chaiyasit N, 2017, J PERINAT MED, V45, P539, DOI 10.1515/jpm-2016-0344; Chen C., 2004, TECHNICAL REPORT; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; CHEROUNY PH, 1993, AM J OBSTET GYNECOL, V169, P1299, DOI 10.1016/0002-9378(93)90297-V; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Cole CR, 2008, PEDIATRICS, V122, pE573, DOI 10.1542/peds.2007-3449; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Dixon CL, 2018, ENDOCRINOLOGY, V159, P2229, DOI 10.1210/en.2018-00073; Dong Y, 2011, WORLD J PEDIATR, V7, P199, DOI 10.1007/s12519-011-0290-8; Dudley DJ, 1997, J REPROD IMMUNOL, V33, P147, DOI 10.1016/S0165-0378(97)00020-X; Dudley DJ, 1996, AM J PERINAT, V13, P443, DOI 10.1055/s-2007-994385; Dujardin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100760; Eigenbrod T, 2008, J IMMUNOL, V181, P8194, DOI 10.4049/jimmunol.181.12.8194; Eken C, 2008, J IMMUNOL, V180, P817, DOI 10.4049/jimmunol.180.2.817; Eken C, 2013, IMMUNOBIOLOGY, V218, P382, DOI 10.1016/j.imbio.2012.05.021; Eken C, 2010, J BIOL CHEM, V285, P39914, DOI 10.1074/jbc.M110.126748; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Farhadihosseinabadi B, 2018, ARTIF CELL NANOMED B, V46, P431, DOI 10.1080/21691401.2018.1458730; Fitzgerald W, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12860; Fitzgerald W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27190-x; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Fritz T, 2018, ACTA OBSTET GYN SCAN, V97, P1388, DOI 10.1111/aogs.13387; Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Gomez R, 1997, INFECT DIS CLIN N AM, V11, P135, DOI 10.1016/S0891-5520(05)70347-0; Gomez-Lopez N, 2019, J IMMUNOL, V203, P2757, DOI 10.4049/jimmunol.1900901; Gomez-Lopez N, 2019, J PERINAT MED, V47, P822, DOI 10.1515/jpm-2019-0262; Gomez-Lopez N, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13184; Gomez-Lopez N, 2019, BIOL REPROD, V100, P1306, DOI 10.1093/biolre/ioy264; Gomez-Lopez N, 2019, J PERINAT MED, V47, P276, DOI 10.1515/jpm-2018-0271; Gomez-Lopez N, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13049; Gomez-Lopez N, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.09.013; Gomez-Lopez N, 2017, REPROD SCI, V24, P1382, DOI 10.1177/1933719116687656; Gomez-Lopez N, 2017, REPROD SCI, V24, P1139, DOI 10.1177/1933719116678690; Gomez-Lopez N, 2016, AM J REPROD IMMUNOL, V75, P3, DOI 10.1111/aji.12443; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P605, DOI 10.1080/14767050802212109; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064; GREIG PC, 1995, AM J OBSTET GYNECOL, V173, P1223, DOI 10.1016/0002-9378(95)91358-0; GREIG PC, 1993, AM J OBSTET GYNECOL, V169, P1035, DOI 10.1016/0002-9378(93)90050-S; HALPERIN W, 1967, J ULTRA MOL STRUCT R, V18, P428, DOI 10.1016/S0022-5320(67)80128-X; Hargreaves DC, 2005, J CLIN IMMUNOL, V25, P503, DOI 10.1007/s10875-005-8065-4; Hell L, 2017, TRANSL RES, V184, P12, DOI 10.1016/j.trsl.2017.01.003; Hirsch E, 2005, J SOC GYNECOL INVEST, V12, P145, DOI 10.1016/j.jsgi.2005.01.007; HOFFMAN DR, 1990, AM J OBSTET GYNECOL, V162, P525, DOI 10.1016/0002-9378(90)90423-5; Holst D, 2008, EUR J OBSTET GYN R B, V141, P3, DOI 10.1016/j.ejogrb.2008.07.020; Holst RM, 2005, ACTA OBSTET GYN SCAN, V84, P551, DOI 10.1111/j.0001-6349.2005.00708.x; Hsu CD, 1998, AM J OBSTET GYNECOL, V178, P428, DOI 10.1016/S0002-9378(98)70414-4; Hsu CD, 1997, AM J OBSTET GYNECOL, V177, P793, DOI 10.1016/S0002-9378(97)70270-9; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Kaplan D, 1996, IMMUNOL TODAY, V17, P303, DOI 10.1016/0167-5699(96)30017-0; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kemp B, 2002, ACTA OBSTET GYN SCAN, V81, P938, DOI 10.1034/j.1600-0412.2002.811007.x; Kemp MW, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00574; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Klebanoff M, 2006, BJOG-INT J OBSTET GY, V113, P43, DOI 10.1111/j.1471-0528.2006.01121.x; Koenker R, 2004, J MULTIVARIATE ANAL, V91, P74, DOI 10.1016/j.jmva.2004.05.006; Konadu KA, 2015, J INFECT DIS, V211, P1712, DOI 10.1093/infdis/jiu676; Kovach MA, 2016, J LEUKOCYTE BIOL, V100, P413, DOI 10.1189/jlb.4A0315-087R; Krohn MA, 1998, AM J OBSTET GYNECOL, V178, P381, DOI 10.1016/S0002-9378(98)80029-X; LAHAM N, 1993, ACTA ENDOCRINOL-COP, V129, P220, DOI 10.1530/acta.0.1290220; LAHAM N, 1994, EUR J ENDOCRINOL, V131, P607, DOI 10.1530/eje.0.1310607; Li PF, 2019, J CARDIOVASC TRANSL, V12, P37, DOI 10.1007/s12265-018-9791-3; Li X, 2016, EBIOMEDICINE, V8, P72, DOI 10.1016/j.ebiom.2016.04.030; Li YW, 2018, INT J NANOMED, V13, P467, DOI 10.2147/IJN.S151110; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Maddipati KR, 2016, J LIPID RES, V57, P1906, DOI 10.1194/jlr.P069096; Maddipati KR, 2016, FASEB J, V30, P3296, DOI 10.1096/fj.201600583R; Margolis L, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000363; Maritati M, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0152-9; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Martinez-Varea A, 2017, J PERINAT MED, V45, P523, DOI 10.1515/jpm-2016-0225; Maymon E, 2001, J PERINAT MED, V29, P308, DOI 10.1515/JPM.2001.044; Mazor M, 1996, ACTA OBSTET GYN SCAN, V75, P624, DOI 10.3109/00016349609054686; MAZOR M, 1993, J REPROD MED, V38, P799; McGregor, 1997, Medscape Womens Health, V2, P1; Meldolesi J, 2018, CURR BIOL, V28, pR435, DOI 10.1016/j.cub.2018.01.059; Mellows B, 2017, STEM CELLS DEV, V26, P1316, DOI 10.1089/scd.2017.0089; Meyer D, 2009, PLANT J, V57, P986, DOI 10.1111/j.1365-313X.2008.03743.x; Mikamo H, 1998, AM J OBSTET GYNECOL, V179, P1579, DOI 10.1016/S0002-9378(98)70028-6; Newton ER, 1997, AM J OBSTET GYNECOL, V176, P672, DOI 10.1016/S0002-9378(97)70568-4; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Olmos-Ortiz LM, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12426; Para R, 2020, J MATERN-FETAL NEO M, V33, P4117, DOI 10.1080/14767058.2019.1597047; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; Plazyo O, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.144139; Radeghieri A, 2017, BIOCHEM BIOPH RES CO, V483, P706, DOI 10.1016/j.bbrc.2016.12.077; Regente M, 2017, J EXP BOT, V68, P5485, DOI 10.1093/jxb/erx355; Regente M, 2009, FEBS LETT, V583, P3363, DOI 10.1016/j.febslet.2009.09.041; Renner U, 1996, EUR J ENDOCRINOL, V135, P515, DOI 10.1530/eje.0.1350515; RIECKMANN P, 1991, J IMMUNOL, V146, P3462; RiveroMarcotegui A, 1997, CLIN CHEM, V43, P857; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P805, DOI 10.1016/0002-9378(93)90009-8; ROMERO R, 1992, CIBA F SYMP, V167, P205; ROMERO R, 1991, CLIN OBSTET GYNECOL, V34, P769, DOI 10.1097/00003081-199112000-00013; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P757, DOI 10.1016/0002-9378(90)91063-I; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1993, J REPROD MED, V38, P543; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P114, DOI 10.1016/0002-9378(88)90503-0; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; ROMERO R, 1990, J CLIN INVEST, V85, P1392, DOI 10.1172/JCI114583; ROMERO R, 1993, AM J REPROD IMMUNOL, V30, P167, DOI 10.1111/j.1600-0897.1993.tb00618.x; ROMERO R, 1990, J REPROD MED, V35, P235; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; ROMERO R, 1989, AM J OBSTET GYNECOL, V161, P817, DOI 10.1016/0002-9378(89)90409-2; Romero R, 2008, J PERINAT MED, V36, P388, DOI 10.1515/JPM.2008.076; Romero R, 2008, AM J OBSTET GYNECOL, V198, P1, DOI 10.1016/j.ajog.2007.11.031; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12685; Romero R, 2016, J PERINAT MED, V44, P33, DOI 10.1515/jpm-2015-0119; Romero R, 2016, J PERINAT MED, V44, P53, DOI 10.1515/jpm-2015-0121; Romero R, 2016, J PERINAT MED, V44, P5, DOI 10.1515/jpm-2015-0045; Romero R, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.037; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1343, DOI 10.3109/14767058.2014.954243; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2014, J MATERN-FETAL NEO M, V27, P1397, DOI 10.3109/14767058.2013.860963; Romero R, 2010, J MATERN-FETAL NEO M, V23, P261, DOI 10.3109/14767050903067386; Romero R, 2012, J MATERN-FETAL NEO M, V25, P558, DOI 10.3109/14767058.2011.599083; Romero R, 2009, J MATERN-FETAL NEO M, V22, P636, DOI 10.1080/14767050902784171; ROTHWELL NJ, 1991, J ENDOCRINOL, V128, P171, DOI 10.1677/joe.0.1280171; Ruegger C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-17; Rutter BD, 2017, PLANT PHYSIOL, V173, P728, DOI 10.1104/pp.16.01253; Sadallah S, 2008, J LEUKOCYTE BIOL, V84, P1316, DOI 10.1189/jlb.0108013; Sadallah S, 2016, J IMMUNOL, V197, P1663, DOI 10.4049/jimmunol.1502658; Sadallah S, 2011, J IMMUNOL, V186, P6543, DOI 10.4049/jimmunol.1002788; Sadallah S, 2011, SEMIN IMMUNOPATHOL, V33, P487, DOI 10.1007/s00281-010-0232-x; SANTHANAM U, 1991, CYTOKINE, V3, P155, DOI 10.1016/1043-4666(91)90037-E; Schorey JS, 2015, EMBO REP, V16, P24, DOI 10.15252/embr.201439363; Sedrakyan S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17061-2; Sheller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157614; Sheller-Miller S, 2017, J REPROD IMMUNOL, V123, P3, DOI 10.1016/j.jri.2017.08.003; Sheller-Miller S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00432; Silva C M, 1998, Adv Protein Chem, V52, P199; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Soler N, 2008, RES MICROBIOL, V159, P390, DOI 10.1016/j.resmic.2008.04.015; Son GH, 2016, AM J REPROD IMMUNOL, V75, P155, DOI 10.1111/aji.12451; Song JE, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0552-0; Tan DBA, 2017, RESP MED, V132, P261, DOI 10.1016/j.rmed.2017.04.014; Tan JL, 2018, STEM CELL TRANSL MED, V7, P180, DOI 10.1002/sctm.17-0185; Tarca AL, 2017, AM J REPROD IMMUNOL, V78, DOI 10.1111/aji.12686; Ti DD, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0642-6; Tokarz Aleksandra, 2015, Folia Med Cracov, V55, P35; Triantafilou M, 2013, PLOS ONE, V8, DOI [10.1371/annotation/1dc00176-e096-4621-9494-2d848dac8262, 10.1371/journal.pone.0061199]; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Krogt L, 2017, EUR J OBSTET GYN R B, V214, P173, DOI 10.1016/j.ejogrb.2017.05.001; Vassilopoulou-Sellin R, 1994, Oncology (Williston Park), V8, P43; Veith GL, 1999, GYNECOL OBSTET INVES, V48, P163, DOI 10.1159/000010165; WARING PM, 1994, AM J OBSTET GYNECOL, V171, P1335, DOI 10.1016/0002-9378(94)90157-0; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Xiao GY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23120; Yamakawa T, 2016, EARLY HUM DEV, V92, P7, DOI 10.1016/j.earlhumdev.2015.10.019; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Zhao B, 2017, J MOL HISTOL, V48, P121, DOI 10.1007/s10735-017-9711-x	182	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227881	10.1371/journal.pone.0227881	http://dx.doi.org/10.1371/journal.pone.0227881			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945128	Green Published, gold			2022-12-26	WOS:000534370100069
J	Zink, RM; Botero-Canola, S; Martinez, H; Herzberg, KM				Zink, Robert M.; Botero-Canola, Sebastian; Martinez, Helen; Herzberg, Katelyn M.			Niche modeling reveals life history shifts in birds at La Brea over the last twenty millennia	PLOS ONE			English	Article							CLIMATE; CONSERVATISM; DIVERGENCE; MAMMALS	A species presence at a particular site can change over time, resulting in temporally dynamic species pools. Ecological niche models provide estimates of species presence at different time intervals. The avifauna of La Brea includes approximately 120 species dating to approximately 15,000 years ago. Niche models predicted presence at the Last Glacial Maximum for over 90% of 89 landbird species. This confirms that niche modeling produces sensible range estimates at the Last Glacial Maximum. For 97 currently local species that are as yet undocumented at La Brea over 90% were predicted to occur; absence is due to insufficient study, lack of the ecological niche, transient occurrence or a behavioral ability to avoid entrapment. Our 366 niche models provide a prospective checklist of the landbird fauna of La Brea. The models indicate fluidity in life history strategies and a higher proportion of resident birds at the LGM (88% to 60%). We evaluated a subset of 103 species in breeding and winter periods using two climate models (MIROC- ESM, CCSM4) with a variety of differing parameters, finding differences in 5% of the niche models. Niche breadths in bark-foraging birds changed little between the present and LGM, suggesting that greater species diversity at the LGM was due to greater niche availability rather than contractions of niche breadths (i.e., niche partitioning).	[Zink, Robert M.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Zink, Robert M.; Botero-Canola, Sebastian] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Zink, Robert M.] Univ Nebraska, Nebraska State Museum, Lincoln, NE 68588 USA; [Botero-Canola, Sebastian] Univ Nebraska, Harold W Manter Lab Parasitol, Lincoln, NE 68588 USA; [Martinez, Helen; Herzberg, Katelyn M.] Univ Nebraska, Coll Agr & Nat Resources, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zink, RM (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.; Zink, RM (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.; Zink, RM (corresponding author), Univ Nebraska, Nebraska State Museum, Lincoln, NE 68588 USA.	rzink2@unl.edu						Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; [Anonymous], 2011, ECOLOGICAL NICHES GE; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Campbell KE, 2010, REC AUST MUS, V62, P123, DOI 10.3853/j.0067-1975.62.2010.1534; DAWSON WILLIAM R., 1948, CONDOR, V50, P57, DOI 10.2307/1363979; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Escalante T, 2013, BIOL J LINN SOC, V110, P485, DOI 10.1111/bij.12142; Fragomeni A., 2011, NEW MEXICO MUSEUM NA, V53, P511; Glor RE, 2011, EVOLUTION, V65, P673, DOI 10.1111/j.1558-5646.2010.01177.x; Gotelli Nicholas J., 2011, P39; Grinnell J., 1922, Auk Lancaster Pa, V39, P373; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2004, DIVA GIS VERSION 7 1; Howard H., 1962, Contr Los Angeles Mus, VNo. 58, P1; Howard H., 1930, Condor Berkeley, V32, P81, DOI 10.2307/1363526; HOWARD HILDEGARDE, 1936, CONDOR, V38, P32, DOI 10.2307/1363591; JOHNSTON DW, 1961, BIOSYSTEMATICS AM CR; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; LEVINS RICHARD, 1968; LYNCH JF, 1974, CONDOR, V76, P370, DOI 10.2307/1365812; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; MILLER ALDEN H., 1929, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V19, P1; Miller Alden H., 1947, CONDOR, V49, P22, DOI 10.2307/1364424; Myers CE, 2015, PALEOBIOLOGY, V41, P226, DOI 10.1017/pab.2014.19; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nakazawa Y, 2004, AUK, V121, P610, DOI 10.1642/0004-8038(2004)121[0610:SNONMB]2.0.CO;2; Norris D, 2014, TROP CONSERV SCI, V7, P529, DOI 10.1177/194008291400700311; Pena-Peniche A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202678; Perez-Moreno H, 2016, ECOL EVOL, V6, P2022, DOI 10.1002/ece3.1973; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prothero DR, 2012, QUATERNARY SCI REV, V56, P1, DOI 10.1016/j.quascirev.2012.08.015; Ribeiro V, 2016, AUSTRAL ECOL, V41, P768, DOI 10.1111/aec.12363; Simpson GG, 1943, AM J SCI, V241, P1, DOI 10.2475/ajs.241.1.1; Title PO, 2018, ECOGRAPHY, V41, P291, DOI 10.1111/ecog.02880; Varela S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129037; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Yannic G, 2014, NAT CLIM CHANGE, V4, P132, DOI 10.1038/NCLIMATE2074; Zink RM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603133; Zink RM, 2014, J BIOGEOGR, V41, P999, DOI 10.1111/jbi.12252	44	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227361	10.1371/journal.pone.0227361	http://dx.doi.org/10.1371/journal.pone.0227361			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945101	Green Published, gold			2022-12-26	WOS:000534370100033
J	Krajcova, A; Urban, T; Megvinet, D; Waldauf, P; Balik, M; Hlavicka, J; Budera, P; Janousek, L; Pokorna, E; Duska, F				Krajcova, Adela; Urban, Tomas; Megvinet, David; Waldauf, Petr; Balik, Martin; Hlavicka, Jan; Budera, Petr; Janousek, Libor; Pokorna, Eva; Duska, Frantisek			High resolution respirometry to assess function of mitochondria in native homogenates of human heart muscle	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY CONTROL; DYSFUNCTION; FIBERS; TISSUE; PERMEABILIZATION; MYOCARDIUM; METABOLISM; DISEASE	Impaired myocardial bioenergetics is a hallmark of many cardiac diseases. There is a need of a simple and reproducible method of assessment of mitochondrial function from small human myocardial tissue samples. In this study we adopted high-resolution respirometry to homogenates of fresh human cardiac muscle and compare it with isolated mitochondria. We used atria resected during cardiac surgery (n = 18) and atria and left ventricles from brain-dead organ donors (n = 12). The protocol we developed consisting of two-step homogenization and exposure of 2.5% homogenate in a respirometer to sequential addition of 2.5 mM malate, 15 mM glutamate, 2.5 mM ADP, 10 mu M cytochrome c, 10 mM succinate, 2.5 mu M oligomycin, 1.5 mu M FCCP, 3.5 mu M rotenone, 4 mu M antimycin and 1 mM KCN or 100 mM Sodium Azide. We found a linear dependency of oxygen consumption on oxygen concentration. This technique requires <20 mg of myocardium and the preparation of the sample takes <20 min. Mitochondria in the homogenate, as compared to subsarcolemmal and interfibrillar isolated mitochondria, have comparable or better preserved integrity of outer mitochondrial membrane (increase of respiration after addition of cytochrome c is up to 11.7 +/- 1.8% vs. 15.7 +/- 3.1%, p<0.05 and 11.7 +/- 3.5%, p = 0.99, resp.) and better efficiency of oxidative phosphorylation (Respiratory Control Ratio = 3.65 +/- 0.5 vs. 3.04 +/- 0.27, p<0.01 and 2.65 +/- 0.17, p<0.0001, resp.). Results are reproducible with coefficient of variation between two duplicate measurements <= 8% for all indices. We found that whereas atrial myocardium contains less mitochondria than the ventricle, atrial bioenergetic profiles are comparable to left ventricle. In conclusion, high resolution respirometry has been adapted to homogenates of human cardiac muscle and shown to be reliable and reproducible.	[Krajcova, Adela; Urban, Tomas; Megvinet, David; Waldauf, Petr; Duska, Frantisek] Charles Univ Prague, Fac Med 3, Dept Anaesthesia & Intens Care, OXYLAB Lab Mitochondrial Physiol, Prague, Czech Republic; [Krajcova, Adela; Urban, Tomas; Megvinet, David; Waldauf, Petr; Hlavicka, Jan; Budera, Petr; Duska, Frantisek] FNKV Univ Hosp, Prague, Czech Republic; [Balik, Martin] Charles Univ Prague, Med Fac 1, Dept Anaesthesia & Intens Care, Prague, Czech Republic; [Balik, Martin] Gen Univ Hosp, Prague, Czech Republic; [Hlavicka, Jan; Budera, Petr] Charles Univ Prague, Fac Med 3, Dept Cardiac Surg, Prague, Czech Republic; [Janousek, Libor] Inst Clin & Expt Med, Transplantat Surg Dept, Prague, Czech Republic; [Pokorna, Eva] Inst Clin & Expt Med, Dept Organ Recovery & Transplantat Databases, Prague, Czech Republic	Charles University Prague; University Hospital Vinohrady; Charles University Prague; General University Hospital Prague; Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Duska, F (corresponding author), Charles Univ Prague, Fac Med 3, Dept Anaesthesia & Intens Care, OXYLAB Lab Mitochondrial Physiol, Prague, Czech Republic.; Duska, F (corresponding author), FNKV Univ Hosp, Prague, Czech Republic.	fduska@yahoo.com	Krajčová, Adéla/AAM-6645-2020; Waldauf, Petr/K-6785-2017	Waldauf, Petr/0000-0003-4668-5837; Duska, Frantisek/0000-0003-1559-4078; Urban, Tomas/0000-0001-5061-0585	Czech Health Research Council [NV18-06-00417]; Czech-BioImaging large RI project - MEYS CR [LM2015062]; OP RDE [CZ.02.1.01/0.0/0.0/16_013/0001775]	Czech Health Research Council; Czech-BioImaging large RI project - MEYS CR; OP RDE	The work has been supported solely from the grant of Czech Health Research Council, AZV No. NV18-06-00417 (PRASE). The electron microscopy was performed at the Microscopy Centre - Electron Microscopy CF, IMG AS CR supported by the Czech-BioImaging large RI project (LM2015062 funded by MEYS CR) and by OP RDE (CZ.02.1.01/0.0/0.0/16_013/0001775).; Our thanks belong to all cardiac surgery patients who voluntarily donated their atrial tissue to enable this project, but in particular we thank to all deceased organ donors for their gift of life, and grieved families who consented to it. The electron microscopy was performed at the Microscopy Centre-Electron Microscopy CF, IMG AS CR supported by the Czech-BioImaging large RI project (LM2015062 funded by MEYS CR) and by OP RDE (CZ.02.1.01/0.0/0.0/16_013/0001775 "Modernization and support of research activities of the national infrastructure for biological and medical imaging Czech-BioImaging"). We also thank Dr. Zdenek Drahota for valuable comments and support and prof. Charles Hoppel for proofreading.	Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Cardinale DA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13611; CHANCE B, 1962, J BIOL CHEM, V237, P3540; CHAPPELL JB, 1964, BIOCHEM J, V90, P225, DOI 10.1042/bj0900225; CHIDSEY CA, 1966, J CLIN INVEST, V45, P40, DOI 10.1172/JCI105322; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350; From AM, 2011, MAYO CLIN PROC, V86, P1095, DOI 10.4065/mcp.2011.0296; GIBBS CL, 1978, PHYSIOL REV, V58, P174, DOI 10.1152/physrev.1978.58.1.174; Gnaiger E, 2000, LIFE IN THE COLD, P431; Gnaiger E., 2008, DRUGINDUCED MITOCHON, V327, P325, DOI [DOI 10.1002/9780470372531.CH12, 10.1002/9780470372531.ch12pp]; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; KRIEGER DA, 1980, J APPL PHYSIOL, V48, P23, DOI 10.1152/jappl.1980.48.1.23; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Kuznetsov AV, 2003, ANAL BIOCHEM, V319, P296, DOI 10.1016/S0003-2697(03)00326-9; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Larsen S, 2014, ANAL BIOCHEM, V446, P64, DOI 10.1016/j.ab.2013.10.023; Lemieux H, 2009, J BIOENERG BIOMEMBR, V41, P99, DOI 10.1007/s10863-009-9211-0; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Lopaschuk G, 2014, CARDIAC ENERGY METAB, DOI [10.1007/978-1-4939-1227-8, DOI 10.1007/978-1-4939-1227-8]; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mathers KE, 2015, BIOL OPEN, V4, P858, DOI 10.1242/bio.011544; Mela L, 1979, Methods Enzymol, V55, P39; Murphy J, MAYO CLIN CARDIOLOGY, P1481; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Pecinova A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006; Perry CGR, 2013, DIABETES, V62, P1041, DOI 10.2337/db12-1219; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Quigley AF, 2000, J CARD FAIL, V6, P47, DOI 10.1016/S1071-9164(00)00011-7; Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5; Ruas JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150967; Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; Scheubel RJ, 2002, J AM COLL CARDIOL, V40, P2174, DOI 10.1016/S0735-1097(02)02600-1; SUGA H, 1990, PHYSIOL REV, V70, P247, DOI 10.1152/physrev.1990.70.2.247; Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009; TOLEIKIS A, 1979, J MOL CELL CARDIOL, V11, P57, DOI 10.1016/0022-2828(79)90452-8; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Varga ZV, 2015, AM J PHYSIOL-HEART C, V309, pH1453, DOI 10.1152/ajpheart.00554.2015; Varikmaa M, 2013, J BIOENERG BIOMEMBR, V45, P319, DOI 10.1007/s10863-012-9494-4; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; WIKSTROM M, 1985, FEBS LETT, V183, P293, DOI 10.1016/0014-5793(85)80796-1; WILSON MA, 1978, ANAL BIOCHEM, V85, P255, DOI 10.1016/0003-2697(78)90297-X; Ziak J, 2015, MITOCHONDRION, V21, P106, DOI 10.1016/j.mito.2015.02.002	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226142	10.1371/journal.pone.0226142	http://dx.doi.org/10.1371/journal.pone.0226142			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940313	gold, Green Published			2022-12-26	WOS:000534368000020
J	Mierzejewska, E; Honorato-Rzeszewicz, T; Swiatkowska, D; Jurczak-Czaplicka, M; Maciejewski, T; Fijalkowska, A; Szulc-Kaminska, J; Czach, A; Nalecz, H; Szostak-Wegierek, D; Szamotulska, K				Mierzejewska, Ewa; Honorato-Rzeszewicz, Talita; Swiatkowska, Dorota; Jurczak-Czaplicka, Marzena; Maciejewski, Tomasz; Fijalkowska, Anna; Szulc-Kaminska, Jagna; Czach, Anna; Nalecz, Hanna; Szostak-Wegierek, Dorota; Szamotulska, Katarzyna			Evaluation of questionnaire as an instrument to measure the level of nutritional and weight gain knowledge in pregnant women in Poland. A pilot study	PLOS ONE			English	Article							MATERNAL OBESITY; OUTCOMES; VALIDATION; ADHERENCE; CHILDREN; ORIGINS; DISEASE; EUROPE; DIET	Pregnancy is a period in life in which women are willing to improve their lifestyle. Providing proper information for these women is crucial for their health and the health of their offspring. Clear information about weak points in their nutritional and weight gain knowledge is the first step for proper health care assistance. There are a few previous studies evaluating the nutritional and weight gain knowledge of pregnant women. In the few studies available, different approaches were taken and there was no wider discussion on the content of the questionnaires attempting to measure level of knowledge. The aim of this study, designed in a pilot fashion, was to test the adequacy of the questionnaire as a research instrument in a group of 139 pregnant Polish women. The developed instrument is a 33-item questionnaire comprising four domains: weight gain, importance of nutrients, quality and quantity of food intake. The results of this study indicate that the questionnaire is stable and internal consistency is acceptable (Cronbach's alpha > 0.7) for dimensions with more than four items. For dimensions with less than four items, internal consistency was poor (Cronbach's alpha < 0.7). The cumulative explained variance for domains weight gain, importance of nutrients, quantity and quality of food intake was 54.74%, 42.74%, 54.42% and 48.99% respectively. Results from validity, reliability and factor analysis indicate that the questionnaire is adequate for its purpose.	[Mierzejewska, Ewa; Honorato-Rzeszewicz, Talita; Szamotulska, Katarzyna] Inst Mother & Child Hlth, Dept Epidemiol & Biostat, Warsaw, Poland; [Swiatkowska, Dorota; Maciejewski, Tomasz; Szulc-Kaminska, Jagna; Czach, Anna] Inst Mother & Child Hlth, Obstet & Gynecol Clin, Warsaw, Poland; [Jurczak-Czaplicka, Marzena; Nalecz, Hanna] Inst Mother & Child Hlth, Dept Child & Adolescent Hlth, Warsaw, Poland; [Fijalkowska, Anna] Inst Mother & Child Hlth, Dept Cardiol, Warsaw, Poland; [Szostak-Wegierek, Dorota] Warsaw Med Univ, Dept Clin Dietet, Warsaw, Poland	Medical University of Warsaw	Honorato-Rzeszewicz, T (corresponding author), Inst Mother & Child Hlth, Dept Epidemiol & Biostat, Warsaw, Poland.	talita.honorato@imid.med.pl	Nalecz, Hanna/B-6788-2013; Szostak-Wegierek, Dorota/N-2533-2018	Nalecz, Hanna/0000-0003-0384-6469; Szostak-Wegierek, Dorota/0000-0002-5265-8176; Mierzejewska, Ewa/0000-0003-0822-4781; Honorato- Rzeszewicz, Talita/0000-0002-1873-7516	National Health Programme in Poland [6/1/3.1.1/NPZ/2017/106/612]	National Health Programme in Poland	This study was financed by the National Health Programme in Poland for the years 2016-2020. Agreement number: 6/1/3.1.1/NPZ/2017/106/612.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barker M, 2018, LANCET, V391, P1853, DOI [10.1016/S0140-6736(18)30313-1, 10.1016/s0140-6736(18)30313-1]; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Blumfield ML, 2013, NUTR REV, V71, P118, DOI 10.1111/nure.12003; Bookari K, 2017, WOMEN BIRTH, V30, P9, DOI 10.1016/j.wombi.2016.05.010; Bookari K, 2016, INT J WOMENS HEALTH, V8, P405, DOI 10.2147/IJWH.S110072; Bookari K, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/8162645; Bryant J, 2017, AUST NZ J OBSTET GYN, V57, P315, DOI 10.1111/ajo.12523; Cappelleri JC, 2014, CLIN THER, V36, P648, DOI 10.1016/j.clinthera.2014.04.006; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Downs Danielle Symons, 2014, J Womens Health Care, V3; Doyle IM, 2017, PUBLIC HEALTH NUTR, V20, P1009, DOI 10.1017/S1368980016002937; Flores CA V, 2001, SEBRAE PB, V13, P94; Fontana R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020087; Freitas-Vilela AA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12353; Gernand AD, 2016, NAT REV ENDOCRINOL, V12, P274, DOI 10.1038/nrendo.2016.37; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Guggino A, 2016, J OBSTET GYNAECOL, V36, P964, DOI 10.3109/01443615.2016.1168372; GUS, 2012, ZDROW KOB POLSC LAT; Johnston EO, 2016, MATERN CHILD HLTH J, V20, P1825, DOI 10.1007/s10995-016-1985-1; Kavle JA, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12508; Kennedy RAK, 2017, PUBLIC HEALTH, V143, P71, DOI 10.1016/j.puhe.2016.10.028; Khaing W, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101141; Ministerstwo Zdrowia, 2011, ZYW CIG2Y; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Niedzwiedzka E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092183; Olmedo-Requena R, 2018, WOMEN HEALTH, V58, P1094, DOI 10.1080/03630242.2017.1388332; Perez-Escamilla R, 2018, BMJ-BRIT MED J, V361, DOI [10.1136/bmj.k2252, 10.1136/bmj.j2252]; Peterson RA, 2000, CONSTRUCTING EFFECTI; Phelan S, 2010, AM J OBSTET GYNECOL, V202, DOI [10.1016/j.ajog.2009.06.008, 10.1016/j.ajog.2010.06.051]; Poobalan AS, 2009, OBES REV, V10, P28, DOI 10.1111/j.1467-789X.2008.00537.x; Popa AD, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1105; Popkin B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12108; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; Rasmussen K.M., 2009, WEIGHT GAIN PREGNANC, DOI [10.17226/12584, DOI 10.17226/12584]; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Shub Alexis, 2013, BMC Res Notes, V6, P278, DOI 10.1186/1756-0500-6-278; Silvestris E, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0336-z; Suliga E, 2017, MED STUD, V33, P40, DOI 10.5114/ms.2017.66955; Swift JA, 2017, MIDWIFERY, V49, P40, DOI 10.1016/j.midw.2017.01.016; Trakman GL, 2017, PUBLIC HEALTH NUTR, V20, P2670, DOI 10.1017/S1368980017001471; Trujillo J, 2018, J AFFECT DISORDERS, V232, P185, DOI 10.1016/j.jad.2018.02.004; Trumpff C, 2013, J TRACE ELEM MED BIO, V27, P174, DOI 10.1016/j.jtemb.2013.01.002; UN, 2016, DEC PILL NUTR ACT; Variyam J. N., 2002, FoodReview, V25, P13; Wendolowicz A, 2014, MED OGOINA NAUK ZDRO, V20, P341, DOI [10.5604/20834543.1124669, DOI 10.5604/20834543.1124669]; WHO, 2017, POLICY BRIEF, DOI [10.1111/j.1745-6584.1983.tb00740.x, DOI 10.1111/J.1745-6584.1983.TB00740.X]; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhou YB, 2019, OBESITY, V27, P1030, DOI 10.1002/oby.22478	52	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227682	10.1371/journal.pone.0227682	http://dx.doi.org/10.1371/journal.pone.0227682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940402	Green Published, gold			2022-12-26	WOS:000534368000092
J	Roberts, SCM; Berglas, NF; Kimport, K				Roberts, Sarah C. M.; Berglas, Nancy F.; Kimport, Katrina			Complex situations: Economic insecurity, mental health, and substance use among pregnant women who consider - but do not have - abortions	PLOS ONE			English	Article							RESTRICTIVE LAW; DRUG-USE; PREDICTORS	We examine characteristics and experiences of women who considered, but did not have, an abortion for this pregnancy. Participants were recruited at prenatal care clinics in Louisiana and Maryland for a mixed-methods study (N = 589). On self-administered surveys and structured interviews, participants were asked if they had considered abortion for this pregnancy and, if so, reasons they did not obtain one. A subset (n = 83), including participants who considered abortion for this pregnancy, completed in-depth phone interviews. Multivariable logistic regression analyses examined characteristics associated with having considered abortion and experiencing a policy-related barrier to having an abortion; analyses focused on economic insecurity and of mental health/substance use as main predictors of interest. Louisiana interviews (n = 43) were analyzed using modified grounded theory to understand concrete experiences of policy-related factors. In regression analyses, women who reported greater economic insecurity (aOR 1.21 [95% CI 1.17, 1.26]) and more mental health diagnoses/substance use (aOR 1.29 [1.16, 1.45] had higher odds of having considered abortion. Those who reported greater economic insecurity (aOR 1.50 [1.09, 2.08]) and more mental health diagnoses/substance use (aOR 1.45 [95% CI 1.03, 2.05] had higher odds of reporting policy-related barriers. Interviewees who considered abortion and were subject to multiple restrictions on abortion identified material and instrumental impacts of policies that, collectively, contributed to them not having an abortion. Many described simultaneously navigating economic insecurity, mental health disorders, substance use, and interpersonal opposition to abortion from family and the man involved in the pregnancy. Current restrictive abortion policies appear to have more of an impact on women who report greater economic insecurity and more mental health diagnoses/substance use. These policies work in concert with each other, with people's individual complex situations-including economic insecurity, mental health, and substance use-and with anti-abortion attitudes of other people to make abortion care impossible for some pregnant women to access.	[Roberts, Sarah C. M.; Berglas, Nancy F.; Kimport, Katrina] Univ Calif San Francisco, ANSIRH, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Roberts, SCM (corresponding author), Univ Calif San Francisco, ANSIRH, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	sarah.roberts@ucsf.edu			David and Lucile Packard Foundation [2016-64232]; Susan Thompson Buffett foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Susan Thompson Buffett foundation	This study was funded by the David and Lucile Packard Foundation (grant: 2016-64232) and the Susan Thompson Buffett foundation. The sponsors had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Berglas NF, 2019, WOMEN HEALTH ISS, V29, P364, DOI 10.1016/j.whi.2019.07.002; Berglas NF, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2012-x; Burns B, 2014, EVALUATING PRIORITIE; California Department of Health Care Services, STABL RES TOOLK AUDI; Foster DG, 2018, JAMA PEDIAT; Foster DG, 2008, CONTRACEPTION, V77, P289, DOI 10.1016/j.contraception.2007.10.010; Foster DG, 2018, AM J PUBLIC HEALTH, V108, P407, DOI [10.2105/AJPH.2017.304247, 10.2105/ajph.2017.304247]; Foster DG, 2013, PERSPECT SEX REPRO H, V45, P210, DOI 10.1363/4521013; Fuentes L, 2016, CONTRACEPTION, V93, P292, DOI 10.1016/j.contraception.2015.12.017; Gerdts C, 2016, WOMEN HEALTH ISS, V26, P55, DOI 10.1016/j.whi.2015.10.001; Glenza J, 2014, THE GUARDIAN    0901; Gordon M, 2019, KAISER HLTH NEWS; Grossman D, 2014, CONTRACEPTION, V90, P496, DOI 10.1016/j.contraception.2014.07.006; Guttmacher Institute, OV AB LAWS 2019; Guttmacher Institute, 2014, STAT POL BRIEF TARG; Guttmacher Institute, 2018, STAT FACTS AB MAR; Guttmacher Institute, 2015, STAT POL BRIEF STAT; Henshaw SK, 2009, RESTRICTIONS MEDICAI; Institute Guttmacher, 2018, STAT FACTS AB LOUIS; Jacob A, 2018, THE DIAMONDBACK 0329; Kimport K, 2018, CONTRACEPTION, V98, P69, DOI 10.1016/j.contraception.2018.02.016; Lai K.K. Re- becca, 2019, NY TIMES; McCarthy M, 2018, CONTRACEPTION, V97, P303, DOI 10.1016/j.contraception.2017.12.001; Moseson H, 2019, SELF MANAGED ABORTIO; O'Connor E, 2019, BUZZFEED NEWS   0516; Ralph LJ, 2019, ANN INTERN MED; Roberts SCM, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0775-5; Roberts SCM, 2018, J STUD ALCOHOL DRUGS, V79, P293, DOI 10.15288/jsad.2018.79.293; Roberts SCM, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0144-z; Roberts SCM, 2014, WOMEN HEALTH ISS, V24, pE211, DOI 10.1016/j.whi.2014.01.003; Roberts SCM, 2011, MATERN CHILD HLTH J, V15, P333, DOI 10.1007/s10995-010-0594-7; Roberts SCM, 2018, SEX RES SOCIAL POLIC; Upadhyay UD, 2014, AM J PUBLIC HEALTH, V104, P1687, DOI 10.2105/AJPH.2013.301378	33	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226004	10.1371/journal.pone.0226004	http://dx.doi.org/10.1371/journal.pone.0226004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940311	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000015
J	Chisati, EM; Constantinou, D; Lampiao, F				Chisati, Enock M.; Constantinou, Demitri; Lampiao, Fanuel			Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors	PLOS ONE			English	Article							RISK-FACTORS; PHYSICAL-ACTIVITY; FRACTURE RISK; TENOFOVIR; AGE; COMORBIDITIES; EFAVIRENZ; DIAGNOSIS; STRENGTH; DISEASE	Introduction Use of tenofovir based anti-retroviral therapy (ART) in HIV patients is associated with low bone mineral density (BMD). Low BMD predisposes people living with HIV (PLWHIV) to fractures thereby increasing morbidity and mortality. Since the introduction of tenofovir based ARV regimens in 2011, information on the prevalence of low BMD in PLWHIV and receiving ART is still scarce in Malawi. This study aimed to determine the prevalence and associated factors of low BMD among adults living with HIV and receiving ART in Blantyre, Malawi. Methodology This was a cross sectional study involving 282 HIV-positive adults of whom 102 (36%) were males. The participants aged 18-45 years were recruited from three primary and one tertiary health care facilities. Patients with no other comorbidities or conditions associated with low BMD and on ART > 12 months were included. Data on BMD (femoral neck and lumbar spine) were collected using Dual-Energy X-ray Absorptiometry (DEXA). The International Physical Activity Questionnaire (IPAQ) was used to assess the physical activity (PA) levels. Participants' body weight (kg) and height (m) were also measured. Descriptive statistics, Chi-Square test and multivariable logistic regression were used to analyse data. Results Mean age of participants was 37(+/- 6.4) years, mean duration on ART was 5(+/- 3.5) years and mean body mass index (BMI) was 23(+/- 4.5) kg/m(2). Twenty percent (55) had reduced BMD. More males (28%) had reduced BMD than females (14%) (p = 0.04). There was a significant association between lumbar BMD and femoral neck BMD (r = 0.66, p<0.001). However, on average, lumbar BMD (g/cm(2)) was significantly lower than the femoral BMD (p < 0.001). Participants with low PA level (OR 1.23, p = 0.6) had higher odds of having reduced BMD compared to those with high PA level. Conclusions and recommendation Prevalence of reduced BMD is high among PLWHIV in Malawi especially male Malawian adults. Occurrence of low BMD is associated with low PA level. There is need for health care providers to routinely monitor BMD and PA levels of this population.	[Chisati, Enock M.] Univ Malawi, Coll Med, Dept Physiotherapy, Blantyre, Malawi; [Chisati, Enock M.] Consortium Adv Res Training Africa CARTA, Nairobi, Kenya; [Constantinou, Demitri] Univ Witwatersrand, FIMS Collaborating Ctr Sports Med, Ctr Exercise Sci & Sports Med, Johannesburg, South Africa; [Lampiao, Fanuel] Univ Malawi, Coll Med, Dept Biomed Sci, Blantyre, Malawi	University of Malawi; University of Witwatersrand; University of Malawi	Chisati, EM (corresponding author), Univ Malawi, Coll Med, Dept Physiotherapy, Blantyre, Malawi.; Chisati, EM (corresponding author), Consortium Adv Res Training Africa CARTA, Nairobi, Kenya.	echisati@medcol.mw	Constantinou, Demitri/AAQ-8860-2020; Chisati, Enock/T-3785-2019; Constantinou, Demitri/N-8783-2017; Chisati, Enock/AEB-9309-2022	Chisati, Enock/0000-0001-5596-9386; Constantinou, Demitri/0000-0002-3363-7695; , Fanuel/0000-0001-9867-5185	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100113]; DELTAS Africa Initiative [107768/Z/15/Z]; Deutscher Akademischer Austauschdienst (DAAD); African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK); UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100113), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z) and Deutscher Akademischer Austauschdienst (DAAD). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. Enock Chisati is a CARTA PhD fellow. The statements made and views expressed are solely the responsibility of the Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the John Hopkins Project at QECH (Malawi) for providing access to DEXA machine. We also would like to acknowledge Benjamin Bika, Francis Munthali, Stella Katuma, Yamikani Phiri and Sagno Baptiste.	Alonge T O, 2013, J West Afr Coll Surg, V3, P1; [Anonymous], OFF POS AD; Aydin OA, 2013, BRAZ J INFECT DIS, V17, P707, DOI 10.1016/j.bjid.2013.05.009; Bassett DR, 2003, MED SCI SPORT EXER, V35, P1396, DOI 10.1249/01.MSS.0000078923.96621.1D; Baxter-Jones ADG, 2011, J BONE MINER RES, V26, P1729, DOI 10.1002/jbmr.412; Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Borderi M, 2013, HAART HIV CORREL PAT, P182; Brown TT, 2015, J INFECT DIS, V212, P1241, DOI 10.1093/infdis/jiv194; Cardeal D, 2017, J SAO PAULO I TROP M, V59, P1; Chitu-Tișu Cristina-Emilia, 2016, Germs, V6, P50, DOI 10.11599/germs.2016.1089; Choe Han Seong, 2016, J Phys Ther Sci, V28, P1928, DOI 10.1589/jpts.28.1928; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Dave JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144286; Dimai HP, 2017, BONE, V104, P39, DOI 10.1016/j.bone.2016.12.016; Dravid A, 2014, J INT AIDS SOC, V17, P53, DOI 10.7448/IAS.17.4.19567; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Erlandson KM, 2018, JAIDS-J ACQ IMM DEF, V77, P288, DOI [10.1097/QAI.0000000000001591, 10.1097/qai.0000000000001591]; Escota GV, 2016, AIDS RES HUM RETROV, V32, P59, DOI 10.1089/aid.2015.0158; Grant PM, 2016, CURR OPIN HIV AIDS, V11, P326, DOI 10.1097/COH.0000000000000248; Guerri-Fernandez R, 2013, J BONE MINER RES, V28, P1259, DOI 10.1002/jbmr.1874; Guthold R, 2011, AM J PREV MED, V41, P52, DOI 10.1016/j.amepre.2011.03.008; IPAQ Research Committee, 2005, IPAQ, P1; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kruger MJ, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0162-y; Lang TF, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/702735; LESSIG HJ, 1987, CLIN NUCL MED, V12, P811, DOI 10.1097/00003072-198710000-00013; Liu AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023688; Malawi Government, 2014, GLOB AIDS RESP PROGR; Matovu FK, 2016, CURR OPIN HIV AIDS, V11, P306, DOI 10.1097/COH.0000000000000274; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Mirembe BG, 2016, JAIDS-J ACQ IMM DEF, V71, P287, DOI 10.1097/QAI.0000000000000858; Namwongprom Sirianong, 2011, Journal of the Medical Association of Thailand, V94, P725; Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005; Perazzo JD, 2018, J ASSOC NURSE AIDS C, V29, P528, DOI 10.1016/j.jana.2018.03.004; Neto LFSP, 2011, J CLIN DENSITOM, V14, P434, DOI 10.1016/j.jocd.2011.06.004; Purdy JB, 2008, J PEDIATR, V152, P582, DOI 10.1016/j.jpeds.2007.12.020; Santos WR, 2015, J STRENGTH COND RES, V29, P3466, DOI 10.1519/JSC.0000000000001001; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; UNIAIDS, 2017, GLOB AIDS MON 2018; Welz T, 2010, AIDS, V24, P1923, DOI 10.1097/QAD.0b013e32833c3281; World Health Organization, 2015, PREV EL DISR AB FAC, P1; World Health Organization, 2004, SEL PRACT REC CONTR, P1; Yin MT, 2011, J INFECT DIS, V203, P1705, DOI 10.1093/infdis/jir184; Zhang LX, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-224; 2012, GUIDELINES, P1	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227893	10.1371/journal.pone.0227893	http://dx.doi.org/10.1371/journal.pone.0227893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935270	gold, Green Published			2022-12-26	WOS:000534354100064
J	Hauptmann, AL; Paulova, P; Hansen, LH; Sicheritz-Ponten, T; Mulvad, G; Nielsen, DS				Hauptmann, Aviaja L.; Paulova, Petronela; Hansen, Lars Hestbjerg; Sicheritz-Ponten, Thomas; Mulvad, Gert; Nielsen, Dennis S.			Microbiota in foods from Inuit traditional hunting	PLOS ONE			English	Article							SP-NOV.; SHEWANELLA; BACTERIUM; PCR	The foods we eat contain microorganisms that we ingest alongside the food. Industrialized food systems offer great advantages from a safety point of view, but have also been accused of depleting the diversity of the human microbiota with negative implications for human health. In contrast, artisanal traditional foods are potential sources of a diverse food microbiota. Traditional foods of the Greenlandic Inuit are comprised of animal-sourced foods prepared in the natural environment and are often consumed raw. These foods, some of which are on the verge of extinction, have not previously been microbiologically characterized. We mapped the microbiota of foods stemming from traditional Inuit land-based hunting activities. The foods included in the current study are dried muskox and caribou meat, caribou rumen and intestinal content as well as larval parasites from caribou hides, all traditional Inuit foods. This study shows that traditional drying methods are efficient for limiting microbial growth through desiccation. The results also show the rumen content of the caribou to be a highly diverse source of microbes with potential for degradation of plants. Finally, a number of parasites were shown to be included in the biodiversity of the assessed traditional foods. Taken together, the results map out a diverse source of ingested microbes and parasites that originate from the natural environment. These results have implications for understanding the nature-sourced traditional Inuit diet, which is in contrast to current day diet recommendations as well as modern industrialized food systems.	[Hauptmann, Aviaja L.; Mulvad, Gert] Univ Greenland, Ilisimatusarf, Greenland Ctr Hlth Res, Nuuk, Greenland; [Hauptmann, Aviaja L.] Greenland Inst Nat Resources, Nuuk, Greenland; [Paulova, Petronela; Nielsen, Dennis S.] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Paulova, Petronela] Slovak Acad Sci, Biomed Res Ctr, Inst Expt Endocrinol, Bratislava, Slovakia; [Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Sicheritz-Ponten, Thomas] AIMST Univ, Ctr Excellence Om Driven Computat Biodiscovery CO, Bedong, Kedah, Malaysia; [Sicheritz-Ponten, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Hansen, Lars Hestbjerg] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark	Greenland Institute of Natural Resources; University of Copenhagen; Slovak Academy of Sciences; Aarhus University; AIMST University; University of Copenhagen; University of Copenhagen	Hauptmann, AL (corresponding author), Univ Greenland, Ilisimatusarf, Greenland Ctr Hlth Res, Nuuk, Greenland.; Hauptmann, AL (corresponding author), Greenland Inst Nat Resources, Nuuk, Greenland.	alha@uni.gl	; Sicheritz-Ponten, Thomas/A-4325-2017; Nielsen, Dennis Sandris/A-9769-2015	Hauptmann, Aviaja/0000-0002-7070-2820; Hestbjerg Hansen, Lars/0000-0003-0027-1524; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Nielsen, Dennis Sandris/0000-0001-8121-1114	Danish Government [80.23]; Bank of Greenland business foundation [35/2016]	Danish Government; Bank of Greenland business foundation	ALH was awarded The Danish Government's funding for Arctic research grant number 80.23 and The Bank of Greenland business foundation grant number 35/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The collection of samples from traditional foods is an activity which requires a great amount of respect for the traditional culture and just as much help from the local communities that has the knowledge and skillset to be able to make these foods available for sampling. A deepfelt thanks goes to everyone who has made this study possible including the Lyberth family who have hunted at Angujaartorfik since the early 1950s, a particular thanks to Gideon Lyberth for his assistance in hunting and sharing of knowledge and Naja Lyberth-Klausen for support and sharing of knowledge. Thanks also to Michael Rosing for larvae samples as well as knowledgesharing. Qamannga pisumik qujavugut.	Berthelsen A, 1935, MEDDELELSER GRONLAND, V117; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Birket-Smith K, 1971, ESKIMOS; Birket-Smith K., 1924, MEDD GROENL, V66, P380; Cao Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01829; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Courage KH, 2019, CULTURED ANCIENT FOO; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; DHSS, 2005, NUTR FACT SHEET SER; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferreira M. P., 2018, Edible insects in sustainable food systems, P19; Freuchen P, 1927, STORFANGER; GAUTHIER G, 1995, INT J SYST BACTERIOL, V45, P755, DOI 10.1099/00207713-45-4-755; Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013; Helms P, 1986, TIDSSKR GRONL, V5; Helms P, 1988, ATUISOQ, V4, P7; Ilina L, 2018, RES RURAL DEV, P125, DOI 10.22616/rrd.24.2018.062; Jarvis KG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02540; Jay J. M., 1992, MODERN FOOD MICROBIO, DOI DOI 10.1007/B100840; Kampfer P, 2011, INT J SYST EVOL MICR, V61, P2670, DOI 10.1099/ijs.0.026393-0; Kim JY, 2016, INT J SYST EVOL MICR, V66, P2218, DOI 10.1099/ijsem.0.001014; Krych L, 2018, J MICROBIOL METH, V144, P1, DOI 10.1016/j.mimet.2017.10.015; Kuhnlein H.V., 2009, INDIGENOUS PEOPLES F; Lang JM, 2014, PEERJ, V2, DOI 10.7717/peerj.659; Larsen F, 2000, FOOD SO GREENLAND 10; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Odgaard U., 2019, TIDSSKR GRONL, V1; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Palmer SR, 1998, ZOONOSES BIOL CLIN P, P948; Pars T, 2001, ARCTIC, V54, P22; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; R Core Team, 2021, R LANGUAGE ENV STAT; Raundrup K, 2012, VET PARASITOL, V184, P356, DOI 10.1016/j.vetpar.2011.09.010; Rizo J, 2020, CRIT REV FOOD SCI, V60, P791, DOI 10.1080/10408398.2018.1551189; Roberts D.W., 2016, LABDSV ORDINATION MU; Salgado-Flores A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155213; Satomi M, 2003, INT J SYST EVOL MICR, V53, P491, DOI 10.1099/ijs.0.02392-0; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Vasilyeva LV, 2006, INT J SYST EVOL MICR, V56, P2083, DOI 10.1099/ijs.0.64122-0; Villalobo E, 1998, APPL ENVIRON MICROB, V64, P1242; WHO, 2018, HLTH DIET; Wolfe BE, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.CM-0012-2012	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227819	10.1371/journal.pone.0227819	http://dx.doi.org/10.1371/journal.pone.0227819			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935269	gold, Green Published			2022-12-26	WOS:000534354100057
J	Lilian, RR; Rees, K; McIntyre, JA; Struthers, HE; Peters, RPH				Lilian, Rivka R.; Rees, Kate; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.			Same-day antiretroviral therapy initiation for HIV-infected adults in South Africa: Analysis of routine data	PLOS ONE			English	Article							ART INITIATION; VIRAL LOAD; CARE; LINKAGE; SUPPRESSION; PREDICTORS; RETENTION; OUTCOMES	Same-day initiation (SDI) of antiretroviral therapy (ART) has been recommended to improve ART programme outcomes in South Africa since August 2017. This study assessed implementation of SDI over time in two South African districts, describing the characteristics of same-day initiators and evaluating the impact of SDI on retention in ART care. Routine data were analysed for HIV-infected adults who were newly initiating ART in Johannesburg or Mopani Districts between October 2017 and June 2018. Characteristics of same-day ART initiators were compared to later initiators, and losses to follow-up (LTFU) to six months were assessed using Kaplan Meier survival analysis and multivariate logistic regression. The dataset comprised 32 290 records (29 964 from Johannesburg and 2 326 from Mopani). The overall rate of SDI was 40.4% (n = 13 038), increasing from 30.3% in October 2017 to 54.2% in June 2018. Same-day ART initiators were younger, more likely to be female and presented with less advanced clinical disease than those initiating treatment at later times following diagnosis (p<0.001 for all). SDI was associated with disengagement from care: LTFU was 30.1% in the SDI group compared to 22.4%, 19.8% and 21.9% among clients initiating ART 1-7 days, 8-21 days and >= 22 days after HIV diagnosis, respectively (p<0.001). LTFU was significantly more likely among clients in Johannesburg versus Mopani (adjusted odds ratio (aOR) = 1.43, p<0.001) and among same-day versus later initiators (aOR = 1.45, p<0.001), while increasing age reduced LTFU (aOR = 0.97, p<0.001). In conclusion, SDI has increased over time as per national guidelines, but there is serious concern regarding the reduced rate of retention among same-day initiators. Nevertheless, SDI may result in a net programmatic benefit provided that interventions are implemented to support client readiness for treatment and ongoing engagement in ART care, particularly among younger adults in large ART programmes such as Johannesburg.	[Lilian, Rivka R.; Rees, Kate; McIntyre, James A.; Struthers, Helen E.; Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, South Africa; [Rees, Kate; McIntyre, James A.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Struthers, Helen E.] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, Cape Town, South Africa; [Peters, Remco P. H.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Peters, Remco P. H.] Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands	University of Cape Town; University of Cape Town; University of Witwatersrand; Maastricht University	Peters, RPH (corresponding author), Anova Hlth Inst, Johannesburg, South Africa.; Peters, RPH (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.; Peters, RPH (corresponding author), Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands.	rph.peters@gmail.com		Peters, Remco Petrus Hendricus/0000-0003-2124-7275	American people through the US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [72067418CA00023]	American people through the US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study is made possible by the generous support of the American people through the US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under Cooperative Agreement number 72067418CA00023 for the Accelerating Program Achievements to Control the Epidemic (APACE) Activity in South Africa to the Anova Health Institute. The contents are the responsibility of Anova Health Institute and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanyire G, 2016, LANCET HIV, V3, pE539, DOI 10.1016/S2352-3018(16)30090-X; Ankomah A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2075-0; Arnesen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177168; Black Samantha, 2013, S Afr Med J, V103, P557, DOI 10.7196/samj.6565; Bor J, 2018, TROP MED INT HEALTH, V23, P206, DOI 10.1111/tmi.13013; Boyles TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019201; Chan AK, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20672; Charurat M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010584; Fomundam HN, 2017, SAMJ S AFR MED J, V107, P1058, DOI [10.7196/SAMJ.2017.v107i12.12358, 10.7196/samj.2017.v107i12.12358]; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Geng EH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002358; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Hoenigl M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32947; Hoffman S, 2014, AIDS, V28, P2429, DOI 10.1097/QAD.0000000000000427; Johnson LF, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.694; Johnson LF, 2018, THEMBISA MODEL 4 1 N; Katz IT, 2015, AIDS BEHAV, V19, P704, DOI 10.1007/s10461-014-0920-y; Kerschberger B, 2016, 21 INT AIDS C 18 22; Kerschberger B, 2019, TROP MED INT HEALTH, V24, P701, DOI 10.1111/tmi.13234; Koenig SP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002357; Labhardt ND, 2018, JAMA-J AM MED ASSOC, V319, P1103, DOI 10.1001/jama.2018.1818; Langwenya N, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25133; Lilian Rivka R., 2019, South. Afr. j. HIV med. (Online), V20, P1, DOI 10.4102/sajhivmed.v20i1.963; MacKellar D, 2018, MMWR-MORBID MORTAL W, V67, P663, DOI 10.15585/mmwr.mm6723a3; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; Massyn N., 2019, DISTRICT HEATH BAROM; Meintjes G, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.776; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; National Department of Health (NDoH), 2016, IMPL UN TEST TREAT S; National Department of Health of South Africa, 2014, NATL CONSOLIDATED GU; National Department of Health of South Africa, 2017, FAST TRACKL IMPL 90; National Department of Health of South Africa, 2017, 2015 NAT ANT SENT HI; National Department of Health South Africa, 2004, NAT ANT TREATM GUID; Osler M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18908; Pilcher CD, 2017, JAIDS-J ACQ IMM DEF, V74, P44, DOI 10.1097/QAI.0000000000001134; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rufu A, 2018, PUBLIC HEALTH ACTION, V8, P145, DOI 10.5588/pha.18.0030; Stata Corp LLC, 2019, STS TEST TEST EQ SUR; Stevens WS, 2017, JAIDS-J ACQ IMM DEF, V76, P65, DOI 10.1097/QAI.0000000000001456; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Togun T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-24; Tweya H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188488; Wilkinson L, 2015, S AFR J HIV MED, V16, P21, DOI [10.4102/sajhivmed.v16i1.367, 10.4102/SAJHIVMED.V16I1.367]; World Health Organization, 2017, GUID MAN ADV HIV DIS; World Health Organization (WHO), 2019, S AFR HIV COUNTR PRO	46	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227572	10.1371/journal.pone.0227572	http://dx.doi.org/10.1371/journal.pone.0227572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935240	gold, Green Published			2022-12-26	WOS:000534354100032
J	Oz, E				Oz, Emel			Effects of smoke flavoring using different wood chips and barbecuing on the formation of polycyclic aromatic hydrocarbons and heterocyclic aromatic amines in salmon fillets	PLOS ONE			English	Article							COOKING METHODS; MODEL SYSTEMS; COOKED FOODS; MEAT; FISH; RISKS; PAHS; ANTIOXIDANTS; CHEMISTRY; RESIDUES	Herein, the concentrations of food toxicants, polycyclic aromatic hydrocarbons (PAHs) and heterocyclic aromatic amines (HAAs), in salmon fillets smoke flavored with different smoking wood chips (oak, apple, bourbon soaked oak, cherry and hickory) and barbecuing were determined. Benzo[a]anthracene (up to 0.24 ng/g) and chrysene (0.22 ng/g) were determined in the raw salmon fillets. While Sigma PAH8 (benzo[a]anthracene, chrysene, benzo[b] fluoranthene, benzo[k]fluoranthene, benzo[a]pyrene, dibenzo[a,h]anthracene, benzo[g,h,i] perylene, indeno[1,2,3-cd]pyrene) in the raw samples ranged between 0.44 and 0.46 ng/g, smoke flavoring increased the amount of Sigma PAH8 and the amount varied between 0.47 and 0.73 ng/g. Salmon smoked flavored with bourbon soaked oak, cherry and hickory wood chips and barbecued showed significantly (P < 0.05) lower contents of Sigma PAH4 (benzo[a] anthracene, chrysene, benzo[b]fluoranthene, benzo[a]pyrene) and Sigma PAH8 compared to non-smoke flavored barbecued samples. Additionally, smoke flavoring with apple, bourbon soaked oak, and cherry wood chips significantly (P < 0.05) reduced the total HAA contents in barbecued salmon. A remarkable result was that the bourbon-soaked oak and cherry wood chips had inhibitory effects on both PAH and HAA contents. In sum, barbecued non-smoke flavored and smoke flavored salmon with different wood chips could be considered safe from the perspective of the detected amounts of PAHs and HAAs in salmon fillets.	[Oz, Emel] Ataturk Univ, Fac Agr, Dept Food Engn, Erzurum, Turkey	Ataturk University	Oz, E (corresponding author), Ataturk Univ, Fac Agr, Dept Food Engn, Erzurum, Turkey.	emel.oz@atauni.edu.tr		Oz, Emel/0000-0003-3766-2713				Britt C, 1998, J AGR FOOD CHEM, V46, P4891, DOI 10.1021/jf980233y; Chiu CP, 1998, J FOOD PROTECT, V61, P712, DOI 10.4315/0362-028X-61.6.712; Costa M, 2009, J AGR FOOD CHEM, V57, P3173, DOI 10.1021/jf8035808; Duedahl-Olesen L, 2015, FOOD CONTROL, V57, P169, DOI 10.1016/j.foodcont.2015.04.012; Farhadian A, 2011, FOOD CHEM, V124, P141, DOI 10.1016/j.foodchem.2010.05.116; Forsberg ND, 2012, J AGR FOOD CHEM, V60, P6899, DOI 10.1021/jf300978m; GROSS GA, 1992, J CHROMATOGR, V592, P271, DOI 10.1016/0021-9673(92)85095-B; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010, IARC Monogr Eval Carcinog Risks Hum, V92, P1; Iwasaki M, 2010, J FOOD COMPOS ANAL, V23, P61, DOI 10.1016/j.jfca.2009.07.004; Janoszka B, 2011, FOOD CHEM, V126, P1344, DOI 10.1016/j.foodchem.2010.11.097; Kjallstrand J, 2001, FOOD CHEM, V74, P85, DOI 10.1016/S0308-8146(01)00102-9; Malarut JA, 2018, FOOD CONTROL, V85, P98, DOI 10.1016/j.foodcont.2017.09.020; Messner C, 2004, J CHROMATOGR B, V802, P19, DOI 10.1016/j.jchromb.2003.11.015; Moazzen M, 2013, TALANTA, V115, P957, DOI 10.1016/j.talanta.2013.07.005; Murkovic M, 2004, EUR J LIPID SCI TECH, V106, P777, DOI 10.1002/ejlt.200400993; NAGAO M, 1977, CANCER LETT, V2, P221, DOI 10.1016/S0304-3835(77)80025-6; Oz E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221680; Oz F, 2010, LWT-FOOD SCI TECHNOL, V43, P1345, DOI 10.1016/j.lwt.2010.04.014; Oz F, 2016, FOOD CONTROL, V67, P216, DOI 10.1016/j.foodcont.2016.03.013; Oz F, 2016, FOOD CHEM, V203, P59, DOI 10.1016/j.foodchem.2016.02.041; Oz F, 2011, J FOOD PROCESS PRES, V35, P739, DOI 10.1111/j.1745-4549.2011.00524.x; Pais P, 1999, J AGR FOOD CHEM, V47, P1098, DOI 10.1021/jf980644e; Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2; Pohlmann M, 2013, FOOD CONTROL, V34, P347, DOI 10.1016/j.foodcont.2013.05.005; Puangsombat K, 2012, MEAT SCI, V90, P739, DOI 10.1016/j.meatsci.2011.11.005; Remy CC, 2016, J ETHNOBIOL, V36, P312, DOI 10.2993/0278-0771-36.2.312; Rose M, 2015, FOOD CHEM TOXICOL, V78, P1, DOI 10.1016/j.fct.2014.12.018; Sidhu KS, 2003, REGUL TOXICOL PHARM, V38, P336, DOI 10.1016/j.yrtph.2003.07.002; Skog K, 2002, FOOD CHEM TOXICOL, V40, P1197, DOI 10.1016/S0278-6915(02)00052-2; Skog KI, 1998, FOOD CHEM TOXICOL, V36, P879, DOI 10.1016/S0278-6915(98)00061-1; Stolyhwo A, 2005, FOOD CHEM, V91, P303, DOI 10.1016/j.foodchem.2004.06.012; Storelli MM, 2003, J FOOD PROTECT, V66, P1095, DOI 10.4315/0362-028X-66.6.1095; Stumpe-Viksna I, 2008, FOOD CHEM, V110, P794, DOI 10.1016/j.foodchem.2008.03.004; Sun YQ, 2019, TRENDS FOOD SCI TECH, V83, P86, DOI 10.1016/j.tifs.2018.11.015; Toth L., 1984, Advances in Food Research, V29, P87; Rahman UU, 2014, LWT-FOOD SCI TECHNOL, V59, P229, DOI 10.1016/j.lwt.2014.06.005; Viegas O, 2012, FOOD CHEM TOXICOL, V50, P2128, DOI 10.1016/j.fct.2012.03.051; Visciano P, 2006, J FOOD PROTECT, V69, P1134, DOI 10.4315/0362-028X-69.5.1134; Visciano P, 2009, INT J FOOD SCI TECH, V44, P2028, DOI 10.1111/j.1365-2621.2009.02026.x; Vitaglione P, 2004, J CHROMATOGR B, V802, P189, DOI 10.1016/j.jchromb.2003.09.029; WEISBURGER JH, 1994, CANCER LETT, V83, P143, DOI 10.1016/0304-3835(94)90311-5; Zachara A, 2017, FOOD CONTROL, V80, P45, DOI 10.1016/j.foodcont.2017.04.024	42	17	19	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227508	10.1371/journal.pone.0227508	http://dx.doi.org/10.1371/journal.pone.0227508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ7KG	31935242	gold, Green Published			2022-12-26	WOS:000530339100001
J	Simon, H; Vartanian, V; Wong, MH; Nakabeppu, Y; Sharma, P; Lloyd, RS; Sampath, H				Simon, Holly; Vartanian, Vladimir; Wong, Melissa H.; Nakabeppu, Yusaku; Sharma, Priyanka; Lloyd, R. Stephen; Sampath, Harini			OGG1 deficiency alters the intestinal microbiome and increases intestinal inflammation in a mouse model	PLOS ONE			English	Article							8-OXOGUANINE DNA GLYCOSYLASE; OXIDATIVELY DAMAGED DNA; GUT MICROBIOTA; ULCERATIVE-COLITIS; REPAIR ENZYME; SACCHAROMYCES-CEREVISIAE; SER326CYS POLYMORPHISM; SUBSTRATE-SPECIFICITY; MONONUCLEAR-CELLS; OBESITY	OGG1-deficient (Ogg1(-/-)) animals display increased propensity to age-induced and diet-induced metabolic diseases, including insulin resistance and fatty liver. Since the intestinal microbiome is increasingly understood to play a role in modulating host metabolic responses, we examined gut microbial composition in Ogg1(-/-) mice subjected to different nutritional challenges. Interestingly, Ogg1(-/-) mice had a markedly altered intestinal microbiome under both control-fed and hypercaloric diet conditions. Several microbial species that were increased in Ogg1(-/-) animals were associated with increased energy harvest, consistent with their propensity to high-fat diet induced weight gain. In addition, several pro-inflammatory microbes were increased in Ogg1(-/-) mice. Consistent with this observation, Ogg1(-/-) mice were significantly more sensitive to intestinal inflammation induced by acute exposure to dextran sulfate sodium. Taken together, these data indicate that in addition to their proclivity to obesity and metabolic disease, Ogg1(-/-) mice are prone to colonic inflammation. Further, these data point to alterations in the intestinal microbiome as potential mediators of the metabolic and intestinal inflammatory response in Ogg1(-/-) mice.	[Simon, Holly] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97201 USA; [Vartanian, Vladimir; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Wong, Melissa H.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Wong, Melissa H.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Nakabeppu, Yusaku] Med Inst Bioregulat, Dept Immunobiol & Neurosci, Div Neurofunct Gen, Fukuoka, Kyushu, Japan; [Sharma, Priyanka; Sampath, Harini] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Sharma, Priyanka; Sampath, Harini] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Oregon Health & Science University	Sampath, H (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.; Sampath, H (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA.	harini.sampath@rutgers.edu	Nakabeppu, Yusaku/A-8902-2011; Sharma, Priyanka/ACA-6407-2022	Nakabeppu, Yusaku/0000-0002-6739-242X; Lloyd, R. Stephen/0000-0001-7273-372X; Sharma, Priyanka/0000-0001-6544-4284	NIH [R01DK075974, DK100640, U24-DK092993]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported by NIH grants R01DK075974 (to RSL), DK100640 (to HS), and U24-DK092993 (to the UC Davis Mouse Metabolic Phenotyping Center).	Aguilera-Aguirre L, 2015, FREE RADICAL BIO MED, V89, P20, DOI 10.1016/j.freeradbiomed.2015.07.007; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Audebert M, 2000, NUCLEIC ACIDS RES, V28, P2672, DOI 10.1093/nar/28.14.2672; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bacsi A, 2013, DNA REPAIR, V12, P18, DOI 10.1016/j.dnarep.2012.10.002; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Calvo JA, 2012, J CLIN INVEST, V122, P2680, DOI 10.1172/JCI63338; Cani PD, 2008, PATHOL BIOL, V56, P305, DOI 10.1016/j.patbio.2007.09.008; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Capone KA, 2011, J INVEST DERMATOL, V131, P2026, DOI 10.1038/jid.2011.168; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cardozo-Pelaez F, 2005, GENE EXPRESSION, V12, P315, DOI 10.3727/000000005783992007; Casorelli I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012070; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A., 2005, ENCY STAT SCI, P7909; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Core Team R, 2013, R LANG ENV STAT COMP; Daimon M, 2009, BIOCHEM BIOPH RES CO, V386, P26, DOI 10.1016/j.bbrc.2009.05.119; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dezor M, 2011, FOLIA NEUROPATHOL, V49, P123; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Dorszewska J, 2009, DNA CELL BIOL, V28, P579, DOI 10.1089/dna.2009.0926; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edgar RC, 2011, BIOINFORMATICS; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fukae J, 2007, MITOCHONDRION, V7, P58, DOI 10.1016/j.mito.2006.12.002; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Iida T, 2002, ACTA NEUROPATHOL, V103, P20, DOI 10.1007/s004010100418; Jaruga P, 2017, ENVIRON TOXICOL, V32, P2144, DOI 10.1002/tox.22427; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Karahalil B, 1998, NUCLEIC ACIDS RES, V26, P1228, DOI 10.1093/nar/26.5.1228; Kidane D, 2014, CRIT REV BIOCHEM MOL, V49, P116, DOI 10.3109/10409238.2013.875514; Kobayashi T., 2004, Journal of Allergy and Clinical Immunology, V113, pS172, DOI 10.1016/j.jaci.2004.01.053; Komakula SSB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33151-1; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; Krznaric Z, 2019, CURR OPIN CLIN NUTR, V22, P401, DOI 10.1097/MCO.0000000000000587; Lea JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187515; Liao J, 2008, MOL CARCINOGEN, V47, P638, DOI 10.1002/mc.20427; Lipton L, 2003, CANCER RES, V63, P7595; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Luca F, 2018, TRENDS GENET, V34, P30, DOI 10.1016/j.tig.2017.10.001; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Morales-Ruiz T, 2003, BIOCHEMISTRY-US, V42, P3089, DOI 10.1021/bi027226u; Moran CP, 2014, BEST PRACT RES CL GA, V28, P585, DOI 10.1016/j.bpg.2014.07.005; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Neurath MF, 2008, MUCOSAL IMMUNOL, V1, pS28, DOI 10.1038/mi.2008.45; Nunberg M, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00213-17; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Sakumi K, 2003, CANCER RES, V63, P902; Sampath H, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102667; Sampath H, 2014, ENVIRON MOL MUTAGEN, V55, P689, DOI 10.1002/em.21886; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Sampath H, 2011, AM J PHYSIOL-ENDOC M, V300, pE724, DOI 10.1152/ajpendo.00387.2010; SATSANGI J, 1987, CLIN EXP IMMUNOL, V67, P594; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; SHARMA P, 2019, CELLS-BASEL, V8, DOI DOI 10.3390/CELLS8020100; Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Sieber OM, 2004, CANCER RES, V64, P8876, DOI 10.1158/0008-5472.CAN-04-2958; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stevceva L, 2000, GENES IMMUN, V1, P213, DOI 10.1038/sj.gene.6363654; Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Touati E, 2006, HELICOBACTER, V11, P494, DOI 10.1111/j.1523-5378.2006.00442.x; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103; Visnes T, 2018, SCIENCE, V362, P834, DOI 10.1126/science.aar8048; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wan Y, 2019, GUT, V68, P1417, DOI 10.1136/gutjnl-2018-317609; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089	109	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227501	10.1371/journal.pone.0227501	http://dx.doi.org/10.1371/journal.pone.0227501			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935236	gold, Green Published			2022-12-26	WOS:000534354100025
J	Vinikoor, MJ; Sinkala, E; Kanunga, A; Muchimba, M; Zanolini, A; Saag, M; Pry, J; Nsokolo, B; Chisenga, T; Kelly, P				Vinikoor, Michael J.; Sinkala, Edford; Kanunga, Annie; Muchimba, Mutinta; Zanolini, Arianna; Saag, Michael; Pry, Jake; Nsokolo, Bright; Chisenga, Tina; Kelly, Paul			Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia	PLOS ONE			English	Article							VIRUS INFECTION; ANTIRETROVIRAL THERAPY; LIVER FIBROSIS; COINFECTION; PREVENTION; AFRICA; SCREEN; HIV	Introduction We evaluated antiviral therapy (AVT) eligibility in a population-based sample of adults with chronic hepatitis B virus (HBV) infection in Zambia. Materials and methods Using a household survey, adults (18+ years) were tested for hepatitis B surface antigen (HBsAg). Sociodemographic correlates of HBsAg-positivity were identified with multivariable regression. HBsAg-positive individuals were referred to a central hospital for physical examination, elastography, and phlebotomy for HBV DNA, hepatitis B e antigen, serum transaminases, platelet count, and HIV-1/2 antibody. We determined the proportion of HBV monoinfected adults eligible for antiviral therapy (AVT) based on European Association for the Study of the Liver (EASL) 2017 guidelines. We also evaluated the performance of two alternative criteria developed for use in sub-Saharan Africa, the World Health Organization (WHO) and Treat-B guidelines. Results Across 12 urban and 4 rural communities, 4,961 adults (62.9% female) were tested and 18-2 (3.7%) were HBsAg-positive, 80% of whom attended hospital follow-up. HBsAg-positivity was higher among men (adjusted odds ratio [AOR], 1.37; 95% confidence interval [CI], 0.99-1.87) and with decreasing income (AOR, 0.89 per household asset; 95% CI, 0.81-0.98). Trends toward higher HBsAg-positivity were also seen at ages 30-39 years (AOR, 2.11; 95% CI, 0.96-4.63) and among pregnant women (AOR, 1.74; 95% CI, 0.93-3.25). Among HBV monoinfected individuals (i.e., HIV-negative) evaluated for AVT, median age was 31 years, 24.6% were HBeAg-positive, and 27.9% had HBV DNA >2,000 IU/ml. AVT-eligibility was 17.0% by EASL, 10.2% by WHO, and 31.1% by Treat-B. Men had increased odds of eligibility. WHO (area under the receiver operating curve [AUROC], 0.68) and Treat-B criteria (AUROC, 0.76) had modest accuracy. Fourteen percent of HBsAg-positive individuals were HIV coinfection, and most coinfected individuals were taking tenofovir-containing antiretroviral therapy (ART). Conclusion Approximately 1 in 6 HBV monoinfected adults in the general population in Zambia may be AVT-eligible. Men should be a major focus of hepatitis B diagnosis and treatment. Further development and evaluation of HBV treatment criteria for resource-limited settings is needed. In settings with overlapping HIV and HBV epidemics, scale-up of ART has contributed towards hepatitis B elimination.	[Vinikoor, Michael J.; Saag, Michael] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA; [Vinikoor, Michael J.; Sinkala, Edford; Kanunga, Annie; Muchimba, Mutinta; Nsokolo, Bright; Kelly, Paul] Univ Zambia, Sch Med, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia; [Vinikoor, Michael J.; Pry, Jake] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Sinkala, Edford] Univ Teaching Hosp, Dept Med, Lusaka, Zambia; [Zanolini, Arianna] Dept Int Dev, Dar Es Salaam, Tanzania; [Pry, Jake] Univ Calif Davis, Davis, CA 95616 USA; [Chisenga, Tina] Zambian Minist Hlth, Lusaka, Zambia; [Kelly, Paul] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of Alabama System; University of Alabama Birmingham; University of Zambia; University of Zambia; University of California System; University of California Davis; University of London; Queen Mary University London	Vinikoor, MJ (corresponding author), Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA.; Vinikoor, MJ (corresponding author), Univ Zambia, Sch Med, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia.; Vinikoor, MJ (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	mjv3@uab.edu	Pry, Jake Michael/V-7245-2019	Pry, Jake Michael/0000-0001-6312-4420; Sinkala, Edford/0000-0002-5756-5569; Saag, Michael/0000-0002-8866-1043; Kelly, Paul/0000-0003-0844-6448	Gilead Sciences [IN-US-174-3939]; Fogarty International Center at US National Institutes of Health [K01TW009998]	Gilead Sciences(Gilead Sciences); Fogarty International Center at US National Institutes of Health	MJV received research support from Gilead Sciences (IN-US-174-3939; https://www.gilead.com) and the Fogarty International Center at US National Institutes of Health (K01TW009998; https://www.fic.nih.gov).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberra H, 2019, J HEPATOL, V70, P1065, DOI 10.1016/j.jhep.2019.01.037; Aberra H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2549-8; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Feldacker C, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2017.1414997; Garson JA, 2005, J VIROL METHODS, V126, P207, DOI 10.1016/j.jviromet.2005.03.001; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Jaquet A, 2017, HEPATITIS B TREATMEN; Johannessen A, 2019, J HEPATOLOGY; Keane E, 2016, ALIMENT PHARM THER, V44, P1005, DOI 10.1111/apt.13795; KEW MC, 1982, MEDICINE, V61, P98, DOI 10.1097/00005792-198203000-00004; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kiire CF, 1996, GUT, V38, pS5, DOI 10.1136/gut.38.Suppl_2.S5; Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9; Lemoine M, 2016, GUT, V65, P1369, DOI 10.1136/gutjnl-2015-309260; Lok AS, 2017, HEPATOLOGY, V66, P1296, DOI 10.1002/hep.29323; Nsokolo B, 2017, T ROY SOC TROP MED H, V111, P425, DOI 10.1093/trstmh/trx077; Organization WH, 2015, GUID PREV CAR TREATM; Raimondo G, 2012, SEMIN IMMUNOPATHOL, V34; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seremba E, 2017, AIDS, V31, P781, DOI 10.1097/QAD.0000000000001399; Shimakawa Y, 2018, J HEPATOL, V69, P776, DOI 10.1016/j.jhep.2018.05.024; Stabinski L, 2011, J MED VIROL, V83, P796, DOI 10.1002/jmv.22051; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Vinikoor MJ, 2017, CLIN INFECT DIS, V64, P1343, DOI 10.1093/cid/cix122; Wahome E, 2016, HEPATITIS B VIRUS IN; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; World Health Organization, 2016, GUID HEP B C TEST PO; World Health Organization (WHO), GLOB HLTH SECT STRAT; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2; Zambian Ministry of Health, 2019, IMPL FRAM CLIN GUID; Zambian Ministry of Health Centers for Disease Control and Prevention ICAP Columbia University & Central Statistics Office [Zambia], 2016, ZAMB POP BAS HIV IMP	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227041	10.1371/journal.pone.0227041	http://dx.doi.org/10.1371/journal.pone.0227041			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929556	Green Published, gold			2022-12-26	WOS:000534352500026
J	Zuluaga, MYA; Milani, KML; Goncalves, LSA; de Oliveira, ALM				Alzate Zuluaga, Monica Yorlady; Lima Milani, Karina Maria; Azeredo Goncalves, Leandro Simoes; Martinez de Oliveira, Andre Luiz			Diversity and plant growth-promoting functions of diazotrophic/N-scavenging bacteria isolated from the soils and rhizospheres of two species of Solanum	PLOS ONE			English	Article							NITROGEN-FIXING BACTERIA; IN-VITRO; RHIZOBIUM-LEGUMINOSARUM; NON-LEGUMES; RNA GENE; COMMUNITIES; TOMATO; MICROBIOME; RHIZOBACTERIA; POPULATION	Studies of the interactions between plants and their microbiome have been conducted worldwide in the search for growth-promoting representative strains for use as biological inputs for agriculture, aiming to achieve more sustainable agriculture practices. With a focus on the isolation of plant growth-promoting (PGP) bacteria with ability to alleviate N stress, representative strains that were found at population densities greater than 104 cells g(-1) and that could grow in N-free semisolid media were isolated from soils under different management conditions and from the roots of tomato (Solanum lycopersicum) and lulo (Solanum quitoense) plants that were grown in those soils. A total of 101 bacterial strains were obtained, after which they were phylogenetically categorized and characterized for their basic PGP mechanisms. All strains belonged to the Proteobacteria phylum in the classes Alphaproteobacteria (61% of isolates), Betaproteobacteria (19% of isolates) and Gamma-proteobacteria (20% of isolates), with distribution encompassing nine genera, with the predominant genus being Rhizobium (58.4% of isolates). Strains isolated from conventional horticulture (CH) soil composed three bacterial genera, suggesting a lower diversity for the diazotrophs/N scavenger bacterial community than that observed for soils under organic management (ORG) or secondary forest coverture (SF). Conversely, diazotrophs/N scavenger strains from tomato plants grown in CH soil comprised a higher number of bacterial genera than did strains isolated from tomato plants grown in ORG or SF soils. Furthermore, strains isolated from tomato were phylogenetically more diverse than those from lulo. BOX-PCR fingerprinting of all strains revealed a high genetic diversity for several clonal representatives (four Rhizobium species and one Pseudomonas species). Considering the potential PGP mechanisms, 49 strains (48.5% of the total) produced IAA (2.96-193.97 mu g IAA mg protein(-1)), 72 strains (71.3%) solubilized FePO4 (0.40-56.00 mg l(-1)), 44 strains (43.5%) solubilized AlPO4 (0.62-17.05 mg l(-1)), and 44 strains produced siderophores (1.06-3.23). Further, 91 isolates (90.1% of total) showed at least one PGP trait, and 68 isolates (67.3%) showed multiple PGP traits. Greenhouse trials using the bacterial collection to inoculate tomato or lulo plants revealed increases in plant biomass (roots, shoots or both plant tissues) elicited by 65 strains (54.5% of the bacterial collection), of which 36 were obtained from the tomato rhizosphere, 15 were obtained from the lulo rhizosphere, and 14 originated from samples of soil that lacked plants. In addition, 18 strains showed positive inoculation effects on both Solanum species, of which 12 were classified as Rhizobium spp. by partial 16S rRNA gene sequencing. Overall, the strategy adopted allowed us to identify the variability in the composition of culturable diazotroph/N-scavenger representatives from soils under different management conditions by using two Solanum species as trap plants. The present results suggest the ability of tomato and lulo plants to enrich their belowground microbiomes with rhizobia representatives and the potential of selected rhizobial strains to promote the growth of Solanum crops under limiting N supply.	[Alzate Zuluaga, Monica Yorlady; Lima Milani, Karina Maria; Martinez de Oliveira, Andre Luiz] Univ Estadual Londrina, Dept Bioquim & Biotecnol, Londrina, Parana, Brazil; [Azeredo Goncalves, Leandro Simoes] Univ Estadual Londrina, Dept Agron, Londrina, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina	de Oliveira, ALM (corresponding author), Univ Estadual Londrina, Dept Bioquim & Biotecnol, Londrina, Parana, Brazil.	almoliva@uel.br	Gonçalves, Leandro SA/J-5505-2017	Gonçalves, Leandro SA/0000-0001-9700-9375; ALZATE ZULUAGA, MONICA YORLADY/0000-0002-1143-4854; Oliveira, Andre/0000-0003-1555-202X	INCT Plant Growth-Promoting Microorganisms for Agricultural Sustainability and Environmental Responsability (INCT-MPCPAgro); Fundacao Araucaria [309/2012]; CNPq [458099/2014-7]; CAPES; INCT-Plant Growth-Promoting Microorganisms for Agricultural Sustainability and Environmental Responsability (INCT-MPCPAgro); Universidade Estadual de Londrina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	INCT Plant Growth-Promoting Microorganisms for Agricultural Sustainability and Environmental Responsability (INCT-MPCPAgro); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-Plant Growth-Promoting Microorganisms for Agricultural Sustainability and Environmental Responsability (INCT-MPCPAgro); Universidade Estadual de Londrina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the INCT Plant Growth-Promoting Microorganisms for Agricultural Sustainability and Environmental Responsability (INCT-MPCPAgro), Fundacao Araucaria (conv. no. 309/2012), CNPq (conv. No. 458099/2014-7) and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the INCT-Plant Growth-Promoting Microorganisms for Agricultural Sustainability and Environmental Responsability (INCT-MPCPAgro), the CNPq (conv. No. 458099/2014-7), the Fundacao Araucaria and the Universidade Estadual de Londrina for the financial support. The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES) for granting scholarships to Mo ' nica Y. A. Zuluaga and Karina M. L. Milani.	Agler MT, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002352; Agnol RFD, 2017, FEMS MICROBIOL ECOL, V93, P1, DOI DOI 10.1093/FEMSEC/FIX027; Ahmad F, 2008, MICROBIOL RES, V163, P173, DOI 10.1016/j.micres.2006.04.001; Ait-Kaki A, 2014, APPL BIOCHEM BIOTECH, V172, P1735, DOI 10.1007/s12010-013-0617-0; Ambreetha S, 2018, RHIZOSPHERE-NETH, V5, P57, DOI 10.1016/j.rhisph.2017.12.001; Antoun H, 1998, PLANT SOIL, V204, P57, DOI 10.1023/A:1004326910584; Armada E, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy092; Asghar HN, 2002, BIOL FERT SOILS, V35, P231, DOI 10.1007/s00374-002-0462-8; Baez-Rogelio A, 2017, MICROB BIOTECHNOL, V10, P19, DOI 10.1111/1751-7915.12448; Baldani JI, 2014, PLANT SOIL, V384, P413, DOI 10.1007/s11104-014-2186-6; Bashan Y, 2014, PLANT SOIL, V378, P1, DOI 10.1007/s11104-013-1956-x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; Bever JD, 2012, ANNU REV MICROBIOL, V66, P265, DOI 10.1146/annurev-micro-092611-150107; Bhardwaj D, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-66; Billah M, 2019, GEOMICROBIOL J, V36, P904, DOI 10.1080/01490451.2019.1654043; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROUGHTON WJ, 1978, J APPL BACTERIOL, V45, P165, DOI 10.1111/j.1365-2672.1978.tb04213.x; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burghardt LT, 2019, EVOLUTION, V73, P2013, DOI 10.1111/evo.13807; Caballero-Mellado J, 2007, APPL ENVIRON MICROB, V73, P5308, DOI 10.1128/AEM.00324-07; Cai HS, 2018, GENES GENOM, V40, P857, DOI 10.1007/s13258-018-0693-1; Casanova-Saez R, 2019, TRENDS PLANT SCI, V24, P741, DOI 10.1016/j.tplants.2019.05.006; Chabot R, 1996, PLANT SOIL, V184, P311, DOI 10.1007/BF00010460; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Compant S, 2019, J ADV RES, V19, P29, DOI 10.1016/j.jare.2019.03.004; de Goes KCGP, 2012, J MICROBIOL BIOTECHN, V22, P437, DOI 10.4014/jmb.1109.09007; de Souza R, 2015, GENET MOL BIOL, V38, P401, DOI 10.1590/S1415-475738420150053; De-la-Pena C, 2014, PLANT PHYSIOL, V166, P701, DOI 10.1104/pp.114.241810; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI [10.1111/j.1574-6968.2004.tb09695.x, 10.1016/j.femsle.2004.07.013]; Drogue B, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00607; Dutta J, 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE.0182302; GONZÁLEZ OCTAVIO, 2008, Acta biol.Colomb., V13, P163; Heimpel GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072293; Hinsinger P, 2009, PLANT SOIL, V321, P117, DOI 10.1007/s11104-008-9885-9; HUREK T, 1988, PLANT SOIL, V110, P339, DOI 10.1007/BF02226814; ILLMER P, 1995, SOIL BIOL BIOCHEM, V27, P265, DOI 10.1016/0038-0717(94)00205-F; Ji SH, 2019, SCI REP, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Keller KR, 2018, J ECOL, V106, P1046, DOI 10.1111/1365-2745.12938; Kim JS, 2006, WORLD J MICROB BIOT, V22, P1267, DOI 10.1007/s11274-006-9171-z; Koskey G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00968; Koskey G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00443; Kruasuwan W, 2016, J PLANT GROWTH REGUL, V35, P1074, DOI 10.1007/s00344-016-9604-3; Kumar A, 2019, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-019-4778-6; Kumar P, 2018, BIOCATAL AGRIC BIOTE, V15, P264, DOI 10.1016/j.bcab.2018.06.019; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Lee SA, 2016, J MICROBIOL, V54, P823, DOI 10.1007/s12275-016-6410-3; Mehboob I, 2009, CRIT REV PLANT SCI, V28, P432, DOI 10.1080/07352680903187753; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Menna P, 2006, SYST APPL MICROBIOL, V29, P315, DOI 10.1016/j.syapm.2005.12.002; Miranda-Sanchez F, 2016, ENVIRON MICROBIOL, V18, P2375, DOI 10.1111/1462-2920.13061; Mohammed M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36324-0; Mulas D, 2014, BENEFICIAL PLANT-MICROBIAL INTERACTIONS: ECOLOGY AND APPLICATIONS, P300; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Musilova L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081205; Naveed M, 2014, BIOL FERT SOILS, V50, P249, DOI 10.1007/s00374-013-0854-y; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nicolitch O, 2016, SOIL BIOL BIOCHEM, V103, P429, DOI 10.1016/j.soilbio.2016.09.018; Noel TC, 1996, CAN J MICROBIOL, V42, P279, DOI 10.1139/m96-040; Ogata-Gutierrez K, 2017, WORLD J MICROB BIOT, V33, P1, DOI [10.1007/s11274-016-2144-y, DOI 10.1007/S11274-016-2144-Y]; Olanrewaju OS, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2364-9; Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114; Passardi A, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0139468, 10.1371/journal.pone.0134732]; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Pieterse CMJ, 2016, TRENDS PLANT SCI, V21, P171, DOI 10.1016/j.tplants.2016.01.018; Poole P, 2018, NAT REV MICROBIOL, V16, P291, DOI 10.1038/nrmicro.2017.171; Poudel R, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01765-18; Rademaker JLW, 1997, DNA MARKERS, P151; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Romero FM, 2014, FEMS MICROBIOL LETT, V351, P187, DOI 10.1111/1574-6968.12377; Saha M, 2016, ENVIRON SCI POLLUT R, V23, P3984, DOI 10.1007/s11356-015-4294-0; Sanchez-Canizares C, 2017, CURR OPIN MICROBIOL, V38, P188, DOI 10.1016/j.mib.2017.07.001; Santoyo G, 2017, SPAN J AGRIC RES, V15, DOI 10.5424/sjar/2017151-9990; Santoyo G, 2016, MICROBIOL RES, V183, P92, DOI 10.1016/j.micres.2015.11.008; SARWAR M, 1995, LETT APPL MICROBIOL, V20, P282, DOI 10.1111/j.1472-765X.1995.tb00446.x; Schlatter DC, 2015, ECOLOGY, V96, P134, DOI 10.1890/13-1648.1; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Singh BK, 2009, APPL SOIL ECOL, V41, P239, DOI 10.1016/j.apsoil.2008.10.003; Singh T, 2005, ACTA HORTIC, P289; Smyth EM, 2011, J APPL MICROBIOL, V111, P683, DOI 10.1111/j.1365-2672.2011.05079.x; Stefani FOP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128272; Stepkowski T, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030163; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Symanczik S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01263; Tian BY, 2017, AGR ECOSYST ENVIRON, V247, P149, DOI 10.1016/j.agee.2017.06.041; Valenzuela-Aragon B, 2019, PLANT SOIL, V435, P367, DOI 10.1007/s11104-018-03901-1; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Videira SS, 2012, PLANT SOIL, V356, P51, DOI 10.1007/s11104-011-1082-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang SS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46863-9; White LJ, 2017, ENVIRON MICROBIOL, V19, P1391, DOI 10.1111/1462-2920.13602; WRIGHT SF, 1981, APPL ENVIRON MICROB, V42, P97, DOI 10.1128/AEM.42.1.97-101.1981; Yang Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180892; Yanni YG, 1997, PLANT SOIL, V194, P99, DOI 10.1023/A:1004269902246; Zheng T., RHIZOSPHERE EFFECTS	100	21	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227422	10.1371/journal.pone.0227422	http://dx.doi.org/10.1371/journal.pone.0227422			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923250	Green Submitted, Green Published, gold			2022-12-26	WOS:000534350000075
J	Etaware, PM; Adedeji, AR; Osowole, OI; Odebode, AC				Etaware, Peter M.; Adedeji, Abiodun R.; Osowole, Oyedeji I.; Odebode, Adegboyega C.			ETAPOD: A forecast model for prediction of black pod disease outbreak in Nigeria	PLOS ONE			English	Article							CLIMATE-CHANGE; COCOA FARMERS	Food poisoning and environmental pollution are products of excessive chemical usage in Agriculture. In Nigeria, cocoa farmers apply fungicides frequently to control black pod disease (BPD), this practice is life threatening and lethal to the environment. The development of a warning system to detect BPD outbreak can help minimize excessive usage of fungicide by farmers. 8 models (MRM1-MRM8) were developed and 5 (MRM1-MRM5) selected for optimization and performance check. MRM5 (ETAPOD) performed better than the other forecast models. ETAPOD had 100% performance rating for BPD prediction in Ekiti (2009, 2010, 2011 and 2015) with model efficiency of 95-100%. The performance of the model was rated 80% in 2010 and 2015 (Ondo) with model efficiency of 85-90%, 70% in 2011 (Osun) with model efficiency of 81-84%, 60% in 2010 (Ondo and Osun) and 2015 (Osun) with model efficiency of 75-80%, 40% in 2009 (Osun) with model efficiency of 65-69% and 0% 1n 2011 (Ondo) with model efficiency between 0 and 49%. ETAPOD is a simplified BPD detection device for the past, present and future.	[Etaware, Peter M.; Odebode, Adegboyega C.] Univ Ibadan, Dept Bot, Fac Sci, Ibadan, Oyo State, Nigeria; [Adedeji, Abiodun R.] Cocoa Res Inst Nigeria CRIN, Ibadan, Oyo State, Nigeria; [Osowole, Oyedeji I.] Univ Ibadan, Dept Stat, Fac Sci, Ibadan, Oyo State, Nigeria	University of Ibadan; University of Ibadan	Etaware, PM (corresponding author), Univ Ibadan, Dept Bot, Fac Sci, Ibadan, Oyo State, Nigeria.	peterparkers007@gmail.com	Etaware, Peter/AFN-7680-2022	Etaware, Peter/0000-0002-9370-8029				Adegbola M.O.K, 1972, 7 INT COC RES C DOUA, P179; Agbeniyi S. O, 2003, P 14 INT COC RES C, P1377; Agbeniyi S.O., 2014, INT J DEV SUSTAINABI, V3, P388; Akrofi A.Y, 2015, AFRICAN CROP SCI J, V23, P1; [Anonymous], 1995, PEST DIS IN REPORT R, P43; Evans HC, 2007, PHYTOPATHOLOGY, V97, P1640, DOI 10.1094/PHYTO-97-12-1640; International Cocoa Organization [ICCO], 2005, WORLD COC PROD 2005; Lawal J. O., 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P423; Luo W, 2008, THESIS; Oduwole O.O, 2001, P 13 INT COC RES C, P1147; Oluyole K. A., 2008, J INNOVATIVE DEV STR, V2, P1; Oyekale AS, 2015, ANN AGR ENV MED, V22, P357, DOI 10.5604/12321966.1152095; Oyekale Abayomi Samuel, 2012, Journal of Human Ecology, V40, P143; Simon G., 2003, MULTIPLE REGRESSION, P18; Taylor M. N, 2000, COCOA GROWERS B, P1	15	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0209306	10.1371/journal.pone.0209306	http://dx.doi.org/10.1371/journal.pone.0209306			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923186	Green Published, Green Submitted, gold			2022-12-26	WOS:000534350000001
J	Fukunaga, A; Inoue, Y; Chandraratne, N; Yamaguchi, M; Kuwahara, K; Indrawansa, S; Gunawardena, N; Mizoue, T; Samarasinghe, D				Fukunaga, Ami; Inoue, Yosuke; Chandraratne, Nadeeka; Yamaguchi, Miwa; Kuwahara, Keisuke; Indrawansa, Susantha; Gunawardena, Nalika; Mizoue, Tetsuya; Samarasinghe, Diyanath			Healthy lifestyle index and its association with hypertension among community adults in Sri Lanka: A cross-sectional study	PLOS ONE			English	Article							INCIDENT HYPERTENSION; SYSTEMATIC ANALYSIS; INCOME COUNTRIES; BLOOD-PRESSURE; MIDDLE-INCOME; RISK-FACTORS; PREVALENCE; NUTRITION; OBESITY	Objectives To investigate the association between a healthy lifestyle index (HLI) (i.e., a composite score comprising multiple lifestyle factors) and hypertension among community adults living in Sri Lanka. Methods The present study used baseline information of a cluster randomized controlled trial among 456 adults aged 27-65 years in a semi-urban community in Colombo, Sri Lanka. The HLI was constructed by summing a number of low-risk lifestyle factors: low body mass index, sufficient physical activity, non-smoking, low alcohol consumption, and sufficient fruit and vegetable consumption. Hypertension was defined as systolic blood pressure >= 140 mmHg, diastolic blood pressure 90 mmHg, or the use of antihypertensive medication. A logistic regression model was used to investigate the association between the HLI (low: 0-2; middle: 3; high: 4-5) and hypertension. Results A total of 178 (39%) participants were hypertensive. Compared with the low HLI group, multivariate-adjusted odds ratios (95% confidence intervals) of hypertension were 0.72 (0.44-1.19) and 0.28 (0.15-0.54) for the middle and high HLI groups, respectively (p-trend <0.001). Conclusions The present study provides essential evidence on an inverse association between adherence to healthy lifestyles and hypertension.	[Fukunaga, Ami; Inoue, Yosuke; Yamaguchi, Miwa; Kuwahara, Keisuke; Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan; [Chandraratne, Nadeeka] Minist Hlth, Management Dev & Planning Unit, Colombo, Sri Lanka; [Yamaguchi, Miwa] Natl Inst Biomed Innovat Hlth & Nutr, Int Ctr Nutr & Informat, Natl Inst Hlth & Nutr, Tokyo, Japan; [Kuwahara, Keisuke] Teikyo Univ, Grad Sch Publ Hlth, Tokyo, Japan; [Indrawansa, Susantha] Fdn Hlth Promot, Dehiwala, Sri Lanka; [Gunawardena, Nalika] World Hlth Org Country, Off Sri Lanka, Colombo, Sri Lanka; [Samarasinghe, Diyanath] Univ Colombo, Dept Psychol Med, Colombo, Sri Lanka	National Center for Global Health & Medicine - Japan; National Institute of Health & Nutrition - Japan; Teikyo University; University of Colombo	Fukunaga, A (corresponding author), Natl Ctr Global Hlth & Med, Dept Epidemiol & Prevent, Ctr Clin Sci, Tokyo, Japan.	afukunaga@hosp.ncgm.go.jp		Fukunaga, Ami/0000-0002-8705-0056; Inoue, Yosuke/0000-0002-7690-3447; Kuwahara, Keisuke/0000-0002-7503-1333	National Center for Global Health and Medicine [27-Shi-1]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was funded by the grant (27-Shi-1) from the National Center for Global Health and Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriolo V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38783-5; Banda JA, 2010, AM J HYPERTENS, V23, P599, DOI 10.1038/ajh.2010.26; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Nguyen B, 2019, PREV MED, V118, P73, DOI 10.1016/j.ypmed.2018.10.007; Chandraratne N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7142-1; Cohen L, 2012, J AM SOC HYPERTENS, V6, P284, DOI 10.1016/j.jash.2012.06.002; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; Katulanda P, 2014, CLIN EXP HYPERTENS, V36, P484, DOI 10.3109/10641963.2013.863321; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Livingstone KM, 2017, OBESITY, V25, P1610, DOI 10.1002/oby.21911; Meader N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3373-6; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ministry of Health, FOOD BAS DIET GUID S; Ministry of International and Home Affairs and Provincial Councils and Local Government, GRAM NIL HAR DIV SRI; Noble N, 2015, PREV MED, V81, P16, DOI 10.1016/j.ypmed.2015.07.003; Organization WH, 2018, NONCOMMUNICABLE DIS; Owolabi M, 2016, HYPERTENSION, V68, P1328, DOI 10.1161/HYPERTENSIONAHA.116.08290; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; US Dept of Agriculture Center for Nutrition Policy and Promotion, DIET GUID AM 2015 20; Villegas R, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-210; World Health Organization, WHO FRAM CONV TOB CO; World Health Organization, GLOB REC PHYS ACT HL; World Health Organization, GLOB DAT BOD MASS IN; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226773	10.1371/journal.pone.0226773	http://dx.doi.org/10.1371/journal.pone.0226773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923198	gold, Green Published			2022-12-26	WOS:000534350000025
J	Hartley, C; Farmer, S; Berthouze, L				Hartley, Caroline; Farmer, Simon; Berthouze, Luc			Temporal ordering of input modulates connectivity formation in a developmental neuronal network model of the cortex	PLOS ONE			English	Article							RICH-CLUB ORGANIZATION; SUBPLATE NEURONS; HUMAN BRAIN; SCALING BEHAVIOR; OSCILLATIONS; COMPLEX; AUTISM; MECHANISMS; AVALANCHES; MATURATION	Preterm infant brain activity is discontinuous; bursts of activity recorded using EEG (electroencephalography), thought to be driven by subcortical regions, display scale free properties and exhibit a complex temporal ordering known as long-range temporal correlations (LRTCs). During brain development, activity-dependent mechanisms are essential for synaptic connectivity formation, and abolishing burst activity in animal models leads to weak disorganised synaptic connectivity. Moreover, synaptic pruning shares similar mechanisms to spike-timing dependent plasticity (STDP), suggesting that the timing of activity may play a critical role in connectivity formation. We investigated, in a computational model of leaky integrate-and-fire neurones, whether the temporal ordering of burst activity within an external driving input could modulate connectivity formation in the network. Connectivity evolved across the course of simulations using an approach analogous to STDP, from networks with initial random connectivity. Small-world connectivity and hub neurones emerged in the network structure-characteristic properties of mature brain networks. Notably, driving the network with an external input which exhibited LRTCs in the temporal ordering of burst activity facilitated the emergence of these network properties, increasing the speed with which they emerged compared with when the network was driven by the same input with the bursts randomly ordered in time. Moreover, the emergence of small-world properties was dependent on the strength of the LRTCs. These results suggest that the temporal ordering of burst activity could play an important role in synaptic connectivity formation and the emergence of small-world topology in the developing brain.	[Hartley, Caroline] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Hartley, Caroline] Univ Oxford, Dept Paediat, Oxford, England; [Farmer, Simon] UCL, Inst Neurol, London, England; [Berthouze, Luc] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England	University of London; University College London; University of Oxford; University of London; University College London; University of Sussex	Hartley, C (corresponding author), UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England.; Hartley, C (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	caroline.hartley@paediatrics.ac.uk	Berthouze, Luc/C-4168-2008	Berthouze, Luc/0000-0003-3774-2369; Hartley, Caroline/0000-0002-7981-0836	CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London; Wellcome Trust/Royal Society Sir Henry Dale Fellowship; UCLH (University College London Hospitals) Biomedical Research Centre	CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London; Wellcome Trust/Royal Society Sir Henry Dale Fellowship(Wellcome Trust); UCLH (University College London Hospitals) Biomedical Research Centre	CH was funded through CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London for this project. CH is currently funded by a Wellcome Trust/Royal Society Sir Henry Dale Fellowship. SF acknowledges funding support from the UCLH (University College London Hospitals) Biomedical Research Centre. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2010, NEUROPHYSIOL CLIN, V40, P59, DOI 10.1016/j.neucli.2010.02.002; Arichi T, 2017, ELIFE, V6, DOI 10.7554/eLife.27814; Ball G, 2014, P NATL ACAD SCI USA, V111, P7456, DOI 10.1073/pnas.1324118111; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Berthouze L, 2010, CLIN NEUROPHYSIOL, V121, P1187, DOI 10.1016/j.clinph.2010.02.163; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Botcharova M., 2013, MAXIMUM LIKELIHOOD B; Chipaux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079028; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Damaraju E, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00023; Damicelli F, 2017, CHAOS, V27, DOI 10.1063/1.4979561; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Fabrizi L, 2011, CURR BIOL, V21, P1552, DOI 10.1016/j.cub.2011.08.010; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Goodhill GJ, 2004, NEURAL COMPUT, V16, P2221, DOI 10.1162/0899766041941934; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Grunau RE, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10132; Hartley C, CODE TEMPORAL ORDERI; Hartley C, 2014, J MATH NEUROSCI, V4, DOI 10.1186/2190-8567-4-9; Hartley C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031543; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Iyer KK, 2015, BRAIN, V138, P2206, DOI 10.1093/brain/awv129; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kanold PO, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.016.2009; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kiddie G, 2005, PROG BRAIN RES, V147, P67, DOI 10.1016/S0079-6123(04)47006-X; Kostovic I, 2006, SEMIN FETAL NEONAT M, V11, P415, DOI 10.1016/j.siny.2006.07.001; Linkenkaer-Hansen K, 2004, EUR J NEUROSCI, V19, P203, DOI 10.1111/j.1460-9568.2004.03116.x; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; Nikulin VV, 2004, CLIN NEUROPHYSIOL, V115, P1896, DOI 10.1016/j.clinph.2004.03.019; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Piochon C, 2016, NAT NEUROSCI, V19, P1299, DOI 10.1038/nn.4389; Rose SE, 2008, MAGN RESON MED, V60, P761, DOI 10.1002/mrm.21689; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; SCHMIDT JT, 1985, NEUROSCIENCE, V14, P535, DOI 10.1016/0306-4522(85)90308-2; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Smyser CD, 2016, CEREB CORTEX, V26, P322, DOI 10.1093/cercor/bhu251; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Taylor TJ, 2013, J MATH NEUROSCI, V3, DOI 10.1186/2190-8567-3-5; Tolner EA, 2012, J NEUROSCI, V32, P692, DOI 10.1523/JNEUROSCI.1538-11.2012; Ton R, 2016, NEUROIMAGE, V136, P215, DOI 10.1016/j.neuroimage.2016.01.008; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; van den Heuvel MP, 2015, CEREB CORTEX, V25, P3000, DOI 10.1093/cercor/bhu095; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P464, DOI 10.1016/j.siny.2006.07.009; VANOOYEN A, 1994, J THEOR BIOL, V167, P27, DOI 10.1006/jtbi.1994.1047; Vinall J, 2014, PEDIATRICS, V133, P412, DOI 10.1542/peds.2013-1863; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Wiegert JS, 2013, P NATL ACAD SCI USA, V110, pE4510, DOI 10.1073/pnas.1315926110	69	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226772	10.1371/journal.pone.0226772	http://dx.doi.org/10.1371/journal.pone.0226772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923200	Green Published, gold, Green Submitted			2022-12-26	WOS:000534350000024
J	Sastre, DE; Pulschen, AA; Basso, LGM; Pariente, JSB; Netto, CGCM; Machinandiarena, F; Albanesi, D; Navarro, MVAS; de Mendoza, D; Gueiros, FJ				Sastre, Diego E.; Pulschen, Andre A.; Basso, Luis G. M.; Pariente, Jhonathan S. Benites; Marques Netto, Caterina G. C.; Machinandiarena, Federico; Albanesi, Daniela; Navarro, Marcos V. A. S.; de Mendoza, Diego; Gueiros-Filho, Frederico J.			The phosphatidic acid pathway enzyme PlsX plays both catalytic and channeling roles in bacterial phospholipid synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycerophospholipid; Gram-positive bacteria; acyltransferase; membrane biogenesis; lipid binding protein; acylphosphate; PlsX; substrate channeling	BACILLUS-SUBTILIS; FATTY-ACID; MOLECULAR-PROPERTIES; STRUCTURAL-ANALYSIS; MEMBRANE; PROTEIN; BINDING; THIOESTERS; SITE	PlsX is the first enzyme in the pathway that produces phosphatidic acid in Gram-positive bacteria. It makes acylphosphate from acyl-acyl carrier protein (acyl-ACP) and is also involved in coordinating phospholipid and fatty acid biosyntheses. PlsX is a peripheral membrane enzyme in Bacillus subtilis, but how it associates with the membrane remains largely unknown. In the present study, using fluorescence microscopy, liposome sedimentation, differential scanning calorimetry, and acyltransferase assays, we determined that PlsX binds directly to lipid bilayers and identified its membrane anchoring moiety, consisting of a hydrophobic loop located at the tip of two amphipathic dimerization helices. To establish the role of the membrane association of PlsX in acylphosphate synthesis and in the flux through the phosphatidic acid pathway, we then created mutations and gene fusions that prevent PlsX's interaction with the membrane. Interestingly, phospholipid synthesis was severely hampered in cells in which PlsX was detached from the membrane, and results from metabolic labeling indicated that these cells accumulated free fatty acids. Because the same mutations did not affect PlsX transacylase activity, we conclude that membrane association is required for the proper delivery of PlsX's product to PlsY, the next enzyme in the phosphatidic acid pathway. We conclude that PlsX plays a dual role in phospholipid synthesis, acting both as a catalyst and as a chaperone protein that mediates substrate channeling into the pathway.	[Sastre, Diego E.; Pulschen, Andre A.; Pariente, Jhonathan S. Benites; Gueiros-Filho, Frederico J.] Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, SP, Brazil; [Basso, Luis G. M.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Fis, BR-14040901 Ribeirao Preto, SP, Brazil; [Marques Netto, Caterina G. C.] Univ Fed Sao Carlos UFSCar, Dept Quim, BR-13565905 Sao Carlos, SP, Brazil; [Machinandiarena, Federico; Albanesi, Daniela; de Mendoza, Diego] Univ Nacl Rosario, CONICET, Inst Biol Mol & Celular Rosario IBR, S2002LRK, Rosario, Santa Fe, Argentina; [Machinandiarena, Federico; Albanesi, Daniela; de Mendoza, Diego] Univ Nacl Rosario, Dept Microbiol, Fac Ciencias Bioquim & Farmaceut, S2002LRK, Rosario, Santa Fe, Argentina; [Sastre, Diego E.; Navarro, Marcos V. A. S.] Univ Sao Paulo, Dept Biofis Mol, Inst Fis Sao Carlos, Grp Biofis Mol Sergio Mascarenhas, BR-13560970 Sao Carlos, SP, Brazil; [Machinandiarena, Federico; Albanesi, Daniela; de Mendoza, Diego] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gueiros, FJ (corresponding author), Univ Sao Paulo, Dept Bioquim, Inst Quim, BR-05508000 Sao Paulo, SP, Brazil.; de Mendoza, D (corresponding author), Univ Nacl Rosario, CONICET, Inst Biol Mol & Celular Rosario IBR, S2002LRK, Rosario, Santa Fe, Argentina.; de Mendoza, D (corresponding author), Univ Nacl Rosario, Dept Microbiol, Fac Ciencias Bioquim & Farmaceut, S2002LRK, Rosario, Santa Fe, Argentina.	demendoza@ibr-conicet.gov.ar; fgueiros@iq.usp.br	Navarro, Marcos VAS/C-9141-2013; Basso, Luis GM/AAF-9872-2021; Gueiros-Filho, Frederico J./D-2160-2013; Basso, Luis GM/N-6692-2013; Netto, Caterina/M-9992-2014	Basso, Luis GM/0000-0003-1277-1008; Gueiros-Filho, Frederico J./0000-0001-5425-2439; Basso, Luis GM/0000-0003-1277-1008; Albanesi, Daniela/0000-0003-4380-9152; Netto, Caterina/0000-0002-3285-4129; Arashiro Pulschen, Andre/0000-0002-0139-3737; Benites Pariente, Jhonathan Stivins/0000-0001-6595-0478	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/05203-5]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2016-1594]; FAPESP [2014/13411-1, 2015/21583-0, 2014/00206-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 2016/05203-5 (to F. J. G.-F.), Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 2016-1594 (to D. d. M.), FAPESP Postdoctoral Fellowship Grant 2014/13411-1 (to D. E. S), FAPESP Grant 2015/21583-0 (to M. V. A. S. N), and FAPESP scholarship Grant 2014/00206-0 (to L. G. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams DW, 2015, EMBO J, V34, P491, DOI 10.15252/embj.201490177; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; Cuypers MG, 2019, J BIOL CHEM, V294, P38, DOI 10.1074/jbc.RA118.006160; DUBNAU D, 1969, J MOL BIOL, V45, P155, DOI 10.1016/0022-2836(69)90097-7; Gamsjaeger R, 2005, BIOCHEM J, V389, P665, DOI 10.1042/BJ20050156; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hara Y, 2008, GENES GENET SYST, V83, P433, DOI 10.1266/ggs.83.433; Jiang YP, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0562-8; Kim Y., 2009, Journal of Structural and Functional Genomics, V10, P157, DOI 10.1007/s10969-008-9052-9; Kohler P, 1997, J BACTERIOL, V179, P2060; Li ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01821-9; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Paoletti L, 2007, J BACTERIOL, V189, P5816, DOI 10.1128/JB.00602-07; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Robertson RM, 2017, NAT STRUCT MOL BIOL, V24, P666, DOI 10.1038/nsmb.3436; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roggiani M, 2015, ANNU REV GENET, V49, P115, DOI 10.1146/annurev-genet-112414-054958; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sastre DE, 2020, J BIOL CHEM, V295, P2136, DOI 10.1074/jbc.RA119.011122; Sastre DE, 2016, MOL MICROBIOL, V100, P621, DOI 10.1111/mmi.13337; Takada H, 2014, MOL MICROBIOL, V91, P242, DOI 10.1111/mmi.12457; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weisiger RA, 2007, J MOL NEUROSCI, V33, P42, DOI 10.1007/s12031-007-0047-y; Whited AM, 2015, CHEM PHYS LIPIDS, V192, P51, DOI 10.1016/j.chemphyslip.2015.07.015; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018	35	4	4	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2148	2159		10.1074/jbc.RA119.011147	http://dx.doi.org/10.1074/jbc.RA119.011147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919098	Green Published, hybrid			2022-12-26	WOS:000517128200031
J	Tietz, S; Leuenberger, M; Hohner, R; Olson, AH; Fleming, GR; Kirchhoff, H				Tietz, Stefanie; Leuenberger, Michelle; Hohner, Ricarda; Olson, Alice H.; Fleming, Graham R.; Kirchhoff, Helmut			A proteoliposome-based system reveals how lipids control photosynthetic light harvesting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						photosynthesis; membrane biophysics; membrane lipid; lipid-protein interaction; light-harvesting complex (antenna complex); lateral membrane pressure; non-bilayer lipid; non-photochemical quenching; proteoliposome; thylakoid membrane; monogalactosyldiacylglycerol; energy transduction; photosystem	TIME-RESOLVED FLUORESCENCE; CHLOROPHYLL-A/B-COMPLEX; MEMBRANE-PROTEINS; THYLAKOID MEMBRANES; CIRCULAR-DICHROISM; NONBILAYER LIPIDS; CRYSTAL-STRUCTURE; ANTENNA PROTEINS; MOLECULAR SWITCH; HIGHER-PLANTS	Integral membrane proteins are exposed to a complex and dynamic lipid environment modulated by nonbilayer lipids that can influence protein functions by lipid-protein interactions. The nonbilayer lipid monogalactosyldiacylglycerol (MGDG) is the most abundant lipid in plant photosynthetic thylakoid membranes, but its impact on the functionality of energy-converting membrane protein complexes is unknown. Here, we optimized a detergent-based reconstitution protocol to develop a proteoliposome technique that incorporates the major light-harvesting complex II (LHCII) into compositionally well-defined large unilamellar lipid bilayer vesicles to study the impact of MGDG on light harvesting by LHCII. Using steady-state fluorescence spectroscopy, CD spectroscopy, and time-correlated single-photon counting, we found that both chlorophyll fluorescence quantum yields and fluorescence lifetimes clearly indicate that the presence of MGDG in lipid bilayers switches LHCII from a light-harvesting to a more energy-quenching mode that dissipates harvested light into heat. It is hypothesized that in the in vitro system developed here, MGDG controls light harvesting of LHCII by modulating the hydrostatic lateral membrane pressure profile in the lipid bilayer sensed by LHCII-bound peripheral pigments.	[Tietz, Stefanie; Hohner, Ricarda; Olson, Alice H.; Kirchhoff, Helmut] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Leuenberger, Michelle; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Leuenberger, Michelle; Fleming, Graham R.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Tietz, Stefanie] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Hohner, Ricarda] WA State Univ, Sch Biol Sci, POB 644236, Pullman, WA 99164 USA	Washington State University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Michigan State University	Kirchhoff, H (corresponding author), POB 646340, Pullman, WA 99164 USA.	kirchhh@wsu.edu	Kirchhoff, Helmut/AAN-6695-2020	Kirchhoff, Helmut/0000-0001-5874-3681	National Science Foundation [MCB1616982]; U.S. Department of Energy [DE-SC 0017160]; U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Projects [1005351, 0119]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC0205CH11231]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-AC03-76SF000098, FWP 449B]	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Projects; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by National Science Foundation Grant MCB1616982; U.S. Department of Energy Grant DE-SC 0017160; and U.S. Department of Agriculture, National Institute of Food and Agriculture Hatch Projects 1005351 and 0119 (to H. K.). This work was also supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC0205CH11231 and the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy Grants DE-AC03-76SF000098 and FWP 449B (to G. R. F). The authors declare that they have no conflicts of interest with the contents of this article.	Akhtar P, 2015, J BIOL CHEM, V290, P4877, DOI 10.1074/jbc.M114.607770; Anishkin A, 2014, P NATL ACAD SCI USA, V111, P7898, DOI 10.1073/pnas.1313364111; Baczynski K, 2015, BIOCHIMIE, V118, P129, DOI 10.1016/j.biochi.2015.09.007; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Boudiere L, 2014, BBA-BIOENERGETICS, V1837, P470, DOI 10.1016/j.bbabio.2013.09.007; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROWSE J, 1981, BIOCHEM J, V196, P347, DOI 10.1042/bj1960347; BURKE JJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P252, DOI 10.1016/0003-9861(78)90031-0; Cantor RS, 1997, J PHYS CHEM B, V101, P1723, DOI 10.1021/jp963911x; Chegeni FA, 2016, BBA-BIOENERGETICS, V1857, P1849, DOI 10.1016/j.bbabio.2016.09.004; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Chmeliov J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.45, 10.1038/nplants.2016.45]; Crisafi E, 2017, BBA-BIOMEMBRANES, V1859, P40, DOI 10.1016/j.bbamem.2016.10.010; Croce R, 2000, PHOTOSYNTH RES, V64, P221, DOI 10.1023/A:1006455230379; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; deKruijff B, 1997, NATURE, V386, P129, DOI 10.1038/386129a0; Dockter C, 2012, J BIOL CHEM, V287, P2915, DOI 10.1074/jbc.M111.307728; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; Garab G, 2016, SUBCELL BIOCHEM, V86, P127, DOI 10.1007/978-3-319-25979-6_6; Gasulla F, 2013, PLANT J, V75, P726, DOI 10.1111/tpj.12241; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Haferkamp S, 2008, PHOTOSYNTH RES, V95, P129, DOI 10.1007/s11120-007-9253-2; Haferkamp S, 2010, J BIOL CHEM, V285, P17020, DOI 10.1074/jbc.M109.077750; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; IDE JP, 1987, BIOCHIM BIOPHYS ACTA, V893, P349, DOI 10.1016/0005-2728(87)90056-9; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Joyard J, 1998, LIPIDS PHOTOSYNTHESI, P21, DOI DOI 10.1007/0-306-48087-5_; Karasawa A, 2013, J BIOL CHEM, V288, P29862, DOI 10.1074/jbc.M113.499327; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kirchhoff H, 2007, BIOCHEMISTRY-US, V46, P11169, DOI 10.1021/bi700748y; Kirchhoff H, 2018, METHODS MOL BIOL, V1770, P305, DOI 10.1007/978-1-4939-7786-4_18; Klecker M, 2014, PLANT PHYSIOL, V165, P774, DOI 10.1104/pp.114.237990; Kruger TPJ, 2011, P NATL ACAD SCI USA, V108, P13516, DOI 10.1073/pnas.1105411108; Krumova SB, 2008, BBA-BIOMEMBRANES, V1778, P997, DOI 10.1016/j.bbamem.2008.01.004; KUHLBRANDT W, 1983, J CELL BIOL, V96, P1414, DOI 10.1083/jcb.96.5.1414; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Liguori N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15661; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Maatta S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00049; MCDONNEL A, 1980, J CELL BIOL, V84, P40, DOI 10.1083/jcb.84.1.40; Mirkovic T, 2017, CHEM REV, V117, P249, DOI 10.1021/acs.chemrev.6b00002; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Muh F, 2010, J PHYS CHEM B, V114, P13517, DOI 10.1021/jp106323e; Natali A, 2016, J BIOL CHEM, V291, P16730, DOI 10.1074/jbc.M116.730101; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Novoderezhkin V, 2011, PHYS CHEM CHEM PHYS, V13, P17093, DOI 10.1039/c1cp21079c; Orsi M, 2013, FARADAY DISCUSS, V161, P249, DOI 10.1039/c2fd20110k; Palacios MA, 2002, J PHYS CHEM B, V106, P5782, DOI 10.1021/jp014078t; Palacios MA, 2006, PHOTOSYNTH RES, V88, P269, DOI 10.1007/s1120-006-9042-3; Pandit A, 2011, BIOPHYS J, V101, P2507, DOI 10.1016/j.bpj.2011.09.055; Park S, 2018, J AM CHEM SOC, V140, P11965, DOI 10.1021/jacs.8b04844; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Seiwert D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05328-7; SPRAGUE SG, 1984, BIOCHIM BIOPHYS ACTA, V777, P306, DOI 10.1016/0005-2736(84)90433-4; van Eerden FJ, 2015, BBA-BIOMEMBRANES, V1848, P1319, DOI 10.1016/j.bbamem.2015.02.025; van Oort B, 2007, J PHYS CHEM B, V111, P7631, DOI 10.1021/jp070573z; WEBB MS, 1991, BIOCHIM BIOPHYS ACTA, V1060, P133, DOI 10.1016/S0005-2728(09)91002-7; Yang CH, 2008, BBA-BIOENERGETICS, V1777, P1463, DOI 10.1016/j.bbabio.2008.08.009; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010	73	25	25	5	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1857	1866		10.1074/jbc.RA119.011707	http://dx.doi.org/10.1074/jbc.RA119.011707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31929108	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000517128200007
J	Foley, K; McNaughton, D; Ward, P				Foley, Kristen; McNaughton, Darlene; Ward, Paul			Monitoring the 'diabetes epidemic': A framing analysis of United Kingdom print news 1993-2013	PLOS ONE			English	Article							OBESITY; HEALTH; MEDIA; DISCOURSE; MELLITUS; CONSTRUCTION; OVERWEIGHT; ILLNESS; POLICY	Introduction The view that we are in the midst of a global diabetes epidemic has gained considerable ground in recent years and is often linked to the prior 'obesity epidemic'. This research explored how the diabetes epidemic was represented in United Kingdom (UK) news over the same time period that the obesity epidemic was widely reported. The research was motivated by a sociological interest in how postmodern 'epidemics' synergise with each other amidst broader political, economic, moral and sociocultural discourses. Method We analysed three time-bound samples of UK news articles about diabetes: 1993 (n = 19), 2001 (n = 119) and 2013 (n = 324). Until now, UK media has had the least attention regarding portrayal of diabetes. We adopted an empathically neutral approach and used a dual method approach of inductive thematic analysis and deductive framing analysis. The two methods were triangulated to produce the findings. Results Framing of diabetes moved from medical in 1993 to behavioural in 2001, then societal in 2013. By 2001 obesity was conceptualised as causal to diabetes, rather than a risk factor. Between 2001 and 2013 portrayals of the modifiable risk factors for diabetes (i.e. diet, exercise and weight) became increasingly technical. Other risk factors like age, family history and genetics faded during 2001 and 2013, while race, ethnicity and culture were positioned as states of 'high risk' for diabetes. The notion of an 'epidemic' of diabetes 'powered up' these concerns from an individual problem to a societal threat in the context of obesity as a well-known health risk. Discussion and conclusion Portraying diabetes and the diabetes epidemic as anticipated consequences of obesity enlivens the heightened awareness to future risks in everyday life brought about during the obesity epidemic. The freeform adoption of the 'epidemic' term in contemporary health discourse appears to foster individual and societal dependence on biomedicine, giving it political, economic and divisive utility.	[Foley, Kristen; McNaughton, Darlene; Ward, Paul] Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA, Australia	Flinders University South Australia	Foley, K (corresponding author), Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA, Australia.	Kristen.Foley@flinders.edu.au		McNaughton, Darlene/0000-0002-0131-5966; Foley, Kristen/0000-0002-8169-8652; Ward, Paul/0000-0002-5559-9714				Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alhojailan MI., 2012, W E J SOCIAL SCI, V1, P39, DOI DOI 10.4236/JCC.2019.73004; [Anonymous], 2002, GUARDIAN; [Anonymous], 2013, DAILY MAIL; [Anonymous], 2013, THE TIMES       1212; Aphramor L, 2011, DEBATING OBESITY: CRITICAL PERSPECTIVES, P192; ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329; Armstrong D, 1983, POLITICAL ANATOMY BO; Armstrong D, 2014, SOCIOL HEALTH ILL, V36, P15, DOI 10.1111/1467-9566.12037; Barrow M, 2013, TIMES; Bell K., 2009, Critical Public Health, V19, P155, DOI 10.1080/09581590802385664; Bell K, 2012, ALCOHOL TOBACCO OBES; Bell K, 2011, CRIT PUBLIC HEALTH, V21, P49, DOI 10.1080/09581596.2010.529419; Boero N., 2013, KILLER FAT MEDIA MED; Boero N, 2013, CRIT PUBLIC HEALTH, V23, P371, DOI 10.1080/09581596.2013.783686; Borland S, 2013, DAILY MAIL; Boycott R, 2013, MAIL SUNDAY     0915; Brandt A.M., 1997, MORALITY HLTH; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Briffa J, 2001, DAILY MAIL      0731; Briggs C.L., 2016, MAKING HLTH PUBLIC; Brunetti A, 2014, WORLD J DIABETES, V5, P128, DOI 10.4239/wjd.v5.i2.128; Campbell D, 2013, GUARDIAN; Campbell D, 2013, THE GUARDIAN    0228; Campos P, 2006, INT J EPIDEMIOL, V35, P55, DOI 10.1093/ije/dyi254; Campos Paul, 2004, OBESITY MYTH WHY AM; Carter R, 1993, DAILY MAIL      0118; Cavendish C, 2013, THE TIMES       0103; Charter D, 2001, TIMES; Clarke AE, 2003, AM SOCIOL REV, V68, P161, DOI 10.2307/1519765; Clements R, 2001, DAILY MAIL; COHEN S, 1982, DEVIANT BEHAV, V4, P119; Cohen S, 2002, FOLK DEVILS MORAL PA; Collins J, 2001, TIMES; Colls R, 2014, PROG HUM GEOG, V38, P733, DOI 10.1177/0309132513500373; Coreil J, 1984, Int Q Community Health Educ, V5, P103, DOI 10.2190/FYTG-A92T-4P5X-U9XW; Couldry N., 2004, SOC SEMIOT, V14, P115, DOI [10.1080/1035033042000238295, DOI 10.1080/1035033042000238295]; Coveney J, 2008, HEALTH SOCIOL REV, V17, P199, DOI 10.5172/hesr.451.17.2.199; Crane H, 2013, THE GUARDIAN    1113; CRAWFORD R, 1980, INT J HEALTH SERV, V10, P365, DOI 10.2190/3H2H-3XJN-3KAY-G9NY; Crawford R, 1993, HLTH WELLBEING, P133; Crawford R, 2006, HEALTH, V10, P401, DOI 10.1177/1363459306067310; Das A, 2013, SOC SCI MED, V77, P75, DOI 10.1016/j.socscimed.2012.11.007; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dowden A, 2001, DAILY MAIL; Drainey N, 2013, TIMES; Elkins L, 2013, DAILY MAIL; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Entman RM, 2003, POLIT COMMUN, V20, P415, DOI 10.1080/10584600390244176; Espelt A, 2008, DIABETOLOGIA, V51, P1971, DOI 10.1007/s00125-008-1146-1; Estridge B, 2001, DAILY MAIL; Ezzy D, QUALITATIVE ANAL; Fee M, 2006, SOC SCI MED, V62, P2988, DOI 10.1016/j.socscimed.2005.11.062; Finerman R, 1995, Soc Sci Med, V40, P1, DOI 10.1016/0277-9536(94)00121-9; Foley K, 2019, QUAL HEALTH RES, V29, P1810, DOI 10.1177/1049732319826559; GAMSON WA, 1989, AM J SOCIOL, V95, P1, DOI 10.1086/229213; Gard M, 2010, END OBESITY EPIDEMIC; Gard M., 2005, OBESITY EPIDEMIC SCI; Gollust SE, 2009, SOC SCI MED, V69, P1091, DOI 10.1016/j.socscimed.2009.07.009; Gustafsson PE, 2012, SOC SCI MED, V74, P1630, DOI 10.1016/j.socscimed.2012.01.044; Hacking I, MAKING PEOPLE; Hagan P, 2013, DAILY MAIL      0617; Hellyer NE, 2011, HEALTH EDUC RES, V26, P13, DOI 10.1093/her/cyq059; Henderson J, 2014, HEALTH RISK SOC, V16, P615, DOI 10.1080/13698575.2014.966806; Hodgetts D, 2008, HEALTH-LONDON, V12, P43, DOI 10.1177/1363459307083697; Hope J, 2001, DAILY MAIL; Hope J, 2013, DAILY MAIL; Hope J, 2001, DAILY MAIL      0809; Ingram M, 2001, TIMES; Kelly SJ, 2015, ANNU REV PUBL HEALTH, V36, P441, DOI 10.1146/annurev-publhealth-031914-122921; Kent A, 1993, TIMES; Keval H, 2016, CONSTRUCTING RISK FA, P61; Keval H, 2015, NEW GENET SOC, V34, P274, DOI 10.1080/14636778.2015.1036155; Kharroubi AT, 2015, WORLD J DIABETES, V6, P850, DOI 10.4239/wjd.v6.i6.850; Klos LA, 2015, J HEALTH COMMUN, V20, P639, DOI 10.1080/10810730.2014.965371; Knight C, 2011, PUBLIC UNDERST SCI, V20, P706, DOI 10.1177/0963662510391733; Lawrence F., 2013, GUARDIAN; LeBesco K, 2011, CRIT PUBLIC HEALTH, V21, P153, DOI 10.1080/09581596.2010.529422; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; LUPTON D, 1993, INT J HEALTH SERV, V23, P425, DOI 10.2190/16AY-E2GC-DFLD-51X2; Macnair P, 1993, GUARDIAN; Matthes J, 2008, J COMMUN, V58, P258, DOI 10.1111/j.1460-2466.2008.00384.x; McCarthy, 1996, RISE RISE DIABETES A; McMahon B, 2013, TIMES; McNaughton D, DIABESITY STIGMATIZI; McNaughton D, 2016, OBESITY CANADA CRITI; McNaughton D, 2013, CRIT PUBLIC HEALTH, V23, P274, DOI 10.1080/09581596.2013.766671; McNaughton D, 2011, CRIT PUBLIC HEALTH, V21, P179, DOI 10.1080/09581596.2010.523680; Meikle J, 2001, GUARDIAN; Monaghan LF, 2013, CRIT PUBLIC HEALTH, V23, P249, DOI 10.1080/09581596.2013.814312; Monaghan LF, 2017, OBESITY NEOLIBERALIS, DOI [10.1080/0958159620171371278, DOI 10.1080/0958159620171371278.2017]; Nicholas S, 2013, MAIL SUNDAY     1020; O'Hara L., 2012, FAT STUDIES, V1, P32, DOI DOI 10.1080/21604851.2012.627790; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; O'Shea S, 1993, DAILY MAIL      0809; Patterson C, 2013, THE GUARDIAN    0828; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Petersen A, 2003, J MED HUMANITIES, V24, P187, DOI [10.1023/A:1026002202396, DOI 10.1023/A:1026002202396]; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; Raisborough J, 2016, FAT BODIES HLTH MEDI, P51, DOI DOI 10.1057/978-1-137-28887-5_3; Rock M, 2005, AM J PUBLIC HEALTH, V95, P1832, DOI 10.2105/AJPH.2004.049866; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Simpson J, 2013, TIMES; Smalls BL, 2017, ENVIRON BEHAV, V49, P560, DOI 10.1177/0013916516652440; Smith C, 2016, AUST J PRIM HEALTH, V22, P360, DOI 10.1071/PY15008; Smyth C, 2013, THE TIMES       1007; Smyth C, 2013, THE TIMES       0703; Stefanik-Sidener K, 2013, HEALTH COMMUN, V28, P351, DOI 10.1080/10410236.2012.688187; Stephens A, 2001, DAILY MAIL      1113; Stuttaford T, 2001, TIMES; Thomson A, 2013, TIMES; Tillin T, 2015, DIABETIC MED, V32, P226, DOI 10.1111/dme.12576; UK D, 2015, DIAB CAR SCOTL; Ulijaszek SJ, 2016, OBES REV, V17, P397, DOI 10.1111/obr.12386; Vines G, 2001, DAILY MAIL      0910; Whipple T, 2013, THE TIMES       0930; World Health Organization,, 1998, WHO TECHN REP SER	117	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0225794	10.1371/journal.pone.0225794	http://dx.doi.org/10.1371/journal.pone.0225794			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951616	gold, Green Published			2022-12-26	WOS:000534370500003
J	Mao, YM; Fisher, DW; Yang, SX; Kezycki, RM; Dong, HX				Mao, Yimin; Fisher, Daniel W.; Yang, Shuxing; Kezycki, Rachel M.; Dong, Hongxin			Protein-protein interactions underlying the behavioral and psychological symptoms of dementia (BPSD) and Alzheimer's disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRANSLATING BASIC SCIENCE; AMYLOID-BETA TOXICITY; NEUROPSYCHIATRIC SYMPTOMS; TAU-PROTEIN; NERVOUS-SYSTEM; MOUSE MODEL; AGGRESSIVE-BEHAVIOR; GENE POLYMORPHISMS	Alzheimer's Disease (AD) is a devastating neurodegenerative disorder currently affecting 45 million people worldwide, ranking as the 6th highest cause of death. Throughout the development and progression of AD, over 90% of patients display behavioral and psychological symptoms of dementia (BPSD), with some of these symptoms occurring before memory deficits and therefore serving as potential early predictors of AD-related cognitive decline. However, the biochemical links between AD and BPSD are not known. In this study, we explored the molecular interactions between AD and BPSD using protein-protein interaction (PPI) networks built from OMIM (Online Mendelian Inheritance in Man) genes that were related to AD and two distinct BPSD domains, the Affective Domain and the Hyperactivity, Impulsivity, Disinhibition, and Aggression (HIDA) Domain. Our results yielded 8 unique proteins for the Affective Domain (RHOA, GRB2, PIK3R1, HSPA4, HSP90AA1, GSK3beta, PRKCZ, and FYN), 5 unique proteins for the HIDA Domain (LRP1, EGFR, YWHAB, SUMO1, and EGR1), and 6 shared proteins between both BPSD domains (APP, UBC, ELAV1, YWHAZ, YWHAE, and SRC) and AD. These proteins might suggest specific targets and pathways that are involved in the pathogenesis of these BPSD domains in AD.	[Mao, Yimin; Yang, Shuxing] Jiangxi Univ Sci & Technol, Sch Informat & Technol, Ganzhou, Jiangxi, Peoples R China; [Mao, Yimin] Jiangxi Univ Sci & Technol, Appl Sci Inst, Ganzhou, Jiangxi, Peoples R China; [Fisher, Daniel W.; Kezycki, Rachel M.; Dong, Hongxin] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA	Jiangxi University of Science & Technology; Jiangxi University of Science & Technology; Northwestern University; Feinberg School of Medicine	Dong, HX (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA.	h-dong@Northwestern.edu			National Institute of Mental Health [R01MH109466, F30MH10924]; National Institute of Aging [R01AG062249]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute of Mental Health grants R01MH109466 (HD) and F30MH10924 (DWF) as well as National Institute of Aging grant R01AG062249 (HD).	Alonso AD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00338; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Assal F, 2004, ARCH NEUROL-CHICAGO, V61, P1249, DOI 10.1001/archneur.61.8.1249; Bae JR, 2017, BMB REP, V50, P237, DOI 10.5483/BMBRep.2017.50.5.038; Bassiony MM, 2000, INT J GERIATR PSYCH, V15, P99, DOI 10.1002/(SICI)1099-1166(200002)15:2<99::AID-GPS82>3.3.CO;2-X; Benko A, 2010, AM J MED GENET B, V153B, P592, DOI 10.1002/ajmg.b.31025; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Bjork JM, 2002, AM J MED GENET, V114, P336, DOI 10.1002/ajmg.10206; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Blair RJR, 2016, J CHILD ADOL PSYCHOP, V26, P4, DOI 10.1089/cap.2015.0088; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bruban J, 2015, FASEB J, V29, P3702, DOI 10.1096/fj.15-270645; Canter RG, 2016, NATURE, V539, P187, DOI 10.1038/nature20412; Castaneda P, 2015, J NEUROSCI RES, V93, P1476, DOI 10.1002/jnr.23602; Cau Y, 2018, CURR MED CHEM, V25, P5, DOI 10.2174/0929867324666170426095015; Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; Chen XH, 2018, MED SCI MONITOR, V24, P5035, DOI 10.12659/MSM.907809; Cheng P, 2015, J NEUROL SCI, V359, P48, DOI 10.1016/j.jns.2015.10.025; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Coccaro EF, 2011, BIOL PSYCHIAT, V69, P1153, DOI 10.1016/j.biopsych.2011.02.032; Colzato LS, 2010, NEUROSCIENCE, V170, P782, DOI 10.1016/j.neuroscience.2010.07.050; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; D'Amelio M, 2018, PHARMACOL RES, V130, P414, DOI 10.1016/j.phrs.2018.01.016; Dalley JW, 2017, NAT REV NEUROSCI, V18, P158, DOI 10.1038/nrn.2017.8; de Jong LW, 2011, J ALZHEIMERS DIS, V23, P49, DOI 10.3233/JAD-2010-101026; Dickey CA, 2006, FASEB J, V20, P753, DOI 10.1096/fj.05-5343fje; Ding H, 2015, NEUROSCIENCE, V307, P73, DOI 10.1016/j.neuroscience.2015.08.042; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Duman CH, 2015, NEUROSCI LETT, V601, P20, DOI 10.1016/j.neulet.2015.01.022; Eisenberg DTA, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-2; Fontaine SN, 2015, CELL MOL LIFE SCI, V72, P1863, DOI 10.1007/s00018-015-1839-9; Fox ME, 2018, MOL PSYCHIAT; Frazzetto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000486; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gallagher D, 2017, CAN J PSYCHIAT, V62, P161, DOI 10.1177/0706743716648296; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Ghosh H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13365; Girach F, 2013, CELL REP, V5, P1294, DOI 10.1016/j.celrep.2013.10.039; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goni J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-52; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Haberstick BC, 2006, BIOL PSYCHIAT, V59, P836, DOI 10.1016/j.biopsych.2005.10.008; Hakulinen C, 2013, J BEHAV MED, V36, P583, DOI 10.1007/s10865-012-9452-y; Hart DJ, 2003, INT J GERIATR PSYCH, V18, P1037, DOI 10.1002/gps.1013; Herbert J, 2016, FRONT NEUROENDOCRIN, V41, P153, DOI 10.1016/j.yfrne.2015.12.001; Honer WG, 2003, NEUROBIOL AGING, V24, P1047, DOI 10.1016/j.neurobiolaging.2003.04.005; Hoptman MJ, 2015, CNS SPECTRUMS, V20, P280, DOI 10.1017/S1092852915000206; Huesa G, 2010, J ALZHEIMERS DIS, V19, P37, DOI 10.3233/JAD-2010-1203; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Iwakura Y, 2011, J NEUROCHEM, V118, P45, DOI 10.1111/j.1471-4159.2011.07287.x; Jadhav S, 2015, TRANSL NEUROSCI, V6, P214, DOI 10.1515/tnsci-2015-0023; Jakubczyk A, 2012, J PSYCHIATR RES, V46, P44, DOI 10.1016/j.jpsychires.2011.09.001; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Joo Y, 2015, FASEB J, V29, P4133, DOI 10.1096/fj.14-265009; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Joy MT, 2015, EXP NEUROL, V263, P150, DOI 10.1016/j.expneurol.2014.10.011; Kales HC, 2019, INT PSYCHOGERIATR, V31, P83, DOI 10.1017/S1041610218000534; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kaplan A, 2017, NEURON, V93, P1082, DOI 10.1016/j.neuron.2017.02.018; Kaplan A, 2014, MOL NEUROBIOL, V49, P1077, DOI 10.1007/s12035-013-8582-8; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kneynsberg A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00572; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Kuepper Y, 2013, BEHAV BRAIN RES, V247, P73, DOI 10.1016/j.bbr.2013.03.002; Lackie RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00254; Lam LCW, 2004, INT J GERIATR PSYCH, V19, P523, DOI 10.1002/gps.1109; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Leclerc MP, 2018, SCHIZOPHR RES, V201, P27, DOI 10.1016/j.schres.2018.06.016; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Leinster VHL, 2013, EXP NEUROL, V239, P82, DOI 10.1016/j.expneurol.2012.09.007; Leroy K, 2007, NEUROPATH APPL NEURO, V33, P43, DOI 10.1111/j.1365-2990.2006.00795.x; Leung JYK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1070-3; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li JY, 2012, PSYCHIAT GENET, V22, P312, DOI 10.1097/YPG.0b013e32835862e2; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Liu H, 2006, J BIOL CHEM, V281, P23611, DOI 10.1074/jbc.M511205200; Liu XJ, 2017, J ALZHEIMERS DIS, V57, P1157, DOI 10.3233/JAD-161111; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Lopes S, 2016, P NATL ACAD SCI USA, V113, pE3755, DOI 10.1073/pnas.1600953113; Lyness SA, 2003, NEUROBIOL AGING, V24, P1, DOI 10.1016/S0197-4580(02)00057-X; Manuck SB, 2000, PSYCHIAT RES, V95, P9, DOI 10.1016/S0165-1781(00)00162-1; Marcelli S, 2017, MOL NEUROBIOL, V54, P6609, DOI 10.1007/s12035-016-0176-9; Marsden WN, 2013, PROG NEURO-PSYCHOPH, V43, P168, DOI 10.1016/j.pnpbp.2012.12.012; Matosin N, 2018, BIOL PSYCHIAT, V83, P821, DOI 10.1016/j.biopsych.2018.01.021; Matsuo M, 2011, BBA-MOL CELL BIOL L, V1811, P31, DOI 10.1016/j.bbalip.2010.10.004; McEwen BS, 2016, BRAIN RES, V1645, P50, DOI 10.1016/j.brainres.2015.12.043; Medina M, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020021; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Meraz-Rios MA, 2010, J NEUROCHEM, V112, P1353, DOI 10.1111/j.1471-4159.2009.06511.x; Mohamed BA, 2012, J MOL CELL CARDIOL, V53, P459, DOI 10.1016/j.yjmcc.2012.07.014; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Nguyen R, 2014, J NEUROSCI, V34, P14948, DOI 10.1523/JNEUROSCI.2204-14.2014; Nobili A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14727; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paloyelis Y, 2010, NEUROPSYCHOPHARMACOL, V35, P2414, DOI 10.1038/npp.2010.124; Parvizi J, 2001, ANN NEUROL, V49, P53, DOI 10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q; Paulsen JS, 2000, NEUROLOGY, V54, P1965, DOI 10.1212/WNL.54.10.1965; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Perez-Rodriguez MM, 2010, J PSYCHIATR RES, V44, P1075, DOI 10.1016/j.jpsychires.2010.03.014; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qin XK, 2017, AM J PATHOL, V187, P1828, DOI 10.1016/j.ajpath.2017.04.018; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; QUETGLAS A, 2017, RECEPTORS CLIN INVES, V4, DOI DOI 10.3389/FMARS.2017.00106; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Reif A, 2007, NEUROPSYCHOPHARMACOL, V32, P2375, DOI 10.1038/sj.npp.1301359; Rujescu D, 2003, BIOL PSYCHIAT, V54, P34, DOI 10.1016/S0006-3223(02)01831-0; Safari-Alighiarloo Nahid, 2014, Gastroenterol Hepatol Bed Bench, V7, P17; Scarmeas N, 2005, NEUROLOGY, V64, P1696, DOI 10.1212/01.WNL.0000162054.15428.E9; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Sekiguchi H, 2011, BRAIN RES, V1392, P47, DOI 10.1016/j.brainres.2011.03.058; Shafiei SS, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00083; Shimada T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/564534; Shinohara M, 2017, J LIPID RES, V58, P1267, DOI 10.1194/jlr.R075796; Sima S, 2018, BBA-MOL CELL RES, V1865, P889, DOI 10.1016/j.bbamcr.2018.03.008; Simic G, 2017, PROG NEUROBIOL, V151, P101, DOI 10.1016/j.pneurobio.2016.04.001; Soeiro-De-Souza MG, 2013, MOL MED REP, V7, P1067, DOI 10.3892/mmr.2013.1336; Sonuga-Barke EJS, 2011, BIOL PSYCHIAT, V70, P230, DOI 10.1016/j.biopsych.2011.01.040; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Sulistio YA, 2016, MOL NEUROBIOL, V53, P905, DOI 10.1007/s12035-014-9063-4; Sweet RA, 1998, ARCH NEUROL-CHICAGO, V55, P1335, DOI 10.1001/archneur.55.10.1335; Talman V, 2016, BASIC CLIN PHARMACOL, V119, P149, DOI 10.1111/bcpt.12581; Tang LTH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8728; Tata DA, 2010, PHYSIOL BEHAV, V99, P186, DOI 10.1016/j.physbeh.2009.09.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Nguyen TP, 2012, ARTIF INTELL MED, V54, P63, DOI 10.1016/j.artmed.2011.09.003; Nguyen TP, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-179; Thompson SM, 2015, TRENDS NEUROSCI, V38, P279, DOI 10.1016/j.tins.2015.03.003; Tochimoto S, 2015, PSYCHOGERIATRICS, V15, P248, DOI 10.1111/psyg.12114; Toglia P, 2016, CELL CALCIUM, V59, P240, DOI 10.1016/j.ceca.2016.02.013; Torrisi M, 2017, PSYCHOGERIATRICS, V17, P103, DOI 10.1111/psyg.12197; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; van der Linde RM, 2014, INT J GERIATR PSYCH, V29, P562, DOI 10.1002/gps.4037; van Niekerk EA, 2007, P NATL ACAD SCI USA, V104, P12913, DOI 10.1073/pnas.0611562104; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Victoroff J, 2018, J NEUROPSYCH CLIN N, V30, P14, DOI 10.1176/appi.neuropsych.16080155; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Waltes R, 2016, AM J MED GENET B, V171, P650, DOI 10.1002/ajmg.b.32388; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yam PT, 2012, NEURON, V76, P735, DOI 10.1016/j.neuron.2012.09.017; Yoon C, 2013, J BIOL CHEM, V288, P26557, DOI 10.1074/jbc.M113.478552; Zabik NL, 2017, BIOCHEM CELL BIOL, V95, P338, DOI 10.1139/bcb-2016-0227; Zouk H, 2007, AM J MED GENET B, V144B, P996, DOI 10.1002/ajmg.b.30521; Zschatzsch M, 2014, ELIFE, V3, DOI 10.7554/eLife.01699; Zuehlke AD, 2015, GENE, V570, P8, DOI 10.1016/j.gene.2015.06.018	163	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0226021	10.1371/journal.pone.0226021	http://dx.doi.org/10.1371/journal.pone.0226021			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951614	gold, Green Published			2022-12-26	WOS:000534370500004
J	Lopez-Vicchi, F; Ladyman, SR; Ornstein, AM; Gustafson, P; Knowles, P; Luque, GM; Grattan, DR; Becu-Villalobos, D				Lopez-Vicchi, Felicitas; Ladyman, Sharon R.; Ornstein, Ana Maria; Gustafson, Papillon; Knowles, Penelope; Maria Luque, Guillermina; Grattan, David R.; Becu-Villalobos, Damasia			Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake	FASEB JOURNAL			English	Article						AGRP; arcuate nucleus; leptin; NPY; STAT	MESSENGER-RIBONUCLEIC-ACID; DOPAMINE D2 RECEPTORS; BROWN ADIPOSE-TISSUE; DIET-INDUCED OBESITY; LEPTIN RESISTANCE; NEUROPEPTIDE-Y; BODY-WEIGHT; ENERGY-BALANCE; DORSOMEDIAL HYPOTHALAMUS; SIGNAL TRANSDUCER	To study the pathological effects of continuous hyperprolactinemia on food intake mechanisms we used female mice that lack dopamine D2 receptors in lactotropes (lacDrd2KO). These mice had lifelong hyperprolactinemia, increased food intake, and gradual development of obesity from 5 to 10 months of age. Ongoing endogenous prolactin signaling in lacDrd2KO mice was evidenced by increased basal phosphorylation of STAT5b in hypothalamic areas related to food intake, such as the arcuate (ARN), dorsomedial (DMN), and ventromedial nuclei. In the ARN of young lacDrd2KO mice there were higher Prlr mRNA levels and in obese 10-month-old lacDrd2KO mice increased expression of the orexigenic genes Neuropeptide Y (Npy) and Agouti-related peptide, compared to controls. Furthermore, Npy expression was increased in the DMN, probably contributing to increased food intake and decreased expression of Uncoupling protein-1 in brown adipose tissue, both events favoring weight gain. Leptin resistance in obese lacD2RKO mice was evidenced by its failure to lower food intake and a dampened response of STAT3 phosphorylation, specifically in the mediobasal hypothalamus. Our results suggest that pathological chronically high prolactin levels, as found in psychiatric treatments or patients with prolactinomas, may impact on specific hypothalamic nuclei altering gene expression, leptin response, and food intake.	[Lopez-Vicchi, Felicitas; Ornstein, Ana Maria; Maria Luque, Guillermina; Becu-Villalobos, Damasia] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina; [Ladyman, Sharon R.; Gustafson, Papillon; Knowles, Penelope; Grattan, David R.] Univ Otago, Ctr Neuroendocrinol, Dept Anat, Sch Biomed Sci, Dunedin, New Zealand; [Ladyman, Sharon R.; Grattan, David R.] Maurice Wilkins Ctr, Auckland, New Zealand	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Otago	Becu-Villalobos, D (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Vuelta Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	dbecu@dna.uba.ar	Luque, Guillermina/M-9237-2019	Luque, Guillermina/0000-0002-2745-8236; Grattan, Dave/0000-0001-5606-2559	National Institute of Diabetes and Digestive and Kidney Diseases' National Hormone and Pituitary Program [14, 568]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 1343-2015, PICT 526-2016]; Fundacion Rene Baron; Fundacion Williams; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Fundacion Bunge & Born-Oster Fellowship; Health Research Council [14/568]; Maurice Wilkins Centre for Molecular Biodiscovery	National Institute of Diabetes and Digestive and Kidney Diseases' National Hormone and Pituitary Program; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Fundacion Rene Baron; Fundacion Williams; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Bunge & Born-Oster Fellowship; Health Research Council; Maurice Wilkins Centre for Molecular Biodiscovery	National Institute of Diabetes and Digestive and Kidney Diseases' National Hormone and Pituitary Program, Grant/Award Number: 14 and 568,; Agencia Nacional de Promocion Cientifica y Tecnologica, Grant/Award Number: PICT 1343-2015 and PICT 526-2016; Fundacion Rene Baron; Fundacion Williams; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Fundacion Bunge & Born-Oster Fellowship; Health Research Council, Grant/Award Number: 14/568; Maurice Wilkins Centre for Molecular Biodiscovery	Anderson GM, 2006, ENDOCRINOLOGY, V147, P4996, DOI 10.1210/en.2005-0755; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Augustine RA, 2008, ENDOCRINOLOGY, V149, P1049, DOI 10.1210/en.2007-1018; Augustine RA, 2008, J PHYSIOL-LONDON, V586, P387, DOI 10.1113/jphysiol.2007.146316; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Bello EP, 2011, NAT NEUROSCI, V14, P1033, DOI 10.1038/nn.2862; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; Bi S, 2012, NEUROPEPTIDES, V46, P309, DOI 10.1016/j.npep.2012.09.002; Billesa SK, 2012, MOL METAB, V1, P86, DOI 10.1016/j.molmet.2012.07.003; Bridges RS, 2019, J NEUROENDOCRINOL, V31, DOI 10.1111/jne.12669; Brown RSE, 2011, BIOL REPROD, V84, P826, DOI 10.1095/biolreprod.110.089185; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Buonfiglio DC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22421; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Chen PL, 1999, ENDOCRINOLOGY, V140, P2645, DOI 10.1210/en.140.6.2645; Chen PL, 2004, ENDOCRINOLOGY, V145, P823, DOI 10.1210/en.2003-1255; Chhabra KH, 2016, MOL METAB, V5, P869, DOI 10.1016/j.molmet.2016.07.012; Cordeira J, 2011, MOL NEUROBIOL, V44, P441, DOI 10.1007/s12035-011-8212-2; Doknic M, 2002, EUR J ENDOCRINOL, V147, P77, DOI 10.1530/eje.0.1470077; Donner N, 2007, EUR J NEUROSCI, V25, P1804, DOI 10.1111/j.1460-9568.2007.05416.x; EGAWA M, 1991, AM J PHYSIOL, V260, pR328, DOI 10.1152/ajpregu.1991.260.2.R328; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Garcia-Tornadu I, 2009, NEUROPEPTIDES, V43, P267, DOI 10.1016/j.npep.2009.06.002; GERARDOGETTENS T, 1989, AM J PHYSIOL, V256, pR701, DOI 10.1152/ajpregu.1989.256.3.R701; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; GUSTAFSON AB, 1980, J CLIN ENDOCR METAB, V51, P242, DOI 10.1210/jcem-51-2-242; Hofker M, 2009, NAT GENET, V41, P139, DOI 10.1038/ng0209-139; Jeon Y, 2016, BIOCHEM BIOPH RES CO, V470, P818, DOI 10.1016/j.bbrc.2016.01.115; Kamiji MM, 2007, ENDOCR REV, V28, P664, DOI 10.1210/er.2007-0003; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; Kim KS, 2010, J BIOL CHEM, V285, P8905, DOI 10.1074/jbc.M109.079590; Kokay Ilona C, 2018, J Neuroendocrinol, V30, pe12634, DOI 10.1111/jne.12634; Lacruz A, 2000, MOL PSYCHIATR, V5, P70, DOI 10.1038/sj.mp.4000566; Ladyman SR, 2017, J NEUROENDOCRINOL, V29, DOI 10.1111/jne.12474; Ladyman SR, 2012, REPRODUCTION, V144, P83, DOI 10.1530/REP-12-0112; Ladyman SR, 2010, J NEUROENDOCRINOL, V22, P805, DOI 10.1111/j.1365-2826.2010.02017.x; Ladyman SR, 2005, ENDOCRINOLOGY, V146, P3868, DOI 10.1210/en.2005-0194; Ladyman SR, 2004, ENDOCRINOLOGY, V145, P3704, DOI 10.1210/en.2004-0338; Lau J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00313; Le TN, 2013, GENET TEST MOL BIOMA, V17, P567, DOI 10.1089/gtmb.2013.0009; LeBaron MJ, 2007, ENDOCRINOLOGY, V148, P989, DOI 10.1210/en.2006-1219; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Vicchi FL, 2016, PHARMACOL RES, V109, P74, DOI 10.1016/j.phrs.2015.12.029; Luque GM, 2016, AM J PHYSIOL-ENDOC M, V311, pE974, DOI 10.1152/ajpendo.00200.2016; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Naef L, 2007, ENDOCRINOLOGY, V148, P5977, DOI 10.1210/en.2007-0442; Nagaishi VS, 2014, NEUROSCIENCE, V259, P71, DOI 10.1016/j.neuroscience.2013.11.050; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Nilsson L, 2011, MOL GENET METAB, V102, P78, DOI 10.1016/j.ymgme.2010.08.017; Noain D, 2013, J NEUROSCI, V33, P5834, DOI 10.1523/JNEUROSCI.5673-12.2013; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pala NA, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0094-4; Paxinos G, 2008, MOUSE BRAIN STEROTAX; Millan MIP, 2014, ENDOCRINOLOGY, V155, P829, DOI 10.1210/en.2013-1707; Roh E, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.4; Salais-Lopez H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208960; Sapsford TJ, 2012, J COMP NEUROL, V520, P1062, DOI 10.1002/cne.22775; Sauve D, 2000, BRAIN RES, V868, P306, DOI 10.1016/S0006-8993(00)02344-1; Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431; SCHERNTHANER G, 1985, DIABETOLOGIA, V28, P138; Serri O, 2006, CLIN ENDOCRINOL, V64, P366, DOI 10.1111/j.1365-2265.2006.02469.x; Sjoeholm A, 2011, ENDOCRINOLOGY, V152, P1979, DOI 10.1210/en.2010-1220; Tanner JM, 2010, EXP BIOL MED, V235, P1489, DOI 10.1258/ebm.2010.010171; Tuzcu A, 2009, PITUITARY, V12, P330, DOI 10.1007/s11102-009-0183-1; Viengchareun S, 2004, J MOL ENDOCRINOL, V33, P679, DOI 10.1677/jme.1.01563; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Wu QL, 2014, ENDOCRINOLOGY, V155, P840, DOI 10.1210/en.2013-1831; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yavuz D, 2003, EUR J ENDOCRINOL, V149, P187, DOI 10.1530/eje.0.1490187; Zhang Y, 2011, J NEUROSCI, V31, P1873, DOI 10.1523/JNEUROSCI.3223-10.2011	71	13	13	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3902	3914		10.1096/fj.201902357R	http://dx.doi.org/10.1096/fj.201902357R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944423	Bronze			2022-12-26	WOS:000507595100001
J	Mongia, A; Majumdar, A				Mongia, Aanchal; Majumdar, Angshul			Drug-target interaction prediction using Multi Graph Regularized Nuclear Norm Minimization	PLOS ONE			English	Article							INTEGRATION	The identification of potential interactions between drugs and target proteins is crucial in pharmaceutical sciences. The experimental validation of interactions in genomic drug discovery is laborious and expensive; hence, there is a need for efficient and accurate in-silico techniques which can predict potential drug-target interactions to narrow down the search space for experimental verification. In this work, we propose a new framework, namely, Multi-Graph Regularized Nuclear Norm Minimization, which predicts the interactions between drugs and target proteins from three inputs: known drug-target interaction network, similarities over drugs and those over targets. The proposed method focuses on finding a low-rank interaction matrix that is structured by the proximities of drugs and targets encoded by graphs. Previous works on Drug Target Interaction (DTI) prediction have shown that incorporating drug and target similarities helps in learning the data manifold better by preserving the local geometries of the original data. But, there is no clear consensus on which kind and what combination of similarities would best assist the prediction task. Hence, we propose to use various multiple drug-drug similarities and target-target similarities as multiple graph Laplacian (over drugs/targets) regularization terms to capture the proximities exhaustively. Extensive cross-validation experiments on four benchmark datasets using standard evaluation metrics (AUPR and AUC) show that the proposed algorithm improves the predictive performance and outperforms recent state-of-the-art computational methods by a large margin. Software is publicly available at htttps://github.com/aanchalMongia/MGRNNMforDTI.	[Mongia, Aanchal] IIIT Delhi, Dept Comp Sci & Engn, Delhi, India; [Majumdar, Angshul] IIIT Delhi, Dept Elect & Commun Engn, Delhi, India	Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi	Majumdar, A (corresponding author), IIIT Delhi, Dept Elect & Commun Engn, Delhi, India.	aanchalm@iiitd.ac.in						Albert I, 2004, BIOINFORMATICS, V20, P3346, DOI 10.1093/bioinformatics/bth402; Alkan C, 2006, J COMPUT BIOL, V13, P267, DOI 10.1089/cmb.2006.13.267; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Boyd S., 2011, TALK NIPS WORKSH OPT; Candes EJ, 2010, IEEE T INFORM THEORY, V56, P2053, DOI 10.1109/TIT.2010.2044061; Candes EJ, 2009, FOUND COMPUT MATH, V9, P717, DOI 10.1007/s10208-009-9045-5; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062975; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chung F., 1996, SPECTRAL GRAPH THEOR; Cobanoglu MC, 2013, J CHEM INF MODEL, V53, P3399, DOI 10.1021/ci400219z; Combettes PL, 2011, SPRINGER SER OPTIM A, V49, P185, DOI 10.1007/978-1-4419-9569-8_10; Dai YF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/239654; Ezzat A, 2017, IEEE ACM T COMPUT BI, V14, P646, DOI 10.1109/TCBB.2016.2530062; Ezzat Ali, 2018, BRIEFINGS BIOINFORMA, V2018; Frantz S., 2005, DRUG DISCOVERY PLAYI; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hattori M, 2010, NUCLEIC ACIDS RES, V38, pW652, DOI 10.1093/nar/gkq367; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Johnson A, 1991, CONCEPTS APPL MOL SI; Kalofolias V., 2014, ARXIV14081717, DOI DOI 10.1016/j.compchemeng.2009.01.019; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kirrinnis P, 2001, THEOR COMPUT SCI, V259, P623, DOI 10.1016/S0304-3975(00)00322-4; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; LI HL, 2006, NUCL ACIDS RES S2, V34, pW21, DOI DOI 10.2174/157341208783497597; Liu Y, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004760; Majumdar A, 2011, SIGNAL PROCESS, V91, P1334, DOI 10.1016/j.sigpro.2010.12.005; Masoudi-Nejad Ali, 2013, In Silico Pharmacology, V1, P17, DOI 10.1186/2193-9616-1-17; McLean SR, 2005, MOL CANCER THER, V4, P2008, DOI 10.1158/1535-7163.MCT-05-0070; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Nagamine N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000397; Nishihara R., 2015, P 32 INT C MACH LEAR; Pahikkala T, 2015, BRIEF BIOINFORM, V16, P325, DOI 10.1093/bib/bbu010; Recht B, 2011, J MACH LEARN RES, V12, P3413; Sarwar B., 2001, PROC 10 INT WORLD WI, P285, DOI 10.1145/371920.372071; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Shi JY, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0663-x; Shi JY, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1118-2; Shi JY, 2015, IEEE INT C BIOINFORM, P1636, DOI 10.1109/BIBM.2015.7359921; Shi JY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/350983; Shi JY, 2015, LECT NOTES COMPUT SC, V9243, P477, DOI 10.1007/978-3-319-23862-3_47; Shi JY, 2015, METHODS, V83, P98, DOI 10.1016/j.ymeth.2015.04.036; van Laarhoven T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066952; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Vaque M, 2008, CURR PHARM ANAL, V4, P1; Wang MH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1425608; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037608; Zheng XD, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1025	59	18	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0226484	10.1371/journal.pone.0226484	http://dx.doi.org/10.1371/journal.pone.0226484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945078	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100011
J	Robert, P; Vergara, C; Silva-Weiss, A; Osorio, FA; Santander, R; Saenz, C; Gimenez, B				Robert, Paz; Vergara, Cristina; Silva-Weiss, Andrea; Osorio, Fernando A.; Santander, Rocio; Saenz, Carmen; Gimenez, Begona			Influence of gelation on the retention of purple cactus pear extract in microencapsulated double emulsions	PLOS ONE			English	Article							N-3 FATTY-ACIDS; PERFORMANCE LIQUID-CHROMATOGRAPHY; GELLED DOUBLE EMULSIONS; IN-WATER EMULSIONS; DELIVERY-SYSTEM; HYDROXYTYROSOL; STABILITY; BETALAIN; BETANIN; ENCAPSULATION	A purple cactus pear (Opuntia ficus-indica) extract (CP) was encapsulated in double emulsions (DE) gelled with gelatin (DE-CP-G) and with gelatin and transglutaminase (DE-CP-GT), as well as in a DE with a liquid external aqueous phase (DE-CP), in order to study the retention of betanin as colorant agent. Both gelled DEs showed a predominantly elastic behavior,in contrast with DE-CP. The degradation rate constant of betanin was significantly higher in DE-CP-GT (90.2 x 10(-3) days(-1)) than in DE-CP-G (11.0 x 10(-3) days-(1)) and DE-CP (14.6 x 10(-3) days(-1)) during cold-storage (4 degrees C). A shift towards yellow color was found in all the systems during cold-storage (4 degrees C) and after thermal treatment (70 degrees C/30 min), especially in DE-CP-GT, denoting a higher degradation of betanin. Betalamic acid, cyclo-Dopa 5-O-beta-glucoside, 17-decarboxy-betanin and neobetanin were identified by UHPLC-MS/MS as degradation products of betanin.	[Robert, Paz] Univ Chile, Fac Ciencias Quim & Farmaceut, Dept Ciencia Alimentos & Tecnol Quim, Santiago, Chile; [Vergara, Cristina] Inst Invest Agr, INIA La Platina, Santiago, Chile; [Silva-Weiss, Andrea; Osorio, Fernando A.; Gimenez, Begona] Univ Santiago Chile, Fac Tecnol, Dept Ciencia & Tecnol Alimentos, Santiago, Chile; [Santander, Rocio] Univ Santiago Chile, Fac Quim & Biol, Dept Ciencias Ambiente, Santiago, Chile; [Saenz, Carmen] Univ Chile, Fac Ciencias Agron, Dept Agroind & Enol, Santiago, Chile	Universidad de Chile; Universidad de Santiago de Chile; Universidad de Santiago de Chile; Universidad de Chile	Gimenez, B (corresponding author), Univ Santiago Chile, Fac Tecnol, Dept Ciencia & Tecnol Alimentos, Santiago, Chile.	bego.gimenez@usach.cl	Santander, Rocio/K-7645-2013; Osorio, Fernando Alberto/AAY-7304-2021; Vergara, Cristina/AAT-9575-2021; Silva-Weiss, Andrea/AAL-3271-2021; Robert, Paz/G-8198-2014	Osorio, Fernando Alberto/0000-0001-7206-0924; Silva-Weiss, Andrea/0000-0001-7541-9947; 	FONDECYT [1150835]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by FONDECYT 1150835 (Conicyt -Chile).	Andrade J, 2018, FOOD RES INT, V105, P41, DOI 10.1016/j.foodres.2017.10.070; [Anonymous], 2016, FOOD EMULSIONS PRINC; Bou R, 2014, LWT-FOOD SCI TECHNOL, V59, P621, DOI 10.1016/j.lwt.2014.06.044; Bou R, 2014, INNOV FOOD SCI EMERG, V23, P1, DOI 10.1016/j.ifset.2014.04.001; Cai YZ, 1998, J AGR FOOD CHEM, V46, P4491, DOI 10.1021/jf980457g; Cofrades S, 2013, FOOD CHEM, V141, P338, DOI 10.1016/j.foodchem.2013.02.097; Cofrades S, 2017, J FOOD SCI TECH MYS, V54, P1785, DOI 10.1007/s13197-017-2604-x; Dickinson E, 2011, FOOD BIOPHYS, V6, P1, DOI 10.1007/s11483-010-9188-6; Ding SK, 2019, J CONTROL RELEASE, V295, P31, DOI 10.1016/j.jconrel.2018.12.037; Eisinaite V, 2017, J FOOD ENG, V213, P54, DOI 10.1016/j.jfoodeng.2017.05.022; Esatbeyoglu T, 2015, MOL NUTR FOOD RES, V59, P36, DOI 10.1002/mnfr.201400484; Pagano APE, 2018, FOOD RES INT, V109, P489, DOI 10.1016/j.foodres.2018.04.053; Esteves LC, 2018, PHOTOCHEM PHOTOBIOL, V94, P853, DOI 10.1111/php.12897; Fernandez-Lopez JA, 2001, J CHROMATOGR A, V913, P415, DOI 10.1016/S0021-9673(00)01224-3; Flaiz L, 2016, FOOD CHEM, V213, P49, DOI 10.1016/j.foodchem.2016.06.005; FORNI E, 1992, J CHROMATOGR, V593, P177, DOI 10.1016/0021-9673(92)80284-2; Freire M, 2017, J FOOD SCI TECH MYS, V54, P3959, DOI 10.1007/s13197-017-2860-9; Freire M, 2017, FOOD RES INT, V100, P298, DOI 10.1016/j.foodres.2017.08.047; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Herbach KA, 2006, J AGR FOOD CHEM, V54, P390, DOI 10.1021/jf051854b; Herbach KM, 2006, J FOOD SCI, V71, pR41, DOI 10.1111/j.1750-3841.2006.00022.x; Herbach KM, 2004, EUR FOOD RES TECHNOL, V219, P377, DOI 10.1007/s00217-004-0948-8; Herbach KM, 2004, J FOOD SCI, V69, pC491, DOI 10.1111/j.1365-2621.2004.tb10994.x; Jimenez-Colmenero F, 2015, TRENDS FOOD SCI TECH, V44, P177, DOI 10.1016/j.tifs.2015.04.011; Jimenez-Colmenero F, 2013, FOOD RES INT, V52, P64, DOI 10.1016/j.foodres.2013.02.040; Kaimainen M, 2015, LWT-FOOD SCI TECHNOL, V60, P899, DOI 10.1016/j.lwt.2014.10.016; Khan MI, 2016, FOOD CHEM, V197, P1280, DOI 10.1016/j.foodchem.2015.11.043; Kukizaki M, 2007, COLLOID SURFACE A, V293, P87, DOI 10.1016/j.colsurfa.2006.07.011; Lamba H, 2015, FOOD BIOPROCESS TECH, V8, P709, DOI 10.1007/s11947-014-1468-6; Ma LL, 2017, J AGR FOOD CHEM, V65, P9735, DOI 10.1021/acs.jafc.7b04042; Mao LK, 2015, FOOD ENG REV, V7, P439, DOI 10.1007/s12393-015-9108-0; Matos M, 2018, J FOOD ENG, V226, P73, DOI 10.1016/j.jfoodeng.2018.01.007; McClements DJ, 2009, CRIT REV FOOD SCI, V49, P577, DOI 10.1080/10408390902841529; Ninfali P, 2013, FITOTERAPIA, V89, P188, DOI 10.1016/j.fitote.2013.06.004; Pigment Guneser O., 2016, FOOD CHEM, V196, P220, DOI [10.1016/j.foodchem.2015.09.033, DOI 10.1016/J.FOODCHEM.2015.09.033]; ROSSMURPHY SB, 1995, J TEXTURE STUD, V26, P391, DOI 10.1111/j.1745-4603.1995.tb00979.x; Saenz C, 2009, FOOD CHEM, V114, P616, DOI 10.1016/j.foodchem.2008.09.095; Silva W, 2018, FOOD CHEM, V253, P71, DOI 10.1016/j.foodchem.2018.01.128; Stintzing FC, 2005, J AGR FOOD CHEM, V53, P442, DOI 10.1021/jf048751y; Surh J, 2007, J AGR FOOD CHEM, V55, P175, DOI 10.1021/jf061637q; Vergara C, 2014, FOOD CHEM, V157, P246, DOI 10.1016/j.foodchem.2014.02.037; Weiss J, 2005, FOOD HYDROCOLLOID, V19, P605, DOI 10.1016/j.foohyd.2004.10.023; Yang M, 2013, FOOD RES INT, V52, P409, DOI 10.1016/j.foodres.2011.11.012	43	3	3	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227866	10.1371/journal.pone.0227866	http://dx.doi.org/10.1371/journal.pone.0227866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945132	Green Published, gold			2022-12-26	WOS:000534370100068
J	Vargas-Molina, S; Martin-Rivera, F; Bonilla, DA; Petro, JL; Carbone, L; Romance, R; deDiego, M; Schoenfeld, BJ; Benitez-Porres, J				Vargas-Molina, Salvador; Martin-Rivera, Fernando; Bonilla, Diego A.; Petro, Jorge L.; Carbone, Leandro; Romance, Ramon; deDiego, Manuel; Schoenfeld, Brad J.; Benitez-Porres, Javier			Comparison of blood lactate and perceived exertion responses in two matched time-under-tension protocols	PLOS ONE			English	Article							RESISTANCE EXERCISE; HYPERTROPHIC ADAPTATIONS; CONCURRENT VALIDATION; REPETITION DURATION; MUSCLE HYPERTROPHY; HORMONE; ACTIVATION; MECHANISMS	Purpose The aim of this study was to compare the concentration of blood lactate [bLa-] and the subjective perception of exertion of trained men in a moderate repetition protocol (MRP) versus a high repetition protocol (HRP) equated for time under tension. Methods A sample of 40 healthy young men (aged, 23.2 +/- 4.0 years; height, 177.3 +/- 7.0 cm; BMI, 24.3 +/- 2.2) performed two sessions of 8 sets of bicep curls with a one-week recovery interval between the trials. In the HRP protocol, 20 repetitions were performed with a cadence of 2 seconds of eccentric and 1 second of concentric, while in the MRP protocol 10 repetitions were performed with 4 seconds of eccentric and 2 seconds of concentric. Cadences were controlled by a metronome. At the beginning and end of each of the sessions, blood lactate was taken at 2, 15, and 30 minutes, and rating of perceived exertion (OMNI-RES) was assessed immediately after completion of each session. Results There were [bLa-] differences between protocols in the MRP 2 min, (5.2 +/- 1.4); 15 min, (3.2 +/- 1.2); 30 min, (1.9 +/- 0.6); p< 0.05, and the HRP 2 min, (6.1 +/- 1.6); 15 min, (3.7 +/- 1.1); 30 min, (2.2 +/- 0.6); p< 0.01. OMNI-RES was higher in HRP, (8.8 +/- 0.7) than in MRP, (7.7 +/- 0.9). Additionally, a correlation was found between the RPE and [bLa-] values in the HRP protocol (rs = 0.35, p < 0.01). Conclusions Training protocols with high times under tension promote substantial increases in metabolic stress, however, our findings indicate that HRP generates more [bLa-] than MRP. In addition, there were higher RPE values in the HRP protocol compared to MRP in single-joint exercises.	[Vargas-Molina, Salvador; deDiego, Manuel] Univ Wales Trinity St David, EADE, Malaga, Spain; [Vargas-Molina, Salvador; Romance, Ramon; Benitez-Porres, Javier] Univ Malaga, Human Kinet & Body Composit Lab, Malaga, Spain; [Martin-Rivera, Fernando] Univ Valencia, Res Unit Sports & Hlth, Valencia, Spain; [Bonilla, Diego A.] DBSS Int, Res Div, Bogota, Colombia; [Petro, Jorge L.] Univ Cordoba, Res Grp Phys Act Sports & Hlth Sci GICAFS, Monteria, Colombia; [Carbone, Leandro] Univ Salvador, Buenos Aires, DF, Argentina; [Schoenfeld, Brad J.] CUNY Lehman Coll, Hlth Sci Dept, Bronx, NY USA	Universidad de Malaga; University of Valencia; City University of New York (CUNY) System	Benitez-Porres, J (corresponding author), Univ Malaga, Human Kinet & Body Composit Lab, Malaga, Spain.	benitez@uma.es	Petro, Jorge Luis Luis/A-8547-2014; Martín-Rivera, Fernando/AFY-1539-2022; Bonilla, Diego A./I-5769-2019; Benítez-Porres, Javier/R-5211-2019; Petro, Jorge Luis/P-4397-2018; Vargas-Molina, Salvador/AAM-8008-2020	Petro, Jorge Luis Luis/0000-0001-5678-1000; Martín-Rivera, Fernando/0000-0003-1996-8276; Bonilla, Diego A./0000-0002-2634-1220; Benítez-Porres, Javier/0000-0001-7546-7965; Petro, Jorge Luis/0000-0001-5678-1000; Vargas-Molina, Salvador/0000-0001-6775-9159; Carbone, Leandro/0000-0003-3507-1434	Universidad de Ma'by Universidad de Ma'laga, 38-2019-H to JB-P. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. [38-2019-H]	Universidad de Ma'by Universidad de Ma'laga, 38-2019-H to JB-P. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	This work was supported by Universidad de Ma ' laga, 38-2019-H to JB-P. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniceto RR, 2015, J STRENGTH COND RES, V29, P3336, DOI 10.1519/JSC.0000000000000998; Broxterman RM, 2018, J PHYSIOL-LONDON, V596, P2301, DOI 10.1113/JP275817; Buitrago S, 2012, EUR J APPL PHYSIOL, V112, P2739, DOI 10.1007/s00421-011-2249-9; Dankel SJ, 2017, EUR J APPL PHYSIOL, V117, P2125, DOI 10.1007/s00421-017-3690-1; Forsyth JJ, 2000, BRIT J SPORT MED, V34, P35, DOI 10.1136/bjsm.34.1.35; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gentil Paulo, 2006, Journal of Physiological Anthropology, V25, P339, DOI 10.2114/jpa2.25.339; Gentil Paulo, 2006, Rev Bras Med Esporte, V12, P303, DOI 10.1590/S1517-86922006000600001; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hollander DB, 2017, J STRENGTH COND RES, V31, P1387, DOI 10.1519/JSC.0000000000001290; Hollander DB, 2008, J STRENGTH COND RES, V22, P1184, DOI 10.1519/JSC.0b013e31816a8bc2; Kraemer RR, 1996, INT J SPORTS MED, V17, P12, DOI 10.1055/s-2007-972801; Kraemer WJ, 2005, SPORTS MED, V35, P339, DOI 10.2165/00007256-200535040-00004; Lacerda LT, 2016, J STRENGTH COND RES, V30, P251, DOI 10.1519/JSC.0000000000001044; Mangine GT, 2017, J STRENGTH COND RES, V31, P45, DOI 10.1519/JSC.0000000000001491; Morton RW, 2016, J APPL PHYSIOL, V121, P129, DOI 10.1152/japplphysiol.00154.2016; Nalbandian Minas, 2016, Biology-Basel, V5, P38, DOI 10.3390/biology5040038; Oishi Y, 2015, J APPL PHYSIOL, V118, P742, DOI 10.1152/japplphysiol.00054.2014; Pierce JR, 2006, J APPL PHYSIOL, V101, P1588, DOI 10.1152/japplphysiol.00585.2006; PIERCE K, 1993, J STRENGTH COND RES, V7, P211, DOI DOI 10.1519/00124278-199311000-00004; Robertson RJ, 2003, MED SCI SPORT EXER, V35, P333, DOI 10.1249/01.MSS.0000048831.15016.2A; Scherr J, 2013, EUR J APPL PHYSIOL, V113, P147, DOI 10.1007/s00421-012-2421-x; Schoenfeld BJ, 2015, SPORTS MED, V45, P577, DOI 10.1007/s40279-015-0304-0; Schoenfeld BJ, 2013, J STRENGTH COND RES, V27, P1720, DOI 10.1519/JSC.0b013e31828ddd53; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P2857, DOI 10.1519/JSC.0b013e3181e840f3; Suminski RR, 1997, J STRENGTH COND RES, V11, P261; Tsukamoto S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113649; Utter AC, 2002, MED SCI SPORT EXER, V34, P560, DOI 10.1097/00005768-200203000-00026; Weakley JJS, 2017, EUR J APPL PHYSIOL, V117, P1877, DOI 10.1007/s00421-017-3680-3	30	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227640	10.1371/journal.pone.0227640	http://dx.doi.org/10.1371/journal.pone.0227640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940407	Green Published, gold			2022-12-26	WOS:000534368000086
J	Barrio, RA; Alarcon, T; Hernandez-Machado, A				Barrio, R. A.; Alarcon, Tomas; Hernandez-Machado, A.			The dynamics of shapes of vesicle membranes with time dependent spontaneous curvature	PLOS ONE			English	Article							FTSZ FILAMENTS; Z-RING; DIVISION; CONSTRICTION	We study the time evolution of the shape of a vesicle membrane under time-dependent spontaneous curvature by means of phase-field model. We introduce the variation in time of the spontaneous curvature via a second field which represents the concentration of a substance that anchors with the lipid bilayer thus changing the local curvature and producing constriction. This constriction is mediated by the action on the membrane of an structure resembling the role of a Z ring. Our phase-field model is able to reproduce a number of different shapes that have been experimentally observed. Different shapes are associated with different constraints imposed upon the model regarding conservation of membrane area. In particular, we show that if area is conserved our model reproduces the so-called L-form shape. By contrast, if the area of the membrane is allowed to grow, our model reproduces the formation of a septum in the vicinity of the constriction. Furthermore, we propose a new term in the free energy which allows the membrane to evolve towards eventual pinching.	[Barrio, R. A.] Univ Nacl Autonoma Mexico, Inst Fis, Apartado Postal 20-364, Mexico City 01000, DF, Mexico; [Alarcon, Tomas] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain; [Alarcon, Tomas; Hernandez-Machado, A.] Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Bellaterra 08193, Barcelona, Spain; [Alarcon, Tomas] Univ Autonoma Barcelona, Dept Matemat, Bellaterra 08193, Barcelona, Spain; [Alarcon, Tomas; Hernandez-Machado, A.] Barcelona Grad Sch Math BGSMath, Barcelona, Spain; [Hernandez-Machado, A.] Univ Barcelona, Fac Fis, Dept Fis Mat Condensada, Diagonal 645, E-08028 Barcelona, Spain; [Hernandez-Machado, A.] Univ Barcelona, Inst Nanosci & Nanotechnol IN2UB, Barcelona, Spain	Universidad Nacional Autonoma de Mexico; ICREA; Centre de Recerca Matematica (CRM); Autonomous University of Barcelona; University of Barcelona; University of Barcelona	Alarcon, T (corresponding author), ICREA, Pg Lluis Co 23, Barcelona 08010, Spain.; Alarcon, T (corresponding author), Ctr Recerca Matemat, Edifici C,Campus Bellaterra, Bellaterra 08193, Barcelona, Spain.; Alarcon, T (corresponding author), Univ Autonoma Barcelona, Dept Matemat, Bellaterra 08193, Barcelona, Spain.; Alarcon, T (corresponding author), Barcelona Grad Sch Math BGSMath, Barcelona, Spain.	talarcon@crm.cat	Hernandez-Machado, Aurora/H-7425-2012; Alarcon, Tomas/AAW-2908-2021; Alarcon, Tomas/D-9083-2013	Hernandez-Machado, Aurora/0000-0002-0397-5255; Alarcon, Tomas/0000-0002-8566-3676; Alarcon, Tomas/0000-0002-8566-3676	MINECO (Spain) [FIS2016-78883-C2-1-P]; AGAUR [2017SGR-1061]; Conacyt, Mexico [283279 2]; Spanish MINECO [MTM2015-71509-C2-1-R]; Ministry of Economy & Competitivity (MINECO) [MDM-2014-0445]; DGAPA, UNAM; CERCA Programme of the Generalitat de Catalunya	MINECO (Spain)(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Conacyt, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Spanish MINECO(Spanish Government); Ministry of Economy & Competitivity (MINECO); DGAPA, UNAM(Universidad Nacional Autonoma de Mexico); CERCA Programme of the Generalitat de Catalunya	A.H-M. gratefully acknowledges partial financial support from MINECO (Spain) under projects FIS2016-78883-C2-1-P, and AGAUR project 2017SGR-1061. RAB acknowledges support from Conacyt, Mexico through project 283279 2. T.A. gratefully acknowledges the Spanish MINECO for funding under grants MTM2015-71509-C2-1-R. T.A. acknowledges further support from the Ministry of Economy & Competitivity (MINECO) for funding awarded to the Barcelona Graduate School of Mathematics under the ``Maria de Maeztu'' programme, grant number MDM-2014-0445. T.A. has been partially funded by the CERCA Programme of the Generalitat de Catalunya. RAB acknowledges a sabbatical grant from DGAPA, UNAM.	Allard JF, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.158105; Allard JF, 2009, P NATL ACAD SCI USA, V106, P145, DOI 10.1073/pnas.0808657106; Benetatos P, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031802; Campelo F, 2007, EUR PHYS J-SPEC TOP, V143, P101, DOI 10.1140/epjst/e2007-00077-y; Campelo F, 2006, EUR PHYS J E, V20, P37, DOI 10.1140/epje/i2005-10079-5; Campelo F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.088101; Campelo F., 2008, THESIS; Cytrynbaum EN, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011902; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 2010, MOL MICROBIOL, V78, P267, DOI 10.1111/j.1365-2958.2010.07321.x; Fischer-Friedrich E, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026007; Ghosh B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051924; Ghosh B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.178101; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Horger I, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011902; Horger I, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031922; Horger I, 2008, BIOPHYS J, V94, pL81, DOI 10.1529/biophysj.107.128363; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Liu Z, 2014, RSC ADV, V4, P56665, DOI 10.1039/c4ra11129j; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2013, P NATL ACAD SCI USA, V110, P11000, DOI 10.1073/pnas.1222254110; Osawa M, 2011, MOL MICROBIOL, V81, P571, DOI 10.1111/j.1365-2958.2011.07716.x; Picallo CB, 2015, EUR PHYS J E, V38, DOI 10.1140/epje/i2015-15061-0; Shlomovitz R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046017; Varea C, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061922	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227562	10.1371/journal.pone.0227562	http://dx.doi.org/10.1371/journal.pone.0227562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935248	gold, Green Published, Green Submitted			2022-12-26	WOS:000534354100030
J	Ickler, J; Francois, S; Widera, M; Santiago, ML; Dittmer, U; Sutter, K				Ickler, Julia; Francois, Sandra; Widera, Marek; Santiago, Mario L.; Dittmer, Ulf; Sutter, Kathrin			HIV infection does not alter interferon alpha/beta receptor 2 expression on mucosal immune cells	PLOS ONE			English	Article							VIRUS TYPE-1 INFECTION; MICROBIAL TRANSLOCATION; SERUM; PATHOGENESIS; REPLICATION; LYMPHOCYTES; RESPONSES; BETA	The innate immune response induced by type I interferons (IFNs) plays a critical role in the establishment of HIV infection. IFNs are induced early in HIV infection and trigger an antiviral defense program by signaling through the IFN alpha/beta receptor (IFNAR), which consists of two subunits, IFNAR1 and IFNAR2. Changes in IFNAR expression in HIV target cells, as well as other immune cells, could therefore have important consequences for initial HIV spread. It was previously reported that IFNAR2 expression is increased in peripheral blood CD4(+) CXCR4(+) T cells of HIV+ patients compared to HIV uninfected controls, suggesting that HIV infection may alter the IFN responsiveness of target cells. However, the earliest immune cells affected by HIV in vivo reside in the gut-associated lymphoid tissue (GALT). To date, it remains unknown if IFNAR expression is altered in GALT immune cells in the context of HIV infection and exposure to IFNs, including the 12 IFN alpha subtypes. Here, we analyzed the expression of surface bound and soluble IFNAR2 on Lamina propria mononuclear cells (LPMCs) isolated from the GALT of HIV- individuals and in plasma samples of HIV+ patients. IFNAR2 expression varied between different T cells, B cells and natural killer cells, but was not altered following HIV infection. Furthermore, expression of the soluble IFNAR2a isoform was not changed in HIV+ patients compared to healthy donors, nor in LPMCs after HIV-1 infection ex vivo. Even though the 12 human IFN alpha subtypes trigger different biological responses and vary in their affinity to both receptor subunits, stimulation of LPMCs with different recombinant IFN alpha subtypes did not result in any significant changes in IFNAR2 surface expression. Our data suggests that potential changes in the IFN responsiveness of mucosal immune cells during HIV infection are unlikely dictated by changes in IFNAR2 expression.	[Ickler, Julia; Francois, Sandra; Widera, Marek; Dittmer, Ulf; Sutter, Kathrin] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Santiago, Mario L.] Univ Colorado Denver, Dept Med, Aurora, CO USA	University of Duisburg Essen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Sutter, K (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	kathrin.sutter@uni-due.de	Widera, Marek/AAF-3691-2020; Sutter, Kathrin/AAY-9167-2020; Sutter, Kathrin/AAE-9019-2020	Widera, Marek/0000-0001-5417-9307; Sutter, Kathrin/0000-0001-6397-6551	Deutsche Forschungsgemeinschaft [SPP 1923]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the priority programme "Innate Rensing and Restriction of Retroviruses" (SPP 1923) by the Deutsche Forschungsgemeinschaft to UD and KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2016, ONCOTARGET, V7, P78412, DOI 10.18632/oncotarget.12512; Abudulai L, 2016, JORNAL VIRUS ERADICA; Alston B, 1999, J ACQ IMMUN DEF SYND, V22, P348; Ambrus JL, 2003, CANCER, V98, P2730, DOI 10.1002/cncr.11843; Bauer A, 2016, LABORATORIUMSMEDIZIN, V40, P119, DOI 10.1515/labmed-2015-0020; Belyakov IM, 2008, TRENDS IMMUNOL, V29, P574, DOI 10.1016/j.it.2008.07.010; Bosinger SE, 2015, CURR HIV-AIDS REP, V12, P41, DOI 10.1007/s11904-014-0244-6; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2017, PEDIATRICS, V116, DOI [10.1542/peds.2005-0698bbbb, DOI 10.1542/PEDS.2005-0698BBBB]; Chadha K, 2006, ARCH NEUROL-CHICAGO, V63, P1579, DOI 10.1001/archneur.63.11.1579; Cheng L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94366; Cheng L, 2017, J CLIN INVEST, V127, P269, DOI 10.1172/JCI90745; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Farmer JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058813; Fatakdawala T, 2013, SOLUBLE TYPE 1 INTER; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Gazziola C, 2005, INT J ONCOL, V26, P129; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Hardy MP, 2001, BLOOD, V97, P473, DOI 10.1182/blood.V97.2.473; Harper MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005254; Howe R, 2009, CLIN IMMUNOL, V131, P317, DOI 10.1016/j.clim.2008.12.003; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Katabira ET, LACK EYCACY LOW DOSE; Katlinski KV, 2017, CANCER CELL, V31, P194, DOI 10.1016/j.ccell.2017.01.004; Killian MS, 2017, JAIDS-J ACQ IMM DEF, V74, P473, DOI 10.1097/QAI.0000000000001280; Kwaa AKR, 2019, J VIROL, V93, DOI 10.1128/JVI.01541-18; Lapenta C, 1999, EUR J IMMUNOL, V29, P1202, DOI 10.1002/(SICI)1521-4141(199904)29:04<1202::AID-IMMU1202>3.0.CO;2-O; Lavender KJ, 2016, J VIROL, V90, P6001, DOI 10.1128/JVI.00451-16; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Li YP, 2017, J INTERF CYTOK RES, V37, P541, DOI 10.1089/jir.2017.0076; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Marijanovic Z, 2007, BIOCHEM J, V407, P141, DOI 10.1042/BJ20070605; Mizukoshi E, 1999, HEPATOLOGY, V30, P1325, DOI 10.1002/hep.510300516; Munch J, 2007, J VIROL, V81, P13852, DOI 10.1128/JVI.00904-07; Orpez-Zafra T, 2017, MULT SCLER J, V23, P937, DOI 10.1177/1352458516667564; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Samarajiwa SA, 2014, TLR4 MEDIATED SEPTIC; Schneider T, 1995, GUT; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sutter K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54650-9; Sutter K, 2018, CYTOKINE GROWTH F R, V40, P13, DOI 10.1016/j.cytogfr.2018.02.002; Tanaka S, 2012, PATHOBIOLOGY, V79, P24, DOI 10.1159/000331230; Tochizawa Shiro, 2004, Journal of Pharmacological and Toxicological Methods, V50, P59, DOI 10.1016/j.vascn.2004.02.003; Tomasello E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00526; Utay Netanya S, 2016, Pathog Immun, V1, P107; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; Xia C, 2016, J VIROL, V90, P2403, DOI 10.1128/JVI.02749-15; Yoder AC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006226; Zevin AS, 2016, CURR OPIN HIV AIDS, V11, P182, DOI 10.1097/COH.0000000000000234	54	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0218905	10.1371/journal.pone.0218905	http://dx.doi.org/10.1371/journal.pone.0218905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935222	Green Published, gold, Green Submitted			2022-12-26	WOS:000534354100002
J	Mahajan, G; Kaur, V; Thompson, M; Chauhan, BS				Mahajan, Gulshan; Kaur, Vishavdeep; Thompson, Michael; Chauhan, Bhagirath Singh			Growth behavior and glyphosate resistance level in 10 populations of Echinochloa colona in Australia	PLOS ONE			English	Article							EVOLVED RESISTANCE; LOLIUM-RIGIDUM; GRAIN REGION; WEED; CONFIRMATION; MECHANISMS; MANAGEMENT; BIOTYPES	Recently, poor control of Echinochloa colona with glyphosate has been reported in no-till agriculture systems of the northern grain region (NGR) of Australia. Two experiments were conducted using 10 populations of E. colona selected from the NGR of Australia to understand differences in their growth behavior and resistance pattern. Growth studies revealed that these populations differed in plant height (53-70 cm plant(-1)), tiller production (30-52 tillers plant(-1)), leaf production (124-186 leaves plant(-1)) and seed head production (37-65 seed heads plant(-1)). Days taken to seed heads and shoot biomass in these populations ranged between 40-48 d and 21-27 g plant(-1), respectively. Seed production in these populations ranged between 5380 and 10244 seeds plant(-1); lowest for population B17/25 and highest for population B17/13. Correlation studies revealed that seed number plant(-1) had a positive correlation with tiller number plant(-1) (r = 0.73) and negative relation with days taken to seed head initiation (r = - 0.65). The glyphosate dose-response study showed a wide range of responses in these populations and the glyphosate dose required to kill 50% plants (LD50 values) was estimated between 161 to 2339 g a.e. glyphosate ha(-1). LD50 values of populations B17/16, B 17/34 and B17/35 were 1086, 2339 and 1153 g ha(-1), respectively, making them 6.7, 15.1 and 7.2-fold resistant to glyphosate compared with the susceptible population B17/37. Growth behavior and seed production potential in these populations had no correlation with the resistance index. These results suggest that some populations of E. colona are highly problematic; for example, population B17/34 was not only highly glyphosate-resistant, but also produced a high seed number (9300 seeds plant(-1)). This study demonstrated that there is a possibility of great risk with the increased use of glyphosate for managing E. colona in the NGR of Australia. The results warrant integrated weed management strategies and improved stewardship guidelines are required for managing glyphosate-resistant populations of E. colona and to restrict further movement of resistant populations to other regions of Australia.	[Mahajan, Gulshan; Kaur, Vishavdeep; Thompson, Michael; Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Australia	University of Queensland	Mahajan, G (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Australia.	g.mahajan@uq.edu.au						Alarcon-Reverte R, 2015, PEST MANAG SCI, V71, P996, DOI 10.1002/ps.3878; Beckie HJ, 2011, PEST MANAG SCI, V67, P1037, DOI 10.1002/ps.2195; Binkholder KM, 2011, WEED SCI, V59, P286, DOI 10.1614/WS-D-10-00131.1; Caseley J. C., 1985, The herbicide glyphosate, P92; Christoffers MJ, 1999, WEED TECHNOL, V13, P647, DOI 10.1017/S0890037X00046340; Christoffoleti Pedro Jacob, 2002, Sci. agric. (Piracicaba, Braz.), V59, P513, DOI 10.1590/S0103-90162002000300016; Chun JC, 1987, KOREAN J WEED SCI, V7, P247; Damalas CA, 2008, WEED SCI, V56, P416, DOI 10.1614/WS-07-168.1; de Carvalho LB, 2011, WEED SCI, V59, P171, DOI 10.1614/WS-D-10-00113.1; Delye C, 2010, NEW PHYTOL, V186, P1005, DOI 10.1111/j.1469-8137.2010.03233.x; Dickson JW, 2011, WEED TECHNOL, V25, P674, DOI 10.1614/WT-D-11-00040.1; Duke SO, 2003, ENCY AGROCHEMICALS; Friend E., 1983, QUEENSLAND WEED SEED, P206; Gaines TA, 2012, WEED TECHNOL, V26, P480, DOI 10.1614/WT-D-12-00029.1; Heap I, 2018, PEST MANAG SCI, V74, P1040, DOI 10.1002/ps.4760; Heap I, 2014, PEST MANAG SCI, V70, P1306, DOI 10.1002/ps.3696; Holm L. G., 1977, WORLDS WORST WEEDS D; Light GG, 2011, WEED TECHNOL, V25, P480, DOI 10.1614/WT-D-10-00152.1; Llewellyn R.S., 2016, IMPACT WEEDS AUSTR G, P112; Llewellyn RS, 2006, CROP PROT, V25, P520, DOI 10.1016/j.cropro.2005.08.007; Meadley JT, 1977, J AGR SCI, V77, P103; Mueller TC, 2011, WEED SCI, V59, P562, DOI 10.1614/WS-D-11-00063.1; Mutti NK, 2019, WEED SCI, V67, P419, DOI 10.1017/wsc.2019.12; Neve P, 2003, WEED RES, V43, P418, DOI 10.1046/j.0043-1737.2003.00356.x; Norsworthy JK, 2011, WEED TECHNOL, V25, P430, DOI 10.1614/WT-D-10-00155.1; Norsworthy JK, 1998, WEED SCI, V46, P163, DOI 10.1017/S0043174500090366; Osten VA, 2007, AUST J EXP AGR, V47, P57, DOI 10.1071/EA05141; Powles SB, 1998, WEED SCI, V46, P604, DOI 10.1017/S0043174500091165; Preston C, 2009, WEED SCI, V57, P435, DOI 10.1614/WS-08-181.1; Rew LJ, 2005, AUST J EXP AGR, V45, P711, DOI 10.1071/EA03273; Riar DS, 2011, WEED SCI, V59, P299, DOI 10.1614/WS-D-10-00150.1; Shaner DL, 2012, PEST MANAG SCI, V68, P3, DOI 10.1002/ps.2261; Smith AE., 1995, HDB WEED MANAGEMENT, P758; Storrie A, 2008, P 16 AUSTR WEEDS C Q; Swanton CJ, 2000, AGRON J, V92, P1125, DOI 10.2134/agronj2000.9261125x; Tayo T, 1974, THESIS; Thill DC, 1997, WEED SCI, V45, P337, DOI 10.1017/S004317450009295X; THULLEN RJ, 1979, WEED SCI, V27, P502, DOI 10.1017/S0043174500044489; Nguyen T, 2015, 2015 12TH INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY - NEW GENERATIONS, P151, DOI 10.1109/ITNG.2015.29; Walker SR, 2005, AUST J EXP AGR, V45, P79, DOI 10.1071/EA03189; Wu H, 2004, WEED MANAGEMENT BALA	41	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0221382	10.1371/journal.pone.0221382	http://dx.doi.org/10.1371/journal.pone.0221382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935213	gold, Green Published, Green Submitted			2022-12-26	WOS:000534354100004
J	Njau, F; Shushakova, N; Schenk, H; Wulfmeyer, VC; Bollin, R; Menne, J; Haller, H				Njau, Florence; Shushakova, Nelli; Schenk, Heiko; Wulfmeyer, Vera Christine; Bollin, Robin; Menne, Jan; Haller, Hermann			Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXTRACELLULAR DOMAIN; RECEPTOR; ANGIOGENESIS; PERMEABILITY; DYSFUNCTION; INHIBITION; EXPRESSION; PREVENTS; CELLS	Inhibiting vascular endothelial growth factor (VEGF) is a therapeutic option in diabetic microangiopathy. However, VEGF is needed at physiological concentrations to maintain glomerular integrity; complete VEGF blockade has deleterious effects on glomerular structure and function. Anti-VEGF therapy in diabetes raises the challenge of reducing VEGF-induced pathology without accelerating endothelial cell injury. Heparan sulfate (HS) act as a co-receptor for VEGF. Calcium dobesilate (CaD) is a small molecule with vasoprotective properties that has been used for the treatment of diabetic microangiopathy. Preliminary evidence suggests that CaD interferes with HS binding sites of fibroblast growth factor. We therefore tested the hypotheses that (1) CaD inhibits VEGF signaling in endothelial cells, (2) that this effect is mediated via interference between CaD and HS, and (3) that CaD ameliorates diabetic nephropathy in a streptozotocin-induced diabetic mouse model by VEGF inhibition. We found that CaD significantly inhibited VEGF(165)-induced endothelial cell migration, proliferation, and permeability. CaD significantly inhibited VEGF(165)-induced phosphorylation of VEGFR-2 and suppressed the activity of VEGFR-2 mediated signaling cascades. The effects of CaD in vitro were abrogated by heparin, suggesting the involvement of heparin-like domain in the interaction with CaD. In addition, VEGF(121), an isoform which does not bind to heparin, was not inhibited by CaD. Using the proximity ligation approach, we detected inhibition of interaction in situ between HS and VEGF and between VEGF and VEGFR-2. Moreover, CaD reduced VEGF signaling in mice diabetic kidneys and ameliorated diabetic nephropathy and neuropathy, suggesting CaD as a VEGF inhibitor without the negative effects of complete VEGF blockade and therefore could be useful as a strategy in treating diabetic nephropathy.	[Njau, Florence; Shushakova, Nelli; Schenk, Heiko; Wulfmeyer, Vera Christine; Bollin, Robin; Menne, Jan; Haller, Hermann] Hannover Med Sch, Div Nephrol, Hannover, Germany	Hannover Medical School	Njau, F (corresponding author), Hannover Med Sch, Div Nephrol, Hannover, Germany.	Njau.Florence@mh-hannover.de		Njau, Florence/0000-0002-6397-991X	Deutsche Forschungsgemeinschaft (DFG) [Ha 1388/16-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) to HA. Grant number Ha 1388/16-1, https://www.dfg.de/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0413-4; Angulo J, 2011, EUR J PHARMACOL, V667, P153, DOI 10.1016/j.ejphar.2011.06.015; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Bakris GL, 2009, J HYPERTENS, V27, P666, DOI 10.1097/HJH.0b013e328327706a; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bogdanov P, 2017, J DIABETES COMPLICAT, V31, P1481, DOI 10.1016/j.jdiacomp.2017.07.009; Braun L, 2001, LIFE SCI, V69, P2533, DOI 10.1016/S0024-3205(01)01327-3; Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36; Cerezo AB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030249; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Cuevas P, 2006, J CELL MOL MED, V10, P225, DOI 10.1111/j.1582-4934.2006.tb00303.x; Cuevas P, 2005, EUR J MED RES, V10, P454; Cuevas P, 2005, EUR J MED RES, V10, P373; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Edward Conrad H, 1998, HEPARIN BINDING PROT, P7, DOI [10.1016/B978-012186060-8/50003-6, DOI 10.1016/B978-012186060-8/50003-6]; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2010, SEMIN NEPHROL, V30, P582, DOI 10.1016/j.semnephrol.2010.09.006; Estrada CC, 2019, J AM SOC NEPHROL, V30, P187, DOI 10.1681/ASN.2018080853; Fernandez IS, 2010, J BIOL CHEM, V285, P11714, DOI 10.1074/jbc.M109.064618; Fish JE, 2017, DEVELOPMENT, V144, P2428, DOI 10.1242/dev.146050; Flyvbjerg A, 2002, DIABETES, V51, P3090, DOI 10.2337/diabetes.51.10.3090; Garay Ricardo P, 2005, Treat Endocrinol, V4, P221, DOI 10.2165/00024677-200504040-00003; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Goncalves V, 2007, ANAL BIOCHEM, V366, P108, DOI 10.1016/j.ab.2007.03.027; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Haller H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1909258; Han K, 2018, NEUROENDOCRINOL LETT; Hohenstein B, 2006, KIDNEY INT, V69, P1654, DOI 10.1038/sj.ki.5000294; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Javadzadeh A, 2013, MOL VIS, V19, P62; Kiyan Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50068-5; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; Lai XX, 2016, ONCOTARGETS THER, V9, P2421, DOI 10.2147/OTT.S96156; Leal EC, 2010, DIABETES, V59, P2637, DOI 10.2337/db09-1421; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Liu E, 2007, J AM SOC NEPHROL, V18, P2094, DOI 10.1681/ASN.2006010075; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Martins-Green M, 2008, METHOD ENZYMOL, V443, P137, DOI 10.1016/S0076-6879(08)02008-9; Nakagawa T, 2009, DIABETES, V58, P1471, DOI 10.2337/db09-0119; NELSON RG, 1988, DIABETOLOGIA, V31, P730, DOI 10.1007/BF00274774; Nishiguchi KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013493; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; PARVING HH, 1987, BRIT MED J, V294, P1443, DOI 10.1136/bmj.294.6585.1443; Schrijvers BF, 2006, NEPHROL DIAL TRANSPL, V21, P324, DOI 10.1093/ndt/gfi217; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Sola-Adell C, 2017, CURR EYE RES, V42, P1273, DOI 10.1080/02713683.2017.1302591; Tanabe K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5724069; Tejerina T, 1998, GEN PHARMACOL-VASC S, V31, P357, DOI 10.1016/S0306-3623(98)00040-8; Teran M, 2015, J BIOL CHEM, V290, P16451, DOI 10.1074/jbc.M114.627372; Tessler S, 1994, J BIOL CHEM; Thamm Kristina, 2016, World J Transplant, V6, P573, DOI 10.5500/wjt.v6.i3.573; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Wang W, 1996, AM J PHYSIOL-CELL PH, V271, pC1973, DOI 10.1152/ajpcell.1996.271.6.C1973; Wijelath E, 2010, J CELL BIOCHEM, V111, P461, DOI 10.1002/jcb.22727; Wu HY, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6008; Yang WZ, 2013, EXP EYE RES, V115, P96, DOI 10.1016/j.exer.2013.06.011; Zhang XF, 2014, SCI CHINA LIFE SCI, V57, P11, DOI 10.1007/s11427-013-4587-9; Zhang XQ, 2013, EXP THER MED, V5, P295, DOI 10.3892/etm.2012.755; Zhou YJ, 2018, CELL PHYSIOL BIOCHEM, V51, P1119, DOI 10.1159/000495491; Zhou YJ, 2017, MOL MED REP, V16, P8635, DOI 10.3892/mmr.2017.7740	64	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0218494	10.1371/journal.pone.0218494	http://dx.doi.org/10.1371/journal.pone.0218494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935212	Green Published, Green Submitted, gold			2022-12-26	WOS:000534354100001
J	Jang, S; Kim, JH; Choi, SY; Park, SJ; Han, JK				Jang, Siwon; Kim, Jung Hoon; Choi, Seo-Youn; Park, Sang Joon; Han, Joon Koo			Application of computerized 3D-CT texture analysis of pancreas for the assessment of patients with diabetes	PLOS ONE			English	Article							QUANTITATIVE CT TEXTURE; BLOOD-GLUCOSE CONTROL; TUMOR HETEROGENEITY; TYPE-2; VOLUME; COMPLICATIONS; TOMOGRAPHY; CARCINOMA; DENSITY	Objective To evaluate the role of computerized 3D CT texture analysis of the pancreas as quantitative parameters for assessing diabetes. Methods Among 2,493 patients with diabetes, 39 with type 2 diabetes (T2D) and 12 with type 1 diabetes (T1D) who underwent CT using two selected CT scanners, were enrolled. We compared these patients with age-, body mass index- (BMI), and CT scanner-matched normal subjects. Computerized texture analysis for entire pancreas was performed by extracting 17 variable features. A multivariate logistic regression analysis was performed to identify the predictive factors for diabetes. A receiver operator characteristic (ROC) curve was constructed to determine the optimal cut off values for statistically significant variables. Results In diabetes, mean attenuation, standard deviation, variance, entropy, homogeneity, surface area, sphericity, discrete compactness, gray-level co-occurrence matrix (GLCM) contrast, and GLCM entropy showed significant differences (P<.05). Multivariate analysis revealed that a higher variance (adjusted OR, 1.002; P=.005), sphericity (adjusted OR, 1.649x10(4); P=.048), GLCM entropy (adjusted OR, 1.057x10(5); P=.032), and lower GLCM contrast (adjusted OR, 0.997; P<.001) were significant variables. The mean AUCs for each feature were 0.654, 0.689, 0.620, and 0.613, respectively (P <.05). In subgroup analysis, only larger surface area (adjusted OR, 1.000; P=.025) was a significant predictor for T2D. Conclusions Computerized 3D CT texture analysis of the pancreas could be helpful for predicting diabetes. A higher variance, sphericity, GLCM entropy, and a lower GLCM contrast were the significant predictors for diabetes.	[Jang, Siwon] SMG SNU Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Park, Sang Joon; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea; [Choi, Seo-Youn] Soonchunhyang Univ, Bucheon Hosp, Coll Med, Dept Radiol, Bucheon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Soonchunhyang University	Han, JK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Han, JK (corresponding author), Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea.	jhkim2008@gmail.com						Bashir U, 2016, AM J ROENTGENOL, V207, P534, DOI 10.2214/AJR.15.15864; Bayanati H, 2015, EUR RADIOL, V25, P480, DOI 10.1007/s00330-014-3420-6; Beckers RCJ, 2017, EUR J RADIOL, V92, P64, DOI 10.1016/j.ejrad.2017.04.019; Begovatz P, 2015, DIABETOLOGIA, V58, P1646, DOI 10.1007/s00125-015-3544-5; Burute N, 2014, PANCREATOLOGY, V14, P268, DOI 10.1016/j.pan.2014.04.031; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Chen CG, 2017, MOL METAB, V6, P943, DOI 10.1016/j.molmet.2017.06.019; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Eilaghi A, 2017, BMC MED IMAGING, V17, DOI 10.1186/s12880-017-0209-5; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; GILBEAU JP, 1992, AM J ROENTGENOL, V159, P527, DOI 10.2214/ajr.159.3.1503017; Goda K, 2001, ACTA DIABETOL, V38, P145, DOI 10.1007/s005920170012; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Ionescu-Tirgoviste C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14634; Lim S, 2014, ACTA DIABETOL, V51, P739, DOI 10.1007/s00592-014-0581-3; Lubner MG, 2017, RADIOGRAPHICS, V37, P1483, DOI 10.1148/rg.2017170056; Macauley M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126825; Mardon R, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160572; Matsuda A, 2014, PANCREAS, V43, P735, DOI 10.1097/MPA.0000000000000129; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Saisho Yoshifumi, 2016, Rev Diabet Stud, V13, P132, DOI 10.1900/RDS.2016.13.132; Sakata N, 2011, J GASTROINTEST SURG, V15, P525, DOI 10.1007/s11605-010-1406-5; Srinivasan G, 2008, P WORLD ACAD SCI ENG; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WINSTON CB, 1995, JMRI-J MAGN RESON IM, V5, P267, DOI 10.1002/jmri.1880050307; WU CM, 1992, CVGIP-GRAPH MODEL IM, V54, P407, DOI 10.1016/1049-9652(92)90025-S; Xin A, 2017, J CLIN ENDOCR METAB, V102, P3162, DOI 10.1210/jc.2016-3735; Yokota K, 2012, J DIABETES INVEST, V3, P371, DOI 10.1111/j.2040-1124.2012.00212.x	31	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227492	10.1371/journal.pone.0227492	http://dx.doi.org/10.1371/journal.pone.0227492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929591	gold, Green Published			2022-12-26	WOS:000534352500040
J	Kim, D; Shim, CY; Hong, GR; Jeong, H; Ha, JW				Kim, Darae; Shim, Chi Young; Hong, Geu-Ru; Jeong, Hyeonju; Ha, Jong-Won			Morphological and functional characteristics of mitral annular calcification and their relationship to stroke	PLOS ONE			English	Article							CASEOUS CALCIFICATION; EUROPEAN ASSOCIATION; ATRIAL-FIBRILLATION; AMERICAN SOCIETY; AORTIC ATHEROMA; VALVE SCLEROSIS; ALL-CAUSE; DISEASE; RISK; ECHOCARDIOGRAPHY	Background Mitral annular calcification (MAC) is associated with risk of stroke. This study aimed to define the morphological and functional characteristics of MAC that are related to stroke. Methods A total of 460 subjects with MAC from transthoracic echocardiography in a single center from 2012 to 2016 was retrospectively reviewed. Subjects were classified into two groups according to history of stroke [Group 1 (n = 366): without stroke; Group 2 (n = 94): with stroke]. Morphological and functional features of MAC on echocardiogram were scored from 0 to 3 according to MAC mobility, presence of echodense mass with central echolucencies in the periannular region suggesting caseous necrosis, and functional stenosis. Results Significantly more patients in group 2 were men and had history of diabetes mellitus, dyslipidemia, atrial fibrillation, or infective endocarditis. Although MAC thickness and extent did not differ between the two groups, group 2 showed a considerably higher MAC score than group 1 (0.50 +/- 0.77 vs. 0.23 +/- 0.52 p<0.001) as a result of the higher prevalence of each component in group 2 [mobility (22 vs. 11%, p = 0.003), echodense mass with central areas of echolucencies suggesting caseous necrosis (23 vs. 7%, p<0.001), and functional mitral stenosis (12 vs. 7%, p = 0.042)]. On logistic regression analysis, MAC score was independently associated with stroke and showed significant incremental value to demographic factors and comorbidities in association with stroke in a consecutive manner. Conclusions In conclusion, morphological and functional characteristics of MAC had incremental value in association with stroke over traditional risk factors. MAC score consisting of MAC mobility, typical echodense mass with central echolucencies suggesting caseous necrosis, and functional mitral stenosis was independently associated with stroke. MAC with high-risk features may act as a source of stroke or more potent composite surrogate markers for stroke-related risk factors.	[Kim, Darae] Sungkyunkwan Univ, Heart Vasc Stroke Inst, Samsung Med Ctr, Div Cardiol,Dept Med,Sch Med, Seoul, South Korea; [Shim, Chi Young; Hong, Geu-Ru; Jeong, Hyeonju; Ha, Jong-Won] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Shim, CY (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, Seoul, South Korea.	cysprs@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Ha, Jong-Won/0000-0002-8260-2958; Hong, Geu-Ru/0000-0003-4981-3304				Adler Y, 2000, ATHEROSCLEROSIS, V152, P451, DOI 10.1016/S0021-9150(99)00497-9; Adler Y, 1998, STROKE, V29, P1833, DOI 10.1161/01.STR.29.9.1833; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Akram MR, 2009, EUR J ECHOCARDIOGR, V10, P103, DOI 10.1093/ejechocard/jen179; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Atar S, 2003, HEART, V89, P161, DOI 10.1136/heart.89.2.161; BENJAMIN EJ, 1992, NEW ENGL J MED, V327, P374, DOI 10.1056/NEJM199208063270602; Chevalier B, 2011, EUR J CARDIO-THORAC, V39, pE184, DOI 10.1016/j.ejcts.2011.01.038; Deluca G, 2008, J AM SOC ECHOCARDIOG, V21, P828, DOI 10.1016/j.echo.2007.12.004; Eicher JC, 1997, AM J CARDIOL, V79, P1712, DOI 10.1016/S0002-9149(97)00233-6; FERTMAN MH, 1946, AM HEART J, V31, P580, DOI 10.1016/0002-8703(46)90004-X; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Fox CS, 2004, ATHEROSCLEROSIS, V173, P291, DOI 10.1016/j.atherosclerosis.2003.12.018; FURLAN AJ, 1984, STROKE, V15, P801, DOI 10.1161/01.STR.15.5.801; Gardin JM, 2001, AM J CARDIOL, V87, P1051, DOI 10.1016/S0002-9149(01)01460-6; Gondrie MJA, 2011, EUR RADIOL, V21, P963, DOI 10.1007/s00330-010-1995-0; Harpaz D, 2001, J AM SOC ECHOCARDIOG, V14, P825, DOI 10.1067/mje.2001.111877; Kizer JR, 2005, STROKE, V36, P2533, DOI 10.1161/01.STR.0000190005.09442.ad; Kohsaka S, 2008, JACC-CARDIOVASC IMAG, V1, P617, DOI 10.1016/j.jcmg.2008.07.006; KORN D, 1962, NEW ENGL J MED, V267, P900, DOI 10.1056/NEJM196211012671802; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; LIN CS, 1987, ARCH PATHOL LAB MED, V111, P411; Lu MLR, 2016, J AM SOC ECHOCARDIOG, V29, P1171, DOI 10.1016/j.echo.2016.08.020; Marci Marcello, 2009, Cases J, V2, P95, DOI 10.1186/1757-1626-2-95; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; O'Neal WT, 2018, EUR HEART J-CARD IMG, V19, P279, DOI 10.1093/ehjci/jex093; O'Neal WT, 2015, EUROPACE, V17, P358, DOI 10.1093/europace/euu265; POMERANCE A, 1970, J CLIN PATHOL, V23, P354, DOI 10.1136/jcp.23.4.354; Pressman GS, 2017, J AM SOC ECHOCARDIOG, V30, P572, DOI 10.1016/j.echo.2017.01.016; Pujadas R, 2008, ECHOCARDIOGR-J CARD, V25, P124, DOI 10.1111/j.1540-8175.2007.00570.x; Ramaraj R, 2013, EXP CLIN CARDIOL, V18, pE5; VAZIRI S, 1992, ANN INTERN MED, V117, P89, DOI 10.7326/0003-4819-117-1-89; Volzke H, 2010, ATHEROSCLEROSIS, V209, P606, DOI 10.1016/j.atherosclerosis.2009.10.030; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227753	10.1371/journal.pone.0227753	http://dx.doi.org/10.1371/journal.pone.0227753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929595	Green Published, gold, Green Submitted			2022-12-26	WOS:000534352500069
J	Iriyama, T; Wang, W; Parchim, NF; Sayama, S; Kumasawa, K; Nagamatsu, T; Song, AR; Xia, Y; Kellems, RE				Iriyama, Takayuki; Wang, Wei; Parchim, Nicholas F.; Sayama, Seisuke; Kumasawa, Keiichi; Nagamatsu, Takeshi; Song, Anren; Xia, Yang; Kellems, Rodney E.			Reciprocal upregulation of hypoxia-inducible factor-1 alpha and persistently enhanced placental adenosine signaling contribute to the pathogenesis of preeclampsia	FASEB JOURNAL			English	Article						adenosine signaling; angiotensin II type I receptor agonistic autoantibody (AT(1)-AA); hypoxia-inducible factor-1 alpha; preeclampsia; tumor necrosis factor superfamily member 14 (TNFSF14)	AGONISTIC AUTOANTIBODIES; TRANSCRIPTION FACTORS; RECEPTOR; HYPERTENSION; EXPRESSION; HIF-1A; OXYGEN	Recent evidence indicates that elevated placental adenosine signaling contributes to preeclampsia (PE). However, the molecular basis for the chronically enhanced placental adenosine signaling in PE remains unclear. Here, we report that hypoxia-inducible factor-1 alpha (HIF-1 alpha) is crucial for the enhancement of placental adenosine signaling. Utilizing a pharmacologic approach to reduce placental adenosine levels, we found that enhanced adenosine underlies increased placental HIF-1 alpha in an angiotensin receptor type 1 receptor agonistic autoantibody (AT(1)-AA)-induced mouse model of PE. Knockdown of placental HIF-1 alpha in vivo suppressed the accumulation of adenosine and increased ecto-5'-nucleotidase (CD73) and adenosine A(2B) receptor (ADORA2B) in the placentas of PE mouse models induced by AT(1)-AA or LIGHT, a TNF superfamily cytokine (TNFSF14). Human in vitro studies using placental villous explants demonstrated that increased HIF-1 alpha resulting from ADORA2B activation facilitates the induction of CD73, ADORA2B, and FLT-1 expression. Overall, we demonstrated that (a) elevated placental HIF-1 alpha by AT(1)-AA or LIGHT upregulates CD73 and ADORA2B expression and (b) enhanced adenosine signaling through upregulated ADORA2B induces placental HIF-1 alpha expression, which creates a positive feedback loop that promotes FLT-1 expression leading to disease development. Our results suggest that adenosine-based therapy targeting the malicious cycle of placental adenosine signaling may elicit therapeutic effects on PE.	[Iriyama, Takayuki; Sayama, Seisuke; Kumasawa, Keiichi; Nagamatsu, Takeshi] Univ Tokyo, Dept Obstet & Gynecol, Fac Med, Tokyo, Japan; [Iriyama, Takayuki; Wang, Wei; Parchim, Nicholas F.; Sayama, Seisuke; Song, Anren; Xia, Yang; Kellems, Rodney E.] Univ Texas Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX USA; [Wang, Wei; Xia, Yang] Cent South Univ, Dept Nephrol, Xiangya Hosp, Changsha, Peoples R China; [Parchim, Nicholas F.] Univ New Mexico Hosp, Dept Emergency Med, Albuquerque, NM USA; [Xia, Yang; Kellems, Rodney E.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Tokyo; University of Texas System; University of Texas Health Science Center Houston; Central South University; University of New Mexico; University of Texas System; University of Texas Health Science Center Houston	Iriyama, T (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	iriyama-tky@umin.ac.jp	Nagamatsu, Takeshi/AAC-5201-2021	Nagamatsu, Takeshi/0000-0003-1480-5785	MEXT \ Japan Society for the Promotion of Science (JSPS) [15H06171, 19K09774]; Foundation for the National Institutes of Health (FNIH) [RC4HD067977]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for the National Institutes of Health (FNIH)	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H06171 and 19K09774; Foundation for the National Institutes of Health (FNIH), Grant/Award Number: RC4HD067977	Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Eckle T, 2014, J IMMUNOL, V192, P1249, DOI 10.4049/jimmunol.1100593; Espinoza J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.034; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Huang AJ, 2017, HYPERTENSION, V70, P209, DOI 10.1161/HYPERTENSIONAHA.117.09536; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; Iriyama T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46660-4; Iriyama T, 2015, HYPERTENSION, V65, P1307, DOI 10.1161/HYPERTENSIONAHA.115.05314; Iriyama T, 2015, CIRCULATION, V131, P730, DOI 10.1161/CIRCULATIONAHA.114.013740; Januar V, 2015, AM J OBSTET GYNECOL, V213, pS182, DOI 10.1016/j.ajog.2015.07.011; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Liu C, 2014, HYPERTENSION, V63, P353, DOI 10.1161/HYPERTENSIONAHA.113.02361; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Poth JM, 2013, J MOL MED, V91, P183, DOI 10.1007/s00109-012-0988-7; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; Wang W, 2014, HYPERTENSION, V63, P595, DOI 10.1161/HYPERTENSIONAHA.113.02458; Wilson SL, 2018, HUM MOL GENET, V27, P135, DOI 10.1093/hmg/ddx391; Yoneyama Y, 2002, OBSTET GYNECOL, V100, P1266, DOI 10.1016/S0029-7844(02)02247-0; Zhang WR, 2013, CIRC RES, V112, P1466, DOI 10.1161/CIRCRESAHA.111.300166; Zhang YJ, 2012, MICROBES INFECT, V14, P863, DOI 10.1016/j.micinf.2012.05.005; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	36	15	15	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4041	4054		10.1096/fj.201902583R	http://dx.doi.org/10.1096/fj.201902583R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930569	Green Accepted, Bronze			2022-12-26	WOS:000507881000001
J	Lu, HT; Chen, W; Liu, WR; Si, YC; Zhao, TT; Lai, XL; Kang, ZM; Sun, XJ; Guo, ZY				Lu, Hongtao; Chen, Wei; Liu, Wenrui; Si, Yachen; Zhao, Tingting; Lai, Xueli; Kang, Zhimin; Sun, Xuejun; Guo, Zhiyong			Molecular hydrogen regulates PTEN-AKT-mTOR signaling via ROS to alleviate peritoneal dialysis-related peritoneal fibrosis	FASEB JOURNAL			English	Article						hydrogen; peritoneal fibrosis; phosphatase and tensin homolog (PTEN); reactive oxygen species (ROS)	MESOTHELIAL CELLS; TENSIN HOMOLOG; MESENCHYMAL TRANSITION; ACTIVATION; HEMODIALYSIS; PHOSPHATASE; MACROPHAGES; MIR-718; MIR-21; WATER	As a convenient, effective and economical kidney replacement therapy for end-stage renal disease (ESRD), peritoneal dialysis is available in approximately 11% of ESRD patients worldwide. However, long-term peritoneal dialysis treatment causes peritoneal fibrosis. In recent years, the application potential of molecular hydrogen in the biomedicine has been well recognized. Molecular hydrogen selectively scavenges cytotoxic reactive oxygen species (ROS) and acts as an antioxidant. In this experiment, a high glucose-induced peritoneal fibrosis mouse model was successfully established by intraperitoneal injection of high glucose peritoneal dialysate, and peritoneal fibrosis mice were treated with hydrogen-rich peritoneal dialysate. In addition, in vitro studies of high glucose-induced peritoneal fibrosis were performed using MeT-5A cells. In vitro and in vivo experiments show that molecular hydrogen could inhibit peritoneal fibrosis progress induced by high glucose effectively. Furthermore, it has been found that molecular hydrogen alleviate fibrosis by eliminating intracellular ROS and inhibiting the activation of the PTEN/AKT/mTOR pathway. The present data proposes that molecular hydrogen exerts the capacity of anti-peritoneal fibrosis through the ROS/PTEN/AKT/mTOR pathway. Therefore, molecule hydrogen is a potential, safe, and effective treatment agent, with peritoneal protective property and great clinical significance.	[Lu, Hongtao; Chen, Wei; Liu, Wenrui; Si, Yachen; Zhao, Tingting; Lai, Xueli; Guo, Zhiyong] Naval Med Univ, Changhai Hosp, Dept Nephrol, Shanghai, Peoples R China; [Lu, Hongtao; Sun, Xuejun] Naval Med Univ, Dept Naval Med, Shanghai, Peoples R China; [Kang, Zhimin] Shanghai Huikang Hydrogen Med Res Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Chen, W; Guo, ZY (corresponding author), Naval Med Univ, Changhai Hosp, Dept Nephrol, Shanghai, Peoples R China.; Sun, XJ (corresponding author), Naval Med Univ, Dept Naval Med, Shanghai, Peoples R China.	wujiang02@163.com; sunxjk@hotmail.com; drguozhiyong@163.com	Sun, Xuejun/GLR-4436-2022; sun, xuejun/A-5561-2010; yachen, Si yachen/G-1567-2019	Sun, Xuejun/0000-0003-2387-5531; sun, xuejun/0000-0003-2387-5531; 	National Natural Science Foundation of China (NSFC) [81770763, 81800678, 81371316]; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund) [18441905900]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81770763, 81800678 and 81371316; Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund), Grant/Award Number: 18441905900	Balzer MS, 2019, NEPHROL DIAL TRANSPL, V34, P947, DOI 10.1093/ndt/gfy282; Bellon T, 2011, NEPHROL DIAL TRANSPL, V26, P2995, DOI 10.1093/ndt/gfq771; Bhatt K, 2015, J AM SOC NEPHROL, V26, P1588, DOI 10.1681/ASN.2014050463; Busnadiego O, 2015, J AM SOC NEPHROL, V26, P173, DOI 10.1681/ASN.2013070799; Chen J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00499; Gao L, 2019, EXP PHYSIOL, V104, P1942, DOI 10.1113/EP088028; Gupta A, 2017, MOL CELL, V65, P999, DOI 10.1016/j.molcel.2017.02.019; Hung KY, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/642793; Kalantari P, 2017, J BIOL CHEM, V292, P5634, DOI 10.1074/jbc.M116.749325; Kattla JJ, 2008, AM J PHYSIOL-RENAL, V295, pF215, DOI 10.1152/ajprenal.00548.2007; Kim JH, 2018, CELL DEATH DIFFER, V25, P1921, DOI 10.1038/s41418-018-0165-9; Koyama Y, 2014, HEPATOL RES, V44, P663, DOI 10.1111/hepr.12165; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; Lee YC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-35; Leslie NR, 2016, BIOCHEM SOC T, V44, P273, DOI 10.1042/BST20150224; Liu JY, 2014, BIOL TRACE ELEM RES, V161, P202, DOI 10.1007/s12011-014-0091-8; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Mehrotra R, 2016, J AM SOC NEPHROL, V27, P3238, DOI 10.1681/ASN.2016010112; Nakayama M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18537-x; Nakayama M, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0741-0; Nakayama M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184535; Nakayama M, 2009, NEPHRON CLIN PRACT, V112, pC9, DOI 10.1159/000210569; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ren JD, 2016, BBA-MOL CELL RES, V1863, P50, DOI 10.1016/j.bbamcr.2015.10.012; Rivera-Barahona A, 2017, J INHERIT METAB DIS, V40, P471, DOI 10.1007/s10545-017-0018-6; Shin HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05836-6; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sun HY, 2011, J HEPATOL, V54, P471, DOI 10.1016/j.jhep.2010.08.011; Takashima M, 2009, J GASTROENTEROL, V44, P847, DOI 10.1007/s00535-009-0073-3; Tao H, 2017, TOXICOLOGY, V386, P11, DOI 10.1016/j.tox.2017.05.007; Terawaki H, 2015, PERITON DIALYSIS INT, V35, DOI 10.3747/pdi.2013.00255; Terawaki H, 2014, HEMODIAL INT, V18, P459, DOI 10.1111/hdi.12112; Wang B, 2017, J AM SOC NEPHROL, V28, P2632, DOI 10.1681/ASN.2016111213; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xie KL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807635; Xu L, 2017, NEPHROL DIAL TRANSPL, V32, P1285, DOI 10.1093/ndt/gfv382; Xue M, 2014, NUCLEIC ACIDS RES, V42, P9862, DOI 10.1093/nar/gku583; Yang J, 2017, MOL MED REP, V16, P1771, DOI 10.3892/mmr.2017.6849; Yang JM, 2015, METHODS, V77-78, P119, DOI 10.1016/j.ymeth.2014.10.018; Yang T, 2016, SHOCK, V45, P228, DOI 10.1097/SHK.0000000000000503; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhao PH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06630-2; Zhou Q, 2016, KIDNEY INT, V90, P515, DOI 10.1016/j.kint.2016.03.040	43	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4134	4146		10.1096/fj.201901981R	http://dx.doi.org/10.1096/fj.201901981R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930571	Bronze			2022-12-26	WOS:000507880400001
J	Alexandridis, AA; Dasgupta, N; Ringwalt, CL; Rosamond, WD; Chelminski, PR; Marshall, SW				Alexandridis, Apostolos A.; Dasgupta, Nabarun; Ringwalt, Christopher L.; Rosamond, Wayne D.; Chelminski, Paul R.; Marshall, Stephen W.			Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data	PLOS ONE			English	Article							UNITED-STATES; MAINTENANCE TREATMENT; CHRONIC PAIN; OVERDOSE; INTERVENTIONS; ADDICTION; MISUSE; NEED	Background In the US, medication assisted treatment, particularly with office-based buprenorphine, has been an important component of opioid dependence treatment among patients with iatrogenic addiction to opioid analgesics. The predictors of initiating buprenorphine for addiction among opioid analgesic patients have not been well-described. Methods We conducted a time-to-event analysis using data from the North Carolina (NC) Prescription Drug Monitoring Program (PDMP). Our outcome of interest was time-to-initiation of sublingual buprenorphine. Our study population was a prospective cohort of all state residents receiving a full-agonist opioid analgesic between 2011 and 2015. Predictors of initiation of sublingual buprenorphine examined included: age, gender, cumulative pharmacies and prescribers utilized, cumulative opioid intensity (defined as cumulative opioid exposure divided by duration of opioid exposure), and benzodiazepine dispensing. Findings Of 4.3 million patients receiving opioid analgesics in NC between 2011 and 2015 (accumulated 8.30 million person-years of follow-up), and a total of 28,904 patients initiated buprenorphine formulations intended for addiction treatment (overall rate 3.48 per 1,000 person-years). In adjusted multivariate models, the utilization of 3 or more pharmacies (HR: 2.93; 95% CI: 2.82, 3.05) or 6 or more controlled substance prescribers (HR: 12.09; 95% CI: 10.76, 13.57) was associated with buprenorphine initiation. A dose-response relationship was observed for cumulative opioid intensity (HR in highest decile relative to lowest decile: 5.05; 95% CI: 4.70, 5.42). Benzodiazepine dispensing was negatively associated with buprenorphine initiation (HR: 0.63; 95% CI: 0.61, 0.65). Conclusions Opioid analgesic patients utilizing multiple prescribers or pharmacies are more likely to initiate sublingual buprenorphine. This finding suggests that patients with multiple healthcare interactions are more likely to be treated for high-risk opioid use, or may be more likely to be identified and treated for addiction. Future research should utilize prescription monitoring program data linked to electronic health records to include diagnosis information in analytic models.	[Alexandridis, Apostolos A.; Dasgupta, Nabarun; Ringwalt, Christopher L.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Alexandridis, Apostolos A.; Dasgupta, Nabarun; Rosamond, Wayne D.; Marshall, Stephen W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Chelminski, Paul R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Alexandridis, AA (corresponding author), Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA.; Alexandridis, AA (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA.	aaa@unc.edu	Alexandridis, Apostolos Alexander/O-5405-2017	Alexandridis, Apostolos Alexander/0000-0001-9140-2889; Marshall, Stephen/0000-0002-2664-9233; Dasgupta, Nabarun/0000-0002-4098-605X				Alexandridis AA, 2018, INJURY PREV, V24, P48, DOI 10.1136/injuryprev-2017-042396; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004147.pub4; Andrilla CHA, 2018, AM J PREV MED, V54, pS208, DOI 10.1016/j.amepre.2018.02.006; Beauchamp GA, 2014, AM J PUBLIC HEALTH, V104, P2023, DOI 10.2105/AJPH.2014.302147; Carroll KM, 2017, AM J PSYCHIAT, V174, P738, DOI 10.1176/appi.ajp.2016.16070792; Centers for Disease Control and Prevention, 2019, CALC TOT DAIL DOS OP; Ciccarone D, 2019, INT J DRUG POLICY, V71, P183, DOI 10.1016/j.drugpo.2019.01.010; Coyle DT, 2018, PHARMACOEPIDEM DR S, V27, P464, DOI 10.1002/pds.4366; Dasgupta N, 2016, PAIN MED, V17, P85, DOI 10.1111/pme.12907; Daum AM, 2015, JAAPA-J AM ACAD PHYS, V28, P23, DOI 10.1097/01.JAA.0000464268.60257.ad; Dick AW, 2015, HEALTH AFFAIR, V34, P1028, DOI 10.1377/hlthaff.2014.1205; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Emmanuelli J, 2005, ADDICTION, V100, P1690, DOI 10.1111/j.1360-0443.2005.01271.x; Frank D, 2018, SUBST USE MISUSE, V53, P311, DOI 10.1080/10826084.2017.1310247; Haffajee RL, 2018, AM J PREV MED, V54, pS230, DOI 10.1016/j.amepre.2017.12.022; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; James JR, 2019, SUBST ABUS, V40, P11, DOI 10.1080/08897077.2018.1449176; Kansagra Susan M, 2018, N C Med J, V79, P157, DOI 10.18043/ncm.79.3.157; Knudsen HK, 2015, J STUD ALCOHOL DRUGS, V76, P644, DOI 10.15288/jsad.2015.76.644; Kraus ML, 2011, J ADDICT MED, V5, P254, DOI 10.1097/ADM.0b013e3182312983; Lewis ET, 2014, CLIN J PAIN, V30, P654, DOI 10.1097/01.ajp.0000435447.96642.f4; Lipari RN, 2017, PEOPLE OBTAIN PRESCR, P1; Mattick RP, 2014, BUPRENORPHINE MAINTE; McLean K, 2019, INT J DRUG POLICY, V71, P118, DOI 10.1016/j.drugpo.2019.06.019; National Academies of Sciences Engineering and Medicine, 2019, MED OP US DIS SAV LI; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; Plunkett A, 2013, PAIN MANAG, V3, P277, DOI [10.2217/pmt.13.24, 10.2217/PMT.13.24]; Rosen K, 2014, CLIN J PAIN, V30, P295, DOI 10.1097/AJP.0b013e318298ddad; Rosenblatt RA, 2015, ANN FAM MED, V13, P23, DOI 10.1370/afm.1735; Thomas CP, 2017, DRUG ALCOHOL DEPEN, V181, P213, DOI 10.1016/j.drugalcdep.2017.10.002; Wakeland W, 2015, AM J DRUG ALCOHOL AB, V41, P508, DOI 10.3109/00952990.2015.1043435; Zhu YM, 2018, DRUG ALCOHOL DEPEN, V187, P221, DOI 10.1016/j.drugalcdep.2018.02.019	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227350	10.1371/journal.pone.0227350	http://dx.doi.org/10.1371/journal.pone.0227350			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923197	gold, Green Published			2022-12-26	WOS:000534350000069
J	Hamdi, M; Abdel-Bar, HM; Elmowafy, E; Al-Jamal, KT; Awad, GAS				Hamdi, Mohamed; Abdel-Bar, Hend Mohamed; Elmowafy, Enas; Al-Jamal, Khuloud T.; Awad, Gehanne A. S.			An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect	PLOS ONE			English	Article							SOLID LIPID NANOPARTICLES; CELLULAR UPTAKE; PARTICLE-SIZE; PLGA NANOPARTICLES; FORMULATION DESIGN; DELIVERY PLATFORM; ALPHA-TOCOPHEROL; ORAL DELIVERY; DRUG-RELEASE; OPTIMIZATION	A platform capable of specifically delivering an antiviral drug to the liver infected with hepatitis B is a major concern in hepatology. Vaccination has had a major effect on decreasing the emerging numbers of new cases of infection. However, the total elimination of the hepatitis B virus from the body requires prolonged therapy. In this work, we aimed to target the liver macrophages with lipid polymer hybrid nanoparticles (LPH), combining the merit of polymeric nanoparticles and lipid vesicles. The hydrophilic antiviral drug, entecavir (E), loaded LPH nanoparticles were optimized and physicochemically characterized. A modulated lipidic corona, as well as, an additional coat with vitamin E were used to extend the drug release enhance the macrophage uptake. The selected vitamin E coated LPH nanoparticles enriched with lecithin-glyceryl monostearate lipid shell exhibited high entrapment for E (80.47%), a size. 200 nm for liver passive targeting, extended release over one week, proven serum stability, retained stability after refrigeration storage for 6 months. Upon macrophage uptake in vitro assessment, the presented formulation displayed promising traits, enhancing the cellular retention in J774 macrophages cells. In vivo and antiviral activity futuristic studies would help in the potential application of the ELPH in hepatitis B control.	[Hamdi, Mohamed; Abdel-Bar, Hend Mohamed] Univ Sadat City, Dept Pharmaceut, Fac Pharm, Sadat City, Egypt; [Elmowafy, Enas; Awad, Gehanne A. S.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Sadat City, Egypt; [Al-Jamal, Khuloud T.] Kings Coll London, Fac Life Sci & Med, Inst Pharmaceut Sci, London, England	Egyptian Knowledge Bank (EKB); University of Sadat City; Egyptian Knowledge Bank (EKB); Ain Shams University; University of London; King's College London	Abdel-Bar, HM (corresponding author), Univ Sadat City, Dept Pharmaceut, Fac Pharm, Sadat City, Egypt.	hend.abdelbar@fop.usc.edu.eg	Abdel-Bar, Hend Mohamed/H-5871-2017; Amira, Mohamed/AAT-9940-2021; Elmowafy, Enas/AAJ-4255-2021; Al-Jamal, Khuloud/ABD-5668-2021; Abdel-Bar, Hend Mohamed/ABG-6088-2021	Abdel-Bar, Hend Mohamed/0000-0001-5833-9267; Amira, Mohamed/0000-0002-3616-8636; Abdel-Bar, Hend Mohamed/0000-0001-5833-9267; Awad, Gehanne A/0000-0003-0357-3114; AL-JAMAL, KHULOUD/0000-0001-5165-2699				Abdel-Bar HM, 2017, BIOMED PHARMACOTHER, V93, P561, DOI 10.1016/j.biopha.2017.06.093; Aeschimann W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05148-9; Ali MH, 2010, J PHARM PHARMACOL, V62, P1646, DOI 10.1111/j.2042-7158.2010.01090.x; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; Ana R, 2019, INT J PHARMACEUT, V554, P352, DOI 10.1016/j.ijpharm.2018.11.028; Asthana S, 2015, EUR J PHARM BIOPHARM, V89, P62, DOI 10.1016/j.ejpb.2014.11.019; Boltjes A, 2014, J HEPATOL, V61, P660, DOI 10.1016/j.jhep.2014.04.026; Bongiorno D, 2006, INT J PHARMACEUT, V312, P96, DOI 10.1016/j.ijpharm.2006.01.017; Bose RJC, 2017, DRUG DISCOV TODAY, V22, P1258, DOI 10.1016/j.drudis.2017.05.015; Briuglia ML, 2015, DRUG DELIV TRANSL RE, V5, P231, DOI 10.1007/s13346-015-0220-8; Chan JM, 2009, BIOMATERIALS, V30, P1627, DOI 10.1016/j.biomaterials.2008.12.013; Chaudhary Z, 2018, INT J POLYM MATER PO, V67, P86, DOI 10.1080/00914037.2017.1300900; Chen LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37122; Chen RE, 2015, DRUG DELIV, V22, P666, DOI 10.3109/10717544.2014.882446; Chen WL, 2017, MOL PHARMACEUT, V14, P459, DOI 10.1021/acs.molpharmaceut.6b00896; D'Addio SM, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0128; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Das S, 2011, COLLOID SURFACE B, V88, P483, DOI 10.1016/j.colsurfb.2011.07.036; Date T, 2018, J CONTROL RELEASE, V271, P60, DOI 10.1016/j.jconrel.2017.12.016; Dehaini D, 2016, NANOSCALE, V8, P14411, DOI 10.1039/c6nr04091h; Devrim B, 2016, DRUG DEV IND PHARM, V42, P1865, DOI 10.1080/03639045.2016.1180392; Dizaj SM, 2015, J DRUG DELIV SCI TEC, V29, P125, DOI 10.1016/j.jddst.2015.06.015; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Dora CP, 2010, ACTA POL PHARM, V67, P283; Duan R, 2017, COLLOID SURFACE B, V159, P880, DOI 10.1016/j.colsurfb.2017.08.042; El-Gogary RI, 2014, ACS NANO, V8, P1384, DOI 10.1021/nn405155b; Emami J, 2014, RES PHARM SCI, V9, P301; Faure-Dupuy S, 2018, LIVER INT, V38, P1718, DOI 10.1111/liv.13884; Gajra B, 2016, DRUG DEV IND PHARM, V42, P747, DOI 10.3109/03639045.2015.1093496; Gardouh AR, 2013, BRIT J PHARM RES, V3, P326, DOI 10.9734/BJPR/2013/2770; Hadinoto K, 2013, EUR J PHARM BIOPHARM, V85, P427, DOI 10.1016/j.ejpb.2013.07.002; Hallan SS, 2016, ARTIF CELL NANOMED B, V44, P334, DOI 10.3109/21691401.2014.951721; He SS, 2018, MOL PHARMACEUT, V15, P3953, DOI 10.1021/acs.molpharmaceut.8b00408; Ho MJ, 2018, INT J PHARMACEUT, V543, P52, DOI 10.1016/j.ijpharm.2018.03.042; Hodgins NO, 2017, J CONTROL RELEASE, V256, P141, DOI 10.1016/j.jconrel.2017.04.025; Hu Y, 2015, ACTA BIOMATER, V28, P149, DOI 10.1016/j.actbio.2015.09.032; Huo ZJ, 2015, CANCER SCI, V106, P1429, DOI 10.1111/cas.12737; Hussain T, 2013, ACTA POL PHARM, V70, P749; Ishak RAH, 2017, DRUG DELIV, V24, DOI 10.1080/10717544.2017.1410263; Jin X, 2013, DRUG DEV IND PHARM, V39, P1421, DOI 10.3109/03639045.2012.719234; Joshi SA, 2010, EUR J PHARM BIOPHARM, V76, P189, DOI 10.1016/j.ejpb.2010.07.007; Ju C, 2016, CELL MOL IMMUNOL, V13, P316, DOI 10.1038/cmi.2015.104; Jung HJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23040731; Kashif PM, 2017, AAPS PHARMSCITECH, V18, P1810, DOI 10.1208/s12249-016-0653-5; Klippstein R, 2015, SMALL, V11, P4704, DOI 10.1002/smll.201403799; Konjufca VK, 2004, POULTRY SCI, V83, P1530, DOI 10.1093/ps/83.9.1530; Krishnamachari Y, 2007, INT J PHARM, V338, P238, DOI 10.1016/j.ijpharm.2007.02.015; Kulkarni SA, 2013, PHARM RES-DORDR, V30, P2512, DOI 10.1007/s11095-012-0958-3; Kumar R., 2013, DRUG INVENT TODAY, V5, P246; Lalani J, 2015, AAPS PHARMSCITECH, V16, P413, DOI 10.1208/s12249-014-0235-3; Leng DL, 2018, INT J PHARMACEUT, V548, P740, DOI 10.1016/j.ijpharm.2017.08.094; Lewis ED, 2019, IUBMB LIFE, V71, P487, DOI 10.1002/iub.1976; Li AM, 2019, INT J NANOMED, V14, P913, DOI 10.2147/IJN.S190164; Li LJ, 2010, NANO TODAY, V5, P296, DOI 10.1016/j.nantod.2010.06.007; Liang J, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0391-9; Lim JL, 2015, INT J PHARMACEUT, V490, P265, DOI 10.1016/j.ijpharm.2015.05.049; Maboos M, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0783-8; Magarkar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05005; Mandal B, 2016, EUR J PHARM SCI, V81, P162, DOI 10.1016/j.ejps.2015.10.021; Massella D, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10101092; Meng R, 2016, J HUAZHONG U SCI-MED, V36, P14, DOI 10.1007/s11596-016-1535-5; Morales-Cruz Moraima, 2012, Results Pharma Sci, V2, P79; Moran-Valero MI, 2017, COLLOID SURFACE B, V151, P68, DOI 10.1016/j.colsurfb.2016.12.015; Mukherjee A, 2019, INT J NANOMED, V14, P1937, DOI 10.2147/IJN.S198353; Mustafa S, 2017, J DRUG DELIV, V2017, DOI 10.1155/2017/1253294; Nam HY, 2009, J CONTROL RELEASE, V135, P259, DOI 10.1016/j.jconrel.2009.01.018; Nishina K, 2008, MOL THER, V16, P734, DOI 10.1038/mt.2008.14; PAGANO RE, 1972, J MEMBRANE BIOL, V10, P11, DOI 10.1007/BF01867845; Pooja D, 2014, COLLOID SURFACE B, V121, P461, DOI 10.1016/j.colsurfb.2014.06.059; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Salatin S, 2017, RES PHARM SCI, V12, P1, DOI 10.4103/1735-5362.199041; Sato Y, 2012, J CONTROL RELEASE, V163, P267, DOI 10.1016/j.jconrel.2012.09.009; Sengel-Turk CT, 2017, J DRUG DELIV SCI TEC, V39, P16, DOI 10.1016/j.jddst.2017.02.012; Shah B, 2015, EUR J PHARM SCI, V78, P54, DOI 10.1016/j.ejps.2015.07.002; Shah VP, 1998, PHARMACEUT RES, V15, P889, DOI 10.1023/A:1011976615750; Shao XR, 2015, CELL PROLIFERAT, V48, P465, DOI 10.1111/cpr.12192; Silva EJ, 2018, CURR DRUG DELIV, V15, P979, DOI 10.2174/1567201815666171215110026; Singh L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050267; Singh L, 2017, THER ADV INFECT DIS, V4, P105, DOI 10.1177/2049936117713593; Sylvester B, 2018, DRUG DEV IND PHARM, V44, P385, DOI 10.1080/03639045.2017.1395457; Tahir N, 2017, INT J PHARMACEUT, V533, P156, DOI 10.1016/j.ijpharm.2017.09.061; Tamilselvan N, 2015, J YOUNG PHARM, V7, P28, DOI 10.5530/jyp.2015.1.6; Thanki K, 2017, EUR J PHARM BIOPHARM, V120, P22, DOI 10.1016/j.ejpb.2017.07.014; Traber MG, 2007, ANNU REV NUTR, V27, P347, DOI 10.1146/annurev.nutr.27.061406.093819; Uppulurj KB, 2015, BIOMEDICAL PHARM J, V6, P355; Wang AZ, 2010, NANOMEDICINE-UK, V5, P361, DOI 10.2217/NNM.10.6; Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050; Wu XN, 2019, INFECT DRUG RESIST, V12, P745, DOI 10.2147/IDR.S185120; Yanasarn N, 2009, INT J PHARMACEUT, V379, P174, DOI 10.1016/j.ijpharm.2009.06.004; Yokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036; Zhang CY, 2019, INT J PHARMACEUT, V560, P27, DOI 10.1016/j.ijpharm.2019.01.052; Zhang L, 2010, NANO LIFE, V1, P163, DOI 10.1142/S179398441000016X; Zhao PQ, 2012, EUR J PHARM BIOPHARM, V81, P248, DOI 10.1016/j.ejpb.2012.03.004; Zhao X, 2015, BIOMATERIALS, V46, P13, DOI 10.1016/j.biomaterials.2014.12.028; Zingg JM, 2007, MOL ASPECTS MED, V28, P400, DOI 10.1016/j.mam.2007.05.004; Zoubari G, 2017, EUR J PHARM BIOPHARM, V110, P39, DOI 10.1016/j.ejpb.2016.10.021; Zoutendijk R, 2011, HEPATOLOGY, V54, P443, DOI 10.1002/hep.24406	97	14	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227231	10.1371/journal.pone.0227231	http://dx.doi.org/10.1371/journal.pone.0227231			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923260	gold, Green Published			2022-12-26	WOS:000534350000058
J	Che, P; Wagener, BM; Zhao, XK; Brandon, AP; Evans, CA; Cai, GQ; Zhao, R; Xu, ZX; Han, XS; Pittet, JF; Ding, Q				Che, Pulin; Wagener, Brant M.; Zhao, Xueke; Brandon, Angela P.; Evans, Cilina A.; Cai, Guo-Qiang; Zhao, Rui; Xu, Zhi-Xiang; Han, Xiaosi; Pittet, Jean-Francois; Ding, Qiang			Neuronal Wiskott-Aldrich syndrome protein regulates Pseudomonas aeruginosa-induced lung vascular permeability through the modulation of actin cytoskeletal dynamics	FASEB JOURNAL			English	Article						beta-catenin; alpha v beta 6; acute lung injury; small Rho GTPases; VE-cadherin	N-WASP; ENDOTHELIAL BARRIER; IN-VITRO; INTEGRIN; ACTIVATION; KINASE; INJURY; ADHESION; RHOA; FAK	Pulmonary edema associated with increased vascular permeability is a severe complication of Pseudomonas (P.) aeruginosa-induced acute lung injury. The mechanisms underlying P aeruginosa-induced vascular permeability are not well understood. In the present study, we investigated the role of neuronal Wiskott Aldrich syndrome protein (N-WASP) in modulating P aeruginosa-induced vascular permeability. Using lung microvascular endothelial and alveolar epithelial cells, we demonstrated that N-WASP downregulation attenuated P aeruginosa-induced actin stress fiber formation and prevented paracellular permeability. P aeruginosa-induced dissociation between VE-cadherin and beta-catenin, but increased association between N-WASP and VE-cadherin, suggesting a role for N-WASP in promoting P aeruginosa-induced adherens junction rupture. P aeruginosa increased N-WASP-Y256 phosphorylation, which required the activation of Rho GTPase and focal adhesion kinase. Increased N-WASP-Y256 phosphorylation promotes N-WASP and integrin alpha V beta 6 association as well as TGF-beta-mediated permeability across alveolar epithelial cells. Inhibition of N-WASP-Y256 phosphorylation by N-WASP-Y256F overexpression blocked N-WASP effects in P aeruginosa-induced actin stress fiber formation and increased paracellular permeability. In vivo, N-WASP knockdown attenuated the development of pulmonary edema and improved survival in a mouse model of P aeruginosa pneumonia. Together, our data demonstrate that N-WASP plays an essential role in P aeruginosa-induced vascular permeability and pulmonary edema through the modulation of actin cytoskeleton dynamics.	[Che, Pulin; Wagener, Brant M.; Brandon, Angela P.; Evans, Cilina A.; Cai, Guo-Qiang; Pittet, Jean-Francois; Ding, Qiang] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL USA; [Che, Pulin; Wagener, Brant M.; Ding, Qiang] Univ Alabama Birmingham, Mol & Translat Biomed, Birmingham, AL USA; [Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Div Crit Care, Birmingham, AL USA; [Wagener, Brant M.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL USA; [Zhao, Xueke] Guizhou Med Univ, Affiliated Hosp, Dept Infect Dis, Guiyang, Peoples R China; [Zhao, Rui] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA; [Xu, Zhi-Xiang] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Han, Xiaosi] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Guizhou Medical University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ding, Q (corresponding author), Univ Alabama Birmingham, Div Mol & Translat Biomed, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA.	qding@uab.edu	Wagener, Brant/AAI-7480-2020		HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [R01HL143017, R01HL127338]; Flight Attendant Medical Research Institute (FAMRI); Foundation for Anesthesia Education and Research (FAER); American Heart Association (AHA)	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); Flight Attendant Medical Research Institute (FAMRI); Foundation for Anesthesia Education and Research (FAER); American Heart Association (AHA)(American Heart Association)	HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL143017 and R01HL127338; Flight Attendant Medical Research Institute (FAMRI); Foundation for Anesthesia Education and Research (FAER); American Heart Association (AHA)	Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Beaufort N, 2011, CELL MICROBIOL, V13, P1149, DOI 10.1111/j.1462-5822.2011.01606.x; Bechara RI, 2004, AM J RESP CRIT CARE, V170, P188, DOI 10.1164/rccm.200304-478OC; Bir N, 2011, AM J RESP CELL MOL, V45, P632, DOI 10.1165/rcmb.2010-0397OC; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Cai GQ, 2010, EXP CELL RES, V316, P1600, DOI 10.1016/j.yexcr.2010.01.021; Carles M, 2010, ANESTHESIOLOGY, V113, P1134, DOI 10.1097/ALN.0b013e3181f4171b; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Che PL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08453; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Coon TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3881; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Cott C, 2016, BBA-MOL CELL RES, V1863, P1106, DOI 10.1016/j.bbamcr.2016.02.004; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Ding Q, 2003, J BIOL CHEM, V278, P39882, DOI 10.1074/jbc.M304685200; Ding Q, 2002, CANCER RES, V62, P5336; Ding Q, 2008, J BIOL CHEM, V283, P26839, DOI 10.1074/jbc.M803645200; Ding Q, 2013, AM J PATHOL, V182, P1572, DOI 10.1016/j.ajpath.2013.01.026; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Duluc L, 2014, CELL TISSUE RES, V355, P675, DOI 10.1007/s00441-014-1805-0; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Ganter MT, 2009, AM J RESP CELL MOL, V40, P108, DOI 10.1165/rcmb.2007-0454OC; Geiser TK, 2001, CELL MICROBIOL, V3, P223, DOI 10.1046/j.1462-5822.2001.00107.x; Golovkine G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003939; Hijazi MH, 2000, SEMIN RESP CRIT CARE, V21, P245, DOI 10.1055/s-2000-9855; Jian MY, 2013, AM J PHYSIOL-LUNG C, V305, pL844, DOI 10.1152/ajplung.00173.2013; Kloth C, 2018, TOXINS, V10, DOI 10.3390/toxins10050185; Leligdowicz A, 2018, AM J PHYSIOL-LUNG C, V315, pL638, DOI 10.1152/ajplung.00286.2018; Liu AR, 2019, AM J RESP CRIT CARE, V200, P1234, DOI 10.1164/rccm.201812-2296OC; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; Lu Q, 2011, AM J PHYSIOL-LUNG C, V301, pL847, DOI 10.1152/ajplung.00178.2011; Mooren OL, 2015, J BIOL CHEM, V290, P18796, DOI 10.1074/jbc.M115.668285; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Pittet JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063907; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Reboud E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006579; Rello J, 1997, CRIT CARE MED, V25, P1862, DOI 10.1097/00003246-199711000-00026; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sawa T, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0668-9; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schmidt TT, 2013, AM J PHYSIOL-LUNG C, V305, pL291, DOI 10.1152/ajplung.00094.2013; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Song YL, 2008, INFECT IMMUN, V76, P2325, DOI 10.1128/IAI.01431-07; Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419, DOI 10.1152/ajplung.2000.279.3.L419; Sturge J, 2002, J CELL SCI, V115, P699; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Takenawa T, 2001, J CELL SCI, V114, P1801; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Wagener BM, 2016, FASEB J, V30, P2557, DOI 10.1096/fj.201600102R; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; WIENERKRONISH JP, 1993, J APPL PHYSIOL, V75, P1661, DOI 10.1152/jappl.1993.75.4.1661	63	7	7	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3305	3317		10.1096/fj.201902915R	http://dx.doi.org/10.1096/fj.201902915R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916311	Green Accepted			2022-12-26	WOS:000506441800001
J	Das, S; Aria, A; Cheng, JO; Souissi, S; Hwang, JS; Ko, FC				Das, Shagnika; Aria, Andres; Cheng, Jing-O; Souissi, Sami; Hwang, Jiang-Shiou; Ko, Fung-Chi			Occurrence and distribution of anthropogenic persistent organic pollutants in coastal sediments and mud shrimps from the wetland of central Taiwan	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; POLYBROMINATED DIPHENYL ETHERS; POLYCHLORINATED-BIPHENYLS PCBS; GAO-PING RIVER; ORGANOCHLORINE PESTICIDES; SURFACE SEDIMENTS; SOURCE APPORTIONMENT; CARBONACEOUS MATERIALS; YANGTZE ESTUARY; DANSHUI RIVER	Sediment profile and mud shrimp (Austinogebia edulis) from the coastal wetland of central Taiwan in 2017 and 2018 were analyzed for concentration, source, and composition of persistent organic pollutants (POPs) including polycyclic aromatic hydrocarbon (PAHs), polybrominated diphenyl ethers (PBDEs), organochlorine pesticides (OCPs; DDT and HCB), and polychlorinated biphenyls (PCBs). Sediment profiling indicated PAH concentrations reaching 254.38 ng/g dw in areas near industrial areas and PAH concentrations of 41.8 and 58.42 ng/g dw in sampling areas further from industrial areas, suggesting that the determining factor for spatial distribution of POPs might be proximity to contaminant sources in industrial zones. Based on molecular indices, PAHs were substantially of both pyrolytic and petrogenic origins. The main sources for PCBs were Aroclor 1016 and 1260 and the congener BDE-209 was the dominant component among PBDE congeners. While we were unable to obtain live mud shrimp samples from the heavily contaminated areas, in samples from less contaminated areas, the risk assessment on mud shrimp still illustrated a borderline threat, with DDT concentrations almost reaching standardized values of Effects Range-Low (ERL). Bioaccumulation factors for DDTs and PCBs (17.33 and 54.59, respectively) were higher than other POPs in this study. Further study is essential to assess and understand the impact of these chemicals on the wetland ecosystem near this heavily industrialized area.	[Das, Shagnika; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan; [Das, Shagnika; Souissi, Sami] Univ Lille, Univ Littoral Cote Opale, Lab Oceanol & Geosci, CNRS,LOG,UMR 8187, Wimereux, France; [Aria, Andres] Argentine Inst Oceanog, Bahia Blanca, Buenos Aires, Argentina; [Aria, Andres] Natl South Univ, Chem Dept, Area 3, Bahia Blanca, Buenos Aires, Argentina; [Cheng, Jing-O; Ko, Fung-Chi] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Ko, Fung-Chi] Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan	National Taiwan Ocean University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; National Museum of Marine Biology & Aquarium; National Taiwan Ocean University; National Dong Hwa University	Ko, FC (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Ko, FC (corresponding author), Natl Dong Hwa Univ, Inst Marine Biol, Pingtung, Taiwan.	ko@gms.ndhu.edu.tw		Ko, Fung-Chi/0000-0002-8276-2353; Das, Shagnika/0000-0001-6157-6933; Arias, Andres Hugo/0000-0003-3322-330X	Ministry of Science and Technology (MOST) of Taiwan [MOST 104-2611-M-019-004, MOST 105-2621-M-019 001, MOST 105-2918-I-019-001, MOST 106-2621-M-019-001, MOST 107-2621-M-019 001]	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan)	We acknowledge a grant of the Ministry of Science and Technology (MOST) of Taiwan for financial support through grants: MOST 104-2611-M-019-004, MOST 105-2621-M-019 001, MOST 105-2918-I-019-001, MOST 106-2621-M-019001, and MOST 107-2621-M-019 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleye AO, 2016, SCI TOTAL ENVIRON, V541, P1540, DOI 10.1016/j.scitotenv.2015.09.124; Ahmed MM, 2017, MAR POLLUT BULL, V120, P340, DOI 10.1016/j.marpolbul.2017.05.055; [Anonymous], 1979, USITC PUBL, V48; Bartolome L, 2006, MAR POLLUT BULL, V52, P1111, DOI 10.1016/j.marpolbul.2006.05.024; Baumard P, 1998, ENVIRON TOXICOL CHEM, V17, P765, DOI 10.1002/etc.5620170501; Bayen S, 2012, ENVIRON INT, V48, P84, DOI 10.1016/j.envint.2012.07.008; Binelli A, 2008, CHEMOSPHERE, V73, P1129, DOI 10.1016/j.chemosphere.2008.07.019; Budzinski H, 1997, MAR CHEM, V58, P85, DOI 10.1016/S0304-4203(97)00028-5; Cao QM, 2015, ECOTOX ENVIRON SAFE, V111, P42, DOI 10.1016/j.ecoenv.2014.09.023; CCME, 2002, GUID SIT SPEC APPL W; Chang GR, 2018, ENVIRON SCI POLLUT R, V25, P7699, DOI 10.1007/s11356-017-1110-z; Chapman P, 2006, ECOL ENG, V26, P1, DOI 10.1016/j.ecoleng.2005.09.003; Chau KW, 2006, CHEMOSPHERE, V64, P1545, DOI 10.1016/j.chemosphere.2005.11.060; Chen YC, 2016, ENVIRON POLLUT, V218, P372, DOI 10.1016/j.envpol.2016.07.016; Cheng JO, 2018, SCI TOTAL ENVIRON, V637, P1578, DOI 10.1016/j.scitotenv.2018.05.075; Cheng JO, 2012, ENVIRON MONIT ASSESS, V184, P3481, DOI 10.1007/s10661-011-2202-8; Cheng JO, 2010, ARCH ENVIRON CON TOX, V58, P489, DOI 10.1007/s00244-009-9411-y; Connell DW, 1998, CHEMOSPHERE, V36, P2019, DOI 10.1016/S0045-6535(97)10087-X; Das S, 2019, ENVIRON SCI POLLUT R, V26, P7752, DOI 10.1007/s11356-018-04113-x; Das S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187647; deBruyn AMH, 2009, ENVIRON SCI TECHNOL, V43, P3700, DOI 10.1021/es900472k; Denis EH, 2012, ORG GEOCHEM, V45, P7, DOI 10.1016/j.orggeochem.2012.01.005; Doong RA, 2002, MAR POLLUT BULL, V45, P246, DOI 10.1016/S0025-326X(02)00102-9; Doong RA, 2004, WATER RES, V38, P1733, DOI 10.1016/j.watres.2003.12.042; Doong RA, 2008, MAR POLLUT BULL, V57, P846, DOI 10.1016/j.marpolbul.2007.12.015; Duval M. M., 1981, EPA600281161; Fang MD, 2008, SCI TOTAL ENVIRON, V407, P548, DOI 10.1016/j.scitotenv.2008.09.021; Froese KL, 1998, ENVIRON TOXICOL CHEM, V17, P484, DOI 10.1002/etc.5620170320; Fusi M, 2016, MAR POLLUT BULL, V109, P723, DOI 10.1016/j.marpolbul.2016.06.104; Gao SH, 2013, CHEMOSPHERE, V91, P809, DOI 10.1016/j.chemosphere.2013.01.085; Golobocanin DD, 2004, CHEMOMETR INTELL LAB, V72, P219, DOI 10.1016/j.chemolab.2004.01.017; Guzzella L, 2005, ENVIRON INT, V31, P523, DOI 10.1016/j.envint.2004.10.014; HAWKER DW, 1985, CHEMOSPHERE, V14, P1205, DOI 10.1016/0045-6535(85)90142-0; Hong SH, 2006, CHEMOSPHERE, V64, P1479, DOI 10.1016/j.chemosphere.2005.12.056; Hsu CY, 2016, SCI TOTAL ENVIRON, V541, P1139, DOI 10.1016/j.scitotenv.2015.09.122; Huang YP, 2017, CHEMOSPHERE, V184, P1334, DOI 10.1016/j.chemosphere.2017.06.117; Hung CC, 2007, ENVIRON POLLUT, V148, P546, DOI 10.1016/j.envpol.2006.11.036; Hung CC, 2006, CHEMOSPHERE, V65, P1452, DOI 10.1016/j.chemosphere.2006.04.037; Hung CC, 2010, MAR POLLUT BULL, V60, P1010, DOI 10.1016/j.marpolbul.2010.01.026; Iannuzzi J, 2011, ENVIRON TOXICOL CHEM, V30, P1721, DOI 10.1002/etc.550; Jiang JJ, 2011, MAR POLLUT BULL, V62, P815, DOI 10.1016/j.marpolbul.2010.12.019; KHALILI NR, 1995, ATMOS ENVIRON, V29, P533, DOI 10.1016/1352-2310(94)00275-P; Lee HJ, 2014, SCI TOTAL ENVIRON, V470, P1479, DOI 10.1016/j.scitotenv.2013.06.105; Liou ML, 2006, HUM ECOL RISK ASSESS, V12, P390, DOI 10.1080/10807030500536827; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Moon HB, 2007, CHEMOSPHERE, V66, P243, DOI 10.1016/j.chemosphere.2006.05.025; Nakata H, 2003, ENVIRON SCI TECHNOL, V37, P3513, DOI 10.1021/es021083h; Nascimento RA, 2017, MAR POLLUT BULL, V119, P223, DOI 10.1016/j.marpolbul.2017.03.069; Pereira WE, 1996, MAR ENVIRON RES, V41, P299, DOI 10.1016/0141-1136(95)00021-6; Pikkarainen AL, 2007, CHEMOSPHERE, V68, P17, DOI 10.1016/j.chemosphere.2006.12.079; Ramdine G, 2012, ECOTOX ENVIRON SAFE, V79, P80, DOI 10.1016/j.ecoenv.2011.12.005; Ramzi A, 2017, MAR POLLUT BULL, V114, P1081, DOI 10.1016/j.marpolbul.2016.10.015; Sanchez-Avila J, 2013, MAR POLLUT BULL, V72, P119, DOI 10.1016/j.marpolbul.2013.04.010; Sarkar A, 1997, WATER RES, V31, P195, DOI 10.1016/S0043-1354(96)00210-2; Tombesi N, 2017, SCI TOTAL ENVIRON, V575, P1470, DOI 10.1016/j.scitotenv.2016.10.013; Tongo I, 2017, J ENVIRON CHEM ENG, V5, P504, DOI 10.1016/j.jece.2016.12.035; Van Ael E, 2012, ENVIRON INT, V48, P17, DOI 10.1016/j.envint.2012.06.017; Voorspoels S, 2004, MAR POLLUT BULL, V49, P393, DOI 10.1016/j.marpolbul.2004.02.024; Wang XT, 2015, CHEMOSPHERE, V133, P22, DOI 10.1016/j.chemosphere.2015.02.064; Whitall D, 2014, MAR POLLUT BULL, V80, P293, DOI 10.1016/j.marpolbul.2013.12.053; Wright JT, 2004, MAR BIOL, V145, P1061, DOI 10.1007/s00227-004-1399-2; Wurl O, 2005, CHEMOSPHERE, V58, P925, DOI 10.1016/j.chemosphere.2004.09.054; Yang HY, 2011, CHEMOSPHERE, V83, P137, DOI 10.1016/j.chemosphere.2010.12.070; Yeh HC, 2009, ENVIRON MONIT ASSESS, V153, P103, DOI 10.1007/s10661-008-0340-4; Yuan DX, 2001, ENVIRON POLLUT, V114, P101, DOI 10.1016/S0269-7491(00)00200-1; Yuan HZ, 2017, CHEMOSPHERE, V173, P78, DOI 10.1016/j.chemosphere.2017.01.047; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zhao GF, 2012, SCI TOTAL ENVIRON, V427, P139, DOI 10.1016/j.scitotenv.2012.04.001	69	15	15	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227367	10.1371/journal.pone.0227367	http://dx.doi.org/10.1371/journal.pone.0227367			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917823	gold, Green Published			2022-12-26	WOS:000534341100020
J	Guo, FY; Xu, DK; Lin, YZ; Wang, GQ; Wang, F; Gao, Q; Wei, QJ; Lei, SX				Guo, Fuyou; Xu, Dingkang; Lin, Yazhou; Wang, Guoqing; Wang, Fang; Gao, Qiang; Wei, Qingjie; Lei, Shixiong			Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage	FASEB JOURNAL			English	Article						acute intracerebral hemorrhage; BBB; CCL2; p38 MAPK; PG	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CEREBRAL VASOSPASM; BRAIN-INJURY; INHIBITION; ACTIVATION; STROKE; KINASE; MCP-1	Intracerebral hemorrhage (ICH) remains a devastating type of stroke that lacks an effective treatment. Recent evidence has demonstrated that CCL2 is involved in the blood-brain barrier (BBB) disruption and propagermanium (PG) as a CCL2 receptor inhibitor is neuroprotective in ischemic stroke. However, whether PG therapy exert effective role in acute ICH still unclear. In this study, our goal was to investigate the potential role of CCL2 and the effects of PG in ICH. Differentially expressed RNAs including CCL2 were detected in human ICH. CCL2 and the activation of p-p38 MAPK and AQP4 expression were analyzed in rats after ICH. Brain water content and BBB integrity as well as neurological function were also examined after PG administration. In addition, the mechanism by which CCL2-mediated BBB injury was further investigated by cell coculture. Our findings showed that PG could effectively reduce brain edema and improve neurobehavioral functions. p-p38 MAPK and AQP4 expression were significantly inhibited by PG in vivo and in vitro. To the best of our knowledge, this is the first demonstration of PG in neuroprotecting the BBB integrity by inhibition of CCL2-CCR2-p38 MAPK pathway following ICH, targeting CCL2 could be developed as a novel treatment for hemorrhagic stroke.	[Guo, Fuyou; Xu, Dingkang; Wang, Guoqing; Wang, Fang; Gao, Qiang; Wei, Qingjie; Lei, Shixiong] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 East Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China; [Lin, Yazhou] Zhengzhou Univ, Sch Basic Med Sci, Dept Human Anat, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Guo, FY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 East Jianshe Rd, Zhengzhou 450052, Henan, Peoples R China.	chyou666@hotmail.com	Xu, Dingkang/AAC-4094-2020; Gao, Qiang/AGN-1675-2022	Xu, Dingkang/0000-0002-9153-773X; Gao, Qiang/0000-0001-7262-3942	National Natural Science Foundation of China (NSFC) [U1204807]; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department) [192102310113]; Medical science and technique foundation of Henan Province [SB201901007]; Education Department of Henan Province (Henan Provincial Education Department) [19B320017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department); Medical science and technique foundation of Henan Province; Education Department of Henan Province (Henan Provincial Education Department)	National Natural Science Foundation of China (NSFC), Grant/Award Number: U1204807; Science and Technology Department of Henan Province (Henan Provincial Science and Technology Department), Grant/Award Number: 192102310113; Medical science and technique foundation of Henan Province, Grant/Award Number: SB201901007; Education Department of Henan Province (Henan Provincial Education Department), Grant/Award Number: 19B320017	Chu HL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081249; Fang WR, 2018, THERANOSTICS, V8, P3530, DOI 10.7150/thno.24475; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Galego O, 2018, NEURORADIOL J, V31, P456, DOI 10.1177/1971400918769912; Georgakis MK, 2019, CIRCULATION, V139, P256, DOI 10.1161/CIRCULATIONAHA.118.035905; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Guo FY, 2012, TRANSL STROKE RES, V3, P130, DOI 10.1007/s12975-011-0106-0; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Han YW, 2018, EUR J PHARMACOL, V839, P12, DOI 10.1016/j.ejphar.2018.09.018; He SC, 2019, NEUROCHEM INT, V125, P99, DOI 10.1016/j.neuint.2019.02.010; Hirayama C, 2003, J GASTROENTEROL, V38, P525, DOI 10.1007/s00535-003-1098-7; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kim GH, 2008, J NEUROSURG, V109, P38, DOI 10.3171/JNS/2008/109/7/0038; Landreneau MJ, 2018, ANN CLIN TRANSL NEUR, V5, P962, DOI 10.1002/acn3.595; Li GC, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9149-x; Li ZD, 2012, NEUROSCIENCES, V17, P314; Li ZH, 2017, J MOL NEUROSCI, V61, P279, DOI 10.1007/s12031-017-0883-3; Mao LL, 2017, BRAIN, V140, P1914, DOI 10.1093/brain/awx111; Ni YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170346; Roberts TK, 2012, LAB INVEST, V92, P1213, DOI 10.1038/labinvest.2012.80; Sasaki T, 2004, STROKE, V35, P1466, DOI 10.1161/01.STR.0000127425.47266.20; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Song YQ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038492; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; Strecker JK, 2013, STROKE, V44, P2536, DOI 10.1161/STROKEAHA.111.000528; Wang GQ, 2019, NEUROSCIENCE, V415, P135, DOI 10.1016/j.neuroscience.2019.06.038; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Yang Z, 2016, INT IMMUNOPHARMACOL, V33, P18, DOI 10.1016/j.intimp.2016.01.016; Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1; Yao Y, 2012, GLIA, V60, P908, DOI 10.1002/glia.22323; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Yumimoto K, 2019, CANCER SCI, V110, P2090, DOI 10.1111/cas.14075; Zhang LJ, 2018, MOL MED REP, V18, P4213, DOI 10.3892/mmr.2018.9468; Zhang X, 2011, ANN CLIN LAB SCI, V41, P244; Zhang Y, 2019, J CELL BIOCHEM, V120, P14372, DOI 10.1002/jcb.28693; Zhou J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00091; Zhu W, 2018, BRAIN BEHAV IMMUN, V69, P568, DOI 10.1016/j.bbi.2018.02.004	38	29	30	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1872	1884		10.1096/fj.201902203RR	http://dx.doi.org/10.1096/fj.201902203RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914700				2022-12-26	WOS:000507308900124
J	Chen, C; Li, CC; Liu, WC; Guo, F; Kou, X; Sun, S; Ye, TY; Li, SJ; Zhao, AM				Chen, Chao; Li, Congcong; Liu, Weichun; Guo, Feng; Kou, Xi; Sun, Si; Ye, Taiyang; Li, Shanji; Zhao, Aimin			Estrogen-induced FOS-like 1 regulates matrix metalloproteinase expression and the motility of human endometrial and decidual stromal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell invasion; estrogen; estrogen receptor; matrix metalloproteinase (MMP); decidualization; FOS-like 1; human decidual stromal cells; human endometrial stromal cells	VASCULAR DYSFUNCTION; PLACENTAL ISCHEMIA; C-JUN; FRA-1; PREGNANCY; MMP-9; HYPERTENSION; ACTIVATION; DEPOSITION; IMMUNE	The regulation mechanisms involved in matrix metalloproteinase (MMP) expression and the motility of human endometrial and decidual stromal cells (ESCs and DSCs, respectively) during decidualization remain unclear. DSCs show significant increased cell motility and expression of FOS-like 1 (FOSL1) and MMP1, MMP2, and MMP9 compared with ESCs, whereas lack of decidualization inducers leads to a rapid decrease in FOSL1 and MMP1 and MMP9 expression in DSCs in vitro. Therefore, we hypothesized that a link exists between decidualization inducers and FOSL1 in up-regulation of motility during decidualization. Based on the response of ESCs/DSCs to different decidualization systems in vitro, we found that progesterone (P4) alone had no significant effect and that 17?-estradiol (E2) significantly increased cell motility and FOSL1 and MMP1 and MMP9 expression at the mRNA and protein levels, whereas 8-bromo-cAMP significantly decreased cell motility and FOSL1 and MMP9 expression in the presence of P4. In addition, we showed that E2 triggered phosphorylation of estrogen receptor 1 (ESR1), which could directly bind to the promoter of FOSL1 in ESCs/DSCs. Additionally, we also revealed silencing of ESR1 expression by siRNA abrogated E2-induced FOSL1 expression at the transcript and protein levels. Moreover, silencing of FOSL1 expression by siRNA was able to block E2-induced MMP1 and MMP9 expression and cell motility in ESCs/DSCs. Taken together, our data suggest that, in addition to its enhancement of secretory function, the change in MMP expression and cell motility is another component of the decidualization of ESCs/DSCs, including estrogen-dependent MMP1 and MMP9 expression mediated by E2?ESR1?FOSL1 signaling.	[Chen, Chao; Li, Congcong; Liu, Weichun; Guo, Feng; Kou, Xi; Sun, Si; Ye, Taiyang; Li, Shanji; Zhao, Aimin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Obstet & Gynecol, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Chen, Chao; Li, Congcong; Guo, Feng; Zhao, Aimin] Shanghai Key Lab Gynecol Oncol, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University	Zhao, AM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Obstet & Gynecol, 160 Pujian Rd, Shanghai 200127, Peoples R China.	zamzkh0526@126.com	li, congcong/AAE-5664-2021	Ye, Taiyang/0000-0002-2640-1289	National Natural Science Foundation of China [81671481, 81871179]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81671481 and 81871179. The authors declare that they have no conflicts of interest with the contents of this article.	Ali SMJ, 2015, EXPERT OPIN THER TAR, V19, P1495, DOI 10.1517/14728222.2015.1067684; Anacker J., 2010, J REPROD IMMUNOL, V86, P79, DOI [10.1016/j.jri.2010.08.002, DOI 10.1016/J.JRI.2010.08.002]; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Babu RL, 2013, MOL CELL BIOCHEM, V380, P143, DOI 10.1007/s11010-013-1667-x; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen JJ, 2017, PROG MOL BIOL TRANSL, V148, P87, DOI 10.1016/bs.pmbts.2017.04.001; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Das A, 2012, J BIOL CHEM, V287, P19622, DOI 10.1074/jbc.M111.297663; Dong JC, 2002, REPRODUCTION, V123, P621, DOI 10.1530/reprod/123.5.621; Sosa SEY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071448; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gentilini D, 2010, FERTIL STERIL, V93, P706, DOI 10.1016/j.fertnstert.2008.10.014; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Guo D, 2010, CIRC RES, V107, P1275, DOI 10.1161/CIRCRESAHA.110.229054; HAMAGUCHI M, 1990, OBSTET GYNECOL, V76, P783, DOI 10.1097/00006250-199011000-00011; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; IRWIN JC, 1989, FERTIL STERIL, V52, P761; Kent LN, 2011, MOL CELL BIOL, V31, P4801, DOI 10.1128/MCB.05780-11; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Lekontseva O, 2009, J HYPERTENS, V27, P1602, DOI 10.1097/HJH.0b013e32832c41b5; Li W, 2017, AM J PHYSIOL-HEART C, V313, pH491, DOI 10.1152/ajpheart.00207.2017; Li W, 2014, BIOCHEM PHARMACOL, V89, P370, DOI 10.1016/j.bcp.2014.03.017; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mori M, 2016, SEMIN IMMUNOPATHOL, V38, P635, DOI 10.1007/s00281-016-0574-0; Palei ACT, 2013, CURR DRUG TARGETS, V14, P325; Ray A, 2005, BBA-GENE STRUCT EXPR, V1732, P53, DOI 10.1016/j.bbaexp.2005.11.004; Russo Louise A, 2009, Reprod Biol Endocrinol, V7, P124, DOI 10.1186/1477-7827-7-124; Sahay AS, 2018, J CELL BIOCHEM, V119, P6657, DOI 10.1002/jcb.26849; Salmi A, 1996, MOL HUM REPROD, V2, P979, DOI 10.1093/molehr/2.12.979; Shah DA, 2015, BIOCHEM PHARMACOL, V95, P211, DOI 10.1016/j.bcp.2015.04.012; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Staun-Ram E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-135; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yinon Y, 2015, PLACENTA, V36, P121, DOI 10.1016/j.placenta.2014.12.008; Zhang X, 2007, MOL REPROD DEV, V74, P321, DOI 10.1002/mrd.20582; Zhao P, 2008, MOL IMMUNOL, V45, P2187, DOI 10.1016/j.molimm.2007.12.002; Zhu H, 2014, GENE, V551, P1, DOI 10.1016/j.gene.2014.08.047	44	15	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2248	2258		10.1074/jbc.RA119.010701	http://dx.doi.org/10.1074/jbc.RA119.010701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31937587	Green Published, hybrid			2022-12-26	WOS:000517330200009
J	Akgun, KM; Sigel, K; Cheung, KH; Kidwai-Khan, F; Bryant, AK; Brandt, C; Justice, A; Crothers, K				Akgun, Kathleen M.; Sigel, Keith; Cheung, Kei-Hoi; Kidwai-Khan, Farah; Bryant, Alex K.; Brandt, Cynthia; Justice, Amy; Crothers, Kristina			Extracting lung function measurements to enhance phenotyping of chronic obstructive pulmonary disease (COPD) in an electronic health record using automated tools	PLOS ONE			English	Article							INFORMATION; SPIROMETRY; DIAGNOSIS	Background Chronic obstructive pulmonary disease (COPD) is associated with poor quality of life, hospitalization and mortality. COPD phenotype includes using pulmonary function tests to determine airflow obstruction from the forced expiratory volume in one second (FEV1):forced vital capacity. FEV1 is a commonly used value for severity but is difficult to identify in structured electronic health record (EHR) data. Data source and methods Using the Microsoft SQL Server's full-text search feature and string functions supporting regular-expression-like operations, we developed an automated tool to extract FEV1 values from progress notes to improve ascertainment of FEV1 in EHR in the Veterans Aging Cohort Study (VACS). Results The automated tool increased quantifiable FEV1 values from 12,425 to 16,274 (24% increase in numeric FEV1). Using chart review as the reference, positive predictive value of the tool was 99% (95% Confidence interval: 98.2-100.0%) for identifying quantifiable FEV1 values and a recall value of 100%, yielding an F-measure of 0.99. The tool correctly identified FEV1 measurements in 95% of cases. Conclusion A SQL-based full text search of clinical notes for quantifiable FEV1 is efficient and improves the number of values available in VA data. Future work will examine how these methods can improve phenotyping of patients with COPD in the VA.	[Akgun, Kathleen M.; Cheung, Kei-Hoi; Kidwai-Khan, Farah; Brandt, Cynthia; Justice, Amy] VA Connecticut Healthcare Syst, Dept Med, West Haven, CT 06516 USA; [Akgun, Kathleen M.; Kidwai-Khan, Farah; Justice, Amy] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Sigel, Keith] Icahn Sch Med Mt Sinai, Div Gen Internal Med, New York, NY 10029 USA; [Cheung, Kei-Hoi; Brandt, Cynthia] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Bryant, Alex K.] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Crothers, Kristina] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA; [Crothers, Kristina] Univ Washington, Seattle, WA 98195 USA; [Crothers, Kristina] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Icahn School of Medicine at Mount Sinai; Yale University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Akgun, KM (corresponding author), VA Connecticut Healthcare Syst, Dept Med, West Haven, CT 06516 USA.; Akgun, KM (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	Kathleen.akgun@yale.edu	Sigel, Keith Magnus/AAZ-7898-2021	Sigel, Keith Magnus/0000-0002-4051-4861; Akgun, Kathleen/0000-0003-2623-7463	Yale Cancer Center pilot grant [P30CA016359-37S4]; National Institute on Alcohol Abuse and Alcoholism [U24-AA020794, U01-AA020790, U01-AA020795, U01AA020799, U10 AA013566]; National Institutes of Health, National Heart, Lung, and Blood Institute [K07CA180782, R01CA210806, R01 R01CA173754]	Yale Cancer Center pilot grant; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Akgun was supported by the Yale Cancer Center pilot grant (P30CA016359-37S4). This work was also supported by the National Institute on Alcohol Abuse and Alcoholism [U24-AA020794, U01-AA020790, U01-AA020795, U01-AA020799, U10 AA013566-completed to ACJ]; National Institutes of Health, National Heart, Lung, and Blood Institute [K07CA180782 and R01CA210806 to KS; R01 R01CA173754 to KC] and in kind by the US Department of Veterans Affairs. Disclosure: The views expressed in this manuscript represent those of the authors and do not necessarily represent those of the Department of Veterans Affairs.; Dr. Akgu<spacing diaeresis> n was supported by the Yale Cancer Center pilot grant (P30CA016359-37S4). This work was also supported by the National Institute on Alcohol Abuse and Alcoholism [U24-AA020794, U01-AA020790, U01-AA020795, U01AA020799, U10 AA013566-completed to ACJ]; National Institutes of Health, National Heart, Lung, and Blood Institute [K07CA180782 and R01CA210806 to KS; R01 R01CA173754 to KC] and in kind by the US Department of Veterans Affairs.	Bodduluri S, 2018, ANN AM THORAC SOC, V15, P281, DOI 10.1513/AnnalsATS.201705-377FR; Brown SH, 2003, INT J MED INFORM, V69, P135, DOI 10.1016/S1386-5056(02)00131-4; Crothers K, 2019, PHARMACOEPIDEM DR S, V28, P140, DOI 10.1002/pds.4567; de Vries R, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01817-2017; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Garla V, 2011, J AM MED INFORM ASSN, V18, P614, DOI 10.1136/amiajnl-2011-000093; Hinchcliff M, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-106; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Johannessen A, 2013, AM J RESP CRIT CARE, V188, P51, DOI 10.1164/rccm.201212-2276OC; Joo MJ, 2013, COPD, V10, P444, DOI 10.3109/15412555.2013.766683; Prieto-Centurion V, 2014, AM J RESP CRIT CARE, V190, P989, DOI 10.1164/rccm.201406-1166OC; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Sauer Brian C, 2016, EGEMS (Wash DC), V4, P1217, DOI 10.13063/2327-9214.1217; Soysal E, 2018, J AM MED INFORM ASSN, V25, P331, DOI 10.1093/jamia/ocx132; Turchin A, 2006, J AM MED INFORM ASSN, V13, P691, DOI 10.1197/jamia.M2078; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wi CI, 2018, J ALLER CL IMM-PRACT, V6, P126, DOI 10.1016/j.jaip.2017.04.041; Wu HM, 2017, CHEST, V151, P1263, DOI 10.1016/j.chest.2017.01.003	18	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227730	10.1371/journal.pone.0227730	http://dx.doi.org/10.1371/journal.pone.0227730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945115	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100057
J	Sitron, CS; Park, JH; Giafaglione, JM; Brandman, O				Sitron, Cole S.; Park, Joseph H.; Giafaglione, Jenna M.; Brandman, Onn			Aggregation of CAT tails blocks their degradation and causes proteotoxicity in S. cerevisiae	PLOS ONE			English	Article							QUALITY-CONTROL COMPLEX; E3 UBIQUITIN LIGASE; YEAST PSI+ PRION; GUANIDINE-HYDROCHLORIDE; PROTEIN AGGREGATION; TRANSLATIONAL SURVEILLANCE; RIBOSOME; DISSOCIATION; MECHANISM; PROPAGATION	The Ribosome-associated Quality Control (RQC) pathway co-translationally marks incomplete polypeptides from stalled translation with two signals that trigger their proteasome-mediated degradation. The E3 ligase Ltn1 adds ubiquitin and Rqc2 directs the large ribosomal subunit to append carboxy-terminal alanine and threonine residues (CAT tails). When excessive amounts of incomplete polypeptides evade Ltn1, CAT-tailed proteins accumulate and can self-associate into aggregates. CAT tail aggregation has been hypothesized to either protect cells by sequestering potentially toxic incomplete polypeptides or harm cells by disrupting protein homeostasis. To distinguish between these possibilities, we modulated CAT tail aggregation in Saccharomyces cerevisiae with genetic and chemical tools to analyze CAT tails in aggregated and un-aggregated states. We found that enhancing CAT tail aggregation induces proteotoxic stress and antagonizes degradation of CAT-tailed proteins, while inhibiting aggregation reverses these effects. Our findings suggest that CAT tail aggregation harms RQC-compromised cells and that preventing aggregation can mitigate this toxicity.	[Sitron, Cole S.; Park, Joseph H.; Giafaglione, Jenna M.; Brandman, Onn] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Park, Joseph H.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Giafaglione, Jenna M.] Univ Calif Los Angeles, Mol Biol Interdept Program, Los Angeles, CA USA	Stanford University; Stanford University; University of California System; University of California Los Angeles	Brandman, O (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	onn@stanford.edu		Sitron, Cole/0000-0001-6584-5926; Giafaglione, Jenna/0000-0002-1374-5779	Stanford University; US National Institutes of Health [R01GM115968]; National Institute of General Medical Sciences of the US National Institutes of Health [T32GM007276]	Stanford University(Stanford University); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Stanford University (O.B.), the US National Institutes of Health (grant No. R01GM115968 to O.B.), and the National Institute of General Medical Sciences of the US National Institutes of Health (grant No. T32GM007276 to C.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2002, GENES CELLS, V7, P629, DOI 10.1046/j.1365-2443.2002.00549.x; Akerfelt M, 2007, ANN NY ACAD SCI, V1113, P15, DOI 10.1196/annals.1391.005; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Miron-Garcia MC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003297; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Choe YJ, 2016, NATURE, V531, P191, DOI 10.1038/nature16973; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Defenouillere Q, 2017, CURR GENET, V63, P997, DOI 10.1007/s00294-017-0708-5; Defenouillere Q, 2016, J BIOL CHEM, V291, P12245, DOI 10.1074/jbc.M116.722264; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Deplazes A, 2009, EMBO J, V28, P1429, DOI 10.1038/emboj.2009.98; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grimminger V, 2004, J BIOL CHEM, V279, P7378, DOI 10.1074/jbc.M312403200; Ikeuchi K, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00743; Ikeuchi K, 2019, EMBO J, V38, DOI 10.15252/embj.2018100276; Ishimura R, 2014, SCIENCE, V345, P455, DOI 10.1126/science.1249749; Joazeiro CAP, 2019, NAT REV MOL CELL BIO, V20, P368, DOI 10.1038/s41580-019-0118-2; Julio SM, 2000, J BACTERIOL, V182, P1558, DOI 10.1128/JB.182.6.1558-1563.2000; Jung GM, 2002, P NATL ACAD SCI USA, V99, P9936, DOI 10.1073/pnas.152333299; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037; Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039; Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787; Letzring DP, 2010, RNA, V16, P2516, DOI 10.1261/rna.2411710; Lytvynenko I, 2019, CELL, V178, P76, DOI 10.1016/j.cell.2019.05.002; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Moore SD, 2005, MOL MICROBIOL, V58, P456, DOI 10.1111/j.1365-2958.2005.04832.x; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Osuna BA, 2017, ELIFE, V6, DOI 10.7554/eLife.27949; Oussenko IA, 2005, J BACTERIOL, V187, P2758, DOI 10.1128/JB.187.8.2758-2767.2005; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Simms CL, 2017, MOL CELL, V68, P361, DOI 10.1016/j.molcel.2017.08.019; Sitron CS, 2019, NAT STRUCT MOL BIOL, V26, P450, DOI 10.1038/s41594-019-0230-1; Sitron CS, 2017, RNA, V23, P798, DOI 10.1261/rna.060897.117; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Turowski TW, 2016, BIOCHEM SOC T, V44, P1367, DOI 10.1042/BST20160062; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wu ZH, 2019, MOL CELL, V75, P835, DOI 10.1016/j.molcel.2019.06.031; Yan Z, 2008, NAT METHODS, V5, P719, DOI 10.1038/nmeth.1231; Yonashiro R, 2016, ELIFE, V5, DOI 10.7554/eLife.11794	59	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227841	10.1371/journal.pone.0227841	http://dx.doi.org/10.1371/journal.pone.0227841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945107	Green Published, gold, Green Submitted			2022-12-26	WOS:000534370100067
J	Mihailovic, DT; Petric, D; Petrovic, T; Hrnjakovic-Cvjetkovic, I; Djurdjevic, V; Nikolic-Dorc, E; Arsenic, I; Petric, M; Mimic, G; Ignjatovic-Cupina, A				Mihailovic, Dragutin T.; Petric, Dusan; Petrovic, Tamas; Hrnjakovic-Cvjetkovic, Ivana; Djurdjevic, Vladimir; Nikolic-Dorc, Emilija; Arsenic, Ilija; Petric, Mina; Mimic, Gordan; Ignjatovic-Cupina, Aleksandra			Assessment of climate change impact on the malaria vector Anopheles hyrcanus, West Nile disease, and incidence of melanoma in the Vojvodina Province (Serbia) using data from a regional climate model	PLOS ONE			English	Article							LONGIAREOLATA MACQUART; ULTRAVIOLET-RADIATION; SKIN-CANCER; VIRUS; DIPTERA; HEALTH; CIRCULATION; CULICIDAE; MOSQUITO; SRES-A1B	Motivated by the One Health paradigm, we found the expected changes in temperature and UV radiation (UVR) to be a common trigger for enhancing the risk that viruses, vectors, and diseases pose to human and animal health. We compared data from the mosquito field collections and medical studies with regional climate model projections to examine the impact of climate change on the spreading of one malaria vector, the circulation of West Nile virus (WNV), and the incidence of melanoma. We analysed data obtained from ten selected years of standardised mosquito vector sampling with 219 unique location-year combinations, and 10 years of melanoma incidence. Trends in the observed data were compared to the climatic variables obtained by the coupled regional Eta Belgrade University and Princeton Ocean Model for the period 1961-2015 using the A1B scenario, and the expected changes up to 2030 were presented. Spreading and relative abundance of Anopheles hyrcanus was positively correlated with the trend of the mean annual temperature. We anticipated a nearly twofold increase in the number of invaded sites up to 2030. The frequency of WNV detections in Culex pipiens was significantly correlated to overwintering temperature averages and seasonal relative humidity at the sampling sites. Regression model projects a twofold increase in the incidence of WNV positive Cx. pipiens for a rise of 0.5 degrees C in overwintering TOctober-April temperatures. The projected increase of 56% in the number of days with T-max >= 30 degrees C (Hot Days-HD) and UVR doses (up to 1.2%) corresponds to an increasing trend in melanoma incidence. Simulations of the Pannonian countries climate anticipate warmer and drier conditions with possible dominance of temperature and number of HD over other ecological factors. These signal the importance of monitoring the changes to the preparedness of mitigating the risk of vector-borne diseases and melanoma.	[Mihailovic, Dragutin T.; Arsenic, Ilija] Univ Novi Sad, Fac Agr, Dept Field & Vegetable Crops, Novi Sad, Serbia; [Petric, Dusan; Ignjatovic-Cupina, Aleksandra] Univ Novi Sad, Fac Agr, Dept Plant & Environm Protect, Novi Sad, Serbia; [Petrovic, Tamas] Sci Vet Inst Novi Sad, Dept Virol, Novi Sad, Serbia; [Hrnjakovic-Cvjetkovic, Ivana] Inst Publ Hlth Vojvodina, Novi Sad, Serbia; [Hrnjakovic-Cvjetkovic, Ivana] Univ Novi Sad, Fac Med, Novi Sad, Serbia; [Djurdjevic, Vladimir] Univ Belgrade, Fac Phys, Inst Meteorol, Belgrade, Serbia; [Nikolic-Dorc, Emilija] Univ Novi Sad, Fac Agr, Dept Agr Econ, Novi Sad, Serbia; [Petric, Mina] Avia GIS NV, Zoersel, Belgium; [Petric, Mina] Univ Novi Sad, Fac Sci, Dept Phys, Novi Sad, Serbia; [Petric, Mina] Univ Ghent, Fac Sci, Dept Phys & Astron, Ghent, Belgium; [Mimic, Gordan] Univ Novi Sad, BioSense Inst, Novi Sad, Serbia	University of Novi Sad; University of Novi Sad; University of Novi Sad; University of Novi Sad; University of Belgrade; University of Novi Sad; University of Novi Sad; Ghent University; University of Novi Sad	Petric, D (corresponding author), Univ Novi Sad, Fac Agr, Dept Plant & Environm Protect, Novi Sad, Serbia.; Petric, M (corresponding author), Avia GIS NV, Zoersel, Belgium.; Petric, M (corresponding author), Univ Novi Sad, Fac Sci, Dept Phys, Novi Sad, Serbia.; Petric, M (corresponding author), Univ Ghent, Fac Sci, Dept Phys & Astron, Ghent, Belgium.	dusanp@polj.uns.ac.rs; mpetric@avia-gis.com	Petrovic, Tamas/H-3764-2019; Mimić, Gordan/ABV-8557-2022	Petrovic, Tamas/0000-0002-9164-3356; Mimić, Gordan/0000-0001-6879-8969; Djurdjevic, Vladimir/0000-0001-9882-1189; Nikolic-Djoric, Emilija/0000-0003-3661-3258; Mihailovic, Dragutin/0000-0002-8380-1844	Ministry of Education and Science, Republic of Serbia [III43007, TR31084]; Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia; Provincial Secretariat for Science and Technological Development, the Autonomous Province of Vojvodina [114-451-2142/2011]; Avia-GIS NV	Ministry of Education and Science, Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia); Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia; Provincial Secretariat for Science and Technological Development, the Autonomous Province of Vojvodina; Avia-GIS NV	This paper was realised as a part of the projects "Studying climate change and its influence on the environment: impacts, adaptation and mitigation" (III43007 - DTM, DP, IHC, VDj, END, IA, GM, AIC) and TR31084 (DP, TP, AIC) financed by the Ministry of Education and Science, Republic of Serbia (http://www.mpn.gov.rs/).Historical data for mosquito vectors are the outputs of projects supported by the Veterinary Directorate, Ministry of Agriculture and Environment Protection, Republic of Serbia (http://www.minpolj.gov.rs/), and Provincial Secretariat for Science and Technological Development, the Autonomous Province of Vojvodina, project no. 114-451-2142/2011 (DP, TP, IHC, AIC -http://apvvisokoobrazovanje.vojvodina.gov.rs/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MP is affiliated to Avia-GIS NV, which did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Role of Funders Avia-GIS NV provided support in the form of salaries for author (MP) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author (MP) are articulated in the `author contributions' section.	Adamovic Z. R., 1979, Acta Entomologica Jugoslavica, V15, P75; Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; [Anonymous], THESIS; Apalla Z., 2017, DERMATOL PRACT CONCE, V7, DOI [10.5826/dpc.0702a01, DOI 10.5826/DPC.0702A01]; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Blitvich Bradley J., 2008, Animal Health Research Reviews, V9, P71, DOI 10.1017/S1466252307001430; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Calzolari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140915; Cavicchia L, 2018, CLIM DYNAM, V51, P901, DOI 10.1007/s00382-016-3245-x; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Dell'Aquila A, 2018, CLIM DYNAM, V51, P857, DOI 10.1007/s00382-016-3143-2; Demers AA, 2005, J AM ACAD DERMATOL, V53, P320, DOI 10.1016/j.jaad.2005.03.043; Durdevi V., 2012, ADV ENV MODELING MEA, P23; European Centre for Disease Prevention and Control (ECDC), 2018, EP UPD W NIL VIR TRA; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Frison TW, 1997, J GEOPHYS RES-OCEANS, V102, P1051, DOI 10.1029/96JC02993; Halgos J, 2004, BIOLOGIA, V59, P68; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hori M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07383; HS Global Inc, 2016, EV; Jovanovic M, 2009, J BUON, V14, P441; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Kerr JB, 2003, SURFACE ULTRAVIOLET; King LJ, 2008, JAVMA-J AM VET MED A, V233, P259, DOI 10.2460/javma.233.2.259; Kjellstrom T, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20816; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3; Krzic A, 2011, CLIM RES, V49, P73, DOI 10.3354/cr01008; Lacy K., 2013, MEDICINE, V41, P402, DOI [10.1016/j.mpmed.2013.04.00, DOI 10.1016/J.MPMED.2013.04.008, DOI 10.1016/j.mpmed.2013.04.008]; Lebl K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-129; Lupulovic D, 2011, VECTOR-BORNE ZOONOT, V11, P1303, DOI 10.1089/vbz.2010.0249; Malinovic-Milicevic S, 2015, THEOR APPL CLIMATOL, V121, P131, DOI 10.1007/s00704-014-1223-y; Malinovic-Milicevic S, 2013, CLIM RES, V57, P111, DOI 10.3354/cr01163; Malinovic-Milicevic S, 2016, UV RAD HEAT WIV VOJV, V87; Marcantonio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121158; Medic S, 2019, ACTA VET-BEOGRAD, V69, P123, DOI 10.2478/acve-2019-0009; Mihailovic DT, 2015, INT J CLIMATOL, V35, P3320, DOI 10.1002/joc.4209; Mihailovic DT, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/878249; Mihailovic DT, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21020215; Ministry of Environmental Protection of the Republic of Serbia, 2017, 2 NAT COMM REP SERB; Moore CG, 2008, J VECTOR ECOL, V33, P218, DOI 10.3376/1081-1710-33.2.218; Moss Richard, 2008, NEW SCENARIOS ANAL E; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Novikov YM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-389; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Paz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056398; Petric D, 2017, MOL CELL PROBE, V31, P28, DOI 10.1016/j.mcp.2016.10.011; Petric D, 2012, HEALTHMED, V6, P462; Petrovic T, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.44.20622; Petrovic T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195439; Petrovic V, 2016, TRAVEL MED INFECT DI, V14, P60, DOI 10.1016/j.tmaid.2016.01.001; R Core Team, 2016, R LANG ENV STAT COMP; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RIORDAN DF, 1969, MOSQ NEWS, V29, P427; Roeckner E., 2003, 349 M PLANCK I MET, V349, P140, DOI DOI 10.1029/2010JD014036; Seidel Bernhard, 2013, Journal of the European Mosquito Control Association, V31, P17; SRDIC Z, 1986, 4 C PROT SANT HUM CU, P489; TIBCO Software Inc, STATISTICA; Tippelt L, 2017, PARASITOL RES, V116, P3437, DOI 10.1007/s00436-017-5652-2; Vakali A, 2012, EUROSURVEILLANCE, V17, P4; van der Linden P., 2009, ENSEMBLES CLIMATE CH; Vandenbroucke JP, 2012, INT J EPIDEMIOL, V41, P1472, DOI 10.1093/ije/dys142; VANDERLEUN JC, 1984, PHOTOCHEM PHOTOBIOL, V39, P861; Votypka J, 2008, J VECTOR ECOL, V33, P269, DOI 10.3376/1081-1710-33.2.269; WHO, 2018, WORLD MAL REP 2018; Wilson N, 2010, Euro Surveill, V15; Wu SW, 2014, CANCER EPIDEM BIOMAR, V23, P1080, DOI 10.1158/1055-9965.EPI-13-0821; Zeller H, 2010, EUROSURVEILLANCE, V15; Zimmerman B, 2014, ENGAGING COMPLEXITY; Zittra Carina, 2014, Acta ZooBot Austria, V150, P17	72	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227679	10.1371/journal.pone.0227679	http://dx.doi.org/10.1371/journal.pone.0227679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940403	Green Published, gold			2022-12-26	WOS:000534368000090
J	Piatt, JF; Parrish, JK; Renner, HM; Schoen, SK; Jones, TT; Arimitsu, ML; Kuletz, KJ; Bodenstein, B; Garcia-Reyes, M; Duerr, RS; Corcoran, RM; Kaler, RSA; McChesney, GJ; Golightly, RT; Coletti, HA; Suryan, RM; Burgess, HK; Lindsey, J; Lindquist, K; Warzybok, PM; Jahncke, J; Roletto, J; Sydeman, WJ				Piatt, John F.; Parrish, Julia K.; Renner, Heather M.; Schoen, Sarah K.; Jones, Timothy T.; Arimitsu, Mayumi L.; Kuletz, Kathy J.; Bodenstein, Barbara; Garcia-Reyes, Marisol; Duerr, Rebecca S.; Corcoran, Robin M.; Kaler, Robb S. A.; McChesney, Gerard J.; Golightly, Richard T.; Coletti, Heather A.; Suryan, Robert M.; Burgess, Hillary K.; Lindsey, Jackie; Lindquist, Kirsten; Warzybok, Peter M.; Jahncke, Jaime; Roletto, Jan; Sydeman, William J.			Extreme mortality and reproductive failure of common murres resulting from the northeast Pacific marine heatwave of 2014-2016	PLOS ONE			English	Article							SHORT-TAILED SHEARWATERS; HARMFUL ALGAL BLOOMS; VALDEZ OIL-SPILL; CALIFORNIA CURRENT; URIA-AALGE; CLIMATE-CHANGE; OCEAN CLIMATE; FORAGE FISH; BERING-SEA; RHINOCEROS AUKLETS	About 62,000 dead or dying common murres (Uria aalge), the trophically dominant fish-eating seabird of the North Pacific, washed ashore between summer 2015 and spring 2016 on beaches from California to Alaska. Most birds were severely emaciated and, so far, no evidence for anything other than starvation was found to explain this mass mortality. Three-quarters of murres were found in the Gulf of Alaska and the remainder along the West Coast. Studies show that only a fraction of birds that die at sea typically wash ashore, and we estimate that total mortality approached 1 million birds. About two-thirds of murres killed were adults, a substantial blow to breeding populations. Additionally, 22 complete reproductive failures were observed at multiple colonies region-wide during (2015) and after (2016-2017) the mass mortality event. Die-offs and breeding failures occur sporadically in murres, but the magnitude, duration and spatial extent of this die-off, associated with multi-colony and multi-year reproductive failures, is unprecedented and astonishing. These events cooccurred with the most powerful marine heatwave on record that persisted through 2014-2016 and created an enormous volume of ocean water (the "Blob") from California to Alaska with temperatures that exceeded average by 2-3 standard deviations. Other studies indicate that this prolonged heatwave reduced phytoplankton biomass and restructured zooplankton communities in favor of lower-calorie species, while it simultaneously increased metabolically driven food demands of ectothermic forage fish. In response, forage fish quality and quantity diminished. Similarly, large ectothermic groundfish were thought to have increased their demand for forage fish, resulting in greater top-predator demands for diminished forage fish resources. We hypothesize that these bottom-up and top-down forces created an "ectothermic vise" on forage species leading to their system-wide scarcity and resulting in mass mortality of murres and many other fish, bird and mammal species in the region during 2014-2017.	[Piatt, John F.; Schoen, Sarah K.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Parrish, Julia K.; Jones, Timothy T.; Burgess, Hillary K.; Lindsey, Jackie] Univ Washington, Sch Aquat & Fishery Sci, COASST, Seattle, WA 98195 USA; [Renner, Heather M.] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Arimitsu, Mayumi L.; Kaler, Robb S. A.] US Geol Survey, Alaska Sci Ctr, Juneau, AK USA; [Kuletz, Kathy J.] US Fish & Wildlife Serv, Migratory Bird Management, Anchorage, AK USA; [Bodenstein, Barbara] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Garcia-Reyes, Marisol; Sydeman, William J.] Farallon Inst, Petaluma, CA USA; [Duerr, Rebecca S.] San Francisco Bay Ctr, Int Bird Rescue, Fairfield, CA USA; [Corcoran, Robin M.] US Fish & Wildlife Serv, Kodiak Natl Wildlife Refuge, Kodiak, AK USA; [McChesney, Gerard J.] US Fish & Wildlife Serv, San Francisco Bay Natl Wildlife Refuge Complex, Fremont, CA USA; [Golightly, Richard T.] Humboldt State Univ, Dept Wildlife, Arcata, CA 95521 USA; [Coletti, Heather A.] Natl Pk Serv, Fairbanks, AK USA; [Suryan, Robert M.] NOAA Fisheries, Alaska Fisheries Sci Ctr, Auk Bay Labs, Ted Stevens Marine Res Inst, Juneau, AK USA; [Lindsey, Jackie] BeachCOMBERS, Moss Landing Marine Labs, Moss Landing, CA USA; [Lindquist, Kirsten; Roletto, Jan] NOAA, Greater Farallones Natl Marine Sanctuary, San Francisco, CA USA; [Warzybok, Peter M.; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; California State University System; California State Polytechnic University, Humboldt; United States Department of the Interior; National Oceanic Atmospheric Admin (NOAA) - USA; Moss Landing Marine Laboratories; National Oceanic Atmospheric Admin (NOAA) - USA	Piatt, JF (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	jpiatt@usgs.gov	Roletto, Jan/GPS-5159-2022	Piatt, John/0000-0002-4417-5748; Suryan, Robert/0000-0003-0755-8317; Coletti, Heather/0000-0001-9696-6093	USGS Ecosystems Mission Area; NSF EHR/DRL award [1322820]; Washington Department of Fish and Wildlife award [13-1435]; NPS Ocean Alaska Science and Learning Center grant; North Pacific Research board	USGS Ecosystems Mission Area; NSF EHR/DRL award; Washington Department of Fish and Wildlife award; NPS Ocean Alaska Science and Learning Center grant; North Pacific Research board	These analyses were supported by funding from the USGS Ecosystems Mission Area and the North Pacific Research board to JFP; and by NSF EHR/DRL award 1322820 and Washington Department of Fish and Wildlife award 13-1435 to JKP, and NPS Ocean Alaska Science and Learning Center grant to HAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINLEY D.G., 2021, BIRDS OF THE WORLD, DOI [10.2173/bow.commur.02, DOI 10.2173/BOW.COMMUR.02]; Ainley DG, 1996, CONDOR, V98, P691, DOI 10.2307/1369852; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Arimitsu ML, 2018, EXXON VALD OIL SPILL, V1-50; Auth TD, 2018, GLOBAL CHANGE BIOL, V24, P259, DOI 10.1111/gcb.13872; Aydin K., 2007, NOAA TECH MEMO NMFS; Aydin K, 2007, DEEP-SEA RES PT II, V54, P2501, DOI 10.1016/j.dsr2.2007.08.022; Baduini CL, 2001, MAR ECOL PROG SER, V222, P265, DOI 10.3354/meps222265; Bailey EP, 1971, AUK, V91, P215; Baker MR, 2019, MAR ECOL PROG SER, V617, P221, DOI 10.3354/meps12897; Barbara S., 2018, NEW BIOCOMPATIBLE PO, P1; Batten SD, 2018, DEEP RES 2, V147, P79; BAYER RD, 1991, CONDOR, V93, P516, DOI 10.2307/1368183; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Borstad G, 2011, MAR ECOL PROG SER, V424, P285, DOI 10.3354/meps08950; BRETT JR, 1971, AM ZOOL, V11, P99; Brodeur R, 2018, MAR ECOL PROG SER; BROUGHTON JM, 1994, CONDOR, V96, P203, DOI 10.2307/1369079; Bruno JF, 2015, ECOLOGY, V96, P3126, DOI 10.1890/14-1954.1; Burthe S, 2012, MAR ECOL PROG SER, V454, P119, DOI 10.3354/meps09520; Camphuysen C.J., 1999, ICES Cooperative Research Report, V232, P51; Camphuysen CJ, 2007, TECH DOC 41 HDB OIL, P1; Cavole LM, 2016, OCEANOGRAPHY, V29, P273, DOI 10.5670/oceanog.2016.32; Checkley DM, 2017, ANNU REV MAR SCI, V9, P469, DOI 10.1146/annurev-marine-122414-033819; Clifford H, 2011, S BIRD, P10; Cunningham JT, 2018, MAR ECOL PROG SER, V605, P225, DOI 10.3354/meps12761; Danhardt A, 2011, ECOSYSTEMS, V14, P791, DOI 10.1007/s10021-011-9445-7; Daly EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144066; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Dragoo DE, 2019, 201806 AMNWR US FISH, P1; Duerr Rebecca S., 2015, Marine Ornithology, V43, P11; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Elliott KH, 2005, IBIS, V147, P783, DOI 10.1111/j.1474-919x.2005.00462.x; Ellis Hugh I., 2002, P359; Engelhard GH, 2013, ICES J MAR SCI, V70, P1439; Erikstad KE, 2013, MAR ECOL PROG SER, V475, P267, DOI 10.3354/meps10084; Ford RG, 1996, AM FISH S S, V18, P684; Frederiksen M, 2007, MAR ECOL PROG SER, V337, P279, DOI 10.3354/meps337279; FRIEND M., 1999, INFORM TECHNOLOGY RE; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Gaichas S, 2009, PROG OCEANOGR, V81, P47, DOI 10.1016/j.pocean.2009.04.005; Garcia-Borboroglu P, 2010, MAR POLLUT BULL, V60, P1652, DOI 10.1016/j.marpolbul.2010.07.006; Garfield TD, 2016, CALIFORNIA CURRENT I, P1; Gentemann CL, 2017, GEOPHYS RES LETT, V44, P312, DOI 10.1002/2016GL071039; Gibble C, 2018, J WILDLIFE DIS, V54, P569, DOI 10.7589/2017-07-179; Gladics AJ, 2014, MAR BIOL, V161, P837, DOI 10.1007/s00227-013-2384-4; Gorman KB, 2018, DEEP-SEA RES PT II, V147, P116, DOI 10.1016/j.dsr2.2017.10.010; Hampton Steve, 2006, Marine Ornithology, V34, P109; Haney JC, 2014, CARCASS SAMPLING EXP, P1; Harding AMA, 2007, MAR ECOL PROG SER, V352; Harvey C, 2017, NURS INQ, V24, DOI 10.1111/nin.12180; Hobday AJ, 2018, OCEANOGRAPHY, V31, P162, DOI 10.5670/oceanog.2018.205; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; HODDER J, 1985, CONDOR, V87, P535, DOI 10.2307/1367954; Hollowed AB, 2012, DEEP-SEA RES PT II, V65-70, P230, DOI 10.1016/j.dsr2.2012.02.008; Holsman KK, 2019, FISH OCEANOGR, V28, P345, DOI 10.1111/fog.12416; Holsman KK, 2015, MAR ECOL PROG SER, V521, P217, DOI 10.3354/meps11102; Holsman KK, 2017, STOCK ASSESS FISH EV, P181; HORTON C.A., 2012, OREGON BIRDS, V38, P84; Hunt GL, 2000, PICES SCI REP; Hunt GL Jr, 2005, DEEP RES 2, V52; Hyrenbach K. David, 2001, Marine Ornithology, V29, P11; Jones T, 2018, GEOPHYS RES LETT, V45, P3193, DOI 10.1002/2017GL076164; Koehn LE, 2017, TRADE OFFS FORAGE FI; Laevastu T., 1984, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V185, P214; Lance MM, 2005, AUK, V122, P887, DOI 10.1642/0004-8038(2005)122[0887:OIDAFO]2.0.CO;2; Lee DE, 2008, AUK, V125, P316, DOI 10.1525/auk.2008.07007; Lefebvre KA, 2016, HARMFUL ALGAE, V55, P13, DOI 10.1016/j.hal.2016.01.007; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; MacCall AD, 2016, FISH RES, V175, P87, DOI 10.1016/j.fishres.2015.11.013; MacDonald A, 2015, OCEANOGR MAR BIOL, V53, P55; MACHADO PM, 2019, ANIM CONSERV, V40, DOI DOI 10.1111/MAEC.12525; Manuwal DA, 2000, NATURAL HIST POPULAT, V1; McCabe RM, 2016, GEOPHYS RES LETT, V43, P10366, DOI 10.1002/2016GL070023; McClatchie S, 2016, CAL COOP OCEAN FISH, V57; McClatchie S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150628; McGowan DW, 2019, MAR ECOL PROG SER, DOI [10.3354/meps12798, DOI 10.3354/MEPS12798]; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; METHVEN DA, 1991, ICES J MAR SCI, V48, P187, DOI 10.1093/icesjms/48.2.187; Miller AK, 2004, MAR ECOL PROG SER, V281, P207, DOI 10.3354/meps281207; Moffitt EA, 2016, DEEP-SEA RES PT II, V134, P350, DOI 10.1016/j.dsr2.2015.08.002; Morley Tim I., 2016, Seabird, V29, P22; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; Munilla I, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00020.1; Neilson JL, 2018, RECENT DECLINES HUMP; Newton KM, 2009, MAR ECOL PROG SER, V392, P295, DOI 10.3354/meps08152; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Oliver ECJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16101; Parrish J, 2008, BEACHED BIRDS COASST; Parrish JK, 2007, MAR ECOL PROG SER, V352, P275, DOI 10.3354/meps07077; Peterson WT, 2017, J GEOPHYS RES-OCEANS, V122, P7267, DOI [10.1002/2017jc012952, 10.1002/2017JC012952]; PFMC, 2016, STAT PAC COAST GROUN, P1; Piatt JF, 1997, MAR POLLUT BULL, V34, P656, DOI 10.1016/S0025-326X(97)00008-8; PIATT JF, 1990, AUK, V107, P387, DOI 10.2307/4087623; PIATT JF, 1985, AUK, V102, P293, DOI 10.2307/4086771; Piatt JF, 1996, AM FISH S S, V18, P720; Piatt JF, 1996, AM FISH S S, V18, P712; Piatt JF, 1999, N PACIFIC MAR SCI OR, P82; Piatt JF, 2007, LONG TERM ECOLOGICAL, P335; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pyle P, 2008, IDENTIFICATION GUIDE, P1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reed TE, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00001; Roletto Jan, 2003, Marine Ornithology, V31, P21; Romano MD, 2006, WATERBIRDS, V29, P407, DOI 10.1675/1524-4695(2006)29[407:TTJHOM]2.0.CO;2; Roth JE, 2008, ICES J MAR SCI, V65, P1046, DOI 10.1093/icesjms/fsn077; Rowe S, 2015, ORNITHOLGICAL SOC NZ, V28; Russell DJF, 2015, DIVERS DISTRIB, V21, P211, DOI 10.1111/ddi.12272; Sakuma KM, 2016, CAL COOP OCEAN FISH, V57, P163; SANGER GA, 1987, CONDOR, V89, P426, DOI 10.2307/1368499; Savage L, 2017, LAW SOC SER, P1; Schrimpf MB, 2012, MAR ECOL PROG SER, V460, P247, DOI 10.3354/meps09750; Shearn-Bochsler V, 2014, J WILDLIFE DIS, V50, P933, DOI 10.7589/2013-11-296; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Siddon E, 2017, NATL MAR FISH SERV R; Springer AM, 2018, P NATL ACAD SCI USA, V115, pE5038, DOI 10.1073/pnas.1720577115; Springer AM, 2014, P NATL ACAD SCI USA, V111, pE1880, DOI 10.1073/pnas.1319089111; Springer AM, 1999, PROG OCEANOGR, V43, P443, DOI 10.1016/S0079-6611(99)00014-2; Sreenivasan A, 2016, DEEP-SEA RES PT II, V132, P154, DOI 10.1016/j.dsr2.2016.04.004; Stephensen Shawn W., 2003, Marine Ornithology, V31, P167; Sydeman WJ, 2017, FISH OCEANOGR, V26, P379, DOI 10.1111/fog.12204; Tavares DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168717; Thompson SA, 2019, FISH OCEANOGR, V28, P658, DOI 10.1111/fog.12443; Toge K, 2011, P ROY SOC B-BIOL SCI, V278, P2584, DOI 10.1098/rspb.2010.2345; Tuck LM, 1961, CANADIAN WILDLIFE MO; USFWS, 2016, 201604 USFWS AMNWR; Vader W., 1990, Studies in Avian Biology, P175; Van Franeker JA, 2004, ALTERRA RAPPORT, V672, P40; Van Hemert C, 2019, HARMFUL ALGAE; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Vandersea MW, 2018, HARMFUL ALGAE, V77, P81, DOI 10.1016/j.hal.2018.06.008; VanPelt TI, 1995, MAR POLLUT BULL, V30, P794, DOI 10.1016/0025-326X(95)00072-U; von Biela VR, 2019, MAR ECOL PROG SER, V613, P171, DOI 10.3354/meps12891; Wanless S, 2005, MAR ECOL PROG SER, V294, P1, DOI 10.3354/meps294001; Wanless S, 2018, MAR ECOL PROG SER, V600, P193, DOI 10.3354/meps12679; Wells BK, 2017, CAL COOP OCEAN FISH, V58, P1; Whitney FA, 2015, GEOPHYS RES LETT, V42, P428, DOI 10.1002/2014GL062634; Witherell D, 2015, N PACIFIC FISHERY MA, P1; Work T.M., 2000, EPIDEMIOLOGIA, P30; Yang Q, 2019, FISH OCEANOGR, V28, P434, DOI 10.1111/fog.12422; Zaba KD, 2016, GEOPHYS RES LETT, V43, P1241, DOI 10.1002/2015GL067550; Zador S, 2018, NATL MAR FISH SERV R, P1; Zador S, 2015, NATL MAR FISH SERV R, P297; Zador S.G., 2016, ECOSYSTEM CONSIDERAT, V146	145	125	128	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226087	10.1371/journal.pone.0226087	http://dx.doi.org/10.1371/journal.pone.0226087			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940310	gold, Green Published			2022-12-26	WOS:000534368000018
J	Turova, V; Sidorenko, I; Eckardt, L; Rieger-Fackeldey, E; Felderhoff-Muser, U; Alves-Pinto, A; Lampe, R				Turova, Varvara; Sidorenko, Irina; Eckardt, Laura; Rieger-Fackeldey, Esther; Felderhoff-Mueser, Ursula; Alves-Pinto, Ana; Lampe, Renee			Machine learning models for identifying preterm infants at risk of cerebral hemorrhage	PLOS ONE			English	Article							INTRAVENTRICULAR HEMORRHAGE; PRESSURE-PASSIVITY; RATES; FLOW	Intracerebral hemorrhage in preterm infants is a major cause of brain damage and cerebral palsy. The pathogenesis of cerebral hemorrhage is multifactorial. Among the risk factors are impaired cerebral autoregulation, infections, and coagulation disorders. Machine learning methods allow the identification of combinations of clinical factors to best differentiate preterm infants with intra-cerebral bleeding and the development of models for patients at risk of cerebral hemorrhage. In the current study, a Random Forest approach is applied to develop such models for extremely and very preterm infants (23-30 weeks gestation) based on data collected from a cohort of 229 individuals. The constructed models exhibit good prediction accuracy and might be used in clinical practice to reduce the risk of cerebral bleeding in prematurity.	[Turova, Varvara; Alves-Pinto, Ana; Lampe, Renee] Tech Univ Munich, Res Unit Pediat Neuroorthoped & Cerebral Palsy, Orthoped Dept, Klinikum Rechts Isar,Buhl Strohmaier Fdn, Munich, Germany; [Sidorenko, Irina] Tech Univ Munich, Math Fac, Chair Math Modelling, Garching, Germany; [Eckardt, Laura; Felderhoff-Mueser, Ursula] Univ Duisburg Essen, Univ Hosp Essen, Dept Pediat, Essen, Germany; [Eckardt, Laura; Felderhoff-Mueser, Ursula] Univ Duisburg Essen, Univ Hosp Essen, Dept Neonatol, Essen, Germany; [Rieger-Fackeldey, Esther] Tech Univ Munich, Dept Pediat, Klinikum Rechts Isar, Neonatol, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Duisburg Essen; University of Duisburg Essen; Technical University of Munich	Turova, V (corresponding author), Tech Univ Munich, Res Unit Pediat Neuroorthoped & Cerebral Palsy, Orthoped Dept, Klinikum Rechts Isar,Buhl Strohmaier Fdn, Munich, Germany.	turova@ma.tum.de	Rieger-Fackeldey, Esther/AAX-1102-2020; Felderhoff-Müser, Ursula/AAU-9682-2020	Sidorenko, Irina/0000-0003-4158-9416; Turova, Varvara/0000-0002-6613-3311	BuhlStrohmaier-Foundation; Klaus Tschira Foundation; Markus Wurth Foundation	BuhlStrohmaier-Foundation; Klaus Tschira Foundation; Markus Wurth Foundation	This work was funded by the BuhlStrohmaier-Foundation to VT and AAP; the Klaus Tschira Foundation to IS and LE and the Markus Wurth Foundation to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Christine Klindt-Schuster (clinic 'rechts der Isar', Technical University of Munich) for organizational support. Author RL acknowledges the Markus Wurth Professorship at the Technical University of Munich.	Anand V, 2014, J PEDIATR NEUROSCI, V9, P97, DOI 10.4103/1817-1745.139261; Asadi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088225; Askie LM, 2017, COCHRANE DATABASE SY, V4; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Browniee J., 2014, MACHINE LEARNING MAS; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chiesa C, 2011, CLIN CHIM ACTA, V412, P1053, DOI 10.1016/j.cca.2011.02.020; Christian EA, 2016, J NEUROSURG-PEDIATR, V17, P260, DOI 10.3171/2015.7.PEDS15140; Couronne R, 2017, 205 U MUN DEP STAT; Cuestas E, 2009, GENDER MED, V6, P376, DOI 10.1016/j.genm.2009.06.001; Dekom S, 2018, J PERINATOL, V38, P1471, DOI 10.1038/s41372-018-0224-6; Duppre P, 2015, EARLY HUM DEV, V91, P695, DOI 10.1016/j.earlhumdev.2015.09.008; GUIHARDCOSTA AM, 1990, EARLY HUM DEV, V23, P27, DOI 10.1016/0378-3782(90)90126-4; Jare K, 2013, GYNAECOL PERINATOL, V22, P165; Kaiser JR, 2005, PEDIATR RES, V58, P931, DOI 10.1203/01.pdr.0000182180.80645.0c; Kinoshita Y, 2001, AM J NEURORADIOL, V22, P382; Lampe R, 2019, NEUROPEDIATRICS, V50, P103, DOI 10.1055/s-0038-1677515; Lesmeister C., 2015, MASTERING MACHINE LE; LEVENE MI, 1982, ARCH DIS CHILD, V57, P410, DOI 10.1136/adc.57.6.410; Mohamed MA, 2010, PEDIATRICS, V125, pE333, DOI 10.1542/peds.2008-3369; O'Leary H, 2009, PEDIATRICS, V124, P302, DOI 10.1542/peds.2008-2004; Paul DA, 2000, PEDIATR NEUROL, V22, P194, DOI 10.1016/S0887-8994(99)00155-1; PERLMAN JM, 1985, NEW ENGL J MED, V312, P1353, DOI 10.1056/NEJM198505233122104; Piechnik SK, 2008, NEUROIMAGE, V39, P107, DOI 10.1016/j.neuroimage.2007.08.022; Podda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31920-6; Poralla C, 2012, NEONATOLOGY, V102, P270, DOI 10.1159/000341266; Poryo M, 2018, EARLY HUM DEV, V116, P1, DOI 10.1016/j.earlhumdev.2017.08.010; Rastogi S, 2011, J PERINAT MED, V39, P65, DOI [10.1515/JPM.2010.122, 10.1515/jpm.2010.122]; Rittenhouse KJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0198919; Schmid MB, 2013, DTSCH ARZTEBL INT, V110, P489, DOI 10.3238/arztebl.2013.0489; Sidorenko I, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00812; Soul JS, 2007, PEDIATR RES, V61, P467, DOI 10.1203/pdr.0b013e31803237f6; Steinhorn RH., 2018, NEJM J WATCH; Synnes AR, 2006, MED CARE, V44, P754, DOI 10.1097/01.mlr.0000218780.16064.df; Villamor-Martinez E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01253; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221	36	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227419	10.1371/journal.pone.0227419	http://dx.doi.org/10.1371/journal.pone.0227419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940391	gold, Green Published			2022-12-26	WOS:000534368000071
J	Khadir, A; Madhu, D; Kavalakatt, S; Cherian, P; Alarouj, M; Bennakhi, A; Abubaker, J; Tiss, A; Elkum, N				Khadir, Abdelkrim; Madhu, Dhanya; Kavalakatt, Sina; Cherian, Preethi; Alarouj, Monira; Bennakhi, Abdullah; Abubaker, Jehad; Tiss, Ali; Elkum, Naser			PR3 levels are impaired in plasma and PBMCs from Arabs with cardiovascular diseases	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; HUMAN NEUTROPHIL PEPTIDE-1; MATRIX METALLOPROTEINASES; ALPHA-DEFENSINS; MYOCARDIAL-INFARCTION; EXPRESSION; PROTEINASE-3; MATRIX-METALLOPROTEINASE-9; GENE; REGULATORS	Cardiovascular disease (CVD) risks persist in patients despite treatment. CVD susceptibility also varies with sex and ethnicity and is not entirely explained by conventional CVD risk factors. The aim of the present study was to identify novel CVD candidate markers in circulating Peripheral blood mononuclear cells (PBMCs) and plasma from Arab obese subjects with and without CVD using proteomic approaches. Human adults with confirmed CVD (n = 208) and matched non-CVD controls (n = 152) living in Kuwait were examined in the present cross-sectional study. Anthropometric and classical biochemical parameters were determined. We employed a shotgun proteomic profiling approach on PBMCs isolated from a subset of the groups (n = 4, each), and differentially expressed proteins selected between the two groups were validated at the mRNA level using RT-PCR (n = 6, each). Plasma levels of selected proteins from the proteomics profiling: Proteinase-3 (PR3), Annexin-A3 (ANX3), Defensin (DEFA1), and Matrix Metalloproteinase-9 (MMP9), were measured in the entire cohort using human enzyme-linked immunosorbent assay kits and were subsequently correlated with various clinical parameters. Out of the 1407 we identified and quantified from the proteomics profiling, 47 proteins were dysregulated with at least twofold change between the two subject groups. Among the differentially expressed proteins, 11 were confirmed at the mRNA levels. CVD influenced the levels of the shortlisted proteins (MMP9, PR3, ANX3, and DEFA1) in the PBMCs and plasma differentially. Despite the decreased levels of both protein and mRNA in PBMCs, PR3 circulating levels increased significantly in patients with CVD and were influenced by neither diabetes nor statin treatment. No significant changes were; however, observed in the DEFA1, MMP9, and ANX3 levels in plasma. Multivariate logistic regression analysis revealed that only PR3 was independently associated with CVD. Our results suggest that the dysregulation of PR3 levels in plasma and PBMCs reflects underlying residual CVD risks even in the treated population. More prospective and larger studies are required to establish the role of PR3 in CVD progression.	[Khadir, Abdelkrim; Madhu, Dhanya; Kavalakatt, Sina; Cherian, Preethi; Abubaker, Jehad; Tiss, Ali] Dasman Diabet Inst, Res Div, Biochem & Mol Biol Dept, Kuwait, Kuwait; [Alarouj, Monira; Bennakhi, Abdullah] Dasman Diabet Inst, Med Div, Kuwait, Kuwait; [Elkum, Naser] Sidra Med, Doha, Qatar	Sidra Medical & Research Center	Abubaker, J; Tiss, A (corresponding author), Dasman Diabet Inst, Res Div, Biochem & Mol Biol Dept, Kuwait, Kuwait.; Elkum, N (corresponding author), Sidra Med, Doha, Qatar.	jhad.abubaker@dsamaninstiute.org; ali.tiss@dasmaninstitute.org; nelkum@sidra.org	Tiss, Ali/L-6656-2019; Elkum, Naser/AAU-5555-2020	Tiss, Ali/0000-0002-3024-5370; Elkum, Naser/0000-0002-0457-0444; kavalakatt, sina/0000-0003-3795-1881	Kuwait Foundation for the Advancement of Sciences [RA-2010-004]	Kuwait Foundation for the Advancement of Sciences(Kuwait Foundation for the Advancement of Sciences (KFAS))	This research project (RA-2010-004) was funded by Kuwait Foundation for the Advancement of Sciences.	Abdullah MHN, 2012, J CARDIOL, V60, P192, DOI 10.1016/j.jjcc.2012.05.009; Albert MA, 2006, CIRCULATION, V114, pE67, DOI 10.1161/CIRCULATIONAHA.106.613570; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Awan Z, 2015, EUR J PREV CARDIOL, V22, P719, DOI 10.1177/2047487314529350; Bae S, 2012, ENDOCR RES, V37, P35, DOI 10.3109/07435800.2011.620579; Brachemi S, 2007, J AM SOC NEPHROL, V18, P2330, DOI 10.1681/ASN.2006121309; Brook M, 2016, P NATL ACAD SCI USA, V113, P4350, DOI 10.1073/pnas.1601831113; Channanath AM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007043; Chen F, 2005, INT J MOL MED, V15, P57; Choi M, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.2003.00718.x; Christensen HM, 2012, EUR J HEART FAIL, V14, P387, DOI 10.1093/eurjhf/hfs021; Crisford H, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0883-z; Day CJ, 2003, CLIN EXP RHEUMATOL, V21, pS35; de Jong R, 2017, CELL ADHES MIGR, V11, P261, DOI 10.1080/19336918.2016.1259059; Derosa G, 2008, ENDOTHELIUM-J ENDOTH, V15, P219, DOI 10.1080/10623320802228815; Doring Y, 2017, CIRC RES, V120, P736, DOI 10.1161/CIRCRESAHA.116.309692; Fukuda D, 2006, AM J CARDIOL, V97, P175, DOI 10.1016/j.amjcard.2005.08.020; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Haberbosch W, 2005, SCAND J CLIN LAB INV, V65, P513, DOI 10.1080/00365510500206575; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Jonsson S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105572; Kessler C, 2008, ROM J MORPHOL EMBRYO, V49, P27; Khadir A, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9529621; Khadir Abdelkrim, 2015, Mediators Inflamm, V2015, P512603, DOI 10.1155/2015/512603; Kini AS, 2017, J AM COLL CARDIOL, V69, P628, DOI 10.1016/j.jacc.2016.10.029; LECABEC V, 1994, BIOCHEM J, V303, P481, DOI 10.1042/bj3030481; Li YX, 2014, HUM IMMUNOL, V75, P1104, DOI 10.1016/j.humimm.2014.09.014; Lim HS, 2008, J INTERN MED, V263, P620, DOI 10.1111/j.1365-2796.2008.01937.x; Madhu D, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201600169; Maneerat Y, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0285-5; MAYET WJ, 1993, BLOOD, V82, P1221; Meng H, 2019, J CELL PHYSIOL, V234, P10535, DOI 10.1002/jcp.27717; Mirea AM, 2019, MOL MED, V25, DOI 10.1186/s10020-019-0084-3; Mokou M, 2017, EXPERT REV PROTEOMIC, V14, P117, DOI 10.1080/14789450.2017.1274653; Ng LL, 2011, CLIN SCI, V120, P231, DOI 10.1042/CS20100366; OREN A, 1995, J LAB CLIN MED, V125, P340; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Paulin N, 2017, EBIOMEDICINE, V16, P204, DOI 10.1016/j.ebiom.2017.01.006; Pezzato E, 2003, J LEUKOCYTE BIOL, V74, P88, DOI 10.1189/jlb.0203086; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Quinn K, 2008, AM J PHYSIOL-HEART C, V295, pH1817, DOI 10.1152/ajpheart.00472.2008; Richards AM, 2018, EUR HEART J SUPPL, V20, pG37, DOI 10.1093/eurheartj/suy023; Tariq S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-93; Tayebjee MH, 2005, J INTERN MED, V257, P110, DOI 10.1111/j.1365-2796.2004.01431.x; Thomas GS, 2013, CIRC-CARDIOVASC GENE, V6, P154, DOI 10.1161/CIRCGENETICS.112.964015; Tongaonkar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032469; Turk-Adawi K, 2018, NAT REV CARDIOL, V15, P106, DOI 10.1038/nrcardio.2017.138; Ungan Ismail, 2016, Arch Med Sci Atheroscler Dis, V1, pe133, DOI 10.5114/amsad.2016.64164; Voros S, 2014, ATHEROSCLEROSIS, V233, P284, DOI 10.1016/j.atherosclerosis.2013.12.045; Wang J, 2001, CLIN SCI, V101, P87, DOI 10.1042/CS20000317; Xie YQ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.36; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Zhao HJ, 2012, J ATHEROSCLER THROMB, V19, P357, DOI 10.5551/jat.10108; Zhao YQ, 2016, ARTERIOSCL THROM VAS, V36, P928, DOI 10.1161/ATVBAHA.115.306725; Zoega M, 2012, J PROTEOMICS, V75, P1472, DOI 10.1016/j.jprot.2011.11.019	57	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227606	10.1371/journal.pone.0227606	http://dx.doi.org/10.1371/journal.pone.0227606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935243	gold, Green Published			2022-12-26	WOS:000534354100035
J	Pazgan-Simon, M; Kukla, M; Zuwala-Jagiello, J; Derra, A; Bator, M; Menzyk, T; Lekstan, A; Grzebyk, E; Simon, K				Pazgan-Simon, Monika; Kukla, Michal; Zuwala-Jagiello, Jolanta; Derra, Aleksandra; Bator, Martyna; Menzyk, Tomasz; Lekstan, Andrzej; Grzebyk, Ewa; Simon, Krzysztof			Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; OBESITY; ADIPOCYTOKINE; PROLIFERATION; ASSOCIATION; EXPRESSION; ADIPOKINES; CHEMERIN	Hepatocellular carcinoma (HCC) is the most common liver cancer, accountable for 90% cases. Visfatin and vaspin are adipocytokines with various suggested functions and proven significant correlations between BMI and percentage of body fat. The aim was to assess visfatin and vaspin serum levels in HCC patients and controls, compare their levels in patients with different cancer etiology and grade assessed according to the Barcelona-Clinic Liver Cancer (BCLC) staging system. The additional aim was to analyze relationship between analyzed adipokines and metabolic abnormalities and liver disfunction severity. The study was performed on 69 cirrhotic patients (54 males/15 females) with HCC, aged 59.0 +/- 12.1 years, and with BMI 29.0 +/- 4.5 kg/m(2) compared to 20 healthy volunteers. Serum visfatin and vaspin concentrations were significantly increased in HCC patients compared to controls (p = 0.01 and p = 0.02, respectively). Serum vaspin was significantly higher in HCC patients with viral compared to those with non-viral etiology (p = 0.02), with more evident increase in chronic hepatitis C patients (CHC). Serum visfatin levels were significantly higher in patients with higher insulin resistance (p = 0.04) and with platelets count > 100 000/mm(3) (p< 0.001). Patients with BMI > 30 kg/m(2) had markedly up-regulated vaspin levels (p = 0.04). There was no difference in vaspin and visfatin serum levels with respect to liver dysfunction and BCLC classification. In conclusion, our study revealed serum vaspin and visfatin to be significantly increased in HCC patients independently of cancer etiology compared to controls. Additionally, serum vaspin was elevated in viral disease, especially in CHC. Vaspin up-regulation can be a compensatory mechanism against IR in HCC patients. Serum visfatin and vaspin, although up-regulated, seem not to be associated with cancer grade and cirrhosis severity.	[Pazgan-Simon, Monika; Kukla, Michal; Simon, Krzysztof] Wroclaw Med Univ, Dept Infect Dis & Hepatol, Wroclaw, Poland; [Kukla, Michal] Med Univ Silesia, Dept Gastroenterol & Hepatol, Katowice, Poland; [Zuwala-Jagiello, Jolanta; Grzebyk, Ewa] Wroclaw Med Univ, Dept Pharmaceut Biochem, Wroclaw, Poland; [Derra, Aleksandra; Bator, Martyna; Menzyk, Tomasz] Med Univ Silesia, Katowice, Poland; [Lekstan, Andrzej] Med Univ Silesia, Dept Digest Tract Surg, Katowice, Poland	Wroclaw Medical University; Medical University Silesia; Wroclaw Medical University; Medical University Silesia; Medical University Silesia	Kukla, M (corresponding author), Wroclaw Med Univ, Dept Infect Dis & Hepatol, Wroclaw, Poland.; Kukla, M (corresponding author), Med Univ Silesia, Dept Gastroenterol & Hepatol, Katowice, Poland.	kuklamich@poczta.onet.pl	Pazgan-Simon, Monika/AAQ-9836-2020; Zuwala-Jagiello, Jolanta/ABD-4286-2021; Grzebyk, Ewa Maria/AAZ-6337-2021	Grzebyk, Ewa Maria/0000-0002-4872-3756; Zuwala-Jagiello, Jolanta/0000-0003-0314-3253; Derra, Aleksandra/0000-0002-8886-158X; Kukla, Michal/0000-0002-7900-1094; Simon, Krzysztof/0000-0002-8040-0412; Lekstan, Andrzej/0000-0002-7105-6971				Adya R, 2008, CARDIOVASC RES, V78, P356, DOI 10.1093/cvr/cvm111; Akbal E, 2012, J CLIN LAB ANAL, V26, P115, DOI 10.1002/jcla.21491; Altekruse Sean F, 2011, J Registry Manag, V38, P201; Bi TQ, 2010, CANCER BIOL THER, V10, P119, DOI 10.4161/cbt.10.2.12581; Booth A, 2015, HORM MOL BIOL CLIN I, V21, P57, DOI 10.1515/hmbci-2014-0037; Brown JEP, 2010, J MOL ENDOCRINOL, V44, P171, DOI 10.1677/JME-09-0071; Buldak RJ, 2013, ONCOL REP, V29, P771, DOI 10.3892/or.2012.2175; Cholankeril G, 2017, WORLD J HEPATOL, V9, P533, DOI 10.4254/wjh.v9.i11.533; Cymbaluk-Ploska A, 2018, ONCOTARGETS THER, V11, P1363, DOI 10.2147/OTT.S155942; Derra A, 2018, CLIN EXP HEPATOL, V4, P55, DOI 10.5114/ceh.2018.75955; Fazeli MS, 2013, CYTOKINE, V62, P81, DOI 10.1016/j.cyto.2013.02.012; Filippatos TD, 2007, J ENDOCRINOL INVEST, V30, P323, DOI 10.1007/BF03346300; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052346; Kabir F, 2015, J TAIBAH UNIV MED SC, V10, P481, DOI 10.1016/j.jtumed.2014.12.007; Kloting N, 2006, BIOCHEM BIOPH RES CO, V339, P430, DOI 10.1016/j.bbrc.2005.11.039; Kukla M, 2010, J VIRAL HEPATITIS, V17, P661, DOI 10.1111/j.1365-2893.2009.01224.x; Kukla M, 2015, CLIN EXP HEPATOL, V1, P17, DOI 10.5114/ceh.2015.51375; Kukla M, 2017, WORLD J GASTROENTERO, V23, P2613, DOI 10.3748/wjg.v23.i14.2613; Kukla M, 2013, HEPATOL INT, V7, P4, DOI 10.1007/s12072-012-9391-2; Kukla M, 2012, POL J PATHOL, V63, P213, DOI 10.5114/PJP.2012.32767; Kukla M, 2011, MOL MED, V17, P1397, DOI 10.2119/molmed.2010.00105; Kukla M, 2010, SCAND J GASTROENTERO, V45, P235, DOI 10.3109/00365520903443852; Li YK, 2008, J BIOL CHEM, V283, P34833, DOI 10.1074/jbc.M805866200; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Ninomiya S, 2011, CANCER PREV RES, V4, P2092, DOI 10.1158/1940-6207.CAPR-11-0340; Nourbakhsh M, 2015, SCAND J CLIN LAB INV, V75, P183, DOI 10.3109/00365513.2014.1003594; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Said A, 2017, WORLD J CLIN ONCOL, V8, P429, DOI 10.5306/wjco.v8.i6.429; Seeger J, 2008, J CLIN ENDOCR METAB, V93, P247, DOI 10.1210/jc.2007-1853; Stastny J, 2012, DIABETES METAB SYND, V6, P120, DOI 10.1016/j.dsx.2012.08.011; Sun YF, 2017, ONCOTARGET, V8, P23427, DOI 10.18632/oncotarget.15080; Tsai IT, 2017, CYTOKINE, V90, P54, DOI 10.1016/j.cyto.2016.10.007; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 1995, PHYS STAT US INT ANT	38	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227459	10.1371/journal.pone.0227459	http://dx.doi.org/10.1371/journal.pone.0227459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935230	Green Published, gold			2022-12-26	WOS:000534354100020
J	Defoe, DM; Rao, HY; Harris, DJ; Moore, PD; Brocher, J; Harrison, TA				Defoe, Dennis M.; Rao, Huiying; Harris, David J., III; Moore, Preston D.; Brocher, Jan; Harrison, Theresa A.			A non-canonical role for p27(Kip1) in restricting proliferation of corneal endothelial cells during development	PLOS ONE			English	Article							MOSAIC ANALYSIS; MITOTIC INHIBITION; ROCK INHIBITORS; DOUBLE MARKERS; MICE LACKING; IN-VITRO; CYCLIN-A; RHO; MIGRATION; DIFFERENTIATION	The cell cycle regulator p27(Kip1) is a critical factor controlling cell number in many lineages. While its anti-proliferative effects are well-established, the extent to which this is a result of its function as a cyclin-dependent kinase (CDK) inhibitor or through other known molecular interactions is not clear. To genetically dissect its role in the developing corneal endothelium, we examined mice harboring two loss-of-function alleles, a null allele (p27(-)) that abrogates all protein function and a knockin allele (p27(CK-)) that targets only its interaction with cyclins and CDKs. Whole-animal mutants, in which all cells are either homozygous knockout or knockin, exhibit identical proliferative increases (similar to 0.6-fold) compared with wild-type tissues. On the other hand, use of mosaic analysis with double markers (MADM) to produce infrequently-occurring clones of wild-type and mutant cells within the same tissue environment uncovers a roughly three- and six-fold expansion of individual p27(CK-/CK-) and p27(-/-) cells, respectively. Mosaicism also reveals distinct migration phenotypes, with p27(-/-) cells being highly restricted to their site of production and p27(CK-/CK-) cells more widely scattered within the endothelium. Using a density-based clustering algorithm to quantify dispersal of MADM-generated clones, a four-fold difference in aggregation is seen between the two types of mutant cells. Overall, our analysis reveals that, in developing mouse corneal endothelium, p27 regulates cell number by acting cell autonomously, both through its interactions with cyclins and CDKs and through a cyclin-CDK-independent mechanism (s). Combined with its parallel influence on cell motility, it constitutes a potent multi-functional effector mechanism with major impact on tissue organization.	[Defoe, Dennis M.; Harris, David J., III; Moore, Preston D.; Harrison, Theresa A.] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA; [Rao, Huiying] Fujian Prov Hosp, Dept Ophthalmol, Fuzhou, Fujian, Peoples R China; [Moore, Preston D.] East Tennessee State Univ, Quillen Coll Med, Grad Biomed Res Program, Johnson City, TN USA; [Brocher, Jan] BioVoxxel, Ludwigshafen, Germany; [Harris, David J., III] New York Eye & Ear Infirm Mt Sinai, New York, NY USA; [Moore, Preston D.] Sarah Cannon Dev Innovat, Nashville, TN USA	East Tennessee State University; Fujian Provincial Hospital; East Tennessee State University; New York Eye & Ear Infirmary of Mount Sinai	Defoe, DM (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.	defoe@etsu.edu			National Institutes of Health [R15 EY17997]; ETSU Research Development Committee; NIH [C06RR0306551]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ETSU Research Development Committee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the National Institutes of Health (R15 EY17997) and the ETSU Research Development Committee (to DMD). It was also funded by NIH grant C06RR0306551. Support in the form of salary (to JB) was provided by BioVoxxel, Ludwigshafen, Germany. None of these funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `author contributions' section.	Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Berton S, 2014, CELL CYCLE, V13, P3100, DOI 10.4161/15384101.2014.949512; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bonanno JA, 2012, EXP EYE RES, V95, P2, DOI 10.1016/j.exer.2011.06.004; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Defoe DM, 2007, MOL VIS, V13, P273; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Espinosa J Sebastian, 2014, Cold Spring Harb Protoc, V2014, P182, DOI 10.1101/pdb.prot080366; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fabris L, 2015, P NATL ACAD SCI USA, V112, P13916, DOI 10.1073/pnas.1508514112; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Forest F, 2015, MOL VIS, V21, P1345; Germani F, 2018, GENETICS, V208, P473, DOI 10.1534/genetics.117.300256; GORDON SR, 1990, INVEST OPHTH VIS SCI, V31, P94; Harrison TA, 2016, MOL VIS, V22, P31; He ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep29047; HIRSCH M, 1977, EXP EYE RES, V25, P277, DOI 10.1016/0014-4835(77)90094-X; IKEBE H, 1986, EXP EYE RES, V43, P251, DOI 10.1016/S0014-4835(86)80093-8; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Joyce NC, 1998, INVEST OPHTH VIS SCI, V39, P2572; Joyce NC, 2002, INVEST OPHTH VIS SCI, V43, P2152; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KREUTZIGER GO, 1976, EXP EYE RES, V23, P285, DOI 10.1016/0014-4835(76)90129-9; LAING RA, 1976, EXP EYE RES, V22, P587, DOI 10.1016/0014-4835(76)90003-8; LAULE A, 1978, ARCH OPHTHALMOL-CHIC, V96, P2031; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Losick VP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151251; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Meekins LC, 2016, INVEST OPHTH VIS SCI, V57, P6731, DOI 10.1167/iovs.16-20414; MISHIMA S, 1982, AM J OPHTHALMOL, V93, P1; MURPHY C, 1984, INVEST OPHTH VIS SCI, V25, P312; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Okumura N, 2016, INVEST OPHTH VIS SCI, V57, P1284, DOI 10.1167/iovs.15-18586; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P6067, DOI 10.1167/iovs.15-17595; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; RINGVOLD A, 1984, ACTA OPHTHALMOL, V62, P911; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERRARD ES, 1976, EXP EYE RES, V22, P347, DOI 10.1016/0014-4835(76)90227-X; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; TUFT SJ, 1990, EYE, V4, P389, DOI 10.1038/eye.1990.53; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WILSON RS, 1982, BRIT J OPHTHALMOL, V66, P513, DOI 10.1136/bjo.66.8.513; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; YEE RW, 1985, CURR EYE RES, V4, P671, DOI 10.3109/02713688509017661; Yoshida K, 2004, INVEST OPHTH VIS SCI, V45, P2163, DOI 10.1167/iovs.03-1238; Zhu YT, 2012, J CELL SCI, V125, P3636, DOI 10.1242/jcs.103267; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zong H, 2014, METHODS MOL BIOL, V1194, P187, DOI 10.1007/978-1-4939-1215-5_10	63	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226725	10.1371/journal.pone.0226725	http://dx.doi.org/10.1371/journal.pone.0226725			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929545	Green Published, gold, Green Submitted			2022-12-26	WOS:000534352500018
J	Gandhi, JK; Mano, F; Iezzi, R; LoBue, SA; Holman, BH; Fautsch, MP; Olsen, TW; Pulido, JS; Marmorstein, AD				Gandhi, Jarel K.; Mano, Fukutaro; Iezzi, Raymond; LoBue, Stephen A.; Holman, Brad H.; Fautsch, Michael P.; Olsen, Timothy W.; Pulido, Jose S.; Marmorstein, Alan D.			Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantation	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; EMBRYONIC STEM-CELLS; MACULAR DEGENERATION; TRANSPLANTATION; DIFFERENTIATION; SURVIVAL; GLUE	Retinal pigment epithelium (RPE) transplantation for the treatment of macular degeneration has been studied for over 30 years. Human clinical trials have demonstrated that RPE monolayers exhibit improved cellular engraftment and survival compared to single cell suspensions. The use of a scaffold facilitates implantation of a flat, wrinkle-free, precisely placed monolayer. Scaffolds currently being investigated in human clinical trials are non-degradable which results in the introduction of a chronic foreign body. To improve RPE transplant technology, a degradable scaffold would be desirable. Using human fibrin, we have generated scaffolds that support the growth of an RPE monolayer in vitro. To determine whether these scaffolds are degraded in vivo, we developed a surgical approach that delivers a fibrin hydrogel implant to the sub-retinal space of the pig eye and determined whether and how fast they degraded. Using standard ophthalmic imaging techniques, the fibrin scaffolds were completely degraded by postoperative week 8 in 5 of 6 animals. Postmortem histologic analysis confirmed the absence of the scaffold from the subretinal space at 8 weeks, and demonstrated the reattachment of the neurosensory retina and a normal RPE-photoreceptor interface. When mechanical debridement of a region of native RPE was performed during implantation surgery degradation was accelerated and scaffolds were undetectable by 4 weeks. These data represent the first in situ demonstration of a fully biodegradable scaffold for use in the implantation of RPE and other cell types for treatment of macular degeneration and other retinal degenerative diseases.	[Gandhi, Jarel K.; Mano, Fukutaro; Iezzi, Raymond; LoBue, Stephen A.; Holman, Brad H.; Fautsch, Michael P.; Olsen, Timothy W.; Pulido, Jose S.; Marmorstein, Alan D.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA	Mayo Clinic	Marmorstein, AD (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	Marmorstein.alan@mayo.edu		LoBue, Stephen/0000-0003-2899-7730	Gordon and Llura Gund Fund for Career Development in Retinal Degenerative Disease Research; Alfred A. Iversen Family Foundation; PMT Corp.; National Eye Institute [EY21727, EY26490]; VitreoRetinal Surgery Foundation Research Fellowship; Mayo Clinic Discovery Translation Award; Mayo Foundation	Gordon and Llura Gund Fund for Career Development in Retinal Degenerative Disease Research; Alfred A. Iversen Family Foundation; PMT Corp.; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); VitreoRetinal Surgery Foundation Research Fellowship; Mayo Clinic Discovery Translation Award; Mayo Foundation	This work was supported by the Gordon and Llura Gund Fund for Career Development in Retinal Degenerative Disease Research (JKG), the Alfred A. Iversen Family Foundation and PMT Corp. (ADM), National Eye Institute grants EY21727 and EY26490 (MPF), the VitreoRetinal Surgery Foundation Research Fellowship (JKG), a gift to the Mayo Clinic Center for Regenerative Medicine from Mr. Gene Wood (ADM), a Mayo Clinic Discovery Translation Award (ADM) and the Mayo Foundation (ADM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakri SJ, 2014, OSLI RETINA, V45, P243, DOI 10.3928/23258160-20140501-02; de Oliveira PRC, 2017, OSLI RETINA, V48, P358, DOI 10.3928/23258160-20170329-13; da Cruz L, 2018, NAT BIOTECHNOL, V36, P1, DOI 10.1038/nbt.4114; Diniz B, 2013, INVEST OPHTH VIS SCI, V54, P5087, DOI 10.1167/iovs.12-11239; Gandhi JK, 2018, ACTA BIOMATER, V67, P134, DOI 10.1016/j.actbio.2017.11.058; Johnson AA, 2015, INVEST OPHTH VIS SCI, V56, P4619, DOI 10.1167/iovs.15-16910; Kamao H, 2017, INVEST OPHTH VIS SCI, V58, P211, DOI 10.1167/iovs.16-19778; Kashani AH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4097; Kundu J, 2018, J BIOMED MATER RES B, V106, P891, DOI 10.1002/jbm.b.33901; Kundu J, 2016, ACTA BIOMATER, V31, P61, DOI 10.1016/j.actbio.2015.11.028; LI LX, 1988, EXP EYE RES, V47, P771, DOI 10.1016/0014-4835(88)90044-9; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Marmorstein AD, 2001, TRAFFIC, V2, P867, DOI 10.1034/j.1600-0854.2001.21202.x; Marmorstein AD, 2007, TRENDS GENET, V23, P225, DOI 10.1016/j.tig.2007.03.001; Maruotti J, 2013, STEM CELL TRANSL MED, V2, P341, DOI 10.5966/sctm.2012-0106; McUsic AC, 2012, BIOMATERIALS, V33, P1396, DOI 10.1016/j.biomaterials.2011.10.083; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Panda A, 2009, INDIAN J OPHTHALMOL, V57, P371, DOI 10.4103/0301-4738.55079; Pennington BO, 2015, STEM CELL TRANSL MED, V4, P165, DOI 10.5966/sctm.2014-0179; PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P102; Pichler L, 2008, WIEN TIERARZTL MONAT, V95, P282; Pillai CKS, 2010, J BIOMATER APPL, V25, P291, DOI 10.1177/0885328210384890; Sanchez I, 2011, GRAEF ARCH CLIN EXP, V249, P475, DOI 10.1007/s00417-011-1617-9; Scalcione C, 2018, EYE, V32, P463, DOI 10.1038/eye.2017.227; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sharma R, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat5580; SNMMI Newsline, 2016, J NUCL MED, V57, p19N; Spotnitz William D, 2014, ISRN Surg, V2014, P203943, DOI 10.1155/2014/203943; Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019; Takagi S, 2019, OPHTHALMOL RETINA, pS2468653019300909, DOI [10.1016/j.oret.2019.04.021, DOI 10.1016/J.0RET.2019.04.021]; Thompson JR, 2019, ACTA BIOMATER, V94, P204, DOI 10.1016/j.actbio.2019.04.057; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Wolfensberger T., 1998, RETINAL PIGMENT EPIT, P103; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Worthington KS, 2017, ACTA BIOMATER, V55, P385, DOI 10.1016/j.actbio.2017.03.039; 2009, EXPERT REV MOL DIAGN, V9, P325	37	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227641	10.1371/journal.pone.0227641	http://dx.doi.org/10.1371/journal.pone.0227641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KF6TD	31929571	gold, Green Published			2022-12-26	WOS:000509372000001
J	Yang, HS; Kang, TG; Park, H; Heo, JS; Park, J; Lee, KS; Choi, S				Yang, Hyun Seung; Kang, Tae Gu; Park, Hyun; Heo, Ji Su; Park, Jonghoon; Lee, Kyung Sub; Choi, Sangkyung			Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy	PLOS ONE			English	Article							PHOTOCOAGULATION; FEATURES	Purpose To quantify the structural and perfusion changes in choriocapillaris in chronic central serous chorioretinopathy after half-dose photodynamic therapy by using spectral-domain optical coherence tomography and optical coherence tomography angiography. Methods This retrospective interventional case series examined the eyes of patients with central serous chorioretinopathy. Patients underwent full ophthalmic examinations, including spectral-domain optical coherence tomography and angiography, prior to and 1, 3, and 6 months after the treatment. Clinical and tomographic features of the choriocapillaris and choroidal thickness and vascular changes were evaluated by assessing flow signal voids. Results All 56 eyes of 56 patients showed complete resolution of subretinal fluid at 3 months after photodynamic therapy. The best-corrected visual acuity significantly improved at 6 months (p<0.001). The central subfield thickness, subfoveal choroidal thickness, subfoveal choroidal large vessel layer thickness, and mean total area of flow signal voids decreased significantly at 6 months (all p values < 0.001), but the subfoveal choriocapillaris layer thickness did not change significantly at 6 months (p >= 0.16). Multivariate analysis revealed positive linear correlations of the central subfield thickness and subfoveal choroidal large vessel layer thickness with the mean total area of flow signal voids at 6 months (p<0.001). There was a negative linear correlation between the subfoveal choriocapillaris layer and the mean total area of flow signal voids at 6 months (p = 0.013). Conclusion Half-dose photodynamic therapy improved the anatomic and functional outcomes of central serous chorioretinopathy, induced subfoveal choroidal thickness thinning, and increased choriocapillaris perfusion. In addition, the recovery of the subfoveal choriocapillaris layer thickness and improved choriocapillaris perfusion were closely associated.	[Yang, Hyun Seung; Heo, Ji Su; Park, Jonghoon; Lee, Kyung Sub] Seoul Shinsegae Eye Ctr, Dept Ophthalmol, Gyeonggi Do, South Korea; [Kang, Tae Gu; Choi, Sangkyung] Vet Hlth Serv Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Park, Hyun] Seoul Chuk Hosp, Dept Endocrinol, Gyeonggi Do, South Korea	Veterans Health Service Medical Center	Choi, S (corresponding author), Vet Hlth Serv Med Ctr, Dept Ophthalmol, Seoul, South Korea.	pfskchoi@gmail.com	Yang, Hyun Seung/GRS-1440-2022; Yang, Hyun Seung/AAC-4319-2020	Yang, Hyun Seung/0000-0002-0470-676X	Veterans Health Service Medical Center Research Grant, Republic of Korea [VHSMC19027]	Veterans Health Service Medical Center Research Grant, Republic of Korea	This study was supported by a Veterans Health Service Medical Center Research Grant, Republic of Korea (grant VHSMC19027). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Camino A, 2016, BIOMED OPT EXPRESS, V7, P3905, DOI 10.1364/BOE.7.003905; Cennamo G, 2019, PHOTODIAGN PHOTODYN, V27, P162, DOI 10.1016/j.pdpdt.2019.05.041; Demircan A, 2018, PHOTODIAGN PHOTODYN, V21, P375, DOI 10.1016/j.pdpdt.2018.01.015; Demirel S, 2019, GRAEF ARCH CLIN EXP, V257, P905, DOI 10.1007/s00417-018-04226-6; Fayed AE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217109; Izumi T, 2017, BRIT J OPHTHALMOL, V101, P433, DOI 10.1136/bjophthalmol-2016-308921; Ji SL, 2017, INT J CLIN PHARM-NET, V39, P514, DOI 10.1007/s11096-017-0460-4; Koss MJ, 2012, EYE, V26, P307, DOI 10.1038/eye.2011.282; Lanzetta P, 2008, EUR J OPHTHALMOL, V18, P934, DOI 10.1177/112067210801800613; Levy J, 2005, CAN J OPHTHALMOL, V40, P217, DOI 10.1016/S0008-4182(05)80040-7; Lim JW, 2011, BRIT J OPHTHALMOL, V95, P514, DOI 10.1136/bjo.2010.182121; Liu L, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/3926745; Ma JL, 2014, ACTA OPHTHALMOL, V92, pe594, DOI 10.1111/aos.12482; Manayath George Joseph, 2018, Oman J Ophthalmol, V11, P103, DOI 10.4103/ojo.OJO_75_2017; Maruko I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184112; Maruko I, 2017, RETINA-J RET VIT DIS, V37, P460, DOI 10.1097/IAE.0000000000001324; Min JY, 2018, LASER SURG MED, V50, P987, DOI 10.1002/lsm.22952; Nassisi M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112468; Nicholson B, 2013, SURV OPHTHALMOL, V58, P103, DOI 10.1016/j.survophthal.2012.07.004; Petkovsek DS, 2020, BRIT J OPHTHALMOL, V104, P182, DOI 10.1136/bjophthalmol-2019-314047; Rochepeau C, 2018, AM J OPHTHALMOL, V194, P26, DOI 10.1016/j.ajo.2018.07.004; Spaide RF, 2018, PROG RETIN EYE RES, V64, P1, DOI 10.1016/j.preteyeres.2017.11.003; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; van Dijk EHC, 2018, OPHTHALMOLOGY, V125, P1547, DOI 10.1016/j.ophtha.2018.04.021; Van Rijssen TJ, 2019, AM J OPHTHALMOL, V205, P1, DOI 10.1016/j.ajo.2019.03.025; Xu YS, 2017, OPHTHALMOLOGICA, V237, P167, DOI 10.1159/000456676; Yang HS, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0170341; Zhang QQ, 2018, INVEST OPHTH VIS SCI, V59, P203, DOI 10.1167/iovs.17-22953; Zhang QQ, 2017, OPHTHALMOL RETINA, V1, P124, DOI 10.1016/j.oret.2016.08.005; Zhu TP, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12519	32	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227718	10.1371/journal.pone.0227718	http://dx.doi.org/10.1371/journal.pone.0227718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929582	gold, Green Published			2022-12-26	WOS:000534352500065
J	Fischer, K; Marggraf, M; Stark, AW; Kaneko, K; Aghayev, A; Guensch, DP; Huber, AT; Steigner, M; Blankstein, R; Reichlin, T; Windecker, S; Kwong, RY; Grani, C				Fischer, Kady; Marggraf, Maximilian; Stark, Anselm W.; Kaneko, Kyoichi; Aghayev, Ayaz; Guensch, Dominik P.; Huber, Adrian T.; Steigner, Michael; Blankstein, Ron; Reichlin, Tobias; Windecker, Stephan; Kwong, Raymond Y.; Grani, Christoph			Association of ECG parameters with late gadolinium enhancement and outcome in patients with clinical suspicion of acute or subacute myocarditis referred for CMR imaging	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; RISK STRATIFYING PATIENTS; T-WAVE INVERSION; ELECTROCARDIOGRAPHIC PREDICTORS; QTC INTERVAL; DIAGNOSIS; DEATH; MYOPERICARDITIS; INFLAMMATION; MANAGEMENT	Background Risk stratification of myocarditis is challenging due to variable clinical presentations. Cardiovascular magnetic resonance (CMR) is the primary non-invasive imaging modality to investigate myocarditis while electrocardiograms (ECG) are routinely included in the clinical workup. The association of ECG parameters with CMR tissue characterisation and their prognostic value were investigated in patients with clinically suspected myocarditis. Methods and results Consecutive patients with suspected myocarditis who underwent CMR and ECG were analysed. Major adverse cardiovascular event (MACE) included all-cause death, hospitalisation for heart failure, heart transplantation, documented sustained ventricular arrhythmia, or recurrent myocarditis. A total of 587 patients were followed for a median of 3.9 years. A wide QRS-T angle, low voltage and fragmented QRS were significantly associated with late gadolinium enhancement. Further, a wide QRS-T angle, low voltage and prolonged QTc duration were associated with MACE in the univariable analysis. In a multivariable model, late gadolinium enhancement (HR: 1.90, 95%CI: 1.17-3.10; p = 0.010) and the ECG parameters of a low QRS voltage (HR: 1.86, 95%CI: 1.01-3.42; p = 0.046) and QRS-T-angle (HR: 1.01, 95%CI: 1.00-1.01; p = 0.029) remained independently associated with outcome. The cumulative incidence of MACE was incrementally higher when findings of both CMR and ECG were abnormal (p< 0.001). Conclusion In patients with clinically suspected myocarditis, abnormal ECG parameters are associated with abnormal tissue characteristics detected by CMR. Further, ECG and CMR findings have independent prognostic implications for morbidity and mortality. Integrating both exams into clinical decision-making may play a role in risk stratification in this heterogeneous patient population.	[Fischer, Kady; Marggraf, Maximilian; Stark, Anselm W.; Reichlin, Tobias; Windecker, Stephan; Grani, Christoph] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland; [Fischer, Kady; Guensch, Dominik P.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Anaesthesiol & Pain Med, Bern, Switzerland; [Kaneko, Kyoichi; Kwong, Raymond Y.; Grani, Christoph] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div,Noninvas Cardiovasc Imaging, Boston, MA 02115 USA; [Aghayev, Ayaz; Steigner, Michael; Blankstein, Ron] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Noninvas Cardiovasc Imaging, Boston, MA 02115 USA; [Guensch, Dominik P.; Huber, Adrian T.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diagnost Intervent & Paediat Radiol, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Bern; University Hospital of Bern	Grani, C (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland.; Grani, C (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Cardiovasc Div,Noninvas Cardiovasc Imaging, Boston, MA 02115 USA.	christoph.graeni@insel.ch	Huber, Adrian/ABA-2766-2020; Kwong, Raymond Y/R-1925-2016; Aghayev, Ayaz/AAK-3605-2021	Kwong, Raymond Y/0000-0001-8212-0759; Fischer, Kady/0000-0002-7765-4550; Grani, Christoph/0000-0001-6029-0597; Huber, Adrian Thomas/0000-0001-6146-8238; Stark, Anselm W./0000-0002-5861-3753; Gunsch, Dominik/0000-0003-4127-4086				Aquaro GD, 2017, J AM COLL CARDIOL, V70, P1977, DOI 10.1016/j.jacc.2017.08.044; Bozkurt B, 2016, CIRCULATION, V134, pE579, DOI 10.1161/CIR.0000000000000455; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Chen S, 2018, J CARD FAIL, V24, P3, DOI 10.1016/j.cardfail.2017.11.001; Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892; De Lazzari M, 2016, J ELECTROCARDIOL, V49, P587, DOI 10.1016/j.jelectrocard.2016.04.002; Deluigi CC, 2013, INT J CARDIOL, V165, P100, DOI 10.1016/j.ijcard.2011.07.090; Di Bella G, 2012, CLIN RES CARDIOL, V101, P617, DOI 10.1007/s00392-012-0433-5; Fabre A, 2006, HEART, V92, P316, DOI 10.1136/hrt.2004.045518; Ferreira VM, 2018, J AM COLL CARDIOL, V72, P3158, DOI 10.1016/j.jacc.2018.09.072; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Fronza M, 2016, IJC HEART VASC, V11, P7, DOI 10.1016/j.ijcha.2016.02.001; Grani C, 2019, INT J CARDIOVAS IMAG, V35, P1067, DOI 10.1007/s10554-019-01552-6; Grani C, 2019, J CARDIOVASC MAGN R, V21, DOI 10.1186/s12968-019-0520-0; Grani C, 2017, J AM COLL CARDIOL, V70, P1964, DOI 10.1016/j.jacc.2017.08.050; Gruen S, 2012, J AM COLL CARDIOL, V59, P1604, DOI 10.1016/j.jacc.2012.01.007; Hung Y, 2016, ACTA CARDIOL SIN, V32, P223, DOI 10.6515/ACS20150226A; Imazio M, 2008, INT J CARDIOL, V127, P17, DOI 10.1016/j.ijcard.2007.10.053; Jain R, 2014, CURR CARDIOL REV, V10, P277, DOI 10.2174/1573403X10666140514103451; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Kawel-Boehm N, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0111-7; Konno T, 2015, J CARDIOVASC ELECTR, V26, P1081, DOI 10.1111/jce.12742; Kotanidis CP, 2018, JACC-CARDIOVASC IMAG, V11, P1583, DOI 10.1016/j.jcmg.2017.12.008; Laukkanen JA, 2014, AM J CARDIOL, V113, P1178, DOI 10.1016/j.amjcard.2013.12.026; Maanja M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003795; Madias JE, 2014, EUR HEART J-ACUTE CA, V3, P28, DOI 10.1177/2048872613504311; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; MORGERA T, 1992, AM HEART J, V124, P455, DOI 10.1016/0002-8703(92)90613-Z; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Porela P, 2012, ANN NONINVAS ELECTRO, V17, P141, DOI 10.1111/j.1542-474X.2012.00489.x; Schumm J, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-14; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Ukena C, 2011, EUR J HEART FAIL, V13, P398, DOI 10.1093/eurjhf/hfq229; von Knobelsdorff-Brenkenhoff F, 2017, CIRC CARDIOVASC IMAG, V10	35	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227134	10.1371/journal.pone.0227134	http://dx.doi.org/10.1371/journal.pone.0227134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923225	Green Published, gold, Green Submitted			2022-12-26	WOS:000534350000046
J	Mahmoudi, M; Boughalleb, F; Pellegrino, G; Abdellaoui, R; Nasri, N				Mahmoudi, Maher; Boughalleb, Faycal; Pellegrino, Giuseppe; Abdellaoui, Raoudha; Nasri, Nizar			Flower, seed, and fruit development in three Tunisian species of Polygonum: Implications for their taxonomy and evolution of distyly in Polygonaceae	PLOS ONE			English	Article							FLORAL MORPHOLOGY; POLLEN MORPHOLOGY; FOLIAR ANATOMY; ACONOGONON; LEGUMINOSAE; PERSICARIA; INITIATION; ONTOGENY; ACHENE; PLANTS	Polygonum is the largest genus of Polygonaceae and 5 species are reported in Tunisia. In order to characterized flower, seed, and fruit development in Polygonum, flower and fruit of Polygonium equisetiforme (var. graecum and peyerinhoffi), P. aviculare and P. maritimum, collected from Tunisia, were examined. Flowers are composed of five oblong tepals. P. equisetiforme and P. aviculare have whitish-pink distylous flowers with dimorphism of style, filament and anther height, pollen diameter and stigma size. In contrast, P. maritimum shows white homostylous flowers. The floral vasculature showed that the tepals are inserted in one whorl and their traces arise independently in 3+2 manner. The eight stamens are arranged in a 5+3 manner and the staminal bundles arise independently in the two whorls. The epidermis and endothecium cells width were higher in P. maritimum and the lowest endothecium width was observed in P. aviculare. Polygonum aviculare and P. equisetiforme showed circular pollen with shallow colpi and trilobite pollen shape with deep colpi, while P. maritimum rarely showed shallow colpi. The ovule is anatropous with basal placentation in P. equisetiforme and P. aviculare and apical placentation in P. maritimum. The young seed coat was formed by an endotesta with thick-walled cells, a mesotesta and exotesta with thin-walled cells and a tegmen composed of radially elongated cells. The fruits of the studied species are trigonous with ovate-lanceolate shape. In P. aviculare, the exocarp is thicker compared to the two other species, in P. equisetiforme, the mature exocarp consists of smaller rectangular cells with narrow cavities, and in P. maritimum showed a thinner exocarpIn conclusion, P. equisetiforme and P. aviculare are a typically distylous species from the morphological point of view and we discussed the significance of heterostyly in Polygonaceae. From this first morpho-anatomical study of Polygonum species in North Africa, we can conclude mainly that there is no significant difference between P. equisetiforme var. graecum and var. peyerinhoffi supporting a taxonomic grouping of these two varieties.	[Mahmoudi, Maher; Nasri, Nizar] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Mahmoudi, Maher; Boughalleb, Faycal; Abdellaoui, Raoudha] Inst Reg Andes, Lab Ecosyst Pastoraux & Valorisat Plantes Spontan, Medenine, Tunisia; [Pellegrino, Giuseppe] Univ Calabria, Dept Biol Ecol & Hearth Sci, Arcavacata Di Rende, CS, Italy	Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut des Regions Arides; University of Calabria	Pellegrino, G (corresponding author), Univ Calabria, Dept Biol Ecol & Hearth Sci, Arcavacata Di Rende, CS, Italy.	giuseppe.pellegrino@unical.it	Boughalleb, Fayçal/AFQ-6645-2022; Mahmoudi, Maher/AAP-8805-2021; Abdellaoui, Raoudha/G-7219-2019	Mahmoudi, Maher/0000-0002-4114-2959; Boughalleb, Faycal/0000-0002-3583-9303; Pellegrino, Giuseppe/0000-0002-9358-2075; Abdellaoui, Raoudha/0000-0003-2767-9650	Ministry of Higher Education and Scientific Research of Tunisia	Ministry of Higher Education and Scientific Research of Tunisia	Financial support for this research was provided by Ministry of Higher Education and Scientific Research of Tunisia.; We gratefully acknowledge Pr. LOUIS P. RONSE DE CRAENE for his help in improving the manuscript and we thank the technical staff of the Arid Regions Institute, Medenine (IRA), for their help with the conduct of these experiments.	Anjen L., 2003, SMALL, V5, P277; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; Bauer R, 1922, FLORA, V115, P272; Bello MA, 2004, INT J PLANT SCI, V165, P723, DOI 10.1086/422046; Brandbyge J, 1993, POLYGONACEAE FLOWERI, P531; Brummitt R.K., 1992, VASCULAR PLANT FAMIL; Budel Jane M., 2007, Rev. bras. farmacogn., V17, P39, DOI 10.1590/S0102-695X2007000100009; Chehregani A, 2010, TURK J BOT, V34, P241, DOI 10.3906/bot-0908-168; Chen ML, 2012, FLORA, V207, P365, DOI 10.1016/j.flora.2012.01.012; Chen ML, 2010, PLANT SYST EVOL, V288, P139, DOI 10.1007/s00606-010-0318-x; Costea M, 2005, CAN J PLANT SCI, V85, P481, DOI 10.4141/P03-187; de Castro CC, 2004, PLANT SYST EVOL, V244, P131, DOI 10.1007/s00606-003-0036-8; DECRAENE LPR, 1990, NORD J BOT, V10, P411, DOI 10.1111/j.1756-1051.1990.tb01781.x; DECRAENE LPR, 1988, BOT J LINN SOC, V98, P321, DOI 10.1111/j.1095-8339.1988.tb01706.x; Decraene LPR, 2000, BOT J LINN SOC, V134, P301, DOI 10.1111/j.1095-8339.2000.tb02356.x; Deng YM, 2010, SCI HORTIC-AMSTERDAM, V124, P500, DOI 10.1016/j.scienta.2010.02.009; ENDRESS PK, 1994, PLANT SYST EVOL, V192, P79, DOI 10.1007/BF00985910; Faivre AE, 2000, EVOLUTION, V54, P847, DOI 10.1111/j.0014-3820.2000.tb00085.x; Ghimire B, 2018, FLORA, V242, P79, DOI 10.1016/j.flora.2018.03.008; Haraldson K., 1978, ACTA U UPSALIENSIS S; HASSAN MA, 1987, BANGLADESH J BOTANY, V16, P93; Hedberg O., 1946, SVENSK BOT TIDSKR, V40, P371; Heywood V. H., 1969, MICRON, V1, P1, DOI DOI 10.1016/0047-7206(69)90002-8; HILDEBRAND F, 1867, GESCHLECHTER VERTHEI; HONG SP, 1990, GRANA, V29, P177, DOI 10.1080/00173139009427750; Hong SP, 2005, PLANT SYST EVOL, V254, P13, DOI 10.1007/s00606-005-0334-4; HONG SP, 1991, PLANT SYST EVOL, V176, P125, DOI 10.1007/BF00937948; Hu N, 2016, BIOMED MICRODEVICES, V18, DOI 10.1007/s10544-016-0118-3; Huang LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102802; Kantachot C., 2011, TROP NAT HIST, V11, P21; Koch Ana Kelly, 2010, Rodriguésia, V61, P551, DOI 10.1590/2175-7860201061314; Koochak H, 2010, ASIAN PAC J TROP MED, V3, P180, DOI 10.1016/S1995-7645(10)60004-1; Laubengayer RA, 1937, AM J BOT, V24, P329, DOI 10.2307/2437032; Le Floch E., 2010, CATALOGUE SYNONYMIQU; LERSTEN NR, 1992, PLANT SYST EVOL, V182, P71, DOI 10.1007/BF00941415; Lloyd D.G, 1992, EVOLUTION FUNCTION H, P151; Lord, 2011, NEW ZEAL J BOT, V49, P141, DOI [10.1080/0028825x.2011.548764, DOI 10.1080/0028825X.2011.548764]; MARTIN AC, 1954, J WILDLIFE MANAGE, V18, P514, DOI 10.2307/3797087; NEUBAUER BF, 1971, AM J BOT, V58, P655, DOI 10.2307/2441010; Nowicke J.W., 1977, SMITHSON CONTRIB BOT, V37, P1; Nuraliev MS, 2011, INT J PLANT SCI, V172, P735, DOI 10.1086/660189; Pottier-Alapetite G, 1979, FLORE TUNISIE ANGIOS, VI; RAO B H, 1992, Feddes Repertorium, V103, P35; REDDY NP, 1977, J GENET, V63, P79, DOI 10.1007/BF02984278; RICHARDS JH, 1993, AM J BOT, V80, P31, DOI 10.2307/2445117; Roth I., 1977, ENCY PLANT ANATOMY; Sampson BJ, 2013, HORTSCIENCE, V48, P136, DOI 10.21273/HORTSCI.48.2.136; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SUNDBERG MD, 1982, AM J BOT, V69, P1707, DOI 10.2307/2442925; Tucker SC, 2002, AM J BOT, V89, P748, DOI 10.3732/ajb.89.5.748; TUCKER SC, 1989, AM J BOT, V76, P714, DOI 10.2307/2444418; von Balthazar M, 2002, INT J PLANT SCI, V163, P847, DOI 10.1086/342714; Wang CH, 2017, PLANT SYST EVOL, V303, P559, DOI 10.1007/s00606-017-1388-9; [杨世雄 Yang Shixiong], 2002, [广西植物, Guihaia], V22, P340; Yasmin G, 2010, AFR J BIOTECHNOL, V9, P3759; Yasmin G, 2009, INT J AGRIC BIOL, V11, P285; Yurtseva OV, 2014, PLANT SYST EVOL, V300, P749, DOI 10.1007/s00606-013-0917-4; Yurtseva O. V., 1999, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V104, P13; Yurtseva OV, 2016, PEERJ, V4, DOI 10.7717/peerj.1977; Yurtseva OV, 2001, NORD J BOT, V21, P513, DOI 10.1111/j.1756-1051.2001.tb00805.x; Zhang Q, 2017, FLORA, V233, P127, DOI 10.1016/j.flora.2017.05.015; Zhang X.P., 1998, STUDY POLLEN MORPHOL; ZULKARNAIN Z, 2005, HAYATI J BIOSCI, V12, P11, DOI DOI 10.1016/S1978-3019(16)30317-5	63	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227099	10.1371/journal.pone.0227099	http://dx.doi.org/10.1371/journal.pone.0227099			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923204	Green Published, gold			2022-12-26	WOS:000534350000042
J	Mader, J; Huber, J; Bonn, F; Dotsch, V; Rogov, VV; Bremm, A				Mader, Julia; Huber, Jessica; Bonn, Florian; Doetsch, Volker; Rogov, Vladimir V.; Bremm, Anja			Oxygen-dependent asparagine hydroxylation of the ubiquitin-associated (UBA) domain in Cezanne regulates ubiquitin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); ubiquitin; protein-protein interaction; nuclear magnetic resonance (NMR); posttranslational modification (PTM); Cezanne; FIH1; hydroxylation; UBA domain; deubiquitinase (DUB); OTU domain-containing protein 7B (OTUD7B)	STRUCTURAL BASIS; PHOSPHORYLATION; DIMERIZATION; ACTIVATION; PROTEINS; CBL	Deubiquitinases (DUBs) are vital for the regulation of ubiquitin signals, and both catalytic activity of and target recruitment by DUBs need to be tightly controlled. Here, we identify asparagine hydroxylation as a novel posttranslational modification involved in the regulation of Cezanne (also known as OTU domain?containing protein 7B (OTUD7B)), a DUB that controls key cellular functions and signaling pathways. We demonstrate that Cezanne is a substrate for factor inhibiting HIF1 (FIH1)- and oxygen-dependent asparagine hydroxylation. We found that FIH1 modifies Asn(35) within the uncharacterized N-terminal ubiquitin-associated (UBA)-like domain of Cezanne (UBA(Cez)), which lacks conserved UBA domain properties. We show that UBA(Cez) binds Lys(11)-, Lys(48)-, Lys(63)-, and Met(1)-linked ubiquitin chains in vitro, establishing UBA(Cez) as a functional ubiquitin-binding domain. Our findings also reveal that the interaction of UBA(Cez) with ubiquitin is mediated via a noncanonical surface and that hydroxylation of Asn(35) inhibits ubiquitin binding. Recently, it has been suggested that Cezanne recruitment to specific target proteins depends on UBA(Cez). Our results indicate that UBA(Cez) can indeed fulfill this role as regulatory domain by binding various ubiquitin chain types. They also uncover that this interaction with ubiquitin, and thus with modified substrates, can be modulated by oxygen-dependent asparagine hydroxylation, suggesting that Cezanne is regulated by oxygen levels.	[Mader, Julia; Bonn, Florian; Bremm, Anja] Goethe Univ Frankfurt, Inst Biochem 2, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Huber, Jessica; Doetsch, Volker; Rogov, Vladimir V.] Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Huber, Jessica; Doetsch, Volker; Rogov, Vladimir V.] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Bremm, A (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	bremm@em.uni-frankfurt.de	Bremm, Anja/AAI-3146-2021	Huber, Jessica/0000-0003-4269-5720; Bremm, Anja/0000-0003-1386-0926	German Research Foundation [BR 4268/2-1]; CRC/SFB 1177 on selective autophagy	German Research Foundation(German Research Foundation (DFG)); CRC/SFB 1177 on selective autophagy	This work was supported by German Research Foundation Grants BR 4268/2-1 (to A. B.) and CRC/SFB 1177 on selective autophagy (to F. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Bonacci T, 2018, EMBO J, V37, DOI 10.15252/embj.201798701; Bremm A, 2014, EMBO REP, V15, P1268, DOI 10.15252/embr.201438850; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Clague MJ, 2019, NAT REV MOL CELL BIO, V20, P338, DOI 10.1038/s41580-019-0099-1; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Garcia-Santisteban I, 2012, BIOCHEM J, V441, P209, DOI 10.1042/BJ20111300; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Janke K, 2013, J CELL SCI, V126, P2629, DOI 10.1242/jcs.117564; Ji YX, 2018, J CELL BIOCHEM, V119, P1979, DOI 10.1002/jcb.26359; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Moniz S, 2015, J CELL SCI, V128, P3082, DOI 10.1242/jcs.168864; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Pareja F, 2012, ONCOGENE, V31, P4599, DOI 10.1038/onc.2011.587; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Price C, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00054; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Vincendeau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep18934; Walinda E, 2014, J BIOL CHEM, V289, P13890, DOI 10.1074/jbc.M114.555441; Wang B, 2017, NATURE, V545, P365, DOI 10.1038/nature22344; Wang L, 2017, NEW BIOTECHNOL, V38, P16, DOI 10.1016/j.nbt.2016.10.003; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zhou ZR, 2008, PROTEIN SCI, V17, P1805, DOI 10.1110/ps.036384.108	44	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2160	2174		10.1074/jbc.RA119.010315	http://dx.doi.org/10.1074/jbc.RA119.010315			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31937588	Green Published, hybrid			2022-12-26	WOS:000517330200001
J	Panthu, B; Denolly, S; Faivre-Moskalenko, C; Ohlmann, T; Cosset, FL; Jalinot, P				Panthu, Baptiste; Denolly, Solene; Faivre-Moskalenko, Cendrine; Ohlmann, Theophile; Cosset, Francois-Loic; Jalinot, Pierre			Unlike for cellular mRNAs and other viral internal ribosome entry sites (IRESs), the eIF3 subunit e is not required for the translational activity of the HCV IRES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation control; hepatitis C virus (HCV); eukaryotic translation initiation; infection; ribosome; protein synthesis; eukaryotic initiation factor 3 (eIF3); host factor; in vitro reconstitution; internal ribosome entry site (IRES); viral infection	HEPATITIS-C; INITIATION-FACTOR; DEPENDENT TRANSLATION; DNA-REPAIR; VIRUS; PROTEIN; INTERACTS; BINDING; RECRUITMENT; MECHANISM	Viruses depend on the host cell translation machinery for their replication, and one common strategy is the presence of internal ribosome entry sites (IRESs) in the viral RNAs, using different sets of host translation initiation factors. The hepatitis C virus (HCV) IRES binds eukaryotic translation initiation factor 3 (eIF3), but the exact functional role of the eIF3 complex and of its subunits remains to be precisely defined. Toward this goal, here we focused on eIF3 subunit e. We used an in vitro assay combining a ribosome-depleted rabbit reticulocyte lysate and ribosomes prepared from HeLa or Huh-7.5 cells transfected with either control or eIF3e siRNAs. eIF3e silencing reduced translation mediated by the 5?UTR of various cellular genes and HCV-like IRESs. However, this effect was not observed with the bona fide HCV IRES. Silencing of eIF3e reduced the intracellular levels of the c, d, and l subunits of eIF3 and their association with the eIF3 core subunit a. A pulldown analysis of eIF3 subunits associated with the HCV IRES disclosed similar effects and that the a subunit is critical for binding to the HCV IRES. Carrying out HCV infections of control and eIF3e-silenced Huh-7.5 cells, we found that in agreement with the in vitro findings, eIF3e silencing does not reduce HCV replication and viral protein expression. We conclude that unlike for host cellular mRNAs, the entire eIF3 is not required for HCV RNA translation, favoring viral expression under conditions of low eIF3e levels.	[Panthu, Baptiste; Jalinot, Pierre] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CNRS,UMR 5239,INSERM,U1210,LBMC, F-69007 Lyon, France; [Denolly, Solene; Ohlmann, Theophile; Cosset, Francois-Loic] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CIRI,INSERM,U1111,CNRS,UMR5308, F-69007 Lyon, France; [Faivre-Moskalenko, Cendrine] Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CNRS,UMR 5672,Lab Phys, 46 Allee Italie Site Jacques Monod, F-69007 Lyon, France; [Panthu, Baptiste] Hop Lyon Sud, CARMEN, INSERM, U1060,Sect 2, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jalinot, P (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CNRS,UMR 5239,INSERM,U1210,LBMC, F-69007 Lyon, France.; Cosset, FL (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, ENS Lyon, CIRI,INSERM,U1111,CNRS,UMR5308, F-69007 Lyon, France.	flcosset@ens-lyon.fr; pjalinot@ens-lyon.fr	ohlmann, Theophile/M-4463-2014; Carmen, Team2/Y-7383-2019	ohlmann, Theophile/0000-0002-2001-8916; Carmen, Team2/0000-0001-9867-5724; Panthu, Baptiste/0000-0001-9430-4061; Lab, Carmen/0000-0002-5935-3236; Denolly, Solene/0000-0003-1739-0079; Cosset, Francois-Loic/0000-0001-8842-3726	Ligue Nationale Contre le Cancer; French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales" (ANRS); European Research Council Grant [ERC2008-AdG-233130-HEPCENT]; LabEx Ecofect Grant [ANR-11-LABX-0048]	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales" (ANRS)(French National Research Agency (ANR)); European Research Council Grant(European Research Council (ERC)); LabEx Ecofect Grant	This work was supported by grants from the Ligue Nationale Contre le Cancer (to B. P, and P. J.), the French "Agence Nationale de la Recherche sur le SIDA et les Hepatites Virales" (ANRS), European Research Council Grant ERC2008-AdG-233130-HEPCENT, and LabEx Ecofect Grant ANR-11-LABX-0048 (to S. D., C. F.-M., T. O., and F.-L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Angulo J, 2016, NUCLEIC ACIDS RES, V44, P1309, DOI 10.1093/nar/gkv1325; Balvay L, 2009, BBA-GENE REGUL MECH, V1789, P542, DOI 10.1016/j.bbagrm.2009.07.005; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Bradrick SS, 2007, RNA, V13, P1582, DOI 10.1261/rna.556107; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Cai Q, 2010, J MOL BIOL, V403, P185, DOI 10.1016/j.jmb.2010.07.054; Cate JHD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0176; Deforges J, 2015, BIOCHIMIE, V114, P48, DOI 10.1016/j.biochi.2014.12.008; Deniz N, 2009, RNA, V15, P932, DOI 10.1261/rna.1315109; Derry MC, 2006, COLD SPRING HARB SYM, V71, P537, DOI 10.1101/sqb.2006.71.061; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; Hamad IAY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122471; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Jackson RJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011569; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Johnson AG, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1050; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Koev G, 2002, VIROLOGY, V297, P195, DOI 10.1006/viro.2002.1455; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kolupaeva VG, 2000, RNA, V6, P1791, DOI 10.1017/S1355838200000662; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Liu XF, 2018, VIROLOGY, V515, P11, DOI 10.1016/j.virol.2017.11.019; Lozano G, 2015, CURR OPIN VIROL, V12, P113, DOI 10.1016/j.coviro.2015.04.008; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Mengardi C, 2017, NUCLEIC ACIDS RES, V45, P4810, DOI 10.1093/nar/gkw1345; Morris C, 2016, CANCER RES, V76, P6054, DOI 10.1158/0008-5472.CAN-16-0723; Morris C, 2012, CANCER RES, V72, P2006, DOI 10.1158/0008-5472.CAN-11-2562; Morris-Desbois C, 2001, J BIOL CHEM, V276, P45988, DOI 10.1074/jbc.M104966200; Morris-Desbois C, 1999, J CELL SCI, V112, P3331; Neusiedler J, 2012, RNA, V18, P1163, DOI 10.1261/rna.032631.112; Niepmann M, 2013, CURR TOP MICROBIOL, V369, P143, DOI 10.1007/978-3-642-27340-7_6; Niepmann M, 2009, BBA-GENE REGUL MECH, V1789, P529, DOI 10.1016/j.bbagrm.2009.05.002; Panthu B, 2015, BIOCHEM J, V467, P387, DOI 10.1042/BJ20141498; Pestova TV, 2004, EMBO REP, V5, P906, DOI 10.1038/sj.embor.7400240; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Smith MD, 2016, STRUCTURE, V24, P886, DOI 10.1016/j.str.2016.02.024; Sun CM, 2013, NUCLEIC ACIDS RES, V41, P7512, DOI 10.1093/nar/gkt510; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Walsh D, 2014, GENE DEV, V28, P835, DOI 10.1101/gad.236752.113; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	52	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1843	1856		10.1074/jbc.RA119.009502	http://dx.doi.org/10.1074/jbc.RA119.009502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31929110	Green Published, hybrid			2022-12-26	WOS:000517128200006
J	Tsukuda, S; Ikeura, T; Ito, T; Nakamaru, K; Masuda, M; Hori, Y; Ikemune, M; Yanagawa, M; Tanaka, T; Tomiyama, T; Yamaguchi, T; Ando, Y; Uchida, K; Fukui, T; Nishio, A; Terasawa, R; Tanigawa, N; Okazaki, K				Tsukuda, Satoshi; Ikeura, Tsukasa; Ito, Takashi; Nakamaru, Koh; Masuda, Masataka; Hori, Yuichi; Ikemune, Manami; Yanagawa, Masato; Tanaka, Toshihiro; Tomiyama, Takashi; Yamaguchi, Takashi; Ando, Yugo; Uchida, Kazushige; Fukui, Toshiro; Nishio, Akiyoshi; Terasawa, Rika; Tanigawa, Noboru; Okazaki, Kazuichi			Clinical implications of elevated serum interleukin-6 in IgG4-related disease	PLOS ONE			English	Article							CASTLEMANS-DISEASE; AUTOIMMUNE PANCREATITIS; DIAGNOSTIC-CRITERIA; ANTIBODY; THERAPY; IL-6; LYMPHADENOPATHY; HEPATITIS	Introduction Some patients with IgG4-related disease (IgG4-RD) exhibit elevated serum interleukin (IL)6 with excessive inflammatory reactions or with repeating relapse. To date few reports pertaining to clinical implications of elevated serum IL-6 in IgG4-RD patients have been published. The aims of the current retrospective study were to investigate the clinical implications of elevated serum IL-6 in IgG4-RD patients, and to examine whether IL-6 can predict the activity and/or relapse of the disease. Materials and methods We examined the clinical picture at the onset of 43 patients who were diagnosed with IgG4RD in our hospital and were able to measure serum IL-6 before steroid treatment. Results The median level of serum IL-6 was 2.2 pg/mL. There was a significant correlation between IL-6 and C-reactive protein (CRP) level (r = 0.397, p = 0.008), hemoglobin level (r = -0.390, p = 0.010) and albumin level (r = -0.556, p < 0.001). When 43 patients were divided into two groups by using a cut-off IL-6 of 4 pg/mL, the high IL-6 group showed higher age, lower albumin, higher CRP and higher aspartate aminotransferase (AST) (age p = 0.014, albumin p = 0.006, CRP p < 0.001, AST p = 0.009). Hepatic swelling and splenomegaly were significantly more prevalent in the high IL-6 group than it was in the low IL-6 group (liver p < 0.001, spleen p = 0.020). Biliary tract involvement tended to admit more in the high IL-6 group (p = 0.060). Conclusion Serum IL-6 level at the onset of IgG4-RD may be significantly correlated with clinical inflammatory parameters and it may also be associated with involvement of the bile duct, liver, and spleen.	[Tsukuda, Satoshi; Ikeura, Tsukasa; Ito, Takashi; Nakamaru, Koh; Masuda, Masataka; Hori, Yuichi; Ikemune, Manami; Yanagawa, Masato; Tanaka, Toshihiro; Tomiyama, Takashi; Yamaguchi, Takashi; Ando, Yugo; Fukui, Toshiro; Nishio, Akiyoshi; Okazaki, Kazuichi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Hirakata, Osaka, Japan; [Uchida, Kazushige] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi, Japan; [Terasawa, Rika; Tanigawa, Noboru] Kansai Med Univ, Dept Radiol, Hirakata, Osaka, Japan	Kansai Medical University; Kochi University; Kansai Medical University	Okazaki, K (corresponding author), Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Hirakata, Osaka, Japan.	okazaki@hirakata.kmu.ac.jp	Tomiyama, Takashi/AAZ-9910-2020	Nakamaru, Koh/0000-0002-6116-9358; Fukui, Toshiro/0000-0003-1131-4067; Ito, Takashi/0000-0002-4148-4086	Ministry of Culture and Science of Japan [20590810, 23591017, 24591020, 12008507, 17877850, 17K09468, 15K09052]; Ministry of Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Medical Research and Development (AMED) [17824893]	Ministry of Culture and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Medical Research and Development (AMED)	This study was partially supported by (1) Grant-in-Aid for Scientific Research (C) of the Ministry of Culture and Science of Japan (20590810, 23591017, 24591020, 12008507, 17877850, 17K09468, 15K09052), (2) the Research Program on Intractable Diseases, from the Ministry of Labor and Welfare of Japan, and (3) grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, (4) the Research Program from the Japan Medical Research and Development (AMED) (17824893), and (5) The branding program as a world-leading research university on intractable immune and allergic diseases supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Canivet CM, 2016, DIGEST LIVER DIS, V48, P302, DOI 10.1016/j.dld.2015.10.005; Cheuk W, 2012, SEMIN DIAGN PATHOL, V29, P226, DOI 10.1053/j.semdp.2012.07.001; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Ikeura T, 2016, INTERNAL MED, V55, P2623, DOI 10.2169/internalmedicine.55.6919; Ishimaru M, 2014, J TOXICOL SCI, V39, P413, DOI 10.2131/jts.39.413; Kasashima S, 2018, HEART VESSELS, V33, P1471, DOI 10.1007/s00380-018-1203-8; Katsume A, 2002, CYTOKINE, V20, P304, DOI 10.1006/cyto.2002.2012; Kawashima H, 2019, IMMUNOL RES, V67, P99, DOI 10.1007/s12026-019-9070-7; Kurose N., 2016, J KANAZAWA MED U, V41, P76; Liu AY, 2016, LANCET HAEMATOL, V3, pE163, DOI 10.1016/S2352-3026(16)00006-5; Masamune A, 2017, GUT, V66, P487, DOI 10.1136/gutjnl-2016-312049; Matsubayashi H, 2013, J GASTROENTEROL, V48, P942, DOI 10.1007/s00535-012-0692-y; Matsushita M, 2007, AM J GASTROENTEROL, V102, P220; Nara M, 2014, MOD RHEUMATOL, V24, P633, DOI 10.3109/14397595.2013.844390; NIKIAS GA, 1994, J HEPATOL, V21, P866, DOI 10.1016/S0168-8278(94)80251-3; Nishimoto N, 2000, BLOOD, V95, P56, DOI 10.1182/blood.V95.1.56; Okazaki K, 2013, J GASTROENTEROL, V48, P303, DOI 10.1007/s00535-012-0744-3; Otani Kyoko, 2018, Oncotarget, V9, P6691, DOI 10.18632/oncotarget.24068; Pozo AL, 2009, BLOOD REV, V23, P105, DOI 10.1016/j.blre.2008.10.001; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Sasaki T, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000432; Sato Y, 2009, MODERN PATHOL, V22, P589, DOI 10.1038/modpathol.2009.17; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Stimac D, 2006, J CLIN GASTROENTEROL, V40, P209, DOI 10.1097/00004836-200603000-00007; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Takahashi W, 2016, SHOCK, V46, P254, DOI 10.1097/SHK.0000000000000616; Terasaki Y, 2017, HISTOPATHOLOGY, V70, P1114, DOI 10.1111/his.13186; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tomiyama T, 2011, J GASTROENTEROL, V46, P696, DOI 10.1007/s00535-010-0361-y; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Umemura T, 2011, J GASTROENTEROL, V46, P48, DOI 10.1007/s00535-010-0323-4; van Rhee F, 2010, J CLIN ONCOL, V28, P3701, DOI 10.1200/JCO.2009.27.2377; Wallace ZS, 2016, RHEUMATOLOGY, V55, P1000, DOI 10.1093/rheumatology/kev438; Yamamoto M, 2009, RHEUMATOLOGY, V48, P860, DOI 10.1093/rheumatology/kep098; Zoshima T, 2016, AM J SURG PATHOL, V40, P495, DOI 10.1097/PAS.0000000000000575	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227479	10.1371/journal.pone.0227479	http://dx.doi.org/10.1371/journal.pone.0227479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951598	Green Published, gold			2022-12-26	WOS:000534370500020
J	Leal, E; Liang, RY; Liu, Q; Villanova, F; Shi, LJ; Liang, L; Li, JX; Witkin, SS; Cui, SJ				Leal, Elcio; Liang, Ruiying; Liu, Qi; Villanova, Fabiola; Shi, Lijun; Liang, Lin; Li, Jinxiang; Witkin, Steven S.; Cui, Shangjin			Regional adaptations and parallel mutations in Feline panleukopenia virus strains from China revealed by nearly-full length genome analysis	PLOS ONE			English	Article							AUTONOMOUS PARVOVIRUS; CANINE PARVOVIRUS; PANTHERA-TIGRIS; EVOLUTION; INFECTION; MINK; EMERGENCE; SUBGROUP	Protoparvoviruses, widespread among cats and wild animals, are responsible for leukopenia. Feline panleukopenia virus (FPLV) in domestic cats is genetically diverse and some strains may differ from those used for vaccination. The presence of FPLV in two domestic cats from Hebei Province in China was identified by polymerase chain reaction. Samples from these animals were used to isolate FPLV strains in CRFK cells for genome sequencing. Phylogenetic analysis was performed to compare our isolates with available sequences of FPLV, mink parvovirus (MEV) and canine parvovirus (CPV). The isolated strains were closely related to strains of FPLV/MEV isolated in the 1960s. Our analysis also revealed that the evolutionary history of FPLV and MEV is characterized by local adaptations in the Vp2 gene. Thus, it is likely that new FPLV strains are emerging to evade the anti-FPLV immune response.	[Leal, Elcio; Liang, Ruiying; Liu, Qi; Shi, Lijun; Liang, Lin; Li, Jinxiang; Cui, Shangjin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Leal, Elcio; Villanova, Fabiola] Fed Univ Para, Belem, Para, Brazil; [Liang, Ruiying; Shi, Lijun; Liang, Lin; Cui, Shangjin] Minist Agr, Beijing Observat Stn Vet Drug & Vet Biotechnol, Beijing, Peoples R China; [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA; [Witkin, Steven S.] Inst Trop Med, Sao Paulo, Brazil	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Universidade Federal do Para; Ministry of Agriculture & Rural Affairs; Cornell University	Leal, E; Li, JX; Cui, SJ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China.; Leal, E (corresponding author), Fed Univ Para, Belem, Para, Brazil.; Cui, SJ (corresponding author), Minist Agr, Beijing Observat Stn Vet Drug & Vet Biotechnol, Beijing, Peoples R China.	elcioleal@gmail.com; lijinxiang@caas.cn; cuishangjin@caas.cn	Leal, Elcio/M-5275-2019; VILLANOVA, FABIOLA E/E-7437-2013; Leal, Elcio/J-6236-2016; Witkin, Steven/AAW-8602-2021	Leal, Elcio/0000-0003-3463-0492; Leal, Elcio/0000-0003-3463-0492; Witkin, Steven/0000-0002-3502-3929	Agricultural Science and Technology Innovation Program [ASTIP-IAS15]; National Key Research and Development Program of China; Pro-reitoria de pesquisa e pos-graduacao da UFPA [02/2019]	Agricultural Science and Technology Innovation Program; National Key Research and Development Program of China; Pro-reitoria de pesquisa e pos-graduacao da UFPA	We thank the Agricultural Science and Technology Innovation Program (ASTIP-IAS15), the National Key Research and Development Program of China and Pro-reitoria de pesquisa e pos-graduacao da UFPA (Progep #02/2019).	Allison AB, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004475; Allison AB, 2013, J VIROL, V87, P2342, DOI 10.1128/JVI.02428-12; Battilani M, 2006, VIROLOGY, V352, P22, DOI 10.1016/j.virol.2006.06.002; Canuti M, 2017, VIRUS RES, V242, P85, DOI 10.1016/j.virusres.2017.09.015; Christensen J, 2002, J VIROL, V76, P6518, DOI 10.1128/JVI.76.13.6518-6531.2002; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Decaro N, 2008, J GEN VIROL, V89, P2290, DOI 10.1099/vir.0.2008/001503-0; Decaro N, 2004, MICROBIOLOGICA, V27, P177; Demeter Z, 2009, VET REC, V164, P213, DOI 10.1136/vr.164.7.213; Duarte MD, 2009, J ZOO WILDLIFE MED, V40, P354, DOI 10.1638/2008-0015.1; Govindasamy L, 2003, J VIROL, V77, P12211, DOI 10.1128/JVI.77.22.12211-12221.2003; Guo L, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-163; Hoelzer K, 2010, VET RES, V41, DOI 10.1051/vetres/2010011; HORIUCHI M, 1992, VIROLOGY, V189, P600, DOI 10.1016/0042-6822(92)90583-B; Horiuchi M, 1998, VIROLOGY, V249, P440, DOI 10.1006/viro.1998.9335; KARIATSUMARI T, 1991, J GEN VIROL, V72, P867, DOI 10.1099/0022-1317-72-4-867; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leal E, 2012, J GEN VIROL, V93, P2692, DOI 10.1099/vir.0.045765-0; Liu C., 2015, GENOME ANNOUNC, P3; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Miranda C, 2016, J GEN VIROL, V97, P2043, DOI 10.1099/jgv.0.000540; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; Parrish CR, 1999, VET MICROBIOL, V69, P29, DOI 10.1016/S0378-1135(99)00084-X; Pereira CAD, 2007, INFECT GENET EVOL, V7, P399, DOI 10.1016/j.meegid.2006.03.007; Risi E, 2012, J ZOO WILDLIFE MED, V43, P248, DOI 10.1638/2010-0166.1; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Steinel A, 2000, J GEN VIROL, V81, P345, DOI 10.1099/0022-1317-81-2-345; Steinel A, 2001, J WILDLIFE DIS, V37, P594, DOI 10.7589/0090-3558-37.3.594; Stucker KM, 2012, J VIROL, V86, P1514, DOI 10.1128/JVI.06222-11; TRUYEN U, 1995, J VIROL, V69, P4702, DOI 10.1128/JVI.69.8.4702-4710.1995; Truyen U, 2013, VET MICROBIOL, V165, P29, DOI 10.1016/j.vetmic.2013.02.005; UTTENTHAL A, 1990, J VIROL, V64, P2768, DOI 10.1128/JVI.64.6.2768-2779.1990; Villanova F, 2016, ARCH VIROL, V161, P1199, DOI 10.1007/s00705-015-2744-0; Wang XG, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.25; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ST, 2010, VET MICROBIOL, V143, P155, DOI 10.1016/j.vetmic.2009.11.023; Yuan DL, 2014, VIRUS RES, V183, P1, DOI 10.1016/j.virusres.2014.01.012; Zhang RZ, 2010, VIRUS GENES, V40, P397, DOI 10.1007/s11262-010-0466-7; Zhou L, 2016, VIRUS GENES, V52, P411, DOI 10.1007/s11262-016-1309-y	40	5	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227705	10.1371/journal.pone.0227705	http://dx.doi.org/10.1371/journal.pone.0227705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945103	Green Submitted, gold, Green Published			2022-12-26	WOS:000534370100055
J	Heller, DJ; Balzer, LB; Kazi, D; Charlebois, ED; Kwarisiima, D; Mwangwa, F; Jain, V; Kotwani, P; Chamie, G; Cohen, CR; Clark, TD; Ayieko, J; Byonanabye, DM; Petersee, M; Kamya, MR; Havlir, D; Kahn, JG				Heller, David J.; Balzer, Laura B.; Kazi, Dhruv; Charlebois, Edwin D.; Kwarisiima, Dalsone; Mwangwa, Florence; Jain, Vivek; Kotwani, Prashant; Chamie, Gabriel; Cohen, Craig R.; Clark, Tamara D.; Ayieko, James; Byonanabye, Dathan M.; Petersee, Maya; Kamya, Moses R.; Havlir, Diane; Kahn, James G.			Hypertension testing and treatment in Uganda and Kenya through the SEARCH study: An implementation fidelity and outcome evaluation	PLOS ONE			English	Article							BLOOD-PRESSURE; INTEGRATED CARE; HIV; PREVENTION; HEALTH; MANAGEMENT; SETTINGS; LINKAGE; AFRICA; IMPACT	Background Hypertension (HTN) is the single leading risk factor for human mortality worldwide, and more prevalent in sub-Saharan Africa than any other region [1]-although resources for HTN screening, treatment, and control are few. Most regional pilot studies to leverage HIV programs for HTN control have achieved blood pressure control in half of participants or fewer [2,3,4]. But this control gap may be due to inconsistent delivery of services, rather than ineffective underlying interventions. Methods We sought to evaluate the consistency of HTN program delivery within the SEARCH study (NCT01864603) among 95,000 adults in 32 rural communities in Uganda and Kenya from 2013-2016. To achieve this objective, we designed and performed a fidelity evaluation of the step-by-step process (cascade) of HTN care within SEARCH, calculating rates of HTN screening, linkage to care, and follow-up care. We evaluated SEARCH's assessment of each participant's HTN status against measured blood pressure and HTN history. Findings SEARCH completed blood pressure screens on 91% of participants. SEARCH HTN screening was 91% sensitive and over 99% specific for HTN relative to measured blood pressure and patient history. 92% of participants screened HTN+ received clinic appointments, and 42% of persons with HTN linked to subsequent care. At follow-up, 82% of SEARCH clinic participants received blood pressure checks; 75% received medication appropriate for their blood pressure; 66% remained in care; and 46% had normal blood pressure at their most recent visit. Conclusion The SEARCH study's consistency in delivering screening and treatment services for HTN was generally high, but SEARCH could improve effectiveness in linking patients to care and achieving HTN control. Its model for implementing population-scale HTN testing and care through an existing HIV test-and-treat program-and protocol for evaluating the intervention's stepwise fidelity and care outcomes-may be adapted, strengthened, and scaled up for use across multiple resource-limited settings.	[Heller, David J.] Arnhold Inst Global Hlth, New York, NY 10029 USA; [Balzer, Laura B.] Univ Massachusetts, Amherst, MA 01003 USA; [Kazi, Dhruv] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Charlebois, Edwin D.; Jain, Vivek; Kotwani, Prashant; Chamie, Gabriel; Cohen, Craig R.; Clark, Tamara D.; Havlir, Diane; Kahn, James G.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kwarisiima, Dalsone; Mwangwa, Florence; Kamya, Moses R.] Infect Dis Res Collaborat, Kampala, Uganda; [Cohen, Craig R.; Ayieko, James] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Byonanabye, Dathan M.] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Petersee, Maya] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Kamya, Moses R.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda	University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Francisco; Kenya Medical Research Institute; Makerere University; University of California System; University of California Berkeley; Makerere University	Heller, DJ (corresponding author), Arnhold Inst Global Hlth, New York, NY 10029 USA.	david.heller@mssm.edu		Heller, David/0000-0003-0060-8393; Balzer, Laura B./0000-0002-3730-410X	Fogarty International Center; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute at the National Institutes of Health [FIC-NIH 5R25TW009343, NIAID U01AI099959, R01AI07434]; Kenya Medical Research Institute; Infectious Diseases Research Collaboration; World Bank; President's Emergency Plan for AIDS Relief; Gilead Sciences, Inc	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Kenya Medical Research Institute; Infectious Diseases Research Collaboration; World Bank(The World Bank India); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Gilead Sciences, Inc(Gilead Sciences)	Support came from the Fogarty International Center (DJH), https://www.fic.nih.gov; the National Institute of Allergy and Infectious Diseases (DH, MRK) https://www.niaid.nih.gov; and the National Heart, Lung, and Blood Institute at the National Institutes of Health (FIC-NIH 5R25TW009343 (DJH), https://www.nhlbi.nih.gov; NIAID U01AI099959 and R01AI07434); Kenya Medical Research Institute (JA, MRK), http://kemriwellcome.org; Infectious Diseases Research Collaboration (DH, MRK), http://idrc-uganda.org; World Bank (DH, MRK), http://idrc-uganda.org; President's Emergency Plan for AIDS Relief (DH, MRK), https://www.pepfar.gov; and Gilead Sciences, Inc (DH, MRK), https://www.gilead.com.The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.	Abdel-All M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015529; Ahmad O. B., 2000, GPE DISCUSSION PAPER, V31; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2014, PAN AFRICAN MED J; [Anonymous], 2016, COMM BAS HYP IMPR PR; Berry KM, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000348; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Daskalopoulou SS, 2015, CAN J CARDIOL, V31, P549, DOI 10.1016/j.cjca.2015.02.016; Gounder CR, 2012, TROP MED INT HEALTH, V17, P1426, DOI 10.1111/j.1365-3156.2012.03100.x; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Haldane V, 2018, AIDS CARE, V30, P103, DOI 10.1080/09540121.2017.1344350; Healthy Heart Africa, 2014, HLTH HEART AFR STREN; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hill A, 2015, AIDS, V29, P2523, DOI 10.1097/QAD.0000000000000864; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jeet G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180640; Kamwesiga J., 2011, UGANDA HLTH CARE SYS; Kemp CG, 2018, AIDS, V32, pS93, DOI 10.1097/QAD.0000000000001897; Kenya Ministry of Health, KEN CLIN GUID 2009 N; Khetan AK, 2017, GLOB HEART, V12, P233, DOI 10.1016/j.gheart.2016.07.001; Koehler PJ, 2015, ASAPP COMBATS GLOBAL; Kotwani P, 2014, TROP MED INT HEALTH, V19, P459, DOI 10.1111/tmi.12273; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Kwarisiima D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6838-6; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Levi J, 2016, BMJ GLOBAL HLTH E, V1e, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1136/BMJGH-2015-000010; Lunyera J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201001; Ma J, 2008, HYPERTENSION, V51, P1275, DOI 10.1161/HYPERTENSIONAHA.107.107086; Mendis S, 2010, B WORLD HEALTH ORGAN, V88, P412, DOI 10.2471/BLT.08.062364; Mohamed SF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6052-y; Muga R., 2005, OVERVIEW HLTH SYSTEM; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Mwagomba BLM, 2018, AIDS, V32, pS21, DOI 10.1097/QAD.0000000000001885; Naanyu V, 2016, J GEN INTERN MED, V31, P304, DOI 10.1007/s11606-015-3566-1; Njuguna B, 2018, AIDS, V32, pS33, DOI 10.1097/QAD.0000000000001887; O'Neil DS, 2016, HEALTH POLICY PLANN, V31, P878, DOI 10.1093/heapol/czw006; Ogedegbe G, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002561; Ogedegbe G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005983; Pastakia SD, 2017, J GEN INTERN MED, V32, P540, DOI 10.1007/s11606-016-3918-5; StataCorp LP, 2015, STATA 13 1 SE; Uganda Ministry of Health, UG CLIN GUID 2012 NA; Uganda Ministry of Health, UG CLIN GUID 2016 NA; UNAIDS, 2014, 90 90 90 AMB TREATM; Watt N, 2017, HEALTH POLICY PLANN, V32, P13, DOI 10.1093/heapol/czw149; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, GLOB HLTH EST 2014 S	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0222801	10.1371/journal.pone.0222801	http://dx.doi.org/10.1371/journal.pone.0222801			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940346	Green Published, gold			2022-12-26	WOS:000534368000004
J	Lazdins, A; Maurya, AP; Miller, CE; Kamruzzaman, M; Liu, ST; Stephens, ER; Lloyd, GS; Haratianfar, M; Chamberlain, M; Haines, AS; Kreft, JU; Webber, MA; Iredell, J; Thomas, CM				Lazdins, Alessandro; Maurya, Anand Prakash; Miller, Claire E.; Kamruzzaman, Muhammad; Liu, Shuting; Stephens, Elton R.; Lloyd, Georgina S.; Haratianfar, Mona; Chamberlain, Melissa; Haines, Anthony S.; Kreft, Jan-Ulrich; Webber, Mark A.; Iredell, Jonathan; Thomas, Christopher M.			Potentiation of curing by a broad-host-range self-transmissible vector for displacing resistance plasmids to tackle AMR	PLOS ONE			English	Article							COMPLETE DNA-SEQUENCE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; NUCLEOTIDE-SEQUENCE; VIRULENCE PLASMID; R-FACTORS; IN-VITRO; GENE; REPLICATION; STRAINS	Plasmids are potent vehicles for spread of antibiotic resistance genes in bacterial populations and often persist in the absence of selection due to efficient maintenance mechanisms. We previously constructed non-conjugative high copy number plasmid vectors that efficiently displace stable plasmids from enteric bacteria in a laboratory context by blocking their replication and neutralising their addiction systems. Here we assess a low copy number broad-host-range self-transmissible IncP-1 plasmid as a vector for such curing cassettes to displace IncF and IncK plasmids. The wild type plasmid carrying the curing cassette displaces target plasmids poorly but derivatives with deletions near the IncP-1 replication origin that elevate copy number about two-fold are efficient. Verification of this in mini IncP-1 plasmids showed that elevated copy number was not sufficient and that the parB gene, korB, that is central to its partitioning and gene control system, also needs to be included. The resulting vector can displace target plasmids from a laboratory population without selection and demonstrated activity in a mouse model although spread is less efficient and requires additional selection pressure.	[Lazdins, Alessandro; Maurya, Anand Prakash; Miller, Claire E.; Liu, Shuting; Stephens, Elton R.; Lloyd, Georgina S.; Haratianfar, Mona; Chamberlain, Melissa; Haines, Anthony S.; Kreft, Jan-Ulrich; Thomas, Christopher M.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Lazdins, Alessandro; Maurya, Anand Prakash; Miller, Claire E.; Liu, Shuting; Stephens, Elton R.; Lloyd, Georgina S.; Haratianfar, Mona; Chamberlain, Melissa; Haines, Anthony S.; Kreft, Jan-Ulrich; Thomas, Christopher M.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Webber, Mark A.] Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Kamruzzaman, Muhammad; Iredell, Jonathan] Univ Sydney, Ctr Infect Dis & Microbiol, Westmead Inst Med Res, Westmead, NSW, Australia; [Maurya, Anand Prakash] Indian Council Med Res, Delhi, India; [Miller, Claire E.] Birmingham Res Pk Ltd, Biohub, Birmingham, W Midlands, England; [Liu, Shuting] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Haratianfar, Mona] Boston Univ, Ctr Regenerat Med, Boston, MA 02215 USA; [Webber, Mark A.] Quadram Inst, Res Pk, Norwich, Norfolk, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Sydney; Westmead Institute for Medical Research; Indian Council of Medical Research (ICMR); University of Illinois System; University of Illinois Urbana-Champaign; Boston University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute	Thomas, CM (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Thomas, CM (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	c.m.thomas@bham.ac.uk	Kreft, Jan-Ulrich/B-1234-2008; Kamruzzaman, Muhammad/S-2756-2019	Kreft, Jan-Ulrich/0000-0002-2351-224X; Lloyd, Georgina/0000-0002-8104-4878; Maurya, Anand Prakash/0000-0001-5231-8174; Kamruzzaman, Muhammad/0000-0003-2005-9846; Webber, Mark/0000-0001-9169-7592; Haines, Anthony/0000-0003-2736-6371	Wellcome Trust ISSF translational grant; BBSRC [BB/S003533/1]; Darwin Trust of Edinburgh; UK Microbiology Society; National Health and Medical Research Council (NHMRC), Australia [G1084672, G1145914]; Royal Society-SERB Newton International Fellowship; MRC [MR/P028195/1] Funding Source: UKRI	Wellcome Trust ISSF translational grant(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Darwin Trust of Edinburgh; UK Microbiology Society; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Society-SERB Newton International Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly funded by a Wellcome Trust ISSF translational grant awarded to CMT, JUK and MAW and BBSRC grant BB/S003533/1 to CMT that also funded GSL and ERS. AL was funded by a studentship from the Darwin Trust of Edinburgh and received a travel grant from the UK Microbiology Society to work with JI in Sydney. Subsequent mouse work was supported by a National Health and Medical Research Council (NHMRC), Australia grant numbers G1084672 and G1145914 to JI and MK. APM was funded by a Royal Society-SERB Newton International Fellowship. The funders provided support in the form of salaries for authors [Wellcome Trust, CEM; BBSRC, GSL, ERS; NHMRC, MK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions.	BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bahl MI, 2007, APPL ENVIRON MICROB, V73, P341, DOI 10.1128/AEM.01971-06; BECHHOFER DH, 1986, P NATL ACAD SCI USA, V83, P394, DOI 10.1073/pnas.83.2.394; Bhattacharyya A, 2001, J MOL BIOL, V310, P51, DOI 10.1006/jmbi.2001.4729; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BRADLEY DE, 1983, J GEN MICROBIOL, V129, P2545; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Cottell JL, 2011, EMERG INFECT DIS, V17, P645, DOI 10.3201/eid1704.101009; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Dicks LMT, 2019, CURR MICROBIOL, V76, P774, DOI 10.1007/s00284-018-1543-8; Fisher GLM, 2017, ELIFE, V6, DOI 10.7554/eLife.28086; Fox RE, 2008, ISME J, V2, P1024, DOI 10.1038/ismej.2008.53; Freire Martin Irene, 2016, J Med Microbiol, V65, P611, DOI 10.1099/jmm.0.000271; GRINSTED J, 1977, PLASMID, V1, P34, DOI 10.1016/0147-619X(77)90006-3; Haines AS, 2001, THESIS; Hale L, 2010, BIOTECHNIQUES, V48, P223, DOI 10.2144/000113366; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Haneda T, 2001, INFECT IMMUN, V69, P2612, DOI 10.1128/IAI.69.4.2612-2620.2001; HEDGES RW, 1971, NATURE, V234, P220, DOI 10.1038/234220b0; HERSHFIE.V, 1974, P NATL ACAD SCI USA, V71, P3455, DOI 10.1073/pnas.71.9.3455; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; INGRAM LC, 1973, ANTIMICROB AGENTS CH, V3, P279, DOI 10.1128/AAC.3.2.279; Kahn M, 1979, Methods Enzymol, V68, P268; Kamruzzaman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172913; Kawalek A, 2018, NUCLEIC ACIDS RES, V46, P4592, DOI 10.1093/nar/gky257; KITTELL BL, 1991, P NATL ACAD SCI USA, V88, P1389, DOI 10.1073/pnas.88.4.1389; Klumper U, 2015, ISME J, V9, P934, DOI 10.1038/ismej.2014.191; Koraimann Gunther, 2018, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0003-2018; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; LARSEN MH, 1994, J BACTERIOL, V176, P5022, DOI 10.1128/jb.176.16.5022-5032.1994; Lauritsen I, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0748-z; Licht TR, 2003, FEMS MICROBIOL ECOL, V44, P217, DOI 10.1016/S0168-6496(03)00016-3; Lopatkin AJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01532-1; LOWBURY EJL, 1969, LANCET, V2, P448; Makino K, 1998, DNA Res, V5, P1, DOI 10.1093/dnares/5.1.1; Norberg P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1267; O'Neill J., 2016, REV ANTIMICROBIAL RE; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Petersen J, 2011, ARCH MICROBIOL, V193, P313, DOI 10.1007/s00203-011-0686-9; PRASZKIER J, 1991, J BACTERIOL, V173, P2393, DOI 10.1128/JB.173.7.2393-2397.1991; Reister M, 2014, J BIOTECHNOL, V187, P106, DOI 10.1016/j.jbiotec.2014.07.442; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Song D, 2017, NUCLEIC ACIDS RES, V45, P7106, DOI 10.1093/nar/gkx271; STALKER DM, 1981, MOL GEN GENET, V181, P8, DOI 10.1007/BF00338997; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; THOMAS CM, 1984, EMBO J, V3, P1513, DOI 10.1002/j.1460-2075.1984.tb02004.x; THOMAS CM, 1988, NUCLEIC ACIDS RES, V16, P5345, DOI 10.1093/nar/16.12.5345; THOMAS CM, 1984, EMBO J, V3, P57, DOI 10.1002/j.1460-2075.1984.tb01761.x; TREVORS JT, 1986, FEMS MICROBIOL LETT, V32, P149; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Wassenaar TM, 2016, EUR J MICROBIOL IMMU, V6, P147, DOI 10.1556/1886.2016.00029; Williams DR, 1998, MICROBIOL-UK, V144, P3369, DOI 10.1099/00221287-144-12-3369; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zienkiewicz M, 2007, ANTIMICROB AGENTS CH, V51, P1164, DOI 10.1128/AAC.00772-06	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0225202	10.1371/journal.pone.0225202	http://dx.doi.org/10.1371/journal.pone.0225202			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940351	Green Published, gold, Green Accepted			2022-12-26	WOS:000534368000007
J	Schatz, E; Knight, L; Belli, RF; Mojola, SA				Schatz, Enid; Knight, Lucia; Belli, Robert F.; Mojola, Sanyu A.			Assessing the feasibility of a life history calendar to measure HIV risk and health in older South Africans	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; STRATEGIES; QUALITY; MEN; AGE; TRANSMISSION; PREVALENCE; GENDER; ADULTS	Life history calendars capture patterns of behavior over time, uncovering transitions and trajectories. Despite the growing numbers of older persons living with HIV in southern Africa, little is known about how HIV testing and risk unfold in this population. Operationalizing a life course approach with the use of an innovative Testing and Risk History Calendar [TRHC], we collected pilot data on older South Africans' risk and HIV testing. We found older persons were able to provide (1) reference points to facilitate recall over a 10-year period, (2) specifics about HIV tests during that decade, and (3) details that contextualize the testing data, such as living arrangements, relationships, and health status. Interviewer debriefing sessions after each interview captured information on context and links across domains. On a larger scale, the TRHC has potential to reveal pathways between sexual behavior, HIV testing and risk perception, and health at older ages.	[Schatz, Enid] Univ Missouri, Dept Publ Hlth, Columbia, MO 65211 USA; [Schatz, Enid] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC,Wits Rural Hlth & Hlth Transit Unit Agincourt, Johannesburg, South Africa; [Knight, Lucia] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa; [Belli, Robert F.] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Mojola, Sanyu A.] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Mojola, Sanyu A.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Mojola, Sanyu A.] Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA	University of Missouri System; University of Missouri Columbia; University of Witwatersrand; University of the Western Cape; University of Nebraska System; University of Nebraska Lincoln; Princeton University; Princeton University; Princeton University	Schatz, E (corresponding author), Univ Missouri, Dept Publ Hlth, Columbia, MO 65211 USA.; Schatz, E (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC,Wits Rural Hlth & Hlth Transit Unit Agincourt, Johannesburg, South Africa.	schatzej@health.missouri.edu		Schatz, Enid/0000-0003-3963-2745; MOJOLA, SANYU/0000-0002-2610-2625	University of Missouri Research Council; MU School of Health Professions Catalyst Grant; National Institute on Aging [R01 AG049634]	University of Missouri Research Council; MU School of Health Professions Catalyst Grant; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was facilitated by a Fulbright Foundation Research/Teaching Grant and a University of Missouri Research Leave which allowed Enid Schatz to spend 7 months working at the University of Western Cape. Data collection was supported by the University of Missouri Research Council and MU School of Health Professions Catalyst Grant (E Schatz, PI). We are grateful for funding support from the National Institute on Aging - R01 AG049634 HIV after 40 in rural South Africa: Aging in the Context of an HIV epidemic (S. A. Mojola, PI) - and Princeton University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akullian A, 2017, AIDS, V31, P1755, DOI [10.1097/QAD.0000000000001553, 10.1097/qad.0000000000001553]; Angotti N, 2018, CLASSIFYING CONTEXTU; Angotti N, 2018, CULT HEALTH SEX, V20, P262, DOI 10.1080/13691058.2017.1340670; Axinn WG, 1999, SOC SCI RES, V28, P243, DOI 10.1006/ssre.1998.0641; Barber BK, 2017, LANCET, V390, P22; Belli RF, 2007, PUBLIC OPIN QUART, V71, P603, DOI 10.1093/poq/nfm045; Belli RF, 2016, J OFF STAT, V32, P579, DOI 10.1515/JOS-2016-0030; Belli RF, 2016, J APPL RES MEM COGN, V5, P150, DOI 10.1016/j.jarmac.2016.03.004; Belli RF, 2013, PUBLIC OPIN QUART, V77, P194, DOI 10.1093/poq/nfs099; Belli RF, 2012, QUAL QUANT, V46, P813, DOI 10.1007/s11135-010-9415-8; Belli Robert F., 2009, CALENDAR TIME DIARY; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Dunkle KL, 2007, SEX TRANSM INFECT, V83, P173, DOI 10.1136/sti.2007.024950; Freeman E, 2012, INT J STD AIDS, V23, P490, DOI 10.1258/ijsa.2011.011340; Freeman EK, 2014, AGEING SOC, V34, P1118, DOI 10.1017/S0144686X12001481; GLASNER T, 2012, B SOCIOLOGICAL METHO, V115, P45, DOI DOI 10.1177/0759106312445701; Glasner T, 2009, QUAL QUANT, V43, P333, DOI 10.1007/s11135-007-9129-8; Goldberg RE, 2013, DEMOGRAPHY, V50, P725, DOI 10.1007/s13524-012-0150-8; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Gomez-Olive FX, 2019, HIV INCIDENCE OLDER; Harling G, 2015, AIDS BEHAV, P1; Harris DA, 2007, FIELD METHOD, V19, P40, DOI 10.1177/1525822X06292707; Houle B, 2018, AIDS CARE, V30, P1435, DOI 10.1080/09540121.2018.1468008; Houle B, 2016, FIELD METHOD, V28, P112, DOI 10.1177/1525822X15595343; Human Sciences Research Council: South Africa, 2018, 5 S AFR NAT HIV PREV; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Kabiru CW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-412; Kabudula CW, 2017, SOC INDIC RES, V133, P1047, DOI 10.1007/s11205-016-1397-z; Kilburn K, 2018, AIDS, V32, P1669, DOI 10.1097/QAD.0000000000001866; Kipp WE, 2009, AIDS CARE, V21, P118, DOI 10.1080/09540120802068761; Knight L, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0863-4; Luke N, 2011, DEMOGRAPHY, V48, P1151, DOI 10.1007/s13524-011-0051-2; Makusha T, 2017, PUBLIC HEALTH, V143, P1, DOI 10.1016/j.puhe.2016.10.017; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mojola SA, 2019, GLOB PUBLIC HEALTH, DOI 10.1080/17441692.2019.1606265; Mojola SA, 2015, SOC SCI MED, V143, P204, DOI 10.1016/j.socscimed.2015.08.023; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Negin J, 2016, ARCH SEX BEHAV, V45, P441, DOI 10.1007/s10508-015-0582-5; Negin J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-507; Negin Joel, 2012, AIDS, V26 Suppl 1, pS1; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Nelson IA, 2010, FIELD METHOD, V22, P413, DOI 10.1177/1525822X10379793; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Porcellato L, 2016, INT J SOC RES METHOD, V19, P269, DOI 10.1080/13645579.2014.988005; Psaros C, 2018, ARCH SEX BEHAV, V47, P1969, DOI 10.1007/s10508-017-1056-8; Reniers G, 2008, DEMOGRAPHY, V45, P417, DOI 10.1353/dem.0.0002; Richards E, 2013, AJAR-AFR J AIDS RES, V12, P71, DOI 10.2989/16085906.2013.831361; Rosenberg MS, 2017, JAIDS-J ACQ IMM DEF, V74, pE9, DOI 10.1097/QAI.0000000000001173; Schatz E, 2019, J AGING HEALTH, V31, P709, DOI 10.1177/0898264317751945; Schatz E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196158; Shisana O, 2014, S AFRICAN NATL HIV P; Siu GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-33; van der Vaart W., 2014, INT J SOCIAL SCI HUM, V6, P116; van der Vaart W, 2011, FIELD METHOD, V23, P37, DOI 10.1177/1525822X10384367; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS221, DOI 10.1097/QAI.0b013e318299c3f4	57	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226024	10.1371/journal.pone.0226024	http://dx.doi.org/10.1371/journal.pone.0226024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940307	Green Published, gold			2022-12-26	WOS:000534368000017
J	Cha, D; Kim, D; Choi, W; Park, S; Han, H				Cha, Deokjea; Kim, Dongsoo; Choi, Wonil; Park, Sungjun; Han, Hyerim			Point-of-care diagnostic (POCD) method for detecting Bursaphelenchus xylophilus in pinewood using recombinase polymerase amplification (RPA) with the portable optical isothermal device (POID)	PLOS ONE			English	Article							NEMATODE; WOOD	The pinewood nematode (PWN), Bursaphelenchus xylophilus, is a causative agent of pine wilt disease (PWD). To date, although several molecular diagnostic methods have been developed, rapid on-site diagnostic tools for detecting PWN in pinewood are limited. In this study, a point of care diagnostic (POCD) method for detecting PWN in pinewood using recombinase polymerase amplification (RPA) assay was developed. This method comprises quick gDNA extraction buffer (DAP buffer) for the direct extraction of gDNA of PWN from pinewood and a battery-mounted portable optical isothermal device (POID) for the detection of PWD in the field. The RPA assay can distinguish between the PWN and its conspecies which exist in pinewood and can complete diagnostic procedures within 25 min in the field. Moreover, the RPA assay can detect PWN in old wood samples in both natural and stored conditions. The POCD-RPA assay to detect PWN will be useful for epidemiological investigations in the field as well as for quarantine processes in the wood trade.	[Cha, Deokjea; Kim, Dongsoo; Han, Hyerim] Natl Inst Forest Sci, Div Forest Insect Pests & Dis, Seoul, South Korea; [Choi, Wonil] Natl Inst Forest Sci, Div Forest Ecol & Climate Change, Seoul, South Korea; [Park, Sungjun] 2NCBio, Daejeon, South Korea	Korea Forest Research Institute (KFRI); National Institute of Forest Science (NIFOS), Republic of South Korea; Korea Forest Research Institute (KFRI); National Institute of Forest Science (NIFOS), Republic of South Korea	Han, H (corresponding author), Natl Inst Forest Sci, Div Forest Insect Pests & Dis, Seoul, South Korea.	hrhan123@korea.kr			ICT based researches about developing the detection method for PWD [FE0702-2017-03]; National Institute of Forest Science, Republic of Korea	ICT based researches about developing the detection method for PWD; National Institute of Forest Science, Republic of Korea	This study was supported by the ICT based researches about developing the detection method for PWD and PWN-infected pine tree (FE0702-2017-03) from the National Institute of Forest Science, Republic of Korea to HH. 2NCBio provided support in the form of salaries for SP. 2NCBio provided the portable optical isothermal device in development. There was no additional external funding received for this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, J RES, DOI [DOI 10.1007/S10310-003-0034-2, 10.1007/s10310-003-0034-2]; Bass D, 2015, TRENDS PARASITOL, V31, P499, DOI 10.1016/j.pt.2015.06.013; Braasch H., 2009, Journal of Nematode Morphology and Systematics, V12, P65; Cardoso JMS, 2012, EUR J PLANT PATHOL, V133, P419, DOI 10.1007/s10658-011-9915-y; Cha DJ, 2019, FOREST PATHOL, V49, DOI 10.1111/efp.12503; Cheng H. R. (et al.), 1983, Forest Pest and Disease, P1; Hirata A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182837; Hooper D. J., 1993, P1; Hoover K, 2010, J NEMATOL, V42, P101; Hu SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057568; Iwahori H, 2000, FOREST PATHOL, V30, P157, DOI 10.1046/j.1439-0329.2000.00201.x; Kang JS, 2015, FOREST PATHOL, V45, P127, DOI 10.1111/efp.12147; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; Klapwijk MJ, 2016, AMBIO, V45, pS223, DOI 10.1007/s13280-015-0748-3; Leal I, 2015, FOREST PATHOL, V45, P134, DOI 10.1111/efp.12149; Leal I, 2007, NEMATOLOGY, V9, P351, DOI 10.1163/156854107781352098; Li HM, 2009, NEMATOLOGY, V11, P375, DOI 10.1163/156854109X446971; LINIT MJ, 1988, J NEMATOL, V20, P227; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Sato MO, 2018, INT J INFECT DIS, V76, P130, DOI 10.1016/j.ijid.2018.08.018; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Takeuchi Y, 2005, NEMATOLOGY, V7, P775, DOI 10.1163/156854105775142928; Takeuchi Y, 2007, NEMATOLOGY, V9, P243, DOI 10.1163/156854107780739027; Thomas AC, 2016, MOL ECOL RESOUR, V16, P714, DOI 10.1111/1755-0998.12490; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tzean S., 1985, P 6 ROC S ELECT MICR, P38; Vander Zanden MJ, 2010, J GREAT LAKES RES, V36, P199, DOI 10.1016/j.jglr.2009.11.002; Yi C. K., 1989, Research Reports of the Forestry Research Institute (Seoul), P141	30	17	19	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227476	10.1371/journal.pone.0227476	http://dx.doi.org/10.1371/journal.pone.0227476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935232	gold, Green Published			2022-12-26	WOS:000534354100021
J	Berastegui, C; Gomez-Olles, S; Mendoza-Valderrey, A; Pereira-Veiga, T; Culebras, M; Monforte, V; Saez, B; Lopez-Meseguer, M; Sintes-Permanyer, H; de Miguel, VR; Bravo, C; Sacanell, J; Ramon, MA; Romero, L; Deu, M; Roman, A				Berastegui, Cristina; Gomez-Olles, Susana; Mendoza-Valderrey, Alberto; Pereira-Veiga, Thais; Culebras, Mario; Monforte, Victor; Saez, Berta; Lopez-Meseguer, Manuel; Sintes-Permanyer, Helena; Ruiz de Miguel, Victoria; Bravo, Carlos; Sacanell, Judit; Ramon, Maria-Antonia; Romero, Laura; Deu, Maria; Roman, Antonio			Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; HUMAN MUC1 MUCIN; MANAGEMENT; DIAGNOSIS; INJURY	KL-6 is an antigen produced mainly by damaged type II pneumocytes that is involved in interstitial lung disease. Chronic lung allograft dysfunction (CLAD) after lung transplantation (LT) is a major concern for LT clinicians, especially in patients with restrictive allograft syndrome (RAS). We investigated KL-6 levels in serum and bronchoalveolar lavage fluid (BALF) as a potential biomarker of the RAS phenotype. Levels of KL-6 in serum and BALF were measured in 73 bilateral LT recipients, and patients were categorized into 4 groups: stable (ST), infection (LTI), bronchiolitis obliterans syndrome (BOS), and RAS. We also studied a healthy cohort to determine reference values for serum KL-6. The highest levels of KL-6 were found in the serum of patients with RAS (918 [487.8-1638] U/mL). No differences were found for levels of KL-6 in BALF. Using a cut-off value of 465 U/mL serum KL-6 levels was able to differentiate RAS patients from BOS patients with a sensitivity of 100% and a specificity of 75%. Furthermore, higher serum KL-6 levels were associated with a decline in Forced Vital Capacity (FVC) at 6 months after sample collection. Therefore, KL-6 in serum may well be a potential biomarker for differentiating between the BOS and RAS phenotypes of CLAD in LT recipients.	[Berastegui, Cristina; Gomez-Olles, Susana; Mendoza-Valderrey, Alberto; Pereira-Veiga, Thais; Culebras, Mario; Monforte, Victor; Saez, Berta; Lopez-Meseguer, Manuel; Sintes-Permanyer, Helena; Ruiz de Miguel, Victoria; Bravo, Carlos; Ramon, Maria-Antonia; Roman, Antonio] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Servei Pneumol, Barcelona, Spain; [Gomez-Olles, Susana; Monforte, Victor; Bravo, Carlos; Roman, Antonio] Univ Autonoma Barcelona, Ciber Enfermedades Resp Ciberes, Barcelona, Spain; [Sacanell, Judit] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Servei Med Intens, Barcelona, Spain; [Romero, Laura; Deu, Maria] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Servei Cirurgia Torac, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Gomez-Olles, S (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Servei Pneumol, Barcelona, Spain.; Gomez-Olles, S (corresponding author), Univ Autonoma Barcelona, Ciber Enfermedades Resp Ciberes, Barcelona, Spain.	susana.go@vhir.org	MONFORTE, VICTOR/AAN-2971-2021; Lopez Meseguer, Manuel/D-6177-2018; Monforte, Victor/D-8733-2018	Berastegui Garcia, Cristina/0000-0001-9774-9349; Romero Vielva, Laura/0000-0002-5839-4693; Saez-Gimenez, Berta/0000-0002-9307-728X; Lopez Meseguer, Manuel/0000-0003-2650-9238; Mendoza-Valderrey, Alberto/0000-0003-4849-1593; Pereira-Veiga, Thais/0000-0002-4473-7608; Monforte, Victor/0000-0002-2918-7679	Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR [Spanish Society of Pulmonology and Thoracic Surgery]) [PI172/2013]	Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR [Spanish Society of Pulmonology and Thoracic Surgery])	This project was supported by the Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR [Spanish Society of Pulmonology and Thoracic Surgery]; PI172/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berastegui C, 2016, CLIN TRANSPLANT; Bessa V, 2019, TRANSPL IMMUNOL, V52, P40, DOI 10.1016/j.trim.2018.10.006; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Glanville AR, 2019, J HEART LUNG TRANSPL, V38, P483, DOI 10.1016/j.healun.2019.03.008; Haberman B, 2010, PEDIATR TRANSPLANT, V14, P903, DOI 10.1111/j.1399-3046.2010.01373.x; Hirasawa Y, 1997, AM J RESP CELL MOL, V17, P501, DOI 10.1165/ajrcmb.17.4.2253; Horimasu Y, 2012, RESP MED, V106, P1756, DOI 10.1016/j.rmed.2012.09.001; Inoue Y, 1997, AM J RESP CRIT CARE, V156, P109, DOI 10.1164/ajrccm.156.1.9612043; Ishikawa N, 2012, RESPIR INVESTIG, V50, P3, DOI 10.1016/j.resinv.2012.02.001; KOHNO N, 1993, AM REV RESPIR DIS, V148, P637, DOI 10.1164/ajrccm/148.3.637; Kohno Nobuoki, 1999, Journal of Medical Investigation, V46, P151; Lin WC, 2015, SCI REP-UK, V5, DOI 10.1038/srep12463; Meyer KC, 2014, EUR RESPIR J, V44, P1479, DOI 10.1183/09031936.00107514; Nathani N, 2008, CRIT CARE, V12, DOI 10.1186/cc6785; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Ofek E, 2013, MODERN PATHOL, V26, P350, DOI 10.1038/modpathol.2012.171; Ohshimo S, 2005, BIOCHEM BIOPH RES CO, V338, P1845, DOI 10.1016/j.bbrc.2005.10.144; Ohshimo S, 2011, J HEART LUNG TRANSPL, V30, P1374, DOI 10.1016/j.healun.2011.07.010; Oyama T, 2002, Mod Rheumatol, V12, P366, DOI 10.3109/s101650200067; Sato M, 2013, J HEART LUNG TRANSPL, V32, P23, DOI 10.1016/j.healun.2012.09.026; Sato M, 2011, J HEART LUNG TRANSPL, V30, P735, DOI 10.1016/j.healun.2011.01.712; Totani Y, 2000, Nihon Kokyuki Gakkai Zasshi, V38, P437; Tse T, 2017, J HEART LUNG TRANSPL, V36, pS411; Verleden GM, 2019, J HEART LUNG TRANSPL, V38, P493, DOI 10.1016/j.healun.2019.03.009; Verleden GM, 2014, J HEART LUNG TRANSPL, V33, P127, DOI 10.1016/j.healun.2013.10.022; Verleden SE, 2017, J THORAC DIS, V9, P2650, DOI 10.21037/jtd.2017.07.81; Walter JN, 2006, TRANSPLANTATION, V82, P709, DOI 10.1097/01.tp.0000234952.46013.df; Yokoyama A, 2006, RESPIROLOGY, V11, P164, DOI 10.1111/j.1440-1843.2006.00834.x	28	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226488	10.1371/journal.pone.0226488	http://dx.doi.org/10.1371/journal.pone.0226488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929536	Green Published, gold			2022-12-26	WOS:000534352500014
J	Black, HF; Mastromatteo, S; Sinha, S; Ehrlich, RL; Nislow, C; Mell, JC; Redfield, RJ				Black, Hailey Findlay; Mastromatteo, Scott; Sinha, Sunita; Ehrlich, Rachel L.; Nislow, Corey; Mell, Joshua Chang; Redfield, Rosemary J.			A competence-regulated toxin-antitoxin system in Haemophilus influenzae	PLOS ONE			English	Article							NATURAL COMPETENCE; ESCHERICHIA-COLI; RECEPTOR PROTEIN; GENE; TRANSFORMATION; TRANSCRIPTION; TRANSLATION; CLEAVAGE; AVAILABILITY; INDUCTION	Natural competence allows bacteria to respond to environmental and nutritional cues by taking up free DNA from their surroundings, thus gaining both nutrients and genetic information. In the Gram-negative bacterium Haemophilus influenzae, the genes needed for DNA uptake are induced by the CRP and Sxy transcription factors in response to lack of preferred carbon sources and nucleotide precursors. Here we show that one of these genes, HI0659, encodes the antitoxin of a competence-regulated toxin-antitoxin operon ('toxTA'), likely acquired by horizontal gene transfer from a Streptococcus species. Deletion of the putative toxin (HI0660) restores uptake to the antitoxin mutant. The full toxTA operon was present in only 17 of the 181 strains we examined; complete deletion was seen in 22 strains and deletions removing parts of the toxin gene in 142 others. In addition to the expected Sxy- and CRP-dependent-competence promoter, HI0659/660 transcript analysis using RNA-seq identified an internal antitoxin-repressed promoter whose transcription starts within toxT and will yield nonfunctional protein. We propose that the most likely effect of unopposed toxin expression is non-specific cleavage of mRNAs and arrest or death of competent cells in the culture. Although the high frequency of toxT and toxTA deletions suggests that this competence-regulated toxin-antitoxin system may be mildly deleterious, it could also facilitate downregulation of protein synthesis and recycling of nucleotides under starvation conditions. Although our analyses were focused on the effects of toxTA, the RNA-seq dataset will be a useful resource for further investigations into competence regulation.	[Black, Hailey Findlay; Mastromatteo, Scott; Redfield, Rosemary J.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Sinha, Sunita] Univ British Columbia, Sequencing Bioinformat Consortium, Off Vice President, Vancouver, BC, Canada; [Ehrlich, Rachel L.; Mell, Joshua Chang] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Genom Sci, Philadelphia, PA 19104 USA; [Nislow, Corey] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC, Canada; [Black, Hailey Findlay] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Mastromatteo, Scott] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada	University of British Columbia; University of British Columbia; Drexel University; University of British Columbia; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Redfield, RJ (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	redfield@zoology.ubc.ca		Mastromatteo, Scott/0000-0002-3551-2247; Nislow, Corey/0000-0002-4016-8874	Canadian Institutes of Health Research; NIH [F32 AI084427, R01 DC002148]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from Canadian Institutes of Health Research to RJR, an NIH F32 AI084427 grant to JCM, and NIH R01 DC002148 to Garth D. Ehrlich. The funders had no role in study design, data collectiona nd analysis, decision to publish, or preparation of the manuscript.	ALEXANDER HE, 1951, J EXP MED, V93, P345, DOI 10.1084/jem.93.4.345; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambur OH, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0528; Audoux J, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1372-2; BARCAK GJ, 1991, METHOD ENZYMOL, V204, P321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Cameron ADS, 2006, NUCLEIC ACIDS RES, V34, P6001, DOI 10.1093/nar/gkl734; Chan WT, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00009; CHANDLER MS, 1992, P NATL ACAD SCI USA, V89, P1626, DOI 10.1073/pnas.89.5.1626; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; DOROCICZ IR, 1993, J BACTERIOL, V175, P7142, DOI 10.1128/JB.175.22.7142-7149.1993; Gmuender H, 2001, GENOME RES, V11, P28, DOI 10.1101/gr.157701; Goeders N, 2014, TOXINS, V6, P304, DOI 10.3390/toxins6010304; Goeders N, 2013, J BACTERIOL, V195, P2541, DOI 10.1128/JB.02266-12; Gordon GC, 2017, MBIO, V8, DOI 10.1128/mBio.00128-17; Hall AMJ, 2017, CURR OPIN MICROBIOL, V36, P102, DOI 10.1016/j.mib.2017.02.003; Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003; HERRIOTT RM, 1970, J BACTERIOL, V101, P513, DOI 10.1128/JB.101.2.513-516.1970; Hurley JM, 2011, J BIOL CHEM, V286, P14770, DOI 10.1074/jbc.M110.108969; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love M, 2013, DIFFERENTIAL ANAL RN; Ma C, 2000, J BACTERIOL, V182, P3323, DOI 10.1128/JB.182.12.3323-3330.2000; Macfadyen LP, 2001, MOL MICROBIOL, V40, P700, DOI 10.1046/j.1365-2958.2001.02419.x; Maddison W.P., 2013, MESQUITE MODULAR SYS; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Masuda H, 2017, TOXINS, V9, DOI 10.3390/toxins9040140; Maughan H, 2009, EVOLUTION, V63, P1852, DOI 10.1111/j.1558-5646.2009.00658.x; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Poje Grant, 2003, Methods Mol Med, V71, P57; Ramisetty BCM, 2017, MICROBIOL-SGM, V163, P931, DOI 10.1099/mic.0.000487; Redfield RJ, 2005, J MOL BIOL, V347, P735, DOI 10.1016/j.jmb.2005.01.012; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sinha S, 2013, MOL MICROBIOL, V88, P1106, DOI 10.1111/mmi.12245; Sinha S, 2012, J BACTERIOL, V194, P5245, DOI 10.1128/JB.00671-12; Sinha S, 2009, J BACTERIOL, V191, P5180, DOI 10.1128/JB.00476-09; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sweetman WA, 2005, MICROBIOL-SGM, V151, P2751, DOI 10.1099/mic.0.27996-0; Tollervey D, 2006, NATURE, V440, P425, DOI 10.1038/440425a; Tracy E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-101; Turnbull KJ, 2017, MOL MICROBIOL, V104, P781, DOI 10.1111/mmi.13662; WILLIAMS PM, 1994, J BACTERIOL, V176, P6789, DOI 10.1128/JB.176.22.6789-6794.1994	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0217255	10.1371/journal.pone.0217255	http://dx.doi.org/10.1371/journal.pone.0217255			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931516	Green Submitted, gold, Green Published			2022-12-26	WOS:000534352500002
J	Freedberg, M; Reeves, JA; Hussain, SJ; Zaghloul, KA; Wassermann, EM				Freedberg, Michael; Reeves, Jack A.; Hussain, Sara J.; Zaghloul, Kareem A.; Wassermann, Eric M.			Identifying site- and stimulation-specific TMS-evoked EEG potentials using a quantitative cosine similarity metric	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EFFECTIVE CONNECTIVITY; INDEPENDENT COMPONENT ANALYSIS; CORTEX; OSCILLATIONS; EXCITABILITY; RELIABILITY; PERFORMANCE; INHIBITION; BREAKDOWN	The ability to interpret transcranial magnetic stimulation (TMS)-evoked electroencephalography (EEG) potentials (TEPs) is limited by artifacts, such as auditory evoked responses produced by discharge of the TMS coil. TEPs generated from direct cortical stimulation should vary in their topographical activity pattern according to stimulation site and differ from responses to sham stimulation. Responses that do not show these effects are likely to be artifactual. In 20 healthy volunteers, we delivered active and sham TMS to the right prefrontal, left primary motor, and left posterior parietal cortex and compared the waveform similarity of TEPs between stimulation sites and active and sham TMS using a cosine similarity-based analysis method. We identified epochs after the stimulus when the spatial pattern of TMS-evoked activation showed greater than random similarity between stimulation sites and sham vs. active TMS, indicating the presence of a dominant artifact. To do this, we binarized the derivatives of the TEPs recorded from 30 EEG channels and calculated cosine similarity between conditions at each time point with millisecond resolution. Only TEP components occurring before approximately 80 ms differed across stimulation sites and between active and sham, indicating site and condition-specific responses. We therefore conclude that, in the absence of noise masking or other measures to decrease neural artifact, TEP components before about 80 ms can be safely interpreted as stimulation location-specific responses to TMS, but components beyond this latency should be interpreted with caution due to high similarity in their topographical activity pattern.	[Freedberg, Michael; Reeves, Jack A.; Wassermann, Eric M.] NINDS, Behav Neurol Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Freedberg, Michael] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Hussain, Sara J.] NINDS, Human Cort Physiol & Neurorehabil Sect, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Zaghloul, Kareem A.] NINDS, Funct & Restorat Neurosurg Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Freedberg, M (corresponding author), NINDS, Behav Neurol Unit, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Freedberg, M (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	michael.freedberg@nih.gov	Zaghloul, Kareem/AAV-4208-2020	Freedberg, Michael/0000-0003-3738-8259				Belardinelli P, 2019, BRAIN STIMUL, V12, P787, DOI 10.1016/j.brs.2019.01.010; Bortoletto M, 2015, NEUROSCI BIOBEHAV R, V49, P114, DOI 10.1016/j.neubiorev.2014.12.014; Brockhardt, 2011, TMS MOTOR THRESHOLD; Bruckmann S, 2012, BRAIN, V135, P2215, DOI 10.1093/brain/aws071; Conde V, 2019, NEUROIMAGE, V185, P300, DOI 10.1016/j.neuroimage.2018.10.052; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Darmani G, 2016, J NEUROSCI, V36, P12312, DOI 10.1523/JNEUROSCI.1689-16.2016; Du XM, 2017, EXP BRAIN RES, V235, P69, DOI 10.1007/s00221-016-4773-7; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Ferreri F, 2016, HUM BRAIN MAPP, V37, P2083, DOI 10.1002/hbm.23158; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Frantseva M, 2014, CEREB CORTEX, V24, P211, DOI 10.1093/cercor/bhs304; Furnham A, 2002, ERGONOMICS, V45, P203, DOI 10.1080/00140130210121932; Garcia JO, 2011, J NEUROPHYSIOL, V106, P1734, DOI 10.1152/jn.00739.2010; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Harquel S, 2016, NEUROIMAGE, V135, P115, DOI 10.1016/j.neuroimage.2016.05.009; Herring JD, 2015, J NEUROSCI, V35, P14435, DOI 10.1523/JNEUROSCI.1833-15.2015; Herweg NA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01639; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Kerwin LJ, 2018, BRAIN STIMUL, V11, P536, DOI 10.1016/j.brs.2017.12.010; Koch G, 2013, J NEUROSCI, V33, P9725, DOI 10.1523/JNEUROSCI.4988-12.2013; Lioumis P, 2009, HUM BRAIN MAPP, V30, P1387, DOI 10.1002/hbm.20608; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nikouline V, 1999, CLIN NEUROPHYSIOL, V110, P1325, DOI 10.1016/S1388-2457(99)00070-X; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Rogasch NC, 2017, NEUROIMAGE, V147, P934, DOI 10.1016/j.neuroimage.2016.10.031; Rogasch NC, 2015, CORTEX, V64, P68, DOI 10.1016/j.cortex.2014.10.003; Rogasch NC, 2014, NEUROIMAGE, V101, P425, DOI 10.1016/j.neuroimage.2014.07.037; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Siebner HR, 2019, BRAIN STIMUL, V12, P1051, DOI 10.1016/j.brs.2019.03.076; Soderlund GBW, 2016, FRONT PSYCHOL, V7, DOI [10.3389/FPSYG.2016.00007, DOI 10.3389/FPSYG.2016.00007]; Spiegler A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0068-16.2016; Stam C. J., 2006, NONLINEAR BRAIN DYNA; ter Braack EM, 2015, BRAIN TOPOGR, V28, P520, DOI 10.1007/s10548-013-0312-z; Yaffe RB, 2014, P NATL ACAD SCI USA, V111, P18727, DOI 10.1073/pnas.1417017112	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0216185	10.1371/journal.pone.0216185	http://dx.doi.org/10.1371/journal.pone.0216185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929531	Green Submitted, Green Published, gold			2022-12-26	WOS:000534352500001
J	Piedra, FA; Qiu, XT; Teng, MN; Avadhanula, V; Machado, AA; Kim, DK; Hixson, J; Bahl, J; Piedra, PA				Piedra, Felipe-Andres; Qiu, Xueting; Teng, Michael N.; Avadhanula, Vasanthi; Machado, Annette A.; Kim, Do-Kyun; Hixson, James; Bahl, Justin; Piedra, Pedro A.			Non-gradient and genotype-dependent patterns of RSV gene expression	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; TRANSCRIPTION TERMINATION; MESSENGER-RNA; END SEQUENCE; EBOLA-VIRUS; SUBGROUP-B; POLYMERASE; MUTATIONS; GENOME; START	Respiratory syncytial virus (RSV) is a nonsegmented negative-strand RNA virus (NSV) and a leading cause of severe lower respiratory tract illness in infants and the elderly. Transcription of the ten RSV genes proceeds sequentially from the 3' promoter and requires conserved gene start (GS) and gene end (GE) signals. Previous studies using the prototypical GA1 genotype Long and A2 strains have indicated a gradient of gene transcription extending across the genome, with the highest level of mRNA coming from the most promoter-proximal gene, the first nonstructural (NS1) gene, and mRNA levels from subsequent genes dropping until reaching a minimum at the most promoter-distal gene, the polymerase (L) gene. However, recent reports show non-gradient levels of mRNA, with higher than expected levels from the attachment (G) gene. It is unknown to what extent different transcript stabilities might shape measured mRNA levels. It is also unclear whether patterns of RSV gene expression vary, or show strain- or genotype-dependence. To address this, mRNA abundances from five RSV genes were measured by quantitative real-time PCR (qPCR) in three cell lines and in cotton rats infected with RSV isolates belonging to four genotypes (GA1, ON, GB1, BA). Relative mRNA levels reached steady-state between four and 24 hours post-infection. Steady-state patterns were non-gradient and genotype-specific, where mRNA levels from the G gene exceeded those from the more promoter-proximal nucleocapsid (N) gene across isolates. Transcript stabilities could not account for the non-gradient patterns observed, indicating that relative mRNA levels more strongly reflect transcription than decay. Our results indicate that gene expression from a small but diverse set of RSV genotypes is non-gradient and genotype-dependent. We propose novel models of RSV transcription that can account for non-gradient transcription.	[Piedra, Felipe-Andres; Avadhanula, Vasanthi; Machado, Annette A.; Piedra, Pedro A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Qiu, Xueting; Bahl, Justin] Univ Georgia, Coll Vet Med, Dept Infect Dis, Ctr Ecol Infect Dis, Athens, GA USA; [Teng, Michael N.] Univ S Florida, Coll Med, Dept Internal Med, Div Allergy & Immunol, Tampa, FL 33620 USA; [Kim, Do-Kyun; Hixson, James] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Bahl, Justin] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore, Singapore; [Piedra, Pedro A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; University System of Georgia; University of Georgia; State University System of Florida; University of South Florida; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National University of Singapore; Baylor College of Medicine	Piedra, FA (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	Felipe-Andres.Piedra@bcm.edu	Bahl, Justin/A-4728-2011	Bahl, Justin/0000-0001-7572-4300; Qiu, Xueting/0000-0001-6810-7304				ABRAHAM G, 1976, P NATL ACAD SCI USA, V73, P1504, DOI 10.1073/pnas.73.5.1504; Agoti CN, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex006; Agoti CN, 2015, J VIROL, V89, P3444, DOI 10.1128/JVI.03391-14; Aljabr W, 2016, J VIROL, V90, P4876, DOI 10.1128/JVI.02349-15; [Anonymous], 2008, AB STEPONE STEPONEPL; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Bakre AA, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030016; BALL LA, 1976, P NATL ACAD SCI USA, V73, P442, DOI 10.1073/pnas.73.2.442; BARIK S, 1993, J GEN VIROL, V74, P485, DOI 10.1099/0022-1317-74-3-485; BARIK S, 1992, J VIROL, V66, P6813, DOI 10.1128/JVI.66.11.6813-6818.1992; Barr JN, 2008, VIROLOGY, V374, P361, DOI 10.1016/j.virol.2007.12.023; Bose ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120098; Boukhvalova MS, 2007, J VIROL, V81, P9443, DOI 10.1128/JVI.00102-07; Boyle B, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-75; Brauburger K, 2016, J VIROL, V90, P1898, DOI 10.1128/JVI.02341-15; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; COLLINS PL, 1984, J VIROL, V49, P572, DOI 10.1128/JVI.49.2.572-578.1984; COLLINS PL, 1980, J VIROL, V35, P682, DOI 10.1128/JVI.35.3.682-693.1980; COLLINS PL, 1991, P NATL ACAD SCI USA, V88, P9663, DOI 10.1073/pnas.88.21.9663; COLLINS PL, 1983, P NATL ACAD SCI-BIOL, V80, P3208, DOI 10.1073/pnas.80.11.3208; DICKENS LE, 1984, J VIROL, V52, P364, DOI 10.1128/JVI.52.2.364-369.1984; Fearns R, 1999, J VIROL, V73, P388, DOI 10.1128/JVI.73.1.388-397.1999; Hardy RW, 1999, J VIROL, V73, P170, DOI 10.1128/JVI.73.1.170-176.1999; Harmon SB, 2002, VIROLOGY, V300, P304, DOI 10.1006/viro.2002.1541; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P11, DOI 10.1097/INF.0b013e3182a5f324; IVERSON LE, 1981, CELL, V23, P477, DOI 10.1016/0092-8674(81)90143-4; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Kuo L, 1996, J VIROL, V70, P6892, DOI 10.1128/JVI.70.10.6892-6901.1996; Kuo L, 1997, J VIROL, V71, P4944, DOI 10.1128/JVI.71.7.4944-4953.1997; Levitz R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184318; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liuzzi M, 2005, J VIROL, V79, P13105, DOI 10.1128/JVI.79.20.13105-13115.2005; Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Moudy RM, 2004, VIROLOGY, V327, P121, DOI 10.1016/j.virol.2004.06.013; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nicholson EG, 2016, J INFECT DIS, V214, P649, DOI 10.1093/infdis/jiw191; Noton SL, 2015, VIROLOGY, V479, P545, DOI 10.1016/j.virol.2015.01.014; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Piedra FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172953; Schobel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26311; Sedeyn K, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007984; Shepard SS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3138-8; Shepard SS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3030-6; Simoes EAF, 2003, J PEDIATR-US, V143, pS118, DOI 10.1067/S0022-3476(03)00511-0; Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144; Stein RT, 2017, PEDIATR PULM, V52, P556, DOI 10.1002/ppul.23570; Stobart CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13916; Suss B, 2009, J MICROBIOL METH, V76, P316, DOI 10.1016/j.mimet.2008.12.003; Sutherland KA, 2001, VIROLOGY, V288, P295, DOI 10.1006/viro.2001.1105; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Whelan SPJ, 2004, CURR TOP MICROBIOL, V283, P61; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	56	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227558	10.1371/journal.pone.0227558	http://dx.doi.org/10.1371/journal.pone.0227558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923213	Green Published, gold, Green Submitted			2022-12-26	WOS:000534350000091
J	Jojima, K; Edagawa, M; Sawai, M; Ohno, Y; Kihara, A				Jojima, Keisuke; Edagawa, Mai; Sawai, Megumi; Ohno, Yusuke; Kihara, Akio			Biosynthesis of the anti-lipid-microdomain sphingoid base 4,14-sphingadiene by the ceramide desaturase FADS3	FASEB JOURNAL			English	Article						4,14-sphingadiene; ceramide; fatty acid desaturase; lipid; sphingolipid	MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; GENE ENCODES; SPHINGOLIPIDS; 1-PHOSPHATE; ACID; IDENTIFICATION; SPHINGOSINE-1-PHOSPHATE; CHROMATOGRAPHY; SYNTHASE	Sphingolipids are multifunctional lipids. Among the sphingolipid-component sphingoid bases, 4,14-sphingadiene (SPD) is unique such that it has a cis double bond with a bent structure. Although SPD was discovered half a century ago, its tissue distribution, biosynthesis, and degradation remain poorly understood. Here, we established a specific and quantitative method for SPD measurement and found that SPD exists in a wide range of mammalian tissues. SPD was especially abundant in kidney, where the amount of SPD was similar to 2/3 of sphingosine, the most abundant sphingoid base in mammals. Although SPD is metabolized to ceramides and SPD 1-phosphate with almost the same efficiency as sphingosine, it is less susceptible to degradation by a cleavage reaction, at least in vitro. We identified the fatty acid desaturase family protein FADS3 as a ceramide desaturase that produces SPD ceramides by desaturating ceramides containing sphingosine. SPD sphingolipids were preferentially localized outside lipid microdomains, suggesting that SPD has different functions compared to other sphingoid bases in the formation of lipid microdomains. In summary, we revealed the biosynthesis and degradation pathways of SPD and its characteristic membrane localization. Our findings contribute to the elucidation of the molecular mechanism underlying the generation of sphingolipid diversity.	[Jojima, Keisuke; Edagawa, Mai; Sawai, Megumi; Ohno, Yusuke; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Sapporo, Hokkaido, Japan	Hokkaido University	Ohno, Y; Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biochem, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	yusuke-ohno@pharm.hokudai.ac.jp; kihara@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; Ohno, Yusuke/B-5621-2014	KIHARA, AKIO/0000-0001-5889-0788; Sawai-Ogawa, Megumi/0000-0002-7406-802X; Jojima, Keisuke/0000-0003-0721-790X; Ohno, Yusuke/0000-0003-3702-1043	Japan Agency for Medical Research and Development (AMED) [JP19gm0910002h0005]; MEXT | Japan Society for the Promotion of Science (JSPS) [JP18H03976]; MEXT \ Japan Society for the Promotion of Science (JSPS) [JP18H04664]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm0910002h0005; MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H03976; MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP18H04664	Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Castro LFC, 2016, PROG LIPID RES, V62, P25, DOI 10.1016/j.plipres.2016.01.001; Colsch B, 2004, J LIPID RES, V45, P281, DOI 10.1194/jlr.M300331-JLR200; Edagawa M, 2018, BBA-MOL CELL BIOL L, V1863, P1441, DOI 10.1016/j.bbalip.2018.09.002; Essletzbichler P, 2014, GENOME RES, V24, P2059, DOI 10.1101/gr.177220.114; Ishikawa J, 2009, J DERMATOL SCI, V56, P216, DOI 10.1016/j.jdermsci.2009.09.002; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jones JW, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3822; Karsai G, 2019, J CLIN INVEST, V129, P1229, DOI 10.1172/JCI124159; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Kitamura T, 2017, P NATL ACAD SCI USA, V114, pE2616, DOI 10.1073/pnas.1700138114; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Kulkarni AA, 2010, MED RES REV, V30, P327, DOI 10.1002/med.20196; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu X, 2018, CLIN CHEM, V64, P810, DOI 10.1373/clinchem.2017.277905; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Melero R, 2014, STRUCTURE, V22, P1105, DOI 10.1016/j.str.2014.05.015; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Ohno Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14610; PANGANAMALA RV, 1969, J LIPID RES, V10, P445; Pedrono F, 2010, J LIPID RES, V51, P472, DOI 10.1194/jlr.M000588; POLITO AJ, 1968, BIOCHEMISTRY-US, V7, P2609, DOI 10.1021/bi00847a024; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; RENKONEN O, 1969, J LIPID RES, V10, P687; Rioux V, 2013, J LIPID RES, V54, P3438, DOI 10.1194/jlr.M042572; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Sassa T, 2016, J BIOL CHEM, V291, P7477, DOI 10.1074/jbc.M115.695858; Sawai M, 2017, J BIOL CHEM, V292, P15538, DOI 10.1074/jbc.M117.803171; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sugawara T, 2010, J LIPID RES, V51, P1761, DOI 10.1194/jlr.M002204; t'Kindt R, 2012, ANAL CHEM, V84, P403, DOI 10.1021/ac202646v; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Yatomi Y, 2000, BLOOD, V96, P3431; Zhang JY, 2017, PROSTAG LEUKOTR ESS, V123, P25, DOI 10.1016/j.plefa.2017.07.001; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	51	24	24	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3318	3335		10.1096/fj.201902645R	http://dx.doi.org/10.1096/fj.201902645R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916624	hybrid			2022-12-26	WOS:000506440300001
J	Lee, NG; Jeung, IC; Heo, SC; Song, J; Kim, W; Hwang, B; Kwon, MG; Kim, YG; Lee, J; Park, JG; Shin, MG; Cho, YL; Son, MY; Bae, KH; Lee, SH; Kim, JH; Min, JK				Lee, Na Geum; Jeung, In Cheul; Heo, Soon Chul; Song, Jinhoi; Kim, Wooil; Hwang, Byungtae; Kwon, Min-Gi; Kim, Yeon-Gu; Lee, Jangwook; Park, Jong-Gil; Shin, Min-Gyeong; Cho, Young-Lai; Son, Mi-Young; Bae, Kwang-Hee; Lee, Sang-Hyun; Kim, Jae Ho; Min, Jeong-Ki			Ischemia-induced Netrin-4 promotes neovascularization through endothelial progenitor cell activation via Unc-5 Netrin receptor B	FASEB JOURNAL			English	Article						angiogenesis-dependent diseases; endothelial progenitor cells; EPC-based therapy; neovascularization; Netrin-4	GUIDANCE; ANGIOGENESIS; VASCULARIZATION; TRANSPLANTATION; PROLIFERATION; MOBILIZATION; RECRUITMENT; PATHWAYS; BINDING; STEM	Endothelial progenitor cells (EPCs) promote neovascularization and tissue repair by migrating to vascular injury sites; therefore, factors that enhance EPC homing to damaged tissues are of interest. Here, we provide evidence of the prominent role of the Netrin-4 (NTN4)-Unc-5 Netrin receptor B (UNC5B) axis in EPC-specific promotion of ischemic neovascularization. Our results showed that NTN4 promoted the proliferation, chemotactic migration, and paracrine effects of small EPCs (SEPCs) and significantly increased the incorporation of large EPCs (LEPCs) into tubule networks. Additionally, NTN4 prominently augmented neovascularization in mice with hindlimb ischemia by increasing the homing of exogenously transplanted EPCs to the ischemic limb and incorporating EPCs into vessels. Moreover, silencing of UNC5B, an NTN4 receptor, abrogated the NTN4-induced cellular activities of SEPCs in vitro and blood-flow recovery and neovascularization in vivo in ischemic muscle by reducing EPC homing and incorporation. These findings suggest NTN4 as an EPC-based therapy for treating angiogenesis-dependent diseases.	[Lee, Na Geum; Song, Jinhoi; Kim, Wooil; Hwang, Byungtae; Kwon, Min-Gi; Kim, Yeon-Gu; Lee, Jangwook; Park, Jong-Gil; Shin, Min-Gyeong; Lee, Sang-Hyun; Min, Jeong-Ki] Korea Res Inst Biosci & Biotechnol KRIBB, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Lee, Na Geum; Kim, Wooil; Kwon, Min-Gi; Min, Jeong-Ki] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Biomol Sci, Daejeon, South Korea; [Jeung, In Cheul] Catholic Univ Korea, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Heo, Soon Chul; Kim, Jae Ho] Pusan Natl Univ, Dept Physiol, Yangsan Hosp, Yangsan, South Korea; [Cho, Young-Lai; Bae, Kwang-Hee] Korea Res Inst Biosci & Biotechnol KRIBB, Res Ctr Metab Regulat, Daejeon, South Korea; [Son, Mi-Young] Korea Res Inst Biosci & Biotechnol KRIBB, Stem Cell Res Ctr, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Catholic University of Korea; Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, SH; Min, JK (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Biotherapeut Translat Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.; Kim, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 50612, South Korea.	leesh@kribb.re.kr; jhkimst@pusan.ac.kr; jekmin@kribb.re.kr		Min, Jeong-Ki/0000-0003-4924-8739; Kim, Jae Ho/0000-0003-4323-4790; Lee, Sang-Hyun/0000-0002-9682-1473	Korea Research Institute of Bioscience and Biotechnology; National Research Foundation of Korea; Ministry of Science, Information & Communication Technology and Future Planning [NRF-2015M3A9C6030280, NRF-2015M3A9C6030284, NRF-2013M3A9B6046566, NRF2019R1A2C1089258, NRF2018R1A2B2006724]; Research of Korea Centers [2018ER610300]	Korea Research Institute of Bioscience and Biotechnology; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, Information & Communication Technology and Future Planning; Research of Korea Centers	Korea Research Institute of Bioscience and Biotechnology; National Research Foundation of Korea; Ministry of Science, Information & Communication Technology and Future Planning, Grant/Award Number: NRF-2015M3A9C6030280, NRF-2015M3A9C6030284, NRF-2013M3A9B6046566, NRF2019R1A2C1089258 and NRF2018R1A2B2006724; Research of Korea Centers, Grant/Award Number: 2018ER610300	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Alev C, 2011, ANTIOXID REDOX SIGN, V15, P949, DOI 10.1089/ars.2010.3872; Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163; Caiado F, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-4; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Choi HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7943; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dakouane-Giudicelli M, 2015, PLACENTA, V36, P1260, DOI 10.1016/j.placenta.2015.09.007; de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462; Di Santo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095731; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Feng NP, 2015, J MOL NEUROSCI, V57, P426, DOI 10.1007/s12031-015-0589-3; Freitas C, 2008, ANGIOGENESIS, V11, P23, DOI 10.1007/s10456-008-9096-2; Freixa X, 2011, MICROVASC RES, V82, P177, DOI 10.1016/j.mvr.2011.06.008; Hayano Y, 2014, P NATL ACAD SCI USA, V111, P15226, DOI 10.1073/pnas.1402095111; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Hu YZ, 2012, NEOPLASIA, V14, P219, DOI 10.1593/neo.111396; Janic B, 2010, THESCIENTIFICWORLDJO, V10, P1088, DOI 10.1100/tsw.2010.100; Jung C, 2013, INT J CARDIOL, V168, P1017, DOI 10.1016/j.ijcard.2012.10.032; Kim J, 2015, ARTERIOSCL THROM VAS, V35, P2020, DOI 10.1161/ATVBAHA.115.306142; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kociok N, 2016, SCI REP-UK, V6, DOI 10.1038/srep18828; Lambert E, 2012, J BIOL CHEM, V287, P3987, DOI 10.1074/jbc.M111.289371; Larrieu-Lahargue F, 2011, CIRC RES, V109, P770, DOI 10.1161/CIRCRESAHA.111.247239; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lee DG, 2015, J HEPATOL, V63, P1429, DOI 10.1016/j.jhep.2015.08.007; Lee K, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0456-4; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Lejmi E, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-1; Liu NM, 2017, J MOL MED, V95, P335, DOI 10.1007/s00109-016-1490-4; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Nikolopoulos SN, 2005, CELL CYCLE, V4, P429, DOI 10.4161/cc.4.3.1547; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rodriguez-Grande B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0227-y; Shen L, 2011, MED HYPOTHESES, V76, P256, DOI 10.1016/j.mehy.2010.10.014; Shi Y, 2014, EUR CELLS MATER, V27, P64, DOI 10.22203/eCM.v027a06; Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Wu LW, 2019, FASEB J, V33, P2388, DOI 10.1096/fj.201800658R; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yang Y, 2007, CANCER BIOL THER, V6, P743, DOI 10.4161/cbt.6.5.3976; Yebra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022750; Youn SW, 2011, BLOOD, V117, P4376, DOI 10.1182/blood-2010-07-295964; Young PP, 2002, P NATL ACAD SCI USA, V99, P11951, DOI 10.1073/pnas.182215799; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	57	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1231	1246		10.1096/fj.201900866RR	http://dx.doi.org/10.1096/fj.201900866RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914695				2022-12-26	WOS:000507308900083
J	Haider, S; Liaquat, L; Ahmad, S; Batool, Z; Siddiqui, RA; Tabassum, S; Shahzad, S; Rafiq, S; Naz, N				Haider, Saida; Liaquat, Laraib; Ahmad, Saara; Batool, Zehra; Siddiqui, Rafat Ali; Tabassum, Saiqa; Shahzad, Sidrah; Rafiq, Sahar; Naz, Narjis			Naringenin protects AlCl3/D-galactose induced neurotoxicity in rat model of AD via attenuation of acetylcholinesterase levels and inhibition of oxidative stress	PLOS ONE			English	Article							INDUCED ALZHEIMERS-DISEASE; DNA FRAGMENTATION; TRYPTOPHAN-HYDROXYLASE; DIETARY FLAVONOIDS; LIPID-PEROXIDATION; FREE-RADICALS; EMERGING ROLE; D-GALACTOSE; MEMORY; ALUMINUM	Currently prescribed medications for the treatment of Alzheimer's disease (AD) that are based on acetylcholinesterase inhibition only offer symptomatic relief but do not provide protection against neurodegeneration. There appear to be an intense need for the development of therapeutic strategies that not only improve brain functions but also prevent neurodegeneration. The oxidative stress is one of the main causative factors of AD. Various antioxidants are being investigated to prevent neurodegeneration in AD. The objective of this study was to investigate the neuroprotective effects of naringenin (NAR) against AlCl3+D-gal induced AD-like symptoms in an animal model. Rats were orally pre-treated with NAR (50 mg/kg) for two weeks and then exposed to AlCl3+D-gal (150 mg/kg + 300 mg/kg) intraperitoneally for one week to develop AD-like symptoms. The standard drug, donepezil (DPZ) was used as a stimulator of cholinergic activity. Our results showed that NAR pre-treatment significantly protected AD-like behavioral disturbances in rats. In DPZ group, rats showed improved cognitive and cholinergic functions but the neuropsychiatric functions were not completely improved and showed marked histopathological alterations. However, NAR not only prevented AlCl3+D-gal induced AD-like symptoms but also significantly prevented neuropsychiatric dysfunctions in rats. Results of present study suggest that NAR may play a role in enhancing neuroprotective and cognition functions and it can potentially be considered as a neuroprotective compound for therapeutic management of AD in the future.	[Haider, Saida; Liaquat, Laraib; Batool, Zehra; Tabassum, Saiqa; Shahzad, Sidrah; Rafiq, Sahar] Univ Karachi, Dept Biochem, Neurochem & Biochem Neuropharmacol Res Unit, Karachi, Pakistan; [Ahmad, Saara] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Batool, Zehra] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Siddiqui, Rafat Ali] Virginia State Univ, Nutr Sci & Food Chem Lab, Agr Res Stn, Petersburg, VA 23806 USA; [Tabassum, Saiqa] Shaheed Zuifiqar Ali Bhutto Inst Sci & Technol, Dept Biosci, Karachi, Pakistan; [Shahzad, Sidrah] PNS Shifa, Pakistan Navy Med Training Sch & Coll, Karachi, Pakistan; [Naz, Narjis] Univ Karachi, Dept Genet, Karachi, Pakistan	University of Karachi; Aga Khan University; University of Karachi; Virginia State University; University of Karachi	Batool, Z (corresponding author), Univ Karachi, Dept Biochem, Neurochem & Biochem Neuropharmacol Res Unit, Karachi, Pakistan.; Batool, Z (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.	xehra_batool@yahoo.com	Batool, Zehra/C-5614-2018; Haider, Saida/C-5741-2018		Higher Education Commission, Pakistan [NRPU-4480]	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	SH received financial support from Higher Education Commission, Pakistan (http://www.hec.gov.pk/english/pages/home.aspx), under the approved project NRPU-4480. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Haider S received financial support from Higher Education Commission, Pakistan (http://www.hec.gov.pk/english/pages/home.aspx), under the approved project NRPU-4480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7; Batool Z, 2019, ACTA NEUROBIOL EXP, V79, P169, DOI 10.21307/ane-2019-015; Ben Ammar R, 2009, FOOD CHEM, V116, P258, DOI 10.1016/j.foodchem.2009.02.043; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; BLAKE DR, 1987, BRIT MED BULL, V43, P371, DOI 10.1093/oxfordjournals.bmb.a072188; Burns JM, 2005, NEUROLOGY, V64, P1397, DOI 10.1212/01.WNL.0000158423.05224.7F; Cavallo MC, 1997, ALZ DIS ASSOC DIS, V11, P184; Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0; Chonpathompikunlert P, 2010, FOOD CHEM TOXICOL, V48, P798, DOI 10.1016/j.fct.2009.12.009; Chuah LYM, 2009, SLEEP, V32, P999, DOI 10.1093/sleep/32.8.999; Chung JA, 2000, NEUROL CLIN, V18, P829, DOI 10.1016/S0733-8619(05)70228-0; Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9; Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845; Devi L, 2003, BRAIN RES, V960, P9, DOI 10.1016/S0006-8993(02)03699-5; Ekici I, 2015, METAB BRAIN DIS, V30, P793, DOI [10.1007/s11011-014-9643-z, DOI 10.1007/S11011-014-9643-Z]; Exley Christopher, 2014, J Med Case Rep, V8, P41, DOI 10.1186/1752-1947-8-41; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Gao K, 2006, J NUTR BIOCHEM, V17, P89, DOI 10.1016/j.jnutbio.2005.05.009; Garcia-Alloza M, 2005, NEUROPSYCHOLOGIA, V43, P442, DOI 10.1016/j.neuropsychologia.2004.06.007; Gauthier S, 2010, INT PSYCHOGERIATR, V22, P346, DOI 10.1017/S1041610209991505; Ghofrani S, 2015, EUR J PHARMACOL, V764, P195, DOI 10.1016/j.ejphar.2015.07.001; Goncalves PP, 2007, J INORG BIOCHEM, V101, P1291, DOI 10.1016/j.jinorgbio.2007.06.002; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Haider S, 2016, BRAIN RES BULL, V127, P234, DOI 10.1016/j.brainresbull.2016.10.002; Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016; Harman D, 1998, J Int Fed Clin Chem, V10, P24; Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630; Hussain AM, 2000, DRUG METAB DISPOS, V28, P1038; Jacobsen JPR, 2012, PHILOS T R SOC B, V367, P2444, DOI 10.1098/rstb.2012.0109; Jain A., 2012, OXIDANTS ANTIOXIDANT, V1, P41; Kawaii S, 1999, J AGR FOOD CHEM, V47, P3565, DOI 10.1021/jf990153+; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Kenawy S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183565; Khan MB, 2012, NEUROCHEM INT, V61, P1081, DOI 10.1016/j.neuint.2012.07.025; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Klein-Koerkamp Y, 2014, CURR ALZHEIMER RES, V11, P239, DOI 10.2174/1567205011666140131123653; Kumar G Phani, 2012, Pharmacogn Rev, V6, P81, DOI 10.4103/0973-7847.99898; Lakshmi BVS, 2015, BIOL TRACE ELEM RES, V165, P67, DOI 10.1007/s12011-015-0229-3; LASSMANN H, 1995, ACTA NEUROPATHOL, V89, P35, DOI 10.1007/BF00294257; Liaquat L., 2016, PAK J BIOCH MOL BIOL, V49, P53; Liaquat L, 2019, LIFE SCI, V217, P202, DOI 10.1016/j.lfs.2018.12.009; Liaquat L, 2018, LIFE SCI, V194, P213, DOI 10.1016/j.lfs.2017.12.034; Liaquat L, 2017, PAK J PHARM SCI, V30, P647; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Martorana A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00252; Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407; Mira L, 2002, FREE RADICAL RES, V36, P1199, DOI 10.1080/1071576021000016463; Miyata T, 2010, AM J PHYSIOL-CELL PH, V300, P226; Modrego PJ, 2010, J ALZHEIMERS DIS, V21, P1077, DOI 10.3233/JAD-2010-100153; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Naidu RN, 2013, INT J PHARM BIOL SCI, V3, P616, DOI [10.1371/journal. pone.0227631, DOI 10.1371/JOURNAL.PONE.0227631]; Orsolic N, 2011, EUR J PHARMACOL, V656, P110, DOI 10.1016/j.ejphar.2011.01.021; Orzechowska A, 2013, MED SCI MONITOR, V19, P1050, DOI 10.12659/MSM.889778; Pan R, 2008, CHINESE MED J-PEKING, V121, P832, DOI 10.1097/00029330-200805010-00015; Qu MY, 2016, NEUROCHEM RES, V41, P1354, DOI 10.1007/s11064-016-1837-9; Rahigude A, 2012, NEUROSCIENCE, V226, P62, DOI 10.1016/j.neuroscience.2012.09.026; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Renugadevi J, 2010, EXP TOXICOL PATHOL, V62, P171, DOI 10.1016/j.etp.2009.03.010; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Simms D., 1993, FOCUS, V15, P99, DOI [DOI 10.1016/0003-267061)80041-X, DOI 10.1016/0003-2670(61)80041-X]; Spencer JPE, 2008, P NUTR SOC, V67, P238, DOI 10.1017/S0029665108007088; Stadelmann C, 1998, J NEUROPATH EXP NEUR, V57, P456, DOI 10.1097/00005072-199805000-00009; Su JH, 1997, BRAIN RES, V774, P193, DOI 10.1016/S0006-8993(97)81703-9; Sumathi T, 2015, DRUG CHEM TOXICOL, V38, P22, DOI 10.3109/01480545.2014.900068; Tair K, 2016, J ACUTE DIS, V5, P470, DOI 10.1016/j.joad.2016.08.028; Taverni JP, 1998, BRAIN INJURY, V12, P77; Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616; Terry Jr AV, 2006, SOURCE ANIMAL MODELS, P145; Thenmozhi AJ, 2015, NEUROCHEM RES, V40, P767, DOI 10.1007/s11064-015-1525-1; Tsuno N, 2009, EXPERT REV NEUROTHER, V9, P591, DOI 10.1586/ERN.09.23; Tsunoda M, 1999, J TRACE ELEM MED BIO, V13, P224, DOI 10.1016/S0946-672X(99)80040-6; Uddin Shahab, 1995, Comprehensive Therapy, V21, P41; Umukoro S, 2018, BIOMED PHARMACOTHER, V105, P714, DOI 10.1016/j.biopha.2018.06.016; Vauzour D, 2008, GENES NUTR, V3, P115, DOI 10.1007/s12263-008-0091-4; Viggiano MP, 2008, EXP AGING RES, V34, P267, DOI 10.1080/03610730802070241; Walton JR, 2006, NEUROTOXICOLOGY, V27, P385, DOI 10.1016/j.neuro.2005.11.007; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010; Wu B, 2002, FREE RADICAL BIO MED, V33, P649, DOI 10.1016/S0891-5849(02)00917-6; Xiao F, 2011, NEUROSCI BULL, V27, P143, DOI 10.1007/s12264-011-1028-2; Zaki H. F., 2014, Bulletin of the Faculty of Pharmacy, Cairo University, V52, P15, DOI 10.1016/j.bfopcu.2013.11.001; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zhang GL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00225; Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	88	40	40	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227631	10.1371/journal.pone.0227631	http://dx.doi.org/10.1371/journal.pone.0227631			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945778	Green Published, gold			2022-12-26	WOS:000534370100049
J	Hudson, L; Rashdan, E; Bonn, CA; Chavan, B; Rawlings, D; Birch-Machin, MA				Hudson, Laura; Rashdan, Eyman; Bonn, Catherine A.; Chavan, Bhaven; Rawlings, David; Birch-Machin, Mark A.			Individual and combined effects of the infrared, visible, and ultraviolet light components of solar radiation on damage biomarkers in human skin cells	FASEB JOURNAL			English	Article						oxidative stress; photoaging; photodamage; photoprotection; sunlight	MITOCHONDRIAL-DNA DAMAGE; OXIDATIVE STRESS; UVA; KERATINOCYTES; FIBROBLASTS; APOPTOSIS; EXPOSURE; ERYTHEMA; IMPACT; HEAT	The ability of solar ultraviolet (UV) to induce skin cancer and photoaging is well recognized. The effect of the infrared (IR) and visible light (Vis) components of solar radiation on skin and their interaction with UV is less well known. This study compared the effects of physiologically relevant doses of complete (UV + Vis + IR) solar-simulated light and its individual components on matched primary dermal fibroblasts and epidermal keratinocytes from human donors on three biomarkers of cellular damage (reactive oxygen species (ROS) generation, mitochondrial DNA (mtDNA), and nuclear DNA (nDNA) damage). There was a greater induction of ROS, mtDNA, and nDNA damage with the inclusion of the visible and IR components of solar-simulated light in primary fibroblast cells compared to primary keratinocytes (P < .001). Experiments using exposure to specific components of solar light alone or in combination showed that the UV, Vis, and IR components of solar light synergistically increased ROS generation in primary fibroblasts but not primary keratinocytes (P < .001). Skin cell lines were used to confirm these findings. These observations have important implications for different skin cell type responses to the individual and interacting components of solar light and therefore photodamage mechanisms and photoprotection interventions.	[Hudson, Laura; Rashdan, Eyman; Bonn, Catherine A.; Birch-Machin, Mark A.] Newcastle Univ, Sch Med, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Chavan, Bhaven] Croda Europe Ltd, Snaith, England; [Rawlings, David] Freeman Rd Hosp, Northern Med Phys & Clin Engn, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	Birch-Machin, MA (corresponding author), Newcastle Univ, Sch Med, Translat & Clin Res Inst, Dermatol Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	mark.birch-machin@ncl.ac.uk			Innovate UK [BH142095]; DH | National Institute for Health Research (NIHR) [RES0247/7538/122]; UKRI | Biotechnology and Biological Sciences Research Council (BBSRC) [BH172520]; BBSRC [1959726] Funding Source: UKRI	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); DH | National Institute for Health Research (NIHR); UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Innovate UK, Grant/Award Number: BH142095; DH | National Institute for Health Research (NIHR), Grant/Award Number: RES0247/7538/122; UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BH172520	Akhalaya MY, 2014, AGEING RES REV, V16, P1, DOI 10.1016/j.arr.2014.03.006; APPLEGATE LA, 1995, PHOTOCHEM PHOTOBIOL, V61, P285, DOI 10.1111/j.1751-1097.1995.tb03973.x; Avola R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7110197; Barolet D, 2016, J PHOTOCH PHOTOBIO B, V155, P78, DOI 10.1016/j.jphotobiol.2015.12.014; Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x; Bernerd F, 1998, CELL DEATH DIFFER, V5, P792, DOI 10.1038/sj.cdd.4400413; Birch-Machin MA, 2013, BRIT J DERMATOL, V169, P9, DOI 10.1111/bjd.12207; Birch-Machin MA, 2008, PRINCIPLES PRACTICE, P51; Bonn CA, 2018, HPC TODAY, V13, P10; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulton SJ, 2015, EXP DERMATOL, V24, P12, DOI 10.1111/exd.12597; Bowman Amy, 2015, Methods Mol Biol, V1265, P379, DOI 10.1007/978-1-4939-2288-8_27; Cho S, 2008, J DERMATOL SCI, V50, P123, DOI 10.1016/j.jdermsci.2007.11.009; Cho S, 2009, J INVEST DERM SYMP P, V14, P15, DOI 10.1038/jidsymp.2009.7; D'Errico M, 2007, MUTAT RES-FUND MOL M, V614, P37, DOI 10.1016/j.mrfmmm.2006.06.009; de Gruijl FR, 2000, METHOD ENZYMOL, V319, P359; Diffey BL, 1997, PHOTODERMATOL PHOTO, V13, P64, DOI 10.1111/j.1600-0781.1997.tb00110.x; Diffey B, 2016, PHOTOCH PHOTOBIO SCI, V15, P361, DOI 10.1039/c5pp00451a; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Hanna R, 2019, MITOCHONDRION, V46, P172, DOI 10.1016/j.mito.2018.04.009; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Hudson L, 2016, MATURITAS, V93, P34, DOI 10.1016/j.maturitas.2016.04.021; Jantschitsch C, 2009, J INVEST DERMATOL, V129, P1271, DOI 10.1038/jid.2008.362; Kandola K, 2015, INT J COSMETIC SCI, V37, P1, DOI 10.1111/ics.12287; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Koohgoli R, 2017, EXP DERMATOL, V26, P384, DOI 10.1111/exd.13257; Latimer JA, 2015, J INVEST DERMATOL, V135, P2512, DOI 10.1038/jid.2015.194; Liebel F, 2012, J INVEST DERMATOL, V132, P1901, DOI 10.1038/jid.2011.476; Mahmoud BH, 2010, J INVEST DERMATOL, V130, P2092, DOI 10.1038/jid.2010.95; McDaniel D, 2018, J COSMET DERMATOL-US, V17, P124, DOI 10.1111/jocd.12518; Naidoo K, 2017, COSMETICS-BASEL, V4, DOI [10.3390/cosmetics4010004, DOI 10.3390/COSMETICS4010004]; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; Oyewole AO, 2014, FASEB J, V28, P485, DOI 10.1096/fj.13-237008; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Randhawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130949; Schieke SM, 2003, PHOTODERMATOL PHOTO, V19, P228, DOI 10.1034/j.1600-0781.2003.00054.x; Schroeder P, 2007, FREE RADICAL BIO MED, V43, P128, DOI 10.1016/j.freeradbiomed.2007.04.002; Sklar LR, 2013, PHOTOCH PHOTOBIO SCI, V12, P54, DOI 10.1039/c2pp25152c; Stout R, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020029; Tulah AS, 2013, MITOCHONDRION, V13, P444, DOI 10.1016/j.mito.2012.11.007; Zakaria NNA, 2018, PHYTOTHER RES, V32, P1064, DOI 10.1002/ptr.6045	43	22	23	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3874	3883		10.1096/fj.201902351RR	http://dx.doi.org/10.1096/fj.201902351RR		JAN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944399	Green Published, hybrid			2022-12-26	WOS:000507596300001
J	Kamau, MW				Kamau, Mary Wanjira			Time for change is now: Experiences of participants in a community-based approach for iron and folic acid supplementation in a rural county in Kenya, a qualitative study	PLOS ONE			English	Article							HEALTH WORKERS; INTERVENTIONS; SERVICES; AFRICA	Background Iron and Folic Acid Supplementation (IFAS) is recommended by World Health Organization as part of antenatal care to prevent anaemia in pregnancy. In 2010, Kenya adopted this recommendation and the current policy is to provide one combined IFAS tablet for daily use throughout pregnancy, free of charge, in all public health facilities. However, adherence remains low over the years though anaemia in pregnancy remains high. Integration of IFAS into community-based interventions has been recommended because of its excellent outcome. Using Community Health Volunteers (CHVs) to distribute IFAS has not been implemented in Kenya before. Methods Following an intervention study implementing a community-based approach for IFAS in five public health facilities in Lari Sub-County, 19 interviews were conducted among CHVs, nurses and pregnant women participating to describe their experiences. Thematic analysis of data was done using NVivo and findings described, with use of quotes. Findings The nurses, CHVs and pregnant women were all positive and supportive of community-based approach for IFAS. They reported increased access and utilization of both IFAS and antenatal services leading to perceived reduction in anaemia and better pregnancy outcomes. Counselling provided by CHVs improved IFAS knowledge among pregnant women and consequent adherence. The increased IFAS utilization led to main challenge experienced being IFAS stock-outs. All participants recommended complementing antenatal IFAS distribution approach with community-based approach for IFAS. Conclusion Using CHVs to implement a community-based approach for IFAS was successful and increased supplement awareness and utilization. However, the role of CHVs in IFAS programme implementation is not clearly defined in current policy and their potential in IFAS education and distribution is not fully utilized. All participants endorsed integration of community-based approach for IFAS into the antenatal approach to enhance IFAS coverage and adherence among pregnant women for better pregnancy outcomes.	[Kamau, Mary Wanjira] Univ Nairobi, Coll Hlth Sci, Sch Nursing Sci, Nairobi, Kenya	University of Nairobi	Kamau, MW (corresponding author), Univ Nairobi, Coll Hlth Sci, Sch Nursing Sci, Nairobi, Kenya.	kwanjira@uonbi.ac.ke	Kamau, Mary/ABF-7607-2020	Kamau, Mary/0000-0002-4167-3549	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100029]; DELTAS Africa Initiative [107768/Z/15/Z]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK) [107768/Z/15/Z]; UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100029), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) (Grant No: 107768/Z/15/Z) and the UK government. The statements made and views expressed are solely the responsibility of the fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1697-2; [Anonymous], 2012, EFFECTIVE ARE COMMUN; Ara G, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12605; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bigirwa P, 2009, HLTH POLICY DEV, V7, P162; Bin Nisar Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-305; Birhanu Z, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12424; Burnard P, 2008, BRIT DENT J, V204, P429, DOI 10.1038/sj.bdj.2008.292; Campaore A, 2014, MATERNAL CHILD HLTH, V18; CHAROENLARP P, 1988, AM J CLIN NUTR, V47, P280, DOI 10.1093/ajcn/47.2.280; Clarke V, 2013, PSYCHOLOGIST, V26, P120; COUNTY GOVERNMENT OF KIAMBU, 2018, POL UN; Elder LK, 2000, MOTHER CARE MOTHER C; European Commission, 2012, WHAT DRIV COMM HLTH; Galloway R, 2002, SOC SCI MED, V55, P529, DOI 10.1016/S0277-9536(01)00185-X; Gebremedhin S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-607; George A, 2012, AM J TROP MED HYG, V87, P85, DOI 10.4269/ajtmh.2012.11-0757; Gill CJ, 2011, BMJ, V342; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Kamau M, 2018, AAS OPEN RES, V1; Kamau MW, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5437-2; Kane SS, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-286; Kavle JA, 2018, PUBLIC HEALTH NUTR, V21, P346, DOI 10.1017/S1368980017002828; Kc A, 2011, J Nepal Health Res Counc, V9, P107; Kenya National Bureau of Statistics, 2015, KENYA DEMOGRAPHIC HL; Lassi ZS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub2; Lewin SA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub2; Maguire M., 2017, ALL IREL J HIGH ED, V9, P3; Maina-Gathigi L, 2013, MATERN CHILD HLTH J, V17, P1236, DOI 10.1007/s10995-012-1120-x; Martin SL, 2017, MATERN CHILD NUTR, V13, P1, DOI DOI 10.1111/MCN; MCHIP, 2014, COMM BAS DISTR ROUT, DOI [10.2471/BLT.09.069369, DOI 10.2471/BLT.09.069369]; MICAH, 2006, MAL FIN SURV REP WOR, DOI [10.2105/ajph.85.8_pt_1.1055, DOI 10.2105/AJPH.85.8_PT_1.1055]; *MIN PUBL HLTH SAN, 2012, NAT COMM STRAT COMM; Ministry of Health,, 2014, STRAT COMM HLTH 2014; Mithra P, 2014, AFRICAN HLTH SCI, V14; MoH, 2012, ACC RED IR DEF AN PR; MoH, 2012, IFAS DIAL GUID HLTH; MoH, 2013, NAT POL GUID COMB IR; Nisar Y., 2014, BMC Pregnancy and Childbirth, V14; Omotayo MO, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12437; Pal PP, 2013, INT J PREVENTIVE MED, V4, P1213; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; Sanghvi TG, 2010, FOOD NUTR BULL, V31, pS100, DOI 10.1177/15648265100312S202; Shah NM, 2011, HEALTH POLICY PLANN, V26, P275, DOI 10.1093/heapol/czq074; Shakir FK., 2010, COMMUNITY HLTH WORKE; Siekmans K, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12532; Tinago CB, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12350; Titaley CR, 2014, ASIA PAC J CLIN NUTR, V23, P91, DOI 10.6133/apjcn.2014.23.1.18; Vaughan K, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0070-y; WHO, 1989, STRENGTH PERF COMM H; Wilson A., 2011, BMJ, V343; Winichagoon P, 2002, J NUTR, V132, p862S, DOI 10.1093/jn/132.4.862S; WITMER A, 1995, AM J PUBLIC HEALTH, V85, P1055, DOI 10.2105/AJPH.85.8_Pt_1.1055; World Health Organization, 2013, ESS NUTR ACT IMPR MA; Yip R, 2002, J NUTR, V132, p859S, DOI 10.1093/jn/132.4.859S	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227332	10.1371/journal.pone.0227332	http://dx.doi.org/10.1371/journal.pone.0227332			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945073	gold, Green Published			2022-12-26	WOS:000534370100029
J	Liu, YZ; Mrzic, A; Meysman, P; De Vijlder, T; Romijn, EP; Valkenborg, D; Bittremieux, W; Laukens, K				Liu, Youzhong; Mrzic, Aida; Meysman, Pieter; De Vijlder, Thomas; Romijn, Edwin P.; Valkenborg, Dirk; Bittremieux, Wout; Laukens, Kris			MESSAR: Automated recommendation of metabolite substructures from tandem mass spectra	PLOS ONE			English	Article							SPECTROMETRY; METABOLOMICS; FRAGMENTATION; ELUCIDATION; ANNOTATION; DISCOVERY; SEARCH; TOOL	Despite the increasing importance of non-targeted metabolomics to answer various life science questions, extracting biochemically relevant information from metabolomics spectral data is still an incompletely solved problem. Most computational tools to identify tandem mass spectra focus on a limited set of molecules of interest. However, such tools are typically constrained by the availability of reference spectra or molecular databases, limiting their applicability of generating structural hypotheses for unknown metabolites. In contrast, recent advances in the field illustrate the possibility to expose the underlying biochemistry without relying on metabolite identification, in particular via substructure prediction. We describe an automated method for substructure recommendation motivated by association rule mining. Our framework captures potential relationships between spectral features and substructures learned from public spectral libraries. These associations are used to recommend substructures for any unknown mass spectrum. Our method does not require any predefined metabolite candidates, and therefore it can be used for the hypothesis generation or partial identification of unknown unknowns. The method is called MESSAR (MEtabolite Sub-Structure Auto-Recommender) and is implemented in a free online web service available at messar.biodatamining.be.	[Liu, Youzhong; Mrzic, Aida; Meysman, Pieter; Bittremieux, Wout; Laukens, Kris] Univ Antwerp, Dept Math & Comp Sci, Antwerp, Belgium; [Liu, Youzhong; Mrzic, Aida; Meysman, Pieter; Bittremieux, Wout; Laukens, Kris] Univ Antwerp, Biomed Informat Network Antwerpen Biomina, Antwerp, Belgium; [De Vijlder, Thomas; Romijn, Edwin P.] Janssen Res & Dev, Pharmaceut Dev & Mfg Sci PDMS, Beerse, Belgium; [Valkenborg, Dirk] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium; [Bittremieux, Wout] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA	University of Antwerp; University of Antwerp; Johnson & Johnson; Janssen Pharmaceuticals; Hasselt University; University of California System; University of California San Diego	Laukens, K (corresponding author), Univ Antwerp, Dept Math & Comp Sci, Antwerp, Belgium.; Laukens, K (corresponding author), Univ Antwerp, Biomed Informat Network Antwerpen Biomina, Antwerp, Belgium.	kris.laukens@uantwerpen.be	Meysman, Pieter/I-1891-2019; LIU, Youzhong/AAB-7420-2022	Meysman, Pieter/0000-0001-5903-633X; LIU, Youzhong/0000-0002-1449-3841; Bittremieux, Wout/0000-0002-3105-1359; De Vijlder, Thomas/0000-0002-8692-425X; VALKENBORG, Dirk/0000-0002-1877-3496	Belgian American Educational Foundation (BAEF); VlAIO (Vlaams Agentschap Innovatie & Ondernemen) grant [HBC.2016.0890]; Research Foundation Flanders (FWO); Flemish Government department EWI	Belgian American Educational Foundation (BAEF); VlAIO (Vlaams Agentschap Innovatie & Ondernemen) grant; Research Foundation Flanders (FWO)(FWO); Flemish Government department EWI	W.B. is a postdoctoral researcher of the Research Foundation - Flanders (FWO). WB was supported by a post-doctoral fellowship of the Belgian American Educational Foundation (BAEF). TD, ER, KL, and DV were supported by the VlAIO (Vlaams Agentschap Innovatie & Ondernemen) grant HBC.2016.0890. The computational resources and services used in this work were provided by the VSC (Flemish Supercomputer Center), funded by the Research Foundation Flanders (FWO) and the Flemish Government department EWI. TDV and EPR are employed by and receive salary from Janssen Pharmaceutica NV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Mogas A, 2017, ANAL CHEM, V89, P3474, DOI 10.1021/acs.analchem.6b04512; Allen F, 2015, METABOLOMICS, V11, P98, DOI 10.1007/s11306-014-0676-4; Armitage EG, 2014, J PHARMACEUT BIOMED, V87, P1, DOI 10.1016/j.jpba.2013.08.041; Blazenovic I, 2017, J CHEMINFORMATICS, V9, DOI 10.1186/s13321-017-0219-x; Cereto-Massague A, 2015, METHODS, V71, P58, DOI 10.1016/j.ymeth.2014.08.005; Chen X, 2002, J CHEM INFORM COMPUT, V11; Degen J, 2008, CHEMMEDCHEM, V3, P1503, DOI 10.1002/cmdc.200800178; Demarque DP, 2016, NAT PROD REP, V33, P432, DOI 10.1039/c5np00073d; Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Mahieu NG, 2016, ANAL CHEM, V88, P9037, DOI 10.1021/acs.analchem.6b01702; Mrzic A, 2017, RAPID COMMUN MASS SP, V31, P1396, DOI 10.1002/rcm.7910; Naulaerts S, 2015, BRIEF BIOINFORM, V16, P216, DOI 10.1093/bib/bbt074; Nguyen DH, BRIEFINGS BIOINFORMA; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Ridder L, 2012, RAPID COMMUN MASS SP, V26, P2461, DOI 10.1002/rcm.6364; Scheubert K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01318-5; Vu TN, 2014, PROTEOME SCI, V12, DOI 10.1186/s12953-014-0054-1; Vu TN, 2014, J PROTEOME RES, V13, P4175, DOI 10.1021/pr401269z; Tsugawa H, 2016, ANAL CHEM, V88, P7946, DOI 10.1021/acs.analchem.6b00770; van der Hooft JJJ, ANAL CHEM; van der Hooft JJJ, 2016, P NATL ACAD SCI USA, V113, P13738, DOI 10.1073/pnas.1608041113; Wandy J, 2018, BIOINFORMATICS, V34, P317, DOI 10.1093/bioinformatics/btx582; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wolf S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-148; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s	28	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0226770	10.1371/journal.pone.0226770	http://dx.doi.org/10.1371/journal.pone.0226770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945070	Green Published, gold			2022-12-26	WOS:000534370100014
J	Pammi, M; Thapa, S; Balderas, M; Runge, JK; Venkatachalam, A; Luna, RA				Pammi, Mohan; Thapa, Santosh; Balderas, Miriam; Runge, Jessica K.; Venkatachalam, Alamelu; Luna, Ruth Ann			Microbiome signatures in neonatal central line associated bloodstream infections	PLOS ONE			English	Article							CENTRAL VENOUS CATHETER; COAGULASE-NEGATIVE STAPHYLOCOCCI; HUB COLONIZATION; BACTERIAL-DNA; CHILDREN	Neonates are at high risk for central line associated bloodstream infections (CLABSI). Biofilm formation is universal on indwelling catheters but why some biofilms seed the bloodstream to cause CLABSI is not clearly understood. With the objective to test the hypothesis that catheter biofilm microbiome in neonates with CLABSI differs than those without infection, we prospectively enrolled neonates (n = 30) with infected and uninfected indwelling central catheters. Catheters were collected at the time of removal, along with blood samples and skin swabs at the catheter insertion sites. Microbiomes of catheter biofilms, skin swabs and blood were evaluated by profiling the V4 region of the bacterial 16S rRNA gene using Illumina MiSeq sequencing platform. The microbial DNA load was higher from catheter biofilms of CLABSI patients without differences in alpha diversity when compared to that of the non-CLABSI neonates. Proteus and unclassified Staphylococcaceae were more abundant in infected catheter biofilms while Bradyrhizobium, Cloacibacterium, and Sphingomonas were more abundant in the uninfected catheters. A blood microbiome was detected in uninfected samples. The blood microbiome in CLABSI neonates clustered separately from the uninfected blood samples in beta diversity plots. We found that the microbiome signature in catheter biofilm and blood of neonates with CLABSI is different than the microbiomes of non-CLABSI neonates.	[Pammi, Mohan] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA; [Pammi, Mohan] Baylor Coll Med, Houston, TX 77030 USA; [Thapa, Santosh; Balderas, Miriam; Runge, Jessica K.; Venkatachalam, Alamelu; Luna, Ruth Ann] Texas Childrens Hosp, Dept Pathol, Texas Childrens Microbiome Ctr, Houston, TX 77030 USA; [Thapa, Santosh; Balderas, Miriam; Runge, Jessica K.; Venkatachalam, Alamelu; Luna, Ruth Ann] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Pammi, M (corresponding author), Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA.; Pammi, M (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	mohanv@bcm.edu	Pammi, Mohan/A-6454-2008; Venkatachalam, Alamelu/K-1279-2017; Thapa, Santosh/V-3292-2019; Venkatachalam, Alamelu/AAG-3635-2021	Thapa, Santosh/0000-0002-4534-1349; Venkatachalam, Alamelu/0000-0002-7623-5426; Pammi, Mohan/0000-0002-5571-6239	Texas Children's Hospital	Texas Children's Hospital	This study was funded by a pilot grant from the Texas Children's Hospital to MP and RAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAISSIE E, 1995, EUR J CLIN MICROBIOL, V14, P134, DOI 10.1007/BF02111873; Butler-O'Hara M, 2012, J PEDIATR-US, V160, DOI 10.1016/j.jpeds.2011.12.004; Cantey JB, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0044; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CDC, 2011, NAT HEALTHCARE SAF N; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Dinakaran V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105221; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Frances R, 2007, CLIN EXP IMMUNOL, V150, P230, DOI 10.1111/j.1365-2249.2007.03494.x; Gorski A, 2006, FEMS IMMUNOL MED MIC, V46, P313, DOI 10.1111/j.1574-695X.2006.00044.x; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hocevar SN, 2012, INFECT CONT HOSP EP, V33, P1200, DOI 10.1086/668425; Huskins WC, 2012, CURR OPIN PEDIATR, V24, P103, DOI 10.1097/MOP.0b013e32834ebdc3; Leiby JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0575-4; Lepainteur M, 2013, PEDIATR INFECT DIS J, V32, P622, DOI 10.1097/INF.0b013e318289de0f; Luna RA, 2017, CELL MOL GASTROENTER, V3, P218, DOI 10.1016/j.jcmgh.2016.11.008; Mahieu LM, 2001, INFECT CONT HOSP EP, V22, P357, DOI 10.1086/501913; Merlini E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018580; Millar M, 2011, HEALTH TECHNOL ASSES, V15, pXI, DOI 10.3310/hta15070; Moretti EW, 2005, J HOSP INFECT, V61, P139, DOI 10.1016/j.jhin.2005.02.012; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; Nishikawa K, 2010, J HOSP INFECT, V75, P19, DOI 10.1016/j.jhin.2009.11.005; Paisse S, 2016, TRANSFUSION, V56, P1138, DOI 10.1111/trf.13477; Pammi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176669; Pammi M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-257; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Payne NR, 2004, PEDIATRICS, V114, P348, DOI 10.1542/peds.114.2.348; Potgieter M, 2015, FEMS MICROBIOL REV, V39, P567, DOI 10.1093/femsre/fuv013; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RADD I, 1993, J INFECT DIS, V168, P400, DOI 10.1093/infdis/168.2.400; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schelonka RL, 1996, J PEDIATR-US, V129, P275, DOI 10.1016/S0022-3476(96)70254-8; Schierwagen R, 2019, GUT, V68, P578, DOI 10.1136/gutjnl-2018-316227; Schulman J, 2011, PEDIATRICS, V127, P436, DOI 10.1542/peds.2010-2873; SITGESSERRA A, 1984, JPEN-PARENTER ENTER, V8, P668, DOI 10.1177/0148607184008006668; Stevens TP, 2012, ACTA PAEDIATR, V101, P11, DOI 10.1111/j.1651-2227.2011.02547.x; Stewart CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0295-1; Suresh GK, 2012, AM J PERINAT, V29, P57, DOI 10.1055/s-0031-1286182; The National Institutes of Health, 1999, SBIR STTR STUD CONTR; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Wagner M, 2011, ARCH DIS CHILD, V96, P827, DOI 10.1136/adc.2010.208595; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Wolcott R, 2013, CLIN MICROBIOL INFEC, V19, P107, DOI 10.1111/j.1469-0691.2012.04001.x; Xu M, 2018, TRANSFUSION, V58, P633, DOI 10.1111/trf.14455	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227967	10.1371/journal.pone.0227967	http://dx.doi.org/10.1371/journal.pone.0227967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945114	gold, Green Submitted, Green Published			2022-12-26	WOS:000534370100075
J	Marathe, A; Priyadarsanan, DR; Krishnaswamy, J; Shanker, K				Marathe, Aniruddha; Priyadarsanan, Dharma Rajan; Krishnaswamy, Jagdish; Shanker, Kartik			Spatial and climatic variables independently drive elevational gradients in ant species richness in the Eastern Himalaya	PLOS ONE			English	Article							GEOMETRIC CONSTRAINTS; PATTERNS; DIVERSITY; BIODIVERSITY; DENSITY; TEMPERATURE; ABUNDANCE; FORESTS; MAMMALS; MODELS	Elevational gradients are considered important for understanding causes behind gradients in species richness due to the large variation in climate and habitat within a small spatial extent. Geometric constraints are thought to interact with environmental variables and influence elevational patterns in species richness. However, the geographic setting of most mountain ranges, particularly continuity with low elevation areas may reduce the effect of geometric constraints at lower elevations. In the present study, we test the effects of climatic gradients and continuity with the low elevation plains of the eastern Himalayan mountain range on patterns of species richness. We studied species richness of ants (Hymenoptera: Formicidae) on an elevational gradient between 600m and 2400m in the Eastern Himalaya-part of Himalaya biodiversity hotspot. Ants were sampled in nine elevational bands of 200m with four transects in each band using pitfall and Winkler traps. We used regression models to identify the most important environmental variables that predict species richness and used constrained null models to test the effects of contiguity between the mountain range and plains. We find a monotonic decline in species richness of ants with elevation. Temperature was a more important predictor of species richness than habitat complexity. Geometric constraints model weighted by temperature with a soft lower boundary and hard upper boundary best explained the species richness pattern. This suggests that a combination of climate and geometric constraints drive the elevational species richness patterns of ants.	[Marathe, Aniruddha; Priyadarsanan, Dharma Rajan; Krishnaswamy, Jagdish; Shanker, Kartik] ATREE, Bangalore, Karnataka, India; [Marathe, Aniruddha] Manipal Univ, Manipal, India; [Shanker, Kartik] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE); Indian Institute of Science (IISC) - Bangalore	Marathe, A (corresponding author), ATREE, Bangalore, Karnataka, India.; Marathe, A (corresponding author), Manipal Univ, Manipal, India.	aniruddha.pravin.marathe@gmail.com		Krishnaswamy, Jagdish/0000-0001-7985-0005; Shanker, Kartik/0000-0003-4856-0093; Dharma Rajan, Priyadarsanan/0000-0001-8137-3404	John D. and Catherine T. Macarthur Faundation; Ashoka Trust for Research in Ecology and the Environment (ATREE); Ministry of Environment, Forests and Climate Change, Government of India as part of the National Mission on Himalayan Studies	John D. and Catherine T. Macarthur Faundation; Ashoka Trust for Research in Ecology and the Environment (ATREE); Ministry of Environment, Forests and Climate Change, Government of India as part of the National Mission on Himalayan Studies	This work was funded by the John D. and Catherine T. Macarthur Faundation and Ashoka Trust for Research in Ecology and the Environment (ATREE). AM received support from the Ministry of Environment, Forests and Climate Change, Government of India as part of the National Mission on Himalayan Studies during preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Acharya KP, 2011, J BIOGEOGR, V38, P1821, DOI 10.1111/j.1365-2699.2011.02511.x; Araujo Luzia Marcia, 2003, Lundiana, V4, P103; Baniya CB, 2010, LICHENOLOGIST, V42, P83, DOI 10.1017/S0024282909008627; Bates D, 2014, J STAT SOFTW, V6, P43; Bestelmeyer Brandon T., 2000, P122; Bharti H, 2013, ASIAN MYRMECOL, V5, P79; Bhatt JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046237; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Bivand RS, 2008, USE R, P1; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; BROWN JH, 1971, AM NAT, V105, P467, DOI 10.1086/282738; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; Carpenter C, 2005, J BIOGEOGR, V32, P999, DOI 10.1111/j.1365-2699.2005.01249.x; Champion S.H., 1968, REVISED SURVEY FORES; Chettri B, 2010, ACTA OECOL, V36, P16, DOI 10.1016/j.actao.2009.09.004; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Colwell RK, 2016, ECOL LETT, V19, P1009, DOI 10.1111/ele.12640; Connolly SR, 2005, AM NAT, V166, P1, DOI 10.1086/430638; Ding TS, 2005, GLOBAL ECOL BIOGEOGR, V14, P299, DOI 10.1111/j.1466-822x.2005.00159.x; Dunn RR, 2010, ANT ECOLOGY, P38; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Fisher BL, 1999, ECOL APPL, V9, P714, DOI 10.1890/1051-0761(1999)009[0714:IIEACS]2.0.CO;2; Fisher Brian L., 1998, Fieldiana Zoology, V90, P39; Fisher Brian L., 1996, Fieldiana Zoology, V85, P93; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Kaspari M, 2004, OECOLOGIA, V140, P407, DOI 10.1007/s00442-004-1607-2; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; Kluge J, 2017, J BIOGEOGR, V44, P1711, DOI 10.1111/jbi.12955; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Liu C, 2018, ECOGRAPHY, V41, P101, DOI 10.1111/ecog.03067; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Majer JD, 2001, BIOTROPICA, V33, P643; Manish K, 2019, FRONTIERS BIOGEOGRAP, V11, DOI DOI 10.21425/F5FBG38754; Manish K, 2018, PLANT ECOL DIVERS, V11, P501, DOI 10.1080/17550874.2018.1534147; Manish K, 2017, J PLANT RES, V130, P829, DOI 10.1007/s10265-017-0946-0; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2010, ENCY LIFE ELS; Munyai T, 2012, J INSECT CONSERV, P1; Myers N, 2003, BIOSCIENCE, V53, P916; Negi HR, 2002, BIOL CONSERV, V105, P143, DOI 10.1016/S0006-3207(01)00158-6; Nowrouzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153420; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; R Development Core Team, 2014, R LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rana SK, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2548; SABU TK, 2008, J INSECT SCI, V8; Samson DA, 1997, BIOTROPICA, V29, P349, DOI 10.1111/j.1744-7429.1997.tb00436.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Srinivasan U, 2014, GLOBAL ECOL BIOGEOGR, V23, P52, DOI 10.1111/geb.12082; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Szewczyk T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155404; Vetaas OR, 2019, J BIOGEOGR, V46, P1652, DOI 10.1111/jbi.13564; Wang XP, 2012, ECOGRAPHY, V35, P1147, DOI 10.1111/j.1600-0587.2012.07384.x; WHITTAKER RH, 1952, ECOL MONOGR, V22, P1, DOI 10.2307/1948527; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563	72	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227628	10.1371/journal.pone.0227628	http://dx.doi.org/10.1371/journal.pone.0227628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940414	gold, Green Published			2022-12-26	WOS:000534368000085
J	Niu, K; Guo, CJ; Teng, SY; Zhou, DD; Yu, SY; Yin, WZ; Wang, P; Zhu, W; Duan, M				Niu, Kai; Guo, Chunjie; Teng, Shiyong; Zhou, Dandan; Yu, Shuyuan; Yin, Wanzhong; Wang, Ping; Zhu, Wei; Duan, Maoli			Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation	PLOS ONE			English	Article							NF-KAPPA-B; GASTROESOPHAGEAL-REFLUX DISEASE; RISK-FACTOR; LARYNGEAL; CANCER; ACTIVATION; HEAD; TNF; CARCINOMA; SURVIVAL	Pepsin plays an important role in laryngopharyngeal reflux (LPR), a risk factor for the development of hypopharyngeal squamous cell carcinomas (HPSCC). However, the role of pepsin in HPSCC is not clear. We show by immunohistochemistry that pepsin positivity occurs in a significant proportion of human primary HPSCC specimens, and in many cases matched adjacent uninvolved epithelia are negative for pepsin. Pepsin positivity is associated with nodal involvement, suggesting that pepsin may have a role in metastasis. Treatment of FaDu cancer cells with pepsin increased cell proliferation, possibly by inducing G1/S transition. We also observed significant changes in expression of genes involved in NF-kappaB, TRAIL and Notch signaling. Our data suggest that pepsin plays an important role in HPSCC and that targeting pepsin could have potential therapeutic benefits.	[Niu, Kai; Yu, Shuyuan; Yin, Wanzhong; Wang, Ping; Zhu, Wei] First Hosp Jilin Univ, Dept Otolaryngol Head & Neck Surg, Changchun, Peoples R China; [Guo, Chunjie; Zhou, Dandan] First Hosp Jilin Univ, Dept Radiol, Changchun, Peoples R China; [Teng, Shiyong] First Hosp Jilin Univ, Dept Anesthesiol, Changchun, Peoples R China; [Duan, Maoli] Karolinska Inst, Karolinska Univ Hosp, Dept Otolaryngol Head & Neck Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden	Jilin University; Jilin University; Jilin University; Karolinska Institutet; Karolinska University Hospital	Wang, P; Zhu, W (corresponding author), First Hosp Jilin Univ, Dept Otolaryngol Head & Neck Surg, Changchun, Peoples R China.	wangping99@hotmail.com; zhuwei30000@163.com		Niu, Kai/0000-0003-2040-6887	Jilin Provincial Department of Health, China [20132016]	Jilin Provincial Department of Health, China	This work received a grant from Jilin Provincial Department of Health, China (Grant number 20132016) to KN and WY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MMM, 2004, ANN SURG, V239, P491, DOI 10.1097/01.sla.0000118751.95179.c6; Adams J, 2000, ARCH OTOLARYNGOL, V126, P405, DOI 10.1001/archotol.126.3.405; Allen CT, 2010, HEAD NECK-J SCI SPEC, V29, P959; Bacciu A, 2004, CLIN OTOLARYNGOL, V29, P545, DOI 10.1111/j.1365-2273.2004.00851.x; Bardhan Karna Dev, 2012, Int J Otolaryngol, V2012, P646901, DOI 10.1155/2012/646901; Campagnolo AM, 2014, INT ARCH OTORHINOLAR, V18, P184, DOI 10.1055/s-0033-1352504; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2013, DOI 10.1111/j.1572-0241.2001.03934.x; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Green JA, 2000, DIGEST DIS SCI, V45, P2367, DOI 10.1023/A:1005638924929; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Johnston N, 2007, ANN OTO RHINOL LARYN, V116, P934, DOI 10.1177/000348940711601211; Johnston N, 2012, LARYNGOSCOPE, V122, P1317, DOI 10.1002/lary.23307; Johnston N, 2010, ANN OTO RHINOL LARYN, V119, P547, DOI 10.1177/000348941011900808; Kalaitzidis D, 2011, NATURE, V473, P159, DOI 10.1038/473159a; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelly EA, 2014, OTOLARYNG HEAD NECK, V150, P618, DOI 10.1177/0194599813517862; Klein JD, 2010, CANCER BIOL THER, V9, P1; Knight J, 2005, LARYNGOSCOPE, V115, P1473, DOI 10.1097/01.mlg.0000172043.51871.d9; Lagergren J, 2012, BRIT J CANCER, V106, P1342, DOI 10.1038/bjc.2012.72; Langevin SM, 2013, CANCER EPIDEM BIOMAR, V22, P1061, DOI 10.1158/1055-9965.EPI-13-0183; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee SH, 2012, BIOCHEM BIOPH RES CO, V424, P58, DOI 10.1016/j.bbrc.2012.06.065; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Massie CE, 2015, ENDOCR-RELAT CANCER, V22, P131, DOI 10.1530/ERC-14-0454; Mehanna H, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4684; Nyman PE, 2018, CLIN CANCER RES, V24, P6308, DOI 10.1158/1078-0432.CCR-17-3535; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Ren XY, 2007, CANCER BIOL THER, V6, P1031, DOI 10.4161/cbt.6.7.4206; Samuels TL, 2009, OTOLARYNG HEAD NECK, V141, P559, DOI 10.1016/j.otohns.2009.08.022; Sasaki CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168269; Sasaki CT, 2016, HEAD NECK-J SCI SPEC, V38, pE1381, DOI 10.1002/hed.24231; Souza RF, 2016, DIGEST DIS, V34, P483, DOI 10.1159/000445225; WILLINGHAM MC, 1984, P NATL ACAD SCI-BIOL, V81, P175, DOI 10.1073/pnas.81.1.175; Wilson Janet A, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P97, DOI 10.1097/01.moo.0000156170.70827.46; Wirth M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030830; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; Yoldas B, 2011, HEAD NECK-J SCI SPEC, V33, P1278, DOI 10.1002/hed.21598; Yu L, 2014, ONCOL REP, V31, P321, DOI 10.3892/or.2013.2841; Zhao YY, 2017, ADV CLIN EXP MED, V26, P881, DOI 10.17219/acem/64000	39	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227408	10.1371/journal.pone.0227408	http://dx.doi.org/10.1371/journal.pone.0227408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940393	Green Published, gold			2022-12-26	WOS:000534368000070
J	Yan, LD; Hanvoravongchai, P; Aekplakorn, W; Chariyalertsak, S; Kessomboon, P; Assanangkornchai, S; Taneepanichskul, S; Neelapaichit, N; Stokes, AC				Yan, Lily D.; Hanvoravongchai, Piya; Aekplakorn, Wichai; Chariyalertsak, Suwat; Kessomboon, Pattapong; Assanangkornchai, Sawitri; Taneepanichskul, Surasak; Neelapaichit, Nareemarn; Stokes, Andrew C.			Universal coverage but unmet need: National and regional estimates of attrition across the diabetes care continuum in Thailand	PLOS ONE			English	Article							UNITED-STATES; TRENDS; PREVALENCE; CASCADE; GLUCOSE	Background Diabetes is a growing challenge in Thailand. Data to assess health system response to diabetes is scarce. We assessed what factors influence diabetes care cascade retention, under universal health coverage. Methods We conducted a cross-sectional analysis of the 2014 Thai National Health Examination Survey. Diabetes was defined as fasting plasma glucose >= 126mg/dL or on treatment. National and regional care cascades were constructed across screening, diagnosis, treatment, and control. Unmet need was defined as the total loss across cascade levels. Logistic regression was used to examine the demographic and healthcare factors associated with cascade attrition. Findings We included 15,663 individuals. Among Thai adults aged 20+ with diabetes, 67.0% (95% CI 60.9% to 73.1%) were screened, 34.0% (95% CI 30.6% to 37.2%) were diagnosed, 33.3% (95% CI 29.9% to 36.7%) were treated, and 26.0% (95% CI 22.9% to 29.1%) were controlled. Total unmet need was 74.0% (95% CI 70.9% to 77.1%), with regional variation ranging from 58.4% (95% CI 45.0% to 71.8%) in South to 78.0% (95% CI 73.0% to 83.0%) in Northeast. Multivariable models indicated older age (OR 1.76), males (OR 0.65), and a higher density of medical staff (OR 2.40) and health centers (OR 1.58) were significantly associated with being diagnosed among people with diabetes. Older age (OR 1.80) and higher geographical density of medical staff (OR 1.82) and health centers (OR 1.56) were significantly associated with being controlled. Conclusions Substantial attrition in the diabetes care continuum was observed at diabetes screening and diagnosis, related to both individual and health system factors. Even with universal health insurance, Thailand still needs effective behavioral and structural interventions, especially in primary health care settings, to address unmet need in diabetes care for its population.	[Yan, Lily D.] Boston Med Ctr, Internal Med, Boston, MA USA; [Hanvoravongchai, Piya] Chulalongkorn Univ, Fac Med, Bangkok, Thailand; [Aekplakorn, Wichai] Mahidol Univ, Fac Med, Dept Community Med, Ramathibodi Hosp, Bangkok, Thailand; [Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Chariyalertsak, Suwat] Chiang Mai Univ, Fac Publ Hlth, Chiang Mai, Thailand; [Kessomboon, Pattapong] Khon Kaen Univ, Med, Khon Kaen, Thailand; [Assanangkornchai, Sawitri] Prince Songkla Univ, Epidemiol Unit, Hat Yai, Thailand; [Taneepanichskul, Surasak] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Neelapaichit, Nareemarn] Mahidol Univ, Ramathibodi Hosp, Ramathibodi Sch Nursing, Fac Med, Bangkok, Thailand; [Neelapaichit, Nareemarn] Chiang Mai Univ, Thailand Res Inst Hlth Sci, Chiang Mai, Thailand; [Stokes, Andrew C.] Boston Univ, Sch Publ Hlth, Global Hlth, Boston, MA 02118 USA	Boston Medical Center; Chulalongkorn University; Mahidol University; Chiang Mai University; Chiang Mai University; Khon Kaen University; Prince of Songkla University; Chulalongkorn University; Mahidol University; Chiang Mai University; Boston University	Stokes, AC (corresponding author), Boston Univ, Sch Publ Hlth, Global Hlth, Boston, MA 02118 USA.	acstokes@bu.edu	Yan, Lily/AAR-6163-2021; Aekplakorn, Wichai/AAK-6867-2021	Yan, Lily/0000-0001-6363-7920; Kessomboon, Pattapong/0000-0003-2118-5676; Aekplakorn, Wichai/0000-0002-3292-510X				Aekplakorn W, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/1654530; Aekplakorn W, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/396505; Ali MK, 2014, ANN INTERN MED, V161, P681, DOI 10.7326/M14-0019; [Anonymous], 2017, BURDEN DIS INJURIES; Anutrakulchai S, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1792-9; Aungkulanon S, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0479-5; Bauldry S, 2018, STATA J, V18, P924, DOI 10.1177/1536867X1801800410; Berry KM, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000348; Bureau of Policy, 2014, REPPUBL HLTH RES; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Giordano TP, 2015, JAMA INTERN MED, V175, P596, DOI 10.1001/jamainternmed.2014.8199; Hirunrassamee S, 2009, INT J HEALTH CARE FI, V9, P153, DOI 10.1007/s10754-009-9062-6; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Institute for Health Metrics and Evaluation, 2016, THAIL COUNTR PROF; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Manne-Goehler J, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002751; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Nishtar S, 2018, LANCET, V392, P245, DOI 10.1016/S0140-6736(18)31258-3; Perlman DC, 2017, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00296; Sowattanangoon N, 2009, DIABETES RES CLIN PR, V84, P245, DOI 10.1016/j.diabres.2009.02.011; Stokes A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184264; Tangcharoensathien V, 2018, LANCET, V391, P1205, DOI 10.1016/S0140-6736(18)30198-3; Tangcharoensathien V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001726; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wanwong Y., 2017, J HLTH SYST RES, V11, P182; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	30	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226286	10.1371/journal.pone.0226286	http://dx.doi.org/10.1371/journal.pone.0226286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940366	gold, Green Published			2022-12-26	WOS:000534368000026
J	Fredensborg, BL; Kalvalio, IFI; Johannesen, TB; Stensvold, CR; Nielsen, HV; Kapel, CMO				Fredensborg, Brian L.; Fossdal i Kalvalio, Inga; Johannesen, Thor B.; Stensvold, C. Rune; Nielsen, Henrik V.; Kapel, Christian M. O.			Parasites modulate the gut-microbiome in insects: A proof-of-concept study	PLOS ONE			English	Article							HYMENOLEPIS-DIMINUTA CESTODA; TENEBRIO-MOLITOR; HELMINTH-PARASITES; TEMPORAL PATTERNS; THERAPY; MODELS	Host-parasite interactions may be modulated by host- or parasite-associated microbes, but the role of these are often overlooked. Particularly for parasites with intestinal stages (either larval or adult), the host gut microbiome may play a key role for parasite establishment; moreover, the microbiome may change in response to invading parasites. Hypothesis testing at the organismal level may be hampered, particularly in mammalian definitive hosts, by ethical, logistical, and economical restrictions. Thus, invertebrates naturally serving as intermediate hosts to parasites with complex life cycles may inform the development of mammalian models as an early-stage host-parasite model. In addition, several important pathogens are vectored by insects, and insect gut microbiome-pathogen interactions may provide essential base-line knowledge, which may be used to control vectorborne pathogens. Here, we used the grain beetle, Tenebrio molitor, a host of the tapeworm Hymenolepis diminuta, to explore interactions between infection status and resident gut microbiota at two pre-determined time points (day two and seven) post infection. Using 16S/18S microbial profiling, we measured key parameters of the composition, relative abundance, and diversity of the host gut bacteriome and mycobiome. In addition, we quantified the systemic beetle immune response to infection by Phenoloxidase activity and hemocyte abundance. We found significant changes in the gut bacteriome and mycobiome in relation to infection status and beetle age. Thus, the relative abundance of Proteobacteria was significantly higher in the gut of infected beetles and driven mostly by an increased abundance of Acinetobacter. In addition, the mycobiome was less abundant in infected beetles but maintained higher Shannon diversity in infected compared with non-infected beetles. Beetles treated with a broad-spectrum antibiotic (Tetracycline) exhibited significantly reduced parasite establishment compared with the untreated control group, indicating that the host microbiome may greatly influence hatching of eggs and subsequent establishment of H. diminuta larvae. Our results suggest that experimental work using invertebrates may provide a platform for explorative studies of host-parasite-microbe interactions and their underlying mechanisms.	[Fredensborg, Brian L.; Fossdal i Kalvalio, Inga; Kapel, Christian M. O.] Univ Copenhagen, Sect Organismal Biol, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Johannesen, Thor B.; Stensvold, C. Rune; Nielsen, Henrik V.] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Fredensborg, BL (corresponding author), Univ Copenhagen, Sect Organismal Biol, Dept Plant & Environm Sci, Frederiksberg, Denmark.	blf@plen.ku.dk	Kapel, Christian M. O./G-9168-2014; Fredensborg, Brian/G-1548-2014; Stensvold, Christen Rune/H-3718-2011	Kapel, Christian M. O./0000-0002-9539-457X; Fredensborg, Brian/0000-0002-4837-5974; Stensvold, Christen Rune/0000-0002-1417-7048	Villum Foundation [00007457]	Villum Foundation(Villum Fonden)	The study was funded by a grant (no. 00007457) to Brian L. Fredensborg from the Villum Foundation (https://veluxfoundations.dk/en).	Aivelo T, 2018, J ANIM ECOL, V87, P438, DOI 10.1111/1365-2656.12708; ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Barash NR, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00948-16; BERNTZEN AK, 1965, J PARASITOL, V51, P235, DOI 10.2307/3276089; Broderick NA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0295; Brosschot TP, 2018, MUCOSAL IMMUNOL, V11, P1039, DOI 10.1038/s41385-018-0008-5; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Costello SP, 2017, ALIMENT PHARM THER, V46, P213, DOI 10.1111/apt.14173; Danneskiold-Samsoe NB, 2019, FOOD RES INT, V115, P23, DOI 10.1016/j.foodres.2018.07.043; Dhakal S, 2018, INSECTS, V9, DOI 10.3390/insects9010014; Dhakal S, 2015, VET PARASITOL, V207, P49, DOI 10.1016/j.vetpar.2014.11.006; DHEILLYNM, 2015, INFECT GENET EVOL, V34, P251, DOI DOI 10.1016/J.MEEGID.2015.05.027; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Guan GP, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9236196; Haine ER, 2008, J INSECT PHYSIOL, V54, P1090, DOI 10.1016/j.jinsphys.2008.04.013; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; He Q, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix050; Heylen M, 2014, PHARMACOL THERAPEUT, V143, P153, DOI 10.1016/j.pharmthera.2014.02.011; Hjorth MF, 2019, INT J OBESITY, V43, P149, DOI 10.1038/s41366-018-0093-2; HOLMES SD, 1982, PARASITOLOGY, V85, P237, DOI 10.1017/S0031182000055219; HOUSER BB, 1968, J PARASITOL, V54, P69, DOI 10.2307/3276876; HUNDLEY DF, 1969, J PARASITOL, V55, P1095, DOI 10.2307/3277190; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Johnston PR, 2014, G3-GENES GENOM GENET, V4, P947, DOI 10.1534/g3.113.008516; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kelly PH, 2017, MBIO, V8, DOI [10.1128/mBio.01121-16, 10.1128/mbio.01121-16]; Knutie SA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00119-0; Kostic AD, 2013, GENE DEV, V27, P701, DOI 10.1101/gad.212522.112; Lear R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051063; Lee JH, 2017, ADV INSECT PHYSIOL, V52, P111, DOI 10.1016/bs.aiip.2016.11.001; Lethbridge R. C., 1980, Helminthological Abstracts, Series A, V49, P59; LETHBRIDGE RC, 1971, PARASITOLOGY, V62, P445, DOI 10.1017/S0031182000077593; Loke P, 2015, PARASITE IMMUNOL, V37, P314, DOI 10.1111/pim.12193; Louradour I, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12755; McKenney EA, 2015, GUT MICROBES, V6, P182, DOI 10.1080/19490976.2015.1047128; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Parfrey LW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182205; PERRY RN, 1981, PARASITOLOGY, V83, P435, DOI 10.1017/S0031182000085413; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rapin A, 2018, TRENDS IMMUNOL, V39, P724, DOI 10.1016/j.it.2018.06.002; Reynolds LA, 2015, J IMMUNOL, V195, P4059, DOI 10.4049/jimmunol.1501432; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Rodriguez-Ruano SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01167; Russell WMS., 1959, MED J AUSTRALIA; Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373; Scully LR, 2006, FEMS MICROBIOL LETT, V263, P1, DOI 10.1111/j.1574-6968.2006.00388.x; Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7; Shostak AW, 2014, J PARASITOL, V100, P46, DOI 10.1645/13-347.1; Stensvold CR, 2018, TRENDS PARASITOL, V34, P369, DOI 10.1016/j.pt.2018.02.004; Sulima A, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02672; Sulima A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2519-4; Vejzagic N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0986-z; Villarino NF, 2016, P NATL ACAD SCI USA, V113, P2235, DOI 10.1073/pnas.1504887113; Woolsey ID, 2015, PARASITOL RES, V114, P2777, DOI 10.1007/s00436-015-4477-0; Yilmaz B, 2019, NAT MED, V25, P323, DOI 10.1038/s41591-018-0308-z; Yordanova IA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00308; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012	65	24	25	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227561	10.1371/journal.pone.0227561	http://dx.doi.org/10.1371/journal.pone.0227561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935259	Green Published, gold			2022-12-26	WOS:000534354100029
J	Saferali, A; Tang, AC; Strug, LJ; Quon, BS; Zlosnik, J; Sandford, AJ; Turvey, SE				Saferali, Aabida; Tang, Anthony C.; Strug, Lisa J.; Quon, Bradley S.; Zlosnik, James; Sandford, Andrew J.; Turvey, Stuart E.			Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SPLUNC1 PROTEIN; INNATE DEFENSE; SHORT PALATE; CLONE 1; LUNG; PLUNC; INFECTION; VIRUS	Background Cystic fibrosis (CF) is characterized by a progressive decline in lung function due to airway obstruction, infection, and inflammation. CF patients are particularly susceptible to respiratory infection by a variety of pathogens, and the inflammatory response in CF is dysregulated and prolonged. BPI fold containing family A, member 1 (BPIFA1) and BPIFB1 are proteins expressed in the upper airways that may have innate immune activity. We previously identified polymorphisms in the BPIFA1/BPIFB1 region associated with CF lung disease severity. Methods We evaluated whether the BPIFA1/BPIFB1 associations with lung disease severity replicated in individuals with CF participating in the International CF Gene Modifier Consortium (n = 6,365). Furthermore, we investigated mechanisms by which the BPIFA1 and BPIFB1 proteins may modify lung disease in CF. Results The association of the G allele of rs1078761 with reduced lung function was replicated in an independent cohort of CF patients (p = 0.001, n = 2,921) and in a meta-analysis of the full consortium (p = 2.39x10(-5), n = 6,365). Furthermore, we found that rs1078761G which is associated with reduced lung function was also associated with reduced BPIFA1, but not BPIFB1, protein levels in saliva from CF patients. Functional assays indicated that BPIFA1 and BPIFB1 do not have an anti-bacterial role against P. aeruginosa but may have an immunomodulatory function in CF airway epithelial cells. Gene expression profiling using RNAseq identified Rho GTPase signaling pathways to be altered in CF airway epithelial cells in response to treatment with recombinant BPIFA1 and BPIFB1 proteins. Conclusions BPIFA1 and BPIFB1 have immunomodulatory activity and genetic variation associated with low levels of these proteins may increase CF lung disease severity.	[Saferali, Aabida; Quon, Bradley S.; Sandford, Andrew J.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Saferali, Aabida; Quon, Bradley S.; Sandford, Andrew J.] St Pauls Hosp, Vancouver, BC, Canada; [Saferali, Aabida; Tang, Anthony C.; Zlosnik, James; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Saferali, Aabida; Tang, Anthony C.; Zlosnik, James; Turvey, Stuart E.] BC Childrens Hosp, Vancouver, BC, Canada; [Saferali, Aabida] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Saferali, Aabida] Harvard Med Sch, Boston, MA 02115 USA; [Strug, Lisa J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Hosp Sick Children, Program Genet & Genome Biol,Div Biostat, Toronto, ON, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; BC Childrens Hospital; University of British Columbia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Turvey, SE (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.; Turvey, SE (corresponding author), BC Childrens Hosp, Vancouver, BC, Canada.	sturvey@cw.bc.ca	Turvey, Stuart/HGV-1191-2022	Strug, Lisa/0000-0003-0503-9740; Turvey, Stuart/0000-0003-1599-1065	Cystic Fibrosis Canada; Canadian Institutes of Health Research [MOP 258916]; U.S. Cystic Fibrosis Foundation; Genome Canada	Cystic Fibrosis Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. Cystic Fibrosis Foundation; Genome Canada(Genome Canada)	S.E.T. holds the Aubrey J. Tingle Professorship in Pediatric Immunology and is a clinical scholar of the Michael Smith Foundation for Health Research. This study was supported by funding from Cystic Fibrosis Canada and the Canadian Institutes of Health Research (MOP 258916 L.J.S.). The genome-wide association study of lung disease severity in cystic fibrosis was funded by the U.S. Cystic Fibrosis Foundation, Cystic Fibrosis Canada, and Genome Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Cystic Fibrosis Canada.	Ahmad S, 2016, ANTIMICROB AGENTS CH, V60, P6003, DOI 10.1128/AAC.00975-16; Akram KM, 2018, MUCOSAL IMMUNOL, V11, P71, DOI [10.1038/mi.2017.45, 10.1038/mi.2017.109]; Andrews S., 2010, FASTQC QUALITY CONTR; Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; Bingle L, 2005, J PATHOL, V205, P491, DOI 10.1002/path.1726; Bingle L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-79; Bingle L, 2012, HISTOCHEM CELL BIOL, V138, P749, DOI 10.1007/s00418-012-0990-8; Bingle L, 2011, BIOCHEM SOC T, V39, P1023, DOI 10.1042/BST0391023; Campos MA, 2004, AM J RESP CELL MOL, V30, P184, DOI 10.1165/rcmb.2003-0142OC; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Courtney J M, 2004, J Cyst Fibros, V3, P223, DOI 10.1016/j.jcf.2004.06.006; Di YP, 2013, AM J RESP CELL MOL, V49, P759, DOI 10.1165/rcmb.2012-0435OC; Foroushani ABK, 2013, PEERJ, V1, DOI 10.7717/peerj.229; Gally F, 2011, AM J PATHOL, V178, P2159, DOI 10.1016/j.ajpath.2011.01.026; Gambardella L, 2013, J LEUKOCYTE BIOL, V94, P603, DOI 10.1189/jlb.1112564; Garland AL, 2013, P NATL ACAD SCI USA, V110, P15973, DOI 10.1073/pnas.1311999110; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Hobbs CA, 2013, AM J PHYSIOL-LUNG C, V305, pL990, DOI 10.1152/ajplung.00103.2013; Kim CS, 2018, FASEB J, V32, P2478, DOI 10.1096/fj.201701126R; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LaRocque RC, 2009, GENES IMMUN, V10, P267, DOI 10.1038/gene.2009.2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050; Liu YY, 2013, J IMMUNOL, V191, P4259, DOI 10.4049/jimmunol.1202340; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lukinskiene L, 2011, J IMMUNOL, V187, P382, DOI 10.4049/jimmunol.1001769; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mashbat B, 2020, CLIN INFECT DIS, V70, P2045, DOI 10.1093/cid/ciz600; Ou CL, 2015, ONCOL REP, V33, P2779, DOI 10.3892/or.2015.3913; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saferali A, 2016, CYSTIC FIBROSIS MODI, DOI [10.1002/9780470015902.a0020233, DOI 10.1002/9780470015902.A0020233]; Saferali A, 2016, ELS; Saferali A, 2015, AM J RESP CELL MOL, V53, P607, DOI 10.1165/rcmb.2014-0182OC; Sayeed S, 2013, INFECT IMMUN, V81, P285, DOI 10.1128/IAI.00500-12; Schaefer N, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127237; Shin OS, 2011, J INFECT DIS, V204, P1349, DOI 10.1093/infdis/jir544; Taylor C, 2011, PEDIATR PULM, V46, P857, DOI 10.1002/ppul.21456; Thaikoottathil JV, 2012, AM J RESP CELL MOL, V47, P253, DOI 10.1165/rcmb.2012-0064OC; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wright PL, 2010, J EXP MED, V207, P2595, DOI 10.1084/jem.20100786; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3	45	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227067	10.1371/journal.pone.0227067	http://dx.doi.org/10.1371/journal.pone.0227067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931521	Green Published, gold			2022-12-26	WOS:000534352500028
J	Scott, MA; Woolums, AR; Swiderski, CE; Perkins, AD; Nanduri, B; Smith, DR; Karisch, BB; Epperson, WB; Blanton, JR				Scott, Matthew A.; Woolums, Amelia R.; Swiderski, Cyprianna E.; Perkins, Andy D.; Nanduri, Bindu; Smith, David R.; Karisch, Brandi B.; Epperson, William B.; Blanton, John R., Jr.			Whole blood transcriptomic analysis of beef cattle at arrival identifies potential predictive molecules and mechanisms that indicate animals that naturally resist bovine respiratory disease	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ EXPERIMENTS; MAST-CELLS; MANNHEIMIA-HAEMOLYTICA; BACTERIAL PATHOGENS; SIGNAL-TRANSDUCTION; FEEDLOT CATTLE; LUNG LESIONS; VITAMIN-E; PERFORMANCE	Bovine respiratory disease (BRD) is a multifactorial disease complex and the leading infectious disease in post-weaned beef cattle. Clinical manifestations of BRD are recognized in beef calves within a high-risk setting, commonly associated with weaning, shipping, and novel feeding and housing environments. However, the understanding of complex host immune interactions and genomic mechanisms involved in BRD susceptibility remain elusive. Utilizing high-throughput RNA-sequencing, we contrasted the at-arrival blood transcriptomes of 6 beef cattle that ultimately developed BRD against 5 beef cattle that remained healthy within the same herd, differentiating BRD diagnosis from production metadata and treatment records. We identified 135 differentially expressed genes (DEGs) using the differential gene expression tools edgeR and DESeq2. Thirty-six of the DEGs shared between these two analysis platforms were prioritized for investigation of their relevance to infectious disease resistance using WebGestalt, STRING, and Reactome. Biological processes related to inflammatory response, immunological defense, lipoxin metabolism, and macrophage function were identified. Production of specialized pro-resolvin mediators (SPMs) and endogenous metabolism of angiotensinogen were increased in animals that resisted BRD. Protein-protein interaction modeling of gene products with significantly higher expression in cattle that naturally acquire BRD identified molecular processes involving microbial killing. Accordingly, identification of DEGs in whole blood at arrival revealed a clear distinction between calves that went on to develop BRD and those that resisted BRD. These results provide novel insight into host immune factors that are present at the time of arrival that confer protection from BRD.	[Scott, Matthew A.; Woolums, Amelia R.; Smith, David R.; Epperson, William B.] Mississippi State Univ, Dept Pathobiol & Populat Med, Mississippi State, MS 39762 USA; [Swiderski, Cyprianna E.] Mississippi State Univ, Dept Clin Sci, Mississippi State, MS 39762 USA; [Perkins, Andy D.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Karisch, Brandi B.; Blanton, John R., Jr.] Mississippi State Univ, Dept Anim & Dairy Sci, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Scott, MA (corresponding author), Mississippi State Univ, Dept Pathobiol & Populat Med, Mississippi State, MS 39762 USA.	mas1052@msstate.edu		Scott, Matthew/0000-0001-5243-7181; Perkins, Andy/0000-0002-3583-1010	Mississippi State University Department of Pathobiology and Population Medicine, Mississippi State University Department of Animal and Dairy Sciences; Mississippi Agricultural and Forestry Experiment Station	Mississippi State University Department of Pathobiology and Population Medicine, Mississippi State University Department of Animal and Dairy Sciences; Mississippi Agricultural and Forestry Experiment Station	This project was supported by the Mississippi State University Department of Pathobiology and Population Medicine, Mississippi State University Department of Animal and Dairy Sciences, and the Mississippi Agricultural and Forestry Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrews S., 2018, FASTQC SOFTWARE; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Avra TD, 2017, J ANIM SCI, V95, P1521, DOI 10.2527/jas.2016.1254; Babcock AH, 2009, J ANIM SCI, V87, P314, DOI 10.2527/jas.2008-1201; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Brandenburg LO, 2010, J NEUROCHEM, V113, P749, DOI 10.1111/j.1471-4159.2010.06637.x; Carter JN, 2002, AM J VET RES, V63, P1111, DOI 10.2460/ajvr.2002.63.1111; Cheong HS, 2005, J HUM GENET, V50, P628, DOI 10.1007/s10038-005-0304-2; Choa H, 2006, BIOORGAN MED CHEM, V14, P6486, DOI 10.1016/j.bmc.2006.06.030; Coble JP, 2015, AM J PHYSIOL-REG I, V308, pR238, DOI 10.1152/ajpregu.00486.2014; Cruse G, 2010, FASEB J, V24, P4047, DOI 10.1096/fj.10-158378; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; Duvall MG, 2016, EUR J PHARMACOL, V785, P144, DOI 10.1016/j.ejphar.2015.11.001; Earley B, 2017, ANIMAL, V11, P486, DOI 10.1017/S1751731116001622; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Englert JA, 2019, RESP RES, V20, DOI 10.1186/s12931-019-0981-6; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fridley BL, 2011, EUR J HUM GENET, V19, P837, DOI 10.1038/ejhg.2011.57; Fulton RW, 2012, CAN VET J, V53, P754; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Griffin Courtney M, 2018, Bov Pract (Stillwater), V52, P26; Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P381, DOI 10.1016/j.cvfa.2010.04.004; Grissett GP, 2015, J VET INTERN MED, V29, P770, DOI 10.1111/jvim.12597; Guo H, 2019, J MED CHEM, V62, P4624, DOI 10.1021/acs.jmedchem.9b00212; Irsik Max, 2006, Bovine Practitioner, V40, P65; Jippo T, 2003, J EXP MED, V197, P1417, DOI 10.1084/jem.20022157; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kishimoto M, 2017, J VET MED SCI, V79, P517, DOI 10.1292/jvms.16-0489; Klein C, 2012, JAMA-J AM MED ASSOC, V308, P1867, DOI 10.1001/2012.jama.10823; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kruit A, 2006, RESPIRATION, V73, P623, DOI 10.1159/000091190; Kyriakopoulos AM, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/9632018; Larson RL, 2012, VET CLIN N AM-FOOD A, V28, P97, DOI 10.1016/j.cvfa.2011.12.005; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XY, 2019, VALUE HEALTH REG ISS, V18, P1, DOI 10.1016/j.vhri.2018.05.001; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lipkin E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153423; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loneragan GH, 2002, AM J VET RES, V63, P1641, DOI 10.2460/ajvr.2002.63.1641; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Malvisi M, 2016, PLOS ONE, V10, P11; Masuda T, 2003, CLIN EXP ALLERGY, V33, P705, DOI 10.1046/j.1365-2222.2003.01588.x; Maza E, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00164; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McVey D. Scott, 2009, Animal Health Research Reviews, V10, P165, DOI 10.1017/S1466252309990247; Metcalfe SM, 2011, GENES IMMUN, V12, P157, DOI 10.1038/gene.2011.9; Meyer-Manlapat AK, 2008, J ALLERGY CLIN IMMUN, V121, pS114, DOI 10.1016/j.jaci.2007.12.455; Molfino A, 2017, OXIDATIVE MED CELLUL; Murray GM, 2017, J VET DIAGN INVEST, V29, P20, DOI 10.1177/1040638716674757; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Neupane M, 2018, ANIM GENET, V49, P527, DOI 10.1111/age.12718; Nicola I, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0372-5; O'Connor AM, 2013, PREV VET MED, V110, P77, DOI 10.1016/j.prevetmed.2012.11.025; Oki K, 2013, ENDOCRINOLOGY, V154, P214, DOI 10.1210/en.2012-1557; Pavon-Romero GF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00363; Pertea G, 2018, GFFCOMPARE PROGRAM P; Pertea G., 2018, STRINGTIE PREPDE PY; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pien H, 2018, NATURE COMMUNICATION, V9; Pollock KGJ, 2003, J IMMUNOL, V170, P1746, DOI 10.4049/jimmunol.170.4.1746; Profita M, 2000, AM J PHYSIOL-CELL PH, V279, pC1249, DOI 10.1152/ajpcell.2000.279.4.C1249; Profita M, 1999, AM J RESP CELL MOL, V20, P61, DOI 10.1165/ajrcmb.20.1.3151; Reinhardt CD, 2009, J ANIM SCI, V87, P3030, DOI 10.2527/jas.2008-1293; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Silver RB, 2004, P NATL ACAD SCI USA, V101, P13607, DOI 10.1073/pnas.0403208101; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Step DL, 2008, J ANIM SCI, V86, P3146, DOI 10.2527/jas.2008-0883; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Taylor JD, 2010, CAN VET J, V51, P1095; Timsit E, 2016, PREV VET MED, V135, P67, DOI 10.1016/j.prevetmed.2016.11.006; Timsit E, 2019, J VET INTERN MED, V33, P1540, DOI 10.1111/jvim.15483; Timsit E, 2016, ANIM FRONT, V6, P44, DOI 10.2527/af.2016-0022; Tufvesson E, 2002, FEBS LETT, V530, P124, DOI 10.1016/S0014-5793(02)03439-7; USDA, 2011, FEEDL 2011 PART 4 HL; USDA ARS, 2018, ARSUCD12 USDA; Vahanikkila N, 2019, VET MICROBIOL, V231, P107, DOI 10.1016/j.vetmic.2019.03.007; Waghmare A, 2019, BIOL BLOOD MARROW TR, V25, pS372; Walker J, 2011, SHOCK, V36, P410, DOI 10.1097/SHK.0b013e31822798c1; Wang B, 2011, PULM PHARMACOL THER, V24, P434, DOI 10.1016/j.pupt.2011.04.001; Wang X, 2010, J BIOINF COMPUT BIOL, V8, P177, DOI 10.1142/S0219720010005178; White BJ, 2015, J ANIM SCI, V93, P4115, DOI 10.2527/jas.2015-9079; White BJ, 2009, J VET DIAGN INVEST, V21, P446, DOI 10.1177/104063870902100405; Woolums AR, 2018, VET MICROBIOL, V221, P143, DOI 10.1016/j.vetmic.2018.06.005; Woolums AR, 2015, VET CLIN N AM-FOOD A, V31, P381, DOI 10.1016/j.cvfa.2015.05.010; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	108	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227507	10.1371/journal.pone.0227507	http://dx.doi.org/10.1371/journal.pone.0227507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929561	Green Published, gold			2022-12-26	WOS:000534352500042
J	Cordes, M; Bucichowski, P; Alfaar, AS; Tsang, SH; Almedawar, S; Reichhart, N; Strauss, O				Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Tsang, Stephen H.; Almedawar, Seba; Reichhart, Nadine; Strauss, Olaf			Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells	FASEB JOURNAL			English	Article						bestrophin-1; Ca(V)1; 3; retinal degeneration; RPE; surface expression	RETINAL-PIGMENT EPITHELIUM; BEST-DISEASE; MISSENSE MUTATIONS; ION CHANNELS; LIGHT PEAK; CL-CHANNEL; GENE; PHAGOCYTOSIS; MEMBRANE; PROTEIN	The BEST1 gene product bestrophin-1, a Ca2+-dependent anion channel, interacts with Ca(V)1.3 Ca2+ channels in the retinal pigment epithelium (RPE). BEST1 mutations lead to Best vitelliform macular dystrophy. A common functional defect of these mutations is reduced trafficking of bestrophin-1 into the plasma membrane. We hypothesized that this defect affects the interaction partner Ca(V)1.3 channel affecting Ca2+ signaling and altered RPE function. Thus, we investigated the protein interaction between Ca(V)1.3 channels and bestrophin-1 by immunoprecipitation, Ca(V)1.3 activity in the presence of mutant bestrophin-1 and intracellular trafficking of the interaction partners in confluent RPE monolayers. We selected four BEST1 mutations, each representing one mutational hotspot of the disease: T6P, F80L, R218C, and F305S. Heterologously expressed L-type channels and mutant bestrophin-1 showed reduced interaction, reduced Ca(V)1.3 channel activity, and changes in surface expression. Transfection of polarized RPE (porcine primary cells, iPSC-RPE) that endogenously express Ca(V)1.3 and wild-type bestrophin-1, with mutant bestrophin-1 confirmed reduction of Ca(V)1.3 surface expression. For the four selected BEST1 mutations, presence of mutant bestrophin-1 led to reduced Ca(V)1.3 activity by modulating pore-function or decreasing surface expression. Reduced Ca(V)1.3 activity might open new ways to understand symptoms of Best vitelliform macular dystrophy such as reduced electro-oculogram, lipofuscin accumulation, and vision impairment.	[Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Charite Univ Med Berlin, Dept Ophthalmol, Expt Ophthalmol, Berlin, Germany; [Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Freie Univ, Berlin, Germany; [Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Humboldt Univ, Berlin, Germany; [Cordes, Magdalena; Bucichowski, Piotr; Alfaar, Ahmad S.; Reichhart, Nadine; Strauss, Olaf] Berlin Inst Hlth, Berlin, Germany; [Almedawar, Seba] Tech Univ Dresden, CRTD, CMCB, Dresden, Germany; [Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Jonas Childrens Vis Care, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Coll Phys & Surg,Dept Ophthalmol Pathol, Inst Human Nutr,Dept Ophthalmol,Columbia Stem Cel, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, Coll Phys & Surg,Dept Cell Biol, Inst Human Nutr,Dept Ophthalmol,Columbia Stem Cel, New York, NY USA; [Tsang, Stephen H.] New York Presbyterian Hosp, Edward S Harkness Eye Inst, New York, NY USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Technische Universitat Dresden; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital	Reichhart, N; Strauss, O (corresponding author), Charite, Dept Ophthalmol, Expt Ophthalmol, Campus Virchow Clin, Augustenburger Pl 1, D-13353 Berlin, Germany.	Nadine.seichhart@charite.de; olaf.strauss@charite.de	Alfaar, Ahmad/C-8483-2011	Alfaar, Ahmad/0000-0002-0930-4583; Strauss, Olaf/0000-0002-6272-8596	DFG [480/12-1]; German Research Foundation (DFG); Charite-Universitatsmedizin Berlin	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Charite-Universitatsmedizin Berlin	Funding was provided by a DFG grant to Prof. Dr O.Strauss (480/12-1). We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fonds of the Charite-Universitatsmedizin Berlin	Arden GB, 2006, PROG RETIN EYE RES, V25, P207, DOI 10.1016/j.preteyeres.2005.11.001; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Barro-Soria R, 2010, PFLUG ARCH EUR J PHY, V459, P485, DOI 10.1007/s00424-009-0745-0; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Constable PA, 2011, GRAEF ARCH CLIN EXP, V249, P677, DOI 10.1007/s00417-010-1604-6; Gomez NM, 2013, PFLUG ARCH EUR J PHY, V465, P481, DOI 10.1007/s00424-012-1181-0; Guziewicz KE, 2018, ADV EXP MED BIOL, V1074, P309, DOI [10.1007/978-3-319-75402-4_38, 10.1007/978-3-319-75402-4_39]; Guziewicz KE, 2018, P NATL ACAD SCI USA, V115, pE2839, DOI 10.1073/pnas.1720662115; Guziewicz KE, 2017, PROG RETIN EYE RES, V58, P70, DOI 10.1016/j.preteyeres.2017.01.005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Johnson AA, 2017, PROG RETIN EYE RES, V58, P45, DOI 10.1016/j.preteyeres.2017.01.006; Johnson AA, 2013, HUM MOL GENET, V22, P4688, DOI 10.1093/hmg/ddt316; Karl MO, 2008, CELL SIGNAL, V20, P1159, DOI 10.1016/j.cellsig.2008.02.005; Keckeis S, 2017, EXP EYE RES, V154, P139, DOI 10.1016/j.exer.2016.12.003; Korkka I, 2019, STEM CELL TRANSL MED, V8, P179, DOI 10.1002/sctm.18-0026; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21651-z; Marmorstein AD, 2015, MOL VIS, V21, P347; Marmorstein LY, 2002, J BIOL CHEM, V277, P30591, DOI 10.1074/jbc.M204269200; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Marquardt A, 1998, HUM MOL GENET, V7, P1517, DOI 10.1093/hmg/7.9.1517; Milenkovic A, 2019, BIOL OPEN, V8, DOI 10.1242/bio.041335; Milenkovic A, 2018, HUM MOL GENET, V27, P1630, DOI 10.1093/hmg/ddy070; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; Milenkovic VM, 2011, J CELL SCI, V124, P2988, DOI 10.1242/jcs.085878; Milenkovic VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019364; MILLER SS, 1990, J PHYSIOL-LONDON, V424, P283, DOI 10.1113/jphysiol.1990.sp018067; Muller C, 2014, CELL SIGNAL, V26, P968, DOI 10.1016/j.cellsig.2013.12.021; Mullins RF, 2005, ARCH OPHTHALMOL-CHIC, V123, P1588, DOI 10.1001/archopht.123.11.1588; Neussert R, 2010, PFLUG ARCH EUR J PHY, V460, P163, DOI 10.1007/s00424-010-0840-2; Park M, 2019, BIOCHEM BIOPH RES CO, V514, P344, DOI 10.1016/j.bbrc.2019.04.078; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Reichhart N, 2010, EXP EYE RES, V91, P630, DOI 10.1016/j.exer.2010.08.001; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; Rosenthal R, 2001, FASEB J, V15, P970, DOI 10.1096/fj.00-0188com; Singh R, 2015, MOL THER, V23, P1700, DOI 10.1038/mt.2015.141; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strauss O, 2016, ADV EXP MED BIOL, V854, P739, DOI 10.1007/978-3-319-17121-0_98; Strauss O, 2014, ADV EXP MED BIOL, V801, P113, DOI 10.1007/978-1-4614-3209-8_15; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Wu JA, 2007, J NEUROPHYSIOL, V97, P3731, DOI 10.1152/jn.00146.2007; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Zhang YW, 2010, HUM MOL GENET, V19, P1108, DOI 10.1093/hmg/ddp583; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054552	48	4	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4055	4071		10.1096/fj.201901202RR	http://dx.doi.org/10.1096/fj.201901202RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930599	hybrid, Green Published			2022-12-26	WOS:000507260600001
J	Chan, DN; Martin-Ruiz, C; Saretzki, G; Neely, D; Qiu, WL; Kunadian, V				Chan, Danny; Martin-Ruiz, Carmen; Saretzki, Gabriele; Neely, Dermot; Qiu, Weiliang; Kunadian, Vijay			The association of telomere length and telomerase activity with adverse outcomes in older patients with non-ST-elevation acute coronary syndrome	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-DISEASE; MORTALITY; RISK; MEN; PHENOTYPE; PROJECT; BIOLOGY; FRAILTY; HEALTH	Background Non-ST elevation acute coronary syndrome (NSTEACS) occurs more frequently in older patients with an increased occurrence of recurrent cardiac events following the index presentation. Telomeres are structures consisting of repeated DNA sequences as associated shelterin proteins at the ends of chromosomes. We aim to determine whether telomere length (TL) and telomerase activity (TA) predicted poor outcomes in older patients presenting with NSTEACS undergoing invasive care. Method Older patients undergoing invasive management for NSTEACS were recruited to the ICON1 biomarker study (NCT01933581). Peripheral blood mononuclear cells (PBMC) were recovered on 153 patients. DNA was isolated and mean TL was measured by quantitative PCR expressed as relative T (telomere repeat copy number) to S (single copy gene number) ratio (T/S ratio), and a telomere repeat amplification assay was used to assess TA during index presentation with NSTEACS. Primary clinical outcomes consisted of death, myocardial infarction (MI), unplanned revascularisation, stroke and significant bleeding recorded at 1 year. TL and TA were divided into tertile groups for analysis. Cox proportional hazards regression was performed. Ordinal regression was performed to evaluate the relationship between TL and TA and traditional cardiovascular risk factors at baseline. Results 298 patients were recruited in the ICON- 1 study of which 153 had PBMC recovered. The mean age was 81.0 +/- 4.0 years (64% male). Mean telomere length T/S ratio was 0.47 +/- 0.25 and mean TA was 1.52 +/- 0.61 units. The primary composite outcome occurred in 44 (28.8%) patients. There was no association between short TL or low TA and incidence of the primary composite outcome (Hazard Ratio [HR] 1.50, 95% Confidence Interval [CI] 0.68-3.34, p = 0.32 and HR 1.33, 95% CI 0.52-3.36, p = 0.51 respectively). Conclusion TL and TA are not found to be associated with the incidence of adverse outcomes in older patients presenting with NSTEACS undergoing invasive care.	[Chan, Danny; Kunadian, Vijay] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Chan, Danny; Kunadian, Vijay] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Ctr Cardiothorac, Newcastle Upon Tyne, Tyne & Wear, England; [Martin-Ruiz, Carmen] Newcastle Univ, BioScreening Facil, Newcastle Upon Tyne, Tyne & Wear, England; [Saretzki, Gabriele] Newcastle Univ, Ageing Biol Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Saretzki, Gabriele] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Neely, Dermot] Newcastle Upon Tyne Hosp NHS Foundat Trust, Dept Biochem, Newcastle Upon Tyne, Tyne & Wear, England; [Qiu, Weiliang] Sanofi Genzyme, Framingham, MA USA	Newcastle University - UK; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Sanofi-Aventis; Genzyme Corporation	Kunadian, V (corresponding author), Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.; Kunadian, V (corresponding author), Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Ctr Cardiothorac, Newcastle Upon Tyne, Tyne & Wear, England.	vijay.kunadian@newcastle.ac.uk		Kunadian, Vijay/0000-0003-2975-6971; Martin-Ruiz, Carmen/0000-0002-3361-6974	National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastleupon-Tyne Hospitals NHS Foundation Trust and Newcastle University; British Heart Foundation [CS/15/7/31679]	National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastleupon-Tyne Hospitals NHS Foundation Trust and Newcastle University; British Heart Foundation(British Heart Foundation)	The research is supported by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastleupon-Tyne Hospitals NHS Foundation Trust and Newcastle University. VK has received research funding from the British Heart Foundation (CS/15/7/31679). WQ is salaried by Sanofi Genzyme. The funder provided support in the form of salaries for authors VK and WQ but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Batty J, 2019, INT J CARDIOL, V274, P45, DOI 10.1016/j.ijcard.2018.09.086; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Brault ME, 2014, J AM GERIATR SOC, V62, P2205, DOI 10.1111/jgs.13076; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calvert PA, 2011, ARTERIOSCL THROM VAS, V31, P2157, DOI 10.1161/ATVBAHA.111.229237; CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5; Epel ES, 2009, AGING-US, V1, P81; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gardner MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069526; Gu SZ, 2019, EUROINTERVENTION, V15, pE261, DOI 10.4244/EIJ-D-18-00848; Gu SZ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011218; Halaschek-Wiener J, 2008, MECH AGEING DEV, V129, P638, DOI 10.1016/j.mad.2008.07.004; Hammadah M, 2017, CIRC RES, V120, P1130, DOI 10.1161/CIRCRESAHA.116.309421; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164; Ishikawa N, 2012, AGE, V34, P795, DOI 10.1007/s11357-011-9280-y; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kunadian V, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012091; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Perez-Rivera JA, 2014, AM J CARDIOL, V113, P418, DOI 10.1016/j.amjcard.2013.10.009; Richardson GD, 2012, FASEB J, V26, P4832, DOI 10.1096/fj.12-208843; Sinclair H, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000436; Sinclair H, 2016, HEART, V102, P416, DOI 10.1136/heartjnl-2015-307859; Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Veerasamy M, 2015, CARDIOL REV, V23, P26, DOI 10.1097/CRD.0000000000000016; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; Werner CM, 2019, EUR HEART J, V40, P34, DOI 10.1093/eurheartj/ehy585; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wong LSM, 2009, CARDIOVASC RES, V81, P244, DOI 10.1093/cvr/cvn337; Yeh JK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090058; Yu HT, 2017, J AM HEART ASSOC, V6, DOI [10.1161/JAHA.117.006535, 10.1161/jaha.117.006535]; Zaman MJ, 2014, EUR HEART J, V35, P1551, DOI 10.1093/eurheartj/ehu039	38	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227616	10.1371/journal.pone.0227616	http://dx.doi.org/10.1371/journal.pone.0227616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923255	Green Published, gold			2022-12-26	WOS:000534350000100
J	Kouyoumdjian, FG; Lee, JY; Orkin, AM; Cheng, SY; Fung, K; O'Shea, T; Guyatt, G				Kouyoumdjian, Fiona G.; Lee, Ji Yun; Orkin, Aaron M.; Cheng, Stephanie Y.; Fung, Kinwah; O'Shea, Tim; Guyatt, Gordon			Thirty-day readmission after medical-surgical hospitalization for people who experience imprisonment in Ontario, Canada: A retrospective cohort study	PLOS ONE			English	Article							PRIMARY-CARE; HIGH-RISK; HEALTH; INCARCERATION; PHYSICIANS; RELEASE; ACCESS; ADULTS; WOMEN	We aimed to compare 30-day readmission after medical-surgical hospitalization for people who experience imprisonment and matched people in the general population in Ontario, Canada. We used linked population-based correctional and health administrative data. Of people released from Ontario prisons in 2010, we identified those with at least one medical or surgical hospitalization between 2005 and 2015 while they were in prison or within 6 months after release. For those with multiple eligible hospitalizations, we randomly selected one hospitalization. We stratified people by whether they were in prison or recently released from prison at the time of hospital discharge. We matched each person with a person in the general population based on age, sex, hospitalization case mix group, and hospital discharge year. Our primary outcome was 30-day hospital readmission. We included 262 hospitalizations for people in prison and 1,268 hospitalizations for people recently released from prison. Readmission rates were 7.7% (95%CI 4.4-10.9) for people in prison and 6.9% (95% CI 5.5-8.3) for people recently released from prison. Compared with matched people in the general population, the unadjusted HR was 0.72 (95%CI 0.41-1.27) for people in prison and 0.78 (95%CI 0.60-1.02) for people recently released from prison. Adjusted for baseline morbidity and social status, hospitalization characteristics, and post-discharge health care use, the HR for 30-day readmission was 0.74 (95%CI 0.40-1.37) for people in prison and 0.48 (95%CI 0.36-0.63) for people recently released from prison. In conclusion, people recently released from prison had relatively low rates of readmission. Research is needed to elucidate reasons for lower readmission to ensure care quality and access.	[Kouyoumdjian, Fiona G.] McMaster Univ, Dept Family Med, Hamilton, ON, Canada; [Kouyoumdjian, Fiona G.; Cheng, Stephanie Y.; Fung, Kinwah] ICES, Toronto, ON, Canada; [Kouyoumdjian, Fiona G.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Lee, Ji Yun] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada; [Orkin, Aaron M.] St Josephs Hlth Ctr, Unity Hlth, Dept Emergency Med, Toronto, ON, Canada; [Orkin, Aaron M.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Orkin, Aaron M.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [O'Shea, Tim; Guyatt, Gordon] McMaster Univ, Dept Med, Fac Med, Hamilton, ON, Canada	McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario); University of Toronto; University of Toronto; McMaster University	Kouyoumdjian, FG (corresponding author), McMaster Univ, Dept Family Med, Hamilton, ON, Canada.; Kouyoumdjian, FG (corresponding author), ICES, Toronto, ON, Canada.; Kouyoumdjian, FG (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.	kouyouf@mcmaster.ca	Orkin, Aaron/K-2500-2014	Orkin, Aaron/0000-0002-1111-8720; Kouyoumdjian, Fiona/0000-0002-6869-7516; O'Shea, Tim/0000-0002-0793-6915	Physicians' Services Incorporated Foundation [15-22]	Physicians' Services Incorporated Foundation	FK received funding from Physicians' Services Incorporated Foundation (15-22).	Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Baillargeon J, 2010, AM J COMMUN PSYCHOL, V46, P361, DOI 10.1007/s10464-010-9345-6; Balogh R, 2018, PSYCHIAT SERV, V69, P353, DOI 10.1176/appi.ps.201600534; Bergseth KJ, 2011, WOMEN CRIM JUSTICE, V21, P100, DOI 10.1080/08974454.2011.558799; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Canadian Institutes of Health Research NSaERCoC Social Sciences and Humanities Research Council of Canada, 2014, SOC SCI HUM RES COUN; Colbert AM, 2016, J FORENSIC NURS, V12, P19, DOI 10.1097/JFN.0000000000000102; Fahmy N, 2018, ANN FAM MED, V16, P549, DOI 10.1370/afm.2314; Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7; Frank Joseph W, 2014, Health Justice, V2, P6; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Government of Ontario, 2017, APPL OHIP GET HLTH C; Graffam Joe, 2004, J OFFENDER REHABIL, V40, P147, DOI DOI 10.1300/J076V40N01_08; Green Samantha, 2016, BMC Res Notes, V9, P131, DOI 10.1186/s13104-016-1935-4; Howell BA, 2016, J GEN INTERN MED, V31, P1496, DOI 10.1007/s11606-016-3857-1; Hu C, 2019, ACHIEVING CONTINUITY; Institute for Clinical Evaluative Sciences, 2018, MENT HLTH ADD SYST P; Jha AK, 2018, JAMA NETWORK OPEN, V1; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Kangovi S, 2011, JAMA-J AM MED ASSOC, V306, P1796, DOI 10.1001/jama.2011.1562; Kinner SA, 2014, AM J PUBLIC HEALTH, V104, P1352, DOI 10.2105/AJPH.2014.301883; Kouyoumdjian F, 2016, CAN FAM PHYSICIAN, V62, P215; Kouyoumdjian FG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201592; Kouyoumdjian Fiona G, 2016, CMAJ Open, V4, pE153, DOI 10.9778/cmajo.20150098; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Pager D, 2003, AM J SOCIOL, V108, P937, DOI 10.1086/374403; PINK GH, 1994, CAN MED ASSOC J, V150, P1255; Ramaswamy M, 2015, AM J HEALTH BEHAV, V39, P221, DOI 10.5993/AJHB.39.2.9; Saab D, 2016, J GEN INTERN MED, V31, P1011, DOI 10.1007/s11606-016-3680-8; The Johns Hopkins University, J HOPK ACG SYST 2018; Ti LP, 2015, AM J PUBLIC HEALTH, V105, pE53, DOI 10.2105/AJPH.2015.302885; Turney K, 2013, AM SOCIOL REV, V78, P949, DOI 10.1177/0003122413505589; Urach C, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1128-7; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Wang EA, 2013, JAMA INTERN MED, V173, P1621, DOI 10.1001/jamainternmed.2013.9008	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227588	10.1371/journal.pone.0227588	http://dx.doi.org/10.1371/journal.pone.0227588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923231	Green Published, gold			2022-12-26	WOS:000534350000097
J	Mumith, A; San Cheong, V; Fromme, P; Coathup, MJ; Blunn, GW				Mumith, Aadil; San Cheong, Vee; Fromme, Paul; Coathup, Melanie J.; Blunn, Gordon W.			The effect of strontium and silicon substituted hydroxyapatite electrochemical coatings on bone ingrowth and osseointegration of selective laser sintered porous metal implants	PLOS ONE			English	Article							TITANIUM IMPLANTS; MECHANICAL-PROPERTIES; ELECTRON-BEAM; OSTEOBLAST; SCAFFOLDS; STRENGTH; COLLARS; GROWTH; REGENERATION; PROGRESSION	Additive manufactured, porous bone implants have the potential to improve osseointegration and reduce failure rates of orthopaedic devices. Substantially porous implants are increasingly used in a number of orthopaedic applications. HA plasma spraying-a line of sight process-cannot coat the inner surfaces of substantially porous structures, whereas electrochemical deposition of calcium phosphate can fully coat the inner surfaces of porous implants for improved bioactivity, but the osseous response of different types of hydroxyapatite (HA) coatings with ionic substitutions has not been evaluated for implants in the same in vivo model. In this study, laser sintered Ti6Al4V implants with pore sizes of O 700 mu m and O 1500 mu m were electrochemically coated with HA, silicon-substituted HA (SiHA), and strontium-substituted HA (SrHA), and implanted in ovine femoral condylar defects. Implants were retrieved after 6 weeks and histological and histomorphometric evaluation were compared to electrochemically coated implants with uncoated and HA plasma sprayed controls. The HA, SiHA and SrHA coatings had Ca:P, Ca:(P+Si) and (Ca+Sr):P ratios of 1.53, 1.14 and 1.32 respectively. Electrochemically coated implants significantly promoted bone attachment to the implant surfaces of the inner pores and displayed improved osseointegration compared to uncoated scaffolds for both pore sizes (p< 0.001), whereas bone ingrowth was restricted to the surface for HA plasma coated or uncoated implants. Electrochemically coated HA implants achieved the highest osseointegration, followed by SrHA coated implants, and both coatings exhibited significantly more bone growth than plasma sprayed groups (p <= 0.01 for all 4 cases). SiHA had significantly more osseointegration when compared against the uncoated control, but no significant difference compared with other coatings. There was no significant difference in ingrowth or osseointegration between pore sizes, and the bone-implant-contact was significantly higher in the electrochemical HA than in SiHA or SrHA. These results suggest that osseointegration is insensitive to pore size, whereas surface modification through the presence of an osteoconductive coating plays an important role in improving osseointegration, which may be critically important for extensively porous implants.	[Mumith, Aadil; San Cheong, Vee; Coathup, Melanie J.; Blunn, Gordon W.] Univ Coll London, Royal Natl Orthopaed Hosp, Inst Orthopaed & Musculoskeletal Sci, Stanmore, Middx, England; [San Cheong, Vee; Fromme, Paul] UCL, Dept Mech Engn, London, England; [San Cheong, Vee] Univ Sheffield, Dept Automat Controls & Syst Engn, Sheffield, S Yorkshire, England; [San Cheong, Vee] Univ Sheffield, Insigne Inst Silico Med, Sheffield, S Yorkshire, England; [Coathup, Melanie J.] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA; [Blunn, Gordon W.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Sheffield; University of Sheffield; State University System of Florida; University of Central Florida; University of Portsmouth	San Cheong, V (corresponding author), Univ Coll London, Royal Natl Orthopaed Hosp, Inst Orthopaed & Musculoskeletal Sci, Stanmore, Middx, England.; San Cheong, V (corresponding author), UCL, Dept Mech Engn, London, England.; San Cheong, V (corresponding author), Univ Sheffield, Dept Automat Controls & Syst Engn, Sheffield, S Yorkshire, England.; San Cheong, V (corresponding author), Univ Sheffield, Insigne Inst Silico Med, Sheffield, S Yorkshire, England.	v.cheong@ucl.ac.uk	Fromme, Paul/C-1879-2008	Fromme, Paul/0000-0001-5992-2526	Orthopaedic Research UK [515]; Royal College of Surgeons; Skeletal Action Cancer Trust	Orthopaedic Research UK; Royal College of Surgeons; Skeletal Action Cancer Trust	This work was supported by the Orthopaedic Research UK (grant #515), the Royal College of Surgeons and the Skeletal Action Cancer Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabnejad S, 2016, ACTA BIOMATER, V30, P345, DOI 10.1016/j.actbio.2015.10.048; Bain SD, 2009, OSTEOPOROSIS INT, V20, P1417, DOI 10.1007/s00198-008-0815-8; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011; Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057; Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454; Biemond JE, 2013, J MATER SCI-MATER M, V24, P745, DOI 10.1007/s10856-012-4836-7; Bose S, 2018, PROG MATER SCI, V93, P45, DOI 10.1016/j.pmatsci.2017.08.003; Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806; Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005; Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975; Coathup MJ, 2015, CLIN ORTHOP RELAT R, V473, P1505, DOI 10.1007/s11999-014-4116-6; Cortet Bernard, 2011, Curr Osteoporos Rep, V9, P25, DOI 10.1007/s11914-010-0042-z; de Wild M, 2016, 3D PRINT ADDIT MANUF, V3, P142, DOI 10.1089/3dp.2016.0004; de Wild M, 2013, TISSUE ENG PT A, V19, P2645, DOI [10.1089/ten.TEA.2012.0753, 10.1089/ten.tea.2012.0753]; DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203; Douard N, 2011, MAT SCI ENG C-MATER, V31, P531, DOI 10.1016/j.msec.2010.11.008; Fromme P, 2017, MED ENG PHYS, V41, P19, DOI 10.1016/j.medengphy.2016.12.007; Hacking SA, 2002, CLIN ORTHOP RELAT R, P24, DOI 10.1097/01.blo.0000038469.05771.3d; Hing KA, 2006, BIOMATERIALS, V27, P5014, DOI 10.1016/j.biomaterials.2006.05.039; Honda M, 2012, J MATER SCI-MATER M, V23, P2923, DOI 10.1007/s10856-012-4744-x; Huang Y, 2013, APPL SURF SCI, V271, P299, DOI 10.1016/j.apsusc.2013.01.187; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9; Kokubo T, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00176; Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008; Li YF, 2010, BIOMATERIALS, V31, P9006, DOI 10.1016/j.biomaterials.2010.07.112; Liang YQ, 2014, INT J MOL SCI, V15, P9952, DOI 10.3390/ijms15069952; Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021; Mumith A, 2017, BONE JOINT J, V99B, P276, DOI [10.1302/0301-620X.99B2, 10.1302/0301-620X.99B2.BJJ-2016-0584.R1]; Patel N, 2005, J MATER SCI-MATER M, V16, P429, DOI 10.1007/s10856-005-6983-6; Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076; Pattanayak DK, 2011, ACTA BIOMATER, V7, P1398, DOI 10.1016/j.actbio.2010.09.034; Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006; Reznikov N, 2019, BIOMATERIALS, V194, P183, DOI 10.1016/j.biomaterials.2018.11.026; San Cheong V, 2020, ANN BIOMED ENG, V48, P502, DOI 10.1007/s10439-019-02369-z; San Cheong V, 2018, J MECH BEHAV BIOMED, V87, P230, DOI 10.1016/j.jmbbm.2018.07.019; Shah FA, 2019, ACTA BIOMATER, V84, P1, DOI 10.1016/j.actbio.2018.11.018; Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C; Sing SL, 2016, J ORTHOP RES, V34, P369, DOI 10.1002/jor.23075; Surmenev RA, 2019, EUR POLYM J, V113, P67, DOI 10.1016/j.eurpolymj.2019.01.042; Taniguchi N, 2016, MAT SCI ENG C-MATER, V59, P690, DOI 10.1016/j.msec.2015.10.069; Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293; WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012; Xia W., 2010, J BIOMATER NANOBIOTE, V1, P7, DOI DOI 10.4236/JBNB.2010.11002; Yamada M, 2003, BIOL TRACE ELEM RES, V95, P113, DOI 10.1385/BTER:95:2:113; Yang GL, 2012, INT J ORAL MAX IMPL, V27, P1332; Zhu SL, 2008, MAT SCI ENG C-BIO S, V28, P1271, DOI 10.1016/j.msec.2007.11.010	48	17	17	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227232	10.1371/journal.pone.0227232	http://dx.doi.org/10.1371/journal.pone.0227232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923253	Green Published, gold, Green Submitted			2022-12-26	WOS:000534350000059
J	Restrepo-Cardona, JS; Echeverry-Galvis, MA; Maya, DL; Vargas, FH; Tapasco, O; Renjifo, LM				Sebastian Restrepo-Cardona, Juan; Angela Echeverry-Galvis, Maria; Lucia Maya, Diana; Hernan Vargas, Felix; Tapasco, Omar; Miguel Renjifo, Luis			Human-raptor conflict in rural settlements of Colombia	PLOS ONE			English	Article							HARPY EAGLE; FOOD-HABITS; CONSERVATION; PERCEPTIONS; PREDATOR; GENDER; LIVESTOCK; PATTERNS; PREY; AREA	In human-transformed landscapes, predators may feed on domesticated animals, and thus affect human well-being, creating negative perceptions and leading to conflict with people that can result in the persecution of the predator. We studied the factors that influence the perception of the Black-and-chestnut Eagle (Spizaetus isidori) in four rural Andean communities in Colombia and compiled historical and recent evidence on the persecution and other causes of mortality of this species in the country. We applied 267 questionnaires and conducted 16 interviews with local inhabitants, via visits to homes and schools in the surroundings of S. isidori nests. The perception of S. isidori by the inhabitants was largely negative and influenced by different socio-demographic factors such as gender, chicken (Gallus gallus) ownership, and chicken management. The records we obtained indicate that 47 eagles were shot, 16 were captured (three for illegal trafficking) and two were electrocuted on high-tension wires. The persecution of S. isidori occurs as retaliation or as a preventative measure against chicken predation, and is a significant cause of mortality of this species in Colombia. Effective conservation planning for S. isidori in Colombia needs to go further than the protected areas system, and include a socioecological perspective in conservation practices applied at landscapes scales that are dominated by people. Education programs and socioecological research, along with participatory work in local communities are key to the conservation of S. isidori in breeding territories. This approach can also prevent conflict over food resources-G. gallus and other poultry-that are shared by humans and S. isidori in rural landscapes.	[Sebastian Restrepo-Cardona, Juan; Angela Echeverry-Galvis, Maria] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Programa Maestria Conservac & Uso Biodiversidad, Bogota, Colombia; [Sebastian Restrepo-Cardona, Juan; Hernan Vargas, Felix] Peregrine Fund, Boise, ID 83709 USA; [Angela Echeverry-Galvis, Maria; Lucia Maya, Diana; Miguel Renjifo, Luis] Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Dept Ecol & Terr, Bogota, Colombia; [Tapasco, Omar] Univ Caldas, Fac Ciencias Exactas & Nat, Dept Matemat, Manizales, Colombia	Pontificia Universidad Javeriana; Pontificia Universidad Javeriana; Universidad de Caldas	Restrepo-Cardona, JS (corresponding author), Pontificia Univ Javeriana, Fac Estudios Ambientales & Rurales, Programa Maestria Conservac & Uso Biodiversidad, Bogota, Colombia.; Restrepo-Cardona, JS (corresponding author), Peregrine Fund, Boise, ID 83709 USA.	jsrestrepoc@gmail.com	TAPASCO-ALZATE, OMAR/AAL-8022-2020	Renjifo, Luis Miguel/0000-0003-1907-2760; MAYA VELEZ, DIANA LUCIA/0000-0001-6632-2262; Echeverry-Galvis, Maria Angela/0000-0002-5273-8694; Vargas, Felix Hernan/0000-0002-0035-7670; Restrepo, Juan Sebastian/0000-0002-1281-201X	Peregrine Fund; Vicerrectoria de Investigacion of Pontificia Universidad Javeriana	Peregrine Fund; Vicerrectoria de Investigacion of Pontificia Universidad Javeriana	This work was made possible with funding provided by The Peregrine Fund and the Vicerrectoria de Investigacion of Pontificia Universidad Javeriana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal B, 2009, ECOL ECON, V68, P2785, DOI 10.1016/j.ecolecon.2009.04.025; Allen BP, 2006, ECOL ECON, V56, P49, DOI 10.1016/j.ecolecon.2005.09.008; [Anonymous], 2008, OFF J EUR UNION; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Bennett NJ, 2017, BIOL CONSERV, V205, P93, DOI 10.1016/j.biocon.2016.10.006; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Birdlife International, 2018, SPEC FACTSH SPIZ IS; Birdlife International, 2018, CAR LUT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22728892A94999996, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22728892A94999996]; de Azevedo FCC, 2008, BIOTROPICA, V40, P494, DOI 10.1111/j.1744-7429.2008.00404.x; Castro-Diaz L, 2018, HUM ECOL, V46, P411, DOI 10.1007/s10745-018-9992-z; Cortes-Avizanda A, 2018, BIOL CONSERV, V218, P173, DOI 10.1016/j.biocon.2017.09.028; Curti M, 2009, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.4.3-16; DIAZ L.G., 2009, ANALISIS ESTADISTICO; Donazar JA, 2016, ARDEOLA, V63, P181, DOI 10.13157/arla.63.1.2016.rp8; Echeverry-Galvis M.A., 2014, LIBRE ROJO AYES COLO, P104; Enriquez Paula L., 1998, Quercus, V150, P22; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Etter A, 2000, AMBIO, V29, P432, DOI 10.1639/0044-7447(2000)029[0432:POLTIC]2.0.CO;2; Ferguson-Lees J, 2001, RAPTORS WORLD; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Greenway JC, 1967, EXTINCT VANISHING BI; Aguiar-Silva FH, 2014, J RAPTOR RES, V48, P24, DOI 10.3356/JRR-13-00017.1; Hernan Sarasola Jose, 2010, Endangered Species Research, V11, P207, DOI 10.3354/esr00280; Howell T. R., 1954, Condor, V56, P283, DOI 10.2307/1364852; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Khan U, 2018, BIODIVERS CONSERV, V27, P2795, DOI 10.1007/s10531-018-1570-6; Lehmann V F. C., 1959, Novedades Colombianas, V1, P169; Lopez B, 2002, SERIE LIBROS ROJOS E; Marchini S, 2018, BIOL CONSERV, V224, P230, DOI 10.1016/j.biocon.2018.06.001; Margalida A, 2014, ORYX, V48, P172, DOI 10.1017/S0030605312000889; McPherson SC, 2016, URBAN ECOSYST, V19, P383, DOI 10.1007/s11252-015-0500-6; Miranda EBP, 2018, J ORNITHOL, V159, P141, DOI 10.1007/s10336-017-1482-3; Morales-Reyes Z, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12392; Muniz-Lopez R, 2017, STUD NEOTROP FAUNA E, V52, P81, DOI 10.1080/01650521.2016.1276716; Murgatroyd M, 2016, J AVIAN BIOL, V47, P834, DOI 10.1111/jav.00944; Murn C, 2016, ECOL EVOL, V6, P1092, DOI 10.1002/ece3.1931; Ogra Monica V., 2012, Environment Development and Sustainability, V14, P407, DOI 10.1007/s10668-011-9332-6; Osorio F., 2016, JOVENES TERRITORIOS, P17; Osorio FE, 2005, NOMADAS, V23, P122; Parks MH, 2015, GEOJOURNAL, V80, P61, DOI 10.1007/s10708-014-9523-4; Pena-Mondragon JL, 2017, ORYX, V51, P254, DOI 10.1017/S0030605315001088; Pooley S, 2017, CONSERV BIOL, V31, P513, DOI 10.1111/cobi.12859; Potapov P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600821; Renjifo LM, 2014, LIBRO ROJO AVES COLO, VI; Rodriguez B, 2018, CURR ZOOL, V64, P173, DOI 10.1093/cz/zox005; Sarasola J.H., 2018, BIRDS PREY BIOL CONS, P373, DOI DOI 10.1007/978-3-319-73745-4_16; Sarasola JH, 2006, ORYX, V40, P347, DOI 10.1017/S0030605306001013; Restrepo-Cardona JS, 2019, TROP CONSERV SCI, V12, DOI 10.1177/1940082919831838; Sunderland T, 2014, WORLD DEV, V64, pS56, DOI 10.1016/j.worlddev.2014.03.003; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Treves A., 2006, HUMAN DIMENSIONS WIL, V11, P43, DOI DOI 10.1080/10871200500470993; Trinca Cristiano Trape, 2008, Cotinga, V30, P12; VISAUTA B, 2003, ANALISIS ESTADISTICO, V2; White J, 2018, URBAN ECOSYST, V21, P271, DOI 10.1007/s11252-017-0713-y; Yang Naiyi, 2010, International Journal of Biodiversity Science Ecosystem Services & Management, V6, P61, DOI 10.1080/21513732.2010.509630; Zuluaga S, 2016, ORNITOL NEOTROP, V27, P113	56	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227704	10.1371/journal.pone.0227704	http://dx.doi.org/10.1371/journal.pone.0227704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KD9MH	31923262	Green Published, gold, Green Submitted			2022-12-26	WOS:000508185000001
J	Gazda, LD; Matuz, KJ; Nagy, T; Motyan, JA; Tozser, J				Gazda, Livia Diana; Matuz, Krisztina Joone; Nagy, Tibor; Motyan, Janos Andras; Tozser, Jozsef			Biochemical characterization of Ty1 retrotransposon protease	PLOS ONE			English	Article							AMINO-ACID PREFERENCES; RETROVIRAL PROTEASES; SACCHAROMYCES-CEREVISIAE; VIRUS PROTEINASE; SITE; TRANSPOSITION; INHIBITORS; PREDICTION; MUTATIONS; MECHANISM	Ty1 is one of the many transposons in the budding yeast Saccharomyces cerevisiae. The life-cycle of Ty1 shows numerous similarities with that of retroviruses, e.g. the initially synthesized polyprotein precursor undergoes proteolytic processing by the protease. The retroviral proteases have become important targets of current antiretroviral therapies due to the critical role of the limited proteolysis of Gag-Pol polyprotein in the replication cycle and they therefore belong to the most well-studied enzymes. Comparative analyses of retroviral and retroviral-like proteases can help to explore the key similarities and differences which may help understanding how resistance is developed against protease inhibitors, but the available information about the structural and biochemical characteristics of retroviral-like, and especially retrotransposon, proteases is limited. To investigate the main characteristics of Ty1 retrotransposon protease of Saccharomyces cerevisiae, untagged and His6-tagged forms of Ty1 protease were expressed in E. coli. After purification of the recombinant proteins, activity measurements were performed using synthetic oligopeptide and fluorescent recombinant protein substrates, which represented the wild-type and the modified forms of naturally occurring cleavage sites of the protease. We investigated the dependence of enzyme activity on different reaction conditions (pH, temperature, ionic strength, and urea concentration), and determined enzyme kinetic parameters for the studied substrates. Inhibitory potentials of 10 different protease inhibitors were also tested. Ty1 protease was not inhibited by the inhibitors which have been designed against human immunodeficiency virus type 1 protease and are approved as antiretroviral therapeutics. A quaternary structure of homodimeric Ty1 protease was proposed based on homology modeling, and this structure was used to support interpretation of experimental results and to correlate some structural and biochemical characteristics with that of other retroviral proteases.	[Gazda, Livia Diana; Matuz, Krisztina Joone; Motyan, Janos Andras; Tozser, Jozsef] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary; [Nagy, Tibor] Univ Debrecen, Fac Sci & Technol, Dept Appl Chem, Debrecen, Hungary; [Gazda, Livia Diana; Matuz, Krisztina Joone] Touchlight Genet Ltd, Hampton, VA USA; [Matuz, Krisztina Joone] Univ Debrecen, Dept Pharmacol, Fac Med, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Motyan, JA; Tozser, J (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Debrecen, Hungary.	motyan.janos@med.unideb.hu; tozser@med.unideb.hu	Mótyán, János András/AAA-1839-2021	Motyan, Janos Andras/0000-0002-6079-5621	Ministry of Human Capacities in Hungary of the University of Debrecen [GINOP-2.3.2-15-2016-00044]; European Union [GINOP-2.3.3-15-2016-00021]; European Regional Development Fund [GINOP-2.3.3-15-2016-00021]	Ministry of Human Capacities in Hungary of the University of Debrecen; European Union(European Commission); European Regional Development Fund(European Commission)	This work was financed in part by the GINOP-2.3.2-15-2016-00044 "PHARMPROT teaming" project and by the Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary, within the framework of the Biotechnology thematic programme of the University of Debrecen. Furthermore, this paper was also supported by the GINOP-2.3.3-15-2016-00021 project, co-financed by the European Union and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SE, 1987, CELL, V49, P111, DOI 10.1016/0092-8674(87)90761-6; Athauda SBP, 2006, BIOCHEM J, V399, P535, DOI 10.1042/BJ20060800; Bagossi P, 2005, J VIROL, V79, P4213, DOI 10.1128/JVI.79.7.4213-4218.2005; BELCOURT MF, 1990, CELL, V62, P339, DOI 10.1016/0092-8674(90)90371-K; Boross P, 1999, EUR J BIOCHEM, V264, P921, DOI 10.1046/j.1432-1327.1999.00687.x; Bozoki B, 2019, JOVE-J VIS EXP, V143; Bozoki B, 2018, ANAL BIOCHEM, V540, P52, DOI 10.1016/j.ab.2017.11.001; BROOKMAN JL, 1995, VIROLOGY, V212, P69, DOI 10.1006/viro.1995.1454; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; CLARE JJ, 1988, P NATL ACAD SCI USA, V85, P6816, DOI 10.1073/pnas.85.18.6816; Coffin J, 1997, RETROVIRUSES; Curcio MJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0053-2014; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; CURCIO MJ, 1992, MOL CELL BIOL, V12, P2813, DOI 10.1128/MCB.12.6.2813; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Eizert H, 2008, J VIROL, V82, P10111, DOI 10.1128/JVI.00418-08; Feher A, 2002, EUR J BIOCHEM, V269, P4114, DOI 10.1046/j.1432-1033.2002.03105.x; Fenyofalvi G, 1999, FEBS LETT, V462, P397, DOI 10.1016/S0014-5793(99)01563-X; Friedl AA, 2010, MOL GENET GENOMICS, V284, P231, DOI 10.1007/s00438-010-0561-4; GARFINKEL DJ, 1991, J VIROL, V65, P4573, DOI 10.1128/JVI.65.9.4573-4581.1991; Gustchina A, 1996, PROTEIN SCI, V5, P1453, DOI 10.1002/pro.5560050802; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KIRCHNER J, 1993, J VIROL, V67, P19, DOI 10.1128/JVI.67.1.19-28.1993; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laco GS, 2015, BIOCHIMIE, V118, P90, DOI 10.1016/j.biochi.2015.08.009; Lawler JF, 2002, J VIROL, V76, P4233, DOI 10.1128/JVI.76.9.4233-4240.2002; Lawler JF, 2001, J VIROL, V75, P6769, DOI 10.1128/JVI.75.15.6769-6775.2001; Li M, 2011, FEBS J, V278, P4413, DOI 10.1111/j.1742-4658.2011.08364.x; Louis JM, 1999, J BIOL CHEM, V274, P6660, DOI 10.1074/jbc.274.10.6660; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Mahdi M, 2015, VIRUSES-BASEL, V7, P6152, DOI 10.3390/v7122931; Malik HS, 2001, GENOME RES, V11, P1187, DOI 10.1101/gr.185101; Matuz K, 2012, FEBS J, V279, P3276, DOI 10.1111/j.1742-4658.2012.08714.x; MELLOR J, 1985, NUCLEIC ACIDS RES, V13, P6249, DOI 10.1093/nar/13.17.6249; MENENDEZARIAS L, 1994, J BIOL CHEM, V269, P16795; Merkulov GV, 1996, J VIROL, V70, P5548, DOI 10.1128/JVI.70.8.5548-5556.1996; Merkulov GV, 2001, J VIROL, V75, P638, DOI 10.1128/JVI.75.2.638-644.2001; Moore SP, 2000, J VIROL, V74, P11522, DOI 10.1128/JVI.74.24.11522-11530.2000; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Motyan JA, 2018, DATA BRIEF, V18, P203, DOI 10.1016/j.dib.2018.03.031; MULLER F, 1987, MOL GEN GENET, V207, P421, DOI 10.1007/BF00331610; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Roth JF, 2000, YEAST, V16, P785, DOI 10.1002/1097-0061(20000630)16:9<785::AID-YEA550>3.0.CO;2-L; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Sperka T, 2006, PROTEIN ENG DES SEL, V19, P369, DOI 10.1093/protein/gzl021; Strisovsky K, 2000, PROTEIN SCI, V9, P1631, DOI 10.1110/ps.9.9.1631; Tozser J, 1996, J BIOL CHEM, V271, P6781, DOI 10.1074/jbc.271.12.6781; Tozser J, 2010, VIRUSES-BASEL, V2, P147, DOI 10.3390/v2010147; van Eunen K., 2014, PERSPECT SCI, V1, P126, DOI [10.1016/j.pisc.2014.02.011, DOI 10.1016/J.PISC.2014.02.011]; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; YOUNGREN SD, 1988, MOL CELL BIOL, V8, P1421, DOI 10.1128/MCB.8.4.1421	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227062	10.1371/journal.pone.0227062	http://dx.doi.org/10.1371/journal.pone.0227062			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917798	gold, Green Published			2022-12-26	WOS:000534341100013
J	Yamauchi, M; Kinjo, T; Parrott, G; Miyagi, K; Haranaga, S; Nakayama, Y; Chibana, K; Fujita, K; Nakamoto, A; Higa, F; Owan, I; Yonemoto, K; Fujita, J				Yamauchi, Momoko; Kinjo, Takeshi; Parrott, Gretchen; Miyagi, Kazuya; Haranaga, Shusaku; Nakayama, Yuko; Chibana, Kenji; Fujita, Kaori; Nakamoto, Atsushi; Higa, Futoshi; Owan, Isoko; Yonemoto, Koji; Fujita, Jiro			Diagnostic performance of serum interferon gamma, matrix metalloproteinases, and periostin measurements for pulmonary tuberculosis in Japanese patients with pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MYCOBACTERIUM-TUBERCULOSIS; DISEASE; MATRIX-METALLOPROTEINASE-9; SEVERITY; PROTEIN; PLASMA; MYOFIBROBLASTS; BIOMARKER; ASTHMA	Serum markers that differentiate between tuberculous and non-tuberculous pneumonia would be clinically useful. However, few serum markers have been investigated for their association with either disease. In this study, serum levels of interferon gamma (IFN-gamma), matrix metalloproteinases 1 and 9 (MMP-1 and MMP-9, respectively), and periostin were compared between 40 pulmonary tuberculosis (PTB) and 28 non-tuberculous pneumonia (non-PTB) patients. Diagnostic performance was assessed by analysis of receiver-operating characteristic (ROC) curves and classification trees. Serum IFN-gamma and MMP-1 levels were significantly higher and serum MMP-9 levels significantly lower in PTB than in non-PTB patients (p < 0.001, p = 0.002, p < 0.001, respectively). No significant difference was observed in serum periostin levels between groups. ROC curve analysis could not determine the appropriate cut-off value with high sensitivity and specificity; therefore, a classification tree method was applied. This method identified patients with limited infiltration into three groups with statistical significance (p = 0.01), and those with MMP-1 levels < 0.01 ng/mL and periostin levels >= 118.8 ng/mL included only non-PTB patients (95% confidence interval 0.0-41.0). Patients with extensive infiltration were also divided into three groups with statistical significance (p < 0.001), and those with MMP-9 levels < 3.009 ng/mL included only PTB patients (95% confidence interval 76.8-100.0). In conclusion, the novel classification tree developed using MMP-1, MMP-9, and periostin data distinguished PTB from non-PTB patients. Further studies are needed to validate our cut-off values and the overall clinical usefulness of these markers.	[Yamauchi, Momoko; Kinjo, Takeshi; Parrott, Gretchen; Miyagi, Kazuya; Haranaga, Shusaku; Fujita, Jiro] Univ Ryukyus, Dept Infect Resp & Digest Med, Grad Sch Med, Okinawa, Japan; [Haranaga, Shusaku] Univ Ryukyus Hosp, Ctr Gen Clin Training & Educ, Okinawa, Japan; [Nakayama, Yuko; Chibana, Kenji; Fujita, Kaori; Nakamoto, Atsushi; Higa, Futoshi; Owan, Isoko] Natl Hosp Org Okinawa Hosp, Dept Resp Med, Okinawa, Japan; [Yonemoto, Koji] Univ Ryukyus, Sch Hlth Sci, Div Biostat, Fac Med, Okinawa, Japan; [Yonemoto, Koji] Univ Ryukyus, Div Biostat, Adv Med Res Ctr, Fac Med, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus; University of the Ryukyus; University of the Ryukyus	Kinjo, T (corresponding author), Univ Ryukyus, Dept Infect Resp & Digest Med, Grad Sch Med, Okinawa, Japan.	t_kinjo@med.u-ryukyu.ac.jp						Al Shammari B, 2015, J INFECT DIS, V212, P463, DOI 10.1093/infdis/jiv076; Andrade BB, 2015, J IMMUNOL, V195, P2763, DOI 10.4049/jimmunol.1500942; [Anonymous], 1997, JPN J CHEMOTHER, V45, P762; Bircan HA, 2015, TURK J MED SCI, V45, P593, DOI 10.3906/sag-1402-51; Chandrashekara S, 2016, CYTOKINE, V81, P57, DOI 10.1016/j.cyto.2016.02.003; Chon SB, 2013, INT J TUBERC LUNG D, V17, P1626, DOI 10.5588/ijtld.13.0183; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Elkington PT, 2011, EUR RESPIR J, V38, P456, DOI 10.1183/09031936.00015411; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Jhun BW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30967-9; Kaarteenaho-Wiik R, 2007, HUM PATHOL, V38, P147, DOI 10.1016/j.humpath.2006.07.001; Koguchi Y, 2003, AM J RESP CRIT CARE, V167, P1355, DOI 10.1164/rccm.200209-1113OC; Li W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0218-2; Li YT, 2016, INT J MED SCI, V13, P638, DOI 10.7150/ijms.16187; Matsumoto H, 2014, ALLERGOL INT, V63, P153, DOI 10.2332/allergolint.13-RAI-0678; Min FG, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5089752; Namuganga AR, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2687-z; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Ong CWM, 2014, AM J RESP CRIT CARE, V190, P9, DOI 10.1164/rccm.201311-2106PP; OOTAKI A, 1998, APPL TREE BASED METH; Peto L, 2014, T ROY SOC TROP MED H, V108, P326, DOI 10.1093/trstmh/tru058; Sathyamoorthy T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117605; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Tamayose M, 2015, J INFECT CHEMOTHER, V21, P456, DOI 10.1016/j.jiac.2015.02.009; Verma SC, 2016, TUBERCULOSIS, V97, P172, DOI 10.1016/j.tube.2015.10.009; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Xu DD, 2015, PROTEOMICS, V15, P58, DOI 10.1002/pmic.201400366; Yamada G, 2000, AM J RESP CRIT CARE, V161, P1786, DOI 10.1164/ajrccm.161.6.9911054; Yang SF, 2005, CLIN CHIM ACTA, V352, P209, DOI 10.1016/j.cccn.2004.09.025	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227636	10.1371/journal.pone.0227636	http://dx.doi.org/10.1371/journal.pone.0227636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917802	Green Published, gold			2022-12-26	WOS:000534341100028
J	Lafita-Navarro, MC; Liano-Pons, J; Quintanilla, A; Varela, I; Blanco, R; Ourique, F; Bretones, G; Aresti, J; Molina, E; Carroll, P; Hurlin, P; Romero, OA; Sanchez-Cespedes, M; Eisenman, RN; Delgado, MD; Leon, J				Lafita-Navarro, M. Carmen; Liano-Pons, Judit; Quintanilla, Andrea; Varela, Ignacio; Blanco, Rosa; Ourique, Fabiana; Bretones, Gabriel; Aresti, Julia; Molina, Ester; Carroll, Patrick; Hurlin, Peter; Romero, Octavio A.; Sanchez-Cespedes, Montse; Eisenman, Robert N.; Delgado, M. Dolores; Leon, Javier			The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); proliferation; gene regulation; promoter; transcription; basic helix-loop-helix leucine zipper protein; MAX dimerization protein MLX; MAX network transcriptional repressor (MNT); MXD family; MYC-associated factor X (MAX)	MAX-INTERACTING PROTEIN; NERVE GROWTH-FACTOR; C-MYC; BHLHZIP PROTEIN; CYCLE CONTROL; E-BOX; DIFFERENTIATION; NETWORK; MLX; INDUCTION	The MAX network transcriptional repressor (MNT) is an MXD family transcription factor of the basic helix-loop-helix (bHLH) family. MNT dimerizes with another transcriptional regulator, MYC-associated factor X (MAX), and down-regulates genes by binding to E-boxes. MAX also dimerizes with MYC, an oncogenic bHLH transcription factor. Upon E-box binding, the MYC?MAX dimer activates gene expression. MNT also binds to the MAX dimerization protein MLX (MLX), and MNT?MLX and MNT?MAX dimers co-exist. However, all MNT functions have been attributed to MNT?MAX dimers, and no functions of the MNT?MLX dimer have been described. MNT's biological role has been linked to its function as a MYC oncogene modulator, but little is known about its regulation. We show here that MNT localizes to the nucleus of MAX-expressing cells and that MNT?MAX dimers bind and repress the MNT promoter, an effect that depends on one of the two E-boxes on this promoter. In MAX-deficient cells, MNT was overexpressed and redistributed to the cytoplasm. Interestingly, MNT was required for cell proliferation even in the absence of MAX. We show that in MAX-deficient cells, MNT binds to MLX, but also forms homodimers. RNA-sequencing experiments revealed that MNT regulates the expression of several genes even in the absence of MAX, with many of these genes being involved in cell cycle regulation and DNA repair. Of note, MNT?MNT homodimers regulated the transcription of some genes involved in cell proliferation. The tight regulation of MNT and its functionality even without MAX suggest a major role for MNT in cell proliferation.	[Lafita-Navarro, M. Carmen; Liano-Pons, Judit; Quintanilla, Andrea; Varela, Ignacio; Blanco, Rosa; Ourique, Fabiana; Bretones, Gabriel; Aresti, Julia; Molina, Ester; Delgado, M. Dolores; Leon, Javier] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain; [Lafita-Navarro, M. Carmen; Liano-Pons, Judit; Quintanilla, Andrea; Varela, Ignacio; Blanco, Rosa; Ourique, Fabiana; Bretones, Gabriel; Aresti, Julia; Molina, Ester; Delgado, M. Dolores; Leon, Javier] Univ Cantabria, Dept Mol Biol, E-39005 Santander, Spain; [Carroll, Patrick; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hurlin, Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children Res Ctr, Portland, OR 97239 USA; [Hurlin, Peter] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Knight Canc Inst, Portland, OR 97239 USA; [Romero, Octavio A.; Sanchez-Cespedes, Montse] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Genes & Canc Grp, Barcelona 08908, Spain; [Quintanilla, Andrea] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Ourique, Fabiana] Univ Fed Santa Catarina, Dept Biochem, BR-88040900 Florianopolis, SC, Brazil; [Bretones, Gabriel] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo 33003, Asturias, Spain; [Aresti, Julia] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, NL-9712 CP Groningen, Netherlands; [Sanchez-Cespedes, Montse] Josep Carreras Leukemia Res Inst, Campus ICO Germans Trias & Pujol, Barcelona 08916, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Universidad de Cantabria; Fred Hutchinson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Edinburgh; Universidade Federal de Santa Catarina (UFSC); University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Groningen; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Leon, J (corresponding author), Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain.; Leon, J (corresponding author), Univ Cantabria, Dept Mol Biol, E-39005 Santander, Spain.	leonj@unican.es	Leon, Javier/K-4615-2014; Varela, Ignacio/AAA-7680-2021; Sanchez-Cespedes, Montse/H-8485-2012; Romero, Octavio A./AAA-8078-2020; Bretones, Gabriel/AAB-4637-2021; Delgado, M. Dolores/K-9056-2014	Varela, Ignacio/0000-0002-0969-506X; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Romero, Octavio A./0000-0003-0229-6530; Bretones, Gabriel/0000-0002-1521-5544; Delgado, M. Dolores/0000-0003-4682-4040; Carroll, Patrick/0000-0001-8147-5750; MOLINA, Ester/0000-0002-5138-6826; Ourique, Fabiana/0000-0002-2663-4015; LIANO-PONS, Judit/0000-0001-8097-4750; Lafita Navarro, Maria del Carmen/0000-0002-7266-651X	Agencia Estatal de Investigacion, Spanish Government [SAF2017-88026-R]; FEDER Program from the European Union; National Institutes of Health from NCI [CA57138/CA]; Shriners Hospitals for Children	Agencia Estatal de Investigacion, Spanish Government; FEDER Program from the European Union; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Shriners Hospitals for Children	This work was supported by Grant SAF2017-88026-R from Agencia Estatal de Investigacion, Spanish Government (to J. L. and M. D. D.), funded in part by FEDER Program from the European Union, National Institutes of Health Grant CA57138/CA from NCI (to R. N. E.), and grants from Shriners Hospitals for Children (to P. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albajar M, 2011, MOL CANCER RES, V9, P564, DOI 10.1158/1541-7786.MCR-10-0356; Altieri DC, 2015, SEMIN CELL DEV BIOL, V39, P91, DOI 10.1016/j.semcdb.2014.12.007; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Campbell KJ, 2017, CELL DEATH DIFFER, V24, P2117, DOI 10.1038/cdd.2017.131; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; CONACCISORRELL M, 2014, CSH PERSPECT MED, V4, DOI DOI 10.1101/CSHPERSPECT.A014357; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Lafita-Navarro MDC, 2016, ONCOTARGET, V7, P69536, DOI 10.18632/oncotarget.11766; Dezfouli S, 2006, MOL CELL BIOL, V26, P2080, DOI 10.1128/MCB.26.6.2080-2092.2006; Diolaiti D, 2015, BBA-GENE REGUL MECH, V1849, P484, DOI 10.1016/j.bbagrm.2014.05.016; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferrandiz N, 2009, DNA REPAIR, V8, P390, DOI 10.1016/j.dnarep.2008.12.001; Foley KP, 1998, EMBO J, V17, P774, DOI 10.1093/emboj/17.3.774; Gallant P, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014324; Garcia-Sanz P, 2014, J BIOL CHEM, V289, P22221, DOI 10.1074/jbc.M113.538744; GUERRERO I, 1988, BIOCHEM BIOPH RES CO, V150, P1185, DOI 10.1016/0006-291X(88)90754-1; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOPEWELL R, 1995, MOL CELL BIOL, V15, P3470; Hurlin PJ, 1997, CURR TOP MICROBIOL, V224, P115; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Link JM, 2012, P NATL ACAD SCI USA, V109, P19685, DOI 10.1073/pnas.1206406109; MARUYAMA K, 1987, ONCOGENE, V1, P361; Mathsyaraja H, 2019, GENE DEV, V33, P1252, DOI 10.1101/gad.325878.119; Mauleon I, 2004, MOL CARCINOGEN, V39, P85, DOI 10.1002/mc.20000; Meroni G, 1997, EMBO J, V16, P2892, DOI 10.1093/emboj/16.10.2892; Meroni G, 2000, ONCOGENE, V19, P3266, DOI 10.1038/sj.onc.1203634; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nilsson JA, 2004, MOL CELL BIOL, V24, P1560, DOI 10.1128/MCB.24.4.1560-1569.2004; Popov N, 2005, ONCOGENE, V24, P8326, DOI 10.1038/sj.onc.1208961; Queva C, 1999, CELL GROWTH DIFFER, V10, P785; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Terragni J, 2011, J BIOL CHEM, V286, P36215, DOI 10.1074/jbc.M111.246116; Toyo-oka K, 2004, HUM MOL GENET, V13, P1057, DOI 10.1093/hmg/ddh116; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vaque JP, 2008, MOL CANCER RES, V6, P325, DOI 10.1158/1541-7786.MCR-07-0180; Walker W, 2005, J CELL BIOL, V169, P405, DOI 10.1083/jcb.200411013; Yang G, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020083	50	8	8	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2001	2017		10.1074/jbc.RA119.010389	http://dx.doi.org/10.1074/jbc.RA119.010389			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31919096	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000517128200019
J	Olson, AK; Bouchard, B; Zhu, WZ; Chatham, JC; Des Rosiers, C				Olson, Aaron K.; Bouchard, Bertrand; Zhu, Wei Zhong; Chatham, John C.; Des Rosiers, Christine			First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in ex vivo mouse heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose; glucose metabolism; carbohydrate metabolism; cardiac metabolism; O-linked N-acetylglucosamine (O-GlcNAc); post-translational modification (PTM); glucosamine; hexosamine biosynthesis pathway; metabolic flux; protein glycosylation; UDP-GlcNAc	PROTEIN O-GLCNACYLATION; LIQUID-CHROMATOGRAPHY; GLCNAC LEVELS; RAT-HEART; HYPERTROPHY; REPERFUSION; INHIBITION; GLUTAMINE; AMIDOTRANSFERASE; OVEREXPRESSION	The hexosamine biosynthesis pathway (HBP) branches from glycolysis and forms UDP-GlcNAc, the moiety for O-linked ?-GlcNAc (O-GlcNAc) post-translational modifications. An inability to directly measure HBP flux has hindered our understanding of the factors regulating protein O-GlcNAcylation. Our goals in this study were to (i) validate a LC-MS method that assesses HBP flux as UDP-GlcNAc (C-13)-molar percent enrichment (MPE) and concentration and (ii) determine whether glucose availability or workload regulate cardiac HBP flux. For (i), we perfused isolated murine working hearts with [U-C-13(6)]glucosamine (1, 10, 50, or 100 ?m), which bypasses the rate-limiting HBP enzyme. We observed a concentration-dependent increase in UDP-GlcNAc levels and MPE, with the latter reaching a plateau of 56.3 ? 2.9%. For (ii), we perfused isolated working hearts with [U-C-13(6)]glucose (5.5 or 25 mm). Glycolytic efflux doubled with 25 mm [U-C-13(6)]glucose; however, the calculated HBP flux was similar among the glucose concentrations at ?2.5 nmol/g of heart protein/min, representing ?0.003?0.006% of glycolysis. Reducing cardiac workload in beating and nonbeating Langendorff perfusions had no effect on the calculated HBP flux at ?2.3 and 2.5 nmol/g of heart protein/min, respectively. To the best of our knowledge, this is the first direct measurement of glucose flux through the HBP in any organ. We anticipate that these methods will enable foundational analyses of the regulation of HBP flux and protein O-GlcNAcylation. Our results suggest that in the healthy ex vivo perfused heart, HBP flux does not respond to acute changes in glucose availability or cardiac workload.	[Olson, Aaron K.] Univ Washington, Dept Pediat, Div Cardiol, Seattle, WA 98105 USA; [Olson, Aaron K.; Zhu, Wei Zhong] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Bouchard, Bertrand; Des Rosiers, Christine] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Bouchard, Bertrand; Des Rosiers, Christine] Univ Montreal, Dept Nutr, Montreal, PQ H1T 1C8, Canada; [Chatham, John C.] Univ Alabama Birmingham, Dept Pathol, Div Mol & Cellular Pathol, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; Universite de Montreal; Universite de Montreal; University of Alabama System; University of Alabama Birmingham	Olson, AK (corresponding author), Seattle Childrens Res Inst, Seattle, WA 98101 USA.	Aaron.Olson@seattlechildrens.org		Olson, Aaron/0000-0002-5237-400X	NHLBI, National Institutes of Health [R01HL122546]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Grant R01HL122546 (to A. K. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Chatham JC, 2010, CURR SIGNAL TRANSD T, V5, P49, DOI 10.2174/157436210790226492; Chen SY, 2017, J THORAC DIS, V9, P1725, DOI 10.21037/jtd.2017.05.34; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Dassanayaka S, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0612-7; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Fricovsky ES, 2012, AM J PHYSIOL-REG I, V303, pR689, DOI 10.1152/ajpregu.00548.2011; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Han J, 2013, ANAL CHEM, V85, P5965, DOI 10.1021/ac400769g; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hu Y, 2005, CIRC RES, V96, P1006, DOI 10.1161/01.RES.0000165478.06813.58; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Khairallah M, 2004, AM J PHYSIOL-HEART C, V286, pH1461, DOI 10.1152/ajpheart.00942.2003; KORNFELD R, 1967, J BIOL CHEM, V242, P3135; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Lauzier B, 2013, J MOL CELL CARDIOL, V55, P92, DOI 10.1016/j.yjmcc.2012.11.008; Lauzier B, 2011, AM J PHYSIOL-HEART C, V300, pH845, DOI 10.1152/ajpheart.01034.2010; Ledee D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135262; Ledee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065532; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu J, 2007, J MOL CELL CARDIOL, V42, P177, DOI 10.1016/j.yjmcc.2006.09.015; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Mailleux F, 2016, BBA-MOL BASIS DIS, V1862, P2232, DOI 10.1016/j.bbadis.2016.08.012; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Nabeebaccus AA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96184; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Olson AK, 2013, J MOL CELL CARDIOL, V55, P156, DOI 10.1016/j.yjmcc.2012.07.005; Ruiz M, 2015, METHOD ENZYMOL, V561, P107, DOI 10.1016/bs.mie.2015.06.026; Standage SW, 2017, AM J PHYSIOL-HEART C, V312, pH239, DOI 10.1152/ajpheart.00457.2016; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; Vincent G, 2003, MOL CELL BIOCHEM, V242, P89, DOI 10.1023/A:1021189728877; Wakamatsu A, 2005, J SEP SCI, V28, P1823, DOI 10.1002/jssc.200400027; Watson LJ, 2010, P NATL ACAD SCI USA, V107, P17797, DOI 10.1073/pnas.1001907107; Yokoe S, 2010, GLYCOBIOLOGY, V20, P1217, DOI 10.1093/glycob/cwq071; Zhu WZ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011260	42	36	36	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2018	2033		10.1074/jbc.RA119.010565	http://dx.doi.org/10.1074/jbc.RA119.010565			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915250	hybrid, Green Published			2022-12-26	WOS:000517128200020
J	Torres-Ramos, S; Salido-Ruiz, RA; Espinoza-Valdez, A; Gomez-Velazquez, FR; Gonzalez-Garrido, AA; Roman-Godinez, I				Torres-Ramos, Sulema; Salido-Ruiz, Ricardo A.; Espinoza-Valdez, Aurora; Gomez-Velazquez, Fabiola R.; Gonzalez-Garrido, Andres A.; Roman-Godinez, Israel			A brain connectivity characterization of children with different levels of mathematical achievement based on graph metrics	PLOS ONE			English	Article							EEG COHERENCE; OCULAR ARTIFACTS; TASK; SYNCHRONIZATION; PERFORMANCE; THETA; MATH; ICA	Recent studies aiming to facilitate mathematical skill development in primary school children have explored the electrophysiological characteristics associated with different levels of arithmetic achievement. The present work introduces an alternative EEG signal characterization using graph metrics and, based on such features, a classification analysis using a decision tree model. This proposal aims to identify group differences in brain connectivity networks with respect to mathematical skills in elementary school children. The methods of analysis utilized were signal-processing (EEG artifact removal, Laplacian filtering, and magnitude square coherence measurement) and the characterization (Graph metrics) and classification (Decision Tree) of EEG signals recorded during performance of a numerical comparison task. Our results suggest that the analysis of quantitative EEG frequency-band parameters can be used successfully to discriminate several levels of arithmetic achievement. Specifically, the most significant results showed an accuracy of 80.00% (alpha band), 78.33% (delta band), and 76.67% (theta band) in differentiating high-skilled participants from low-skilled ones, averaged-skilled subjects from all others, and averaged-skilled participants from low-skilled ones, respectively. The use of a decision tree tool during the classification stage allows the identification of several brain areas that seem to be more specialized in numerical processing.	[Torres-Ramos, Sulema; Salido-Ruiz, Ricardo A.; Espinoza-Valdez, Aurora; Roman-Godinez, Israel] Univ Guadalajara, Dept Ciencias Comp, Guadalajara, Jalisco, Mexico; [Gomez-Velazquez, Fabiola R.; Gonzalez-Garrido, Andres A.] Univ Guadalajara, Inst Neurociencias, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara	Roman-Godinez, I (corresponding author), Univ Guadalajara, Dept Ciencias Comp, Guadalajara, Jalisco, Mexico.	israel.roman@cucei.udg.mx	González-Garrido, Andrés A./T-3044-2019; Salido-Ruiz, Ricardo Antonio/B-3957-2018; Gómez-Velázquez, Fabiola R/AAE-8467-2022	González-Garrido, Andrés A./0000-0003-4594-5270; Salido-Ruiz, Ricardo Antonio/0000-0001-6135-9306; Gómez-Velázquez, Fabiola R/0000-0002-2081-6280; Roman-Godinez, Israel/0000-0002-7404-8096				Abboud S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7026; Allwein E. L., 2001, Journal of Machine Learning Research, V1, P113, DOI 10.1162/15324430152733133; Ansari D, 2005, NEUROREPORT, V16, P1769, DOI 10.1097/01.wnr.0000183905.23396.f1; Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Arvaneh M., 2010, P 2 APSIPA ANN SUMMI, P225; Barry RJ, 2005, INT J PSYCHOPHYSIOL, V55, P313, DOI 10.1016/j.ijpsycho.2004.09.001; Bosch P, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/4638903; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Chorlian DB, 2009, EXP BRAIN RES, V198, P59, DOI 10.1007/s00221-009-1936-9; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Deng S., 2011, INT J BIOELECTROMAGN, V13, P173; Deng SY, 2012, IEEE T BIO-MED ENG, V59, P2979, DOI 10.1109/TBME.2012.2183638; Dimitriadis SI, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00454; Eva Oana Diana, 2015, International Journal of Advanced Research in Artificial Intelligence, V4, P8; Flexer A, 2005, NEURAL NETWORKS, V18, P998, DOI 10.1016/j.neunet.2005.03.012; Gonzalez-Garrido AA, 2018, BRAIN COGNITION, V124, P57, DOI 10.1016/j.bandc.2018.04.006; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Graziano AB, 1999, NEUROL RES, V21, P139, DOI 10.1080/01616412.1999.11740910; Grillner S, 2005, CURR OPIN NEUROBIOL, V15, P614, DOI 10.1016/j.conb.2005.08.017; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han J, 2012, MOR KAUF D, P1; Hastie T, 1998, ADV NEUR IN, V10, P507; Hawkins D.M, 1980, IDENTIFICATION OUTLI, V11; Hesse PN, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00070; Hidasi Z, 2007, INT J PSYCHOPHYSIOL, V65, P252, DOI 10.1016/j.ijpsycho.2007.05.002; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Holloway ID, 2010, NEUROIMAGE, V49, P1006, DOI 10.1016/j.neuroimage.2009.07.071; Horschig JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138685; Jadhav PN, 2014, IEEE ENG MED BIO, P1881, DOI 10.1109/EMBC.2014.6943977; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jiang Zheng-yan, 2005, J Zhejiang Univ Sci B, V6, P1213, DOI 10.1631/jzus.2005.B1213; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jutten C., 1988, Signal Processing IV: Theories and Applications. Proceedings of EUSIPCO-88. Fourth European Signal Processing Conference, P643; Jutten C, 1991, P INT WORKSH HIGH OR, P273; Kaufmann L, 2006, NEUROREPORT, V17, P587, DOI 10.1097/00001756-200604240-00007; Kitaura Y, 2017, CLIN NEUROPHYS PRACT, V2, P193, DOI 10.1016/j.cnp.2017.09.002; Klados MA, 2017, INT J PSYCHOPHYSIOL, V122, P24, DOI 10.1016/j.ijpsycho.2017.05.003; Klados MA, 2011, BIOMED SIGNAL PROCES, V6, P291, DOI 10.1016/j.bspc.2011.02.001; Knorr E. M., 1998, Proceedings of the Twenty-Fourth International Conference on Very-Large Databases, P392; Knorr EM, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P211; Knyazeva MG, 1999, J NEUROPHYSIOL, V82, P3095, DOI 10.1152/jn.1999.82.6.3095; Kuhn-Popp N, 2016, SOC NEUROSCI-UK, V11, P49, DOI 10.1080/17470919.2015.1024887; Lai K. W., 2014, ADV MED DIAGNOSTIC T; Lotte F, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab2f2; Lowe MJ, 2016, J INT NEUROPSYCH SOC, V22, P105, DOI 10.1017/S1355617716000060; Masuda N, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00007; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; Mizuhara H, 2005, NEUROIMAGE, V27, P553, DOI 10.1016/j.neuroimage.2005.04.030; Moazami-Goudarzi M, 2008, NEUROIMAGE, V41, P985, DOI 10.1016/j.neuroimage.2008.03.032; Moore RA, 2012, INT J PSYCHOPHYSIOL, V85, P135, DOI 10.1016/j.ijpsycho.2012.06.006; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; NUNEZ PL, 1994, ELECTROEN CLIN NEURO, V90, P40, DOI 10.1016/0013-4694(94)90112-0; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Price GR, 2018, DEV COGN NEUROS-NETH, V30, P280, DOI 10.1016/j.dcn.2017.02.006; Price GR, 2011, NEUROIMAGE, V57, P1205, DOI 10.1016/j.neuroimage.2011.05.035; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Reilly C, 2014, EPILEPSIA, V55, P1910, DOI 10.1111/epi.12826; Gomez-Velazquez FR, 2015, BRAIN RES, V1627, P189, DOI 10.1016/j.brainres.2015.09.009; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schwartz F, 2018, NEUROIMAGE-CLIN, V20, P1255, DOI 10.1016/j.nicl.2018.10.020; Schwartz S, 2017, PEDIATR NEUROL, V67, P7, DOI 10.1016/j.pediatrneurol.2016.10.018; Shalev RS, 2001, PEDIATR NEUROL, V24, P337, DOI 10.1016/S0887-8994(00)00258-7; Soltanlou M, 2019, DEV NEUROPSYCHOL, V44, P325, DOI 10.1080/87565641.2019.1586906; Soltanlou M, 2017, COGN AFFECT BEHAV NE, V17, P724, DOI 10.3758/s13415-017-0508-x; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Spuler M, 2016, ZDM-MATH EDUC, V48, P267, DOI 10.1007/s11858-015-0754-8; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Szucs D, 2013, DEV DYSCALCULIA FRES; Talia D, 2016, COMPUT SCI REV TR, P1; THATCHER RW, 1986, ELECTROEN CLIN NEURO, V64, P123, DOI 10.1016/0013-4694(86)90107-0; Vanbinst K, 2018, J EXP CHILD PSYCHOL, V166, P232, DOI 10.1016/j.jecp.2017.08.008; Vecchiato G, 2013, BRAIN TOPOGR, V26, P303, DOI 10.1007/s10548-012-0259-5; Vecchio F, 2016, NEUROSCIENCE, V316, P143, DOI 10.1016/j.neuroscience.2015.12.036; Vecchio F, 2017, BRAIN IMAGING BEHAV, V11, P473, DOI 10.1007/s11682-016-9528-3; Vigario RN, 1997, ELECTROEN CLIN NEURO, V103, P395, DOI 10.1016/S0013-4694(97)00042-8; Vildavski VY, 2019, COMMUNICATION; Wang Q, 2013, IEEE T NEUR SYS REH, V21, P225, DOI 10.1109/TNSRE.2012.2236576; Wang S, 2014, P IEEE S COMP COMM I, P1, DOI DOI 10.1109/ITPRO.2014.7029303; Wei JH, 1998, ELECTROEN CLIN NEURO, V106, P416, DOI 10.1016/S0013-4694(97)00161-2; Widagdo MM, 1998, INT J NEUROSCI, V95, P63, DOI 10.3109/00207459809000650; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Williams CC, 2019, NEUROIMAGE, V189, P574, DOI 10.1016/j.neuroimage.2019.01.048; Witten IH, 2011, MOR KAUF D, P1; Zhang HM, 2017, ENVIRON HEALTH PERSP, V125, P746, DOI 10.1289/EHP478	86	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227613	10.1371/journal.pone.0227613	http://dx.doi.org/10.1371/journal.pone.0227613			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PU	31951604	gold, Green Published			2022-12-26	WOS:000534370500024
J	Caro, JC; Valizadeh, P; Correa, A; Silva, A; Ng, SW				Caro, Juan Carlos; Valizadeh, Pourya; Correa, Alejandrina; Silva, Andres; Ng, Shu Wen			Combined fiscal policies to promote healthier diets: Effects on purchases and consumer welfare	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; PRICE ELASTICITY; DEMAND SYSTEMS; PUBLIC-HEALTH; FOOD TAXES; JUNK-FOOD; FAT-TAX; OBESITY; CONSUMPTION; IMPACT	Taxes on unhealthy foods and sweetened beverages, as well as subsidies to healthy foods, have become increasingly popular strategies to curb obesity and related non-communicable diseases. The existing evidence on the welfare effects of such fiscal policies is mixed and almost uniquely focused on tax schemes. Using the 2016-2017 Chilean Household Budget Survey, we estimate a censored Exact Affine Stone Index (EASI) incomplete demand system and simulate changes in purchases, tax incidence, and consumer welfare of three different policy scenarios: (1) a 5 percentage point additional tax on sweetened beverages (currently taxed at 18%) and a new 18% tax on sweets and snacks, (2) a healthy subsidy by zero-rating fruits and vegetables from the current 19% value-added tax, and (3) a combined (tax plus subsidy) policy. Under full pass-through of these policies, the combined scheme captures the incentives to switch purchases from both single-policy alternatives, resulting in a net welfare gain and subsidy transfer for the average Chilean household. In terms of welfare, low-income households strictly benefit from a combined policy, while high-income households experience a small consumer welfare loss, resulting in re-distributional effects.	[Caro, Juan Carlos] Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Valizadeh, Pourya; Ng, Shu Wen] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Correa, Alejandrina] Univ Chile, Dept Econ, Santiago, Chile; [Silva, Andres] Univ Cent Chile, Dept Econ Govt & Commun, Santiago, Chile; [Ng, Shu Wen] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Universidad de Chile; Universidad Central de Chile; University of North Carolina; University of North Carolina Chapel Hill	Caro, JC (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	juancaro@live.unc.edu		Caro, Juan C/0000-0002-1124-2617; Ng, Shu Wen/0000-0003-0582-110X; Valizadeh, Pourya/0000-0001-9564-4754	Bloomberg Philanthropies; Chile's Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); CPC NIH grant [P2C HD050924]; CPC [P2C HD050924]; CONICYT PAI/INDUSTRIA [79090016]	Bloomberg Philanthropies; Chile's Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CPC NIH grant; CPC; CONICYT PAI/INDUSTRIA	Funding for this research comes predominantly from Bloomberg Philanthropies with added funding for JCC from Chile's Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) and CPC NIH grant P2C HD050924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Bloomberg Philanthropies, and CPC P2C HD050924 for financial support. This work was also funded by the CONICYT PAI/INDUSTRIA 79090016. None of the authors have conflict of interests of any type with respect to this manuscript. Any errors and shortcomings are our own. The views expressed in this article are those of the authors and do not necessarily represent those of their institutions.	Allais O, 2015, J HEALTH ECON, V43, P27, DOI 10.1016/j.jhealeco.2015.06.003; Anand SS, 2015, J AM COLL CARDIOL, V66, P1590, DOI 10.1016/j.jacc.2015.07.050; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Colchero MA, 2017, J NUTR, V147, P1552, DOI 10.3945/jn.117.251892; Batis C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002057; Benzarti Y, 2017, WHAT GOES MAY NOT CO; Bertail P, 2008, AM J AGR ECON, V90, P827, DOI 10.1111/j.1467-8276.2008.01138.x; Biro A, 2015, FOOD POLICY, V54, P107, DOI 10.1016/j.foodpol.2015.05.003; Brownell KD, 2009, PUBLIC HLTH ECONOMIC; Caillavet F, 2016, EUR REV AGRIC ECON, V43, P537, DOI 10.1093/erae/jbv041; Capacci S, 2011, J HEALTH ECON, V30, P87, DOI 10.1016/j.jhealeco.2010.10.006; Caro J. Carlos, 2019, CHILD DEV OBESITY PR; Caro JC, 2017, FOOD POLICY, V71, P86, DOI 10.1016/j.foodpol.2017.08.001; Chouinard HH, 2007, FORUM HLTH EC POLICY, V10, P1, DOI DOI 10.2202/1558-9544.1071; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Corvalan C, 2013, OBES REV, V14, P79, DOI 10.1111/obr.12099; COX TL, 1986, AM J AGR ECON, V68, P908, DOI 10.2307/1242137; DEATON A, 1988, AM ECON REV, V78, P418; Etile F, 2015, HEALTH ECON, V24, P1147, DOI 10.1002/hec.3157; Finkelstein E, 2005, AM J HEALTH PROMOT, V20, P45, DOI 10.4278/0890-1171-20.1.45; Finkelstein E, 2007, LIFETIME MEDICAL COS; Finkelstein EA, 2013, J HEALTH ECON, V32, P219, DOI 10.1016/j.jhealeco.2012.10.005; Gorman W.M., 1981, ESSAYS THEORY MEASUR, P7, DOI 10.1017/cbo9780511984082.003; Griffith R, 2016, USING TAXATION REDUC; HANEMANN M, 1992, J ENVIRON ECON MANAG, V22, P241, DOI 10.1016/0095-0696(92)90031-Q; Harding M, 2017, J HEALTH ECON, V53, P53, DOI 10.1016/j.jhealeco.2017.02.003; Harkanen T, 2014, FOOD POLICY, V49, P196, DOI 10.1016/j.foodpol.2014.07.001; Hawkes C, 2017, OBES REV, V18, P1374, DOI 10.1111/obr.12594; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; HEIEN D, 1990, J BUS ECON STAT, V8, P365, DOI 10.2307/1391973; Instituto Nacional de Estadisticas, 2018, 8VA ENC PRES FAM; LAFRANCE JT, 1989, AM J AGR ECON, V71, P262, DOI 10.2307/1241583; Lewbel A, 2006, EQUIVALENCE SCALES E; Lewbel A, 2009, AM ECON REV, V99, P827, DOI 10.1257/aer.99.3.827; Lusk JL, 2012, HEALTH ECON, V21, P1367, DOI 10.1002/hec.1789; Madden D, 2015, HEALTH ECON, V24, P104, DOI 10.1002/hec.3006; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Miao Z, 2013, HEALTH ECON, V22, P1318, DOI 10.1002/hec.2885; Ministerio de Salud, 2017, ENCUESTA NACL SALUD; Muller L, 2017, ECON J, V127, P2066, DOI 10.1111/ecoj.12357; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; O'Donoghue T, 2006, J PUBLIC ECON, V90, P1825, DOI 10.1016/j.jpubeco.2006.03.001; Organization for Economic Co-operation and Development, 2017, OB UPD 2017; Pendakur K, 2009, CONTRIB ECON ANAL, V288, P179, DOI 10.1108/S0573-8555(2009)0000288010; Politi RB, 2011, CAN J ECON, V44, P1438, DOI 10.1111/j.1540-5982.2011.01680.x; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Sassi F, 2018, LANCET, V391, P2059, DOI [10.1016/S0140-6736(18)30531-2, 10.1016/s0140-6736(18)30531-2]; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Smed S, 2005, BRIT FOOD J, V107, P173, DOI 10.1108/00070700510586498; Smed S, 2005, DIFFERENTIATED FOOD; Stanhope KL, 2012, ANNU REV MED, V63, P329, DOI 10.1146/annurev-med-042010-113026; Strnad J, 2004, SOUTH CALIF LAW REV, V78, P1221; Thiele S, 2010, 115 JOINT EAAE AAEA, P0; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Tiffin R, 2011, EUR J CLIN NUTR, V65, P427, DOI 10.1038/ejcn.2010.281; Valizadeh P, 2019, IMPLICATIONS FOOD BE; van Oordt M, 2018, FISC STUD, V39, P489, DOI 10.1111/1475-5890.12168; World Cancer Research Fund International, 2018, BUILD MOM; World Health Organization, 2016, FISC POL DIET PREV N; Yaniv G, 2009, J PUBLIC ECON, V93, P823, DOI 10.1016/j.jpubeco.2009.02.004; Zhen C, 2014, AM J AGR ECON, V96, P1, DOI 10.1093/ajae/aat049; Zhen C, 2011, AM J AGR ECON, V93, P175, DOI 10.1093/ajae/aaq155	63	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226731	10.1371/journal.pone.0226731	http://dx.doi.org/10.1371/journal.pone.0226731			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940371	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000039
J	Marahatta, SB; Yadav, RK; Giri, D; Lama, S; Rijal, KR; Mishra, SR; Shrestha, A; Bhattrai, PR; Mahato, RK; Adhikari, B				Marahatta, Sujan Babu; Yadav, Rajesh Kumar; Giri, Deena; Lama, Sarina; Rijal, Komal Raj; Mishra, Shiva Raj; Shrestha, Ashish; Bhattrai, Pramod Raj; Mahato, Roshan Kumar; Adhikari, Bipin			Barriers in the access, diagnosis and treatment completion for tuberculosis patients in central and western Nepal: A qualitative study among patients, community members and health care workers	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ADHERENCE; DELAY	Background Nepal has achieved a significant reduction of TB incidence over the past decades. Nevertheless, TB patients continue to experience barriers in access, diagnosis and completion of the treatment. The main objective of this study was to explore the factors affecting the access to the health services, diagnosis and the treatment completion for TB patients in central and western Nepal. Methods Data were collected using in-depth interviews (IDI) with the TB patients (n = 4); Focus Group Discussions (FGDs) with TB suspected patients (n = 16); Semi Strucutred Interviews (SSIs) with health workers (n = 24) and traditional healers (n = 2); and FGDs with community members (n = 8). All data were audio recorded, transcribed and translated to English. All transcriptions underwent thematic analysis using qualitative data analysis software: Atlas.ti. Results Barriers to access to the health centre were the long distance, poor road conditions, and costs associated with travelling. In addition, lack of awareness of TB and its consequences, and the belief, prompted many respondents to visit traditional healers. Early diagnosis of TB was hindered by lack of trained health personnel to use the equipment, lack of equipment and irregular presence of health workers. Additional barriers that impeded the adherence and treatment completion were the need to visit health centre daily for DOTS treatment and associated constraints, complex treatment regimen, and the stigma. Conclusions Barriers embedded in health services and care seekers' characteristics can be dealt by strengthening the peripheral health services. A continuous availability of (trained) human resources and equipment for diagnosis is critical. As well as increasing the awareness and collaborating with the traditional healers, health services utilization can be enhanced by compensating the costs associated with it, including the modification in current DOTS strategy by providing medicine for a longer term under the supervision of a family member, peer or a community volunteer.	[Marahatta, Sujan Babu; Yadav, Rajesh Kumar; Giri, Deena; Lama, Sarina] Manmohan Mem Inst Hlth Sci, Kathmandu, Nepal; [Rijal, Komal Raj] Tribhuwan Univ, Cent Dept Microbiol, Kathmandu, Nepal; [Mishra, Shiva Raj] Univ Queensland, Brisbane, Qld, Australia; [Shrestha, Ashish; Bhattrai, Pramod Raj] Natl TB Ctr, Bhaktapur, Nepal; [Mahato, Roshan Kumar] Dhulikhel Hosp, Dhulikhel, Nepal; [Adhikari, Bipin] Nepal Community Hlth & Dev Ctr, Kathmandu, Nepal; [Adhikari, Bipin] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England	Tribhuvan University; University of Queensland; University of Oxford	Adhikari, B (corresponding author), Nepal Community Hlth & Dev Ctr, Kathmandu, Nepal.; Adhikari, B (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.	biopion@gmail.com	Mishra, Shiva Raj/C-4172-2014; Rijal, Komal Raj/AAG-2828-2019	Mishra, Shiva Raj/0000-0002-2993-3504; Rijal, Komal Raj/0000-0001-6281-8236; Mahato, Roshan Kumar/0000-0001-9287-2743; Adhikari, Bipin/0000-0001-8981-3910	WHO-TDR, the Special Programme for Research and Training in Tropical Diseases [178861]	WHO-TDR, the Special Programme for Research and Training in Tropical Diseases	This study was funded by grants from the WHO-TDR, the Special Programme for Research and Training in Tropical Diseases. ID number: 178861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157746; Adhikari B, 2013, J Nepal Health Res Counc, V11, P264; Adhikari B, 2013, J MANMOHAN MEMORIAL, V1, P3; Adhikari B, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4070-9; Adhikari B, 2017, DISASTER MED PUBLIC, V11, P625, DOI 10.1017/dmp.2016.195; Adhikari B, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1366136; Adhikari B, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1593-y; Adhikari B, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00121; Adhikari B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002940; Banstola A, 2012, ISSUES THREATS TUBER; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Birch S, 2016, HEALTH POLICY PLANN, V31, P454, DOI 10.1093/heapol/czv084; Cai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120088; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Desalegn Daniel Melese, 2018, BMC Res Notes, V11, P291, DOI 10.1186/s13104-018-3414-6; Devkota B, 2013, J Nepal Health Res Counc, V11, P133; Dussault Gilles, 2003, Hum Resour Health, V1, P1, DOI 10.1186/1478-4491-1-1; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Glasser B.G., 1967, DISCOVERY GROUNDED T; Guneylioglu D, 2004, MED SCI MONITOR, V10, pCR62; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Kaehler N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129086; Khan MA, 2005, HEALTH POLICY PLANN, V20, P354, DOI 10.1093/heapol/czi047; Khan MS, 2017, HEALTH POLICY PLANN, V32, P43, DOI 10.1093/heapol/czx093; Kliner M, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0059-8; Kumar G, 2013, SAARC J TUBERCULOSIS, V10, P15; Law S, 2017, LANCET PUBLIC HEALTH, V2, pE47, DOI 10.1016/S2468-2667(16)30035-4; Mahato Roshan Kumar, 2015, J Clin Diagn Res, V9, pLC05, DOI 10.7860/JCDR/2015/16307.6633; Makwakwa L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-132; Marahatta S B, 2015, J Nepal Health Res Counc, V13, P95; Marahatta SB, 2016, J MANMOHAN MEMORIAL, V2, P76; Marahatta SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209676; Marino P, 2007, SOC WORK HEALTH CARE, V45, P67, DOI 10.1300/J010v45n01_05; McPake B, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-46; Mishra R, 2005, INT J TUBERC LUNG D, V9, P1134; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nakigozi G, 2015, JAIDS-J ACQ IMM DEF, V70, P75, DOI 10.1097/QAI.0000000000000710; National Tuberculosis Centre Ministry of Health Government of Nepal, 2018, NAT TUB PROGR NEP; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; Pedrazzoli D, 2015, EUR RESPIR J, V46, P564, DOI 10.1183/09031936.00227914; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Pokharel S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-002104; Raut S, 2016, LANCET INFECT DIS, V16, P997, DOI 10.1016/S1473-3099(16)30194-3; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Sherchand JB, 2013, J I MED, V35; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; ten Asbroek AHA, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-7; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Van Brakel Wim H, 2006, Psychol Health Med, V11, P307, DOI 10.1080/13548500600595160; Waisbord S., 2004, BEHAV BARRIERS TUBER; WHO, GLOB TUB REP 2018; WHO, TUBERCULOSIS; WHO Tuberculosis Programme, 1995, WHO REP TUB EP; World Health Organization, 2018, GLOB TUB REP 2018	58	31	31	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227293	10.1371/journal.pone.0227293	http://dx.doi.org/10.1371/journal.pone.0227293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940375	Green Published, gold			2022-12-26	WOS:000534368000063
J	Solanki, A; Rajendran, A; Mohan, S; Raj, R; Vundinti, BR				Solanki, Avani; Rajendran, Aruna; Mohan, Sheila; Raj, Revathy; Vundinti, Babu Rao			Mitochondrial DNA variations and mitochondrial dysfunction in Fanconi anemia	PLOS ONE			English	Article							COMPLEMENTATION GROUP; IDENTIFICATION; SENSITIVITY; DEGRADATION	In-vitro studies with different Fanconi anemia (FA) cell lines and FANC gene silenced cell lines indicating involvement of mitochondria function in pathogenesis of FA have been reported. However, in-vivo studies have not been studied so far to understand the role of mitochondrial markers in pathogenesis of FA. We have carried out a systematic set of biomarker studies for elucidating involvement of mitochondrial dysfunction in disease pathogenesis for Indian FA patients. We report changes in the mtDNA number in 59% of FA patients studied, a high frequency of mtDNA variations (37.5% of non-synonymous variations and 62.5% synonymous variations) and downregulation of mtDNA complex-I and complex-III encoding genes of OXPHOS (p< 0.05) as strong biomarkers for impairment of mitochondrial functions in FA. Deregulation of expression of mitophagy genes (ATG; p>0.05, Beclin-1; p>0.05, and MAP1-LC3, p<0.05) has also been observed, suggesting inability of FA cells to clear off impaired mitochondria. We hypothesize that accumulation of such impaired mitochondria in FA cells therefore may be the principal cause for bone marrow failure (BMF) and a plausible effect of inefficient clearance of impaired mitochondria in FA.	[Solanki, Avani; Vundinti, Babu Rao] Natl Inst & Mmunohaematol, Dept Cytogenet, KEM Hosp Campus, Mumbai, Maharashtra, India; [Rajendran, Aruna] Inst Child Hlth & Hosp Children, Dept Hematol, Chennai, Tamil Nadu, India; [Mohan, Sheila; Raj, Revathy] Apollo Childrens Hosp, Pediat Haematol Dept, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Vundinti, BR (corresponding author), Natl Inst & Mmunohaematol, Dept Cytogenet, KEM Hosp Campus, Mumbai, Maharashtra, India.	vbaburao@hotmail.com			Indian Council of Medical Research (ICMR) [45/5/2014-HUM-BMS]; National Institute of Immunohaematology (ICMR), Mumbai, India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); National Institute of Immunohaematology (ICMR), Mumbai, India	Funded by Senior Research Fellowship (45/5/2014-HUM-BMS) was awarded to Ms. Avani Solanki from Indian Council of Medical Research (ICMR). The project was funded by intramural grant from National Institute of Immunohaematology (ICMR), Mumbai, India.	Cotan D, 2011, FASEB J, V25, P2669, DOI 10.1096/fj.10-165340; Faivre L, 2000, BLOOD, V96, P4064; Kabekkodu SP, 2014, MITOCHONDRION, V16, P73, DOI 10.1016/j.mito.2013.07.001; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kumari U, 2012, ONCOGENE, V2013, P1; Linnartz B, 2004, CANCER RES, V64, P1966, DOI 10.1158/0008-5472.CAN-03-2956; Liu SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138716; Lyakhovich A, 2013, RARE DIS, V1, DOI 10.4161/rdis.24048; Malik AN, 2011, BIOCHEM BIOPH RES CO, V412, P1, DOI 10.1016/j.bbrc.2011.06.067; Mamrak NE, 2017, BLOOD REV, V31, P93, DOI 10.1016/j.blre.2016.10.002; Mozhey OI, 2014, MOL BIOL+, V48, P590, DOI 10.1134/S0026893314040074; Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ravera S, 2013, BIOCHIMIE, V95, P1828, DOI 10.1016/j.biochi.2013.06.006; Reinecke F, 2009, BBA-MOL BASIS DIS, V1792, P1113, DOI 10.1016/j.bbadis.2009.04.003; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Salehi MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094069; Shyamsunder P, 2016, ONCOTARGET, V7, P58065, DOI 10.18632/oncotarget.11161; Solanki A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147016; Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865; Sumpter R, 2017, J CELL SCI, V130, P2657, DOI 10.1242/jcs.204909; Sumpter R, 2016, CELL, V165, P867, DOI 10.1016/j.cell.2016.04.006; Thyagarajan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065968; Vanniarajan A, 2011, MITOCHONDRION, V11, P450, DOI 10.1016/j.mito.2011.01.002; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309	26	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227603	10.1371/journal.pone.0227603	http://dx.doi.org/10.1371/journal.pone.0227603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940411	gold, Green Published			2022-12-26	WOS:000534368000083
J	Ytterberg, C; Kristensen, HK; Tistad, M; von Koch, L				Ytterberg, Charlotte; Kristensen, Hanne Kaae; Tistad, Malin; von Koch, Lena			Factors related to met needs for rehabilitation 6 years after stroke	PLOS ONE			English	Article							SHARED DECISION-MAKING; TERM UNMET NEEDS; LIFE SATISFACTION; CARE; IMPACT; SELF; SURVIVORS; CONSEQUENCES; EXPERIENCES; DEMANDS	Introduction Research on stroke rehabilitation mainly concerns the first year of recovery, and there is a lack of knowledge regarding long-term rehabilitation needs and associated factors. Aim The aim was to explore the perceived needs for rehabilitation services of people six years after stroke and factors associated with having rehabilitation services needs met. Methods The study was a 6-year follow up of a prospective study on the rehabilitation process after stroke. Data on perceived needs for rehabilitation, personal factors, disease specific factors, and patient-reported disability were collected through face-to-face interviews in the participants' homes. Logistic regression models were created to explore associations between having rehabilitation services needs met in 11 problem areas (dependent variable) and the independent variables: involvement in decisions regarding care and treatment, sex, age, sense of coherence, self-defined level of private financing, stroke severity, frequency of social everyday activities, perceived impact of stroke, and life satisfaction. Results The 121 participants had a mean age of 63 years at stroke onset and 58% were men. In all problem areas the majority (53-88%) reported having needs met at six years after stroke, however 47% reported unmet needs regarding fatigue and 45% regarding mobility. A lower perceived impact on participation was found to be associated with having rehabilitation services needs met in seven problem areas: mobility, falls, pain, fatigue, concentration, memory, and sight. The strongest association for having needs met was found for the independent variable, involvement in care and treatment, within the three problem areas mobility, falls, and speaking. Conclusion In a long-term perspective, there were several modifiable factors associated with having rehabilitation services needs met. The most prominent were perceived involvement in care and treatment, and perceived participation. These factors had a stronger association with having rehabilitation services needs met than disease specific factors six years after stroke.	[Ytterberg, Charlotte; Tistad, Malin; von Koch, Lena] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Ytterberg, Charlotte; von Koch, Lena] Karolinska Univ Hosp, Huddinge, Sweden; [Ytterberg, Charlotte; Kristensen, Hanne Kaae] Univ Southern Denmark, Inst Clin Res, Res Unit Rehabil, Odense, Denmark; [Kristensen, Hanne Kaae] Univ Coll Lillebaelt, Hlth Sci Res Ctr, Odense, Denmark; [Tistad, Malin] Dalarna Univ, Sch Educ Hlth & Social Studies, Falun, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Southern Denmark; Dalarna University	Ytterberg, C (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.; Ytterberg, C (corresponding author), Karolinska Univ Hosp, Huddinge, Sweden.; Ytterberg, C (corresponding author), Univ Southern Denmark, Inst Clin Res, Res Unit Rehabil, Odense, Denmark.	charlotte.ytterberg@ki.se	von Koch, Lena/P-2310-2018	von Koch, Lena/0000-0002-8560-3016; Kristensen, Hanne Kaae/0000-0002-9596-5571; Ytterberg, Charlotte/0000-0003-3704-8887	Swedish Research Council [20073087, 2013-2806]; Stockholms Lans Landsting [2006-0700]; Swedish Stroke Association; Promobilia Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholms Lans Landsting; Swedish Stroke Association; Promobilia Foundation	LvK: Swedish Research Council 20073087 and 2013-2806 http://www.vr.se/, Stockholms Lans Landsting 2006-0700 https://www.sll.se/.CY: Swedish Stroke Association www.strokeforbundet.se/and the Promobilia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali L., 2017, J CLIN NURS; Andrew NE, 2014, INT J STROKE, V9, P106, DOI 10.1111/ijs.12325; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Armstrong MJ, 2017, STROKE VASC NEUROL, V2, P84, DOI 10.1136/svn-2017-000081; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Blomgren C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216822; Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; Burton CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-63; de Port IGLV, 2007, DISABIL REHABIL, V29, P1841, DOI 10.1080/09638280601129157; Dean SG, 2012, INTERPROFESSIONAL RE, P45; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; Dworzynski K, 2015, CLIN MED, V15, P461, DOI 10.7861/clinmedicine.15-5-461; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Elf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161942; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Erikson A, 2016, J REHABIL MED, V48, P847, DOI 10.2340/16501977-2161; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Govan L, 2009, STROKE, V40, P3396, DOI 10.1161/STROKEAHA.109.557645; Jaracz K, 2014, NEUROL NEUROCHIR POL, V48, P280, DOI 10.1016/j.pjnns.2014.07.004; Kersten P, 2002, DISABIL REHABIL, V24, P860, DOI 10.1080/09638280210142167; Kristensen HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157149; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Levack WMM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009727.pub2; Lindsay P, 2014, INT J STROKE, V9, P4, DOI 10.1111/ijs.12371; Lund A, 2018, SCAND J OCCUP THER, V25, P127, DOI 10.1080/11038128.2017.1341958; MAHONEY F I, 1965, Md State Med J, V14, P61; McKevitt C, 2011, STROKE, V42, P1398, DOI 10.1161/STROKEAHA.110.598839; Norlander A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149395; Northcott S, 2016, CLIN REHABIL, V30, P811, DOI 10.1177/0269215515602136; Olaiya MT, 2017, NEUROLOGY, V89, P68, DOI 10.1212/WNL.0000000000004063; Pallesen H, 2019, REHABIL RES PRACT, V2019, DOI 10.1155/2019/1726964; Parsons JGM, 2018, DISABIL REHABIL, V40, P309, DOI 10.1080/09638288.2016.1253115; Plant SE, 2016, CLIN REHABIL, V30, P921, DOI 10.1177/0269215516655856; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Pound P, 1999, STROKE, V30, P49, DOI 10.1161/01.STR.30.1.49; Regan EW, 2019, DISABIL HLTH J; Reimer WJMSO, 1999, QUAL HEALTH CARE, V8, P30, DOI 10.1136/qshc.8.1.30; Rose A, 2017, PATIENT EDUC COUNS, V100, P65, DOI 10.1016/j.pec.2016.07.030; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Sennfalt S, 2019, STROKE, V50, P53, DOI 10.1161/STROKEAHA.118.022913; Shay LA, 2015, MED DECIS MAKING, V35, P114, DOI 10.1177/0272989X14551638; Singam A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144344; Slomic M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1808-5; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Susanne P, 2012, J NEUROL SCI, V321, P29, DOI 10.1016/j.jns.2012.07.024; Tistad M, 2013, HEALTH EXPECT, V16, pE24, DOI 10.1111/hex.12095; Tistad M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-40; Tistad M, 2012, J NEUROL SCI, V313, P160, DOI 10.1016/j.jns.2011.08.038; Ullberg T, 2016, STROKE, V47, P539, DOI 10.1161/STROKEAHA.115.011670; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Verberne DPJ, 2018, NEUROREHAB NEURAL RE, V32, P821, DOI 10.1177/1545968318796341; VIITANEN M, 1988, SCAND J REHABIL MED, V20, P17; Wade D T, 1985, Int Rehabil Med, V7, P176; Wade D, 2016, CLIN REHABIL, V30, P109, DOI 10.1177/0269215515601177; Wolf A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016491; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796; World Health Organization, WHO FRAM INT PEOPL C; Wu SM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007030.pub3; Ytterberg C, 2017, J REHABIL MED, V49, P637, DOI 10.2340/16501977-2258	59	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227867	10.1371/journal.pone.0227867	http://dx.doi.org/10.1371/journal.pone.0227867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940423	gold, Green Published			2022-12-26	WOS:000534368000105
J	Majam, M; Mazzola, L; Rhagnath, N; Lalla-Edward, ST; Mahomed, R; Venter, WDF; Fischer, AE				Majam, Mohammed; Mazzola, Laura; Rhagnath, Naleni; Lalla-Edward, Samanta T.; Mahomed, Raees; Venter, Willem Daniel Francois; Fischer, Alex Emilio			Usability assessment of seven HIV self-test devices conducted with lay-users in Johannesburg, South Africa	PLOS ONE			English	Article								Introduction The first 90 of the 90-90-90 initiative introduced by the World Health Organization(WHO) in 2015 requires 90% of people with HIV be aware of their status by 2020. In South Africa, conventional facility-based testing had reached 84.9% in 2018; innovative new methods, like HIV self-testing(HIVST) may close the testing gap. This study aimed to determine the usability of seven HIVST kits among untrained South Africans. Methods This cross-sectional study of 1400 adults in Johannesburg evaluated the usability of five blood fingerstick and two oral fluid HIVSTs, using WHO prequalification criteria, from June 2016 to June 2018. Participants were handed one kit, with no further information about the device or test procedure, and asked to perform the test in front of an observer. The observer used product-specific semi-structured questionnaires organized into a composite usability index(UI) using a HIVST process checklist, a contrived results interpretation and a post-test interview that expanded on participant experiences with the device and instructions-of-use (IFU). Participants were not tested themselves, but provided with contrived results to interpret. Results The average UI was 92.8%(84.2%-97.6%); the major difficulty was obtaining and transferring the specimen. Participants correctly interpreted 96.1% of the non-reactive/negative, 97.0% of the reactive/positive, 98.0% of the invalid and 79.9% of the weak positive results. Almost all participants(97.0%) stated they would visit a clinic or seek treatment for positive results; with negative results, half(50.6%) stated they should re-test in the next three months while one-third(36.1%) said they should condomize. Nearly all found the devices easy to use(96.6%), the IFUSs easy to understand(97.9%) and felt confident using the test unassisted(95.9%) but suggested improvements to packaging/IFUs to further increase usability; 19.9% preferred clinic-based testing to HIVST. Conclusion The UI and interpretation of results was high and in-line with previous usability studies, suggesting that these kits are appropriate for use in the general, untrained and unsupervised public.	[Majam, Mohammed; Rhagnath, Naleni; Lalla-Edward, Samanta T.; Mahomed, Raees; Venter, Willem Daniel Francois; Fischer, Alex Emilio] Univ Witwatersrand, Ezintsha, Johannesburg, Gauteng, South Africa; [Mazzola, Laura] Halteres Associates, San Francisco, CA USA	University of Witwatersrand	Fischer, AE (corresponding author), Univ Witwatersrand, Ezintsha, Johannesburg, Gauteng, South Africa.	afischer@wrhi.ac.za	Lalla-Edward, Samanta Tresha/H-9379-2019	Lalla-Edward, Samanta Tresha/0000-0003-3597-1643; Majam, Mohammed/0000-0003-0302-5353; Venter, Willem/0000-0002-4157-732X	Bill and Melinda Gates Foundation [OPP1132929]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	MM, NR, LM, STLE, WDFV, AEF were awarded grant number OPP1132929 from the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Halteres Associates provided support in the form of salaries for author LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AIDS, 2017, GLOB AIDS UPD; Blood Products Advisory Committee, 2012, FIN ADV COMM BRIEF M; Brooke J., 1996, USABILITY EVALUATION, V189, P4; Bwana P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202491; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Gotsche C, 2017, 9 IAS C HIV SCI IAS; Gresenguet Gerard, 2017, Open AIDS J, V11, P101, DOI 10.2174/1874613601711010101; Human Sciences Research Council (HSRC), 2018, 5 S AFR NAT HIV PREV; Indravudh PP, 2018, CURR OPIN INFECT DIS, V31, P14, DOI 10.1097/QCO.0000000000000426; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21594; Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z; Kortum Philip, 2015, JMIR Hum Factors, V2, pe10, DOI 10.2196/humanfactors.4570; Lippman SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206849; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; National Department of Health South Africa, 2018, NAT HIV SELF SCREEN; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Richter M, 2016, SO AFRICAN J MED, V13, P186; Smith P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21111; Unitaid, 2018, MARK TECHN LANDSC HI, V4th; WHO, 2016, GUID HIV SELF TEST P; Wong V, 2014, AIDS BEHAV, V18, pS415, DOI 10.1007/s10461-014-0825-9; World Health Organization, 2017, TECHN SPEC SER SUBM; World Health Organization, 2017, NUMB COUNTR AD HIV S	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227198	10.1371/journal.pone.0227198	http://dx.doi.org/10.1371/journal.pone.0227198			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935228	Green Submitted, Green Published, gold			2022-12-26	WOS:000534354100013
J	O'Brien, C; Darcy-Dunne, MR; Murphy, BA				O'Brien, Christiane; Darcy-Dunne, Megan Ruth; Murphy, Barbara Anne			The effects of extended photoperiod and warmth on hair growth in ponies and horses at different times of year	PLOS ONE			English	Article							DOSE-DEPENDENT SUPPRESSION; BLUE-LIGHT; ENVIRONMENTAL-TEMPERATURE; REPRODUCTIVE ACTIVITY; PROLACTIN SECRETION; SEASONAL-VARIATION; MELATONIN; COAT; SYSTEM; CYCLE	Photoperiod is considered the most dominant environmental cue allowing animals to anticipate and adapt to seasonal changes. In seasonally breeding mammals, changes in daylength alter pineal melatonin secretion and pituitary prolactin secretion. During the seasonal transition to shorter winter daylengths, increased production of melatonin and declining prolactin are associated with triggering winter coat growth in many animals. Similarly, studies have shown that artificial extension of photoperiod suppresses melatonin secretion and lifts prolactin inhibition to activate moulting. Four longitudinal cohort studies were conducted to determine if extended photoperiod and warmth, provided by mobile light masks and rugs (horse blankets), could reverse the onset of winter coat growth, maintain the summer coat and accelerate winter coat shedding in horses and in ponies. Studies began at dates corresponding to the autumnal equinox, one month post-summer solstice, one month pre-winter solstice and one month post-winter solstice, respectively. To extend photoperiod to approximately 15h of light, commercially available head-worn light masks provided low intensity blue light to one eye until 11pm daily. Coat condition and shedding rate were scored and hair samples collected, measured and weighed bi-weekly. Data from control and treatment groups were analysed by repeated measures ANOVA. Results revealed that extended photoperiod 1) did not reverse winter coat growth when initiated at the autumnal equinox, 2) effectively maintained the summer coat in stabled horses when initiated one month postsummer solstice, 3) accelerated shedding in outdoor living horses when initiated one month pre-winter solstice and 4) did not accelerate shedding in indoor or outdoor living ponies when initiated one month post-winter solstice. To successfully manage equine coat growth while also preserving optimal thermoregulation in both competition and breeding stock correct timing of light application is crucial and requires careful monitoring of environmental temperature. Further studies are needed where variations in breed and management are considered.	[O'Brien, Christiane] Equilume Ltd, Naas, Kildare, Ireland; [Darcy-Dunne, Megan Ruth; Murphy, Barbara Anne] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland	University College Dublin	Murphy, BA (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland.	barbara.murphy@ucd.ie		O'Brien, Christiane/0000-0003-2589-5595; Murphy, Barbara/0000-0003-2163-7927	Equilume Ltd.; UCD's School of Agriculture and Food Science	Equilume Ltd.; UCD's School of Agriculture and Food Science	The funders Equilume Ltd. [www.equilume.com] and UCD's School of Agriculture and Food Science [www.ucd.ie] provided support in the form of research material and salaries for authors COB and BAM, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BARTNESS TJ, 1989, EXPERIENTIA, V45, P939, DOI 10.1007/BF01953051; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Brainard GC, 2008, J BIOL RHYTHM, V23, P379, DOI 10.1177/0748730408323089; Craven AJ, 2006, J ENDOCRINOL, V191, P415, DOI 10.1677/joe.1.06685; Dhakal Pramod, 2011, J Equine Sci, V22, P29, DOI 10.1294/jes.22.29; Fitzgerald BP, 2000, DOMEST ANIM ENDOCRIN, V18, P395, DOI 10.1016/S0739-7240(00)00058-8; Foitzik K, 2003, AM J PATHOL, V162, P1611, DOI 10.1016/S0002-9440(10)64295-2; Gebbie FE, 1999, J REPROD FERTIL, V116, P25, DOI 10.1530/jrf.0.1160025; Geyfman M, 2015, BIOL REV, V90, P1179, DOI 10.1111/brv.12151; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; GUERIN MV, 1994, THERIOGENOLOGY, V42, P1053, DOI 10.1016/0093-691X(94)90127-5; JOHNSON AL, 1986, J ANIM SCI, V62, P1012, DOI 10.2527/jas1986.6241012x; LANGLOIS B, 1994, LIVEST PROD SCI, V40, P1, DOI 10.1016/0301-6226(94)90260-7; Lauvergne JJ, 1994, P EUR S S AM CAM CAM, P59; MACCORMACK JAD, 1991, FARM BUILD PROGR, P10; MARTINET L, 1984, J ENDOCRINOL, V103, P9, DOI 10.1677/joe.0.1030009; Mirmahmoudi R, 2011, SMALL RUMINANT RES, V100, P131, DOI 10.1016/j.smallrumres.2011.07.002; Monecke S, 2003, J PHYSL, V549, P945, DOI [10.1113/jphysiol.2003.040477, DOI 10.1113/JPHYSIOL.2003.040477]; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Morgan K, 2007, LOWER CRITICAL TEMPE; MORGAN PJ, 1994, P NUTR SOC, V53, P483, DOI 10.1079/PNS19940059; Mount LE, 1973, HEAT LOSS ANIMALS MA, P425; Murphy BA, 2014, EQUINE VET J, V46, P601, DOI 10.1111/evj.12153; Murphy BA, 2019, J EQUINE VET SCI, V76, P14, DOI 10.1016/j.jevs.2019.02.026; Murphy Barbara A, 2011, J Circadian Rhythms, V9, P3, DOI 10.1186/1740-3391-9-3; Nolan MB, 2017, THERIOGENOLOGY, V100, P126, DOI 10.1016/j.theriogenology.2017.06.012; Parry AL, 1995, ACTA ANAT, V154, P283; Paul MJ, 2007, AM J PHYSIOL-REG I, V293, pR2363, DOI 10.1152/ajpregu.00520.2007; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Provencio I., 2012, WILEY INTERDISCIPLIN, P228, DOI [DOI 10.1002/WMTS.29, 10.1002/wmts.29]; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSE J, 1985, J PINEAL RES, V2, P13, DOI 10.1111/j.1600-079X.1985.tb00624.x; Schmidt K, 2017, THERIOGENOLOGY, V97, P170, DOI 10.1016/j.theriogenology.2017.04.035; Schrammel N, 2016, THERIOGENOLOGY, V85, P946, DOI 10.1016/j.theriogenology.2015.11.003; SCRABA ST, 1985, THERIOGENOLOGY, V24, P667, DOI 10.1016/0093-691X(85)90165-7; Stachurska A, 2015, J ANIM SCI, V93, P1411, DOI 10.2527/jas.2014-8668; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Walsh CM, 2013, VET J, V196, P231, DOI 10.1016/j.tvjl.2012.09.003; WEBSTER JR, 1985, J REPROD FERTIL, V73, P255, DOI 10.1530/jrf.0.0730255; West KE, 2011, J APPL PHYSIOL, V110, P619, DOI 10.1152/japplphysiol.01413.2009; Young BA, 1973, SOME EFFECTS COLD HO	41	7	7	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227115	10.1371/journal.pone.0227115	http://dx.doi.org/10.1371/journal.pone.0227115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935219	Green Published, gold			2022-12-26	WOS:000534354100011
J	Baek, S; Park, S; Park, HK; Chun, BC				Baek, Soojin; Park, Seongwoo; Park, Hye Kyung; Chun, Byung Chul			The epidemiological characteristics and spatio-temporal analysis of childhood hand, foot and mouth disease in Korea, 2011-2017	PLOS ONE			English	Article								Objectives Hand-foot-mouth disease (HFMD) is a common viral infection in children, with a significant disease burden due to its high contagion rate. This report studied the epidemiological characteristics as well as the chronological and geographical distribution of HFMD in children younger than 6 years of age in Korea. Methods This report established a database by integrating population and geographical data from health insurance claims for HFMD between 2011 and 2017, with an age restriction of <= 6 years, and explored the epidemiological characteristics of both HFMD patients and hospitalized cases in Korea. The relative risk ratio and spatio-temporal scan statistics were calculated by administrative district, using SaTScan. Results Over a 7-year period, 1,879,342 children under the age of 6 were diagnosed with HFMD (8.4 of 100 persons younger than 6 years of age). Seasonal incidence tended to increase from week 17 (May) peak between weeks 29 (July) and 39 (September), and increase rapidly in 1- to 2-year cycles. HFMD primarily occurred in children younger than 4 years of age. Furthermore, the greatest proportion of cases occurred at ages 1 (39.2%) and 2 (25.7%). Overall, 92.6% of all cases occurred before the age of 6. The proportion of cases before the age of 6was slightly higher in males. The timing of HFMD epidemics differed over the years. In 2015, the HFMD cumulative incidence was the lowest (5.5/1,000), and the spatio-temporal cluster (RR 2.32) was predominantly located south-central Korea, covering 65 counties for twenty-two weeks. In 2016, however, its cumulative incidence was high (RR 6.34) over a short period (11 weeks) in specific areas such as Ulsan, Daegu, Busan, and Gyeongnam. Also, the southern parts of Korea were found to have a higher rate of hospitalization. Conclusions HFMD in Korea is common in children younger than 6 years of age, and it tends to peak in the summer.	[Baek, Soojin; Chun, Byung Chul] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Baek, Soojin; Park, Seongwoo; Park, Hye Kyung] Korea Ctr Dis Control & Prevent, Div Strateg Planning Emerging Dis, Chungcheongbuk Do, South Korea; [Chun, Byung Chul] Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Korea University; Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea University; Korea University Medicine (KU Medicine)	Chun, BC (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.; Chun, BC (corresponding author), Korea Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.	chun@korea.ac.kr	Chun, Byung Chul/AGO-1458-2022; Chun, Byung Chul/AGO-1390-2022	Chun, Byung Chul/0000-0001-6576-8916; Chun, Byung Chul/0000-0001-6576-8916				Abzug MJ, 2007, NELSON TXB PEDIAT, P1350; [Anonymous], 2017, GUID PREV CONTR ENT; [Anonymous], 2018, W PAC REG HAND FOOT; [Anonymous], 2018, PUBL HLTH WEEKL REP; Belanger M, 2009, ANN EPIDEMIOL, V19, P180, DOI 10.1016/j.annepidem.2008.12.008; [Chinese Center for Disease Control and Prevention Office of the World Health Organization in China], 2008, REP HAND FOOT MOUTH; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Han Junhee, 2016, [Journal of the Korean Data And Information Science Sociaty, 한국데이터정보과학회지], V27, P1193, DOI 10.7465/jkdi.2016.27.5.1193; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Koh WM, 2016, PEDIATR INFECT DIS J, V35, pE285, DOI 10.1097/INF.0000000000001242; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Li LF, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5169-3; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Urashima M, 2003, JPN J INFECT DIS, V56, P48; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu XR, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2742-9; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6	18	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227803	10.1371/journal.pone.0227803	http://dx.doi.org/10.1371/journal.pone.0227803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931518	gold, Green Published			2022-12-26	WOS:000534352500077
J	Edwards, ST; Ernst, L; Sherman, AK; Davis, AM				Edwards, Sarah T.; Ernst, Linda; Sherman, Ashley K.; Davis, Ann M.			Increased episodes of aspiration on videofluoroscopic swallow study in children with nasogastric tube placement	PLOS ONE			English	Article							PENETRATION; DYSPHAGIA	Background Given the limited evidence available, the impact of nasogastric (NG) tube placement on swallowing in children is not well understood. When a child needs to be fed enterally, the current standard is to initially place an NG tube and leave it in place for the first few months of supplemental or total enteral nutrition. It is important to understand if placement of NG tubes has a negative effect on a patient's swallow. Methods We retrospectively reviewed the charts of those children who had videofluoroscopic swallow studies (VFSS) to identify all children who had an NG tube in place at the time of swallow study. Age and sex matched children were identified who had undergone VFSS without an NG in place. These charts were reviewed for diagnosis at the time of the VFSS and presence or absence of aspiration or laryngeal penetrations. Results Sixty-three children with NG tubes were identified, along with 63 age and sex matched children without NG tubes in place, at the time of VFSS. Ages ranged from 7 days to 13 years. The NG group had a significantly higher proportion demonstrating aspiration (46% vs. 23.8%, p = 0.0089). Conclusions This study supports the need for further prospective evaluation of NG tubes and their effect on swallow, as well as more careful consideration of prolonged NG tube placement in patients with feeding problems. Consideration should be given to removal of the NG prior to VFSS to prevent the impact of NG placement on results of the swallow study which could lead to inappropriate modifications to the patient's care plan.	[Edwards, Sarah T.] Univ Missouri, Div Gastroenterol Hepatol & Nutr, Childrens Mercy Kansas City, Kansas City, MO 64110 USA; [Ernst, Linda] Childrens Mercy Kansas City, Div Hearing & Speech, Kansas City, MO USA; [Sherman, Ashley K.] Childrens Mercy Kansas City, Hlth Serv & Outcomes Res, Kansas City, MO USA; [Davis, Ann M.] Univ Kansas, Med Ctr, Dept Pediat, Kansas City, KS 66103 USA; [Davis, Ann M.] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; Children's Mercy Hospital; University of Kansas; University of Kansas Medical Center	Edwards, ST (corresponding author), Univ Missouri, Div Gastroenterol Hepatol & Nutr, Childrens Mercy Kansas City, Kansas City, MO 64110 USA.	sedwards1@cmh.edu						Alnassar M, 2011, PEDIATR RADIOL, V41, P317, DOI 10.1007/s00247-010-1834-0; Arvedson JC, 2002, PEDIAT SWALLOWING FE, P527; Boullata JI, 2017, JPEN-PARENTER ENTER, V41, P15, DOI 10.1177/0148607116673053; Dziewas R, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-28; Fishbein M, 2013, JPEN-PARENTER ENTER, V37, P667, DOI 10.1177/0148607112460683; Friedman B, 2000, DYSPHAGIA, V15, P153, DOI 10.1007/s004550010018; Huggins PS, 1999, DYSPHAGIA, V14, P157, DOI 10.1007/PL00009598; Leder SB, 2008, ARCH PHYS MED REHAB, V89, P648, DOI 10.1016/j.apmr.2007.09.038; Lee SI, 2013, ARCH PHYS MED REHAB, V94, P120, DOI 10.1016/j.apmr.2012.07.016; ROBBINS J, 1992, GASTROENTEROLOGY, V103, P823, DOI 10.1016/0016-5085(92)90013-O; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Wang TG, 2006, ARCH PHYS MED REHAB, V87, P1270, DOI 10.1016/j.apmr.2006.05.019	12	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227777	10.1371/journal.pone.0227777	http://dx.doi.org/10.1371/journal.pone.0227777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929585	Green Published, gold			2022-12-26	WOS:000534352500073
J	Yuan, Q; Xu, XC; Zhao, JW; Zeng, Q				Yuan, Quan; Xu, Xuecai; Zhao, Junwei; Zeng, Qiang			Investigation of injury severity in urban expressway crashes: A case study from Beijing	PLOS ONE			English	Article							STATISTICAL-ANALYSIS; LOGISTIC-REGRESSION; VEHICLE; MODELS; SINGLE; SPEED	Urban expressway is the main artery of traffic network, and an in-depth analysis of the crashes is crucial for improving the traffic safety level of expressways. This study intended to address the injury severity of expressways in Beijing by proposing Bayesian ordered logistic regression model. Crash data were collected from urban express rings and expressways in 2015 and 2016. The results showed that crash location, time and crash season are significant variables influencing injury severity. The findings revealed that the proposed model can address the ordinal feature of injury severity, while accommodating the data with small sample sizes that may not adequately represent population characteristics. The conclusions can provide the management departments with valuable suggestions for the injury prevention and safety improvement on the urban expressways.	[Yuan, Quan] Tsinghua Univ, Sch Vehicle & Mobil, State Key Lab Automot Safety & Energy, Beijing, Peoples R China; [Xu, Xuecai] Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan, Peoples R China; [Zhao, Junwei] Changan Univ, Sch Automobile, Xian, Peoples R China; [Zeng, Qiang] South China Univ Sci & Technol, Sch Transportat, Guangzhou, Peoples R China	Tsinghua University; Huazhong University of Science & Technology; Chang'an University	Xu, XC (corresponding author), Huazhong Univ Sci & Technol, Sch Civil Engn & Mech, Wuhan, Peoples R China.	xuecai_xu@hust.edu.cn			National Natural Science Foundation of China [71801095]; Fundamental Research Fund for the Central Universities [HUST: 2018KFYYXJJ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	This study was jointly supported by National Natural Science Foundation of China (No: 71801095) to QY and Fundamental Research Fund for the Central Universities [HUST: 2018KFYYXJJ001] to XX.	Abegaz T, 2014, ACCIDENT ANAL PREV, V71, P15, DOI 10.1016/j.aap.2014.05.003; Al-Ghamdi AS, 2002, ACCIDENT ANAL PREV, V34, P729, DOI 10.1016/S0001-4575(01)00073-2; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Eluru N, 2012, ACCIDENT ANAL PREV, V47, P119, DOI 10.1016/j.aap.2012.01.027; Jang K, 2013, TRANSPORT RES REC, P104, DOI 10.3141/2393-12; Lord D, 2010, TRANSPORT RES A-POL, V44, P291, DOI 10.1016/j.tra.2010.02.001; Ma CX, 2018, J ADV TRANSPORT, DOI 10.1155/2018/9841498; Mannering F, 2014, ANAL METHODS ACCID R, V1, P1, DOI 10.1016/j.amar.2013.09.001; Michalaki P, 2015, J SAFETY RES, V55, P89, DOI 10.1016/j.jsr.2015.09.004; Morgan A, 2011, ACCIDENT ANAL PREV, V43, P1852, DOI 10.1016/j.aap.2011.04.024; Rezapour M, 2019, J SAFETY RES, V68, P107, DOI 10.1016/j.jsr.2018.12.006; Savolainen PT, 2011, ACCIDENT ANAL PREV, V43, P1666, DOI 10.1016/j.aap.2011.03.025; Sun J, 2016, ACCIDENT ANAL PREV, V95, P503, DOI 10.1016/j.aap.2015.12.011; Washington S., 2011, STAT ECONOMETRIC MET, V2nd, DOI DOI 10.1201/9780429244018; Xiao DQ, 2019, J ADV TRANSPORT, V2019, DOI 10.1155/2019/8521649; Xie YC, 2009, J TRANSP ENG, V135, P18, DOI 10.1061/(ASCE)0733-947X(2009)135:1(18); Xu XC, 2016, J ADV TRANSPORT, V50, P2015, DOI 10.1002/atr.1442; Yoon S, 2017, TRANSPORT RES REC, DOI 10.3141/2647-01; Yu RJ, 2018, ACCIDENT ANAL PREV, V120, P304, DOI 10.1016/j.aap.2018.06.007; Yu RJ, 2014, ACCIDENT ANAL PREV, V62, P161, DOI 10.1016/j.aap.2013.08.009; Yuan Q, 2020, ACCIDENT ANAL PREV, V134, DOI 10.1016/j.aap.2019.105324; Yuan Q, 2017, INT J CRASHWORTHINES, V22, P260, DOI 10.1080/13588265.2016.1248226; Zeng Q, 2017, J ADV TRANSPORT, V1953, P1	24	6	6	13	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227869	10.1371/journal.pone.0227869	http://dx.doi.org/10.1371/journal.pone.0227869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929601	gold, Green Published			2022-12-26	WOS:000534352500079
J	Girrbach, F; Landeck, T; Schneider, D; Reske, SU; Hempel, G; Hammermuller, S; Gottschaldt, U; Salz, P; Noreikat, K; Stehr, SN; Wrigge, H; Reske, AW				Girrbach, Felix; Landeck, Tobias; Schneider, Dominic; Reske, Stefan U.; Hempel, Gunther; Hammermueller, Soren; Gottschaldt, Udo; Salz, Peter; Noreikat, Katharina; Stehr, Sebastian N.; Wrigge, Hermann; Reske, Andreas W.			Detection of posttraumatic pneumothorax using electrical impedance tomography-An observer-blinded study in pigs with blunt chest trauma	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; END-EXPIRATORY PRESSURE; OCCULT PNEUMOTHORACES; COMPUTED-TOMOGRAPHY; PLEURAL DRAINAGE; CRITICAL-CARE; NEED	Introduction Posttraumatic pneumothorax (PTX) is often overseen in anteroposterior chest X-ray. Chest sonography and Electrical Impedance Tomography (EIT) can both be used at the bedside and may provide complementary information. We evaluated the performance of EIT for diagnosing posttraumatic PTX in a pig model. Methods This study used images from an existing database of images acquired from 17 mechanically ventilated pigs, which had sustained standardized blunt chest trauma and had undergone repeated thoracic CT and EIT. 100 corresponding EIT/CT datasets were randomly chosen from the database and anonymized. Two independent and blinded observers analyzed the EIT data for presence and location of PTX. Analysis of the corresponding CTs by a radiologist served as reference. Results 87/100 cases had at least one PTX detected by CT. Fourty-two cases showed a PTX > 20% of the sternovertebral diameter (PTXtrans20), whereas 52/100 PTX showed a PTX> 3 cm in the craniocaudal diameter (PTXcc3), with 20 cases showing both a PTXtranscc and a PTXcc3. We found a very low agreement between both EIT observers considering the classification overall PTX/noPTX (kappa = 0.09, p = 0.183). For PTXtrans20, sensitivity was 59% for observer 1 and 17% for observer 2, with a specificity of 48% and 50%, respectively. For PTXcc3, observer 1 showed a sensitivity of 60% with a specificity of 51% while the sensitivity of observer 2 was 17%, with a specificity of 89%. By programming a semi-automatized detection algorithm, we significantly improved the detection rate of PTXcc3, with a sensitivity of 73% and a specificity of 70%. However, detection of PTXtranscc was not improved. Conclusion In our analysis, visual interpretation of EIT without specific image processing or comparison with baseline data did not allow clinically useful diagnosis of posttraumatic PTX. Multimodal imaging approaches, technical improvements and image postprocessing algorithms might improve the performance of EIT for diagnosing PTX in the future.	[Girrbach, Felix; Hempel, Gunther; Hammermueller, Soren; Noreikat, Katharina; Stehr, Sebastian N.; Reske, Andreas W.] Univ Leipzig, Dept Anesthesiol & Intens Care Med, Leipzig, Germany; [Girrbach, Felix; Landeck, Tobias; Schneider, Dominic; Salz, Peter; Reske, Andreas W.] Univ Leipzig, Innovat Ctr Comp Assisted Surg ICCAS, Leipzig, Germany; [Reske, Stefan U.] Heinrich Braun Hosp Zwickau, Dept Radiol, Zwickau, Germany; [Gottschaldt, Udo; Reske, Andreas W.] Heinrich Braun Hosp Zwickau, Dept Anesthesiol & Intens Care Med, Zwickau, Germany; [Wrigge, Hermann] Bergmannstrost Hosp Halle, Dept Anesthesiol Intens Care & Emergency Med, Pain Therapy, Halle, Germany	Leipzig University; Leipzig University	Girrbach, F (corresponding author), Univ Leipzig, Dept Anesthesiol & Intens Care Med, Leipzig, Germany.; Girrbach, F (corresponding author), Univ Leipzig, Innovat Ctr Comp Assisted Surg ICCAS, Leipzig, Germany.	felixfrederic.girrbach@medizin.uni-leipzig.de	Wrigge, Hermann/AAJ-8985-2021	Wrigge, Hermann/0000-0002-9035-6822				Ball CG, 2005, J TRAUMA, V59, P917, DOI 10.1097/01.ta.0000174663.46453.86; Bhatia R, 2012, INTENS CARE MED, V38, P308, DOI 10.1007/s00134-011-2421-z; Brower RG, 2004, NEW ENGL J MED, V351, P327; Cambiaghi B, 2018, CLIN PHYSIOL FUNCT I, V38, P158, DOI 10.1111/cpf.12385; Charbit J, 2015, AM J EMERG MED, V33, P796, DOI 10.1016/j.ajem.2015.03.057; Coimbra R, 2013, J TRAUMA ACUTE CARE, V74, P754; Costa ELV, 2008, CRIT CARE MED, V36, P1230, DOI 10.1097/CCM.0b013e31816a0380; Ding W, 2011, CHEST, V140, P859, DOI 10.1378/chest.10-2946; Ernst AA, 2012, WEST J EMERG MED, V13, P437, DOI 10.5811/westjem.2011.9.6781; Frerichs I, 2017, THORAX, V72, P83, DOI 10.1136/thoraxjnl-2016-208357; Kirkpatrick AW, 2013, J TRAUMA ACUTE CARE, V74, P747, DOI 10.1097/TA.0b013e3182827158; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Lichtenstein DA, 2009, PEDIATR CRIT CARE ME, V10, P693, DOI 10.1097/PCC.0b013e3181b7f637; Miedema M, 2011, NEONATOLOGY, V99, P10, DOI 10.1159/000292626; Miedema M, 2016, AM J RESP CRIT CARE, V194, P116, DOI 10.1164/rccm.201602-0292LE; Morais CCA, 2017, AM J RESP CRIT CARE, V195, P1070, DOI 10.1164/rccm.201609-1780LE; Muders T, 2012, CRIT CARE MED, V40, P903, DOI 10.1097/CCM.0b013e318236f452; Nestler C, 2017, BRIT J ANAESTH, V119, P1194, DOI 10.1093/bja/aex192; Omar Hesham R, 2010, J Trauma Manag Outcomes, V4, P12, DOI 10.1186/1752-2897-4-12; Suarez-Sipmann F, 2007, CRIT CARE MED, V35, P214, DOI 10.1097/01.CCM.0000251131.40301.E2; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Wilson H, 2009, INJURY, V40, P928, DOI 10.1016/j.injury.2009.04.005; Zhang M, 2016, EUR J TRAUMA EMERG S, V42, P785, DOI 10.1007/s00068-016-0645-x	23	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227518	10.1371/journal.pone.0227518	http://dx.doi.org/10.1371/journal.pone.0227518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923268	Green Published, gold			2022-12-26	WOS:000534350000089
J	Mougi, A				Mougi, Akihiko			Natural selection contributes to food web stability	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; INTRASPECIFIC VARIATION; HABITAT FRAGMENTATION; EVOLUTIONARY DYNAMICS; SPECIES COEXISTENCE; GENETIC DIVERSITY; RAPID EVOLUTION; COMMUNITY; PREDATOR; COEVOLUTION	How biodiversity is maintained in ecosystems is a central issue in ecology. According to the evolutionary theory, heritable variations between individuals are important for the generation of species diversity, linking both intra and interspecific variations. The present food web model shows that intraspecific variations via natural selection also play crucial roles in maintaining the stability of large communities with diverse species. In particular, our computations indicate that larger communities need more intraspecific variation to be maintained and are powerfully stabilized when multiple traits are variable. Consequently, these variations are likely to be maintained in larger communities. Hence, intra and interspecific diversities may support each other during evolution.	[Mougi, Akihiko] Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Matsue, Shimane, Japan	Shimane University	Mougi, A (corresponding author), Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Matsue, Shimane, Japan.	amougi@gmail.com			Japan Society for the Promotion of Science [16K18621]; Faculty of Life and Environmental Science at Shimane University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Faculty of Life and Environmental Science at Shimane University	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (num. #16K18621) and the Faculty of Life and Environmental Science at Shimane University to AM.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Barabas G, 2016, ECOL LETT, V19, P977, DOI 10.1111/ele.12636; Barraclough TG, 2015, ANNU REV ECOL EVOL S, V46, P25, DOI 10.1146/annurev-ecolsys-112414-054030; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Becks L, 2010, ECOL LETT, V13, P989, DOI 10.1111/j.1461-0248.2010.01490.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cohen J.E., 1990, COMMUNITY FOOD WEBS; Darwin C, 1928, EVERYMANS LIB; de Andreazzi CS, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2596; Des Roches S, 2018, NAT ECOL EVOL, V2, P57, DOI 10.1038/s41559-017-0402-5; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Duffy MA, 2010, FRESHWATER BIOL, V55, P995, DOI 10.1111/j.1365-2427.2009.02336.x; Elton C., 1927, ANIMAL ECOLOGY; Fisher RA, 1930, GENETICAL THEORY NAT; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Harper J. L, 1977, POPULATION BIOL PLAN; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; HUMPHREYS WF, 1979, J ANIM ECOL, V48, P427, DOI 10.2307/4171; JANZEN DH, 1980, EVOLUTION, V34, P611, DOI 10.1111/j.1558-5646.1980.tb04849.x; Jones LE, 2009, PHILOS T R SOC B, V364, P1579, DOI 10.1098/rstb.2009.0004; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; Klauschies T, 2016, ECOL EVOL, V6, P4141, DOI 10.1002/ece3.2172; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Mayr E, 1942, SYSTEMATICS ORIGIN S; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Mougi A, 2016, EVOL ECOL, V30, P365, DOI 10.1007/s10682-015-9810-7; Mougi A, 2013, THEOR ECOL-NETH, V6, P165, DOI 10.1007/s12080-012-0168-y; Mougi A, 2010, P ROY SOC B-BIOL SCI, V277, P3163, DOI 10.1098/rspb.2010.0691; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Post DM, 2009, PHILOS T R SOC B, V364, P1629, DOI 10.1098/rstb.2009.0012; Robbins C.T., 1983, WILDLIFE FEEDING NUT; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; terHorst CP, 2018, AM NAT, V191, P368, DOI 10.1086/695835; Tilman D., 1982, Monographs in Population Biology, pi; Toju H, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0024; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Yamaguchi W, 2011, POPUL ECOL, V53, P59, DOI 10.1007/s10144-010-0212-y; Yamauchi A, 2009, OIKOS, V118, P55, DOI 10.1111/j.1600-0706.2008.16736.x; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	62	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227420	10.1371/journal.pone.0227420	http://dx.doi.org/10.1371/journal.pone.0227420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923285	gold, Green Published			2022-12-26	WOS:000534350000074
J	Ryan, L; Rahman, T; Strang, A; Heinle, R; Shaffer, TH				Ryan, Lauren; Rahman, Tariq; Strang, Abigail; Heinle, Robert; Shaffer, Thomas H.			Diagnostic differences in respiratory breathing patterns and work of breathing indices in children with Duchenne muscular dystrophy	PLOS ONE			English	Article							MUSCLE STRENGTH; INFANTS	Rationale Pulmonary function testing (PFT) provides diagnostic information regarding respiratory physiology. However, many forms of PFT are time-intensive and require patient cooperation. Respiratory inductance plethysmography (RIP) provides thoracoabdominal asynchrony (TAA) and work of breathing (WOB) data. pneuRIPTM is a noninvasive, wireless analyzer that provides real-time assessment of RIP via an iPad. In this study, we show that pneuRIPTM can be used in a hospital clinic setting to differentiate WOB indices and breathing patterns in children with DMD as compared to age-matched healthy subjects. Methods RIP using the pneuRIPTM was conducted on 9 healthy volunteers and 7 DMD participants (ages 5-18) recruited from the neuromuscular clinic, under normal resting conditions over 3-5 min during routine outpatient visits. The tests were completed in less than 10 minutes and did not add excessive time to the clinic visit. Variables recorded included laboredbreathing index (LBI), phase angle (F) between abdomen and rib cage, respiratory rate (RR), percentage of rib cage input (RC%), and heart rate (HR). The data were displayed in histogram plots to identify distribution patterns within the normal ranges. The percentages of data within the ranges (0 <= Phi <= 30 deg.; median RC %+/- 10%; median RR +/- 5%; 1 <= LBI <= 1.1) were compared. Unpaired t-tests determined significance of the data between groups. Results 100% patient compliance demonstrates the feasibility of such testing in clinical settings. DMD patients showed a significant elevation in F, LBI, and HR averages (P< 0.006, P< 0.002, P< 0.046, respectively). Healthy subjects and DMD patients had similar BPM and RC% averages. All DMD data distributions were statistically different from healthy subjects based on analysis of histograms. The DMD patients showed significantly less data within the normal ranges, with only 49.7% Phi, 48.0% RC%, 69.2% RR, and 50.7% LBI. Conclusion In this study, noninvasive pneuRIP (TM) testing provided instantaneous PFT diagnostic results. As compared to healthy subjects, patients with DMD showed abnormal results with increased markers of TAA, WOB indices, and different breathing patterns. These results are similar to previous studies evaluating RIP in preterm infants. Further studies are needed to compare these results to other pulmonary testing methods. The pneuRIP (TM) testing approach provides immediate diagnostic information in outpatient settings.	[Ryan, Lauren; Rahman, Tariq; Shaffer, Thomas H.] Nemours Alfred I duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA; [Strang, Abigail; Heinle, Robert] Nemours Alfred I duPont Hosp Children, Div Pulm Med, Wilmington, DE USA; [Shaffer, Thomas H.] Nemours Alfred I duPont Hosp Children, Ctr Pediat Lung Res, Wilmington, DE 19803 USA	Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children	Shaffer, TH (corresponding author), Nemours Alfred I duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA.; Shaffer, TH (corresponding author), Nemours Alfred I duPont Hosp Children, Ctr Pediat Lung Res, Wilmington, DE 19803 USA.	tshaffer@nemours.org		Rahman, Tariq/0000-0002-4460-7790; Shaffer, Thomas/0000-0003-1757-8506	Nemours Foundation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [NIH COBRE P30GM114736]; University of Delaware, Center for Advanced Technology (CAT) Program Grant [44058]	Nemours Foundation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; University of Delaware, Center for Advanced Technology (CAT) Program Grant	Supported in part by The Nemours Foundation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number NIH COBRE P30GM114736 (PI: Thomas H Shaffer); and The University of Delaware, Center for Advanced Technology (CAT) Program Grant #44058 (Tariq Rahman and Thomas H. Shaffer, Co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JL, 1991, PEDIATR PULM, V11, P37, DOI 10.1002/ppul.1950110107; Balasubramaniam SL, 2019, PAEDIATR RESPIR REV, V29, P60, DOI 10.1016/j.prrv.2018.03.010; Daftary AS, 2007, PEDIATRICS, V119, pE320, DOI 10.1542/peds.2006-1400; de Jongh BE, 2014, J PERINATOL, V34, P27, DOI 10.1038/jp.2013.120; Fauroux B, 2014, RESPIROLOGY, V19, P782, DOI 10.1111/resp.12330; Gauld LM, 2014, CHEST, V146, P795, DOI 10.1378/chest.14-0166; Giordano K, 2012, PULM MED, V2012, DOI 10.1155/2012/724139; Khirani S, 2014, PEDIATR PULM, V49, P473, DOI 10.1002/ppul.22847; LoMauro A, 2015, THER CLIN RISK MANAG, V11, P1475, DOI 10.2147/TCRM.S55889; Perez A, 1996, CHEST, V110, P454, DOI 10.1378/chest.110.2.454; Rahman T, 2017, J MED DEVICES, V11, DOI 10.1115/1.4035546; Saito W, 2017, ASIAN SPINE J, V11, P787, DOI 10.4184/asj.2017.11.5.787; Steier J, 2007, THORAX, V62, P975, DOI 10.1136/thx.2006.072884; Victor RG, 2017, NEUROLOGY, V89, P1811, DOI 10.1212/WNL.0000000000004570; WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1032, DOI 10.1152/jappl.1992.72.3.1032	15	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226980	10.1371/journal.pone.0226980	http://dx.doi.org/10.1371/journal.pone.0226980			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923192	Green Published, gold			2022-12-26	WOS:000534350000035
J	Wilson, TJB; Cooley, SR; Tai, TC; Cheung, WWL; Tyedmers, PH				Wilson, Tyler J. B.; Cooley, Sarah R.; Tai, Travis C.; Cheung, William W. L.; Tyedmers, Peter H.			Potential socioeconomic impacts from ocean acidification and climate change effects on Atlantic Canadian fisheries	PLOS ONE			English	Article							MARINE; VULNERABILITY; SUSTAINABILITY; MANAGEMENT	Ocean acidification is an emerging consequence of anthropogenic carbon dioxide emissions. The full extent of the biological impacts are currently not entirely defined. However, it is expected that invertebrate species that rely on the mineral calcium carbonate will be directly affected. Despite the limited understanding of the full extent of potential impacts and responses there is a need to identify potential pathways for human societies to be affected by ocean acidification. Research on these social implications is a small but developing field. This research contributes to this field by using an impact assessment framework, informed by a biophysical model of future species distributions, to investigate potential impacts facing Atlantic Canadian society from potential changes in shellfish fisheries driven by ocean acidification and climate change. New Brunswick and Nova Scotia are expected to see declines in resource accessibility but are relatively socially insulated from these changes. Conversely, Prince Edward Island, along with Newfoundland and Labrador are more socially vulnerable to potential losses in fisheries, but are expected to experience relatively minor net changes in access.	[Wilson, Tyler J. B.; Tyedmers, Peter H.] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada; [Cooley, Sarah R.] Ocean Conservancy, Washington, DC USA; [Tai, Travis C.; Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada	Dalhousie University; University of British Columbia	Wilson, TJB (corresponding author), Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS, Canada.	tjbwilson@dal.ca	Tyedmers, Peter/I-7490-2012	Tyedmers, Peter/0000-0002-5150-0756	Marine Environmental Observation Prediction and Response Network (MEOPAR); Social Sciences and Humanities Research Council (SSHRC) in the form of the Canadian Graduate Scholarship-Masters Program (CGS-M); Social Sciences and Humanities Research Council of Canada (SSHRC); Nippon Foundation-University of British Columbia Nereus Program	Marine Environmental Observation Prediction and Response Network (MEOPAR); Social Sciences and Humanities Research Council (SSHRC) in the form of the Canadian Graduate Scholarship-Masters Program (CGS-M); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Nippon Foundation-University of British Columbia Nereus Program	TJBW, TCT, WWLC and PHT acknowledge the support from the Marine Environmental Observation Prediction and Response Network (MEOPAR) http://www.meopar.ca/-under the Canadian Ocean Acidification Research Program (COARp) https://meopar.ca/projects/cycle-ii-research/.TJBW also acknowledges scholarship support from the Social Sciences and Humanities Research Council (SSHRC) in the form of the Canadian Graduate Scholarship-Masters Program (CGS-M)-http://www.sshrc-crsh.gc.ca/.TCT and WWLC also acknowledge support from the Social Sciences and Humanities Research Council of Canada (SSHRC) - http://www.sshrc-crsh.gc.ca/; and through the OceanCanada Partnership - https://oceancanada.org/.WWLC also acknowledges funding support from the Nippon Foundation-University of British Columbia Nereus Program - http://nereusprogram.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CLIMATIC CHANGE, DOI DOI 10.1007/s10584-011-0157-y; [Anonymous], 2014, M MAP M MAP MAPPING; Bank of Canada, 2017, INFL CALC; Branch TA, 2013, TRENDS ECOL EVOL, V28, P178, DOI 10.1016/j.tree.2012.10.001; Brander L, 1994, RIGHTS BASED VS COMP, P14; Cardona OD, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P65; Cheung W.W.L., 2008, FISH CENT RES REP, V16, P72; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Clements JC, 2017, REV AQUACULT, V9, P326, DOI 10.1111/raq.12140; Cooley SR, 2012, FISH FISH, V13, P182, DOI 10.1111/j.1467-2979.2011.00424.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DFC, 2017, FED SUPP PROV TERR; DFO, 2015, INT FISH MAN PLAN IN; DFO, 2017, AQUACULTURE; DFO, 2004, ATL FISH POL REV POL; DFO, 2017, CAN FISH FAST FACTS, P6; DFO, 2007, COSTS EARN SURV 2004, P72; DFO, 2002, C411 DFO, P5; DFO, 2017, ATL REG LIC; DFO, 2017, SEAF LAND; Divovich E, 2015, 201556 U BRIT COL; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Ekstrom JA, 2015, NAT CLIM CHANGE, V5, P207, DOI 10.1038/NCLIMATE2508; Food and Agriculture Organization (FAO), 2016, STAT WORLD FISH AQ C; Gardner Pinfold Consulting, 2006, PROF ATL SHRIMP IND, P50; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Ghedini G, 2017, FOOD WEBS, V13, P53; Hajkowicz S, 2006, ECOL ECON, V57, P122, DOI 10.1016/j.ecolecon.2005.03.023; Heinrich L, 2017, INTEGR ENVIRON ASSES, V13, P778, DOI 10.1002/ieam.1843; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Kelly RP, 2011, SCIENCE, V332, P1036, DOI 10.1126/science.1203815; Kroeker KJ, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2016.0802; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kunreuther H, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P151; Lam VWY, 2016, FISH FISH, V17, P335, DOI 10.1111/faf.12106; Madin EMP, 2012, GLOBAL ENVIRON CHANG, V22, P137, DOI 10.1016/j.gloenvcha.2011.10.008; Mathis JT, 2015, PROG OCEANOGR, V136, P71, DOI 10.1016/j.pocean.2014.07.001; Mumby PJ, 2017, GLOBAL CHANGE BIOL, V23, P4483, DOI 10.1111/gcb.13698; Narita D, 2017, J ENVIRON PLANN MAN, V60, P500, DOI 10.1080/09640568.2016.1162705; Narita D, 2012, CLIMATIC CHANGE, V113, P1049, DOI 10.1007/s10584-011-0383-3; OECD, 2008, HDB CONSTRUCTING COM, DOI DOI 10.1787/9789264043466-EN; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Palomares M. L. D., 2017, SEALIFEBASE; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2018, GLOBAL CHANGE BIOL, V24, pE15, DOI 10.1111/gcb.13831; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2009, FISH PHYSIOL, V27, P143, DOI 10.1016/S1546-5098(08)00004-6; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rosen JP, 2011, SIGADA 2011: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON ADA AND RELATED TECHNOLOGIES, P35; RUSTICI G, 2006, CANCER RES S, V66; Smith MD, 2010, SCIENCE, V327, P784, DOI 10.1126/science.1185345; Statistics Canada, 2017, 2820002 STAT CAN; Statistics Canada, 2017, 3790030 STAT CAN; Statistics Canada, 2017, 2820004 STAT CAN; Stevens G, EVOLUTION MANAGEMENT, P14; Stortini CH, 2015, ICES J MAR SCI, V72, P1731, DOI 10.1093/icesjms/fsv022; Tai TC, 2018, ECOL MODEL, V385, P1, DOI 10.1016/j.ecolmodel.2018.07.007; Tremblay M. J., 1997, Journal of Northwest Atlantic Fishery Science, V21, P7; Tremblay MJ, 2012, 2012028 DFO, P18; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; Washington State Blue Ribbon Panel on Ocean Acidification, 2012, OCEAN ACIDIFICATION	65	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226544	10.1371/journal.pone.0226544	http://dx.doi.org/10.1371/journal.pone.0226544			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923278	Green Submitted, gold, Green Published			2022-12-26	WOS:000534350000017
J	Flem-Karlsen, K; Nyakas, M; Farstad, IN; McFadden, E; Wernhoff, P; Jacobsen, KD; Florenes, VA; Maelandsmo, GM				Flem-Karlsen, Karine; Nyakas, Marta; Farstad, Inger Nina; McFadden, Erin; Wernhoff, Patrik; Jacobsen, Kari Dolven; Florenes, Vivi Ann; Maelandsmo, Gunhild Mari			Soluble AXL as a marker of disease progression and survival in melanoma	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; RESISTANCE; EXPRESSION; INHIBITOR; THERAPY; GAS6; BRAF	Receptor tyrosine kinase AXL is a one-pass transmembrane protein upregulated in cancers and associated with lower survival and therapy resistance. AXL can be cleaved by the A Disintegrin and Metalloproteinases (ADAM)10 and ADAM17, yielding a soluble version of the protein. Elevated soluble AXL (sAXL) has been reported to be associated with disease progression in hepatocellular carcinoma, renal cancer, neurofibromatosis type 1 and inflammatory diseases. In the present work, we analyzed sAXL levels in blood from melanoma patients and showed that sAXL increases with disease progression. Additionally, increased sAXL levels were found correlated with shorter two-year survival in stage IV patients treated with ipilimumab. Furthermore, we showed that sAXL levels were related to the percentage of cells expressing AXL in resected melanoma lymph node metastases. This finding was verified in vitro, where sAXL levels in the cell media corresponded to AXL expression in the cells. AXL inhibition using the small-molecular inhibitor BGB324 reduced sAXL levels, while the cellular expression was elevated through increased protein stability. Our findings signify that quantification of sAXL blood levels is a simple and easily assessable method to determine cellular AXL levels and should be further evaluated for its use as a biomarker of disease progression and treatment response.	[Flem-Karlsen, Karine; Farstad, Inger Nina; McFadden, Erin; Wernhoff, Patrik; Florenes, Vivi Ann] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Flem-Karlsen, Karine; Nyakas, Marta; Farstad, Inger Nina] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Nyakas, Marta; Maelandsmo, Gunhild Mari] Oslo Univ Hosp, Inst Canc Res, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway; [Nyakas, Marta; Jacobsen, Kari Dolven] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Maelandsmo, Gunhild Mari] UiT Arctic Univ Norway, Inst Med Biol, Fac Hlth Sci, Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso	Flem-Karlsen, K (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.; Flem-Karlsen, K (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	kaflem@rr-research.no	Mælandsmo, Gunhild Mari/AFV-4446-2022	Nyakas, Marta/0000-0001-6331-3440; Flem Karlsen, Karine/0000-0001-8405-3406	Southern and Eastern Norway Regional Health Authority [39873]; Bodil and Magnes Foundation	Southern and Eastern Norway Regional Health Authority; Bodil and Magnes Foundation	This work was supported by the following grants: KFK, EM: Southern and Eastern Norway Regional Health Authority (Project number 39873) and MN: Bodil and Magnes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral T, 2017, EUR J CANCER, V73, P93, DOI 10.1016/j.ejca.2016.12.012; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Dengler M, 2017, ONCOTARGET, V8, P46234, DOI 10.18632/oncotarget.17598; Dengler M, 2016, ASSAY DRUG DEV TECHN, V14, P543, DOI 10.1089/adt.2016.743; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Florenes VA, 2019, TRANSL ONCOL, V12, P951, DOI 10.1016/j.tranon.2019.04.001; Gay CM, 2017, BRIT J CANCER, V116, P415, DOI 10.1038/bjc.2016.428; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Grzywa TM, 2017, TRANSL ONCOL, V10, P956, DOI 10.1016/j.tranon.2017.09.007; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Huebinger R, 2012, ADV ALZHEIMERS DIS, V1, P51, DOI DOI 10.1016/J.JALZ.2012.1005.1767; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Karimkhani C, 2017, BRIT J DERMATOL, V177, P134, DOI 10.1111/bjd.15510; Kariolis MS, 2017, J CLIN INVEST, V127, P183, DOI 10.1172/JCI85610; Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]; Karlsen MF, 2019, GYNECOL ONCOL, V152, P408, DOI 10.1016/j.ygyno.2018.11.012; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Lauter M, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0377-8; Lin JZ, 2017, ONCOTARGET, V8, P41064, DOI 10.18632/oncotarget.17026; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Maio M, 2015, J CLIN ONCOL, V33, P1191, DOI 10.1200/JCO.2014.56.6018; Miller MA, 2016, CANCER DISCOV, V6, P382, DOI 10.1158/2159-8290.CD-15-0933; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Myers KV, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1022-2; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Rambow F, 2018, CELL, V174, P843, DOI 10.1016/j.cell.2018.06.025; Rankin EB, 2016, CANCERS, V8, DOI 10.3390/cancers8110103; Reichl P, 2015, INT J CANCER, V137, P385, DOI 10.1002/ijc.29394; Scaltriti M, 2016, CLIN CANCER RES, V22, P1313, DOI 10.1158/1078-0432.CCR-15-1458; Schoumacher M, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0579-4; Sensi M, 2011, J INVEST DERMATOL, V131, P2448, DOI 10.1038/jid.2011.218; Tanaka K, 2016, CLIN BREAST CANCER, V16, P520, DOI 10.1016/j.clbc.2016.06.015; Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	41	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227187	10.1371/journal.pone.0227187	http://dx.doi.org/10.1371/journal.pone.0227187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917795	gold, Green Published			2022-12-26	WOS:000534341100016
J	Arias-Arias, JL; MacPherson, DJ; Hill, ME; Hardy, JA; Mora-Rodriguez, R				Arias-Arias, Jorge L.; MacPherson, Derek J.; Hill, Maureen E.; Hardy, Jeanne A.; Mora-Rodriguez, Rodrigo			A fluorescence-activatable reporter of flavivirus NS2B?NS3 protease activity enables live imaging of infection in single cells and viral plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; dengue virus (DENV); flavivirus; fluorescence; protease; cell-based reporter; internal cleavage; NS2B?NS3; plaque assay; Zika virus (ZIKV)	DENGUE-VIRUS; ANIMAL-MODELS; NS1	The genus Flavivirus in the family Flaviviridae comprises many medically important viruses, such as dengue virus (DENV), Zika virus (ZIKV), and yellow fever virus. The quest for therapeutic targets to combat flavivirus infections requires a better understanding of the kinetics of virus?host interactions during infections with native viral strains. However, this is precluded by limitations of current cell-based systems for monitoring flavivirus infection in living cells. In the present study, we report the construction of fluorescence-activatable sensors to detect the activities of flavivirus NS2B?NS3 serine proteases in living cells. The system consists of GFP-based reporters that become fluorescent upon cleavage by recombinant DENV-2/ZIKV proteases in vitro. A version of this sensor containing the flavivirus internal NS3 cleavage site linker reported the highest fluorescence activation in stably transduced mammalian cells upon DENV-2/ZIKV infection. Moreover, the onset of fluorescence correlated with viral protease activity. A far-red version of this flavivirus sensor had the best signal-to-noise ratio in a fluorescent Dulbecco's plaque assay, leading to the construction of a multireporter platform combining the flavivirus sensor with reporter dyes for detection of chromatin condensation and cell death, enabling studies of viral plaque formation with single-cell resolution. Finally, the application of this platform enabled the study of cell-population kinetics of infection and cell death by DENV-2, ZIKV, and yellow fever virus. We anticipate that future studies of viral infection kinetics with this reporter system will enable basic investigations of virus?host interactions and facilitate future applications in antiviral drug research to manage flavivirus infections.	[Arias-Arias, Jorge L.; Mora-Rodriguez, Rodrigo] Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, Ciudad Univ Rodrigo Facio, San Jose 115012060, Costa Rica; [MacPherson, Derek J.; Hill, Maureen E.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	Universidad Costa Rica; University of Massachusetts System; University of Massachusetts Amherst	Mora-Rodriguez, R (corresponding author), Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, Ciudad Univ Rodrigo Facio, San Jose 115012060, Costa Rica.	rodrigo.morarodriguez@ucr.ac.cr		Hardy, Jeanne/0000-0002-3406-7997; Mora-Rodriguez, Rodrigo/0000-0001-7964-3575	Universidad de Costa Rica Project [VI-803-B9-505]; National Science Foundation [NSF CBET1511367]; International Centre for Genetic Engineering and Biotechnology Grant [CRP/CRI18-02]	Universidad de Costa Rica Project; National Science Foundation(National Science Foundation (NSF)); International Centre for Genetic Engineering and Biotechnology Grant	This work was supported by Universidad de Costa Rica Project VI-803-B9-505 (to J. L. A.-A. and R. M.-R.), National Science Foundation Grant NSF CBET1511367 (to J. A. H.), and International Centre for Genetic Engineering and Biotechnology Grant CRP/CRI18-02 (to R. M.-R). The authors declare that they have no conflicts of interest with the contents of this article.	Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817; Arias-Arias JL, 2018, AM J TROP MED HYG, V99, P1451, DOI 10.4269/ajtmh.18-0175; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99; Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013; Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07; Constant DA, 2018, P NATL ACAD SCI USA, V115, P10136, DOI 10.1073/pnas.1805195115; d'Herelle F., 1926, NATURE, V118, P183, DOI [10.2307/3901538, DOI 10.2307/3901538]; de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93; Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978; Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508; Hsieh MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188170; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2; Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723; Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12; Leavesley SJ, 2016, CYTOM PART A, V89A, P325, DOI 10.1002/cyto.a.22851; Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64; Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Lindenbach BD, 2013, FIELDS VIROLOGY, P712; LIPRANDI F, 1981, J GEN VIROL, V56, P363, DOI 10.1099/0022-1317-56-2-363; Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400; McFadden MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020095; Medin CL, 2015, J VIROL METHODS, V211, P55, DOI 10.1016/j.jviromet.2014.10.010; Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; Nicholls SB, 2013, PROTEIN SCI, V22, P247, DOI 10.1002/pro.2188; Nicholls SB, 2011, J BIOL CHEM, V286, P24977, DOI 10.1074/jbc.M111.221648; Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514; Petrova E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010068; Reynolds ES, 2017, COMPARATIVE MED, V67, P232; Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8; Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136; Tamura T, 2018, J VIROL, V92, DOI 10.1128/JVI.01582-17; Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8; Wu P, 2013, BIOPHYS J, V104, P1605, DOI 10.1016/j.bpj.2013.01.058; Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013; Yakimovich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138760; Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398	56	12	12	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2212	2226		10.1074/jbc.RA119.011319	http://dx.doi.org/10.1074/jbc.RA119.011319			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31919100	hybrid, Green Published			2022-12-26	WOS:000517330200006
J	Bjerkli, IH; Jetlund, O; Karevold, G; Karlsdottir, A; Jaatun, E; Uhlin-Hansen, L; Rikardsen, OG; Hadler-Olsen, E; Steigen, SE				Bjerkli, Inger-Heidi; Jetlund, Olav; Karevold, Gunnhild; Karlsdottir, Asa; Jaatun, Ellen; Uhlin-Hansen, Lars; Rikardsen, Oddveig G.; Hadler-Olsen, Elin; Steigen, Sonja E.			Characteristics and prognosis of primary treatment-naive oral cavity squamous cell carcinoma in Norway, a descriptive retrospective study	PLOS ONE			English	Article							NECK-CANCER; OROPHARYNGEAL CANCER; TONGUE CANCER; UNITED-STATES; AHNS SERIES; HEAD; EPIDEMIOLOGY; PRINCIPLES; GUIDELINES; SURVIVAL	Objectives Incidence of oral cavity squamous cell carcinomas is rising worldwide, and population characterization is important to follow for future trends. The aim of this retrospective study was to present a large cohort of primary oral cavity squamous cell carcinoma from all four health regions of Norway, with descriptive clinicopathological characteristics and five-year survival outcomes. Materials and methods Patients diagnosed with primary treatment-naive oral cavity squamous cell carcinomas at all four university hospitals in Norway between 2005-2009 were retrospectively included in this study. Clinicopathological data from the electronic health records were compared to survival data. Results A total of 535 patients with primary treatment-naive oral cavity squamous cell carcinomas were identified. The median survival follow-up time was 48 months (range 0-125 months) after treatment. The median five-year overall survival was found to be 47%. Median five-year disease-specific survival was 52%, ranging from 80% for stage I to 33% for stage IV patients. For patients given treatment with curative intent, the overall survival was found to be 56% and disease-specific survival 62%. Median age at diagnosis was 67 years (range 24-101 years), 64 years for men and 72 years for women. The male: female ratio was 1.2. No gender difference was found in neither tumor status (p = 0.180) nor node status (p = 0.266), but both factors influenced significantly on survival (p<0.001 for both). Conclusions We present a large cohort of primary treatment-naive oral cavity squamous cell carcinomas in Norway. Five-year disease-specific survival was 52%, and patients eligible for curative treatment had a five-year disease-specific survival up to 62%.	[Bjerkli, Inger-Heidi; Rikardsen, Oddveig G.] Univ Hosp North Norway, Dept Otorhinolaryngol, Tromso, Norway; [Bjerkli, Inger-Heidi; Uhlin-Hansen, Lars; Rikardsen, Oddveig G.; Hadler-Olsen, Elin; Steigen, Sonja E.] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Jetlund, Olav; Karevold, Gunnhild] Oslo Univ Hosp, Rikshosp, Dept Otorhinolaryngol Head & Neck Surg, Div Head Neck & Reconstruct Surg, Oslo, Norway; [Karlsdottir, Asa] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Jaatun, Ellen] St Olays Univ Hosp, Dept Otorhinolaryngol, Trondheim, Norway; [Jaatun, Ellen] Norwegian Univ Sci & Technol, Trondheim, Norway; [Uhlin-Hansen, Lars; Hadler-Olsen, Elin; Steigen, Sonja E.] Univ Hosp North Norway, Dept Pathol, Tromso, Norway; [Hadler-Olsen, Elin] UiT Arctic Univ Norway, Dept Clin Dent, Tromso, Norway; [Jetlund, Olav] Ringshusveien 6, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Steigen, SE (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway.; Steigen, SE (corresponding author), Univ Hosp North Norway, Dept Pathol, Tromso, Norway.	Sonja.eriksson.steigen@uit.no		Hadler-Olsen, Elin/0000-0001-8476-9439	North Norwegian Regional Health Authorities; UiT The Arctic University of Norway	North Norwegian Regional Health Authorities; UiT The Arctic University of Norway	The work was supported by grants from the North Norwegian Regional Health Authorities. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.; This work was supported by grants from the North Norwegian Regional Health Authorities.	Annertz K, 2012, ACTA OTO-LARYNGOL, V132, P552, DOI 10.3109/00016489.2011.649146; [Anonymous], 2017, UNION INT CANC CONTR; Ayubi E, 2017, ORAL ONCOL, V69, P128, DOI 10.1016/j.oraloncology.2017.04.006; Barnes LE, 2005, WHO CLASSIF TUMOUR, P163, DOI DOI 10.1016/J.UROLOGY.2004.09.048; Benson E, 2014, ORAL ONCOL, V50, P565, DOI 10.1016/j.oraloncology.2013.09.008; Braakhuis BJM, 2002, HEAD NECK-J SCI SPEC, V24, P198, DOI 10.1002/hed.10042.abs; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang JS, 2013, ORAL ONCOL, V49, P1010, DOI 10.1016/j.oraloncology.2013.07.004; Chang S, 2019, LARYNGOSCOPE, V129, P1816, DOI 10.1002/lary.27565; Cheng YJ, 2018, CANCER MED-US, V7, P3073, DOI 10.1002/cam4.1611; Conway DI, 2018, BRIT DENT J, V225, P867, DOI 10.1038/sj.bdj.2018.922; de Abreu PM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4247-3; Digonnet A, 2013, EUR ARCH OTO-RHINO-L, V270, P1569, DOI 10.1007/s00405-012-2172-7; Fakhry C, 2014, ORAL ONCOL, V50, P353, DOI 10.1016/j.oraloncology.2014.03.010; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gatta G, 2015, EUR J CANCER, V51, P2130, DOI 10.1016/j.ejca.2015.07.043; Gooi Z, 2016, HEAD NECK-J SCI SPEC, V38, P987, DOI 10.1002/hed.24448; Gussgard AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091733; ICD-10 W, 2016, INT STAT CLASS DIS R; Javed F, 2016, CRIT REV ONCOL HEMAT, V97, P197, DOI 10.1016/j.critrevonc.2015.08.018; Karamzad N, 2017, WORLD J UROL, V35, P1467, DOI 10.1007/s00345-016-1974-4; Karnov KKS, 2017, ACTA ONCOL, V56, P1204, DOI 10.1080/0284186X.2017.1307516; Li R, 2013, OTOLARYNG HEAD NECK, V148, P792, DOI 10.1177/0194599813477992; Maasland DHE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-187; Mariotto Angela B, 2014, J Natl Cancer Inst Monogr, V2014, P145, DOI 10.1093/jncimonographs/lgu024; Mehanna H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4690; Miller MC, 2017, HEAD NECK-J SCI SPEC, V39, P791, DOI 10.1002/hed.24654; Montero PH, 2015, SURG ONCOL CLIN N AM, V24, P491, DOI 10.1016/j.soc.2015.03.006; Mroueh R, 2017, HEAD NECK-J SCI SPEC, V39, P1306, DOI 10.1002/hed.24744; Network NCC, 2019, NAT COMPR CANC NETW; Norway S., ALCOHOL CONSUMPTION; Norway S., 2019, TOBACCO ALCOHOL OTHE; Pires FR, 2013, J APPL ORAL SCI, V21, P460, DOI 10.1590/1679-775720130317; Rennemo E, 2009, RADIOTHER ONCOL, V93, P559, DOI 10.1016/j.radonc.2009.08.005; Rikardsen OG, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-103; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P1327, DOI 10.1080/00016480510012273; Ruhstaller T, 2006, EUR J CANCER, V42, P2459, DOI 10.1016/j.ejca.2006.03.034; Safiri S, 2017, HEPATOLOGY, V66, P999, DOI 10.1002/hep.29261; SCHWARTZ LH, 1994, CANCER, V74, P1933, DOI 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X; Shield KD, 2017, CA-CANCER J CLIN, V67, P51, DOI 10.3322/caac.21384; Society AC, 2019, SURV RAT OR CAV OR C, DOI [10.1002/cncr.32208, DOI 10.1002/CNCR.32208]; Taberna M, 2017, ANN ONCOL, V28, P2386, DOI 10.1093/annonc/mdx304; Torrecillas V, 2018, ORAL ONCOL, V85, P1, DOI 10.1016/j.oraloncology.2018.07.019; Tota JE, 2017, ORAL ONCOL, V67, P146, DOI 10.1016/j.oraloncology.2017.02.019; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Weatherspoon DJ, 2015, CANCER EPIDEMIOL, V39, P497, DOI 10.1016/j.canep.2015.04.007; WHO, 2018, GLOB STAT REP ALC HE; WHO E, 2019, ALC CONS EUR COUNTR; Wirsing AM, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-38; Wittekind C., 2005, TNM ATLAS 2005 ILLUS, P5	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227738	10.1371/journal.pone.0227738	http://dx.doi.org/10.1371/journal.pone.0227738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945122	gold, Green Published			2022-12-26	WOS:000534370100058
J	Esgro, MW; Lindholm, J; Nickols, KJ; Bredvik, J				Esgro, Michael W.; Lindholm, James; Nickols, Kerry J.; Bredvik, Jessica			Early conservation benefits of a de facto marine protected area at San Clemente Island, California	PLOS ONE			English	Article							BIODIVERSITY; RESERVES; FISH; RESPONSES; SCIENCE; SUSTAINABILITY; CONNECTIVITY; POPULATIONS; ABUNDANCE; SHEEPHEAD	De facto marine protected areas (DFMPAs) are regions of the ocean where human activity is restricted for reasons other than conservation. Although DFMPAs are widespread globally, their potential role in the protection of marine habitats, species, and ecosystems has not been well studied. In 2012 and 2013, we conducted remotely operated vehicle (ROV) surveys of marine communities at a military DFMPA closed to all civilian access since 2010 and an adjacent fished reference site at San Clemente Island, the southernmost of California's Channel Islands. We used data extracted from ROV imagery to compare density and biomass of focal species, as well as biodiversity and community composition, between the two sites. Generalized linear modeling indicated that both density and biomass of California sheephead (Semicossyphus pulcher) were significantly higher inside the DFMPA. Biomass of ocean whitefish (Caulolatilus princeps) was also significantly higher inside the DFMPA. However, species richness and Shannon-Weaver diversity were not significantly higher inside the DFMPA, and overall fish community composition did not differ significantly between sites. Demonstrable differences between the DFMPA and fished site for two highly sought-after species hint at early potential benefits of protection, though the lack of differences in the broader community suggests that a longer trajectory of recovery may be required for other species. A more comprehensive understanding of the potential conservation benefits of DFMPAs is important in the context of marine spatial planning and global marine conservation objectives.	[Esgro, Michael W.; Lindholm, James] Calif State Univ Monterey Bay, Inst Appl Marine Ecol, Seaside, CA 93955 USA; [Nickols, Kerry J.] Calif State Univ Northridge, Northridge, CA 91330 USA; [Bredvik, Jessica] Naval Facil Engn Command Southwest, San Diego, CA USA	California State University System; California State University Monterey Bay; California State University System; California State University Northridge	Esgro, MW (corresponding author), Calif State Univ Monterey Bay, Inst Appl Marine Ecol, Seaside, CA 93955 USA.	mesgro@gmail.com		Esgro, Michael W./0000-0002-2431-0631	United States Pacific Fleet (US Army Corps of Engineers Award) [W9126G-12-2-0041]	United States Pacific Fleet (US Army Corps of Engineers Award)	Funded by JL - United States Pacific Fleet (US Army Corps of Engineers Award W9126G-122-0041). https://www.usace.army.mil/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Generous financial support for this project came from the United States Pacific Fleet (US Army Corps of Engineers Award W9126G-12-2-0041) and private donations. We thank the crews of the F/V Donna Kathleen and Marine Applied Research and Exploration for key assistance in the field. Finally, we thank two anonymous reviewers, whose suggestions and contributions greatly improved this manuscript.	Adreani MS, 2004, ENVIRON BIOL FISH, V71, P13, DOI 10.1023/B:EBFI.0000043177.98895.f7; Alonzo SH, 2004, STATUS CALIFORNIA SH; [Anonymous], 2013, SAN CLEMENTE ISLAND; Bassett M, 2018, ENVIRON BIOL FISH, V101, P203, DOI 10.1007/s10641-017-0692-0; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; California Department of Fish and Wildlife, 2019, CAL RECR FISH SURV C; California Department of Fish and Wildlife, 2007, SPEC LIL BEN EST MAR; Carr M. H., 2010, STANF J LAW SCI POLI, V2, P1; Costello MJ, 2015, TRENDS ECOL EVOL, V30, P507, DOI 10.1016/j.tree.2015.06.011; Diz D, 2018, MAR POLICY, V93, P251, DOI 10.1016/j.marpol.2017.08.019; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Foley MM, 2010, MAR POLICY, V34, P955, DOI 10.1016/j.marpol.2010.02.001; Fulton CJ, 2016, ECOL INDIC, V70, P222, DOI 10.1016/j.ecolind.2016.06.032; Grober-Dunsmore R., 2008, STAT NAT FACT PROT A; Halpern BS, 2012, MAR POLICY, V36, P198, DOI 10.1016/j.marpol.2011.05.004; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Hamilton SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024580; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; HORN MH, 1978, J BIOGEOGR, V5, P23, DOI 10.2307/3038105; Husson F., 2016, PACKAGE FACTOMINER; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; IUCN, 2016, IUCN RES REC OTH DEC; JONAS H., 2018, PARKS, V24, P9, DOI DOI 10.2305/IUCN.CH.2018.PARKS-24-SIHDJ.EN; Kaplan KA, 2019, ECOL APPL, V29, DOI 10.1002/eap.1949; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lindholm J, 2004, MAR ECOL PROG SER, V269, P61, DOI 10.3354/meps269061; Lindholm J, 2015, FISHERY B, V113; Lindholm JB, 2001, CONSERV BIOL, V15, P424, DOI 10.1046/j.1523-1739.2001.015002424.x; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; Menge BA, 1997, LIMNOL OCEANOGR, V42, P57, DOI 10.4319/lo.1997.42.1.0057; Moffitt EA, 2013, MAR ECOL PROG SER, V489, P17, DOI 10.3354/meps10425; Murray SN, BIOGEOGRAPHY CALIFOR; Naval Undersea Warfare Center Division, 2009, SO CAL SOCAL FISH ST; Nickols KJ, 2019, J APPL ECOL, V56, P2376, DOI 10.1111/1365-2664.13463; Nickols KJ, 2015, AM NAT, V185, P196, DOI 10.1086/679503; NOAA National Marine Protected Areas Center, 2017, FACT MAR PROT AR; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pedlosky J, 1997, J MAR RES, V55, P1199, DOI 10.1357/0022240973224085; Pondella DJ, 2005, J BIOGEOGR, V32, P187, DOI 10.1111/j.1365-2699.2004.01180.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rogers-Bennett L, 2013, BIOL CONSERV, V157, P423, DOI 10.1016/j.biocon.2012.06.023; Ruzicka JJ, 2012, PROG OCEANOGR, V102, P19, DOI 10.1016/j.pocean.2012.02.002; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Shears NT, 2006, ROLE HAURAKI GULF CA; Starr RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118502; Topping DT, 2006, MAR ECOL PROG SER, V326, P257, DOI 10.3354/meps326257; United Nations Convention on Biological Diversity, 2018, DEC AD C PART CONV B; United Nations Convention on Biological Diversity, 2010, DEC AD C PART CONV B; United States Department of the Navy, 2008, SO CAL RANG COMPL EN; United States Department of the Navy, 2013, HAW SOC TRAIN TEST E; Warren SD, 2007, RESTOR ECOL, V15, P606, DOI 10.1111/j.1526-100X.2007.00272.x; White JW, 2013, CONSERV LETT, V6, P180, DOI 10.1111/j.1755-263X.2012.00295.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	60	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0224060	10.1371/journal.pone.0224060	http://dx.doi.org/10.1371/journal.pone.0224060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945056	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100007
J	Miyatake, N; Adachi, H; Nomura-Nakayama, K; Okada, K; Okino, K; Hayashi, N; Fujimoto, K; Furuichi, K; Yokoyama, H				Miyatake, Nobuhiko; Adachi, Hiroki; Nomura-Nakayama, Kanae; Okada, Keiichiro; Okino, Kazuaki; Hayashi, Norifumi; Fujimoto, Keiji; Furuichi, Kengo; Yokoyama, Hitoshi			Circulating CTRP9 correlates with the prevention of aortic calcification in renal allograft recipients	PLOS ONE			English	Article							MOLECULAR-WEIGHT FORM; INSULIN-RESISTANCE; ADIPONECTIN; APOPTOSIS; ASSOCIATION; DISEASE	Background Cardiovascular disease (CVD) due to atherosclerosis is a major cause of death in renal allograft recipients. Recently, C1q/INF-alpha related protein-9 (CTRP9), which is a paralog of adiponectin (ADPN), has been suggested to be related to the prevention of atherosclerosis and the occurrence of CVD, but this relationship has not been confirmed in renal allograft recipients. Subjects and methods The relationships among the serum CTRP9 concentration, serum ADPN concentration, and vascular calcification were investigated in 50 kidney transplantation recipients at our hospital. Calcification of the abdominal aorta was evaluated according to the aortic calcification area index (ACAI) calculated from CT images. Changes in the serum CTRP9 and ADPN fractions and ACAI were examined for 8 years. In addition, the expression of CTRP9 and ADPN and their respective receptors AdipoRl and R2 in muscular arteries of the kidney was examined by immunofluorescence. Results In renal allograft recipients, the serum CTRP9 concentration at the start of the observation was not significant correlated with eGFR or serum high-molecular-weight (HMW)-ADPN concentration (rS = -0.009, p = 0.950; rS = -0.226, p = 0.114, respectively). However, the change in the serum CTRP9 concentration was positively correlated with the change in the serum HMW-ADPN concentration (rS = 0.315, p = 0.026) and negatively correlated with the change in ACAI (rS = -0.367, p = 0.009). Multiple regression analysis revealed that the serum HMW-ADPN concentration was a significant positive factor for the change in the serum CTRP9 concentration. Moreover, for ACAI, an increase in the serum CTRP9 concentration was an improving factor, but aging was an exacerbating factor. Furthermore, colocalization of CTRP9 and AdipoRl was noted in the luminal side of intra-renal arterial intima. Conclusion In renal allograft recipients, both CTRP9 and HMW-ADPN were suggested to prevent the progression of aortic calcification through AdipoR1.	[Miyatake, Nobuhiko; Adachi, Hiroki; Nomura-Nakayama, Kanae; Okada, Keiichiro; Okino, Kazuaki; Hayashi, Norifumi; Fujimoto, Keiji; Furuichi, Kengo; Yokoyama, Hitoshi] Kanazawa Med Univ, Dept Nephrol, Sch Med, Daiga Ku, Uchinada, Ishikawa, Japan	Kanazawa Medical University	Yokoyama, H (corresponding author), Kanazawa Med Univ, Dept Nephrol, Sch Med, Daiga Ku, Uchinada, Ishikawa, Japan.	h-yoko@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [18K08256]; Ministry of Health, Labour, and Welfare of Japan; Japan Agency for Medical Research and Development [S2017-7, C2017-4]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; (C) 18K08256 (HY); Grants for Intractable Renal Disease Research and for Health and Labour Sciences Research from the Ministry of Health, Labour, and Welfare of Japan (HY); a Grant-in-Aid for Investigating New Evidences to Understand the safety of Kidney Transplantation from marginal Donors, Promotion of renal Disease Control Grants from Japan Agency for Medical Research and Development (K Furuichi, HY), Grants for Study at Kanazawa Medical University (No. S2017-7) (HA) and Grants for a Cooperative Study at Kanazawa Medical University (No. C2017-4) (HY).	Adachi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163899; Arimatsu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04828; BIA MJ, 1995, KIDNEY INT, V47, P1470, DOI 10.1038/ki.1995.206; Cheng L. B., 2016, ARABIAN J GEOSCIENCE, V9, P1; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Indolfi C, 2002, CIRC RES, V91, P1190, DOI 10.1161/01.RES.0000046233.94299.D6; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Janigan DT, 2000, AM J KIDNEY DIS, V35, P588, DOI 10.1016/S0272-6386(00)70003-5; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kamon J, 2004, BIOCHEM BIOPH RES CO, V323, P242, DOI 10.1016/j.bbrc.2004.08.083; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lau WB, 2017, CIRC J, V81, P920, DOI 10.1253/circj.CJ-17-0458; Liu Q, 2017, J CELL MOL MED, V21, P2823, DOI 10.1111/jcmm.13196; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meigs JB, 2002, DIABETES CARE, V25, P1313, DOI 10.2337/diacare.25.8.1313; Moradi N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192159; Nishizawa Y, 2005, J RENAL NUTR, V15, P178, DOI 10.1053/j.jrn.2004.09.027; Nomura-Nakayama K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195066; Ojo AO, 2006, TRANSPLANTATION, V82, P603, DOI 10.1097/01.tp.0000235527.81917.fe; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Song KY, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.4_suppl.139; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Ushigome H., 2016, JAPANESE J TRANSPLAN, V51, P331; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhao L, 2019, CELL TRANSPLANT	31	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0226526	10.1371/journal.pone.0226526	http://dx.doi.org/10.1371/journal.pone.0226526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945100	gold, Green Published			2022-12-26	WOS:000534370100012
J	Runge, CA; Daigle, RM; Hausner, VH				Runge, Claire A.; Daigle, Remi M.; Hausner, Vera H.			Quantifying tourism booms and the increasing footprint in the Arctic with social media data	PLOS ONE			English	Article							LAST-CHANCE TOURISM; PROTECTED AREAS; CRUISE TOURISM; MANAGEMENT; PATTERNS; BIODIVERSITY; INFORMATION; TRENDS	Arctic tourism has rapidly increased in the past two decades. We used social media data to examine localized tourism booms and quantify the spatial expansion of the Arctic tourism footprint. We extracted geotagged locations from over 800,000 photos on Flickr and mapped these across space and time. We critically examine the use of social media as a data source in data-poor regions, and find that while social media data is not suitable as an early warning system of tourism growth in less visited parts of the world, it can be used to map changes at large spatial scales. Our results show that the footprint of summer tourism quadrupled and winter tourism increased by over 600% between 2006 and 2016, although large areas of the Arctic remain untouched by tourism. This rapid increase in the tourism footprint raises concerns about the impacts and sustainability of tourism on Arctic ecosystems and communities. This boom is set to continue, as new parts of the Arctic are being opened to tourism by melting sea ice, new airports and continued promotion of the Arctic as a 'last chance to see' destination. Arctic societies face complex decisions about whether this ongoing growth is socially and environmentally sustainable.	[Runge, Claire A.; Hausner, Vera H.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Sustainabil Lab, Tromso, Norway; [Daigle, Remi M.] Univ Laval, Dept Biol, Quebec City, PQ, Canada	UiT The Arctic University of Tromso; Laval University	Runge, CA (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Arctic Sustainabil Lab, Tromso, Norway.	claire.runge@uqconnect.edu.au	Runge, Claire/Q-2110-2018	Runge, Claire/0000-0003-3913-8560	FRAM - High North Research Centre for Climate and the Environment through the Flagship MIKON (Project RConnected); Arctic Belmont Forum Arctic Observing and Research for Sustainability (Project CONNECT); Norwegian Research Council grant [247474]	FRAM - High North Research Centre for Climate and the Environment through the Flagship MIKON (Project RConnected); Arctic Belmont Forum Arctic Observing and Research for Sustainability (Project CONNECT); Norwegian Research Council grant(Research Council of Norway)	The work was funded by grants awarded to VHH from FRAM - High North Research Centre for Climate and the Environment through the Flagship MIKON (Project RConnected; https://www.framcentre.com/) and the Arctic Belmont Forum Arctic Observing and Research for Sustainability (Project CONNECT; https://www.belmontforum.org/). The Norwegian collaboration was financed by Norwegian Research Council grant 247474 (https://www.forskningsradet.no/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen H, 2012, ECOL SOC, V17, DOI 10.5751/ES-05142-170446; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Atwood TC, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1370; Barchiesi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128470; Becken S., 2006, Journal of Sustainable Tourism, V14, P323, DOI 10.2167/jost547.0; Brandt JS, 2018, CURR OPIN ENV SUST, V32, P112, DOI 10.1016/j.cosust.2018.04.004; BUTLER RW, 1980, CAN GEOGR-GEOGR CAN, V24, P5, DOI 10.1111/j.1541-0064.1980.tb00970.x; Garcia-Palomares JC, 2015, APPL GEOGR, V63, P408, DOI 10.1016/j.apgeog.2015.08.002; Csagoly Z, 2017, J OUTDOOR REC TOUR, V17, P1, DOI 10.1016/j.jort.2016.10.004; de Albuquerque JP, 2015, INT J GEOGR INF SCI, V29, P667, DOI 10.1080/13658816.2014.996567; Fay G, 2011, POLAR GEOGR, V34, P63, DOI 10.1080/1088937X.2011.585779; Fredman P, 2010, SCAND J HOSP TOUR, V10, P177, DOI 10.1080/15022250.2010.502365; Gao YZ, 2018, INT J GEOGR INF SCI, V32, P425, DOI 10.1080/13658816.2017.1406943; Girardin F, 2008, J LOCAT BASED SERV, V2, P41, DOI 10.1080/17489720802261138; Goswami A, 2016, SOC NETW ANAL MIN, V6, DOI 10.1007/s13278-016-0414-1; Groulx M, 2016, J SUSTAIN TOUR, V24, P1523, DOI 10.1080/09669582.2015.1134556; Hale BW, 2018, ENVIRON MANAGE, V62, P446, DOI 10.1007/s00267-018-1056-z; Halliday WD, 2018, MAR POLICY, V97, P72, DOI 10.1016/j.marpol.2018.08.035; Hausmann A, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12343; Helwig NE, 2015, SPAT STAT-NETH, V14, P491, DOI 10.1016/j.spasta.2015.09.002; Kidd A, J SUSTAIN TOUR, DOI [10.1080/09669582.2019.1612905, DOI 10.1080/09669582.2019.1612905]; Kim Y, 2019, TOURISM MANAGE, V72, P249, DOI 10.1016/j.tourman.2018.12.005; Lamers M, 2018, CURR ISSUES TOUR, V21, P440, DOI 10.1080/13683500.2015.1092947; Lasserre F, 2015, POLAR REC, V51, P24, DOI 10.1017/S0032247413000508; Lemelin H, 2010, CURR ISSUES TOUR, V13, P477, DOI 10.1080/13683500903406367; Leung D, 2013, J TRAVEL TOUR MARK, V30, P3, DOI 10.1080/10548408.2013.750919; Levin N, 2017, APPL GEOGR, V79, P115, DOI 10.1016/j.apgeog.2016.12.009; Li LN, 2013, CARTOGR GEOGR INF SC, V40, P61, DOI 10.1080/15230406.2013.777139; Ma M, 2013, ANN TOURISM RES, V41, P89, DOI 10.1016/j.annals.2012.12.004; Maher PT, 2017, SPR POLAR SCI, P213, DOI 10.1007/978-3-319-57532-2_22; Mancini F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200565; Meijer JR, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabd42; OPPERMANN M, 1993, ANN TOURISM RES, V20, P535, DOI 10.1016/0160-7383(93)90008-Q; Oteros-Rozas E, 2018, ECOL INDIC, V94, P74, DOI 10.1016/j.ecolind.2017.02.009; Panteras G, 2015, T GIS, V19, P694, DOI 10.1111/tgis.12122; Pashkevich A., 2015, POLAR J, V6, P112; Pebesma E, 2018, R J; Schlieder C, 2009, SPAT COGN COMPUT, V9, P212, DOI 10.1080/13875860903121848; Scott D, 2015, TOUR RECREAT RES, V40, P269, DOI 10.1080/02508281.2015.1075739; Stewart E. J., 2006, Tourism in Marine Environments, V3, P77, DOI 10.3727/154427306779435210; Stewart EJ, 2011, J HOSP TOUR MANAG, V18, P95, DOI 10.1375/jhtm.18.1.95; Tenkanen H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18007-4; Tolvanen A, 2016, J ENVIRON MANAGE, V169, P58, DOI 10.1016/j.jenvman.2015.12.011; UNEP-WCMC and IUCN, 2018, PROT PLAN WORLD DAT; van Zanten BT, 2016, P NATL ACAD SCI USA, V113, P12974, DOI 10.1073/pnas.1614158113; Walden-Schreiner C, 2018, AMBIO, V47, P781, DOI 10.1007/s13280-018-1020-4; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	48	17	17	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227189	10.1371/journal.pone.0227189	http://dx.doi.org/10.1371/journal.pone.0227189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945097	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100023
J	Barrett, JM; Tapies, MGR; Shepherd, GMG				Barrett, John M.; Tapies, Martinna G. Raineri; Shepherd, Gordon M. G.			Manual dexterity of mice during food-handling involves the thumb and a set of fast basic movements	PLOS ONE			English	Article							MOTOR CORTEX; MOUSE; ORGANIZATION; FOREPAW; ANATOMY; IMAGE; RATS; LIMB	The small first digit (D1) of the mouse's hand resembles a volar pad, but its thumb-like anatomy suggests ethological importance for manipulating small objects. To explore this possibility, we recorded high-speed close-up video of mice eating seeds and other food items. Analyses of ethograms and automated tracking with DeepLabCut revealed multiple distinct microstructural features of food-handling. First, we found that mice indeed made extensive use of D1 for dexterous manipulations. In particular, mice used D1 to hold food with either of two grip types: a pincer-type grasp, or a "thumb-hold" grip, pressing with D1 from the side. Thumb-holding was preferentially used for handling smaller items, with the smallest items held between the two D1 s alone. Second, we observed that mice cycled rapidly between two postural modes while feeding, with the hands positioned either at the mouth (oromanual phase) or resting below (holding phase). Third, we identified two highly stereotyped D1-related movements during feeding, including an extraordinarily fast (similar to 20 ms) "regrip" maneuver, and a fast (similar to 100 ms) "sniff" maneuver. Lastly, in addition to these characteristic simpler movements and postures, we also observed highly complex movements, including rapid D1-assisted rotations of food items and dexterous simultaneous double-gripping of two food fragments. Manipulation behaviors were generally conserved for different food types, and for head-fixed mice. Wild squirrels displayed a similar repertoire of D1-related movements. Our results define, for the mouse, a set of kinematic building-blocks of manual dexterity, and reveal an outsized role for D1 in these actions.	[Barrett, John M.; Tapies, Martinna G. Raineri; Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Barrett, JM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	john.barrett@cantab.net		Barrett, John/0000-0002-7524-6035	National Institute of Neurological Disorders and Stroke at the National Institutes of Health [NS061963]	National Institute of Neurological Disorders and Stroke at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grant NS061963 from the National Institute of Neurological Disorders and Stroke at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou T, 2015, J NEUROPHYSIOL, V113, P487, DOI 10.1152/jn.00094.2014; Allred RP, 2008, J NEUROSCI METH, V170, P229, DOI 10.1016/j.jneumeth.2008.01.015; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bab I. A., 2007, MICROTOMOGRAPHIC ATL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollu T, 2019, BIORXIV, DOI [10.1101/655852, DOI 10.1101/655852]; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Datta SR, 2019, NEURON, V104, P11, DOI 10.1016/j.neuron.2019.09.038; De Filippis B, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/326184; Fleckman P, 2013, ANAT REC, V296, P521, DOI 10.1002/ar.22660; Galinanes GL, 2018, CELL REP, V22, P2767, DOI 10.1016/j.celrep.2018.02.042; Greene E.C., 1935, T AM PHILOS SOC, V27, P1; Guo JZ, 2015, ELIFE, V4, DOI 10.7554/eLife.10774; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Hartstone-Rose A, 2020, AM J PHYS ANTHROPOL, V171, P8, DOI 10.1002/ajpa.23936; Igarashi M, 2019, J NEUROPHYSIOL, V121, P490, DOI 10.1152/jn.00295.2018; Iwaniuk AN, 2000, TRENDS NEUROSCI, V23, P372, DOI 10.1016/S0166-2236(00)01618-0; Kardong KV., 2015, RESP SYSTEM VERTEBRA; Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Lungmus JK, 2019, P NATL ACAD SCI USA, V116, P6903, DOI 10.1073/pnas.1802543116; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Mathis MW, 2017, NEURON, V93, P1493, DOI 10.1016/j.neuron.2017.02.049; Nath T., 2018, BIORXIV, DOI [10.1101/476531, DOI 10.1101/476531]; Pellis SM, 2012, BEHAV BRAIN RES, V231, P378, DOI 10.1016/j.bbr.2011.08.046; Phillips C, 1985, MOVEMENTS HAND; Pratt V., 1987, COMPUT GRAPHICS-US, V21, P145, DOI [10.1145/37402.37420, DOI 10.1145/37402.37420, DOI 10.1145/37401.37420]; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Sustaita D, 2013, BIOL REV, V88, P380, DOI 10.1111/brv.12010; Tennant Kelly A, 2010, J Vis Exp, DOI 10.3791/2076; TSUGANE M, 1995, ANAT REC, V242, P225, DOI 10.1002/ar.1092420212; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; WATERS RS, 1995, EXP BRAIN RES, V103, P183; Whishaw IQ, 2019, FASCINAT LIFE SCI, P159, DOI 10.1007/978-3-030-13739-7_6; Whishaw IQ, 2018, BEHAV BRAIN RES, V341, P37, DOI 10.1016/j.bbr.2017.12.006; Whishaw IQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10796-y; WHISHAW IQ, 1992, BEHAV BRAIN RES, V48, P113, DOI 10.1016/S0166-4328(05)80147-0; Whishaw IQ, 1998, BEHAV BRAIN RES, V96, P79, DOI 10.1016/S0166-4328(97)00200-3; WHISHAW IQ, 1989, BEHAV BRAIN RES, V32, P11, DOI 10.1016/S0166-4328(89)80067-1; Whishaw IQ, 1996, BEHAV BRAIN RES, V77, P135, DOI 10.1016/0166-4328(95)00209-X; Wiltschko AB, 2015, NEURON, V88, P1121, DOI 10.1016/j.neuron.2015.11.031; Woolsey CN, 1958, BIOL BIOCH BASES BEH, P63; Zagouras A, 2013, SOL ENERGY, V97, P1, DOI 10.1016/j.solener.2013.08.005	46	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226774	10.1371/journal.pone.0226774	http://dx.doi.org/10.1371/journal.pone.0226774			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940368	Green Submitted, gold, Green Published			2022-12-26	WOS:000534368000040
J	Hossain, Z; Akter, R; Sultana, N; Kabir, E				Hossain, Zakir; Akter, Rozina; Sultana, Nasrin; Kabir, Enamul			Modelling zero-truncated overdispersed antenatal health care count data of women in Bangladesh	PLOS ONE			English	Article							SERVICES; TESTS	Overdispersion in count data analysis is very common in many practical fields of health sciences. Ignorance of the presence of overdispersion in such data analysis may cause misleading inferences and thus lead to incorrect interpretations of the results. Researchers should account for the consequences of overdispersion and need to select the correct choice of models for the analysis of such data. In this paper, Generalized Linear Models (GLMs) are applied in modelling and analysis of antenatal care (ANC) count data extracted from the Bangladesh Demographic and Health Survey (BDHS) 2014. Pearson chi-square and different score tests are used to investigate the effect of overdispersion in the analysis. Overdispersion is found to be significant in the antenatal health care count data and so appropriate modelling is used to produce valid inferences for the regression parameters. The zero-truncated negative binomial regression (0-NBR) is found to be the best choice for analysing such data while excluding zero counts. Study findings reveal that place of residence, order of birth, exposure to mass media, wealth index and education of mother have significant impacts on the ANC status of women during pregnancy in Bangladesh.	[Hossain, Zakir; Akter, Rozina] Univ Dhaka, Dept Stat, Dhaka, Bangladesh; [Sultana, Nasrin] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Kansas City, MO USA; [Kabir, Enamul] Univ Southern Queensland, Sch Sci, Toowoomba, Qld, Australia	University of Dhaka; University of Kansas; University of Southern Queensland	Hossain, Z (corresponding author), Univ Dhaka, Dept Stat, Dhaka, Bangladesh.	zakir.hossain@du.ac.bd		Hossain, Zakir/0000-0003-4128-3097; Kabir, Enamul/0000-0002-6157-2753	National Science and Technology (NST) Fellowship, Ministry of Science and Technology, Government of Bangladesh; National Science and Technology (NST), Ministry of Science and Technology, Government of Bangladesh	National Science and Technology (NST) Fellowship, Ministry of Science and Technology, Government of Bangladesh; National Science and Technology (NST), Ministry of Science and Technology, Government of Bangladesh	RA was funded by the National Science and Technology (NST) Fellowship, Ministry of Science and Technology, Government of Bangladesh under the supervision of ZH.; The authors would like to acknowledge DHS (Demographic and Health Surveys) who made their data available for free and National Science and Technology (NST), Ministry of Science and Technology, Government of Bangladesh for funding this work. We would like to express our gratitude to Department of Statistics, University of Dhaka, Bangladesh and Faculty of Health, Engineering and Sciences (HES) of University of Southern Queensland, Australia for the technical support.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2007, STAND MAT NEON CAR; Becker S, 1993, Health Transit Rev, V3, P77; BMMS. Bangladesh Maternal Mortality and Health Care Survey, 2016, PRELIMINARY REPORT; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Chowdhury Rafiqul Islam, 2007, World Health Popul, V9, P9; DEAN C, 1989, J AM STAT ASSOC, V84, P467, DOI 10.2307/2289931; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Islam M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2392-6; Jayaraman A., 2008, DHS WORKING PAPERS, V59; Kiser H, 2018, HEALTH INF SCI SYST, V7, DOI 10.1007/s13755-018-0064-y; Latif AHMM, 2008, AUST J STAT, V37, P175; McCullagh P, 1989, GEN LINEAR MODELS; Mohammad K, 2018, BANGLADESH J SCI RES, V30, P23, DOI [10.3329/bjsr.v30i1-2.36117, DOI 10.3329/BJSR.V30I1-2.36117]; Mustafizur Rahman K.M., 2009, RES J APPL SCI, V4, P113; National Institute of Population Research and Training (NIPORT) and ICF. 2019, BANGL DEM HLTH SURV; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Nisar N, 2003, J Pak Med Assoc, V53, P47; Pandit R D, 1992, Asia Oceania J Obstet Gynaecol, V18, P1; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-61; WHO, 2018, WHO SUST DEV GOALS S; Winkelmann R, 2008, ECONOMETRIC ANAL COU; World Health Organization, 2019, MAT MORT; Yebyo H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124718	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227824	10.1371/journal.pone.0227824	http://dx.doi.org/10.1371/journal.pone.0227824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935274	Green Published, Green Accepted, gold			2022-12-26	WOS:000534354100058
J	Tukayo, BLA; Sunderland, B; Parsons, R; Czarniak, P				Tukayo, Brechkerts Lieske Angruni; Sunderland, Bruce; Parsons, Richard; Czarniak, Petra			High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; INTENSIVE-CARE UNITS; CHILDREN; MEDICINES	Background Data on off-label and unlicensed prescribing in children in Indonesia is limited. The aims of this study were to determine the prevalence of off-label and unlicensed prescribing for paediatric patients in a public hospital, Indonesia. Method A retrospective cross-sectional study of 200 randomly selected paediatric patients admitted to hospital between August and October 2014, collected patient details and all drugs prescribed. Licensed drugs were classified as off-label if there was a non-compliance with the Product Information for age, weight, indication, dose, frequency and route of administration, if there was a contraindication, special precautions or not recommended for children. Unlicensed drugs were those not approved for use in Indonesia. The main outcome was the prevalence of off-label or unlicensed prescribing to infants, children and adolescents and the impact of age group on off-label prescribing. Results A total of 200 patients received 1961 medicines of which 1807/1961 (92.1%) were licensed and 154/1961 (7.9%) were unlicensed. There were 1403/1961 (71.5%) drugs prescribed off-label. More than half of the total drugs (n = 1066; 54.4%) were administered parenterally. Every patient was prescribed at least one off-label drug. Indication (n = 810; 34.6%) was the most common reason for off-label prescribing. Ranitidine was the most frequent drug prescribed off label. Darplex (R) (dihydroartemisinin and piperaquine), although manufactured in Indonesia, was unlicensed. There was a significant difference between age group and offlabel prescribing in that children were prescribed significantly less off-label drugs (p< 0.0003). Conclusion This study revealed a high prevalence of off-label and unlicensed drug use in paediatric patients in this hospital, exposing them to drug treatments or regimens that had not been approved by regulatory authorities. The high incidence of invasive parenteral prescribing is of concern for paediatric patients. Incentives are needed to encourage specific drug evaluation in paediatric populations.	[Tukayo, Brechkerts Lieske Angruni; Sunderland, Bruce; Czarniak, Petra] Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA, Australia; [Tukayo, Brechkerts Lieske Angruni] Indonesian Minist Hlth, Hlth Polytech Jayapura, Jakarta, Indonesia; [Parsons, Richard] Curtin Univ, Sch Occupat Therapy Social Work & Speech Pathol, Bentley, WA, Australia	Curtin University; Ministry of Health - Indonesia; Curtin University	Czarniak, P (corresponding author), Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA, Australia.	P.Czarniak@curtin.edu.au		Tukayo, Brechkerts Lieske Angruni/0000-0003-3720-9329				Allegaert K, 2014, PEDIATR ANESTH, V24, P30, DOI 10.1111/pan.12176; [Anonymous], 2015, MIMS IND PET KONS 14; [Anonymous], 2017, REV LAWS REGULATIONS; [Anonymous], 2017, STATE PAEDIAT MED EU; [Anonymous], 2015, MONTHL IND MED SPEC; Balan S, 2018, WORLD J PEDIATR, V14, P528, DOI 10.1007/s12519-018-0186-y; Ballard CDJ, 2013, J PAEDIATR CHILD H, V49, P38, DOI 10.1111/jpc.12065; Bavdekar SB, 2009, INDIAN J PEDIATR, V76, P1113, DOI 10.1007/s12098-009-0238-3; Bonati M, 2017, ARCH DIS CHILD, V102, P53, DOI 10.1136/archdischild-2016-311527; Carnovale C, 2013, EUR J PEDIATR, V172, P1679, DOI 10.1007/s00431-013-2111-7; Contopoulos-Ioannidis DG, 2010, J PEDIATR-US, V157, P322, DOI 10.1016/j.jpeds.2010.02.011; Corny Jennifer, 2015, J Pediatr Pharmacol Ther, V20, P316, DOI 10.5863/1551-6776-20.4.316; Czarniak P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120630; Delmas S, UNLICENSED OFF LABEL; Ferreira LD, 2012, REV ASSOC MED BRAS, V58, P82; Hill P, 2005, ARCH DIS CHILD, V90, pI17, DOI 10.1136/adc.2004.058867; Hsien L, 2008, PHARM WORLD SCI, V30, P497, DOI 10.1007/s11096-008-9193-8; Ivanovska V, 2014, PEDIATRICS, V134, P361, DOI 10.1542/peds.2013-3225; Jonville-Bera AP, 2005, EUR J CLIN PHARMACOL, V61, P231, DOI 10.1007/s00228-004-0881-6; Khdour MR, 2011, INT J CLIN PHARM-NET, V33, P650, DOI 10.1007/s11096-011-9520-3; Knellwolf AL, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-12; Laforgia N, 2014, PEDIATR INT, V56, P57, DOI 10.1111/ped.12190; Landwehr C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210237; Lathyris D, 2014, PEDIATRICS, V133, pE666, DOI 10.1542/peds.2013-3128; Lee JL, 2013, INT J CLIN PHARM-NET, V35, P1025, DOI 10.1007/s11096-013-9846-0; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Lindell-Osuagwu L, 2014, J CLIN PHARM THER, V39, P144, DOI 10.1111/jcpt.12119; Magalhaes J, 2015, EUR J CLIN PHARMACOL, V71, P1, DOI 10.1007/s00228-014-1768-9; Rahajeng Bangunawati, 2018, INT J PHARM PHARM SC, V10, P119, DOI [10.22159/ijpps.2018v10i5.25388, DOI 10.22159/IJPPS.2018V10I5.25388]; Ramadaniati HU, 2017, ASIAN J PHARM CLIN R, V10, P355; Sabtu N, 2015, BRIT MED BULL, V116, P105, DOI 10.1093/bmb/ldv041; Slaneva J., 2012, EUR PHARM J, V59, P48; The Head of Drug and Food Controller Agency, REG HEAD DRUG FOOD C; The National Agency of Drug and Food Control, 2015, INDONESIA; Wallerstedt SM, 2011, DRUG SAFETY, V34, P669, DOI 10.2165/11591730-000000000-00000; WHO Collaborating Centre for Drug Statistics Methodology, 2015, ATC DDD IND 2015; World Health Organisation, 2002, SAF APPR US INJ WORL; Yamashiro Y, 2012, J PEDIATR GASTR NUTR, V55, P506, DOI 10.1097/MPG.0b013e318272af1f	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227687	10.1371/journal.pone.0227687	http://dx.doi.org/10.1371/journal.pone.0227687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935254	Green Published, gold			2022-12-26	WOS:000534354100044
J	Maseko, B; Hill, LM; Phanga, T; Bhushan, N; Vansia, D; Kamtsendero, L; Pettifor, AE; Bekker, LG; Hosseinipour, MC; Rosenberg, NE				Maseko, Bertha; Hill, Lauren M.; Phanga, Twambilile; Bhushan, Nivedita; Vansia, Dhrutika; Kamtsendero, Linda; Pettifor, Audrey E.; Bekker, Linda-Gail; Hosseinipour, Mina C.; Rosenberg, Nora E.			Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi	PLOS ONE			English	Article								Background Oral Pre-Exposure Prophylaxis (PrEP) is an effective HIV prevention strategy for adherent users. Adolescent girls and young women (AGYW) in sub-Saharan Africa may particularly benefit from PrEP because of the disproportionate burden of HIV in this group. Understanding potential users' perceptions of and interest in using PrEP is critical to promote the utilization of PrEP by individuals at risk of HIV. Methods This qualitative investigation of AGYW's knowledge of and interest in PrEP use was conducted in the context of Girl Power, a quasi-experimental cohort study comparing four models of service delivery at four health centers in Lilongwe, Malawi. We conducted individual in-depth interviews (IDIs) with 40 HIV-negative AGYW ages 15-24 years old six months after enrolment in the parent study. An explanation of PrEP was provided to participants. Interview topics included participants' prior knowledge of, interest in, concerns about, and delivery preferences for PrEP. Analysis consisted of structural coding of interview transcripts corresponding to interview topics, summary of responses within these topics, and identification and description of emerging themes within each topic. Results None of the AGYW had knowledge of PrEP prior to the IDIs, but once explained, a majority expressed an interest in using it due to inconsistencies in condom use, condom use errors, their own or their partners' concurrent sexual partnerships, and rape. Most AGYW hoped that PrEP would be available in youth-friendly sections of health centers for easy access and youth-friendly counselling. They suggested that discrete packaging of PrEP would be needed to ensure user privacy. Concerns about relationship destabilization and accusations of promiscuity were raised as potential barriers to use. Conclusion General interest in PrEP among AGYW was high. Discrete packaging and access to youth-friendly PrEP delivery modalities may facilitate the utilization of PrEP as a prevention strategy among sexually active AGYW. Attention to potential negative reactions from partners and community members to PrEP use will be needed when introducing PrEP to this population.	[Maseko, Bertha; Phanga, Twambilile; Bhushan, Nivedita; Vansia, Dhrutika; Kamtsendero, Linda; Hosseinipour, Mina C.; Rosenberg, Nora E.] UNC Project Malawi, Lilongwe, Malawi; [Hill, Lauren M.; Rosenberg, Nora E.] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Hill, Lauren M.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA; [Bhushan, Nivedita; Hosseinipour, Mina C.] Univ N Carolina, Sch Med, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA; [Pettifor, Audrey E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Bekker, Linda-Gail] UCT, Desmond Tutu HIV Ctr, Fac Hlth Sci, Cape Town, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Cape Town	Maseko, B (corresponding author), UNC Project Malawi, Lilongwe, Malawi.	bmaseko@unclilongwe.org	Bekker, Linda-Gail/AAZ-8929-2020	Pettifor, Audrey/0000-0002-3387-0817; BEKKER, LINDA-GAIL/0000-0002-0755-4386	Evidence for HIV Prevention in Southern Africa (EHPSA), a DFID program; National Institute of Mental Health [R00 MH104154]; National Institutes of Health Fogarty International Center [R25TW009340]	Evidence for HIV Prevention in Southern Africa (EHPSA), a DFID program; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We declare that we have no conflicts of interest. The study was funded by Evidence for HIV Prevention in Southern Africa (EHPSA), a DFID program managed by Mott MacDonald. NER is funded by the National Institute of Mental Health (R00 MH104154). NLB was supported by the National Institutes of Health Fogarty International Center (R25TW009340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atujuna M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191251; AVERT, 2018, MAL RES; Calabrese SK, 2019, AIDS PATIENT CARE ST, V33, P79, DOI 10.1089/apc.2018.0166; CDC, 2019, PREP HIV BAS HIV AID; Celum C, 2012, ANTIVIR THER, V17, P1483, DOI 10.3851/IMP2492; Corneli Amy L, 2014, J Int AIDS Soc, V17, P19152, DOI 10.7448/IAS.17.3.19152; Davey DJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197143; Dunbar MS, 2018, SEX HEALTH, V15, P513, DOI 10.1071/SH18061; Eakle R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4959-3; Hartmann M, 2018, AIDS BEHAV, V22, P3468, DOI 10.1007/s10461-018-2044-2; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Mathur S, 2016, LANCET HIV, V3, pE406, DOI 10.1016/S2352-3018(16)30115-1; Montgomery MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157742; National Statistical Office, 2010, MDHS 2010; Ortblad KF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3415-z; Pilgrim N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196280; Pintye J, 2018, AIDS PATIENT CARE ST, V32, P538, DOI 10.1089/apc.2018.0058; Rosenberg NE, 2018, JAIDS-J ACQ IMM DEF, V79, P458, DOI 10.1097/QAI.0000000000001830; Rosenberg NE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018480; Tolley E, 2016, QUALITATIVE METHODS, P85; UNAIDS, 2016, GET FAST TRACK LIFE; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vazquez L, 2019, AIDS PATIENT CARE ST, V33, P214, DOI 10.1089/apc.2018.0242; World Health Organization, 2018, WHO IMPL TOOL PREEXP	24	25	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226062	10.1371/journal.pone.0226062	http://dx.doi.org/10.1371/journal.pone.0226062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929547	Green Published, gold			2022-12-26	WOS:000534352500006
J	Schiffer, V; Santiago-Mujika, E; Flunkert, S; Schmidt, S; Farcher, M; Loeffler, T; Schilcher, I; Posch, M; Neddens, J; Sun, Y; Kehr, J; Hutter-Paier, B				Schiffer, Victoria; Santiago-Mujika, Estibaliz; Flunkert, Stefanie; Schmidt, Staffan; Farcher, Martina; Loeffler, Tina; Schilcher, Irene; Posch, Maria; Neddens, Joerg; Sun, Ying; Kehr, Jan; Hutter-Paier, Birgit			Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease	PLOS ONE			English	Article							SAPOSIN C DEFICIENCY; ALPHA-SYNUCLEIN; TARGETED DISRUPTION; POINT MUTATIONS; MOUSE MODELS; GLUCOCEREBROSIDASE; GLUCOSYLSPHINGOSINE; BRAIN; GLUCOSYLCERAMIDE; NEUROPATHOLOGY	Gaucher disease is caused by a deficiency in glucocerebrosidase that can result in non-neuronal as well as neuronal symptoms. Common visceral symptoms are an increased organ size, specifically of the spleen, and glucosylceramide as well as glucosylsphingosine substrate accumulations as a direct result of the glucocerebrosidase deficiency. Neuronal symptoms include motor deficits and strong alterations in the cerebellum. To evaluate the effect of new compounds for the treatment of this devastating disease, animal models are needed that closely mimic the human phenotype. The 4L/PS-NA mouse as model of Gaucher disease is shown to present reduced glucocerebrosidase activity similar to human cases but an in-depth characterization of the model was still not performed. We therefore analyzed 4L/PS-NA mice for visceral alterations, motor deficits and also neuronal changes like glucocerebrosidase activity, substrate levels and neuroinflammation. A special focus was set at pathological changes of the cerebellum. Our results show that 4L/PS-NA mice have strongly enlarged visceral organs that are infiltrated by enlarged leukocytes and macrophages. Furthermore, animals present strong motor deficits that are accompanied by increased glucosylceramide and glucosylsphingosine levels in the brain, astrocytosis and activated microglia in the cortex and hippocampus as well as reduced calbindin levels in the cerebellum. The latter was directly related to a strong Purkinje cell loss. Our results thus provide a detailed characterization of the 4L/PS-NA mouse model over age showing the translational value of the model and validating its usefulness for preclinical efficiency studies to evaluate new compounds against Gaucher disease.	[Schiffer, Victoria; Santiago-Mujika, Estibaliz; Flunkert, Stefanie; Farcher, Martina; Loeffler, Tina; Schilcher, Irene; Posch, Maria; Neddens, Joerg; Hutter-Paier, Birgit] QPS Austria GmbH, Neuropharmacol, Grambach, Austria; [Schmidt, Staffan; Kehr, Jan] Pronexus Analyt AB, Bromma, Sweden; [Sun, Ying] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Santiago-Mujika, Estibaliz] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Leicester	Flunkert, S (corresponding author), QPS Austria GmbH, Neuropharmacol, Grambach, Austria.	Stefanie.Flunkert@qps.com		Flunkert, Stefanie/0000-0003-3806-3907; Santiago Mujika, Estibaliz/0000-0002-5809-5300; Kehr, Jan/0000-0002-2410-124X	QPS Austria GmbH; BHP	QPS Austria GmbH; BHP	QPS Austria GmbH provided support in the form of salaries for authors VS, ESM, SF, MF, TL, IS, MP, JN and BHP and covered material costs for animal housing, breeding, tissue sampling, behavioral analyses, GCase measurement and all histological analyses. Pronexus Analytical AB provided support in the form of salaries for authors SS and JK and covered material costs for Glucosylceramide and Glucosylsphingosine measurements. Both companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abdelwahab M, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000158; Abdelwahab M, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000055; Amir G, 1999, HUM PATHOL, V30, P666, DOI 10.1016/S0046-8177(99)90092-8; Burrow TA, 2015, MOL GENET METAB, V114, P233, DOI 10.1016/j.ymgme.2014.08.011; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; CONRADI N, 1991, ACTA NEUROPATHOL, V82, P152, DOI 10.1007/BF00293959; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Farfel-Becker T, 2011, HUM MOL GENET, V20, P1375, DOI 10.1093/hmg/ddr019; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Fuller M, 2015, CLIN CHIM ACTA, V450, P6, DOI 10.1016/j.cca.2015.07.026; Ginns EI, 2014, MOL GENET METAB, V111, P152, DOI 10.1016/j.ymgme.2013.12.003; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Hamler R, 2017, ANAL CHEM, V89, P8288, DOI 10.1021/acs.analchem.7b01442; Jones EE, 2017, SLAS DISCOV, V22, P1218, DOI 10.1177/2472555217719372; Li YQ, 2015, CELL MOL NEUROBIOL, V35, P755, DOI 10.1007/s10571-015-0176-8; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Maor G, 2019, HUM MOL GENET, V28, P1768, DOI 10.1093/hmg/ddz005; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; Murugesan V, 2016, AM J HEMATOL, V91, P1082, DOI 10.1002/ajh.24491; Nishino M, 2006, RADIOGRAPHICS, V26, P335, DOI 10.1148/rg.262045213; Pampols T, 1999, ACTA NEUROPATHOL, V97, P91, DOI 10.1007/s004010050960; Rabl R, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0341-8; Rabl R, 2016, J NEUROSCI METH, V274, P125, DOI 10.1016/j.jneumeth.2016.10.006; Ran C, 2016, NEUROBIOL AGING, V45, DOI 10.1016/j.neurobiolaging.2016.04.022; Rolfs A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079732; SIDRANSKY E, 1992, PEDIATR RES, V32, P494, DOI 10.1203/00006450-199210000-00023; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sorrentino P, 2016, J PARKINSON DIS, V6, P191, DOI 10.3233/JPD-150660; Stirnemann J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020441; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Sun Y, 2002, MOL GENET METAB, V76, P271, DOI 10.1016/S1096-7192(02)00114-2; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Sun Y, 2010, HUM MOL GENET, V19, P634, DOI 10.1093/hmg/ddp531; Taguchi YV, 2017, J NEUROSCI, V37, P9617, DOI 10.1523/JNEUROSCI.1525-17.2017; Tajima A, 2009, MOL GENET METAB, V97, P272, DOI 10.1016/j.ymgme.2009.05.001; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; Tylki-Szymanska A, 2010, J INHERIT METAB DIS, V33, P339, DOI 10.1007/s10545-009-9009-6; VERITY MA, 1977, NEUROPADIATRIE, V8, P89, DOI 10.1055/s-0028-1091508; Vilageliu L, 2017, CURR PROTEIN PEPT SC, V18, P758, DOI 10.2174/1389203717666160311115956; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Weiss K, 2015, MOL GENET METAB, V114, P110, DOI 10.1016/j.ymgme.2014.11.008; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; Yoneshige A, 2010, J NEUROSCI RES, V88, P2118, DOI 10.1002/jnr.22371	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227077	10.1371/journal.pone.0227077	http://dx.doi.org/10.1371/journal.pone.0227077			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929594	gold, Green Published			2022-12-26	WOS:000534352500029
J	Bernier-Lachance, J; Arsenault, J; Usongo, V; Parent, E; Labrie, J; Jacques, M; Malouin, F; Archambault, M				Bernier-Lachance, Jocelyn; Arsenault, Julie; Usongo, Valentine; Parent, Eric; Labrie, Josee; Jacques, Mario; Malouin, Francois; Archambault, Marie			Prevalence and characteristics of Livestock-Associated Methicillin-Resistant Staphylococcus aureus (LA-MRSA) isolated from chicken meat in the province of Quebec, Canada	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; RETAIL MEAT; BROILER FLOCKS; MULTIPLEX PCR; RISK-FACTORS; GENES; ST398; STRAINS; POULTRY	This study was conducted to estimate the prevalence of Livestock-Associated Methicillin-Resistant Staphylococcus aureus (LA-MRSA) in retail chicken meat and broiler chickens from the Province of Quebec, Canada, and to characterize LA-MRSA isolates. A total of 309 chicken drumsticks and thighs were randomly selected in 2013 from 43 retail stores in the Monteregie. In addition, nasal swabs and caeca samples were collected in 2013-2014 from 200 broiler chickens of 38 different flocks. LA-MRSA was not detected in broiler chickens. Fifteen LAMRSA isolates were recovered from four (1.3%) of the 309 chicken meat samples. Multi-Locus Sequence Typing (MLST) and SCCmec typing revealed two profiles (ST398-MRSA-V and ST8-MRSA-IVa), which were distinct using pulse-field gel electrophoresis (PFGE) and microarray (antimicrobial resistance and virulence genes) analyses. In addition to beta-lactam resistance, tetracycline and spectinomycin resistance was detected in all isolates from the 3 positive samples of the ST398 profile. Southern blot hybridization revealed that the resistance genes aad(D) and lnu(A), encoding resistances to aminoglycosides and lincosamides respectively, were located on plasmid. All isolates were able to produce biofilms, but biofilm production was not correlated with hld gene expression. Our results show the presence of two separate lineages of MRSA in retail chicken meat in Quebec, one of which is likely of human origin.	[Bernier-Lachance, Jocelyn; Arsenault, Julie; Usongo, Valentine; Parent, Eric; Labrie, Josee; Malouin, Francois; Archambault, Marie] Univ Montreal, CRIPA, FRQNT, Fac Med Vet, St Hyacinthe, PQ, Canada; [Bernier-Lachance, Jocelyn; Usongo, Valentine; Parent, Eric; Labrie, Josee; Jacques, Mario; Archambault, Marie] Univ Montreal, Grp Rech Malad Infect Prod Anim GREMIP, Fac Med Vet, St Hyacinthe, PQ, Canada; [Arsenault, Julie] Univ Montreal, Grp Rech Epiderniol Zoonoses & Sante Publ GREZOSP, Fac Med Vet, St Hyacinthe, PQ, Canada; [Malouin, Francois] Univ Sherbrooke, Fac Sci, Dept Biol, CEVDM, Sherbrooke, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Sherbrooke	Archambault, M (corresponding author), Univ Montreal, CRIPA, FRQNT, Fac Med Vet, St Hyacinthe, PQ, Canada.; Archambault, M (corresponding author), Univ Montreal, Grp Rech Malad Infect Prod Anim GREMIP, Fac Med Vet, St Hyacinthe, PQ, Canada.	marie.archambault@umontreal.ca	Arsenault, Julie/D-5077-2015; Usongo, Valentine/CAG-1903-2022	Arsenault, Julie/0000-0001-8382-7326; Malouin, Francois/0000-0001-5031-345X; Parent, Eric/0000-0001-7923-3840	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN-191461, RGPIN-2016-04203, RGPIN-89758-2010]; Programme de Soutien a l'Innovation (PSI) of the Ministere de l'Agriculture et des Pecheries et de l'Alimentation du Quebec (MAPAQ); NSERC [2015-05916]; 'Centre de Recherche en Infectiologie Porcine et Aviaire' (CRIPA) (FQRNT Regroupements strategiques) [111946]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Programme de Soutien a l'Innovation (PSI) of the Ministere de l'Agriculture et des Pecheries et de l'Alimentation du Quebec (MAPAQ); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); 'Centre de Recherche en Infectiologie Porcine et Aviaire' (CRIPA) (FQRNT Regroupements strategiques)	The work was financially supported in part by the Natural Sciences and Engineering Research Council (NSERC) of Canada (M. Archambault, RGPIN-191461; F. Malouin RGPIN-89758-2010; and M. Jacques (RGPIN-201604203). M. Archambault and F. Malouin were supported by the Programme de Soutien a l'Innovation (PSI) of the Ministere de l'Agriculture et des Pecheries et de l'Alimentation du Quebec (MAPAQ). This research was also funded in part by a NSERC discovery grant (No. 2015-05916) to F. Malouin. The 'Centre de Recherche en Infectiologie Porcine et Aviaire' (CRIPA) (FQRNT Regroupements strategiques 111946) grant is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoletti F, 2014, VET MICROBIOL, V170, P172, DOI 10.1016/j.vetmic.2014.01.035; Allard M, 2006, MICROBES INFECT, V8, P1679, DOI 10.1016/j.micinf.2006.01.022; Barski P, 1996, MOL CELL PROBE, V10, P471, DOI 10.1006/mcpr.1996.0066; Benito D, 2014, FOODBORNE PATHOG DIS, V11, P354, DOI 10.1089/fpd.2013.1689; Bhargava K, 2011, EMERG INFECT DIS, V17, P1135, DOI [10.3201/eid1706.101095, 10.3201/eid/1706.101905]; Boost MV, 2013, FOODBORNE PATHOG DIS, V10, P705, DOI 10.1089/fpd.2012.1415; Buyukcangaz E, 2013, FOODBORNE PATHOG DIS, V10, P608, DOI 10.1089/fpd.2012.1427; Christianson S, 2007, J CLIN MICROBIOL, V45, P1904, DOI 10.1128/JCM.02500-06; Clinical and Laboratory Standards Institute, 2010, PERFORMANCE STANDARD; Clinical and Laboratory Standards Institute, 2018, PERF STAND ANT DISK; Crombe F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00057; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Dressler AE, 2012, VET REC, V170, P495, DOI 10.1136/vr.100570; Elliott AC, 2011, COMPUT METH PROG BIO, V102, P75, DOI 10.1016/j.cmpb.2010.11.002; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; EUCAST, 2013, EUCAST CLIN BREAKP T; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Fromm S, 2014, PREV VET MED, V117, P180, DOI 10.1016/j.prevetmed.2014.08.014; Garcia-Graells C, 2012, EPIDEMIOL INFECT, V140, P383, DOI 10.1017/S0950268811002263; Goerke C, 2000, INFECT IMMUN, V68, P1304, DOI 10.1128/IAI.68.3.1304-1311.2000; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Hanson B M, 2011, J Infect Public Health, V4, P169, DOI 10.1016/j.jiph.2011.06.001; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Huber H, 2010, EUROSURVEILLANCE, V15, P7; Jacques Mario, 2010, Animal Health Research Reviews, V11, P97, DOI 10.1017/S1466252310000149; Jensen SO, 2009, FUTURE MICROBIOL, V4, P565, DOI 10.2217/FMB.09.30; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Karageorgopoulos DE, 2012, J ANTIMICROB CHEMOTH, V67, P255, DOI 10.1093/jac/dkr466; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Krupa P, 2014, POULTRY SCI, V93, P3179, DOI 10.3382/ps.2014-04321; Lakhundi S, 2018, CLIN MICROBIOL REV, V31, DOI [10.1128/CMR.00020-18, 10.1128/cmr.00020-18]; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lina G, 1999, ANTIMICROB AGENTS CH, V43, P1062, DOI 10.1128/AAC.43.5.1062; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Luthje P, 2007, J ANTIMICROB CHEMOTH, V59, P600, DOI 10.1093/jac/dkm008; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Nemati M, 2009, AVIAN PATHOL, V38, P513, DOI 10.1080/03079450903349212; Nemeghaire S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-153; Nemeghaire S, 2013, AVIAN PATHOL, V42, P342, DOI 10.1080/03079457.2013.805183; Nicholson TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073376; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; O'Brien AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030092; O'Neill E, 2007, J CLIN MICROBIOL, V45, P1379, DOI 10.1128/JCM.02280-06; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Paterson GK, 2014, TRENDS MICROBIOL, V22, P42, DOI 10.1016/j.tim.2013.11.003; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; Pletinckx LJ, 2011, INFECT GENET EVOL, V11, P2133, DOI 10.1016/j.meegid.2011.07.008; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Pu SH, 2009, APPL ENVIRON MICROB, V75, P265, DOI 10.1128/AEM.01110-08; ROUCH DA, 1987, J GEN MICROBIOL, V133, P3039; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Tremblay YDN, 2014, VET MICROBIOL, V172, P511, DOI 10.1016/j.vetmic.2014.06.007; Tremblay YDN, 2013, J DAIRY SCI, V96, P234, DOI 10.3168/jds.2012-5795; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; Verhegghe M, 2013, ZOONOSES PUBLIC HLTH, V60, P366, DOI 10.1111/zph.12007; Waters AE, 2011, CLIN INFECT DIS, V52, P1227, DOI 10.1093/cid/cir181; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x; Weese JS, 2010, CAN VET J, V51, P749; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x; Zarfel G, 2013, EPIDEMIOL INFECT, V141, P888, DOI 10.1017/S0950268812001343; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zimmermann-Meisse G, 2017, TOXINS, V9, DOI 10.3390/toxins9010041	78	19	19	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227183	10.1371/journal.pone.0227183	http://dx.doi.org/10.1371/journal.pone.0227183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923238	Green Published, gold			2022-12-26	WOS:000534350000052
J	Luborsky, J; Barua, A; Edassery, S; Bahr, JM; Edassery, SL				Luborsky, Judith; Barua, Animesh; Edassery, Seara; Bahr, Janice M.; Edassery, Seby L.			Inflammasome expression is higher in ovarian tumors than in normal ovary	PLOS ONE			English	Article							HYDROCARBON RECEPTOR REPRESSOR; NLRP3 INFLAMMASOME; FUNCTIONAL-CHARACTERIZATION; CANCER; ACTIVATION; CELLS; MACROPHAGES; MECHANISMS; SUPPRESSOR; CHICKEN	Chronic inflammation fundamentally influences cancer risk and development. A mechanism of chronic inflammation is the formation of inflammasome complexes which results in the sustained secretion of the pro-inflammatory cytokines IL1 beta and IL18. Inflammasome expression and actions vary among cancers. There is no information on inflammasome expression in ovarian cancer (OvCa). To determine if ovarian tumors express inflammasome components, mRNA and protein expression of NLRP3 (nucleotide-binding domain, leucine-rich repeat family, pyrin domain containing 3), caspase-1, IL1 beta, and IL18 expression in hen and human OvCa was assessed. Chicken (hen) OvCa a valid model of spontaneous human OvCa. Hens were selected into study groups with or without tumors using ultrasonography; tumors were confirmed by histology, increased cellular proliferation, and expression of immune cell marker mRNA. mRNA expression was higher for hallmarks of inflammasome activity (caspase-1, 5.9x increase, p = 0.04; IL1 beta, 4x increase, p = 0.04; and IL18, 7.8x increase, p = 0.0003) in hen OvCa compared to normal ovary. NLRP3, caspase-8 and caspase-11 mRNA did not differ significantly between tumor and non-tumor containing ovaries. Similar results occurred for human OvCa. Protein expression by immunohistochemistry paralleled mRNA expression and was qualitatively higher in tumors. Increased protein expression of caspase-1, IL1 beta, and IL18 occurred in surface epithelium, tumor cells, and immune cells. The aryl hydrocarbon receptor (AHR), a potential tumor suppressor and NLRP3 regulator, was higher in hen (2.4x increase, p = 0.002) and human tumors (1.8x increase, p = 0.038), suggesting a role in OvCa. Collectively, the results indicate that inflammasome expression is associated with hen and human OvCa, although the NLR sensor type remains to be determined.	[Luborsky, Judith] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Luborsky, Judith; Barua, Animesh] Rush Univ, Med Ctr, Dept Obstet & Gynecol, Chicago, IL 60612 USA; [Barua, Animesh] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Barua, Animesh; Edassery, Seara; Edassery, Seby L.] Rush Univ, Med Ctr, Dept Cell & Mol Med, Chicago, IL 60612 USA; [Bahr, Janice M.] Univ Illinois, Dept Anim Sci, Champaign, IL USA; [Luborsky, Judith] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Edassery, Seby L.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Rush University; Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Urbana-Champaign; Woods Hole Oceanographic Institution; Northwestern University; Feinberg School of Medicine	Luborsky, J (corresponding author), Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA.; Luborsky, J (corresponding author), Rush Univ, Med Ctr, Dept Obstet & Gynecol, Chicago, IL 60612 USA.; Luborsky, J (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	jluborsky@whoi.edu		Luborsky, Judith/0000-0002-5693-3323	NIH [NCI R03CA182120]; DOD [W81XWH-08-1-0203]; Swim Across America	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Swim Across America	This research was made possible by NIH grant NCI R03CA182120 (JL), DOD grant W81XWH-08-1-0203 (JL) and Swim Across America (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acadeny N, 2011, GUIDE CARE USE LAB A; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Barua A, 2007, J ULTRAS MED, V26, P909, DOI 10.7863/jum.2007.26.7.909; Barua A, 2009, INT J GYNECOL CANCER, V19, P500, DOI 10.1111/IGC.0b013e3181a39db1; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bradaric MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074147; Chang CC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113311; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Fan YX, 2010, CANCER RES, V70, P212, DOI 10.1158/0008-5472.CAN-09-3090; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Hales DB, 2008, ENDOCRINE, V33, P235, DOI 10.1007/s12020-008-9080-z; Hanieh H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/520763; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Huai WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5738; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kantono M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01132; Karki R, 2017, CANCER IMMUNOL RES, V5, P94, DOI 10.1158/2326-6066.CIR-16-0269; Khorram O, 2002, MOL HUM REPROD, V8, P75, DOI 10.1093/molehr/8.1.75; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee JS, 2011, TOXICOL SCI, V119, P319, DOI 10.1093/toxsci/kfq336; Lin C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00271; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Pellegrini C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00036; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shah CA, 2008, GYNECOL ONCOL, V109, P215, DOI 10.1016/j.ygyno.2008.01.010; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Singh Saroj, 2017, Biochim Open, V4, P8, DOI 10.1016/j.biopen.2016.11.002; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Spitzer C, 2010, J PSYCHIATR RES, V44, P15, DOI 10.1016/j.jpsychires.2009.06.002; Thi HTH, 2017, J CANCER PREV, V22, P62, DOI 10.15430/JCP.2017.22.2.62; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Vogel Christoph F. A., 2017, Current Opinion in Toxicology, V2, P109, DOI 10.1016/j.cotox.2017.02.004; Wang K, 2013, CANCER LETT, V340, P63, DOI 10.1016/j.canlet.2013.06.026; Wei Q, 2014, LAB INVEST, V94, P52, DOI 10.1038/labinvest.2013.126; Wei YX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4938473; Xue P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00286; Yasui T, 2007, TOXICOL SCI, V99, P101, DOI 10.1093/toxsci/kfm139; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	49	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227081	10.1371/journal.pone.0227081	http://dx.doi.org/10.1371/journal.pone.0227081			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923221	Green Published, gold			2022-12-26	WOS:000534350000041
J	Neher, TP; Ma, LY; Moorman, TB; Howe, AC; Soupir, ML				Neher, Timothy P.; Ma, Lanying; Moorman, Thomas B.; Howe, Adina C.; Soupir, Michelle L.			Catchment-scale export of antibiotic resistance genes and bacteria from an agricultural watershed in central Iowa	PLOS ONE			English	Article							23S RIBOSOMAL-RNA; MANURE APPLICATION; TRANSPORT; TYLOSIN; SWINE; SOIL; MUTATIONS; DRAINAGE; TIAMULIN; SUSCEPTIBILITY	Antibiotics are administered to livestock in animal feeding operations (AFOs) for the control, prevention, and treatment of disease. Manure from antibiotic treated livestock contains unmetabolized antibiotics that provide selective pressure on bacteria, facilitating the expression of anti-microbial resistance (AMR). Manure application on row crops is an agronomic practice used by growers to meet crop nutrient needs; however, it can be a source of AMR to the soil and water environment. This study in central Iowa aims to directly compare AMR indicators in outlet runoff from two adjacent (221 to 229 ha) manured and non-manured catchments (manure comparison), and among three catchments (600 to 804 ha) with manure influence, no known manure application (control), and urban influences (mixed land use comparison). Monitored AMR indicators included antibiotic resistance genes (ARGs) ermB, ermF (macrolide), tetA, tetM, tetO, tetW (tetracycline), sul1, sul2 (sulfonamide), aadA2 (aminoglycoside), vgaA, and vgaB (pleuromutilin), and tylosin and tetracycline resistant enterococci bacteria. Results of the manure comparison showed significantly higher (p< 0.05) tetracycline and tylosin resistant bacteria from the catchment with manure application in 2017, but no differences in 2018, possibly due to changes in antibiotic use resulting from the Veterinary Feed Directive. Moreover, the ARG analysis indicated a larger diversity of ARGs at the manure amended catchment. The mixed land use comparison showed the manure amended catchment had significantly higher (p<0.05) tetracycline resistant bacteria in 2017 and significantly higher tylosin resistant bacteria in 2017 and 2018 than the urban influenced catchment. The urban influenced catchment had significantly higher ermB concentrations in both sampling years, however the manure applied catchment runoff consisted of higher relative abundance of total ARGs. Additionally, both catchments showed higher AMR indicators compared to the control catchment. This study identifies four ARGs that might be specific to AMR as a result of agricultural sources (tetM, tetW, sul1, sul2) and optimal for use in watershed scale monitoring studies for tracking resistance in the environment.	[Neher, Timothy P.; Ma, Lanying; Howe, Adina C.; Soupir, Michelle L.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Moorman, Thomas B.] ARS, Natl Lab Agr & Environm, USDA, Ames, IA USA	Iowa State University; United States Department of Agriculture (USDA)	Neher, TP (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.	tpneher@iastate.edu		Neher, Timothy/0000-0001-6935-4032; Moorman, Thomas/0000-0001-7409-0609	USDA National Institute of Food and Agriculture grant [2018-67017-27629]; AFRI food safety grant [2016-68003-24604]	USDA National Institute of Food and Agriculture grant; AFRI food safety grant	Funded by AH: USDA National Institute of Food and Agriculture grant no. 2018-67017-27629; https://nifa.usda.gov/.AH: AFRI food safety grant no. 2016-68003-24604; https://nifa.usda.gov/program/afri-food-safety-challenge-area.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; [Anonymous], SUMM REP ANT SOLD DI; [Anonymous], 2011, BLACK HAWK LAKE WATE; Berendsen BJA, 2018, CHEMOSPHERE, V204, P267, DOI 10.1016/j.chemosphere.2018.04.042; Brendel C, 2017, WATER-SUI, V9, DOI 10.3390/w9030154; Brendel CE, 2019, J ENVIRON QUAL, V48, P117, DOI 10.2134/jeq2018.07.0265; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; CLSI. Clinical and Laboratory Standards Institute, 2010, PERFORMANCE STANDARD; Collins R, 2005, J APPL MICROBIOL, V99, P126, DOI 10.1111/j.1365-2672.2005.02580.x; Diaz FJ, 2010, AGR WATER MANAGE, V97, P1813, DOI 10.1016/j.agwat.2010.06.015; Dobriyal P, 2017, APPL WATER SCI, V7, P2617, DOI 10.1007/s13201-016-0488-y; Fahrenfeld N, 2014, ENVIRON SCI TECHNOL, V48, P2643, DOI 10.1021/es404988k; Fausey N. R., 1987, Miscellaneous Publication, US Department of Agriculture, P48; FAUSEY NR, 1995, J IRRIG DRAIN E-ASCE, V121, P283, DOI 10.1061/(ASCE)0733-9437(1995)121:4(283); Fohner AE, 2017, PHARMACOGENET GENOM, V27, P164, DOI 10.1097/FPC.0000000000000270; Garder JL, 2014, J ENVIRON QUAL, V43, P1484, DOI 10.2134/jeq2013.09.0379; Ghanbari Fahimeh, 2016, Adv Biomed Res, V5, P62, DOI 10.4103/2277-9175.179184; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hill R., 2018, PREVALENCE ANTIBIOTI; Jamieson R. C., 2002, CAN BIOSYST ENG, V44, P1; Jechalke S, 2014, TRENDS MICROBIOL, V22, P536, DOI 10.1016/j.tim.2014.05.005; KHALEEL R, 1981, J ENVIRON QUAL, V10, P133, DOI 10.2134/jeq1981.00472425001000020002x; Kim SY, 2016, ENVIRON SCI POLLUT R, V23, P22190, DOI 10.1007/s11356-016-7574-4; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Li BB, 2010, FEMS MICROBIOL LETT, V308, P144, DOI 10.1111/j.1574-6968.2010.02003.x; Lipsitcht M, 2002, P NATL ACAD SCI USA, V99, P5752, DOI 10.1073/pnas.092142499; Luby EM, 2016, SCI TOTAL ENVIRON, V550, P1126, DOI 10.1016/j.scitotenv.2016.01.132; McKinney CW, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy010; Miller K, 2008, ANTIMICROB AGENTS CH, V52, P1737, DOI 10.1128/AAC.01015-07; Mishra A, 2008, WATER AIR SOIL POLL, V189, P127, DOI 10.1007/s11270-007-9561-3; ONeill J., 2016, TACKLING DRUG RESIST; Pappas EA, 2008, T ASABE, V51, P1567, DOI 10.13031/2013.25313; Paukner S, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a027110; Pringle M, 2004, MOL MICROBIOL, V54, P1295, DOI 10.1111/j.1365-2958.2004.04373.x; Prior J. C., 2017, MOINES LOBE; Richkus J, 2016, PEERJ, V4, DOI 10.7717/peerj.2713; Rieke EL, 2018, SCI TOTAL ENVIRON, V610, P1173, DOI 10.1016/j.scitotenv.2017.08.116; Sanderson H, 2016, ENVIRON REV, V24, P205, DOI 10.1139/er-2015-0069; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwaiger K, 2009, VET MICROBIOL, V139, P386, DOI 10.1016/j.vetmic.2009.06.005; Soni B, 2015, J ENVIRON QUAL, V44, P895, DOI 10.2134/jeq2014.09.0389; Stedtfeld RD, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy130; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s; Thurston-Enriquez Jeanette A., 2005, Journal of Water and Health, V3, P157; Tomer MD, 2008, J SOIL WATER CONSERV, V63, P360, DOI 10.2489/jswc.63.6.360; Unc A, 2004, APPL SOIL ECOL, V25, P1, DOI 10.1016/j.apsoil.2003.08.007; Uyaguari-Diaz MI, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00852; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Goethem MW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0424-5; Warnemuende E. A., 2001, 2001 ASAE ANN M ST J; Washington MT, 2018, SCI TOTAL ENVIRON, V612, P358, DOI 10.1016/j.scitotenv.2017.08.090; West BM, 2011, WATER AIR SOIL POLL, V217, P473, DOI 10.1007/s11270-010-0602-y; Williams MR, 2015, AGR WATER MANAGE, V158, P42, DOI 10.1016/j.agwat.2015.04.009; Zhang BW, 2017, EARTH SYST SCI DATA, V9, P667, DOI 10.5194/essd-9-667-2017; Zhang YJ, 2017, ENVIRON POLLUT, V231, P1621, DOI 10.1016/j.envpol.2017.09.074; Zhou ZC, 2018, ENVIRON INT, V121, P1155, DOI 10.1016/j.envint.2018.10.032	58	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227136	10.1371/journal.pone.0227136	http://dx.doi.org/10.1371/journal.pone.0227136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923233	gold, Green Published			2022-12-26	WOS:000534350000047
J	Gomez, ERR; Regino, WO; Monterrey, PA; Rangel, AAT				Rodriguez Gomez, Eliana Rocio; Regino, William Otero; Monterrey, Pedro A.; Trespalacios Rangel, Alba Alicia			cagA gene EPIYA motif genetic characterization from Colombian Helicobacter pylori isolates: Standardization of a molecular test for rapid clinical laboratory detection	PLOS ONE			English	Article							PHOSPHORYLATION MOTIFS; GASTRIC-CANCER; STRAINS; PROTEIN; NUMBER; POLYMORPHISMS; EPIDEMIOLOGY; ASSOCIATION; ACTIVATION; DIVERSITY	The aim of this work was to determine current cagA gene EPIYA motifs present in Colombian Helicobacter pylori isolates using a fast and reliable molecular test. DNA from eightyfive Helicobacter pylori-cagA positive strains were analyzed. Strains were obtained from patients diagnosed with functional dyspepsia at Clinica Fundadores in Bogota. The 3' region of the cagA gene was amplified through conventional Polymerase Chain Reaction (PCR). Obtained amplicons were sequenced using the Sanger method and analyzed with bioinformatics tools. Additionally, a significant Spearman correlation coefficient was determined between the patients' age and the number of EPIYA-C repeats; with p values < 0.05 considered significant. Estimates were obtained using a 95% CI. The 3 ' variable region of the cagA gene was amplified and PCR products of the following sizes corresponded to the following EPIYA motifs: 400 bp: EPIYA AB, 500 bp: EPIYA ABC, 600 bp: EPIYA ABCC and 700 bp: ABCCC. A single PCR band was observed for 58 out of 85 Helicobacter pylori isolates, with an EPIYA distribution motif as follows: 7/85 AB (8.2%), 34/85 ABC (40%), 26/85 ABCC (30.6%) and 18/85 ABCCC (21.2%). However, in 27 out of 85 Helicobacter pylori isolates, two or more bands were observed, where the most predominant cagA genotype were ABC-ABCC (26%, 7/27) and ABCC-ABCCC (22.2%, 6/27). A direct proportionality between the number of EPIYA-C repeats and an increase in the patients' age was observed, finding a greater number of EPIYA ABCC and ABCCC repeats in the population over 50 years old. All isolates were of the Western cagA type and 51.8% of them were found to have multiple EPIYA-C repeats. These standardized molecular test allowed to identify the number of EPIYA C motifs based on band size.	[Rodriguez Gomez, Eliana Rocio; Trespalacios Rangel, Alba Alicia] Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia; [Regino, William Otero] Clin Fundadores, Gastroenterol Unit, Bogota, Colombia; [Monterrey, Pedro A.] Univ Rosario, Sch Nat Sci & Math, Bogota, Colombia	Pontificia Universidad Javeriana; Universidad del Rosario	Gomez, ERR (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Bogota, Colombia.	erodriguezg@javeriana.edu.co			Pontificia Universidad Javeriana - Vicerrectoria de Investigacion [6234]	Pontificia Universidad Javeriana - Vicerrectoria de Investigacion	The research reported in this manuscript has been funded by Pontificia Universidad Javeriana - Vicerrectoria de Investigacion, Award number: Grant ID 6234. AATR received award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta N, 2010, WORLD J GASTROENTERO, V16, P3936, DOI 10.3748/wjg.v16.i31.3936; Fajardo CA, 2013, WORLD J GASTRO ONCOL, V5, P50, DOI 10.4251/wjgo.v5.i3.50; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Argent RH, 2008, J MED MICROBIOL, V57, P1062, DOI 10.1099/jmm.0.2008/001818-0; Argent RH, 2008, CLIN CANCER RES, V14, P2227, DOI 10.1158/1078-0432.CCR-07-2022; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Batista SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-61; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; Ferreira RM, 2012, HISTOPATHOLOGY, V60, P992, DOI 10.1111/j.1365-2559.2012.04190.x; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Greenberger NJ., 2011, DIAGNOSTICO TRATAMIE; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Hatakeyama M, 2011, CANCER SCI, V102, P36, DOI 10.1111/j.1349-7006.2010.01743.x; Hayashi T, 2017, CELL REP, V20, P2876, DOI 10.1016/j.celrep.2017.08.080; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Quiroga AJ, 2010, BIOMEDICA, V30, P251, DOI 10.7705/biomedica.v30i2.188; Kalaf EA, 2013, SAUDI J GASTROENTERO, V19, P69, DOI 10.4103/1319-3767.108474; Li QP, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000006620, 10.1097/md.0000000000006620]; Malfertheiner P., 2017, Gut, V66, P6, DOI [10.1136/gutjnl-2016-312288, DOI 10.1136/GUTJNL-2016-312288]; Occhialini A, 2001, INFECT IMMUN, V69, P1902, DOI 10.1128/IAI.69.3.1902-1908.2001; Beltran-Anaya FO, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0223-9; Panayotopoulou EG, 2007, J CLIN MICROBIOL, V45, P488, DOI 10.1128/JCM.01616-06; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Piazuelo MB, 2010, INFECT DIS CLIN N AM, V24, P853, DOI 10.1016/j.idc.2010.07.010; Reyes-Leon A, 2007, INFECT IMMUN, V75, P3445, DOI 10.1128/IAI.01951-06; Schneider N, 2009, J INFECT DIS, V199, P1218, DOI 10.1086/597416; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Torres LE, 2012, BIOMEDICA, V32, P23, DOI 10.1590/S0120-41572012000100004; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 2000, EPIDEMIOL INFECT, V124, P91, DOI 10.1017/S0950268899003209; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227275	10.1371/journal.pone.0227275	http://dx.doi.org/10.1371/journal.pone.0227275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923209	Green Published, gold			2022-12-26	WOS:000534350000108
J	Xue, MT; Shi, Y; Pang, AM; Men, L; Hu, YH; Zhou, PF; Long, GF; Tian, X; Wang, R; Zhao, YH; Liao, XD; Shen, YN; Cui, YJ				Xue, Meiting; Shi, Yue; Pang, Aiming; Men, Li; Hu, Yahui; Zhou, Pengfei; Long, Guangfeng; Tian, Xin; Wang, Rong; Zhao, Yonghua; Liao, Xudong; Shen, Yanna; Cui, Yujie			Corin plays a protective role via upregulating MAPK and downregulating eNOS in diabetic nephropathy endothelial dysfunction	FASEB JOURNAL			English	Article						Corin; diabetic nephropathy; endothelial dysfunction; eNOS; MAPK	ATRIAL-NATRIURETIC-PEPTIDE; SERINE-PROTEASE; PROGRESSION	Diabetic nephropathy (DN) is one of the leading causes of mortality in diabetic patients, but its pathogenesis is unclear. We aimed to study the role of the pro-ANP convertase Corin in the pathogenesis of DN. Corin and ANP expression in DN rat kidneys and high-glucose-treated HK-2 cells was analyzed by real-time PCR, western blotting, and immunohistochemical staining. The effect of Corin-siRNA or ANP-siRNA HK-2 cells on EA.hy926 cell migration was determined by scratch-wound healing assay. The expression of mitogen-activated protein kinase (MAPK) and endothelial NO synthase (eNOS) in EA.hy926 cells treated with conditioned medium from Corin-siRNA- or ANP-siRNA-transfected HK-2 cells was determined by western blotting. We found a significant reduction in Corin and ANP expression in DN rat kidneys. These results were recapitulated in HK-2 cells treated with high glucose. EA.hy926 cells treated with conditioned medium from Corin-deficient HK-2 cells had inhibited migration, increased MAPK activity, and decreased eNOS activity. Similar effects were observed with ANP-siRNA transfection. Finally, adding ANP to the Corin-deficient HK-2 conditioned medium rescued the above defects, indicating that Corin mediates its effects through ANP. In conclusion, Corin plays a renoprotective role through pro-ANP processing, and defects in Corin cause endothelial dysfunction through MAPK and eNOS signaling in DN.	[Xue, Meiting; Shi, Yue; Men, Li; Hu, Yahui; Zhou, Pengfei; Long, Guangfeng; Tian, Xin; Wang, Rong; Shen, Yanna; Cui, Yujie] Tianjin Med Univ, Sch Med Lab, 1 Guangdong Rd, Tianjin 300203, Peoples R China; [Xue, Meiting] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Xue, Meiting] Tianjins Clin Res Ctr Canc, Key Lab Canc Immunol & Biotherapy, Tianjin, Peoples R China; [Pang, Aiming] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Hematopoiet Stem Cell Transplantat Ctr, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Zhao, Yonghua] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China; [Liao, Xudong] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Univ Hosp Cleveland Med Ctr, Cleveland, OH USA	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; University of Macau; Case Western Reserve University; University Hospitals of Cleveland	Shen, YN; Cui, YJ (corresponding author), Tianjin Med Univ, Sch Med Lab, 1 Guangdong Rd, Tianjin 300203, Peoples R China.	shenyanna@sina.com; yujiecui1@126.com	Zhao, Yonghua/AAC-4728-2019	Zhao, Yonghua/0000-0001-8714-0476	National Natural Science Foundation of China [81200116, 81772252, 81601836]; Yeehong Business School of Shenyang Pharmaceutical University (Sansheng TCP Young Research Funding) [57]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yeehong Business School of Shenyang Pharmaceutical University (Sansheng TCP Young Research Funding)	This work was supported by the National Natural Science Foundation of China (81200116, 81772252, and 81601836) and Thrombocytopenia Funding from Yeehong Business School of Shenyang Pharmaceutical University (Sansheng TCP Young Research Funding, No. 57)	Breton-Romero R, 2016, ARTERIOSCL THROM VAS, V36, P561, DOI 10.1161/ATVBAHA.115.306578; Chandra S, 2019, EUR J PHARMACOL, V844, P26, DOI 10.1016/j.ejphar.2018.11.027; Charan K, 2016, J SURG RES, V201, P272, DOI 10.1016/j.jss.2015.10.045; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Everett TR, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0717-2; Fang CD, 2013, CLIN SCI, V124, P709, DOI 10.1042/CS20120517; Fathy SA, 2015, BIOMARKERS, V20, P460, DOI 10.3109/1354750X.2015.1093032; Hou BY, 2017, CELL PHYSIOL BIOCHEM, V44, P2378, DOI 10.1159/000486154; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Kerkela R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002423; King GL, 2016, DIABETES, V65, P1462, DOI 10.2337/db16-0152; Klein JD, 2010, KIDNEY INT, V78, P635, DOI 10.1038/ki.2010.223; Lin XP, 2018, J VASC RES, V55, P169, DOI 10.1159/000489958; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nicholls SJ, 2008, J AM COLL CARDIOL, V52, P255, DOI 10.1016/j.jacc.2008.03.051; Pang AM, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0298-9; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Polzin D, 2010, KIDNEY INT, V78, P650, DOI 10.1038/ki.2010.197; Qi HY, 2017, DIABETES, V66, P763, DOI 10.2337/db16-0695; Ricciardi CA, 2016, CLIN EXP MED, V16, P443, DOI 10.1007/s10238-015-0374-1; Roussel R, 2004, DIABETES, V53, P1394, DOI 10.2337/diabetes.53.5.1394; Sharma A, 2015, DIABETES, V64, P3937, DOI 10.2337/db15-0472; Shi Y, 2017, J DIABETES, V9, P434, DOI 10.1111/1753-0407.12521; Singh Lakhwinder, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P499, DOI 10.1515/jbcpp-2017-0146; Stark RJ, 2018, FASEB J, V32, P945, DOI 10.1096/fj.201700410R; Tulafu M, 2014, J SURG RES, V186, P217, DOI 10.1016/j.jss.2013.07.033; Vicen M, 2019, FASEB J, V33, P6099, DOI 10.1096/fj.201802245R; Wang J, 2017, J CELL BIOCHEM, V118, P2325, DOI 10.1002/jcb.25889; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodman OL, 2008, LIFE SCI, V82, P847, DOI 10.1016/j.lfs.2008.01.016; Xu XD, 2019, ECOTOX ENVIRON SAFE, V170, P188, DOI 10.1016/j.ecoenv.2018.11.124; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zhou HB, 2018, J TISSUE ENG REGEN M, V12, P973, DOI 10.1002/term.2514	35	8	9	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					95	106		10.1096/fj.201900531RR	http://dx.doi.org/10.1096/fj.201900531RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914697				2022-12-26	WOS:000507308900008
J	Mehta, SJK; Kumar, V; Mishra, RK				Mehta, Saurabh Jayesh Kumar; Kumar, Vimlesh; Mishra, Ram Kumar			Drosophila ELYS regulates Dorsal dynamics during development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NF-?B transcription factor; nuclear envelope; nuclear pore; nuclear organization; nuclear translocation; nuclear structure; development; Drosophila; Drosophila genetics	NF-KAPPA-B; NUCLEAR-PORE COMPLEX; TRANSCRIPTION FACTORS; NUP107-160 COMPLEX; NUCLEOPORIN; CHROMATIN; ENVELOPE; APOPTOSIS; ORGANIZATION; DCP-1	Embryonic large molecule derived from yolk sac (ELYS) is a constituent protein of nuclear pores. It initiates assembly of nuclear pore complexes into functional nuclear pores toward the end of mitosis. Using cellular, molecular, and genetic tools, including fluorescence and Electron microscopy, quantitative PCR, and RNAi-mediated depletion, we report here that the ELYS ortholog (dElys) plays critical roles during Drosophila development. dElys localized to the nuclear rim in interphase cells, but during mitosis it was absent from kinetochores and enveloped chromatin. We observed that RNAi-mediated dElys depletion leads to aberrant development and, at the cellular level, to defects in the nuclear pore and nuclear lamina assembly. Further genetic analyses indicated that dElys depletion re-activates the Dorsal (NF-?B) pathway during late larval stages. Re-activated Dorsal caused untimely expression of the Dorsal target genes in the post-embryonic stages. We also demonstrate that activated Dorsal triggers apoptosis during later developmental stages by up-regulating the pro-apoptotic genes reaper and hid. The apoptosis induced by Reaper and Hid was probably the underlying cause for developmental abnormalities observed upon dElys depletion. Moreover, we noted that dElys has conserved structural features, but contains a noncanonical AT-hook?like motif through which it strongly binds to DNA. Together, our results uncover a novel epistatic interaction that regulates Dorsal dynamics by dElys during development.	[Mehta, Saurabh Jayesh Kumar; Mishra, Ram Kumar] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Nups & SUMO Biol Grp, Bhopal By Pass Rd, Bhopal 462066, Madhya Pradesh, India; [Kumar, Vimlesh] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Neurogenet Lab, Acad Bldg 3,Bhopal By Pass Rd, Bhopal 462066, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal; Indian Institute of Science Education & Research (IISER) - Bhopal	Mishra, RK (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Nups & SUMO Biol Grp, Bhopal By Pass Rd, Bhopal 462066, Madhya Pradesh, India.	rkmishra@iiserb.ac.in	Mishra, Ram/AAJ-1538-2020; Mishra, Ram/ABA-6071-2020	Mishra, Ram/0000-0002-9528-0476; Mehta, Saurabh Jayesh Kumar/0000-0002-0474-2429; Kumar, Vimlesh/0000-0003-2206-4905	Science and Engineering Research Board (SERB), Ministry of Science and Technology, Government of India [EMR/2016/001819]; Indian Institute of Science Education and Research-Bhopal; CSIR-UGC; IISER-Bhopal	Science and Engineering Research Board (SERB), Ministry of Science and Technology, Government of India; Indian Institute of Science Education and Research-Bhopal; CSIR-UGC(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); IISER-Bhopal	This work was supported by an extramural grant from the Science and Engineering Research Board (SERB), Ministry of Science and Technology, Government of India, Grant EMR/2016/001819 (to R. K. M.) and Intramural Funding from the Indian Institute of Science Education and Research-Bhopal. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CSIR-UGC and IISER-Bhopal.	Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Aitchison JD, 1995, J CELL BIOL, V131, P1659, DOI 10.1083/jcb.131.6.1659; Andlauer TFM, 2014, ELIFE, V3, DOI 10.7554/eLife.03895; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4413, DOI 10.1093/nar/26.19.4413; Banerjee HN, 2010, MOL CELL BIOCHEM, V343, P21, DOI 10.1007/s11010-010-0494-6; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BELVIN MP, 1995, GENE DEV, V9, P783, DOI 10.1101/gad.9.7.783; Bilokapic S, 2013, STRUCTURE, V21, P572, DOI 10.1016/j.str.2013.02.006; Buster Daniel W, 2010, J Vis Exp, DOI 10.3791/1982; Campbell K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007167; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Cerveny KL, 2010, DEVELOPMENT, V137, P2107, DOI 10.1242/dev.047753; Choudhury SD, 2017, SYNAPSE, V71, DOI 10.1002/syn.21969; Clever M, 2012, NUCLEUS-PHILA, V3, P187, DOI 10.4161/nucl.19595; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; de Jong-Curtain TA, 2009, GASTROENTEROLOGY, V136, P902, DOI 10.1053/j.gastro.2008.11.012; DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934; DeVorkin L, 2014, J CELL BIOL, V205, P477, DOI 10.1083/jcb.201303144; Emtage JLT, 1997, J CELL SCI, V110, P911; Espin-Palazon R, 2016, EXP HEMATOL, V44, P519, DOI 10.1016/j.exphem.2016.03.010; Fabre E, 1997, ANNU REV GENET, V31, P277, DOI 10.1146/annurev.genet.31.1.277; Fatima R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027822; Fernandez AG, 2006, CURR BIOL, V16, P1757, DOI 10.1016/j.cub.2006.07.071; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Galy V, 2006, CURR BIOL, V16, P1748, DOI 10.1016/j.cub.2006.06.067; Ganguly A, 2005, DEVELOPMENT, V132, P3419, DOI 10.1242/dev.01903; Gao N, 2011, GASTROENTEROLOGY, V140, P1547, DOI 10.1053/j.gastro.2011.01.048; Genenncher B, 2016, PLANT PHYSIOL, V172, P1293, DOI 10.1104/pp.16.00832; Georgieva S, 2000, MOL CELL BIOL, V20, P1639, DOI 10.1128/MCB.20.5.1639-1648.2000; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Gomez-Saldivar G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006131; Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Gullaud M, 2003, CELL DEATH DIFFER, V10, P641, DOI 10.1038/sj.cdd.4401222; HAREL A, 1989, J CELL SCI, V94, P463; Hattersley N, 2016, DEV CELL, V38, P463, DOI 10.1016/j.devcel.2016.08.006; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Ilyin AA, 2017, NUCLEIC ACIDS RES, V45, P7666, DOI 10.1093/nar/gkx355; Johansen KM, 2004, METH MOL B, V247, P215; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Katsani KR, 2008, MOL BIOL CELL, V19, P3652, DOI 10.1091/mbc.E07-11-1162; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimura N, 2002, GENES CELLS, V7, P435, DOI 10.1046/j.1365-2443.2002.00529.x; Kuhn TM, 2019, J CELL BIOL, V218, P2945, DOI 10.1083/jcb.201807139; Lim HY, 2006, DEVELOPMENT, V133, P3529, DOI 10.1242/dev.02524; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; Metcalf CE, 2006, J BIOL CHEM, V281, P30015, DOI 10.1074/jbc.M606289200; Mimura Y, 2016, J CELL SCI, V129, P4200, DOI 10.1242/jcs.190678; Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okita K, 2004, GENES CELLS, V9, P1083, DOI 10.1111/j.1365-2443.2004.00791.x; Okita K, 2003, BIOCHEM BIOPH RES CO, V305, P327, DOI 10.1016/S0006-291X(03)00772-1; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.E05-11-1061; Park MH, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020015; Parrott BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025087; Pascual-Garcia P, 2017, MOL CELL, V66, P63, DOI 10.1016/j.molcel.2017.02.020; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Reeves GT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000836; RIEMER D, 1995, J CELL SCI, V108, P3189; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Song ZW, 1997, SCIENCE, V275, P536, DOI 10.1126/science.275.5299.536; Sonneville R, 2015, CELL REP, V12, P405, DOI 10.1016/j.celrep.2015.06.046; Uv AE, 2000, GENE DEV, V14, P1945; Velentzas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080530; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Vollmer B, 2015, DEV CELL, V33, P717, DOI 10.1016/j.devcel.2015.04.027; Wagner N, 2004, J CELL SCI, V117, P2015, DOI 10.1242/jcs.01052; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yang XJ, 2015, MOL CELL BIOL, V35, P1110, DOI 10.1128/MCB.01181-14; Yokoyama H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4270; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	87	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2421	2437		10.1074/jbc.RA119.009451	http://dx.doi.org/10.1074/jbc.RA119.009451			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31941789	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000517330200023
J	Musilli, S; Abramowski, V; Roch, B; de Villartay, JP				Musilli, Stefania; Abramowski, Vincent; Roch, Benoit; de Villartay, Jean-Pierre			An in vivo study of the impact of deficiency in the DNA repair proteins PAXX and XLF on development and maturation of the hemolymphoid system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; immunology; lymphocyte; genetics; gene knockout; double-strand break; immunogenetics; immunoglobulin class switch recombination; lymphoma; V(D)J recombination	V(D)J RECOMBINATION; LETHALITY; XRCC4; MICE; MECHANISMS; EXPRESSION; PATHWAYS	Repair of DNA double-strand breaks by the nonhomologous end joining pathway is central for proper development of the adaptive immune system. This repair pathway involves eight factors, including XRCC4-like factor (XLF)/Cernunnos and the paralog of XRCC4 and XLF, PAXX nonhomologous end joining factor (PAXX). Xlf(?/?) and Paxx(?/?) mice are viable and exhibit only a mild immunophenotype. However, mice lacking both PAXX and XLF are embryonic lethal because postmitotic neurons undergo massive apoptosis in embryos. To decipher the roles of PAXX and XLF in both variable, diversity, and joining recombination and immunoglobulin class switch recombination, here, using Cre/lox-specific deletion to prevent double-KO embryonic lethality, we developed two mouse models of a conditional Xlf KO in a Paxx(?/?) background. Cre expressed under control of the iVav or CD21 promoter enabled Xlf deletion in early hematopoietic progenitors and splenic mature B cells, respectively. We demonstrate the XLF and PAXX interplay during variable, diversity, and joining recombination in vivo but not during class switch recombination, for which PAXX appeared to be fully dispensable. Xlf/Paxx double KO in hematopoietic progenitors resulted in a shorter lifespan associated with onset of thymic lymphomas, revealing a genome caretaking function of XLF/PAXX.	[Musilli, Stefania; Abramowski, Vincent; Roch, Benoit; de Villartay, Jean-Pierre] Univ Paris, Lab Genome Dynam Immune Syst, Imagine Inst, INSERM,UMR 1163, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	de Villartay, JP (corresponding author), INSERM, UMR1163, Inst Imagine, Equipe Labellisee La Ligue, 24 Bd Montparnasse, F-75015 Paris, France.	devillartay@gmail.com	de villartay, jeanpierre/H-9353-2017	de villartay, jeanpierre/0000-0001-5987-0463	INSERM; Institut National du Cancer [INCa PLBIO16-280]; La Ligue Nationale contre le Cancer (Equipe Labelisee LA LIGUE); AT-Europe Foundation	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National du Cancer(Institut National du Cancer (INCA) France); La Ligue Nationale contre le Cancer (Equipe Labelisee LA LIGUE); AT-Europe Foundation	This work was supported by grants from INSERM and the Institut National du Cancer (INCa PLBIO16-280) and by grants from La Ligue Nationale contre le Cancer (Equipe Labelisee LA LIGUE) and the AT-Europe Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from the AT-Europe Foundation.	Abramowski V, 2018, CELL DEATH DIFFER, V25, P444, DOI 10.1038/cdd.2017.184; Arya R, 2017, TRENDS GENET, V33, P479, DOI 10.1016/j.tig.2017.04.006; Balmus G, 2016, GENE DEV, V30, P2152, DOI 10.1101/gad.290510.116; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Betermier M, 2020, TRENDS CELL BIOL, V30, P87, DOI 10.1016/j.tcb.2019.11.005; Bhargava R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04867-5; Boboila C, 2012, ADV IMMUNOL, V116, P1, DOI 10.1016/B978-0-12-394300-2.00001-6; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; de Villartay JP, 2015, BRIT MED BULL, V114, P157, DOI 10.1093/bmb/ldv020; de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247; Deriano L, 2011, NATURE, V471, P119, DOI 10.1038/nature09755; Dewan A, 2018, FEBS OPEN BIO, V8, P442, DOI 10.1002/2211-5463.12380; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gago-Fuentes R, 2018, FEBS OPEN BIO, V8, P426, DOI 10.1002/2211-5463.12381; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Han L, 2008, J EXP MED, V205, P2745, DOI 10.1084/jem.20081623; Hung PJ, 2018, MOL CELL, V71, P332, DOI 10.1016/j.molcel.2018.06.018; Hung PJ, 2017, CELL CYCLE, V16, P286, DOI 10.1080/15384101.2016.1253640; Kumar V, 2016, P NATL ACAD SCI USA, V113, P10619, DOI 10.1073/pnas.1611882113; Kumar V, 2014, DNA REPAIR, V16, P11, DOI 10.1016/j.dnarep.2014.01.010; Lescale C, 2016, CELL REP, V16, P2967, DOI 10.1016/j.celrep.2016.08.069; Lescale C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10529; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; Methot SP, 2017, ADV IMMUNOL, V133, P37, DOI 10.1016/bs.ai.2016.11.002; Roch B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00443; Soulas-Sprauel P, 2007, J EXP MED, V204, P1717, DOI 10.1084/jem.20070255; Takahashi K, 1997, J IMMUNOL, V159, P1557; Vera G, 2013, MOL CELL BIOL, V33, P701, DOI 10.1128/MCB.01057-12; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604; Zha S, 2010, J EXP MED, V207, P1369, DOI 10.1084/jem.20100285; Zhao BL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11507-z	35	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2398	2406		10.1074/jbc.AC119.010924	http://dx.doi.org/10.1074/jbc.AC119.010924			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31915249	hybrid, Green Published			2022-12-26	WOS:000517330200021
J	Gupta, A; Okesli-Armlovich, A; Morgens, D; Bassik, MC; Khosla, C				Gupta, Amita; Okesli-Armlovich, Aye; Morgens, David; Bassik, Michael C.; Khosla, Chaitan			A genome-wide analysis of targets of macrolide antibiotics in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotics; shRNA; drug action; mitochondria; natural product; erythromycin; josamycin; mitochondrial translation	ACTIVATED PROTEIN-KINASE; IN-VITRO; THERAPEUTIC STRATEGY; HUMAN NEUTROPHILS; STEM-CELLS; DNA-PK; MITOCHONDRIAL; INHIBITION; P38; EXPRESSION	Macrolide antibiotics, such as erythromycin and josamycin, are natural polyketide products harboring 14- to 16-membered macrocyclic lactone rings to which various sugars are attached. These antibiotics are used extensively in the clinic because of their ability to inhibit bacterial protein synthesis. More recently, some macrolides have been shown to also possess anti-inflammatory and other therapeutic activities in mammalian cells. To better understand the targets and effects of this drug class in mammalian cells, we used a genome-wide shRNA screen in K562 cancer cells to identify genes that modulate cellular sensitivity to josamycin. Among the most sensitizing hits were proteins involved in mitochondrial translation and the mitochondrial unfolded protein response, glycolysis, and the mitogen-activated protein kinase signaling cascade. Further analysis revealed that cells treated with josamycin or other antibacterial agents exhibited impaired oxidative phosphorylation and metabolic shifts to glycolysis. Interestingly, we observed that knockdown of the mitogen-activated protein kinase kinase kinase 4 (MAP3K4) gene, which contributes to p38 mitogen-activated protein kinase signaling, sensitized cells only to josamycin but not to other antibacterial agents. There is a growing interest in better characterizing the therapeutic effects and toxicities of antibiotics in mammalian cells to guide new applications in both cellular and clinical studies. To our knowledge, this is the first report of an unbiased genome-wide screen to investigate the effects of a clinically used antibiotic on human cells.	[Gupta, Amita; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Okesli-Armlovich, Aye; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Morgens, David; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Gupta, Amita; Okesli-Armlovich, Aye; Bassik, Michael C.; Khosla, Chaitan] Stanford Univ, Stanford Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA; [Okesli-Armlovich, Aye] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Gilead Sciences	Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X; Morgens, David/0000-0002-5005-0669	NIAID, National Institute of Health [U19-AI109662]; NIGMS, National Institutes of Health [R01-GM087934]; NIH, Director's New Innovator Award [1DP2HD084069-01]; Stanford Chemistry, Engineering and Medicine for Human Health (ChEM-H)	NIAID, National Institute of Health; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Chemistry, Engineering and Medicine for Human Health (ChEM-H)	This work was funded by NIAID, National Institute of Health grant U19-AI109662; NIGMS, National Institutes of Health Grant R01-GM087934; NIH, Director's New Innovator Award Grant 1DP2HD084069-01; and a seed grant from Stanford Chemistry, Engineering and Medicine for Human Health (ChEM-H). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelghaffar H, 1997, J IMMUNOL, V159, P3995; Abell AN, 2007, J BIOL CHEM, V282, P30476, DOI 10.1074/jbc.M705783200; Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Al-Furoukh N, 2015, BBA-MOL CELL RES, V1853, P2580, DOI 10.1016/j.bbamcr.2015.06.016; Arsic B, 2018, INT J ANTIMICROB AG, V51, P283, DOI 10.1016/j.ijantimicag.2017.05.020; Asano K, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/692352; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bearden DT, 1999, INFECT MED, V16, P480; Bindu LH, 2008, INT J AUDIOL, V47, P702, DOI 10.1080/14992020802215862; Borgeling Y, 2014, J BIOL CHEM, V289, P13, DOI 10.1074/jbc.M113.469239; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Cameron EJ, 2012, CLIN EXP ALLERGY, V42, P1302, DOI 10.1111/j.1365-2222.2012.03979.x; Chow S, 1996, CYTOMETRY, V24, P360; Cole A, 2015, CANCER CELL, V27, P864, DOI 10.1016/j.ccell.2015.05.004; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; Crosbie PAJ, 2009, EUR RESPIR J, V33, P171, DOI 10.1183/09031936.00042208; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]; Donath E, 2013, RESP MED, V107, P1385, DOI 10.1016/j.rmed.2013.05.004; Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hicks LA, 2015, CLIN INFECT DIS, V60, P1308, DOI 10.1093/cid/civ076; Jost M, 2018, ACS CHEM BIOL, V13, P366, DOI 10.1021/acschembio.7b00965; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Kudoh S, 1998, AM J RESP CRIT CARE, V157, P1829, DOI 10.1164/ajrccm.157.6.9710075; LABRO MT, 1990, J ANTIMICROB CHEMOTH, V26, P515, DOI 10.1093/jac/26.4.515; LABRO MT, 1991, EUR J CLIN MICROBIOL, V10, P124, DOI 10.1007/BF01964424; LABRO MT, 1989, J ANTIMICROB CHEMOTH, V24, P561, DOI 10.1093/jac/24.4.561; Lamb R, 2015, ONCOTARGET, V6, P14005, DOI 10.18632/oncotarget.4159; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Li CH, 2010, TOXICOL SCI, V116, P140, DOI 10.1093/toxsci/kfq085; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mannam P, 2013, J IMMUNOL, V190, P1264, DOI 10.4049/jimmunol.1202012; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Matheny CJ, 2013, CHEM BIOL, V20, P1352, DOI 10.1016/j.chembiol.2013.09.014; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; MORIKAWA K, 1994, ANTIMICROB AGENTS CH, V38, P2643, DOI 10.1128/AAC.38.11.2643; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nadanaciva S, 2010, J BIOMOL SCREEN, V15, P937, DOI 10.1177/1087057110373547; Nagiec EE, 2005, ANTIMICROB AGENTS CH, V49, P3896, DOI 10.1128/AAC.49.9.3896-3902.2005; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Papeta N, 2010, J CLIN INVEST, V120, P4055, DOI 10.1172/JCI43721; Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.04.008, 10.1016/j.cmet.2017.07.005]; Pillozzi S, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.32; Poletti V, 2006, EUR RESPIR J, V28, P862, DOI 10.1183/09031936.06.00131805; Ribeiro CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005806; Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019; RIESBECK K, 1990, ANTIMICROB AGENTS CH, V34, P167, DOI 10.1128/AAC.34.1.167; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shimizu T, 2003, AM J RESP CRIT CARE, V168, P581, DOI 10.1164/rccm.200212-1437OC; Shin HB, 2015, INT IMMUNOPHARMACOL, V27, P65, DOI 10.1016/j.intimp.2015.04.045; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Steel HC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/584262; Sugamata R, 2014, J ANTIBIOT, V67, P213, DOI 10.1038/ja.2013.132; Takase S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02016-4; Takizawa H, 1997, AM J RESP CRIT CARE, V156, P266, DOI 10.1164/ajrccm.156.1.9612065; van Nuffel AMT, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.513; Villarino N, 2013, VET J, V198, P352, DOI 10.1016/j.tvjl.2013.07.032; Viluksela M, 1996, J ANTIMICROB CHEMOTH, V38, P465, DOI 10.1093/jac/38.3.465; Wingert S, 2016, STEM CELLS, V34, P699, DOI 10.1002/stem.2282; Wong EHC, 2014, LANCET RESP MED, V2, P657, DOI 10.1016/S2213-2600(14)70107-9; Yamanaka Y, 2001, BIOCHEM BIOPH RES CO, V287, P198, DOI 10.1006/bbrc.2001.5550; Zarogoulidis P, 2012, EUR J CLIN PHARMACOL, V68, P479, DOI 10.1007/s00228-011-1161-x; Zhang L, 2005, FEBS LETT, V579, P6423, DOI 10.1016/j.febslet.2005.09.103; Zuckerman JM, 2011, MED CLIN N AM, V95, P761, DOI 10.1016/j.mcna.2011.03.012	77	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2057	2067		10.1074/jbc.RA119.010770	http://dx.doi.org/10.1074/jbc.RA119.010770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915244	hybrid, Green Published			2022-12-26	WOS:000517128200023
J	Cai, MX; Lin, JS; Li, ZY; Lin, ZC; Ma, YY; Wang, YB; Ming, R				Cai, Mingxing; Lin, Jishan; Li, Zeyun; Lin, Zhicong; Ma, Yaying; Wang, Yibin; Ming, Ray			Allele specific expression of Dof genes responding to hormones and abiotic stresses in sugarcane	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR FAMILY; REGULATED EXPRESSION; VASCULAR DEVELOPMENT; CIRCADIAN CLOCK; FLOWERING-TIME; DNA-BINDING; ARABIDOPSIS; IDENTIFICATION; EVOLUTION	Dof transcription factors plant-specific and associates with growth and development in plants. We conducted comprehensive and systematic analyses of Dof transcription factors in sugarcane, and identified 29 SsDof transcription factors in sugarcane genome. Those SsDof genes were divided into five groups, with similar gene structures and conserved motifs within the same groups. Segmental duplications are predominant in the evolution of Dof in sugarcane. Cis-element analysis suggested that the functions of SsDofs were involved in growth and development, hormones and abiotic stresses responses in sugarcane. Expression patterns indicated that SsDof7, SsDof23 and SsDof24 had a comparatively high expression in all detected tissues, indicating these genes are crucial in sugarcane growth and development. Moreover, we examined the transcription levels of SsDofs under four plant hormone treatments, SsDof7-3 and SsDof7-4 were down-regulated after ABA treatment, while SsDof7-1 and SsDof7-2 were induced after the same treatment, indicating different alleles may play different roles in response to plant hormones. We also analyzed SsDofs' expression profiling under four abiotic stresses, SsDof5 and SsDof28 significantly responded to these four stresses, indicating they are associate with abiotic stresses responses. Collectively, our results yielded allele specific expression of Dof genes responding to hormones and abiotic stresses in sugarcane, and their cis-elements could be crucial for sugarcane improvement.	[Cai, Mingxing; Lin, Jishan; Li, Zeyun; Ma, Yaying; Wang, Yibin; Ming, Ray] Fujian Agr & Forestry Univ, Coll Life Sci, Ctr Genom & Biotechnol, Fujian Prov Key Lab Haixia Appl Plant Syst Biol, Fuzhou, Fujian, Peoples R China; [Lin, Zhicong] Fujian Agr & Forestry Univ, Coll Crop Sci, Fuzhou, Fujian, Peoples R China; [Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; University of Illinois System; University of Illinois Urbana-Champaign	Ming, R (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Ctr Genom & Biotechnol, Fujian Prov Key Lab Haixia Appl Plant Syst Biol, Fuzhou, Fujian, Peoples R China.; Ming, R (corresponding author), Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA.	rayming@illinois.edu		wang, yibin/0000-0002-0781-3966	Fujian Agriculture and Forestry University [35]; International Consortium for Sugarcane Biotechnology project [35]; US DOE [DE-SC0010686, EBI BP2012002J17]	Fujian Agriculture and Forestry University; International Consortium for Sugarcane Biotechnology project; US DOE(United States Department of Energy (DOE))	The authors acknowledge funding from Fujian Agriculture and Forestry University, the International Consortium for Sugarcane Biotechnology project #35 to R.M., US DOE, DE-SC0010686, and EBI BP2012002J17.	[Anonymous], 2018, TBTOOLS TOOLKIT BIOL; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baumann K, 1999, PLANT CELL, V11, P323, DOI 10.1105/tpc.11.3.323; Cai XF, 2013, J INTEGR PLANT BIOL, V55, P552, DOI 10.1111/jipb.12043; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen WQ, 1996, PLANT J, V10, P955, DOI 10.1046/j.1365-313X.1996.10060955.x; Chen YH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3535-7; Chow CN, 2019, NUCLEIC ACIDS RES, V47, pD1155, DOI 10.1093/nar/gky1081; Corrales AR, 2014, J EXP BOT, V65, P995, DOI 10.1093/jxb/ert451; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Gardiner J, 2010, INT J DEV BIOL, V54, P1389, DOI 10.1387/ijdb.093006jg; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo Ya, 2013, PLOS ONE, V8; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu WC, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1495-y; Iwamoto M, 2009, PLANT CELL ENVIRON, V32, P592, DOI 10.1111/j.1365-3040.2009.01954.x; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Konishi M, 2007, PLANT PHYSIOL BIOCH, V45, P623, DOI 10.1016/j.plaphy.2007.05.001; Kushwaha H, 2011, MOL BIOL REP, V38, P5037, DOI 10.1007/s11033-010-0650-9; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Lin JS, 2019, TROP PLANT BIOL, V12, P206, DOI 10.1007/s12042-019-09238-y; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Liu Y, PLANT GROWTH REGULAT, V63, P225; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma J, PLANT MOL BIOL REPOR, V30, P195; Ma J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1242-9; Ma PP, 2019, TROP PLANT BIOL, V12, P158, DOI 10.1007/s12042-019-09225-3; Moore RC, 2005, CURR OPIN PLANT BIOL, V8, P122, DOI 10.1016/j.pbi.2004.12.001; Moreno-Risueno MA, 2007, PLANT J, V51, P352, DOI 10.1111/j.1365-313X.2007.03146.x; Negi J, 2013, CURR BIOL, V23, P479, DOI 10.1016/j.cub.2013.02.001; Nelson DR, 2019, TROP PLANT BIOL, V12, P150, DOI 10.1007/s12042-019-09226-2; Papi M, 2000, GENE DEV, V14, P28; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Posada D, 2003, CURR PROTOC BIOINFOR, V6; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Shi Y, 2019, TROPICAL PLANT BIOL; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Venkatesh J, 2015, PLANT PHYSIOL BIOCH, V94, P73, DOI 10.1016/j.plaphy.2015.05.010; Walther D, 2007, PLOS GENET, V3, P216, DOI 10.1371/journal.pgen.0030011; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang J, TROPICAL PLANT BIOL; Washio K, 2001, BBA-GENE STRUCT EXPR, V1520, P54, DOI 10.1016/S0167-4781(01)00251-2; Washio K, 2003, PLANT PHYSIOL, V133, P850, DOI 10.1104/pp.103.027334; Wen CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23072; Wu ZG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01653; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Yang J, 2011, PLANT SCI, V181, P667, DOI 10.1016/j.plantsci.2011.05.003; Zhang JS, 2018, NAT GENET, V50, P1565, DOI 10.1038/s41588-018-0237-2; Zhang JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-314; Zhang Q, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2419-6; Zhang WP, 2019, TROP PLANT BIOL, V12, P219, DOI 10.1007/s12042-019-09239-x	56	8	8	9	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227716	10.1371/journal.pone.0227716	http://dx.doi.org/10.1371/journal.pone.0227716			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945094	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100056
J	Witte, M; Jaspers, S; Wenck, H; Rubhausen, M; Fischer, F				Witte, Maximilian; Jaspers, Soeren; Wenck, Horst; Ruebhausen, Michael; Fischer, Frank			Noise reduction and quantification of fiber orientations in greyscale images	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; COLLAGEN ORGANIZATION; HUMAN SKIN; MICROSCOPY; ALIGNMENT; BEHAVIOR	Quantification of the angular orientation distribution of fibrous tissue structures in scientific images benefits from the Fourier image analysis to obtain quantitative information. Measurement uncertainties represent a major challenge and need to be considered by propagating them in order to determine an adaptive anisotropic Fourier filter. Our adaptive filter method (AF) is based on the maximum relative uncertainty delta(cut) of the power spectrum as well as a weighted radial sum with weighting factor a. We use a Monte-Carlo simulation to obtain realistic greyscale images that include defined variations in fiber thickness, length, and angular dispersion as well as variations in noise. From this simulation the best agreement between predefined and derived angular orientation distribution is found for evaluation parameters delta(cut) = 2.1% and alpha = 1.5. The resulting cumulative orientation distribution was modeled by a sigmoid function to obtain the mean angle and the fiber dispersion. A comparison to a state-of-the-art band-pass method revealed that the AF method is more suitable for the application on greyscale fiber images, since the error of the fiber dispersion significantly decreased from (33.9 +/- 26.5)% to (13.2 +/- 12.7)%. Both methods were found to accurately quantify the mean fiber orientation with an error of (1.9 +/- 1.5)degrees and (2.3 +/- 2.1)degrees in case of the AF and the band-pass method, respectively. We demonstrate that the AF method is able to accurately quantify the fiber orientation distribution in in vivo second-harmonic generation images of dermal collagen with a mean fiber orientation error of (6.0 +/- 4.0)degrees and a dispersion error of (9.3 +/- 12.1)%.	[Witte, Maximilian; Ruebhausen, Michael] Univ Hamburg, Ctr Free Electron Laser Sci CFEL, Hamburg, Germany; [Witte, Maximilian; Jaspers, Soeren; Wenck, Horst; Fischer, Frank] Beiersdorf AG, Hamburg, Germany	University of Hamburg; Beiersdorf AG	Fischer, F (corresponding author), Beiersdorf AG, Hamburg, Germany.	frank.fischer@beiersdorf.com	Fischer, Frank/AFO-7637-2022	Fischer, Frank/0000-0002-7932-7174; Witte, Maximilian/0000-0002-2923-8907	Beiersdorf AG	Beiersdorf AG	Beiersdorf AG provided support in the form of salaries for authors MW, SJ, HW and FF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `authors contribution' section.	Annaidh AN, 2012, ANN BIOMED ENG, V40, P1666, DOI 10.1007/s10439-012-0542-3; Annaidh AN, 2012, J MECH BEHAV BIOMED, V5, P139, DOI 10.1016/j.jmbbm.2011.08.016; [Anonymous], 2018, MATLAB CURV FITT TOO; [Anonymous], 2018, MATLAB IM PROC TOOLB; Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643; Bancelin S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17635; Becker RI, 2002, IEEE T SIGNAL PROCES, V44, P133; Brazzo L, 2010, QUEST-ISS CONTEMP JE, P5; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052; Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014; Frahs SM, 2018, ANN BIOMED ENG, V46, P1882, DOI 10.1007/s10439-018-2064-0; Frisch KE, 2012, ACTA HISTOCHEM, V114, P140, DOI 10.1016/j.acthis.2011.03.010; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Ghassemieh E, 2002, P I MECH ENG L-J MAT, V216, P199, DOI 10.1243/146442002760186720; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lau TY, 2012, OPT EXPRESS, V20, P21821, DOI 10.1364/OE.20.021821; Levillain A, 2016, J MECH BEHAV BIOMED, V61, P308, DOI 10.1016/j.jmbbm.2016.04.006; Liu C, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.12; Lutz V, 2012, INT J COSMETIC SCI, V34, P209, DOI 10.1111/j.1468-2494.2012.00705.x; Lutz V, 2012, SKIN RES TECHNOL, V18, P168, DOI 10.1111/j.1600-0846.2011.00549.x; Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003; MATLAB, 2018, VERS 9 4 0 R2018A; Mega Y, 2012, OPT LETT, V37, P3312, DOI 10.1364/OL.37.003312; Mercatelli R, 2017, J BIOPHOTONICS, V10, P75, DOI 10.1002/jbio.201600122; Moisan L, 2011, J MATH IMAGING VIS, V39, P161, DOI 10.1007/s10851-010-0227-1; Morrill EE, 2016, BIOMECH MODEL MECHAN, V15, P1467, DOI 10.1007/s10237-016-0776-3; Nesbitt S, 2015, MATERIALS, V8, P1841, DOI 10.3390/ma8041841; Paul E, 2010, CRIT STUD ASIA PAC S, P127; Polzer S, 2013, MICROSC MICROANAL, V19, P1395, DOI 10.1017/S1431927613013251; Pourdeyhimi B, 1997, TEXT RES J, V67, P143, DOI 10.1177/004051759706700211; Puschmann S, 2012, PROC SPIE, V8216, DOI 10.1117/12.906460; Redon C, 1998, J MICROSC-OXFORD, V191, P258; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Ribeiro JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054724; Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847; Schriefl AJ, 2012, J R SOC INTERFACE; Schriefl AJ, 2012, J R SOC INTERFACE, V9, P3081, DOI 10.1098/rsif.2012.0339; Stender CJ, 2018, BIOMECH MODEL MECHAN, V17, P543, DOI 10.1007/s10237-017-0977-4; University of Wisconsin, PUBL DOM TEST IM HOM; van Zuijlen PPM, 2003, BURNS, V29, P423, DOI 10.1016/S0305-4179(03)00052-4; Withayachumnankul W, 2008, J OPT SOC AM B, V25, P1059, DOI 10.1364/JOSAB.25.001059; Wu HJ, 2010, J MATER SCI-MATER M, V21, P3207, DOI 10.1007/s10856-010-4164-8; Wu SL, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3565439; Yang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7649; Zhao HY, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/12/125006	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227534	10.1371/journal.pone.0227534	http://dx.doi.org/10.1371/journal.pone.0227534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945084	gold, Green Published, Green Submitted			2022-12-26	WOS:000534370100043
J	Gillet, C; Kurth, S; Kuenzel, T				Gillet, Charlene; Kurth, Stefanie; Kuenzel, Thomas			Muscarinic modulation of M and h currents in gerbil spherical bushy cells	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; I-H; POTASSIUM CHANNELS; CA2+ CURRENT; CONDUCTANCES; PHARMACOLOGY; COLLATERALS; SUPPRESSION; INHIBITION; RECEPTORS	Descending cholinergic fibers innervate the cochlear nucleus. Spherical bushy cells, principal neurons of the anterior part of the ventral cochlear nucleus, are depolarized by cholinergic agonists on two different time scales. A fast and transient response is mediated by alpha-7 homomeric nicotinic receptors while a slow and long-lasting response is mediated by muscarinic receptors. Spherical bushy cells were shown to express M3 receptors, but the receptor subtypes involved in the slow muscarinic response were not physiologically identified yet. Whole-cell patch clamp recordings combined with pharmacology and immunohistochemistry were performed to identify the muscarinic receptor subtypes and the effector currents involved. Spherical bushy cells also expressed both M1 and M2 receptors. The M1 signal was stronger and mainly somatic while the M2 signal was localized in the neuropil and on the soma of bushy cells. Physiologically, the M-current was observed for the gerbil spherical bushy cells and was inhibited by oxotremorine-M application. Surprisingly, long application of carbachol showed only a transient depolarization. Even though no muscarinic depolarization could be detected, the input resistance increased suggesting a decrease in the cell conductance that matched with the closure of M-channels. The hyperpolarization-activated currents were also affected by muscarinic activation and counteracted the effect of the inactivation of M-current on the membrane potential. We hypothesize that this double muscarinic action might allow adaptation of effects during long durations of cholinergic activation.	[Gillet, Charlene; Kuenzel, Thomas] Rhein Westfal TH Aachen, Dept Chemosensat, Auditory Neurophysiol Grp, Aachen, Germany; [Kurth, Stefanie; Kuenzel, Thomas] Rhein Westfal TH Aachen, Dept Chemosensat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Kuenzel, T (corresponding author), Rhein Westfal TH Aachen, Dept Chemosensat, Auditory Neurophysiol Grp, Aachen, Germany.; Kuenzel, T (corresponding author), Rhein Westfal TH Aachen, Dept Chemosensat, Aachen, Germany.	kuenzel@bio2.rwth-aachen.de		Kuenzel, Thomas/0000-0003-0993-8524	DFG Priority Program 1608 "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"with German Research Foundation [KU2529/2-1, KU2529/2-2]; German Research Foundation [KU2529/3-1]	DFG Priority Program 1608 "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"with German Research Foundation; German Research Foundation(German Research Foundation (DFG))	This work was funded by the DFG Priority Program 1608 "Ultrafast and Temporally Precise Information Processing: Normal and Dysfunctional Hearing"with German Research Foundation Grants KU2529/2-1 (TK), KU2529/2-2 (CG and TK) and by German Research Foundation regular grant KU2529/3-1 (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P223, DOI 10.1113/jphysiol.1982.sp014411; Baashar A, 2019, J COMP NEUROL, V527, P2273, DOI 10.1002/cne.24681; Baashar A, 2015, HEARING RES, V325, P35, DOI 10.1016/j.heares.2015.02.011; Bellingham MC, 1998, J PHYSIOL-LONDON, V511, P861, DOI 10.1111/j.1469-7793.1998.861bg.x; BERNHEIM L, 1992, P NATL ACAD SCI USA, V89, P9544, DOI 10.1073/pnas.89.20.9544; Bista P, 2015, J PHYSIOL-LONDON, V593, P127, DOI 10.1113/jphysiol.2014.276527; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Buskila Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1538-9; Chen C, 1997, HEARING RES, V110, P179, DOI 10.1016/S0378-5955(97)00078-6; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Dannenberg H, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00102; Fujino K, 2001, J NEUROSCI, V21, P7372, DOI 10.1523/JNEUROSCI.21-18-07372.2001; Gillet C, 2018, J COMP NEUROL, V526, P1647, DOI 10.1002/cne.24433; Goyer D, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0186-16.2016; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Hadley JK, 2003, J NEUROSCI, V23, P5012; Hajos N, 1998, NEUROSCIENCE, V82, P355; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Horvath M, 2000, J COMP NEUROL, V422, P95; Jones CK, 2012, NEUROPSYCHOPHARMACOL, V37, P16, DOI 10.1038/npp.2011.199; Kishan AU, 2011, OPEN J NEUROSCI, V1, P2; Leao KE, 2006, J PHYSIOL-LONDON, V576, P849, DOI 10.1113/jphysiol.2006.114702; Liao ZD, 2010, J GEN PHYSIOL, V136, P247, DOI 10.1085/jgp.201010488; Liu LW, 2006, J NEUROSCI, V26, P11588, DOI 10.1523/JNEUROSCI.2102-06.2006; MANIS PB, 1991, J NEUROSCI, V11, P2865; MARRION NV, 1989, BRIT J PHARMACOL, V98, P557, DOI 10.1111/j.1476-5381.1989.tb12630.x; Mellott JG, 2011, NEUROSCIENCE, V180, P138, DOI 10.1016/j.neuroscience.2011.02.010; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Romanelli MN, 2016, CURR TOP MED CHEM, V16, P1764, DOI 10.2174/1568026616999160315130832; Rouse ST, 2000, NEUROSCI LETT, V278, P61, DOI 10.1016/S0304-3940(99)00914-3; Sartiani L, 2017, PHARMACOL REV, V69, P354, DOI 10.1124/pr.117.014035; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schofield BR, 2011, HEARING RES, V279, P85, DOI 10.1016/j.heares.2010.12.019; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; Shaikh AG, 2003, HEARING RES, V183, P126, DOI 10.1016/S0378-5955(03)00224-7; SMITH DI, 1987, HEARING RES, V27, P157, DOI 10.1016/0378-5955(87)90016-5; TRYBULSKI EJ, 1993, J MED CHEM, V36, P3533, DOI 10.1021/jm00075a007; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Williams AD, 2015, J PHYSIOL-LONDON, V593, P2779, DOI 10.1113/JP270453; Zhao Z, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00071; Zwart R, 2016, EUR J PHARMACOL, V791, P221, DOI 10.1016/j.ejphar.2016.08.037	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226954	10.1371/journal.pone.0226954	http://dx.doi.org/10.1371/journal.pone.0226954			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940388	Green Published, gold			2022-12-26	WOS:000534368000051
J	Morkune, R; Marciukaitis, M; Jurkin, V; Gecevicius, G; Morkunas, J; Raudonikis, L; Markevicius, A; Narscius, A; Gasiunaite, ZR				Morkune, Rasa; Marciukaitis, Mantas; Jurkin, Viaceslav; Gecevicius, Giedrius; Morkunas, Julius; Raudonikis, Liutauras; Markevicius, Antanas; Narscius, Aleksas; Gasiunaite, Zita R.			Wind energy development and wildlife conservation in Lithuania: A mapping tool for conflict assessment	PLOS ONE			English	Article							IMPACTS; FARMS	The paper presents a mapping tool aiming to identify and minimise potential conflicts between onshore wind energy development and wildlife conservation in Lithuania. It merges current information on the distribution, conservation status and sensitivity of birds and bats to wind power with an integrated evaluation of wind resources (modelled wind speed), special planning status and technical perspectives of wind energy development. The paper includes assessment of the selected wildlife species which were described as sensitive to wind power (69 breeding and 43 migratory bird species and 17 bat species bats in the country). Used species level information allowed the precise identification of sensitive territories and might be used to mitigate negative wind farm effects using special measures based on species behavior. Finally, we delivered overlaps as possible conflicts among the most promising wind farm areas and the areas with high sensitivity in relation to bird and bat distribution. These overlaps point to the required attention and relevant decisions that are needed to ensure sustainable development of wind energy throughout the country. We suggest this tool for initial determination of appropriate areas for wind energy development in the country and as supplement to Environmental Impact Assessment.	[Morkune, Rasa; Jurkin, Viaceslav; Morkunas, Julius; Narscius, Aleksas; Gasiunaite, Zita R.] Klaipeda Univ, Marine Res Inst, Klaipeda, Lithuania; [Marciukaitis, Mantas; Markevicius, Antanas] Lithuanian Energy Inst, Kaunas, Lithuania; [Jurkin, Viaceslav; Gasiunaite, Zita R.] Coastal Res & Planning Inst, Klaipeda, Lithuania; [Gecevicius, Giedrius] Univ Appl Sci, Kaunas, Lithuania; [Morkunas, Julius; Raudonikis, Liutauras] Lithuanian Ornithol Soc, Vilnius, Lithuania	Klaipeda University; Lithuanian Energy Institute	Morkune, R (corresponding author), Klaipeda Univ, Marine Res Inst, Klaipeda, Lithuania.	rasa.morkune@ku.lt	Gasiunaite, Zita Rasuole/AAT-7108-2021	Gasiunaite, Zita R./0000-0002-8598-0524; Marciukaitis, Mantas/0000-0003-2783-1667; Morkune, Rasa/0000-0002-5918-1614	Ministry of Environment of the Republic of Lithuania from the European Economic Area financial mechanism 2009-2014 Biodiversity and ecosystem services (LT03 Programme) [EEE-LT03-AM-01-K-01-004]	Ministry of Environment of the Republic of Lithuania from the European Economic Area financial mechanism 2009-2014 Biodiversity and ecosystem services (LT03 Programme)	This work was based on the project VENBIS which was supported by the Ministry of Environment of the Republic of Lithuania from the European Economic Area financial mechanism 2009-2014 Biodiversity and ecosystem services (LT03 Programme) [grant number EEE-LT03-AM-01-K-01-004, 2015-2017].	Aarts B, 2009, NATL WINDMOLENRISICO; [Anonymous], 2019, ENERGY ZONES MAPPING; [Anonymous], 2012, DEV TESTING METHODOL; [Anonymous], 2017, DATABASE PROJECT VEN; [Anonymous], 2017, INF SYST PROT SPEC L; [Anonymous], 2015, BIRD SENSITIVITY MAP; Arnett EB, 2016, HUM-WILDL INTERACT, V10, P28; Aydin NY, 2010, RENEW SUST ENERG REV, V14, P364, DOI 10.1016/j.rser.2009.07.023; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bright JA, 2009, MAPPED WRITTEN GUIDA; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Cellura M, 2008, RENEW ENERG, V33, P1237, DOI 10.1016/j.renene.2007.08.012; Cowell R, 2010, LAND USE POLICY, V27, P222, DOI 10.1016/j.landusepol.2009.01.006; Everaert J, 2011, C WIND EN WILDL IMP; Gualtieri G, 2012, RENEW ENERG, V43, P183, DOI 10.1016/j.renene.2011.12.022; Hoover SL, 2005, J WILDLIFE MANAGE, V69, P150, DOI 10.2193/0022-541X(2005)069<0150:BORHIA>2.0.CO;2; Kurlavicius P, 2006, ATLAS BREEDING BIRDS; Langston RHW, 2003, BERN CONV CONS EUR W; Liechti F, 2013, BIOL CONSERV, V162, P24, DOI 10.1016/j.biocon.2013.03.018; Nugent D, 2014, ENERG POLICY, V65, P229, DOI 10.1016/j.enpol.2013.10.048; Retief EF, 2013, UNPUB; Rodrigues L, 2008, EUROBATS PUBLICATION, P51; Rydell J., 2012, EFFECT WIND POWER BI, P6511; The Ministry of Agriculture of the Republic of Lithuania, GRPK SPAT DAT SET GE; van Haaren R, 2011, RENEW SUST ENERG REV, V15, P3332, DOI 10.1016/j.rser.2011.04.010; Wang SF, 2015, RENEW SUST ENERG REV, V44, P599, DOI 10.1016/j.rser.2015.01.031; Zalakevicius M, 1986, PAUKSCIU MIGRACIJOS	27	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227735	10.1371/journal.pone.0227735	http://dx.doi.org/10.1371/journal.pone.0227735			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940412	gold, Green Published			2022-12-26	WOS:000534368000096
J	Parimuchova, A; Zurovcova, M; Papac, V; Kovac, L				Parimuchova, Andrea; Zurovcova, Martina; Papac, Vladimir; Kovac, Lubomir			Subterranean Deuteraphorura Absolon, 1901, (Hexapoda, Collembola) of the Western Carpathians - Troglomorphy at the northern distributional limit in Europe	PLOS ONE			English	Article							SPECIES DELIMITATION; CAVE; ONYCHIURIDAE; DIVERSITY; DNA; ENTOMOBRYIDAE; AMPLIFICATION; SUBSTITUTIONS; CONVERGENCE; TOMOCERIDAE	An integrative approach employing molecular, morphological and geographical data were applied to species delimitation among Deuteraphorura congeners occupying caves of the Western Carpathian Mts. A new species of Deuteraphorura from the Western Carpathians is described. D. muranensis sp. nov. belongs among species with 4 pso at the hind margin of the head and possesses highly troglomorphic features. It is conspicuous with its distinctly elongated claws and long, hair-like body chaetae. The status of the new species was confirmed by DNA barcoding based on the mitochondrial COI marker. Populations of D. kratochvili (Nosek, 1963), the most widespread species, were studied in detail. Both ABGD and PTP analyses brought results congruent with geography, i.e. the molecular and geographic distance of the populations were positively correlated. However, some molecular separation based on pairwise distance and the number of substitutions was indicated within two of the studied populations. Despite the indistinct morphological differences, the tested populations were well isolated both geographically and genetically, which indicates that each studied population may represent a cryptic species. The troglomorphy of cave Collembola at the northernmost border of the distribution of cave-adapted species in the Europe is discussed. It is clear that the level of troglomorphy is closely associated with conditions of the microhabitat occupied by the individual subterranean species. The results of our study enhance the importance of the Western Carpathians regarding the diversity pattern of obligate cave species in Europe.	[Parimuchova, Andrea; Kovac, Lubomir] Safarik Univ, Fac Sci, Inst Biol & Ecol, Dept Zool, Kosice, Slovakia; [Zurovcova, Martina] Biol Ctr AS CR, Inst Entomol, Vvi, Ceske Budejovice, Czech Republic; [Papac, Vladimir] Slovak Caves Adm, Cave Care Dept, State Nat Conservancy Slovak Republ, Rimayska Sobota, Slovakia	University of Pavol Jozef Safarik Kosice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Parimuchova, A (corresponding author), Safarik Univ, Fac Sci, Inst Biol & Ecol, Dept Zool, Kosice, Slovakia.	andrea.parimuchova@upjs.sk	Kováč, Ľubomír/J-5954-2015; Žurovcova, Martina/AAD-8240-2022; Zurovcova, Martina/G-9254-2014	Kováč, Ľubomír/0000-0001-8194-2128; Žurovcova, Martina/0000-0003-1539-9774; 	Slovak Research and Development Agency [APVV-17-0477]; Scientific Grant Agency [VEGA1/0346/18]; Pavol Jozef Safarik University in Kosice [VVGS-PF-2018-796]	Slovak Research and Development Agency(Slovak Research and Development Agency); Scientific Grant Agency; Pavol Jozef Safarik University in Kosice	The study was supported by the Slovak Research and Development Agency (APVV-17-0477), Scientific Grant Agency (VEGA1/0346/18) and grant providing by the Pavol Jozef Safarik University in Kosice (VVGS-PF-2018-796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbea Javier I., 2015, Boletin de la SEA, P79; Barjadze S, 2016, ZOOTAXA, V4126, P77, DOI 10.11646/zootaxa.4126.1.3; Bellinger P.F., 1996, CHECKLIST COLLEMBOLA; Beruete E., 2001, Boletin de la Asociacion Espanola de Entomologia, V25, P9; CHRISTIANSEN K, 1987, J BIOGEOGR, V14, P459, DOI 10.2307/2844976; CHRISTIANSEN K, 1961, EVOLUTION, V15, P288, DOI 10.2307/2406229; Christiansen K., 2012, ENCY CAVES, P517, DOI 10.1016/B978-0-12-383832-2.00075-X; Christiansen K., 1962, SPELUNCA, V2, P75, DOI DOI 10.1017/CB09781107415324.004; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; Cicconardi F, 2013, MOL ECOL, V22, P5382, DOI 10.1111/mec.12472; Culver David C., 2004, Subterranean Biology, V2, P27; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Culver DC, 2006, ECOGRAPHY, V29, P120; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Deharveng L., 1983, Travaux du Laboratoire d'Ecobiologie des Arthropodes Edaphiques Toulouse, V4, P1; Deharveng L, 2018, ECOL STUD-ANAL SYNTH, V235, P107, DOI 10.1007/978-3-319-98852-8_7; Deharveng L, 2015, ZOOTAXA, V3920, P281, DOI 10.11646/zootaxa.3920.2.4; Ding YH, 2019, INSECT SCI, V26, P587, DOI 10.1111/1744-7917.12559; Fanciulli PP, 2018, ZOOKEYS, P29, DOI 10.3897/zookeys.739.20923; Fanciulli PP, 2005, ITAL J ZOOL, V72, P167, DOI 10.1080/11250000509356667; Fjellberg A., 1998, ZOOL ANZ, V237, P309; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Howarth FG, 2018, ECOL STUD-ANAL SYNTH, V235, P41, DOI 10.1007/978-3-319-98852-8_4; Katz AD, 2015, ZOOL J LINN SOC-LOND, V173, P818, DOI 10.1111/zoj.12220; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kovac L, 2014, SPELEOLOGIA SLOVACA, V5; Kovac L, 2010, ZOOTAXA, P36; Kovac L, 2016, BIOL J LINN SOC, V119, P571, DOI 10.1111/bij.12555; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lukic M., 2008, ADV STUDIES FAUNA BA, P119; Lukic M, 2018, INVERTEBR SYST, V32, P1118, DOI 10.1071/IS17088; Lukic M, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.69.739; Pan ZX, 2015, ZOOTAXA, V3918, P285, DOI 10.11646/zootaxa.3918.2.9; Papac V, 2016, ZOOTAXA, V4088, P51, DOI 10.11646/zootaxa.4088.1.2; Papac V, 2013, ZOOTAXA, V 3737, P545, DOI 10.11646/zootaxa.3737.5.3; Parimuchova A, 2017, ZOOTAXA, V4350, P185, DOI 10.11646/zootaxa.4350.1.12; Parimuchova A, 2017, ARTHROPOD SYST PHYLO, V75, P351; Parimuchova A, 2016, ZOOTAXA, V4168, P327, DOI 10.11646/zootaxa.4168.2.6; Pipan T, 2012, BIOL J LINN SOC, V107, P1, DOI 10.1111/j.1095-8312.2012.01964.x; Porco D, 2012, INVERTEBR SYST, V26, P470, DOI 10.1071/IS12026; Porco D, 2014, MOL ECOL RESOUR, V14, P249, DOI 10.1111/1755-0998.12172; Porco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046056; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Raschmanova N, 2017, J ZOOL SYST EVOL RES, V55, P19, DOI 10.1111/jzs.12150; Rusek J., 1975, MIKROKOSMOS, V12, P376, DOI DOI 10.1017/S0040298200034719; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Soto-Adames FN, 2002, MOL PHYLOGENET EVOL, V25, P27, DOI 10.1016/S1055-7903(02)00250-6; Sun X, 1986, 10 INT SEM APT 17 21, P38; Sun X, 2018, PEERJ, V6, DOI 10.7717/peerj.5021; Sun X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08381-4; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Vargovitsh RS, 2019, ZOOTAXA, V4619, P267, DOI 10.11646/zootaxa.4619.2.4; Weiner WM, 2014, FLA ENTOMOL, V97, P247, DOI 10.1653/024.097.0133; Yu DY, 2018, ARTHROPOD SYST PHYLO, V76, P147; Zagmajster M, 2018, ECOL STUD-ANAL SYNTH, V235, P195, DOI 10.1007/978-3-319-98852-8_9; Zhang F, 2018, INVERTEBR SYST, V32, P1298, DOI 10.1071/IS18019; Zhang F, 2018, ZOOL SCR, V47, P342, DOI 10.1111/zsc.12279; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	63	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226966	10.1371/journal.pone.0226966	http://dx.doi.org/10.1371/journal.pone.0226966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940408	Green Published, gold			2022-12-26	WOS:000534368000052
J	Stroobants, S; Creemers, J; Bosmans, G; D'Hooge, R				Stroobants, Stijn; Creemers, John; Bosmans, Guy; D'Hooge, Rudi			Post-weaning infant-to-mother bonding in nutritionally independent female mice	PLOS ONE			English	Article							MATERNAL SEPARATION; SOCIAL-BEHAVIOR; ULTRASONIC VOCALIZATIONS; AUTISM; ATTACHMENT; GENE; MECHANISMS; RESPONSES; OXYTOCIN; ODOR	Infant-parent attachment is highly selective and continues beyond essential care in primates, most prominently in humans, and the quality of this attachment crucially determines cognitive and emotional development of the infant. Altricial rodent species such as mice (Mus musculus) display mutual recognition and communal nursing in wild and laboratory environments, but parental bonding beyond the nursing period has not been reported. We presently demonstrated that socially and nutritionally independent mice still prefer to interact selectively with their mother dam. Furthermore, we observed gender differences in the mother-infant relationship, and showed disruption of this relationship in haploinsufficient Nbea(+/-) mice, a putative autism model with neuroendocrine dysregulation. To our knowledge, this is the first observation of murine infant-to-mother bonding beyond the nursing period.	[Stroobants, Stijn; D'Hooge, Rudi] Katholieke Univ Leuven, Lab Biol Psychol, Leuven, Belgium; [Stroobants, Stijn; D'Hooge, Rudi] Katholieke Univ Leuven, mINT Behav Phenotyping Facil, Leuven, Belgium; [Creemers, John] Katholieke Univ Leuven, Lab Biochem Neuroendocrinol, Leuven, Belgium; [Bosmans, Guy] Katholieke Univ Leuven, Parenting & Special Educ Res Unit, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Stroobants, S (corresponding author), Katholieke Univ Leuven, Lab Biol Psychol, Leuven, Belgium.; Stroobants, S (corresponding author), Katholieke Univ Leuven, mINT Behav Phenotyping Facil, Leuven, Belgium.	stijn.stroobants@kuleuven.be	Bosmans, Guy/L-8822-2015	Bosmans, Guy/0000-0001-9057-6027	federal science fund (FWO \ Het Fonds voor Wetenschappelijk Onderzoek - Vlaanderen) [G070717N]	federal science fund (FWO \ Het Fonds voor Wetenschappelijk Onderzoek - Vlaanderen)	This work was supported by federal science fund (FWO vertical bar Het Fonds voor Wetenschappelijk Onderzoek - Vlaanderen |https//www.fwo.be) grant G070717N to GB and RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisa B, 2008, NEUROSCIENCE, V154, P1218, DOI 10.1016/j.neuroscience.2008.05.011; Arakawa H, 2018, BEHAV BRAIN RES, V341, P98, DOI 10.1016/j.bbr.2017.12.022; Bondar NP, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/1538931; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; Bowlby J, 1969, ATTACHMENT LOSS SEPA; BREEN MF, 1977, PHYSIOL BEHAV, V18, P527, DOI 10.1016/0031-9384(77)90269-4; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Chocyk A, 2014, BEHAV BRAIN RES, V264, P161, DOI 10.1016/j.bbr.2014.01.040; Coria-Avila GA, 2014, NEUROSCI BIOBEHAV R, V43, P173, DOI 10.1016/j.neubiorev.2014.04.004; Cox KH, 2011, GENES BRAIN BEHAV, V10, P465, DOI 10.1111/j.1601-183X.2011.00688.x; Curley JP, 2016, FRONT NEUROENDOCRIN, V40, P52, DOI 10.1016/j.yfrne.2015.11.001; Curley JP, 2009, DEV NEUROSCI-BASEL, V31, P318, DOI 10.1159/000216543; Edelmann MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057396; Esposito G, 2017, BEHAV BRAIN RES, V325, P87, DOI 10.1016/j.bbr.2017.03.025; Esposito G, 2013, CURR BIOL, V23, P739, DOI 10.1016/j.cub.2013.03.041; Fabricius K, 2008, BRAIN STRUCT FUNCT, V212, P403, DOI 10.1007/s00429-007-0169-6; Fraley RC, 2011, J PERS SOC PSYCHOL, V101, P974, DOI 10.1037/a0024150; Gernsbacher MA, 2005, SCIENCE, V307, P1201, DOI 10.1126/science.307.5713.1201; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Gubernick D.J., 1981, P243; Hahn ME, 1998, BEHAV GENET, V28, P315, DOI 10.1023/A:1021679615792; Hammock EAD, 2015, NEUROPSYCHOPHARMACOL, V40, P24, DOI 10.1038/npp.2014.120; Hammock EAD, 2013, HORM BEHAV, V63, P352, DOI 10.1016/j.yhbeh.2012.12.006; Heyser CJ., 2004, CURRENT PROTOCOLS NE, DOI 10.1002/0471142301.ns0818s25; Kaidanovich-Beilin Oksana, 2011, J Vis Exp, DOI 10.3791/2473; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; Kikusui T, 2009, J NEUROENDOCRINOL, V21, P427, DOI 10.1111/j.1365-2826.2009.01837.x; Kikusui T, 2007, BRAIN RES, V1133, P115, DOI 10.1016/j.brainres.2006.11.031; Landers MS, 2012, DEV NEUROSCI-BASEL, V34, P101, DOI 10.1159/000336732; Lassi G, 2017, GENES BRAIN BEHAV, V16, P612, DOI 10.1111/gbb.12385; Lee JH, 2007, NEUROSCI RES, V58, P32, DOI 10.1016/j.neures.2007.01.008; Lucion AB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00017; McCrory E, 2012, J ROY SOC MED, V105, P151, DOI 10.1258/jrsm.2011.110222; Mogi K, 2017, BEHAV BRAIN RES, V325, P138, DOI 10.1016/j.bbr.2016.08.044; Mogi K, 2014, PHYSIOL BEHAV, V133, P68, DOI 10.1016/j.physbeh.2014.05.010; Mogi K, 2011, PROG NEURO-PSYCHOPH, V35, P1232, DOI 10.1016/j.pnpbp.2010.08.024; MOORE CL, 1979, J COMP PHYSIOL PSYCH, V93, P677, DOI 10.1037/h0077599; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Naert A, 2011, BRAIN RES BULL, V85, P354, DOI 10.1016/j.brainresbull.2011.03.027; Nagasawa M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00031; Nishi M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00166; Numan M, 2016, HORM BEHAV, V77, P98, DOI 10.1016/j.yhbeh.2015.05.015; Nuytens K, 2013, NEUROBIOL DIS, V51, P144, DOI 10.1016/j.nbd.2012.11.004; Okabe S, 2013, BEHAV NEUROSCI, V127, P432, DOI 10.1037/a0032395; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Raineki C, 2009, NEUROSCIENCE, V159, P31, DOI 10.1016/j.neuroscience.2008.12.012; RICHMOND G, 1984, DEV PSYCHOBIOL, V17, P87, DOI 10.1002/dev.420170108; Richter SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167652; Richter SH, 2016, ANIM BEHAV, V114, P261, DOI 10.1016/j.anbehav.2016.02.003; Rutgers AH, 2004, J CHILD PSYCHOL PSYC, V45, P1123, DOI 10.1111/j.1469-7610.2004.t01-1-00305.x; Shair HN, 2014, DEV PSYCHOBIOL, V56, P1689, DOI 10.1002/dev.21222; Shin SW, 2016, ANAL BIOCHEM, V508, P124, DOI 10.1016/j.ab.2016.05.004; Sivaratnam CS, 2015, REV J AUTISM DEV DIS, V2, P222, DOI 10.1007/s40489-015-0048-7; Stoesz BM, 2013, NEUROSCI BIOBEHAV R, V37, P123, DOI 10.1016/j.neubiorev.2012.11.007; Takahashi T, 2016, MOL PSYCHIATR, V21, P1208, DOI 10.1038/mp.2015.190; Tractenberg SG, 2016, NEUROSCI BIOBEHAV R, V68, P489, DOI 10.1016/j.neubiorev.2016.06.021; Vivanti G, 2017, BEHAV BRAIN RES, V325, P251, DOI 10.1016/j.bbr.2016.10.025; Volders K, 2011, CURR MOL MED, V11, P204, DOI 10.2174/156652411795243432; Wang L, 2011, PSYCHOPHARMACOLOGY, V216, P207, DOI 10.1007/s00213-011-2209-4; Wang ZS, 2011, NEUROPSYCHOPHARMACOL, V36, P772, DOI 10.1038/npp.2010.211; Wise A, 2015, J NEUROGENET, V29, P135, DOI 10.3109/01677063.2015.1064916; Wohr M, 2013, CELL TISSUE RES, V354, P81, DOI 10.1007/s00441-013-1607-9; Xu HY, 2018, BEHAV BRAIN FUNCT, V14, DOI 10.1186/s12993-018-0142-y; Yoshida S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-50	65	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227034	10.1371/journal.pone.0227034	http://dx.doi.org/10.1371/journal.pone.0227034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940385	Green Published, gold			2022-12-26	WOS:000534368000054
J	Faria, DR; Sakita, KM; Capoci, IRG; Arita, GS; Rodrigues-Vendramini, FAV; de Oliveira, AG; Felipe, MSS; de Mendonca, PDB; Svidzinski, TIE; Kioshima, ES				Faria, Daniella Renata; Sakita, Karina Mayumi; Grenier Capoci, Isis Regina; Arita, Glaucia Sayuri; Vilugron Rodrigues-Vendramini, Franciele Abigail; de Oliveira Junior, Admilton Goncalves; Soares Felipe, Maria Sueli; Bonfim de Mendonca, Patricia de Souza; Estivalet Svidzinski, Terezinha Inez; Kioshima, Erika Seki			Promising antifungal activity of new oxadiazole against Candida krusei	PLOS ONE			English	Article							IN-VITRO; ECHINOCANDIN RESISTANCE; HISTORICAL TRENDS; AMPHOTERICIN-B; TIME-KILL; FLUCONAZOLE; EPIDEMIOLOGY; SYNERGY; SURVEILLANCE; COMBINATION	Candida krusei is one of the most common agents of invasive candidiasis and candidemia worldwide, leading to high morbidity and mortality rates. This species has become a problem due to its intrinsic resistance and reduced susceptibility to azoles and polyenes. Moreover, the number of antifungal drugs available for candidiasis treatment is limited, demonstrating the urgent need for the discovery of novel alternative therapies. In this work, the in vivo and in vitro activities of a new oxadiazole (LMM11) were evaluated against C. krusei. The minimum inhibitory concentration ranged from 32 to 64 mu g/mL with a significant reduction in the colony forming unit (CFU) count (similar to 3 log(10)). LMM11 showed fungicidal effect, similar to amphotericin, reducing the viable cell number (> 99.9%) in the time-kill curve. Yeast cells presented morphological alterations and inactive metabolism when treated with LMM11. This compound was also effective in decreasing C. krusei replication inside and outside macrophages. A synergistic effect between fluconazole and LMM11 was observed. In vivo treatment with the new oxadiazole led to a significant reduction in CFU (0.85 log(10)). Furthermore, histopathological analysis of the treated group exhibited a reduction in the inflammatory area. Taken together, these results indicate that LMM11 is a promising candidate for the development of a new antifungal agent for the treatment of infections caused by resistant Candida species such as C. krusei.	[Faria, Daniella Renata; Sakita, Karina Mayumi; Grenier Capoci, Isis Regina; Arita, Glaucia Sayuri; Vilugron Rodrigues-Vendramini, Franciele Abigail; Bonfim de Mendonca, Patricia de Souza; Estivalet Svidzinski, Terezinha Inez; Kioshima, Erika Seki] Univ Estadual Maringa, Lab Med Mycol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil; [de Oliveira Junior, Admilton Goncalves] Univ Estadual Londrina, Dept Microbiol, Lab Microbial Biotechnol, Londrina, Parana, Brazil; [Soares Felipe, Maria Sueli] Univ Brasilia, Dept Cell Biol, Lab Mol Biol, Brasilia, DF, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Londrina; Universidade de Brasilia	Kioshima, ES (corresponding author), Univ Estadual Maringa, Lab Med Mycol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.	eskioshima@gmail.com	KIOSHIMA, ERIKA S/L-9305-2018; de Oliveira, Admilton Goncalves/M-4143-2013	KIOSHIMA, ERIKA S/0000-0003-3290-8577; Sakita, Karina/0000-0003-2899-2657; de Oliveira, Admilton Goncalves/0000-0003-1556-5146; Arita, Glaucia Sayuri/0000-0002-0334-7566; Faria, Daniella Renata/0000-0002-4979-5647	National Council for Scientific and Technological Development (CNPq) [552276/2011-1]; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by National Council for Scientific and Technological Development (CNPq) (http://www.cnpq.br/) -Grant number 552276/2011-1 to ESK, TIES and the Coordination for the Improvement of Higher Education Personnel (CAPES) to DRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bagatin MC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00165-17, 10.1128/aac.00165-17]; Cely MVT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00720; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI; CLSI, 2008, REFERENCE METHOD BRO; Colombo AL, 2014, INTENS CARE MED, V40, P1489, DOI 10.1007/s00134-014-3400-y; Danishuddin M, 2015, METHODS, V71, P135, DOI 10.1016/j.ymeth.2014.10.019; Das B, 2016, SCI REP-UK, V6, DOI 10.1038/srep36403; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Doi AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146909; Enoch DA, 2017, METHODS MOL BIOL, V1508, P17, DOI 10.1007/978-1-4939-6515-1_2; Essid R, 2017, APPL MICROBIOL BIOT, V101, P6993, DOI 10.1007/s00253-017-8442-y; European Centre for Disease Prevention and Control, 2019, POINT PREV SURV HEAL; Forastiero A, 2015, ANTIMICROB AGENTS CH, V59, P6975, DOI 10.1128/AAC.01005-15; Garcia-Rodas R, 2011, INFECT IMMUN, V79, P2136, DOI 10.1128/IAI.00044-11; Gill K, 2015, INDIAN J MED MICROBI, V33, P110, DOI 10.4103/0255-0857.148404; Graybill JR, 1997, ANTIMICROB AGENTS CH, V41, P1937, DOI 10.1128/AAC.41.9.1937; GRECO WR, 1995, PHARMACOL REV, V47, P331; Capoci IRG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02130; Guinea J, 2014, CLIN MICROBIOL INFEC, V20, P5, DOI 10.1111/1469-0691.12539; Hrabovsky V, 2017, FOLIA MICROBIOL, V62, P525, DOI 10.1007/s12223-017-0525-8; Ishikane M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165346; Joffe LS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00535; Kang K, 2010, MYCOSES, V53, P495, DOI 10.1111/j.1439-0507.2009.01747.x; Katragkou A, 2017, MED MYCOL, V55, P859, DOI 10.1093/mmy/myx006; Khan MSA, 2012, MED MYCOL, V50, P33, DOI 10.3109/13693786.2011.582890; Khodavandi A, 2011, FEMS MICROBIOL LETT, V315, P87, DOI 10.1111/j.1574-6968.2010.02170.x; Kioshima ES, 2018, Patent No. [BR1020180090208, 1020180090208]; Kitamura A, 2010, EXPERT OPIN DRUG DIS, V5, P739, DOI 10.1517/17460441.2010.498472; Klepser ME, 1997, ANTIMICROB AGENTS CH, V41, P1392, DOI 10.1128/AAC.41.6.1392; Kwolek-Mirek M, 2014, FEMS YEAST RES, V14, P1068, DOI 10.1111/1567-1364.12202; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Leroy O, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-015-0103-7; Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345; Li L, 2015, NAT PROD COMMUN, V10; Lionakis MS, 2011, J INNATE IMMUN, V3, P180, DOI 10.1159/000321157; Low Chian-Yong, 2011, F1000 Med Rep, V3, P14, DOI 10.3410/M3-14; Magalhaes YC, 2015, BRAZ J MICROBIOL, V46, P117, DOI 10.1590/S1517-838246120120296; Majithiya J, 2009, J ANTIMICROB CHEMOTH, V63, P161, DOI 10.1093/jac/dkn431; Meletiadis J, 2005, MED MYCOL, V43, P133, DOI 10.1080/13693780410001731547; Mor V, 2015, MBIO, V6, DOI 10.1128/mBio.00647-15; Moraes RC, 2017, PHARM BIOL, V55, P406, DOI 10.1080/13880209.2016.1242631; Motoa G, 2017, REV IBEROAM MICOL, V34, P17, DOI 10.1016/j.riam.2016.02.006; Munoz P, 2005, J ANTIMICROB CHEMOTH, V55, P188, DOI 10.1093/jac/dkh532; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pappas PG, 2016, CLIN INFECT DIS, V62, P409, DOI 10.1093/cid/civ1194; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P515, DOI 10.1128/JCM.01915-07; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Pierce CG, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.12; Ravinarayanan H, 2015, IEEE ENG MED BIO, P4419, DOI 10.1109/EMBC.2015.7319375; Abadio AKR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142926; Roemer T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019703; Salci TP, 2017, FUTURE MICROBIOL, V12, P1283, DOI 10.2217/fmb-2017-0065; Sanguinetti M, 2015, MYCOSES, V58, P2, DOI 10.1111/myc.12330; Sharifzadeh A, 2017, MICROB PATHOGENESIS, V107, P390, DOI 10.1016/j.micpath.2017.04.021; Sharma Y, 2017, J GLOB INFECT DIS, V9, P8, DOI 10.4103/0974-777X.199995; Strollo S, 2017, EMERG INFECT DIS, V23, P7, DOI 10.3201/eid2301.161198; Tavernier E, 2015, BONE MARROW TRANSPL, V50, P158, DOI 10.1038/bmt.2014.230; Rodrigues-Vendramini FAV, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007441; Watamoto T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01453; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Wille MP, 2013, MEM I OSWALDO CRUZ, V108, P288, DOI 10.1590/S0074-02762013000300005; WINGARD JR, 1991, NEW ENGL J MED, V325, P1274, DOI 10.1056/NEJM199110313251803; Wong SSW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085836	66	7	7	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227876	10.1371/journal.pone.0227876	http://dx.doi.org/10.1371/journal.pone.0227876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935275	gold, Green Published			2022-12-26	WOS:000534354100061
J	Kenigsberg, C; Abramovich, S; Hyams-Kaphzan, O				Kenigsberg, Chen; Abramovich, Sigal; Hyams-Kaphzan, Orit			The effect of long-term brine discharge from desalination plants on benthic foraminifera	PLOS ONE			English	Article							POLLUTION; MARINE; ASSEMBLAGES; ENVIRONMENT; RESPONSES; AMMONIA	Desalination plants along the Mediterranean Israeli coastline currently provide similar to 587 million m(3) drinking water/year, and their production is planned to increase gradually. Production of drinking water is accompanied by a nearly equivalent volume of brine discharge with a salinity of similar to 80 that is twice the normal, which can potentially impact marine ecosystems. The goal of this study was to examine whether benthic foraminifera, a known sensitive marine bio-indicator, are affected by this brine-discharge. For that, we investigated the seasonal and cumulative effect of brine discharges of three operating desalination facilities along the Israeli coast. Those facilities are located in Ashkelon, Hadera, and Sorek. The brine-discharge in the first two desalination plants is associated with thermal pollution, while the Sorek facility entails increased salinity but no thermal pollution. In four seasonal cruises during one year, we collected surface sediment samples in triplicates by grabs from the outfall (near the discharge site), and from a non-impacted control station adjacent to each study site. Our results highlight that the most robust responses were observed at two out of three desalination shallow sites (Ashkelon and Hadera), where the brine was discharged directly from a coastal outfall and was accompanied with thermal pollution from the nearby power plants. The total foraminiferal abundance and diversity were, generally, lower near the outfalls, and increased towards the control stations. Moreover, changes in the relative abundances of selected species indicate their sensitivity to the brine discharge. The most noticeable response to exclusively elevated salinity was detected at Sorek discharge site, where we observed a sharp decline in organic-cemented agglutinated benthic foraminifera, suggesting that these are particularly sensitive to elevated salinity. The herein study contribute new insights into the effect of brine discharge from desalination plants, on benthic foraminifera, and propose a scientifically-based ecological monitoring tool that can help stakeholders.	[Kenigsberg, Chen; Abramovich, Sigal] Ben Gurion Univ Negev, Dept Geol & Environm Sci, Beer Sheva, Israel; [Kenigsberg, Chen; Hyams-Kaphzan, Orit] Geol Survey Israel, Jerusalem, Israel	Ben Gurion University; Geological Survey Israel	Hyams-Kaphzan, O (corresponding author), Geol Survey Israel, Jerusalem, Israel.	orithy@gsi.gov.il	Abramovich, Sigal/AAR-5034-2021	Abramovich, Sigal/0000-0003-3124-1387	Israel Ministry of Science, Technology, and Space [3-12376]; ISF [941/17]; Mediterranean Sea Research Center of Israel (MERCI)	Israel Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); ISF(Israel Science Foundation); Mediterranean Sea Research Center of Israel (MERCI)	The work was funded by a grant awarded by the Israel Ministry of Science, Technology, and Space (contract number 3-12376) and ISF Grant number 941/17.; This study represents part of the M.Sc. thesis of the senior author in the Department of Geological and Environmental Sciences at the Ben-Gurion University of the Negev in collaboration with the Geological Survey of Israel. We are thankful to the captain and crew of the RV Mediterranean Explorer for their professional assistance at sea. Eyal Rahav, Eli Biton, Jack Silverman and Natasha Belkin from IOLR, Haifa, are appreciated for their assistance on board. We also thank Danna Titelboim and Roni Tadir from BGU for their assistance in the lab. We are grateful for the sample pretreatments and lab work performed by Misha Kitin and the technical help and measurements provided by the geochemical and sedimentological laboratories of the Geological Survey of Israel (GSI). We acknowledge the support provided to Chen Kenigsberg by the Mediterranean Sea Research Center of Israel (MERCI). We greatly thank the referees and the editor for their significant contribution toward the improvement of this paper.	Abramson K, 2016, MONITORING PROGRAM M; Almagor G, 2000, MAR GEORESOUR GEOTEC, V18, P1, DOI 10.1080/10641190009353781; ALMOGILABIN A, 1992, J FORAMIN RES, V22, P257, DOI 10.2113/gsjfr.22.3.257; ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; Amao AO, 2018, J FORAMIN RES, V48, P29, DOI 10.2113/gsjfr.48.1.29; [Anonymous], 2018, SUSTAINABLE DESALINA, P437, DOI DOI 10.1016/B978-0-12-809240-8.00011-3; [Anonymous], 2018, ISR WAT SECT; Arieli RN, 2011, MAR POLLUT BULL, V62, P1002, DOI 10.1016/j.marpolbul.2011.02.036; Avnaim-Katav S, 2015, J SEA RES, V99, P97, DOI 10.1016/j.seares.2015.02.006; Ben Yosef D, 2017, RELP22017 ISR EL COR; Ben Yosef D, 2017, RELP32017 ISR EL COR; Bleninger T, 2008, DESALINATION, V221, P585, DOI 10.1016/j.desal.2007.02.059; BRENNER IB, 1980, CHEM GEOL, V28, P321, DOI 10.1016/0009-2541(80)90052-2; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Debenay JP, 1998, MAR MICROPALEONTOL, V34, P235, DOI 10.1016/S0377-8398(98)00010-3; Einav R, 2003, DESALINATION, V156, P79, DOI 10.1016/S0011-9164(03)00328-X; Frank H, 2019, WATER RES, V151, P478, DOI 10.1016/j.watres.2018.12.046; Fritzmann C, 2007, DESALINATION, V216, P1, DOI 10.1016/j.desal.2006.12.009; Frontalini Fabrizio, 2011, Revue de Micropaleontologie, V54, P115, DOI 10.1016/j.revmic.2011.03.001; Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021; Geslin E, 2002, MAR MICROPALEONTOL, V45, P151, DOI 10.1016/S0377-8398(01)00042-1; Gorley C.K., 2006, GETTING STARTED PRIM; Greenlee LF, 2009, WATER RES, V43, P2317, DOI 10.1016/j.watres.2009.03.010; Grossowicz M, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00142; Henri E., 1974, SEPM J SEDIMENT RES, V44, DOI [10.1306/74D729D7-2B21-11D7-8648000102C1865D, DOI 10.1306/74D729D7-2B21-11D7-8648000102C1865D]; Hottinger L., 1993, RECENT FORAMINIFERID; Hyams O., 2000, THESIS; Hyams-Kaphzan O, 2008, NEUES JAHRB GEOL P-A, V248, P315, DOI 10.1127/0077-7749/2008/0248-0315; Hyams-Kaphzan O, 2009, MAR POLLUT BULL, V58, P1888, DOI 10.1016/j.marpolbul.2009.07.010; Inman D.L., 1984, P 19 INT C COAST ENG, P1600, DOI [10.1061/9780872624382.110, DOI 10.1061/9780872624382.110]; Jorissen FJ, 1995, MAR MICROPALEONTOL, V26, P3, DOI 10.1016/0377-8398(95)00047-X; Kress N, 2017, MONITORING PROGRAM M; Langer M.R., 1991, MEDITERRANEAN FORAMI; Loeblich A. R., 1994, FORAMINIFERA SAHUL S, V31; Loeblich AR., 1987, FORAMINIFERAL GENERA; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Milker Y, 2012, TAXONOMIC GUIDE MODE; Missimer TM, 2015, ENVIRON SCI ENG, P351, DOI 10.1007/978-3-319-13203-7_15; MURRARY JW, 1970, LETHAIA, V3, P51, DOI 10.1111/j.1502-3931.1970.tb01263.x; Murray JW, 1999, PALAEOGEOGR PALAEOCL, V146, P195, DOI 10.1016/S0031-0182(98)00132-1; MURRAY JW, 1970, J NAT HIST, V4, P55, DOI 10.1080/00222937000770061; Murray JW, 2002, BENTHIC FORAMINIFERA; Parent B, 2018, MAR MICROPALEONTOL, V144, P1, DOI 10.1016/j.marmicro.2018.07.003; Roberts DA, 2010, WATER RES, V44, P5117, DOI 10.1016/j.watres.2010.04.036; Roni T, 2017, MAR POLLUT BULL, V117, P50, DOI 10.1016/j.marpolbul.2016.12.045; Saraswat R, 2004, MAR POLLUT BULL, V48, P91, DOI 10.1016/S0025-326X(03)00330-8; SC da(University of A Le Coze FEB Mamo BU of HK Vachard D des S et T de L, 2019, WORMS WORLD REGISTER; Schmidt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132917; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Shenvi SS, 2015, DESALINATION, V368, P10, DOI 10.1016/j.desal.2014.12.042; Sivan D, 1999, ES3299 GEOL SURV ISR; Spiritos E, 2013, WATER POLICY ISRAEL, DOI [10.1007/978-94-007-5911-4, DOI 10.1007/978-94-007-5911-4]; Titelboim D, 2016, MAR POLLUT BULL, V105, P324, DOI 10.1016/j.marpolbul.2016.02.002; Y' acov Nir, 1984, RECENT SEDIMENTS ISR; Yu ZS, 2001, GEOSTANDARD NEWSLETT, V25, P199, DOI 10.1111/j.1751-908X.2001.tb00596.x	56	17	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227589	10.1371/journal.pone.0227589	http://dx.doi.org/10.1371/journal.pone.0227589			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935245	Green Published, gold			2022-12-26	WOS:000534354100033
J	Gniesmer, S; Brehm, R; Hoffmann, A; de Cassan, D; Menzel, H; Hoheisel, AL; Glasmacher, B; Willbold, E; Reifenrath, J; Ludwig, N; Zimmerer, R; Tavassol, F; Gellrich, NC; Kampmann, A				Gniesmer, Sarah; Brehm, Ralph; Hoffmann, Andrea; de Cassan, Dominik; Menzel, Henning; Hoheisel, Anna Lena; Glasmacher, Birgit; Willbold, Elmar; Reifenrath, Janin; Ludwig, Nils; Zimmerer, Ruediger; Tavassol, Frank; Gellrich, Nils-Claudius; Kampmann, Andreas			Vascularization and biocompatibility of poly(epsilon-caprolactone) fiber mats for rotator cuff tear repair	PLOS ONE			English	Article							BIOLOGIC AUGMENTATION; BIODEGRADABLE SCAFFOLDS; CELLS; PATCH; ANGIOGENESIS; NANOFIBERS; STRATEGIES	Rotator cuff tear is the most frequent tendon injury in the adult population. Despite current improvements in surgical techniques and the development of grafts, failure rates following tendon reconstruction remain high. New therapies, which aim to restore the topology and functionality of the interface between muscle, tendon and bone, are essentially required. One of the key factors for a successful incorporation of tissue engineered constructs is a rapid ingrowth of cells and tissues, which is dependent on a fast vascularization. The dorsal skinfold chamber model in female BALB/cJZtm mice allows the observation of microhemodynamic parameters in repeated measurements in vivo and therefore the description of the vascularization of different implant materials. In order to promote vascularization of implant material, we compared a porous polymer patch (a commercially available porous polyurethane based scaffold from Biomerix (TM)) with electrospun polycaprolactone (PCL) fiber mats and chitosan-graft-PCL coated electrospun PCL (CS-g-PCL) fiber mats in vivo. Using intravital fluorescence microscopy microcirculatory parameters were analyzed repetitively over 14 days. Vascularization was significantly increased in CS-g-PCL fiber mats at day 14 compared to the porous polymer patch and uncoated PCL fiber mats. Furthermore CS-g-PCL fiber mats showed also a reduced activation of immune cells. Clinically, these are important findings as they indicate that the CS-g-PCL improves the formation of vascularized tissue and the ingrowth of cells into electrospun PCL scaffolds. Especially the combination of enhanced vascularization and the reduction in immune cell activation at the later time points of our study points to an improved clinical outcome after rotator cuff tear repair.	[Gniesmer, Sarah; Zimmerer, Ruediger; Tavassol, Frank; Gellrich, Nils-Claudius; Kampmann, Andreas] Hannover Med Sch, Dept Oral & Maxillofacial Surg, Hannover, Germany; [Gniesmer, Sarah; Hoffmann, Andrea; Hoheisel, Anna Lena; Glasmacher, Birgit; Willbold, Elmar; Reifenrath, Janin; Kampmann, Andreas] NIFE Lower Saxony Ctr Biomed Engn Implant Res & D, Hannover, Germany; [Brehm, Ralph] Univ Vet Med Hannover, Inst Anat, Hannover, Germany; [Hoffmann, Andrea] Hannover Med Sch, Dept Orthoped Surg, Lab Biomech & Biomat, Graded Implants & Regenerat Strategies, Hannover, Germany; [de Cassan, Dominik; Menzel, Henning] Braunschweig Univ Technol, Inst Tech Chem, Braunschweig, Germany; [Hoheisel, Anna Lena; Glasmacher, Birgit] Leibniz Univ Hannover, Inst Multiphase Proc, Hannover, Germany; [Willbold, Elmar; Reifenrath, Janin] Hannover Med Sch, Dept Orthoped Surg, Hannover, Germany; [Ludwig, Nils] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Braunschweig University of Technology; Leibniz University Hannover; Hannover Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kampmann, A (corresponding author), Hannover Med Sch, Dept Oral & Maxillofacial Surg, Hannover, Germany.; Kampmann, A (corresponding author), NIFE Lower Saxony Ctr Biomed Engn Implant Res & D, Hannover, Germany.	Kampmann.Andreas@mh-hannover.de	Hoffmann, Andrea/AAG-4488-2020; Menzel, Henning/AAZ-6446-2020; Zimmerer, Rüdiger/AHB-2586-2022	Hoffmann, Andrea/0000-0003-2318-8985; Zimmerer, Rüdiger/0000-0002-1859-4324; Glasmacher, Birgit/0000-0002-2452-1666	German Research foundation (DFG) [FOR 2180, KA 4236/1-1, KA 4236/1-2]	German Research foundation (DFG)(German Research Foundation (DFG))	This research project has been supported by the German Research foundation (DFG), research unit FOR 2180 "Gradierte Implantate fur Sehnen-Knochen-Verbindungen". Grant numbers KA 4236/1-1 and KA 4236/1-2 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A; Beason DP, 2012, J SHOULDER ELB SURG, V21, P245, DOI 10.1016/j.jse.2011.10.021; Becker A., 2015, CURRENT DIRECTIONS B, V1, P104, DOI [10.1515/cdbme-2015-0027, DOI 10.1515/CDBME-2015-0027, DOI 10.1515/]; Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056; Chim H, 2006, INT J ORAL MAX SURG, V35, P928, DOI 10.1016/j.ijom.2006.03.024; Cole BJ, 2007, KNEE SURG SPORT TR A, V15, P632, DOI 10.1007/s00167-006-0187-6; Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008; de Cassan D, 2018, COLLOID SURFACE B, V163, P309, DOI 10.1016/j.colsurfb.2017.12.050; Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7; Encalada-Diaz I, 2011, J SHOULDER ELB SURG, V20, P788, DOI 10.1016/j.jse.2010.08.013; Fealy S, 2006, AM J SPORT MED, V34, P120, DOI 10.1177/0363546505280212; Gerber C, 2004, J BONE JOINT SURG AM; Gerber C, 2009, J SHOULDER ELB SURG, V18, P163, DOI 10.1016/j.jse.2008.09.003; Gniesmer S, 2019, J TISSUE ENG REGEN M, V13, P1190, DOI 10.1002/term.2868; Harada Y, 2017, J ORTHOP RES, V35, P289, DOI 10.1002/jor.23289; Huang H, 2007, BIOMATERIALS, V28, P3815, DOI 10.1016/j.biomaterials.2007.05.004; Jing X, 2015, ACS APPL MATER INTER, V7, P6955, DOI 10.1021/acsami.5b00900; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105; Lahteenmaki HE, 2006, J SHOULDER ELB SURG, V15, P148, DOI 10.1016/j.jse.2005.07.006; Lam CXF, 2008, J BIOMED MAT RES A, V906; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; LEHR HA, 1993, AM J PATHOL, V143, P1055; Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101; Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]; Malikmammadov E, 2018, J BIOMAT SCI-POLYM E, V29, P805, DOI 10.1080/09205063.2017.1354671; McCormack RA, 2014, B NYU HOSP JT DIS; Meyer DC, 2004, J ORTHOPAED RES, V22, P1004, DOI 10.1016/j.orthres.2004.02.009; Nho SJ, 2010, AM J SPORT MED, V38, P619, DOI 10.1177/0363546509343199; Pham QP, 2006, MICROFIBER SCAFFOLDS, P2796; Ribeiro Jose Carlos Viana, 2017, ScientificWorldJournal, V2017, P8639898, DOI 10.1155/2017/8639898; Ricchetti ET, 2012, J SHOULDER ELB SURG, V21, P251, DOI 10.1016/j.jse.2011.10.003; Rodeo SA, 2007, J SHOULDER ELB SURG, V16, p191S, DOI 10.1016/j.jse.2007.03.012; Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033; Santoni BG, 2010, AM J SPORT MED, V38, P679, DOI 10.1177/0363546510366866; Schumann P, 2011, J BIOMED MATER RES A, V97A, P383, DOI 10.1002/jbm.a.33069; Seppel G, 2017, AM J SPORT MED, V45, P759, DOI 10.1177/0363546516676261; Serrano-Aroca A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061796; Tavassol F, 2011, TISSUE ENG PT A, V17, P1935, DOI [10.1089/ten.tea.2010.0603, 10.1089/ten.TEA.2010.0603]; Tellado SF, 2015, ADV DRUG DELIVER REV, V94, P126, DOI 10.1016/j.addr.2015.03.004; Venugopal J, 2005, CELL BIOL INT; Wang F, 2014, ADV MATER SCI ENG, V2014, P9; Wang XF, 2013, BIOMACROMOLECULES, V14, P3557, DOI 10.1021/bm400928b; Willbold E, 2013, ACTA BIOMATER, V9, P8509, DOI 10.1016/j.actbio.2013.02.015; Williams GR, 2004, J BONE JOINT SURG AM, V86A, P2764, DOI 10.2106/00004623-200412000-00027; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006; Zimmerer RM, 2017, MICROVASC RES, V112, P101, DOI 10.1016/j.mvr.2017.03.006; Zumstein MA, 2014, J SHOULDER ELB SURG, V23, P3, DOI 10.1016/j.jse.2013.08.017	49	11	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227563	10.1371/journal.pone.0227563	http://dx.doi.org/10.1371/journal.pone.0227563			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929570	Green Published, Green Submitted, gold			2022-12-26	WOS:000534352500045
J	Dunning, JL; Pant, S; Murphy, K; Prather, JF				Dunning, Jeffery L.; Pant, Santosh; Murphy, Karagh; Prather, Jonathan F.			Female finches prefer courtship signals indicating male vigor and neuromuscular ability	PLOS ONE			English	Article							MALE SONG; MATE CHOICE; DEVELOPMENTAL STRESS; MATING SUCCESS; ZEBRA FINCHES; HONEST SIGNAL; SPARROWS; DISPLAYS; REPERTOIRE; NUTRITION	Female songbirds use male song to discriminate among individuals and evaluate their quality as potential mates. Previous behavioral experiments in many species, including the species studied here, have shown that females will solicit copulation in response to song even if no male is present. Those data demonstrate that female mate choice is closely tied to song features, but they leave open the question of which song parameters are most influential in female mate selection. We sought to identify features of male song that are salient for mate choice in female Bengalese finches. Using a novel experimental approach, we simultaneously tested the possible influence of specific notes or note transitions, the number of different note types in the male's repertoire, the complexity of note content and note sequence, and the stereotypy of note content and note sequence. In additional experiments, we also tested the influence of the pitch and tempo of note production. Our results demonstrate that females generally preferred songs containing increased tempo in the context of species-typical frequency bandwidth, consistent with the idea that females prefer songs that are especially challenging to produce. Female preference for song features that pose a neuromuscular challenge has also been reported in other species. Our data extend those observations into a species that thrives in a laboratory setting and is commonly used in studies of the neural basis of behavior. These results provide an excellent new model system in which to study female preference and the neural mechanisms that underlie signal evaluation and mate choice.	[Dunning, Jeffery L.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Pant, Santosh; Murphy, Karagh; Prather, Jonathan F.] Univ Wyoming, Dept Zool & Physiol, Neurosci Program, Laramie, WY 82071 USA	Vanderbilt University; University of Wyoming	Prather, JF (corresponding author), Univ Wyoming, Dept Zool & Physiol, Neurosci Program, Laramie, WY 82071 USA.	Jonathan.Prather@uwyo.edu		Prather, Jonathan/0000-0001-5996-8399	National Science Foundation (NSF IOS CAREER) [1453084]; National Center for Research Resources [P30RR32128]; National Institute of General Medical Sciences [P30 GM 103398]	National Science Foundation (NSF IOS CAREER)(National Science Foundation (NSF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (NSF IOS CAREER 1453084 to JFP; https://www.nsf.gov/div/index.jsp?div=IOS), the National Center for Research Resources (P30RR32128, PI: F Flynn, subaward to JFP) and the National Institute of General Medical Sciences (P30 GM 103398, PI: F Flynn, subaward to JFP; https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballentine B, 2004, BEHAV ECOL, V15, P163, DOI 10.1093/beheco/arg090; Ballentine B, 2009, ANIM BEHAV, V77, P973, DOI 10.1016/j.anbehav.2008.12.027; Barske J, 2011, P ROY SOC B-BIOL SCI, V278, P3523, DOI 10.1098/rspb.2011.0382; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Burley NT, 2006, ANIM BEHAV, V72, P713, DOI 10.1016/j.anbehav.2006.01.017; BYERS JA, 1994, ANIM BEHAV, V47, P33, DOI 10.1006/anbe.1994.1005; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Caro SP, 2010, BEHAV ECOL, V21, P562, DOI 10.1093/beheco/arq022; CATCHPOLE CK, 1986, BEHAV ECOL SOCIOBIOL, V19, P439, DOI 10.1007/BF00300547; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Clark CJ, 2012, ANIM BEHAV, V84, P269, DOI 10.1016/j.anbehav.2012.04.012; CLAYTON N, 1989, ANIM BEHAV, V38, P352, DOI 10.1016/S0003-3472(89)80096-X; Cooper BG, 2012, NEUROBIOL AGING, V33, P564, DOI 10.1016/j.neurobiolaging.2010.04.014; Dunning JL, 2018, J COMP NEUROL, V526, P1703, DOI 10.1002/cne.24440; Dunning JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089438; EENS M, 1991, BEHAVIOUR, V116, P210, DOI 10.1163/156853991X00049; Elie J, BRAIN BEHAV EVOL; Gentner TQ, 2000, ANIM BEHAV, V59, P443, DOI 10.1006/anbe.1999.1313; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Hebets EA, 1999, ANIM BEHAV, V57, P865, DOI 10.1006/anbe.1998.1048; Holveck MJ, 2014, ANIM BEHAV, V88, P125, DOI 10.1016/j.anbehav.2013.11.023; Honarmand M, 2016, DEV NEUROBIOL, V76, P107, DOI 10.1002/dneu.22302; James LS, 2014, J NEUROPHYSIOL, V112, P2040, DOI 10.1152/jn.00217.2014; Katahira K, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0842; Kato Y, 2010, J ETHOL, V28, P447, DOI 10.1007/s10164-010-0203-7; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; Lewis SM, 2008, ANNU REV ENTOMOL, V53, P293, DOI 10.1146/annurev.ento.53.103106.093346; MacDonald IF, 2006, P ROY SOC B-BIOL SCI, V273, P2559, DOI 10.1098/rspb.2006.3547; Marler P., 2004, NATURES MUSIC SCI BI; Mooney R., 2008, LEARNING MEMORY COMP, P441, DOI [10.1016/b978-012370509-9.00116-9, DOI 10.1016/B978-012370509-9.00116-9]; Morisaka Tadamichi, 2008, Ornithological Science, V7, P75, DOI 10.2326/1347-0558(2008)7[75:VIPFCS]2.0.CO;2; Nagle L, 1997, CAN J ZOOL, V75, P1346, DOI 10.1139/z97-759; Nowicki S, 1998, AM ZOOL, V38, P179; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Nowicki S, ANN NY ACAD SCI, P704; PODOS J, 1995, ANIM BEHAV, V50, P1287, DOI 10.1016/0003-3472(95)80044-1; Podos J, 1996, ANIM BEHAV, V51, P1061, DOI 10.1006/anbe.1996.0107; Pravosudov VV, 2005, BEHAV NEUROSCI, V119, P1368, DOI 10.1037/0735-7044.119.5.1368; Rehsteiner U, 1998, ANIM BEHAV, V55, P1471, DOI 10.1006/anbe.1998.0733; Reid JM, 2004, ANIM BEHAV, V68, P1055, DOI 10.1016/j.anbehav.2004.07.003; Schuppe ER, 2018, FUNCT ECOL, V32, P450, DOI 10.1111/1365-2435.13010; SEARCY WA, 1992, NATO ADV SCI I A-LIF, V228, P175; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Spencer KA, 2003, HORM BEHAV, V44, P132, DOI 10.1016/S0018-506X(03)00124-7; STILES FG, 1982, CONDOR, V84, P208, DOI 10.2307/1367674; Vallet E, 1998, ANIM BEHAV, V55, P291, DOI 10.1006/anbe.1997.0631; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Wainwright PE, 2006, AM J CLIN NUTR, V84, P961, DOI 10.1093/ajcn/84.5.961; WASSERMAN FE, 1991, BEHAV ECOL SOCIOBIOL, V29, P55, DOI 10.1007/BF00164295; Woodgate JL, 2012, ANIM BEHAV, V83, P773, DOI 10.1016/j.anbehav.2011.12.027; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062	52	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226580	10.1371/journal.pone.0226580	http://dx.doi.org/10.1371/journal.pone.0226580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923176	gold, Green Published			2022-12-26	WOS:000534350000018
J	Nyamaruze, P; Govender, K				Nyamaruze, Patrick; Govender, Kaymarlin			"I like the way I am, but I feel like I could get a little bit bigger": Perceptions of body image among adolescents and youth living with HIV in Durban, South Africa	PLOS ONE			English	Article							SELF-DISCREPANCY; MEN; INFECTION; ADHERENCE; WOMENS	Body image concerns are common among people living with HIV (PLHIV). Research into how young people living with HIV (YPLHIV) experience and make sense of feared or actual body changes is limited, yet these changes have emotional, psychological and interpersonal implications for young people who associate physical attractiveness with social desirability. The current study examined the subjective perceptions of body appearance and coping mechanisms among a sample of YPLHIV in Durban, South Africa. An interpretive qualitative inquiry was adopted to understand their lived experiences in relation to their body image and body satisfaction. In-depth interviews were conducted with 18 YPLHIV (15-24 years). Findings indicate physical and psychosocial effects of living with HIV among young people including weight loss, skin sores, body dissatisfaction, loss of self-esteem and social withdrawal. The study builds on previous research suggesting that PLHIV may experience a discrepancy between their actual self and ideal self. Enhancing existing coping mechanisms such as religious beliefs, support networks and physical exercises among YPLHIV can counter the physical and psychosocial effects of living with HIV and improve well-being. Body image concerns should be acknowledged when addressing HIV-related health in both health and family settings.	[Nyamaruze, Patrick] Univ KwaZulu Natal, Sch Appl Human Sci, Discipline Psychol, Durban, South Africa; [Govender, Kaymarlin] Univ KwaZulu Natal, Hlth Econ & HIV & AIDS Res Div, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Nyamaruze, P (corresponding author), Univ KwaZulu Natal, Sch Appl Human Sci, Discipline Psychol, Durban, South Africa.	nyamruzepatrick@yahoo.com		govender, kaymarlin/0000-0002-9586-1510; Nyamaruze, Patrick/0000-0003-2390-5307				Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Bessenoff GR, 2006, SEX ROLES, V54, P727, DOI 10.1007/s11199-006-9038-7; Blashill AJ, 2014, HEALTH PSYCHOL, V33, P677, DOI 10.1037/hea0000081; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Coetzee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048116; Fingeret MC, 2007, BODY IMAGE, V4, P201, DOI 10.1016/j.bodyim.2007.01.005; Finkelstein JL, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19033; Franko DL, 2002, J PSYCHOSOM RES, V53, P975, DOI 10.1016/S0022-3999(02)00490-7; Frederick D. A., 2008, PSIHOLOGIJSKE TEME P, V17, P203, DOI DOI 10.1037/1524-9220.8.2.103; Grogan S., 2016, BODY IMAGE UNDERSTAN; Grogan S, 2019, J HEALTH PSYCHOL, V24, P1368, DOI 10.1177/1359105317730896; Halkitis P. N., 2004, International Journal of Men's Health, V3, P27, DOI 10.3149/jmh.0301.27; Halliwell E, 2006, PERS SOC PSYCHOL B, V32, P447, DOI 10.1177/0146167205284005; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; Holloway I, 1996, QUALITATIVE RES NURS; Huang JS, 2006, AIDS PATIENT CARE ST, V20, P668, DOI 10.1089/apc.2006.20.668; Innes S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-183; Jain P., 2016, INT J INDIAN PSYCHOL, V3, P81, DOI [10.25215/0302.097, DOI 10.25215/0302.097, 10.25215/0302.011, DOI 10.25215/0302.011]; Jenkins V, 2000, BRIT J CANCER, V82, P1783, DOI 10.1054/bjoc.2000.1142; Kelch-Oliver K, 2011, WOMEN THER, V34, P345, DOI 10.1080/02703149.2011.592065; Kelly JS, 2009, AIDS CARE, V21, P1560, DOI 10.1080/09540120902923014; Ley C, 2014, AJAR-AFR J AIDS RES, V13, P313, DOI 10.2989/16085906.2014.961937; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; MacDonell K, 2013, AIDS BEHAV, V17, P86, DOI 10.1007/s10461-012-0364-1; Martinez SM, 2005, AIDS PATIENT CARE ST, V19, P150, DOI 10.1089/apc.2005.19.150; MORETTI MM, 1990, J EXP SOC PSYCHOL, V26, P108, DOI 10.1016/0022-1031(90)90071-S; Mudgal S, 2015, INT J INDIAN PSYCHOL, V3, P101; Muhangi L, 2013, PUBLIC HEALTH NUTR, V16, P1548, DOI 10.1017/S1368980013000499; Naswa Smriti, 2010, Indian J Sex Transm Dis AIDS, V31, P1, DOI 10.4103/0253-7184.68993; O'Dea J.A., 2012, ENCY BODY IMAGE HUMA, VVol. 1, P141, DOI DOI 10.1016/B978-0-12-384925-0.00021-3; Ozdemir A., 2016, INT J CARING SCI, V9, P717; Sharma M, 2007, INT J DRUG POLICY, V18, P319, DOI 10.1016/j.drugpo.2007.04.001; Tate H, 2001, AIDS CARE, V13, P163, DOI 10.1080/09540120020027323; Tseelon Efrat., 1995, MASQUE FEMININITY; Varas-Diaz N, 2003, FORUM QUALITATIVE SO, V4; Vartanian LR., 2012, ENCY BLAND HUMAN APP, V2, P711, DOI DOI 10.1016/B978-0-12-384925-0.00112-7; Voelker DK, 2015, ADOLESC HEALTH MED T, V6, P149, DOI 10.2147/AHMT.S68344; Willis N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190423; Yang HJ., 2015, IJBSBT, V7, P315, DOI [10.14257/ijbsbt.2015.7.4.31, DOI 10.14257/IJBSBT.2015.7.4.31]	40	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227583	10.1371/journal.pone.0227583	http://dx.doi.org/10.1371/journal.pone.0227583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923249	Green Published, gold			2022-12-26	WOS:000534350000094
J	Zhu, FC; Sun, J; Yan, GY; Huang, JM; Chen, C; He, LS				Zhu, Fang-Chao; Sun, Jin; Yan, Guo-Yong; Huang, Jiao-Mei; Chen, Chong; He, Li-Sheng			Insights into the strategy of micro-environmental adaptation: Transcriptomic analysis of two alvinocaridid shrimps at a hydrothermal vent	PLOS ONE			English	Article							OKINAWA TROUGH; SEQUENCE; TOOL; TEMPERATURE; ANNOTATION; DECAPODA; CARIDEA; GENOME	Diffusing fluid at a deep-sea hydrothermal vent creates rapid, acute physico-chemical gradients that correlate strongly with the distribution of the vent fauna. Two alvinocaridid shrimps, Alvinocaris longirostris and Shinkaicaris leurokolos occupy distinct microhabitats around these vents and exhibit different thermal preferences. S. leurokolos inhabits the central area closer to the active chimney, while A. longirostris inhabits the peripheral area. In this study, we screened candidate genes that might be involved in niche separation and microhabitat adaptation through comparative transcriptomics. The results showed that among the top 20% of overexpressed genes, gene families related to protein synthesis and structural components were much more abundant in S. leurokolos compared to A. longirostris. Moreover, 15 out of 25 genes involved in cellular carbohydrate metabolism were related to trehalose biosynthesis, versus 1 out of 5 in A. longirostris. Trehalose, a non-reducing disaccharide, is a multifunctional molecule and has been proven to act as a protectant responsible for thermotolerance in Saccharomyces cerevisiae. Putative positively selected genes involved in chitin metabolism and the immune system (lectin, serine protease and antimicrobial peptide) were enriched in S. leurokolos. In particular, one collagen and two serine proteases were found to have experienced strong positive selection. In addition, sulfotransferase-related genes were both overexpressed and positively selected in S. leurokolos. Finally, genes related to structural proteins, immune proteins and protectants were overexpressed or positively selected. These characteristics could represent adaptations of S. leurokolos to its microhabitat, which need to be confirmed by more evidence, such as data from large samples and different development stages of these alvinocaridid shrimps.	[Zhu, Fang-Chao; Yan, Guo-Yong; Huang, Jiao-Mei; He, Li-Sheng] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya, Hainan, Peoples R China; [Zhu, Fang-Chao; Huang, Jiao-Mei] Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China; [Sun, Jin] Hong Kong Univ Sci & Technol, Dept Ocean Sci, Hong Kong, Peoples R China; [Chen, Chong] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan	Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong University of Science & Technology; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	He, LS (corresponding author), Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya, Hainan, Peoples R China.	he-lisheng@idsse.ac.cn	Sun, Jin/C-1458-2010; Chen, Chong/F-7489-2019	Sun, Jin/0000-0001-8002-6881; Chen, Chong/0000-0002-5035-4021; Zhu, Fang-chao/0000-0001-6504-9911	National Key R&D Program of China [2018YFC0309804, 2016YFC0304905, 2016YFC0302504]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB06010103]; Council for Science, Technology, and Innovation (CSTI) of Japan [KR15-17]	National Key R&D Program of China; "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Council for Science, Technology, and Innovation (CSTI) of Japan	This study was supported by the National Key R&D Program of China (grant NO.2016YFC0304905), the National Key R&D Program of China (grant NO. 2016YFC0302504), the National Key R&D Program of China (grant NO.2018YFC0309804), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences (grant NO. XDB06010103). This study and the research cruise KR15-17 were also supported by Council for Science, Technology, and Innovation (CSTI) of Japan as the Cross Ministerial Strategic Innovation Promotion Program (SIP), Next-generation Technology for Ocean Resource Exploration.	Bailly X, 2005, J INORG BIOCHEM, V99, P142, DOI 10.1016/j.jinorgbio.2004.10.012; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chen C., 2020, TBTOOLS TOOLKIT BIOL, V289660, P289660, DOI DOI 10.1101/289660; Chen LY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10098; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cottin D, 2008, J EXP BIOL, V211, P2196, DOI 10.1242/jeb.018606; Cottin D, 2010, MAR GENOM, V3, P71, DOI 10.1016/j.margen.2010.05.002; Cottin D, 2010, J EXP MAR BIOL ECOL, V393, P9, DOI 10.1016/j.jembe.2010.06.008; Cuvelier D, 2011, MAR ECOL-EVOL PERSP, V32, P243, DOI 10.1111/j.1439-0485.2010.00431.x; DEVIRGILIO C, 1994, EUR J BIOCHEM, V219, P179; Dias RO, 2018, INSECT MOL BIOL, V27, P46, DOI 10.1111/imb.12340; Egger L, 2003, CELL DEATH DIFFER, V10, P1188, DOI 10.1038/sj.cdd.4401288; FISHER CR, 1988, DEEP-SEA RES, V35, P1769, DOI 10.1016/0198-0149(88)90049-0; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Gonzalez-Rey M, 2010, MAR ECOL, V28, P100; Gonzalez-Rey M, 2008, MAR ENVIRON RES, V66, P35, DOI 10.1016/j.marenvres.2008.02.015; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hawkins AJS, 1999, AM ZOOL, V39, P401; Hui M, 2018, DEEP-SEA RES PT I, V135, P23, DOI 10.1016/j.dsr.2018.03.014; Husson B, 2017, DEEP-SEA RES PT II, V137, P6, DOI 10.1016/j.dsr2.2016.05.028; HUTCHISON JS, 1981, BIOCHEM BIOPH RES CO, V99, P722, DOI 10.1016/0006-291X(81)91803-9; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelly N, 2007, AQUAT BIOL, V1, P1, DOI 10.3354/ab00001; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Komai T, 2005, J NAT HIST, V39, P1111, DOI 10.1080/00222930400002499; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu XL, 2019, FISH SHELLFISH IMMUN, V92, P1, DOI 10.1016/j.fsi.2019.05.057; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Sanchez-Salgado JL, 2017, AQUAC RES, V48, P4001, DOI 10.1111/are.13394; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mestre NC, 2015, COMP BIOCHEM PHYS A, V181, P54, DOI 10.1016/j.cbpa.2014.11.015; Nakamura K, 2015, GEOCHEM J, V49, P579, DOI 10.2343/geochemj.2.0387; Paul S, 2015, J PHYS CHEM B, V119, P1598, DOI 10.1021/jp510423n; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Piquet B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211499; Pradillon F, 2007, J MAR SCI TECH-TAIW, V15, P37; Rastrick SPS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060050; Ravaux J, 2003, J EXP BIOL, V206, P2345, DOI 10.1242/jeb.00419; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Seebacher F, 2012, FUNCT ECOL, V26, P1418, DOI 10.1111/j.1365-2435.2012.02052.x; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sun SE, 2018, COMP BIOCHEM PHYS D, V25, P42, DOI 10.1016/j.cbd.2017.11.002; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Tang B, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00030; Vereshchaka AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129975; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang X., 2018, THESIS; Watanabe H, 2015, SUBSEAFLOOR BIOSPHER, P449, DOI [10.1007/978-4-431-54865-210.1007/978-4-431-54865-2, DOI 10.1007/978-4-431-54865-2_34]; Watanabe H, 2016, MAR ECOL-EVOL PERSP, V37, P1282, DOI 10.1111/maec.12318; Wong YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16597; Yahagi T, 2015, MAR ECOL PROG SER, V529, P159, DOI 10.3354/meps11267; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02073-9; Zhang YJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46205; Zhang Z, 2012, BIOCHEM BIOPH RES CO, V419, P779, DOI 10.1016/j.bbrc.2012.02.101	63	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227587	10.1371/journal.pone.0227587	http://dx.doi.org/10.1371/journal.pone.0227587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923275	gold, Green Published			2022-12-26	WOS:000534350000096
J	Ramchandran, RS; Yilmaz, S; Greaux, E; Dozier, A				Ramchandran, Rajeev S.; Yilmaz, Sule; Greaux, Evelyn; Dozier, Ann			Patient perceived value of teleophthalmology in an urban, low income US population with diabetes	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; EYE CARE; QUALITATIVE RESEARCH; AFRICAN-AMERICANS; TELEMEDICINE; RETINOPATHY; ATTITUDES; BARRIERS; HEALTH; OPHTHALMOLOGY	Dilated eye exams are the standard of care to detect advancing, vision threatening, but often asymptomatic retinopathy in a timely fashion, allowing for vision preserving treatments. Annual exam rates are suboptimal, especially in underserved populations. Although teleophthalmology programs tremendously improve annual exam rates in low income/under resourced settings, widespread adoption is limited. Using a mixed methods approach, three focus groups and individual interviews were conducted for patients with type 2 diabetes (N = 23) who had a teleophthalmology exam or a dilated eye exam. A survey and discussion assessed patients' perspectives and value of teleophthalmology, including willingness to pay (WTP). Financial, transportation, and motivational barriers to obtaining an annual dilated eye exam were identified. Patients greatly valued having primary care (PC) based teleophthalmology for its convenience and ability to detect disease to allow for timely treatment and would recommend such a service. Although their WTP was at least the amount of their usual copay, cost was universally cited as a concern. Having a conveniently offered PC based teleophthalmology exam was valued. Educating patients on the value and costs of having such exams may be helpful to encourage informed discussions on eye care, especially in low income, underserved populations. Our study is among the few to provide insight on the value and perceptions of teleophthalmology in US low income, urban minority populations needed to help increase uptake of this innovation. Using surveys followed by facilitated discussion allowed for richer and more varied responses.	[Ramchandran, Rajeev S.] Univ Rochester, Med Ctr, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY 14642 USA; [Yilmaz, Sule] Univ Rochester, Dept Human Dev & Counseling, Warner Sch Educ, Rochester, NY 14627 USA; [Greaux, Evelyn] Univ Rochester, Dept Biol, Coll Arts & Sci, Rochester, NY 14627 USA; [Dozier, Ann] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Ramchandran, RS (corresponding author), Univ Rochester, Med Ctr, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY 14642 USA.; Yilmaz, S (corresponding author), Univ Rochester, Dept Human Dev & Counseling, Warner Sch Educ, Rochester, NY 14627 USA.	Rajeev_Ramchandran@urmc.rochester.edu; suleyilmaz@gmail.com		Ramchandran, Rajeev S./0000-0002-6635-4181	Prevent Blindness America 2016 Joanne Angle Investigator Award; 2012 Greater Rochester Health Foundation Grant; NIH Clinical and Translational Science Institute Grant [UL1 TR000042]; Research to Prevent Blindness (RPB)	Prevent Blindness America 2016 Joanne Angle Investigator Award; 2012 Greater Rochester Health Foundation Grant; NIH Clinical and Translational Science Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	The research reported in this paper was primarily supported by the Prevent Blindness America 2016 Joanne Angle Investigator Award, with additional support from a 2012 Greater Rochester Health Foundation Grant, a NIH Clinical and Translational Science Institute Grant #UL1 TR000042 and Research to Prevent Blindness (RPB). -(RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 1998, DIABETES CARE, V21, P1387, DOI 10.2337/diacare.21.9.1387; [Anonymous], 2015, FACTS DIAB EYE DIS; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Cavallerano JD, 2011, HEALTH N Y, V17, P814; Coyne KS, 2004, FAM PRACT, V21, P447, DOI 10.1093/fampra/cmh417; Daskivich LP, 2017, JAMA INTERN MED, V177, P642, DOI 10.1001/jamainternmed.2017.0204; Dawn AG, 2005, ARCH OPHTHALMOL-CHIC, V123, P534, DOI 10.1001/archopht.123.4.534; Ellish NJ, 2007, INVEST OPHTH VIS SCI, V48, P1989, DOI 10.1167/iovs.06-0934; Greenhalgh T, 1998, BRIT MED J, V316, P978, DOI 10.1136/bmj.316.7136.978; Hartnett ME, 2005, ARCH OPHTHALMOL-CHIC, V123, P387, DOI 10.1001/archopht.123.3.387; Hipwell AE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005498; Jani PD, 2017, JAMA OPHTHALMOL, V135, P706, DOI 10.1001/jamaophthalmol.2017.1150; Keenum Z, 2016, JAMA OPHTHALMOL, V134, P1221, DOI 10.1001/jamaophthalmol.2016.3081; Kurji Khaliq, 2013, Middle East Afr J Ophthalmol, V20, P56, DOI 10.4103/0974-9233.106388; Labiris G, 2018, INT J OPHTHALMOL-CHI, V11, P314, DOI 10.18240/ijo.2018.02.22; Lee PP, 2003, OPHTHALMOLOGY, V110, P1952, DOI 10.1016/S0161-6420(03)00817-0; Liu Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022594; Liu Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206742; Liu Y, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0911-2; Livingston P.M., 2008, AUST NZ J PUBL HEAL, V22, P220; Luzio S, 2004, DIABETIC MED, V21, P1121, DOI 10.1111/j.1464-5491.2004.01305.x; Mathieson K, 2017, J HEALTH CARE POOR U, V28, P1522, DOI 10.1353/hpu.2017.0131; Moss S E, 1995, Arch Fam Med, V4, P529, DOI 10.1001/archfami.4.6.529; Mukamel D B, 1999, Ophthalmic Epidemiol, V6, P61; Nagpal K, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0175-0; Ogunyemi Omolola, 2013, AMIA Annu Symp Proc, V2013, P1082; Olsen JA, 2001, HEALTH ECON, V10, P39, DOI 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P2797, DOI 10.1167/iovs.06-0107; Paul PG, 2006, TELEMED J E-HEALTH, V12, P571, DOI 10.1089/tmj.2006.12.571; Paz SH, 2006, OPHTHALMOLOGY, V113, P1372, DOI 10.1016/j.ophtha.2006.04.018; Qureshi AA, 2006, TELEMED J E-HEALTH, V12, P639, DOI 10.1089/tmj.2006.12.639; Rani PK, 2006, J TELEMED TELECARE, V12, P159, DOI 10.1258/135763306776738639; Rathi S, 2017, OPHTHALMOLOGY, V124, P1729, DOI 10.1016/j.ophtha.2017.05.026; Rotvold GH, 2003, J TELEMED TELECARE, V9, P109, DOI 10.1258/135763303321327984; Sharafeldin N, 2018, BRIT J OPHTHALMOL, V102, P1485, DOI 10.1136/bjophthalmol-2017-311452; Silva PS, 2015, JAMA OPHTHALMOL, V133, P525, DOI 10.1001/jamaophthalmol.2015.0333; SINGER DE, 1992, ANN INTERN MED, V116, P660, DOI 10.7326/0003-4819-116-8-660; Snoswell C, 2017, J TELEMED TELECARE, V23, P792, DOI 10.1177/1357633X16671407; Snoswell CL, 2018, J TELEMED TELECARE, V24, P683, DOI 10.1177/1357633X18799582; Surendran Thandalam Sundararajan, 2014, J Diabetes Sci Technol, V8, P262; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Valikodath NG, 2017, TELEMED E-HEALTH, V23, P205, DOI 10.1089/tmj.2016.0108; Walker EA, 1997, J DIABETES COMPLICAT, V11, P298, DOI 10.1016/S1056-8727(96)00121-3; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wu YD, 2010, IEEE T INF TECHNOL B, V14, P1259, DOI 10.1109/TITB.2010.2058124	45	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0225300	10.1371/journal.pone.0225300	http://dx.doi.org/10.1371/journal.pone.0225300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5ER	31917793	Green Published, gold			2022-12-26	WOS:000534341100005
J	Singh, S; Halder, A; Sinha, O; Sarkar, PK; Singh, P; Banerjee, A; Ahmed, SA; Alharbi, A; Obaid, RJ; Ghosh, SK; Mitra, A; Pal, SK				Singh, Soumendra; Halder, Animesh; Sinha, Oindrila; Sarkar, Probir Kumar; Singh, Priya; Banerjee, Amrita; Ahmed, Saleh A.; Alharbi, Ahmed; Obaid, Rami J.; Ghosh, Sanjay K.; Mitra, Amitabha; Pal, Samir Kumar			Nanoparticle-based 'turn-on' scattering and post-sample fluorescence for ultrasensitive detection of water pollution in wider window	PLOS ONE			English	Article							SEMICONDUCTOR QUANTUM DOTS; FLUOROMETRIC SENSOR; MERCURY; ADSORPTION	Ultrasensitive detection of heavy metal ions in available water around us is a great challenge for scientists since long time. We developed an optical technique that combines Rayleigh scattering of UV light (365 nm) and post-sample fluorescence detection from colloidal silver (Ag) nanoparticles (NPs) having a surface plasmon resonance (SPR) band at 420 nm. The efficacy of the technique is tested by the detection of several model toxic ions, including mercury, lead, and methylmercury in aqueous media. The light scattering from the Hg-included/inflated Ag NPs at 395 nm was observed to saturate the light sensor even with ppm-order concentrations of Hg ions in the water sample. However, the pollutant is not detected at lower concentrations at this wavelength. Instead, the fluorescence of a high-pass filter (cutoff at 400 nm) at 520 nm is applied to detect pollutant concentrations of up to several hundreds of ppm in the water sample. We also detected lead and methylmercury as model pollutants in aqueous media and validated the efficacy of our strategy. Finally, we report the development of a working prototype based on the strategy developed for efficient detection of pollutants in drinking/agricultural water.	[Singh, Soumendra; Singh, Priya; Pal, Samir Kumar] SN Bose Natl Ctr Basic Sci, Dept Chem Biol & Macromol Sci, Kolkata, W Bengal, India; [Singh, Soumendra; Ghosh, Sanjay K.; Mitra, Amitabha] Bose Inst, Ctr Astroparticle Phys & Space Sci, Kolkata, W Bengal, India; [Halder, Animesh; Banerjee, Amrita; Pal, Samir Kumar] SN Bose Natl Ctr Basic Sci, Tech Res Ctr, Kolkata, W Bengal, India; [Halder, Animesh] Univ Calcutta, Dept Appl Opt & Photon, Kolkata, W Bengal, India; [Sinha, Oindrila] Presidency Univ, Dept Life Sci, Kolkata, W Bengal, India; [Sarkar, Probir Kumar] Ananda Mohan Coll, Dept Phys, Kolkata, W Bengal, India; [Ahmed, Saleh A.; Alharbi, Ahmed; Obaid, Rami J.] Umm Al Qura Univ, Fac Appl Sci, Dept Chem, Mecca, Saudi Arabia	Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS); University of Calcutta; Presidency University, Kolkata; Umm Al Qura University	Pal, SK (corresponding author), SN Bose Natl Ctr Basic Sci, Dept Chem Biol & Macromol Sci, Kolkata, W Bengal, India.; Pal, SK (corresponding author), SN Bose Natl Ctr Basic Sci, Tech Res Ctr, Kolkata, W Bengal, India.	skpal@bose.res.in	Alharbi, Ahmed/AAZ-5732-2020; Obaid, Rami/AAJ-5562-2021	Alharbi, Ahmed/0000-0002-1863-4672; 	Abdul Kalam Technology Innovation National Fellowship [INAE/121/AKF]; DST	Abdul Kalam Technology Innovation National Fellowship; DST(Department of Science & Technology (India))	Abdul Kalam Technology Innovation National Fellowship (INAE/121/AKF) from DST, Govt. of India for all phases of this study.	Andjelkovic I, 2015, ACS APPL MATER INTER, V7, P9758, DOI 10.1021/acsami.5b01624; [Anonymous], 2013, MINAMATA CONVENTION; Bernaus A, 2006, ENVIRON SCI TECHNOL, V40, P4090, DOI 10.1021/es052392l; Boening DW, 2000, CHEMOSPHERE, V40, P1335, DOI 10.1016/S0045-6535(99)00283-0; Castoldi AF, 2001, BRAIN RES BULL, V55, P197, DOI 10.1016/S0361-9230(01)00458-0; Chen Y, 2012, MICROCHIM ACTA, V177, P341, DOI 10.1007/s00604-012-0777-6; Costa-Fernandez JM, 2006, TRAC-TREND ANAL CHEM, V25, P207, DOI 10.1016/j.trac.2005.07.008; Costas-Mora I, 2014, ANAL CHEM, V86, P4536, DOI 10.1021/ac500517h; Diez S, 2009, ARCH ENVIRON CON TOX, V56, P615, DOI 10.1007/s00244-008-9213-7; Flores CY, 2010, J COLLOID INTERF SCI, V350, P402, DOI 10.1016/j.jcis.2010.06.052; Frasco MF, 2009, SENSORS-BASEL, V9, P7266, DOI 10.3390/s90907266; Freeman R, 2012, CHEM SOC REV, V41, P4067, DOI 10.1039/c2cs15357b; Guo T, 1996, ANAL CHIM ACTA, V320, P171, DOI 10.1016/0003-2670(95)00459-9; Lan MH, 2014, ACS APPL MATER INTER, V6, P21270, DOI 10.1021/am5062568; Lan MH, 2013, ACS APPL MATER INTER, V5, P2283, DOI 10.1021/am400319g; Lan MH, 2012, J AM CHEM SOC, V134, P6685, DOI 10.1021/ja211570a; Langford NJ, 1999, J HUM HYPERTENS, V13, P651, DOI 10.1038/sj.jhh.1000896; Lee MH, 2008, ORG LETT, V10, P213, DOI 10.1021/ol702558p; Lee MH, 2010, CHEM COMMUN, V46, P1407, DOI 10.1039/b921526c; Leopold K, 2010, ANAL CHIM ACTA, V663, P127, DOI 10.1016/j.aca.2010.01.048; Liaw JW, 2012, J QUANT SPECTROSC RA, V113, P2234, DOI 10.1016/j.jqsrt.2012.08.002; Miao R, 2014, NANO LETT, V14, P3124, DOI 10.1021/nl500276x; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Renzoni A, 1998, ENVIRON RES, V77, P68, DOI 10.1006/enrs.1998.3832; Velazquez-Gonzalez JS, 2017, SENSOR ACTUAT B-CHEM, V242, P912, DOI 10.1016/j.snb.2016.09.164; Sarkar PK, 2017, WATER AIR SOIL POLL, V228, DOI 10.1007/s11270-017-3479-1; Sarkar PK, 2016, ACS SENSORS, V1, P789, DOI 10.1021/acssensors.6b00153; Senapati T, 2011, CHEM COMMUN, V47, P10326, DOI 10.1039/c1cc13157e; Tchounwou PB, 2003, ENVIRON TOXICOL, V18, P149, DOI 10.1002/tox.10116; Tripathi K.M., 2018, NANOTECHNOL SUSTAIN, V1, P141; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P3982, DOI 10.1021/acssuschemeng.6b03182; Wang HT, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2764554; Wu JS, 2011, CHEM SOC REV, V40, P3483, DOI 10.1039/c0cs00224k; Yorifuji T., 2013, LATE LESSONS EARLY W; Yu S-Y, 2015, FARADAY TYNDALL EFFE, P1; Zhang G, 2000, SENSOR ACTUAT B-CHEM, V69, P144, DOI 10.1016/S0925-4005(00)00528-1	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227584	10.1371/journal.pone.0227584	http://dx.doi.org/10.1371/journal.pone.0227584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917807	gold, Green Published			2022-12-26	WOS:000534341100027
J	Howard, MC; Nauser, CL; Farrar, CA; Wallis, R; Sacks, SH				Howard, Mark C.; Nauser, Christopher L.; Farrar, Conrad A.; Wallis, Russell; Sacks, Steven H.			l-Fucose prevention of renal ischaemia/reperfusion injury in Mice	FASEB JOURNAL			English	Article						collectin-11; complement; ischemia; reperfusion; l-fucose; lectin pathway; transplantation	ISCHEMIA-REPERFUSION INJURY; DELAYED GRAFT FUNCTION; COLLECTIN 11 CL-11; LECTIN PATHWAY; COMPLEMENT; COMPLEXES; CL-K1; MASPS; CL-L1	In a recent study, we identified a fucosylated damage-associated ligand exposed by ischemia on renal tubule epithelial cells, which after recognition by collectin-11 (CL-11 or collectin kidney 1 (CL-K1)), initiates complement activation and acute kidney injury. We exploited the ability to increase the local tissue concentration of free l-fucose following systemic administration, in order to block ligand binding by local CL-11 and prevent complement activation. We achieved a thirty-five-fold increase in the intrarenal concentration of l-fucose following an IP bolus given before the ischemia induction procedure - a concentration found to significantly block in vitro binding of CL-11 on hypoxia-stressed renal tubule cells. At this l-fucose dose, complement activation and acute post-ischemic kidney injury are prevented, with additional protection achieved by a second bolus after the induction procedure. CL-11(-/-) mice gained no additional protection from l-fucose administration, indicating that the mechanism of l-fucose therapy was largely CL-11-dependent. The hypothesis is that a high dose of l-fucose delivered to the kidney obstructs the carbohydrate recognition site on CL-11 thereby reducing complement-mediated damage following ischemic insult. Further work will examine the utility in preventing post-ischemic injury during renal transplantation, where acute kidney injury is known to correlate with poor graft survival.	[Howard, Mark C.; Nauser, Christopher L.; Farrar, Conrad A.; Sacks, Steven H.] Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, MRC Ctr Transplantat, London, England; [Wallis, Russell] Univ Leicester, Dept Resp Sci & Infect, London, England	University of London; King's College London; University of Leicester	Howard, MC (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Peter Gorer Dept Immunobiol, MRC,Ctr Transplantat,Guys Hosp, 5th Floor Tower Wing, London SE1 9RT, England.	mark.howard@kcl.ac.uk		Howard, Mark/0000-0001-9779-5302	RCUK | MRC | Medical Research Foundation [MR/M012263/1]; MRC [MR/M012263/1] Funding Source: UKRI	RCUK | MRC | Medical Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RCUK | MRC | Medical Research Foundation, Grant/Award Number: MR/M012263/1	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Asgari E, 2014, FASEB J, V28, P3996, DOI 10.1096/fj.13-246306; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Damman J, 2008, TRANSPLANTATION, V85, P923, DOI 10.1097/TP.0b013e3181683cf5; Dobo J, 2016, IMMUNOL REV, V274, P98, DOI 10.1111/imr.12460; Fanelli G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15212-z; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Farrar CA, 2016, J CLIN INVEST, V126, P1911, DOI 10.1172/JCI83000; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; Girija UV, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0136-2; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Hansen SWK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01757; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Howard M, 2018, SEMIN IMMUNOPATHOL, V40, P75, DOI 10.1007/s00281-017-0642-0; Keshi H, 2006, MICROBIOL IMMUNOL, V50, P1001, DOI 10.1111/j.1348-0421.2006.tb03868.x; Killick J, 2018, SEMIN IMMUNOPATHOL, V40, P37, DOI 10.1007/s00281-017-0644-y; Kjaer TR, 2015, STRUCTURE, V23, P342, DOI 10.1016/j.str.2014.10.024; Li K, 2004, J AM SOC NEPHROL, V15, P2414, DOI 10.1097/01.ASN.0000135974.06478.7B; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Munye MM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006679; Nauser CL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02023; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pfaff WW, 1998, TRANSPLANTATION, V65, P219; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; Pirsch JD, 1996, TRANSPLANTATION, V61, P1581, DOI 10.1097/00007890-199606150-00006; Ponticelli C, 2014, NEPHROL DIAL TRANSPL, V29, P1134, DOI 10.1093/ndt/gft488; Rooryck C, 2011, NAT GENET, V43, P197, DOI 10.1038/ng.757; Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225; Schnaar RL, 2015, J ALLERGY CLIN IMMUN, V135, P609, DOI 10.1016/j.jaci.2014.10.057; Selman L, 2012, IMMUNOBIOLOGY, V217, P851, DOI 10.1016/j.imbio.2011.12.008; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tomsik P, 2011, CENT EUR J BIOL, V6, P1, DOI 10.2478/s11535-010-0087-0; Wild MK, 2002, CELLS TISSUES ORGANS, V172, P161, DOI 10.1159/000066968; Yaseen S, 2017, FASEB J, V31, P2210, DOI 10.1096/fj.201601306R; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	39	10	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					822	834		10.1096/fj.201901582R	http://dx.doi.org/10.1096/fj.201901582R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914693	Green Published, hybrid			2022-12-26	WOS:000507308900056
J	Limbad, C; Oron, TR; Alimirah, F; Davalos, AR; Tracy, TE; Gan, L; Desprez, PY; Campisi, J				Limbad, Chandani; Oron, Tal Ronnen; Alimirah, Fatouma; Davalos, Albert R.; Tracy, Tara E.; Gan, Li; Desprez, Pierre-Yves; Campisi, Judith			Astrocyte senescence promotes glutamate toxicity in cortical neurons	PLOS ONE			English	Article							CELLULAR SENESCENCE; ALZHEIMERS-DISEASE; AMYLOID-BETA; STEM-CELLS; EXCITOTOXICITY; DYSFUNCTION; GENE; PATHOGENESIS; MECHANISMS; TRANSPORT	Neurodegeneration is a major age-related pathology. Cognitive decline is characteristic of patients with Alzheimer's and related dementias and cancer patients after chemo- or radiotherapies. A recently emerged driver of these and other age-related pathologies is cellular senescence, a cell fate that entails a permanent cell cycle arrest and pro-inflammatory senescence-associated secretory phenotype (SASP). Although there is a link between inflammation and neurodegenerative diseases, there are many open questions regarding how cellular senescence affects neurodegenerative pathologies. Among the various cell types in the brain, astrocytes are the most abundant. Astrocytes have proliferative capacity and are essential for neuron survival. Here, we investigated the phenotype of primary human astrocytes made senescent by X-irradiation, and identified genes encoding glutamate and potassium transporters as specifically downregulated upon senescence. This down regulation led to neuronal cell death in co-culture assays. Unbiased RNA sequencing of transcripts expressed by non-senescent and senescent astrocytes confirmed that glutamate homeostasis pathway declines upon senescence. Our results suggest a key role for cellular senescence, particularly in astrocytes, in excitotoxicity, which may lead to neurodegeneration including Alzheimer's disease and related dementias.	[Limbad, Chandani; Oron, Tal Ronnen; Alimirah, Fatouma; Davalos, Albert R.; Tracy, Tara E.; Desprez, Pierre-Yves; Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Limbad, Chandani] Univ Calif Berkeley, Comparat Biochem Grad Program, Berkeley, CA 94720 USA; [Tracy, Tara E.; Gan, Li] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Tracy, Tara E.; Gan, Li] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA USA; [Desprez, Pierre-Yves] Calif Pacific Med Ctr, San Francisco, CA USA; [Campisi, Judith] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Buck Institute for Research on Aging; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; California Pacific Medical Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Campisi, J (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Campisi, J (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	jcampisi@buckinstitute.org	Limbad, Chandani/S-8476-2017		NIH [AG009909, AG017242]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AG009909 and AG017242. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bussian TJ, 2018, NATURE, V562, P578, DOI 10.1038/s41586-018-0543-y; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carter DB, 2005, SUB CELL BIOCHEM, V38, P255; Caudle WM, 2009, EXP NEUROL, V220, P230, DOI 10.1016/j.expneurol.2009.09.027; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092; Chinta SJ, 2015, EXP GERONTOL, V68, P3, DOI 10.1016/j.exger.2014.09.018; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crowe EP, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00208; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Howard R, 2015, LANCET NEUROL, V14, P1171, DOI 10.1016/S1474-4422(15)00258-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Jeon HY, 2016, TUMOR BIOL, V37, P5857, DOI 10.1007/s13277-015-4439-2; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kobayashi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19442-7; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Kulijewicz-Nawrot M, 2013, ASN NEURO, V5, P273, DOI 10.1042/AN20130017; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lecot P, 2016, BRIT J CANCER, V114, P1180, DOI 10.1038/bjc.2016.115; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Mombach JCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125217; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Pereira AC, 2017, MOL PSYCHIATR, V22, P296, DOI 10.1038/mp.2016.33; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Riemenschneider Markus J, 2009, Recent Results Cancer Res, V171, P3, DOI 10.1007/978-3-540-31206-2_1; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sanchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011; Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tan FCC, 2014, BIOGERONTOLOGY, V15, P643, DOI 10.1007/s10522-014-9532-1; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van den Bosch L, 2006, BBA-MOL BASIS DIS, V1762, P1068, DOI 10.1016/j.bbadis.2006.05.002; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78; Zoccolella S, 2007, EUR J NEUROL, V14, P262, DOI 10.1111/j.1468-1331.2006.01575.x; Zou Y, 2012, BIOCHEM BIOPH RES CO, V426, P100, DOI 10.1016/j.bbrc.2012.08.043; Zumkehr J, 2015, NEUROBIOL AGING, V36, P2260, DOI 10.1016/j.neurobiolaging.2015.04.005	63	67	70	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227887	10.1371/journal.pone.0227887	http://dx.doi.org/10.1371/journal.pone.0227887			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945125	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100071
J	Faramarz, A; Balk, JA; van Schie, JJM; Oostra, AB; Ghandour, CA; Rooimans, MA; Wolthuis, RMF; de Lange, J				Faramarz, Atiq; Balk, Jesper A.; van Schie, Janne J. M.; Oostra, Anneke B.; Ghandour, Cherien A.; Rooimans, Martin A.; Wolthuis, Rob M. F.; de Lange, Job			Non-redundant roles in sister chromatid cohesion of the DNA helicase DDX11 and the SMC3 acetyl transferases ESCO1 and ESCO2	PLOS ONE			English	Article							DE-LANGE-SYNDROME; HUMAN HOMOLOG; ESTABLISHMENT; MUTATIONS; PROTEIN; REPLICATION; BINDING; BREAKAGE; COMPLEX; NIPBL	In a process linked to DNA replication, duplicated chromosomes are entrapped in large, circular cohesin complexes and functional sister chromatid cohesion (SCC) is established by acetylation of the SMC3 cohesin subunit. Roberts Syndrome (RBS) and Warsaw Breakage Syndrome (WABS) are rare human developmental syndromes that are characterized by defective SCC. RBS is caused by mutations in the SMC3 acetyltransferase ESCO2, whereas mutations in the DNA helicase DDX11 lead to WABS. We found that WABS-derived cells predominantly rely on ESCO2, not ESCO1, for residual SCC, growth and survival. Reciprocally, RBS-derived cells depend on DDX11 to maintain low levels of SCC. Synthetic lethality between DDX11 and ESCO2 correlated with a prolonged delay in mitosis, and was rescued by knockdown of the cohesin remover WAPL. Rescue experiments using human or mouse cDNAs revealed that DDX11, ESCO1 and ESCO2 act on different but related aspects of SCC establishment. Furthermore, a DNA binding DDX11 mutant failed to correct SCC in WABS cells and DDX11 deficiency reduced replication fork speed. We propose that DDX11, ESCO1 and ESCO2 control different fractions of cohesin that are spatially and mechanistically separated.	[Faramarz, Atiq; Balk, Jesper A.; van Schie, Janne J. M.; Oostra, Anneke B.; Ghandour, Cherien A.; Rooimans, Martin A.; Wolthuis, Rob M. F.; de Lange, Job] Amsterdam Univ Med Ctr, Dept Clin Genet, Sect Oncogenet, Canc Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam	Wolthuis, RMF; de Lange, J (corresponding author), Amsterdam Univ Med Ctr, Dept Clin Genet, Sect Oncogenet, Canc Ctr Amsterdam, Amsterdam, Netherlands.	r.wolthuis@amsterdamumc.nl; j.delange1@amsterdamumc.nl		de Lange, Job/0000-0002-9002-8829; Wolthuis, Rob/0000-0002-3109-1588; van Schie, Janne J.M./0000-0001-8633-835X	Netherlands Organisation for Scientific research (TOP-GO grant) [854.10.013]; Cancer Center Amsterdam [CCA2015-5-25]; Dutch Cancer Society (Young Investigator grant) [10701/2016-2]	Netherlands Organisation for Scientific research (TOP-GO grant); Cancer Center Amsterdam; Dutch Cancer Society (Young Investigator grant)	This work was supported by the Netherlands Organisation for Scientific research (TOP-GO grant 854.10.013), the Cancer Center Amsterdam (grant CCA2015-5-25) and by the Dutch Cancer Society (Young Investigator grant 10701/2016-2, to JdL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2016, ONCOTARGET, V7, P67934, DOI 10.18632/oncotarget.11982; Alomer RM, 2017, P NATL ACAD SCI USA, V114, P9906, DOI 10.1073/pnas.1708291114; Banerji R, 2016, DEV DYNAM, V245, P7, DOI [10.1002/DVDY.24354, 10.1002/dvdy.24354]; Benedict B, 2019, WAPL DEPENDENT UNPUB; Bharti SK, 2014, CELL MOL LIFE SCI, V71, P2625, DOI 10.1007/s00018-014-1569-4; Borges V, 2013, CHROMOSOMA; Bose T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002749; Cali F, 2016, NUCLEIC ACIDS RES, V44, P705, DOI 10.1093/nar/gkv1112; Castronovo P, 2009, CHROMOSOME RES, V17, P763, DOI 10.1007/s10577-009-9066-6; Chen ZM, 2012, G3-GENES GENOM GENET, V2, P1161, DOI 10.1534/g3.112.003327; Chetaille P, 2014, NAT GENET, V46, P1245, DOI 10.1038/ng.3113; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cortone G, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007622; Cota CD, 2012, DEV DYNAM, V241, P1249, DOI 10.1002/dvdy.23810; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; de Lange J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9399; Deardorff MA, 2012, NATURE; Deardorff MA, 2012, AM J HUM GENET; Deardorff MA, 2007, AM J HUM GENET, V80, P485, DOI 10.1086/511888; Ding H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140755; Fernius J, 2013, CURR BIOL, V23, P599, DOI 10.1016/j.cub.2013.02.022; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Hermsen MAJA, 1996, GENE CHROMOSOME CANC, V15, P1; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Ivanov MP, 2018, EMBO J, V37, DOI 10.15252/embj.201797150; Kawasumi R, 2017, GENE DEV, V31, P2136, DOI 10.1101/gad.306084.117; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Liu H, 2013, NAT CELL BIOL, V15, P40, DOI 10.1038/ncb2637; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Minamino M, 2018, CURR BIOL, V28, P2665, DOI 10.1016/j.cub.2018.06.037; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Murayama Y, 2018, CELL, V172, P465, DOI 10.1016/j.cell.2017.12.021; Musio A, 2006, NAT GENET, V38, P528, DOI 10.1038/ng1779; Nishiyama T, 2010, CELL, V143, P737, DOI 10.1016/j.cell.2010.10.031; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; Pisani FM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110564; Remeseiro S, 2013, DEVELOPMENT, V140, P3715, DOI 10.1242/dev.090605; Rowland BD, 2009, MOL CELL, V33, P763, DOI 10.1016/j.molcel.2009.02.028; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Skibbens RV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004036; Skibbens RV, 2010, CELL CYCLE, V9, P1601, DOI 10.4161/cc.9.8.11307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Srinivasan M, 2019, ELIFE, V8, DOI 10.7554/eLife.44736; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; van der Lelij P, 2010, ANEMIA, V2010, DOI 10.1155/2010/565268; van der Lelij P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006936; van der Lelij P, 2010, AM J HUM GENET, V86, P262, DOI 10.1016/j.ajhg.2010.01.008; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vega H, 2010, J MED GENET, V47, P30, DOI 10.1136/jmg.2009.068395; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Whelan G, 2011, EMBO J; Wu Y, 2011, J BIOL CHEM; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Xu BS, 2015, HUM MOL GENET, V24, P1540, DOI 10.1093/hmg/ddu565; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190; Zhang NG, 2011, J BIOL CHEM, V286, P41826, DOI 10.1074/jbc.M111.305888	71	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0220348	10.1371/journal.pone.0220348	http://dx.doi.org/10.1371/journal.pone.0220348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935221	Green Published, gold, Green Submitted			2022-12-26	WOS:000534354100003
J	Sebok, A; Labancz, V; Czinkota, I; Nemes, A				Sebok, Andras; Labancz, Viktoria; Czinkota, Imre; Nemes, Attila			The effect of various metal-salts on the sedimentation of soil in a water-based suspension	PLOS ONE			English	Article							MAGNESIUM-CHLORIDE; DRINKING-WATER; PHOSPHORUS; COAGULATION; PARTICLES; TURBIDITY; CHEMISTRY; REMOVAL; NORWAY; DUST	Soil particles and bound nutrients that erode from agricultural land may end up in surface waters and cause undesirable changes to the environment. Various measures, among them constructed wetlands have been proposed as mitigation, but their efficiency varies greatly. This work was motivated by the assumption that the induced coagulation of particles may accelerate sedimentation in such wetlands and by that help reduce the amount of material that is lost from the vicinity of the diffuse source. Our specific aim was to laboratory-test the effectiveness of various salt-based coagulants in accelerating the process of sedimentation. We tested the effect of Na+, Mg2+, Ca2+, Fe3+ and Al3+ cations in 10, 20, 40 and 80 mg L-1 doses added to a soil solution in select, soluble forms of their chlorides, sulphates and hydroxides. We mixed such salts with 1 gram of physically dispersed, clay and silt rich (>85% in total) soil material in 500 mL of solution and used time-lapse photography and image analysis to evaluate the progress of sedimentation over 3 hours. We found that 2040 mg L-1 doses of Mg2+, Ca2+ in their chloride or sulphate forms appeared to provide the best consensus in terms of efficiently accelerating sedimentation using environmentally present and acceptable salts but keeping their dosage to a minimum. Comprehensive infield efficiency and environmental acceptability testing is warranted prior to any practical implementation, as well as an assessment of small scale economic and large-scale environmental benefits by retaining soil and nutrients at/near the farm.	[Sebok, Andras; Labancz, Viktoria; Czinkota, Imre] Szent Istvan Univ, Dept Soil Sci & Agrochem, Godollo, Hungary; [Nemes, Attila] Norwegian Inst Bioecon Res, As, Norway	Hungarian University of Agriculture & Life Sciences; Norwegian Institute of Bioeconomy Research	Sebok, A (corresponding author), Szent Istvan Univ, Dept Soil Sci & Agrochem, Godollo, Hungary.	sebok.andras@mkk.szie.hu		Sebok, Andras/0000-0001-5710-0609	Hungarian programme [EFOP-3.6.1-16-2016-00016]	Hungarian programme	The measurements were supported by the Hungarian EFOP-3.6.1-16-2016-00016 programme.	Aldrin M, 2008, ATMOS ENVIRON, V42, P1762, DOI 10.1016/j.atmosenv.2007.11.024; Amuda OS, 2007, J HAZARD MATER, V141, P778, DOI 10.1016/j.jhazmat.2006.07.044; [Anonymous], 2016, COAGULATION FLOCCULA; Atalay A, 2001, SOIL SEDIMENT CONTAM, V10, P317, DOI 10.1080/20015891109284; Baartman JEM, 2013, CATENA, V109, P25, DOI 10.1016/j.catena.2013.05.003; Blankenberg A.-G.B., 2016, NATURAL CONSTRUCTED, P23, DOI [10.1007/978-3-319-38927-1_2, DOI 10.1007/978-3-319-38927-1_2]; Blankenberg AGB, 2015, ROLE OF NATURAL AND CONSTRUCTED WETLANDS IN NUTRIENT CYCLING AND RETENTION ON THE LANDSCAPE, P137, DOI 10.1007/978-3-319-08177-9_10; Braskerud BC, 2000, J ENVIRON QUAL, V29, P2013, DOI 10.2134/jeq2000.00472425002900060039x; CORNFORTIS, 1968, J AGR SCI 1, V70, P83, DOI DOI 10.1017/S0021859600017238; De-Campos AB, 2009, SOIL SCI SOC AM J, V73, P550, DOI 10.2136/sssaj2007.0425; DONG A, 1983, WATER RES, V17, P569, DOI 10.1016/0043-1354(83)90116-1; Ge F, 2008, J HAZARD MATER, V151, P676, DOI 10.1016/j.jhazmat.2007.06.041; Goodrich BA, 2009, J ENVIRON QUAL, V38, P2373, DOI 10.2134/jeq2009.0042; Grayson RB, 1996, J ENVIRON MANAGE, V47, P257, DOI 10.1006/jema.1996.0051; International Fertilizer Development Center (IFDC), 2010, USDA TECHNICAL B; Kristoffersen T, 2012, REDUST SEM OCT 31; Liming Filipek T, 2011, ENCY EARTH SCI SERIE; Lundekvam H, 1998, SOIL USE MANAGE, V14, P84, DOI 10.1111/j.1475-2743.1998.tb00620.x; Lyklema J, 2015, J COLLOID INTERF SCI, V446, P308, DOI 10.1016/j.jcis.2014.10.052; Metcalf & Eddy Inc, 2003, WASTEWATER ENG TREAT, V4nd; NOWICKI W, 1994, J CHEM EDUC, V71, P624, DOI 10.1021/ed071p624; Pavanelli D, 2005, BIOSYST ENG, V90, P75, DOI 10.1016/j.biosystemseng.2004.09.001; Puustinen M, 2005, AGR ECOSYST ENVIRON, V105, P565, DOI 10.1016/j.agee.2004.08.005; Raddum GG, 2003, AMBIO, V32, P230, DOI 10.1639/0044-7447(2003)032[0230:LORASN]2.0.CO;2; Raghu S, 2007, J HAZARD MATER, V149, P324, DOI 10.1016/j.jhazmat.2007.03.087; Somasundaran P, 2006, ENCYLOPEDIA SURFACE, V2; SSDS (Soil Science Division Staff),, 1993, SOIL SURV MAN HDB; Sveistrup TE, 2008, BOREAL ENVIRON RES, V13, P275; Tang XM, 2016, DESALIN WATER TREAT, V57, P1733, DOI 10.1080/19443994.2014.977959; Thao HTB, 2008, SOIL SCI PLANT NUTR, V54, P148, DOI 10.1111/j.1747-0765.2007.00220.x; Ulen B, 2004, WATER AIR SOIL POLL, V157, P331, DOI 10.1023/B:WATE.0000038906.18517.e2; USDA, 1999, SOIL QUALITY AGRONOM, V8, P6; Uusi-Kamppa J., 1998, J ENVIRON QUAL, V29, P151; Wang DS, 2002, ENVIRON SCI TECHNOL, V36, P1815, DOI 10.1021/es001936a; Zhang L, 2015, INT J ENV RES PUB HE, V12, P14312, DOI 10.3390/ijerph121114312	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227338	10.1371/journal.pone.0227338	http://dx.doi.org/10.1371/journal.pone.0227338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935229	Green Published, gold			2022-12-26	WOS:000534354100016
J	Chou, EH; Mann, S; Hsu, TC; Hsu, WT; Liu, CCY; Bhakta, T; Hassani, DM; Lee, CC				Chou, Eric H.; Mann, Shaynna; Hsu, Tzu-Chun; Hsu, Wan-Ting; Liu, Carolyn Chia-Yu; Bhakta, Toral; Hassani, Dahlia M.; Lee, Chien-Chang			Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; RISK; EPIDEMIOLOGY; DEFINITIONS; STEWARDSHIP; THERAPY; COSTS; CARE	Purpose To determine the trends of infection sites and outcome of sepsis using a national population-based database. Materials and methods Using the Nationwide Inpatient Sample database of the US, adult sepsis hospitalizations and infection sites were identified using a validated approach that selects admissions with explicit ICD-9-CM codes for sepsis and diagnosis/procedure codes for acute organ dysfunctions. The primary outcome was the trend of incidence and in-hospital mortality of specific infection sites in sepsis patients. The secondary outcome was the impact of specific infection sites on in-hospital mortality. Results During the 9-year period, we identified 7,860,687 admissions of adult sepsis. Genitourinary tract infection (36.7%), lower respiratory tract infection (36.6%), and systemic fungal infection (9.2%) were the leading three sites of infection in patients with sepsis. Intra-abdominal infection (30.7%), lower respiratory tract infection (27.7%), and biliary tract infection (25.5%) were associated with highest mortality rate. The incidences of all sites of infections were trending upward. Musculoskeletal infection (annual increase: 34.2%) and skin and skin structure infection (annual increase: 23.0%) had the steepest increase. Mortality from all sites of infection has decreased significantly (trend p<0.001). Skin and skin structure infection had the fastest declining rate (annual decrease: 5.5%) followed by primary bacteremia (annual decrease: 5.3%) and catheter related bloodstream infection (annual decrease: 4.8%). Conclusions The anatomic site of infection does have a differential impact on the mortality of septic patients. Intra-abdominal infection, lower respiratory tract infection, and biliary tract infection are associated with higher mortality in septic patients.	[Chou, Eric H.; Mann, Shaynna] John Peter Smith Hosp, Dept Emergency Med, Ft Worth, TX 76104 USA; [Chou, Eric H.; Bhakta, Toral; Hassani, Dahlia M.] Baylor Scott & White All St Med Ctr, Dept Emergency Med, Ft Worth, TX USA; [Hsu, Tzu-Chun; Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsu, Tzu-Chun; Lee, Chien-Chang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hsu, Wan-Ting] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Liu, Carolyn Chia-Yu] BPP Univ, Sch Hlth, McTimoney Coll Chiropract, Abingdon, Oxon, England	Baylor Health Care System; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Harvard University; Harvard T.H. Chan School of Public Health	Lee, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Lee, CC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	cclee100@gmail.com	Hsu, Wan-Ting/AAE-9422-2021; Lee, Chien-Chang/HHM-5986-2022	Hsu, Wan-Ting/0000-0002-6677-0951; LEE, CHIEN-CHANG/0000-0002-1243-2463				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2015, OVERVIEW NATL INPATI; Arnold HM, 2011, SEMIN RESP CRIT CARE, V32, P215, DOI 10.1055/s-0031-1275534; Baldo V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166637; Brook I, 2008, DIGEST DIS SCI, V53, P2585, DOI 10.1007/s10620-007-0194-6; Chen CC, 2006, EMERG MED J, V23, P281, DOI 10.1136/emj.2004.020933; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Early Goal-Directed Therapy Collaborative Group of Zhejiang Province, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P331; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Goff DA, 2011, CURR OPIN INFECT DIS, V24, pS11, DOI 10.1097/01.qco.0000393484.17894.05; Huggan PJ, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx106; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Jeganathan N, 2017, J CRIT CARE, V41, P170, DOI 10.1016/j.jcrc.2017.05.019; Jolley RJ, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0847-3; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Lee CC, 2017, J INFECTION, V75, P409, DOI 10.1016/j.jinf.2017.08.012; Leligdowicz A, 2014, AM J RESP CRIT CARE, V189, P1204, DOI 10.1164/rccm.201310-1875OC; Luna CM, 2018, CURR OPIN PULM MED, V24, P205, DOI 10.1097/MCP.0000000000000478; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Motzkus CA, 2017, J INTENSIVE CARE MED, V32, P473, DOI 10.1177/0885066615627778; Prucha M, 2017, ARCH IMMUNOL THER EX, V65, P37, DOI 10.1007/s00005-016-0415-9; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Whitney CG, 2004, INFECT DIS CLIN N AM, V18, P899, DOI 10.1016/j.idc.2004.07.008; Whittaker SA, 2013, CRIT CARE MED, V41, P945, DOI 10.1097/CCM.0b013e31827466f1; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Zahar JR, 2011, CRIT CARE MED, V39, P1886, DOI 10.1097/CCM.0b013e31821b827c; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	37	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227752	10.1371/journal.pone.0227752	http://dx.doi.org/10.1371/journal.pone.0227752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929577	gold, Green Published			2022-12-26	WOS:000534352500068
J	Rondinone, V; Serrecchia, L; Parisi, A; Fasanella, A; Manzulli, V; Cipolletta, D; Galante, D				Rondinone, Valeria; Serrecchia, Luigina; Parisi, Antonio; Fasanella, Antonio; Manzulli, Viviana; Cipolletta, Dora; Galante, Domenico			Genetic characterization of Bacillus anthracis strains circulating in Italy from 1972 to 2018	PLOS ONE			English	Article							DIVERSITY; OUTBREAKS	In Italy anthrax is an endemic disease, with a few outbreaks occurring almost every year. We surveyed 234 B. anthracis strains from animals (n = 196), humans (n = 3) and the environment (n = 35) isolated during Italian outbreaks in the years 1972-2018. Despite the considerable genetic homogeneity of B. anthracis, the strains were effectively differentiated using canonical single nucleotide polymorphisms (CanSNPs) assay and multiple-locus variable-number tandem repeat analysis (MLVA). The phylogenetic identity was determined through the characterization of 14 CanSNPs. In addition, a subsequent 31-loci MLVA assay was also used to further discriminate B. anthracis genotypes into subgroups. The analysis of 14 CanSNPs allowed for the identification of four main lineages: A.Br.011/009, A.Br.008/011 (respectively belonging to A.Br.008/009 sublineage, also known Trans-Eurasian or TEA group), A.Br.005/006 and B.Br.CNEVA. A.Br.011/009, the most common subgroup of lineage A, is the major genotype of B. anthracis in Italy. The MLVA analysis revealed the presence of 55 different genotypes in Italy. Most of the genotypes are genetically very similar, supporting the hypothesis that all strains evolved from a local common ancestral strain, except for two genotypes representing the branch A.Br.005/006 and B.Br.CNEVA. The genotyping analysis applied in this study remains a very valuable tool for studying the diversity, evolution, and molecular epidemiology of B. anthracis.	[Rondinone, Valeria; Serrecchia, Luigina; Parisi, Antonio; Fasanella, Antonio; Manzulli, Viviana; Cipolletta, Dora; Galante, Domenico] Anthrax Reference Inst Italy, Expt Zooprophylact Inst Apulia & Basilicata Reg, Foggia, Italy		Galante, D (corresponding author), Anthrax Reference Inst Italy, Expt Zooprophylact Inst Apulia & Basilicata Reg, Foggia, Italy.	domenico.galante@izspb.it	Galante, Domenico/F-9217-2019; Manzulli, Viviana/AAC-4932-2022	Galante, Domenico/0000-0002-1159-2801; Parisi, Antonio/0000-0003-2744-1140; RONDINONE, VALERIA/0000-0001-7842-8697	Italian Ministry of Health [IZS PB 005/15 RC]	Italian Ministry of Health(Ministry of Health, Italy)	The study was funded by Italian Ministry of Health, by a research program "Ricerca corrente IZS PB 005/15 RC" (www.salute.gov.it) to AF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikembayev AM, 2010, EMERG INFECT DIS, V16, P789, DOI 10.3201/eid1605.091427; Antwerpen M, 2011, EUR J CLIN MICROBIOL, V30, P923, DOI 10.1007/s10096-011-1177-2; Beyer W, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001534; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Derzelle S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134699; Derzelle S, 2013, BIOSECUR BIOTERROR, V11, pS166, DOI 10.1089/bsp.2013.0003; DRAGON DC, 1995, CAN VET J, V36, P295; Fasanella A, 2005, J CLIN MICROBIOL, V43, P3398, DOI 10.1128/JCM.43.7.3398-3401.2005; Fasanella A, 2010, NEW MICROBIOL, V33, P83; Fasanella A, 2010, VET MICROBIOL, V140, P318, DOI 10.1016/j.vetmic.2009.08.016; Girault G., 2014, Advances in Bioscience and Biotechnology, V5, P669, DOI 10.4236/abb.2014.57079; Hicks CW, 2012, INTENS CARE MED, V38, P1092, DOI 10.1007/s00134-012-2541-0; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Manzulli V, 2019, J VET SCI, V20, P58, DOI 10.4142/jvs.2019.20.1.58; Marston CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028274; Nicastri E, 2019, EUROSURVEILLANCE, V24, P13, DOI 10.2807/1560-7917.ES.2019.24.24.1800685; Palazzo L., 2012, Open Journal of Veterinary Medicine, V2, P74, DOI 10.4236/ojvm.2012.22012; Peculi A., 2015, J BIOTERROR BIODEF, V6, DOI [10.4127/2157-2526.1000131, DOI 10.4127/2157-2526.1000131]; Ramisse V, 1996, FEMS MICROBIOL LETT, V145, P9, DOI 10.1016/0378-1097(96)00358-8; Rume FI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153548; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Steiner I, 2013, ZOONOSES PUBLIC HLTH, V60, P202, DOI 10.1111/j.1863-2378.2012.01513.x; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Timofeev V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209140; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461	30	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227875	10.1371/journal.pone.0227875	http://dx.doi.org/10.1371/journal.pone.0227875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931511	gold, Green Published			2022-12-26	WOS:000534352500080
J	Dakup, PP; Porter, KI; Gajula, RP; Goel, PN; Cheng, ZK; Gaddameedhi, S				Dakup, Panshak P.; Porter, Kenneth I.; Gajula, Rajendra P.; Goel, Peeyush N.; Cheng, Zhaokang; Gaddameedhi, Shobhan			The circadian clock protects against ionizing radiation-induced cardiotoxicity	FASEB JOURNAL			English	Article						Bmal1; circadian clock; heart; radiation; toxicity	DNA-DAMAGE RESPONSE; CARDIOVASCULAR-DISEASE RISK; CONTRACTILE FUNCTION; GENE-EXPRESSION; HEART-DISEASE; CANCER-CELLS; METABOLISM; SENSITIVITY; REPAIR; CRYPTOCHROME	Radiation therapy (RT) is commonly used to treat solid tumors of the breast, lung, and esophagus; however, the heart is an unintentional target of ionizing radiation (IR). IR exposure to the heart results in chronic toxicities including heart failure. We hypothesize that the circadian system plays regulatory roles in minimizing the IR-induced cardiotoxicity. We treated mice in control (Day Shift), environmentally disrupted (Rotating Shift), and genetically disrupted (Per 1/2 mutant) circadian conditions with 18 Gy of IR to the heart. Compared to control mice, circadian clock disruption significantly exacerbated post-IR systolic dysfunction (by ultrasound echocardiography) and increased fibrosis in mice. At the cellular level, Bmal1 protein bound to Atm, Brca1, and Brca2 promoter regions and its expression level was inversely correlated with the DNA damage levels based on the state of the clock. Further studies with circadian synchronized cardiomyocytes revealed that Bmal1 depletion increased the IR-induced DNA damage and apoptosis. Collectively, these findings suggest that the circadian clock protects from IR-induced toxicity and potentially impacts RT treatment outcome in cancer patients through IR-induced DNA damage responses.	[Dakup, Panshak P.; Porter, Kenneth I.; Gajula, Rajendra P.; Goel, Peeyush N.; Cheng, Zhaokang; Gaddameedhi, Shobhan] Washington State Univ, Coll Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Spokane, WA USA; [Gaddameedhi, Shobhan] Washington State Univ, Sleep & Performance Res Ctr, Spokane, WA USA; [Goel, Peeyush N.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Washington State University; Washington State University; University of Pennsylvania; Pennsylvania Medicine	Gaddameedhi, S (corresponding author), Washington State Univ, POB 1495, Spokane, WA 99210 USA.	shobhan.gaddameedhi@wsu.edu	Goel, Peeyush/AAA-6017-2019; Dakup, Panshak/AAR-6158-2020; GADDAMEEDHI, SHOBHAN/GZM-8298-2022; Porter, Kenneth/AAQ-5751-2020; Dakup, Panshak/AAQ-2090-2020	GADDAMEEDHI, SHOBHAN/0000-0002-4978-6951; Porter, Kenneth/0000-0003-3644-1011; Dakup, Panshak/0000-0003-3534-7744; Cheng, Zhaokang/0000-0002-9646-4824	HHS | NIH | National Cancer Institute (NCI) [CA227381]; American Heart Association (AHA) [19PRE34450077]	HHS | NIH | National Cancer Institute (NCI); American Heart Association (AHA)(American Heart Association)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: CA227381; American Heart Association (AHA), Grant/Award Number: 19PRE34450077	Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; Abbott DW, 1998, J NATL CANCER I, V90, P978, DOI 10.1093/jnci/90.13.978; Azimi R, 2012, MED PHYS, V39, P3766, DOI 10.1118/1.4735339; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Boekel NB, 2016, INT J RADIAT ONCOL, V94, P1061, DOI 10.1016/j.ijrobp.2015.11.040; Bray FN, 2016, DERMATOLOGY THER, V6, P185, DOI 10.1007/s13555-016-0120-y; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Chan S, 2017, ANN PALLIAT MED, V6, P14, DOI 10.21037/apm.2016.09.07; Cheng Z, 2014, J MOL CELL CARDIOL, V67, P1, DOI 10.1016/j.yjmcc.2013.12.002; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Dakup P, 2017, PHOTOCHEM PHOTOBIOL, V93, P296, DOI 10.1111/php.12662; Dakup Panshak P, 2018, Oncotarget, V9, P14524, DOI 10.18632/oncotarget.24539; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Gotoh T, 2015, MOL BIOL CELL, V26, P359, DOI 10.1091/mbc.E14-05-0994; Gu Q, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-253; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; IJIRI K, 1990, INT J RADIAT BIOL, V58, P165, DOI 10.1080/09553009014551521; Janko M, 2012, RADIAT RES, V178, P166, DOI 10.1667/RR3097.1; Ka NL, 2017, CANCER RES, V77, P2453, DOI 10.1158/0008-5472.CAN-16-2099; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Kohsaka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112811; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kumar V, 2017, NUCLEIC ACIDS RES, V45, P10595, DOI 10.1093/nar/gkx705; Kuznetsov AV, 2015, BBA-MOL CELL RES, V1853, P276, DOI 10.1016/j.bbamcr.2014.11.015; LAPPENBUSCH WL, 1972, RADIAT RES, V50, P600, DOI 10.2307/3573557; Latimer JJ, 2015, PHOTOCHEM PHOTOBIOL, V91, P493, DOI 10.1111/php.12387; Lee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002918; Martino TA, 2015, J BIOL RHYTHM, V30, P183, DOI 10.1177/0748730415575246; McMenamin TM, 2007, MON LABOR REV, P1; Mezzaroma E, 2012, INT J CARDIOL, V156, P231, DOI 10.1016/j.ijcard.2012.01.038; Montaigne D, 2018, LANCET, V391, P59, DOI 10.1016/S0140-6736(17)32132-3; Morris CJ, 2016, P NATL ACAD SCI USA, V113, pE1402, DOI 10.1073/pnas.1516953113; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Puukila S, 2017, RADIAT RES, V188, P539, DOI 10.1667/RR14864.1; Ruben MD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat8806; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 2015, BIOCHEMISTRY-US, V54, P110, DOI 10.1021/bi5007354; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sulli G, 2018, NATURE, V553, P351, DOI 10.1038/nature25170; Tripathi K, 2015, ONCOTARGET, V6, P5237, DOI 10.18632/oncotarget.3026; Trump RP, 2013, J MED CHEM, V56, P4729, DOI 10.1021/jm400458q; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; Van Dycke KCG, 2015, CURR BIOL, V25, P1932, DOI 10.1016/j.cub.2015.06.012; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Welch RD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17496-7; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	64	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3347	3358		10.1096/fj.201901850RR	http://dx.doi.org/10.1096/fj.201901850RR		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919902	Green Accepted			2022-12-26	WOS:000506612100001
J	Pooley, JR; Rivers, CA; Kilcooley, MT; Paul, SN; Cavga, AD; Kershaw, YM; Muratcioglu, S; Gursoy, A; Keskin, O; Lightman, SL				Pooley, John R.; Rivers, Caroline A.; Kilcooley, Michael T.; Paul, Susana N.; Cavga, Ayse Derya; Kershaw, Yvonne M.; Muratcioglu, Serena; Gursoy, Attila; Keskin, Ozlem; Lightman, Stafford L.			Beyond the heterodimer model for mineralocorticoid and glucocorticoid receptor interactions in nuclei and at DNA	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; BINDING DOMAIN; CORTICOSTEROID RECEPTORS; RESPONSE ELEMENTS; STEROID-BINDING; LIVING CELLS; WEB SERVER; DIMERIZATION; HORMONE; BRAIN	Glucocorticoid (GR) and mineralocorticoid receptors (MR) are believed to classically bind DNA as homodimers or MR-GR heterodimers to influence gene regulation in response to pulsatile basal or stress-evoked glucocorticoid secretion. Pulsed corticosterone presentation reveals MR and GR co-occupy DNA only at the peaks of glucocorticoid oscillations, allowing interaction. GR DNA occupancy was pulsatile, while MR DNA occupancy was prolonged through the inter-pulse interval. In mouse mammary 3617 cells MR-GR interacted in the nucleus and at a chromatin-associated DNA binding site. Interactions occurred irrespective of ligand type and receptors formed complexes of higher order than heterodimers. We also detected MR-GR interactions ex-vivo in rat hippocampus. An expanded range of MR-GR interactions predicts structural allostery allowing a variety of transcriptional outcomes and is applicable to the multiple tissue types that co-express both receptors in the same cells whether activated by the same or different hormones.	[Pooley, John R.; Rivers, Caroline A.; Kilcooley, Michael T.; Paul, Susana N.; Kershaw, Yvonne M.; Lightman, Stafford L.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Pooley, John R.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Cavga, Ayse Derya; Gursoy, Attila; Keskin, Ozlem] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Muratcioglu, Serena] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Muratcioglu, Serena] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Bristol; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Koc University; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Pooley, JR (corresponding author), Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England.; Pooley, JR (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA.	john.pooley@bristol.ac.uk		Cavga, Ayse Derya/0000-0001-5017-5042	Biotechnology and Biological Sciences Research Council [BB/L007622/1]; Intramural Research Program of the NIH, National Cancer Institute; Center for Cancer Research (USA); Neuroendocrinology Charitable Trust [12/13-5751, 13/14-5810]; Society for Endocrinology Early Career Grant; Biotechnology and Biological Sciences Research Council International Scientific Interchange Scheme; British Society for Neuroendocrinology Project Support Grant; BBSRC Alert 13 capital grant [BB/L014181/1]; BBSRC [BB/L007622/1, BB/L014181/1] Funding Source: UKRI; MRC [MR/R010919/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural Research Program of the NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Neuroendocrinology Charitable Trust; Society for Endocrinology Early Career Grant; Biotechnology and Biological Sciences Research Council International Scientific Interchange Scheme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Society for Neuroendocrinology Project Support Grant; BBSRC Alert 13 capital grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by Biotechnology and Biological Sciences Research Council grant BB/L007622/1 awarded to S.L.L., [in part] the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research (USA), the Neuroendocrinology Charitable Trust grants 12/13-5751 and 13/14-5810 (to S.L.L.), a Society for Endocrinology Early Career Grant awarded to J.R.P., a Biotechnology and Biological Sciences Research Council International Scientific Interchange Scheme award to S.L.L., and a British Society for Neuroendocrinology Project Support Grant (to J.R. P.). A confocal microscope used was funded through BBSRC Alert 13 capital grant BB/L014181/1. https://bbsrc.ukri.org/. https://www.cancer.gov/. https://www.endocrinology.org/. https://www.neuroendo.org.uk/. Researchers at NCI played a role in the development of the research tools (plasmids, cell lines) used in this manuscript, and in the methodological training of the corresponding author. They also contributed to the collection and analysis of some data presented and were offered authorship, but declined to pursue their own interests in this area. They had no role in the preparation of the manuscript but agree with the decision to publish. Other funders listed had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2019, BRAIN STIMUL MAR; ARMANINI D, 1988, ACTA ENDOCRINOL-COP, V118, P479, DOI 10.1530/acta.0.1180479; ARNOLD SF, 1995, P NATL ACAD SCI USA, V92, P7475, DOI 10.1073/pnas.92.16.7475; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Aumais JP, 1996, J BIOL CHEM, V271, P12568, DOI 10.1074/jbc.271.21.12568; Baspinar A, 2014, NUCLEIC ACIDS RES, V42, pW285, DOI 10.1093/nar/gku397; Beavan S, 2001, J BONE MINER RES, V16, P1496, DOI 10.1359/jbmr.2001.16.8.1496; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BRADBURY MJ, 1994, ENDOCRINOLOGY, V134, P1286, DOI 10.1210/en.134.3.1286; CAIRNS W, 1991, J BIOL CHEM, V266, P11221; Cavga AD, 2015, CURR TOP MED CHEM, V15, P2005, DOI 10.2174/1568026615666150519101956; CHAKRABORTI PK, 1991, J BIOL CHEM, V266, P22075; Chen SY, 1997, J BIOL CHEM, V272, P14087, DOI 10.1074/jbc.272.22.14087; Chen ZP, 1998, J MOL BIOL, V275, P55, DOI 10.1006/jmbi.1997.1413; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Clancy JW, 2019, NAT CELL BIOL, V21, P856, DOI 10.1038/s41556-019-0345-y; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Conway-Campbell BL, 2007, ENDOCRINOLOGY, V148, P5470, DOI 10.1210/en.2007-0585; Conway-Campbell BL, 2012, MOL CELL ENDOCRINOL, V348, P383, DOI 10.1016/j.mce.2011.08.014; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Derfoul A, 2000, ENDOCRINE, V13, P287, DOI 10.1385/ENDO:13:3:287; Derfoul A, 1998, J BIOL CHEM, V273, P20702, DOI 10.1074/jbc.273.33.20702; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; EDWARDS DP, 1995, J STEROID BIOCHEM, V53, P449, DOI 10.1016/0960-0760(95)00091-D; ERIKSSON P, 1990, J BIOL CHEM, V265, P3535; FARMAN N, 1991, AM J PHYSIOL, V260, pC226, DOI 10.1152/ajpcell.1991.260.2.C226; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; Fukushima R, 2018, METHODS, V140, P161, DOI 10.1016/j.ymeth.2018.03.007; George CL, 2017, MOL CELL ENDOCRINOL, V439, P46, DOI 10.1016/j.mce.2016.10.019; GOUILLEUX F, 1991, NUCLEIC ACIDS RES, V19, P1563, DOI 10.1093/nar/19.7.1563; Griekspoor Alexander, 2007, Nucl Recept Signal, V5, pe003; Groeneweg FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090532; Grossmann C, 2012, CHEM BIOL, V19, P742, DOI 10.1016/j.chembiol.2012.04.014; Hall JM, 2002, MOL ENDOCRINOL, V16, P469, DOI 10.1210/me.16.3.469; Han F, 2005, NEUROSCI RES, V51, P371, DOI 10.1016/j.neures.2004.12.013; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; HIRST MA, 1992, P NATL ACAD SCI USA, V89, P5527, DOI 10.1073/pnas.89.12.5527; Hoppmann J, 2010, J ENDOCRINOL, V204, P153, DOI 10.1677/JOE-09-0292; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; JOELS M, 1994, PROG NEUROBIOL, V43, P1, DOI 10.1016/0301-0082(94)90014-0; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Kiilerich P, 2015, J MOL ENDOCRINOL, V55, P55, DOI 10.1530/JME-15-0002; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; KLEIN JF, 1992, AM FAM PHYSICIAN, V46, P1469; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; LEHMANN JM, 1993, MOL CELL BIOL, V13, P7698, DOI 10.1128/MCB.13.12.7698; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Liu WH, 1995, P NATL ACAD SCI USA, V92, P12480, DOI 10.1073/pnas.92.26.12480; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; LOMBES M, 1993, BIOCHEM J, V292, P577, DOI 10.1042/bj2920577; Lubner CE, 2017, NAT CHEM BIOL, V13, P655, DOI 10.1038/nchembio.2348; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Marzolla V, 2012, MOL CELL ENDOCRINOL, V350, P281, DOI 10.1016/j.mce.2011.09.011; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Medina A, 2013, J PSYCHIATR RES, V47, P307, DOI 10.1016/j.jpsychires.2012.11.002; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mifsud KR, 2016, P NATL ACAD SCI USA, V113, P11336, DOI 10.1073/pnas.1605246113; Miranda TB, 2013, MOL CELL ENDOCRINOL, V380, P16, DOI 10.1016/j.mce.2013.03.002; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Neumann FR, 2012, GENE DEV, V26, P369, DOI 10.1101/gad.176156.111; Nishi M, 2004, J NEUROSCI, V24, P4918, DOI 10.1523/JNEUROSCI.5495-03.2004; Ou XM, 2001, J BIOL CHEM, V276, P14299, DOI 10.1074/jbc.M005363200; PEARCE D, 1993, SCIENCE, V259, P1161, DOI 10.1126/science.8382376; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Planey SL, 2002, J BIOL CHEM, V277, P42188, DOI 10.1074/jbc.M205085200; Presman DM, 2016, P NATL ACAD SCI USA, V113, P8236, DOI 10.1073/pnas.1606774113; Presman DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001813; Presman DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013279; Qian XX, 2012, ENDOCRINOLOGY, V153, P4346, DOI 10.1210/en.2012-1484; Rebuffat AG, 2004, MOL CELL ENDOCRINOL, V214, P27, DOI 10.1016/j.mce.2003.11.027; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Rivers CA, 2019, ENDOCRINOLOGY, V160, P1044, DOI 10.1210/en.2018-00819; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Smith CL, 1997, J BIOL CHEM, V272, P14227, DOI 10.1074/jbc.272.22.14227; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Stephens B, 2013, PROG MOL BIOL TRANSL, V115, P375, DOI 10.1016/B978-0-12-394587-7.00009-9; Stolte EH, 2006, J ENDOCRINOL, V190, P17, DOI 10.1677/joe.1.06703; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Swinstead EE, 2016, BIOESSAYS, V38, P1150, DOI 10.1002/bies.201600137; TRAPP T, 1994, NEURON, V13, P1457, DOI 10.1016/0896-6273(94)90431-6; Tsugita M, 2009, MOL CELL ENDOCRINOL, V302, P18, DOI 10.1016/j.mce.2008.12.008; Tuncbag N, 2011, NAT PROTOC, V6, P1341, DOI 10.1038/nprot.2011.367; van der Valk J B, 1991, Amino Acids, V1, P91, DOI 10.1007/BF00808095; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; van Tilborg MAA, 2000, J MOL BIOL, V301, P947, DOI 10.1006/jmbi.2000.4001; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Voss TC, 2009, J CELL SCI, V122, P345, DOI 10.1242/jcs.035865; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Watson LC, 2013, NAT STRUCT MOL BIOL, V20, P876, DOI 10.1038/nsmb.2595; WRANGE O, 1989, J BIOL CHEM, V264, P5253; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	110	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227520	10.1371/journal.pone.0227520	http://dx.doi.org/10.1371/journal.pone.0227520			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KD9MO	31923266	gold, Green Published			2022-12-26	WOS:000508185700001
J	Majaneva, S; Fridolfsson, E; Casini, M; Legrand, C; Lindehoff, E; Margonski, P; Majaneva, M; Nilsson, J; Rubene, G; Wasmund, N; Hylander, S				Majaneva, Sanna; Fridolfsson, Emil; Casini, Michele; Legrand, Catherine; Lindehoff, Elin; Margonski, Piotr; Majaneva, Markus; Nilsson, Jonas; Rubene, Gunta; Wasmund, Norbert; Hylander, Samuel			Deficiency syndromes in top predators associated with large-scale changes in the Baltic Sea ecosystem	PLOS ONE			English	Article							SALMON SALMO-SALAR; HERRING CLUPEA-HARENGUS; EARLY MORTALITY SYNDROME; SPRAT SPRATTUS-SPRATTUS; LONG-TERM TRENDS; ATLANTIC SALMON; THIAMINE-DEFICIENCY; REPRODUCTIVE DISORDER; TROPHIC CASCADES; REGIME SHIFTS	Vitamin B-1 (thiamin) deficiency is an issue periodically affecting a wide range of taxa worldwide. In aquatic pelagic systems, thiamin is mainly produced by bacteria and phytoplankton and is transferred to fish and birds via zooplankton, but there is no general consensus on when or why this transfer is disrupted. We focus on the occurrence in salmon (Salmo salar) of a thiamin deficiency syndrome (M74), the incidence of which is highly correlated among populations derived from different spawning rivers. Here, we show that M74 in salmon is associated with certain large-scale abiotic changes in the main common feeding area of salmon in the southern Baltic Sea. Years with high M74 incidence were characterized by stagnant periods with relatively low salinity and phosphate and silicate concentrations but high total nitrogen. Consequently, there were major changes in phytoplankton and zooplankton, with, e.g., increased abundances of Cryptophyceae, Dinophyceae, Diatomophyceae and Euglenophyceae and Acartia spp. during high M74 incidence years. The prey fish communities also had increased stocks of both herring and sprat in these years. Overall, this suggests important changes in the entire food web structure and nutritional pathways in the common feeding period during high M74 incidence years. Previous research has emphasized the importance of the abundance of planktivorous fish for the occurrence of M74. By using this 27-year time series, we expand this analysis to the entire ecosystem and discuss potential mechanisms inducing thiamin deficiency in salmon.	[Majaneva, Sanna; Fridolfsson, Emil; Legrand, Catherine; Lindehoff, Elin; Majaneva, Markus; Nilsson, Jonas; Hylander, Samuel] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Dept Biol & Environm Sci, Kalmar, Sweden; [Majaneva, Sanna] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Majaneva, Sanna] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Casini, Michele] Swedish Univ Agr Sci, Inst Marine Res, Dept Aquat Resources, Lysekil, Sweden; [Margonski, Piotr] Natl Marine Fisheries Res Inst, Gdynia, Poland; [Majaneva, Markus] Norwegian Univ Sci & Technol, NTNU Univ Museum, Trondheim, Norway; [Rubene, Gunta] Inst Food Safety Anim Hlth & Environm BIOR, Fish Resources Res Dept, Riga, Latvia; [Wasmund, Norbert] Leibniz Inst Balt Sea Res, Warnernunde, Germany	Linnaeus University; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); Swedish University of Agricultural Sciences; National Marine Fisheries Research Institute; Norwegian University of Science & Technology (NTNU); Institute of Food Safety, Animal Health & Environment "BIOR"; Leibniz Institut fur Ostseeforschung Warnemunde	Majaneva, S (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst EEMiS, Dept Biol & Environm Sci, Kalmar, Sweden.; Majaneva, S (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.; Majaneva, S (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway.	sanna.majaneva@gmail.com	Fridolfsson, Emil/AAC-7762-2020; Margonski, Piotr/M-2169-2015	Fridolfsson, Emil/0000-0003-4871-7441; Majaneva, Markus/0000-0003-3884-2548; Casini, Michele/0000-0003-4910-5236; Margonski, Piotr/0000-0002-8767-1880	Swedish research council FORMAS [215-2012-1319]; Strong Research Environment ECOCHANGE (Ecosystem dynamics in the Baltic Sea in a changing climate); Carl Trygger Foundation; Royal Swedish Academy of Sciences; Linnaeus University Centre for Ecology and Evolution in Microbial Model Systems (EEMiS); Joint Baltic Sea Research and Development Programme BONUS [185]; EU; Swedish Research Council Formas (Sweden)	Swedish research council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Strong Research Environment ECOCHANGE (Ecosystem dynamics in the Baltic Sea in a changing climate); Carl Trygger Foundation; Royal Swedish Academy of Sciences; Linnaeus University Centre for Ecology and Evolution in Microbial Model Systems (EEMiS); Joint Baltic Sea Research and Development Programme BONUS; EU(European Commission); Swedish Research Council Formas (Sweden)(Swedish Research Council Formas)	The study was financially supported by the Swedish research council FORMAS (grant number 215-2012-1319, https://www.formas.se) (to SH), the Strong Research Environment ECOCHANGE (Ecosystem dynamics in the Baltic Sea in a changing climate; https://lnu.se/en/research/searchresearch/ecochange/) (to CL), Carl Trygger Foundation (to SH; https://www.carltryggersstiftelse.se/), The Royal Swedish Academy of Sciences (to SH; https://www.kva.se/), and the Linnaeus University Centre for Ecology and Evolution in Microbial Model Systems (EEMiS; https://lnu.se/en/research/searchresearch/linnaeusuniversity-centre-for-ecology-and-evolution-in-microbial-model-systems/).MC was funded by the BONUS INSPIRE project supported by the Joint Baltic Sea Research and Development Programme BONUS (Art 185; https://www.bonusportal.org/) and jointly by the EU and the Swedish Research Council Formas (Sweden; https://www.formas.se).Polish zooplankton data were collected within the National Monitoring Programme, and permission to use them was granted by the Chief Inspector of Environmental Protection (http://www.gios.gov.pl).The authors do not have any competing interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was financially supported by the Swedish research council FORMAS (grant number 215-2012-1319) (to SH), the Strong Research Environment ECOCHANGE (Ecosystem dynamics in the Baltic Sea in a changing climate) (to CL), Carl Trygger Foundation (to SH), The Royal Swedish Academy of Sciences (to SH), and the Linnaeus University Centre for Ecology and Evolution in Microbial Model Systems (EEMiS). MC was funded by the BONUS INSPIRE project supported by the Joint Baltic Sea Research and Development Programme BONUS (Art 185) and jointly by the EU and the Swedish Research Council Formas (Sweden). Polish zooplankton data were collected within the National Monitoring Programme, and permission to use them was granted by the Chief Inspector of Environmental Protection (http://www.gios.gov.pl).The authors do not have any competing interests.	Ahlgren G, 2005, CAN J FISH AQUAT SCI, V62, P2240, DOI 10.1139/F05-140; Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; Amcoff P, 1999, AMBIO, V28, P48; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Arrhenius F, 1996, ICES J MAR SCI, V53, P792, DOI 10.1006/jmsc.1996.0100; Balk L, 2016, SCI REP-UK, V6, DOI 10.1038/srep38821; Balk L, 2009, P NATL ACAD SCI USA, V106, P12001, DOI 10.1073/pnas.0902903106; Bengtsson BE, 1999, AMBIO, V28, P2; Borjeson H, 1999, AMBIO, V28, P30; Borjesson H, 2016, REDOVISNING M74 FORE, P1; Brown SB, 2005, J AQUAT ANIM HEALTH, V17, P113, DOI 10.1577/H04-015.1; Carini P, 2014, ISME J, V8, P1727, DOI 10.1038/ismej.2014.61; Casini M, 2004, ICES J MAR SCI, V61, P1267, DOI 10.1016/j.icesjms.2003.12.011; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Combs GF., 2012, VITAMINS, V4th ed; Cooray R, 1999, AMBIO, V28, P77; Croft MT, 2006, EUKARYOT CELL, V5, P1175, DOI 10.1128/EC.00097-06; Dancey C, 2011, STAT MATHS PSYCHOL U; Ejsmond MJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46422-2; Fitzsimons JD, 1999, AMBIO, V28, P9; Fitzsimons JD, 2005, J AQUAT ANIM HEALTH, V17, P26, DOI 10.1577/H04-002.1; Fridolfsson E, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3520-6; Fridolfsson E, 2018, LIMNOL OCEANOGR, V63, P2423, DOI 10.1002/lno.10949; Gomez-Consarnau L, 2018, ENVIRON MICROBIOL, V20, P2809, DOI 10.1111/1462-2920.14133; Gorley Clarke, 2015, PRIMER V7 USER MANUA; Gutowska MA, 2017, MBIO, V8, DOI [10.1128/mBio.01459-17, 10.1128/mbio.01459-17]; Hansson S, 2001, J FISH BIOL, V58, P1730, DOI 10.1006/jfbi.2001.1585; Heal KR, 2014, RAPID COMMUN MASS SP, V28, P2398, DOI 10.1002/rcm.7040; HELCOM, 1988, BALT SEA ENV P, V27; Honeyfield DC, 2005, J AQUAT ANIM HEALTH, V17, P4, DOI 10.1577/H03-078.1; Hong JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036845; HUNTLEY ME, 1983, MAR BIOL, V74, P151, DOI 10.1007/BF00413918; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; ICES, 2014, ICES CM ACOM; Jutila E, 2003, FISH RES, V60, P333, DOI 10.1016/S0165-7836(02)00169-8; Kallio-Nyberg I, 2015, FISH RES, V165, P85, DOI 10.1016/j.fishres.2014.12.022; KALLIONYBERG I, 1992, ICES J MAR SCI, V49, P191, DOI 10.1093/icesjms/49.2.191; Karlsson L, 1999, AMBIO, V28, P37; Karlsson Lars, 1994, Dana, V10, P61; Keinanen M, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3418-8; Keinanen M, 2017, HELGOLAND MAR RES, V71, P1, DOI 10.1186/s10152-017-0484-0; Keinanen M, 2012, ICES J MAR SCI, V69, P516, DOI 10.1093/icesjms/fss041; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Kornilovs G., 2004, 2004L13 ICES CM; Kraft CE, 2017, Q REV BIOL, V92, P151, DOI 10.1086/692168; Ku┬ster F., 2003, ICES MAR SCI S, V219, P294; Langefors AH, 2005, ENVIRON BIOL FISH, V74, P297, DOI 10.1007/s10641-005-0501-z; McKinnell S, 1998, J FISH BIOL, V52, P1175, DOI 10.1111/j.1095-8649.1998.tb00964.x; McRose D, 2014, ISME J, V8, P2517, DOI 10.1038/ismej.2014.146; Mikkonen J, 2011, ICES J MAR SCI, V68, P2134, DOI 10.1093/icesjms/fsr156; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; Mollmann C, 2012, ADV ECOL RES, V47, P303, DOI 10.1016/B978-0-12-398315-2.00004-1; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Mohrholz V, 2015, J MARINE SYST, V148, P152, DOI 10.1016/j.jmarsys.2015.03.005; Morner T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13884-1; NORRGREN L, 1993, ENVIRON TOXICOL CHEM, V12, P2065, DOI 10.1002/etc.5620121114; Otto SA, 2014, MAR ECOL PROG SER, V498, P73, DOI 10.3354/meps10613; Paerl RW, 2018, P NATL ACAD SCI USA, V115, pE10447, DOI 10.1073/pnas.1806425115; Paerl RW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24321-2; Paerl RW, 2017, ISME J, V11, P753, DOI 10.1038/ismej.2016.145; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109; Sanudo-Wilhelmy SA, 2014, ANNU REV MAR SCI, V6, P339, DOI 10.1146/annurev-marine-120710-100912; Suffridge C, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00011; Sutherland WJ, 2018, TRENDS ECOL EVOL, V33, P47, DOI 10.1016/j.tree.2017.11.006; Sylvander P, 2013, MICROB ECOL, V65, P566, DOI 10.1007/s00248-012-0156-1; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tillitt DE, 2005, J AQUAT ANIM HEALTH, V17, P13, DOI 10.1577/H03-081.1; Torniainen J, 2014, ICES J MAR SCI, V71, P336, DOI 10.1093/icesjms/fst153; Vargas CA, 2006, ECOLOGY, V87, P2992, DOI 10.1890/0012-9658(2006)87[2992:PFQDTW]2.0.CO;2; Vuorinen PJ, 2002, ICES J MAR SCI, V59, P480, DOI 10.1006/jmsc.2002.1200; Wasmund N, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00153; Wasmund N, 2013, J PLANKTON RES, V35, P393, DOI 10.1093/plankt/fbs101; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Wistbacka S, 2008, J FISH BIOL, V72, P787, DOI 10.1111/j.1095-8649.2007.01722.x; Wistbacka S, 2002, J FISH BIOL, V60, P1031, DOI 10.1006/jfbi.2002.1912; WOODWARD B, 1994, AQUACULTURE, V124, P133, DOI 10.1016/0044-8486(94)90375-1	78	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227714	10.1371/journal.pone.0227714	http://dx.doi.org/10.1371/journal.pone.0227714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917814	Green Published, Green Submitted, gold			2022-12-26	WOS:000534341100034
J	Li, X; Peng, ZM; Long, LL; Tuo, Y; Wang, LQ; Zhao, XY; Le, W; Wan, Y				Li, Xiang; Peng, Zhiming; Long, Lingli; Tuo, Ying; Wang, Liqin; Zhao, Xiaoyang; Le, Wang; Wan, Yong			Wnt4-modified NSC transplantation promotes functional recovery after spinal cord injury	FASEB JOURNAL			English	Article						neural stem cell transplantation; neuronal differentiation; Notch; Wnt	NEURAL STEM-CELLS; OLFACTORY ENSHEATHING CELLS; CATENIN SIGNALING PATHWAY; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; NOTCH; ACTIVATION; NEUROGENESIS; MAINTENANCE; THERAPY	Spinal cord injury (SCI) can lead to severe motor and sensory dysfunction, yet there are no effective therapies currently due to the failure of reconstructing the interruption of the neuroanatomical circuit. While neural stem cell (NSC) transplantation has been considered a potential strategy to repair the neural circuit after SCI, the efficacy of this strategy remains unproven. The main reason is that most of the transplanted NSC differentiates into astrocyte rather than neuron in the microenvironment of SCI. Our results demonstrated that Wnt4 significantly promotes the differentiation of NSC into neuron by activating both beta-catenin and MAPK/JNK pathways and suppressing the activation of Notch signaling, which is acknowledged as prevention of NSC differentiation into neuron, through downregulating NICD expression, translocating and preventing the combination of NICD and RbpJ in nucleus. In addition, Wnt4 rescues the negative effect of Jagged, the ligand of Notch signaling, to promote neuronal differentiation. Moreover, in vivo study, transplantation of Wnt4-modified NSC efficaciously repairs the injured spinal cord and recovers the motor function of hind limbs after SCI. This study sheds new light into mechanisms that Wnt4-modified NSC transplantation is sufficient to repair the injured spinal cord and recover the motor dysfunction after SCI.	[Li, Xiang; Peng, Zhiming; Zhao, Xiaoyang; Le, Wang; Wan, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine Surg, Guangzhou, Peoples R China; [Long, Lingli] Sun Yat Sen Univ, Affiliated Hosp 1, Res Ctr Translat Med, Guangzhou, Peoples R China; [Tuo, Ying] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China; [Wang, Liqin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Peoples R China; [Le, Wang; Wan, Yong] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Orthopaed & Traumatol, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wan, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Orthopaed, 58 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China.	wanyong65@outlook.com			National Natural Science Foundation of China [81472069, 81971151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81472069 and 81971151	Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blakely BD, 2013, STEM CELLS DEV, V22, P2132, DOI 10.1089/scd.2013.0066; Chen NN, 2016, CRIT CARE MED, V44, pE146, DOI 10.1097/CCM.0000000000001351; Ding Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-35; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Gao YH, 2016, J PINEAL RES, V60, P303, DOI 10.1111/jpi.12311; Gomes ED, 2019, NEURAL REGEN RES, V14, P69, DOI 10.4103/1673-374.243705; Hirabayashi Y, 2004, CELL STRUCT FUNCT, V29, P83; Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Inoue S, 2013, J THORAC CARDIOV SUR, V146, P696, DOI 10.1016/j.jtcvs.2012.11.040; Ishizaki Y, 2008, FEBS J, V275, P90; Jang S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/178618; Jin MC, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2018.12.FOCUS18602; Klein S, 2005, NAT NEUROSCI, V8, P259, DOI 10.1038/nn0305-259; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Li G, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00241; Mackay-Sim A, 2011, EXP NEUROL, V229, P174, DOI 10.1016/j.expneurol.2010.08.025; Ohta K, 1999, SPINAL CORD, V37, P580, DOI 10.1038/sj.sc.3100881; Park SY, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0383-6; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Simard JM, 2013, SPINAL CORD, V51, P823, DOI 10.1038/sc.2013.99; Song Y, 2012, J BIOL CHEM, V287, P17716, DOI 10.1074/jbc.M112.360719; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Yang L, 2018, INT J CLIN EXP MED, V11, P10487; Zhang J, 2008, NEUROSCIENCE, V153, P406, DOI 10.1016/j.neuroscience.2008.02.067; Zhang RR, 2018, CELL TISSUE RES, V371, P73, DOI 10.1007/s00441-017-2641-9; Zhao XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23751-2; Zhu YC, 2018, DEV DYNAM, V247, P75, DOI 10.1002/dvdy.24558	38	23	24	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					82	94		10.1096/fj.201901478RR	http://dx.doi.org/10.1096/fj.201901478RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914702				2022-12-26	WOS:000507308900007
J	Visootsat, A; Nakamura, A; Vignon, P; Watanabe, H; Uchihashi, T; Iino, R				Visootsat, Akasit; Nakamura, Akihiko; Vignon, Paul; Watanabe, Hiroki; Uchihashi, Takayuki; Iino, Ryota			Single-molecule imaging analysis reveals the mechanism of a high-catalytic-activity mutant of chitinase A from Serratia marcescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chitinase; processivity; single-molecule biophysics; Serratia marcescens; chitin; biomass conversion; biotechnology; chitin degradation; high-speed atomic force microscopy; single-molecule fluorescence imaging	PROTEIN-CARBOHYDRATE INTERACTIONS; CELLOBIOHYDROLASE I; AROMATIC RESIDUES; PROCESSIVITY; BINDING; CEL7A; HYDROLYSIS; ALPHA; COCKTAILS; MOVEMENT	Chitin degradation is important for biomass conversion and has potential applications for agriculture, biotechnology, and the pharmaceutical industry. Chitinase A from the Gram-negative bacterium Serratia marcescens (SmChiA) is a processive enzyme that hydrolyzes crystalline chitin as it moves linearly along the substrate surface. In a previous study, the catalytic activity of SmChiA against crystalline chitin was found to increase after the tryptophan substitution of two phenylalanine residues (F232W and F396W), located at the entrance and exit of the substrate binding cleft of the catalytic domain, respectively. However, the mechanism underlying this high catalytic activity remains elusive. In this study, single-molecule fluorescence imaging and high-speed atomic force microscopy were applied to understand the mechanism of this high-catalytic-activity mutant. A reaction scheme including processive catalysis was used to reproduce the properties of SmChiA WT and F232W/F396W, in which all of the kinetic parameters were experimentally determined. High activity of F232W/F396W mutant was caused by a high processivity and a low dissociation rate constant after productive binding. The turnover numbers for both WT and F232W/F396W, determined by the biochemical analysis, were well-replicated using the kinetic parameters obtained from single-molecule imaging analysis, indicating the validity of the reaction scheme. Furthermore, alignment of amino acid sequences of 258 SmChiA-like proteins revealed that tryptophan, not phenylalanine, is the predominant amino acid at the corresponding positions (Phe-232 and Phe-396 for SmChiA). Our study will be helpful for understanding the kinetic mechanisms and further improvement of crystalline chitin hydrolytic activity of SmChiA mutants.	[Visootsat, Akasit; Nakamura, Akihiko; Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Funct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Visootsat, Akasit; Nakamura, Akihiko; Vignon, Paul; Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Vignon, Paul] Chim ParisTech, F-75231 Paris, France; [Watanabe, Hiroki; Uchihashi, Takayuki] Nagoya Univ, Dept Phys, Nagoya, Aichi 4648601, Japan; [Watanabe, Hiroki; Uchihashi, Takayuki] Natl Inst Nat Sci, Exploratory Res Ctr Life & Living Syst ExCELLS, Okazaki, Aichi 4448787, Japan	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; The Exploratory Research Center on Life & Living Systems (ExCELLS)	Iino, R (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	iino@ims.ac.jp	Iino, Ryota/B-7746-2011; Uchihashi, Takayuki/D-5209-2011	Iino, Ryota/0000-0003-0110-5704; Uchihashi, Takayuki/0000-0002-0263-5312; VISOOTSAT, AKASIT/0000-0002-1258-6745; Nakamura, Akihiko/0000-0003-0409-5759	Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP18H05424, JP18H02418, JP18H04755]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Engine" JP18H05424 (to R. I.) and Grants-in-Aid for Scientific Research JP18H02418 and JP18H04755 (to R. I.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	BAMBARA RA, 1978, J BIOL CHEM, V253, P413; Beckham GT, 2011, J PHYS CHEM B, V115, P4516, DOI 10.1021/jp200912q; Bonderoff JM, 2010, NUCLEIC ACIDS RES, V38, P7054, DOI 10.1093/nar/gkq566; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Deguchi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11907; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Einbu A, 2008, BIOMACROMOLECULES, V9, P1870, DOI 10.1021/bm8001123; Hamed I, 2016, TRENDS FOOD SCI TECH, V48, P40, DOI 10.1016/j.tifs.2015.11.007; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hu GH, 2002, BIOCHEMISTRY-US, V41, P7677, DOI 10.1021/bi0201926; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jana S, 2016, J PHYS CHEM B, V120, P1236, DOI 10.1021/acs.jpcb.5b12610; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kawai F, 2018, ACS OMEGA, V3, P7715, DOI 10.1021/acsomega.8b00663; Kurasin M, 2015, J BIOL CHEM, V290, P29074, DOI 10.1074/jbc.M115.684977; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Langner T, 2016, CURR GENET, V62, P243, DOI 10.1007/s00294-015-0530-x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu T, 2017, J BIOL CHEM, V292, P2080, DOI [10.1074/jbc.M116.755330, 10.1074/jbc.m116.755330]; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luterbacher JS, 2013, BIOTECHNOL BIOENG, V110, P108, DOI 10.1002/bit.24597; Madhuprakash J, 2018, BIOCHEMISTRY-US, V57, P4325, DOI 10.1021/acs.biochem.8b00381; Mekasha S, 2017, PROCESS BIOCHEM, V56, P132, DOI 10.1016/j.procbio.2017.02.021; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; Nakamura A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06362-3; Nakamura A, 2018, PHYS CHEM CHEM PHYS, V20, P3010, DOI 10.1039/c7cp04606e; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Pantoom Supansa, 2008, BMC Biochemistry, V9, P2, DOI 10.1186/1471-2091-9-2; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Snoberger A, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00018; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Sorlie M, 2012, BIOCATAL BIOTRANSFOR, V30, P353, DOI 10.3109/10242422.2012.676282; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; VONHIPPEL PH, 1994, ANN NY ACAD SCI, V726, P118; Williams SJ, 2001, TRENDS BIOTECHNOL, V19, P356, DOI 10.1016/S0167-7799(01)01699-7; Yan N, 2015, NATURE, V524, P155, DOI 10.1038/524155a; Zakariassen H, 2011, BIOCHEMISTRY-US, V50, P5693, DOI 10.1021/bi2002532; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200	55	6	6	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1915	1925		10.1074/jbc.RA119.012078	http://dx.doi.org/10.1074/jbc.RA119.012078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31924658	hybrid, Green Published			2022-12-26	WOS:000517128200012
J	Vutukuri, R; Koch, A; Trautmann, S; Schreiber, Y; Thomas, D; Mayser, F; zu Heringdorf, DM; Pfeilschifter, J; Pfeilschifter, W; Brunkhorst, R				Vutukuri, Rajkumar; Koch, Alexander; Trautmann, Sandra; Schreiber, Yannick; Thomas, Dominique; Mayser, Franziska; zu Heringdorf, Dagmar Meyer; Pfeilschifter, Josef; Pfeilschifter, Waltraud; Brunkhorst, Robert			S1P d20:1, an endogenous modulator of S1P d18:1/S1P(2)-dependent signaling	FASEB JOURNAL			English	Article						brain; cyclooxygenase 2; glioblastoma cells; S1P receptors; sphingosine 1-phosphate	MAMMALIAN SERINE PALMITOYLTRANSFERASE; LONG-CHAIN BASES; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2; COX-2 EXPRESSION; CANCER; RISK; CYCLOOXYGENASE-2; PERMEABILITY; INTEGRITY	Sphingosine 1-phosphate (S1P) signaling influences numerous cell biological mechanisms such as differentiation, proliferation, survival, migration, and angiogenesis. Intriguingly, our current knowledge is based solely on the role of S1P with an 18-carbon long-chain base length, S1P d18:1. Depending on the composition of the first and rate-limiting enzyme of the sphingolipid de novo metabolism, the serine palmitoyltransferase, other chain lengths have been described in vivo. While cells are also able to produce S1P d20:1, its abundance and function remains elusive so far. Our experiments are highlighting the role of S1P d20:1 in the mouse central nervous system (CNS) and human glioblastoma. We show here that S1P d20:1 and its precursors are detectable in both healthy mouse CNS-tissue and human glioblastoma. On the functional level, we focused our work on one particular, well-characterized pathway, the induction of cyclooxygenase (COX)-2 expression via the S1P receptor 2 (S1P(2)). Intriguingly, S1P d20:1 only fairly induces COX-2 expression and can block the S1P d18:1-induced COX-2 expression mediated via S1P(2) activation in the human glioblastoma cell line LN229. This data indicates that S1P d20:1 might act as an endogenous modulator of S1P signaling via a partial agonism at the S1P(2) receptor. While our findings might stimulate further research on the relevance of long-chain base lengths in sphingolipid signaling, the metabolism of S1P d20:1 has to be considered as an integral part of S1P signaling pathways in vivo.	[Vutukuri, Rajkumar; Koch, Alexander; zu Heringdorf, Dagmar Meyer; Pfeilschifter, Josef] Goethe Univ Frankfurt, Univ Hosp, Inst Gen Pharmacol & Toxicol, Frankfurt, Germany; [Trautmann, Sandra; Thomas, Dominique] Goethe Univ Frankfurt, Univ Hosp, Inst Clin Pharmacol, Frankfurt, Germany; [Schreiber, Yannick] Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany; [Mayser, Franziska; Pfeilschifter, Waltraud; Brunkhorst, Robert] Goethe Univ Frankfurt, Univ Hosp, Dept Neurol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Brunkhorst, R (corresponding author), Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany.	robert.brunkhorst@kgu.de	Heringdorf, Dagmar Meyer zu/A-7705-2018	Heringdorf, Dagmar Meyer zu/0000-0003-1246-9677	Deutsche Forschungsgemeinschaft (DFG) [SFB1039]; Fondation Leducq	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fondation Leducq(Leducq Foundation)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1039; Fondation Leducq	Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Blankenbach KV, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00167; Brunkhorst R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051390; Chajes V, 1999, INT J CANCER, V83, P585, DOI 10.1002/(SICI)1097-0215(19991126)83:5&lt;585::AID-IJC2&gt;3.0.CO;2-Z; CHIGORNO V, 1994, EUR J BIOCHEM, V221, P1095, DOI 10.1111/j.1432-1033.1994.tb18829.x; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799; Cruz-Orengo L, 2014, J CLIN INVEST, V124, P2571, DOI 10.1172/JCI73408; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hsu CK, 2015, J CELL PHYSIOL, V230, P702, DOI 10.1002/jcp.24795; Imeri F, 2014, NEUROPHARMACOLOGY, V85, P314, DOI 10.1016/j.neuropharm.2014.05.012; Kelly FD, 2001, EUR J CLIN NUTR, V55, P88, DOI 10.1038/sj.ejcn.1601122; Kim GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8893; Kim JI, 2003, J BIOL CHEM, V278, P31731, DOI 10.1074/jbc.M300625200; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kuhn T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0552-3; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lepley D, 2005, CANCER RES, V65, P3788, DOI 10.1158/0008-5472.CAN-04-2311; Mahajan-Thakur S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112448; Mondul AM, 2015, INT J CANCER, V137, P2124, DOI 10.1002/ijc.29576; O'Sullivan C, 2013, TRENDS PHARMACOL SCI, V34, P401, DOI 10.1016/j.tips.2013.05.002; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Qiu JG, 2017, DRUG DISCOV TODAY, V22, P148, DOI 10.1016/j.drudis.2016.09.017; SAMBASIVARAO K, 1964, J LIPID RES, V5, P103; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; SCHWARZ HP, 1967, J NEUROCHEM, V14, P91, DOI 10.1111/j.1471-4159.1967.tb09497.x; Skoura A, 2011, ARTERIOSCL THROM VAS, V31, P81, DOI 10.1161/ATVBAHA.110.213496; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Sung H. K., 2007, J BIOL CHEM, V282, P1938; Suriyanarayanan S, 2019, NEUROMOL MED, V21, P182, DOI 10.1007/s12017-019-08534-w; Troupiotis-Tsailaki A., 2017, SCI REP-UK, V7, P1; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112	39	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3932	3942		10.1096/fj.201902391R	http://dx.doi.org/10.1096/fj.201902391R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944406	hybrid, Green Published			2022-12-26	WOS:000507594100001
J	Peng, YH; Lin, YS; Chen, CH; Tsai, KY; Hung, YC; Chen, HJ; Liao, WC; Ho, WC				Peng, Yi-Hao; Lin, Yu-Sheng; Chen, Chia-Hung; Tsai, Kun-Yuan; Hung, Yi-Chih; Chen, Hsuan-Ju; Liao, Wei-Chih; Ho, Wen-Chao			Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; CLINICAL CONSEQUENCES; VASCULAR-DISEASE; MEDICAL THERAPY; MELLITUS; COMPLICATIONS; EPIDEMIOLOGY; PATHOPHYSIOLOGY; THICKNESS; CHILDREN	Background It has been unclear whether diabetes mellitus (DM) is positively associated with a risk of venous thromboembolism (VTE). In addition, whether the risk of VTE is altered in patients with type 1 diabetes (T1DM) has rarely been explored. Aim We investigated whether patients with T1DM are at a relatively high risk of VTE development. Methods We retrieved data from the National Health Insurance Research Database of Taiwan to conduct this retrospective cohort study. The T1DM group consisted of 4967 patients diagnosed as having T1DM before 2003. The non-T1DM group comprised 19 868 age- and sex-matched enrollees without T1DM. Cox proportional hazard regression analysis was used to investigate the hazard ratio of VTE in patients with T1DM relative to those without T1DM. Results During a mean follow-up period of 8.61 years, the risk of VTE in the T1DM group was 5.33-fold higher than in the non-T1DM group after adjusting for dyslipidemia, hypertension, stroke, lower leg fracture or surgery, and obesity. Further stratified analysis revealed that the risk of VTE was significantly high in both sexes and in all age groups below the age of 60. Conclusion T1DM appears to be an independent risk factor for VTE development.	[Peng, Yi-Hao; Ho, Wen-Chao] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Peng, Yi-Hao] Asia Univ, Asia Univ Hosp, Dept Resp Therapy, Taichung, Taiwan; [Peng, Yi-Hao] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Lin, Yu-Sheng] Asia Univ, Asia Univ Hosp, Dept Chest Med, Div Internal Med, Taichung, Taiwan; [Chen, Chia-Hung; Liao, Wei-Chih] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Tsai, Kun-Yuan] Chung Hsin Clin, Div Endocrinol & Metab, New Taipei, Taiwan; [Hung, Yi-Chih] China Med Univ, China Med Univ Hosp, Dept Med, Div Endocrinol & Metab, Taichung, Taiwan; [Hung, Yi-Chih] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chen, Hsuan-Ju] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Ho, Wen-Chao] Asia Univ, Dept Nursing, Taichung, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Ho, WC (corresponding author), China Med Univ, Dept Publ Hlth, Taichung, Taiwan.; Liao, WC (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.; Ho, WC (corresponding author), Asia Univ, Dept Nursing, Taichung, Taiwan.	weichih.liao@gmail.com; whocmu@gmail.com		Peng, Yi-Hao/0000-0001-9104-4487	Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW108-TDU-B-212-133004]; China Medical University [CMU105-S-48]; China Medical University Hospital; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial Center; China Medical University(China Medical University); China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133004), China Medical University (CMU105-S-48), China Medical University Hospital, Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Agren A, 2014, DIABETES CARE, V37, P2007, DOI 10.2337/dc13-1776; Ajjan RA, 2013, BLOOD, V122, P134, DOI 10.1182/blood-2013-04-494641; Bai J, 2015, THROMB RES, V135, P90, DOI 10.1016/j.thromres.2014.11.003; Bell EJ, 2016, DIABETES RES CLIN PR, V111, P10, DOI 10.1016/j.diabres.2015.10.019; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dogra G, 2001, DIABETOLOGIA, V44, P593, DOI 10.1007/s001250051665; Genuth S, 1999, DIABETES CARE, V22, P99; Heit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6; Hess K, 2012, DIABETOLOGIA, V55, P1103, DOI 10.1007/s00125-011-2301-7; Huang L, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0207-z; Jarvisalo MJ, 2004, CIRCULATION, V109, P1750, DOI 10.1161/01.CIR.0000124725.46165.2C; Kennedy A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017813; Liao S, 2014, J THROMB HAEMOST, V12, P214, DOI 10.1111/jth.12464; Luscher TF, 2003, CIRCULATION, V108, P1655, DOI 10.1161/01.CIR.0000089189.70578.E2; Michota FA, 2007, J GEN INTERN MED, V22, P1762, DOI 10.1007/s11606-007-0369-z; Ou HT, 2016, VALUE HEALTH, V19, P976, DOI 10.1016/j.jval.2016.05.017; Pompili M, 2014, J PSYCHOSOM RES, V76, P352, DOI 10.1016/j.jpsychores.2014.02.009; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh A, 2012, DIABETES CARE, V35, P1322, DOI 10.2337/dc11-2114; Singh TP, 2003, J AM COLL CARDIOL, V41, P661, DOI 10.1016/S0735-1097(02)02894-2; Stein PD, 2009, AM J MED SCI, V337, P259, DOI 10.1097/MAJ.0b013e31818bbb8b; Waden J, 2008, DIABETES CARE, V31, P230, DOI 10.2337/dc07-1238; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; White RH, 2000, NEW ENGL J MED, V343, P1758, DOI 10.1056/NEJM200012143432403; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	28	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0226997	10.1371/journal.pone.0226997	http://dx.doi.org/10.1371/journal.pone.0226997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935226	Green Published, gold			2022-12-26	WOS:000534354100010
J	Capasso, J; Bhadha, JH; Bacon, A; Vardanyan, L; Khatiwada, R; Pachon, J; Clark, M; Lang, T				Capasso, Jay; Bhadha, Jehangir H.; Bacon, Allan; Vardanyan, Lilit; Khatiwada, Raju; Pachon, Julio; Clark, Mark; Lang, Timothy			Influence of flow on phosphorus-dynamics and particle size in agricultural drainage ditch sediments	PLOS ONE			English	Article							SOIL-PHOSPHORUS; ORGANIC-MATTER; FARM CANALS; TEXTURE; STORAGE; EXTRACTION; SORPTION; RELEASE	Particle size is one factor affecting phosphorus (P) dynamics in soils and sediments. This study investigated how flow facilitated by hydraulic pumps and aquatic vegetation species water lettuce (Pistia stratiotes) and water hyacinth (Eichhornia crassipes) affected particle size and P-dynamics in organic sediments in agricultural drainage ditches. Sediments with finer particle size (>0.002 mm) were hypothesized to contain greater total P (TP) and less labile P than sediments with coarser particle size. Particle size was determined using a LS 13 320 Laser Diffraction Particle Size Analyzer. Sediments were tested for pH, TP, and organic matter. Fractions of P were determined using a sequential fractionation experiment and 31 P Nuclear Magnetic Resonance (NMR) Spectroscopy. Larger average particle size and lower average total P concentrations were found in the inflows of the field ditches compared to the outflows. Presence of flow and aquatic vegetation did not have a significant impact on particle size, TP, or labile P fractions. Median (p = 0.10) particle size was not significantly correlated to TP. Overall, there was an average trend of coarser particle size and lower P concentrations in the inflow compared to the outflow. The presence of inorganic limerock could have affected results due to increased P adsorption capacity and larger average particle size compared to the organic fraction of the sediment.	[Capasso, Jay] Univ Florida, UF FAS Columbia Cty Extens, Lake City, FL USA; [Bhadha, Jehangir H.; Khatiwada, Raju; Lang, Timothy] Univ Florida, Everglades Res & Educ Ctr, Soil & Water Sci Dept, Belle Glade, FL 33430 USA; [Bhadha, Jehangir H.; Bacon, Allan; Vardanyan, Lilit; Pachon, Julio; Clark, Mark] Univ Florida, Soil & Water Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bhadha, JH (corresponding author), Univ Florida, Everglades Res & Educ Ctr, Soil & Water Sci Dept, Belle Glade, FL 33430 USA.; Bhadha, JH (corresponding author), Univ Florida, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	jango@ufl.edu	Bhadha, Jehangir/AAR-6075-2020	Bhadha, Jehangir/0000-0002-9436-1725; Capasso, Jay/0000-0002-1721-3083; K, Raju/0000-0003-4470-6374; Vardanyan, Lilit/0000-0002-0026-9646	U.S. Environmental Protection Agency - Florida Department of Environmental Protection for the Nonpoint Source Management Program [G0434, 319H]	U.S. Environmental Protection Agency - Florida Department of Environmental Protection for the Nonpoint Source Management Program	This study was funded by the U.S. Environmental Protection Agency - Florida Department of Environmental Protection for the Nonpoint Source Management Program (319H), agreement number G0434 to JHB. Wedgworth Farm and TRU-FLOW Corporation provided the land and hydraulic pumps for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, USDA SUBS STUD EV AG; Bhadha JH, 2015, J AQUAT PLANT MANAGE, V53, P44; Bhadha JH, 2014, J SOIL SEDIMENT, V14, P991, DOI 10.1007/s11368-013-0832-x; Bhadha JH, 2010, SOIL SCI SOC AM J, V74, P1816, DOI 10.2136/sssaj2010.0063; Brix H, 1997, WATER SCI TECHNOL, V35, P11, DOI 10.1016/S0273-1223(97)00047-4; Cade-Menun BJ, 1996, SOIL SCI, V161, P770, DOI 10.1097/00010694-199611000-00006; Childers DL, 2003, J ENVIRON QUAL, V32, P344, DOI 10.2134/jeq2003.0344; COLE C. V., 1959, SOIL SCI SOC AMER PROC, V23, P119; Dalal R. C., 1977, Advances in Agronomy, V29, P83; Daroub SH, 2002, PARTICULATE PHOSPHOR, V197; Daroub SH, 2016, ANN REPORT SUBMITTED; Das J, 2012, WATER AIR SOIL POLL, V223, P2865, DOI 10.1007/s11270-012-1152-2; Das J, 2012, J SOIL SEDIMENT, V12, P952, DOI 10.1007/s11368-012-0508-y; DONG A, 1983, WATER RES, V17, P569, DOI 10.1016/0043-1354(83)90116-1; Eshel G, 2004, SOIL SCI SOC AM J, V68, P736, DOI 10.2136/sssaj2004.0736; Gunderson Lance H., 1994, P323; HEDLEY MJ, 1982, SOIL BIOL BIOCHEM, V14, P377, DOI 10.1016/0038-0717(82)90009-8; House WA, 2002, SCI TOTAL ENVIRON, V282, P341, DOI 10.1016/S0048-9697(01)00923-8; Huang LD, 2012, J SOIL SEDIMENT, V12, P443, DOI 10.1007/s11368-011-0455-z; Huffman SA, 1996, SOIL SCI SOC AM J, V60, P1095, DOI 10.2136/sssaj1996.03615995006000040019x; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; OHALLORAN IP, 1985, CAN J SOIL SCI, V65, P475, DOI 10.4141/cjss85-051; Reddy KR, 1998, SOIL SCI SOC AM J, V62, P1134, DOI 10.2136/sssaj1998.03615995006200040039x; REDDY KR, 1983, AGR ECOSYST ENVIRON, V9, P373, DOI 10.1016/0167-8809(83)90022-1; Rice R, 2013, PROC FL STATE HORTIC, V126, P300; Rice RW, 2005, SSAGR246 U FLOR; Snyder G.H., 1994, EVERGLADES AGR AREA, V3, P27; Snyder GH, 2005, EVERGLADES AGR AREA; Suner L., 2015, INT J PLANT SOIL SCI, V7, P109, DOI [10.9734/IJPSS/2015/16939, DOI 10.9734/IJPSS/2015/16939]; Turner BL, 2005, TALANTA, V66, P294, DOI 10.1016/j.talanta.2004.11.012; Turner BL, 2003, SOIL SCI SOC AM J, V67, P497, DOI 10.2136/sssaj2003.0497; United States Environmental Protection Agency, 1993, 33651 USEPA; Villapando RR, 2001, SOIL SCI SOC AM J, V65, P331, DOI 10.2136/sssaj2001.652331x; Zheng Z, 2003, CAN J SOIL SCI, V83, P395, DOI 10.4141/S02-073; Zhu YR, 2013, ENVIRON EARTH SCI, V68, P1041, DOI 10.1007/s12665-012-1806-9; Zobeck TM, 2004, APPL ENG AGRIC, V20, P633	36	2	2	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227489	10.1371/journal.pone.0227489	http://dx.doi.org/10.1371/journal.pone.0227489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929553	Green Published, gold			2022-12-26	WOS:000534352500039
J	Vlerick, L; Devreese, M; Peremans, K; Dockx, R; Croubels, S; Duchateau, L; Polis, I				Vlerick, Lise; Devreese, Mathias; Peremans, Kathelijne; Dockx, Robrecht; Croubels, Siska; Duchateau, Luc; Polis, Ingeborgh			Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; RANDOMIZED CONTROLLED-TRIAL; 5-HT2A RECEPTOR-BINDING; CONSTANT-RATE-INFUSION; S-KETAMINE; SEPARATION ANXIETY; DRUG-DELIVERY; SEVERE PAIN; NORKETAMINE; MIDAZOLAM	Intranasal ketamine has recently gained interest in human medicine, not only for its sedative, anaesthetic or analgesic properties, but also in the management of treatment resistant depression, where it has been shown to be an effective, fast acting alternative treatment. Since several similarities are reported between human psychiatric disorders and canine anxiety disorders, intranasal ketamine could serve as an alternative treatment for anxiety disordered dogs. However, to the authors knowledge, intranasal administration of ketamine and its pharmacokinetics have never been described in dogs. Therefore, this study aimed to examine the pharmacokinetics, absolute bioavailability and tolerability of intranasal ketamine administration compared with intravenous administration. Seven healthy, adult laboratory Beagle dogs were included in this randomized crossover study. The dogs received 2 mg/kg body weight ketamine intravenously (IV) or intranasally (IN), with a two-week washout period. Prior to ketamine administration, dogs were sedated intramuscularly with dexmedetomidine. Venous blood samples were collected at fixed times until 480 min post-administration and ketamine plasma concentrations were determined by liquid chromatographytandem mass spectrometry. Cardiovascular parameters and sedation scores were recorded at the same time points. Non-compartmental pharmacokinetic analysis revealed a rapid (Tmax = 0.25 +/- 0.14 h) and complete IN bioavailability (F = 147.65 +/- 49.97%). Elimination half-life was similar between both administration routes (T1/2el IV = 1.47 +/- 0.24 h, T1/2el IN = 1.50 +/- 0.97 h). Heart rate and sedation scores were significantly higher at 5 and 10 min following IV administration compared to IN administration, but not at the later time-points.	[Vlerick, Lise; Polis, Ingeborgh] Univ Ghent, Fac Vet Med, Small Anim Dept, Merelbeke, Belgium; [Devreese, Mathias; Croubels, Siska] Univ Ghent, Dept Pharmacol Toxicol & Biochem, Fac Vet Med, Merelbeke, Belgium; [Peremans, Kathelijne; Dockx, Robrecht] Univ Ghent, Fac Vet Med, Dept Vet Med Imaging & Small Anim Orthopaed, Merelbeke, Belgium; [Dockx, Robrecht] Univ Ghent, Ghent Expt Psychiat GHEP Lab, Dept Psychiat & Med Psychol, Ghent, Belgium; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Biometr Res Ctr, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University	Vlerick, L (corresponding author), Univ Ghent, Fac Vet Med, Small Anim Dept, Merelbeke, Belgium.	lise.vlerick@ugent.be		Croubels, Siska/0000-0001-6357-3517	Ghent University [01D26115]	Ghent University(Ghent University)	Funding for this study was provided by Special Research Fund Grant from the Ghent University (https://www.ugent.be/nl/onderzoek/financiering/bof., No 01D26115, assigned to LV). The Ghent University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi SK, 2013, NEUROLOGY, V80, P642, DOI 10.1212/WNL.0b013e3182824e66; Andrade C, 2015, J CLIN PSYCHIAT, V76, pE628, DOI 10.4088/JCP.15f10026; Beata C, 2007, J VET BEHAV, V2, P175, DOI 10.1016/j.jveb.2007.08.001; Bergadano A, 2009, VET J, V182, P252, DOI 10.1016/j.tvjl.2008.06.003; Bjorkman S, 2000, J PHARM PHARMACOL, V52, P1065, DOI 10.1211/0022357001774985; BUHRER M, 1994, ANESTHESIOLOGY, V80, P1216; Canpolat I, 2016, INT J DEV RES, V6, P8634; Canuso CM, 2018, AM J PSYCHIAT, V175, P620, DOI 10.1176/appi.ajp.2018.17060720; Charalambous M, 2017, J VET INTERN MED, V31, P1149, DOI 10.1111/jvim.14734; Daly EJ, 2018, JAMA PSYCHIAT, V75, P139, DOI 10.1001/jamapsychiatry.2017.3739; Deckersbach T, 2006, J NEUROIMAGING, V16, P1, DOI 10.1177/1051228405001474; Devreese M, 2015, J IRAN CHEM SOC, V12, P1357, DOI 10.1007/s13738-015-0601-4; Eren I, 2003, PSYCHIAT RES-NEUROIM, V123, P135, DOI 10.1016/S0925-4927(03)00062-3; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Graudins A, 2015, ANN EMERG MED, V65, P248, DOI 10.1016/j.annemergmed.2014.09.024; Gurney M, 2009, J SMALL ANIM PRACT, V50, P474, DOI 10.1111/j.1748-5827.2009.00786.x; Holcomb HH, 2001, NEUROPSYCHOPHARMACOL, V25, P165, DOI 10.1016/S0893-133X(01)00229-9; Holcomb HH, 2005, NEUROPSYCHOPHARMACOL, V30, P2275, DOI 10.1038/sj.npp.1300824; Huge V, 2010, EUR J PAIN, V14, P387, DOI 10.1016/j.ejpain.2009.08.002; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Jarnum H, 2011, ACTA PSYCHIAT SCAND, V124, P435, DOI 10.1111/j.1600-0447.2011.01766.x; Kaka U, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0815-4; Kastner S. B. R., 2016, BSAVA MANUAL CANINE, P190; Landsberg GM, 2008, J VET BEHAV, V3, P12, DOI 10.1016/j.jveb.2007.09.001; Lapidus KAB, 2014, BIOL PSYCHIAT, V76, P970, DOI 10.1016/j.biopsych.2014.03.026; Lawrence CJ, 1996, ANESTH ANALG, V83, P1160, DOI 10.1097/00000539-199612000-00005; Malinovsky JM, 1996, BRIT J ANAESTH, V77, P203, DOI 10.1093/bja/77.2.203; Marjani M, 2015, VET ANAESTH ANALG, V42, P178, DOI 10.1111/vaa.12183; Mintun MA, 2004, BIOL PSYCHIAT, V55, P217, DOI 10.1016/j.biopsych.2003.08.015; Murrell J C, 2016, BSAVA MANUAL CANINE, P170, DOI DOI 10.22233/9781910443231.13; Musulin SE, 2011, J VET PHARMACOL THER, V34, P17, DOI 10.1111/j.1365-2885.2010.01186.x; Nielsen BN, 2014, PEDIATR ANESTH, V24, P170, DOI 10.1111/pan.12268; Orr HE, 2005, VET ANAESTH ANALG, V32, P271, DOI 10.1111/j.1467-2995.2005.00211.x; Pandey R, 2015, J CLIN PEDIATR DENT, V36, P79; Pollak TA, 2015, PSYCHOPHARMACOLOGY, V232, P4515, DOI 10.1007/s00213-015-4078-8; Pypendop BH, 2005, AM J VET RES, V66, P2034, DOI 10.2460/ajvr.2005.66.2034; Riediger C, 2015, J PAIN RES, V8, P87, DOI 10.2147/JPR.S75928; Roelofse J A, 2004, Anesth Prog, V51, P114; Rogers MA, 2004, NEUROSCI RES, V50, P1, DOI 10.1016/j.neures.2004.05.003; Romagnoli N, 2017, RES VET SCI, V112, P208, DOI 10.1016/j.rvsc.2017.05.005; Rowland LM, 2010, PSYCHOPHARMACOLOGY, V208, P575, DOI 10.1007/s00213-009-1758-2; Sandbaumhuter FA, 2016, J CHROMATOGR A, V1467, P436, DOI 10.1016/j.chroma.2016.07.060; Sarrau S, 2007, J SMALL ANIM PRACT, V48, P670, DOI 10.1111/j.1748-5827.2007.00362.x; Sherman BL, 2008, VET CLIN N AM-SMALL, V38, P1081, DOI 10.1016/j.cvsm.2008.04.012; Shimonovich S, 2016, BMC EMERG MED, V16, P1, DOI 10.1186/s12873-016-0107-0; Takeuchi Y, 2000, J AM VET MED ASSOC, V217, P342, DOI 10.2460/javma.2000.217.342; Tobias JD, 2012, PEDIATR CRIT CARE ME, V13, P423, DOI 10.1097/PCC.0b013e318238b81c; Trivedi S, 2016, J CLIN DIAGN RES, V10, pUC1, DOI 10.7860/JCDR/2016/18397.8225; Vermeire S, 2009, BRAIN IMAGING BEHAV, V3, P342, DOI 10.1007/s11682-009-9076-1; Vermeire ST, 2009, J NUCL MED, V50, P284, DOI 10.2967/jnumed.108.055731; Vlerick L, 2019, PSYCHIAT RES-NEUROIM, V285, P18, DOI 10.1016/j.pscychresns.2019.01.005; Vlerick L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209316; Waelbers T, 2015, J VET BEHAV, V10, P332, DOI 10.1016/j.jveb.2015.03.009; Wagner AE, 2002, J AM VET MED ASSOC, V221, P72, DOI 10.2460/javma.2002.221.72; Weber F, 2003, CAN J ANAESTH, V50, P470, DOI 10.1007/BF03021058; Weiland LC, 2017, VET ANAESTH ANALG, V44, P98, DOI 10.1111/vaa.12408; Wong YC, 2010, PHARM RES-DORDR, V27, P1208, DOI 10.1007/s11095-010-0127-5; Yanagihara Y, 2003, BIOPHARM DRUG DISPOS, V24, P37, DOI 10.1002/bdd.336; Yatham LN, 2000, ARCH GEN PSYCHIAT, V57, P850, DOI 10.1001/archpsyc.57.9.850; Yeaman F, 2014, EMERG MED AUSTRALAS, V26, P237, DOI 10.1111/1742-6723.12173	61	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227762	10.1371/journal.pone.0227762	http://dx.doi.org/10.1371/journal.pone.0227762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929589	Green Published, gold			2022-12-26	WOS:000534352500071
J	Garcia-Vazquez, V; Calvo, FA; Ledesma-Carbayo, MJ; Sole, CV; Calvo-Haro, J; Desco, M; Pascau, J				Garcia-Vazquez, Veronica; Calvo, Felipe A.; Ledesma-Carbayo, Maria J.; Sole, Claudio V.; Calvo-Haro, Jose; Desco, Manuel; Pascau, Javier			Intraoperative computed tomography imaging for dose calculation in intraoperative electron radiation therapy: Initial clinical observations	PLOS ONE			English	Article							BEAM RADIOTHERAPY; TRANSPORTATION; RATIONALE; DOSIMETRY; IMPACT	In intraoperative electron radiation therapy (IOERT) the energy of the electron beam is selected under the conventional assumption of water-equivalent tissues at the applicator end. However, the treatment field can deviate from the theoretic flat irradiation surface, thus altering dose profiles. This patient-based study explored the feasibility of acquiring intraoperative computed tomography (CT) studies for calculating three-dimensional dose distributions with two factors not included in the conventional assumption, namely the air gap from the applicator end to the irradiation surface and tissue heterogeneity. In addition, dose distributions under the conventional assumption and from preoperative CT studies (both also updated with intraoperative data) were calculated to explore whether there are other alternatives to intraoperative CT studies that can provide similar dose distributions. The IOERT protocol was modified to incorporate the acquisition of intraoperative CT studies before radiation delivery in six patients. Three studies were not valid to calculate dose distributions due to the presence of metal artefacts. For the remaining three cases, the average gamma pass rates between the doses calculated from intraoperative CT studies and those obtained assuming water-equivalent tissues or from preoperative CT studies were 73.4% and 74.0% respectively. The agreement increased when the air gap was included in the conventional assumption (98.1%) or in the preoperative CT images (98.4%). Therefore, this factor was the one mostly influencing the dose distributions of this study. Our experience has shown that intraoperative CT studies are not recommended when the procedure includes the use of shielding discs or surgical retractors unless metal artefacts are removed. IOERT dose distributions calculated under the conventional assumption or from preoperative CT studies may be inaccurate unless the air gap (which depends on the surface irregularities of the irradiated volume and on the applicator pose) is included in the calculations.	[Garcia-Vazquez, Veronica; Calvo, Felipe A.; Sole, Claudio V.; Calvo-Haro, Jose; Desco, Manuel; Pascau, Javier] Inst Invest Sanitaria Gregorio Maranon, Madrid, Comunidad De Ma, Spain; [Calvo, Felipe A.] Hosp Gen Univ Gregorio Maranon, Dept Oncol, Madrid, Comunidad De Ma, Spain; [Calvo, Felipe A.] Univ Complutense Madrid, Fac Med, Madrid, Comunidad De Ma, Spain; [Calvo, Felipe A.] Clin Univ Navarra, Madrid, Comunidad De Ma, Spain; [Ledesma-Carbayo, Maria J.] Univ Politecn Madrid, Escuela Tecn Super Ingn Telecomunicac, Biomed Image Technol Lab BIT, Madrid, Comunidad De Ma, Spain; [Ledesma-Carbayo, Maria J.] CIBER BBN, Madrid, Comunidad De Ma, Spain; [Sole, Claudio V.] Inst Radiomed, Dept Radiat Oncol, Santiago, Region Metropol, Chile; [Calvo-Haro, Jose] Hosp Gen Univ Gregorio Maranon, Serv Cirugra Ortoped & Traumatol, Madrid, Comunidad De Ma, Spain; [Calvo-Haro, Jose] Univ Complutense Madrid, Fac Med, Dept Cirugra, Madrid, Comunidad De Ma, Spain; [Desco, Manuel; Pascau, Javier] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Comunidad De Ma, Spain; [Desco, Manuel] Ctr Invest Biorned Red Salud Mental CIBERSAM, Madrid, Comunidad De Ma, Spain; [Desco, Manuel] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Comunidad De Ma, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; University of Navarra; Universidad Politecnica de Madrid; ETS de Ingenieros de Telecomunicacion; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; General University Gregorio Maranon Hospital; Complutense University of Madrid; Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Garcia-Vazquez, V; Pascau, J (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Comunidad De Ma, Spain.; Pascau, J (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Comunidad De Ma, Spain.	vgarcia@hggm.es; jpascau@ing.uc3m.es	García-Vázquez, Verónica/L-3446-2017; Ledesma-Carbayo, Maria J/D-5529-2009; Pascau, Javier/B-5734-2013	García-Vázquez, Verónica/0000-0002-8140-3527; Ledesma-Carbayo, Maria J/0000-0001-6846-3923; Pascau, Javier/0000-0003-1484-731X; Vazquez-Garcia, Veronica/0000-0002-0689-4397	Ministerio de Ciencia, Innovacion y Universidades [TEC201348251-C2]; European Regional Development Fund (ERDF), "A way of making Europe"; Ministerio de Ciencia, Innovacion y Universidades; Instituto de Salud Carlos III [DTS14/00192, PI15/02121, PI18/01625]; Comunidad de Madrid [TOPUS-CM S2013/MIT3024]; European Structural and Investment Fund; Pro CNIC Foundation	Ministerio de Ciencia, Innovacion y Universidades; European Regional Development Fund (ERDF), "A way of making Europe"; Ministerio de Ciencia, Innovacion y Universidades; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); European Structural and Investment Fund; Pro CNIC Foundation	This study was supported by Ministerio de Ciencia, Innovacion y Universidades (http://www.ciencia.gob.es) [grant number TEC201348251-C2 to JP, VG-V and MJL-C], co-funded by European Regional Development Fund (ERDF), "A way of making Europe"(https://ec.europa.eu/regional_policy/en/funding/erdf); by Ministerio de Ciencia, Innovacion y Universidades (http://www.ciencia.gob.es), Instituto de Salud Carlos III (https://www.isciii.es) [grant numbers DTS14/00192 to JP, VG-V and FAC; PI15/02121 to FAC and JC-H; PI18/01625 to JP], co-funded by European Regional Development Fund (ERDF), "A way of making Europe" (https://ec.europa.eu/regional_policy/en/funding/erdf); and by Comunidad de Madrid (http://www.comunidad.madrid) [grant number TOPUS-CM S2013/MIT3024 to JP], co-funded by European Structural and Investment Fund (https://ec.europa.eu/info/funding-tenders/funding-opportunities/fundingprogrammes/overview-funding-programmes_en).The CNIC is supported by the Ministerio de Ciencia, Innovacio ' n y Universidades (http://www.ciencia.gob.es) and the Pro CNIC Foundation (https://www.fundacionprocnic.es) [to MD], and is a Severo Ochoa Center of Excellence (SEV-20150505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamada H, 2019, PHYS MEDICA, V57, P207, DOI 10.1016/j.ejmp.2018.12.037; Bresciani S, 2013, MED PHYS, V40, DOI 10.1118/1.4829515; Calvo FA, 2013, CLIN TRANSL ONCOL, V15, P683, DOI 10.1007/s12094-013-1019-z; Calvo FA, 2006, CRIT REV ONCOL HEMAT, V59, P106, DOI 10.1016/j.critrevonc.2005.11.004; Calvo FA, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0764-5; Consorti R, 2005, INT J RADIAT ONCOL, V63, P952, DOI 10.1016/j.ijrobp.2005.02.049; Costa F, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160193; Costa F, 2015, PHYS MEDICA, V31, P692, DOI 10.1016/j.ejmp.2015.05.013; Garcia-Vazquez V, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1181-0; Garcia-Vazquez V, 2017, Z MED PHYS, V27, P218, DOI 10.1016/j.zemedi.2016.07.002; Giantsoudi D, 2017, PHYS MED BIOL, V62, DOI 10.1088/1361-6560/aa5293; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Guerra P, 2014, PHYS MED BIOL, V59, P7159, DOI 10.1088/0031-9155/59/23/7159; Gunderson LL, 2011, CURR CLIN ONCOL, P3, DOI 10.1007/978-1-61779-015-7_1; Hensley FW, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-016-0754-z; Herranz E, 2015, PHYS MED BIOL, V60, P375, DOI 10.1088/0031-9155/60/1/375; Khan F.M., 2014, KHANS PHYS RAD THERA, P256; Lopez-Tarjuelo J, 2014, RADIOTHER ONCOL, V113, P283, DOI 10.1016/j.radonc.2014.11.012; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Nemoto K, 2003, INT J RADIAT ONCOL, V55, P1102, DOI 10.1016/S0360-3016(02)04513-3; Oshima T, 2009, PHYS MED BIOL, V54, P3491, DOI 10.1088/0031-9155/54/11/014; Pascau J, 2011, INT J RADIAT ONCOL, V81, pS90, DOI 10.1016/j.ijrobp.2011.06.184; Pascau J., 2006, SCI PAPERS MOL IMAGI, V8, P97; Pascau J, 2012, INT J RADIAT ONCOL, V83, pE287, DOI 10.1016/j.ijrobp.2011.12.063; Pascau J, 2009, MOL IMAGING BIOL, V11, P107, DOI 10.1007/s11307-008-0166-z; Rankin TM, 2014, J SURG RES, V189, P193, DOI 10.1016/j.jss.2014.02.020; Soriani A, 2012, MED PHYS, V39, P6080, DOI 10.1118/1.4749968; Trifiletti DM, 2015, FUTURE ONCOL, V11, P1047, DOI 10.2217/fon.15.26; Valdivieso-Casique MF, 2015, TRANSL CANCER RES, V4, P196, DOI 10.3978/j.issn.2218-676X.2015.04.05	29	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227155	10.1371/journal.pone.0227155	http://dx.doi.org/10.1371/journal.pone.0227155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923183	gold, Green Published			2022-12-26	WOS:000534350000049
J	Iannuzzi, A; Braun, M; Genualdo, V; Perucatti, A; Reinartz, S; Proios, I; Heppelmann, M; Rehage, J; Hulskotter, K; Beineke, A; Metzger, J; Distl, O				Iannuzzi, Alessandra; Braun, Marina; Genualdo, Viviana; Perucatti, Angela; Reinartz, Sina; Proios, Ioannis; Heppelmann, Maike; Rehage, Juergen; Huelskoetter, Kirsten; Beineke, Andreas; Metzger, Julia; Distl, Ottmar			Clinical, cytogenetic and molecular genetic characterization of a tandem fusion translocation in a male Holstein cattle with congenital hypospadias and a ventricular septal defect	PLOS ONE			English	Article							MATE GENITOURINARY SYSTEM; URETHRAL DIVERTICULUM; PERINEAL HYPOSPADIA; FISH; CHROMOSOME; GENOME; DOG; CRYPTORCHIDISM; ABNORMALITIES; CONSEQUENCES	Hypospadias, disorder of sex development (DSD), is a sporadic congenital abnormality of the genital region in male ruminants, which is characterized by a non-fused urethra during fetal development. Detailed clinical examination classified the hypospadias phenotype of a male Holstein calf studied here as the perineal type. In combined use of cytogenetic analysis and whole genome sequencing, a non-mosaic, pseudo-monosomy 59, XY + tan(18;27) was detected. This chromosomal aberration had its origin in a tandem fusion translocation of the bovine autosomes (BTA) 18 and 27 with an accompanying loss of genomic sequences mainly in the distal end of BTA 18 and the proximal end of BTA 27. The resulting phenotype included hypospadias, growth retardation and ventricular septal defect.	[Iannuzzi, Alessandra; Genualdo, Viviana; Perucatti, Angela] Natl Res Council CNR, Inst Anim Prod Syst Mediterranean Environm ISPAAM, Naples, Italy; [Braun, Marina; Reinartz, Sina; Metzger, Julia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Proios, Ioannis; Heppelmann, Maike; Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Huelskoetter, Kirsten; Beineke, Andreas] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de	Perucatti, Angela/B-7743-2015; Iannuzzi, Alessandra/B-8085-2015	Perucatti, Angela/0000-0003-4642-9921; Proios, Ioannis/0000-0003-2020-5807; Hulskotter, Kirsten/0000-0003-1577-5856	North-German Supercomputing Alliance (HLRN)	North-German Supercomputing Alliance (HLRN)	The authors wish to thank Prof. L. Iannuzzi (CNR-ISPAAM) for his interest and criticism to the present study. The excellent support in laboratory work of M.C. Codjia Risch, M. Drabert, H. Klippert-Hasberg, and N. Wagner (Institute for Animal Breeding and Genetics, University of Veterinary Medicine Hannover, Hannover), as well as support in computational (J. Wrede, Institute for Animal Breeding and Genetics, University of Veterinary Medicine Hannover, Hannover) and cytogenetic (D. Incarnato and C. Rossetti, CNR-ISPAAM, Naples) analyses are greatly appreciated. We gratefully acknowledge support from the North-German Supercomputing Alliance (HLRN) for HPC-resources that contributed to the research results.	Alam MR, 2005, VET MED-CZECH, V50, P506, DOI 10.17221/5655-VETMED; Almind GJ, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-6; Almubarak AM, 2016, PENILE URETHRAL HYPO; Aslan Halil, 2003, BMC Pregnancy Childbirth, V3, P1, DOI 10.1186/1471-2393-3-1; Belligni EF, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-9; Berry DP, 2017, J ANIM SCI, V95, P1042, DOI 10.2527/jas.2016.1279; Bleul U, 2007, VET J, V173, P679, DOI 10.1016/j.tvjl.2006.03.005; Bokhari SG, 2013, J ANIM PLANT SCI, V23, P675; Braun M, 2018, ANIM GENET, V49, P349, DOI 10.1111/age.12669; Brink P, 2011, VET SURG, V40, P120, DOI 10.1111/j.1532-950X.2010.00762.x; BRUERE AN, 1969, CYTOGENETICS, V8, P148, DOI 10.1159/000130031; Buczinski S, 2006, CAN VET J, V47, P246; Cassata R, 2008, CYTOGENET GENOME RES, V120, P140, DOI 10.1159/000118753; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; De Lorenzi L, 2010, SEX DEV, V4, P352, DOI 10.1159/000319527; Ducos A, 2008, CYTOGENET GENOME RES, V120, P26, DOI 10.1159/000118738; Eggen A, 2001, GENET SEL EVOL, V33, P543, DOI 10.1051/gse:2001132; El-Din MMM., 2014, SCH J AGR VET SCI, V1, P288; Fiorentino F, 2014, HUM REPROD, V29, P2802, DOI 10.1093/humrep/deu277; Fredell L, 2002, HUM GENET, V111, P231, DOI 10.1007/s00439-002-0799-y; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Garcia Nilda M, 2006, J Pediatr Urol, V2, P233, DOI 10.1016/j.jpurol.2006.03.006; Genualdo V, 2018, LIVEST SCI, V216, P36, DOI 10.1016/j.livsci.2018.07.005; GOLDBLATT J, 1987, AM J DIS CHILD, V141, P1168, DOI 10.1001/archpedi.1987.04460110038017; Hayes H, 2000, CYTOGENET CELL GENET, V90, P315, DOI 10.1159/000056795; Herzog A., 2001, PAREYS LEXIKON SYNDR; HORIIKE S, 1990, CANCER, V65, P1350, DOI 10.1002/1097-0142(19900315)65:6<1350::AID-CNCR2820650617>3.0.CO;2-J; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P27, DOI 10.1016/j.bjps.2003.08.019; Hynes PJ, 2004, BRIT J PLAST SURG, V57, P112, DOI 10.1016/j.bjps.2003.08.018; Iannuzzi A, 2014, CYTOGENET GENOME RES, V142, P174, DOI 10.1159/000361000; Iannuzzi A, 2013, CYTOGENET GENOME RES, V139, P97, DOI 10.1159/000346193; Iannuzzi A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180158; Iannuzzi A, 2015, CYTOGENET GENOME RES, V146, P222, DOI 10.1159/000438973; Iannuzzi L, 2001, HEREDITAS, V134, P147, DOI 10.1111/j.1601-5223.2001.00147.x; Jeong WonSeok, 2008, Journal of Veterinary Clinics, V25, P557; Jurka P, 2009, VET REC, V164, P331, DOI 10.1136/vr.164.11.331; Kalfa N, 2009, INT J ANDROL, V32, P187, DOI 10.1111/j.1365-2605.2008.00899.x; King GJ, 2000, J SMALL ANIM PRACT, V41, P508, DOI 10.1111/j.1748-5827.2000.tb03973.x; KLUTH D, 1988, J PEDIATR SURG, V23, P1095, DOI 10.1016/S0022-3468(88)80322-1; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KUMIDIAKA J, 1979, THERIOGENOLOGY, V11, P163, DOI 10.1016/0093-691X(79)90068-2; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maiti SK, 2018, IRAN J VET RES, V19, P57; Mariat D, 2001, CYTOGENET CELL GENET, V92, P144, DOI 10.1159/000056886; McFARLAND L Z, 1958, J Am Vet Med Assoc, V133, P81; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Meinecke B, 2003, PLACENTA, V24, P107, DOI 10.1053/plac.2002.0872; Metzger J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4877-5; Mihsler L, 2015, TIERAERZTL PRAX G N, V43, P105, DOI 10.15653/TPG-140945; Misk NA, 2013, INT J VET MED RES RE; Murakami T., 2008, Journal of the Japan Veterinary Medical Association, V61, P931; Nassar N, 2007, ARCH DIS CHILD, V92, P580, DOI 10.1136/adc.2006.112862; NIGAM JM, 1984, AGRI-PRACTICE, V5, P38; Omidi A., 2011, Comparative Clinical Pathology, V20, P417, DOI 10.1007/s00580-010-1143-x; Pamuk K, 2010, KOCATEPE VETERINARY, V3; Park YongSang, 2012, Journal of Veterinary Clinics, V29, P352; Phiri A., 2016, INT J LIVEST RES, V6, P98; PINHEIRO LEL, 1995, HEREDITAS, V122, P99, DOI 10.1111/j.1601-5223.1995.00099.x; POPESCU CP, 1977, ANN GENET SEL ANIM, V9, P463, DOI 10.1186/1297-9686-9-4-463; Rahal SC, PERINEAL HYPOSPADIAS; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Richard MA, 2019, BIRTH DEFECTS RES, V111, P932, DOI 10.1002/bdr2.1522; Riegel M, 2005, EUR J MED GENET, V48, P167, DOI 10.1016/j.ejmg.2005.01.026; Roder P, 1929, BERL TIERARZTL WOCHE, V47, P797; Sakhaee E, 2009, IRAN J VET RES, V10, P298; Sandeep Potliya, 2016, Haryana Veterinarian, V55, P118; SAUNDERS PJ, 1978, AUST VET J, V54, P10, DOI 10.1111/j.1751-0813.1978.tb00261.x; Schwarzenbacher H, FRAME SHIFT MUTATION; Smith K, 2006, VET RECORD J BRIT VE, V158; Smith KC, 2012, REPROD DOMEST ANIM, V47, P740, DOI 10.1111/j.1439-0531.2011.01952.x; Stratmann N, 2004, TIERARZTL PRAX K H, V32, P294; Switonski M, 2012, SEX DEV, V6, P128, DOI 10.1159/000330921; Switonski M, 2011, SEXUAL DEV GENETICS, V6, P128; Switonski M, 2018, SEX DEV, V12, P244, DOI 10.1159/000490079; Thauvin-Robinet C, 2004, AM J MED GENET A, V126A, P303, DOI 10.1002/ajmg.a.20596; Torres AAA, 2017, BRAZILIAN J VET PATH, V6, P65; Usta Z., 2017, Ataturk Universitesi Veteriner Bilimleri Dergisi, V12, P195; van der Zanden LFM, 2012, HUM REPROD UPDATE, V18, P260, DOI 10.1093/humupd/dms002; van der Zanden LFM, 2011, NAT GENET, V43, P48, DOI 10.1038/ng.721; Veena P., 2011, Journal of Advanced Veterinary Research, V1, P76; Vidal G, 2011, JAVMA-J AM VET MED A, V239, P1295, DOI 10.2460/javma.239.10.1295; Volpato R, 2013, J BUFFALO SCI, V2, P85; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Zneimer SM, 2000, CLIN GENET, V58, P129, DOI 10.1034/j.1399-0004.2000.580207.x	86	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227117	10.1371/journal.pone.0227117	http://dx.doi.org/10.1371/journal.pone.0227117			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923267	Green Published, gold			2022-12-26	WOS:000534350000043
J	Ohkuma, R; Yada, E; Ishikawa, S; Komura, D; Ishizaki, H; Tamada, K; Kubota, Y; Hamada, K; Ishida, H; Hirasawa, Y; Ariizumi, H; Satoh, E; Shida, M; Watanabe, M; Onoue, R; Ando, K; Tsurutani, J; Yoshimura, K; Yokobori, T; Sasada, T; Aoki, T; Murakami, M; Norose, T; Ohike, N; Takimoto, M; Izumizaki, M; Kobayashi, S; Tsunoda, T; Wada, S				Ohkuma, Ryotaro; Yada, Erica; Ishikawa, Shumpei; Komura, Daisuke; Ishizaki, Hidenobu; Tamada, Koji; Kubota, Yutaro; Hamada, Kazuyuki; Ishida, Hiroo; Hirasawa, Yuya; Ariizumi, Hirotsugu; Satoh, Etsuko; Shida, Midori; Watanabe, Makoto; Onoue, Rie; Ando, Kiyohiro; Tsurutani, Junji; Yoshimura, Kiyoshi; Yokobori, Takehiko; Sasada, Tetsuro; Aoki, Takeshi; Murakami, Masahiko; Norose, Tomoko; Ohike, Nobuyuki; Takimoto, Masafumi; Izumizaki, Masahiko; Kobayashi, Shinichi; Tsunoda, Takuya; Wada, Satoshi			High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer	PLOS ONE			English	Article							HUMAN TUMOR XENOGRAFTS; OLFM4 EXPRESSION; PROTEIN; PROGRESSION; HGC-1; GENE; PROMOTES; MARKER; GW112; DIFFERENTIATION	Pancreatic cancer has an extremely poor prognosis, and identification of novel predictors of therapeutic efficacy and prognosis is urgently needed. Chemoresistance-related molecules are correlated with poor prognosis and may be effective targets for cancer treatment. Here, we aimed to identify novel molecules correlated with chemoresistance and poor prognosis in pancreatic cancer. We established 10 patient-derived xenograft (PDX) lines from patients with pancreatic cancer and performed next-generation sequencing (NGS) of tumor tissues from PDXs after treatment with standard drugs. We established a gene-transferred tumor cell line to express chemoresistance-related molecules and analyzed the chemoresistance of the established cell line against standard drugs. Finally, we performed immunohistochemical (IHC) analysis of chemoresistance-related molecules using 80 pancreatic cancer tissues. From NGS analysis, we identified olfactomedin-4 (OLFM4) as having high expression in the PDX group treated with anticancer drugs. In IHC analysis, OLFM4 expression was also high in PDXs administered anticancer drugs compared with that in untreated PDXs. Chemoresistance was observed by in vitro analysis of tumor cell lines with forced expression of OLFM4. In an assessment of tissue specimens from 80 patients with pancreatic cancer, Kaplan-Meier analysis showed that patients in the low OLFM4 expression group had a better survival rate than patients in the high OLFM4 expression group. Additionally, multivariate analysis showed that high expression of OLFM4 was an independent prognostic factor predicting poor outcomes. Overall, our study revealed that high expression of OLFM4 was involved in chemoresistance and was an independent prognostic factor in pancreatic cancer. OLFM4 may be a candidate therapeutic target in pancreatic cancer.	[Ohkuma, Ryotaro; Shida, Midori; Watanabe, Makoto; Onoue, Rie; Ando, Kiyohiro; Wada, Satoshi] Showa Univ, Dept Clin Diagnost Oncol, Clin Res Inst Clin Pharmacol & Therapeut, Tokyo, Japan; [Ohkuma, Ryotaro; Kubota, Yutaro; Hamada, Kazuyuki; Ishida, Hiroo; Hirasawa, Yuya; Ariizumi, Hirotsugu; Satoh, Etsuko; Tsurutani, Junji; Yoshimura, Kiyoshi; Tsunoda, Takuya; Wada, Satoshi] Showa Univ, Dept Med, Div Med Oncol, Sch Med, Tokyo, Japan; [Ohkuma, Ryotaro; Izumizaki, Masahiko] Showa Univ, Grad Sch Med, Dept Physiol, Tokyo, Japan; [Yada, Erica; Sasada, Tetsuro] Kanagawa Canc Ctr, Res Inst, Yokohama, Kanagawa, Japan; [Ishikawa, Shumpei; Komura, Daisuke] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Ishizaki, Hidenobu] Noile Immune Biotech Inc, Tokyo, Japan; [Tamada, Koji] Yamaguchi Univ, Grad Sch Med, Dept Immunol, Yamaguchi, Japan; [Hirasawa, Yuya] Dept Clin Immuno Oncol, Clin Res Inst Clin Pharmacol & Therapeut, Tokyo, Japan; [Shida, Midori; Watanabe, Makoto; Onoue, Rie; Ando, Kiyohiro; Yoshimura, Kiyoshi; Kobayashi, Shinichi; Wada, Satoshi] Showa Univ, Clin Res Inst Clin Pharmacol & Therapeut, Tokyo, Japan; [Tsurutani, Junji] Showa Univ, Adv Canc Translat Res Inst, Tokyo, Japan; [Yokobori, Takehiko] Gunma Univ, Grad Sch Med, Dept Innovat Immune Oncol Therapeut, Gunma, Japan; [Aoki, Takeshi; Murakami, Masahiko] Showa Univ, Sch Med, Dept Surg, Div Gen & Gastroenterol Surg, Tokyo, Japan; [Norose, Tomoko; Ohike, Nobuyuki; Takimoto, Masafumi] Showa Univ, Sch Med, Dept Pathol & Lab Med, Tokyo, Japan	Showa University; Showa University; Showa University; Kanagawa Prefectural Cancer Center; University of Tokyo; Yamaguchi University; Showa University; Showa University; Gunma University; Showa University; Showa University	Wada, S (corresponding author), Showa Univ, Dept Clin Diagnost Oncol, Clin Res Inst Clin Pharmacol & Therapeut, Tokyo, Japan.; Wada, S (corresponding author), Showa Univ, Dept Med, Div Med Oncol, Sch Med, Tokyo, Japan.; Wada, S (corresponding author), Showa Univ, Clin Res Inst Clin Pharmacol & Therapeut, Tokyo, Japan.	st-wada@med.showa-u.ac.jp	Komura, Daisuke/AAF-2481-2019	Komura, Daisuke/0000-0002-0038-728X; Ohkuma, Ryotaro/0000-0003-4121-2491	Noile-Immune Biotech, Inc.; Noile-Immune Biotech Inc.	Noile-Immune Biotech, Inc.; Noile-Immune Biotech Inc.	This study was funded by Noile-Immune Biotech, Inc. All funding was performed as the collaborative research project and was only used to purchase the reagents and equipment needed for the experiment. The funder had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder also provided support in the form of salaries to HI. The specific roles of these authors are articulated in the 'author contributions' section support in the form of salaries to HI. The specific roles of these authors are articulated in the `author contributions' section.; This study is supported by research funds from Noile-Immune Biotech Inc.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Cecconi D, 2011, PROTEOMICS, V11, P816, DOI 10.1002/pmic.201000401; Chen L, 2011, CARCINOGENESIS, V32, P986, DOI 10.1093/carcin/bgr065; Chidambaram NV, 2000, J INTERF CYTOK RES, V20, P661, DOI 10.1089/107999000414844; Chijiwa T, 2015, INT J ONCOL, V47, P61, DOI 10.3892/ijo.2015.2997; Cho SY, 2016, MOL CELLS, V39, P77, DOI 10.14348/molcells.2016.2350; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Duan C, 2014, J CELL MOL MED, V18, P863, DOI 10.1111/jcmm.12232; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Grover PK, 2010, CANCER METAST REV, V29, P761, DOI 10.1007/s10555-010-9262-z; Guette C, 2015, PROTEOM CLIN APPL, V9, P58, DOI 10.1002/prca.201400083; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Jang BG, 2015, VIRCHOWS ARCH, V467, P285, DOI 10.1007/s00428-015-1793-9; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Kim KK, 2010, MOL CARCINOGEN, V49, P259, DOI 10.1002/mc.20596; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Kobayashi D, 2007, CANCER SCI, V98, P334, DOI 10.1111/j.1349-7006.2007.00397.x; Komura D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3207-z; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ledford H, 2016, NATURE, V530, P391, DOI 10.1038/nature.2016.19364; Li HZ, 2013, AM J PATHOL, V183, P1329, DOI 10.1016/j.ajpath.2013.06.028; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Liu W, 2007, HISTOPATHOLOGY, V51, P157, DOI 10.1111/j.1365-2559.2007.02763.x; Liu WL, 2008, CLIN CANCER RES, V14, P1041, DOI 10.1158/1078-0432.CCR-07-4125; Liu WL, 2006, EXP CELL RES, V312, P1785, DOI 10.1016/j.yexcr.2006.02.011; Luo ZY, 2011, J CANCER RES CLIN, V137, P1713, DOI 10.1007/s00432-011-1042-9; Ma HY, 2016, ONCOTARGET, V7, P10594, DOI 10.18632/oncotarget.7236; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; Mayama A, 2018, CANCER SCI, V109, P3350, DOI 10.1111/cas.13770; Ministry of Health Labour and Welfare Japan, NAT VIT STAT 2017; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seko N, 2010, EXP THER MED, V1, P73, DOI 10.3892/etm_00000013; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Su WM, 2015, HUM PATHOL, V46, P732, DOI 10.1016/j.humpath.2015.01.013; Suguitan Jr AL, 2011, PLOS ONE, V6; Takadate T, 2013, INT J CANCER, V132, P1368, DOI 10.1002/ijc.27797; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang XY, 2018, WORLD J GASTROENTERO, V24, P1881, DOI 10.3748/wjg.v24.i17.1881; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Xiong B, 2017, BIOMED PHARMACOTHER, V86, P67, DOI 10.1016/j.biopha.2016.11.081; Yada E, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0136; Yan HC, 2011, HEPATO-GASTROENTEROL, V58, P1354, DOI 10.5754/hge10623; Yu L, 2011, INT J GYNECOL CANCER, V21, P367, DOI 10.1097/IGC.0b013e31820866fe; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443	54	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226707	10.1371/journal.pone.0226707	http://dx.doi.org/10.1371/journal.pone.0226707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KF6SX	31923206	Green Published, gold			2022-12-26	WOS:000509371300001
J	Srikandarajah, N; Noble, A; Clark, S; Wilby, M; Freeman, BJC; Fehlings, MG; Williamson, PR; Marson, T				Srikandarajah, Nisaharan; Noble, Adam; Clark, Simon; Wilby, Martin; Freeman, Brian J. C.; Fehlings, Michael G.; Williamson, Paula R.; Marson, Tony			Cauda Equina Syndrome Core Outcome Set (CESCOS): An international patient and healthcare professional consensus for research studies	PLOS ONE			English	Article							HERNIATION	Background Cauda Equina Syndrome (CES) is an emergency condition that requires acute intervention and can lead to permanent neurological deficit in working age adults. A Core Outcome Set (COS) is the minimum set of outcomes that should be reported by a research study within a specific disease area. There is significant heterogeneity in outcome reporting for CES, which does not allow data synthesis between studies. The hypothesis is that a COS for CES can be developed for future research studies using patients and healthcare professionals (HCPs) as key stakeholders. Methods and findings Qualitative semi-structured interviews with CES patients were audio-recorded, transcribed and analysed using NVivo to identify the outcomes of importance. These were combined with the outcomes obtained from a published systematic literature review of CES patients. The outcomes were grouped into a list of 37, for rating through two rounds of an international Delphi survey according to pre-set criteria. The Delphi survey had an overall response rate of 63% and included 172 participants (104 patients, 68 HCPs) from 14 countries who completed both rounds. Thirteen outcomes reached consensus at the end of the Delphi survey and there was no attrition bias detected. The results were discussed at an international consensus meeting attended by 34 key stakeholders (16 patients and 18 HCPs) from 8 countries. A further three outcomes were agreed to be included. There was no selection bias detected at the consensus meeting. There are 16 outcomes in total in the CESCOS. Discussion This is the first study in the literature that has determined the core outcomes in CES using a transparent international consensus process involving healthcare professionals and CES patients as key stakeholders. This COS is recommended as the most important outcomes to be reported in any research study investigating CES outcomes and will allow evidence synthesis in CES.	[Srikandarajah, Nisaharan; Marson, Tony] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Noble, Adam] Univ Liverpool, Inst Populat Hlth Sci, Dept Hlth Serv Res, Liverpool, Merseyside, England; [Clark, Simon; Wilby, Martin] Walton Ctr NHS Fdn Trust, Dept Spinal Surg, Liverpool, Merseyside, England; [Freeman, Brian J. C.] Univ Adelaide, Royal Adelaide Hosp, Dept Spinal Surg, Adelaide, SA, Australia; [Fehlings, Michael G.] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Univ Hlth Network, Toronto Western Hosp, Spine Program, Toronto, ON, Canada; [Williamson, Paula R.] Univ Liverpool, Inst Translat Med, MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England	University of Liverpool; University of Liverpool; Walton Centre; Royal Adelaide Hospital; University of Adelaide; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Liverpool	Srikandarajah, N (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England.	nishsri09@gmail.com	Clark, Simon/AAT-5610-2020; Marson, Anthony/AAW-9776-2020	Marson, Anthony/0000-0002-6861-8806; Noble, Adam/0000-0002-8070-4352	Walton Centre charity funds; Coloplast Limited; Cauda Equina Foundation	Walton Centre charity funds; Coloplast Limited; Cauda Equina Foundation	Educational grants from The Walton Centre charity funds, Coloplast Limited, and Cauda Equina Foundation were greatly appreciated to enable the consensus meeting. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn UM, 2000, SPINE, V25, P1515, DOI 10.1097/00007632-200006150-00010; Balasubramanian K, 2010, BRIT J NEUROSURG, V24, P383, DOI 10.3109/02688697.2010.505987; Biggane AM, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2493-y; Blazeby JM, 2015, BRIT J SURG, V102, P936, DOI 10.1002/bjs.9840; Brookes ST, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1479-x; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Daniels EW, 2012, ORTHOPEDICS, V35, pE414, DOI 10.3928/01477447-20120222-15; Dodd S, 2018, J CLIN EPIDEMIOL, V96, P84, DOI 10.1016/j.jclinepi.2017.12.020; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; Fish R, 2018, LANCET GASTROENTEROL, V3, P865, DOI 10.1016/S2468-1253(18)30264-4; Gardner A, 2011, EUR SPINE J, V20, P690, DOI 10.1007/s00586-010-1668-3; Germon T, 2015, SPINE J, V15, p2S, DOI 10.1016/j.spinee.2015.01.006; Gitelman Alex, 2008, Am J Orthop (Belle Mead NJ), V37, P556; Gleave JRW, 2002, BRIT J NEUROSURG, V16, P325, DOI 10.1080/0268869021000032887; Jones JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172937; Keeley T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0553-0; Kirkham JJ, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2262; Kirkham JJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002148; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Korse NS, 2013, EUR SPINE J, V22, P1019, DOI 10.1007/s00586-012-2601-8; Korse NS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175987; Kostuik JP, 1993, CURRENT OPIN ORTHOPA, V4, P125; Prinsen CAC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1555-2; Renzetti C., 1993, RES SENSITIVE TOPICS; Srikandarajah N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024002; Srikandarajah N, 2018, SPINE, V43, pE1005, DOI 10.1097/BRS.0000000000002605; Srikandarajah N, 2015, SPINE, V40, P580, DOI 10.1097/BRS.0000000000000813; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; WILLIAMSON PR, 2017, TRIALS S3, V18, DOI DOI 10.1186/S13063-017-1978-4; Woodfield J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-025230	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0225907	10.1371/journal.pone.0225907	http://dx.doi.org/10.1371/journal.pone.0225907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923259	gold, Green Published			2022-12-26	WOS:000534350000012
J	Westman, G; Schoofs, C; Ingelsson, M; Jarhult, JD; Muradrasoli, S				Westman, Gabriel; Schoofs, Catherine; Ingelsson, Martin; Jarhult, Josef D.; Muradrasoli, Shaman			Torque teno virus viral load is related to age, CMV infection and HLA type but not to Alzheimer's disease	PLOS ONE			English	Article							TT VIRUS; TRANSPLANTATION; ASSOCIATION; HEPATITIS; CHILDREN; VIREMIA; GENES; CELLS; RISK	Torque teno virus (TTV) is an unenveloped, circular, single stranded DNA virus with a genome size of approximately 3.8 kb. Previous studies have demonstrated varying grades of association between TTV DNA levels and immune deficiencies related to age, chronic infections and cancer. Alzheimer's disease (AD) has been related to persistent viral infections such as HSV-1 and CMV, but it is not known whether TTV viral load could serve as a functional biomarker of cellular immunity in this setting. Therefore, the objective of this study was to investigate whether TTV infection and viral load is related to AD status, CMV immunity, systemic inflammation or HLA types connected to anti-viral immunity. A total of 50 AD subjects and 51 non-demented controls were included in the study. AD subjects were diagnosed according to NINCDS-ADRDA and DSM-IV criteria and neuroradiologic findings were consistent with the diagnosis. TTV viral load was analyzed in plasma samples using a quantitative real-time PCR. Using a cut-off for TTV status at 200 copies/ml, 88% (89/101) of the study subjects were classified as TTV positive. TTV viral load significantly increased with age (beta 0.049 per year, p< 0.001) but significantly decreased in relation to CMV IgG levels (beta -0.022 per 1000 units, p = 0.005) and HLA-B27 positivity (beta -0.53, p = 0.023). In conclusion, TTV immune control is not significantly affected by AD status, but appears related to age, CMV humoral immune response and HLA type.	[Westman, Gabriel; Jarhult, Josef D.] Uppsala Univ, Dept Med Sci, Sect Infect Dis, Uppsala, Sweden; [Schoofs, Catherine; Muradrasoli, Shaman] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Ingelsson, Martin] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University	Westman, G (corresponding author), Uppsala Univ, Dept Med Sci, Sect Infect Dis, Uppsala, Sweden.	gabriel.westman@medsci.uu.se	Jarhult, Josef D./ABE-8149-2020	Jarhult, Josef D./0000-0002-7075-1059	Fredrik och Ingrid Thurings stiftelse; Uppsala County Council; Swedish Research Council VR [2016-02606]	Fredrik och Ingrid Thurings stiftelse; Uppsala County Council; Swedish Research Council VR(Swedish Research Council)	This study was funded by Fredrik och Ingrid Thurings stiftelse (GW), Uppsala County Council (ALF grant, GW), and Swedish Research Council VR (grant number 2016-02606, JJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423; Borkosky SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032160; Brassard J, 2015, J CLIN VIROL, V72, P55, DOI 10.1016/j.jcv.2015.08.020; Crux NB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00832; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fitzmaurice K, 2015, GUT, V64, P813, DOI 10.1136/gutjnl-2013-306287; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Fogli M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/829584; Garcia-Alvarez M, 2013, EUR J CLIN MICROBIOL, V32, P289, DOI 10.1007/s10096-012-1744-1; Giacconi R, 2018, EXP GERONTOL, V112, P103, DOI 10.1016/j.exger.2018.09.003; Gorzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007; Haloschan M, 2014, AGE, V36, DOI 10.1007/s11357-014-9716-2; Hsiao KL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149901; Itoh Y, 2000, BIOCHEM BIOPH RES CO, V279, P718, DOI 10.1006/bbrc.2000.4013; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Lovheima H, 2018, J ALZHEIMERS DIS, V61, P939, DOI 10.3233/JAD-161305; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Sherman KE, 2001, DIGEST DIS SCI, V46, P2401, DOI 10.1023/A:1012307416122; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Spandole-Dinu S, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3248-9; Vasilyev EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134; Westman G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096779; Westman G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077921; Zhong S, 2001, ANN NY ACAD SCI, V945, P84	27	5	5	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227670	10.1371/journal.pone.0227670	http://dx.doi.org/10.1371/journal.pone.0227670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917803	Green Published, gold			2022-12-26	WOS:000534341100031
J	Liu, H; Chen, ZY; Weng, XD; Chen, H; Du, Y; Diao, CH; Liu, XH; Wang, L				Liu, Hao; Chen, Zhiyuan; Weng, Xiaodong; Chen, Hui; Du, Yang; Diao, Changhui; Liu, Xiuheng; Wang, Lei			Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model	FASEB JOURNAL			English	Article						enhancer of zeste homolog 2; ischemia-reperfusion injury; oxidative stress; pyroptosis; Nox4; reactive oxygen species	RENAL ISCHEMIA; NADPH OXIDASES; MECHANISM; METHYLTRANSFERASE; EPIGENETICS; INHIBITION; APOPTOSIS; FIBROSIS	Enhancer of zeste homolog 2 (EZH2), a well-known methyltransferase, mediates histone H3 lysine 27 trimethylation (H3K27me3) and plays a crucial role in several kidney disease models. However, its role in renal ischemia/reperfusion (I/R) injury still remains unclear. In this study, we found that EZH2 was positively related to renal I/R injury and inhibition of EZH2 with DZNeP alleviated I/R injury and blocked the activation of oxidative stress and pyroptosis in vivo. Similarly, inhibition of EZH2 with either DZNeP or si-RNA also exerted an inhibitory effect on hypoxia/reoxygenation (H/R)-induced oxidative stress and pyroptosis in vitro. Moreover, further study revealed that ablation of reactive oxygen species (ROS) with N-acetyl-cysteine (NAC) suppressed pyroptosis in human renal proximal tubular epithelial cell line cells exposed to H/R stimulation. Furthermore, Nox4, which was positively related to the generation of ROS, was upregulated during H/R process, while it could be reversed by EZH2 inhibition. Consistently, Nox4-mediated ROS generation was attenuated upon inhibition of EZH2 with DZNeP or si-RNA. Additionally, the transcriptional activity of Nox4 was enhanced by the activation of ALK5/Smad2/3 signaling pathway, which was abolished by ALK5 knockdown in vitro. Finally, EZH2 inhibition blocked H/R and I/R-activated ALK5/Smad2/3 pathway and also resulted in an obvious decrease in the transcriptional activity and protein expression levels of Nox4. In conclusion, our results proved that EZH2 inhibition alleviated renal pyroptosis by blocking Nox4-dependent ROS generation through ALK5/Smad2/3 signaling pathway, indicating that EZH2 could be a potential therapeutic target for renal I/R injury.	[Liu, Hao; Chen, Zhiyuan; Weng, Xiaodong; Chen, Hui; Du, Yang; Diao, Changhui; Liu, Xiuheng; Wang, Lei] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Hubei, Peoples R China	Wuhan University	Wang, L (corresponding author), Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan 430060, Hubei, Peoples R China.	drwanglei@whu.edu.cn			Application and Basic Reseaach Project of Wuhan City [2018060401011321]; Wuhan Morning Light Plan of Youth Science and Technology [2017050304010281]; Research Project of Wuhan University [2042017kf0097]; Innovation Project of Medical School of Wuhan University [TFZZ2018017]; Natural Science Foundation of Hubei Province [2016CFB114, 2017CFB181]	Application and Basic Reseaach Project of Wuhan City; Wuhan Morning Light Plan of Youth Science and Technology; Research Project of Wuhan University; Innovation Project of Medical School of Wuhan University; Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The Application and Basic Reseaach Project of Wuhan City, Grant/Award Number: 2018060401011321; Wuhan Morning Light Plan of Youth Science and Technology, Grant/Award Number: 2017050304010281; Research Project of Wuhan University, Grant/Award Number: 2042017kf0097; Innovation Project of Medical School of Wuhan University, Grant/Award Number: TFZZ2018017; Natural Science Foundation of Hubei Province, Grant/Award Number: 2016CFB114 and 2017CFB181	Amani H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42633-9; Arai S, 2016, NAT MED, V22, P183, DOI 10.1038/nm.4012; Bamidele AO, 2019, CELL MOL GASTROENTER, V7, P55, DOI 10.1016/j.jcmgh.2018.08.009; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Ben Mkaddem S, 2010, CELL DEATH DIFFER, V17, P1474, DOI 10.1038/cdd.2010.26; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cui J, 2019, MOL CANC RES; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Italiano A, 2016, PHARMACOL THERAPEUT, V165, P26, DOI 10.1016/j.pharmthera.2016.05.003; Kim SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02563; Li ZY, 2019, AGING-US, V11, P1226, DOI 10.18632/aging.101831; Liang H, 2019, INFLAMM RES, V68, P325, DOI 10.1007/s00011-019-01221-3; Liu H, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101195; Liu ZH, 2019, MOL IMMUNOL, V106, P153, DOI 10.1016/j.molimm.2018.12.028; Lou Z, 2018, EXP THER MED, V16, P1671, DOI 10.3892/etm.2018.6377; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mitic T, 2015, MOL THER, V23, P32, DOI 10.1038/mt.2014.163; Qin J, 2015, KIDNEY BLOOD PRESS R, V40, P89, DOI 10.1159/000368485; Qiu Z, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9743280; Rabadi M, 2016, AM J PHYSIOL-RENAL, V311, pF437, DOI 10.1152/ajprenal.00254.2016; Raup-Konsavage WM, 2018, KIDNEY INT, V93, P365, DOI 10.1016/j.kint.2017.08.014; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shi YF, 2019, AM J PHYSIOL-RENAL, V316, pF488, DOI 10.1152/ajprenal.00234.2018; Tajima T, 2019, KIDNEY INT, V95, P1120, DOI 10.1016/j.kint.2018.11.034; Tang JH, 2015, CURR OPIN NEPHROL HY, V24, P351, DOI 10.1097/MNH.0000000000000140; Walker LM, 2001, TOXICOL SCI, V63, P143, DOI 10.1093/toxsci/63.1.143; Wang WG, 2014, BIRTH DEFECTS RES C, V102, P37, DOI 10.1002/bdrc.21058; Wang Y, 2018, ONCOL LETT, V16, P1231, DOI 10.3892/ol.2018.8779; Wang YF, 2019, J MOL CELL BIOL, V11, P1069, DOI 10.1093/jmcb/mjz020; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Wu HY, 2016, CELL PHYSIOL BIOCHEM, V40, P1692, DOI 10.1159/000453218; Xiao X, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12915; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Yang Y, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0039-0; Yoo KH, 2012, INT J BIOL SCI, V8, P59, DOI 10.7150/ijbs.8.59; Zhang KM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1596-z; Zhou X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1012-0; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zhu K, 2015, FREE RADICAL BIO MED, V83, P21, DOI 10.1016/j.freeradbiomed.2015.02.009	41	27	29	3	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					835	852		10.1096/fj.201901816R	http://dx.doi.org/10.1096/fj.201901816R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914694	hybrid			2022-12-26	WOS:000507308900057
J	Shaheen, ZR; Stafford, JD; Voss, MG; Oleson, BJ; Stancill, JS; Corbett, JA				Shaheen, Zachary R.; Stafford, Joshua D.; Voss, Michael G.; Oleson, Bryndon J.; Stancill, Jennifer S.; Corbett, John A.			The location of sensing determines the pancreatic ?-cell response to the viral mimetic dsRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						interferon; cytokine; beta cell; pathogen-associated molecular pattern (PAMP); diabetes; dsRNA; IL-1; poly(I; C); dsRNA sensors; type I interferon; IFN response; inducible nitric oxide synthase; innate immunity; autoimmune diabetes; picornavirus	DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; PROTEIN-KINASE PKR; NITRIC-OXIDE; ENCEPHALOMYOCARDITIS-VIRUS; BETA-CELLS; RIG-I; SUBCELLULAR-LOCALIZATION; GENE-TRANSCRIPTION	Viral infection is an environmental trigger that has been suggested to initiate pancreatic ?-cell damage, leading to the development of autoimmune diabetes. Viruses potently activate the immune system and can damage ? cells by either directly infecting them or stimulating the production of secondary effector molecules (such as proinflammatory cytokines) during bystander activation. However, how and where ? cells recognize viruses is unclear, and the antiviral responses that are initiated following virus recognition are incompletely understood. In this study, we show that the ?-cell response to dsRNA, a viral replication intermediate known to activate antiviral responses, is determined by the cellular location of sensing (intracellular versus extracellular) and differs from the cellular response to cytokine treatment. Using biochemical and immunological methods, we show that ? cells selectively respond to intracellular dsRNA by expressing type I interferons (IFNs) and inducing apoptosis, but that they do not respond to extracellular dsRNA. These responses differ from the activities of cytokines on ? cells, which are mediated by inducible nitric oxide synthase expression and ?-cell production of nitric oxide. These findings provide evidence that the antiviral activities of type I IFN production and apoptosis are elicited in ? cells via the recognition of intracellular viral replication intermediates and that ? cells lack the capacity to respond to extracellular viral intermediates known to activate innate immune responses.	[Shaheen, Zachary R.; Stafford, Joshua D.; Voss, Michael G.; Oleson, Bryndon J.; Stancill, Jennifer S.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Shaheen, Zachary R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Voss, Michael G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Oleson, Bryndon J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Stancill, Jennifer/0000-0002-1612-4695	National Institutes of Health [DK-052194, AI-44458]; F30 Fellowship [DK102363-01A1]; NIGMS, National Institutes of Health [T32-GM080202]; American Heart Association [17PRE32530001, 14PRE20380585]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F30 Fellowship; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants DK-052194 and AI-44458 (to J. A. C.); F30 Fellowship DK102363-01A1 (to Z. R. S.); NIGMS, National Institutes of Health, Training Grant T32-GM080202 (to Z. R. S.); and American Heart Association Grants 17PRE32530001 (to J. D. S.) and 14PRE20380585 (to B. J. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arnush M, 1998, J IMMUNOL, V160, P2684; Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Broniowska KA, 2014, VITAM HORM, V95, P299, DOI 10.1016/B978-0-12-800174-5.00012-0; Carocci M, 2011, J VIROL, V85, P10741, DOI 10.1128/JVI.00394-11; Carrasco RA, 2003, BIOTECHNIQUES, V34, P1064, DOI 10.2144/03345dd02; Christmann BS, 2011, AM J PATHOL, V179, P2941, DOI 10.1016/j.ajpath.2011.08.012; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dogusan Z, 2008, DIABETES, V57, P1236, DOI 10.2337/db07-0844; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gil J, 1999, MOL CELL BIOL, V19, P4653; Gingras AC, 1996, P NATL ACAD SCI USA, V93, P5578, DOI 10.1073/pnas.93.11.5578; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GOLD R, 1994, LAB INVEST, V71, P219; GORCZYCA W, 1993, LEUKEMIA, V7, P659; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Groppo R, 2007, J VIROL, V81, P13067, DOI 10.1128/JVI.00185-07; Groppo R, 2011, VIROLOGY, V410, P257, DOI 10.1016/j.virol.2010.11.002; Hato SV, 2007, CELL MICROBIOL, V9, P2921, DOI 10.1111/j.1462-5822.2007.01006.x; Heitmeier MR, 1998, J BIOL CHEM, V273, P15301, DOI 10.1074/jbc.273.24.15301; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Iordanov MS, 2001, MOL CELL BIOL, V21, P61, DOI 10.1128/MCB.21.1.61-72.2001; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Jaeckel E, 2002, ANN NY ACAD SCI, V958, P7; Jun HS, 2001, DIABETOLOGIA, V44, P271, DOI 10.1007/s001250051614; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KAUFMAN DL, 1992, J CLIN INVEST, V89, P283, DOI 10.1172/JCI115573; Kaufman RJ, 1999, P NATL ACAD SCI USA, V96, P11693, DOI 10.1073/pnas.96.21.11693; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Khan P, 2014, APPL BIOCHEM BIOTECH, V173, P333, DOI 10.1007/s12010-014-0850-1; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LACY PE, 1991, AM J PATHOL, V138, P1183; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Moran JM, 2005, J VIROL, V79, P10226, DOI 10.1128/JVI.79.16.10226-10236.2005; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Oleson BJ, 2018, ANTIOXID REDOX SIGN, V29, P1432, DOI 10.1089/ars.2017.7351; Oleson BJ, 2016, MOL CELL BIOL, V36, P2067, DOI 10.1128/MCB.00262-16; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Paul S, 2006, J GEN VIROL, V87, P1237, DOI 10.1099/vir.0.81642-0; Pham AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005489; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Romanova LI, 2009, J VIROL, V83, P7273, DOI 10.1128/JVI.00467-09; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shaheen ZR, 2019, AM J PHYSIOL-REG I, V316, pR525, DOI 10.1152/ajpregu.00019.2019; Shaheen ZR, 2015, BIOMOLECULES, V5, P1938, DOI 10.3390/biom5031938; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; VERGE CF, 1995, DIABETES, V44, P1176, DOI 10.2337/diabetes.44.10.1176; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoon JW, 2006, ANN NY ACAD SCI, V1079, P138, DOI 10.1196/annals.1375.021; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102	77	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2385	2397		10.1074/jbc.RA119.010267	http://dx.doi.org/10.1074/jbc.RA119.010267			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31915247	hybrid, Green Published			2022-12-26	WOS:000517330200020
J	Yang, B; Li, SF; Chen, Z; Feng, F; He, L; Liu, B; He, TW; Wang, X; Chen, RQ; Chen, ZH; Xie, PG; Rong, LM				Yang, Bu; Li, Shangfu; Chen, Zheng; Feng, Feng; He, Lei; Liu, Bin; He, Tianwei; Wang, Xuan; Chen, Ruiqiang; Chen, Zihao; Xie, Peigen; Rong, Limin			Amyloid beta peptide promotes bone formation by regulating Wnt/beta-catenin signaling and the OPG/RANKL/RANK system	FASEB JOURNAL			English	Article						Amyloid beta; bone formation; mesenchymal stem cell; osteoblast differentiation; osteoclasts; Wnt; beta-catenin	NF-KAPPA-B; ALZHEIMERS-DISEASE; MEMORY IMPAIRMENT; BRAIN; ACTIVATION; PRECURSOR; TISSUES	Background Amyloid beta peptide (A beta) is involved in osteoporosis, but the effects of A beta on osteoblast and bone formation remain unclear. In this study, we investigated the effect of A beta on bone formation. Methods An animal model of osteoporosis was established by ovariectomy in C57BL/6 mice. The mice received intraperitoneal injection of A beta. The effect of A beta on the osteogenic differentiation of human bone marrow stromal stem cells (hBMSCs) and differentiation of both pre-osteoblasts and pre-osteoclasts in a co-culture system were investigated. Results In the animal study, intraperitoneal injection of A beta for 8 weeks promoted early and late osteogenic differentiation of hBMSCs. A beta treatment significantly elevated osterix(+) (osteoblastic) cells but decreased TRAP(+) cells (osteoclasts) in the distal femur bone. In vitro study showed that A beta treatment significantly enhanced matrix mineralization and osteogenic markers (Runx2 and osteocalcin). A beta treatment activated Wnt/beta-catenin signaling in hBMSCs. The effect of A beta was blocked by DKK1 (a Wnt/beta-catenin inhibitor) treatment. In the co-culture system, A beta treatment significantly increased the ALP activities of MC3T3-E1 cells (pre-osteoblasts) but reduced the TRAP(+) RAW264.7 cells (pre-osteoclasts). A beta treatment upregulated TCF1 and OPG proteins in MC3T3-E1 cells. A beta treatment upregulated I kappa B-alpha but downregulated NFATc1protein in RAW264.7 cells. These effects were blocked by XAV-939 (a Wnt signaling antagonist), and then rescued by additional Wnt3a (a Wnt agonist). Conclusion A beta treatment simultaneously promoted osteogenic differentiation via Wnt/beta-catenin signaling, and inhibited osteoclasts differentiation via the OPG/RANKL/RANK system, suggesting A beta is a positive regulator of osteoblast differentiation and bone formation.	[Yang, Bu; Li, Shangfu; Feng, Feng; He, Lei; Liu, Bin; He, Tianwei; Wang, Xuan; Chen, Ruiqiang; Chen, Zihao; Xie, Peigen; Rong, Limin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, 600 Tianhe Rd, Guangzhou 510630, Peoples R China; [Chen, Zheng] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Stomatol, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Xie, PG; Rong, LM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, 600 Tianhe Rd, Guangzhou 510630, Peoples R China.	xiepeigen120@163.com; ronglimin@21cn.com	Chen, zihao/HGE-3792-2022	Rong, Limin/0000-0003-0373-7393	Guangzhou Science and Technology Projects [1563000225]; National Natural Science Foundation of China [81472122, 81772398]	Guangzhou Science and Technology Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guangzhou Science and Technology Projects, Grant/Award Number: 1563000225; National Natural Science Foundation of China, Grant/Award Number: 81472122 and 81772398	Arias CF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204171; Boonen RACM, 2009, AGEING RES REV, V8, P71, DOI 10.1016/j.arr.2008.11.003; Cui S, 2011, J BONE MINER RES, V26, P1084, DOI 10.1002/jbmr.299; Ding M, 2006, CALCIFIED TISSUE INT, V78, P113, DOI 10.1007/s00223-005-0028-5; Herz J, 2003, J CLIN INVEST, V112, P1483, DOI 10.1172/JCI200320337; Hwang CJ, 2016, BRAIN BEHAV IMMUN, V53, P113, DOI 10.1016/j.bbi.2015.11.013; Hwang CJ, 2015, MOL NEUROBIOL, V52, P176, DOI 10.1007/s12035-014-8853-z; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Kenkre JS, 2018, ANN CLIN BIOCHEM, V55, P308, DOI 10.1177/0004563218759371; Levin-Allerhand J, 2001, J NEUROCHEM, V79, P796, DOI 10.1046/j.1471-4159.2001.00627.x; Li SF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101683; Li SF, 2014, BONE, V61, P164, DOI 10.1016/j.bone.2014.01.010; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Matsuoka K, 2014, J BONE MINER RES, V29, P1522, DOI 10.1002/jbmr.2187; McGee-Lawrence ME, 2014, BONE, V66, P277, DOI 10.1016/j.bone.2014.06.022; McLeod J, 2009, FASEB J, V23, P2942, DOI 10.1096/fj.08-121657; Moorer MC, 2018, ENDOCRINOL METAB, V33, P318, DOI 10.3803/EnM.2018.33.3.318; Nunan J, 2002, ESSAYS BIOCHEM, V38, P37, DOI 10.1042/bse0380037; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Sajjad R, 2018, INDIAN J PHARM SCI, V80, P581; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Silva I, 2011, ACTA REUMATOL PORT, V36, P209; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Weller I, 2004, ANN EPIDEMIOL, V14, P319, DOI 10.1016/j.annepidem.2003.08.005; Zhong ZD, 2014, WIRES DEV BIOL, V3, P489, DOI 10.1002/wdev.159; Zhou R, 2011, J ALZHEIMERS DIS, V24, P101, DOI 10.3233/JAD-2010-101467; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947	29	20	25	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3583	3593		10.1096/fj.201901550R	http://dx.doi.org/10.1096/fj.201901550R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944393	hybrid			2022-12-26	WOS:000507595700001
J	Polgari, P; Causin, JB; Weiner, L; Bertschy, G; Giersch, A				Polgari, Patrik; Causin, Jean-Baptiste; Weiner, Luisa; Bertschy, Gilles; Giersch, Anne			Novel method to measure temporal windows based on eye movements during viewing of the Necker cube	PLOS ONE			English	Article							BINOCULAR-RIVALRY; VOLUNTARY CONTROL; BISTABLE PERCEPTION; REVERSALS; SWITCHES; DYNAMICS; SACCADES; FIGURES; VISION	Bistable stimuli can give rise to two different interpretations between which our perception will alternate. Recent results showed a strong coupling between eye movements and reports of perceptual alternations with motion stimuli, which provides useful tools to objectively assess perceptual alternations. However, motion might entrain eye movements, and here we check with a static picture, the Necker cube, whether eye movements and perceptual reports (manual responses) reveal similar or different alternation rates, and similar or different sensitivity to attention manipulations. Using a cluster analysis, ocular temporal windows were defined based on the dynamics of ocular fixations during viewing of the Necker cube and compared to temporal windows extracted from manual responses. Ocular temporal windows were measured also with a control condition, where the physical stimulus presented to viewers alternated between two non-ambiguous versions of the Necker cube. Attention was manipulated by asking subjects to either report spontaneous alternations, focus on one percept, or switch as fast as possible between percepts. The validity of the ocular temporal windows was confirmed by the correspondence between ocular fixations when the physical stimulus changed and when the bistable Necker cube was presented. Ocular movements defined smaller time windows than time windows extracted from manual responses. The number of manual and ocular windows both increased between the spontaneous condition and the switch condition. However, only manual, and not ocular windows, increased in duration in the focus condition. Manual responses involve decisional mechanisms, and they may be decoupled from automatic oscillations between the two percepts, as suggested by the fact that both the number and duration of ocular windows remained stable between the spontaneous and focus conditions. In all, the recording of eye movements provides an objective measure of time windows, and reveals faster perceptual alternations with the Necker cube and less sensitivity to attention manipulations than manual responses.	[Polgari, Patrik; Causin, Jean-Baptiste; Weiner, Luisa; Bertschy, Gilles; Giersch, Anne] INSERM U1114, Strasbourg, France; [Polgari, Patrik; Causin, Jean-Baptiste; Weiner, Luisa; Bertschy, Gilles; Giersch, Anne] Univ Strasbourg, Strasbourg, France; [Causin, Jean-Baptiste; Weiner, Luisa; Bertschy, Gilles; Giersch, Anne] Univ Hosp Strasbourg, Psychiat Dept, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Giersch, A (corresponding author), INSERM U1114, Strasbourg, France.; Giersch, A (corresponding author), Univ Strasbourg, Strasbourg, France.; Giersch, A (corresponding author), Univ Hosp Strasbourg, Psychiat Dept, Strasbourg, France.	giersch@unistra.fr	Giersch, Anne/H-6444-2016	Giersch, Anne/0000-0002-8577-6021; Polgari, Patrik/0000-0001-7367-3685	French National Research Agency (ANR AutoTime); Grand-Est Region; University Hospital of Strasbourg [PRI 5582]; INSERM; University Hospital of Strasbourg	French National Research Agency (ANR AutoTime)(French National Research Agency (ANR)); Grand-Est Region; University Hospital of Strasbourg; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Hospital of Strasbourg	The first author (PP) was financed by the French National Research Agency (ANR AutoTime) (https://anr.fr/) and the Grand-Est Region (https://www.grandest.fr/).The funding of the research was provided by a grant attributed to GB (PRI 5582) by the University Hospital of Strasbourg (http://www.chru-strasbourg.fr/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank INSERM and the University Hospital of Strasbourg who provided support for this research.	Atmanspacher H, 2010, J MATH PSYCHOL, V54, P314, DOI 10.1016/j.jmp.2009.12.001; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp J, 2015, NAT NEUROSCI, V18, P1672, DOI 10.1038/nn.4130; Einhauser W, 2004, EUR J NEUROSCI, V20, P2811, DOI 10.1111/j.1460-9568.2004.03722.x; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; Giersch A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01659; Grossberg S, 2008, VISION RES, V48, P2232, DOI 10.1016/j.visres.2008.06.024; Hancock S, 2012, I-PERCEPTION, V3, P88, DOI 10.1068/i0486; Hoffman RE, 2001, BIOL PSYCHIAT, V49, P500, DOI 10.1016/S0006-3223(00)01071-4; Hupe JM, 2008, J VISION, V8, DOI 10.1167/8.7.1; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kornmeier J, 2012, FRONT HUM NEUROSCI, P6; Kornmeier J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223843; Kornmeier J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189197; Kornmeier J, 2009, BRAIN COGNITION, V69, P138, DOI 10.1016/j.bandc.2008.06.005; Krug K, 2008, P ROY SOC B-BIOL SCI, V275, P1839, DOI 10.1098/rspb.2008.0043; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Mathes B, 2006, NEUROSCI LETT, V402, P145, DOI 10.1016/j.neulet.2006.03.063; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Nakatani H, 2011, COGN NEURODYNAMICS, V5, P399, DOI 10.1007/s11571-011-9168-7; PELTON LH, 1968, AM J PSYCHOL, V81, P585, DOI 10.2307/1421064; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poppel E, 2009, PHILOS T R SOC B, V364, P1887, DOI 10.1098/rstb.2009.0015; Ross J, 2004, NAT NEUROSCI, V7, P65, DOI 10.1038/nn1163; Schmack K, 2013, EUR J NEUROSCI, V38, P3378, DOI 10.1111/ejn.12339; SCOTTO M, 1991, PERCEPT MOTOR SKILL, V73, P835, DOI 10.2466/PMS.73.7.835-843; Shannon RW, 2011, J VISION, V11, DOI 10.1167/11.3.8; Spering M, 2015, TRENDS NEUROSCI, V38, P247, DOI 10.1016/j.tins.2015.02.002; Spering M, 2011, PSYCHOL SCI, V22, P216, DOI 10.1177/0956797610394659; Stoerig P, 1996, TRENDS NEUROSCI, V19, P401, DOI 10.1016/S0166-2236(96)10051-5; Struber D, 1999, PERCEPTION, V28, P1185, DOI 10.1068/p2973; TOPPINO TC, 1987, PERCEPT PSYCHOPHYS, V42, P37, DOI 10.3758/BF03211512; Tsuchiya N, 2015, TRENDS COGN SCI, V19, P757, DOI 10.1016/j.tics.2015.10.002; van Dam LCJ, 2006, VISION RES, V46, P787, DOI 10.1016/j.visres.2005.10.011; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; van Ee R, 2005, VISION RES, V45, P29, DOI 10.1016/j.visres.2004.07.039; Wernery J, 2015, PERCEPTION, V44, P157, DOI 10.1068/p7780; Wexler M, 2018, J VISION, V18, DOI 10.1167/18.5.7; Wexler M, 2015, P NATL ACAD SCI USA, V112, P14990, DOI 10.1073/pnas.1508847112; White PA, 2017, PSYCHOL BULL, V143, P735, DOI 10.1037/bul0000104; Wilbertz G, 2018, NEUROIMAGE, V171, P190, DOI 10.1016/j.neuroimage.2017.12.094; Witten IH, 2011, MOR KAUF D, P1; WITTMANN M, 2011, FRONT INTEGR NEUROSC, V5	44	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227506	10.1371/journal.pone.0227506	http://dx.doi.org/10.1371/journal.pone.0227506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940327	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000077
J	Yu, HF; Duan, CC; Yang, ZQ; Wang, YS; Yue, ZP; Guo, B				Yu, Hai-Fan; Duan, Cui-Cui; Yang, Zhan-Qing; Wang, Yu-Si; Yue, Zhan-Peng; Guo, Bin			Malic enzyme 1 is important for uterine decidualization in response to progesterone/cAMP/PKA/HB-EGF pathway	FASEB JOURNAL			English	Article						decidualization; Me1; mitochondrial function; HB-EGF; progesterone-cAMP-PKA pathway; uterus	EPIDERMAL-GROWTH-FACTOR; MITOCHONDRIAL DYSFUNCTION; NADPH HOMEOSTASIS; STROMAL CELLS; HB-EGF; EXPRESSION; MOUSE; DIFFERENTIATION; METABOLISM; REGULATOR	Malic enzyme 1 (Me1), a member of the malic enzymes involving in glycolytic pathway and citric acid cycle, is essential for the energy metabolism and maintenance of intracellular redox balance state, but its physiological role and regulatory mechanism in the uterine decidualization are still unknown. Current study showed that Me1 was strongly expressed in decidual cells, and could promote the proliferation and differentiation of stromal cells followed by an accelerated cell cycle transition, indicating an importance of Me1 in the uterine decidualization. Silencing of Me1 attenuated NADPH generation and reduced GR activity, while addition of NADPH improved the defect of GR activity elicited by Me1 depletion. Further analysis found that Me1 modulated intracellular GSH content via GR. Meanwhile, Me1 played a role in maintaining mitochondrial function as indicated by these observations that blockadge of Me1 led to the accumulation of mitochondrial O2- level and decreased ATP production and mtDNA copy numbers accompanied with defective mitochondrial membrane potential. In uterine stromal cells, progesterone induced Me1 expression through PR-cAMP-PKA pathway. Knockdown of HB-EGF might impede the regulation of progesterone and cAMP on Me1. Collectively, Me1 is essential for uterine decidualization in response to progesterone/cAMP/PKA/HB-EGF pathway and plays an important role in preventing mitochondrial dysfunction.	[Yu, Hai-Fan; Yang, Zhan-Qing; Wang, Yu-Si; Yue, Zhan-Peng; Guo, Bin] Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China; [Duan, Cui-Cui] Jilin Acad Agr Sci, Inst Agrofood Technol, Changchun, Peoples R China	Jilin University; Jilin Academy of Agricultural Sciences	Yue, ZP; Guo, B (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130062, Peoples R China.	yuezp@jlu.edu.cn; guobin79@jlu.edu.cn		Guo, Bin/0000-0001-5950-8974; Yu, Hai-Fan/0000-0002-0418-8800; Yue, Zhan-Peng/0000-0001-6776-9015; Yang, Zhan-Qing/0000-0003-1416-7242	National Natural Science Foundation of China [31672503, 31873003, 31472158]; National Key Research and Development Program of China, Stem Cell and Translational Research [2017YFA0105101]; Graduate Innovation Fund of Jilin University [101832018C096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China, Stem Cell and Translational Research; Graduate Innovation Fund of Jilin University(Jilin University)	National Natural Science Foundation of China, Grant/Award Number: 31672503, 31873003 and 31472158; National Key Research and Development Program of China, Stem Cell and Translational Research, Grant/Award Number: 2017YFA0105101; Graduate Innovation Fund of Jilin University, Grant/Award Number: 101832018C096	Agarwal A, 2008, ANTIOXID REDOX SIGN, V10, P1375, DOI 10.1089/ars.2007.1964; Al-Dwairi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113058; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; Benkhalifa M, 2014, INT J BIOCHEM CELL B, V55, P60, DOI 10.1016/j.biocel.2014.08.011; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Chobotova K, 2005, J CLIN ENDOCR METAB, V90, P913, DOI 10.1210/jc.2004-0476; Couto N, 2016, FREE RADICAL BIO MED, V95, P27, DOI 10.1016/j.freeradbiomed.2016.02.028; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Harvey AJ, 2019, REPRODUCTION, V157, pR159, DOI 10.1530/REP-18-0431; Hu M, 2019, AM J PHYSIOL-ENDOC M, V316, pE794, DOI 10.1152/ajpendo.00359.2018; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Lahey R, 2018, CIRC RES, V122, P836, DOI 10.1161/CIRCRESAHA.118.312660; Li DD, 2014, J ENDOCRINOL, V220, P73, DOI 10.1530/JOE-13-0429; Liang XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22744; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu J, 2017, J ENDOCRINOL, V234, P247, DOI 10.1530/JOE-16-0636; Liu MN, 2018, INT J ONCOL, V52, P1923, DOI 10.3892/ijo.2018.4342; Lu YX, 2018, CANCER RES, V78, P1972, DOI 10.1158/0008-5472.CAN-17-3155; Ma XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026774; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Murai S, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.34; Ou XH, 2012, HUM REPROD, V27, P2130, DOI 10.1093/humrep/des137; Qi QR, 2015, CELL CYCLE, V14, P1842, DOI 10.1080/15384101.2015.1033593; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Ratledge C, 2014, BIOTECHNOL LETT, V36, P1557, DOI 10.1007/s10529-014-1532-3; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Stelmanska E, 2013, J STEROID BIOCHEM, V134, P37, DOI 10.1016/j.jsbmb.2012.10.006; Wakefield SL, 2011, BIOL REPROD, V84, P572, DOI 10.1095/biolreprod.110.087262; Wang W, 2010, ENDOCRINOLOGY, V151, P3929, DOI 10.1210/en.2009-1437; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Xin QL, 2017, THERIOGENOLOGY, V104, P55, DOI 10.1016/j.theriogenology.2017.08.005; Yu HF, 2018, J CELL PHYSIOL, V233, P1612, DOI 10.1002/jcp.26067; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang Y, 2018, FASEB J, V32, P1891, DOI 10.1096/fj.201700626RR; ZHANG ZM, 1994, ENDOCRINOLOGY, V134, P1089, DOI 10.1210/en.134.3.1089; Zhou JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27096; Zhu W, 2018, HYPERTENSION, V71, P752, DOI 10.1161/HYPERTENSIONAHA.117.10213	41	6	6	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3820	3837		10.1096/fj.201902289R	http://dx.doi.org/10.1096/fj.201902289R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944402	Bronze			2022-12-26	WOS:000507591800001
J	Singh, DR; Ghimire, S; Upadhayay, SR; Singh, S; Ghimire, U				Singh, Devendra Raj; Ghimire, Saruna; Upadhayay, Satya Raj; Singh, Sunita; Ghimire, Umesh			Food insecurity and dietary diversity among lactating mothers in the urban municipality in the mountains of Nepal	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HOUSEHOLD INCOME; PREGNANCY; SECURITY; CHILDREN; FAMILY; WOMEN; AREA	Background Adequate nutrition is essential during the lactation period for better maternal and child health outcomes. Although food insecurity and dietary monotony (defined as less diverse diet), two important determinants of undernutrition, are endemic in the rural mountains of Nepal, insufficiently examined and assessed for risk factors in mothers during lactation, a life stage of high nutritional demand. This study aimed to assess the status and factors associated with food insecurity and dietary diversity among lactating mothers residing in the mountains of Nepal. Methods A community-based cross-sectional study was conducted in an urban municipality in the mountainous Bajhang District of far-western Nepal. The sampling frame and strategy led to 417 randomly selected lactating mothers. Household Food Insecurity Access Scale (HFIAS) and the tool "Minimum Dietary Diversity for Women" developed by the Food and Agriculture Organization were used to measure food insecurity and dietary diversity, respectively. Additional information on socio-demographics and risk factors were collected. Multivariable logistics regression assessed correlates of study outcomes. Results Overall, 54% of the households were food insecure, and over half (53%) of the mothers had low dietary diversity. Food insecurity status (mild food insecurity AOR = 10.12, 95% CI = 4.21-24.34; moderate food insecurity AOR = 8.17, 95% CI = 3.24-20.59, and severe food insecurity AOR = 10.56, 95% CI = 3.92-28.43) were associated with higher odds of dietary monotony. Likewise, participants with lower dietary diversity were 8.5 times more likely to be food insecure than those with higher dietary diversity (AOR = 8.48, 95% CI = 3.76-19.14). The monthly income of the family was positively associated with food insecurity. Participants' (AOR = 3.92 95%CI = 1.76-8.71) or spouses' (AOR = 2.90, 95% CI = 1.07-7.85) unemployment was associated with higher odds of being food insecure. Likewise, owning a cultivable land (AOR = 0.49, 95% CI = 0.28-0.84) and participant's unemployment status (AOR = 5.92, 95% CI = 3.02-11.63), were significantly associated with increased odds of dietary monotony. Conclusion The observed food insecurity and poor dietary diversity among lactating mothers, the correlates associated with these outcomes, may help local stakeholders to identify local health needs and subgroups for targeted interventions. Socioeconomically disadvantaged mothers should be specifically targeted for relevant programs and policies.	[Singh, Devendra Raj] Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Satdobato, Lalitpur, Nepal; [Singh, Devendra Raj] SADAN, Lalitpur, Nepal; [Ghimire, Saruna] Miami Univ, Dept Sociol & Gerontol, Oxford, OH 45056 USA; [Ghimire, Saruna] Miami Univ, Scripps Gerontol Ctr, Oxford, OH 45056 USA; [Upadhayay, Satya Raj] Pokhara Univ, Natl Open Coll, Dept Publ Hlth, Sanepa, Lalitpur, Nepal; [Singh, Sunita] Tribhuvan Univ, Cent Dept Home Sci, Padma Kanya Campus, Kathmandu, Nepal; [Ghimire, Umesh] New ERA, Kathmandu, Nepal	University System of Ohio; Miami University; University System of Ohio; Miami University; Tribhuvan University	Singh, DR (corresponding author), Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Satdobato, Lalitpur, Nepal.; Singh, DR (corresponding author), SADAN, Lalitpur, Nepal.	dsingh3797@gmail.com	Singh, Devendra Raj/R-2197-2019	Singh, Devendra Raj/0000-0003-1450-9476; Ghimire, Umesh/0000-0002-4246-8379				Abdu J, 2018, J ENVIRON PUBLIC HEA, V2018, DOI 10.1155/2018/7659204; [Anonymous], 2017, POP SIT AN NEP; Bennett L, 2006, CASTE ETHNIC REGIONA; Bhandari S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0114-3; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bouis HE, 2011, FOOD NUTR BULL, V32, pS14, DOI 10.1177/15648265110321S103; Broaddus-Shea ET, 2018, CURR DEV NUTR, V2, DOI 10.1093/cdn/nzy058; Central Bureau of Statistics, 2012, NATL REPORT; Central Bureau of Statistics, 2014, POPULATION MONOGRAPH; Chyne DAL, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12557; Coates J., 2007, FOOD NUTR TECHNICAL; Costa NS, 2017, PREVALENCE FACTORS A; Edin K., 1997, MAKING ENDS MEET, DOI [10.7758/9781610441759, DOI 10.7758/9781610441759]; Epstein LH, 2014, AM J CLIN NUTR, V100, P884, DOI 10.3945/ajcn.113.079772; Faber M., 2009, International Journal of Food Safety, Nutrition and Public Health, V2, P1, DOI 10.1504/IJFSNPH.2009.026915; Food and Agriculture Organization of The United Nations, 2003, TRAD REF FOOD SEC CO; Frongillo EA, 2019, J NUTR, V149, P159, DOI 10.1093/jn/nxy249; Gallant MP, 2007, RES AGING, V29, P375, DOI 10.1177/0164027507303169; Girard AW, 2012, PAEDIATR PERINAT EP, V26, P191, DOI 10.1111/j.1365-3016.2012.01278.x; Government of Nepal National Planning Commission United Nations Development Programme, 2014, NEP HUM DEV REP 2014; Gundersen C, 2011, APPL ECON PERSPECT P, V33, P281, DOI 10.1093/aepp/ppr022; Harris-Fry H, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0603-1; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Harris-Fry HA, 2018, EUR J CLIN NUTR, V72, P1524, DOI 10.1038/s41430-017-0063-0; HEBERT JR, 1995, INT J EPIDEMIOL, V24, P389, DOI 10.1093/ije/24.2.389; Henjum S, 2015, PUBLIC HEALTH NUTR, V18, P3201, DOI 10.1017/S1368980015000671; Institute of Medicine, 2006, ESSENTIAL GUIDE NUTR, DOI [10.17226/11537, DOI 10.17226/11537, DOI 10.17226/11537.HTTPS://WWW.NAL.USDA.GOV/SITES/DEFAULT/FILES/FNIC_UPLOADS/DRIESSENTIALGUIDENUTREQ.PDF]; Joshi N, 2012, MATERN CHILD NUTR, V8, P45, DOI 10.1111/j.1740-8709.2011.00384.x; Kavle JA, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12508; Kennedy G, 2010, PUBLIC HEALTH NUTR, V13, P2010, DOI 10.1017/S136898001000145X; Leung CW, 2019, J ACAD NUTR DIET, V119, P1676, DOI 10.1016/j.jand.2018.10.011; Lin HL, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0645-6; LONNERDAL B, 1986, J NUTR, V116, P499; Madjdian DS, 2016, ECON HIST DEV REG, V31, P198, DOI 10.1080/20780389.2015.1114416; Maharjan K.L., 2006, P INT INT AGR EC C G; Martin-Prevel Y, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.001701; Ministry of Health and Population; New Era;UNICEF; USAID; and CDC, 2018, NEP NAT MICR STAT SU; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Moafi F, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1947-2; Muhammad Andrew, 2017, BMJ Glob Health, V2, pe000184, DOI 10.1136/bmjgh-2016-000184; Na MZ, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12564; Na MZ, 2016, J NUTR, V146, P2109, DOI 10.3945/jn.116.234229; Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1; National Planning Commission, 2016, NEP MILL DEV GOALS F; Nepal Development Research Institute and UNFPA, 2017, SIT ASS IMPR GEND BA; Parajuli RP, 2012, J BIOSOC SCI, V44, P401, DOI 10.1017/S0021932012000065; Perez-Escamilla R, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.000513; Ruel Marie T., 2003, Food and Nutrition Bulletin, V24, P231; SCHIFF M, 1990, AM J AGR ECON, V72, P1318, DOI 10.2307/1242554; Sekine K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180176; Shariff ZM, 2015, NUTR RES PRACT, V9, P278, DOI 10.4162/nrp.2015.9.3.278; Shrestha K, 2014, Nepal Med Coll J, V16, P135; Singh A, 2014, FOOD NUTR BULL, V35, P3, DOI 10.1177/156482651403500101; Torheim LE, 2013, DIET QUALITY NUTR HL; Verma Priyanka, 2016, WION; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; von Grebmer K., 2017, GLOBAL HUNGER INDEX; WHO, 2017, GUID PROT PROM SUPP; Wight Vanessa, 2014, J Child Poverty, V20, P1; Withers M, 2018, MIDWIFERY, V56, P158, DOI 10.1016/j.midw.2017.10.019; World Economic Forum, 2018, GLOBAL COMPETITIVENE	63	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227873	10.1371/journal.pone.0227873	http://dx.doi.org/10.1371/journal.pone.0227873			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935272	Green Published, gold			2022-12-26	WOS:000534354100060
J	van Hout, D; Verschuuren, TD; Bruijning-Verhagen, PCJ; Bosch, T; Schurch, AC; Willems, RJL; Bonten, MJM; Kluytmans, JAJW				van Hout, Denise; Verschuuren, Tess D.; Bruijning-Verhagen, Patricia C. J.; Bosch, Thijs; Schurch, Anita C.; Willems, Rob J. L.; Bonten, Marc J. M.; Kluytmans, Jan A. J. W.			Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014-2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content	PLOS ONE			English	Article							QUINOLONE; FLUOROQUINOLONE; INCREASE; STRAINS; UK	Background Knowledge on the molecular epidemiology of Escherichia coli causing E. coli bacteremia (ECB) in the Netherlands is mostly based on extended-spectrum beta-lactamase-producing E. coli (ESBL-Ec). We determined differences in clonality and resistance and virulence gene (VG) content between non-ESBL-producing E. coli (non-ESBL-Ec) and ESBL-Ec isolates from ECB episodes with different epidemiological characteristics. Methods A random selection of non-ESBL-Ec isolates as well as all available ESBL-Ec blood isolates was obtained from two Dutch hospitals between 2014 and 2016. Whole genome sequencing was performed to infer sequence types (STs), serotypes, acquired antibiotic resistance genes and VG scores, based on presence of 49 predefined putative pathogenic VG. Results ST73 was most prevalent among the 212 non-ESBL-Ec (N = 26, 12.3%) and ST131 among the 69 ESBL-Ec (N = 30, 43.5%). Prevalence of ST131 among non-ESBL-Ec was 10.4% (N = 22, P value < .001 compared to ESBL-Ec). O25:H4 was the most common serotype in both non-ESBL-Ec and ESBL-Ec. Median acquired resistance gene counts were 1 (IQR 1-6) and 7 (IQR 4-9) for non-ESBL-Ec and ESBL-Ec, respectively (P value < .001). Among non-ESBL-Ec, acquired resistance gene count was highest among blood isolates from a primary gastro-intestinal focus (median 4, IQR 1-8). Median VG scores were 13 (IQR 9-20) and 12 (IQR 8-14) for non-ESBL-Ec and ESBL-Ec, respectively (P value = .002). VG scores among non-ESBL-Ec from a primary urinary focus (median 15, IQR 11-21) were higher compared to non-ESBL-Ec from a primary gastro-intestinal (median 10, IQR 5-13) or hepatic-biliary focus (median 11, IQR 5-18) (P values = .007 and.04, respectively). VG content varied between different E. coli STs. Conclusions Non-ESBL-Ec and ESBL-Ec blood isolates from two Dutch hospitals differed in clonal distribution, resistance gene and VG content. Also, resistance gene and VG content differed between non-ESBL-Ec from different primary foci of ECB.	[van Hout, Denise; Verschuuren, Tess D.; Bruijning-Verhagen, Patricia C. J.; Bonten, Marc J. M.; Kluytmans, Jan A. J. W.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bruijning-Verhagen, Patricia C. J.; Bosch, Thijs; Bonten, Marc J. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands; [Schurch, Anita C.; Willems, Rob J. L.; Bonten, Marc J. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Hosp, Microvida Lab Med Microbiol, Breda, Netherlands; [Kluytmans, Jan A. J. W.] Amphia Hosp, Dept Infect Control, Breda, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Amphia Hospital; Amphia Hospital	van Hout, D (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	D.vanHout-3@umcutrecht.nl	Bruijning-Verhagen, Patricia C.J.L./E-4134-2015; Willems, Rob JL/E-3681-2010	Bruijning-Verhagen, Patricia C.J.L./0000-0003-4105-9669; Willems, Rob JL/0000-0002-7370-0812; van Hout, Denise/0000-0003-0579-8149				Abernethy J, 2017, J HOSP INFECT, V95, P365, DOI 10.1016/j.jhin.2016.12.008; Abernethy JK, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.01.001; Alhashash F, 2016, J ANTIMICROB CHEMOTH, V71, P339, DOI 10.1093/jac/dkv365; Ciesielczuk H, 2016, EUR J CLIN MICROBIOL, V35, P1661, DOI 10.1007/s10096-016-2707-8; Dale AP, 2015, J INFECTION, V71, P615, DOI 10.1016/j.jinf.2015.09.009; Dale AR, 2018, J INFECTION, V77, P534, DOI 10.1016/j.jinf.2018.10.011; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; Dunn SJ, 2019, CURR OPIN MICROBIOL, V51, P51, DOI 10.1016/j.mib.2019.06.004; Fitzpatrick JM, 2016, CLIN MICROBIOL INFEC, V22, P244, DOI 10.1016/j.cmi.2015.10.034; Frenck RW, 2019, LANCET INFECT DIS, V19, P631, DOI 10.1016/S1473-3099(18)30803-X; Geurtsen J, 2011, ECCMID C; Goswami C, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000190; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hertz FB, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0681-z; Horcajada JP, 2005, J CLIN MICROBIOL, V43, P2962, DOI 10.1128/JCM.43.6.2962-2964.2005; Huttner A, 2017, LANCET INFECT DIS, V17, P528, DOI [10.1016/s1473-3099(17)30108-1, 10.1016/S1473-3099(17)30108-1]; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Johnson JR, 2019, J INFECT DIS, V219, P121, DOI [10.1093/infdis/jiy459, 10.1093/infdis/154.1.121]; Johnson James R, 2018, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0004-2017; Johnson JR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00732-17, 10.1128/aac.00732-17]; Johnson JR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv083; Johnson JR, 2003, J INFECT DIS, V188, P759, DOI 10.1086/377455; Johnson JR, 2002, J INFECT DIS, V186, P1852, DOI 10.1086/345767; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Johnson JR, 2017, OPEN FORUM INFECT DI, V4, DOI DOI 10.1093/OFID/OFX089; Kallonen T, 2017, GENOME RES, V27, P1437, DOI 10.1101/gr.216606.116; Liu B, 2019, NUCLEIC ACIDS RES, V47, pD687, DOI 10.1093/nar/gky1080; Manges AR, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00135-18; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; McNally A, 2019, MBIO, V10, DOI 10.1128/mBio.00644-19; McNally A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006280; Moreno E, 2006, J ANTIMICROB CHEMOTH, V57, P204, DOI 10.1093/jac/dki468; Nicolas-Chanoine MH, 2014, CLIN MICROBIOL REV, V27, P543, DOI 10.1128/CMR.00125-13; Overdevest I T M A, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.02.020; Schlackow I, 2012, J ANTIMICROB CHEMOTH, V67, P1514, DOI 10.1093/jac/dks082; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; van der Bij AK, 2011, ANTIMICROB AGENTS CH, V55, P3576, DOI 10.1128/AAC.00074-11; van der Steen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138088; van Hout D, 2019, DESIGN EPIGENEC STUD, DOI [10.20944/preprints201902.0066.v1., DOI 10.20944/PREPRINTS201902.0066.V1]; Velasco M, 2001, CLIN INFECT DIS, V33, P1682, DOI 10.1086/323810; Vihta KD, 2018, LANCET INFECT DIS, V18, P1138, DOI 10.1016/S1473-3099(18)30353-0; Vila J, 2002, J INFECT DIS, V186, P1039, DOI 10.1086/342955; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	43	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227604	10.1371/journal.pone.0227604	http://dx.doi.org/10.1371/journal.pone.0227604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935253	Green Published, Green Submitted, gold			2022-12-26	WOS:000534354100034
J	Dillon, CF; Weisman, MH; Miller, FW				Dillon, Charles F.; Weisman, Michael H.; Miller, Frederick W.			Population-based estimates of humoral autoimmunity from the US National Health and Nutrition Examination Surveys, 1960-2014	PLOS ONE			English	Article							PASSIVE TRANSFER; ANTINUCLEAR ANTIBODIES; RHEUMATOID-ARTHRITIS; UNITED-STATES; AUTOANTIBODIES; DISEASE; PREVALENCE; RISK; CLASSIFICATION; EPIDEMIOLOGY	Objective Based on US National Health and Nutrition Examination Survey (NHANES) data, we attempted to provide an unbiased, population-based estimate of autoantibody prevalence overall and by age and sex. Methods US autoantibody prevalence estimates for detectable rheumatoid factor, anti-thyroglobulin, anti-thyroperoxidase, anti-transglutaminase, anti-endomysial, anti-GAD65, antinuclear autoantibodies, and autoantibodies to extractable nuclear antigens were estimated from the 1960-1962 National Health Examination Survey, NHANES III (1988-1994), and the NHANES 1999-2014 cross-sectional surveys. Survey design variables and sample weights were used to account for differential probabilities of selection within the complex survey design. Data analysis used SASTM and SUDAANT software. US Census Bureau data were used to estimate the absolute numbers of persons with autoantibodies. Results NHANES III data show that the overall US prevalence of having a detectable serum autoantibody is substantial in adults, in both women and men. Thyroid autoantibodies were present in 18% of US adults (31 million persons) including 10% of younger adults and 25% of older persons. Overall autoantibody prevalences increased significantly with age: 32% of US adults 60+ years of age (12.8 million persons) had at least one of the four autoantibodies rheumatoid factor, anti-thyroglobulin, anti-thyroperoxidase, or anti-tissue transglutaminase. Older women had higher levels of autoantibodies, but this was a relative difference. Autoantibody prevalence in both sexes was substantial (women 39%; men 22%). Fourteen percent of adults 60+ years of age have multiple autoantibodies. Conclusions Autoantibodies are present in a significant fraction of the general population, especially in older adults and women relative to men. Although all known clinically significant autoantibodies were not analyzed, these data provide an important population perspective on the scope and magnitude of humoral autoimmunity in the US. This is vital for prevention efforts to reduce autoimmune disease and helps clarify the potential impact of autoimmunity on the general population.	[Dillon, Charles F.; Miller, Frederick W.] NIEHS, NIH, Bethesda, MD 20892 USA; [Weisman, Michael H.] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Miller, FW (corresponding author), NIEHS, NIH, Bethesda, MD 20892 USA.	millerf@mail.nih.gov	Miller, Frederick/D-2431-2019	Miller, Frederick/0000-0003-2831-9593	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; [Anonymous], 1994, Vital Health Stat 1, P1; [Anonymous], 1996, ANAL REPORTING GUIDE; Barinas-Mitchell E, 2004, DIABETES, V53, P1293, DOI 10.2337/diabetes.53.5.1293; Bizzaro N, 2014, AUTOIMMUN REV, V13, P565, DOI 10.1016/j.autrev.2014.01.042; BORRADORI L, 1995, ARCH DERMATOL, V131, P590, DOI 10.1001/archderm.131.5.590; Bourn R, 2015, CURR OPIN RHEUMATOL, V27, P433, DOI 10.1097/BOR.0000000000000199; BOZICEVICH J, 1958, P SOC EXP BIOL MED, V97, P180; BROSS ID, 1985, BIOMETRICS, V41, P785, DOI 10.2307/2531299; Caforio ALP, 2015, INT J CARDIOL, V179, P166, DOI 10.1016/j.ijcard.2014.10.165; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; COUCHMAN KG, 1970, J CHRON DIS, V23, P45, DOI 10.1016/0021-9681(70)90108-6; Curtin Lester R, 2013, Vital Health Stat 2, P1; DAVIS P, 1977, ANN RHEUM DIS, V36, P157, DOI 10.1136/ard.36.2.157; De Leo S, 2018, LANCET DIABETES ENDO, V6, P575, DOI 10.1016/S2213-8587(17)30402-3; Deane KD, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0754-0; Demoruelle MK, 2012, ARTHRITIS RHEUM-US, V64, P1756, DOI 10.1002/art.34344; Dillon CF, 2018, RHEUM DIS CLIN N AM, V44, P215, DOI 10.1016/j.rdc.2018.01.010; Edwards CJ, 2007, HEART, V93, P1263, DOI 10.1136/hrt.2006.097816; Engel A, 1966, Vital Health Stat 11, P1; Ferri C, 2016, AUTOIMMUN REV, V15, P61, DOI 10.1016/j.autrev.2015.09.003; Frohlich E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00521; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Gerlag DM, 2019, ANN RHEUM DIS, V78, P179, DOI 10.1136/annrheumdis-2017-212763; Greenbaum C, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0932-x; GRUBIN CE, 1994, DIABETOLOGIA, V37, P344, DOI 10.1007/BF00408469; Gunther J, 2015, SEMIN IMMUNOPATHOL, V37, P529, DOI 10.1007/s00281-015-0513-5; Gunter EW, 2018, ANTIMICROSOMAL ANTIB; Gunter EW, 1996, LAB PROCEDURES USED; Gunter EW, 2018, ANTITHYROGLOBULIN SE; Haller-Kikkatalo K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44846; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hwang J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003668; Iseme RA, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/9407971; Jacobsen LM, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00070; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; James JA, 2019, EBIOMEDICINE, V42, P76, DOI 10.1016/j.ebiom.2019.03.063; Korevaar TIM, 2019, JAMA-J AM MED ASSOC, V322, P1718, DOI 10.1001/jama.2019.17746; Lleo A, 2010, AUTOIMMUN REV, V9, pA259, DOI 10.1016/j.autrev.2009.12.002; Ludwig RJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00603; Majka DS, 2014, RHEUM DIS CLIN N AM, V40, P659, DOI 10.1016/j.rdc.2014.07.006; Majka DS, 2013, INFLAMM RES, V62, P919, DOI 10.1007/s00011-013-0652-x; Malviya M, 2017, ANN CLIN TRANSL NEUR, V4, P768, DOI 10.1002/acn3.444; Mauro FR, 2017, HAEMATOLOGICA, V102, P473, DOI 10.3324/haematol.2017.177675; McQuillan Geraldine M, 2015, Vital Health Stat 2, P1; Meier LA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00911; Miliaresis CIP, 2018, DUBOIS LUPUS ERYTHEM, P486; MILLER FW, 1990, J CLIN INVEST, V85, P468, DOI 10.1172/JCI114461; MILLER FW, 1990, P NATL ACAD SCI USA, V87, P9933, DOI 10.1073/pnas.87.24.9933; Murray J, 2018, NATL HLTH NUTR EXAMI; National Health and Nutrition Examination Survey, 2018, HIST SUMM COMP CONT; Negro R, 2011, J CLIN ENDOCR METAB, V96, pE920, DOI 10.1210/jc.2011-0026; Nielsen SF, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5244; Olsen NJ, 2018, TRIALS, V19, DOI 10.1186/s13063-018-3076-7; Panaitescu AM, 2018, J MATERN-FETAL NEO M, V31, P1798, DOI 10.1080/14767058.2017.1326904; Pollard K. Michael, 2018, Current Opinion in Toxicology, V10, P15, DOI 10.1016/j.cotox.2017.11.009; Pollard KM, 2010, CHEM RES TOXICOL, V23, P455, DOI 10.1021/tx9003787; Prete M, 2011, AUTOIMMUN REV, V11, P123, DOI 10.1016/j.autrev.2011.09.001; Psianou K, 2018, AUTOIMMUN REV, V17, P1053, DOI 10.1016/j.autrev.2018.05.005; Rasch EK, 2003, ARTHRITIS RHEUM, V48, P917, DOI 10.1002/art.10897; Reeves WH, 2006, MANUAL OF MOLECULAR AND CLINICAL LABORATORY IMMUNOLOGY, 7TH EDITION, P1007; Reeves WH, 2008, MANUAL MOL CLIN LAB, V7, P1007; Robertson JM, 2014, RHEUM DIS CLIN N AM, V40, P621, DOI 10.1016/j.rdc.2014.07.004; Rubin RL, 2015, EXPERT OPIN DRUG SAF, V14, P361, DOI 10.1517/14740338.2015.995089; Rubio-Tapia A, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0547-8; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rusak E, 2016, ADV MED SCI-POLAND, V61, P175, DOI 10.1016/j.advms.2015.12.004; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Simmons K, 2014, RHEUM DIS CLIN N AM, V40, P797, DOI 10.1016/j.rdc.2014.07.008; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Solow EB, 2018, CLIN EXP RHEUMATOL, V36, P1031; Solow EB, 2015, J AM COLL CARDIOL, V65, P2669, DOI 10.1016/j.jacc.2015.03.578; SonarSource, 2019, SON DOC SEC REL RUL; Spinillo A, 2016, ARTHRITIS RHEUMATOL, V68, P2555, DOI 10.1002/art.39737; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Tracy A, 2017, SEMIN IMMUNOPATHOL, V39, P423, DOI 10.1007/s00281-017-0620-6; Troyanov Y, 2014, MEDICINE, V93, P318, DOI 10.1097/MD.0000000000000222; Tunbridge WMG, 2000, ENDOCRIN METAB CLIN, V29, P239, DOI 10.1016/S0889-8529(05)70129-8; US National Health & Nutrition Examination Survey, 2018, NHANES 3 AUGM DAT SP; van Dijk MM, 2018, THYROID, V28, P257, DOI 10.1089/thy.2017.0413; Verschuuren JJGM, 2018, ANN NY ACAD SCI, V1413, P111, DOI 10.1111/nyas.13543; von Stemann JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179981; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Wang LF, 2015, J INTERN MED, V278, P369, DOI 10.1111/joim.12395; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205; Xiao X, 2014, J AUTOIMMUN, V48-49, P66, DOI 10.1016/j.jaut.2014.01.005	91	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226516	10.1371/journal.pone.0226516	http://dx.doi.org/10.1371/journal.pone.0226516			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929535	Green Published, gold			2022-12-26	WOS:000534352500016
J	Lehmann, S; Baghestan, E; Bordahl, PE; Irgens, LM; Rasmussen, S				Lehmann, Sjur; Baghestan, Elham; Bordahl, Per E.; Irgens, Lorentz M.; Rasmussen, Svein			Low risk pregnancies after a cesarean section: Determinants of trial of labor and its failure	PLOS ONE			English	Article							MEDICAL BIRTH REGISTRY; VAGINAL BIRTH; SOCIOECONOMIC-STATUS; VALIDITY; WOMEN; DELIVERY; NORWAY; PREECLAMPSIA; PREDICTION; POPULATION	Introduction In pregnancies after a previous cesarean section (CS), a planned repeat CS delivery has been associated with excess risk of adverse outcome. However, also the alternative, a trial of labor after CS (TOLAC), has been associated with excess risks. A TOLAC failure, involving a non-planned CS, carries the highest risk of adverse outcome and a vaginal delivery the lowest. Thus, the decision regarding delivery mode is pivotal in clinical handling of these pregnancies. However, even with a high TOLAC rate, as seen in Norway, repeat CSs are regularly performed for no apparent medical reason. The objective of the present study was to assess to which extent demographic, socioeconomic, and health system factors are determinants of TOLAC and TOLAC failure in low risk pregnancies, and whether any effects observed changed with time. Materials and methods The study group comprised 24 645 second deliveries (1989-2014) after a first delivery CS. Thus, none of the women had prior vaginal deliveries or more than one CS. Included pregnancies were low risk, cephalic, single, and had gestational age. 37 weeks. Data were obtained from the Medical Birth Registry of Norway (MBRN). The exposure variables were (second delivery) maternal age, length of maternal education, maternal country of origin, size of the delivery unit, health region (South-East, West, Mid, North), and maternal county of residence. The outcomes were TOLAC and TOLAC failure, as rates (%), relative risk (RR) and relative risk adjusted (ARR). Changes in determinant effects over time were assessed by comparing rates in two periods, 1989-2002 vs 2003-2014, and including these periods in an interaction model. Results The TOLAC rate was 74.9%, with a TOLAC failure rate of 16.2%, resulting in a vaginal birth rate of 62.8%. Low TOLAC rates were observed at high maternal age and in women from East Asia or Latin America. High TOLAC failure rates were observed at high maternal age, in women with less than 11 years of education, and in women of non-western origin. The effects of health system factors, i.e. delivery unit size and administrative region were considerable, on both TOLAC and TOLAC failure. The effects of several determinants changed significantly (P < 0.05) from 1989-2002 to 2003-2014: The association between non-TOLAC and maternal age > 39 years became weaker, the association between short education and TOLAC failure became stronger, and the association between TOLAC failure and small size of delivery unit became stronger. Conclusion Low maternal age, high education, and western country of origin were associated with high TOLAC rates, and low TOLAC failure rates. Maternity unit characteristics (size and region) contributed with effects on the same level as individual determinants studied. Temporal changes were observed in determinant effects.	[Lehmann, Sjur; Bordahl, Per E.; Rasmussen, Svein] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Baghestan, Elham; Bordahl, Per E.; Rasmussen, Svein] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Irgens, Lorentz M.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH)	Lehmann, S (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	sjur.lehmann@uib.no			University of Bergen, Norway	University of Bergen, Norway	The study was funded by a PhD grant to first author SL from the University of Bergen, Norway, (www.uib.no).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the University of Bergen for funding the study, and to the Medical Birth Registry of Norway for providing research files.	[Anonymous], 1999, UNITED NATIONS STAND; Attanasio LB, 2019, J WOMENS HEALTH, V28, P1302, DOI 10.1089/jwh.2018.7270; Cameron CA, 2004, INT J GYNECOL OBSTET, V85, P267, DOI 10.1016/j.ijgo.2003.09.002; Colais P, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2018-4; Eden KB, 2010, OBSTET GYNECOL, V116, P967, DOI 10.1097/AOG.0b013e3181f2de49; Fagerberg MC, 2015, EUR J OBSTET GYN R B, V188, P88, DOI 10.1016/j.ejogrb.2015.02.031; Grobman WA, 2007, OBSTET GYNECOL, V109, P806, DOI 10.1097/01.AOG.0000259312.36053.02; Gross MM, 2015, J PERINAT MED, V43, P177, DOI 10.1515/jpm-2014-0108; Grytten J, 2013, J HUM RESOUR, V48, P142; Guise Jeanne-Marie, 2010, Evid Rep Technol Assess (Full Rep), P1; Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f; HENRY OA, 1995, AM J PUBLIC HEALTH, V85, P1143, DOI 10.2105/AJPH.85.8_Pt_1.1143; Herstad L, 2012, ACTA OBSTET GYN SCAN, V91, P816, DOI 10.1111/j.1600-0412.2012.01405.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Iversen T, 2013, ECON HUM BIOL, V11, P1, DOI 10.1016/j.ehb.2012.02.003; KING DE, 1994, JAMA-J AM MED ASSOC, V272, P524, DOI 10.1001/jama.272.7.524; Klungsoyr K, 2014, PAEDIATR PERINAT EP, V28, P362, DOI 10.1111/ppe.12138; Knight HE, 2014, BJOG-INT J OBSTET GY, V121, P183, DOI 10.1111/1471-0528.12508; Lehmann S, 2019, ACTA OBSTET GYNECOL; Lehmann S, 2017, ACTA OBSTET GYN SCAN, V96, P892, DOI 10.1111/aogs.13115; Linn G, 2019, THER CLIN RISK MANAG, V15, P991, DOI 10.2147/TCRM.S205009; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; Melve KK, 2008, ACTA OBSTET GYN SCAN, V87, P824, DOI 10.1080/00016340802217184; Merry L, 2016, BEST PRACT RES CL OB, V32, P88, DOI 10.1016/j.bpobgyn.2015.09.002; Moth FN, 2016, ACTA OBSTET GYN SCAN, V95, P519, DOI 10.1111/aogs.12868; Naimy Z, 2015, BJOG-INT J OBSTET GY, V122, P859, DOI 10.1111/1471-0528.12978; Newton ER, 2007, OBSTET GYNECOL, V109, P796, DOI 10.1097/01.AOG.0000260113.80756.79; Pang MW, 2009, EUR J OBSTET GYN R B, V143, P24, DOI 10.1016/j.ejogrb.2008.10.016; Richardson A, 2012, J HEALTH CARE POOR U, V23, P1477, DOI 10.1353/hpu.2012.0181; Salvesen Helga B, 2004, Tidsskr Nor Laegeforen, V124, P2780; Schemann K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0609-x; Selo-Ojeme D, 2008, INT J GYNECOL OBSTET, V102, P156, DOI 10.1016/j.ijgo.2008.03.008; Skomsvoll JF, 2002, ACTA OBSTET GYN SCAN, V81, P831, DOI 10.1034/j.1600-0412.2002.810905.x; Stattmiller S, 2016, J PERINATOL, V36, P808, DOI 10.1038/jp.2016.36; Studsgaard A, 2013, ACTA OBSTET GYN SCAN, V92, P1256, DOI 10.1111/aogs.12240; Thomsen LCV, 2013, ACTA OBSTET GYN SCAN, V92, P943, DOI 10.1111/aogs.12159; Triebwasser JE, 2019, J PERINATOL, V39, P904, DOI 10.1038/s41372-019-0373-2; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Vangen S, 1999, Ethn Health, V4, P19; Vikanes A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-115; Vyas DA, 2019, WOMEN HEALTH ISS, V29, P201, DOI 10.1016/j.whi.2019.04.007; Yeh J, 2006, AM J OBSTET GYNECOL, V194, P144, DOI 10.1016/j.ajog.2005.06.079	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226894	10.1371/journal.pone.0226894	http://dx.doi.org/10.1371/journal.pone.0226894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929542	gold, Green Published			2022-12-26	WOS:000534352500021
J	Siddiqui, N; Chan, RHM				Siddiqui, Nabeel; Chan, Rosa H. M.			Multimodal hand gesture recognition using single IMU and acoustic measurements at wrist	PLOS ONE			English	Article							CONDENSER MICROPHONE; SEMG	To facilitate hand gesture recognition, we investigated the use of acoustic signals with an accelerometer and gyroscope at the human wrist. As a proof-of-concept, the prototype consisted of 10 microphone units in contact with the skin placed around the wrist along with an inertial measurement unit (IMU). The gesture recognition performance was evaluated through the identification of 13 gestures used in daily life. The optimal area for acoustic sensor placement at the wrist was examined using the minimum redundancy and maximum relevance feature selection algorithm. We recruited 10 subjects to perform over 10 trials for each set of hand gestures. The accuracy was 75% for a general model with the top 25 features selected, and the intra-subject average classification accuracy was over 80% with the same features using one microphone unit at the mid-anterior wrist and an IMU. These results indicate that acoustic signatures from the human wrist can aid IMU sensing for hand gesture recognition, and the selection of a few common features for all subjects could help with building a general model. The proposed multimodal framework helps address the single IMU sensing bottleneck for hand gestures during arm movement and/or locomotion.	[Siddiqui, Nabeel; Chan, Rosa H. M.] City Univ Hong Kong, Dept Elect Engn, Tat Chee Avey, Hong Kong, Peoples R China	City University of Hong Kong	Chan, RHM (corresponding author), City Univ Hong Kong, Dept Elect Engn, Tat Chee Avey, Hong Kong, Peoples R China.	rosachan@cityu.edu.hk		Siddiqui, Nabeel/0000-0003-4278-6649; CHAN, Rosa/0000-0003-4808-2490	Research Grants Council of the Hong Kong Special Administrative Region, China [CityU11215618]; City University of Hong Kong [7004614]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); City University of Hong Kong(City University of Hong Kong)	This work was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China [Project No. CityU11215618] and a grant from City University of Hong Kong [Project No. 7004614]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck TW, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-67; Estevez PA, 2009, IEEE T NEURAL NETWOR, V20, P189, DOI 10.1109/TNN.2008.2005601; Fulcher B, 2017, CELL SYST, V5, P527, DOI 10.1016/j.cels.2017.10.001; Galka J, 2016, IEEE SENS J, V16, P6310, DOI 10.1109/JSEN.2016.2583542; Guo WC, 2017, IEEE SENS J, V17, P3100, DOI 10.1109/JSEN.2017.2679806; Harrison AP, 2018, CLIN PHYSIOL FUNCT I, V38, P312, DOI 10.1111/cpf.12417; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hua J, 2016, INT J COMPUT MAT SCI, V5, DOI 10.1142/S2047684116500111; Jiang S, 2018, IEEE T IND INFORM, V14, P3376, DOI 10.1109/TII.2017.2779814; Jiang XT, 2018, IEEE T HUM-MACH SYST, V48, P219, DOI 10.1109/THMS.2017.2693245; Kim Tae-Kwang, 2008, Journal of Physiological Anthropology, V27, P33, DOI 10.2114/jpa2.27.33; Lim J.-M., 2010, P INT C CONS EL, P197; Liu L, 2018, PATTERN RECOGN, V81, P545, DOI 10.1016/j.patcog.2018.04.022; Liu XM, 2016, 2016 INTERNATIONAL CONFERENCE ON LOGISTICS, INFORMATICS AND SERVICE SCIENCES (LISS' 2016); ORIZIO C, 1992, J ELECTROMYOGR KINES, V2, P141, DOI 10.1016/1050-6411(92)90011-7; ORIZIO C, 1989, EUR J APPL PHYSIOL O, V58, P528, DOI 10.1007/BF02330708; Orizio C, 1996, J BIOMECH, V29, P475, DOI 10.1016/0021-9290(95)00063-1; Repnik E, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18092767; Savur C, 2015, 2015 IEEE 14TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), P497, DOI 10.1109/ICMLA.2015.212; Shull PB, 2019, IEEE T NEUR SYS REH, V27, P724, DOI 10.1109/TNSRE.2019.2905658; Siddiqui N, 2017, IEEE ENG MED BIO, P4443, DOI 10.1109/EMBC.2017.8037842; Watakabe M, 2001, MED BIOL ENG COMPUT, V39, P195, DOI 10.1007/BF02344804; Xu C, 2015, 16TH INTERNATIONAL WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS (HOTMOBILE' 15), P9, DOI 10.1145/2699343.2699350; Zhang ZC, 2018, IEEE SOUTHEASTCON, DOI 10.1080/10837450.2018.1469147; Zhu YH, 2018, INT CONF WEARAB IMPL, P181	25	14	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227039	10.1371/journal.pone.0227039	http://dx.doi.org/10.1371/journal.pone.0227039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929544	gold, Green Published			2022-12-26	WOS:000534352500025
J	Thiruganasambandamoorthy, V; Stiell, IG; Chaudry, H; Mukarram, M; Booth, RA; Toarta, C; Hebert, G; Beanlands, RS; Wells, GA; Nemnom, MJ; Taljaard, M				Thiruganasambandamoorthy, Venkatesh; Stiell, Ian G.; Chaudry, Hina; Mukarram, Muhammad; Booth, Ronald A.; Toarta, Cristian; Hebert, Guy; Beanlands, Robert S.; Wells, George A.; Nemnom, Marie-Joe; Taljaard, Monica			Use of conventional cardiac troponin assay for diagnosis of non-ST-elevation myocardial infarction: 'The Ottawa Troponin Pathway'	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT PATIENTS; HIGH-SENSITIVITY TROPONIN; CHEST-PAIN	Background Serial conventional cardiac troponin (cTn) measurements 6-9 hours apart are recommended for non-ST-elevation MI (NSTEMI) diagnosis. We sought to develop a pathway with 3-hour changes for major adverse cardiac event (MACE) identification and assess the added value of the HEART [History, Electrocardiogram (ECG), Age, Risk factors, Troponin] score to the pathway. Methods We prospectively enrolled adults with NSTEMI symptoms at two-large emergency departments (EDs) over 32-months. Patients with STEMI, unstable angina and one cTn were excluded. We collected baseline characteristics, Siemens Vista conventional cTnI at 0, 3 or 6-hours after ED presentation; HEART score predictors; disposition and ED length of stay (LOS). Adjudicated primary outcome was 15-day MACE (acute MI, revascularization, or death due to cardiac ischemia/unknown cause). We analyzed multiples of 99th percentile cut-off cTnI values (45, 100 and 250ng/L). Results 1,683 patients (mean age 64.7 years; 55.3% female; median LOS 7-hours; 88 patients with 15-day MACE) were included. 1,346 (80.0%) patients with both cTnI <= 45 ng/L; and 155 (9.2%) of the 213 patients with one value >= 100ng/L but both< 250ng/L or <= 20% change did not suffer MACE. Among 124 patients (7.4%) with one of the two values> 45ng/L but< 100ng/L based on 3 or 6-hour cTnI, one patient with absolute change< 10ng/L and 6 of the 19 patients with >= 20ng/L were diagnosed with NSTEMI (patients with Delta 10- 19ng/L between first and second cTnI had third one at 6-hours). Based on the results, we developed the Ottawa Troponin Pathway (OTP) with a 98.9% sensitivity (95% CI 93.8-100%) and 94.6% specificity (95% CI 93.3-95.6%). Addition of the HEART score improved the sensitivity to 100% (95% CI 95.9-100%) and decreased the specificity to 26.5% (95% CI 24.3-28.7%). Conclusion The OTP with conventional cTnI 3-hours apart, should lead to better NSTEMI identification particularly those with values > 99th percentile, standardize management and reduce the ED LOS.	[Thiruganasambandamoorthy, Venkatesh; Stiell, Ian G.; Hebert, Guy] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Thiruganasambandamoorthy, Venkatesh; Stiell, Ian G.; Chaudry, Hina; Mukarram, Muhammad; Nemnom, Marie-Joe; Taljaard, Monica] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Thiruganasambandamoorthy, Venkatesh; Stiell, Ian G.; Toarta, Cristian; Wells, George A.; Taljaard, Monica] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Booth, Ronald A.] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Toarta, Cristian] Univ Toronto, Div Emergency Med, Toronto, ON, Canada; [Beanlands, Robert S.] Univ Ottawa, Div Cardiol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa	Thiruganasambandamoorthy, V (corresponding author), Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada.; Thiruganasambandamoorthy, V (corresponding author), Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Thiruganasambandamoorthy, V (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	vthirug@ohri.ca		Nemnom, Marie-Joe/0000-0002-0102-1984; Taljaard, Monica/0000-0002-3978-8961	Innovation Fund for Academic Health Sciences Centres of Ontario through The Ottawa Hospital Academic Medical Organization (TOHAMO)	Innovation Fund for Academic Health Sciences Centres of Ontario through The Ottawa Hospital Academic Medical Organization (TOHAMO)	The study was funded by the Innovation Fund for Academic Health Sciences Centres of Ontario through The Ottawa Hospital Academic Medical Organization (TOHAMO). Initials of the authors who received the award: VT, IGS, RAB, GH, RSB, GAW, MT. Grant Number: Not applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Apple FS, 2009, CLIN CHEM, V55, P1303, DOI 10.1373/clinchem.2009.128363; Backus BE, 2013, INT J CARDIOL, V168, P2153, DOI 10.1016/j.ijcard.2013.01.255; Bhuiya Farida A, 2010, NCHS Data Brief, P1; Chapman AR, 2018, CIRCULATION, V138, P1654, DOI 10.1161/CIRCULATIONAHA.118.036426; Chew DP, 2016, CIRC-CARDIOVASC QUAL, V9, P542, DOI 10.1161/CIRCOUTCOMES.115.002488; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hess EP, 2012, ANN EMERG MED, V59, P115, DOI 10.1016/j.annemergmed.2011.07.026; Mahler SA, 2016, ACAD EMERG MED, V23, P70, DOI 10.1111/acem.12835; Mahler SA, 2015, CIRC-CARDIOVASC QUAL, V8, P195, DOI 10.1161/CIRCOUTCOMES.114.001384; Mahler SA, 2013, INT J CARDIOL, V168, P795, DOI 10.1016/j.ijcard.2012.10.010; Neumann JT, 2019, NEW ENGL J MED, V380, P2529, DOI 10.1056/NEJMoa1803377; Rui P, 2015, NATL HOSP AMBULATORY; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Tomaszewski CA, 2018, ANN EMERG MED, V72, pE65, DOI 10.1016/j.annemergmed.2018.07.045	16	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226892	10.1371/journal.pone.0226892	http://dx.doi.org/10.1371/journal.pone.0226892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923216	Green Published, gold			2022-12-26	WOS:000534350000031
J	Herrera, F; Shi, G; Mays, C; Ichinnorov, N; Takahashi, M; Bevitt, JJ; Herendeen, PS; Crane, PR				Herrera, Fabiany; Shi, Gongle; Mays, Chris; Ichinnorov, Niiden; Takahashi, Masamichi; Bevitt, Joseph J.; Herendeen, Patrick S.; Crane, Peter R.			Reconstructing Krassilovia mongolica supports recognition of a new and unusual group of Mesozoic conifers	PLOS ONE			English	Article							SEED PLANT PHYLOGENY; PERMIAN PALEOBOTANY; SP-NOV; REPRODUCTIVE-BIOLOGY; EXTANT GYMNOSPERMS; GNETALES; EVOLUTION; ANGIOSPERMS; PALYNOLOGY; CONE	Previously unrecognized anatomical features of the cone scales of the enigmatic Early Cretaceous conifer Krassilovia mongolica include the presence of transversely oriented paracytic stomata, which is unusual for all other extinct and extant conifers. Identical stomata are present on co-occurring broad, linear, multiveined leaves assigned to Podozamites harrisii, providing evidence that K. mongolica and P. harrisii are the seed cones and leaves of the same extinct plant. Phylogenetic analyses of the relationships of the reconstructed Krassilovia plant place it in an informal Glade that we name the Krassilovia Clade, which also includes Swedenborgia cryptomerioides-Podozamites schenkii, and Cycadocarpidium erdmanni-Podozamites schenkii. All three of these plants have linear leaves that are relatively broad compared to most living conifers, and that are also multiveined with transversely oriented paracytic stomata. We propose that these may be general features of the Krassilovia Clade. Paracytic stomata, and other features of this new group, recall features of extant and fossil Gnetales, raising questions about the phylogenetic homogeneity of the conifer Glade similar to those raised by phylogenetic analyses of molecular data.	[Herrera, Fabiany; Herendeen, Patrick S.] Chicago Bot Garden, Glencoe, IL 60022 USA; [Shi, Gongle] Chinese Acad Sci, Nanjing Inst Geol & Palaeontol, State Key Lab Palaeobiol & Stratig, Nanjing, Peoples R China; [Shi, Gongle] Chinese Acad Sci, Ctr Excellence Life & Paleoenvironm, Nanjing, Peoples R China; [Mays, Chris] Swedish Museum Nat Hist, Dept Palaeobiol, Stockholm, Sweden; [Mays, Chris] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia; [Ichinnorov, Niiden] Mongolian Acad Sci, Inst Paleontol & Geol, Ulan Bator, Mongolia; [Takahashi, Masamichi] Niigata Univ, Fac Sci, Dept Environm Sci, Nishi Ku, Niigata, Japan; [Bevitt, Joseph J.] Australian Nucl Sci & Technol Org, Australian Ctr Neutron Scattering, Lucas Heights, NSW, Australia; [Crane, Peter R.] Oak Spring Garden Fdn, Upperville, VA USA; [Crane, Peter R.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Swedish Museum of Natural History; Monash University; Mongolian Academy of Sciences; Niigata University; Australian Nuclear Science & Technology Organisation; Yale University	Herrera, F (corresponding author), Chicago Bot Garden, Glencoe, IL 60022 USA.	fherrera@chicagobotanic.org	Shi, Gongle/E-3840-2012; Herendeen, Patrick/F-3032-2010	Shi, Gongle/0000-0003-3374-6637; Herrera, Fabiany/0000-0002-2412-672X; Herendeen, Patrick/0000-0003-2657-8671; Bevitt, Joseph/0000-0002-3502-4649; Mays, Chris/0000-0002-5416-2289	National Science Foundation [DEB-1748286, 1348456]; Oak Spring Garden Foundation [21405010, 24405015]; Japan Society for the Promotion of Science	National Science Foundation(National Science Foundation (NSF)); Oak Spring Garden Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding for this work was provided by National Science Foundation grants DEB-1748286 to P.S.H., P.R.C. and F.H., and 1348456 to P.R.C. and P.S.H., the Oak Spring Garden Foundation to F. H., and Grants-in-Aid for Scientific Research (21405010 and 24405015) from the Japan Society for the Promotion of Science to M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.M., 2003, STRELITZIA, V15, P1; [Anonymous], 1937, MEDDELELSER GRONLAND; ARCHANGELSKY S, 1987, REV PALAEOBOT PALYNO, V51, P3, DOI 10.1016/0034-6667(87)90016-9; ASH S R, 1972, Palaeontology (Oxford), V15, P598; Axsmith BJ, 1998, AM J BOT, V85, P704, DOI 10.2307/2446541; Barthel M., 1977, HALLESCHES JB GEOWIS, V2, P73; Barthel M., 1999, VEROFFENTLICHUNGEN N, V14, P59; Bomfleur B, 2013, INT J PLANT SCI, V174, P425, DOI 10.1086/668686; Bomfleur B, 2011, ANTARCT SCI, V23, P379, DOI 10.1017/S0954102011000241; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Burleigh JG, 2004, AM J BOT, V91, P1599, DOI 10.3732/ajb.91.10.1599; Chamberlain C.J., 1935, GYMNOSPERMS STRUCTUR; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; CLEMENTWESTERHOF JA, 1984, REV PALAEOBOT PALYNO, V41, P51, DOI 10.1016/0034-6667(84)90043-5; CLEMENTWESTERHOF JA, 1987, REV PALAEOBOT PALYNO, V52, P375, DOI 10.1016/0034-6667(87)90066-2; Cneo NR., 1985, AMEGHINIANA, V22, P269; Coiro M, 2018, PALEOBIOLOGY, V44, P490, DOI 10.1017/pab.2018.23; CRANE P R, 1985, Cladistics, V1, P329, DOI 10.1111/j.1096-0031.1985.tb00432.x; Crane P.R., 1988, ORIGIN EVOLUTION GYM, P218; CRANE PR, 1985, ANN MO BOT GARD, V72, P716, DOI 10.2307/2399221; Delevoryas T., 1954, PALAEONTOGRAPHICA  B, V96, P12; Delevoryas T., 1956, CONTRIB MUS PALEONTO, V12, P285; Donoghue MJ, 2000, CURR BIOL, V10, pR106, DOI 10.1016/S0960-9822(00)00304-3; DOYLE JA, 1986, BOT REV, V52, P321, DOI 10.1007/BF02861082; Doyle JA, 1996, INT J PLANT SCI, V157, pS3, DOI 10.1086/297401; Engler A., 1897, NATURLICHEN PFLANZ 2; Escapa IH, 2010, INT J PLANT SCI, V171, P560, DOI 10.1086/651948; Farjon A, 2010, HANDBOOK OF THE WORLD'S CONIFERS, VOL 1, P1, DOI 10.1163/9789047430629; FARJON A, 1990, ABIES CEDRUS PSEUDOL; Farjon A, 2005, MONOGRAPH CUPRESSACE; FLORIN R, 1954, BIOL REV, V29, P367, DOI 10.1111/j.1469-185X.1954.tb01515.x; Florin R., 1964, MEM GEOPALEONTOL U F, V1, P3; Florin R., 1938, PALAEONTOGR ABT B, V85, P1; Florin R., 1951, ACTA HORTI BERGIANI, V15, P285; Florin R., 1953, ACTA HORTI BERGIANI, V16, P257; FLORIN RUDOLF, 1927, ARKIVFOR BOT, V21A, P1; Forest F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24365-4; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2019, INT J PLANT SCI, V180, P643, DOI 10.1086/704356; Friis EM, 2013, INT J PLANT SCI, V174, P530, DOI 10.1086/668250; Friis EM, 2009, AM J BOT, V96, P252, DOI 10.3732/ajb.0800113; Govaerts R, 2010, WORLD CHECKLIST CONI; Grauvogel-Stamm L, 1978, MEMOIRS SCI GEOLOGIQ; Hansen A, 1999, MOL BIOL EVOL, V16, P1006, DOI 10.1093/oxfordjournals.molbev.a026176; HARRIS T. M., 1935, MEDDELELSER OM GRONLAND, V112, P1; Harris T.M., 1979, YORKSHIRE JURASSIC F; Harris T.M., 1926, MEDDELELSER GRONLAND, V68, P45; HARRIS TM, 1976, AM J BOT, V63, P902, DOI 10.2307/2442052; Hasegawa H, 2018, ISL ARC, V27, DOI 10.1111/iar.12243; Hernandez-Castillo GR, 2009, REV PALAEOBOT PALYNO, V157, P218, DOI 10.1016/j.revpalbo.2009.05.003; Hernandez-Castillo GR, 2009, INT J PLANT SCI, V170, P1201, DOI 10.1086/605874; Hernandez-Castillo GR, 2009, INT J PLANT SCI, V170, P1056, DOI 10.1086/605115; Hernandez-Castillo GR, 2003, INT J PLANT SCI, V164, P443, DOI 10.1086/373981; Hernandez-Castillo GR, 2001, INT J PLANT SCI, V162, P1155, DOI 10.1086/321920; Herrera F, 2017, AM J BOT, V104, P1370, DOI 10.3732/ajb.1700246; Herrera F, 2017, P NATL ACAD SCI USA, V114, pE2385, DOI 10.1073/pnas.1621409114; Herrera F, 2017, INT J PLANT SCI, V178, P19, DOI 10.1086/689577; Herrera F, 2016, BOTANY, V94, P885, DOI 10.1139/cjb-2016-0042; Herrera F, 2015, INT J PLANT SCI, V176, P791, DOI 10.1086/683060; Ichinnorov N., 2003, MONG GEOSCI, V22, P12; KERP JHF, 1990, REV PALAEOBOT PALYNO, V62, P205, DOI 10.1016/0034-6667(90)90090-6; KRASSILOV V, 1982, Palaeontographica Abteilung B Palaeophytologie, V181, P1; Kunzmann L, 2009, REV PALAEOBOT PALYNO, V158, P193, DOI 10.1016/j.revpalbo.2009.09.001; Leslie AB, 2018, AM J BOT, V105, P1531, DOI 10.1002/ajb2.1143; Leslie AB, 2013, AM J BOT, V100, P2426, DOI 10.3732/ajb.1300173; Looy CV, 2014, INT J PLANT SCI, V175, P841, DOI 10.1086/676973; Losada JM, 2019, NEW PHYTOL, V222, P396, DOI 10.1111/nph.15563; Mapes G., 1991, NEUES JB GEOL PAL, V183, P269; Mapes R.H., 1988, REGIONAL GEOLOGY PAL, P225; Mays C, 2018, J SYST PALAEONTOL, V16, P551, DOI 10.1080/14772019.2017.1314898; Meyen SV, 1997, REV PALAEOBOT PALYNO, V96, P351, DOI 10.1016/S0034-6667(96)00046-2; MILLER CN, 1977, BOT REV, V43, P217, DOI 10.1007/BF02860718; MILLER CN, 1982, REV PALAEOBOT PALYNO, V37, P99, DOI 10.1016/0034-6667(82)90039-2; Miller CN, 1999, BOT REV, V65, P239, DOI 10.1007/BF02857631; Nichols DJ, 2006, CRETACEOUS RES, V27, P241, DOI 10.1016/j.cretres.2005.11.004; Nosova N, 2017, REV PALAEOBOT PALYNO, V238, P88, DOI 10.1016/j.revpalbo.2016.11.005; Peppe D. J., 2018, METHODS PALEOECOLOGY, P289, DOI [10.1007/978-3-319-94265-0_13, DOI 10.1007/978-3-319-94265-0_13]; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Ran JH, 2018, MOL PHYLOGENET EVOL, V129, P106, DOI 10.1016/j.ympev.2018.08.011; Rothwell G.W., 1975, PALAEONTOGR ABT B, V151B, P171; Rothwell GW, 2016, AM J BOT, V103, P923, DOI 10.3732/ajb.1600030; ROTHWELL GW, 1994, SYST BOT, V19, P443, DOI 10.2307/2419767; ROTHWELL GW, 1981, REV PALAEOBOT PALYNO, V32, P103, DOI 10.1016/0034-6667(81)90076-2; Rothwell GW, 2000, PALAEOGEOGR PALAEOCL, V156, P139, DOI 10.1016/S0031-0182(99)00136-4; Rothwell GW, 2005, TAXON, V54, P733, DOI 10.2307/25065430; ROTHWELL GW, 1993, INT J PLANT SCI, V154, P572, DOI 10.1086/297140; ROTHWELL GW, 1984, BOT GAZ, V145, P275, DOI 10.1086/337456; Rothwell GW, 2003, TAXON, V52, P329, DOI 10.2307/3647406; Rothwell GW, 1996, J PALEONTOL, V70, P1067, DOI 10.1017/S0022336000038750; Rothwell GW, 2001, INT J PLANT SCI, V162, P637, DOI 10.1086/320129; Royer DL, 2007, PALEOBIOLOGY, V33, P574, DOI 10.1666/07001.1; Royer DL, 2010, AM J BOT, V97, P438, DOI 10.3732/ajb.0900290; Rudall PJ, 2019, ANN BOT-LONDON, V124, P149, DOI 10.1093/aob/mcz053; Rudall PJ, 2019, BIOL REV, V94, P1179, DOI 10.1111/brv.12497; Rudall PJ, 2013, NEW PHYTOL, V200, P598, DOI 10.1111/nph.12406; Rydin C, 2002, INT J PLANT SCI, V163, P197, DOI 10.1086/338321; Schweitzer H-J., 1963, PALAEONTOGR ABT B, V113, P1; Schweitzer Hans-Joachim, 1996, Palaeontographica Abteilung B Palaeophytologie, V238, P77; Schweitzer Hans-Joachim, 1996, Palaeontographica Abteilung B Palaeophytologie, V239, P1; Serbet R, 2010, REV PALAEOBOT PALYNO, V161, P168, DOI 10.1016/j.revpalbo.2010.03.011; Shi GL, 2019, J SYST PALAEONTOL, V17, P997, DOI 10.1080/14772019.2018.1493547; Shi GL, 2018, J SYST PALAEONTOL, V16, P111, DOI 10.1080/14772019.2016.1274343; Shi GL, 2016, NEW PHYTOL, V210, P1418, DOI 10.1111/nph.13871; Shi GL, 2014, INT J PLANT SCI, V175, P911, DOI 10.1086/677651; Soltis DE, 2002, AM J BOT, V89, P1670, DOI 10.3732/ajb.89.10.1670; Sporne K.R., 1965, MORPHOLOGY GYMNOSPER; Stefanovic S, 1998, AM J BOT, V85, P688, DOI 10.2307/2446539; Stewart W.N., 1993, PALEOBOTANY EVOLUTIO; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; TRIVETT ML, 1985, SYST BOT, V10, P205, DOI 10.2307/2418347; Watson J., 1992, MONOGRAPH PALAEONTOG, V145, P2; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Xi ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080870; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170	115	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226779	10.1371/journal.pone.0226779	http://dx.doi.org/10.1371/journal.pone.0226779			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940374	Green Published, gold			2022-12-26	WOS:000534368000041
J	Togano, S; Yashiro, M; Miki, Y; Yamamato, Y; Sera, T; Kushitani, Y; Sugimoto, A; Kushiyama, S; Nishimura, S; Kuroda, K; Okuno, T; Yoshii, M; Tamura, T; Toyokawa, T; Tanaka, H; Muguruma, K; Tanaka, S; Ohira, M				Togano, Shingo; Yashiro, Masakazu; Miki, Yuichiro; Yamamato, Yurie; Sera, Tomohiro; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Shuhei; Nishimura, Sadaaki; Kuroda, Kenji; Okuno, Tomohisa; Yoshii, Mami; Tamura, Tatsuro; Toyokawa, Takahiro; Tanaka, Hiroaki; Muguruma, Kazuya; Tanaka, Sayaka; Ohira, Masaichi			Microscopic distance from tumor invasion front to serosa might be a useful predictive factor for peritoneal recurrence after curative resection of T3-gastric cancer	PLOS ONE			English	Article							EARLY GASTRIC-CANCER; ADJUVANT CHEMOTHERAPY; DISSEMINATION; RISK; S-1	Background Peritoneal recurrence is one of the most frequent recurrent diseases in gastric cancer. Although the exposure of cancer cells to the serosal surface is considered a common risk factor for peritoneal recurrence, there are some cases of peritoneal recurrence without infiltration to the serosal surface even after curative surgery. This study sought to clarify the risk factors of peritoneal recurrence in the absence of invasion to the serosal surface. Materials and methods Ninety-six patients with gastric cancer who underwent curative surgery were enrolled. In all 96 cases, the depth of tumor invasion was subserosal (T3). The microscopic distance from the tumor invasion front to the serosa (DIFS) was measured using tissue slides by H&E staining and pan-cytokeratin staining. E-cadherin expression was evaluated by immunohistochemical staining. Results Among the 96 patients, 16 developed peritoneal recurrence after curative surgery. The DIFS of the tumors with peritoneal recurrence (156 +/- 220 mu m) was significantly shorter (p = 0.011) than that without peritoneal recurrence (360 +/- 478 mu m). Peritoneal recurrence was significantly correlated with DIFS <= 234 mu m (p = 0.023), but not with E-cadherin expression. The prognosis of DIFS <= 234 mu m was significantly poorer than that of DIFS >234 mu m (log rank, p = 0.007). A multivariate analysis of the patients' five-year overall survival revealed that DIFS <= 234 mu m and lymph node metastasis were significantly correlated with survival (p = 0.005, p = 0.032, respectively). Conclusion The measurement of the DIFS might be useful for the prediction of peritoneal recurrence in T3-gastric cancer patients after curative surgery.	[Togano, Shingo; Yashiro, Masakazu; Miki, Yuichiro; Sera, Tomohiro; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Shuhei; Nishimura, Sadaaki; Kuroda, Kenji; Okuno, Tomohisa; Yoshii, Mami; Tamura, Tatsuro; Toyokawa, Takahiro; Tanaka, Hiroaki; Muguruma, Kazuya; Ohira, Masaichi] Osaka City Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan; [Togano, Shingo; Yashiro, Masakazu; Miki, Yuichiro; Yamamato, Yurie; Sera, Tomohiro; Kushitani, Yukako; Sugimoto, Atsushi; Kushiyama, Shuhei; Nishimura, Sadaaki; Kuroda, Kenji; Okuno, Tomohisa] Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan; [Yashiro, Masakazu; Yamamato, Yurie] Osaka City Univ, Canc Ctr Translat Res, Grad Sch Med, Osaka, Japan; [Tanaka, Sayaka] Osaka City Univ, Dept Diagnost Pathol, Grad Sch Med, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan.; Yashiro, M (corresponding author), Osaka City Univ, Mol Oncol & Therapeut, Grad Sch Med, Osaka, Japan.; Yashiro, M (corresponding author), Osaka City Univ, Canc Ctr Translat Res, Grad Sch Med, Osaka, Japan.	m9312510@med.osaka-cu.ac.jp	Miki, Yuichiro/ABH-6790-2020	Sugimoto, Atsushi/0000-0003-3311-2562	KAKENHI [18H02883]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Grant-in-Aid for Scientific Research, Nos. 18H02883(M.Y.).	Bando E, 1999, AM J SURG, V178, P256, DOI 10.1016/S0002-9610(99)00162-2; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Brierley J.D., 2016, TNM CLASSIFICATION M, Veighth; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gao MN, 2016, ONCOTARGET, V7, P85502, DOI 10.18632/oncotarget.13453; Hiratsuka M, 1995, Gan To Kagaku Ryoho, V22, P703; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Katai H, 2018, GASTRIC CANCER, V21, P144, DOI 10.1007/s10120-017-0716-7; Li Y., 2012, P S PHOT OPT MAY, P1, DOI DOI 10.1002/JS0.23008; Liang GZ, 2015, ONCOL LETT, V10, P1527, DOI 10.3892/ol.2015.3475; Maehara Y, 2000, BRIT J SURG, V87, P353, DOI 10.1046/j.1365-2168.2000.01358.x; Miki Y, 2017, SURG ONCOL, V26, P352, DOI 10.1016/j.suronc.2017.07.008; Nishimura S, 1996, BRIT J CANCER, V74, P1406, DOI 10.1038/bjc.1996.556; Noh SH, 2014, LANCET ONCOL, V15, P1389, DOI 10.1016/S1470-2045(14)70473-5; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Sun F, 2017, ONCOL LETT, V14, P6991, DOI 10.3892/ol.2017.7149; Tanaka T, 2000, J SURG ONCOL, V75, P165, DOI 10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5; Torabizadeh Zhila, 2017, Int J Hematol Oncol Stem Cell Res, V11, P158; Yamamoto M, 2006, SURG TODAY, V36, P835, DOI 10.1007/s00595-006-3253-2; YASHIRO M, 1995, BRIT J CANCER, V72, P1200, DOI 10.1038/bjc.1995.486; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Yonemura Y, 1997, ONCOL REP, V4, P743; Yoshida M, 2016, VIRCHOWS ARCH, V469, P155, DOI 10.1007/s00428-016-1960-7	24	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0225958	10.1371/journal.pone.0225958	http://dx.doi.org/10.1371/journal.pone.0225958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940352	Green Published, gold			2022-12-26	WOS:000534368000011
J	Liu, L; Zhou, M; Zhu, RF; Zhou, J; Ni, L; Wang, ZD; Liu, NC; Zhu, F; Shi, TG; Deng, ZT; Wang, Y; Tian, YX; Li, RQ; Yang, HL; Wang, ZH; Jiang, JN; Xu, YZ				Liu, Lei; Zhou, Ming; Zhu, Ruofu; Zhou, Jun; Ni, Li; Wang, Zhidong; Liu, Naicheng; Zhu, Feng; Shi, Tongguo; Deng, Zhantao; Wang, Yong; Tian, Yixing; Li, Rongqun; Yang, Huilin; Wang, Zhenheng; Jiang, Jiannong; Xu, Yaozeng			Hydrogen sulfide protects against particle-induced inflammatory response and osteolysis via SIRT1 pathway in prosthesis loosening	FASEB JOURNAL			English	Article						GYY4137; hydrogen sulfide; inflammation; SIRT1; wear particles	OSTEOCLAST FORMATION; PERIPROSTHETIC OSTEOLYSIS; MOUSE MODEL; BONE LOSS; IN-VITRO; H2S; INTERLEUKIN-6; PATHOGENESIS; MACROPHAGES; ACTIVATION	Wear debris-induced osteolysis and ensuing aseptic loosening is the main cause of implant failure and revision surgery. Wear debris-induced inflammatory response plays key roles in peri-implant osteolysis. Recently, substantial of evidence suggests that hydrogen sulfide (H2S), the third gasotransmitter, is a critical player regulating inflammation. However, the role and therapeutic potential of H2S in wear debris-induced inflammation and osteolysis remains to be defined. In the present study, we investigated the effect of H2S on wear debris-induced pro-inflammatory cytokines expression and osteolysis in vitro and in vivo. With a slow-releasing H2S donor GYY4137, our study demonstrated that H2S attenuated wear debris-induced osteolysis and osteoclastogenesis in murine calvaria resorption models. The expression of tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6) that stimulated by wear particles were significantly reduced by GYY4137. Further, the level of sirtuin 1 (SIRT1), which possesses anti-inflammation property, was examined in vivo and in macrophages. And we found that wear debris decreased the expression of SIRT1. Cotreated macrophages with GYY4137 in part reversed the decline of SIRT1. More importantly, with the SIRT1 recombinant lentivirus and small interfering RNAs (siRNA) against SIRT1, our data indicated that SIRT1 mediated the inhibitory effects of GYY4137 on wear debris-induced inflammation. Collectively, these results suggested that exogenous H2S production (via H2S donors) may represent a potential approach for the treatment of wear particle-induced osteolysis.	[Liu, Lei; Zhou, Ming; Zhu, Ruofu; Zhou, Jun; Ni, Li; Wang, Zhidong; Liu, Naicheng; Zhu, Feng; Tian, Yixing; Li, Rongqun; Yang, Huilin; Wang, Zhenheng; Xu, Yaozeng] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, 899 Pinghai Rd, Suzhou 215000, Peoples R China; [Liu, Lei; Zhou, Ming; Wang, Yong; Jiang, Jiannong] Jiangsu Univ, Affiliated Yixing Hosp, Dept Orthoped, Yixing, Peoples R China; [Liu, Lei; Jiang, Jiannong] Yangzhou Univ, Sch Med, Affiliated Yixing Clin Sch, Yixing, Peoples R China; [Shi, Tongguo] First Affiliated Hosp Soochow, Jiangsu Inst Clin Immunol, Suzhou, Peoples R China; [Deng, Zhantao] Guangdong Gen Hosp, Guangdong Acad Med Sci, Dept Surg, Div Orthoped Surg, Guangzhou, Peoples R China	Soochow University - China; Jiangsu University; Yangzhou University; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wang, ZH; Xu, YZ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, 899 Pinghai Rd, Suzhou 215000, Peoples R China.	wangzhenheng1987@163.com; staff1225@yxph.com; xuyaozeng@163.com	Shi, Tongguo/AAS-3460-2021	Shi, Tongguo/0000-0002-5382-2775	National Natural Science Foundation of China (NSFC) [81802223, 81702214, 81802843, 81802222, 81572111, 81772318]; Clinical Medicine and Technological Development Foundation of Jiangsu University [JLY20180071, JLY20180006]; health planning committee younth project of wuxi [Q201710]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Clinical Medicine and Technological Development Foundation of Jiangsu University; health planning committee younth project of wuxi	National Natural Science Foundation of China (NSFC), Grant/Award Number: 8 1802223,81702214,81802843,81802222, 81572111,81772318; Grants from health planning committee younth project of wuxi, Grant/Award Number: Q201710; Clinical Medicine and Technological Development Foundation of Jiangsu University, Grant/Award Number: JLY20180071,JLY20180006	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alves CH, 2016, CLIN REV ALLERG IMMU, V51, P27, DOI 10.1007/s12016-015-8522-7; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Bhatia M, 2015, HANDB EXP PHARMACOL, V230, P165, DOI 10.1007/978-3-319-18144-8_8; Burguera EF, 2017, CURR DRUG TARGETS, V18, P1641, DOI 10.2174/1389450117666160829112824; Castelblanco M, 2018, J BIOL CHEM, V293, P2546, DOI 10.1074/jbc.M117.806869; Deng ZT, 2017, ACTA BIOMATER, V49, P541, DOI 10.1016/j.actbio.2016.11.051; Du CK, 2019, ANTIOXID REDOX SIGN, V30, P184, DOI 10.1089/ars.2017.7195; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Flannigan KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071962; Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779; Goodman SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0962; Ha CZ, 2015, INT J MOL MED, V35, P1657, DOI 10.3892/ijmm.2015.2183; Huang CWH, 2016, PHARMACOL RES, V113, P533, DOI 10.1016/j.phrs.2016.09.032; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Ito H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3238; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1; Karrholm J, 2018, SWEDISH HIP ARTHROPL; Kauther MD, 2013, BIOMATERIALS, V34, P2911, DOI 10.1016/j.biomaterials.2013.01.034; Kim HN, 2015, MOL ENDOCRINOL, V29, P1498, DOI 10.1210/me.2015-1133; Kitaura H, 2004, J IMMUNOL, V173, P4838, DOI 10.4049/jimmunol.173.8.4838; Kloesch B, 2010, CELL BIOL INT, V34, P477, DOI 10.1042/CBI20090436; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Langlois J, 2011, INT ORTHOP, V35, P245, DOI 10.1007/s00264-010-1143-0; Lehil MS, 2014, J ARTHROPLASTY, V29, P1915, DOI 10.1016/j.arth.2014.05.017; Li JJ, 2015, INT J MOL SCI, V16, P12560, DOI 10.3390/ijms160612560; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Lin Z, 2018, BBA-MOL BASIS DIS, V1864, P2890, DOI 10.1016/j.bbadis.2018.05.023; LOMBARDI AV, 1989, J BONE JOINT SURG AM, V71A, P1337, DOI 10.2106/00004623-198971090-00009; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; Mendes KL, 2017, CYTOKINE GROWTH F R, V38, P98, DOI 10.1016/j.cytogfr.2017.11.001; Morigi M, 2018, J AM SOC NEPHROL, V29, P1799, DOI 10.1681/ASN.2017111218; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakamura I, 2006, VITAM HORM, V74, P357, DOI 10.1016/S0083-6729(06)74015-8; National Joint Registry for England Wales Northern Ireland and the Isle of Man, 2017, 14 ANN REP 2017; Nevius E, 2016, CLIN REV ALLERG IMMU, V51, P59, DOI 10.1007/s12016-015-8520-9; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Ong ALC, 2018, AGEING RES REV, V43, P64, DOI 10.1016/j.arr.2018.02.004; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rao AJ, 2013, J BIOMED MATER RES A, V101, P1925, DOI 10.1002/jbm.a.34486; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Ruscitti P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/782382; Stuhlmeier KM, 2009, EXP BIOL MED, V234, P1327, DOI 10.3181/0904-RM-137; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2013, BIOMATERIALS, V34, P2611, DOI 10.1016/j.biomaterials.2013.01.025; Wang ZH, 2017, INT J NANOMED, V12, DOI 10.2147/IJN.S130485; Wang ZH, 2017, ACTA BIOMATER, V48, P489, DOI 10.1016/j.actbio.2016.11.020; Wang ZH, 2015, AUTOPHAGY, V11, P2358, DOI 10.1080/15548627.2015.1106779; Wedemeyer C, 2007, CALCIFIED TISSUE INT, V81, P394, DOI 10.1007/s00223-007-9077-2; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005	59	14	14	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3743	3754		10.1096/fj.201900393RR	http://dx.doi.org/10.1096/fj.201900393RR		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31943384	Bronze			2022-12-26	WOS:000507480500001
J	Van Zyl, KN; Whitelaw, AC; Newton-Foot, M				Van Zyl, Kristien Nel; Whitelaw, Andrew C.; Newton-Foot, Mae			The effect of storage conditions on microbial communities in stool	PLOS ONE			English	Article							REAL-TIME PCR; FIRMICUTES; FECES	Microbiome research has experienced a surge of interest in recent years due to the advances and reduced cost of next-generation sequencing technology. The production of high quality and comparable data is dependent on proper sample collection and storage and should be standardized as far as possible. However, this becomes challenging when samples are collected in the field, especially in resource-limited settings. We investigated the impact of different stool storage methods common to the TB-CHAMP clinical trial on the microbial communities in stool. Ten stool samples were subjected to DNA extraction after 48-hour storage at -80 degrees C, room temperature and in a cooler-box, as well as immediate DNA extraction. Three stool DNA extraction kits were evaluated based on DNA yield and quality. Quantitative PCR was performed to determine the relative abundance of the two major gut phyla Bacteroidetes and Firmicutes, and other representative microbial groups. The bacterial populations in the frozen group closely resembled the immediate extraction group, supporting previous findings that storage at -80 degrees C is equivalent to the gold standard of immediate DNA extraction. More variation was seen in the room temperature and cooler-box groups, which may be due to the growth temperature preferences of certain bacterial populations. However, for most bacterial populations, no significant differences were found between the storage groups. As seen in other microbiome studies, the variation between participant samples was greater than that related to differences in storage. We determined that the risk of introducing bias to microbial community profiling through differences in storage will likely be minimal in our setting.	[Van Zyl, Kristien Nel; Whitelaw, Andrew C.; Newton-Foot, Mae] Stellenbosch Univ, Div Med Microbiol, Dept Pathol, Stellenbosch, South Africa; [Whitelaw, Andrew C.; Newton-Foot, Mae] Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Whitelaw, Andrew C.] Stellenbosch Univ, African Microbiome Inst, Stellenbosch, South Africa	Stellenbosch University; Tygerberg Hospital; Stellenbosch University	Van Zyl, KN (corresponding author), Stellenbosch Univ, Div Med Microbiol, Dept Pathol, Stellenbosch, South Africa.	knvz@sun.ac.za	Van Zyl, Kristien Nel/AAH-6243-2021	Van Zyl, Kristien Nel/0000-0001-5529-4526; Newton-Foot, Mae/0000-0002-3880-8203; Whitelaw, Andrew/0000-0001-9070-5247	NHLS Research Trust of South Africa [GRANT004_ 94632, GRANT004_94679]; Harry Crossley Foundation	NHLS Research Trust of South Africa; Harry Crossley Foundation	This study was supported by grants funded through the NHLS Research Trust of South Africa (MNF received GRANT004_ 94632 and GRANT004_94679) and the Harry Crossley Foundation (KN received a HCF grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; Delroisse JM, 2008, MICROBIOL RES, V163, P663, DOI 10.1016/j.micres.2006.09.004; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139529; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Huseyin CE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01432; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Kwok L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093631; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; McDonald JH, 2014, HDB BIOL STAT, P157; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206	27	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227486	10.1371/journal.pone.0227486	http://dx.doi.org/10.1371/journal.pone.0227486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935223	Green Published, gold			2022-12-26	WOS:000534354100023
J	Alonso, F; Esteban, C; Gonzalez-Marin, A; Alfaro, E; Useche, SA				Alonso, Francisco; Esteban, Cristina; Gonzalez-Marin, Adela; Alfaro, Elisa; Useche, Sergio A.			Job stress and emotional exhaustion at work in Spanish workers: Does unhealthy work affect the decision to drive?	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; PSYCHOSOCIAL FACTORS; BURNOUT; FATIGUE; HEALTH; STRAIN; DEPRESSION; ACCIDENTS; ANGER; PERSONALITY	Objectives The purpose of this study was to assess the relationships among the following elements: unhealthy work indicators (job stress and emotional exhaustion at work), the decision to drive (or not), and driving crashes suffered by Spanish workers. Methods For this cross-sectional study, a full sample of 1,200 Spanish drivers (44% women and 56% men) was used, their mean age being 42.8 years. They answered a questionnaire divided into three sections: demographic and driving-related data; burnout, job stress, and life stress; and self-reported road behaviors and driving safety indicators. Results Overall, 41.6% of drivers reported emotional exhaustion at work. Furthermore, 80.2% of the participants showing substantial signs of job stress or exhaustion had experienced one or more important stressful life events during the previous year. Job stress was associated with the number of driving crashes suffered along the last 3 years. Also, and especially in situations where drivers admit not feeling well enough to drive, job stress and emotional exhaustion seem to be independent from the decision to drive, and from perceiving these variables as potential impairers of driving performance. Conclusions First of all, this study showed a high prevalence of job stress and emotional exhaustion symptoms experienced at work by Spanish workers. Moreover, significant relationships were found among self-rated driving performance, workplace stress and burnout indicators, which suggests that job stress and emotional exhaustion levels may, indeed, impair driving performance, but they do not influence the decision to drive or not. In other words, even when they are significantly affected by job stress or emotional exhaustion at work, most Spanish drivers still drive.	[Alonso, Francisco; Esteban, Cristina; Useche, Sergio A.] Univ Valencia, INTRAS Univ Res Inst Traff & Rd Safety, DATS Dev & Advising Traff Safety Res Gr, Valencia, Spain; [Gonzalez-Marin, Adela] Spanish Air Force Acad, Univ Ctr Def, Murcia, Spain; [Alfaro, Elisa] Univ Valencia, INTRAS Univ Res Inst Traff & Rd Safety, PRECOVIR Risk Prevent Rd Behav Res Grp, Valencia, Spain	University of Valencia; University of Valencia	Useche, SA (corresponding author), Univ Valencia, INTRAS Univ Res Inst Traff & Rd Safety, DATS Dev & Advising Traff Safety Res Gr, Valencia, Spain.	sergio.useche@uv.es	Gonzalez-Marin, Adela/ABF-8137-2021; Gonzalez, Adela/ABD-8754-2021; Alonso, Francisco/D-5659-2012; Useche, Sergio A./O-7552-2014; Esteban, Cristina/ABD-4209-2021	Gonzalez, Adela/0000-0003-3372-3910; Alonso, Francisco/0000-0002-9482-8874; Useche, Sergio A./0000-0002-5099-4627; Esteban, Cristina/0000-0002-4066-1319	Audi Attitudes Program [UV20071472]	Audi Attitudes Program	This research was supported by the Audi Attitudes Program -grant number UV20071472. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg L, 2008, EUR REV APPL PSYCHOL, V58, P23, DOI 10.1016/j.erap.2005.09.014; Ahola K, 2009, OCCUP ENVIRON MED, V66, P284, DOI 10.1136/oem.2008.038935; Ahola K, 2009, J AFFECT DISORDERS, V115, P150, DOI 10.1016/j.jad.2008.09.021; Alonso F, 2016, INT J PSYCHOL BRAIN, V1, P54, DOI [10.11648/j.ijpbs.20160103.13, DOI 10.11648/J.IJPBS.20160103.13]; Alonso F, 2008, TEORIA PRACTICAS TRA; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; CARRERE S, 1991, J OCCUP PSYCHOL, V64, P305, DOI 10.1111/j.2044-8325.1991.tb00562.x; Cendales B, 2014, IND HEALTH, V52, P279, DOI 10.2486/indhealth.2013-0156; Cendales-Ayala B, 2017, J OCCUP HEALTH PSYCH, V22, P518, DOI 10.1037/ocp0000040; Charbotel B, 2001, EUR J EPIDEMIOL, V17, P773, DOI 10.1023/A:1015667114529; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Demerouti E, 2014, J OCCUP HEALTH PSYCH, V19, P96, DOI 10.1037/a0035062; DERRYBERRY D, 1988, MOTIV EMOTION, V12, P23, DOI 10.1007/BF00992471; Garrosa E, 2008, INT J NURS STUD, V45, P418, DOI 10.1016/j.ijnurstu.2006.09.003; Gee GC, 2004, SOC SCI MED, V59, P405, DOI 10.1016/j.socscimed.2003.10.027; Halbesleben JRB, 2007, J APPL PSYCHOL, V92, P93, DOI 10.1037/0021-9010.92.1.93; Hege A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207322; Hoggan BL, 2007, ACCIDENT ANAL PREV, V39, P1286, DOI 10.1016/j.aap.2007.03.014; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Huerta-Franco Maria-Raquel, 2013, World J Gastrointest Pathophysiol, V4, P108, DOI 10.4291/wjgp.v4.i4.108; Huibers MJH, 2003, OCCUP ENVIRON MED, V60, P26; Iacovides A, 2003, J AFFECT DISORDERS, V75, P209, DOI 10.1016/S0165-0327(02)00101-5; Karasek R., 1998, ENCY OCCUPATIONAL HL, V4, p34.36; Kee S., 2010, GLOB J HLTH SCI, V2, P167; Khamisa N, 2013, INT J ENV RES PUB HE, V10, P2214, DOI 10.3390/ijerph10062214; Komissarova E. M., 2011, Meditsina Truda i Promyshlennaya Ekologiya, P19; Kuper H, 2002, OCCUP ENVIRON MED, V59, P777, DOI 10.1136/oem.59.11.777; LeMay S. A., 2013, INT J COMMERCE MANAG, V23, P262, DOI [10.1108/IJCoMA-03-2013-0028, DOI 10.1108/IJCOMA-03-2013-0028]; Li F, 2017, ACCIDENT ANAL PREV, V98, P198, DOI 10.1016/j.aap.2016.10.013; Marti-Belda A, 2019, EUR J PSYCHOL APPL L, V11, P81, DOI 10.5093/ejpalc2019a3; Maslach C, 2016, MASLACH BURNOUT INVE; McLinton SS, 2010, ACCIDENT ANAL PREV, V42, P174, DOI 10.1016/j.aap.2009.07.016; Montoro L, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030497; National Institute of Occupational Health and Safety (NIOSH), 1999, STRESS WORK; Oyeleke J. T., 2016, INT J HUM SOCIAL SCI, V6, P162; Pagnin D, 2014, ACAD PSYCHIATR, V38, P438, DOI 10.1007/s40596-014-0093-z; Pereira-Lima K, 2015, PSYCHOL HEALTH MED, V20, P353, DOI 10.1080/13548506.2014.936889; Perinelli E, 2016, J CLIN PSYCHOL, V72, P534, DOI 10.1002/jclp.22284; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Pikhart H, 2004, SOC SCI MED, V58, P1475, DOI 10.1016/S0277-9536(03)00350-2; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Salavecz G., 2001, ASS WORK STRESS HLTH; Sánchez F., 2008, Psychological Intervention, V17, P45, DOI 10.4321/s1132-05592008000100005; Sanderson K, 2006, CAN J PSYCHIAT, V51, P63, DOI 10.1177/070674370605100202; SCHNALL PL, 1994, AM J PUBLIC HEALTH, V84, P320, DOI 10.2105/AJPH.84.2.320; Schonfeld IS, 2016, J CLIN PSYCHOL, V72, P22, DOI 10.1002/jclp.22229; Semeijn J, 2019, LOGISTICS-BASEL, V3, DOI 10.3390/logistics3010006; Shad R, 2015, CUREUS, V7, DOI 10.7759/cureus.361; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siegrist J., 2002, HIST CURRENT PERSPEC, P261, DOI DOI 10.1016/S1479-3555(02)02007-3; Siegrist J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040432; Smith LA, 2005, STRESS HEALTH, V21, P113, DOI 10.1002/smi.1045; SWOV, 2005, EM TRAFF RES ACT; Taylor AH, 2006, ANNU REV PUBL HEALTH, V27, P371, DOI 10.1146/annurev.publhealth.27.021405.102117; Theorell T, 1999, SCAND J WORK ENV HEA, V25, P616, DOI 10.5271/sjweh.489; Useche S., 2017, J ENV OCCUP SCI, V6, P1, DOI [10.5455/jeos.20170202074636, DOI 10.5455/JE0S.20170202074636]; Useche S, 2017, DATA BRIEF, V15, P335, DOI 10.1016/j.dib.2017.09.032; Useche SA, 2017, ACCIDENT ANAL PREV, V104, P106, DOI 10.1016/j.aap.2017.04.023; van Vegchel N, 2005, SOC SCI MED, V60, P1117, DOI 10.1016/j.socscimed.2004.06.043; Vic Roads Corporation, MED REV; Weiten WL, 2006, PSYCHOL APPL MODERN; Xu JJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193542	64	9	9	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227328	10.1371/journal.pone.0227328	http://dx.doi.org/10.1371/journal.pone.0227328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929546	Green Published, gold			2022-12-26	WOS:000534352500034
J	Dmochowska-Boguta, M; Kloc, Y; Zielezinski, A; Werecki, P; Nadolska-Orczyk, A; Karlowski, WM; Orczyk, W				Dmochowska-Boguta, Marta; Kloc, Yuliya; Zielezinski, Andrzej; Werecki, Przemyslaw; Nadolska-Orczyk, Anna; Karlowski, Wojciech M.; Orczyk, Waclaw			TaWAK6 encoding wall-associated kinase is involved in wheat resistance to leaf rust similar to adult plant resistance	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE; COMPONENTS; RECEPTOR; SYSTEM; TRANSFORMATION; LR34	In wheat, adult plant resistance (APR) to leaf rust (Puccinia triticina), is effective in restricting pathogen growth and provides durable resistance against a wide range of virulent forms of P. triticina. Despite the importance, there is limited knowledge on the molecular basis of this type of resistance. We isolated and characterized the wall-associated kinase encoding gene in wheat, and assigned it as TaWAK6. Localization of TaWAK6 homeologs in A and B wheat subgenomes was consistent with the presence of the gene's orthologs in T. urartu (AA) and T. dicoccoides (AABB) and with the absence of its orthologs in Aegilops tauschii (DD). Overexpression of TaWAK6 did not change the wheat phenotype, nor did it affect seedling resistance. However, the adult plants overexpressing TaWAK6 showed that important parameters of APR were significantly elevated. Infection types scored on the first (flag), second and third leaves indicated elevated resistance, which significantly correlated with expression of TaWAK6. Analysis of plant-pathogen interactions showed a lower number of uredinia and higher rates of necrosis at the infection sites and this was associated with smaller size of uredinia and a longer latent period. The results indicated a role of TaWAK6 in quantitative partial resistance similar to APR in wheat. It is proposed that TaWAK6, which is a non-arginine-aspartate (non-RD) kinase, represents a novel class of quantitative immune receptors in monocots.	[Dmochowska-Boguta, Marta; Kloc, Yuliya; Werecki, Przemyslaw; Orczyk, Waclaw] Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Radzikow, Blonie, Poland; [Zielezinski, Andrzej; Karlowski, Wojciech M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Computat Biol, Poznan, Poland; [Nadolska-Orczyk, Anna] Nat Res Inst, Dept Funct Genom, Plant Breeding & Acclimatizat Inst, Radzikow, Blonie, Poland	Institute of Plant Breeding & Acclimatization; Adam Mickiewicz University; Institute of Plant Breeding & Acclimatization	Orczyk, W (corresponding author), Natl Res Inst, Plant Breeding & Acclimatizat Inst, Dept Genet Engn, Radzikow, Blonie, Poland.	w.orczyk@ihar.edu.pl	; Zielezinski, Andrzej/I-1342-2018	Nadolska-Orczyk, Anna/0000-0001-6127-3860; Dmochowska-Boguta, Marta/0000-0002-4526-0418; Kloc, Yuliya/0000-0001-6837-2255; Zielezinski, Andrzej/0000-0002-8096-3776	National Science Centre [UMO-2014/13/B/NZ9/02387]; Ministry of Agriculture and Rural Development [2.1.3]; PBAI-NRI	National Science Centre(National Science Centre, Poland); Ministry of Agriculture and Rural Development; PBAI-NRI	This research was supported by the National Science Centre, grant UMO-2014/13/B/NZ9/02387, by the Ministry of Agriculture and Rural Development, PW Task No 2.1.3 and a statutory grant of PBAI-NRI.	Anderson CM, 2001, PLANT MOL BIOL, V47, P197, DOI 10.1023/A:1010691701578; Avni R, 2017, SCIENCE, V357, P93, DOI 10.1126/science.aan0032; Binka A, 2012, J APPL GENET, V53, P1, DOI 10.1007/s13353-011-0064-y; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cayrol B, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1149676; Chartrain L, 2005, PLANT PATHOL, V54, P134, DOI 10.1111/j.1365-3059.2005.01164.x; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; DAS MK, 1993, EUPHYTICA, V68, P99, DOI 10.1007/BF00024159; Delteil A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0711-x; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Dmochowska-Boguta M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1932-3; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Giarola V, 2016, NEW PHYTOL, V210, P535, DOI 10.1111/nph.13766; Harkenrider M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147310; Harwood WA, 2000, EUPHYTICA, V111, P67, DOI 10.1023/A:1003700300235; Herrera-Foessel SA, 2007, EUPHYTICA, V155, P361, DOI 10.1007/s10681-006-9337-7; Hiebert CW, 2007, THEOR APPL GENET, V115, P877, DOI 10.1007/s00122-007-0604-3; Hoogkamp TJH, 1998, PHYTOPATHOLOGY, V88, P856, DOI 10.1094/PHYTO.1998.88.8.856; Hu KM, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.9; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kloppers FJ, 1997, PLANT PATHOL, V46, P737, DOI 10.1046/j.1365-3059.1997.d01-58.x; Kohorn BD, 2016, MOL CELL PROTEOMICS, V15, P1351, DOI 10.1074/mcp.M115.055368; Kohorn BD, 2016, J EXP BOT, V67, P489, DOI 10.1093/jxb/erv467; Kohorn BD, 2012, MOL PLANT, V5, P841, DOI 10.1093/mp/ssr096; Kohorn BD, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00088; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Li H, 2009, PLANT MOL BIOL, V69, P337, DOI 10.1007/s11103-008-9430-5; Liu DD, 2018, INT J BIOL MACROMOL, V111, P1083, DOI 10.1016/j.ijbiomac.2018.01.113; Liu Y, 2006, FUNCT PLANT BIOL, V33, P811, DOI 10.1071/FP06041; Orczyk W, 2010, PLANT PATHOL, V59, P567, DOI 10.1111/j.1365-3059.2010.02257.x; da Silva GBP, 2018, PHYTOPATHOLOGY, V108, P1344, DOI 10.1094/PHYTO-06-18-0208-RVW; Pont C, 2017, CURR OPIN PLANT BIOL, V36, P29, DOI 10.1016/j.pbi.2017.01.001; Rasul S, 2012, PLANT CELL ENVIRON, V35, P1483, DOI 10.1111/j.1365-3040.2012.02505.x; ROELFS AP, 1988, PHYTOPATHOLOGY, V78, P526, DOI 10.1094/Phyto-78-526; Rosli HG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r139; Saintenac C, 2018, NAT GENET, V50, P368, DOI 10.1038/s41588-018-0051-x; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Shi GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600822; Singh D, 1999, PLANT PATHOL, V48, P567, DOI 10.1046/j.1365-3059.1999.00391.x; Singh RP, 2003, EUPHYTICA, V129, P371, DOI 10.1023/A:1022216327934; Soleiman NH, 2014, J PHYTOPATHOL, V162, P359, DOI 10.1111/jph.12197; Streatfield SJ, 2004, TRANSGENIC RES, V13, P299, DOI 10.1023/B:TRAG.0000040053.23687.9c; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wall Dennis P., 2007, V396, P95; Wang N, 2012, PLANT PHYSIOL, V160, P696, DOI 10.1104/pp.112.203943; Yang K, 2014, CROP J, V2, P255, DOI 10.1016/j.cj.2014.04.010; Yang P, 2019, NEW PHYTOL, V221, P976, DOI 10.1111/nph.15419; Zalewski W, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-206; Zhang N, 2017, MOL PLANT MICROBE IN, V30, P455, DOI [10.1094/MPMI-11-16-0238-R, 10.1094/mpmi-11-16-0238-r]; Zhang ZY, 2012, NEW PHYTOL, V196, P1155, DOI 10.1111/j.1469-8137.2012.04353.x; Zhu XL, 2014, PLANT PHYSIOL, V164, P1499, DOI 10.1104/pp.113.229575; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	55	17	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227713	10.1371/journal.pone.0227713	http://dx.doi.org/10.1371/journal.pone.0227713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929605	Green Published, gold			2022-12-26	WOS:000534352500064
J	Berkowitz, BA; Olds, HK; Richards, C; Joy, J; Rosales, T; Podolsky, RH; Childers, KL; Hubbard, WB; Sullivan, PG; Gao, SS; Li, YC; Qian, HH; Roberts, R				Berkowitz, Bruce A.; Olds, Hailey K.; Richards, Collin; Joy, Joydip; Rosales, Tilman; Podolsky, Robert H.; Childers, Karen Lins; Hubbard, W. Brad; Sullivan, Patrick G.; Gao, Shasha; Li, Yichao; Qian, Haohua; Roberts, Robin			Novel imaging biomarkers for mapping the impact of mild mitochondrial uncoupling in the outer retina in vivo	PLOS ONE			English	Article							FREE-RADICAL PRODUCTION; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; OXYGEN-CONSUMPTION; RESERVE CAPACITY; MOUSE MODEL; DNP; QUANTIFICATION; CONTRIBUTES; HOMEOSTASIS	Purpose To test the hypothesis that imaging biomarkers are useful for evaluating in vivo rod photoreceptor cell responses to a mitochondrial protonophore. Methods Intraperitoneal injections of either the mitochondrial uncoupler 2,4 dinitrophenol (DNP) or saline were given to mice with either higher [129S6/eVTac (S6)] or lower [C57BL/6J (B6)] mitochondrial reserve capacities and were studied in dark or light. We measured: (i) the external limiting membrane-retinal pigment epithelium region thickness (ELM-RPE; OCT), which decreases substantially with upregulation of a pH-sensitive water removal co-transporter on the apical portion of the RPE, and (ii) the outer retina R1 (= 1/(spin lattice relaxation time (T1), an MRI parameter proportional to oxygen / free radical content. Results In darkness, baseline rod energy production and consumption are relatively high compared to that in light, and additional metabolic stimulation with DNP provoked thinning of the ELM-RPE region compared to saline injection in S6 mice; ELM-RPE thickness was unresponsive to DNP in B6 mice. Also, dark-adapted S6 mice given DNP showed a decrease in outer retina R1 values compared to saline injection in the inferior retina. In dark-adapted B6 mice, transretinal R1 values were unresponsive to DNP in superior and inferior regions. In light, with its relatively lower basal rod energy production and consumption, DNP caused ELM-RPE thinning in both S6 and B6 mice. Conclusions The present results raise the possibility of non-invasively evaluating the mouse rod mitochondrial energy ecosystem using new DNP-assisted OCT and MRI in vivo assays.	[Berkowitz, Bruce A.; Olds, Hailey K.; Richards, Collin; Joy, Joydip; Rosales, Tilman; Roberts, Robin] Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, Detroit, MI USA; [Podolsky, Robert H.; Childers, Karen Lins] Beaumont Hlth, Beaumont Res Inst, Royal Oak, MI USA; [Hubbard, W. Brad; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Hubbard, W. Brad; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Sullivan, Patrick G.] Lexington VA Hlth Care Syst, Lexington, KY USA; [Gao, Shasha; Li, Yichao; Qian, Haohua] NEI, Visual Funct Core, NIH, Bethesda, MD 20892 USA; [Gao, Shasha] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou, Peoples R China	Wayne State University; Beaumont Health; University of Kentucky; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Zhengzhou University	Berkowitz, BA (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, Detroit, MI USA.	baberko@med.wayne.edu	Podolsky, Robert/GRY-0740-2022	Childers, Karen/0000-0002-7645-1583; Berkowitz, Bruce/0000-0003-0291-2209; Richards, Collin/0000-0002-9833-5938	National Institutes of Health [RO1 EY026584, R01 AG058171]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [14-13A]; VA Merit Award [1I01BX003405]; NIH intramural Research Programs [EY000503, EY000530]; NEI Core Grant [P30 EY04068]; Research to Prevent Blindness; Fight for Sight Summer Student Fellowship; Wayne State University School of Medicine Medical Student Summer Research Fellowships	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT); VA Merit Award(US Department of Veterans Affairs); NIH intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI Core Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fight for Sight Summer Student Fellowship; Wayne State University School of Medicine Medical Student Summer Research Fellowships	This research was gratefully supported by the National Institutes of Health [RO1 EY026584 (BAB) and R01 AG058171 (BAB)], Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) Grant 14-13A and VA Merit Award 1I01BX003405 (PGS), NIH intramural Research Programs EY000503 and EY000530 to HQ, NEI Core Grant P30 EY04068, and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute, BAB), a Fight for Sight Summer Student Fellowship (CR), and Wayne State University School of Medicine Medical Student Summer Research Fellowships (HKO and JJ).	Adijanto J, 2009, J GEN PHYSIOL, V133, P603, DOI 10.1085/jgp.200810169; Berkowitz BA, 2008, RETINAL AND CHOROIDAL ANGIOGENESIS, P151, DOI 10.1007/978-1-4020-6780-8_8; Berkowitz BA, 2019, INVEST OPHTH VIS SCI, V60, P1566, DOI 10.1167/iovs.18-26164; Berkowitz BA, 2018, INVEST OPHTH VIS SCI, V59, P5957, DOI 10.1167/iovs.18-25682; Berkowitz BA, 2018, INVEST OPHTH VIS SCI, V59, P2999, DOI 10.1167/iovs.18-23829; Berkowitz BA, 2018, J MAGN RESON, V291, P94, DOI 10.1016/j.jmr.2018.01.013; Berkowitz BA, 2017, FASEB J, V31, P4179, DOI 10.1096/fj.201700229R; Berkowitz BA, 2017, INVEST OPHTH VIS SCI, V58, P3286, DOI 10.1167/iovs.17-21850; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P5314, DOI 10.1167/iovs.16-20186; Berkowitz BA, 2016, INVEST OPHTH VIS SCI, V57, P577, DOI 10.1167/iovs.15-18972; Berkowitz BA, 2016, PROG RETIN EYE RES, V51, P90, DOI 10.1016/j.preteyeres.2015.09.001; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P7931, DOI 10.1167/iovs.15-18420; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P606, DOI 10.1167/iovs.14-15687; Berkowitz BA, 2014, NEUROBIOL AGING, V35, P1883, DOI 10.1016/j.neurobiolaging.2014.02.020; Berry BJ, 2018, J MOL BIOL, V430, P3873, DOI 10.1016/j.jmb.2018.03.025; Bissig D, 2012, MOL VIS, V18, P2561; Bissig D, 2011, NEUROIMAGE, V58, P749, DOI 10.1016/j.neuroimage.2011.06.062; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Chen JJ, 2008, MAGN RESON MED, V59, P731, DOI 10.1002/mrm.21570; Cheng HY, 2006, P NATL ACAD SCI USA, V103, P17525, DOI 10.1073/pnas.0605790103; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Geisler JG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030280; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/NCHEMBIO.2287, 10.1038/nchembio.2287]; Goldgof M, 2014, J BIOL CHEM, V289, P19341, DOI 10.1074/jbc.M114.568204; Haacke E. M., 1999, MAGNETIC RESONANCE I; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Khan RS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7180632; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kolesnikov AV, 2011, J NEUROSCI, V31, P7900, DOI 10.1523/JNEUROSCI.0438-11.2011; Kooragayala K, 2015, INVEST OPHTH VIS SCI, V56, P8428, DOI 10.1167/iovs.15-17901; Li YC, 2018, INVEST OPHTH VIS SCI, V59, P1084, DOI 10.1167/iovs.17-23011; Li YC, 2016, INVEST OPHTH VIS SCI, V57, pOCT105, DOI 10.1167/iovs.15-18539; LINSENMEIER RA, 1992, J GEN PHYSIOL, V99, P177, DOI 10.1085/jgp.99.2.177; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Mellon EA, 2010, P NATL ACAD SCI USA, V107, P11787, DOI 10.1073/pnas.1006951107; Muhlhans J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026496; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; NUUTINEN EM, 1983, AM J PHYSIOL, V244, pH396, DOI 10.1152/ajpheart.1983.244.3.H396; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Paasonen J, 2018, NEUROIMAGE, V172, P9, DOI 10.1016/j.neuroimage.2018.01.014; Pallanck LJ, 2010, J CELL BIOL, V191, P1225, DOI 10.1083/jcb.201011068; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; PARVER L M, 1991, Eye (London), V5, P181; Perkins GA, 2003, MOL VIS, V9, P60; Perron NR, 2013, J BIOENERG BIOMEMBR, V45, P101, DOI 10.1007/s10863-012-9477-5; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Quarrie R, 2014, AM J PHYSIOL-HEART C, V307, pH996, DOI 10.1152/ajpheart.00189.2014; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Trick GL, 2005, PROG RETIN EYE RES, V24, P259, DOI 10.1016/j.preteyeres.2004.08.001; Wu B, 2017, EXP NEUROL, V293, P83, DOI 10.1016/j.expneurol.2017.03.020; Zhurakovskaya E, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0456-18.2019	59	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226840	10.1371/journal.pone.0226840	http://dx.doi.org/10.1371/journal.pone.0226840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923239	Green Published, gold			2022-12-26	WOS:000534350000028
J	Lee, SH; Bang, S; Jang, HH; Lee, EB; Kim, BS; Kim, SH; Kang, SH; Lee, KW; Kim, DW; Kim, JB; Choe, JS; Park, SY; Lillehoj, HS				Lee, Sung-Hyen; Bang, Sohyun; Jang, Hwan-Hee; Lee, Eun-Byeol; Kim, Bong-Sang; Kim, Seung-Hwan; Kang, Sang-Hyun; Lee, Kyung-Woo; Kim, Dong-Wook; Kim, Jung-Bong; Choe, Jeong-Sook; Park, Shin-Young; Lillehoj, Hyun S.			Effects of Allium hookeri on gut microbiome related to growth performance in young broiler chickens	PLOS ONE			English	Article							DIETARY SUPPLEMENTATION; EIMERIA-ACERVULINA; IMMUNE-SYSTEM; POLYPHENOLS; RESISTANCE; INFECTION; METABOLITES; EXPRESSION; CAPSICUM; ALLICIN	Healthy food promotes beneficial bacteria in the gut microbiome. A few prebiotics act as food supplements to increase fermentation by beneficial bacteria, which enhance the host immune system and health. Allium hookeri is a healthy food with antioxidant and anti-inflammatory activities. A. hookeri is used as a feed supplement for broiler chickens to improve growth performance. Although the underlying mechanism is unknown, A. hookeri may alter the gut microbiome. In the current study, 16S rRNA sequencing has been carried out using samples obtained from the cecum of broiler chickens exposed to diets comprising different tissue types (leaf and root) and varying amounts (0.3% and 0.5%) of A. hookeri to investigate their impact on gut microbiome. The microbiome composition in the groups supplemented with A. hookeri leaf varied from that of the control group. Especially, exposure to 0.5% amounts of leaf resulted in differences in the abundance of genera compared with diets comprising 0.3% leaf. Exposure to a diet containing 0.5% A. hookeri leaf decreased the abundance of the following bacteria: Eubacterium nodatum, Marvinbryantia, Oscillospira, and Gelria. The modulation of gut microbiome by leaf supplement correlated with growth traits including body weight, bone strength, and infectious bursal disease antibody. The results demonstrate that A. hookeri may improve the health benefits of broiler chickens by altering the gut microbiome.	[Lee, Sung-Hyen; Jang, Hwan-Hee; Lee, Eun-Byeol; Kim, Jung-Bong; Choe, Jeong-Sook; Park, Shin-Young] Rural Dev Adm, Natl Inst Agr Sci, Wanju Gun, Jeollabuk Do, South Korea; [Bang, Sohyun] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Kim, Bong-Sang] Seoul Natl Univ, Dept Agr & Life Sci, Seoul, South Korea; [Kim, Bong-Sang] Seoul Natl Univ, Res Inst Populat Genom, Seoul, South Korea; [Kim, Seung-Hwan; Kang, Sang-Hyun] KYOCHON F&B CO, Osan, Kyounggido, South Korea; [Lee, Kyung-Woo] Konkuk Univ, Dept Anim Sci & Technol, Seoul, South Korea; [Kim, Dong-Wook] Korean Natl Coll Agr & Fisheries, Dept Poultry Sci, Jeonju Si, Jeollabuk Do, South Korea; [Lillehoj, Hyun S.] ARS, Anim Biosci & Biotechnol Lab, Beltsville Agr Res Ctr, Dept Agr, Beltsville, MD USA	National Institute of Agricultural Sciences; Rural Development Administration (RDA); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University	Lee, SH (corresponding author), Rural Dev Adm, Natl Inst Agr Sci, Wanju Gun, Jeollabuk Do, South Korea.	sunghyeonl@yahoo.co.kr	Lee, Kyung-Woo/D-5494-2019	Lee, Kyung-Woo/0000-0002-3533-7979	Agriculture Science & Technology Development from National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea [PJ01178705, PJ01327901]	Agriculture Science & Technology Development from National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea	This research was fully supported by the fund of Agriculture Science & Technology Development (PJ01178705, PJ01327901) from National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea. The fund was used in this study design, data collection and analysis, or preparation of the manuscript. Bong-Sang Kim received support in the form of a salary from C&K genomics. SeungHwan Kim and Sang-Hyun Kang received support in the form of salaries from BHNBIO (KYOCHON F&B CO). The specific roles of the authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchini F, 2001, ENVIRON HEALTH PERSP, V109, P893; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448; Cervantes HM, 2015, J APPL POULTRY RES, V24, P91, DOI 10.3382/japr/pfv006; Clatworthy M, 2018, ACCOUNT BUS RES, V48, P1, DOI 10.1080/00014788.2017.1394607; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; D'Amelio P, 2018, CALCIFIED TISSUE INT, V102, P415, DOI 10.1007/s00223-017-0331-y; Edwards CA, 2017, NUTR BULL, V42, P356, DOI 10.1111/nbu.12296; Ferrario C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01749; Fujisawa H, 2009, BIOSCI BIOTECH BIOCH, V73, P1948, DOI 10.1271/bbb.90096; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Kim DK, 2013, POULTRY SCI, V92, P2635, DOI 10.3382/ps.2013-03095; Kim DK, 2013, BRIT J NUTR, V109, P76, DOI 10.1017/S0007114512000530; Kim JE, 2015, RES VET SCI, V102, P150, DOI 10.1016/j.rvsc.2015.07.022; Kim JH, 2018, ITAL J ANIM SCI, V17, P9, DOI [10.1080/1828051X.2017.1326856, 10.1080/1828051x.2017.1326856]; Kim Nam-Seok, 2015, [Korean Journal of Pharmacognosy, 생약학회지], V46, P78; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee HC, 2006, RES MICROBIOL, V157, P876, DOI 10.1016/j.resmic.2006.07.004; 황정승, 2015, [Korean Journal of Food Science and Technology, 한국식품과학회지], V47, P261, DOI 10.9721/KJFST.2015.47.2.261; Lee KW, 2013, ASIAN AUSTRAL J ANIM, V26, P1592, DOI 10.5713/ajas.2013.13178; Lee Kwan-Wook, 2014, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V43, P1808; 김창현, 2012, [Journal of the Korean Society of Food Science and Nutrition, 한국식품영양과학회지], V41, P1645; Lee SH, 2009, POULTRY SCI, V88, P562, DOI 10.3382/ps.2008-00340; Lee SeonHye, 2015, Korean Journal of Pharmacognosy, V46, P148; Lee SH, 2013, BRIT J NUTR, V110, P840, DOI 10.1017/S0007114512006083; Lee SH, 2011, BRIT J NUTR, V106, P862, DOI 10.1017/S0007114511001073; Lee SH, 2011, VET PARASITOL, V181, P97, DOI 10.1016/j.vetpar.2011.05.003; Lee Y, 2017, J POULT SCI, V54, P142, DOI 10.2141/jpsa.0160108; Lee Y, 2017, RES VET SCI, V112, P149, DOI 10.1016/j.rvsc.2017.03.019; Lee Yuan-Kun, 2013, Biosci Microbiota Food Health, V32, P1, DOI 10.12938/bmfh.32.1; Li L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192066; Lillehoj Hyun S, 2011, BMC Proc, V5 Suppl 4, pS34, DOI 10.1186/1753-6561-5-S4-S34; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Nencini C, 2007, PHYTOTHER RES, V21, P874, DOI 10.1002/ptr.2168; Ohlsson C, 2015, TRENDS ENDOCRIN MET, V26, P69, DOI 10.1016/j.tem.2014.11.004; Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027; Rahman SU, 2017, ACTA HISTOCHEM, V119, P446, DOI 10.1016/j.acthis.2017.04.004; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reiter J, 2017, MOLECULES, V22, DOI 10.3390/molecules22101711; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roh SS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1032-1; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sakamoto M, 2006, INT J SYST EVOL MICR, V56, P1599, DOI 10.1099/ijs.0.64192-0; SANTOSO U, 1995, BRIT J NUTR, V74, P523, DOI 10.1079/BJN19950155; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Sengupta Archana, 2004, Asian Pac J Cancer Prev, V5, P237; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Sjogren K, 2012, J BONE MINER RES, V27, P1357, DOI 10.1002/jbmr.1588; Song EY, 2014, KOREAN J FOOD SCI AN, V34, P263, DOI 10.5851/kosfa.2014.34.3.263; Viveros A, 2011, POULTRY SCI, V90, P566, DOI 10.3382/ps.2010-00889; Zeng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09342; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226833	10.1371/journal.pone.0226833	http://dx.doi.org/10.1371/journal.pone.0226833			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923247	gold, Green Published, Green Submitted			2022-12-26	WOS:000534350000027
J	Troullinaki, M; Chen, LS; Witt, A; Pyrina, I; Phieler, J; Kourtzelis, I; Chmelar, J; Sprott, D; Gercken, B; Koutsilieris, M; Chavakis, T; Chatzigeorgiou, A				Troullinaki, Maria; Chen, Lan-Sun; Witt, Anke; Pyrina, Iryna; Phieler, Julia; Kourtzelis, Ioannis; Chmelar, Jindrich; Sprott, David; Gercken, Bettina; Koutsilieris, Michael; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios			Robo4-mediated pancreatic endothelial integrity decreases inflammation and islet destruction in autoimmune diabetes	FASEB JOURNAL			English	Article						endothelium; insulitis; leukocyte infiltration; pancreatic islets; Type 1 Diabetes Mellitus (T1DM)	BETA-CELL DEATH; GENE-EXPRESSION; ADHESION MOLECULES; ADIPOSE-TISSUE; REAL-TIME; ROBO4; ANGIOGENESIS; RECEPTOR; GROWTH; DISRUPTION	In Type 1 Diabetes Mellitus (T1DM), leukocyte infiltration of the pancreatic islets and the resulting immune-mediated destruction of beta cells precede hyperglycemia and clinical disease symptoms. In this context, the role of the pancreatic endothelium as a barrier for autoimmunity- and inflammation-related destruction of the islets is not well studied. Here, we identified Robo4, expressed on endothelial cells, as a regulator of pancreatic vascular endothelial permeability during autoimmune diabetes. Circulating levels of Robo4 were upregulated in mice subjected to the Multiple Low-Dose Streptozotocin (MLDS) model of diabetes. Upon MLDS induction, Robo4-deficiency resulted in increased pancreatic vascular permeability, leukocyte infiltration to the islets and islet apoptosis, associated with reduced insulin levels and faster diabetes development. On the contrary, in vivo administration of Slit2 in mice modestly delayed the emergence of hyperglycaemia and ameliorated islet inflammation in MLDS-induced diabetes. Thus, Robo4-mediated endothelial barrier integrity reduces insulitis and islet destruction in autoimmune diabetes. Our findings highlight the importance of the endothelium as gatekeeper of pancreatic inflammation during T1DM development and may pave the way for novel Robo4-related therapeutic approaches for autoimmune diabetes.	[Troullinaki, Maria; Chen, Lan-Sun; Witt, Anke; Pyrina, Iryna; Phieler, Julia; Kourtzelis, Ioannis; Sprott, David; Gercken, Bettina; Chavakis, Triantafyllos; Chatzigeorgiou, Antonios] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Inst Clin Chem & Lab Med, Dresden, Germany; [Chmelar, Jindrich] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Koutsilieris, Michael; Chatzigeorgiou, Antonios] Natl & Kapodistrian Univ Athens, Med Sch, Dept Physiol, Athens, Greece; [Chavakis, Triantafyllos] Tech Univ Dresden, Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Dresden, Germany; [Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Dresden, Germany; [Chavakis, Triantafyllos] German Ctr Diabet Res DZD, Neuherberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of South Bohemia Ceske Budejovice; National & Kapodistrian University of Athens; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Chatzigeorgiou, A (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Fac Med, Fetscherstr 74, D-01307 Dresden, Germany.	Antonios.Chatzigeorgiou@uniklinikum-dresden.de	Chmelař, Jindřich/U-1750-2017; Chavakis, Triantafyllos/ABE-8845-2020	Chmelař, Jindřich/0000-0002-7089-6143; Chatzigeorgiou, Antonios/0000-0002-7039-4223; Pyrina, Iryna/0000-0002-9849-6408; Chen, Lan-Sun/0000-0002-5917-3083; Kourtzelis, Ioannis/0000-0003-3006-8885	Deutsche Forschungsgemeinschaft (DFG) [IRTG 2251]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CH 1862/2-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: CH 1862/3-1; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB-TR 127; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: IRTG 2251	Al-awar A, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9051426; Blockus H, 2016, DEVELOPMENT, V143, P3037, DOI 10.1242/dev.132829; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Burke-Gaffney A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111459; Chia JSJ, 2013, DIABETES, V62, P2026, DOI 10.2337/db12-0625; Choi EY, 2015, MOL PSYCHIATR, V20, P880, DOI 10.1038/mp.2014.146; Chung KJ, 2017, NAT IMMUNOL, V18, P654, DOI 10.1038/ni.3728; Coleman HA, 2010, DEVELOPMENT, V137, P2417, DOI 10.1242/dev.047993; Eberhard D, 2010, TRENDS ENDOCRIN MET, V21, P457, DOI 10.1016/j.tem.2010.03.003; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Garcia-Martin R, 2016, MOL CELL BIOL, V36, P376, DOI 10.1128/MCB.00430-15; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Gohrig A, 2014, CANCER RES, V74, P1529, DOI 10.1158/0008-5472.CAN-13-1012; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; In't Veld P, 2015, DIABETOLOGIA, V58, P4, DOI 10.1007/s00125-014-3418-2; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kaliberov SA, 2013, VIROLOGY, V447, P312, DOI 10.1016/j.virol.2013.09.020; Kaur S, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-61; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kourtzelis I, 2016, THROMB HAEMOSTASIS, V115, P781, DOI 10.1160/TH15-05-0429; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Masjkur J, 2014, J BIOL CHEM, V289, P35503, DOI 10.1074/jbc.M114.590687; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Nirantharakumar K, 2018, DIABETOLOGIA, V61, P1064, DOI 10.1007/s00125-018-4574-6; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Orlova V, 2007, THROMB HAEMOSTASIS, V98, P327, DOI 10.1160/Th07-03-0206; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Paviovic S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02646; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; Pi LY, 2012, FASEB J, V26, P3365, DOI 10.1096/fj.11-200154; Pugliese A, 2016, PEDIATR DIABETES, V17, P31, DOI 10.1111/pedi.12388; Quan W, 2013, DIABETES OBES METAB, V15, P141, DOI 10.1111/dom.12153; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Sherchan P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00827-z; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Tanno T, 2007, FEBS LETT, V581, P1022, DOI 10.1016/j.febslet.2007.02.001; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Xie JN, 2017, GENE, V616, P31, DOI 10.1016/j.gene.2017.03.027; Yang YHC, 2013, P NATL ACAD SCI USA, V110, P16480, DOI 10.1073/pnas.1214312110; Zanone MM, 2008, CURR DIABETES REV, V4, P1, DOI 10.2174/157339908783502415; Zhao HL, 2014, J IMMUNOL, V192, P385, DOI 10.4049/jimmunol.1302021	50	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3336	3346		10.1096/fj.201900125RR	http://dx.doi.org/10.1096/fj.201900125RR		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916652				2022-12-26	WOS:000506442300001
J	Zheng, WW; Ding, BB; Li, XL; Liu, DQ; Yokota, H; Zhang, P				Zheng, Weiwei; Ding, Beibei; Li, Xinle; Liu, Daquan; Yokota, Hiroki; Zhang, Ping			Knee loading repairs osteoporotic osteoarthritis by relieving abnormal remodeling of subchondral bone via Wnt/beta-catenin signaling	FASEB JOURNAL			English	Article						knee loading; osteoblast; osteoclast; osteoporotic osteoarthritis; Wnt signaling	FEMORAL-HEAD; CARTILAGE; HISTOPATHOLOGY; PATHOGENESIS; EXPRESSION; MODEL	Osteoporotic osteoarthritis (OPOA) is a common bone disease mostly in the elderly, but the relationship between Osteoporotic (OP) and osteoarthritis (OA) is complex. It has been shown that knee loading can mitigate OA symptoms. However, its effects on OPOA remain unclear. In this study, we characterized pathological linkage of OP to OA, and evaluated the effect of knee loading on OPOA. We employed two mouse models (OA and OPOA), and conducted histology, cytology, and molecular analyses. In the OA and OPOA groups, articular cartilage was degenerated and Osteoarthritis Research Society International score was increased. Subchondral bone underwent abnormal remodeling, the differentiation of bone marrow mesenchymal stem cells (BMSCs) to osteoblasts and chondrocytes was reduced, and migration and adhesion of pre-osteoclasts were enhanced. Compared to the OA group, the pathological changes of OA in the OPOA group were considerably aggravated. After knee loading, however, cartilage degradation was effectively prevented, and the abnormal remodeling of subchondral bone was significantly inhibited. The differentiation of BMSCs was also improved, and the expression of Wnt/beta-catenin was elevated. Collectively, this study demonstrates that osteoporosis aggravates OA symptoms. Knee loading restores OPOA by regulating subchondral bone remodeling, and may provide an effective method for repairing OPOA.	[Zheng, Weiwei; Ding, Beibei; Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Li, Xinle; Liu, Daquan; Zhang, Ping] Tianjin Med Univ, Key Lab Hormones & Dev, Tianjin Key Lab Metab Dis, Minist Hlth, Tianjin, Peoples R China; [Yokota, Hiroki; Zhang, Ping] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Zhang, Ping] Tianjin Med Univ, Tianjin Key Lab Spine & Spinal Cord, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Tianjin Medical University	Zhang, P (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Anat & Histol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	pizhang@tmu.edu.cn			NIAMS NIH HHS [R01 AR052144] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Bultink IEM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0328-0; Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z; Compston JE, 2019, LANCET, V393, P364, DOI 10.1016/S0140-6736(18)32112-3; Dequeker J, 2003, AGING CLIN EXP RES, V15, P426, DOI 10.1007/BF03327364; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Hamamura K, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-312; Herrero-Beaumont G, 2013, NAT REV RHEUMATOL, V9, P448, DOI 10.1038/nrrheum.2013.113; Holopainen JT, 2008, BONE, V43, P1108, DOI 10.1016/j.bone.2008.07.254; Iijima H, 2016, OSTEOARTHR CARTILAGE, V24, P354, DOI 10.1016/j.joca.2015.09.001; Im GI, 2014, J BONE MINER METAB, V32, P101, DOI 10.1007/s00774-013-0531-0; Javaheri B, 2014, J BONE MINER RES, V29, P705, DOI 10.1002/jbmr.2064; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kodric K, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0294-3; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Li CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18541-1; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Li XH, 2013, INT J MOL MED, V31, P1349, DOI 10.3892/ijmm.2013.1341; Li XL, 2019, FASEB J, V33, P8913, DOI 10.1096/fj.201802711R; Li XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24668; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Loeser RF, 2016, NAT REV RHEUMATOL, V12, P412, DOI 10.1038/nrrheum.2016.65; Lotinun S, 2019, J CLIN INVEST, V129, P3058, DOI 10.1172/JCI122936; Lv HC, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0530-5; Moskowitz RW, 2006, OSTEOARTHR CARTILAGE, V14, P1, DOI 10.1016/j.joca.2005.08.015; Mussazhanova Z, 2016, ENDOCR J, V63, P457, DOI 10.1507/endocrj.EJ15-0629; Neogi T, 2010, ANN RHEUM DIS, V69, P841, DOI 10.1136/ard.2009.110114; Park OJ, 2019, J BONE MINER RES, V34, P975, DOI 10.1002/jbmr.3706; Roman-Blas JA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0494-0; Sharma R, 2013, HUM MOL GENET, V22, P4818, DOI 10.1093/hmg/ddt333; Shuai B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132104; Tan N, 2018, HEPATOL RES, V48, P839, DOI 10.1111/hepr.13076; Wang CJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4601; Wang HL, 2014, SHOCK, V41, P324, DOI 10.1097/SHK.0000000000000122; Wu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024917; Xiao GZ, 2012, J BIOL CHEM, V287, P21450, DOI 10.1074/jbc.M111.331249; Yang S, 2019, FASEB J, V33, P10742, DOI 10.1096/fj.201900306RR; Yokota H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-197; Zhang P, 2007, BONE, V40, P538, DOI 10.1016/j.bone.2006.09.018; Zhang P, 2012, J BONE MINER METAB, V30, P31, DOI 10.1007/s00774-011-0292-6; Zhang P, 2011, BONE, V49, P867, DOI 10.1016/j.bone.2011.06.020; Zhang P, 2009, BONE, V44, P989, DOI 10.1016/j.bone.2009.01.367; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; Zheng WW, 2019, FASEB J, V33, P4077, DOI 10.1096/fj.201801851R; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	49	13	16	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3399	3412		10.1096/fj.201902117R	http://dx.doi.org/10.1096/fj.201902117R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31925860	Green Submitted, Bronze, Green Accepted			2022-12-26	WOS:000514663600099
J	Bittar, LF; da Silva, LQ; Orsi, FLD; Zapponi, KCS; Mazetto, BD; de Paula, EV; Montalvao, SAD; Annichino-Bizzacchi, JM				Bittar, Luis Fernando; da Silva, Leticia Queiroz; de Andrade Orsi, Fernanda Loureiro; Senger Zapponi, Kiara Cristina; Mazetto, Bruna de Moraes; de Paula, Erich Vinicius; de Lima Montalvao, Silmara Aparecida; Annichino-Bizzacchi, Joyce Maria			Increased inflammation and endothelial markers in patients with late severe post-thrombotic syndrome	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; MATRIX METALLOPROTEINASES; ADHESION MOLECULES; VENOUS THROMBOSIS; PLASMA; RISK; MATRIX-METALLOPROTEINASE-9; DETERMINANTS; PREDICTORS; BURDEN	Introduction Post-thrombotic syndrome (PTS) is a limiting long-term complication present in 20-50% of patients with deep venous thrombosis (DVT) of the lower limbs. A panel of biomarkers with potential relevance to enhance knowledge on the pathophysiology of PTS was investigated. Methods This case-control study included 93 patients with DVT in the lower limbs, 31 with severe PTS (cases) and 62 with mild/no PTS (controls), over 24 months after an acute episode. Thirty-one healthy individuals (HI) with no history of DVT were included as a reference to the population. FVIII activity, D-dimer, inflammatory cytokines, endothelial dysfunction markers, matrix metalloproteinases, and their inhibitors, tissue remodeling and growth factor levels were evaluated. The classification of PTS was, by the Villalta scale. Results Patients with severe PTS showed elevated levels of CRP, sICAM-1, sE-selectin, and decreased MMP-9 and MCP-1 levels when compared to patients with mild/no PTS. Moreover, DVT patients presented higher levels of FVIII and D-dimer when compared to HI. Conclusions DVT patients present an inflammatory status, endothelial dysfunction and altered proteolysis MMPs activity, even a long time after the acute thrombotic episode, which is more significant in severe PTS. These results suggest a possible role of these mediators in the maintenance and worsening of PTS severity.	[Bittar, Luis Fernando; da Silva, Leticia Queiroz; de Andrade Orsi, Fernanda Loureiro; Senger Zapponi, Kiara Cristina; Mazetto, Bruna de Moraes; de Paula, Erich Vinicius; de Lima Montalvao, Silmara Aparecida; Annichino-Bizzacchi, Joyce Maria] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil	Universidade Estadual de Campinas	da Silva, LQ (corresponding author), Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil.	Queiroz.leticia1994@gmail.com	De Lima Montalvão, Silmara/F-2853-2019; Orsi, Fernanda L.A./H-1203-2014; Mazetto Fonseca, Bruna de Moraes/AIE-7685-2022; De Paula, Erich V/C-5943-2012	De Lima Montalvão, Silmara/0000-0002-8920-3765; Orsi, Fernanda L.A./0000-0002-7908-9073; Mazetto, Bruna/0000-0002-8778-4658; Queiroz da Silva, Leticia/0000-0003-1632-4678; De Paula, Erich V/0000-0003-1539-7912	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/14172-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. JMAB also received fundings from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - Finance Code 2016/14172-6.	Ali T, 2006, J VASC SURG, V43, P601, DOI 10.1016/j.jvs.2005.10.073; Back M, 2010, PROG CARDIOVASC DIS, V52, P410, DOI 10.1016/j.pcad.2009.12.002; Bittar LF, 2015, THROMB RES, DOI [10.1016/j.thromres.2014.12, DOI 10.1016/J.THROMRES.2014.12]; Bouman AC, 2014, THROMB RES, V134, P369, DOI 10.1016/j.thromres.2014.06.010; Bouman AC, 2012, J THROMB HAEMOST, V10, P1532, DOI 10.1111/j.1538-7836.2012.04798.x; Bucek RA, 2003, BLOOD COAGUL FIBRIN, V14, P653, DOI 10.1097/00001721-200310000-00006; da Silva LQ, 2018, REGEN MED, V13, P775, DOI 10.2217/rme-2018-0035; de Franciscis S, 2016, INT WOUND J, V13, P1237, DOI 10.1111/iwj.12489; Deatrick KB, 2005, J VASC SURG, V42, P140, DOI 10.1016/j.jvs.2005.04.014; Deatrick KB, 2013, THROMB RES, V132, P360, DOI 10.1016/j.thromres.2013.06.027; Deatrick KB, 2011, J VASC SURG, V53, P139, DOI 10.1016/j.jvs.2010.07.043; Deroo S, 2010, THROMB HAEMOSTASIS, V104, P681, DOI 10.1160/TH10-03-0183; Diaz J A, 2013, J Vasc Surg Venous Lymphat Disord, V1, DOI 10.1016/j.jvsv.2012.12.002; Dustin ML, 2014, J KOREAN PHYS SOC, DOI [10.1186/2193-1801-3-571, DOI 10.1186/2193-1801-3-571]; Folco EJ, 2018, ARTERIOSCL THROM VAS, V38, P1901, DOI 10.1161/ATVBAHA.118.311150; Gabriel F, 2004, THROMB HAEMOSTASIS, V92, P328, DOI 10.1160/TH03-11-0700; Galanaud JP, 2013, J THROMB HAEMOST, V11, P474, DOI 10.1111/jth.12106; Galanaud JP, 2018, THROMB RES, V164, P100, DOI 10.1016/j.thromres.2017.07.026; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Guanella R, 2011, J THROMB HAEMOST, V9, P2397, DOI 10.1111/j.1538-7836.2011.04516.x; Henke PK, 2011, J VASC SURG, V53, P500, DOI 10.1016/j.jvs.2010.08.050; Jacob MP, 2002, CIRCULATION, V106, P535, DOI 10.1161/01.CIR.0000027521.83518.4C; Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62; Kahn SR, 2008, J THROMB HAEMOST, V6, P1105, DOI 10.1111/j.1538-7836.2008.03002.x; Kahn SR, 2009, J THROMB HAEMOST, V7, P884, DOI 10.1111/j.1538-7836.2009.03339.x; Kahn SR, 2011, THROMB RES, V127, pS89, DOI 10.1016/S0049-3848(11)70024-X; Kjaergaard AG, 2013, BASIC CLIN PHARMACOL, V113, P273, DOI 10.1111/bcpt.12091; Kucukguven A, 2013, CURR DRUG TARGETS, DOI [10.2174/138945013804998972, DOI 10.2174/138945013804998972]; Latella J, 2010, J THROMB HAEMOST, V8, P2169, DOI 10.1111/j.1538-7836.2010.04001.x; Lee KR, 2014, ONCOL REP, V31, P2447, DOI 10.3892/or.2014.3103; MacColl E, 2015, J PHARMACOL EXP THER, V355, P410, DOI 10.1124/jpet.115.227330; Marchena YP, 2006, AN MED INTERN, V23, P105, DOI [10.4321/s0212-71992006000300002, DOI 10.4321/S0212-71992006000300002]; Nadar S, 2004, CURR PHARM DESIGN, V10, P3591, DOI 10.2174/1381612043382765; Nguyen KP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139145; Phillips LJ, 2007, J VASC SURG, V45, p116A, DOI 10.1016/j.jvs.2007.02.034; PIGOTT R, 1992, BIOCHEM BIOPH RES CO, V187, P584, DOI 10.1016/0006-291X(92)91234-H; Pikovsky O, 2018, THROMB RES, V164, P116, DOI 10.1016/j.thromres.2017.07.008; Prandoni P, 2012, EUR J HAEMATOL, V88, P185, DOI 10.1111/j.1600-0609.2011.01733.x; Rabinovich A, 2017, J THROMB HAEMOST, V15, P230, DOI 10.1111/jth.13569; Rabinovich A, 2015, J THROMB HAEMOST, V13, P398, DOI 10.1111/jth.12814; Raffetto JD, 2008, CURR VASC PHARMACOL, V6, P158, DOI 10.2174/157016108784911957; da Silva FAR, 2017, INT J CLIN EXP MED, V10, P7533; Ribeiro Rosy Iara Maciel de Azambuja, 2008, J. Bras. Patol. Med. Lab., V44, P115; Roberts LN, 2013, BRIT J HAEMATOL, V160, P817, DOI 10.1111/bjh.12192; Roumen-Klappe EM, 2009, J THROMB HAEMOST, V7, P582, DOI 10.1111/j.1538-7836.2009.03286.x; Sartori M, 2014, THROMB RES, V134, P320, DOI 10.1016/j.thromres.2014.05.043; Shbaklo H, 2009, THROMB HAEMOSTASIS, V101, P505, DOI 10.1160/TH08-08-0511; Siudut J, 2016, J THROMB HAEMOST, V14, P784, DOI 10.1111/jth.13264; Stain M, 2005, J THROMB HAEMOST, V3, P2671, DOI 10.1111/j.1538-7836.2005.01648.x; Steiner JL, 2014, CYTOKINE, V66, P60, DOI 10.1016/j.cyto.2013.12.011; Wakefield TW, 2008, ARTERIOSCL THROM VAS, V28, P387, DOI 10.1161/ATVBAHA.108.162289; Wakefield Thomas W, 2005, Semin Vasc Surg, V18, P118, DOI 10.1053/j.semvascsurg.2005.05.003; Yeniel AO, 2014, EUR J OBSTET GYN R B, DOI [10.1016/j, DOI 10.1016/J]; Zhang W, 2015, CELL PHYSL BIOCH, DOI [10.1159/, DOI 10.1159/]	54	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227150	10.1371/journal.pone.0227150	http://dx.doi.org/10.1371/journal.pone.0227150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945777	gold, Green Published, Green Submitted			2022-12-26	WOS:000534370100021
J	Dessalles, R; Fromion, V; Robert, P				Dessalles, Renaud; Fromion, Vincent; Robert, Philippe			Models of protein production along the cell cycle: An investigation of possible sources of noise	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; GROWTH-RATE; FLUCTUATIONS	In this article, we quantitatively study, through stochastic models, the effects of several intracellular phenomena, such as cell volume growth, cell division, gene replication as well as fluctuations of available RNA polymerases and ribosomes. These phenomena are indeed rarely considered in classic models of protein production and no relative quantitative comparison among them has been performed. The parameters for a large and representative class of proteins are determined using experimental measures. The main important and surprising conclusion of our study is to show that despite the significant fluctuations of free RNA polymerases and free ribosomes, they bring little variability to protein production contrary to what has been previously proposed in the literature. After verifying the robustness of this quite counter-intuitive result, we discuss its possible origin from a theoretical view, and interpret it as the result of a mean-field effect.	[Dessalles, Renaud] Univ Calif Los Angeles, Dept Biomath, Los Angeles, CA USA; [Fromion, Vincent] Univ Paris Saclay, INRA, MaIAGE, Jouy En Josas, France; [Robert, Philippe] INRIA Paris, Paris, France	University of California System; University of California Los Angeles; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Fromion, V (corresponding author), Univ Paris Saclay, INRA, MaIAGE, Jouy En Josas, France.	vincent.fromion@inra.fr		Robert, Philippe/0000-0001-8122-8880	award Contrat Jeune Scientifique from INRA	award Contrat Jeune Scientifique from INRA	RD work was funded by the award Contrat Jeune Scientifique from INRA (http://www.inra.fr/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Ziv R, 2016, TRENDS GENET, V32, P717, DOI 10.1016/j.tig.2016.08.006; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Bertaux F, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.172234; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; COLLINS JF, 1962, J GEN MICROBIOL, V28, P15, DOI 10.1099/00221287-28-1-15; Dessalles R., 2017, STOCHASTIC MODELS PR; Dessalles R, 2017, J MATH BIOL, V75, P1253, DOI 10.1007/s00285-017-1116-7; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fromion V, 2015, SIAM J APPL MATH, V75, P2562, DOI 10.1137/140994782; Fromion V, 2013, SIAM J APPL MATH, V73, P195, DOI 10.1137/120879592; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kempe H, 2015, MOL BIOL CELL, V26, P797, DOI 10.1091/mbc.E14-08-1296; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; KOCH AL, 1955, J BIOL CHEM, V217, P947; Lin J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06714-z; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; MARR AG, 1991, MICROBIOL REV, V55, P316, DOI 10.1128/MMBR.55.2.316-333.1991; Narula J, 2015, CELL, V162, P328, DOI 10.1016/j.cell.2015.06.012; Osella M, 2014, P NATL ACAD SCI USA, V111, P3431, DOI 10.1073/pnas.1313715111; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; RIGNEY DR, 1977, J THEOR BIOL, V69, P761, DOI 10.1016/0022-5193(77)90381-2; Robert L, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-17; Schwabe A, 2012, BIOPHYS J, V103, P1152, DOI [10.1016/j.bpj.2012.07.011, 10.1016/j.bpj.2012.07011]; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Siwiak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073943; Soifer I, 2014, ARXIV14104771CONDMAT; Soltani M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004972; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Thomas P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35927-x; Thomas P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06912-9; TYSON JJ, 1986, J THEOR BIOL, V118, P405, DOI 10.1016/S0022-5193(86)80162-X; Walker N, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0231-z; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045	42	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0226016	10.1371/journal.pone.0226016	http://dx.doi.org/10.1371/journal.pone.0226016			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945071	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100009
J	Setiawan, AB; Teo, CH; Kikuchi, S; Sassa, H; Kato, K; Koba, T				Setiawan, Agus Budi; Teo, Chee How; Kikuchi, Shinji; Sassa, Hidenori; Kato, Kenji; Koba, Takato			Centromeres of Cucumis melo L. comprise Cmcent and two novel repeats, CmSat162 and CmSat189	PLOS ONE			English	Article							REPETITIVE DNA; SATELLITE REPEAT; TANDEM REPEAT; SEQUENCES; TRANSCRIPTION; ORGANIZATION; EVOLUTION; ELEMENT; GENOME; CENTO	Centromeres are prerequisite for accurate segregation and are landmarks of primary constrictions of metaphase chromosomes in eukaryotes. In melon, high-copy-number satellite DNAs (SatDNAs) were found at various chromosomal locations such as centromeric, peri-centromeric, and subtelomeric regions. In the present study, utilizing the published draft genome sequence of melon, two new SatDNAs (CmSat162 and CmSat189) of melon were identified and their chromosomal distributions were confirmed using fluorescence in situ hybridization. DNA probes prepared from these SatDNAs were successfully hybridized to melon somatic and meiotic chromosomes. CmSat162 was located on 12 pairs of melon chromosomes and co-localized with the centromeric repeat, Cmcent, at the centromeric regions. In contrast, CmSat189 was found to be located not only on centromeric regions but also on specific regions of the chromosomes, allowing the characterization of individual chromosomes of melon. It was also shown that these SatDNAs were transcribed in melon. These results suggest that CmSat162 and CmSat189 might have some functions at the centromeric regions.	[Setiawan, Agus Budi; Kikuchi, Shinji; Sassa, Hidenori; Koba, Takato] Chiba Univ, Grad Sch Hort, Lab Genet & Plant Breeding, Matsudo, Chiba, Japan; [Teo, Chee How] Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur, Malaysia; [Kato, Kenji] Okayama Univ, Grad Sch Environm & Life Sci, Kita Ku, Okayama, Japan; [Setiawan, Agus Budi] Univ Gadjah Mada, Fac Agr, Lab Genet & Plant Breeding, Jalan Flora Bulaksumur, Yogyakarta, Indonesia	Chiba University; Universiti Malaya; Okayama University; Gadjah Mada University	Koba, T (corresponding author), Chiba Univ, Grad Sch Hort, Lab Genet & Plant Breeding, Matsudo, Chiba, Japan.	koba@faculty.chiba-u.jp	Sassa, Hidenori/Q-7561-2018; Teo, Chee How/AAL-4452-2020; Koba, Takato/AAV-4512-2020; Setiawan, Agus Budi/M-4819-2019	Teo, Chee How/0000-0002-8118-2592; Setiawan, Agus Budi/0000-0002-6023-3311; Koba, Takato/0000-0002-9204-8858	Japan Society for Promotion of Science (JSPS) KAKENHI [JP 16K07588]	Japan Society for Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported in part by Japan Society for Promotion of Science (JSPS) KAKENHI Grant Number JP 16K07588 to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscotti MA, 2015, CHROMOSOME RES, V23, P415, DOI 10.1007/s10577-015-9499-z; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; BRENNICKE A, 1983, Z NATURFORSCH C, V38, P1062; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Comai L, 2017, CURR OPIN PLANT BIOL, V36, P158, DOI 10.1016/j.pbi.2017.03.003; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Garrido-Ramos MA, 2015, CYTOGENET GENOME RES, V146, P153, DOI 10.1159/000437008; Gent JI, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1249-4; Gindullis F, 2001, GENOME RES, V11, P253, DOI 10.1101/gr.162301; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Han YH, 2009, P NATL ACAD SCI USA, V106, P14937, DOI 10.1073/pnas.0904833106; HEMLEBEN V, 1982, NUCLEIC ACIDS RES, V10, P631, DOI 10.1093/nar/10.2.631; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Kalendar R, 2017, GENOMICS, V109, P312, DOI 10.1016/j.ygeno.2017.05.005; Kato Seiji, 2009, Chromosome Science, V12, P43; Koo DH, 2010, CHROMOSOME RES, V18, P325, DOI 10.1007/s10577-010-9116-0; Kubis S, 1998, ANN BOT-LONDON, V82, P45, DOI 10.1006/anbo.1998.0779; Lee HR, 2006, MOL BIOL EVOL, V23, P2505, DOI 10.1093/molbev/msl127; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; Melon Pitrat M., 2008, HDB CROP BREEDING, VI, P283; Minamikawa MF, 2013, PLANT BIOTECHNOL-NAR, V30, P119, DOI 10.5511/plantbiotechnology.13.0109a; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00912; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Rosic S, 2014, J CELL BIOL, V207, P335, DOI 10.1083/jcb.201404097; Schmidt T, 1999, PLANT MOL BIOL, V40, P903, DOI 10.1023/A:1006212929794; Setiawan AB, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-018-0380-6; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Tek AL, 2011, CHROMOSOME RES, V19, P969, DOI 10.1007/s10577-011-9247-y; Teo CH, 2007, THESIS; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Waminal NE, 2017, J GINSENG RES, V41, P469, DOI 10.1016/j.jgr.2016.08.002; Zhang WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13091-y; Zhang WL, 2005, PLANT PHYSIOL, V139, P306, DOI 10.1104/pp.105.064147	39	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227578	10.1371/journal.pone.0227578	http://dx.doi.org/10.1371/journal.pone.0227578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945109	gold, Green Published			2022-12-26	WOS:000534370100046
J	Wang, HF; Kruger, T; Varnik, F				Wang, Haifeng; Kruger, Timm; Varnik, Fathollah			Effects of size and elasticity on the relation between flow velocity and wall shear stress in side-wall aneurysms: A lattice Boltzmann-based computer simulation study	PLOS ONE			English	Article							BLOOD-FLOW; INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSM; ARTERY ANEURYSMS; RISK-FACTORS; STEADY FLOW; HEMODYNAMICS; DYNAMICS; MODEL; RUPTURE	Blood flow in an artery is a fluid-structure interaction problem. It is widely accepted that aneurysm formation, enlargement and failure are associated with wall shear stress (WSS) which is exerted by flowing blood on the aneurysmal wall. To date, the combined effect of aneurysm size and wall elasticity on intra-aneurysm (IA) flow characteristics, particularly in the case of side-wall aneurysms, is poorly understood. Here we propose a model of three-dimensional viscous flow in a compliant artery containing an aneurysm by employing the immersed boundary-lattice Boltzmann-finite element method. This model allows to adequately account for the elastic deformation of both the blood vessel and aneurysm walls. Using this model, we perform a detailed investigation of the flow through aneurysm under different conditions with a focus on the parameters which may influence the wall shear stress. Most importantly, it is shown in this work that the use of flow velocity as a proxy for wall shear stress is well justified only in those sections of the vessel which are close to the ideal cylindrical geometry. Within the aneurysm domain, however, the correlation between wall shear stress and flow velocity is largely lost due to the complexity of the geometry and the resulting flow pattern. Moreover, the correlations weaken further with the phase shift between flow velocity and transmural pressure. These findings have important implications for medical applications since wall shear stress is believed to play a crucial role in aneurysm rupture.	[Wang, Haifeng; Varnik, Fathollah] Ruhr Univ Bochum, Interdisciplinary Ctr Adv Mat Simulat ICAMS, Bochum, Germany; [Kruger, Timm] Univ Edinburgh, Sch Engn, Inst Multiscale Thermofluids, Edinburgh, Midlothian, Scotland	Ruhr University Bochum; University of Edinburgh	Wang, HF; Varnik, F (corresponding author), Ruhr Univ Bochum, Interdisciplinary Ctr Adv Mat Simulat ICAMS, Bochum, Germany.	Haifeng.Wang@rub.de; Fathollah.Varnik@rub.de	Krüger, Timm/N-1745-2014	Krüger, Timm/0000-0003-2934-2699; Wang, Haifeng/0000-0001-8786-2479	IMPRS-SurMat scholarship; STKS department funds at ICAMS, Ruhr-Universitat Bochum; University of Edinburgh; state of North-Rhine Westphalia; European Commission of the European Regional Development Fund (ERDF)	IMPRS-SurMat scholarship; STKS department funds at ICAMS, Ruhr-Universitat Bochum; University of Edinburgh; state of North-Rhine Westphalia; European Commission of the European Regional Development Fund (ERDF)	HW acknowledges his IMPRS-SurMat scholarship and the STKS department funds at ICAMS, Ruhr-Universitat Bochum. TK thanks the University of Edinburgh for the award of a Chancellor's Fellowship. ICAMS acknowledges funding from its industrial sponsors, the state of North-Rhine Westphalia and the European Commission in the framework of the European Regional Development Fund (ERDF).	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ariane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174795; Arthurs KM, 1998, J COMPUT PHYS, V147, P402, DOI 10.1006/jcph.1998.6097; Asinari P, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016702; Baharoglu MI, 2010, STROKE, V41, P1423, DOI 10.1161/STROKEAHA.109.570770; Bederson JB, 2000, STROKE, V31, P2742, DOI 10.1161/01.STR.31.11.2742; Bouvy WH, 2016, NMR BIOMED, V29, P1295, DOI 10.1002/nbm.3306; Carvalho JLA, 2010, MAGN RESON MED, V63, P1537, DOI 10.1002/mrm.22325; Castro MA, 2006, AM J NEURORADIOL, V27, P2061; Castro MA, 2013, ISRN RADIOLOGY, V013; Cebral JR, 2005, IEEE T MED IMAGING, V24, P457, DOI 10.1109/TMI.2005.844159; Chadwick P., 1972, J ELASTICITY, V2, P123, DOI [10.1007/BF00046061, DOI 10.1007/BF00046061]; Charalambous Haralambia P, 2017, Open Biomed Eng J, V11, P85, DOI 10.2174/1874120701711010085; d'Humieres D, 2009, COMPUT MATH APPL, V58, P823, DOI 10.1016/j.camwa.2009.02.008; Diagbouga MR, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12992; Duan ZH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24732-1; Fung Y.C., 1981, BIOMECHANICS MECH PR; Furukawa K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191287; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Gilmanov A, 2003, J COMPUT PHYS, V191, P660, DOI 10.1016/S0021-9991(03)00321-8; Gompper G, 1996, J PHYS I, V6, P1305, DOI 10.1051/jp1:1996246; Gross M, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/68006; Gross M, 2014, SOFT MATTER, V10, P4360, DOI 10.1039/c4sm00081a; Grotberg JB, 2004, ANNU REV FLUID MECH, V36, P121, DOI 10.1146/annurev.fluid.36.050802.121918; Guo ZL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046308; HAN HC, 1995, J BIOMECH, V28, P637, DOI 10.1016/0021-9290(94)00091-H; Hassan T, 2005, J NEUROSURG, V103, P662, DOI 10.3171/jns.2005.103.4.0662; Humphrey JD, 2008, ANNU REV BIOMED ENG, V10, P221, DOI 10.1146/annurev.bioeng.10.061807.160439; Isaksen JG, 2008, STROKE, V39, P3172, DOI 10.1161/STROKEAHA.107.503698; JENSEN OE, 1989, J FLUID MECH, V206, P339, DOI 10.1017/S0022112089002326; Juvela S, 2003, STROKE, V34, P1852, DOI 10.1161/01.STR.0000080380.56799.DD; Kamm R, 2015, 20 310J MOL CELLULAR; Kim MO, 2015, J HYPERTENS, V33, P1233, DOI 10.1097/HJH.0000000000000539; Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840; Krafczyk M, 1998, J BIOMECH, V31, P453, DOI 10.1016/S0021-9290(98)00036-0; Krejza J, 2005, AM J NEURORADIOL, V26, P730; Kruger T, 2011, COMPUT MATH APPL, V61, P3485, DOI 10.1016/j.camwa.2010.03.057; Kruger T, 2013, SOFT MATTER, V9, P9008, DOI 10.1039/c3sm51645h; Kruger T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046704; Lallemand P, 2000, PHYS REV E, V61, P6546, DOI 10.1103/PhysRevE.61.6546; Long YL, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-17; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Mouches P, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0034-5; Novitzke Jill, 2008, J Vasc Interv Neurol, V1, P89; Ogoh S, 2005, AM J PHYSIOL-HEART C, V288, pH1526, DOI 10.1152/ajpheart.00979.2004; Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031; Oshinski JN, 1995, JMRI-J MAGN RESON IM, V5, P640; Peskin C.S., 1972, FLOW PATTERNS HEART; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; Pierce DM, 2015, J MECH BEHAV BIOMED, V41, P92, DOI 10.1016/j.jmbbm.2014.10.003; Rodriguez J, 2011, MECH RES COMMUN, V38, P203, DOI 10.1016/j.mechrescom.2011.02.004; Shapiro A. H., 1977, J BIOMECHANICAL ENG, V99, P126; Shishir SS, 2015, PROCEDIA ENGINEER, V105, P919, DOI 10.1016/j.proeng.2015.05.116; SKALAK R, 1973, BIOPHYS J, V13, P245, DOI 10.1016/S0006-3495(73)85983-1; Smith KM, 2003, AM J PHYSIOL-RENAL, V284, pF1080, DOI 10.1152/ajprenal.00141.2002; Szajer J, 2018, MAGN RESON IMAGING, V48, P62, DOI 10.1016/j.mri.2017.12.005; Tateshima S, 2010, NEURORADIOLOGY, V52, P1135, DOI 10.1007/s00234-010-0687-4; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Updegrove A, 2017, ANN BIOMED ENG, V45, P525, DOI 10.1007/s10439-016-1762-8; Valencia A, 2006, COMPUT STRUCT, V84, P1326, DOI 10.1016/j.compstruc.2006.03.008; Volokh KY, 2008, J BIOMECH, V41, P1015, DOI 10.1016/j.jbiomech.2007.12.014; Warriner RK, 2008, PHYSIOL MEAS, V29, P157, DOI 10.1088/0967-3334/29/2/001; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; Xu JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138648; Xu LJ, 2018, COMPUT BIOL MED, V101, P51, DOI 10.1016/j.compbiomed.2018.08.004; Xu L, 2016, TECHNOL HEALTH CARE, V24, P349, DOI 10.3233/THC-161135; Yamaguchi R, 2016, INT J NEUROL NEUROTH, V3, DOI [10.23937/2378-3001/3/3/1049, DOI 10.23937/2378-3001/3/3/1049]	68	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227770	10.1371/journal.pone.0227770	http://dx.doi.org/10.1371/journal.pone.0227770			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945111	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100062
J	Ezzat, MI; Okba, MM; Ahmed, SH; El-Banna, HA; Prince, A; Mohamed, SO; Ezzat, SM				Ezzat, Marwa, I; Okba, Mona M.; Ahmed, Sherif H.; El-Banna, Hossny A.; Prince, Abdelbary; Mohamed, Shanaz O.; Ezzat, Shahira M.			In-depth hepatoprotective mechanistic study of Phyllanthus niruri: In vitro and in vivo studies and its chemical characterization	PLOS ONE			English	Article							TETRACHLORIDE-INDUCED HEPATOTOXICITY; INDUCED LIVER-DAMAGE; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; TIME-COURSE; ANTIOXIDANT ACTIVITY; HEPATIC-INJURY; KUPFFER CELLS	Phyllanthus niruri L. is a widespread tropical plant which is used in Ayurvedic system for liver and kidney ailments. The present study aims at specifying the most active hepatoprotective extract of P. niruriand applying a bio-guided protocol to identify the active compounds responsible for this effect. P. niruri aerial parts were extracted separately with water, 50%, 70% and 80% ethanol. The cytoprotective activity of the extracts was evaluated against CCl4-induced hepatotoxicity in clone-9 and Hepg2 cells. Bioassay-guided fractionation of the aqueous extract (AE) was accomplished for the isolation of the active compounds. Antioxidant activity was assessed using DPPH (1, 1-diphenyl-2-picrylhydrazyl) radical scavenging method and ferric reducing antioxidant power (FRAP). The in vivo hepatoprotective activity of AE was evaluated in CCl4-induced hepatotoxicity in rats at different doses after determination of its LD50. Pretreatment of clone-9 and Hepg2 with different concentrations of AE (1, 0.1, 0.01 mg/ml) had significantly reduced the levels of alanine amino-transferase (ALT) and aspartate aminotransferase (AST) against CCl4 injures, and restored the activity of the natural antioxidants; glutathione (GSH) and superoxide dismutase (SOD) towards normalization. Fractionation of AE gave four fractions (I-IV). Fractions I, II, and IV showed a significant in vitro hepatoprotective activity. Purification of I, II and IV yielded seven compounds; corilagin C1, isocorilagin C2, brevifolin C3, quercetin C4, kaempferol rhamnoside C5, gallic acid C6, and brevifolin carboxylic acid C7. Compounds C1, C2, C5, and C7 showed the highest (p< 0.001) hepatoprotective potency, while C3, C4, and C6 exhibited a moderate (p< 0.001) activity. The AE exhibited strong antioxidant DPPH (IC50 11.6 +/- 2 mu g/ml) and FRAP (79.352 +/- 2.88 mM Ferrous equivalents) activity. In vivo administration of AE in rats (25, 50, 100 and 200 mg/kg) caused normalization of AST, ALT, alkaline phosphatase (ALP), lactate dehydrogenase (LDH), total cholesterol (TC), triglycyrides (TG), total bilirubin (TB), glucose, total proteins (TP), urea and creatinine levels which were elevated by CCl4. AE also decreased TNF-alpha, NF-kappa B, IL-6, IL-8, IL-10 and COX-2 expression, and significantly antagonizes the effect of CCl4 on the antioxidant enzymes SOD, catalase (CAT), glutathione reductase (GR), and glutathione peroxidase (GSP). The histopathological study also supported the hepatoprotective effect of AE. P. niruri isolates exhibited a potent hepatoprotective activity against CCl4-induced hepatotoxicity in clone-9 and Hepg2 cell lines through reduction of lipid peroxidation and maintaining glutathione in its reduced form. This is attributable to their phenolic nature and hence antioxidative potential.	[Ezzat, Marwa, I; Okba, Mona M.; Ezzat, Shahira M.] Cairo Univ, Fac Pharm, Pharmacognosy Dept, Kasr El Ainy St, Cairo, Egypt; [Ahmed, Sherif H.] Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt; [El-Banna, Hossny A.] Cairo Univ, Fac Vet Med, Dept Pharmacol, Giza, Egypt; [Prince, Abdelbary] Cairo Univ, Fac Vet Med, Dept Biochem, Giza, Egypt; [Mohamed, Shanaz O.] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Ezzat, Shahira M.] October Univ Modern Sci & Arts MSA, Dept Pharmacognosy, Fac Pharm, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Universiti Sains Malaysia; Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA)	Ezzat, MI (corresponding author), Cairo Univ, Fac Pharm, Pharmacognosy Dept, Kasr El Ainy St, Cairo, Egypt.	marwa.ezzat@pharma.cu.edu.eg	Ezzat, Shahira/AAJ-3122-2021	Prince, Abdelbary/0000-0002-6155-8871; Ezzat, Shahira/0000-0003-2232-7357; Ezzat, Marwa I./0000-0002-7776-0265	Ministry of Agriculture Malaysia initiative under the New Key Economic Areas Entry Point Project on High Value Herbals	Ministry of Agriculture Malaysia initiative under the New Key Economic Areas Entry Point Project on High Value Herbals	The authors received no specific funding for this work. Natural Wellness Biotech organization only provided support in the form of research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was made possible as part of Ministry of Agriculture Malaysia initiative under the New Key Economic Areas Entry Point Project on High Value Herbals awarded to Natural Wellness Biotech (M) Sdn Bhd. The authors express their gratitude and appreciation for the trust and opportunity given. The authors extend their gratitude to Cairo University staff for their collaboration and excellent teamwork.	Al-Shabanah OA, 1999, LIFE SCI, V66, P265; Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; ANIYA Y, 1993, BIOCHEM PHARMACOL, V45, P37; Asha VV, 2004, J ETHNOPHARMACOL, V92, P67, DOI 10.1016/j.jep.2004.02.005; Bagalkotkar G, 2006, J PHARM PHARMACOL, V58, P1559, DOI 10.1211/jpp.58.12.0001; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BEYER W, 1991, PROG NUCLEIC ACID RE, V40, P221; Bhattacharjee R, 2007, FOOD CHEM TOXICOL, V45, P817, DOI 10.1016/j.fct.2006.10.029; Bilal C, 2016, HEALING IN UROLOGY C; Breikaa RM, 2013, BIOSCI BIOTECH BIOCH, V77, P909, DOI 10.1271/bbb.120675; Calixto JB, 1998, MED RES REV, V18, P225, DOI 10.1002/(SICI)1098-1128(199807)18:4&lt;225::AID-MED2&gt;3.0.CO;2-X; CHAMULITRAT W, 1994, MOL PHARMACOL, V46, P391; Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148; COLTEN HR, 1992, J APPL PHYSIOL, V72, P1; de Abajo FJ, 2004, BRIT J CLIN PHARMACO, V58, P71, DOI 10.1111/j.1365-2125.2004.02133.x; DeCicco LA, 1998, TOXICOL LETT, V98, P115, DOI 10.1016/S0378-4274(98)00110-6; Deepak HB, 2012, PHARMACOGN MAG, V8, P116, DOI 10.4103/0973-1296.96553; DISIMPLICIO P, 1983, TOXICOL LETT, V18, P285, DOI 10.1016/0378-4274(83)90108-X; EDWARDS MJ, 1993, TOXICOL APPL PHARM, V119, P275, DOI 10.1006/taap.1993.1069; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; FRIDOVICH I, 1993, FREE RADICAL BIO MED, V15, P472, DOI 10.1016/0891-5849(93)90188-Z; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Gulati Raj Kumari, 1995, Indian Journal of Experimental Biology, V33, P261; Habib-Ur-Rehman, 2007, NAT PROD RES, V21, P775, DOI 10.1080/14786410601124664; Harish R, 2006, FOOD CHEM, V95, P180, DOI 10.1016/j.foodchem.2004.11.049; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; HORN HJ, 1956, BIOMETRICS, V12, P311, DOI 10.2307/3001470; Hsu CT, 1998, J AUTONOM NERV SYST, V70, P79, DOI 10.1016/S0165-1838(98)00035-6; Hu KQ, 2003, PROSTAG LEUKOTR ESS, V69, P329, DOI 10.1016/j.plefa.2003.07.001; ISHIYAMA H, 1995, EUR J PHARM-ENVIRON, V292, P135, DOI 10.1016/0926-6917(95)90005-5; Ismail Nagwa A, 2010, Saudi J Gastroenterol, V16, P90, DOI 10.4103/1319-3767.61234; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jain Nilesh Kumar, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P49, DOI 10.3736/jcim20110109; Janakat S, 2002, J PHARMACOL TOXICOL, V48, P41, DOI 10.1016/S1056-8719(03)00019-4; Kalekar SA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-257; Khanna AK, 2002, J ETHNOPHARMACOL, V82, P19, DOI 10.1016/S0378-8741(02)00136-8; Khatoon S, 2006, J ETHNOPHARMACOL, V104, P79, DOI 10.1016/j.jep.2005.08.048; Kinoshita S, 2007, PHYTOMEDICINE, V14, P755, DOI 10.1016/j.phymed.2006.12.012; Krithika R, 2009, CHEM-BIOL INTERACT, V181, P351, DOI 10.1016/j.cbi.2009.06.014; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee NYS, 2016, J PHARM PHARMACOL, V68, P953, DOI 10.1111/jphp.12565; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; Lykkesfeldt J, 2007, CLIN CHIM ACTA, V380, P50, DOI 10.1016/j.cca.2007.01.028; Manjrekar AP, 2008, INDIAN J EXP BIOL, V46, P514; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; McGregor D, 1996, MUTAT RES-REV GENET, V366, P181; MEHENDALE HM, 1994, FASEB J, V8, P1285, DOI 10.1096/fasebj.8.15.8001741; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Morio LA, 2001, TOXICOL APPL PHARM, V172, P44, DOI 10.1006/taap.2000.9133; Murugaiyah V, 2009, J ETHNOPHARMACOL, V124, P233, DOI 10.1016/j.jep.2009.04.026; NAWWAR MAM, 1994, PHYTOCHEMISTRY, V36, P793, DOI 10.1016/S0031-9422(00)89820-9; Orhan DD, 2007, J ETHNOPHARMACOL, V112, P145, DOI 10.1016/j.jep.2007.02.013; Pareek A, 2013, J ETHNOPHARMACOL, V150, P973, DOI 10.1016/j.jep.2013.09.048; Popovic M, 2008, MOLECULES, V13, P2249, DOI 10.3390/molecules13092249; Pramyothin P, 2007, J ETHNOPHARMACOL, V114, P169, DOI 10.1016/j.jep.2007.07.037; Ramkumar KM, 2003, NUTRITION, V19, P358, DOI 10.1016/S0899-9007(02)00961-9; Rasool MK, 2010, J PHARM PHARMACOL, V62, P638, DOI 10.1211/jpp.62.05.0012; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; REES KR, 1960, J PATHOL BACTERIOL, V80, P297, DOI 10.1002/path.1700800213; Rhiouani H, 1999, THERAPIE, V54, P735; ROCKEY DC, 1997, AM J PHYSL 1, V273, pG12, DOI DOI 10.1152/AJPGI.1997.273.1.G124; Sabir SM, 2008, FOOD CHEM, V111, P845, DOI 10.1016/j.foodchem.2008.04.060; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; SMEJKALOVA J, 1985, PHYSIOL BOHEMOSLOV, V34, P494; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Smyth R, 2009, INT J EXP PATHOL, V90, P500, DOI 10.1111/j.1365-2613.2009.00666.x; Sprenger RF, 2016, ORG BIOMOL CHEM, V14, P3369, DOI 10.1039/c6ob00049e; Sturgill MG, 1997, CLIN CHEM, V43, P1512; SYAMASUNDAR KV, 1985, J ETHNOPHARMACOL, V14, P41, DOI 10.1016/0378-8741(85)90026-1; Tatiya AU, 2012, PHARMACOGN RES, V4, P50, DOI 10.4103/0974-8490.91040; Tewari D, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00519; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vos TA, 1999, HEPATOLOGY, V29, P421, DOI 10.1002/hep.510290231; Zhang Lan-zhen, 2000, Zhongguo Zhongyao Zazhi, V25, P615; Zhu RZ, 2012, HEPATOL RES, V42, P741, DOI 10.1111/j.1872-034X.2012.00996.x; Zhu W, 2000, FREE RADICAL BIO MED, V29, P870, DOI 10.1016/S0891-5849(00)00396-8	78	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226185	10.1371/journal.pone.0226185	http://dx.doi.org/10.1371/journal.pone.0226185			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940365	Green Published, gold			2022-12-26	WOS:000534368000021
J	Lathe, R; Singadia, S; Jordan, C; Riedel, G				Lathe, Richard; Singadia, Sheena; Jordan, Crispin; Riedel, Gernot			The interoceptive hippocampus: Mouse brain endocrine receptor expression highlights a dentate gyrus (DG)-cornu ammonis (CA) challenge-sufficiency axis	PLOS ONE			English	Article							LONG-TERM POTENTIATION; FIBROBLAST-GROWTH-FACTOR; INTERFERON-ALPHA; ADULT NEUROGENESIS; GLUCOCORTICOID-RECEPTORS; SYNAPTIC-TRANSMISSION; ESTROGEN-RECEPTORS; DEPRESSION; ACTIVATION; SYSTEM	The primeval function of the mammalian hippocampus (HPC) remains uncertain. Implicated in learning and memory, spatial navigation, and neuropsychological disorders, evolutionary theory suggests that the HPC evolved from a primeval chemosensory epithelium. Deficits in sensing of internal body status ('interoception') in patients with HPC lesions argue that internal sensing may be conserved in higher vertebrates. We studied the expression patterns in mouse brain of 250 endocrine receptors that respond to blood-borne ligands. Key findings are (i) the proportions and levels of endocrine receptor expression in the HPC are significantly higher than in all other comparable brain regions. (ii) Surprisingly, the distribution of endocrine receptor expression within mouse HPC was found to be highly structured: receptors signaling 'challenge' are segregated in dentate gyrus (DG), whereas those signaling 'sufficiency' are principally found in cornu ammonis (CA) regions. Selective expression of endocrine receptors in the HPC argues that interoception remains a core feature of hippo-campal function. Further, we report that ligands of DG receptors predominantly inhibit both synaptic potentiation and neurogenesis, whereas CA receptor ligands conversely promote both synaptic potentiation and neurogenesis. These findings suggest that the hippocampus acts as an integrator of body status, extending its role in context-dependent memory encoding from 'where' and 'when' to 'how I feel'. Implications for anxiety and depression are discussed.	[Lathe, Richard] Univ Edinburgh, Div Infect Med, Med Sch, Edinburgh, Midlothian, Scotland; [Singadia, Sheena; Riedel, Gernot] Univ Aberdeen, Inst Med Sci, Div Behav Neurosci, Aberdeen, Scotland; [Jordan, Crispin] Univ Edinburgh, Div Biomed Sci, Med Sch, George Sq, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Aberdeen; University of Edinburgh	Lathe, R (corresponding author), Univ Edinburgh, Div Infect Med, Med Sch, Edinburgh, Midlothian, Scotland.; Riedel, G (corresponding author), Univ Aberdeen, Inst Med Sci, Div Behav Neurosci, Aberdeen, Scotland.	richard.lathe@ed.ac.uk; g.riedel@abdn.ac.uk		Lathe, Richard/0000-0001-9698-9834	Carnegie Trust for the Universities of Scotland	Carnegie Trust for the Universities of Scotland	We thank the Allen Brain Institute (Seattle, WA, USA) and Janelia (Ashburn, VA, USA) for making their data publicly available, and to whom we express our deep appreciation. S.S. thanks the Carnegie Trust for the Universities of Scotland for a vacation scholarship. We also thank an anonymous reviewer for suggesting further genes for study. All data needed to evaluate the conclusions in the paper are presented in the paper and/or the supplementary materials online.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; [Anonymous], 2019, R LANG ENV STAT COMP; Bauer M, 1998, NEUROPSYCHOPHARMACOL, V18, P444, DOI 10.1016/S0893-133X(97)00181-4; Bean LA, 2014, NEUROSCIENTIST, V20, P534, DOI 10.1177/1073858413519865; Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Bienkowski MS, 2018, NAT NEUROSCI, V21, P1628, DOI 10.1038/s41593-018-0241-y; Bingman VP, 2017, BRAIN BEHAV EVOLUT, V90, P53, DOI 10.1159/000475592; Bjerregaard-Olesen C, 2016, STEROIDS, V105, P50, DOI 10.1016/j.steroids.2015.11.009; Borsini A, 2018, INT J NEUROPSYCHOPH, V21, P187, DOI 10.1093/ijnp/pyx083; Borsini A, 2017, BRAIN BEHAV IMMUN, V65, P230, DOI 10.1016/j.bbi.2017.05.006; Canty A., 2021, R PACKAGE VERSION 1; Capuron L, 2001, PSYCHONEUROENDOCRINO, V26, P797, DOI 10.1016/S0306-4530(01)00030-0; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Chan M, 2014, J NEUROENDOCRINOL, V26, P386, DOI 10.1111/jne.12159; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Clifton PG, 1998, BEHAV NEUROSCI, V112, P502, DOI 10.1037/0735-7044.112.3.502; Coogan A, 1997, NEUROREPORT, V8, P2107, DOI 10.1097/00001756-199707070-00004; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; CREAVEN PJ, 1987, CANCER CHEMOTH PHARM, V20, P137; Davidson TL, 2010, BEHAV NEUROSCI, V124, P97, DOI 10.1037/a0018402; DAVIDSON TL, 1993, BEHAV NEURAL BIOL, V59, P167, DOI 10.1016/0163-1047(93)90925-8; Davies BJ, 1998, J BIOL CHEM, V273, P23004, DOI 10.1074/jbc.273.36.23004; Davison AC, 1997, BOOTSTRAP METHODS TH; DEKLOET ER, 1990, J STEROID BIOCHEM, V37, P387, DOI 10.1016/0960-0760(90)90489-8; Dong J, 2005, NEUROTOXICOLOGY, V26, P417, DOI 10.1016/j.neuro.2005.03.003; Duvernoy HM., 2013, HUMAN HIPPOCAMPUS FU, V4th ed.; Eigler T, 2014, J MOL ENDOCRINOL, V53, pR1, DOI 10.1530/JME-14-0034; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Exton MS, 2002, NEUROPSYCHOBIOLOGY, V45, P199, DOI 10.1159/000063671; Fowler CD, 2008, BRAIN RES REV, V57, P342, DOI 10.1016/j.brainresrev.2007.06.011; Gastambide F, 2010, HIPPOCAMPUS, V20, P745, DOI 10.1002/hipo.20680; Gastambide F, 2009, PSYCHOPHARMACOLOGY, V202, P153, DOI 10.1007/s00213-008-1204-x; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Griffin R, 2006, J NEUROCHEM, V99, P1263, DOI 10.1111/j.1471-4159.2006.04165.x; Gruber AJ, 2000, PSYCHOTHER PSYCHOSOM, V69, P19, DOI 10.1159/000012362; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; HEBBEN N, 1985, BEHAV NEUROSCI, V99, P1031, DOI 10.1037/0735-7044.99.6.1031; HISAJIMA H, 1992, J NEUROSCI RES, V31, P549, DOI 10.1002/jnr.490310319; Huang CQ, 2009, ACTA BIOCHIM POL, V56, P279; Ikegaya Y, 1997, JPN J PHARMACOL, V75, P87, DOI 10.1254/jjp.75.87; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; ISHIYAMA J, 1991, NEUROSCI RES, V12, P403, DOI 10.1016/0168-0102(91)90071-6; Itoh N, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00154; Jost B, 1997, BIOCHEM J, V327, P95, DOI 10.1042/bj3270095; Kang WF, 2015, J NEUROSCI, V35, P10217, DOI 10.1523/JNEUROSCI.1469-15.2015; KATSUKI H, 1990, EUR J PHARMACOL, V181, P323, DOI 10.1016/0014-2999(90)90099-R; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Lathe R, 2014, STEROIDS, V82, P14, DOI 10.1016/j.steroids.2014.01.002; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Lledo PM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018945; MATSUOKA N, 1991, BRAIN RES, V553, P188, DOI 10.1016/0006-8993(91)90823-E; Mendoza-Fernandez V, 2000, BRAIN RES, V885, P14, DOI 10.1016/S0006-8993(00)02877-8; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Odaka H, 2017, NEURAL REGEN RES, V12, P1028, DOI 10.4103/1673-5374.211174; Prevot TD, 2017, NEUROPSYCHOPHARMACOL, V42, P1647, DOI 10.1038/npp.2016.281; Prevot TD, 2018, PROG NEURO-PSYCHOPH, V86, P390, DOI 10.1016/j.pnpbp.2018.01.022; Pryce CR, 2005, EUR J NEUROSCI, V21, P1521, DOI 10.1111/j.1460-9568.2005.04003.x; Raison CL, 2005, CNS DRUGS, V19, P105, DOI 10.2165/00023210-200519020-00002; RISS W, 1969, ANN NY ACAD SCI, V159, P1096, DOI 10.1111/j.1749-6632.1969.tb13000.x; Rose K, 2001, J BIOL CHEM, V276, P23937, DOI 10.1074/jbc.M011564200; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Saaltink DJ, 2014, CELL MOL LIFE SCI, V71, P2499, DOI 10.1007/s00018-014-1568-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SECKL JR, 1991, BRAIN RES, V561, P332, DOI 10.1016/0006-8993(91)91612-5; Shughrue PJ, 2000, NEUROSCIENCE, V99, P605, DOI 10.1016/S0306-4522(00)00242-6; SMITH JW, 1992, J CLIN ONCOL, V10, P1141, DOI 10.1200/JCO.1992.10.7.1141; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Steel M, 1998, HIPPOCAMPUS, V8, P444, DOI 10.1002/(SICI)1098-1063(1998)8:5<444::AID-HIPO5>3.0.CO;2-X; Sugiyama N, 2009, MOL PSYCHIATR, V14, P223, DOI 10.1038/mp.2008.118; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; TANCREDI V, 1990, BRAIN RES, V525, P149, DOI 10.1016/0006-8993(90)91331-A; Taskin E, 2011, NEUROENDOCRINOLOGY, V94, P218, DOI 10.1159/000328513; Thin TH, 2002, J BIOL CHEM, V277, P36499, DOI 10.1074/jbc.M202824200; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Valentine AD, 1998, SEMIN ONCOL, V25, P39; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vara H, 2003, HIPPOCAMPUS, V13, P816, DOI 10.1002/hipo.10132; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Wei W, 2016, CELL METAB, V23, P479, DOI 10.1016/j.cmet.2015.12.010; Weiland NG, 1997, J COMP NEUROL, V388, P603, DOI 10.1002/(SICI)1096-9861(19971201)388:4<603::AID-CNE8>3.0.CO;2-6; Wilken MS, 2016, CURR OPIN GENET DEV, V40, P57, DOI 10.1016/j.gde.2016.05.028; Yan HC, 2011, CURR MED CHEM, V18, P4359, DOI 10.2174/092986711797200471; YASUI M, 1995, JPN J PHARMACOL, V68, P441, DOI 10.1254/jjp.68.441; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc; [No title captured]	93	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227575	10.1371/journal.pone.0227575	http://dx.doi.org/10.1371/journal.pone.0227575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940330	gold, Green Submitted, Green Published			2022-12-26	WOS:000534368000081
J	Martynov, A; Lundin, K; Picton, B; Fletcher, K; Malmberg, K; Korshunova, T				Martynov, Alexander; Lundin, Kennet; Picton, Bernard; Fletcher, Karin; Malmberg, Klas; Korshunova, Tatiana			Multiple paedomorphic lineages of soft-substrate burrowing invertebrates: parallels in the origin of Xenocratena and Xenoturbella	PLOS ONE			English	Article							ONTOGENIC-SYSTEMATICS; SISTER GROUP; EVOLUTION; HETEROCHRONY; NUDIBRANCHIA; PEDOMORPHOSIS; PROGENESIS; XENACOELOMORPHA; PHYLOGENOMICS; GASTROPODA	Paedomorphosis is an important evolutionary force. It has previously been suggested that a soft-substrate sediment-dwelling (infaunal) environment facilitates paedomorphic evolution in marine invertebrates. However, until recently this proposal was never rigorously tested with robust phylogeny and broad taxon selection. Here, for the first time, we present a molecular phylogeny for a majority of the 21 families of one of the largest nudibranch sub-groups (Aeolidacea) and show that the externally highly simplified vermiform nudibranch family, Pseudovermidae, with clearly defined paedomorphic traits and inhabiting a soft-sub-strata environment, is a sister group to the complex nudibranch family, Cumanotidae. We also report the rediscovery of one of the most enigmatic nudibranchs-Xenocratena suecica-on the Swedish and Norwegian coasts 70 years after it was first found. Xenocratena was described from the same location and environment in the Swedish Gullmar fjord as one of the most enigmatic vermiform organisms, Xenoturbella bocki, which represents either an original simple bilaterian body plan or secondary simplification of a more complex organisation. Our results show that Xenocratena suecica reveals an onset of parallel paedomorphic evolution so we have proposed the new family, Xenocratenidae fam. n., to accommodate the molecular and morphological disparities we discovered. The paedomorphic origin of another aeolidacean family, Embletoniidae, is also demonstrated for the first time. Thus, by presenting three independent lineages from non-closely related aeolidacean families, Xenocratenidae fam. n., Cumanotidae and Embletoniidae, we confirm with phylogenetic data that a soft-substrata burrowing-related environment strongly favours paedomorphic evolution. We suggest criteria to distinguish ancestral and derived characters in the context of modifications of ontogenetic cycles. Applying an evolutionary model of the soft substrate-driven multiple paedomorphic origin of several families of nudibranch molluscs we propose that it is plausible to extend this model to other marine invertebrates and suggest that the ancestral organisation of the enigmatic metazoan, Xenoturbella, might correspond to the larval part of a complex ancestral bilaterian ontogenetic cycle with sedentary/semi-sedentary adult stages and planula-like larval stages.	[Martynov, Alexander; Korshunova, Tatiana] Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia; [Lundin, Kennet] Gothenburg Nat Hist Museum, Gothenburg, Sweden; [Lundin, Kennet; Malmberg, Klas] Gothenburg Global Biodivers Ctr, Gothenburg, Sweden; [Picton, Bernard] Natl Museums Northern Ireland, Holywood, North Ireland; [Picton, Bernard] Queens Univ, Belfast, Antrim, North Ireland; [Fletcher, Karin] Milltech Marine, Port Orchard, WA USA; [Korshunova, Tatiana] RAS, Koltzov Inst Dev Biol, Moscow, Russia	Lomonosov Moscow State University; University of Gothenburg; Queens University Belfast; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences	Martynov, A (corresponding author), Moscow MV Lomonosov State Univ, Zool Museum, Moscow, Russia.	martynov@zmmu.msu.ru	Martynov, Alexander/AAE-3682-2021; Korshunova, Tatiana/T-7821-2017	Picton, Bernard/0000-0002-1500-2215	MSU Zoological Museum [AAAA-A16-116021660077-3]	MSU Zoological Museum	This study was supported by a research project of MSU Zoological Museum (AAAA-A16-116021660077-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Rudolf Svensen, Leif Bruntveit, Michael Lundin, Erling Svensen, Torkild Bakken (NTNU University Museum) and Gulen Dive Center (Christian Skauge, Orjan Sandnes, Monica Bakkeli and Guido Schmitz) for their help during fieldwork in Norway and Sweden. Erling Svensen, Rudolf Svensen and Leif Bruntveit are thanked for providing images of living Xenocratena. Dominique Horst is thanked for providing images of burrowing Cumanotus and its egg-mass. Electron Microscopy Laboratory (MSU) is thanked for support with electron microscopy. We would like to thank reviewers who suggested improvements to this paper.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Andrade SCS, 2015, MOL BIOL EVOL, V32, P2860, DOI 10.1093/molbev/msv157; Andrikou C, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000408; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Balavoine G, 1998, AM ZOOL, V38, P843; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; BOADEN PJ, 1961, NATURE, V191, P512, DOI 10.1038/191512a0; BOADEN PJS, 1989, ZOOL J LINN SOC-LOND, V96, P217, DOI 10.1111/j.1096-3642.1989.tb02257.x; Bocak L, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2350; Bonett RM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2304; Bonett RM, 2017, P NATL ACAD SCI USA, V114, P9936, DOI 10.1073/pnas.1703877114; Bonett RM, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-27; Borisenko I, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0700-6; Brauchle M, 2018, GENOME BIOL EVOL, V10, P2205, DOI 10.1093/gbe/evy170; Brenzinger B, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-37; Buckland-Nicks J, 2019, ZOOMORPHOLOGY, V138, P13, DOI 10.1007/s00435-018-0425-8; Budd GE, 2017, BIOL REV, V92, P446, DOI 10.1111/brv.12239; Bufill E, 2011, AM J HUM BIOL, V23, P729, DOI 10.1002/ajhb.21225; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cannon JT, 2016, NATURE, V530, P89, DOI 10.1038/nature16520; Cavalier-Smith T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0476; Delsuc F, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0499-2; Denoel M, 2000, P ROY SOC B-BIOL SCI, V267, P1481, DOI 10.1098/rspb.2000.1168; Denoel M, 2014, J ANIM ECOL, V83, P606, DOI 10.1111/1365-2656.12173; Flammensbeck CK, 2019, ORG DIVERS EVOL, V19, P41, DOI 10.1007/s13127-018-0386-2; Fritzenwanker JH, 2019, P NATL ACAD SCI USA, V116, P8403, DOI 10.1073/pnas.1817496116; Garstang W, 1929, Q J MICROSC SCI, V72, P51; Giard A., 1887, B SCI FR BELG, V1-2, P1; Godfrey LR, 1996, AM J PHYS ANTHROPOL, V99, P17, DOI 10.1002/ajpa.1330990102; Goodheart JA, 2018, FRONT ZOOL, V15, DOI 10.1186/s12983-018-0289-2; Goodheart JA, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1066-0; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haszprunar G, 2016, ORG DIVERS EVOL, V16, P363, DOI 10.1007/s13127-015-0249-z; Janssen R, 2016, DEV GENES EVOL, V226, P69, DOI 10.1007/s00427-016-0529-4; Jorger KM, 2014, MAR BIODIVERS, V44, P327, DOI 10.1007/s12526-014-0224-5; Kainz F, 2011, DEVELOPMENT, V138, P5015, DOI 10.1242/dev.073395; Kano Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30908; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katz PS, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0057; Kayal E, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1142-0; Klingenberg CP, 1998, BIOL REV, V73, P79, DOI 10.1017/S000632319800512X; Koehler R., 1897, Annales des Sciences Naturelles, V(8), P277; Kollman J, 1885, VERHANDLUNGEN NATURF, V7, P387; Korshunova TA, ZOOL J LINN SOC; Korshunova T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42297-5; Korshunova T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192177; Korshunova T, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.717.21885; Korshunova T, 2017, ZOOTAXA, V4324, P1, DOI 10.11646/zootaxa.4324.1.1; Kristensen RM, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0076; Laumer CE, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0831; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Leininger S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4905; Luque J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3875; Maddison WP, 2019, MESQUITE MODULAR SYS; Marletaz F, 2019, CURR BIOL, V29, P312, DOI 10.1016/j.cub.2018.11.042; Marshall N.B., 1984, P91; Martin R, 2009, MAR BIOL, V156, P261, DOI 10.1007/s00227-008-1080-2; Martynov AV, 2012, PALEONTOL J+, V46, P833, DOI 10.1134/S0031030112080072; Martynov AV, 2012, BIOL BULL+, V39, P393, DOI 10.1134/S106235901205010X; Martynov A.V., 2006, Ruthenica, V16, P73; Martynov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139463; Martynov A, 2015, J MOLLUS STUD, V81, P365, DOI 10.1093/mollus/eyv003; Martynov A, 2011, ZOOL J LINN SOC-LOND, V163, P585, DOI 10.1111/j.1096-3642.2011.00720.x; Martynov A, 2011, J MOLLUS STUD, V77, P129, DOI 10.1093/mollus/eyq047; Martynov AV, 2011, THALASSAS, V27, P193; Martynov AV, 2015, 5 INT WORKSH OP AB S, P32; McKinney ML, 1991, EVOLUTION ONTOGENY; McNamara Kenneth J., 2012, Evolution Education and Outreach, V5, P203; McNamara KJ, 2005, PALEOBIOLOGY, V31, P17, DOI 10.1666/0094-8373(2005)031[0017:HDAM]2.0.CO;2; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; MILLER MC, 1992, J MOLLUS STUD, V58, P1, DOI 10.1093/mollus/58.1.1; Minelli A, 2015, EVOLUTIONARY DEV BIO, V1, P1, DOI DOI 10.1007/978-3-7091-1862-7_1; MolluscaBase, 2018, XENOCRATENA ODHNER 1; Nakano H, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-015-0018-z; Nakano H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2556; Nielsen C, 2008, EVOL DEV, V10, P241, DOI 10.1111/j.1525-142X.2008.00231.x; Nuzzo G, 2012, MAR DRUGS, V10, P1799, DOI 10.3390/md10081799; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Hara TD, 2017, MOL PHYLOGENET EVOL, V107, P415, DOI 10.1016/j.ympev.2016.12.006; Odhner NH, 1940, ARK ZOOL A, V32, P1; Pabst EA, 2018, J MOLLUS STUD, V84, P259, DOI 10.1093/mollus/eyy013; Philippe H, 2019, CURR BIOL, V29, P1818, DOI 10.1016/j.cub.2019.04.009; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; PICTON BE, 1991, MALACOLOGIA, V32, P219; Rahman IA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0776; Reilly SM, 1997, BIOL J LINN SOC, V60, P119; Renard E, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700237; RIEGER RM, 1994, AM ZOOL, V34, P484; Rouse GW, 2016, NATURE, V530, P94, DOI 10.1038/nature16545; Rozhnov SV, 2014, PALEONTOL J+, V48, P1243, DOI 10.1134/S0031030114120090; Ruiz-Trillo I, 2016, ORG DIVERS EVOL, V16, P391, DOI 10.1007/s13127-015-0239-1; Rundell RJ, 2010, BIOESSAYS, V32, P430, DOI 10.1002/bies.200900116; Sevastopoulo G.D., 1988, Current Geological Concepts, P245; Shkil FN, 2012, J APPL ICHTHYOL, V28, P398, DOI 10.1111/j.1439-0426.2012.01992.x; SIMION P, 2017, CURR BIOL, V27, P27, DOI [10.1016/j.cub.2017.02.03, DOI 10.1016/J.CUB.2017.02.03]; Smirnov AV, 2015, PALEONTOL J+, V49, P1597, DOI 10.1134/S003103011514018X; Smirnov SV, 1991, SOVREMENNAYA EVOLYUT, P88; Smith AB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1197; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stohr S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164562; Tagawa K, 2016, CURR OPIN GENET DEV, V39, P71, DOI 10.1016/j.gde.2016.05.023; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tassia MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162564; Topper TP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09059-3; Van Iten H, 2014, PALAEONTOLOGY, V57, P677, DOI 10.1111/pala.12116; Vinther J, 2017, NATURE, V542, P471, DOI 10.1038/nature21055; Wagele H, 2014, ORG DIVERS EVOL, V14, P133, DOI 10.1007/s13127-013-0151-5; Wagele H, 2000, ZOOL J LINN SOC-LOND, V130, P83, DOI 10.1006/zjls.1999.0214; Westblad E., 1949, ARK ZOOL, V1, P11; WESTHEIDE W, 1987, J NAT HIST, V21, P843, DOI 10.1080/00222938700770501; Worsaae K, 2018, INVERTEBR SYST, V32, P774, DOI 10.1071/IS17063; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529; Yushin VV, 2014, RUSS J MAR BIOL+, V40, P71, DOI 10.1134/S1063074014020114; Zhao Y, 2019, CURR BIOL, V29, P1112, DOI 10.1016/j.cub.2019.02.036	116	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227173	10.1371/journal.pone.0227173	http://dx.doi.org/10.1371/journal.pone.0227173			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940379	Green Published, gold			2022-12-26	WOS:000534368000060
J	Schmidt, EKA; Torres-Espin, A; Raposo, PJF; Madsen, KL; Kigerl, KA; Popovich, PG; Fenrich, KK; Fouad, K				Schmidt, Emma K. A.; Torres-Espin, Abel; Raposo, Pamela J. F.; Madsen, Karen L.; Kigerl, Kristina A.; Popovich, Phillip G.; Fenrich, Keith K.; Fouad, Karim			Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; ONE-TRIAL TOLERANCE; CLOSTRIDIUM-DIFFICILE INFECTION; BACTERIAL TRANSLOCATION; IMMUNE SUPPRESSION; OPEN-FIELD; MICROBIOTA; DEPRESSION; INFLAMMATION; SYSTEM	Secondary manifestations of spinal cord injury beyond motor and sensory dysfunction can negatively affect a person's quality of life. Spinal cord injury is associated with an increased incidence of depression and anxiety; however, the mechanisms of this relationship are currently not well understood. Human and animal studies suggest that changes in the composition of the intestinal microbiota (dysbiosis) are associated with mood disorders. The objective of the current study is to establish a model of anxiety following a cervical contusion spinal cord injury in rats and to determine whether the microbiota play a role in the observed behavioural changes. We found that spinal cord injury caused dysbiosis and increased symptoms of anxiety-like behaviour. Treatment with a fecal transplant prevented both spinal cord injury-induced dysbiosis as well as the development of anxiety-like behaviour. These results indicate that an incomplete unilateral cervical spinal cord injury can cause affective disorders and intestinal dysbiosis, and that both can be prevented by treatment with fecal transplant therapy.	[Schmidt, Emma K. A.; Fenrich, Keith K.; Fouad, Karim] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Torres-Espin, Abel; Raposo, Pamela J. F.; Fenrich, Keith K.; Fouad, Karim] Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada; [Torres-Espin, Abel; Raposo, Pamela J. F.; Fouad, Karim] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Madsen, Karen L.] Univ Alberta, Fac Med & Dent, Div Gastroenterol, Edmonton, AB, Canada; [Kigerl, Kristina A.; Popovich, Phillip G.] Ohio State Univ, Belford Ctr Spinal Cord Injury, Ctr Brain & Spinal Cord Repair, Dept Neurosci,Wexner Med Ctr, Columbus, OH 43210 USA	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University System of Ohio; Ohio State University	Fouad, K (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.; Fouad, K (corresponding author), Univ Alberta, Fac Rehabil Med, Edmonton, AB, Canada.; Fouad, K (corresponding author), Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada.	karim.fouad@ualberta.ca	Madsen, Karen L/H-5898-2011; Fenrich, Keith/AAG-2780-2020; Torres Espin, Abel/HGA-5068-2022; Torres-Espin, Abel/ABD-1354-2020	Fenrich, Keith/0000-0003-4360-064X; Torres-Espin, Abel/0000-0002-9787-8738; Doolin, Emma/0000-0001-9803-6391	Craig Neilsen Foundation [NPRG 542589]; Canadian Institutes of Health Research [MOP 119281]	Craig Neilsen Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Craig Neilsen Foundation (NPRG 542589), https://chnfoundation.org/, to KF; and Canadian Institutes of Health Research (MOP 119281), http://www.cihr-irsc.gc.ca.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 2017, AM J MED GENET B, V174, P651, DOI 10.1002/ajmg.b.32567; Albrechet-Souza L, 2009, NEUROSCIENCE, V164, P387, DOI 10.1016/j.neuroscience.2009.08.038; BERG RD, 1992, J MED, V23, P217; Bertoglio LJ, 2002, PHARMACOL BIOCHEM BE, V73, P963, DOI 10.1016/S0091-3057(02)00958-9; Bik EM, 2014, GENOME BIOL, V15, DOI 10.1186/gb4182; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Chapman BC, 2016, J TRAUMA ACUTE CARE, V81, P756, DOI 10.1097/TA.0000000000001195; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; DEVIVO MJ, 1991, PARAPLEGIA, V29, P620, DOI 10.1038/sc.1991.91; Santo CCD, 2019, BRAIN BEHAV IMMUN, V78, P91, DOI 10.1016/j.bbi.2019.01.012; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; FILE SE, 1990, PSYCHOPHARMACOLOGY, V102, P98, DOI 10.1007/BF02245751; FILE SE, 1990, PSYCHOPHARMACOLOGY, V100, P281, DOI 10.1007/BF02244419; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Geissler S.A., 2013, J SPINE, DOI [10.4172/2165-7939.S4-001, DOI 10.4172/2165-7939.S4-001]; Gungor B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145878; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Hawrelak Jason A, 2004, Altern Med Rev, V9, P180; Huang RX, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080483; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kohler O, 2014, JAMA PSYCHIAT, V71, P1381, DOI 10.1001/jamapsychiatry.2014.1611; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lim SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169623; Liu JW, 2004, SPINE, V29, P164, DOI 10.1097/01.BRS.0000107234.74249.CD; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Luedtke K, 2014, J NEUROTRAUM, V31, P1107, DOI 10.1089/neu.2013.3204; Lynch AC, 2000, SPINAL CORD, V38, P717, DOI 10.1038/sj.sc.3101058; Maldonado-Bouchard S, 2016, BRAIN BEHAV IMMUN, V51, P176, DOI 10.1016/j.bbi.2015.08.009; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Naseribafrouei A, 2014, NEUROGASTROENT MOTIL, V26, P1155, DOI 10.1111/nmo.12378; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; O'Connor G, 2018, J NEUROTRAUM, V35, P2159, DOI 10.1089/neu.2017.5349; O'Donovan A, 2010, BRAIN BEHAV IMMUN, V24, P1074, DOI 10.1016/j.bbi.2010.03.003; ODWYER ST, 1988, ARCH SURG-CHICAGO, V123, P1459; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Peruga I, 2011, BEHAV BRAIN RES, V220, P20, DOI 10.1016/j.bbr.2011.01.018; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Pop M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r76; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; R Core Team, R LANG ENV STAT COMP; R Studio Team, 2015, RSTUDIO INT DEV R; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Smith PA, 2015, NATURE, V526, P312, DOI 10.1038/526312a; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013; Zhou H, 2015, PHARMACOL BIOCHEM BE, V135, P40, DOI 10.1016/j.pbb.2015.05.009; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	70	39	42	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226128	10.1371/journal.pone.0226128	http://dx.doi.org/10.1371/journal.pone.0226128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940312	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000019
J	Wright, AA; Cross, AR; Harper, SJ				Wright, Alice A.; Cross, Alex R.; Harper, Scott J.			A bushel of viruses: Identification of seventeen novel putative viruses by RNA-seq in six apple trees	PLOS ONE			English	Article							MOSAIC-VIRUS; GENOME; GENERATION; MOVEMENT; FAMILY	Apple decline in Washington state has been increasing in incidence, particularly on Honey-crisp trees grown on G.935 rootstock. In this disease the trees exhibit dieback with necrosis at the graft union and in the rootstock. The cause of this disease remains unknown. To identify viral candidates, RNA-seq was performed on six trees: four trees exhibiting decline and two healthy trees. Across the samples, eight known viruses and Apple hammerhead viroid were detected, however none appear to be specifically associated with the disease. A BLASTx analysis of the RNA-seq data was performed to identify novel viruses that might be associated with apple decline. Seventeen novel putative viruses were detected, including an ilarvirus, two tombus-like viruses, a barna-like virus, a picorna-like virus, three ourmia-like viruses, three partiti-like viruses, and two narna-like viruses. Four additional viruses could not be classified. Three of the viruses appeared to be missing key genes, suggesting they may be dependent upon helper viruses for their function. Others showed a specific tropism, being detected only in the roots or only in the leaves. While, like the known apple viruses, none were consistently associated with diseased trees, it is possible these viruses may have a synergistic effect when co-infecting that could contribute to disease. Or the presence of these viruses may weaken the trees for some other factor that ultimately causes decline. Additional research will be needed to determine how these novel viruses contribute to apple decline.	[Wright, Alice A.; Cross, Alex R.; Harper, Scott J.] Washington State Univ, Dept Plant Pathol, Prosser, WA 99350 USA	Washington State University	Wright, AA (corresponding author), Washington State Univ, Dept Plant Pathol, Prosser, WA 99350 USA.	alice.wright@wsu.edu			Washington Tree Fruit Research Commission [33615900]	Washington Tree Fruit Research Commission	Harper, S.J. (PI), 33615900, Washington Tree Fruit Research Commission, https://www.treefruitresearch.com/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This project was funded by the Washington Tree Fruit Research Commission.	Al Rwahnih M, 2011, ARCH VIROL, V156, P397, DOI 10.1007/s00705-010-0869-8; [Anonymous], 2011, VIRUS VIRUSLIKE DIS; Bastianel M, 2010, PLANT DIS, V94, P284, DOI 10.1094/PDIS-94-3-0284; Beaver-Kanuya E, 2019, J VIROL METHODS, V266, P25, DOI 10.1016/j.jviromet.2018.12.008; Choi SK, 2002, J GEN VIROL, V83, P3173, DOI 10.1099/0022-1317-83-12-3173; Czotter N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00122; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Eastwell KC, 2014, COMPENDIUM APPLE PEA, P96; Fauquet CM, 2005, VIRUS TAXONOMY, P914; Fauquet CM, 2005, VIRUS TAXONOMY, P582; GIESMANCOOKMEYER D, 1995, VIROLOGY, V213, P38, DOI 10.1006/viro.1995.1544; Grigg-McGuffin K, 2016, APPLE TREE COLLAPSE; Grisoni M, 2017, ARCH VIROL, V162, P3855, DOI 10.1007/s00705-017-3540-9; Harper SJ, 2014, VIROLOGY, V460, P91, DOI 10.1016/j.virol.2014.04.035; HILLIS D.M., 1993, SYSTEMATIC BIOL, V42, P182; Hillman BI, 2013, ADV VIRUS RES, V86, P149, DOI 10.1016/B978-0-12-394315-6.00006-4; Howell WE, 2014, COMPENDIUM APPLE PEA, P97; James D, 2013, ARCH VIROL, V158, P1877, DOI 10.1007/s00705-013-1678-7; Jelkmann W., 2011, VIRUS VIRUS LIKE DIS, P35; Jo Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5138-3; Jo Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31671-4; Jo Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20256-w; Jo Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3838-8; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karyeija RF, 2000, VIROLOGY, V269, P26, DOI 10.1006/viro.1999.0169; Kinoti WM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01219; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li YQ, 2018, ARCH VIROL, V163, P1079, DOI 10.1007/s00705-017-3690-9; Lim HS, 2011, PLANT PATHOLOGY J, V27, P315, DOI 10.5423/PPJ.2011.27.4.315; Liu HW, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0998-3; Maliogka VI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080436; Massart S., 2011, VIRUS VIRUS LIKE DIS, P29; Matsumura EE, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040092; Messmer A, 2017, CAN J PLANT PATHOL, V39, P342, DOI 10.1080/07060661.2017.1354334; Navarro B, 2018, MOL PLANT PATHOL, V19, P1075, DOI 10.1111/mpp.12587; Olendraite I, 2017, J GEN VIROL, V98, P2368, DOI 10.1099/jgv.0.000902; Palanga E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165188; Pallas V, 2013, ADV VIRUS RES, V87, P139, DOI 10.1016/B978-0-12-407698-3.00005-3; Peter K., 2020, APPLE DIS RAPID APPL; Rastgou M, 2009, J GEN VIROL, V90, P2525, DOI 10.1099/vir.0.013086-0; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Rott ME, 2018, PLANT DIS, V102, P1254, DOI 10.1094/PDIS-06-17-0851-RE; Setiono FJ, 2018, PLANT DIS, V102, P2187, DOI 10.1094/PDIS-03-18-0450-RE; Singh J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213293; Subere CVQ, 2011, ACTA HORTIC, V902, P349, DOI 10.17660/ActaHortic.2011.902.39; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Temmam S, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01662-18; Thompson D, 2011, VIRUS VIRUS LIKE DIS, P299; Turina M, 2017, J GEN VIROL, V98, P129, DOI 10.1099/jgv.0.000725; Wright AA, 2018, ARCH VIROL, V163, P3339, DOI 10.1007/s00705-018-3999-z; Wright PS, 2005, VIRUS TAXONOMY, P1125; Yaegashi H., 2011, VIRUS VIRUS LIKE DIS, P17, DOI DOI 10.1094/9780890545010.004	54	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227669	10.1371/journal.pone.0227669	http://dx.doi.org/10.1371/journal.pone.0227669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929569	gold, Green Published			2022-12-26	WOS:000534352500059
J	Liu, YY; Lei, P; Row, S; Andreadis, ST				Liu, Yayu; Lei, Pedro; Row, Sindhu; Andreadis, Stelios T.			Cadherin-11 binds to PDGFR beta and enhances cell proliferation and tissue regeneration via the PDGFR-AKT signaling axis	FASEB JOURNAL			English	Article						AKT signaling; Cadherin-11; knockout mice; PDGF receptor; proliferation; wound healing	SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; RECEPTOR; EXPRESSION; ADHESION; IDENTIFICATION; ACTIVATION; MIGRATION; SURVIVAL; CANCER	Intercellular adhesion through homotypic interaction between cadherins regulates multiple cellular processes including cytoskeletal organization, proliferation, and survival. In this paper, we provide evidence that cadherin-11 (CDH11) binds to and promotes cell proliferation both in vitro and in vivo in synergy with the platelet-derived growth factor receptor beta (PDGFR beta). Engagement of CDH11 increased the sensitivity of cells to PDGF-BB by 10- to 100-fold, resulting in rapid and sustained phosphorylation of AKT, ultimately promoting and cell proliferation and tissue regeneration. Indeed, wound healing experiments showed that healing was severely compromised in Cdh11(-/-) mice, as evidenced by significantly decreased proliferation, AKT phosphorylation, and extracellular matrix (ECM) synthesis of dermal cells. Our results shed light into understanding how intercellular adhesion can promote cell proliferation and may have implications for tissue regeneration and cancer progression.	[Liu, Yayu; Andreadis, Stelios T.] Univ Buffalo State Univ New York, Dept Biomed Engn, Amherst, NY 14260 USA; [Lei, Pedro; Row, Sindhu; Andreadis, Stelios T.] Univ Buffalo State Univ New York, Dept Chem & Biol Engn, Amherst, NY 14260 USA; [Andreadis, Stelios T.] Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA		Andreadis, ST (corresponding author), Univ Buffalo State Univ New York, Bioengn Lab, Dept Chem & Biol Engn, 908 Furnas Hall, Amherst, NY 14260 USA.	sandread@buffalo.edu	liu, yayu/AAX-3849-2021		National Science Foundation (NSF) [CBET1403086]	National Science Foundation (NSF)(National Science Foundation (NSF))	National Science Foundation (NSF), Grant/Award Number: CBET1403086	Alimperti S, 2014, J CELL SCI, V127, P2627, DOI 10.1242/jcs.134833; Assefnia S, 2014, ONCOTARGET, V5, P1458, DOI 10.18632/oncotarget.1538; Blaue C, 2018, SEMIN CELL DEV BIOL, V73, P95, DOI 10.1016/j.semcdb.2017.08.058; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Cheung LWT, 2011, ONCOGENE, V30, P2964, DOI 10.1038/onc.2011.7; Coon BG, 2015, J CELL BIOL, V208, P975, DOI 10.1083/jcb.201408103; ERIKSSON A, 1991, J BIOL CHEM, V266, P21138; Fedor-Chaiken M, 2003, CELL COMMUN ADHES, V10, P105, DOI 10.1080/714040416; Feltes CM, 2002, CANCER RES, V62, P6688; Geer DJ, 2005, AM J PATHOL, V167, P1575, DOI 10.1016/S0002-9440(10)61242-4; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HOFFMANN I, 1995, DEV BIOL, V169, P337, DOI 10.1006/dbio.1995.1148; Kaur H, 2012, MOL CANCER RES, V10, P293, DOI 10.1158/1541-7786.MCR-11-0457; KIMURA Y, 1995, DEV BIOL, V169, P347, DOI 10.1006/dbio.1995.1149; Langhe RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10909; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee J, 2002, IN VITRO MUTAGENESIS, V182; Li L, 2012, ONCOGENE, V31, P3901, DOI 10.1038/onc.2011.541; Mathavan K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188963; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Nakajima Go, 2008, Cancer Genomics & Proteomics, V5, P37; Pedroza M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187109; Pohlodek K, 2016, ONCOL LETT, V12, P4393, DOI 10.3892/ol.2016.5236; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Row S, 2016, J CELL SCI, V129, P2950, DOI 10.1242/jcs.183772; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Takeichi M, 1994, Prog Clin Biol Res, V390, P145; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Theisen CS, 2007, MOL BIOL CELL, V18, P1220, DOI 10.1091/mbc.E06-10-0960; WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2; Wu MH, 2014, ARTHRITIS RHEUMATOL, V66, P1010, DOI 10.1002/art.38275; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	34	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3792	3804		10.1096/fj.201902613R	http://dx.doi.org/10.1096/fj.201902613R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930567	Bronze			2022-12-26	WOS:000508012100001
J	Vorstandlechner, V; Laggner, M; Kalinina, P; Haslik, W; Radtke, C; Shaw, L; Lichtenberger, BM; Tschachler, E; Ankersmit, HJ; Mildner, M				Vorstandlechner, Vera; Laggner, Maria; Kalinina, Polina; Haslik, Werner; Radtke, Christine; Shaw, Lisa; Lichtenberger, Beate Maria; Tschachler, Erwin; Ankersmit, Hendrik Jan; Mildner, Michael			Deciphering the functional heterogeneity of skin fibroblasts using single-cell RNA sequencing	FASEB JOURNAL			English	Article						CD26; DPP4; extracellular matrix; fibrosis; transcriptome	DIPEPTIDYL-PEPTIDASE-IV; RETICULAR FIBROBLASTS; GENE-EXPRESSION; 4 INHIBITOR; PAPILLARY; FIBROSIS; DISTINCT; MARKERS; LEPTIN; DIFFERENTIATION	Though skin fibroblasts (FB) are the main cell population within the dermis, the different skin FB subsets are not well characterized and the traditional classification into reticular and papillary FBs has little functional relevance. To fill the gap of knowledge on FB diversity in human skin, we performed single-cell RNA sequencing. Investigation of marker genes for the different skin cell subtypes revealed a heterogeneous picture of FBs. When mapping reticular and papillary FB markers, we could not detect cluster specificity, suggesting that these two populations show a higher transcriptional heterogeneity than expected. This finding was further confirmed by in situ hybridization, showing that DPP4 was expressed in both dermal layers. Our analysis identified six FB clusters with distinct transcriptional signatures. Importantly, we could demonstrate that in human skin DPP4(+) FBs are the main producers of factors involved in extracellular matrix (ECM) assembly. In conclusion, we provide evidence that hitherto considered FB markers are not ideal to characterize skin FB subpopulations in single-cell sequencing analyses. The identification of DPP4(+) FBs as the main ECM-producing cells in human skin will foster the development of anti-fibrotic treatments for the skin and other organs.	[Vorstandlechner, Vera; Laggner, Maria; Ankersmit, Hendrik Jan] Med Univ Vienna, Div Thorac Surg, Vienna, Austria; [Kalinina, Polina; Tschachler, Erwin; Mildner, Michael] Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Lazarettgasse 14, A-1090 Vienna, Austria; [Haslik, Werner; Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria; [Shaw, Lisa] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Lichtenberger, Beate Maria] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Mildner, M (corresponding author), Med Univ Vienna, Dept Dermatol, Res Div Biol & Pathobiol Skin, Lazarettgasse 14, A-1090 Vienna, Austria.	michael.mildner@mixluniwien.ac.at	Lichtenberger, Beate M./AAD-1717-2019; Radtke, Christine/B-8491-2018	Lichtenberger, Beate M./0000-0001-6882-0257; Radtke, Christine/0000-0001-6877-5038; Mildner, Michael/0000-0002-6892-925X; Shaw, Lisa/0000-0003-2273-7655; Haslik, Werner/0000-0002-2731-2720; Vorstandlechner, Vera/0000-0002-5938-1552	Osterreichische Forschungsforderungsgesellschaft (FFG) [852748/862068]; Wirtschaftsagentur Wien [2343727]; OAD Sparcling Science [SPA06/055]	Osterreichische Forschungsforderungsgesellschaft (FFG); Wirtschaftsagentur Wien; OAD Sparcling Science	Osterreichische Forschungsforderungsgesellschaft (FFG), Grant/Award Number: 852748/862068; Wirtschaftsagentur Wien, Grant/Award Number: 2343727; OAD Sparcling Science, Grant/Award Number: SPA06/055	Aroor AR, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0544-4; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; CASTOR CW, 1962, LAB INVEST, V11, P703; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; D'souza AM, 2017, MOL METAB, V6, P1052, DOI 10.1016/j.molmet.2017.04.011; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Freytag Saskia, 2018, F1000Res, V7, P1297, DOI 10.12688/f1000research.15809.2; Gerhard GS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219764; Gschwandtner M, 2017, ALLERGY, V72, P85, DOI 10.1111/all.12919; Gschwandtner M, 2013, ALLERGY, V68, P37, DOI 10.1111/all.12051; Halfon S, 2011, STEM CELLS DEV, V20, P53, DOI 10.1089/scd.2010.0040; Haydont V, 2019, MECH AGEING DEV, V179, P60, DOI 10.1016/j.mad.2019.01.003; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heinosalo T, 2018, HUM REPROD, V33, P817, DOI 10.1093/humrep/dey026; Hiraoka C, 2016, J DERMATOL SCI, V82, P84, DOI 10.1016/j.jdermsci.2016.01.009; Hong SK, 2017, METABOLISM, V76, P42, DOI 10.1016/j.metabol.2017.07.007; Hu MS, 2016, PLAST RECONSTR SURG, V138, P1026, DOI 10.1097/PRS.0000000000002634; Janson D, 2013, EXP DERMATOL, V22, P48, DOI 10.1111/exd.12069; Janson DG, 2012, J INVEST DERMATOL, V132, P2565, DOI 10.1038/jid.2012.192; Kaji K, 2014, J GASTROENTEROL, V49, P481, DOI 10.1007/s00535-013-0783-4; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Klemann C, 2016, CLIN EXP IMMUNOL, V185, P1, DOI 10.1111/cei.12781; Klinkhammer BM, 2018, MOL ASPECTS MED, V62, P44, DOI 10.1016/j.mam.2017.11.008; Korosec A, 2019, J INVEST DERMATOL, V139, P342, DOI 10.1016/j.jid.2018.07.033; Li J, 2019, EBIOMEDICINE, V40, P43, DOI 10.1016/j.ebiom.2019.01.009; Lotia S, 2013, BIOINFORMATICS, V29, P1350, DOI 10.1093/bioinformatics/btt138; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maier AB, 2009, AGEING RES REV, V8, P237, DOI 10.1016/j.arr.2009.01.004; Murad A, 2003, FASEB J, V17, P1895, DOI 10.1096/fj.03-0068fje; Nauroy P, 2017, J INVEST DERMATOL, V137, P1787, DOI 10.1016/j.jid.2017.03.028; Novelli M, 1996, BRIT J DERMATOL, V134, P1052, DOI 10.1046/j.1365-2133.1996.d01-900.x; Ong CT, 2010, BRIT J DERMATOL, V162, P1302, DOI 10.1111/j.1365-2133.2010.09660.x; Pageon H, 2012, EUR J DERMATOL, V22, P324, DOI 10.1684/ejd.2012.1693; Pantano S, 2013, J MOL HISTOL, V44, P733, DOI 10.1007/s10735-013-9524-5; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Philippeos C, 2018, J INVEST DERMATOL, V138, P811, DOI 10.1016/j.jid.2018.01.016; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Ring BD, 2000, ENDOCRINOLOGY, V141, P446, DOI 10.1210/en.141.1.446; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; SCHAFER IA, 1985, MECH AGEING DEV, V31, P275, DOI 10.1016/0047-6374(85)90095-8; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Sriram G, 2015, EUR J CELL BIOL, V94, P483, DOI 10.1016/j.ejcb.2015.08.001; STUART T, 2018, COMPREHENSIVE INTEGR; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Suzuki T, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0660-4; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Thielitz A, 2008, FRONT BIOSCI-LANDMRK, V13, P2864, DOI 10.2741/2850; Thielitz A, 2008, J INVEST DERMATOL, V128, P855, DOI 10.1038/sj.jid.5701104; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Uchida T, 2017, RENAL FAILURE, V39, P340, DOI 10.1080/0886022X.2017.1279553; Van den Oord JJ, 1998, BRIT J DERMATOL, V138, P615; van Lingen RG, 2008, BRIT J DERMATOL, V158, P1264, DOI 10.1111/j.1365-2133.2008.08515.x; Wada N, 2014, J CHEM NEUROANAT, V61-62, P191, DOI 10.1016/j.jchemneu.2014.09.002; Walmsley GG, 2015, TISSUE ENG PART C-ME, V21, P314, DOI [10.1089/ten.tec.2014.0118, 10.1089/ten.TEC.2014.0118]; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wu J, 2004, J TRAUMA, V57, P1276, DOI 10.1097/01.TA.0000108997.49513.DC; Xiao L, 2015, JOVE-J VIS EXP, DOI 10.3791/53072	65	61	62	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3677	3692		10.1096/fj.201902001RR	http://dx.doi.org/10.1096/fj.201902001RR		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930613	hybrid			2022-12-26	WOS:000507261000001
J	Endo, M; Tanaka, Y; Otsuka, M; Minami, Y				Endo, Mitsuharu; Tanaka, Yuki; Otsuka, Mako; Minami, Yasuhiro			E2F1-Ror2 signaling mediates coordinated transcriptional regulation to promote G1/S phase transition in bFGF-stimulated NIH/3T3 fibroblasts	FASEB JOURNAL			English	Article						basic fibroblast growth factor (bFGF); cell cycle; cell signaling; Forkhead box O (FoxO); gene transcription	RECEPTOR TYROSINE KINASE; PLANAR CELL POLARITY; RETINOBLASTOMA PROTEIN; OSTEOSARCOMA CELLS; ROR2; EXPRESSION; MIGRATION; PROLIFERATION; PATHWAY; TARGET	Ror2 signaling has been shown to regulate the cell cycle progression in normal and cancer cells. However, the molecular mechanism of the cell cycle progression upon activation of Ror2 signaling still remains unknown. Here, we found that the expression levels of Ror2 in G1-arrested NIH/3T3 fibroblasts are low and are rapidly increased following the cell cycle progression induced by basic fibroblast growth factor (bFGF) stimulation. By expressing wild-type or a dominant negative mutant of E2F1, we show that E2F1 mediates bFGF-induced expression of Ror2, and that E2F1 binds to the promoter of the Ror2 gene to activate its expression. We also found that G1/S phase transition of bFGF-stimulated NIH/3T3 cells is delayed by the suppressed expression of Ror2. RNA-seq analysis revealed that the suppressed expression of Ror2 results in the decreased expression of various E2F target genes concomitantly with increased expression of Forkhead box O (FoxO) target genes, including p21(Cip1), and p27(Kip1). Moreover, the inhibitory effect of Ror2 knockdown on the cell cycle progression can be restored by suppressed expression of p21(Cip1), p27(Kip1),or FoxO3a. Collectively, these findings indicate that E2F1-Ror2 signaling mediates the transcriptional activation and inhibition of E2F1-driven and FoxO3a-driven cell cycle-regulated genes, respectively, thereby promoting G1/S phase transition of bFGF-stimulated NIH/3T3 cells.	[Endo, Mitsuharu; Tanaka, Yuki; Otsuka, Mako; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan	Kobe University	Endo, M; Minami, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan.	mendo@med.kobe-u.ac.jp; minami@kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [18K06486, 16H05152]; Japan Agency for Medical Research and Development (AMED) [JP19gm5010001, JP19gm1210005]; Hyogo Science and Technology association	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hyogo Science and Technology association	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 18K06486 and 16H05152; Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP19gm5010001 and JP19gm1210005; Hyogo Science and Technology association	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Fernandez NB, 2016, MOL CARCINOGEN, V55, P1772, DOI 10.1002/mc.22426; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carrero I, 2019, ONCOGENE, V38, P3551, DOI 10.1038/s41388-018-0659-4; Chavali M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02440-0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Dai B, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0482-y; Endo M, 2017, GLIA, V65, P182, DOI 10.1002/glia.23086; Endo M, 2015, INT REV CEL MOL BIO, V314, P117, DOI 10.1016/bs.ircmb.2014.10.003; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Frenquelli M, 2020, LEUKEMIA, V34, P257, DOI 10.1038/s41375-019-0486-9; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; HIEBERT SW, 1992, GENE DEV, V6, P177, DOI 10.1101/gad.6.2.177; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Huang JJ, 2015, ONCOL LETT, V10, P3705, DOI 10.3892/ol.2015.3797; Ishizuya-Oka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107611; Kamizaki K, 2017, J BIOL CHEM, V292, P15939, DOI 10.1074/jbc.M117.785709; KATO J, 1993, GENE DEV, V7, P331; Laine A, 2014, CLIN CANCER RES, V20, P3644, DOI 10.1158/1078-0432.CCR-13-1942; Laird DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002428; Liu YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127092; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Siu WY, 1999, FEBS LETT, V461, P299, DOI 10.1016/S0014-5793(99)01481-7; Taguchi A, 2014, PROTEOMICS, V14, P2750, DOI 10.1002/pmic.201400378; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Xu Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317701627; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Zhang HS, 2019, ELIFE, V8, DOI 10.7554/eLife.45303; Zhang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046853	49	12	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3413	3428		10.1096/fj.201902849R	http://dx.doi.org/10.1096/fj.201902849R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31922321	Bronze			2022-12-26	WOS:000506611700001
J	Fossa, A; Smeland, KH; Fluge, O; Tronstad, KJ; Loge, JH; Midttun, O; Ueland, PM; Kiserud, CE				Fossa, Alexander; Smeland, Knut Halvor; Fluge, Oystein; Tronstad, Karl Johan; Loge, Jon Havard; Midttun, Oivind; Ueland, Per Magne; Kiserud, Cecilie Essholt			Metabolic analysis of amino acids and vitamin B6 pathways in lymphoma survivors with cancer related chronic fatigue	PLOS ONE			English	Article							KYNURENINE PATHWAY; HODGKINS-DISEASE; PLASMA; RISK; INFLAMMATION; DYSFUNCTION; PREVALENCE; SERUM; POPULATION; BIOMARKERS	Chronic cancer-related fatigue (CF) is a common and distressing condition in a subset of cancer survivors and common also after successful treatment of malignant lymphoma. The etiology and pathogenesis of CF is unknown, and lack of biomarkers hampers development of diagnostic tests and successful therapy. Recent studies on the changes of amino acid levels and other metabolites in patients with chronic fatigue syndrome/myalgic encephalopathy (CFS/ME) have pointed to possible central defects in energy metabolism. Here we report a comprehensive analysis of serum concentrations of amino acids, including metabolites of tryptophan, the kynurenine pathway and vitamin B6 in a well characterized national Norwegian cohort of lymphoma survivors after high-dose therapy and autologous stem cell transplantation. Among the 20 standard amino acids in humans, only tryptophan levels were significantly lower in both males and females with CF compared to non-fatigued survivors, a strikingly different pattern than seen in CFS/ME. Markers of tryptophan degradation by the kynurenine pathway (kynurenine/tryptophan ratio) and activation of vitamin B6 catabolism (pyridoxic acid/(pyridoxal + pyridoxal 5'-phosphate), PAr index) differed in survivors with or without CF and correlated with known markers of immune activation and inflammation, such as neopterin, C-reactive protein and Interleukin-6. Among personal traits and clinical findings assessed simultaneously in participating survivors, higher neuroticism score, obesity and higher PAr index were significantly associated with increased risk of CF. Collectively, these data point to low grade immune activation and inflammation as a basis for CF in lymphoma survivors.	[Fossa, Alexander; Smeland, Knut Halvor; Kiserud, Cecilie Essholt] Oslo Univ Hosp, Natl Advisory Unit Late Effects Canc Treatment, Dept Oncol, Oslo, Norway; [Fossa, Alexander; Smeland, Knut Halvor] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Fossa, Alexander] Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway; [Fluge, Oystein] Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway; [Tronstad, Karl Johan] Univ Bergen, Dept Biomed, Bergen, Norway; [Loge, Jon Havard] Oslo Univ Hosp, Reg Ctr Excellence Palliat Care, Oslo, Norway; [Midttun, Oivind; Ueland, Per Magne] Bevital AS, Bergen, Norway; [Ueland, Per Magne] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; University of Bergen	Fossa, A (corresponding author), Oslo Univ Hosp, Natl Advisory Unit Late Effects Canc Treatment, Dept Oncol, Oslo, Norway.; Fossa, A (corresponding author), Oslo Univ Hosp, Dept Oncol, Oslo, Norway.; Fossa, A (corresponding author), Univ Oslo, KG Jebsen Ctr B Cell Malignancies, Oslo, Norway.	aff@ous-hf.no	Ueland, Per M/C-7340-2013	Tronstad, Karl Johan/0000-0003-3496-3123; Ueland, Per Magne/0000-0002-1903-0571	Norwegian Cancer Society; Radiumhospitalets legater	Norwegian Cancer Society(Norwegian Cancer Society); Radiumhospitalets legater	This study was supported in part by research funding from the Norwegian Cancer Society and Radiumhospitalets legater. OM and PMU are both at least partially employed by Bevital, a non-profit organization. Bevital has only paid parts of the salaries of these two coauthors, and not had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder provided support in the form of salaries for authors [OM and PMU], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawy AAB, 2019, INT J TRYPTOPHAN RES, V12, DOI 10.1177/1178646919868978; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; Bower JE, 2011, BRAIN BEHAV IMMUN, V25, P147, DOI 10.1016/j.bbi.2010.09.010; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Christensen MHE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192169; Clarke G, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-6; COWEN PJ, 1989, J AFFECT DISORDERS, V16, P27, DOI 10.1016/0165-0327(89)90051-7; Doolin K, 2018, PSYCHONEUROENDOCRINO, V95, P8, DOI 10.1016/j.psyneuen.2018.05.019; Fava M, 2014, DEPRESS ANXIETY, V31, P250, DOI 10.1002/da.22199; Fluge O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89376; Gieseg SP, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7070080; Grov EK, 2009, ACTA ONCOL, V48, P842, DOI 10.1080/02841860902795232; Hamre H, 2013, BRAIN BEHAV IMMUN, V30, P80, DOI 10.1016/j.bbi.2013.01.006; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jason LA, 2015, J HUM BEHAV SOC ENVI, V25, P657, DOI 10.1080/10911359.2015.1011256; Knobel H, 2001, J CLIN ONCOL, V19, P3226, DOI 10.1200/JCO.2001.19.13.3226; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Loge JH, 1999, J CLIN ONCOL, V17, P253, DOI 10.1200/JCO.1999.17.1.253; Midttun O, 2016, ANAL CHEM, V88, P10427, DOI 10.1021/acs.analchem.6b02325; Midttun O, 2013, ANAL BIOANAL CHEM, V405, P2009, DOI 10.1007/s00216-012-6602-6; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Murbraech K, 2015, J CLIN ONCOL, V33, P2683, DOI 10.1200/JCO.2015.60.8125; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; Myte R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43434; Naviaux RK, 2016, P NATL ACAD SCI USA, V113, pE5472, DOI 10.1073/pnas.1607571113; Ng AK, 2005, ANN ONCOL, V16, P1949, DOI 10.1093/annonc/mdi407; Orre IJ, 2011, J PSYCHOSOM RES, V71, P136, DOI 10.1016/j.jpsychores.2011.04.003; Pedersen ER, 2015, ARTERIOSCL THROM VAS, V35, P455, DOI 10.1161/ATVBAHA.114.304674; Platten M, 2019, NAT REV DRUG DISCOV, V18, P379, DOI 10.1038/s41573-019-0016-5; Reinertsen KV, 2017, J PAIN SYMPTOM MANAG, V53, P551, DOI 10.1016/j.jpainsymman.2016.09.011; Reinertsen Kristin Valborg, 2017, Tidsskr Nor Laegeforen, V137, DOI 10.4045/tidsskr.17.0040; Seland M, 2015, LEUKEMIA LYMPHOMA, V56, P3306, DOI 10.3109/10428194.2015.1036258; Servaes P, 2002, EUR J CANCER, V38, P27, DOI 10.1016/S0959-8049(01)00332-X; Smeland KB, 2019, BONE MARROW TRANSPL, V54, P607, DOI 10.1038/s41409-018-0342-y; Smeland Knut Bjoro, 2013, Tidsskr Nor Laegeforen, V133, P1735, DOI 10.4045/tidsskr.13.0319; Sprauten M, 2015, ANN ONCOL, V26, P2133, DOI 10.1093/annonc/mdv328; Stenehjem JS, 2017, BONE MARROW TRANSPL, V52, P646, DOI 10.1038/bmt.2016.338; Stone PC, 2008, EUR J CANCER, V44, P1097, DOI 10.1016/j.ejca.2008.02.037; Strasser B, 2017, NEUROPHARMACOLOGY, V112, P286, DOI 10.1016/j.neuropharm.2016.02.030; Tomas C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186802; Ueland PM, 2017, MOL ASPECTS MED, V53, P10, DOI 10.1016/j.mam.2016.08.001; Ueland PM, 2015, ANNU REV NUTR, V35, P33, DOI 10.1146/annurev-nutr-071714-034330; Ulvik A, 2014, AM J CLIN NUTR, V100, P250, DOI 10.3945/ajcn.114.083196; Ulvik A, 2013, AM J CLIN NUTR, V98, P934, DOI 10.3945/ajcn.113.064998; Wang QX, 2015, FRONT BIOSCI-LANDMRK, V20, P1116, DOI 10.2741/4363; WERNER ER, 1987, CLIN CHEM, V33, P2028; Wolfe F, 1996, J RHEUMATOL, V23, P1407; Yamano E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34990; Ye ZX, 2019, J CANCER, V10, P2771, DOI 10.7150/jca.31727; Zuo H, 2018, AM J CLIN NUTR, V107, P105, DOI 10.1093/ajcn/nqx012	50	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227384	10.1371/journal.pone.0227384	http://dx.doi.org/10.1371/journal.pone.0227384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923274	Green Published, gold			2022-12-26	WOS:000534350000072
J	Haldar, B; Hamilton, CL; Solodushko, V; Abney, KA; Alexeyev, M; Honkanen, RE; Scammell, JG; Cioffi, DL				Haldar, Barnita; Hamilton, Caleb L.; Solodushko, Viktoriya; Abney, Kevin A.; Alexeyev, Mikhail; Honkanen, Richard E.; Scammell, Jonathan G.; Cioffi, Donna L.			S100A6 is a positive regulator of PPP5C-FKBP51-dependent regulation of endothelial calcium signaling	FASEB JOURNAL			English	Article						calcium entry; endothelial I-SOC; endothelial barrier	CELL-CYCLE PROGRESSION; PROTEIN PHOSPHATASE 5; I-SOC; FUNCTIONAL EXPRESSION; TAU; MEMBRANE; CHANNEL; ENTRY; ACTIVATION; BINDING	I-SOC is a cation current permeating the ISOC channel. In pulmonary endothelial cells, I-SOC activation leads to formation of inter-endothelial cell gaps and barrier disruption. The immunophilin FK506-binding protein 51 (FKBP51), in conjunction with the serine/threonine protein phosphatase 5C (PPP5C), inhibits I-SOC. Free PPP5C assumes an autoinhibitory state, which has low "basal" catalytic activity. Several S100 protein family members bind PPP5C increasing PPP5C catalytic activity in vitro. One of these family members, S100A6, exhibits a calcium-dependent translocation to the plasma membrane. The goal of this study was to determine whether S100A6 activates PPP5C in pulmonary endothelial cells and contributes to I-SOC inhibition by the PPP5C-FKBP51 axis. We observed that S100A6 activates PPP5C to dephosphorylate tau T231. Following I-SOC activation, cytosolic S100A6 translocates to the plasma membrane and interacts with the TRPC4 subunit of the ISOC channel. Global calcium entry and I-SOC are decreased by S100A6 in a PPP5C-dependent manner and by FKBP51 in a S100A6-dependent manner. Further, calcium entry-induced endothelial barrier disruption is decreased by S100A6 dependent upon PPP5C, and by FKBP51 dependent upon S100A6. Overall, these data reveal that S100A6 plays a key role in the PPP5C-FKBP51 axis to inhibit I-SOC and protect the endothelial barrier against calcium entry-induced disruption.	[Haldar, Barnita; Solodushko, Viktoriya; Abney, Kevin A.; Honkanen, Richard E.; Cioffi, Donna L.] Univ S Alabama, Dept Biochem & Mol Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA; [Haldar, Barnita; Alexeyev, Mikhail; Cioffi, Donna L.] Univ S Alabama, Ctr Lung Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA; [Hamilton, Caleb L.] Alabama Coll Osteopath Med, Dept Anat & Mol Med, Dothan, AL USA; [Alexeyev, Mikhail] Univ S Alabama, Physiol & Cell Biol, Mobile, AL 36688 USA; [Scammell, Jonathan G.] Univ S Alabama, Comparat Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Cioffi, DL (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA.; Cioffi, DL (corresponding author), Univ S Alabama, Ctr Lung Biol, 5851 USA Dr N,MSB 2316, Mobile, AL 36688 USA.	dlcioffi@southalabama.edu			National Institutes of Health [R01HL107778, R56HL107778]; University of South Alabama, College of Medicine Intramural Grant Programs [000927, 000540]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Alabama, College of Medicine Intramural Grant Programs	This work was supported by the National Institutes of Health (R01HL107778 to DLC; R56HL107778 to DLC) and the University of South Alabama, College of Medicine Intramural Grant Programs (000927 to DLC; 000540 to BH)	Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Bao LY, 2012, FEBS J, V279, P4576, DOI 10.1111/febs.12044; Bischoff I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23671; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Chatterjee A, 2010, J BIOL CHEM, V285, P3872, DOI 10.1074/jbc.M109.088427; Chazotte B, 2011, COLD SPRING HARB PRO, V2011; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cortajarena AL, 2006, PROTEIN SCI, V15, P1193, DOI 10.1110/ps.062092506; Courtois-Coutry N, 2002, J BIOL CHEM, V277, P25728, DOI 10.1074/jbc.M112435200; Creighton JR, 2003, AM J PHYSIOL-LUNG C, V284, pL100, DOI 10.1152/ajplung.00083.2002; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donier E, 2005, J BIOL CHEM, V280, P38666, DOI 10.1074/jbc.M505981200; Girard C, 2002, EMBO J, V21, P4439, DOI 10.1093/emboj/cdf469; Gong CX, 2004, J NEUROCHEM, V88, P298, DOI 10.1046/j.1471-4159.2003.02147.x; Hamilton CL, 2018, PULM CIRC, V8, DOI 10.1177/2045893217753156; Hamilton CL, 2018, PULM CIRC, V8, DOI 10.1177/2045893217749987; Hermann A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00067; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Kadeba PI, 2013, CELL CALCIUM, V53, P275, DOI 10.1016/j.ceca.2012.12.008; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Lerchenmuller C, 2016, ARTERIOSCL THROM VAS, V36, P1854, DOI 10.1161/ATVBAHA.115.306415; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2005, J BIOL CHEM, V280, P1790, DOI 10.1074/jbc.M410775200; Lockwich TP, 2000, J BIOL CHEM, V275, P11934, DOI 10.1074/jbc.275.16.11934; Mandinova A, 1998, J CELL SCI, V111, P2043; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Moore TM, 1998, AM J PHYSIOL-LUNG C, V275, pL574, DOI 10.1152/ajplung.1998.275.3.L574; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Mueller A, 1999, HISTOCHEM CELL BIOL, V111, P453, DOI 10.1007/s004180050381; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Shimamoto S, 2008, J BIOL CHEM, V283, P28246, DOI 10.1074/jbc.M801473200; Shimamoto S, 2010, FEBS LETT, V584, P1119, DOI 10.1016/j.febslet.2010.02.055; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sinclair C, 1999, J BIOL CHEM, V274, P23666, DOI 10.1074/jbc.274.33.23666; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Stradal TB, 1999, J BIOL CHEM, V274, P31593, DOI 10.1074/jbc.274.44.31593; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Wu SW, 2007, J BIOL CHEM, V282, P34801, DOI 10.1074/jbc.M704522200; Wu SW, 2005, CIRC RES, V96, P856, DOI 10.1161/01.RES.0000163632.67282.1f; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Xia C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01908; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	54	7	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3179	3196		10.1096/fj.201901777R	http://dx.doi.org/10.1096/fj.201901777R		JAN 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916625	Green Accepted			2022-12-26	WOS:000506443400001
J	Brubaker, G; Lorkowski, SW; Gulshan, K; Hazen, SL; Gogonea, V; Smith, JD				Brubaker, Gregory; Lorkowski, Shuhui W.; Gulshan, Kailash; Hazen, Stanley L.; Gogonea, Valentin; Smith, Jonathan D.			First eight residues of apolipoprotein A-I mediate the C-terminus control of helical bundle unfolding and its lipidation	PLOS ONE			English	Article							CELL-SURFACE; APOA-I; BINDING; DOMAIN; HDL; STABILITY; EFFLUX; MODEL; ABCA1; KINETICS	The crystal structure of a C-terminal deletion of apolipoprotein A-I (apoA1) shows a large helical bundle structure in the amino half of the protein, from residues 8 to 115. Using site directed mutagenesis, guanidine or thermal denaturation, cell free liposome clearance, and cellular ABCA1-mediated cholesterol efflux assays, we demonstrate that apoA1 lipidation can occur when the thermodynamic barrier to this bundle unfolding is lowered. The absence of the C-terminus renders the bundle harder to unfold resulting in loss of apoA1 lipidation that can be reversed by point mutations, such as Trp8Ala, and by truncations as short as 8 residues in the amino terminus, both of which facilitate helical bundle unfolding. Locking the bundle via a disulfide bond leads to loss of apoA1 lipidation. We propose a model in which the C-terminus acts on the N-terminus to destabilize this helical bundle. Upon lipid binding to the C-terminus, Trp8 is displaced from its interaction with Phe57, Arg61, Leu64, Val67, Phe71, and Trp72 to destabilize the bundle. However, when the C-terminus is deleted, Trp8 cannot be displaced, the bundle cannot unfold, and apoA1 cannot be lipidated.	[Brubaker, Gregory; Lorkowski, Shuhui W.; Gulshan, Kailash; Hazen, Stanley L.; Gogonea, Valentin; Smith, Jonathan D.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Hazen, Stanley L.; Smith, Jonathan D.] Case Western Reserve Univ, Dept Mol Med, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA; [Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Smith, JD (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA.; Smith, JD (corresponding author), Case Western Reserve Univ, Dept Mol Med, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA.	smithj4@ccf.org	Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [R01 HL128268, R01 HL128300]; American Heart Association [SDG25710128]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by grants R01 HL128268 (JDS) and R01 HL128300 (SLH) from the National Institutes of Health (www.nih.gov/).KG was supported by Scientist Development Award SDG25710128 from the American Heart Association (www.heart.org).The funders played no role in this study or manuscript.	Beckstead JA, 2005, BIOCHEMISTRY-US, V44, P4591, DOI 10.1021/bi0477135; Burgess JW, 1999, BIOCHEMISTRY-US, V38, P14524, DOI 10.1021/bi990930z; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Gross E, 2006, BIOPHYS J, V90, P1362, DOI 10.1529/biophysj.105.075069; Gulshan K, 2016, CIRC RES, V119, P827, DOI 10.1161/CIRCRESAHA.116.308856; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; JONAS A, 1980, J BIOL CHEM, V255, P2190; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Liu MJ, 2019, J LIPID RES, V60, P44, DOI 10.1194/jlr.M084376; Mei XH, 2016, J LIPID RES, V57, P1507, DOI 10.1194/jlr.M068874; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Melchior JT, 2017, NAT STRUCT MOL BIOL, V24, P1093, DOI 10.1038/nsmb.3501; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Pollard RD, 2013, BIOCHEMISTRY-US, V52, P9470, DOI 10.1021/bi401080k; POWNALL HJ, 1978, BIOCHEMISTRY-US, V17, P1183, DOI 10.1021/bi00600a008; Remaley AT, 2003, J LIPID RES, V44, P828, DOI 10.1194/jlr.M200475-JLR200; Ryan RO, 2003, PROTEIN EXPRES PURIF, V27, P98, DOI 10.1016/S1046-5928(02)00568-5; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Segrest JP, 2014, BIOCHEMISTRY-US, V53, P7625, DOI 10.1021/bi501111j; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Tanaka M, 2011, BBA-MOL CELL BIOL L, V1811, P25, DOI 10.1016/j.bbalip.2010.10.003; Wang SH, 2014, BIOFACTORS, V40, P547, DOI 10.1002/biof.1187; Wang SH, 2013, ARTERIOSCL THROM VAS, V33, P1197, DOI 10.1161/ATVBAHA.112.301195	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0221915	10.1371/journal.pone.0221915	http://dx.doi.org/10.1371/journal.pone.0221915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945064	Green Submitted, Green Published, gold			2022-12-26	WOS:000534370100005
J	Lin, PY; Wang, JY; Tseng, PC; Shih, DP; Yang, CL; Liang, WM; Kuo, HW				Lin, Ping-Yi; Wang, Jong-Yi; Tseng, Pochang; Shih, Dann-Pyng; Yang, Ching-Lan; Liang, Wen-Miin; Kuo, Hsien-Wen			Environmental tobacco smoke (ETS) and hyperlipidemia modified by perceived work stress	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASE; LIFE EVENTS; RISK	Background Accumulating evidence has shown that exposure to environmental tobacco smoke (ETS) is associated with cardiovascular diseases (CVDs) However, few studies have assessed both exposure to ETS and high-perceived work stress on hyperlipidemia. The aim of the present study is to assess the interaction effect of ETS exposure and high-perceived work stress on the risk of hyperlipidemia. Methods A total of 11,875 middle-aged civil servants from 647 registered institutions employed by the Taiwan government were randomly selected using multistage stratified cluster sampling based on proportional probabilistic sampling. Each participant anonymously and independently filled out a web-based questionnaire and informed consent. Results The prevalence of hyperlipidemia in middle-aged civil servants diagnosed by physicians was 11.5% for men and 6.1% for women. Hyperlipidemia was significantly associated with smoking, alcohol consumption, betel nut chewing, weight gain and perceived work stress. In both the obesity and smoking groups, there were consistent interaction effects of ETS exposure and perceived work stress on hyperlipidemia for middle-aged civil servants. Non-obese and non-smoking groups were more at risk for hyperlipidemia from exposure to both ETS and high-perceived work stress. Conclusion There is an interaction effect of ETS exposure and high-perceived work stress on hyperlipidemia, regardless of obesity and smoking. It is crucial to immediately reduce ETS exposure and stressful work by enforcing smoke-free policies and reducing pressure for civil servants.	[Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Lin, Ping-Yi] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Ping-Yi] Da Yeh Univ, Dept Nursing, Changhua, Taiwan; [Wang, Jong-Yi; Liang, Wen-Miin] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Tseng, Pochang] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan; [Tseng, Pochang; Kuo, Hsien-Wen] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan; [Shih, Dann-Pyng] Changhua Christian Hosp, Int Med Dept, Changhua, Taiwan; [Shih, Dann-Pyng] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Yang, Ching-Lan] Far Eastern Mem Hosp, Dept Occupat Dis, New Taipei, Taiwan; [Kuo, Hsien-Wen] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	Changhua Christian Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Da Yeh University; China Medical University Taiwan; National Yang Ming Chiao Tung University; Changhua Christian Hospital; China Medical University Taiwan; Far Eastern Memorial Hospital; National Defense Medical Center	Kuo, HW (corresponding author), Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan.; Kuo, HW (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	hwkuo@ym.edu.tw			Tobacco Health and Welfare Surcharge, Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan, ROC [2016/B1050406]; China Medical University [CMU108-MF-32, CMU 108-S-15, CMU108-S-17]; China Medical University Hospital [DMR-109-145, DMR-109-188, DMR-109192]	Tobacco Health and Welfare Surcharge, Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan, ROC; China Medical University(China Medical University); China Medical University Hospital	This study was supported by funding from Tobacco Health and Welfare Surcharge, Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan, ROC (Civil servants health survey program 2016/B1050406), the China Medical University (CMU108-MF-32, CMU 108-S-15, and CMU108-S-17) and the China Medical University Hospital (DMR-109-145, DMR-109-188, and DMR-109192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Administration HP, 2012, TAIW TOB CONTR ANN R; Barnoya J, 2006, J CARDIOVASC NURS, V21, P457, DOI 10.1097/00005082-200611000-00008; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Chang FC, 2011, HEALTH EDUC RES, V26, P179, DOI 10.1093/her/cyq073; Chang FC, 2011, J HEALTH COMMUN, V16, P343, DOI 10.1080/10810730.2010.535110; Chang WC, 2006, INT J OBESITY, V30, P359, DOI 10.1038/sj.ijo.0803053; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; DiGiacomo SI, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010096; Ferguson TS, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-20; Finney C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-82; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Guan SZ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080872; He BM, 2013, J CELL BIOCHEM, V114, P2431, DOI 10.1002/jcb.24581; Hirokawa Kumi, 2016, Prev Med Rep, V4, P61, DOI 10.1016/j.pmedr.2016.05.010; Hosey GM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-895; Jonsson P, 2015, PHYSIOL BEHAV, V151, P327, DOI 10.1016/j.physbeh.2015.07.020; Kouvonen A, 2005, J EPIDEMIOL COMMUN H, V59, P63, DOI 10.1136/jech.2004.019752; Li YH, 2018, J CHIN MED ASSOC, V81, P853, DOI 10.1016/j.jcma.2018.05.003; Low WY, 2013, ASIA-PAC J PUBLIC HE, V25, P296, DOI 10.1177/1010539513498486; Nakamura K, 2009, HEART, V95, P909, DOI 10.1136/hrt.2008.147066; Olasky SJ, 2012, GLOB HEART, V7, P151, DOI 10.1016/j.gheart.2012.05.002; Phillips AC, 2005, PSYCHOSOM MED, V67, P384, DOI 10.1097/01.psy.0000160464.63264.5d; Pilic L, 2016, NUTR REV, V74, P645, DOI 10.1093/nutrit/nuw028; Pistilli M, 2019, ANN EPIDEMIOL, V32, P28, DOI 10.1016/j.annepidem.2019.01.012; Roy MP, 1998, J PERS SOC PSYCHOL, V75, P1273, DOI 10.1037/0022-3514.75.5.1273; SCHAUBROECK J, 1993, J APPL PSYCHOL, V78, P73, DOI 10.1037/0021-9010.78.1.73; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Tsai WC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-162; Tseng HP, 2002, TAIWAN J PUBLIC HLTH, V21, P420; Wilson MD, 2014, INT J OCCUP ENV HEAL, V20, P271, DOI 10.1179/2049396714Y.0000000076	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227348	10.1371/journal.pone.0227348	http://dx.doi.org/10.1371/journal.pone.0227348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945779	Green Published, gold			2022-12-26	WOS:000534370100031
J	Ruiter, ELM; Saat, JJEH; Molleman, GRM; Fransen, GAJ; van Der Velden, K; van Jaarsveld, CHM; Engels, RCME; Assendelft, WJJ				Ruiter, Emilie L. M.; Saat, Jenneke J. E. H.; Molleman, Gerard R. M.; Fransen, Gerdine A. J.; van Der Velden, Koos; van Jaarsveld, Cornelia H. M.; Engels, Rutger C. M. E.; Assendelft, Willem J. J.			Parents' underestimation of their child's weight status. Moderating factors and change over time: A cross-sectional study	PLOS ONE			English	Article							MATERNAL PERCEPTIONS; 4-YEAR-OLD CHILDREN; OVERWEIGHT; OBESITY; HEIGHT; LIFE	Background Parents' underestimation of their child's weight status can hinder active participation in overweight prevention programs. We examined the level of agreement between the parents' perception of their child's weight status and the child's actual weight status, moderating factors, and change over time. Methods This cross-sectional study used data collected in 2009 (n = 8105), 2013 (n = 8844) and 2017 (n = 11,022) from a community-based survey conducted among parents of children age 2-12 years in the Netherlands. Parents classified their perception of their child's weight status on a 5-point Likert scale. In 2009 and 2013, the child's BMI was calculated from self-reported data by parents. The level of agreement between the parent's perception of the weight status and the actual weight status was examined using Cohen's kappa. The role of demographic factors on parents' perception were examined using logistic regression. Results In 2009, 2013 and 2017, 6%, 6% and 5% of the parents, respectively, classified their child as heavy/extremely heavy. In 2009 and 2013, 64.7% and 61.0% of parents, respectively, underestimated the weight status of their overweight child. This was even higher among parents of obese children. Overall, the agreement between the parents' perception and the actual weight status improved from 2009 (kappa = 0.38) to 2013 (kappa = 0.43) (p<0.05), but remained unsatisfactory. The parents' underestimation of their child's overweight/obesity status was associated with the child's age in 2009 and 2013 (2-7 years; OR: 0.18), the child's gender in 2009 (male; OR: 0.55), and the parents' education level in 2009 (middle and high education; OR: 0.56 and 0.44 respectively). Conclusions Parents' underestimation of their child's weight status remains alarmingly high, particularly among parents of young, obese children. This underestimation is a barrier to preventing childhood overweight/obesity. Healthcare professionals should take this underestimation into consideration and should actively encourage parents to take steps to prevent overweight/obesity in their children.	[Ruiter, Emilie L. M.; Saat, Jenneke J. E. H.; Molleman, Gerard R. M.; Fransen, Gerdine A. J.; van Der Velden, Koos] Radboud Univ Nijmegen, Acad Collaborat Ctr AMPHI, Dept Primary & Community Care, Integrated Hlth Policy,Med Ctr,ELG, Nijmegen, Netherlands; [van Jaarsveld, Cornelia H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, ELG, Nijmegen, Netherlands; [Engels, Rutger C. M. E.; Assendelft, Willem J. J.] Erasmus Univ, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam	Ruiter, ELM (corresponding author), Radboud Univ Nijmegen, Acad Collaborat Ctr AMPHI, Dept Primary & Community Care, Integrated Hlth Policy,Med Ctr,ELG, Nijmegen, Netherlands.	Emilie.Ruiter@Radboudumc.nl	van der Velden, J./H-8101-2014; Van Jaarsveld, Cornelia HM/A-4632-2016	Van Jaarsveld, Cornelia HM/0000-0002-4269-0041; Engels, Rutger/0000-0003-1944-9126	Netherlands Organization for Health Research and Development (ZonMW) [505010296015/200100001]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMW) [project number 505010296015/200100001]. This funding source played no role in the design of execution of this study and will not play any role in the analysis or interpretation of the data, nor in the decision to publish the results.	Akerman A, 2007, J HEALTH PSYCHOL, V12, P871, DOI 10.1177/1359105307082449; Baughcum AE, 1998, ARCH PEDIAT ADOL MED, V152, P1010; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Bossink-Tuna HN, 2009, EUR J PEDIATR, V168, P333, DOI 10.1007/s00431-008-0787-x; Brettschneider AK, 2012, INT J ENV RES PUB HE, V9, P632, DOI 10.3390/ijerph9020632; Buttitta M, 2014, QUAL LIFE RES, V23, P1117, DOI 10.1007/s11136-013-0568-5; Campbell MWC, 2006, MED J AUSTRALIA, V184, P274, DOI 10.5694/j.1326-5377.2006.tb00236.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; DAVIS H, 1994, J AM DIET ASSOC, V94, P512, DOI 10.1016/0002-8223(94)90213-5; de Hoog MLA, 2012, INT J OBESITY, V36, P53, DOI 10.1038/ijo.2011.199; De La O A, 2009, J PEDIATR HEALTH CAR, V23, P216, DOI 10.1016/j.pedhc.2007.12.014; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Eurostat, 2007, TASK FORC COR SOC VA; Fisher Louise, 2006, Aust J Rural Health, V14, P56, DOI 10.1111/j.1440-1584.2006.00764.x; Genovesi S, 2005, ACTA PAEDIATR, V94, P747, DOI 10.1080/08035250510028894; Gerards SMPL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-291; Gerards SMPL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-267; Gubbels JS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-18; Hager ER, 2012, ARCH PEDIAT ADOL MED, V166, P417, DOI 10.1001/archpediatrics.2011.1900; Hruby A, 2014, PHARMACOECONOMICS, P1, DOI DOI 10.1007/S40273-013-0118-6; Jansen W, 2006, EUR J PUBLIC HEALTH, V16, P645, DOI 10.1093/eurpub/ckl100; Jones AR, 2011, INT J OBESITY, V35, P953, DOI 10.1038/ijo.2011.106; Keij I., 2000, HOE DOET CBS DAT NOU; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Lowry R, KAPPA MEASURE CONCOR; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Manios Y, 2009, PUBLIC HEALTH NUTR, V12, P1099, DOI 10.1017/S1368980008004412; Maynard LM, 2003, PEDIATRICS, V111, P1226; Muller M J, 2001, Obes Rev, V2, P15; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oyeyemi GM, 2010, ASIAN J MATH STAT, V3, P33; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rhee KE, 2005, PEDIATRICS, V116, pE94, DOI 10.1542/peds.2004-2479; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Ruiter ELM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1394-1; Scholtens S, 2007, EUR J PUBLIC HEALTH, V17, P369, DOI 10.1093/eurpub/ckl253; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Timmermans SH, 2014, PEDIATR OBES, V9, pE14, DOI 10.1111/j.2047-6310.2012.00141.x; Towns Nichole, 2009, J Pediatr Nurs, V24, P115, DOI 10.1016/j.pedn.2008.02.032; Tschamler JM, 2009, CLIN PEDIATR; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Van der Star M., 2010, REGIORAPPORT KINDERM; van Koperen Marije Tm, 2014, BMC Obes, V1, P5, DOI 10.1186/2052-9538-1-5; West DS, 2008, OBESITY, V16, P630, DOI 10.1038/oby.2007.108; West F, 2010, BEHAV RES THER, V48, P1170, DOI 10.1016/j.brat.2010.08.008; World Health Organization, 2012, PRIOR AR ACT FIELD P; Young-Hyman D, 2000, OBES RES, V8, P241, DOI 10.1038/oby.2000.28; Zwiauer KFM, 2000, EUR J PEDIATR, V159, pS56, DOI 10.1007/PL00014367	54	13	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227761	10.1371/journal.pone.0227761	http://dx.doi.org/10.1371/journal.pone.0227761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945129	Green Published, gold			2022-12-26	WOS:000534370100061
J	Anchoori, RK; Tan, M; Tseng, SH; Peng, SW; Soong, RS; Algethami, A; Foran, P; Das, S; Wang, CG; Wang, TL; Liang, H; Hung, CF; Roden, RBS				Anchoori, Ravi K.; Tan, Marietta; Tseng, Ssu-Hsueh; Peng, Shiwen; Soong, Ruey-Shyang; Algethami, Aliyah; Foran, Palmer; Das, Samarjit; Wang, Chenguang; Wang, Tian-Li; Liang, Hong; Hung, Chien-Fu; Roden, Richard B. S.			Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN RECEPTOR RPN13; PHASE-I TRIAL; OVARIAN-CANCER; PROTEASOME INHIBITORS; ENDOPLASMIC-RETICULUM; RECURRENT OVARIAN; 26S PROTEASOME; BORTEZOMIB; MYELOMA	We sought to design ubiquitin-proteasome system inhibitors active against solid cancers by targeting ubiquitin receptor RPN13 within the proteasome's 19S regulatory particle. The prototypic bis-benzylidine piperidone-based inhibitor RA190 is a michael acceptor that adducts Cysteine 88 of RPN13. In probing the pharmacophore, we showed the benefit of the central nitrogen-bearing piperidone ring moiety compared to a cyclohexanone, the importance of the span of the aromatic wings from the central enone-piperidone ring, the contribution of both wings, and that substituents with stronger electron withdrawing groups were more cytotoxic. Potency was further enhanced by coupling of a second warhead to the central nitrogen-bearing piperidone as RA375 exhibited ten-fold greater activity against cancer lines than RA190, reflecting its nitro ring substituents and the addition of a chloroacetamide warhead. Treatment with RA375 caused a rapid and profound accumulation of high molecular weight polyubiquitinated proteins and reduced intracellular glutathione levels, which produce endoplasmic reticulum and oxidative stress, and trigger apoptosis. RA375 was highly active against cell lines of multiple myeloma and diverse solid cancers, and demonstrated a wide therapeutic window against normal cells. For cervical and head and neck cancer cell lines, those associated with human papillomavirus were significantly more sensitive to RA375. While ARID1A-deficiency also enhanced sensitivity 4-fold, RA375 was active against all ovarian cancer cell lines tested. RA375 inhibited proteasome function in muscle for >72h after single i.p. administration to mice, and treatment reduced tumor burden and extended survival in mice carrying an orthotopic human xenograft derived from a clear cell ovarian carcinoma.	[Anchoori, Ravi K.; Tseng, Ssu-Hsueh; Peng, Shiwen; Soong, Ruey-Shyang; Algethami, Aliyah; Foran, Palmer; Das, Samarjit; Wang, Tian-Li; Liang, Hong; Hung, Chien-Fu; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Anchoori, Ravi K.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA; [Tan, Marietta] Johns Hopkins Univ, Dept Otolaryngol, Baltimore, MD USA; [Das, Samarjit] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Wang, Chenguang] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.; Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.; Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21218 USA.	roden@jhmi.edu		Foran, Palmer/0000-0003-0876-2678; Das, Samarjit/0000-0002-4377-2823	National Institutes of Health [P50CA098252, P50CA228991, P30CA06973]; Allegheny Health Network-Johns Hopkins Cancer Research Fund; Ovarian Cancer Research Fund Alliance [458972]; Dr. Richard W. TeLinde endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allegheny Health Network-Johns Hopkins Cancer Research Fund; Ovarian Cancer Research Fund Alliance; Dr. Richard W. TeLinde endowment	This work was supported by grants from the National Institutes of Health (https://www.nih.gov/) grant P50CA098252, P50CA228991 and P30CA06973, the Allegheny Health Network-Johns Hopkins Cancer Research Fund (https://www.ahn.org/cancer-institute), and the Ovarian Cancer Research Fund Alliance (https://ocrahope.org/) #458972 (to RKA, C-FH, and RBSR). The project was also supported in part by the Dr. Richard W. TeLinde endowment (https://professorships.jhu.edu/professorship/richard-w-telinde-distinguishedprofessorship-in-gynecological-pathology/).The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aghajanian C, 2005, J CLIN ONCOL, V23, P5943, DOI 10.1200/JCO.2005.16.006; Aghajanian C, 2009, GYNECOL ONCOL, V115, P215, DOI 10.1016/j.ygyno.2009.07.023; Anchoori RK, 2018, ACS OMEGA, V3, P11917, DOI 10.1021/acsomega.8b01479; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Anchoori RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023888; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bazzaro M, 2006, CANCER RES, V66, P3754, DOI 10.1158/0008-5472.CAN-05-2321; Bazzaro M, 2011, J MED CHEM, V54, P449, DOI 10.1021/jm100589p; Berko D, 2014, J BIOL CHEM, V289, P5609, DOI 10.1074/jbc.M113.509380; Broyl A, 2010, LANCET ONCOL, V11, P1057, DOI 10.1016/S1470-2045(10)70206-0; Chen L, 2017, CELL REP, V18, P3143, DOI 10.1016/j.celrep.2017.03.010; Chen X, 2015, MOL CELL, V57, P767, DOI 10.1016/j.molcel.2015.02.025; Coughlin K, 2014, CLIN CANCER RES, V20, P3174, DOI 10.1158/1078-0432.CCR-13-2658; Cresta S, 2008, EUR J CANCER, V44, P1829, DOI 10.1016/j.ejca.2008.05.022; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Dou QP, 2014, CURR CANCER DRUG TAR, V14, P517, DOI 10.2174/1568009614666140804154511; Fejzo MS, 2008, GENE CHROMOSOME CANC, V47, P873, DOI 10.1002/gcc.20592; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Hamazaki J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005401; Hemmis CW, 2019, J BIOL CHEM, V294, P9659, DOI 10.1074/jbc.AC119.008881; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Jandial DA, 2017, GYNECOL ONCOL, V145, P236, DOI 10.1016/j.ygyno.2017.03.013; Jiang RT, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0347-y; Jiao LY, 2014, PROTEIN CELL, V5, P616, DOI 10.1007/s13238-014-0046-z; Kisselev AF, 2013, CANCER CELL, V24, P691, DOI 10.1016/j.ccr.2013.11.016; Kobrinsky B, 2013, CANCER CHEMOTH PHARM, V72, P1073, DOI 10.1007/s00280-013-2295-6; LAU DHM, 1991, CANCER RES, V51, P5181; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Liu YF, 2011, CELL RES, V21, P867, DOI 10.1038/cr.2011.75; Liu Z, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0089-7; Lu XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15540; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140518; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896; Nawrocki ST, 2005, CANCER RES, V65, P11658, DOI 10.1158/0008-5472.CAN-05-2370; Ogiwara H, 2019, CANCER CELL, V35, P177, DOI 10.1016/j.ccell.2018.12.009; Parma G, 2012, INT J GYNECOL CANCER, V22, P792, DOI 10.1097/IGC.0b013e318251051a; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ramirez PT, 2008, GYNECOL ONCOL, V108, P68, DOI 10.1016/j.ygyno.2007.08.071; Ramkumar K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13084; Randles L, 2016, J BIOL CHEM, V291, P8773, DOI 10.1074/jbc.M115.694588; Rao G, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00392; Ri M, 2010, LEUKEMIA, V24, P1506, DOI 10.1038/leu.2010.137; Robak P, 2018, CANCER TREAT REV, V70, P199, DOI 10.1016/j.ctrv.2018.09.001; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song Y, 2016, LEUKEMIA, V30, P1877, DOI 10.1038/leu.2016.97; Song Y, 2019, LEUKEMIA, V33, P2685, DOI 10.1038/s41375-019-0467-z; Soong RS, 2016, ONCOTARGET, V7, P68489, DOI 10.18632/oncotarget.12095; Starheim KK, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.56; Strauss SJ, 2007, CANCER RES, V67, P2783, DOI 10.1158/0008-5472.CAN-06-3254; Tsuboi K, 2011, J AM CHEM SOC, V133, P16605, DOI 10.1021/ja2066972; VanderLinden RT, 2017, J BIOL CHEM, V292, P9493, DOI 10.1074/jbc.M117.785287; Walerych D, 2016, NAT CELL BIOL, V18, P897, DOI 10.1038/ncb3380; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep26979; Yu GY, 2018, CELL PHYSIOL BIOCHEM, V47, P1152, DOI 10.1159/000490210	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227727	10.1371/journal.pone.0227727	http://dx.doi.org/10.1371/journal.pone.0227727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940398	gold, Green Published			2022-12-26	WOS:000534368000095
J	Liu, GY; Tang, O; Brotman, DJ; Miller, ER; Moliterno, AR; Juraschek, SP				Liu, Gigi Y.; Tang, Olive; Brotman, Daniel J.; Miller, Edgar R., III; Moliterno, Alison R.; Juraschek, Stephen P.			Gamma gap thresholds and HIV, hepatitis C, and monoclonal gammopathy	PLOS ONE			English	Article							SERUM-PROTEIN ELECTROPHORESIS; ALL-CAUSE MORTALITY; DISEASE SEVERITY; ALBUMIN; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULINS; RECOMMENDATIONS; ACTIVATION; OUTCOMES; THERAPY	Background An elevated gamma gap (>4 g/dL), the difference between serum total protein and albumin, can trigger testing for chronic infections or monoclonal gammopathy, despite a lack of evidence supporting this clinical threshold. Methods Using the National Health and Nutrition Examination Survey (NHANES) 1999-2014, gamma gap was derived in three subpopulations based on availability of testing for human immunodeficiency virus (HIV; N = 25,680), hepatitis C (HCV; N = 45,134), and monoclonal gammopathy of unknown significance (MGUS; N = 6,118). Disease status was confirmed by HIV antibody and Western blot, HCV RNA test, or electrophoresis with immunofixation. Sensitivity, specificity, and likelihood ratios were calculated for different gamma gap thresholds. Area under the curve (AUC) was used to assess performance and cubic splines were used to characterize the relationship between the gamma gap and each disease. Results Mean gamma gaps of participants with HIV, HCV, or MGUS ranged from 3.4-3.8 g/dL. The AUC was 0.80 (95%CI: 0.75,0.85) for HIV, 0.74 (0.72,0.76) for HCV, and 0.64 (0.60,0.69) for MGUS. An elevated gamma gap of over 4 g/dL corresponded to sensitivities of 39.3%, 19.0%, and 15.4% and specificities of 98.4%, 97.8%, and 95.4% for HIV, HCV, and MGUS, respectively. A higher prevalence of all three diseases was observed at both low and high gamma gaps. Discussion An elevated gamma gap of 4 g/dL is insensitive for HIV, HCV, or MGUS, but has a high specificity for HIV and HCV, suggesting that the absence of an elevated gamma gap does not rule out HIV, HCV, or MGUS. Conversely, an elevated gap may justify further testing for HIV and HCV, but does not justify electrophoresis in the absence of additional clinical information.	[Liu, Gigi Y.; Brotman, Daniel J.; Miller, Edgar R., III; Juraschek, Stephen P.] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21218 USA; [Tang, Olive; Miller, Edgar R., III] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Tang, Olive; Miller, Edgar R., III] Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Moliterno, Alison R.] Johns Hopkins Univ, Div Hematol, Sch Med, Baltimore, MD USA; [Juraschek, Stephen P.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Liu, GY (corresponding author), Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD 21218 USA.	gliu12@jhmi.edu		Juraschek, Stephen/0000-0003-4168-2696; Liu, Gigi/0000-0002-6407-1874	NIH/NHLBI grant [7K23HL135273-02]; NIH Medical Scientist Training Program [5T32GM007309]	NIH/NHLBI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SPJ is supported by NIH/NHLBI grant 7K23HL135273-02. OT is supported by the NIH Medical Scientist Training Program Grant 5T32GM007309.; SPJ is supported by NIH/NHLBI grant 7K23HL135273-02. OT is supported by the NIH Medical Scientist Training Program Grant 5T32GM007309. The authors thank the staff and participants of the NHANES for their important contributions.	Adedeji AL, 2014, EXCLI J, V13, P761; [Anonymous], 2006, MMWR RECOMM REP; Blade J, 2008, LEUKEMIA, V22, P1651, DOI 10.1038/leu.2008.203; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cesana C, 2002, J CLIN ONCOL, V20, P1625, DOI 10.1200/JCO.20.6.1625; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Clarke K, HOSP MED; Cornella SL, 2015, POSTGRAD MED, V127, P413, DOI 10.1080/00325481.2015.1021660; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; Dispenzieri A, 2001, MAYO CLIN PROC, V76, P476, DOI 10.4065/76.5.476; Dupuis MM, 2017, BLOOD, V130; Feldman LS, 2013, JAMA INTERN MED, V173, P903, DOI 10.1001/jamainternmed.2013.232; Gonzalez-Quintela A, 2003, HEPATO-GASTROENTEROL, V50, P2121; Hughes M, 2006, ANN CLIN BIOCHEM, V43, P372, DOI 10.1258/000456306778520133; Juraschek SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143494; Kadar K, 2012, PATHOL ONCOL RES, V18, P557, DOI 10.1007/s12253-012-9506-z; Kim JE, 2010, ANN HEMATOL, V89, P391, DOI 10.1007/s00277-009-0841-4; Konstantinopoulos PA, 2007, AM J CLIN PATHOL, V128, P596, DOI 10.1309/QWTQFGA9FXN02YME; Loprinzi PD, 2016, INT J CLIN PRACT, V70, P625, DOI 10.1111/ijcp.12817; MALACRIDA V, 1987, J CLIN PATHOL, V40, P793, DOI 10.1136/jcp.40.7.793; Maruyama S, 2007, HEPATO-GASTROENTEROL, V54, P493; O'Connell TX, 2005, AM FAM PHYSICIAN, V71, P105; Pirrucello J, GAMMA GAP; Redgrave BE, 2005, HIV MED, V6, P307, DOI 10.1111/j.1468-1293.2005.00312.x; SALT HB, 1956, CLIN CHEM, V2, P35; Scherzer R, 2017, AIDS, V31, P71, DOI 10.1097/QAD.0000000000001278; Serpa J, 2010, INT J INFECT DIS, V14, pE41, DOI 10.1016/j.ijid.2009.10.007; SHIRAI A, 1992, J CLIN INVEST, V89, P561, DOI 10.1172/JCI115621; Stohl W, 2018, ARTHRITIS RHEUM, V70; Sugalski JM, 2010, J IMMUNOL, V185, P3019, DOI 10.4049/jimmunol.1000879; Suh B, 2014, ANN ONCOL, V25, P2260, DOI 10.1093/annonc/mdu274; Thakkinstian A, 2008, J GEN INTERN MED, V23, P1688, DOI 10.1007/s11606-008-0712-z; Vavricka SR, 2009, DIGESTION, V79, P203, DOI 10.1159/000212077; Waxman AJ, 2015, LEUKEMIA, V29, P751, DOI 10.1038/leu.2014.313; Wheeler D, 2016, VA REPORT ELEVATED P; Yang M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19534-4; Zhang GL, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8061091	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0224977	10.1371/journal.pone.0224977	http://dx.doi.org/10.1371/journal.pone.0224977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940353	Green Published, gold			2022-12-26	WOS:000534368000006
J	Rezaie, AM; Loerzel, J; Ferreira, CM				Rezaie, Ali Mohammad; Loerzel, Jarrod; Ferreira, Celso M.			Valuing natural habitats for enhancing coastal resilience: Wetlands reduce property damage from storm surge and sea level rise	PLOS ONE			English	Article							CLIMATE-CHANGE; HURRICANE INTENSITY; PROTECTION SERVICE; POTENTIAL IMPACT; MODEL; VULNERABILITY; MITIGATION; MARSHES; WAVES; CONSERVATION	Storm surge and sea level rise (SLR) are affecting coastal communities, properties, and ecosystems. While coastal ecosystems, such as wetlands and marshes, have the capacity to reduce the impacts of storm surge and coastal flooding, the increasing rate of SLR can induce the transformation and migration of these natural habitats. In this study, we combined coastal storm surge modeling and economic analysis to evaluate the role of natural habitats in coastal flood protection. We focused on a selected cross-section of three coastal counties in New Jersey adjacent to the Jacques Cousteau National Estuarine Research Reserve (JCNERR) that is protected by wetlands and marshes. The coupled coastal hydrodynamic and wave models, ADCIRC+SWAN, were applied to simulate flooding from historical and synthetic storms in the Mid-Atlantic US for current and future SLR scenarios. The Sea Level Affecting Marshes Model (SLAMM) was used to project the potential migration and habitat transformation in coastal marshes due to SLR in the year 2050. Furthermore, a counterfactual land cover approach, in which marshes are converted to open water in the model, was implemented for each storm scenario in the present and the future to estimate the amount of flooding that is avoided due to the presence of natural habitats and the subsequent reduction in residential property damage. The results indicate that this salt marshes can reduce up to 14% of both the flood depth and property damage during relatively low intensity storm events, demonstrating the efficacy of natural flood protection for recurrent storm events. Monetarily, this translates to the avoidance of up to $13.1 and $32.1 million in residential property damage in the selected coastal counties during the '50-year storm' simulation and hurricane Sandy under current sea level conditions, and in the year '2050 SLR scenario', respectively. This research suggests that protecting and preserving natural habitats can contribute to enhance coastal resilience.	[Rezaie, Ali Mohammad; Ferreira, Celso M.] George Mason Univ, Civil Environm & Infrastruct Engn, Fairfax, VA 22030 USA; [Loerzel, Jarrod] CSS Inc, Charleston, SC USA	George Mason University	Rezaie, AM (corresponding author), George Mason Univ, Civil Environm & Infrastruct Engn, Fairfax, VA 22030 USA.	rezaie06buet@gmail.com	; ferreira, celso/I-3647-2015	Rezaie, Ali/0000-0001-5583-6268; ferreira, celso/0000-0001-9032-9624	The commercial company (CSS Inc)	The commercial company (CSS Inc)	The commercial company (CSS Inc), funder, provided support in the form of salaries for the author [J L] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, Virginia Sea Grant (VASG) provided support in the form of salaries for the authors [AMR CMF] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2014, COAST ENG, V83, P82, DOI 10.1016/j.coastaleng.2013.10.004; [Anonymous], [No title captured]; ARCADIS, 2013, ADCIRC BAS STORM SUR; ARCADIS, 2011, ADCIRC BAS STORM SUR; Arkema KK, 2017, ANN NY ACAD SCI, V1399, P5, DOI 10.1111/nyas.13322; Atkinson J., 2011, FLORIDA WATERSHED, V4, P22; Barbier E.B., 1997, EC VALUATION WETLAND; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Barbier EB, 2014, J ENVIRON ECON POLIC, V3, P167, DOI 10.1080/21606544.2013.876370; Barbier EB, 2015, ECOSYST SERV, V11, P32, DOI 10.1016/j.ecoser.2014.06.010; Barbier EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058715; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Bigalbal A, 2018, J MAR SCI ENG, V6, DOI 10.3390/jmse6030086; Booij N, 1999, J GEOPHYS RES-OCEANS, V104, P7649, DOI 10.1029/98JC02622; Boutwell J. L, 2015, NAT RESOUR, V6, P48, DOI DOI 10.4236/NR.2015.61006; Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Church JA, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1137; Church JA, 2011, SURV GEOPHYS, V32, P585, DOI 10.1007/s10712-011-9119-1; Clough J., 2016, SLAMM 6 7 TECHNICAL; Clough J, 2016, ENVIRON MODELL SOFTW, V84, P349, DOI 10.1016/j.envsoft.2016.06.023; Colle BA, 2008, MON WEATHER REV, V136, P3894, DOI 10.1175/2008MWR2369.1; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Cowardin LM, 1979, CLASSIFICATION WETLA, V79; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; D'Alpaos A, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000537; Deb M, 2018, J FLOOD RISK MANAG, V11, pS750, DOI 10.1111/jfr3.12254; Dietrich JC, 2010, MON WEATHER REV, V138, P378, DOI 10.1175/2009MWR2907.1; Dietrich Joel Casey, 2010, DEV APPL COUPLED HUR; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; ESRI, WORLD IM; ESRI, WORLD TOP MAP; ESRI, WORLD OC BAS; Feagin RA, 2009, P NATL ACAD SCI USA, V106, P10109, DOI 10.1073/pnas.0901297106; FEMA, 2014, REG 2 STORM SURG PRO; FEMA, 2014, REH 2 STORM SURG PRO; FEMA, 2014, REG 2 COAST STORM SU; Ferreira CM, 2014, COAST ENG, V94, P102, DOI 10.1016/j.coastaleng.2014.08.011; Ferreira CM, 2014, J GEOPHYS RES-OCEANS, V119, P1812, DOI 10.1002/2013JC009604; Ferreira CM, 2014, J AM WATER RESOUR AS, V50, P219, DOI 10.1111/jawr.12127; Frey AE, 2010, J AM WATER RESOUR AS, V46, P1049, DOI 10.1111/j.1752-1688.2010.00475.x; GARRATT JR, 1977, MON WEATHER REV, V105, P915, DOI 10.1175/1520-0493(1977)105<0915:RODCOO>2.0.CO;2; Garzon JL, 2019, COAST ENG, V146, P32, DOI 10.1016/j.coastaleng.2018.11.001; Garzon JL, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030045; Gesch D, 2009, STRATEGIES, P4; Glass EM, 2018, LIMNOL OCEANOGR, V63, P951, DOI 10.1002/lno.10682; Glick P, 2013, J COASTAL RES, P211, DOI [10.2112/S163-017.1, 10.2112/SI63-0017.1]; Haddad J, 2016, NAT HAZARDS, V80, P839, DOI 10.1007/s11069-015-2000-7; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hallegatte S, 2011, CLIMATIC CHANGE, V104, P1, DOI 10.1007/s10584-010-9981-8; Handley BL, 2009, COMPARISON NLCD NWI; Hu KL, 2018, COAST ENG, V132, P63, DOI 10.1016/j.coastaleng.2017.11.001; Kennish MJ, 2007, PROFILE REPORT JACQU; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Kousky C, 2014, ECOL ECON, V104, P119, DOI 10.1016/j.ecolecon.2014.05.001; Lathrop R, 2014, ISPRS INT J GEO-INF, V3, P408, DOI 10.3390/ijgi3020408; Lawler S, 2016, OCEAN COAST MANAGE, V134, P226, DOI 10.1016/j.ocecoaman.2016.10.008; Lin N, 2017, STOCH ENV RES RISK A, V31, P2379, DOI 10.1007/s00477-016-1377-5; Lin N, 2016, P NATL ACAD SCI USA, V113, P12071, DOI 10.1073/pnas.1604386113; Lin N, 2010, WEATHER FORECAST, V25, P1342, DOI 10.1175/2010WAF2222349.1; Linhoss AC, 2015, J COASTAL RES, V31, P36, DOI 10.2112/JCOASTRES-D-13-00215.1; Luettich R, 2004, FORMULATION NUMERICA, VXX, P1; Luettich R.A., 1995, IMPLEMENTATION TESTI; Mattocks, 2006, DESIGN IMPLEMENTATIO, V103; Mattocks C, 2008, OCEAN MODEL, V25, P95, DOI 10.1016/j.ocemod.2008.06.008; McFadden L, 2007, HYDROBIOLOGIA, V577, P5, DOI 10.1007/s10750-006-0413-8; Moller I, 2014, NAT GEOSCI, V7, P848, DOI [10.1038/ngeo2251, 10.1038/NGEO2287, 10.1038/NGEO2251]; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Murdukhayeva A, 2013, J COASTAL RES, V29, P1, DOI 10.2112/JCOASTRES-D-12-00196.1; Nadal-caraballo N.C., 2015, COASTAL STORM HAZARD; Narayan S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09269-z; Narayan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154735; Neumann JE, 2015, CLIMATIC CHANGE, V129, P337, DOI 10.1007/s10584-014-1304-z; NOAA-CSC, 2013, C CAP LAND COV ATL; NOAA's Coastal Change Analysis Program (C-CAP), 2016, REGIONAL LAND COVER; Paquier AE, 2017, ESTUAR COAST, V40, P930, DOI 10.1007/s12237-016-0190-1; Parris A., 2012, GLOBAL SEA LEVEL RIS; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Remoundou K, 2015, ECOSYST SERV, V11, P87, DOI 10.1016/j.ecoser.2014.11.003; Resio DT, 2008, PHYS TODAY, V61, P33, DOI 10.1063/1.2982120; Sathirathai S, 2001, CONTEMP ECON POLICY, V19, P109, DOI 10.1093/cep/19.2.109; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Seidel V, 2013, REAL ESTATE ISSUES, V38, P16; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Spencer T, 2016, GLOBAL PLANET CHANGE, V139, P15, DOI 10.1016/j.gloplacha.2015.12.018; Stark J, 2016, ESTUAR COAST SHELF S, V175, P34, DOI 10.1016/j.ecss.2016.03.027; Strauss B, 2012, SAS SEA LEVEL RISE S, P1; Temmerman S, 2007, GEOLOGY, V35, P631, DOI 10.1130/G23502A.1; USACE, 2003, 0401 USACE EGM; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wamsley TV, 2009, NAT HAZARDS, V51, P207, DOI 10.1007/s11069-009-9378-z; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855	99	18	19	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226275	10.1371/journal.pone.0226275	http://dx.doi.org/10.1371/journal.pone.0226275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940378	gold, Green Published			2022-12-26	WOS:000534368000025
J	Almeida, MGMD; Aredes, DS; Majerowicz, D; Faergeman, NJ; Knudsen, J; Gondim, KC				Almeida, Muriel G. M. D.; Aredes, Daniela S.; Majerowicz, David; Faergeman, Nils J.; Knudsen, Jens; Gondim, Katia C.			Expression of acyl-CoA-binding protein 5 from Rhodnius prolixus and its inhibition by RNA interference	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; FUNCTIONAL-CHARACTERIZATION; LIPID-METABOLISM; GENE-EXPRESSION; KNOCKDOWN LEADS; DOWN-REGULATION; LIGAND-BINDING; FAT-BODY; ACBP; LIPOPHORIN	The acyl-CoA-binding proteins (ACBP) act by regulating the availability of acyl-CoA in the cytoplasm and must have essential functions in lipid metabolism. The genome of the kissing-bug Rhodnius prolixus encodes five proteins of this family, but little is known about them. In this study we investigated the expression and function of RpACBP-5. Feeding induced RpACBP-5 gene expression in the posterior midgut, and an increase of about four times was observed two days after the blood meal. However, the amount of protein, which was only detected in this organ, did not change during digestion. The RpACBP-5 gene was also highly expressed in pre-vitellogenic and vitellogenic oocytes. Recombinant RpACBP-5 was shown to bind to acyl-CoA of different lengths, and it exhibited nanomolar affinity to lauroyl-CoA in an isothermal titration assay, indicating that RpACBP-5 is a functional ACBP. RpACBP-5 knockdown by RNA interference did not affect digestion, egg laying and hatching, survival, or accumulation of triacylglycerol in the fat body and oocytes. Similarly, double knockdown of RpACBP-1 and RpACBP-5 did not alter egg laying and hatching, survival, accumulation of triacylglycerol in the fat body and oocytes, or the neutral lipid composition of the posterior midgut or hemolymph. These results show that RpACBP-5 is a functional ACBP but indicate that the lack of a detectable phenotype in the knockdown insects may be a consequence of functional overlap of the proteins of the ACBP family found in the insect.	[Almeida, Muriel G. M. D.; Aredes, Daniela S.; Gondim, Katia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil; [Majerowicz, David; Faergeman, Nils J.; Knudsen, Jens] Univ So Denmark, Inst Biokemi & Mol Biol, Odense, Denmark; [Majerowicz, David] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; University of Southern Denmark; Universidade Federal do Rio de Janeiro	Gondim, KC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, Rio De Janeiro, Brazil.	katia@bioqmed.ufrj.br	Gondim, Katia C./AAN-4059-2020	Faergeman, Nils/0000-0002-9281-5287	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [471784/2013-3, 404915/2018-3]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [202.846/2017, 203.257/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br), to KCG (471784/2013-3) and DM (404915/2018-3); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; www.faperj.br), to KCG (202.846/2017) and DM (203.257/2017); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; https://www.capes.gov.br), to MGMDA, DM and KCG (Finance Code 001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Hashema KAH, 2001, INT J BIOCHEM CELL B, V33, P807, DOI 10.1016/S1357-2725(01)00049-8; Alves-Bezerra M, 2016, BBA-MOL CELL BIOL L, V1861, P650, DOI 10.1016/j.bbalip.2016.04.007; Alves-Bezerra M, 2012, BBA-MOL CELL BIOL L, V1821, P1462, DOI 10.1016/j.bbalip.2012.08.002; Alves-Bezerra M, 2010, INSECT BIOCHEM MOLEC, V40, P119, DOI 10.1016/j.ibmb.2010.01.002; Augoff K, 2010, ACTA BIOCHIM POL, V57, P533; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Elle IC, 2011, BIOCHEM J, V437, P231, DOI 10.1042/BJ20102099; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Faergeman NJ, 1996, BIOCHEMISTRY-US, V35, P14118, DOI 10.1021/bi960545z; Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147; Gondim KC, 2018, INSECT BIOCHEM MOLEC, V101, P108, DOI 10.1016/j.ibmb.2018.08.005; GONDIM KC, 1989, J INSECT PHYSIOL, V35, P19, DOI 10.1016/0022-1910(89)90032-2; Grillo LAM, 2007, INSECT BIOCHEM MOLEC, V37, P579, DOI 10.1016/j.ibmb.2007.03.002; KOLMER M, 1994, MOL CELL BIOL, V14, P6983, DOI 10.1128/MCB.14.10.6983; Landrock D, 2010, LIPIDS, V45, P567, DOI 10.1007/s11745-010-3437-9; Larsen MK, 2006, MOL BIOL CELL, V17, P4318, DOI 10.1091/mbc.E06-01-0035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Majerowicz D, 2016, INSECT BIOCHEM MOLEC, V72, P41, DOI 10.1016/j.ibmb.2016.03.002; Majerowicz D, 2013, ARCH INSECT BIOCHEM, V82, P129, DOI 10.1002/arch.21080; MANDRUP S, 1991, BIOCHEM J, V276, P817, DOI 10.1042/bj2760817; Matsumoto S, 2001, INSECT BIOCHEM MOLEC, V31, P603, DOI 10.1016/S0965-1748(00)00165-X; Melloni E, 2000, J BIOL CHEM, V275, P82, DOI 10.1074/jbc.275.1.82; Meng W, 2011, NEW PHYTOL, V189, P1170, DOI 10.1111/j.1469-8137.2010.03546.x; Monzani PS, 2010, BBA-PROTEINS PROTEOM, V1804, P115, DOI 10.1016/j.bbapap.2009.09.020; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Neess D, 2006, MOL CELL BIOCHEM, V284, P149, DOI 10.1007/s11010-005-9039-9; Neess D, 2015, PROG LIPID RES, V59, P1, DOI 10.1016/j.plipres.2015.04.001; Neess D, 2013, CELL REP, V5, P1403, DOI 10.1016/j.celrep.2013.11.010; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; Oikari S, 2008, PFLUG ARCH EUR J PHY, V456, P369, DOI 10.1007/s00424-007-0416-y; OLIVEIRA PL, 1986, J INSECT PHYSIOL, V32, P859, DOI 10.1016/0022-1910(86)90101-0; Petrescu AD, 2008, PROTEIN EXPRES PURIF, V58, P184, DOI 10.1016/j.pep.2007.11.010; Pontes EG, 2008, J INSECT PHYSIOL, V54, P790, DOI 10.1016/j.jinsphys.2008.02.003; RASMUSSEN JT, 1994, BIOCHEM J, V299, P165, DOI 10.1042/bj2990165; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; ROSENDAL J, 1993, BIOCHEM J, V290, P321, DOI 10.1042/bj2900321; Ryuda M, 2011, J BIOL CHEM, V286, P38417, DOI 10.1074/jbc.M111.267344; Santos R, 2011, ARCH INSECT BIOCHEM, V77, P1, DOI 10.1002/arch.20414; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Snyder MJ, 1997, CELL TISSUE RES, V288, P177, DOI 10.1007/s004410050804; Takato H, 2013, J PLANT PHYSIOL, V170, P591, DOI 10.1016/j.jplph.2012.11.011; Vock C, 2010, CELL PHYSIOL BIOCHEM, V25, P675, DOI 10.1159/000315087; Wang JL, 2008, ARCH INSECT BIOCHEM, V68, P79, DOI 10.1002/arch.20250	46	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227685	10.1371/journal.pone.0227685	http://dx.doi.org/10.1371/journal.pone.0227685			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935250	Green Published, gold			2022-12-26	WOS:000534354100043
J	Lanza, E; Muglia, R; Bolengo, I; Poretti, D; D'Antuono, F; Ceriani, R; Torzilli, G; Pedicini, V				Lanza, Ezio; Muglia, Riccardo; Bolengo, Isabella; Poretti, Dario; D'Antuono, Felice; Ceriani, Roberto; Torzilli, Guido; Pedicini, Vittorio			Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL EMBOLIZATION; SYMPTOMATIC TREATMENT; CONTROLLED-TRIAL; CHEMOEMBOLIZATION; CYANOACRYLATE; THERAPY; MANAGEMENT; ABLATION; LIPIODOL	Locoregional therapies for hepatocellular carcinoma (HCC) include endovascular treatments such as chemoembolization (TACE) and bland embolization (TAE). TACE is the most adopted technique, despite a lack of definitive evidence of superiority over TAE, which is less costly and better tolerated due to the absence of chemotherapy. However, few studies have reported data on TAE monotherapy for unresectable HCC. We report our results in a cohort of 230 patients with unresectable HCC treated with TAE (TAE with 40-100 micron microparticles, TAE with microparticles plus n-butyl-2-cyanoacrylate, TAE with Lipiodol) over the course of seven years. Thirty-seven patients (14%) were down-staged during observation and also received a percutaneous ablation. We observed 1-, 2-, 3-, 4- and 5year rates of 84,8%, 58,7%, 38,3%, 28,3%, and 18,7%. Patients who also received percutaneous treatment performed best. Our results broaden the body of evidence for the use of TAE in advanced HCC.	[Lanza, Ezio; Poretti, Dario; D'Antuono, Felice; Pedicini, Vittorio] Humanitas Clin & Res Hosp IRCCS, Dept Diagnost & Intervent Radiol, Milan, Italy; [Muglia, Riccardo; Bolengo, Isabella] Humanitas Univ, Training Sch Radiol, Milan, Italy; [Ceriani, Roberto] Humanitas Clin & Res Hosp IRCCS, Dept Internal Med Hepatol, Milan, Italy; [Torzilli, Guido] Humanitas Clin & Res Hosp IRCCS, Dept Surg Hepatobiliary & Gen Surg, Milan, Italy	Humanitas University	Lanza, E (corresponding author), Humanitas Clin & Res Hosp IRCCS, Dept Diagnost & Intervent Radiol, Milan, Italy.	eziolanza@gmail.com	Lanza, Ezio/AAO-8516-2020; D'Antuono, Felice/AAV-2822-2020	Lanza, Ezio/0000-0003-1889-8798; D'Antuono, Felice/0000-0002-9973-0593; Ceriani, Roberto/0000-0003-4838-7366; pedicini, vittorio/0000-0001-7830-6307				Berghammer P, 1998, CARDIOVASC INTER RAD, V21, P214, DOI 10.1007/s002709900247; Bonomo G, 2010, CARDIOVASC INTER RAD, V33, P552, DOI 10.1007/s00270-009-9752-y; Bouvier A, 2011, EUR RADIOL, V21, P1719, DOI 10.1007/s00330-011-2118-2; Bruix J, 1998, HEPATOLOGY, V27, P1578, DOI 10.1002/hep.510270617; Burroughs A, 2004, LANCET ONCOL, V5, P409, DOI 10.1016/S1470-2045(04)01508-6; CHANG JM, 1994, CANCER, V74, P2449, DOI 10.1002/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO;2-4; Chevallier P, 2015, DIAGN INTERV IMAG, V96, P637, DOI 10.1016/j.diii.2015.04.006; Colombo GL, 2015, THER CLIN RISK MANAG, V11, P1603, DOI 10.2147/TCRM.S88208; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Facciorusso A, 2017, UNITED EUR GASTROENT, V5, P511, DOI 10.1177/2050640616673516; Gbolahan OB, 2017, J GASTROINTEST ONCOL, V8, P215, DOI 10.21037/jgo.2017.03.13; Idee JM, 2013, CRIT REV ONCOL HEMAT, V88, P530, DOI 10.1016/j.critrevonc.2013.07.003; Katsanos K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184597; KAWAI S, 1992, CANCER CHEMOTH PHARM, V31, pS1, DOI 10.1007/BF00687096; Kudo M, 2017, LIVER CANCER, V6, P16, DOI 10.1159/000449343; Lanza E, 2018, J ARTHROPLASTY, V33, P2273, DOI 10.1016/j.arth.2018.02.005; Lanza E, 2017, NUCL MED COMMUN, V38, P826, DOI 10.1097/MNM.0000000000000719; Lanza E, 2017, LIVER CANCER, V6, P27, DOI 10.1159/000449347; Lanza E, 2014, J VASC INTERV RADIOL, V25, P1482, DOI 10.1016/j.jvir.2014.05.018; LIN DY, 1988, GASTROENTEROLOGY, V94, P453, DOI 10.1016/0016-5085(88)90436-2; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Loewe C, 2002, J VASC INTERV RADIOL, V13, P61, DOI 10.1016/S1051-0443(07)60010-4; Malagari K, 2010, CARDIOVASC INTER RAD, V33, P541, DOI 10.1007/s00270-009-9750-0; Marelli L, 2007, CARDIOVASC INTER RAD, V30, P6, DOI 10.1007/s00270-006-0062-3; Meyer T, 2013, BRIT J CANCER, V108, P1252, DOI 10.1038/bjc.2013.85; Monsignore LM, 2015, CLINICS, V70, P781, DOI 10.6061/clinics/2015(12)04; Oliveri RS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004787.pub2; Pedicini V, 2017, J VASC INTERV RADIOL, V28, P1444, DOI 10.1016/j.jvir.2017.06.020; Prajapati HJ, 2014, AM J ROENTGENOL, V203, pW706, DOI 10.2214/AJR.13.12308; Wang Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201525; Wang YXJ, 2015, CHINESE J CANCER RES, V27, P96, DOI 10.3978/j.issn.1000-9604.2015.03.03; Young S, 2019, EUR RADIOL, V29, P3287, DOI 10.1007/s00330-018-5782-7; Young S, 2018, J CLIN TRANSL HEPATO, V6, P189, DOI 10.14218/JCTH.2017.00059; Yu SCH, 2014, RADIOLOGY, V270, P607, DOI 10.1148/radiol.13130498	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227711	10.1371/journal.pone.0227711	http://dx.doi.org/10.1371/journal.pone.0227711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935255	Green Published, gold			2022-12-26	WOS:000534354100045
J	Evdokimov, D; Dinkel, P; Frank, J; Sommer, C; Uceyler, N				Evdokimov, Dimitar; Dinkel, Philine; Frank, Johanna; Sommer, Claudia; Uceyler, Nurcan			Characterization of dermal skin innervation in fibromyalgia syndrome	PLOS ONE			English	Article							NERVE-FIBERS; CUTANEOUS INNERVATION; SUBSTANCE-P; PAIN; CLASSIFICATION; REINNERVATION; EXPRESSION; DIAGNOSIS; EPIDERMIS; CRITERIA	Introduction We characterized dermal innervation in patients with fibromyalgia syndrome (FMS) as potential contribution to small fiber pathology. Methods Skin biopsies of the calf were collected (86 FMS patients, 35 healthy controls). Skin was immunoreacted with antibodies against protein gene product 9.5, calcitonine gene-related peptide, substance P, CD31, and neurofilament 200 for small fiber subtypes. We assessed two skin sections per patient; on each skin section, two dermal areas (150 x 700 mu m each) were investigated for dermal nerve fiber length (DNFL). Results In FMS patients we found reduced DNFL of fibers with vessel contact compared to healthy controls (p<0.05). There were no differences for the other nerve fiber subtypes. Discussion We found less dermal nerve fibers in contact with blood vessels in FMS patients than in controls. The pathophysiological relevance of this finding is unclear, but we suggest the possibility of a relationship with impaired thermal tolerance commonly reported by FMS patients.	[Evdokimov, Dimitar; Dinkel, Philine; Frank, Johanna; Sommer, Claudia; Uceyler, Nurcan] Univ Wurzburg, Dept Neurol, Wurzburg, Germany	University of Wurzburg	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	ueceyler_n@ukw.de		Dinkel, Philine/0000-0002-3503-6682; Uceyler, Nurcan/0000-0001-6973-6428	Else Kroner-Fresenius-Stiftung [2014_A129]; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG: UE171-5/1]; Open Access Publication Fund of the University of Wuerzburg	Else Kroner-Fresenius-Stiftung; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Wuerzburg	The study was supported by an unrestricted grant from the Else Kroner-FreseniusStiftung (N.U.: 2014_A129). N.U. was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG: UE171-5/1). This publication was supported by the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2013, PAIN MED, V14, P895, DOI 10.1111/pme.12139; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BENNETT RM, 1991, ARTHRITIS RHEUM, V34, P264, DOI 10.1002/art.1780340303; Caro XJ, 2014, ARTHRITIS RHEUMATOL, V66, P1945, DOI 10.1002/art.38662; DALSGAARD CJ, 1983, EXPERIENTIA, V39, P1018, DOI 10.1007/BF01989781; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; Duraku LS, 2013, EXP NEUROL, V241, P13, DOI 10.1016/j.expneurol.2012.11.029; Eich W, 2012, SCHMERZ, V26, P247, DOI 10.1007/s00482-012-1169-x; Evdokimov D, 2019, ANN NEUROL, V86, P504, DOI 10.1002/ana.25565; Kambiz S, 2015, J NEUROSURG, V123, P254, DOI 10.3171/2014.12.JNS141075; Karlsson P, 2013, J PERIPHER NERV SYST, V18, P48, DOI 10.1111/jns5.12007; Kimura J, 2001, ELECTRODIAGNOSIS DIS; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Lauria G, 2011, NEUROLOGY, V77, P242, DOI 10.1212/WNL.0b013e318225ab51; Lindenlaub T, 2002, ACTA NEUROPATHOL, V104, P137, DOI 10.1007/s00401-002-0527-7; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; Morf S, 2005, ARTHRITIS RES THER, V7, pR209, DOI 10.1186/ar1459; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Oaklander AL, 2013, PAIN, V154, P2310, DOI 10.1016/j.pain.2013.06.001; Schulze E, 1997, ACTA HISTOCHEM, V99, P301, DOI 10.1016/S0065-1281(97)80024-4; Serra J, 2014, ANN NEUROL, V75, P196, DOI 10.1002/ana.24065; Simone DA, 1998, J NEUROSCI, V18, P8947; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Wallengren J, 2004, ACTA DERM-VENEREOL, V84, P111, DOI 10.1080/00015550310022899; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zamuner AR, 2015, CLIN EXP RHEUMATOL, V33, pS53	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227674	10.1371/journal.pone.0227674	http://dx.doi.org/10.1371/journal.pone.0227674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929578	Green Published, gold			2022-12-26	WOS:000534352500060
J	Kubota, J; Hamano, SI; Daida, A; Hiwatari, E; Ikemoto, S; Hirata, Y; Matsuura, R; Hirano, D				Kubota, Jun; Hamano, Shin-Ichiro; Daida, Atsuro; Hiwatari, Erika; Ikemoto, Satoru; Hirata, Yuko; Matsuura, Ryuki; Hirano, Daishi			Predictive factors of first dosage intravenous immunoglobulin-related adverse effects in children	PLOS ONE			English	Article							ASEPTIC-MENINGITIS; PAIN ASSESSMENT; THERAPY; EVENTS; HYPERVISCOSITY; RELIABILITY; MANAGEMENT; IMMEDIATE; SAFETY	Background Intravenous immunoglobulin (IVIG) therapy is used in the treatment of various diseases, and IVIG-related adverse effects (IVIG-AEs) vary from mild to severe. However, the mechanisms underlying IVIG-AEs and the potential predictive factors are not clear. This study investigated whether certain IVIG-AEs can be predicted before IVIG administration. Study design and methods This retrospective cohort study at the Division of Neurology, Saitama Children's Medical Center included patients enrolled from 2008 to 2018 who were < 18 years old and received IVIG for the first time. IVIG-AEs were classified according to the Common Terminology Criteria for Adverse Events version 5.0. Results A total of 104 patients fulfilled the inclusion criteria. The rate of IVIG-AEs was 37.5% (39/104). The most frequent IVIG-AEs were fever (41.0% [16/39]) and headache (38.5% [15/39]). AEs were below grade 2 in all except one patient and there were no grade 4 AEs. High serum total protein (TP) level was significantly related to the occurrence of IVIG-AEs (odds ratio, 14.8; 95% confidence interval, 2.4-90.5; P < 0.01). The optimal cutoff TP level was 6.7 g/dL. Although low WBC count and immunoglobulin G level may be predictive risk factors of IVIG-AEs, it was not confirmed in this study. Conclusion IVIG-AEs occurred in 37.5% of cases, and most were mild. TP was the best predictive risk factor of IVIG-AEs before IVIG administration. These results may aid in elucidating the mechanism underlying IVIG-AEs.	[Kubota, Jun; Hamano, Shin-Ichiro; Daida, Atsuro; Hiwatari, Erika; Hirata, Yuko; Matsuura, Ryuki] Saitama Childrens Med Ctr, Div Neurol, Saitama, Japan; [Kubota, Jun; Hiwatari, Erika; Hirano, Daishi] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Hamano, Shin-Ichiro; Ikemoto, Satoru] Saitama Childrens Med Ctr, Dept Child Hlth & Human Dev, Saitama, Japan	Saitama Children's Medical Center; Jikei University; Saitama Children's Medical Center	Kubota, J (corresponding author), Saitama Childrens Med Ctr, Div Neurol, Saitama, Japan.; Kubota, J (corresponding author), Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan.	junkubota13@gmail.com	Hirano, Daishi/AAG-1008-2021	Daida, Atsuro/0000-0003-1350-7700				Bentley P, 2012, J CLIN PHARM THER, V37, P286, DOI 10.1111/j.1365-2710.2011.01287.x; Bharath V, 2015, TRANSFUSION, V55, P2597, DOI 10.1111/trf.13200; Bichuetti-Silva DC, 2014, INT IMMUNOPHARMACOL, V23, P442, DOI 10.1016/j.intimp.2014.09.015; Cherin P, 2016, AUTOIMMUN REV, V15, P71, DOI 10.1016/j.autrev.2015.09.002; Crellin DJ, 2015, PAIN, V156, P2132, DOI 10.1097/j.pain.0000000000000305; Geng JS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008557.pub3; Graf J, 2019, ACTA NEUROL SCAND, V140, P290, DOI 10.1111/ane.13144; Guo Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01299; Hurelbrink CB, 2013, J CLIN NEUROSCI, V20, P1114, DOI 10.1016/j.jocn.2012.10.026; Katz U, 2007, AUTOIMMUN REV, V6, P257, DOI 10.1016/j.autrev.2006.08.011; Kwaan HC, 2013, CLIN HEMORHEOL MICRO, V55, P75, DOI 10.3233/CH-131691; Lemm G, 2002, NEUROLOGY, V59, pS28, DOI 10.1212/WNL.59.12_suppl_6.S28; Malviya S, 2006, PEDIATR ANESTH, V16, P258, DOI 10.1111/j.1460-9592.2005.01773.x; Markvardsen LH, 2015, BASIC CLIN PHARMACOL, V117, P409, DOI 10.1111/bcpt.12428; Matsuishi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194094; Merkel S I, 1997, Pediatr Nurs, V23, P293; Nosadini M, 2016, DEV MED CHILD NEUROL, V58, P1180, DOI 10.1111/dmcn.13159; Orbach H, 2005, CLIN REV ALLERG IMMU, V29, P173, DOI 10.1385/CRIAI:29:3:173; Palabrica FRR, 2013, ASIA PAC ALLERGY, V3, P249, DOI 10.5415/apallergy.2013.3.4.249; Pedersen LK, 2015, SCAND J PAIN, V9, P57, DOI 10.1016/j.sjpain.2015.06.007; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Saeedian M, 2014, INT ARCH ALLERGY IMM, V164, P151, DOI 10.1159/000363445; SEKUL EA, 1994, ANN INTERN MED, V121, P259, DOI 10.7326/0003-4819-121-4-199408150-00004; Shah S, 2005, AM J HEALTH-SYST PH, V62, pS5, DOI 10.2146/ajhp050282; Sherer Y, 2001, PHARMACOLOGY, V62, P133, DOI 10.1159/000056085; Singh-Grewal D, 2006, ARCH DIS CHILD, V91, P651, DOI 10.1136/adc.2005.078733; Souayah Nizar, 2011, J Clin Neuromuscul Dis, V12 Suppl 4, pS1, DOI 10.1097/CND.0b013e3182212589; Stangel M, 2003, J NEUROL, V250, P818, DOI 10.1007/s00415-003-1085-1; Steinberger BA, 2003, AM J HEMATOL, V73, P97, DOI 10.1002/ajh.10325; Stone MJ, 2012, BLOOD, V119, P2205, DOI 10.1182/blood-2011-04-347690; Thornby KA, 2015, ANN PHARMACOTHER, V49, P715, DOI 10.1177/1060028015576362; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2017, COMM TERM CRIT ADV E; Yelehe-Okouma M, 2018, FUND CLIN PHARMACOL, V32, P252, DOI 10.1111/fcp.12349	33	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227796	10.1371/journal.pone.0227796	http://dx.doi.org/10.1371/journal.pone.0227796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929600	Green Published, gold			2022-12-26	WOS:000534352500075
J	Pereira, LE; Katz, SS; Sun, YC; Mills, P; Taylor, W; Atkins, P; Thurlow, CM; Chi, KH; Danavall, D; Cook, N; Ahmed, T; Debra, A; Philip, S; Cohen, S; Workowski, KA; Kersh, E; Fakile, Y; Chen, CY; Pillay, A				Pereira, Lara E.; Katz, Samantha S.; Sun, Yongcheng; Mills, Patrick; Taylor, Willie; Atkins, Patricia; Thurlow, Charles M.; Chi, Kai-Hua; Danavall, Damien; Cook, Nicholas; Ahmed, Tamanna; Debra, Alyssa; Philip, Susan; Cohen, Stephanie; Workowski, Kimberly A.; Kersh, Ellen; Fakile, Yetunde; Chen, Cheng Y.; Pillay, Allan			Successful isolation of Treponema pallidum strains from patients' cryopreserved ulcer exudate using the rabbit model	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL SYPHILIS; SUBSP PALLIDUM; MACROLIDE RESISTANCE; ACTIVE SYPHILIS; EFFICACY; MUTATIONS; DIVERSITY; THERAPY	Clinical isolates of Treponema pallidum subspecies pallidum (T. pallidum) would facilitate study of prevalent strains. We describe the first successful rabbit propagation of T. pallidum from cryopreserved ulcer specimens. Fresh ulcer exudates were collected and cryopreserved with consent from syphilis-diagnosed patients (N = 8). Each of eight age-matched adult male rabbits were later inoculated with a thawed specimen, with two rabbits receiving 1.3 ml intratesticularly (IT), and six receiving 0.6 ml intravenously (IV) and IT. Monitoring of serology, blood PCR and orchitis showed that T. pallidum grew in 2/8 rabbits that were inoculated IV and IT with either a penile primary lesion specimen (CDC-SF003) or a perianal secondary lesion specimen (CDC-SF007). Rabbit CDC-SF003 was seroreactive by T. pallidum Particle Agglutination (TP-PA) and Rapid Plasma Reagin (RPR) testing, PCR+, and showed orchitis by week 6. Euthanasia was performed in week 7, with treponemal growth in the testes confirmed and quantified by qPCR and darkfield microscopy (DF). Serial passage of the extract in a second age-matched rabbit also yielded treponemes. Similarly, rabbit CDC-SF007 showed negligible orchitis, but was seroreactive and PCR+ by week 4 and euthanized in week 6 to yield T. pallidum, which was further propagated by second passage. Using the 4-component molecular typing system for syphilis, 3 propagated strains (CDC-SF003, CDC-SF007, CDC-SF008) were typed as 14d9f, 14d9g, and 14d10c, respectively. All 3 isolates including strain CDC-SF011, which was not successfully propagated, had the A2058G mutation associated with azithromycin resistance. Our results show that immediate cryopreservation of syphilitic ulcer exudate can maintain T. pallidum viability for rabbit propagation.	[Pereira, Lara E.; Katz, Samantha S.; Sun, Yongcheng; Chi, Kai-Hua; Danavall, Damien; Workowski, Kimberly A.; Kersh, Ellen; Fakile, Yetunde; Chen, Cheng Y.; Pillay, Allan] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30341 USA; [Mills, Patrick; Taylor, Willie] Ctr Dis Control & Prevent, Div Sci Resources, Atlanta, GA USA; [Atkins, Patricia] Charles River Labs, Wilmington, MA USA; [Thurlow, Charles M.; Cook, Nicholas; Ahmed, Tamanna; Debra, Alyssa] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Philip, Susan; Cohen, Stephanie] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Workowski, Kimberly A.] Emory Univ, Dept Med, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; San Francisco Department of Public Health; Emory University	Pereira, LE (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA 30341 USA.	vvg3@cdc.gov		Katz, Samantha/0000-0001-8481-3444	Advanced Molecular Detection (AMD) program at the CDC	Advanced Molecular Detection (AMD) program at the CDC	This work was made possible through CDC Division of STD Prevention with partial support from the Advanced Molecular Detection (AMD) program at the CDC. Patricia Atkins [PA] is employed by Charles River Laboratories. Charles River Laboratories provided support in the form of salary for author Patricia Atkins [PA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.; We would like to thank the CDC CMB veterinary and technical staff, Dr. Hsi Liu at the CDC Division of STD Prevention, Charles River Laboratories veterinary technicians, the San Francisco City Clinic Team, and Barbara Molini and Dr. Sheila Lukehart at the University of Washington for helpful consults and/or assistance regarding specimens and animal procedures.	American Veterinary Medical Association, 2013, AVMA GUIDELINES EUTH; [Anonymous], 2017, CDC CALL ACTION LETS; Arora N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.245; BAKERZANDER SA, 1989, ANTIMICROB AGENTS CH, V33, P1465, DOI 10.1128/AAC.33.9.1465; Beale MA, 2018, GENOMIC EPIDEMIOLOGY, DOI [10.1101/413161, DOI 10.1101/413161]; Cameron Caroline E, 2018, Sex Transm Dis, V45, pS17, DOI 10.1097/OLQ.0000000000000831; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Centers for Disease Control and Prevention, 2016, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2016, CLIN ADV OC SYPH US; Chen CY, 2013, J CLIN MICROBIOL, V51, P908, DOI 10.1128/JCM.02770-12; COLLART P, 1971, BRIT J VENER DIS, V47, P389; COX DL, 1994, METHOD ENZYMOL, V236, P390; Edmondson DG, 2018, MBIO, V9, DOI 10.1128/mBio.01153-18; FIELDSTEEL AH, 1981, INFECT IMMUN, V32, P908, DOI 10.1128/IAI.32.2.908-915.1981; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gao K, 2018, J INFECT DIS, V218, P835, DOI 10.1093/infdis/jiy241; Giacani L, 2010, J BACTERIOL, V192, P2645, DOI 10.1128/JB.00159-10; Grillova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202619; Grimes M, 2012, SEX TRANSM DIS, V39, P954, DOI 10.1097/OLQ.0b013e31826ae7a8; Henao-Martinez Andres F, 2014, Neurol Clin Pract, V4, P114; Kast CC, 1929, AM J SYPH, V13, P419; Katz KA, 2010, SEX TRANSM DIS, V37, P660, DOI 10.1097/OLQ.0b013e3181e1a77a; KORTING HC, 1993, CHEMOTHERAPY, V39, P331, DOI 10.1159/000239145; Kumar S, 2018, MBIO, V9, DOI [10.1128/mBio.01006-18, 10.1128/mbio.01006-18]; LaFond RE, 2006, INFECT IMMUN, V74, P1896, DOI 10.1128/IAI.74.3.1896-1906.2006; LaFond RE, 2003, J BACTERIOL, V185, P6262, DOI 10.1128/JB.185.21.6262-6268.2003; Lin LR, 2020, CLIN MICROBIOL INFEC, V26, P240, DOI 10.1016/j.cmi.2019.06.004; Lithgow KV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14273; Liu H, 2001, J CLIN MICROBIOL, V39, P1941, DOI 10.1128/JCM.39.5.1941-1946.2001; LUKEHART SA, 1990, J ANTIMICROB CHEMOTH, V25, P91, DOI 10.1093/jac/25.suppl_A.91; LUKEHART SA, 1988, ANN INTERN MED, V109, P855, DOI 10.7326/0003-4819-109-11-855; LUKEHART SA, 1984, ANTIMICROB AGENTS CH, V25, P390, DOI 10.1128/AAC.25.3.390; LUKEHART SA, 1987, ANTIMICROB AGENTS CH, V31, P187, DOI 10.1128/AAC.31.2.187; LUKEHART SA, 1992, J INFECT DIS, V166, P1449, DOI 10.1093/infdis/166.6.1449; Lukehart Sheila A, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12a01s7; MARRA C, 1991, J INFECT DIS, V163, P825, DOI 10.1093/infdis/163.4.825; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; MILLER JN, 1964, J INVEST DERMATOL, V42, P367, DOI 10.1038/jid.1964.80; Molini BJ, 2016, SEX TRANSM DIS, V43, P579, DOI 10.1097/OLQ.0000000000000486; Morgan CA, 2003, INFECT IMMUN, V71, P5605, DOI 10.1128/IAI.71.10.5605-5612.2003; Morgan CA, 2002, J IMMUNOL, V169, P952, DOI 10.4049/jimmunol.169.2.952; MOTHERSHED SM, 1967, BRIT J VENER DIS, V43, P267; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; NOGUCHI H., 1916, Ann. Inst. Pasteur, V30, P1; NORRIS SJ, 1986, INFECT IMMUN, V53, P534, DOI 10.1128/IAI.53.3.534-539.1986; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Petrosova H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001832; Pillay A, 2002, J CLIN MICROBIOL, V40, P256, DOI 10.1128/JCM.40.1.256-258.2002; Pillay A, 1998, SEX TRANSM DIS, V25, P408, DOI 10.1097/00007435-199809000-00004; Pillay A, 2019, SEX TRANSM DIS, V46, pE42, DOI 10.1097/OLQ.0000000000000935; Pillay A, 2015, EDUC CHANGE, V19, P4, DOI 10.1080/16823206.2015.1085619; Pinto M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.190; Ratnam Sam, 2005, Can J Infect Dis Med Microbiol, V16, P45; Reid TB, 2014, INFECT IMMUN, V82, P4959, DOI 10.1128/IAI.02236-14; RICE M, 1985, CAN J MICROBIOL, V31, P62, DOI 10.1139/m85-013; Rolfs RT, 1997, NEW ENGL J MED, V337, P307, DOI 10.1056/NEJM199707313370504; Salazar JC, 2007, INFECT IMMUN, V75, P2954, DOI 10.1128/IAI.00090-07; Schereschewsky J, 1909, DTSCH MED WCHNSCHR, V35, P835, DOI DOI 10.1055/S-0029-1201453; SELL S, 1982, LAB INVEST, V46, P355; Sena A, 2015, MANUAL CLIN MICROBIO, V1; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; SMITH JL, 1965, BRIT J VENER DIS, V41, P15; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Sun J, 2016, ONCOTARGET, V7, P42904, DOI 10.18632/oncotarget.10154; Tantalo LC, 2005, J INFECT DIS, V191, P75, DOI 10.1086/426510; Tong ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182768; Tong ML, 2017, CLIN CHIM ACTA, V464, P136, DOI 10.1016/j.cca.2016.11.031; TURNER T B, 1957, Monogr Ser World Health Organ, P3; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838	69	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227769	10.1371/journal.pone.0227769	http://dx.doi.org/10.1371/journal.pone.0227769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929602	Green Published, gold			2022-12-26	WOS:000534352500072
J	Ricardo, LIC; Wendt, A; Galliano, LM; Muller, WD; Cruz, GIN; Wehrmeister, F; Brage, S; Ekelund, U; Silva, ICM				Cardoso Ricardo, Luiza Isnardi; Wendt, Andrea; Galliano, Leony Morgana; Muller, Werner de Andrade; Nino Cruz, Gloria Izabel; Wehrmeister, Fernando; Brage, Soren; Ekelund, Ulf; Silva, Inacio Crochemore M.			Number of days required to estimate physical activity constructs objectively measured in different age groups: Findings from three Brazilian (Pelotas) population-based birth cohorts	PLOS ONE			English	Article							PROFILE UPDATE; YOUTH; INACTIVITY; HEALTH; WRIST; STATE; TIME	Purpose The present study aims to estimate the minimum number of accelerometer measurement days needed to estimate habitual physical activity (PA) among 6- (2010), 18- (2011) and 30(2012) year-old participants, belonging to three population-based Brazilian birth cohorts. Method PA was assessed by triaxial wrist-worn GENEActiv accelerometers and the present analysis is restricted to participants with at least 6 consecutive days of measurement. Accelerometer raw data were analyzed with R-package GGIR. Description of PA measures (overall PA, moderate-to-vigorous PA (MVPA), light PA (LPA)) on weekdays and weekend days were conducted, and statistical differences were tested with chi-squared and Kruskal-Wallis tests. Spearman Brown Formulae was applied to test reliability of different number of days of accelerometer use. Results Differences between week and weekend days regarding LPA, MVPA and overall PA, were only observed among 30-year-olds. Higher levels of MVPA (p = 0.006) and overall PA (p< 0.001) were identified on weekdays. For overall PA, to achieve a reliability coefficient > 0.70, two and three days of measurement were needed in adults and children, respectively. For LPA, a reliability coefficient > 0.70 was achieved with five days in 6-year-old children, three days in 18-year-old young adults, and four days in 30-year-old adults. Considering MVPA, four days would be necessary to represent a week of measurement among all cohort groups. Conclusion Our results show that four and five measurement days are needed to estimate all habitual PA constructs, for children and adults, respectively. Also, among 30-year-old adults, it is important to make efforts towards weekend days measurement.	[Cardoso Ricardo, Luiza Isnardi; Wendt, Andrea; Nino Cruz, Gloria Izabel; Wehrmeister, Fernando; Silva, Inacio Crochemore M.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Galliano, Leony Morgana; Muller, Werner de Andrade; Silva, Inacio Crochemore M.] Univ Fed Pelotas, Postgrad Program Phys Educ, Pelotas, RS, Brazil; [Brage, Soren] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	Universidade Federal de Pelotas; Universidade Federal de Pelotas; University of Cambridge; Norwegian School of Sport Sciences	Ricardo, LIC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	luizaicricardo@gmail.com	Ricardo, Luiza/B-8439-2017; Ekelund, Ulf/AAE-8471-2019; Wendt, Andrea/V-3818-2018; Wehrmeister, Fernando/A-3006-2014; Brage, Soren/C-6415-2013; , Leony/I-8447-2017; da Silva, Inacio Crochemore M/L-9896-2017	Ricardo, Luiza/0000-0002-1244-4501; Ekelund, Ulf/0000-0003-2115-9267; Wendt, Andrea/0000-0002-4640-2254; Wehrmeister, Fernando/0000-0001-7137-1747; Brage, Soren/0000-0002-1265-7355; , Leony/0000-0002-5599-0377; da Silva, Inacio Crochemore M/0000-0001-5390-8360; de Andrade Muller, Werner/0000-0001-9326-4854; Nino Cruz, Gloria Isabel/0000-0002-4951-5991	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Fundacao Medica do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq); Wellcome Trust; MRC [MC_UU_12015/3, MC_UU_00006/4] Funding Source: UKRI	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Medica do Rio Grande do Sul; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. LMG was funded by the Fundacao Medica do Rio Grande do Sul; FCW has a research productivity grant, level 2, granted by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq). All three birth cohorts were partially funded by Wellcome Trust.	Addy CL, 2014, PEDIATR EXERC SCI, V26, P103, DOI 10.1123/pes.2013-0021; Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; [Anonymous], 2000, WHO TECHN REP SER; Arena R, 2017, PROG CARDIOVASC DIS, V59, P422, DOI 10.1016/j.pcad.2017.02.002; Barr AL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001044; Bassett DR, 2015, MED SCI SPORT EXER, V47, P833, DOI 10.1249/MSS.0000000000000468; Bull FC, 2004, COMP QUANTIFICATION, DOI DOI 10.1016/j.diabres.2013.11.002; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; da Silva ICM, 2014, INT J EPIDEMIOL, V43, P1959, DOI 10.1093/ije/dyu203; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dillon CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0109913; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; Eisinga R, 2013, INT J PUBLIC HEALTH, V58, P637, DOI 10.1007/s00038-012-0416-3; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Goncalves H, 2014, INT J EPIDEMIOL, V43, P1082, DOI 10.1093/ije/dyu077; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Hislop J, 2014, PHYSIOL MEAS, V35, P2213, DOI 10.1088/0967-3334/35/11/2213; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; Jaeschke L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5415-8; Kim Y, 2012, J SCI MED SPORT, V15, P311, DOI 10.1016/j.jsams.2011.12.001; Lande R G, 2015, WINNOWER, P1, DOI DOI 10.15200/WINN.143518.81744; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Nilsson A, 2009, SCAND J MED SCI SPOR, V19, P10, DOI 10.1111/j.1600-0838.2007.00762.x; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Roscoe Clare M P, 2019, J Funct Morphol Kinesiol, V4, DOI 10.3390/jfmk4030065; Rutstein SO, 2015, STEPS CONSTRUCTING N; Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5; Santos IS, 2014, INT J EPIDEMIOL, V43, P1437, DOI 10.1093/ije/dyu144; Scheers T, 2012, EUR J APPL PHYSIOL, V112, P1653, DOI 10.1007/s00421-011-2131-9; Treuth MS, 2007, OBESITY, V15, P1782, DOI 10.1038/oby.2007.212; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; van Hees VT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31266-z; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91	40	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0216017	10.1371/journal.pone.0216017	http://dx.doi.org/10.1371/journal.pone.0216017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923194	Green Published, gold			2022-12-26	WOS:000534350000002
J	Yong, HY; Shariff, ZM; Yusof, BNM; Rejali, Z; Appannah, G; Bindels, J; Tee, YYS; van der Beek, EM				Yong, Heng Yaw; Shariff, Zalilah Mohd; Yusof, Barakatun-Nisak Mohd; Rejali, Zulida; Appannah, Geeta; Bindels, Jacques; Tee, Yvonne Yee Siang; van der Beek, Eline M.			The association between dietary patterns before and in early pregnancy and the risk of gestational diabetes mellitus (GDM): Data from the Malaysian SECOST cohort	PLOS ONE			English	Article							WEIGHT-GAIN; LIFE-STYLE; WOMEN	Generally, dietary patterns (DP)s have been linked to the risk of diabetes mellitus, however, only few studies examined the associations between DPs in early pregnancy and the risk of gestational diabetes mellitus (GDM). This study aims to determine the association between DPs before and during pregnancy and risk of GDM in Malaysian pregnant women. DPs were derived using principal component analysis of consumed 126 food and beverage items assessed using a validated semi-quantitative food frequency questionnaire collecting data retrospectively for pre-pregnancy, but prospectively for the first and second trimester. Three different DPs were identified at each time point and labelled as DP 1-3 (pre-pregnancy), DP 4-6 (first trimester), and DP 7-9 (second trimester). About 10.6% (n = 48) of pregnant women were diagnosed with GDM in our cohort. Women with high adherence (HA) to DP 2 (adjusted OR: 0.45, 95% CI: 0.20-0.91) and DP 5 (adjusted OR: 0.28, 95% CI: 0.11-0.68) showed a significantly reduced risk of GDM compared to women with low adherence (LA). Other DPs were not significantly associated with GDM risk. Compared to women with GDM, non-GDM women showed HA scores for all DPs throughout pregnancy. Overall, a relative low percentage of women with GDM was found in this cohort. The risk was lower in women with HA to a relatively unhealthy dietary pattern, i.e. DP 2 and DP 5. The lower body mass index (BMI) status and energy intake of women showing a HA to DP 2 in the first trimester may underlie the observed association with a lower GDM risk. Additionally, genetic variance might explain the less susceptibility to GDM despite HA to unhealthy DPs among non-GDM women.	[Yong, Heng Yaw; Shariff, Zalilah Mohd; Yusof, Barakatun-Nisak Mohd; Appannah, Geeta] Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Rejali, Zulida] Univ Putra Malaysia, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Bindels, Jacques; van der Beek, Eline M.] Danone Nutricia Res, Utrecht, Netherlands; [Tee, Yvonne Yee Siang] Danone Dumex M Shd Bhd, Nilai, Negeri Sembilan, Malaysia; [van der Beek, Eline M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands	Universiti Putra Malaysia; Universiti Putra Malaysia; Danone Nutricia; University of Groningen	Shariff, ZM (corresponding author), Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.	zalilahms@upm.edu.my	Yusof, Barakatun Nisak Mohd/J-8414-2014; Yong, Heng Yaw/J-8425-2017	Yusof, Barakatun Nisak Mohd/0000-0003-0403-5895; Yong, Heng Yaw/0000-0002-0454-641X; Mohd Shariff, Zalilah/0000-0002-5347-4627	Danone Dumex (Malaysia) Shd. Bhd.	Danone Dumex (Malaysia) Shd. Bhd.(Danone Nutricia)	SECOST was supported by a research grant from Danone Dumex (Malaysia) Shd. Bhd. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PHYS STAT US INT ANT; Bao W, 2014, AM J CLIN NUTR, V99, P1378, DOI 10.3945/ajcn.113.082966; Bastani A, 2013, PLOS ONE; Black AE., 2000, CRITICAL EVALUATION; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Cespedes EM, 2015, AM J CLIN NUTR, V101, P899, DOI 10.3945/ajcn.115.110213; Chong YS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-345; Nguyen CL, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/6536974; Daraki V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126327; de Seymour J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090574; Dekker Louise H., 2015, FOOD NUTR RES, V59, P1; DeSisto CL, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130415; Donazar-Ezcurra M, 2017, BR J NUTR, P1; Du HY, 2017, BIOMED ENVIRON SCI, V30, P887, DOI 10.3967/bes2017.119; Gorgulho BM, 2019, REV BRAS EPIDEMIOL, V22; Grieger JA, 2014, J NUTR; He JR, 2015, BRIT J NUTR, V113, P1292, DOI 10.1017/S0007114515000707; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Hu FB., DIETARY PATTERN ANAL, P3; International Diabetes Federation (IDF), 2017, IDF DIABETES ATLAS; IPH, 2016, NAT HLTH MORB SURV 2; Jarman M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070914; Jeganathan R., 2015, PRELIMINARY REPORT N; Koivusalo SB, 2016, DIABETES CARE, V39, P24, DOI 10.2337/dc15-0511; Kwapisz J, 2013, PRELIMINARY REPORT N, P1; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; Lamminpaa R, 2018, EUR J NUTR, V57, P1721, DOI 10.1007/s00394-017-1567-z; Liu FL, 2015, CHINESE MED J-PEKING, V128, P1778, DOI 10.4103/0366-6999.159354; Logakodie S, 2017, Malays Fam Physician, V12, P9; Loy S L, 2011, Malays J Nutr, V17, P1; Loy SL, 2013, INT J FOOD SCI NUTR, V7486, P1; Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; Michels KB, 2005, NUTR RES REV, V18, P241, DOI 10.1079/NRR2005107; Ministry of Health Malaysia, 2013, PER CAR MAN, V3rd; Ministry of Health Malaysia, 2005, REC NUTR INT MAL; Ministry of Health Malaysia, 2007, MAL AD NUTR SURV MAN; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Oostvogels AJJM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177554; Petrella E, 2014, J MATERN-FETAL NEO M, V27, P1348, DOI 10.3109/14767058.2013.858318; Radesky JS, 2008, PAEDIATR PERINAT EP, V22, P47, DOI 10.1111/j.1365-3016.2007.00899.x; Rasmussen MA, 2014, PLOS ONE; Santana JD, 2015, NUTR HOSP, V32, P130, DOI 10.3305/nh.2015.32.1.8970; Schoenaker DAJM, 2016, DIABETES CARE, V39, P16, DOI 10.2337/dc15-0540; Schoenaker DAJM, 2015, DIABETOLOGIA, V58, P2726, DOI 10.1007/s00125-015-3742-1; Schoenaker DAJM, 2015, AM J CLIN NUTR, V102, P94, DOI 10.3945/ajcn.114.102475; Sedaghat F, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/5173926; Shadman Z, 2014, IRAN RED CRESCENT ME, V16; Shimodaira M, 2016, DIABETES METAB SYND, V10, pS102, DOI 10.1016/j.dsx.2016.03.003; Shin D, 2015, NUTRIENTS, V7, P9369, DOI 10.3390/nu7115472; Tielemans MJ, 2015, NUTRIENTS, V7, P9383, DOI 10.3390/nu7115476; Tobias DK, 2012, AM J CLIN NUTR, V96, P289, DOI 10.3945/ajcn.111.028266; Tryggvadottir EA, 2016, EUR J CLIN NUTR, V70, P237, DOI 10.1038/ejcn.2015.145; Watanabe RM, 2011, GENOME MED, V3, DOI 10.1186/gm232; Wei YM, 2014, CHINESE MED J-PEKING, V127, P3553, DOI 10.3760/cma.j.issn.0366-6999.20140898; Wu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep30539; Yin YN, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092596; Yong HY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018321; Yong HY, 2019, ASS DIETARY PATTERNS; Zareei S, 2018, DIABETES METAB SYND, V12, P399, DOI 10.1016/j.dsx.2018.03.004; Zhang C, 2006, DIABETOLOGIA, V49, P2604, DOI 10.1007/s00125-006-0422-1; Zhang CL, 2013, HUM REPROD UPDATE, V19, P376, DOI 10.1093/humupd/dmt013	63	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227246	10.1371/journal.pone.0227246	http://dx.doi.org/10.1371/journal.pone.0227246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923230	Green Published, gold			2022-12-26	WOS:000534350000107
J	Zhang, L; Zhao, SQ; Zhu, YF				Zhang, Lei; Zhao, Shiqi; Zhu, Yunfeng			Long noncoding RNA growth arrest-specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2	FASEB JOURNAL			English	Article						diabetic nephropathy; enhancer of zeste homolog 2; histone H3 methylated Lys27; long noncoding RNA growth arrest-specific transcript 5; matrix metalloproteinase 9; renal fibrosis	LNCRNA GAS5; TUMOR-GROWTH; EXPRESSION; PATHOGENESIS; CELLS; MMP9	Diabetic nephropathy (DN) is a frequently occurred microvascular complication associated with type I and type II diabetes mellitus. The participation of long noncoding RNAs (lncRNAs) in diabetes-related microvascular complications has been reported extensively. We attempted to unveil the possible regulatory mechanism of lncRNA growth arrest-specific transcript 5 (GAS5) and matrix metalloproteinase 9 (MMP9), an important inflammatory protein, in the progression of DN. A rat DN model was induced by streptozocin (STZ). The low expression of GAS5 and high expression of MMP9 in DN rats with DN was then determined by RT-qPCR and western blot analysis, and lentivirus-mediated GAS5 overexpression was shown to ameliorate STZ-induced renal interstitial fibrosis (RIF) and inflammatory reaction in the kidney of DN rats. Moreover, MMP9 was found to be upregulated in STZ-induced DN, while MMP9 silencing induced by lentivirus expressing shRNA against MMP9 reduced RIF and suppressed inflammation in the kidney of DN rats. RIP, RNA pull-down, and ChIP assays demonstrated that GAS5 downregulated MMP9 via recruiting enhancer of zeste homolog 2 (EZH2) in the promoter region of MMP9. Overall, our study reveals that GAS5 downregulates MMP9 expression through recruiting EZH2 to MMP9 promoter region and alleviates the progression of renal fibrosis in DN rats, which sheds new light on the therapeutic potential of GAS5-targeted therapies in combating that disease.	[Zhang, Lei] Linyi Peoples Hosp, Dept Kidney Med, Linyi, Shandong, Peoples R China; [Zhao, Shiqi; Zhu, Yunfeng] Linyi Peoples Hosp, Dept Emergency Med, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China		Zhu, YF (corresponding author), Linyi Peoples Hosp, Dept Emergency Med, 27 Jiefang Rd, Linyi 276000, Shandong, Peoples R China.	ever919@163.com						Biranvand AS, 2018, INT ANGIOL, V37, P451, DOI 10.23736/S0392-9590.18.04022-1; Cakirca G, 2018, IRAN J KIDNEY DIS, V12, P299; Carter G, 2015, BBA CLIN, V4, P102, DOI 10.1016/j.bbacli.2015.09.001; Chen L, 2016, ONCOTARGETS THER, V9, P4075, DOI 10.2147/OTT.S98203; Chen S, 2017, J DIABETES COMPLICAT, V31, P569, DOI 10.1016/j.jdiacomp.2016.11.017; Fernandez-Fernandez B, 2014, NAT REV NEPHROL, V10, P325, DOI 10.1038/nrneph.2014.74; Fineberg D, 2013, NAT REV ENDOCRINOL, V9, P713, DOI 10.1038/nrendo.2013.184; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gao JJ, 2018, BIOMED PHARMACOTHER, V106, P543, DOI 10.1016/j.biopha.2018.06.104; Geng XM, 2019, NEPHROLOGY, V24, P405, DOI 10.1111/nep.13476; Gnudi L, 2016, TRENDS ENDOCRIN MET, V27, P820, DOI 10.1016/j.tem.2016.07.002; Goustin AS, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5030046; Hu MS, 2017, J CELL MOL MED, V21, P2732, DOI 10.1111/jcmm.13189; Inada A, 2008, J CELL PHYSIOL, V215, P383, DOI 10.1002/jcp.21316; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Leti F, 2017, PERS MED, V14, P271, DOI 10.2217/pme-2016-0107; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Lin CY, 2018, J FORMOS MED ASSOC, V117, P727, DOI 10.1016/j.jfma.2017.09.012; Liu HL, 2019, EUR REV MED PHARMACO, V23, P4414, DOI 10.26355/eurrev_201905_17949; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lotfy M, 2017, CURR DIABETES REV, V13, P3, DOI 10.2174/1573399812666151016101622; Nagib AM, 2019, EXP CLIN TRANSPLANT, V17, P138, DOI 10.6002/ect.2018.0157; Qi M, 2017, CELL PHYSIOL BIOCHEM, V41, P466, DOI 10.1159/000456599; Rao P, 2019, LAB INVEST, V99, P1689, DOI 10.1038/s41374-019-0276-z; Shi Y, 2019, CELL CHEM BIOL, V26, P319, DOI 10.1016/j.chembiol.2018.11.012; Sun DY, 2017, EMBO REP, V18, P1801, DOI 10.15252/embr.201643668; Tan RJ, 2012, AM J PHYSIOL-RENAL, V302, pF1351, DOI 10.1152/ajprenal.00037.2012; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tandon A, 2011, BIOINFORMATION, V5, P310, DOI 10.6026/97320630005310; Umanath K, 2018, AM J KIDNEY DIS, V71, P884, DOI 10.1053/j.ajkd.2017.10.026; van der Zijl NJ, 2010, CLIN BIOCHEM, V43, P635, DOI 10.1016/j.clinbiochem.2010.02.006; Wang HY, 2011, INDIAN J BIOCHEM BIO, V48, P308; Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8; Wang Y, 2018, CURR GENE THER, V18, P275, DOI 10.2174/1566523218666181008125010; Yang XH, 2018, ENDOKRYNOL POL, V69, P269, DOI 10.5603/EP.a2018.0029; Ye JM, 2018, EXP CELL RES, V369, P348, DOI 10.1016/j.yexcr.2018.05.039; Yuan J, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0708-1; Zanchi C, 2017, DIABETOLOGIA, V60, P1114, DOI 10.1007/s00125-017-4248-9; Zhang Q, 2015, ONCOTARGET, V6, P37335, DOI 10.18632/oncotarget.6135; Zheng L, 2017, MOL MED REP, V15, P1702, DOI 10.3892/mmr.2017.6208; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850; Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593; Zhou Z, 2017, DIABETES THER, V8, P555, DOI 10.1007/s13300-017-0256-5	43	32	35	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2703	2714		10.1096/fj.201901380RR	http://dx.doi.org/10.1096/fj.201901380RR		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916627				2022-12-26	WOS:000506442700001
J	Kim, JH; Ahn, JB; Kim, DH; Kim, S; Ma, HW; Che, X; Seo, DH; Kim, TI; Kim, WH; Cheon, JH; Kim, SW				Kim, J. H.; Ahn, J. B.; Kim, D. H.; Kim, S.; Ma, H. W.; Che, X.; Seo, D. H.; Kim, T. I.; Kim, W. H.; Cheon, J. H.; Kim, S. W.			Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22	JOURNAL OF CROHNS & COLITIS			English	Meeting Abstract									[Kim, J. H.; Kim, D. H.; Ma, H. W.; Che, X.; Seo, D. H.; Kim, T. I.; Cheon, J. H.; Kim, S. W.] Yonsei Univ, Brain Korea 21 PLUS Project Med Sci, Coll Med, Seoul, South Korea; [Ahn, J. B.] Yonsei Univ, Dept Med, Coll Med, Seoul, South Korea; [Kim, S.; Kim, W. H.] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, S.; Kim, W. H.] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System			Cheon, Jae Hee/B-4523-2015	Cheon, Jae Hee/0000-0002-2282-8904; Kim, Seung Won/0000-0002-1692-1192; Kim, Soochan/0000-0002-2577-2969; Kim, Won Ho/0000-0002-5682-9972; Kim, Tae Il/0000-0003-4807-890X; KIM, JAEHYEON/0000-0003-0064-6656					0	9	9	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1873-9946	1876-4479		J CROHNS COLITIS	J. Crohns Colitis	JAN	2020	14			1		P105	S188	S188						1	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	KT1WK	31916636				2022-12-26	WOS:000518803401004
J	Coombes, D; Davies, JS; Newton-Vesty, MC; Horne, CR; Setty, TG; Subramanian, R; Moir, JWB; Friemann, R; Panjikar, S; Griffin, MDW; North, RA; Dobson, RCJ				Coombes, David; Davies, James S.; Newton-Vesty, Michael C.; Horne, Christopher R.; Setty, Thanuja G.; Subramanian, Ramaswamy; Moir, James W. B.; Friemann, Rosmarie; Panjikar, Santosh; Griffin, Michael D. W.; North, Rachel A.; Dobson, Renwick C. J.			The basis for non-canonical ROK family function in the N-acetylmannosamine kinase from the pathogen Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Staphylococcus aureus (S; aureus); X-ray crystallography; analytical ultracentrifugation; small-angle X-ray scattering (SAXS); structural biology; N-aceytlmannosamine kinase; repressor; open reading frame; kinase; ROK protein family; sialic acid; sugar kinase	X-RAY DIFFRACTION; SIALIC-ACID CATABOLISM; MOLECULAR REPLACEMENT; ESCHERICHIA-COLI; ACETYLNEURAMINATE LYASE; CRYSTAL-STRUCTURES; BACILLUS-SUBTILIS; GLUCOSE KINASE; PURIFICATION; CRYSTALLIZATION	In environments where glucose is limited, some pathogenic bacteria metabolize host-derived sialic acid as a nutrient source. N-Acetylmannosamine kinase (NanK) is the second enzyme of the bacterial sialic acid import and degradation pathway and adds phosphate to N-acetylmannosamine using ATP to prime the molecule for future pathway reactions. Sequence alignments reveal that Gram-positive NanK enzymes belong to the Repressor, ORF, Kinase (ROK) family, but many lack the canonical Zn-binding motif expected for this function, and the sugar-binding EXGH motif is altered to EXGY. As a result, it is unclear how they perform this important reaction. Here, we study the Staphylococcus aureus NanK (SaNanK), which is the first characterization of a Gram-positive NanK. We report the kinetic activity of SaNanK along with the ligand?free, N-acetylmannosamine?bound and substrate analog GlcNAc?bound crystal structures (2.33, 2.20, and 2.20 ? resolution, respectively). These demonstrate, in combination with small-angle X-ray scattering, that SaNanK is a dimer that adopts a closed conformation upon substrate binding. Analysis of the EXGY motif reveals that the tyrosine binds to the N-acetyl group to select for the ?boat? conformation of N-acetylmannosamine. Moreover, SaNanK has a stacked arginine pair coordinated by negative residues critical for thermal stability and catalysis. These combined elements serve to constrain the active site and orient the substrate in lieu of Zn binding, representing a significant departure from canonical NanK binding. This characterization provides insight into differences in the ROK family and highlights a novel area for antimicrobial discovery to fight Gram-positive and S. aureus infections.	[Coombes, David; Davies, James S.; Newton-Vesty, Michael C.; Horne, Christopher R.; North, Rachel A.; Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Coombes, David; Davies, James S.; Newton-Vesty, Michael C.; Horne, Christopher R.; North, Rachel A.; Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Setty, Thanuja G.; Subramanian, Ramaswamy] NCBS, Inst Stem Cell Biol & Regenerat Med, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India; [Setty, Thanuja G.] Univ Trans Disciplinary Hlth Sci & Technol TDU, Bangalore 560064, Karnataka, India; [Moir, James W. B.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Friemann, Rosmarie] Sahlgrens Univ Hosp, Dept Clin Microbiol, Guldhedsgatan 10A, S-41346 Gothenburg, Sweden; [Friemann, Rosmarie] Univ Gothenburg, Ctr Antibiot Resistance Res CARe, S-40530 Gothenburg, Sweden; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Panjikar, Santosh] Australian Synchrotron, ANSTO, Clayton, Vic 3168, Australia; [Griffin, Michael D. W.; Dobson, Renwick C. J.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Canterbury; University of Canterbury; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of York - UK; Sahlgrenska University Hospital; University of Gothenburg; Monash University; Australian Nuclear Science & Technology Organisation; University of Melbourne	Dobson, RCJ (corresponding author), Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand.; Dobson, RCJ (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand.; North, RA (corresponding author), POB 4800, Christchurch 8140, New Zealand.	rachel.north@dbb.su.se; renwick.dobson@canterbury.ac.nz	North, Rachel/W-3575-2019; Dobson, Renwick/AAZ-7020-2021; Friemann, Rosmarie/C-1018-2008; Panjikar, Santosh/D-2709-2012	North, Rachel/0000-0001-5011-1567; Dobson, Renwick/0000-0002-5506-4939; Friemann, Rosmarie/0000-0002-5633-2894; Gangisetty, Thanuja/0000-0002-3162-8138; Subramanian, Ramaswamy/0000-0002-6709-190X; Griffin, Michael/0000-0001-9845-7735; Coombes, David/0000-0001-6384-2617; Davies, James/0000-0003-4029-1650; Panjikar, Santosh/0000-0001-7429-3879; Horne, Christopher R./0000-0003-1318-514X	New Zealand Royal Society Marsden Fund [UOC1506]; Ministry of Business, Innovation and Employment Smart Ideas Grant [UOCX1706]; Biomolecular Interactions Centre (University of Canterbury); Australian Research Council [FT140100544]; University of Canterbury; DBT-Indo Swedish Grant [BT/IN/SWEDEN/06/SR/2017-18]; Council of Scientific and Industrial Research (CSIR); Swedish Governmental Agency for Innovation Systems (VINNOVA) [2017-00180]; Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg; Erskine distinguished Visiting Fellowship	New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Ministry of Business, Innovation and Employment Smart Ideas Grant; Biomolecular Interactions Centre (University of Canterbury); Australian Research Council(Australian Research Council); University of Canterbury; DBT-Indo Swedish Grant; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Swedish Governmental Agency for Innovation Systems (VINNOVA)(Vinnova); Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg; Erskine distinguished Visiting Fellowship	This work was supported by in part by New Zealand Royal Society Marsden Fund contract UOC1506, Ministry of Business, Innovation and Employment Smart Ideas Grant UOCX1706, and the Biomolecular Interactions Centre (University of Canterbury) (to R. C. J. D.), Australian Research Council Future Fellowship project FT140100544 (to M. D. W. G.), University of Canterbury Doctoral Scholarships (to D. C. and R. A. N.), New Zealand Royal Society Marsden Fund contract UOC1506 (to R. A. N.), DBT-Indo Swedish Grant BT/IN/SWEDEN/06/SR/2017-18 (to R. S. and T. G. S.), a Senior Research fellowship from the Council of Scientific and Industrial Research (CSIR) (to T. G. S.), Swedish Governmental Agency for Innovation Systems (VINNOVA) Grant 2017-00180 (to R. F.) and the Centre for Antibiotic Resistance Research (CARe) at University of Gothenburg (to R. F.), and an Erskine distinguished Visiting Fellowship (to J. W. B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abergel C, 2013, ACTA CRYSTALLOGR D, V69, P2167, DOI 10.1107/S0907444913015291; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Caing-Carlsson R, 2017, ACTA CRYSTALLOGR F, V73, P356, DOI 10.1107/S2053230X17007439; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conejo MS, 2010, J MOL EVOL, V70, P545, DOI 10.1007/s00239-010-9351-1; Coombes D, 2019, BIOCHEM SOC T, V47, P1533, DOI 10.1042/BST20180626; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P129; Davies JS, 2019, FEBS LETT, V593, P52, DOI 10.1002/1873-3468.13289; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Griffin MDW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040318; HORECKER BL, 1948, J BIOL CHEM, V175, P385; Imriskova I, 2005, RES MICROBIOL, V156, P361, DOI 10.1016/j.resmic.2004.11.001; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kakkar T, 2000, J PHARMACOL EXP THER, V293, P861; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Komatsuzawa H, 2004, MOL MICROBIOL, V53, P1221, DOI 10.1111/j.1365-2958.2004.04200.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larion M, 2007, BIOCHEMISTRY-US, V46, P13564, DOI 10.1021/bi700924d; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Martinez J, 2012, J BIOL CHEM, V287, P13656, DOI 10.1074/jbc.M111.318170; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mesak LR, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-6; Miyazono K, 2012, J BACTERIOL, V194, P607, DOI 10.1128/JB.06173-11; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nocek B, 2011, J MOL BIOL, V406, P325, DOI 10.1016/j.jmb.2010.12.021; North RA, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00233; North Rachel A, 2018, Biophys Rev, V10, P219, DOI 10.1007/s12551-017-0343-x; North RA, 2016, FEBS LETT, V590, P4414, DOI 10.1002/1873-3468.12462; North RA, 2014, ACTA CRYSTALLOGR F, V70, P650, DOI 10.1107/S2053230X14007171; North RA, 2013, ACTA CRYSTALLOGR F, V69, P306, DOI 10.1107/S1744309113003060; Olson ME, 2013, J BACTERIOL, V195, P1779, DOI 10.1128/JB.02294-12; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Pelissier MC, 2014, J BIOL CHEM, V289, P35215, DOI 10.1074/jbc.M114.604272; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plumbridge J, 2015, J MOL MICROB BIOTECH, V25, P154, DOI 10.1159/000369583; Ringborg RH, 2016, REACT CHEM ENG, V1, P10, DOI 10.1039/c5re00045a; Ryan TM, 2018, J APPL CRYSTALLOGR, V51, P97, DOI 10.1107/S1600576717017101; Schiefner A, 2005, J BIOL CHEM, V280, P29073, DOI 10.1074/jbc.M504215200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skarlatos P, 1998, J BACTERIOL, V180, P3222, DOI 10.1128/JB.180.12.3222-3226.1998; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Thompson J, 2002, J BIOL CHEM, V277, P34310, DOI 10.1074/jbc.M206397200; Uehara T, 2004, J BACTERIOL, V186, P7273, DOI 10.1128/JB.186.21.7273-7279.2004; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vergne-Vaxelaire C, 2018, APPL MICROBIOL BIOT, V102, P5569, DOI 10.1007/s00253-018-9018-1; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wahlgren WY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04045-7; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	62	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3301	3315		10.1074/jbc.RA119.010526	http://dx.doi.org/10.1074/jbc.RA119.010526			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	31949045	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000519597300033
J	Bloodgood, JCG; Hernandez, SM; Isaiah, A; Suchodolski, JS; Hoopes, LA; Thompson, PM; Waltzek, TB; Norton, TM				Bloodgood, Jennifer C. G.; Hernandez, Sonia M.; Isaiah, Anitha; Suchodolski, Jan S.; Hoopes, Lisa A.; Thompson, Patrick M.; Waltzek, Thomas B.; Norton, Terry M.			The effect of diet on the gastrointestinal microbiome of juvenile rehabilitating green turtles (Chelonia mydas)	PLOS ONE			English	Article							COMMUNITY; HINDGUT; EVOLUTION; HABITAT; FLORIDA; HEALTH; SHIFTS; LIFE	Threatened and endangered green turtles (Chelonia mydas) are unique because as juveniles they recruit from pelagic to near-shore waters and shift from an omnivorous to primarily herbivorous diet (i.e. seagrass and algae). Nevertheless, when injured and ill animals are admitted to rehabilitation, animal protein (e.g. seafood) is often offered to combat poor appetite and emaciation. We examined how the fecal microbiome of juvenile green turtles changed in response to a dietary shift during rehabilitation. We collected fecal samples from January 2014 -January 2016 from turtles (N = 17) in rehabilitation at the Georgia Sea Turtle Center and used next generation sequencing to analyze bacterial community composition. Samples were collected at admission, mid-rehabilitation, and recovery, which entailed a shift from a mixed seafood-vegetable diet at admission to a primarily herbivorous diet at recovery. The dominant phyla changed over time, from primarily Firmicutes (55.0%) with less Bacteroidetes (11.4%) at admission, to primarily Bacteroidetes (38.4%) and less Firmicutes (31.8%) at recovery. While the microbiome likely shifts with the changing health status of individuals, this consistent inversion of Bacteroidetes and Firmicutes among individuals likely reflects the increased need for protein digestion, for which Bacteroidetes are important. Firmicutes are significant in metabolizing plant polysaccharides; thus, fewer Firmicutes may result in underutilization of wild diet items in released individuals. This study demonstrates the importance of transitioning rehabilitating green turtles to an herbivorous diet as soon as possible to afford them the best probability of survival.	[Bloodgood, Jennifer C. G.; Hernandez, Sonia M.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Bloodgood, Jennifer C. G.; Hernandez, Sonia M.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Isaiah, Anitha; Suchodolski, Jan S.] Texas A&M Univ, Gastrointestinal Lab, Coll Vet Med & Biomed Sci, College Stn, TX USA; [Hoopes, Lisa A.] Georgia Aquarium, Atlanta, GA USA; [Thompson, Patrick M.; Waltzek, Thomas B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL USA; [Norton, Terry M.] Jekyll Isl Author, Georgia Sea Turtle Ctr, Jekyll Isl, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of Florida	Bloodgood, JCG (corresponding author), Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.; Bloodgood, JCG (corresponding author), Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	bloodgood.jennifer@gmail.com	Waltzek, Thomas/AHD-3209-2022	Bloodgood, Jennifer/0000-0002-9044-8591; Isaiah, Anitha/0000-0001-7118-4124; Hernandez, Sonia/0000-0002-6336-7286	American Association of Zoo Veterinarians Wild Animal Health Fund; Coca-Cola Company; Georgia Aquarium	American Association of Zoo Veterinarians Wild Animal Health Fund; Coca-Cola Company; Georgia Aquarium	This work was made possible with funding from the American Association of Zoo Veterinarians Wild Animal Health Fund (https://wildanimalhealthfund.org/), The Coca-Cola Company, and Georgia Aquarium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman KFA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01060; Ahasan MS, 2018, MICROBIOL RES, V207, P91, DOI 10.1016/j.micres.2017.11.010; Ahasan MS, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix139; Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Arizza V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220329; Arthur KE, 2008, MAR ECOL PROG SER, V362, P303, DOI 10.3354/meps07440; Biagi E, 2019, ENV MICROBIOL REP, V11, P361, DOI 10.1111/1758-2229.12683; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Bloodgood JCG, 2019, J ZOO WILDLIFE MED, V50, P69, DOI 10.1638/2017-0250; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Campos P, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0454-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardona L, 2010, J EXP MAR BIOL ECOL, V393, P83, DOI 10.1016/j.jembe.2010.07.004; Cardona L, 2009, MAR BIOL, V156, P1487, DOI 10.1007/s00227-009-1188-z; Colston TJ, 2016, MOL ECOL, V25, P3776, DOI 10.1111/mec.13730; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eigeland KA, 2012, AQUAT MAMM, V38, P402, DOI 10.1578/AM.38.4.2012.402; Carman VG, 2012, J EXP MAR BIOL ECOL, V429, P64, DOI 10.1016/j.jembe.2012.06.007; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Howell LN, 2016, MAR ECOL PROG SER, V559, P217, DOI 10.3354/meps11897; Julliand V, 2016, J ANIM SCI, V94, P2262, DOI 10.2527/jas.2015-0198; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Merson SD, 2014, FEMS MICROBIOL ECOL, V87, P601, DOI 10.1111/1574-6941.12248; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Price JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177642; Rafii Fatemeh, 2008, Ther Clin Risk Manag, V4, P1343; Rawski M, 2018, ANIM SCI PAP REP, V36, P87; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seminoff J.A., 2004, CHELONIA MYDAS; Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Yuan ML, 2015, MOL ECOL, V24, P2521, DOI 10.1111/mec.13169; Zhang X, 2014, AQUACULT NUTR, V20, P667, DOI 10.1111/anu.12128	38	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227060	10.1371/journal.pone.0227060	http://dx.doi.org/10.1371/journal.pone.0227060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940380	Green Submitted, Green Published, gold			2022-12-26	WOS:000534368000058
J	Brugueras, S; Molina, VI; Casas, X; Gonzalez, YD; Forcada, N; Romero, D; Rodes, A; Altet, MN; Maldonado, J; Martin-Sanchez, M; Cayla, JA; Orcau, A; Rius, C; Millet, JP				Brugueras, Silvia; Molina, Vinicio-Israel; Casas, Xavier; Gonzalez, Yoel-Domingo; Forcada, Nuria; Romero, Dora; Rodes, Anna; Altet, Maria-Neus; Maldonado, Jose; Martin-Sanchez, Mario; Cayla, Joan A.; Orcau, Angels; Rius, Cristina; Millet, Joan-Pau			Tuberculosis recurrences and predictive factors in a vulnerable population in Catalonia	PLOS ONE			English	Article							EXOGENOUS REINFECTION; RISK-FACTORS; HIV-INFECTION; RELAPSE; IMPACT	Background Patients with a history of tuberculosis (TB) have a high probability of recurrence because long-term cure is not always maintained in successfully treated patients. The aim of this study was to identify the probability of TB recurrence and its predictive factors in a cohort of socially vulnerable patients who completed treatment in the TB referral center in Catalonia, which acts as the center for patients with social and health problems. Methods This retrospective open cohort study included all patients diagnosed with TB who were admitted and successfully treated in Serveis Clinics between 2000 and 2016 and who remained disease-free for a minimum of 1 year after treatment completion. We calculated the incidence density of TB recurrences per person-years of follow-up. We also estimated the cumulative incidence of TB recurrence at 1, 2, 5, and 10 years of follow-up. Bivariate analysis was conducted using Kaplan-Meier curves. Multivariate analysis was conducted using Cox regression. Hazard ratios (HR) were calculated with their 95% confidence intervals (95%CI). Results There were 839 patients and 24 recurrences (2.9%), representing 0.49 per 100 person-years. The probability of a recurrence was 0.63% at 1 year of follow-up, 1.35% at 2 years, and 3.69% at 5 years. The multivariate analysis showed that the predictive factors of recurrence were age older than 34 years (aHR = 3.90; CI = 1.06-14.34 at age 35-45 years and aHR = 3.88; CI = 1.02-14.80 at age > 45 years) and resistance to at least one anti-TB drug (aHR = 2.91; CI = 1.11-7.65). Conclusions Attention should be paid to socially vulnerable persons older than 34 years with a previous episode of resistant TB. Surveillance resources should be directed toward adequately treated patients who nevertheless have a high risk of recurrence.	[Brugueras, Silvia; Orcau, Angels; Rius, Cristina; Millet, Joan-Pau] Agencia Salut Publ Barcelona ASPB, Epidemiol Serv, Barcelona, Spain; [Brugueras, Silvia; Orcau, Angels; Rius, Cristina; Millet, Joan-Pau] Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain; [Brugueras, Silvia; Rius, Cristina] Univ Autonoma Barcelona, Fac Med, Dept Pediat Obstet & Ginecol & Med Prevent, Barcelona, Spain; [Molina, Vinicio-Israel; Casas, Xavier; Gonzalez, Yoel-Domingo; Forcada, Nuria; Romero, Dora; Altet, Maria-Neus; Maldonado, Jose; Millet, Joan-Pau] Serv Clin, Barcelona, Spain; [Rodes, Anna] Agencia Salut Publ Catalunya, Barcelona, Spain; [Martin-Sanchez, Mario] Pompeu Fabra Univ, Publ Hlth Agcy Barcelona PSMar UPF ASPB, Prevent Med & Publ Hlth Training Unit Parc Salut, Barcelona, Spain; [Cayla, Joan A.; Orcau, Angels; Millet, Joan-Pau] Fdn TB Res Unit Barcelona fuiTB, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Pompeu Fabra University	Brugueras, S (corresponding author), Agencia Salut Publ Barcelona ASPB, Epidemiol Serv, Barcelona, Spain.; Brugueras, S (corresponding author), Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain.; Brugueras, S (corresponding author), Univ Autonoma Barcelona, Fac Med, Dept Pediat Obstet & Ginecol & Med Prevent, Barcelona, Spain.	silviabruguerastorrella@gmail.com		Martin-Sanchez, Mario/0000-0002-2221-5331; Brugueras Torrella, Silvia/0000-0001-6439-0050	SEPAR research grant; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) [088/2015]	SEPAR research grant; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)	The health center Serveis Clinics provided support in the form of salaries for authors VIM, XC, YDG, NF, DR, NA, JM, JPM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. VIM funded by SEPAR research grant. Project 088/2015. Sociedad Espanola de Neumologi ' a y Cirugi ' a Tora ' cica (SEPAR) https://www.separ.es/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alseda Graells M, 2008, DOCUMENTS VIGILANCIA; Anaam MS, 2012, PUBLIC HEALTH ACTION, V2, P168, DOI 10.5588/pha.12.0044; Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001; Bestrashniy JRBM, 2018, INT J INFECT DIS, V74, P31, DOI 10.1016/j.ijid.2018.06.013; Blondal K, 2012, INT J TUBERC LUNG D, V16, P1228, DOI 10.5588/ijtld.12.0037; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Cayla JA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-127; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Centers for Disease Control and Prevention CDC, 2009, TUB 2009 CAS DEF; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V30, P645; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Chiang CY, 2005, LANCET INFECT DIS, V5, P629, DOI 10.1016/S1473-3099(05)70240-1; Cox H, 2006, PLOS MED, V3, P1836, DOI 10.1371/journal.pmed.0030384; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; de Boer AS, 2003, INT J TUBERC LUNG D, V7, P145; Declaracion de Helsinki de la Asociacion Medica Mundial, 2013, PRINCIPIOS ETICOS IN; Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108; El Sahly HM, 2004, INT J TUBERC LUNG D, V8, P333; Garcia de Viedma D, 2002, ARCH INTERN MED, V162, P1873, DOI 10.1001/archinte.162.16.1873; Golub JE, 2008, AIDS, V22, P2527, DOI 10.1097/QAD.0b013e328311ac4e; Interrante JD, 2015, ANN AM THORAC SOC, V12, P1619, DOI 10.1513/AnnalsATS.201507-429OC; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Kim L, 2016, INT J TUBERC LUNG D, V20, P49, DOI 10.5588/ijtld.15.0442; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lonnroth K, ACTION FRAMEWORK LOW, P928; Mallory KF, 2000, INT J TUBERC LUNG D, V4, P455; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064898; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Parvaresh L, 2018, RECURRENCE TUBERCULO, P4; Pascopella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026541; Pettit AC, 2011, INT J TUBERC LUNG D, V15, P906, DOI 10.5588/ijtld.10.0448; Red Nacional de Vigilancia Epidemiologica, 2003, AMPL DEF CAS TUB RED; Rodes Monegal A, 2018, INFORM ANUAL 2016; Rosser A, 2018, INT J TUBERC LUNG D, V22, P139, DOI 10.5588/ijtld.17.0590; Rosser A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2933-4; Cerezales MS, 2011, ENFERM INFEC MICR CL, V29, P20, DOI 10.1016/S0213-005X(11)70014-3; Schiroli C, 2015, INFECTION, V43, P647, DOI 10.1007/s15010-015-0759-9; Schiroli Consuelo, 2013, Infez Med, V21, P251; Selassie AW, 2005, ANN EPIDEMIOL, V15, P519, DOI 10.1016/j.annepidem.2005.03.002; Sun Y., 2017, PLOS ONE, V12, P1, DOI DOI 10.1371/J0URNAL.P0NE; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; van der Heijden YF, 2018, INT J TUBERC LUNG D, V22, P871, DOI 10.5588/ijtld.17.0766; Verver S, 2005, RATE REINFECTION TUB; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization (WHO), 2003, TREATM TUB GUID; Yen YF, 2014, INT J TUBERC LUNG D, V18, P492, DOI 10.5588/ijtld.13.0694	48	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227291	10.1371/journal.pone.0227291	http://dx.doi.org/10.1371/journal.pone.0227291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940383	Green Published, gold			2022-12-26	WOS:000534368000062
J	Cook, GW; Benton, MG; Akerley, W; Mayhew, GF; Moehlenkamp, C; Raterman, D; Burgess, DL; Rowell, WJ; Lambert, C; Eng, K; Gu, J; Baybayan, P; Fussell, JT; Herboldl, HD; O'Shea, JM; Varghese, TK; Emerson, LL				Cook, George W.; Benton, Michael G.; Akerley, Wallace; Mayhew, George F.; Moehlenkamp, Cynthia; Raterman, Denise; Burgess, Daniel L.; Rowell, William J.; Lambert, Christine; Eng, Kevin; Gu, Jenny; Baybayan, Primo; Fussell, John T.; Herboldl, Heath D.; O'Shea, John M.; Varghese, Thomas K.; Emerson, Lyska L.			Structural variation and its potential impact on genome instability: Novel discoveries in the EGFR landscape by long-read sequencing	PLOS ONE			English	Article							CELL LUNG-CANCER; ALU REPEATS; MICROSATELLITE INSTABILITY; GENE CONVERSION; RECOMBINATION; MUTATIONS; DNA; DELETIONS; ADENOCARCINOMA; MECHANISMS	Structural variation (SV) is typically defined as variation within the human genome that exceeds 50 base pairs (bp). SV may be copy number neutral or it may involve duplications, deletions, and complex rearrangements. Recent studies have shown SV to be associated with many human diseases. However, studies of SV have been challenging due to technological constraints. With the advent of third generation (long-read) sequencing technology, exploration of longer stretches of DNA not easily examined previously has been made possible. In the present study, we utilized third generation (long-read) sequencing techniques to examine SV in the EGFR landscape of four haplotypes derived from two human samples. We analyzed the EGFR gene and its landscape (+/- 500,000 base pairs) using this approach and were able to identify a region of non-coding DNA with over 90% similarity to the most common activating EGFR mutation in non-small cell lung cancer. Based on previously published Alu-element genome instability algorithms, we propose a molecular mechanism to explain how this non-coding region of DNA may be interacting with and impacting the stability of the EGFR gene and potentially generating this cancer-driver gene. By these techniques, we were also able to identify previously hidden structural variation in the four haplotypes and in the human reference genome (hg38). We applied previously published algorithms to compare the relative stabilities of these five different EGFR gene landscape haplotypes to estimate their relative potentials to generate the EGFR exon 19, 15 bp canonical deletion. To our knowledge, the present study is the first to use the differences in genomic architecture between targeted cancer-linked phased haplotypes to estimate their relative potentials to form a common cancer-linked driver mutation.	[Cook, George W.; Fussell, John T.; Herboldl, Heath D.] Sentry Genom, Baton Rouge, LA USA; [Benton, Michael G.] Louisiana State Univ, Dept Chem Engn, Baton Rouge, LA 70803 USA; [Akerley, Wallace] Univ Utah, Sch Med, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT USA; [Mayhew, George F.; Moehlenkamp, Cynthia; Raterman, Denise; Burgess, Daniel L.] Roche Sequencing Solut, Madison, WI USA; [Rowell, William J.; Lambert, Christine; Eng, Kevin; Gu, Jenny; Baybayan, Primo] Pacific Biosci, Menlo Pk, CA USA; [O'Shea, John M.] Huntsman Canc Inst, Biorepository Mol Pathol, Salt Lake City, UT USA; [Varghese, Thomas K.] Univ Utah, Sch Med, Dept Surg, Huntsman Canc Inst,Div Thorac Surg, Salt Lake City, UT USA; [Emerson, Lyska L.] Univ Utah, Sch Med, Dept Pathol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Louisiana State University System; Louisiana State University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Emerson, LL (corresponding author), Univ Utah, Sch Med, Dept Pathol, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	lyska.emerson@hsc.utah.edu	Rowell, William J/P-2840-2019	Rowell, William J/0000-0002-7422-1194; Mayhew, George/0000-0003-0609-6018; Cook, George/0000-0001-6413-8680; Eng, Kevin/0000-0002-7076-5397; Burgess, Daniel/0000-0001-8566-7100				Aleshin A, 2010, MOL BIOL EVOL, V27, P2300, DOI 10.1093/molbev/msq116; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], [No title captured]; Aygun N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08300; Bagshaw ATM, 2017, GENOME BIOL EVOL, V9, P2428, DOI 10.1093/gbe/evx164; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Cook GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065188; Cook GW, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-10; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; English AC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1479-3; Fazza AC, 2009, GENET MOL BIOL, V32, P25, DOI 10.1590/S1415-47572009005000018; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Franke G, 2009, HUM MUTAT, V30, P776, DOI 10.1002/humu.20948; Gadgil R, 2017, BIOPHYS CHEM, V225, P38, DOI 10.1016/j.bpc.2016.11.007; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; Greer SU, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0447-8; Gu S, 2015, HUM MOL GENET, V24, P4061, DOI 10.1093/hmg/ddv146; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Han KD, 2008, P NATL ACAD SCI USA, V105, P19366, DOI 10.1073/pnas.0807866105; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hile SE, 2013, MUTAT RES-FUND MOL M, V743, P67, DOI 10.1016/j.mrfmmm.2012.11.003; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; Jang JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09755; KASS DH, 1995, MOL CELL BIOL, V15, P19, DOI 10.1128/MCB.15.1.19; Kaushal S, 2019, GENE CHROMOSOME CANC, V58, P270, DOI 10.1002/gcc.22721; Kawaguchi T, 2016, J CLIN ONCOL, V34, P2247, DOI 10.1200/JCO.2015.64.2322; Khurana E, 2016, NAT REV GENET, V17, P93, DOI 10.1038/nrg.2015.17; Kim JC, 2013, CURR OPIN GENET DEV, V23, P280, DOI 10.1016/j.gde.2013.04.009; Kitada K, 2013, CYTOGENET GENOME RES, V139, P1, DOI 10.1159/000342885; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Levy SE, 2016, ANNU REV GENOM HUM G, V17, P95, DOI 10.1146/annurev-genom-083115-022413; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lupski JR, 2015, ENVIRON MOL MUTAGEN, V56, P419, DOI 10.1002/em.21943; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mantere T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00426; Martin M., 2016, WHATSHAP FAST ACCURA, DOI [10.1101/085050, DOI 10.1101/085050]; Midha A, 2015, AM J CANCER RES, V5, P2892; Mokarram P, 2014, MOL BIOL REP, V41, P2835, DOI 10.1007/s11033-014-3138-1; Nandakumar D, 2015, CELL, V160, P809, DOI 10.1016/j.cell.2015.02.007; Polleys EJ, 2017, DNA REPAIR, V56, P156, DOI 10.1016/j.dnarep.2017.06.018; Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Roy AM, 2000, GENOME RES, V10, P1485, DOI 10.1101/gr.152300; Schrock AB, 2016, COMPREHENSIVE GENOMI; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; SMIT AFA, 1995, NUCLEIC ACIDS RES, V23, P98, DOI 10.1093/nar/23.1.98; Song X, 2018, GENOME RES; Startek M, 2015, NUCLEIC ACIDS RES, V43, P2188, DOI 10.1093/nar/gku1394; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Tian YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201682; Vogt J, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r80; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhi DG, 2007, GENE, V390, P117, DOI 10.1016/j.gene.2006.09.030; Zhou B, 2019, NUCLEIC ACIDS RES, V47, P3846, DOI 10.1093/nar/gkz169	66	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226340	10.1371/journal.pone.0226340	http://dx.doi.org/10.1371/journal.pone.0226340			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940362	Green Published, gold			2022-12-26	WOS:000534368000028
J	Czekaj-Zastawny, A; Rauba-Bukowska, A; Kukulka, A; Kufel-Diakowska, B; Litynska-Zajac, M; Moskal-del Hoyo, M; Wilczynski, J				Czekaj-Zastawny, Agnieszka; Rauba-Bukowska, Anna; Kukulka, Agnieszka; Kufel-Diakowska, Bernadeta; Litynska-Zajac, Maria; Moskal-del Hoyo, Magdalena; Wilczynski, Jaroslaw			The earliest farming communities north of the Carpathians: The settlement at Gwozdziec site 2	PLOS ONE			English	Article							CROP; LINEARBANDKERAMIK; CULTURES	The appearance of the Linear Pottery Culture (LBK) on Poland territory initiated the process of neolithization in the area. However, as we will see in this article, this colonization took place later than previously thought. The stage, which in Poland is called as the early phase, actually corresponds only to the Fomborn/Ackovy stage of LBK, and the earliest dating currently indicates around 5350 BC. Due to the small number of sites from this phase excavated on a large scale in Poland, this stage of the culture's development is poorly known. The Gwozdziec Project is focused on the earliest stage of LBK settlement in south-eastern Poland. Excavation at the site was finished in 2018. Therefore, the article presents preliminary results of interdisciplinary analyzes, such as research on ceramics, flint production and use, and botanical remains. They point to various aspects of the economy of these early agricultural communities and significantly enrich the knowledge of this period in Central Europe. They also expose the chronological development of the oldest LBK development stage in Poland.	[Czekaj-Zastawny, Agnieszka; Rauba-Bukowska, Anna; Litynska-Zajac, Maria] Polish Acad Sci IAE PAS, Inst Archaeol & Ethnol, Krakow, Poland; [Kukulka, Agnieszka] Reg Museum Tarnow, Tarnow, Poland; [Kufel-Diakowska, Bernadeta] Univ Wroclaw, Inst Archaeol, Wroclaw, Poland; [Moskal-del Hoyo, Magdalena] Polish Acad Sci IB PAS, W Szafer Inst Bot, Krakow, Poland; [Wilczynski, Jaroslaw] Polish Acad Sci ISEA PAS, Inst Systemat & Evolut Anim, Krakow, Poland	Polish Academy of Sciences; Institute of Archaeology & Ethnology of the Polish Academy of Sciences; University of Wroclaw; Polish Academy of Sciences; W. Szafer Institute of Botany of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences	Czekaj-Zastawny, A (corresponding author), Polish Acad Sci IAE PAS, Inst Archaeol & Ethnol, Krakow, Poland.	aczekajzastawny@gmail.com	; Moskal-del Hoyo, Magdalena/B-2696-2012	Rauba-Bukowska, Anna/0000-0002-6653-3614; Kufel-Diakowska, Bernadeta/0000-0002-1316-6216; Moskal-del Hoyo, Magdalena/0000-0003-3632-7227; Wilczynski, Jaroslaw/0000-0002-9786-0693	National Science Centre, Poland [NCN 2014/15/B/HS3/02460, 5600/5500-5300 BC]	National Science Centre, Poland(National Science Centre, Poland)	The research presented in this paper has been funded by the National Science Centre, Poland, within the grant No. NCN 2014/15/B/HS3/02460 (2015-2019),,The oldest phase of the Linearband Culture in Lesser Poland (5600/5500-5300 BC) - genesis, dating, settlement, economy". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, VIA ARCHAEOLOGICA ZR, P437; [Anonymous], 1990, ANATOMIE EUROPAISCHE; Balcer B, 1983, WYTWORCZOK NARZADZI; Banffy E., 2018, DOCUMENTA PRAEHISTOR, V45, P120; Banffy E., 2010, NEOLITHISIERUNG MITT, P255; Bieniek A, 2001, VEG HIST ARCHAEOBOT, V10, P105, DOI 10.1007/PL00006918; Bieniek A, 2007, ORIGINS SPREAD DOMES, P327; Cappers R. T. J, 2006, DIGITAL SEED ATLAS N; Cappers RTJ, 2009, DIGITAL ATLAS EC P 1; Cappers RTJ, 2009, DIGITAL ATLAS EC 2B; Cappers RTJ, 2009, DIGITAL ATLAS EC 2A; Chabal L., 1999, LA BOT, P43; Colledge S, 2007, ORIGINS SPREAD DOMES, P327; Concolly J, 2008, J ARCHAEOL SCI, V35, P2797, DOI 10.1016/j.jas.2008.05.006; Czekaj-Zastawny A., 2017, MATIERES PENSER RAW, P81; Czekaj-Zastawny A, 2014, VIA ARCHAEOLOGICA ZR; Czekaj-Zastawny A, 2008, OSADNICTWO SPOTECZNO; Czekaj-Zastawny A, 2009, 1 NEOLITHIC SITES CE, VV; Dreslerova D, 2013, VEG HIST ARCHAEOBOT, V22, P257, DOI 10.1007/s00334-012-0377-8; Ehlert M, 2014, SILESIA ANTIGUA, V49, P7; Ginter B, 1990, TECHNIKI OBROBKI TYP; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Jakucs J, 2016, J WORLD PREHIST, V29, P267, DOI 10.1007/s10963-016-9096-x; Kotova N., 2019, EARLY NEOLITHIC SETT, V88, P407; Kreuz A, 2005, VEG HIST ARCHAEOBOT, V14, P237, DOI 10.1007/s00334-005-0080-0; Kreuz A, 2017, VEG HIST ARCHAEOBOT, V26, P639, DOI 10.1007/s00334-017-0643-x; Krystek M., 2011, BIUL PANSTW INST GEO, V444, P113; Kufel-Diakowska B, 2017, SLASKIE SPRAWOZDANIA, V59, P7; Kukulka A, 1998, MAT SPRAWOZDANIA RZE, V19, P175; Kukulka A., 2001, NEOLIT POCZ TKI BR Z, P11; Kukulka A, 1997, MAT SPRAWOZDANIA RZE, V18, P161; Kulczycka-Leciejewiczowa A, 2008, STUDIUM PRZEMIAN KUL; Kulczycka-Leciejewiczowa A, 2000, PAMATKY ARCHEOL S, V13, P196; Kulczycka-Leciejewiczowa A, 1988, ZEITSCHIFT ARCHAOLOG, V23, P137; Kulczycka-Leciejewiczowa A., 1979, PRAHISTORIA ZIEM POL, VII, P19; Kulpa W., 1974, NASIONOZNAWSTWO CHWA, V2nd; Lech J, 1985, MAT KULTURY CERAMIKI, V27, P69; Litynska-Zajac M., 2014, BRZEZIE 17 OSADA KUL, P405; Litynska-Zajac M., 2017, SPRAWOZDANIA ARCHEOL, V69, P233; Litynska-Zajac M., 2017, STAN PROBLEMATYKA BA, P719; Litynska-Zajac M, 2005, CHWASTY UPRAWACH ROA; Litynska-Zajac M., 2005, PRZEWODNIK BADAN ARC; Litynska-Zajac M, 2008, VEG HIST ARCHAEOBOT, V17, pS81, DOI 10.1007/s00334-008-0179-1; Marguerie D, 2007, J ARCHAEOL SCI, V34, P1417, DOI 10.1016/j.jas.2006.10.032; MATEICIUCOVA I, 2001, PREISTORIA ALPINA, V37, P81; Mateiciucova I., 2008, DISSERTATIONES ARCHA; Matuszkiewicz JM, 2008, POTENCJALNA ROALINNO; Miotk-Szpiganowicz G., 2004, LATE GLACIAL HOLOCEN, P79; MIREK Z, 2002, BIODIVERSITY POLAND, V1; Modderman PJR, 1986, PAMATKY ARCHEOL, V77, P288; Moskal-del Hoyo M, 2010, J ARCHAEOL SCI, V37, P2106, DOI 10.1016/j.jas.2010.02.007; Moskal-del Hoyo M., 2015, EARLY FARMERS E SLOV, P197; Moskal-del Hoyo M, 2009, SPRAWOZDANIA ARCHEOL, V61, P253; Moskal-del Hoyo M, 2017, VEG HIST ARCHAEOBOT, V26, P329, DOI 10.1007/s00334-016-0595-6; Moskal-Del Hoyo Magdalena, 2016, Acta Palaeobotanica, V56, P91, DOI 10.1515/acpa-2016-0003; Neugebauer-Maresch Ch, 2015, LINEARBANDKERAMISCHE, P402; Nowinski M, 1955, PRACE KOMISJI BIOL, V18, P3; nska-Zaj ac M., 2007, ORIGINS SPREAD DOMES, P315; Ntinou M, 2002, BAR IS, V1083; Pelisiak A, 2013, STUDIEN ARCHAOLOGIE, V11, P225; PTG, 2009, ROCZNIKI GLEBOZNAWCZ, V60, P5; Pyzel J, 2010, GDANSKIE STUDIA ARCH, V1; Pyzel Joanna, 2010, PANTA RHEI STUDIES C, P539; Quinn P. S, 2013, CERAMIC PETROGRAPHY; Ralska-Jasiewiczowa M., 2004, LATE GLACIAL HOLOCEN; Rauba-Bukowska A, 2019, SCALES TRANSFORMATIO, V7; Rauba-Bukowska A, 2007, SPRAWOZDANIA ARCHEOL, V59, P63; Schweingruber F.H., 1982, MIKROSKOPISCHE HOLZA; Siska S., 1989, KULTURA S VYCHODNOU; Smart T. L., 1988, CURRENT PALEOETHNOBO, P167; Szafer W, 1986, SZATA ROSLINNA POLSK, V1; Trzcinska-Tacik H, 1979, ROZPRAWY HABILITACYJ, V32, P1; Urbanczyk P., 2017, SOC POLISH LANDS 1 E, V2, P21; Valde-Nowak P, 1988, ETAPY STREFY ZASIEDL; Valde-Nowak P, 2009, RECHERCHES ARCHEOLOG, V1, P15; Wilczynski J, 2014, VIA ARCHAEOLOGICA ZR, P459; WOJCIECHOWSKI W., 1995, STUDIA ARCHEOLOGICZN, V27; ZAJAC M, 1992, PRACE BOT, V24, P7; Zastawny A, 2014, TARGOWISKO STA N 10	79	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227008	10.1371/journal.pone.0227008	http://dx.doi.org/10.1371/journal.pone.0227008			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940392	Green Published, gold			2022-12-26	WOS:000534368000053
J	Noel, A; Van Soen, G; Rouaud, I; Hitti, E; Tomasi, S				Noel, Alba; Van Soen, Gwendoline; Rouaud, Isabelle; Hitti, Eric; Tomasi, Sophie			Optimization of cytotoxic activity of Nocardia sp culture broths using a design of experiments	PLOS ONE			English	Article							STREPTOMYCES; COMPOUND	In the context of research for new cytotoxic compounds, obtaining bioactive molecules from renewable sources remain a big challenge. Microorganisms and more specifically Actinobacteria from original sources are well known for their biotechnological potential and are hotspots for the discovery of new bioactive compounds. The strain DP94 studied here had shown an interesting cytotoxic activity of its culture broth (HaCaT: IC50 = 8.0 +/- 1.5 mu g/mL; B16: IC50 = 4.6 +/- 1.8 mu g/mL), which could not been explained by the compounds isolated in a previous work. The increase of the cytotoxic activity of extracts was investigated, based on a Taguchi L9 orthogonal array design, after DP94 culture in TY medium using two different vessels (bioreactor or Erlenmeyer flasks). Various culture parameters such as temperature, pH and inoculum ratio (%) were studied. For experiments conducted in a bioreactor, stirring speed was included as an additional parameter. Significant differences in the cytotoxic activities of different extracts on B16 melanoma cancer cell lines, highlighted the influence of culture temperature on the production of cytotoxic compound(s) using a bioreactor. A culture in Erlenmeyer flasks was also performed and afforded an increase of the production of the active compounds. The best conditions for the highest cytotoxicity (IC50 on B16: 6 +/- 0.5 mu g/mL) and the highest yield (202.0 mg/L) were identified as: pH 6, temperature 37 degrees C and 5% inoculum.	[Noel, Alba; Van Soen, Gwendoline; Rouaud, Isabelle; Tomasi, Sophie] Univ Rennes, CNRS, ISCR UMR 6226, Rennes, France; [Hitti, Eric] LTSI, UFR Sci Pharmaceut & Biol, UMR S 1099, Rennes, France; [Noel, Alba] I2BC, CNRS UMR 9198, Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Tomasi, S (corresponding author), Univ Rennes, CNRS, ISCR UMR 6226, Rennes, France.	sophie.tomasi@univ-rennes1.fr	Sophie, Tomasi/ABF-6796-2021; HITTI, Eric/ABC-7717-2020	Tomasi, Sophie/0000-0001-9827-527X	Ligue contre le Cancer 35	Ligue contre le Cancer 35	The Funder "Ligue contre le Cancer 35" gave financial support (named BaLI) for the purchase of a Bioreactor BioFlo 115 (R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2014, MAR DRUGS, V12, P1220, DOI 10.3390/md12031220; Aschenbrenner IA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00180; Axenov-Gibanov DV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149216; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458; Bhattacharya A, 2009, PROD ENG-RES DEV, V3, P31, DOI 10.1007/s11740-008-0132-2; Bilyk O, 2016, CURR OPIN BIOTECH, V42, P98, DOI 10.1016/j.copbio.2016.03.008; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1116, DOI 10.1271/bbb.110943; Dutta S, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2260-3; Grube M, 2009, ISME J, V3, P1105, DOI 10.1038/ismej.2009.63; Jia B, 2008, APPL BIOCHEM BIOTECH, V144, P133, DOI 10.1007/s12010-007-8012-3; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; LACAL JC, 1980, J ANTIBIOT, V33, P441, DOI 10.7164/antibiotics.33.441; LINKE HAB, 1974, J ANTIBIOT, V27, P155, DOI 10.7164/antibiotics.27.155; Nemoto A, 2002, J ANTIBIOT, V55, P593, DOI 10.7164/antibiotics.55.593; Noel A, 2017, MOLECULES, V22, DOI 10.3390/molecules22030371; Parrot D, 2018, PHYTOCHEMISTRY, V145, P57, DOI 10.1016/j.phytochem.2017.10.005; Parrot D, 2016, PLANTA MED, V82, P1143, DOI 10.1055/s-0042-105571; Parrot D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15839; Perrone P, 2007, J MED CHEM, V50, P5463, DOI 10.1021/jm070362i; Schrader KK, 2015, J IND MICROBIOL BIOT, V42, P759, DOI 10.1007/s10295-015-1600-2; Selbmann L, 2010, POLAR BIOL, V33, P71, DOI 10.1007/s00300-009-0686-2; Shirling ET, 1966, INT J SYST EVOL MICR, V16, P313, DOI DOI 10.1099/00207713-16-3-313; Suzuki MT, 2016, APPL MICROBIOL BIOT, V100, P583, DOI 10.1007/s00253-015-7114-z; UMEZAWA H, 1967, CANCER, V20, P891, DOI 10.1002/1097-0142(1967)20:5<891::AID-CNCR2820200550>3.0.CO;2-V	28	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227816	10.1371/journal.pone.0227816	http://dx.doi.org/10.1371/journal.pone.0227816			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935268	Green Published, gold			2022-12-26	WOS:000534354100056
J	Torres-Reveron, A; Rana, M; Gorabi, V; Rivera-Lopez, LL; Appleyard, CB				Torres-Reveron, Annelyn; Rana, Maahrose; Gorabi, Varesh; Rivera-Lopez, Leslie L.; Appleyard, Caroline B.			Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis	PLOS ONE			English	Article							CORTICOSTEROID-BINDING GLOBULIN; CORTICOTROPIN-RELEASING-FACTOR; STRESS; PITUITARY; HORMONE; EXPRESSION; SECRETION; PARAMETERS; QUALITY; MOUSE	Endometriosis is a chronic inflammatory disorder in which endometrial tissue is found outside the uterine cavity. Previous reports suggest that there is a dysregulation of the hypothalamic pituitary adrenal axis during the progression of endometriosis. Our previous report showed that a short-term treatment with antalarmin, a corticotrophin releasing hormone receptor type 1 (CRHR1) antagonist decreases the number and size of endometriotic vesicles in the auto-transplantation rat model of endometriosis. Our current goal was to examine the mRNA expression of intra-adrenal receptors to better understand the mechanisms of the hypothalamic pituitary adrenal (HPA) axis involvement in endometriosis. We used two groups of female rats. The first received sham surgery or endometriosis surgery before collecting the adrenals after 7 days of the disease progression. The second group of animals received endometriosis surgery and a treatment of either vehicle or antalarmin (20 mg/kg, i. p.) during the first 7 days after endometriosis induction and then the disease was allowed to progress until day 60. Rats with sham surgery served as controls. Results showed that the mRNA expression of the mineralocorticoid (MRC2) receptor was lower in the rats after 7 days of endometriosis surgery and in rats with endometriosis that received antalarmin. In addition, the CRHR1 was significantly elevated in animals that received antalarmin and this was counteracted by a non-significant elevation in CRHR2 mRNA. The glucocorticoid receptor mRNA within the adrenals was not affected by endometriosis or antalarmin treatment. This report is one of the first to explore intra-adrenal mRNA for receptors involved in the HPA axis signaling as well as in the sympatho-adrenal signaling, calling for additional research towards understanding the role of the adrenal glands in chronic inflammatory diseases such as endometriosis.	[Torres-Reveron, Annelyn] DHR Hlth Inst Res & Dev, Edinburg, TX 78539 USA; [Rana, Maahrose; Gorabi, Varesh] Univ Texas Rio Grande Valley, Dept Biomed Sci, Edinburg, TX USA; [Rivera-Lopez, Leslie L.] Univ Texas Rio Grande Valley, Sch Med, Dept Neurosci, Edinburg, TX USA; [Appleyard, Caroline B.] Ponce Hlth Sci Univ, Div Basic Sci, Ponce, PR USA; [Appleyard, Caroline B.] Ponce Hlth Sci Univ, Sch Med, Dept Internal Med, Ponce, PR USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; Ponce Health Sciences University; Ponce Health Sciences University	Torres-Reveron, A (corresponding author), DHR Hlth Inst Res & Dev, Edinburg, TX 78539 USA.	anne.torres@dhr-rgv.com	Torres, Annelyn/AAS-1981-2021	Appleyard, Caroline/0000-0002-1211-4246; RIVERA-LOPEZ, LESLIE L./0000-0001-9620-040X	National Institutes of Health [K07AT008027, R15AT009915, R21HD098481]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the following National Institutes of Health grants: K07AT008027 to A.T.R.; R15AT009915 to C.B.A.; R21HD098481 to A.T.R and C.B.A. The funders had no role in the study.	Appleyard CB, 2015, REPROD SCI, V22, P431, DOI 10.1177/1933719114542022; BAGDY G, 1990, REGUL PEPTIDES, V31, P83, DOI 10.1016/0167-0115(90)90111-9; Berkley KJ, 2007, PAIN, V132, pS150, DOI 10.1016/j.pain.2007.09.022; Briassoulis G, 2011, ENDOCR PRACT, V17, P941, DOI 10.4158/EP11061.RA; BRUHN TO, 1987, ANN NY ACAD SCI, V512, P115, DOI 10.1111/j.1749-6632.1987.tb24954.x; Cason AM, 2003, HORM BEHAV, V44, P123, DOI 10.1016/S0018-506X(03)00121-1; Cuevas M, 2012, REPROD SCI, V19, P851, DOI 10.1177/1933719112438443; Deng Q, 2015, ENDOCRINOLOGY, V156, P3215, DOI 10.1210/EN.2015-1265; Dermitzaki E, 2007, ENDOCRINOLOGY, V148, P1524, DOI 10.1210/en.2006-0967; EDWARDS AV, 1988, J PHYSIOL-LONDON, V400, P89, DOI 10.1113/jphysiol.1988.sp017112; Fukuda T, 2005, J CLIN ENDOCR METAB, V90, P4671, DOI 10.1210/jc.2005-0090; Garrido N, 2002, HUM REPROD UPDATE, V8, P95, DOI 10.1093/humupd/8.1.95; Gomez-Sanchez E, 2014, COMPR PHYSIOL, V4, P965, DOI 10.1002/cphy.c130044; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Hill LA, 2016, J ENDOCRINOL, V230, P215, DOI 10.1530/JOE-16-0047; Johnson Paula D, 2002, ILAR J, V43, P202; Konno R, 2007, AM J REPROD IMMUNOL, V58, P330, DOI 10.1111/j.1600-0897.2007.00507.x; Kyrous I, 2005, ADRRENAL GLANDS DIAG; Lagana AS, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.08.24; Long QQ, 2016, HUM REPROD, V31, P2506, DOI 10.1093/humrep/dew237; MAZZOCCHI G, 1994, MOL CELL NEUROSCI, V5, P345, DOI 10.1006/mcne.1994.1041; Meyer EJ, 2016, HORM METAB RES, V48, P359, DOI 10.1055/s-0042-108071; Meyer EJ, 2017, EXPERT REV ENDOCRINO, V12, P241, DOI 10.1080/17446651.2017.1332991; Miller R, 2016, PSYCHONEUROENDOCRINO, V73, P16, DOI 10.1016/j.psyneuen.2016.07.201; MINAMINO N, 1988, PEPTIDES, V9, P37, DOI 10.1016/0196-9781(88)90007-1; MISAO R, 1995, REPROD NUTR DEV, V35, P155, DOI 10.1051/rnd:19950204; MOON CEM, 1993, AM J OBSTET GYNECOL, V169, P676, DOI 10.1016/0002-9378(93)90642-V; Muller MB, 2001, ENDOCRINOLOGY, V142, P4150, DOI 10.1210/en.142.9.4150; NAITO Y, 1990, NEUROENDOCRINOLOGY, V51, P637, DOI 10.1159/000125404; NOTHNICK WB, 1994, AM J REPROD IMMUNOL, V31, P151, DOI 10.1111/j.1600-0897.1994.tb00860.x; Nussdorfer GG, 1996, PHARMACOL REV, V48, P495; Petrelluzzi KFS, 2008, STRESS, V11, P390, DOI 10.1080/10253890701840610; Quinones Maria, 2015, J Reprod Biol Health, V3; Rojas-Cartagena C, 2005, BIOL REPROD, V73, P1211, DOI 10.1095/biolreprod.105.044131; Sharpe-Timms KL, 2002, ANN NY ACAD SCI, V955, P318, DOI 10.1111/j.1749-6632.2002.tb02792.x; Sharpe- Timms KL, 2002, ANN NY ACAD SCI, V955, P396; Starr LR, 2019, PSYCHONEUROENDOCRINO, V100, P156, DOI 10.1016/j.psyneuen.2018.10.003; Sugaya N, 2012, INT J PSYCHOPHYSIOL, V84, P39, DOI 10.1016/j.ijpsycho.2012.01.006; Torres-Reveron A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197698; Torres-Reveron A, 2018, REPROD SCI, V25, P1336, DOI 10.1177/1933719117741374; Uchiide I, 2002, FERTIL STERIL, V78, P782, DOI 10.1016/S0015-0282(02)03327-7; van Aken M, 2018, PSYCHONEUROENDOCRINO, V89, P216, DOI 10.1016/j.psyneuen.2018.01.001; Verbeeten KC, 2018, J PEDIATR ENDOCR MET, V31, P107, DOI 10.1515/jpem-2017-0270; VERNON MW, 1985, FERTIL STERIL, V44, P684; Walker JJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0875; Witz Craig A, 2003, Hum Fertil (Camb), V6, P34, DOI 10.1080/1464770312331368973	46	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227456	10.1371/journal.pone.0227456	http://dx.doi.org/10.1371/journal.pone.0227456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935235	Green Published, gold			2022-12-26	WOS:000534354100019
J	Banerjee, A; Percival-Smith, A				Banerjee, Anirban; Percival-Smith, Anthony			Post-translational modifications of Drosophila melanogaster HOX protein, Sex combs reduced	PLOS ONE			English	Article							FUSHI-TARAZU PROTEIN; LINEAR MOTIFS; ENGRAILED PROTEIN; GENE-EXPRESSION; RNA-POLYMERASE; DNA-BINDING; PHOSPHORYLATION; HOMEODOMAIN; TRANSCRIPTION; ANTENNAPEDIA	Homeotic selector (HOX) transcription factors (TFs) regulate gene expression that determines the identity of Drosophila segments along the anterior-posterior (A-P) axis. The current challenge with HOX proteins is understanding how they achieve their functional specificity while sharing a highly conserved homeodomain (HD) that recognize the same DNA binding sites. One mechanism proposed to regulate HOX activity is differential post-translational modification (PTM). As a first step in investigating this hypothesis, the sites of PTM on a Sex combs reduced protein fused to a triple tag (SCRTT) extracted from developing embryos were identified by Tandem Mass Spectrometry (MS/MS). The PTMs identified include phosphorylation at S185, S201, T315, S316, T317 and T324, acetylation at K218, S223, S227, K309, K434 and K439, formylation at K218, K309, K325, K341, K369, K434 and K439, methylation at S19, S166, K168 and T364, carboxylation at D108, K298, W307, K309, E323, K325 and K369, and hydroxylation at P22, Y87, P107, D108, D111, P269, P306, R310, N321, K325, Y334, R366, P392 and Y398. Of the 44 modifications, 18 map to functionally important regions of SCR. Besides a highly conserved DNA-binding HD, HOX proteins also have functionally important, evolutionarily conserved small motifs, which may be Short Linear Motifs (SLiMs). SLiMs are proposed to be preferential sites of phosphorylation. Although 6 of 7 phosphosites map to regions of predicted SLiMs, we find no support for the hypothesis that the individual S, T and Y residues of predicted SLiMs are phosphorylated more frequently than S, T and Y residues outside of predicted SLiMs.	[Banerjee, Anirban; Percival-Smith, Anthony] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Banerjee, A (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	abanerj7@uwo.ca		Banerjee, Anirban/0000-0002-4353-3419	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-06356]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant No. RGPIN-2015-06356 to AP-S (URL: http://www.nserc-crsng.gc.ca/index_eng.asp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2015, CELL, V161, P307, DOI 10.1016/j.cell.2015.02.008; Akam M, 1998, INT J DEV BIOL, V42, P445; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Ardito F, 2017, INT J MOL MED, V40, P271, DOI 10.3892/ijmm.2017.3036; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946; BILLETER M, 1990, J MOL BIOL, V214, P183, DOI 10.1016/0022-2836(90)90155-F; BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dong JL, 1998, EMBO J, V17, P2308, DOI 10.1093/emboj/17.8.2308; Draime A, 2018, INT J DEV BIOL, V62, P733, DOI 10.1387/ijdb.180178rr; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; GAVIS ER, 1991, DEVELOPMENT, V112, P1077; GAY NJ, 1988, NUCLEIC ACIDS RES, V16, P6637, DOI 10.1093/nar/16.14.6637; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GIBSON G, 1990, CELL, V62, P1087, DOI 10.1016/0092-8674(90)90386-S; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gogl G, 2019, J MOL BIOL, V431, P1234, DOI 10.1016/j.jmb.2019.01.038; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Haneskog Lars, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4221; Hittinger CT, 2005, DEVELOPMENT, V132, P5261, DOI 10.1242/dev.02146; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Hraber P, 2020, TRENDS BIOTECHNOL, V38, P113, DOI 10.1016/j.tibtech.2019.07.004; Hu YH, 2019, G3-GENES GENOM GENET, V9, P1, DOI 10.1534/g3.118.200637; Humphrey SJ, 2015, NAT BIOTECHNOL, V33, P990, DOI 10.1038/nbt.3327; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jaffe L, 1997, GENE DEV, V11, P1327, DOI 10.1101/gad.11.10.1327; Janody F, 2000, DEVELOPMENT, V127, P279; Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103; Johnson H, 2010, METHODS MOL BIOL, V658, P93, DOI 10.1007/978-1-60761-780-8_5; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Khan AN, 2005, J BIOL CHEM, V280, P36073, DOI 10.1074/jbc.M508247200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; KRAUSE HM, 1989, EMBO J, V8, P1197, DOI 10.1002/j.1460-2075.1989.tb03492.x; KRAUSE HM, 1988, GENE DEV, V2, P1021, DOI 10.1101/gad.2.8.1021; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS RA, 1980, GENETICS, V95, P383; Loughran ST, 2011, METHODS MOL BIOL, V681, P311, DOI 10.1007/978-1-60761-913-0_17; Merabet S, 2014, DEV DYNAM, V243, P16, DOI 10.1002/dvdy.24002; Merabet S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002302; Moazzen H, 2009, MECH DEVELOP, V126, P605, DOI 10.1016/j.mod.2009.06.1084; MYLIN LM, 1989, GENE DEV, V3, P1157, DOI 10.1101/gad.3.8.1157; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2006, CURR OPIN BIOTECH, V17, P465, DOI 10.1016/j.copbio.2006.08.002; O'Connell NE, 2015, FEBS LETT, V589, P3237, DOI 10.1016/j.febslet.2015.09.020; OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x; PANZER S, 1992, DEVELOPMENT, V114, P49; Park JM, 2015, PROTEIN CELL, V6, P804, DOI 10.1007/s13238-015-0204-y; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Percival-Smith A, 1997, DEVELOPMENT, V124, P5049; Percival-Smith A, 2013, DEV GENES EVOL, V223, P375, DOI 10.1007/s00427-013-0454-8; Primon M, 2019, CANCERS, V11, DOI 10.3390/cancers11040508; Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; RONCHI E, 1993, CELL, V74, P347, DOI 10.1016/0092-8674(93)90425-P; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sivanantharajah L, 2015, DEV BIOL, V398, P1, DOI 10.1016/j.ydbio.2014.11.001; Sivanantharajah L, 2014, G3-GENES GENOM GENET, V4, P829, DOI 10.1534/g3.114.010769; Sivanantharajah L, 2009, GENETICS, V182, P191, DOI 10.1534/genetics.109.100438; Steen H, 2006, MOL CELL PROTEOMICS, V5, P172, DOI 10.1074/mcp.M500135-MCP200; Sterck L, 2012, NAT METHODS, V9, P1041, DOI 10.1038/nmeth.2242; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stultz BG, 2006, DEV BIOL, V290, P482, DOI 10.1016/j.ydbio.2005.11.041; Thummel CS, 1992, DROS INF SERV, V71, P150; Tiefenbach J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009797; Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Wang CG, 2011, J STEROID BIOCHEM, V123, P91, DOI 10.1016/j.jsbmb.2010.12.003; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Wieschaus E., 1986, P199; Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]; ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343	100	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227642	10.1371/journal.pone.0227642	http://dx.doi.org/10.1371/journal.pone.0227642			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931520	Green Submitted, Green Published, gold			2022-12-26	WOS:000534352500057
J	Boynukalin, FK; Gultomruk, M; Cavkaytar, S; Turgut, E; Findikli, N; Serdarogullari, M; Coban, O; Yarkiner, Z; Rubio, C; Bahceci, M				Boynukalin, Fazilet Kubra; Gultomruk, Meral; Cavkaytar, Sabri; Turgut, Emre; Findikli, Necati; Serdarogullari, Munevver; Coban, Onder; Yarkiner, Zalihe; Rubio, Carmen; Bahceci, Mustafa			Parameters impacting the live birth rate per transfer after frozen single euploid blastocyst transfer	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; BODY-MASS INDEX; ADVANCED MATERNAL AGE; RANDOMIZED CONTROLLED-TRIAL; TROPHECTODERM MORPHOLOGY; CLINICAL PREGNANCY; PREDICTS OUTCOMES; ADVERSELY AFFECT; EMBRYO QUALITY; OBESE WOMEN	Background To assess the predictive value of patient characteristics, controlled ovarian stimulation and embryological parameters on the live birth outcome of single euploid frozen-warmed blastocyst transfer (FBT). Methods This was a retrospective cohort study including 707 single FBTs after preimplantation genetic testing for aneuploidy (PGT-A) that were performed from October 1, 2015, to January 1, 2018. The effects of patient-, cycle-and embryology-related parameters on the live birth outcome after FBT were assessed. Results In the subgroup analysis based on live birth, patients who achieved a live birth had a significantly lower body mass index (BMI) than patients who did not achieve a live birth (22.7 (21.5-24.6) kg/m(2) vs 27 (24-29.2) kg/m(2), p<0.001). The percentage of blastocysts with inner cell mass (ICM) A or B was significantly higher among patients achieving a live birth, at 91.6% vs. 82.6% (p<0.001). Day-5 biopsies were also more prevalent among patients achieving a live birth, at 82.9% vs 68.1% (p<0.001). On the other hand, the mitochondrial DNA (mtDNA) levels were significantly lower among cases with a successful live birth, at 18.7 (15.45-23.68) vs 20.55 (16.43-25.22) (p = 0.001). The logistic regression analysis showed that BMI (p<0.001, OR: 0.789, 95% CI [0.734-0.848]), day of trophectoderm (TE) biopsy (p<0.001, OR: 0.336, 95% CI [0.189-0.598]) and number of previous miscarriages (p = 0.004, OR: 0.733, 95% CI [0.594-0.906]) were significantly correlated with live birth. Patients with elevated BMIs, cycles in which embryos were biopsied on day-6 and a higher number of miscarriages were at increased risks of reduced live birth rates. Conclusion A high BMI, an embryo biopsy on day-6 and a high number of miscarriages negatively affect the live birth rate after single euploid	[Boynukalin, Fazilet Kubra; Cavkaytar, Sabri; Turgut, Emre; Bahceci, Mustafa] Bahceci Hlth Grp, Dept Reprod Endocrinol, Istanbul, Turkey; [Boynukalin, Fazilet Kubra; Cavkaytar, Sabri; Turgut, Emre; Bahceci, Mustafa] Bahceci Hlth Grp, IVF Ctr, Istanbul, Turkey; [Gultomruk, Meral; Findikli, Necati; Serdarogullari, Munevver; Coban, Onder] Bahceci Hlth Grp, Dept Embryol, Istanbul, Turkey; [Gultomruk, Meral; Findikli, Necati; Serdarogullari, Munevver; Coban, Onder] Bahceci Hlth Grp, R&D Ctr, Istanbul, Turkey; [Yarkiner, Zalihe] Cyprus Sci Univ, Kyrenia, Cyprus; [Rubio, Carmen] Igenomix, Valencia, Spain	Cyprus Science University	Boynukalin, FK (corresponding author), Bahceci Hlth Grp, Dept Reprod Endocrinol, Istanbul, Turkey.; Boynukalin, FK (corresponding author), Bahceci Hlth Grp, IVF Ctr, Istanbul, Turkey.	kboynukalin@bahceci.com	Serdarogullari, Munevver/ABE-1887-2020; Yarkiner, Zalihe/Z-2339-2019; Findikli, Necati/I-4924-2018; Yarkiner, Zalihe/HDM-3460-2022; Rubio, Carmen/D-7753-2018	Yarkiner, Zalihe/0000-0002-4766-6454; Findikli, Necati/0000-0001-9362-5912; Yarkiner, Zalihe/0000-0002-4766-6454; 				Ahlstrom A, 2011, HUM REPROD, V26, P3289, DOI 10.1093/humrep/der325; Bellver J, 2010, FERTIL STERIL, V93, P447, DOI 10.1016/j.fertnstert.2008.12.032; Blockeel C, 2008, REPROD BIOMED ONLINE, V17, P848, DOI 10.1016/S1472-6483(10)60414-2; Boots CE, 2014, FERTIL STERIL, V102, P455, DOI 10.1016/j.fertnstert.2014.05.005; Borm G, 2000, HUM REPROD, V15, P1490; Caillon H, 2015, OBES RES CLIN PRACT, V9, P382, DOI 10.1016/j.orcp.2015.02.009; Capalbo A, 2014, HUM REPROD, V29, P1173, DOI 10.1093/humrep/deu033; Chen XJ, 2014, J ASSIST REPROD GEN, V31, P1475, DOI 10.1007/s10815-014-0317-x; Dechaud H, 2006, EUR J OBSTET GYN R B, V127, P88, DOI 10.1016/j.ejogrb.2005.12.009; Devroey P, 1998, HUM REPROD UPDATE, V4, P856, DOI 10.1093/humupd/4.6.856; Diez-Juan A, 2015, FERTIL STERIL, V104, P534, DOI 10.1016/j.fertnstert.2015.05.022; Fedorcsak P, 2004, HUM REPROD, V19, P2523, DOI 10.1093/humrep/deh485; Fedorcsak P, 2000, ACTA OBSTET GYN SCAN, V79, P43, DOI 10.1034/j.1600-0412.2000.079001043.x; Ferreux L, 2018, HUM REPROD, V33, P390, DOI 10.1093/humrep/dey004; Forman EJ, 2013, FERTIL STERIL, V100, P100, DOI 10.1016/j.fertnstert.2013.02.056; Fragouli E, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005241; Gardner DK, 1999, CURR OPIN OBSTET GYN, V11, P307, DOI 10.1097/00001703-199906000-00013; Goldman KN, 2015, FERTIL STERIL, V103, P744, DOI 10.1016/j.fertnstert.2014.11.029; Goto S, 2011, FERTIL STERIL, V95, P948, DOI 10.1016/j.fertnstert.2010.06.067; Hardarson T, 2008, HUM REPROD, V23, P2806, DOI 10.1093/humrep/den217; Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087; Hill MJ, 2013, FERTIL STERIL, V99, P1283, DOI 10.1016/j.fertnstert.2012.12.003; Irani M, 2018, FERTIL STERIL, V110, P95, DOI 10.1016/j.fertnstert.2018.03.032; Kawwass JF, 2016, FERTIL STERIL, V106, P1742, DOI 10.1016/j.fertnstert.2016.08.028; Klimczak AM, 2018, J ASSIST REPROD GEN, V35, P871, DOI 10.1007/s10815-018-1147-z; Kuliev A, 2011, REPROD BIOMED ONLINE, V22, P2, DOI 10.1016/j.rbmo.2010.08.014; Kung A, 2015, REPROD BIOMED ONLINE, V31, P760, DOI 10.1016/j.rbmo.2015.09.002; Lashen H, 1999, HUM REPROD, V14, P712, DOI 10.1093/humrep/14.3.712; Maheshwari A, 2007, HUM REPROD UPDATE, V13, P433, DOI 10.1093/humupd/dmm017; Marquard K, 2010, FERTIL STERIL, V94, P1473, DOI 10.1016/j.fertnstert.2009.06.041; Mastenbroek S, 2007, NEW ENGL J MED, V357, P9, DOI 10.1056/NEJMoa067744; Mersereau JE, 2008, FERTIL STERIL, V90, P1287, DOI 10.1016/j.fertnstert.2007.08.010; Metwally M, 2007, REPROD BIOMED ONLINE, V14, P328, DOI 10.1016/S1472-6483(10)60875-9; Meyer LR, 2009, FERTIL STERIL, V91, P1731, DOI 10.1016/j.fertnstert.2008.02.162; Murugappan G, 2016, HUM REPROD, V31, P1668, DOI 10.1093/humrep/dew135; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Ozekinci M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0223-0; Rabinowitz M, 2012, FERTIL STERIL, V97, P395, DOI 10.1016/j.fertnstert.2011.11.034; Richter KS, 2001, FERTIL STERIL, V76, P1157, DOI 10.1016/S0015-0282(01)02870-9; Rittenberg V, 2011, REPROD BIOMED ONLINE, V23, P421, DOI 10.1016/j.rbmo.2011.06.018; Robker Rebecca L, 2008, Pathophysiology, V15, P115, DOI 10.1016/j.pathophys.2008.04.004; Rubio C, 2013, FERTIL STERIL, V99, P1400, DOI 10.1016/j.fertnstert.2012.11.041; Rubio C, 2009, REPROD BIOMED ONLINE, V18, P687, DOI 10.1016/S1472-6483(10)60015-6; Ryynanen M, 1997, FERTIL STERIL, V68, P439, DOI 10.1016/S0015-0282(97)00224-0; Sarais V, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030109; Schliep KC, 2015, FERTIL STERIL, V103, P388, DOI 10.1016/j.fertnstert.2014.10.048; Scott RT, 2013, FERTIL STERIL, V100, P697, DOI 10.1016/j.fertnstert.2013.04.035; Serdarogullari M, 2018, SYST BIOL REPROD MED, P1; Staessen C, 2008, HUM REPROD, V23, P2818, DOI 10.1093/humrep/den367; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; Stankewicz T, 2017, FERTIL STERIL, V107, pE14; Stryne-Gross A, 2005, FERTIL STERIL, V83, P1629, DOI 10.1016/j.fertnstert.2005.01.099; Sunkara SK, 2010, HUM REPROD, V25, P1906, DOI 10.1093/humrep/deq143; Thompson SM, 2013, J ASSIST REPROD GEN, V30, P1577, DOI 10.1007/s10815-013-0100-4; Treff NR, 2017, HUM REPROD, V32, P954, DOI 10.1093/humrep/dex034; Tremellen K, 2017, REPROD BIOMED ONLINE, V34, P90, DOI 10.1016/j.rbmo.2016.09.011; Vaegter KK, 2017, FERTIL STERIL, V107, P641, DOI 10.1016/j.fertnstert.2016.12.005; Van den Abbeel E, 2013, REPROD BIOMED ONLINE, V27, P353, DOI 10.1016/j.rbmo.2013.07.006; Veleva Z, 2008, HUM REPROD, V23, P878, DOI 10.1093/humrep/den017; Veleva Z, 2013, HUM REPROD, V28, P2425, DOI 10.1093/humrep/det251; Wang JX, 2000, BRIT MED J, V321, P1320, DOI 10.1136/bmj.321.7272.1320; WARBURTON D, 1987, AM J HUM GENET, V41, P465; Weissman A, 2017, REPROD BIOMED ONLINE, V35, P693, DOI 10.1016/j.rbmo.2017.09.001; Wells D, 2014, J MED GENET, V51, P553, DOI 10.1136/jmedgenet-2014-102497; Yang HY, 2016, J ASSIST REPROD GEN, V33, P865, DOI 10.1007/s10815-016-0712-6; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24; Zander-Fox DL, 2012, AUST NZ J OBSTET GYN, V52, P270, DOI 10.1111/j.1479-828X.2012.01453.x; Zhao HB, 2019, ARCH GYNECOL OBSTET, V299, P1487, DOI 10.1007/s00404-019-05084-1	68	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227619	10.1371/journal.pone.0227619	http://dx.doi.org/10.1371/journal.pone.0227619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929583	Green Published, gold			2022-12-26	WOS:000534352500053
J	Nimpagaritse, M; Korachais, C; Meessen, B				Nimpagaritse, Manassee; Korachais, Catherine; Meessen, Bruno			Effects in spite of tough constraints - A theory of change based investigation of contextual and implementation factors affecting the results of a performance based financing scheme extended to malnutrition in Burundi	PLOS ONE			English	Article							HEALTH-CARE; SERVICES; RWANDA	Background From January 2015 to December 2016, the health authorities in Burundi piloted the inclusion of child nutrition services into the pre-existing performance-based financing free health care policy (PBF-FHC). An impact evaluation, focused on health centres, found positive effects both in terms of volume of services and quality of care. To some extent, this result is puzzling given the harshness of the contextual constraints related to the fragile setting. Methods With a multi-methods approach, we explored how contextual and implementation constraints interacted with the pre-identified tracks of effect transmission embodied in the intervention. For our analysis, we used a hypothetical Theory of Change (ToC) that mapped a set of seven tracks through which the intervention might develop positive effects for children suffering from malnutrition. We built our analysis on (1) findings from the facility surveys and (2) extra qualitative data (logbooks, interviews and operational document reviews). Findings Our results suggest that six constraints have weighted upon the intervention: (1) initial low skills of health workers; (2) unavailability of resources (including nutritional dietary inputs and equipment); (3) payment delays; (4) suboptimal information; (5) restrictions on autonomy; and (6) low intensity of supervision. Together, they have affected the intensity of the intervention, especially during its first year. From our analysis of the ToC, we noted that the positive effects largely occurred as a result of the incentive and information tracks. Qualitative data suggests that health centres have circumvented the many constraints by relying on a community-based recruitment strategy and a better management of inputs at the level of the facility and the patient himself. Conclusion Frontline actors have agency: when incentives are right, they take the initiative and find solutions. However, they cannot perform miracles: Burundi needs a holistic societal strategy to resolve the structural problem of child malnutrition.	[Nimpagaritse, Manassee] Inst Natl Sante Publ, Bujumbura, Burundi; [Nimpagaritse, Manassee; Korachais, Catherine; Meessen, Bruno] Inst Trop Med, Dept Publ Hlth, Hlth Econ Unit, Antwerp, Belgium; [Nimpagaritse, Manassee] Catholic Univ Louvain, Inst Rech Sante & Soc, Clos Chapelle Aux Champs, Brussels, Belgium	Institute of Tropical Medicine (ITM)	Nimpagaritse, M (corresponding author), Inst Natl Sante Publ, Bujumbura, Burundi.; Nimpagaritse, M (corresponding author), Inst Trop Med, Dept Publ Hlth, Hlth Econ Unit, Antwerp, Belgium.; Nimpagaritse, M (corresponding author), Catholic Univ Louvain, Inst Rech Sante & Soc, Clos Chapelle Aux Champs, Brussels, Belgium.	mnimpagaritse@yahoo.fr		Korachais, Catherine/0000-0002-5869-563X	World Bank; ITM; Directorate General for Development (DGD, Belgium)	World Bank(The World Bank India); ITM; Directorate General for Development (DGD, Belgium)	This study builds on an impact evaluation financed through an agreement between the World Bank (1818 H street, N.W. Washington, DC 20433, USA) and ITM (Nationalestraat 155, Antwerp 2000, Belgium). The first author (MN) is funded, for his PhD, by the Directorate General for Development (DGD, Belgium) under a comprehensive capacity strengthening programme of the Institute of Tropical Medicine (ITM_itg.be) of Antwerp (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, WORLD DEV IND 2015; Anselmi L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0540-1; Antony M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2148-9; Aoki M., 2007, J I ECON, V1, P1, DOI [DOI 10.1017/S1744137406000531, 10.1017/S1744137406000531]; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Bertone MP, 2018, CONFL HEALTH, V12, DOI 10.1186/s13031-018-0166-9; Bertone MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195301; Bertone MP, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1546-8; Bertone MP, 2013, HLTH POLICY PLAN; Bertone MP, 2018, GLOBAL HLTH; Bertone MP, 2018, BMC CONLICT HEAL CON, V12, P1; Bhatnagar A, 2016, HLTH POLICY PLAN; Binyaruka P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135013; Bonfrer I, 2014, INTRO PERFORMANCE BA, P12; Bonfrer I, 2014, SOC SCI MED; Borghi J, 2018, BMJ GLOB HEAL; Brenner S, 2017, B WORLD HEALTH ORGAN, V95, P491, DOI 10.2471/BLT.16.178202; Brenner S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-180; Dale EM, 2014, PERFMANCE BASED PAYM; De Allegri M, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000693; EU, 2016, DECISION CONSEI REL; Falisse JB, 2015, HEALTH POLICY PLANN, V30, P1251, DOI 10.1093/heapol/czu132; Fox S, 2014, HLTH POLICY PLAN; Fritsche G., 2014, PERFORMANCE BASED FI; ISTEEBU I de S et d'Etudes E du B MSPLS M de la SP et de la L contre le S ICF I. Burundi, 2010, ET B MSPLS M SP S IC; Kalk A, 2010, TROP MED INT HEALTH, V15, P182, DOI 10.1111/j.1365-3156.2009.02430.x; Kane S, 2019, INT J HEAL POLICY MA, V8; Korachais C, 2019, IMPACT EXTENSION PER; Korachais C, 2018, FBP NUTR BURUNDI EVA; Lohmann J, 2018, HLTH POLICY PLAN; Lohmann J, 2016, SOC SCI MED, V169, P1, DOI 10.1016/j.socscimed.2016.09.006; McKim CA, 2017, J MIX METHOD RES, V11, P202, DOI 10.1177/1558689815607096; Meessen B., 2009, THESIS; Meessen B, 2011, B WORLD HEALTH ORGAN, V89, P153, DOI 10.2471/BLT.10.077339; Meessen B, 2006, TROP MED INT HEALTH, V11, P1303, DOI 10.1111/j.1365-3156.2006.01680.x; Messner J. J., 2016, FRAGILE STATES INDEX; Midgley G., 2006, AM J PUBLIC HLTH; MoH, 2011, NAT HLTH DEV PLAN 20; MSPLS, 2017, RAPP VER DONN QUANT; MSPLS, 2016, RAPP MIS OEUVR IN BA; MSPLS, 2014, MAN PROC MIS OEUV FI; MSPLS, 2017, RAPP MIS OEUVR FIN B; Nimpagaritse M, 2019, BMC NUTR, V5, DOI [10.1186/240795-019-0282-y, DOI 10.1186/240795-019-0282-Y]; Nimpagaritse M, 2011, HLTH POLICY PLANNING; Nimpagaritse M, 2019, ADDRESSING BURDEN MA; Nimpagaritse M, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0382-0; OECD, 2016, STAT FRAG 2016 UND V; Ogundeji YK, 2016, HEALTH POLICY PLANN, V31, P955, DOI 10.1093/heapol/czw016; Olafsdottir AE, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-392; Paina L, 2012, HLTH POLICY PLAN; Paul E, 2018, INT J HEALTH POLICY, V7, P35, DOI 10.15171/ijhpm.2017.42; Peerenboom PB, 2014, SANTE PUBLIQUE, V26, P229, DOI 10.3917/spub.138.0229; PNUD, 2017, PERSP CROISS EC BUR; Renmans D, 2016, REV LIT; Renmans D, 2017, PERFORMANCE BASED FI; Renmans D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091007; Ridde V, 2018, INT J HEALTH PLAN M, V33, pE153, DOI 10.1002/hpm.2439; Ritchie J.L., 2014, QUALITATIVE RES PRAC, P269; Rudasingwa M, 2015, GLOB J HLTH SCI, V7, P15; Rudasingwa M, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1327241; Shen GC, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0179-2; Witter S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-367; Woodward A, 2017, HEAL RES POLICY SYST, P15; World Bank, 2018, BUR OV	64	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226376	10.1371/journal.pone.0226376	http://dx.doi.org/10.1371/journal.pone.0226376			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31929554	Green Published, gold			2022-12-26	WOS:000534352500010
J	Ji, XQ; Jiang, PL; Luo, JT; Li, MJ; Bai, YJ; Zhang, JF; Han, BS				Ji, Xiangqin; Jiang, Penglei; Luo, Juntao; Li, Mengjia; Bai, Yajing; Zhang, Junfang; Han, Bingshe			Identification and characterization of miRNAs involved in cold acclimation of zebrafish ZF4 cells	PLOS ONE			English	Article							STRESS RESPONSES; GENE-EXPRESSION; MECHANISM; MICRORNA; APOPTOSIS; BINDING; MODELS	MicroRNAs (miRNAs) play vital roles in various biological processes under multiple stress conditions by leading to mRNA cleavage or translational repression. However, the detailed roles of miRNAs in cold acclimation in fish are still unclear. In the present study, high-throughput sequencing was performed to identify miRNAs from 6 small RNA libraries from the zebrafish embryonic fibroblast ZF4 cells under control (28 degrees C, 30 days) and cold-acclimation (18 degrees C, 30 days) conditions. A total of 414 miRNAs, 349 known and 65 novel, were identified. Among those miRNAs, 24 (19 known and 5 novel) were up-regulated, and 23 (9 known and 14 novel) were down-regulated in cold acclimated cells. The Gene Ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) enrichment analyses indicated that the target genes of known differentially expressed miRNAs (DE-miRNA) are involved in cold acclimation by regulation of phosphorylation, cell junction, intracellular signal transduction, ECM-receptor interaction and so on. Moreover, both miR-100-3p inhibitor and miR-16b mimics could protect ZF4 cells under cold stress, indicating the involvement of miRNA in cold acclimation. Further study showed that miR-100-3p and miR-16b could regulate inversely the expression of their target gene (atad5a, cyp2ae1, lamp1, rilp, atxn7, tnika, btbd9), and that overexpression of miR-100-3p disturbed the early embryonic development of zebrafish. In summary, the present data show that miRNAs are closely involved in cold acclimation in zebrafish ZF4 cells and provide information for further understanding of the roles of miRNAs in cold acclimation in fish.	[Ji, Xiangqin; Jiang, Penglei; Luo, Juntao; Li, Mengjia; Bai, Yajing; Zhang, Junfang; Han, Bingshe] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Ji, Xiangqin; Jiang, Penglei; Luo, Juntao; Li, Mengjia; Bai, Yajing; Han, Bingshe] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Zhang, Junfang] Shanghai Ocean Univ, Minist Sci & Technol, Int Res Ctr Marine Biosci, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University	Han, BS (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.; Han, BS (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.	bs-han@shou.edu.cn	jiang, penglei/GPX-0521-2022		National Natural Science Foundation of China [81770165, 31372516]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (grant No. 81770165. awarded to BH and 31372516 awarded to JZ).; This study was supported by grants from National Natural Science Foundation of China (grant No. 81770165 awarded to BH and 31372516 awarded to JZ).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berthelot C, 2019, GENOME BIOL EVOL, V11, P220, DOI 10.1093/gbe/evy262; Braga TV, 2017, BIOMED PHARMACOTHER, V92, P864, DOI 10.1016/j.biopha.2017.05.144; Burke TL, 2013, J BIOL CHEM, V288, P34266, DOI 10.1074/jbc.M113.487538; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Eremina M, 2016, CELL MOL LIFE SCI, V73, P797, DOI 10.1007/s00018-015-2089-6; Feng RZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08689; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Guo WJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2090, DOI 10.1159/000489449; Han BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160358; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He PP, 2018, GENE, V677, P24, DOI 10.1016/j.gene.2018.07.042; He Y, 2017, ONCOTARGET, V8, P73846, DOI 10.18632/oncotarget.17994; Hu P, 2015, NUCLEIC ACIDS RES, V43, P9198, DOI 10.1093/nar/gkv780; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195468; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Koh W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu GP, 2019, ARTIF CELL NANOMED B, V47, P1200, DOI 10.1080/21691401.2019.1593998; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Ma C, 2015, PLANT J, V84, P169, DOI 10.1111/tpj.12999; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; Margiotta A, 2017, EUR J HISTOCHEM, V61, P118, DOI 10.4081/ejh.2017.2783; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mukai N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218797; Pal AS, 2017, ADV CANCER RES, V135, P53, DOI 10.1016/bs.acr.2017.06.006; Peterson RT, 2008, NEUROTOXICOLOGY, V29, P546, DOI 10.1016/j.neuro.2008.04.006; Pinto R, 2005, FEBS LETT, V579, P5553, DOI 10.1016/j.febslet.2005.09.019; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shin SC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0468-1; Soyano K, 2018, ADV EXP MED BIOL, V1081, P149, DOI 10.1007/978-981-13-1244-1_9; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sun XY, 2018, ONCOL LETT, V15, P8333, DOI 10.3892/ol.2018.8420; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Wang H, 2018, ONCOL REP, V39, P247, DOI 10.3892/or.2017.6088; Wang QQ, 2017, ONCOL LETT, V14, P4729, DOI 10.3892/ol.2017.6757; Wang Xiangfeng, 2011, Frontiers in Genetics, V2, P25, DOI 10.3389/fgene.2011.00025; Yang RL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-605; Yang YT, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4231-3; Yu Z, 2018, EUR REV MED PHARMACO, V22, P5867, DOI 10.26355/eurrev_201809_15913; Zhen L, 2017, J THERM BIOL, V66, P114, DOI 10.1016/j.jtherbio.2017.03.005; Zheng YS, 2019, J CELL BIOCHEM, V120, P3922, DOI 10.1002/jcb.27676	51	5	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226905	10.1371/journal.pone.0226905	http://dx.doi.org/10.1371/journal.pone.0226905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923196	gold, Green Published			2022-12-26	WOS:000534350000032
J	Lempiainen, JK; Manjur, ABMK; Malinen, M; Ketola, K; Niskanen, EA; Palvimo, JJ				Lempiainen, Joanna K.; Manjur, A. B. M. Kaiser; Malinen, Marjo; Ketola, Kirsi; Niskanen, Einari A.; Palvimo, Jorma J.			BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation	ONCOGENE			English	Article							LENZ MICROPHTHALMIA SYNDROMES; GROUP PROTEIN EZH2; BCL6 BTB DOMAIN; TRANSCRIPTION FACTORS; HOMEOBOX GENE; HOX GENES; POLYCOMB; COMPLEX; CELLS; EXPRESSION	We have identified BCL6 corepressor (BCOR) as a hormone-dependent interaction partner of androgen receptor (AR), a key transcription factor in the development of normal and cancerous prostate. BCOR is often mutated in cancers and hematological diseases and as a component of a non-canonical polycomb repressive complex 1 (ncPRC1.1) required for arranging many facets of cellular differentiation. However, its role in androgen signaling or prostate cancer cells remains unknown. Here, our genome-wide analyses reveal that BCOR is recruited in an androgen-dependent fashion to majority of AR-binding chromatin sites in castration-resistant prostate cancer (CRPC) cells. Interestingly, depletion of BCOR has a significant effect on the expression of androgen-repressed genes linked to regulation of cell proliferation, differentiation and development. At many of these genes, such as HOX genes, the depletion leads to a decrease in H2A K119 monoubiquitination and an increase in mRNA expression. Consistently, BCOR depletion impairs the proliferation and viability of CRPC cells, inducing their apoptosis. Collectively, our data indicate a key role for the BCOR-ncPRC1.1 complex in the corepression of an important subset of AR target genes and the regulation of prostate cancer cell proliferation.	[Lempiainen, Joanna K.; Manjur, A. B. M. Kaiser; Malinen, Marjo; Ketola, Kirsi; Niskanen, Einari A.; Palvimo, Jorma J.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Malinen, Marjo] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland	University of Eastern Finland; University of Eastern Finland	Palvimo, JJ (corresponding author), Univ Eastern Finland, Inst Biomed, Kuopio, Finland.	jorma.palvimo@uef.fi	Ketola, Kirsi/O-1071-2016; Niskanen, Einari/F-2883-2017; Lempiainen, Joanna/M-8833-2017	Ketola, Kirsi/0000-0001-6484-9861; Manjur, Kaiser/0000-0001-8260-1915; Niskanen, Einari/0000-0001-9471-7026; Palvimo, Jorma/0000-0003-2373-0578; Lempiainen, Joanna/0000-0001-6100-5815	Academy of Finland; Cancer Foundation Finland; Sigrid Juselius Foundation; UEF Doctoral Programme in Molecular Medicine; Jalmari and Rauha Ahokas Foundation; Instrumentarium Foundation; Orion Research Foundation; Ida Montini Foundation; Kuopio University Foundation	Academy of Finland(Academy of Finland); Cancer Foundation Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); UEF Doctoral Programme in Molecular Medicine; Jalmari and Rauha Ahokas Foundation; Instrumentarium Foundation; Orion Research Foundation; Ida Montini Foundation; Kuopio University Foundation	This work was supported by the Academy of Finland, the Cancer Foundation Finland, the Sigrid Juselius Foundation, the UEF Doctoral Programme in Molecular Medicine, the Jalmari and Rauha Ahokas Foundation, the Instrumentarium Foundation, the Orion Research Foundation, the Ida Montini Foundation and the Kuopio University Foundation.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Astolfi A, 2019, EPIGENOMICS-UK, V11, P835, DOI 10.2217/epi-2018-0195; Axlund SD, 2010, MOL CANCER RES, V8, P1643, DOI 10.1158/1541-7786.MCR-10-0111; Banerjee PP, 2018, AM J CLIN EXP UROL, V6, P62; Beguelin W, 2016, CANCER CELL, V30, P197, DOI 10.1016/j.ccell.2016.07.006; Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao Q, 2016, LEUKEMIA, V30, P1155, DOI 10.1038/leu.2016.2; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Cohen I, 2018, CELL STEM CELL, V22, P726, DOI 10.1016/j.stem.2018.04.005; Connelly ZM, 2018, AM J CLIN EXP UROL, V6, P172; Cooper S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13661; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dickson BC, 2018, GENE CHROMOSOME CANC, V57, P598, DOI 10.1002/gcc.22649; Dobashi A, 2016, GENE CHROMOSOME CANC, V55, P460, DOI 10.1002/gcc.22348; Foley C, 2016, HORM CANCER-US, V7, P84, DOI 10.1007/s12672-015-0239-9; Fursova NA, 2019, MOL CELL, V74, P1020, DOI 10.1016/j.molcel.2019.03.024; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Granadino-Roldan JM, 2014, J MOL GRAPH MODEL, V50, P142, DOI 10.1016/j.jmgm.2014.04.003; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Han SJ, 2016, MOL PHARMACOL, V89, P14, DOI 10.1124/mol.115.100925; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Heemers HV, 2010, PROSTATE, V70, P959, DOI 10.1002/pros.21130; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helsen C, 2014, ENDOCR-RELAT CANCER, V21, pT105, DOI 10.1530/ERC-13-0545; Hilton E, 2009, EUR J HUM GENET, V17, P1325, DOI 10.1038/ejhg.2009.52; Hsiao JJ, 2016, J BIOL CHEM, V291, P18818, DOI 10.1074/jbc.M116.732313; Hsiao JJ, 2015, MOL ENDOCRINOL, V29, P1195, DOI 10.1210/me.2015-1021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh KD, 2000, GENE DEV, V14, P1810; Javed S, 2014, BJU INT, V113, P535, DOI 10.1111/bju.12269; Junco SE, 2013, STRUCTURE, V21, P665, DOI 10.1016/j.str.2013.02.013; Karvonen U, 1997, J BIOL CHEM, V272, P15973, DOI 10.1074/jbc.272.25.15973; Kelly MJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09250-6; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lempiainen JK, 2017, MOL CELL PROTEOMICS, V16, P1462, DOI 10.1074/mcp.M117.067488; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Linke T, 2011, METHODS MOL BIOL, V776, P225, DOI 10.1007/978-1-61779-243-4_14; Liu QP, 2019, INT J CANCER, V145, P415, DOI 10.1002/ijc.32118; Liu S, 2017, ELIFE, V6, DOI 10.7554/eLife.28482.001; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Malinen M, 2017, NUCLEIC ACIDS RES, V45, P619, DOI 10.1093/nar/gkw855; Manjur ABMK, 2019, J STEROID BIOCHEM, V192, DOI 10.1016/j.jsbmb.2019.105382; Meier K, 2014, EPIGENETICS-US, V9, P1485, DOI 10.4161/15592294.2014.971580; Millard CJ, 2013, J MOL ENDOCRINOL, V51, pT23, DOI 10.1530/JME-13-0227; Miller GJ, 2003, CANCER RES, V63, P5879; Minner S, 2019, PROSTATE, V79, P302, DOI 10.1002/pros.23736; Mostaghel EA, 2014, CLIN CANCER RES, V20, P791, DOI 10.1158/1078-0432.CCR-12-3601; Ng D, 2004, NAT GENET, V36, P411, DOI 10.1038/ng1321; Oliviero G, 2015, SCI REP-UK, V5, DOI 10.1038/srep18388; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P733, DOI 10.1002/gcc.22068; Pretorius E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159867; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Ren CY, 2016, ACS MED CHEM LETT, V7, P601, DOI 10.1021/acsmedchemlett.6b00042; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rytinki MM, 2011, METHODS MOL BIOL, V776, P183, DOI 10.1007/978-1-61779-243-4_12; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuettengruber B, 2017, CELL, V171, P34, DOI 10.1016/j.cell.2017.08.002; Shah N, 2017, ELIFE, V6, DOI 10.7554/eLife.27861; Skowron KJ, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110471; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelloo S, 2018, ONCOGENE, V37, P313, DOI 10.1038/onc.2017.330; Su WJ, 2019, CANCER CELL, V36, P139, DOI 10.1016/j.ccell.2019.06.009; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Tiberi L, 2014, CANCER CELL, V26, P797, DOI 10.1016/j.ccell.2014.10.021; Tilki D, 2016, EUR UROL FOCUS, V2, P499, DOI 10.1016/j.euf.2016.11.013; Toropainen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep33510; Toropainen S, 2015, NUCLEIC ACIDS RES, V43, P848, DOI 10.1093/nar/gku1375; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang Z, 2018, CELL STEM CELL, V22, P235, DOI 10.1016/j.stem.2017.12.002; Wei M, 2017, ONCOTARGET, V8, P5323, DOI 10.18632/oncotarget.14142; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yamamoto Y, 2014, MOL CANCER RES, V12, P479, DOI 10.1158/1541-7786.MCR-13-0596; Yamamoto Y, 2010, BLOOD, V116, P4274, DOI 10.1182/blood-2010-01-264432; Yao JQ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46064-4; Zhang X, 2016, ONCOL REP, V36, P2349, DOI 10.3892/or.2016.5018; Zhu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02863-3	88	6	6	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2020	39	11					2391	2407		10.1038/s41388-020-1153-3	http://dx.doi.org/10.1038/s41388-020-1153-3		JAN 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KU0ZS	31925334				2022-12-26	WOS:000508151400001
J	Tsai, WL; Wang, CF; Cheng, JS; Chen, WC; Bair, MJ; Lo, CC				Tsai, Wei-Lun; Wang, Chih-Feng; Cheng, Jin-Shiung; Chen, Wen-Chi; Bair, Ming-Jong; Lo, Ching-Chu			Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; PLUS RIBAVIRIN; VIRUS-INFECTION; DACLATASVIR; CIRRHOSIS; THERAPY; RATES; LIFE	Background Sofosbuvir (SOF)-based regimens achieve excellent efficacy and safety in the treatment of chronic hepatitis C (CHC) with various genotypes. There are few real-world instances of the use of SOF-based regimens to treat genotype 2 CHC. This study determines the effectiveness and safety of SOF/Ribavirn (RBV), SOF/Daclatasvir (DCV) and SOF/DCV/RBV in the treatment of genotype 2 CHC patients in Taiwan. Material and methods Patients with genotype 2 CHC were treated for 12 weeks with SOF/RBV, SOF/DCV or SOF/ DCV/RBV under the National Health Insurance reimbursement program in three hospitals in Taiwan. The sustained virological response at 12 weeks (SVR12) was determined. Adverse events were recorded for a safety analysis. Results A total of 467 genotype 2 CHC patients were enrolled from January to October 2018. One hundred and eleven patients (24%) had cirrhosis, including 10 patients (2.1%) with hepatic decompensation. Fifty-five patients (12%) had already experienced interferon-alpha/RBV treatment. Forty-two patients (9%) had a history of hepatocellular carcinoma (HCC) in the baseline. Three hundred and fifty-five patients received SOF/RBV, forty-seven patients received SOF/DCV and sixty-two patients received SOF/DCV/RBV. The SOF/DCV group featured a greater HCV viral load than the SOF/RBV or SOF/DCV/RBV groups. SVR12 was achieved in 94.6% of the SOF/RBV group, 95.7% of the SOF/DCV group and 96.8% of then SOF/DCV/RBV group (P = NS). Thirteen out of 352 patients (3.7%) in the SOF/RBV group, 1 out of 62 patients (1.6%) in the SOF/DCV/RBV group and 1 out of 47 patients (2.1%) in the SOF/DCV group developed virological failure. There are no differences in virological failure between the three groups (P = NS). Multi-variate analysis shows that history of HCC is an independent factor that is associated with the failure of treatment in the SOF/RBV group (odds ratio:4.905, 95% confidence interval (CI): 1.321-18.205, P = 0.017). Hemoglobin levels at 12 weeks are significantly lower in the SOF/RBV and the SOF/RBV/DCV group than in the SOF/DCV group (P<0.05). Serious adverse events (SAE) occurred in six patients (1.6%) in the SOF/RBV group and in one patient (1.6%) in the SOF/RBV/DCV group. No patients in the SOF/DCV group experienced SAE. Conclusions SOF/RBV, SOF/DCV or SOF/DCV/RBV for 12 weeks all achieve very high SVR rates and are equally effective in the treatment of genotype 2 CHC patients in the real world in Taiwan. Patients in the SOF/RBV group who have a history of HCC exhibit a lower SVR rate.	[Tsai, Wei-Lun; Wang, Chih-Feng; Cheng, Jin-Shiung; Chen, Wen-Chi] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan; [Tsai, Wei-Lun; Wang, Chih-Feng; Cheng, Jin-Shiung; Chen, Wen-Chi; Lo, Ching-Chu] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Bair, Ming-Jong] Taitung Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taitung, Taiwan; [Bair, Ming-Jong] Mackay Med Coll, New Taipei, Taiwan; [Lo, Ching-Chu] St Martin De Porres Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi, Taiwan; [Lo, Ching-Chu] Chung Jen Jr Coll Nursing Hlth Sci & Management, Chiayi, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Mackay Medical College	Lo, CC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Bair, MJ (corresponding author), Taitung Mackay Mem Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taitung, Taiwan.; Bair, MJ (corresponding author), Mackay Med Coll, New Taipei, Taiwan.; Lo, CC (corresponding author), St Martin De Porres Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Chiayi, Taiwan.; Lo, CC (corresponding author), Chung Jen Jr Coll Nursing Hlth Sci & Management, Chiayi, Taiwan.	a5963@mmh.org.tw; locc0320@gmail.com		Tsai, Wei-Lun/0000-0001-7557-3370	Ministry of Science and Technology of Taiwan [107-2314-B-075B-002 -MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology of Taiwan, 107-2314-B-075B-002 -MY2.	Akahane T, 2019, HEPATOL RES, V49, P264, DOI 10.1111/hepr.13246; Backus LI, 2015, ALIMENT PHARM THER, V42, P559, DOI 10.1111/apt.13300; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Belperio PS, 2019, J HEPATOL, V70, P15, DOI 10.1016/j.jhep.2018.09.018; Beste LA, 2017, J HEPATOL, V67, P32, DOI 10.1016/j.jhep.2017.02.027; Cheng X, 2016, P INT COMP SOFTW APP, P2, DOI 10.1109/COMPSAC.2016.70; Cheung MCM, 2016, J HEPATOL, V65, P741, DOI 10.1016/j.jhep.2016.06.019; Chung RT, 2018, CLIN INFECT DIS, V67, P1477, DOI 10.1093/cid/ciy585; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/m16-2575, 10.7326/M16-2575]; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Foster GR, 2015, GASTROENTEROLOGY, V149, P1462, DOI 10.1053/j.gastro.2015.07.043; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Huang CF, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026703; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Kanda T, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6020030; Kao JH, 2005, LIVER INT, V25, P696, DOI 10.1111/j.1478-3231.2005.01139.x; Kao JH, 2016, LIVER INT, V36, P1101, DOI 10.1111/liv.13082; LIN DY, 1993, J CLIN ULTRASOUND, V21, P303, DOI 10.1002/jcu.1870210502; Liu CH, 2018, ALIMENT PHARM THER, V47, P1690, DOI 10.1111/apt.14647; Mangia A, 2017, J HEPATOL, V66, P711, DOI 10.1016/j.jhep.2016.12.002; Mangia A, 2016, LIVER INT, V36, P971, DOI 10.1111/liv.13069; Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Omata M, 2016, HEPATOL INT, V10, P702, DOI 10.1007/s12072-016-9717-6; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Prenner SB, 2017, J HEPATOL, V66, P1173, DOI 10.1016/j.jhep.2017.01.020; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Swallow E, 2016, CLIN THER, V38, P404, DOI 10.1016/j.clinthera.2015.12.017; Tacke F, 2017, LIVER INT, V37, P205, DOI 10.1111/liv.13206; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Welsch C, 2012, GASTROENTEROLOGY, V142, P1351, DOI 10.1053/j.gastro.2011.12.062; Welzel TM, 2017, GUT, V66, P1844, DOI 10.1136/gutjnl-2016-311609; Wu SH, 2019, J CHIN MED ASSOC, V82, P693, DOI 10.1097/JCMA.0000000000000148; Yen YH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222605; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Zhou N, 2016, J ANTIMICROB CHEMOTH, V71, P3495, DOI 10.1093/jac/dkw336	41	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227424	10.1371/journal.pone.0227424	http://dx.doi.org/10.1371/journal.pone.0227424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923251	Green Published, gold			2022-12-26	WOS:000534350000076
J	La, YK; Choi, YH; Chu, MK; Nam, JM; Choi, YC; Kim, WJ				La, Yun Kyung; Choi, Yun Ho; Chu, Min Kyung; Nam, Jung Mo; Choi, Young-Chul; Kim, Won-Joo			Gender differences influence over insomnia in Korean population: A cross-sectional study	PLOS ONE			English	Article							SLEEP QUALITY INDEX; SEX-DIFFERENCES; PSYCHIATRIC-DISORDERS; GENERAL-POPULATION; SEVERITY INDEX; PREVALENCE; DEPRESSION; SYMPTOMS; EPIDEMIOLOGY; ANXIETY	Study objectives Insomnia is the most common sleep disorder with significant psychiatric/physical comorbidities in the general population. The aim of this study is to investigate whether socioeconomic and demographic factors are associated with gender differences in insomnia and subtypes in Korean population. Method The present study used data from the nationwide, cross-sectional study on sleep among all Koreans aged 19 to 69 years. The Insomnia Severity Index (ISI) was used to classify insomnia symptoms and their subtypes (cutoff value: 9.5). The Pittsburgh Sleep Quality Index (PSQI), Goldberg Anxiety Scale (GAS) and Patient Health Questionnaire-9 (PHQ-9) were used to measure sleep quality, anxiety and depression. Results A total of 2695 participants completed the survey. The overall prevalence of insomnia symptoms was 10.7%, including difficulty in initiating sleep (DIS) (6.8%), difficulty in maintaining sleep (DMS) (6.5%) and early morning awakening (EMA) (6.5%), and these symptoms were more prevalent in women than in men. Multivariate analysis showed that female gender, shorter sleep time and psychiatric complications were found to be independent predictors for insomnia symptoms and subtypes. After adjusting for covariates among these factors, female gender remained a significant risk factor for insomnia symptoms and their subtypes. As for men, low income was related to insomnia. Conclusion Approximately one-tenth of the sample from the Korean general population had insomnia symptoms. The prevalence of insomnia symptom and the subtypes were more prevalent in women than men. Gender is an independent factor for insomnia symptoms.	[La, Yun Kyung; Choi, Young-Chul; Kim, Won-Joo] Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Choi, Yun Ho] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Neurol, Incheon, South Korea; [Chu, Min Kyung] Yonsei Univ, Coll Med, Severance Hosp, Dept Neurol, Seoul, South Korea; [Nam, Jung Mo] Yonsei Univ, Coll Med, Severance Hosp, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Catholic University of Korea; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, WJ (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea.	kzoo@yuhs.ac		Chu, Min Kyung/0000-0001-6221-1346; Kim, Won-Joo/0000-0002-5850-010X; Nam, Chung Mo/0000-0003-0985-0928; Choi, Young-Chul/0000-0001-5525-6861; La, YunKyung/0000-0002-3439-0479	2011 grant from Korean Academy of Medical Sciences; Korean Neurological Association [KNA-10-MI-03]	2011 grant from Korean Academy of Medical Sciences; Korean Neurological Association	This study was supported by a 2011 grant from Korean Academy of Medical Sciences and Korean Neurological Association (grant #KNA-10-MI-03). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 1999, SLEEP, V22, pS347; Association A.P., 2013, DIAGNOSTIC STAT MANU; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Benca RM, 2005, PSYCHIAT SERV, V56, P332, DOI 10.1176/appi.ps.56.3.332; Bixler EO, 1979, AM J PSYCHIAT; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Calhoun SL, 2014, SLEEP MED, V15, P91, DOI 10.1016/j.sleep.2013.08.787; Cao XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170772; Chiu HF, 1999, SLEEP, V22, P717, DOI 10.1093/sleep/22.6.717; Choi HS, 2007, KOREAN J FAM MED, V28, P114; Cusmano DM, 2014, ENDOCRINOLOGY, V155, P204, DOI 10.1210/en.2013-1624; Daley M, 2009, SLEEP, V32, P55; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Gallo EAG, 2018, CHILD ABUSE NEGLECT, V79, P107, DOI 10.1016/j.chiabu.2018.01.003; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Hara C, 2011, SLEEP, V34, P1111, DOI 10.5665/SLEEP.1172; HENDERSON S, 1995, MED J AUSTRALIA, V162, P22, DOI 10.5694/j.1326-5377.1995.tb138406.x; Itani O, 2017, SLEEP MED, V32, P246, DOI 10.1016/j.sleep.2016.08.006; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Kim JS, 1997, J KOREAN ACAD FAM ME, V18, P1452; Kim K, 2000, SLEEP, V23, P41; Leger D, 2002, SLEEP, V25, P625; Li RHY, 2002, J PSYCHOSOM RES, V53, P601, DOI 10.1016/S0022-3999(02)00437-3; Liu PY, 2003, J CLIN ENDOCR METAB, V88, P3605, DOI 10.1210/jc.2003-030236; Moline ML, 2004, MED CLIN N AM, V88, P705, DOI 10.1016/j.mcna.2004.01.009; Mong JA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0110; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nomura K, 2005, SLEEP, V28, P1328, DOI 10.1093/sleep/28.10.1328; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P593, DOI 10.1016/S0022-3999(02)00449-X; Ohayon MM, 2001, J PSYCHOSOM RES, V51, P745, DOI 10.1016/S0022-3999(01)00285-9; Ohayon MM, 2000, CAN J PSYCHIAT, V45, P166, DOI 10.1177/070674370004500207; Pallesen S, 2001, SLEEP, V24, P771; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Polo-Kantola P, 1998, AM J OBSTET GYNECOL, V178, P1002, DOI 10.1016/S0002-9378(98)70539-3; Savard J, 2013, PSYCHO-ONCOLOGY, V22, P1381, DOI 10.1002/pon.3150; Thase ME, 2005, GEN HOSP PSYCHIAT, V27, P100, DOI 10.1016/j.genhosppsych.2004.09.006; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Yeo B. K. L., 1996, Singapore Medical Journal, V37, P282; Zhang B, 2006, SLEEP, V29, P85, DOI 10.1093/sleep/29.1.85; Zhang JH, 2016, SLEEP, V39, P1563, DOI 10.5665/sleep.6022; Zhang JH, 2012, PAIN, V153, P666, DOI 10.1016/j.pain.2011.12.003	48	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227190	10.1371/journal.pone.0227190	http://dx.doi.org/10.1371/journal.pone.0227190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5ER	31917784	gold, Green Published			2022-12-26	WOS:000534341100017
J	Tian, DY; Hong, HL; Shang, WB; Ho, CC; Dong, JH; Tian, XY				Tian, Danyang; Hong, Huiling; Shang, Wenbin; Ho, Chin Chung; Dong, Jinghui; Tian, Xiao Yu			Deletion of Ppard in CD11c(+) cells attenuates atherosclerosis in ApoE knockout mice	FASEB JOURNAL			English	Article						atherosclerosis; dendritic cells; inflammation; PPARdelta	DENDRITIC CELLS; AGGRAVATES ATHEROSCLEROSIS; REDUCES ATHEROSCLEROSIS; DELTA; ACTIVATION; HOMEOSTASIS; EXPRESSION	Ppard delta, one of the lipid-activated nuclear receptor expressed in many cell types to activate gene transcription, also regulates cellular functions other than lipid metabolism. The mechanism regulating the function of antigen-presenting cells during the development of atherosclerosis is not fully understood. Here we aimed to study the involvement of PPAR delta in CD11c(+) cells in atherosclerosis. We used the Cre-loxP approach to make conditional deletion of Ppard in CD11c(+) cells in mice on Apoe(-/-) background, which were fed with high cholesterol diet to develop atherosclerosis. Ppard deficiency in CD11c(+) cells attenuated atherosclerotic plaque formation and infiltration of myeloid-derived dendritic cells (DCs) and T lymphocytes. Reduced lesion was accompanied by reduced activation of dendritic cells, and also a reduction of activation and differentiation of T cells to Th1 cells. In addition, DC migration to lymph node was also attenuated with Ppard deletion. In bone marrow-derived DCs, Ppard deficiency reduced palmitic acid-induced upregulation of co-stimulatory molecules and pro-inflammatory cytokine IL12 and TNF alpha. Our results indicated PPAR delta activation by fatty acid resulted in the activation of myeloid DCs and subsequent polarization of T lymphocytes, which contributed to atherosclerosis in Apoe(-/-) mice. These findings also reveal the potential regulatory role of PPAR delta in antigen presentation to orchestrate the immune responses during atherosclerosis.	[Tian, Danyang; Hong, Huiling; Shang, Wenbin; Ho, Chin Chung; Tian, Xiao Yu] Chinese Univ Hong Kong, Inst Vasc Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Tian, Danyang; Dong, Jinghui] Hebei Med Univ, Dept Physiol, Shijiazhuang, Hebei, Peoples R China	Chinese University of Hong Kong; Hebei Medical University	Tian, XY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, LIBSB, Shatin, Room 208A, Hong Kong, Peoples R China.	xytian@cuhk.edu.hk	Tian, Xiao Yu/P-1092-2016; HONG, HUILING/AAT-9954-2020	Tian, Xiao Yu/0000-0003-3472-9898; 	NSFC [91739103]; Hong Kong Research Grant Council [24122318, CUHK4014-16W]; CUHK start-up; Hong Kong Food and Health Bureau Health and Medical Research Fund [05162906]; Department of Education Hebei Province China [CXZZBS2018064]	NSFC(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council(Hong Kong Research Grants Council); CUHK start-up; Hong Kong Food and Health Bureau Health and Medical Research Fund; Department of Education Hebei Province China	This study was supported by NSFC Major Research Programme 91739103, Hong Kong Research Grant Council Early Career Scheme 24122318, Collaborative Research Fund CUHK4014-16W; CUHK start-up; Hong Kong Food and Health Bureau Health and Medical Research Fund 05162906, to X.Y.T; and Postgraduate Innovational Funding Project CXZZBS2018064 from the Department of Education Hebei Province China to D.T.	Adhikary T, 2015, NUCLEIC ACIDS RES, V43, P5033, DOI 10.1093/nar/gkv331; Alberts-Grill N, 2016, J IMMUNOL, V197, P4651, DOI 10.4049/jimmunol.1600206; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Beceiro S, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00534-17; Butcher MJ, 2016, ARTERIOSCL THROM VAS, V36, P1496, DOI 10.1161/ATVBAHA.116.307892; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chaudhari SM, 2015, ARTERIOSCL THROM VAS, V35, P2316, DOI 10.1161/ATVBAHA.115.306171; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Clement M, 2018, CIRC RES, V122, P813, DOI 10.1161/CIRCRESAHA.118.312713; Fainaru O, 2005, P NATL ACAD SCI USA, V102, P10598, DOI 10.1073/pnas.0504787102; Gautier EL, 2009, CIRCULATION, V119, P2367, DOI 10.1161/CIRCULATIONAHA.108.807537; Gil-Pulido J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181947; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; Haddad Y, 2017, CIRC RES, V121, P234, DOI 10.1161/CIRCRESAHA.117.310960; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kusters P, 2017, AM J PATHOL, V187, P2912, DOI 10.1016/j.ajpath.2017.08.016; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Li G, 2016, GENE THER, V23, P78, DOI 10.1038/gt.2015.78; Li YL, 2017, EBIOMEDICINE, V18, P188, DOI 10.1016/j.ebiom.2017.04.008; Lieber S, 2015, MOL PHARMACOL, V87, P162, DOI 10.1124/mol.114.094672; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Marvin J, 2019, ATHEROSCLEROSIS, V285, P108, DOI 10.1016/j.atherosclerosis.2019.04.221; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Sun L, 2018, LEUKEMIA, V32, P184, DOI 10.1038/leu.2017.162; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Weber C, 2011, J CLIN INVEST, V121, P2898, DOI 10.1172/JCI44925; Wu DJ, 2016, IMMUNITY, V44, P1325, DOI 10.1016/j.immuni.2016.06.006; Zhao FL, 2018, J IMMUNOL, V201, P2664, DOI 10.4049/jimmunol.1800374; Zuo XS, 2019, GASTROENTEROLOGY, V157, P163, DOI 10.1053/j.gastro.2019.03.018	36	4	4	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3367	3378		10.1096/fj.201902069R	http://dx.doi.org/10.1096/fj.201902069R		JAN 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919912	Bronze			2022-12-26	WOS:000506587300001
J	Frolov, AO; Malysheva, MN; Ganyukova, AI; Spodareva, VV; Kralova, J; Yurchenko, V; Kostygov, AY				Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna, I; Spodareva, Viktoria V.; Kralova, Jana; Yurchenko, Vyacheslav; Kostygov, Alexei Y.			If host is refractory, insistent parasite goes berserk: Trypanosomatid Blastocrithidia raabei in the dock bug Coreus marginatus	PLOS ONE			English	Article							LYGAEUS-PANDURUS HEMIPTERA; REDUVIID BUG; TRIATOMAE TRYPANOSOMATIDAE; SALIVARY-GLANDS; LEPTOMONAS-PYRRHOCORIS; EVOLUTIONARY HISTORY; N MASTIGOPHORA; LIFE-CYCLES; HETEROPTERA; CRITHIDIA	Here we characterized the development of the trypanosomatid Blastocrithidia raabei in the dock bug Coreus marginatus using light and electron microscopy. This parasite has been previously reported to occur in the host hemolymph, which is rather typical for dixenous try-panosomatids transmitted to a plant or vertebrate with insect's saliva. In addition, C. marginatus has an unusual organization of the intestine, which makes it refractory to microbial infections: two impassable segments isolate the anterior midgut portion responsible for digestion and absorption from the posterior one containing symbiotic bacteria. Our results refuted the possibility of hemolymph infection, but revealed that the refractory nature of the host provokes very aggressive behavior of the parasite and makes its life cycle more complex, reminiscent of that in some dixenous trypanosomatids. In the pre-barrier midgut portion, the epimastigotes of B. raabei attach to the epithelium and multiply similarly to regular insect trypanosomatids. However, when facing the impassable constricted region, the parasites rampage and either fiercely break through the isolating segments or attack the intestinal epithelium in front of the barrier. The cells of the latter group pass to the basal lamina and accumulate there, causing degradation of the epitheliocytes and thus helping the epimastigotes of the former group to advance posteriorly. In the symbiont-containing post-barrier midgut segment, the parasites either attach to bacterial cells and produce cyst-like amastigotes (CLAs) or infect enterocytes. In the rectum, all epimastigotes attach either to the cuticular lining or to each other and form CLAs. We argue that in addition to the specialized life cycle B. raabei possesses functional cell enhancements important either for the successful passage through the intestinal barriers (enlarged rostrum and well-developed Golgi complex) or as food reserves (vacuoles in the posterior end).	[Frolov, Alexander O.; Malysheva, Marina N.; Ganyukova, Anna, I; Spodareva, Viktoria V.; Kostygov, Alexei Y.] Russian Acad Sci, Zool Inst, St Petersburg, Russia; [Spodareva, Viktoria V.; Kralova, Jana; Yurchenko, Vyacheslav; Kostygov, Alexei Y.] Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic; [Yurchenko, Vyacheslav] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia	Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences; University of Ostrava; Sechenov First Moscow State Medical University	Kostygov, AY (corresponding author), Russian Acad Sci, Zool Inst, St Petersburg, Russia.; Kostygov, AY (corresponding author), Univ Ostrava, Fac Sci, Life Sci Res Ctr, Ostrava, Czech Republic.	kostygov@gmail.com	Frolov, Alexander/AAP-9475-2020; Kostygov, Alexei Y/D-3931-2015; Frolov, Alexander O./P-3414-2015; Yurchenko, Vyacheslav/E-4532-2013	Frolov, Alexander/0000-0003-1444-3104; Kostygov, Alexei Y/0000-0002-1516-437X; Yurchenko, Vyacheslav/0000-0003-4765-3263	Russian Science Foundation [18-1400134]; European Regional Funds [16_019/0000759]; Grant Agency of the Czech Republic [18-15962S, RRC/10/2017]; University of Ostrava; Russian Science Foundation [18-14-00134] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); European Regional Funds; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); University of Ostrava; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (http://rscf.ru/en/) grant 18-1400134 to AOF, MNM, AIG, and AYK (material collection, light and electron microscopy, molecular characterization of European B. raabei samples, phylogenetic analyses). Morphological and molecular characterization of the material from the Kurgan Oblast as well as identification of symbiotic bacteria of the dock bugs was supported by European Regional Funds (https://ec.europa.eu/regional_policy/en/funding/erdf/) grant 16_019/0000759 and Grant Agency of the Czech Republic (gacr.cz) grant 18-15962S to VY; Moravskoslezsky ' Kraj research initiative (www.msk.cz) grant RRC/10/2017 to JK, and a grant from the University of Ostrava (http://www.osu.cz) to VVS, JK, and VY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JMP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-190; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beattie P, 1997, PARASITOLOGY, V115, P47, DOI 10.1017/S0031182097001042; Bianchi C, 2019, MOL BIOCHEM PARASIT, V232, DOI 10.1016/j.molbiopara.2019.111199; Bruschi F., 2018, LEISHMANIASES OLD NE; Cunha-e-Silva N, 2006, PARASITOL RES, V99, P325, DOI 10.1007/s00436-006-0190-3; d'Avila-Levy CM, 2015, MEM I OSWALDO CRUZ, V110, P956, DOI 10.1590/0074-02760150253; ELLIS DS, 1980, Z PARASITENKD, V62, P63, DOI 10.1007/BF00925367; Flegontov P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23704; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; FREYMULLER E, 1990, J PROTOZOOL, V37, P225, DOI 10.1111/j.1550-7408.1990.tb01132.x; Frolov A. O., 2016, Parazitologiya (St. Petersburg), V50, P97; Frolov A. O., 2015, Parazitologiya (St. Petersburg), V49, P233; Frolov A.O., 1995, Tsitologiya, V37, P539; Frolov A. O., 1993, Parazitologiya (St. Petersburg), V27, P227; Frolov AO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214484; Frolov AO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204467; Frolov AO, 2017, EUR J PROTISTOL, V57, P85, DOI 10.1016/j.ejop.2016.10.007; Frolov AO, 2016, EUR J PROTISTOL, V52, P1, DOI 10.1016/j.ejop.2015.08.002; FROLOV AO, 1988, PARAZITOLOGIYA+, V22, P481; FROLOV AO, 1987, PARAZITOLOGIYA+, V21, P3; Gerasimov ES, 2012, EUR J PROTISTOL, V48, P185, DOI 10.1016/j.ejop.2011.09.002; Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12; Gutierrez G, 2017, PROTIST, V168, P408, DOI 10.1016/j.protis.2017.06.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HECKER H, 1990, PARASITOL RES, V76, P311, DOI 10.1007/BF00928185; Hoare C.A., 1972, P1; Jackson AP, 2016, CURR BIOL, V26, P161, DOI 10.1016/j.cub.2015.11.055; JENSEN C, 1990, PARASITOLOGY, V100, P1, DOI 10.1017/S0031182000060054; Kalantari Mohsen, 2018, Journal of Parasitic Diseases, V42, P511, DOI 10.1007/s12639-018-1027-6; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kostygov A.Yu., 2007, Parazitologiya (St. Petersburg), V41, P126; Kostygov AY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01940; Kostygov AY, 2016, MBIO, V7, DOI 10.1128/mBio.01985-15; Kostygov AY, 2019, TROP MED INT HEALTH, V24, P127, DOI 10.1111/tmi.13168; Kraeva N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005127; Kraeva N, 2017, INFECT GENET EVOL, V50, P121, DOI 10.1016/j.meegid.2016.06.054; Kralova J, 2019, INT J PARASITOL, V49, P1075, DOI 10.1016/j.ijpara.2019.09.004; Kuechler SM, 2016, MICROBES ENVIRON, V31, P145, DOI 10.1264/jsme2.ME16042; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Landfear SM, 2001, MOL BIOCHEM PARASIT, V115, P1, DOI 10.1016/S0166-6851(01)00262-6; LAUGE G, 1977, J MORPHOL, V154, P291, DOI 10.1002/jmor.1051540207; LIPA JERZY J., 1966, ACTA PROTOZOOL, V4, P19; LIPA JJ, 1977, ACTA PROTOZOOL, V16, P121; Losev A, 2015, PARASITOL RES, V114, P1071, DOI 10.1007/s00436-014-4277-y; Motta MCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060209; Maruyama SR, 2019, EMERG INFECT DIS, V25, P2088, DOI 10.3201/eid2511.181548; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; Maslov DA, 2019, PARASITOLOGY, V146, P1, DOI 10.1017/S0031182018000951; Maslov DA, 2010, J EUKARYOT MICROBIOL, V57, P177, DOI 10.1111/j.1550-7408.2009.00464.x; Caicedo AM, 2011, MEM I OSWALDO CRUZ, V106, P301, DOI 10.1590/S0074-02762011000300008; MOLYNEUX DH, 1981, J NAT HIST, V15, P395, DOI 10.1080/00222938100770301; Morio F, 2008, J CLIN MICROBIOL, V46, P3845, DOI 10.1128/JCM.01098-08; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Ohbayashi T, 2015, P NATL ACAD SCI USA, V112, pE5179, DOI 10.1073/pnas.1511454112; Opperdoes FR, 2016, J EUKARYOT MICROBIOL, V63, P657, DOI 10.1111/jeu.12315; PENG PL, 1982, J PROTOZOOL, V29, P464, DOI 10.1111/j.1550-7408.1982.tb05434.x; PODLIPAEV SA, 1987, PARAZITOLOGIYA+, V21, P545; PODLIPAEV SA, 1988, ZOOL ZH, V67, P1407; Podlipaev SA, 1990, CATALOGUE WORLD FAUN; Ravoet J, 2015, J INVERTEBR PATHOL, V130, P21, DOI 10.1016/j.jip.2015.06.007; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; SCHAUB GA, 1990, J INVERTEBR PATHOL, V55, P17, DOI 10.1016/0022-2011(90)90027-4; SCHAUB GA, 1992, ADV PARASIT, V31, P255, DOI 10.1016/S0065-308X(08)60023-8; SCHAUB GA, 1988, PARASITOL RES, V75, P88, DOI 10.1007/BF00932706; SCHAUB GA, 1989, J PROTOZOOL, V36, P171, DOI 10.1111/j.1550-7408.1989.tb01067.x; SCHAUB GA, 1986, J PROTOZOOL, V33, P266, DOI 10.1111/j.1550-7408.1986.tb05604.x; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; SCHAUB GA, 1989, ANN TROP MED PARASIT, V83, P215, DOI 10.1080/00034983.1989.11812335; Seward EA, 2017, PROTIST, V168, P71, DOI 10.1016/j.protis.2016.11.002; Skalicky T, 2017, P NATL ACAD SCI USA, V114, P11757, DOI 10.1073/pnas.1712311114; SMIRNOFF WA, 1970, J INVERTEBR PATHOL, V16, P187, DOI 10.1016/0022-2011(70)90059-5; TETLEY L, 1985, J CELL SCI, V74, P1; TIESZEN K, 1985, Z PARASITENKD, V71, P179, DOI 10.1007/BF00926268; TIESZEN KL, 1989, J PARASITOL, V75, P441, DOI 10.2307/3282603; TIESZEN KL, 1986, PARASITOLOGY, V92, P1, DOI 10.1017/S003118200006340X; TIESZEN KL, 1989, PARASITOLOGY, V98, P395, DOI 10.1017/S0031182000061473; VICKERMAN K, 1973, J PROTOZOOL, V20, P394, DOI 10.1111/j.1550-7408.1973.tb00909.x; Vickerman K., 1990, P267; Volf P, 2004, INT J PARASITOL, V34, P1221, DOI 10.1016/j.ijpara.2004.07.010; Votypka J, 2014, PROTIST, V165, P825, DOI 10.1016/j.protis.2014.09.002; Votypka J, 2012, INT J PARASITOL, V42, P489, DOI 10.1016/j.ijpara.2012.03.007; Weisse S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037296; Westenberger SJ, 2004, PARASITOLOGY, V129, P537, DOI 10.1017/S003118200400592X; Yourth CP, 2006, P ROY SOC B-BIOL SCI, V273, P655, DOI 10.1098/rspb.2005.3371; Yurchenko V, 2016, J EUKARYOT MICROBIOL, V63, P198, DOI 10.1111/jeu.12268; Zahonova K, 2016, CURR BIOL, V26, P2364, DOI 10.1016/j.cub.2016.06.064	89	6	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227832	10.1371/journal.pone.0227832	http://dx.doi.org/10.1371/journal.pone.0227832			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945116	Green Published, gold			2022-12-26	WOS:000534370100066
J	Forrester, SJ; Dolmatova, EV; Griendling, KK				Forrester, Steven J.; Dolmatova, Elena, V; Griendling, Kathy K.			An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999-2016: An observational study	PLOS ONE			English	Article							UNITED-STATES; DISEASE; OUTCOMES; RISK	Background Hypertension-related mortality has been increasing in recent years; however, limited information exists concerning rate, temporal, secular, and geographic trends in the United States. Methods and results Using CDC death certificate data spanning 1999-2016, we sought to delineate trends in deaths attributable to an underlying cause of hypertension using joinpoint regression and proportion testing. From 1999-2016, the hypertension-related mortality rate increased by 36.4% with an average annual percent change (AAPC) of 1.8% for individuals >= 35 years of age. Interestingly, there was a notable acceleration in the AAPC of hypertension mortality between 2011 and 2016 (2.7% per year). This increase was due to a significant uptick in mortality for individuals >= 55 years of age with the greatest AAPC occurring in individuals 55-64 (4.5%) and 65-74 (5.1%) years of age. Increased mortality and AAPC were pervasive throughout sex, ethnicity, and White and American Indian or Alaska Native race, but not Black or African American race. From 2011-2016, there were significant increases in AAPC for hypertension-related mortality with contributing causes of atrial fibrillation, heart failure, diabetes, obesity, and vascular dementia. Elevated mortality was observed for conditions with a contributing cause of hypertension that included chronic obstructive pulmonary disease, diabetes, Alzheimer's, Parkinson's, and all types of falls. Geographically, increases in AAPCs and mortality rates were observed for 25/51 States between 2011 and 2016. Conclusions Our results indicate hypertension-related mortality may have accelerated since 2011 for middle-aged and older Americans, which may create new challenges in care and healthcare planning.	[Forrester, Steven J.; Dolmatova, Elena, V; Griendling, Kathy K.] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA	Emory University	Forrester, SJ (corresponding author), Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	sjforrester32@gmail.com		Griendling, Kathy/0000-0002-9456-8582	NIH [5T32HL007745-24, HL095070, UL1TR002378]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	SJF and EVD are supported by NIH 5T32HL007745-24. KKG is supported by NIH HL095070 and UL1TR002378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, INTRO STAT QUALITY C; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brooks EG, 2015, CLIN MED RES, V13, P74, DOI 10.3121/cmr.2015.1276; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cook NR, 2016, J AM COLL CARDIOL, V68, P1609, DOI 10.1016/j.jacc.2016.07.745; Dorans KS, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008888, 10.1161/jaha.118.008888]; Dunford EK, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060610; Egan BM, 2014, CIRCULATION, V130, P1692, DOI 10.1161/CIRCULATIONAHA.114.010676; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; FRIEDE A, 1993, AM J PUBLIC HEALTH, V83, P1289, DOI 10.2105/AJPH.83.9.1289; Gangavati A, 2011, J AM GERIATR SOC, V59, P383, DOI 10.1111/j.1532-5415.2011.03317.x; Gelman A, 2016, P NATL ACAD SCI USA, V113, pE816, DOI 10.1073/pnas.1523465113; German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005; Hou LY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00162; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jim MA, 2014, AM J PUBLIC HEALTH, V104, pS295, DOI 10.2105/AJPH.2014.301933; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kirkland EB, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008731; Klein D, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-50; Klein RJ., 2001, HLTH PEOPLE 2010 STA, DOI DOI 10.1037/E583772012-001; Kung Hsiang-Ching, 2015, NCHS Data Brief, P1; Lerman PM., 1980, APPL STATIST, V29, P77, DOI [DOI 10.2307/2346413, 10.2307/2346413]; Ma JM, 2015, JAMA-J AM MED ASSOC, V314, P1731, DOI 10.1001/jama.2015.12319; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; Patel SA, 2015, ANN INTERN MED, V163, P245, DOI 10.7326/M14-1753; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Seeman T, 2018, P NATL ACAD SCI USA, V115, P3296, DOI 10.1073/pnas.1710502115; Tapper EB, 2018, BMJ-BRIT MED J, V362, DOI [10.1136/bm1k2817, 10.1136/bmj.k2817]; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; World Health Organization, 2004, INT STAT CLASS DIS R	33	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0225207	10.1371/journal.pone.0225207	http://dx.doi.org/10.1371/journal.pone.0225207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940349	Green Published, gold			2022-12-26	WOS:000534368000008
J	Honap, TP; Sankaranarayanan, K; Schnorr, SL; Ozga, AT; Warinner, C; Lewis, CM				Honap, Tanvi P.; Sankaranarayanan, Krithivasan; Schnorr, Stephanie L.; Ozga, Andrew T.; Warinner, Christina; Lewis, Cecil M., Jr.			Biogeographic study of human gut-associated crAssphage suggests impacts from industrialization and recent expansion	PLOS ONE			English	Article							MICROBIOME; METAGENOME; ALIGNMENT; BACTERIOPHAGES; PREDICTION; TRACKING; VIRUSES; SAMPLES; VIROME; TWINS	CrAssphage (cross-assembly phage) is a bacteriophage that was first discovered in human gut metagenomic data. CrAssphage belongs to a diverse family of crAss-like bacteriophages thought to infect gut commensal bacteria belonging to Bacteroides species. However, not much is known about the biogeography of crAssphage and whether certain strains are associated with specific human populations. In this study, we screened publicly available human gut metagenomic data from 3,341 samples for the presence of crAssphage sensu stricto (NC_024711.1). We found that crAssphage prevalence is low in traditional, hunter-gatherer populations, such as the Hadza from Tanzania and Matses from Peru, as compared to industrialized, urban populations. Statistical comparisons showed no association of crAssphage prevalence with variables such as age, sex, body mass index, and health status of individuals. Phylogenetic analyses show that crAssphage strains reconstructed from the same individual over multiple time-points, cluster together. CrAssphage strains from individuals from the same study population do not always cluster together. Some evidence of clustering is seen at the level of broadly defined geographic regions, however, the relative positions of these clusters within the crAssphage phylogeny are not well-supported. We hypothesize that this lack of strong biogeographic structuring is suggestive of an expansion event within crAssphage. Using a Bayesian dating approach, we estimate that this expansion has occurred fairly recently. Overall, we determine that crAssphage presence is associated with an industrialized lifestyle and the absence of strong biogeographic structuring within global crAssphage strains is likely due to a recent population expansion within this bacteriophage.	[Honap, Tanvi P.; Sankaranarayanan, Krithivasan; Schnorr, Stephanie L.; Ozga, Andrew T.; Warinner, Christina; Lewis, Cecil M., Jr.] Univ Oklahoma, Labs Mol Anthropol & Microbiome Res, Norman, OK 73019 USA; [Honap, Tanvi P.; Ozga, Andrew T.; Warinner, Christina; Lewis, Cecil M., Jr.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Sankaranarayanan, Krithivasan] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Schnorr, Stephanie L.] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Schnorr, Stephanie L.] Konrad Lorenz Inst Evolut & Cognit Res, Martinstr, Klosterneuburg, Austria; [Ozga, Andrew T.] Nova Southeastern Univ, Halmos Coll Nat Sci & Oceanog, Ft Lauderdale, FL 33314 USA; [Warinner, Christina] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nova Southeastern University; Harvard University	Lewis, CM (corresponding author), Univ Oklahoma, Labs Mol Anthropol & Microbiome Res, Norman, OK 73019 USA.; Lewis, CM (corresponding author), Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA.	cmlewis@ou.edu		Honap, Tanvi Prasad/0000-0001-5271-9162; Warinner, Christina/0000-0002-4528-5877	National Institutes of Health [NIH R01 GM089886]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a grant from the National Institutes of Health (https://www.nih.gov/), NIH R01 GM089886, awarded to C.M.L., C.W., and K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens EM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040070; Ahmed W, 2018, WATER RES, V131, P142, DOI 10.1016/j.watres.2017.12.011; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cinek O, 2018, J MED VIROL, V90, P767, DOI 10.1002/jmv.25012; De Paepe M, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00039; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2019, NATURE MICROBIOLOGY; Farkas K, 2019, FOOD ENV VIROLOGY; Garcia-Aljaro C, 2017, MICROB BIOTECHNOL, V10, P1775, DOI 10.1111/1751-7915.12841; Guerin E, 2018, CELL HOST MICROBE, V24, P653, DOI 10.1016/j.chom.2018.10.002; Gupta VK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01162; Holmfeldt K, 2013, P NATL ACAD SCI USA, V110, P12798, DOI 10.1073/pnas.1305956110; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Liu WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34826; Maixner F, 2016, SCIENCE, V351, P162, DOI 10.1126/science.aad2545; Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113; Modi SR, 2013, NATURE, V499, P219, DOI 10.1038/nature12212; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Ozga AT, 2015, THESIS U OKLAHOMA NO; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rohwer F, 2011, NAT REV MICROBIOL, V9, P308, DOI 10.1038/nrmicro2563; Sankaranarayanan K, 2015, CURR BIOL, V25, P3161, DOI 10.1016/j.cub.2015.10.060; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Shkoporov AN, 2019, CELL HOST MICROBE, V26, P527, DOI 10.1016/j.chom.2019.09.009; Shkoporov AN, 2019, CELL HOST MICROBE, V25, P195, DOI 10.1016/j.chom.2019.01.017; Shkoporov AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07225-7; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Stachler E, 2017, ENVIRON SCI TECHNOL, V51, P9146, DOI 10.1021/acs.est.7b02703; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamburini FB, TRANSMISSION PERSIST; TEAM RC, 2010, R LANG ENV STAT COMP; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Williams SCP, 2013, P NATL ACAD SCI USA, V110, P2682, DOI 10.1073/pnas.1300923110; Xie HL, 2016, CELL SYST, V3, P572, DOI 10.1016/j.cels.2016.10.004; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yutin N, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0053-y; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	58	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226930	10.1371/journal.pone.0226930	http://dx.doi.org/10.1371/journal.pone.0226930			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940321	Green Published, gold, Green Submitted			2022-12-26	WOS:000534368000050
J	Silva, SR; Plachno, BJ; Carvalho, SGM; Miranda, VFO				Silva, Saura Rodrigues; Plachno, Bartosz Jan; Medeiros Carvalho, Samanta Gabriela; Oliveira Miranda, Vitor Fernandes			Genlisea hawkingii (Lentibulariaceae), a new species from Serra da Canastra, Minas Gerais, Brazil	PLOS ONE			English	Article							REVISION	Genlisea hawkingii, which is a new species of Genlisea subgen. Tayloria (Lentibulariaceae) from cerrado in southwest Brazil, is described and illustrated. This species has been found in only one locality thus far, in the Serra da Canastra, which is located in the Delfinopolis municipality in Minas Gerais, Brazil. The new species is morphologically similar to Genlisea violacea and G. flexuosa, but differs from them in having a corolla with a conical and curved spur along with sepals with an acute apex and reproductive organs that only have glandular hairs. Moreover, it is similar to G. uncinata's curved spur. G. hawkingii is nested within the subgen. Tayloria Glade as a sister group to all the other species of this subgenus. Therefore, both morphological and phylogenetic results strongly support G. hawkingiias a new species in the subgen. Tayloria.	[Silva, Saura Rodrigues; Medeiros Carvalho, Samanta Gabriela; Oliveira Miranda, Vitor Fernandes] Sao Paulo State Univ, Sch Agr & Vet Sci, Lab Plant Systemat, Unesp, Jaboticabal, SP, Brazil; [Plachno, Bartosz Jan] Jagiellonian Univ Krakow, Fac Biol, Inst Bot, Dept Plant Cytol & Embryol, Krakow, Poland	Universidade Estadual Paulista; Jagiellonian University	Miranda, VFO (corresponding author), Sao Paulo State Univ, Sch Agr & Vet Sci, Lab Plant Systemat, Unesp, Jaboticabal, SP, Brazil.	vitor.miranda@unesp.br	Płachno, Bartosz/AAJ-6128-2021; Miranda, Vitor F. O./B-2800-2011; Silva, Saura/I-1953-2015	Płachno, Bartosz/0000-0001-5579-5101; Miranda, Vitor F. O./0000-0003-0574-9865; Silva, Saura/0000-0002-6333-5268; Carvalho, Samanta/0000-0002-2071-9608	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/02285-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [001]; Unesp/PROPe, Univ Estadual Paulista, Brazil; International Association for Plant Taxonomy (IAPT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [312908/2018-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Unesp/PROPe, Univ Estadual Paulista, Brazil; International Association for Plant Taxonomy (IAPT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funded by 1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, #2018/02285-6). 2. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, Finance Code 001). 3. Unesp/PROPe, Univ Estadual Paulista, Brazil. 4. International Association for Plant Taxonomy (IAPT) for the funding for the field expedition. 5. Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq) for the fellowship of VFOM (Bolsa de Produtividade - Proc. #312908/2018-0).; We sincerely thank all of the members of the Laboratory of Plant Systematics for the fruitful discussions and support during the field expeditions. This paper was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, #2018/02285-6), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes, Finance Code 001), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Unesp/PROPe, Univ Estadual Paulista, Brazil. We wish to thank the International Association for Plant Taxonomy (IAPT) for the funding for the field expedition and VFOM would like to thank the Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (CNPq) for the fellowship (Bolsa de Produtividade -Proc. #312908/2018-0). We also thank the reviewers for their valuable suggestions.	Agnarsson I, 2008, CLADISTICS, V24, P51, DOI [10.1111/j.1096-0031.2007.00168.x, 10.1111/j.1096-0031.2008.00229.x]; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2019, FLORA BRASIL 2020 CO; Aranguren Y, 2018, PLANT BIOLOGY, V20, P591, DOI 10.1111/plb.12683; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; [Anonymous], 2018, Rodriguésia, V69, P1513, DOI 10.1590/2175-7860201869402; Fischer E, 2000, NORD J BOT, V20, P291, DOI 10.1111/j.1756-1051.2000.tb00746.x; Fleischmann A., 2012, MONOGRAPH GENUS GENL; Fleischmann A, 2017, PHYTOTAXA, V319, P289, DOI 10.11646/phytotaxa.319.3.9; Fleischmann A, 2014, ANN BOT-LONDON, V114, P1651, DOI 10.1093/aob/mcu189; Fleischmann A, 2011, PHYTOTAXA, V33, P1; Fleischmann A, 2010, MOL PHYLOGENET EVOL, V56, P768, DOI 10.1016/j.ympev.2010.03.009; Fromm-Trinta E., 1977, B MUSEU NACL RIO JAN, V44, P1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Miller M.A., 2010, P GAT COMP ENV WORKS; Muller J, 2004, MOL ECOL NOTES, V4, P786, DOI 10.1111/j.1471-8286.2004.00813.x; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Silva G, 2018, PLURALIST, V13, P1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thiers B, 2022, INDEX HERBARIORUM GL; Wang Q, 2013, PLANT SYST EVOL, V299, P1263, DOI 10.1007/s00606-013-0794-x	27	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226337	10.1371/journal.pone.0226337	http://dx.doi.org/10.1371/journal.pone.0226337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940359	gold, Green Published			2022-12-26	WOS:000534368000027
J	Yaffe, JA; Zlotnik, Y; Ifergane, G; Levy-Tzedek, S				Yaffe, Jacob A.; Zlotnik, Yair; Ifergane, Gal; Levy-Tzedek, Shelly			Implicit task switching in Parkinson's disease is preserved when on medication	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; TARGET WIDTH; GAIT; DISCRETE; MOVEMENT; DYNAMICS; DEFICITS; TRANSITION; PEOPLE; FORCES	People with Parkinson's disease have been shown to have difficulty switching between movement plans. In the great majority of studies, the need to switch between tasks was made explicitly. Here, we tested whether people with Parkinson's disease, taking their normal medication, have difficulty switching between implicitly specified tasks. We further examined whether this switch is performed predictively or reactively. Twenty five people with Parkinson's disease continuously increased or decreased the frequency of their arm movements, inducing an abrupt-but unaware-switch between rhythmic movements (at high frequencies) and discrete movements (at low frequencies). We tested whether that precipitous change was performed reactively or predictively. We found that 56% of participants predictively switched between the two movement types. The ability of people with Parkinson's disease, taking their regular medication, to predictively control their movements on implicit tasks is thus preserved.	[Yaffe, Jacob A.] Ben Gurion Univ Negev, Fac Hlth Sci, Goldman Med Sch, Beer Sheva, Israel; [Zlotnik, Yair; Ifergane, Gal] Soroka Univ, Med Ctr, Neurol Dept, Beer Sheva, Israel; [Levy-Tzedek, Shelly] Ben Gurion Univ Negev, Dept Phys Therapy, Recanati Sch Community Hlth Profess, Beer Sheva, Israel; [Levy-Tzedek, Shelly] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel; [Levy-Tzedek, Shelly] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Freiburg, Germany	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; University of Freiburg	Levy-Tzedek, S (corresponding author), Ben Gurion Univ Negev, Dept Phys Therapy, Recanati Sch Community Hlth Profess, Beer Sheva, Israel.; Levy-Tzedek, S (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel.; Levy-Tzedek, S (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Freiburg, Germany.	shelly@bgu.ac.il			Promobilia Foundation; Borten Family Foundation; Israeli Science Foundation [535/16, 2166/16]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [754340]; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center, at the Ben-Gurion University of the Negev; Marcus Endowment Fund, at the Ben-Gurion University of the Negev	Promobilia Foundation; Borten Family Foundation; Israeli Science Foundation(Israel Science Foundation); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center, at the Ben-Gurion University of the Negev; Marcus Endowment Fund, at the Ben-Gurion University of the Negev	All funding for author SL from the following funders is gratefully acknowledged: The Promobilia Foundation; the Borten Family Foundation; The Israeli Science Foundation (grants #535/16 and 2166/16); the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 754340; the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center, and the Marcus Endowment Fund, both at the Ben-Gurion University of the Negev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2014, NEUROPSYCHOLOGIA, V62, P390, DOI 10.1016/j.neuropsychologia.2014.05.023; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Ben-Tov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046983; Berry AS, 2018, J COGNITIVE NEUROSCI, V30, P1330, DOI 10.1162/jocn_a_01286; Blinch J, 2019, EXP BRAIN RES, V237, P1129, DOI 10.1007/s00221-019-05493-3; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Buchanan JJ, 2004, NEUROSCI LETT, V367, P317, DOI 10.1016/j.neulet.2004.06.028; Buchanan JJ, 2003, EXP BRAIN RES, V150, P473, DOI 10.1007/s00221-003-1471-z; Buchanan JJ, 2006, EXP BRAIN RES, V175, P710, DOI 10.1007/s00221-006-0589-1; Cole KJ, 2002, EXP BRAIN RES, V143, P35, DOI 10.1007/s00221-001-0965-9; Cools R, 2001, BRAIN, V124, P2503, DOI 10.1093/brain/124.12.2503; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Crescentini C, 2012, J NEUROPSYCHOL, V6, P94, DOI 10.1111/j.1748-6653.2011.02018.x; de Bondt CC, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0254-y; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; Diedrich FJ, 1998, TIMING OF BEHAVIOR, P323; Fahn S., 2011, PRINCIPLES PRACTICE, VSecond, P66, DOI [10.1016/B978-1-4377-2369-4.00004-4, DOI 10.1016/B978-1-4377-2369-4.00004-4]; FLANAGAN JR, 1994, J EXP PSYCHOL HUMAN, V20, P944, DOI 10.1037/0096-1523.20.5.944; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fournier LR, 2019, ATTEN PERCEPT PSYCHO, V81, P489, DOI 10.3758/s13414-018-1633-5; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Galea JM, 2012, J NEUROSCI, V32, P542, DOI 10.1523/JNEUROSCI.3621-11.2012; Getchell N, 2004, J MOTOR BEHAV, V36, P13, DOI 10.3200/JMBR.36.1.13-27; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; GUIARD Y, 1993, ACTA PSYCHOL, V82, P139, DOI 10.1016/0001-6918(93)90009-G; Guiard Y, 1997, HUM MOVEMENT SCI, V16, P97, DOI 10.1016/S0167-9457(96)00045-0; Hall LM, 2013, NEUROSCIENCE, V250, P483, DOI 10.1016/j.neuroscience.2013.07.006; Hirsch P, 2016, ACTA PSYCHOL, V170, P66, DOI 10.1016/j.actpsy.2016.06.008; Hodgson TL, 2013, NEUROPSYCHOLOGIA, V51, P1350, DOI 10.1016/j.neuropsychologia.2013.03.026; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Hulbert S, 2015, DISABIL REHABIL, V37, P1382, DOI 10.3109/09638288.2014.961661; Jacobs JV, 2009, NEUROSCIENCE, V164, P877, DOI 10.1016/j.neuroscience.2009.08.002; Jacobs JV, 2009, EXP NEUROL, V215, P334, DOI 10.1016/j.expneurol.2008.10.019; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kanekar N, 2014, AGE, V36, P1067, DOI 10.1007/s11357-014-9621-8; Karrer TM, 2017, NEUROBIOL AGING, V57, P36, DOI 10.1016/j.neurobiolaging.2017.05.006; Kashi S, 2018, RESTOR NEUROL NEUROS, V36, P147, DOI 10.3233/RNN-170756; Lehtonen E, 2012, TRANSPORT RES F-TRAF, V15, P369, DOI 10.1016/j.trf.2011.08.007; Levy-Tzedek S, 2007, ADV ROBOTICS, V21, P1201, DOI 10.1163/156855307781389383; Levy-Tzedek S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03430-4; Levy-Tzedek S, 2011, J NEUROPHYSIOL, V106, P2120, DOI 10.1152/jn.00266.2011; Levy-Tzedek S, 2011, BRAIN RES BULL, V85, P283, DOI 10.1016/j.brainresbull.2010.11.010; Levy-Tzedek S, 2011, EXP BRAIN RES, V211, P277, DOI 10.1007/s00221-011-2685-0; Levy-Tzedek S, 2010, EXP BRAIN RES, V202, P733, DOI 10.1007/s00221-010-2176-8; Levy-Tzedek S, 2018, RESTORATIVE NEUROL N, P1; Levy-Tzedek S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00375; Lin CC, 2016, J NEUROL PHYS THER, V40, P40, DOI 10.1097/NPT.0000000000000112; Mancini M, 2017, NEUROSCIENCE, V343, P222, DOI 10.1016/j.neuroscience.2016.11.045; Mawase F, 2010, EXP BRAIN RES, V203, P447, DOI 10.1007/s00221-010-2249-8; Meiran N, 2004, BRAIN COGNITION, V54, P260, DOI 10.1016/j.bandc.2004.02.043; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Nonnekes J, 2015, LANCET NEUROL, V14, P768, DOI 10.1016/S1474-4422(15)00041-1; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Porr B, 2003, ADV NEURAL INFORM PR, P1555; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Rakitin BC, 2006, ENCY COGNITIVE SCI, DOI [10.1002/0470018860.s00317, DOI 10.1002/0470018860.S00317]; Rosenbaum DA, 2019, CURRENT DIRECTIONS P; Rosenbaum DA, 2007, HUM MOVEMENT SCI, V26, P525, DOI 10.1016/j.humov.2007.04.001; Rosenbaum DA, 2014, PSYCHOL SCI, V25, P1487, DOI 10.1177/0956797614532657; Slijper H, 2002, BRAIN RES, V924, P184, DOI 10.1016/S0006-8993(01)03233-4; TAYLOR AE, 1995, BRAIN COGNITION, V28, P281, DOI 10.1006/brcg.1995.1258; THORSTENSSON A, 1987, ACTA PHYSIOL SCAND, V131, P211, DOI 10.1111/j.1748-1716.1987.tb08228.x; Vaillancourt DE, 2013, MOVEMENT DISORD, V28, P1920, DOI 10.1002/mds.25687; Valyear KF, 2018, PSYCHONOMIC B REV, P1; Weiss A, 2019, GAIT POSTURE, V67, P224, DOI 10.1016/j.gaitpost.2018.10.018; Woodward TS, 2002, NEUROPSYCHOLOGIA, V40, P1948, DOI 10.1016/S0028-3932(02)00068-4; Wu T, 2015, NEUROBIOL DIS, V82, P226, DOI 10.1016/j.nbd.2015.06.014; Zhu M, 2018, J CONSUM RES, V45, P673, DOI 10.1093/jcr/ucy008	72	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227555	10.1371/journal.pone.0227555	http://dx.doi.org/10.1371/journal.pone.0227555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935247	Green Published, gold			2022-12-26	WOS:000534354100028
J	Pardo, JV; Sheikh, SA; Schwindt, G; Lee, JT; Adson, DE; Rittberg, B; Abuzzahab, FS				Pardo, Jose V.; Sheikh, Sohail A.; Schwindt, Graeme; Lee, Joel T.; Adson, David E.; Rittberg, Barry; Abuzzahab, Faruk S., Sr.			A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; STATE FUNCTIONAL CONNECTIVITY; POSITRON-EMISSION-TOMOGRAPHY; SUBGENUAL PREFRONTAL CORTEX; VAGUS NERVE-STIMULATION; OLANZAPINE/FLUOXETINE COMBINATION; GLUCOSE-METABOLISM; MAJOR DEPRESSION; TEST-RETEST; AMYGDALA	Treatment-resistant depression (TRD) occurs in many patients and causes high morbidity and mortality. Because TRD subjects are particularly difficult to study especially longitudinally, biological data remain very limited. In a preliminary study to judge feasibility and power, 25 TRD patients were referred from specialty psychiatric practices. All were severely and chronically depressed and mostly had comorbid psychiatric disorders as is typical in TRD. Nine patients were able to complete all required components of the protocol that included diagnostic interview; rating scales; clinical magnetic resonance imaging; medication washout; treatment with maximally tolerated olanzapine-fluoxetine combination for 8 weeks; and pre- and post-treatment fluorodeoxyglucose positron emission tomography. This drug combination is an accepted standard of treatment for TRD. Dropouts arose from worsening depression, insomnia, and anxiety. One patient remitted; three responded. A priori regions of interest included the amygdala and subgenual cingulate cortex (sgACC; Brodmann area BA25). Responders showed decreased metabolism with treatment in the right amygdala that correlated with clinical response; no significant changes in BA25; better response to treatment the higher the baseline BA25 metabolism; and decreased right ventromedial prefrontal metabolism (VMPFC; broader than BA25) with treatment which did not correlate with depression scores. The baseline metabolism of all individuals showed heterogeneous patterns when compared to a normative metabolic database. Although preliminary given the sample size, this study highlights several issues important for future work: marked dropout rate in this study design; need for large sample size for adequate power; baseline metabolic heterogeneity of TRD requiring careful subject characterization for future studies of interventions; relationship of amygdala activity decreases with response; and the relationship between baseline sgACC and VMPFC activity with response. Successful treatment of TRD with olanzapine-fluoxetine combination shows changes in cerebral metabolism like those seen in treatment-responsive major depression.	[Pardo, Jose V.; Sheikh, Sohail A.; Schwindt, Graeme; Lee, Joel T.] Minneapolis VA Hlth Care Syst, Mental Hlth PSL, Cognit Neuroimaging Unit, Minneapolis, MN 55417 USA; [Pardo, Jose V.; Sheikh, Sohail A.; Adson, David E.; Rittberg, Barry; Abuzzahab, Faruk S., Sr.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Sheikh, Sohail A.] Hawkes Bay Hosp, Dept Psychiat, Gisborne & Hawkes Bay, Napier, New Zealand; [Schwindt, Graeme] Sunnybrook Hlth Sci Ctr, Dept Family Med, Toronto, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Pardo, JV (corresponding author), Minneapolis VA Hlth Care Syst, Mental Hlth PSL, Cognit Neuroimaging Unit, Minneapolis, MN 55417 USA.; Pardo, JV (corresponding author), Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA.	jvpardo@umn.edu			Department of Veterans Affairs [I01CX000501]; Eli Lilly Co.; lilly.com	Department of Veterans Affairs(US Department of Veterans Affairs); Eli Lilly Co.(Eli Lilly); lilly.com	This work was supported by JVP (PI) Department of Veterans Affairs, I01CX000501, www.minneapolis.va.gov; JVP (PI); Eli Lilly & Co.; lilly.com; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho FR, 2011, NEUROSCI LETT, V497, P99, DOI 10.1016/j.neulet.2011.04.039; Ambrosi E, 2017, ACTA PSYCHIAT SCAND, V136, P129, DOI 10.1111/acps.12724; Bobo WV, 2010, EXPERT REV NEUROTHER, V10, P651, DOI 10.1586/ERN.10.44; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Brown SSG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46687-7; Brunner E, 2014, NEUROPSYCHOPHARMACOL, V39, P2549, DOI 10.1038/npp.2014.101; Cao B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23685-9; Conway CR, 2013, BRAIN STIMUL, V6, P788, DOI 10.1016/j.brs.2012.11.006; Corruble E, 1998, EUR PSYCHIAT, V13, P264, DOI 10.1016/S0924-9338(98)80032-1; Cullen KR, 2014, JAMA PSYCHIAT, V71, P1138, DOI 10.1001/jamapsychiatry.2014.1087; De Carlo V, 2016, PSYCHIAT RES, V240, P421, DOI 10.1016/j.psychres.2016.04.034; Dodd Seetal, 2008, Expert Rev Neurother, V8, P1299, DOI 10.1586/14737175.8.9.1299; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Epstein LR, 2009, PHARMANOTE, V24, P1; Fagiolini A, 2003, BIOL PSYCHIAT, V53, P640, DOI 10.1016/S0006-3223(02)01670-0; Fallmar D, 2016, AM J NUCL MED MOLEC, V6, P269; Fantino B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-26; First M.B., 2014, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2012, BIOL PSYCHIAT, V72, P595, DOI 10.1016/j.biopsych.2012.04.028; Gosnell SN, 2019, J AFFECT DISORDERS, V242, P211, DOI 10.1016/j.jad.2018.08.026; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Haridas R M, 2003, Indian J Psychiatry, V45, P234; Horowitz JM, 2003, SYNAPSE, V50, P353, DOI 10.1002/syn.10276; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Koch S, 2004, NEUROPHARMACOLOGY, V46, P232, DOI 10.1016/j.neuropharm.2003.09.001; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee Joel T, 2008, BMC Med Imaging, V8, P10, DOI 10.1186/1471-2342-8-10; Li CT, 2016, HUM BRAIN MAPP, V37, P1080, DOI 10.1002/hbm.23085; Li CT, 2015, BRIT J PSYCHIAT, V206, P316, DOI 10.1192/bjp.bp.113.140434; Li CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070089; Li CT, 2010, J AFFECT DISORDERS, V127, P219, DOI 10.1016/j.jad.2010.05.028; Liotti M, 2001, J CLIN EXP NEUROPSYC, V23, P121, DOI 10.1076/jcen.23.1.121.1223; Luan SX, 2017, NEUROPSYCH DIS TREAT, V13, P609, DOI 10.2147/NDT.S127453; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 2002, AM J PSYCHIAT, V159, P728, DOI 10.1176/appi.ajp.159.5.728; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McNair D.M., 1971, MANUAL PROFILES MOOD; MINOSHIMA S, 1994, J NUCL MED, V35, P1528; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; Nobler MS, 2001, AM J PSYCHIAT, V158, P305, DOI 10.1176/appi.ajp.158.2.305; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papakostas GI, 2003, J CLIN PSYCHIAT, V64, P1357, DOI 10.4088/JCP.v64n1112; Pardo JV, 2008, NEUROIMAGE, V42, P879, DOI 10.1016/j.neuroimage.2008.04.267; Pardo JV, 2010, ALZHEIMERS DEMENT, V6, P326, DOI 10.1016/j.jalz.2009.09.005; Pardo JV, 2007, DEPRESSION MIND BODY, V3, P57; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Ramasubbu R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00017; Riva-Posse P, 2014, BIOL PSYCHIAT, V76, P963, DOI 10.1016/j.biopsych.2014.03.029; Rizvi SJ, 2014, CAN J PSYCHIAT, V59, P349, DOI 10.1177/070674371405900702; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Schaefer SM, 2000, HUM BRAIN MAPP, V10, P1, DOI 10.1002/(SICI)1097-0193(200005)10:1<1::AID-HBM10>3.0.CO;2-O; Schmidt ME, 1996, J NUCL MED, V37, P1142; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Sharma KK, 2020, CEREB CORTEX, V30, P550, DOI 10.1093/cercor/bhz106; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shelton RC, 2001, AM J PSYCHIAT, V158, P131, DOI 10.1176/appi.ajp.158.1.131; Shelton RC, 2005, J CLIN PSYCHIAT, V66, P1289, DOI 10.4088/JCP.v66n1012; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Souery D, 2007, J CLIN PSYCHIAT, V68, P1062, DOI 10.4088/JCP.v68n0713; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Thase ME, 1997, J CLIN PSYCHIAT, V58, P23; Trivedi MH, 2009, J CLIN PSYCHIAT, V70, P387, DOI 10.4088/JCP.08m04064; Vaccarino AL, 2008, DEPRESS ANXIETY, V25, P1006, DOI 10.1002/da.20435; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Watson D, 1999, J PERS SOC PSYCHOL, V44, P644; Zachary R, 1986, SHIPLEY I LIVING SCA; Zald DH, 2002, P NATL ACAD SCI USA, V99, P2450, DOI 10.1073/pnas.042457199; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143; Zhang W, 2000, NEUROPSYCHOPHARMACOL, V23, P250, DOI 10.1016/S0893-133X(00)00119-6; Zimovetz Evelina A, 2012, Cost Eff Resour Alloc, V10, P1, DOI 10.1186/1478-7547-10-1	85	2	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226486	10.1371/journal.pone.0226486	http://dx.doi.org/10.1371/journal.pone.0226486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IZ	31931515	Green Published, Green Submitted, gold			2022-12-26	WOS:000534352500013
J	Yu, TB; Dodd, S; Yu, LG; Subramanian, S				Yu, Tony B.; Dodd, Susanna; Yu, Lu-Gang; Subramanian, Sreedhar			Serum galectins as potential biomarkers of inflammatory bowel diseases	PLOS ONE			English	Article							METASTASIS-PROMOTING CYTOKINES; INCREASED CIRCULATION; FECAL CALPROTECTIN; CANCER-PATIENTS; CROHNS-DISEASE; T-LYMPHOCYTES; COLITIS; PATHOGENESIS; SECRETION; COLON	The inflammatory bowel diseases (IBD), which include mainly Crohn's disease (CD) and ulcerative colitis (UC), are common chronic inflammatory conditions of the digestive system. The diagnosis of IBD relies on the use of a combination of factors including symptoms, endoscopy and levels of serum proteins such as C-reactive protein (CRP) or faecal calprotectin. Currently there is no single reliable biomarker to determine IBD. Galectins are a family of galactoside-binding proteins that are commonly altered in the circulation of disease conditions such as cancer and inflammation. This study investigated serum galectin levels as possible biomarkers in determining IBD and IBD disease activity. Levels of galectins-1, -2, -3, -4, -7 and -8 were analysed in 208 samples from ambulant IBD patients (97 CD, 71 UC) patients and 40 from healthy people. Disease activity was assessed using HarveyBradshaw Index for CD and simple clinical colitis activity index for UC. The relationship of each galectin in determining IBD and IBD disease activity were analysed and compared with current IBD biomarker CRP. It was found that serum level of galectin-1 and -3, but not galectins-2, -4, -7 and -8, were significantly higher in IBD patients than in healthy people. At cut-off of 4.1ng/ml, galectin-1 differentiated IBD from healthy controls with 71% sensitivity and 87% specificity. At cut-off of 38.5ng/ml, galectin-3 separated IBD from healthy controls with 53% sensitivity and 87% specificity. None of the galectins however were able to distinguish active disease from remission in UC or CD. Thus, levels of galectins-1 and -3 are significantly elevated in both UC and CD patients compared to healthy people. Although the increased galectin levels are not able to separate active and inactive UC and CD, they may have the potential to be developed as useful biomarkers for IBD diagnosis either alone or in combination with other biomarkers.	[Yu, Tony B.] Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Midlothian, Scotland; [Yu, Tony B.; Yu, Lu-Gang; Subramanian, Sreedhar] Univ Liverpool, Inst Translat Med, Gastroenterol Res Unit, Liverpool, Merseyside, England; [Dodd, Susanna] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England; [Subramanian, Sreedhar] Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool, Merseyside, England	University of Edinburgh; University of Liverpool; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Subramanian, S (corresponding author), Univ Liverpool, Inst Translat Med, Gastroenterol Res Unit, Liverpool, Merseyside, England.; Subramanian, S (corresponding author), Royal Liverpool Univ Hosp, Dept Gastroenterol, Liverpool, Merseyside, England.	sreedhar.subramanian@rlbuht.nhs.uk		Yu, Lu-Gang/0000-0001-9641-3712; Subramanian, Sreedhar/0000-0002-6483-1730; Dodd, Susanna/0000-0003-2851-3337	Royal Liverpool University Hospital; Wellcome Trust [201871/Z/16/Z]	Royal Liverpool University Hospital; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was sponsored by Royal Liverpool University Hospital (to SS) and a Wellcome Trust Vocation Scholarship (to TB Yu, Wellcome Trust 201871/Z/16/Z).	Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Barrow H, 2011, INT J CANCER, V129, P1, DOI 10.1002/ijc.25945; Brewer CF, 2002, BBA-GEN SUBJECTS, V1572, P255, DOI 10.1016/S0304-4165(02)00312-4; Cao ZQ, 2016, PROTEIN CELL, V7, P314, DOI 10.1007/s13238-016-0262-9; Chen C, 2014, BRIT J CANCER, V110, P741, DOI 10.1038/bjc.2013.793; Chen C, 2013, CLIN CANCER RES, V19, P1693, DOI 10.1158/1078-0432.CCR-12-2940; Cibor D, 2019, J PHYSL PHARM, V70, DOI [10.26402/jpp.2019.1.06, DOI 10.264024882019.1.06]; Colomb F, 2017, J BIOL CHEM, V292, P8381, DOI 10.1074/jbc.M117.783431; Frol'ova L, 2009, INFLAMM RES, V58, P503, DOI 10.1007/s00011-009-0016-8; Gitt MA, 1998, J BIOL CHEM, V273, P2954, DOI 10.1074/jbc.273.5.2954; HARVEY RF, 1980, LANCET, V1, P514; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Jones GR, 2019, GUT, DOI [10.1136/gutjnl-2019-318936, DOI 10.1136/DU-TIN]; Lippert E, 2007, GUT, V56, P43, DOI 10.1136/gut.2005.081646; Lippert E, 2008, CLIN EXP IMMUNOL, V152, P285, DOI 10.1111/j.1365-2249.2008.03618.x; Marechal C, 2017, UNITED EUR GASTROENT, V5, P702, DOI 10.1177/2050640616686517; Markovic BS, 2016, J CROHNS COLITIS, V10, P593, DOI 10.1093/ecco-jcc/jjw013; Muglia CI, 2016, J CELL PHYSIOL, V231, P1575, DOI 10.1002/jcp.25249; Paclik D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002629; Paclik D, 2008, J MOL MED, V86, P1395, DOI 10.1007/s00109-007-0290-2; Gobbi RP, 2016, BIOFACTORS, V42, P93, DOI 10.1002/biof.1252; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Shinzaki S, 2017, J BIOCHEM, V161, P409, DOI 10.1093/jb/mvx010; Sindrewicz P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00079; Srikrishna G, 2005, J IMMUNOL, V175, P5412, DOI 10.4049/jimmunol.175.8.5412; Travis SPL, 1996, GUT, V38, P905, DOI 10.1136/gut.38.6.905; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; Vande Casteele N, 2014, GUT, DOI [10.1136/gutjnl-2014-307883, DOI 10.11364088-2014-307883]; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Walmsley RS, 1998, GUT, V43, P29, DOI 10.1136/gut.43.1.29; Walsh AJ, 2016, NAT REV GASTRO HEPAT, V13, P567, DOI 10.1038/nrgastro.2016.128; Walsham NE, 2016, CLIN EXP GASTROENTER, V9, P21, DOI 10.2147/CEG.S51902; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227306	10.1371/journal.pone.0227306	http://dx.doi.org/10.1371/journal.pone.0227306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929564	Green Published, gold			2022-12-26	WOS:000534352500033
J	Forstner, P; Knoll, B				Foerstner, Philip; Knoell, Bernd			Interference of neuronal activity-mediated gene expression through serum response factor deletion enhances mortality and hyperactivity after traumatic brain injury	FASEB JOURNAL			English	Article						c-Fos; Egr; hematoma; hyperactivity; immediate early gene; transcription	CLOSED-HEAD INJURY; TRANSCRIPTION FACTORS; SYNAPSE DEVELOPMENT; C-JUN; ACTIVATION; SRF; RECEPTORS; MEMORY; CREB; NEUROINFLAMMATION	Traumatic brain injury (TBI) is one of the most frequent causes of brain injury and mortality in young adults with detrimental sequelae such as cognitive impairments, epilepsy, and attention-deficit hyperactivity disorder. TBI modulates the neuronal excitability resulting in propagation of a neuronal activity-driven gene expression program. However, the impact of such neuronal activity mediated gene expression in TBI has been poorly studied. In this study we analyzed mouse mutants of the prototypical neuronal activity-dependent transcription factor SRF (serum response factor) in a weight-drop TBI model. Neuron-restricted SRF deletion elevated TBI inflicted mortality suggesting a neuroprotective SRF function during TBI. Behavioral inspection uncovered elevated locomotor activity in Srf mutant mice after TBI in contrast to hypoactivity observed in wild-type littermates. This indicates an SRF role in modulation of TBI-associated alterations in locomotor activity. Finally, induction of a neuronal activity induced gene expression program composed of immediate early genes (IEGs) such as Egr1, Egr2, Egr3, Npas4, Atf3, Arc, Ptgs2, and neuronal pentraxins (Nptx2) was compromised upon SRF depletion. Overall, our data show a role of neuronal activity-mediated gene transcription during TBI and suggest a molecular link between TBI and such post-TBI neurological comorbidities involving hyperactivity phenotypes.	[Foerstner, Philip; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany	Ulm University	Knoll, B (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	bernd.knoell@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG) [SFB1149]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1149	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Aid S, 2011, BIOCHIMIE, V93, P46, DOI 10.1016/j.biochi.2010.09.009; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anastasiadou S, 2016, EXP NEUROL, V279, P243, DOI 10.1016/j.expneurol.2016.03.012; Anastasiadou S, 2015, GLIA, V63, P958, DOI 10.1002/glia.22794; Benito E, 2015, MOL NEUROBIOL, V51, P1071, DOI 10.1007/s12035-014-8772-z; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Kim S, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0025-1; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Losing P, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0310-2; Luckow KS, 2015, EURASIP J EMBED SYST, DOI 10.1186/s13639-015-0020-8; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Mokalled MH, 2010, DEVELOPMENT, V137, P2365, DOI 10.1242/dev.047605; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nader K, 2019, BRAIN STRUCT FUNCT; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Ohnishi YN, 2011, BIOL PSYCHIAT, V70, P487, DOI 10.1016/j.biopsych.2011.04.021; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Parkitna JR, 2010, FASEB J, V24, P2427, DOI 10.1096/fj.09-151423; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Stern S, 2013, J NEUROSCI, V33, P18836, DOI 10.1523/JNEUROSCI.3029-13.2013; Stern S, 2012, J NEUROINFLAMM, V9, DOI [10.1186/1742-2094-9-79, 10.1186/1742-2094-9-78]; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Wang MY, 2018, MOL MED REP, V17, P4925, DOI 10.3892/mmr.2018.8525; Whitfield PC, 2000, NEUROL RES, V22, P138, DOI 10.1080/01616412.2000.11741050; Wong CT, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12506; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zimmermann AM, 2015, BIOL PSYCHIAT, V78, P95, DOI 10.1016/j.biopsych.2014.03.011; Zimprich A, 2017, MOL NEUROBIOL, V54, P8242, DOI 10.1007/s12035-016-0300-x; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	74	6	6	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3855	3873		10.1096/fj.201902257RR	http://dx.doi.org/10.1096/fj.201902257RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31930559	Green Published, hybrid			2022-12-26	WOS:000507880600001
J	Peralta, G; Dickie, IA; Yeates, GW; Peltzer, DA				Peralta, Guadalupe; Dickie, Ian A.; Yeates, Gregor W.; Peltzer, Duane A.			Community- and trophic-level responses of soil nematodes to removal of a non-native tree at different stages of invasion	PLOS ONE			English	Article							ECOLOGICAL IMPACTS; FOOD WEBS; PLANT; DIVERSITY; BIODIVERSITY; RESTORATION; ECOSYSTEMS; MANAGEMENT; METAANALYSIS; GRASSLAND	Success of invasive non-native plant species management is usually measured as changes in the abundance of the invasive plant species or native plant species following invader management, but more complex trophic responses to invader removal are often ignored or assumed. Moreover, the effects of invader removal at different stages of the invasion process is rarely evaluated, despite a growing recognition that invader impacts are density or stage-dependent. Therefore, the effectiveness of invasive species management for restoring community structure and function across trophic levels remains poorly understood. We determined how soil nematode diversity and community composition respond to removal of the globally invasive tree species Pinus contorta at different stages of invasion by reanalysing and expanding an earlier study including uninvaded vegetation (seedlings removed continuously), early invader removal (saplings removed), late removal (trees removed), and no removal (invaded). These treatments allowed us to evaluate the stage-dependent belowground trophic responses to biological invasion and removal. We found that invaded plots had half the nematode taxa richness compared to uninvaded plots, and that tree invasion altered the overall composition of the nematode community. Differences in nematode community composition between uninvaded nematode communities and those under the tree removal strategy tended to dilute higher up the food chain, whereas the composition of uninvaded vs. sapling removal strategies did not differ significantly. Conversely, the composition of invaded compared to uninvaded nematode communities differed across all trophic levels, altering the community structure and function. Specifically, invaded communities were structurally simplified compared to uninvaded communities, and had a higher proportion of short life cycle nematodes, characteristic of disturbed environments. We demonstrate that a shift in management strategies for a globally invasive tree species from removing trees to earlier removal of saplings is needed for maintaining the composition and structure of soil nematode communities to resemble uninvaded conditions.	[Peralta, Guadalupe; Yeates, Gregor W.; Peltzer, Duane A.] Manaaki Whenua Landcare Res, Lincoln, New Zealand; [Dickie, Ian A.] Univ Canterbury, Sch Biol Sci, Bioprotect Res Ctr, Christchurch, New Zealand; [Peralta, Guadalupe] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand	Landcare Research - New Zealand; University of Canterbury; University of Canterbury	Peralta, G (corresponding author), Manaaki Whenua Landcare Res, Lincoln, New Zealand.; Peralta, G (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand.	gdlp.peralta@gmail.com	Peltzer, Duane A/A-9463-2009; Dickie, Ian/C-5419-2013	Peltzer, Duane A/0000-0001-7724-3738; Dickie, Ian/0000-0002-2740-2128	New Zealand Ministry of Business, Innovation and Employment; Winning Against Wildings endeavour research programme	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Winning Against Wildings endeavour research programme	The New Zealand Ministry of Business, Innovation and Employment provided financial support through the Winning Against Wildings endeavour research programme. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barney JN, 2015, ECOL EVOL, V5, P2878, DOI 10.1002/ece3.1551; Biederman LA, 2009, SOIL BIOL BIOCHEM, V41, P1943, DOI 10.1016/j.soilbio.2009.06.019; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Cerevkova A, 2020, J HELMINTHOL, V94, DOI 10.1017/S0022149X19000324; Coffey V, 2019, PLANT SOIL, V435, P437, DOI 10.1007/s11104-018-03906-w; Corbin JD, 2012, INVAS PLANT SCI MANA, V5, P117, DOI 10.1614/IPSM-D-11-00005.1; David P, 2017, ADV ECOL RES, V56, P1, DOI 10.1016/bs.aecr.2016.10.001; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Dickie IA, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu056; Dickie IA, 2011, J APPL ECOL, V48, P926, DOI 10.1111/j.1365-2664.2011.01980.x; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; Ferris H, 2001, APPL SOIL ECOL, V18, P13, DOI 10.1016/S0929-1393(01)00152-4; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Flory SL, 2009, J APPL ECOL, V46, P434, DOI 10.1111/j.1365-2664.2009.01610.x; Funk JL, 2008, TRENDS ECOL EVOL, V23, P695, DOI 10.1016/j.tree.2008.07.013; Gardener MR, 2010, RESTOR ECOL, V18, P20, DOI 10.1111/j.1526-100X.2009.00614.x; Gebremikael MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32862; Gundale MJ, 2014, BIOL INVASIONS, V16, P591, DOI 10.1007/s10530-013-0610-0; Hejda M, 2017, DIVERS DISTRIB, V23, P997, DOI 10.1111/ddi.12596; Hulme PE, 2015, J APPL ECOL, V52, P1418, DOI 10.1111/1365-2664.12470; Kerr NZ, 2016, J APPL ECOL, V53, P305, DOI 10.1111/1365-2664.12592; Kettenring KM, 2011, J APPL ECOL, V48, P970, DOI 10.1111/j.1365-2664.2011.01979.x; Kumschick S, 2015, BIOSCIENCE, V65, P55, DOI 10.1093/biosci/biu193; Laliberte E, 2017, ECOL LETT, V20, P1273, DOI 10.1111/ele.12823; Ledgard N, 2001, FOREST ECOL MANAG, V141, P43, DOI 10.1016/S0378-1127(00)00488-6; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Martin A, 2019, RES SCI EDUC, V49, P885, DOI 10.1007/s11165-017-9644-0; Meisner A, 2014, BIOL INVASIONS, V16, P2551, DOI 10.1007/s10530-014-0685-2; Musil CF, 2005, S AFR J SCI, V101, P337; Myers JH, 2000, TRENDS ECOL EVOL, V15, P316, DOI 10.1016/S0169-5347(00)01914-5; Nunez MA, 2017, BIOL INVASIONS, V19, P3099, DOI 10.1007/s10530-017-1483-4; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pearson DE, 2016, BIOL CONSERV, V197, P8, DOI 10.1016/j.biocon.2016.02.029; Peralta G, 2019, OECOLOGIA, V190, P891, DOI 10.1007/s00442-019-04456-3; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Reid AM, 2009, BIOL CONSERV, V142, P2342, DOI 10.1016/j.biocon.2009.05.011; Reid ML, 2018, BIOL CONSERV, V224, P153, DOI 10.1016/j.biocon.2018.05.026; Rinella MJ, 2009, ECOL APPL, V19, P155, DOI 10.1890/07-1482.1; Scherber C, 2010, NATURE, V468, P553, DOI 10.1038/nature09492; Seibold S, 2018, TRENDS ECOL EVOL, V33, P754, DOI 10.1016/j.tree.2018.07.001; Sieriebriennikov B, 2014, EUR J SOIL BIOL, V61, P90, DOI 10.1016/j.ejsobi.2014.02.004; Simberloff D, 2014, ECOL ENG, V65, P112, DOI 10.1016/j.ecoleng.2013.08.004; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Stewart G, 2008, ANN BOT-LONDON, V101, P957, DOI 10.1093/aob/mcn020; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; van Wilgen BW, 2012, BIOL CONSERV, V148, P28, DOI 10.1016/j.biocon.2011.12.035; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; WARDLE DA, 1993, OECOLOGIA, V93, P303, DOI 10.1007/BF00317685; WHITEHEAD AG, 1965, ANN APPL BIOL, V55, P25, DOI 10.1111/j.1744-7348.1965.tb07864.x; Wubs ERJ, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.107, 10.1038/nplants.2016.107]; Yeates G.W., 1987, Advances in Ecological Research, V17, P61, DOI 10.1016/S0065-2504(08)60244-5; YEATES GW, 1993, J NEMATOL, V25, P315; YEATES GW, 1994, PEDOBIOLOGIA, V38, P97; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2; Zhang P, 2019, ECOL LETT, V22, P200, DOI 10.1111/ele.13181; Zhao J, 2014, NEMATOLOGY, V16, P379, DOI 10.1163/15685411-00002771	61	1	1	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227130	10.1371/journal.pone.0227130	http://dx.doi.org/10.1371/journal.pone.0227130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923283	Green Published, gold, Green Submitted			2022-12-26	WOS:000534350000045
J	Tolles, J; Waterman, G; Coffey, CE; Sandoval, R; Fleischman, RJ; Hess, M; Sarff, L; Lewis, RJ; Spellberg, B				Tolles, Juliana; Waterman, Gabriel; Coffey, Charles E., Jr.; Sandoval, Rebecca; Fleischman, Ross J.; Hess, Mailee; Sarff, Laura; Lewis, Roger J.; Spellberg, Brad		BRAVE Study Grp	A randomized trial of a behavioral intervention to decrease hospital length of stay by decreasing bedrest	PLOS ONE			English	Article							FUNCTIONAL DECLINE; EARLY MOBILIZATION; LOW MOBILITY; DISCHARGE; PROTOCOL; IMPACT	Background Approximately half of hospitalized patients suffer functional decline due to spending the vast majority of their time in bed. Previous studies of early mobilization have demonstrated improvement in outcomes, but the interventions studied have been resource-intensive. We aimed to decrease the time hospital inpatients spend in bed through a pragmatic mobilization protocol. Methods This prospective, non-blinded, controlled clinical trial assigned inpatients to the study wards per routine clinical care in an urban teaching hospital. All subjects on intervention wards were provided with a behavioral intervention, consisting of educational handouts, by the nursing staff. Half of the intervention wards were supplied with recliner chairs in which subjects could sit. The primary outcome was hospital length of stay. The secondary outcome was the '6-Clicks' functional score. Results During a 6-month study period, 6082 patient encounters were included. The median length of stay was 84 hours (IQR 44-175 hours) in the control group, 80 hours (IQR 44-155 hours) in the group who received the behavioral intervention alone, and 88 hours (IQR 44-185 hours) in the group that received both the behavioral intervention and the recliner chair. In the multivariate analysis, neither the behavioral intervention nor the provision of a recliner chair was associated with a significant decrease in length of stay or increase in functional status as measured by the '6-Clicks' functional score. Conclusion The program of educational handouts and provision of recliner chairs to discourage bed rest did not increase functional status or decrease length of stay for inpatients in a major urban academic center. Education and physical resources must be supplemented by other active interventions to reduce time spent in bed, functional decline, and length of stay.	[Tolles, Juliana; Fleischman, Ross J.; Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Tolles, Juliana; Fleischman, Ross J.; Hess, Mailee; Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Waterman, Gabriel] CareMore Hlth, Pico Rivera, CA USA; [Coffey, Charles E., Jr.; Sarff, Laura; Spellberg, Brad] Los Angeles Cty Univ Southern Calif USC, Med Ctr, Los Angeles, CA USA; [Coffey, Charles E., Jr.; Sandoval, Rebecca; Spellberg, Brad] USC, Keck Sch Med, Dept Med, Los Angeles, CA USA; [Hess, Mailee] Harbor UCLA Med Ctr, Dept Med, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of Southern California Keck Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Tolles, J (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA.; Tolles, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	jtolles@emedharbor.edu		Sarff, John/0000-0001-8883-6678	Los Angeles County University of Southern California Medical Center - LAC+USC Medical Center	Los Angeles County University of Southern California Medical Center - LAC+USC Medical Center	Los Angeles County University of Southern California Medical Center, which provided funding for the study as a quality improvement project were involved in the study design and data collection. Funders were not involved in data analysis, the decision to publish, or the preparation of the manuscript.; This was a quality improvement improvement activity funded by LAC+USC Medical Center.	Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; Brown CJ, 2009, J AM GERIATR SOC, V57, P1660, DOI 10.1111/j.1532-5415.2009.02393.x; Chuang KH, 2003, J AM GERIATR SOC, V51, P1729, DOI 10.1046/j.1532-5415.2003.51556.x; Convertino VA, 1997, MED SCI SPORT EXER, V29, P191, DOI 10.1097/00005768-199702000-00005; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Graf C, 2006, AM J NURS, V106, P58, DOI 10.1097/00000446-200601000-00032; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; Hoyer EH, 2015, AM J PHYS MED REHAB, V94, P304, DOI 10.1097/PHM.0000000000000185; Jette DU, 2014, PHYS THER, V94, P1252, DOI 10.2522/ptj.20130359; Jette DU, 2014, PHYS THER, V94, P379, DOI 10.2522/ptj.20130199; Jette DU, 2014, PHYS THER; King Barbara Doherty, 2006, Medsurg Nurs, V15, P265; Mundy LM, 2003, CHEST, V124, P883, DOI 10.1378/chest.124.3.883; Padula CA, 2009, J NURS CARE QUAL, V24, P325, DOI 10.1097/NCQ.0b013e3181a4f79b; Pashikanti L, 2012, CLIN NURSE SPEC, V26, P87, DOI 10.1097/NUR.0b013e31824590e6; Sands LP, 2003, J GERONTOL A-BIOL, V58, P37; Suesada MM, 2007, AM J PHYS MED REHAB, V86, P455, DOI 10.1097/PHM.0b013e31805b7566	17	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226332	10.1371/journal.pone.0226332	http://dx.doi.org/10.1371/journal.pone.0226332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923203	Green Published, gold			2022-12-26	WOS:000534350000015
J	Jones, K; Burgess, G; Budd, AM; Huerlimann, R; Mashkour, N; Ariel, E				Jones, K.; Burgess, G.; Budd, A. M.; Huerlimann, R.; Mashkour, N.; Ariel, E.			Molecular evidence for horizontal transmission of chelonid alphaherpesvirus 5 at green turtle (Chelonia mydas) foraging grounds in Queensland, Australia	PLOS ONE			English	Article							CUTANEOUS FIBROPAPILLOMAS; UNIFIED NOMENCLATURE; GENETIC DIVERSITY; POLYMERASE GENE; MARINE TURTLES; JUVENILE GREEN; TUMOR-TISSUES; HERPESVIRUS; SEQUENCE; POPULATION	Fibropapillomatosis (FP) is a marine turtle disease recognised by benign tumours on the skin, eyes, shell, oral cavity and/or viscera. Despite being a globally distributed disease that affects an endangered species, research on FP and its likely causative agent chelonid alphaherpesvirus 5 (ChHV5) in Australia is limited. Here we present improved molecular assays developed for detection of ChHV5, in combination with a robust molecular and phylogenetic analysis of ChHV5 variants. This approach utilised a multi-gene assay to detect ChHV5 in all FP tumors sampled from 62 marine turtles found at six foraging grounds along the Great Barrier Reef. Six distinct variants of ChHV5 were identified and the distribution of these variants was associated with host foraging ground. Conversely, no association between host genetic origin and ChHV5 viral variant was found. Together this evidence supports the hypothesis that marine turtles undergo horizontal transmission of ChHV5 at foraging grounds and are unlikely to be contracting the disease at rookeries, either during mating or vertically from parent to offspring.	[Jones, K.; Burgess, G.; Mashkour, N.; Ariel, E.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Jones, K.; Budd, A. M.; Huerlimann, R.; Mashkour, N.; Ariel, E.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Jones, K.; Mashkour, N.; Ariel, E.] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia	James Cook University; James Cook University; James Cook University	Jones, K (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.; Jones, K (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Jones, K (corresponding author), James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res, Townsville, Qld, Australia.	karina.jones@jcu.edu.au	Ariel, Ellen/B-7015-2012; mashkour, narges/K-6977-2019	Ariel, Ellen/0000-0002-3171-1679; mashkour, narges/0000-0002-4101-0737; Huerlimann, Roger/0000-0002-6020-334X; Jones, Karina/0000-0001-7715-0507				Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046623; AGUIRRE AA, 1995, PHYSIOL ZOOL, V68, P831, DOI 10.1086/physzool.68.5.30163934; Alfaro-Nunez A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0206-z; Alfaro-Nunez A, 2014, J VIROL METHODS, V206, P38, DOI 10.1016/j.jviromet.2014.05.019; Anderson JD, 2013, J HERPETOL, V47, P251, DOI 10.1670/12-031; Ariel E, 2017, J AQUAT ANIM HEALTH, V29, P150, DOI 10.1080/08997659.2017.1330783; Ariel E, 2017, AUSTR VET J; Bender FC, 2007, J VIROL, V81, P3827, DOI 10.1128/JVI.02710-06; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; Cardenas DM, 2019, J WILDLIFE DIS, V55, P169, DOI 10.7589/2017-12-295; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; Coberley SS, 2002, J VIROL, V76, P10553, DOI 10.1128/JVI.76.20.10553-10558.2002; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dobbs K., 2001, MARINE TURTLES GREAT; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Dutton PH, 2014, PAC SCI, V68, P451, DOI 10.2984/68.4.1; Ene A, 2005, J WILDLIFE DIS, V41, P489, DOI 10.7589/0090-3558-41.3.489; Flint M, 2010, J COMP PATHOL, V142, P341, DOI 10.1016/j.jcpa.2009.10.012; Greenblatt RJ, 2005, J ZOO WILDLIFE MED, V36, P527, DOI 10.1638/04-051.1; Gulko D., 2004, SEA TURTLES ECOLOGIC; Hargrove S, 2016, NOAA TECHNICAL MEMOR, P87; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; Herbst Lawrence H., 1994, Annual Review of Fish Diseases, V4, P389, DOI 10.1016/0959-8030(94)90037-X; HERBST LH, 1995, DIS AQUAT ORGAN, V22, P1, DOI 10.3354/dao022001; JACOBSON ER, 1991, DIS AQUAT ORGAN, V12, P1, DOI 10.3354/dao012001; JACOBSON ER, 1989, J COMP PATHOL, V101, P39, DOI 10.1016/0021-9975(89)90075-3; Jensen MP, 2016, MAR ECOL PROG SER, V543, P241, DOI 10.3354/meps11521; Jones K, 2016, VET J, V212, P48, DOI 10.1016/j.tvjl.2015.10.041; Jones K, 2018, PEERJ, V6, DOI 10.7717/peerj.5651; JUKES T H, 1969, P21; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lackovich JK, 1999, DIS AQUAT ORGAN, V37, P89, DOI 10.3354/dao037089; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Lawrance MF, 2018, VIROLOGY, V521, P190, DOI 10.1016/j.virol.2018.06.012; Limpus C. J., 1994, Memoirs of the Queensland Museum, V37, P195; Limpus C.J., 1985, P47; LIMPUS C.J., 1994, MEMOIRS QUEENSLAND M, V35, P139; LIMPUS CJ, 1992, WILDLIFE RES, V19, P489, DOI 10.1071/WR9920489; Limpus CJ, 2008, BIOLOGICAL REV AUSTR; Lu Y, 2000, ARCH VIROL, V145, P1885, DOI 10.1007/s007050070063; Lu YA, 2003, ARCH VIROL, V148, P1155, DOI 10.1007/s00705-002-0970-8; Lu YN, 2000, J AQUAT ANIM HEALTH, V12, P58, DOI [10.1577/1548-8667(2000)012<0058:DOGTHS>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0058:DOGTHS&gt;2.0.CO;2]; Mashkour N, 2018, J VIROL METHODS, V258, P13, DOI 10.1016/j.jviromet.2018.04.004; Monezi TA, 2016, VET MICROBIOL, V186, P150, DOI 10.1016/j.vetmic.2016.02.020; Morrison CL, 2018, PEERJ, V6, DOI 10.7717/peerj.4386; Musick John A., 1997, P137; Nigro O, 2004, J VIROL METHODS, V120, P107, DOI 10.1016/j.jviromet.2004.04.011; Nigro O, 2004, ARCH VIROL, V149, P337, DOI 10.1007/s00705-003-0204-8; Origgi FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134897; Page-Karjian A, 2015, ENDANGER SPECIES RES, V28, P135, DOI 10.3354/esr00687; Page-Karjian A, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-35; Patricio AR, 2012, J GEN VIROL, V93, P1035, DOI 10.1099/vir.0.038950-0; Quackenbush SL, 1998, VIROLOGY, V246, P392, DOI 10.1006/viro.1998.9207; Quackenbush SL, 2001, VIROLOGY, V287, P105, DOI 10.1006/viro.2001.1023; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Rodenbusch CR, 2014, DIS AQUAT ORGAN, V111, P207, DOI 10.3354/dao02782; Shimada T, 2016, MAR ECOL PROG SER, V562, P163, DOI 10.3354/meps11972; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Work TM, 2017, J VIROL, V91, DOI 10.1128/JVI.00404-17; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2001, J WILDLIFE DIS, V37, P574, DOI 10.7589/0090-3558-37.3.574; Yu Q, 2000, ARCH VIROL, V145, P2669, DOI 10.1007/s007050070015; Yu QG, 2001, J VIROL METHODS, V91, P183, DOI 10.1016/S0166-0934(00)00267-6	66	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227268	10.1371/journal.pone.0227268	http://dx.doi.org/10.1371/journal.pone.0227268			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917785	Green Published, gold, Green Accepted			2022-12-26	WOS:000534341100019
J	Kioka, H; Kato, H; Fujita, T; Asano, Y; Shintani, Y; Yamazaki, S; Tsukamoto, O; Imamura, H; Kogo, M; Kitakaze, M; Sakata, Y; Takashima, S				Kioka, Hidetaka; Kato, Hisakazu; Fujita, Takeshi; Asano, Yoshihiro; Shintani, Yasunori; Yamazaki, Satoru; Tsukamoto, Osamu; Imamura, Hiromi; Kogo, Mikihiko; Kitakaze, Masafumi; Sakata, Yasushi; Takashima, Seiji			In vivo real-time ATP imaging in zebrafish hearts reveals G0s2 induces ischemic tolerance	FASEB JOURNAL			English	Article						ATP; energy metabolism; FRET; in vivo imaging; ischemic tolerance	SWITCH GENE 2; OXIDATIVE-PHOSPHORYLATION; POSITIVE REGULATOR; ENERGY-METABOLISM; HYPOXIA; VISUALIZATION; ADAPTATION; KINASE; MICE	Most eukaryotic cells generate adenosine triphosphate (ATP) through the oxidative phosphorylation system (OXPHOS) to support cellular activities. In cultured cell-based experiments, we recently identified the hypoxia-inducible protein G0/G1 switch gene 2 (G0s2) as a positive regulator of OXPHOS, and showed that G0s2 protects cultured cardiomyocytes from hypoxia. In this study, we examined the in vivo protective role of G0s2 against hypoxia by generating both loss-of-function and gain-of-function models of g0s2 in zebrafish. Zebrafish harboring transcription activator-like effector nuclease (TALEN)-mediated knockout of g0s2 lost hypoxic tolerance. Conversely, cardiomyocyte-specific transgenic zebrafish hearts exhibited strong tolerance against hypoxia. To clarify the mechanism by which G0s2 protects cardiac function under hypoxia, we introduced a mitochondrially targeted FRET-based ATP biosensor into zebrafish heart to visualize ATP dynamics in in vivo beating hearts. In addition, we employed a mosaic overexpression model of g0s2 to compare the contraction and ATP dynamics between g0s2-expressing and non-expressing cardiomyocytes, side-by-side within the same heart. These techniques revealed that g0s2-expressing cardiomyocyte populations exhibited preserved contractility coupled with maintained intra-mitochondrial ATP concentrations even under hypoxic condition. Collectively, these results demonstrate that G0s2 provides ischemic tolerance in vivo by maintaining ATP production, and therefore represents a promising therapeutic target for hypoxia-related diseases.	[Kioka, Hidetaka; Fujita, Takeshi; Asano, Yoshihiro; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Kato, Hisakazu; Tsukamoto, Osamu; Takashima, Seiji] Osaka Univ, Grad Sch Med Frontier Biosci, Dept Med Biochem, Suita, Osaka, Japan; [Fujita, Takeshi; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Shintani, Yasunori; Yamazaki, Satoru] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Mol Pharmacol, Suita, Osaka, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Clin Res & Dev, Suita, Osaka, Japan; [Takashima, Seiji] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Osaka University; Osaka University; Osaka University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Japan Science & Technology Agency (JST)	Kioka, H; Asano, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kioka@cardiology.med.osaka-u.ac.jp; asano@cardiology.med.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020	Kogo, Mikihiko/0000-0002-4556-2491; Tsukamoto, Osamu/0000-0002-9504-8001; Shintani, Yasunori/0000-0001-9579-0727; Kato, Hisakazu/0000-0003-4619-3680; Sakata, Yasushi/0000-0002-5618-4721	JSPS KAKENHI [JP16K09501, JP19K08581]; AMED [JP19ek0109412h0001]; JST CREST [JPMJCR14M2]; Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Research Promotion Society for Cardiovascular Diseases; Japan Medical Association; Takeda Science Foundation; Takeda Medical Research Foundation; Heart Foundation/Novartis; Naito Foundation; Banyu Foundation; Nakatani Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Heart Foundation; Japan Cardiovascular Research Foundation; Japan Research Promotion Society for Cardiovascular Diseases; Japan Medical Association; Takeda Science Foundation(Takeda Science Foundation (TSF)); Takeda Medical Research Foundation; Heart Foundation/Novartis; Naito Foundation(Naito Memorial Foundation); Banyu Foundation; Nakatani Foundation	This research was supported by JSPS KAKENHI Grant Number JP16K09501 and JP19K08581 (to H. Kioka), AMED under Grant Number JP19ek0109412h0001 (to H. Kioka), and JST CREST Grant Number JPMJCR14M2 (to S.T). This research was also supported by grants from the Japan Heart Foundation, Japan Cardiovascular Research Foundation, Japan Research Promotion Society for Cardiovascular Diseases, Japan Medical Association, Takeda Science Foundation, Takeda Medical Research Foundation, Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology, Naito Foundation, Banyu Foundation, and Nakatani Foundation. We thank K. Kawakami, R. Fukuda, and National BioResource Project from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for providing plasmid constructs and crucial lines of zebrafish. We thank T. Yoshida and H. Miyagi (Olympus Corporation) for technical advice regarding microscope; S. Ikezawa and M. Kishimoto for technical assistance; Y. Okada, Y. Kurokawa, and H. Kawasaki for secretarial support.	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BARBOUR RL, 1984, BIOCHEMISTRY-US, V23, P6053, DOI 10.1021/bi00320a024; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Heier C, 2015, J BIOL CHEM, V290, P26141, DOI 10.1074/jbc.M115.671842; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Kobara M, 1996, J MOL CELL CARDIOL, V28, P417, DOI 10.1006/jmcc.1996.0038; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nagao T, 2020, FASEB J, V34, P1859, DOI 10.1096/fj.201800389R; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Picard MH, 2011, J AM SOC ECHOCARDIOG, V24, P1, DOI 10.1016/j.echo.2010.11.006; Ritterhoff J, 2017, CARDIOVASC RES, V113, P411, DOI 10.1093/cvr/cvx017; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sicari R, 2017, CARDIOVASC ULTRASOUN, V15, DOI 10.1186/s12947-017-0099-2; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Turner DA, 2007, TRENDS NEUROSCI, V30, P390, DOI 10.1016/j.tins.2007.06.001; Yoshida T, 2017, METHODS MOL BIOL, V1567, P231, DOI 10.1007/978-1-4939-6824-4_14	33	4	4	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2041	2054		10.1096/fj.201901686R	http://dx.doi.org/10.1096/fj.201901686R		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916304	Bronze			2022-12-26	WOS:000506440400001
J	Aleisa, FA; Sakashita, K; Lee, JM; AbuSamra, DB; Al Alwan, B; Nozue, S; Tehseen, M; Hamdan, SM; Habuchi, S; Kusakabe, T; Merzaban, JS				Aleisa, Fajr A.; Sakashita, Kosuke; Lee, Jae Man; AbuSamra, Dina B.; Al Alwan, Bader; Nozue, Shuho; Tehseen, Muhammad; Hamdan, Samir M.; Habuchi, Satoshi; Kusakabe, Takahiro; Merzaban, Jasmeen S.			Functional binding of E-selectin to its ligands is enhanced by structural features beyond its lectin domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell adhesion; glycoprotein structure; kinetics; glycobiology; carbohydrate-binding protein; dimerization; binding kinetics; complement regulatory repeats; E-selectin; short consensus repeats; silkworm expression; adhesion; glycoprotein; conformational extension; homing; silkworm expression	LEUKOCYTE ADHESION MOLECULE-1; P-SELECTIN; CELL-ADHESION; GLYCOPROTEIN LIGAND-1; CARBOHYDRATE LIGAND; SURFACE ADHESION; HOMING RECEPTOR; EXPRESSION; RECOGNITION; FLOW	Selectins are key to mediating interactions involved in cellular adhesion and migration, underlying processes such as immune responses, metastasis, and transplantation. Selectins are composed of a lectin domain, an epidermal growth factor (EGF)-like domain, multiple short consensus repeats (SCRs), a transmembrane domain, and a cytoplasmic tail. It is well-established that the lectin and EGF domains are required to mediate interactions with ligands; however, the contributions of the other domains in mediating these interactions remain obscure. Using various E-selectin constructs produced in a newly developed silkworm-based expression system and several assays performed under both static and physiological flow conditions, including flow cytometry, glycan array analysis, surface plasmon resonance, and cell-rolling assays, we show here that a reduction in the number of SCR domains is correlated with a decline in functional E-selectin binding to hematopoietic cell E- and/or L-selectin ligand (HCELL) and P-selectin glycoprotein ligand-1 (PSGL-1). Moreover, the binding was significantly improved through E-selectin dimerization and by a substitution (A28H) that mimics an extended conformation of the lectin and EGF domains. Analyses of the association and dissociation rates indicated that the SCR domains, conformational extension, and dimerization collectively contribute to the association rate of E-selectin?ligand binding, whereas just the lectin and EGF domains contribute to the dissociation rate. These findings provide the first evidence of the critical role of the association rate in functional E-selectin?ligand interactions, and they highlight that the SCR domains have an important role that goes beyond the structural extension of the lectin and EGF domains.	[Aleisa, Fajr A.; Sakashita, Kosuke; AbuSamra, Dina B.; Al Alwan, Bader; Nozue, Shuho; Tehseen, Muhammad; Hamdan, Samir M.; Habuchi, Satoshi; Merzaban, Jasmeen S.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia; [Lee, Jae Man; Kusakabe, Takahiro] Kyushu Univ, Lab Insect Genome Sci, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Hakozaki 6-10-1, Fukuoka 8128581, Japan	King Abdullah University of Science & Technology; Kyushu University	Merzaban, JS (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn BESE, Thuwal 239556900, Saudi Arabia.	Jasmeen.Merzaban@kaust.edu.sa	; Merzaban, Jasmeen/V-3147-2018; Habuchi, Satoshi/N-6037-2018	Hamdan, Samir/0000-0001-5192-1852; Merzaban, Jasmeen/0000-0002-7276-2907; Aleisa, Fajr/0000-0001-6403-374X; Habuchi, Satoshi/0000-0002-6663-2807; Al Alwan, Bader/0000-0001-6075-3889; Tehseen, Muhammad/0000-0001-9834-2372	King Abdullah University of Science and Technology (KAUST);  [OCRF-2014-CRG3-2276]	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); 	This research was supported by a King Abdullah University of Science and Technology (KAUST) Faculty Baseline Research Funding Program (to J. S. M.) and by a Competitive Research Grant (OCRF-2014-CRG3-2276) (to J. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	AbuSamra DB, 2015, J BIOL CHEM, V290, P21213, DOI 10.1074/jbc.M114.629451; ALON R, 1995, NATURE, V374, P539, DOI 10.1038/374539a0; ALON R, 1995, J IMMUNOL, V154, P5356; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barkalow FJ, 2000, BLOOD, V96, P3070; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Carlson GE, 2013, JOVE-J VIS EXP, DOI 10.3791/50604; COLLINS T, 1991, J BIOL CHEM, V266, P2466; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; ERBE DV, 1993, J CELL BIOL, V120, P1227, DOI 10.1083/jcb.120.5.1227; Evans E, 2004, P NATL ACAD SCI USA, V101, P11281, DOI 10.1073/pnas.0401870101; Fuhlbrigge RC, 2002, J IMMUNOL, V168, P5645, DOI 10.4049/jimmunol.168.11.5645; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; GENG JG, 1992, J BIOL CHEM, V267, P19846; GIBSON RM, 1995, BLOOD, V85, P151, DOI 10.1182/blood.V85.1.151.bloodjournal851151; GRAVES BJ, 1994, NATURE, V367, P532, DOI 10.1038/367532a0; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; Isshiki M, 2002, J CELL SCI, V115, P475; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; Kato T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01630-6; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Klopocki AG, 2008, J BIOL CHEM, V283, P11493, DOI 10.1074/jbc.M709785200; Levy O, 2013, JOVE-J VIS EXP, DOI 10.3791/50866; LI SH, 1994, J BIOL CHEM, V269, P4431; Ling X, 2003, ACTA BIOCH BIOPH SIN, V35, P567; Lou JZ, 2007, BIOPHYS J, V92, P1471, DOI 10.1529/biophysj.106.097048; Lou JZ, 2006, J CELL BIOL, V174, P1107, DOI 10.1083/jcb.200606056; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Masuda A, 2015, J ASIA-PAC ENTOMOL, V18, P175, DOI 10.1016/j.aspen.2015.01.006; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1998, J BIOL CHEM, V273, P32506, DOI 10.1074/jbc.273.49.32506; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Molenaar TJM, 2002, BLOOD, V100, P3570, DOI 10.1182/blood-2002-02-0641; Ono Chikako, 2007, Journal of Insect Biotechnology and Sericology, V76, P161; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; Patel KD, 1995, J CELL BIOL, V131, P1893, DOI 10.1083/jcb.131.6.1893; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Poeter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4738; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; Preston RC, 2016, J MOL CELL BIOL, V8, P62, DOI 10.1093/jmcb/mjv046; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Revelle BM, 1996, J BIOL CHEM, V271, P4289; Rocheleau AD, 2016, BMC STRUCT BIOL, V16, DOI 10.1186/s12900-016-0060-x; Sackstein R, 2000, BLOOD, V96, P2765, DOI 10.1182/blood.V96.8.2765.h8002765_2765_2774; Sackstein R, 2005, CURR OPIN HEMATOL, V12, P444, DOI 10.1097/01.moh.0000177827.78280.79; Sackstein R, 2009, METHODS MOL BIOL, V536, P343, DOI 10.1007/978-1-59745-542-8_36; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Schwizer D, 2012, CHEM-EUR J, V18, P1342, DOI 10.1002/chem.201102884; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shetty S, 2014, JOVE-J VIS EXP, DOI 10.3791/51330; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87; USAMI S, 1993, ANN BIOMED ENG, V21, P77, DOI 10.1007/BF02368167; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; WATSON SR, 1991, J CELL BIOL, V115, P235, DOI 10.1083/jcb.115.1.235; Wiese Georg, 2009, J Vis Exp, DOI 10.3791/1009; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yin JC, 2007, J BIOTECHNOL, V127, P335, DOI 10.1016/j.jbiotec.2006.07.012; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057202	77	7	7	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3719	3733		10.1074/jbc.RA119.010910	http://dx.doi.org/10.1074/jbc.RA119.010910			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31949047	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000527725300027
J	Tetzlaff, J; Geyer, S; Tetzlaff, F; Epping, J				Tetzlaff, Juliane; Geyer, Siegfried; Tetzlaff, Fabian; Epping, Jelena			Income inequalities in stroke incidence and mortality: Trends in stroke-free and stroke-affected life years based on German health insurance data	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ISCHEMIC-STROKE; UNITED-STATES; RISK-FACTORS; TIME TRENDS; SEVERITY; ADULTS; UPDATE; COSTS	Background Due to substantial improvements in prevention and therapy, stroke incidence and mortality rates have decreased during the last decades, but evidence is still lacking on whether all socioeconomic groups benefited equally and how the length of life affected by stroke developed over time. Our study investigates time trends in stroke-free life years and life years affected by stroke. Special emphasis is given to the question whether trends differ between income groups, leading to decreasing or increasing social inequalities. Methods The analyses are based on claims data of a German statutory health insurance company of the two time periods 2006-2008 and 2014-2016. Income inequalities and time trends in incidence and mortality risks were estimated using multistate survival models. Trends in stroke-free life years and life years affected by stroke are analysed separately for income groups by applying multistate life table analyses. Results Stroke incidence and mortality risks decreased in men and women in all income groups. While stroke-free lifetime could be gained in men having higher incomes, improvements in mortality counterbalanced decreasing incidences, leading to increases in life years affected by stroke among men of the lower and higher income group. Among women, no significant changes in life years could be observed. Conclusions Changes in stroke-affected life years occur among men in all income groups, but are more pronounced in the higher income group. However, irrespective of the income group the proportion of stroke-affected life years remains quite stable over time, pointing towards constant inequalities. Further research is needed on whether impairments due to stroke reduced over time and whether all socioeconomic groups are affected equally.	[Tetzlaff, Juliane; Geyer, Siegfried; Epping, Jelena] Hannover Med Sch, Med Sociol Unit, Hannover, Germany; [Tetzlaff, Fabian] Hannover Med Sch, Inst Gen Practice, Hannover, Germany	Hannover Medical School; Hannover Medical School	Tetzlaff, J (corresponding author), Hannover Med Sch, Med Sociol Unit, Hannover, Germany.	tetzlaff.juliane@mh-hannover.de	Epping, Jelena/AAE-7790-2020; Tetzlaff, Juliane/AAF-8390-2020; Tetzlaff, Fabian/AAF-8374-2020	Tetzlaff, Juliane/0000-0001-5393-5991; Epping, Jelena/0000-0002-1852-5601; Tetzlaff, Fabian/0000-0001-6933-4162	AOK Niedersachsen (Statutory Local Health Insurance of Lower Saxony) as part of a project on morbidity compression	AOK Niedersachsen (Statutory Local Health Insurance of Lower Saxony) as part of a project on morbidity compression	The work done by JT was funded by the AOK Niedersachsen (Statutory Local Health Insurance of Lower Saxony) as part of a project on morbidity compression. No grant number was assigned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the AOK Niedersachsen (Statutory Local Health Insurance of Lower Saxony) for providing the data. In particular, the support of Dr. Jurgen Peter, Dr. Jona Stahmeyer, and Dr. Sveja Eberhard made it possible to carry out this study.	Addo J, 2012, STROKE, V43, P1186, DOI 10.1161/STROKEAHA.111.639732; Andersen KK, 2019, J STROKE CEREBROVASC, V28, P1529, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.013; Bachus L, 2019, GESUNDHEITSWESEN, V81, P351, DOI 10.1055/s-0043-109860; Bejot Y, 2017, EUR J NEUROL, V24, P694, DOI 10.1111/ene.13271; Bejot Y, 2016, PRESSE MED, V45, pE391, DOI 10.1016/j.lpm.2016.10.003; Bray BD, 2018, LANCET PUBLIC HEALTH, V3, pE185, DOI 10.1016/S2468-2667(18)30030-6; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P656, DOI 10.1007/s00103-012-1659-0; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Cook RJ., 2018, MULTISTATE MODELS AN; Destatis, 2017, VERDIENSTE BLICK; Elfassy T, 2019, STROKE, V50, P805, DOI 10.1161/STROKEAHA.118.023782; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Finger JD, 2016, DTSCH ARZTEBL INT, V113, P712, DOI 10.3238/arztebl.2016.0712; Fries James F, 2012, Curr Gerontol Geriatr Res, V2012, P420637, DOI 10.1155/2012/420637; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Geyer S., 2014, ROUTINEDATEN GESUNDH, P223; Geyer S, 2011, J EPIDEMIOL COMMUN H, V65, P491, DOI 10.1136/jech.2009.103390; Gloede TD, 2014, STROKE, V45, P3389, DOI 10.1161/STROKEAHA.114.006200; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hoebel J, 2018, NICOTINE TOB RES, V20, P295, DOI 10.1093/ntr/ntx087; Hoebel J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4478-2; Icks A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188306; Jaunzeme J, 2013, BUNDESGESUNDHEITSBLA, V56, P447, DOI 10.1007/s00103-012-1626-9; Kolominsky-Rabas PL, 2015, NEUROEPIDEMIOLOGY, V44, P24, DOI 10.1159/000371353; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Laditka JN, 2014, DISABIL HEALTH J, V7, P472, DOI 10.1016/j.dhjo.2014.06.005; Lampert T, 2012, BUNDESGESUNDHEITSBLA, V55, P102, DOI 10.1007/s00103-011-1401-3; Lecoffre C, 2017, STROKE, V48, P2939, DOI 10.1161/STROKEAHA.117.017640; Li LX, 2015, LANCET NEUROL, V14, P903, DOI 10.1016/S1474-4422(15)00132-5; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Marshall IJ, 2015, LANCET NEUROL, V14, P1206, DOI 10.1016/S1474-4422(15)00200-8; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; Nordahl H, 2014, STROKE, V45, P2582, DOI 10.1161/STROKEAHA.114.005252; Palloni A., 2001, INCREMENT DECREMENT, P256; Schubert I, 2017, Z EVIDENZ FORTBILD Q, V126, P66, DOI 10.1016/j.zefq.2017.06.008; Statistisches Bundesamt, 2016, SOZ ANG KRANK ERG MI; Thiele I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30350-8; Townsend N, 2015, EUROPEAN HEART J; Van Den Hout A, 2016, MULTISTATE SURVIVAL; Zeiher J, 2018, BUNDESGESUNDHEITSBLA, V61, P1365, DOI 10.1007/s00103-018-2817-9; Zhao YJ, 2016, NEUROLOGY, V87, P458, DOI 10.1212/WNL.0000000000002908	44	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227541	10.1371/journal.pone.0227541	http://dx.doi.org/10.1371/journal.pone.0227541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945102	gold, Green Published, Green Submitted			2022-12-26	WOS:000534370100044
J	Glei, DA; Preston, SH				Glei, Dana A.; Preston, Samuel H.			Estimating the impact of drug use on US mortality, 1999-2016	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; HEROIN-RELATED OVERDOSE; UNITED-STATES; LIFE EXPECTANCY; FOLLOW-UP; PREVALENCE; PEOPLE; DETERMINANTS; ALCOHOL; SMOKING	The impact of rising drug use on US mortality may extend beyond deaths coded as drug-related to include excess mortality from other causes affected by drug use. Here, we estimate the full extent of drug-associated mortality. We use annual death rates for 1999-2016 by state, sex, five-year age group, and cause of death to model the relationship between drug-coded mortality-which serves as an indicator of the population-level prevalence of drug use-and mortality from other causes. Among residents aged 15-64 living in the 50 US states, the estimated number of drug-associated deaths in 2016 (141,695) was 2.2 times the number of drug-coded deaths (63,000). Adverse trends since 2010 in midlife mortality are largely attributable to drug-associated mortality. In the absence of drug use, we estimate that the probability of dying between ages 15 and 65 would have continued to decline after 2010 among men (to 15% in 2016) and would have remained at a low level (10%) among women. Our results suggest that an additional 3.9% of men and 1.8% of women died between ages 15 and 65 in 2016 because of drug use. In terms of life expectancy beyond age 15, we estimate that drug use cost men 1.4 years and women 0.7 years, on average. In the hardest-hit state (West Virginia), drug use cost men 3.6 and women 1.9 life years. Recent declines in US life expectancy have been blamed largely on the drug epidemic. Consistent with that inference, our results imply that, in the absence of drug use, life expectancy at age 15 would have increased slightly between 2014 and 2016. Drug-associated mortality in the US is roughly double that implied by drug-coded deaths alone. The drug epidemic is exacting a heavy cost to American lives, not only from overdoses but from a variety of causes.	[Glei, Dana A.] Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA; [Preston, Samuel H.] Univ Penn, Sociol, Philadelphia, PA 19104 USA	Georgetown University; University of Pennsylvania	Glei, DA (corresponding author), Georgetown Univ, Ctr Populat & Hlth, Washington, DC 20057 USA.	dag77@georgetown.edu		Glei, Dana/0000-0002-2865-9355	National Institute on Aging [1R01AG060115]; Graduate School of Arts and Sciences, Georgetown University	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Graduate School of Arts and Sciences, Georgetown University	This work was supported by grant 1R01AG060115 to the University of Pennsylvania from the National Institute on Aging and by the Graduate School of Arts and Sciences, Georgetown University.	Ahman A, 2018, DRUG ALCOHOL DEPEN, V188, P274, DOI 10.1016/j.drugalcdep.2018.03.053; American Addiction Centers, POT REP SUBST AB RES; American Heart Association, ILL DRUGS HEART DIS; Benjamin-Johnson R, 2009, PSYCHIAT SERV, V60, P1676, DOI 10.1176/ps.2009.60.12.1676; Bernstein L., 2022, WASH POST; Bjorkenstam C, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-11; Case A, 2017, BROOKINGS PAP ECO AC, P397; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Cherlin A. J., 2014, LABORS LOVE LOST RIS; Cherlin AJ, 2016, NEW YORK TIMES  0222, pA19; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Dowell D, 2017, JAMA-J AM MED ASSOC, V318, P1065, DOI 10.1001/jama.2017.9308; European Monitoring Centre for Drugs and Addiction, OV DRUG REL DEATHS M; Fenelon A, 2012, DEMOGRAPHY, V49, P797, DOI 10.1007/s13524-012-0108-x; Geronimus AT, 2019, J HEALTH SOC BEHAV, V60, P222, DOI 10.1177/0022146519849932; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Harrell PT, 2012, ADDICT BEHAV, V37, P678, DOI 10.1016/j.addbeh.2012.01.011; Ho JY, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2562; Ho JY, 2017, DEMOGRAPHY, V54, P1175, DOI 10.1007/s13524-017-0565-3; Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184; Lopez-Quintero C, 2015, DRUG ALCOHOL DEPEN, V149, P55, DOI 10.1016/j.drugalcdep.2015.01.015; Mars SG, 2015, SOC SCI MED, V140, P44, DOI 10.1016/j.socscimed.2015.06.032; Masters RK, 2017, PLANN M SOC STAT INC; Masters RK, 2018, INT J EPIDEMIOL, V47, P81, DOI 10.1093/ije/dyx127; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Muennig PA, 2018, AM J PUBLIC HEALTH, V108, P1626, DOI 10.2105/AJPH.2018.304585; Murphy SL, 2018, MORTALITY US 2017; National Center for Health Statistics, MORT MULT CAUS DEATH; National Center for Health Statistics, OV DEATH RAT TAB DAT; National Institute on Drug Abuse, HLTH CONS DRUG MIS; National Institute on Drug Abuse, HLTH CONS DRUG MIS C; National Institute on Drug Abuse, HLTH CONS DRUG MIS L; National Institute on Drug Abuse, VIR HEP VER REAL CON; National Institute on Drug Abuse, HLTH CONS DRUG MIS R; Office of the Surgeon General, 2016, FAC ADD AM SURG GEN; Olfson M, 2018, JAMA PSYCHIAT, V75, P820, DOI 10.1001/jamapsychiatry.2018.1471; Preston S., 2000, DEMOGRAPHY MEASURING; Preston SH, 2010, INT DIFFERENCES MORT, P105; Priebe MG, 2009, FASEB J, V23; Rockett IRH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197805; Ronka S, 2017, DRUG ALCOHOL DEPEN, V181, P37, DOI 10.1016/j.drugalcdep.2017.09.005; Ruhm C.J., 2018, DEATHS DESPAIR DRUG; Ruhm CJ, 2018, AM J PREV MED, V55, P11, DOI 10.1016/j.amepre.2018.03.014; Shiels MS, 2019, LANCET PUBLIC HEALTH, V4, pE97, DOI 10.1016/S2468-2667(18)30208-1; StataCorp, 2015, STAT REL 14 STAT SOF; Stein EM, 2017, AM J PUBLIC HEALTH, V107, P1541, DOI [10.2105/AJPH.2017.303941, 10.2105/ajph.2017.303941]; Stein R, NATL PUBLIC RADIO LI; Toblin RL, 2010, J CLIN PSYCHIAT, V71, P491, DOI 10.4088/JCP.09m05567blu; Unick G, 2014, ADDICTION, V109, P1889, DOI 10.1111/add.12664; United States Department of Health and Human Services (US DHHS) Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), BRIDG RAC POP EST US; Walker ER, 2017, DRUG ALCOHOL DEPEN, V171, P31, DOI 10.1016/j.drugalcdep.2016.11.026	52	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226732	10.1371/journal.pone.0226732	http://dx.doi.org/10.1371/journal.pone.0226732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KF6TA	31940370	gold, Green Published			2022-12-26	WOS:000509371700001
J	Cardemil, CV; O'Leary, ST; Beaty, BL; Ivey, K; Lindley, MC; Kempe, A; Crane, LA; Hurley, LP; Brtnikova, M; Hall, AJ				Cardemil, Cristina V.; O'Leary, Sean T.; Beaty, Brenda L.; Ivey, Katy; Lindley, Megan C.; Kempe, Allison; Crane, Lori A.; Hurley, Laura P.; Brtnikova, Michaela; Hall, Aron J.			Primary care physician knowledge, attitudes, and diagnostic testing practices for norovirus and acute gastroenteritis	PLOS ONE			English	Article							FELINE CALICIVIRUS; MURINE NOROVIRUS; DISEASE; SURROGATES; PREVENTION; INFECTION; VIRUS; MAIL; RUB	Background Norovirus is a leading cause of acute gastroenteritis (AGE) across the age spectrum; candidate vaccines are in clinical trials. While norovirus diagnostic testing is increasingly available, stool testing may not be performed routinely, which can hamper surveillance and burden of disease estimates. Additionally, lack of knowledge of the burden of disease may inhibit provider vaccine recommendations, which could affect coverage rates and ultimately the impact of the vaccine. Our objectives were to understand physicians' stool testing practices in outpatients with AGE, and physician knowledge of norovirus, in order to improve surveillance and prepare for vaccine introduction. Methods Internet and mail survey on AGE, norovirus, and future norovirus vaccines conducted January to March 2018 among national networks of primary care pediatricians, family practice and general internal medicine physicians. Results The response rate was 59% (820/1383). During peak AGE season, physicians estimated they ordered stool tests for a median of 15% (interquartile range: 5-33%) of their outpatients with AGE. Stool tests were reported as more often available for ova and parasites, Clostridioides difficile, and bacterial culture (> 95% for all specialties) than for norovirus (6-33% across specialties); even when available, norovirus-specific tests were infrequently ordered. Most providers were unaware that norovirus is a leading cause of AGE across all age groups (Pediatricians 80%, Family Practice 86%, General Internal Medicine 89%) or that alcohol-based hand sanitizers are ineffective against norovirus (Pediatricians 51%, Family Practice 66%, General Internal Medicine 62%). Concerns cited as major barriers to implementing a future norovirus vaccine included if the vaccine is not covered by insurance (General Internal Medicine 64%, Pediatricians 67%, Family Practice 74%) and lack of adequate reimbursement for vaccination (Pediatricians 43%, General Internal Medicine 46%, Family Practice 50%). Factors that providers believed were 'not at all a barrier' or 'minor barrier' to new vaccine introduction included the belief that "my patients won't need this vaccine" (General Internal Medicine 78%, Family Practice 86%, Pediatricians 90%) and "my patients already get too many vaccines" (Family Practice 89%, General Internal Medicine 92%, Pediatricians 95%). Conclusions Primary care physicians had few concerns regarding future norovirus vaccine introduction, but have knowledge gaps on norovirus prevalence and hand hygiene for prevention. Also, physicians infrequently order stool tests for outpatients with AGE, which limits surveillance estimates that rely on physician-ordered stool diagnostics. Closing physician knowledge gaps on norovirus burden and transmission can help support norovirus vaccine introduction.	[Cardemil, Cristina V.; Ivey, Katy; Lindley, Megan C.; Hall, Aron J.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [O'Leary, Sean T.; Beaty, Brenda L.; Kempe, Allison; Crane, Lori A.; Hurley, Laura P.; Brtnikova, Michaela] Univ Colorado, Sch Med, Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA; [O'Leary, Sean T.; Beaty, Brenda L.; Kempe, Allison; Crane, Lori A.; Hurley, Laura P.; Brtnikova, Michaela] Childrens Hosp Colorado, Aurora, CO USA; [O'Leary, Sean T.; Kempe, Allison; Brtnikova, Michaela] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Crane, Lori A.] Univ Colorado, Dept Community & Behav Hlth, Anschutz Med Campus, Aurora, CO USA; [Hurley, Laura P.] Denver Hlth, Div Gen Internal Med, Denver, CO USA	Centers for Disease Control & Prevention - USA; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Cardemil, CV (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	ccardemil@cdc.gov		O'Leary, Sean/0000-0003-2365-582X; Lindley, Megan/0000-0002-8368-7375	Centers for Disease Control and Prevention [1U1IP001072-01]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was carried out with funds from Cooperative Agreement number 1U1IP001072-01 from the Centers for Disease Control and Prevention. CDC authors participated in the course of their usual work duties. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MMWRMORBIDITY M 1025, V51; Atkeson LR, 2011, POLIT BEHAV, V33, P161, DOI 10.1007/s11109-010-9121-1; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Brennan-Krohn T., 2018, CLIN MICROBIOLOGY BU, V18, P20; Cardemil CV, 2017, INFECT DIS CLIN N AM, V31, P839, DOI 10.1016/j.idc.2017.07.012; Cardemil CV, 2018, COMMUNICATION   1005; Costantini V, 2018, EMERG INFECT DIS, V24, P1453, DOI 10.3201/eid2408.180126; Crane LA, 2008, EVAL HEALTH PROF, V31, P43, DOI 10.1177/0163278707311872; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Hall Aron J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Harris JP, 2016, J INFECT DIS, V213, pS8, DOI 10.1093/infdis/jiv452; Hurley LP, 2014, ANN INTERN MED, V160, P161, DOI 10.7326/M13-2332; Kirk J, 2016, AM J INFECT CONTROL, V44, P1095, DOI 10.1016/j.ajic.2016.03.005; LIU P, 2009, APPL ENVIRON MICROB, V76, P394, DOI DOI 10.1128/AEM.01729-09; Macinga DR, 2008, APPL ENVIRON MICROB, V74, P5047, DOI 10.1128/AEM.00487-08; Masuda T., 2018, OPEN FORUM INFECT DI, V5, pS674, DOI [10.1093/ofid/ofy210.1929, DOI 10.1093/OFID/OFY210.1929]; Mateo R, 2019, OPEN FORUM INFECT S2, V6, pS2, DOI [10.1093/ofid/ofz359.002, DOI 10.1093/OFID/OFZ359.002]; Mattison CP, 2018, EXPERT REV VACCINES, V17, P773, DOI 10.1080/14760584.2018.1510327; McFarland LV, 2016, WORLD J GASTROENTERO, V22, P3078, DOI 10.3748/wjg.v22.i11.3078; McMahon SR, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e299; Park GW, 2010, J FOOD PROTECT, V73, P2232, DOI 10.4315/0362-028X-73.12.2232; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Schmidt MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201805; Shah MP, 2018, INFECT DIS CLIN N AM, V32, P103, DOI 10.1016/j.idc.2017.11.004; Shimizu-Onda Y, 2013, J INFECT CHEMOTHER, V19, P779, DOI 10.1007/s10156-012-0516-2; Steinmann J, 2015, J HOSP INFECT, V91, P371, DOI 10.1016/j.jhin.2015.07.015; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Tuladhar E, 2015, J HOSP INFECT, V90, P226, DOI 10.1016/j.jhin.2015.02.019; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Vogel L, 2011, CAN MED ASSOC J, V183, pE799, DOI 10.1503/cmaj.109-3922; Yen C, 2013, J PEDIATR INFECT DIS, V2, P61, DOI 10.1093/jpids/pis134; Zhang HW, 2015, CLIN LAB MED, V35, P461, DOI 10.1016/j.cll.2015.02.006	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227890	10.1371/journal.pone.0227890	http://dx.doi.org/10.1371/journal.pone.0227890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935271	gold, Green Published			2022-12-26	WOS:000534354100062
J	Guglielmini, C; Toaldo, MB; Chiesa, A; Contiero, B; Berlanda, M; Poser, H				Guglielmini, Carlo; Toaldo, Marco Baron; Chiesa, Alex; Contiero, Barbara; Berlanda, Michele; Poser, Helen			Effect of temperature variation on hospital admissions and outcomes in dogs with myxomatous mitral valve disease and new onset pulmonary edema	PLOS ONE			English	Article							HEART-FAILURE; SEASONAL-VARIATION; SURVIVAL CHARACTERISTICS; PROGNOSTIC VARIABLES; ENALAPRIL MALEATE; NATURAL-HISTORY; PRESENTATIONS; HYPERTENSION; SCORE; SIZE	The effect of seasonal variation on hospital admissions and outcomes in humans with cardiovascular disease and congestive heart failure (CHF) has been described. This study evaluates the effect of temperature variation on admissions and outcomes in dogs with myxomatous mitral valve disease (MMVD) and first onset CHF. Ninety-three client-owned dogs with MMVD and a first occurrence of pulmonary edema were included in this retrospective clinical cohort study. Recorded clinical and echocardiographic variables were accumulated and analyzed with dogs allocated into groups in a temperature-wise manner that considered the mean of the average (Tave) and maximum ambient temperature (Tmax) of the 14 days preceding hospital admission. A survival analysis was also performed. No difference was found in the percentage of dogs decompensating in three different temperature periods (i.e., cold, intermediate, and hot temperature) according to both Tave and Tmax. Dogs developing CHF during the intermediate temperatures according to Tmax died earlier from cardiacrelated causes (median survival time 280 days, 95% CI = 147-486 days) compared to those decompensating during hot temperatures (median survival time 518 days, 95% CI = 344-819 days, P = 0.039). However, an effect of the ambient temperature on survival was not confirmed by Cox proportional hazard analysis. In conclusion, this study failed to show that ambient temperature has an effect on the first occurrence of CHF and outcomes in dogs with MMVD.	[Guglielmini, Carlo; Chiesa, Alex; Contiero, Barbara; Berlanda, Michele; Poser, Helen] Univ Padua, Dept Anim Med Prod & Hlth, Padua, Italy; [Toaldo, Marco Baron] Alma Mater Studiorum Univ Bologna, Dept Vet Med Sci, Bologna, Italy	University of Padua; University of Bologna	Guglielmini, C (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth, Padua, Italy.	carlo.guglielmini@unipd.it	CONTIERO, BARBARA/AAQ-7791-2020	CONTIERO, BARBARA/0000-0002-6586-5035; Guglielmini, Carlo/0000-0001-7575-3646; Berlanda, Michele/0000-0001-5961-0987				Akintoye E, 2017, CLIN CARDIOL, V40, P1105, DOI 10.1002/clc.22784; Atkins C, 2009, J VET INTERN MED, V23, P1142, DOI 10.1111/j.1939-1676.2009.0392.x; BENCH (BENazepril in Canine Heart disease) Study Group, 1999, J Vet Cardiol, V1, P7, DOI 10.1016/S1760-2734(06)70025-X; Bernay F, 2010, J VET INTERN MED, V24, P331, DOI 10.1111/j.1939-1676.2009.0467.x; Borgarelli M, 2008, J VET INTERN MED, V22, P120, DOI 10.1111/j.1939-1676.2007.0008.x; Borgarelli M, 2015, J VET INTERN MED, V29, P569, DOI 10.1111/jvim.12564; Borgarelli M, 2012, J VET INTERN MED, V26, P69, DOI 10.1111/j.1939-1676.2011.00860.x; Borgarelli M, 2012, J VET CARDIOL, V14, P93, DOI 10.1016/j.jvc.2012.01.011; Borgarelli M, 2010, VET CLIN N AM-SMALL, V40, P651, DOI 10.1016/j.cvsm.2010.03.008; Cornell CC, 2004, J VET INTERN MED, V18, P311, DOI 10.1892/0891-6640(2004)18&lt;311:ASOMCM&gt;2.0.CO;2; Diana A, 2009, JAVMA-J AM VET MED A, V235, P1058, DOI 10.2460/javma.235.9.1058; Ettinger SJ, 1998, J AM VET MED ASSOC, V213, P1573; Ferasin L, 2013, J VET INTERN MED, V27, P286, DOI 10.1111/jvim.12039; Gallerani M, 2011, CLIN CARDIOL, V34, P389, DOI 10.1002/clc.20895; Gotsman I, 2010, CARDIOLOGY, V117, P268, DOI 10.1159/000323511; Guglielmini C, 2009, J VET MED SCI, V71, P9, DOI 10.1292/jvms.71.9; Haggstrom J, 2008, J VET INTERN MED, V22, P1124, DOI 10.1111/j.1939-1676.2008.0150.x; Haggstrom J, 2009, J SMALL ANIM PRACT, V50, P25, DOI 10.1111/j.1748-5827.2009.00800.x; Hezzell MJ, 2012, J VET CARDIOL, V14, P269, DOI 10.1016/j.jvc.2012.01.009; Johnson LR, 2010, J VET INTERN MED, V24, P298, DOI 10.1111/j.1939-1676.2009.0451.x; Jung SW, 2016, J VET INTERN MED, V30, P51, DOI 10.1111/jvim.13800; Kaneko H, 2014, J CARDIOL, V64, P470, DOI 10.1016/j.jjcc.2014.03.004; Kellihan HB, 2010, VET CLIN N AM-SMALL, V40, P623, DOI 10.1016/j.cvsm.2010.03.011; Kim HT, 2017, J VET SCI, V18, P369, DOI 10.4142/jvs.2017.18.3.369; Lopez-Alvarez J, 2015, J VET INTERN MED, V29, P575, DOI 10.1111/jvim.12544; Mattin MJ, 2015, PREV VET MED, V122, P436, DOI 10.1016/j.prevetmed.2015.05.007; Moonarmart W, 2010, J SMALL ANIM PRACT, V51, P84, DOI 10.1111/j.1748-5827.2009.00889.x; Nakamura K, 2016, J VET INTERN MED, V30, P69, DOI 10.1111/jvim.13820; Nakamura K, 2014, J VET INTERN MED, V28, P1746, DOI 10.1111/jvim.12441; Parker HG, 2012, J VET CARDIOL, V14, P19, DOI 10.1016/j.jvc.2012.01.006; Rishniw M, 2000, J VET INTERN MED, V14, P429, DOI 10.1892/0891-6640(2000)014&lt;0429:EOFEMO&gt;2.3.CO;2; Sargent J, 2015, J VET CARDIOL, V17, P1, DOI 10.1016/j.jvc.2014.11.001; Serres Francois, 2009, J Vet Cardiol, V11, P103, DOI 10.1016/j.jvc.2009.07.001; Steinberg GR, 2012, J VET EMERG CRIT CAR, V22, P341, DOI 10.1111/j.1476-4431.2012.00748.x; Stewart S, 2002, J AM COLL CARDIOL, V39, P760, DOI 10.1016/S0735-1097(02)01685-6; Toaldo MB, 2018, J VET INTERN MED, V32, P914, DOI 10.1111/jvim.15093; Vanasse A, 2017, ENVIRON INT, V106, P257, DOI 10.1016/j.envint.2017.06.001; WOODFIELD JA, 1995, J VET INTERN MED, V9, P234; WOODFIELD JA, 1995, J VET INTERN MED, V9, P243, DOI 10.1111/j.1939-1676.1995.tb01075.x; Yamamoto Y, 2015, HEART VESSELS, V30, P193, DOI 10.1007/s00380-013-0461-8	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227807	10.1371/journal.pone.0227807	http://dx.doi.org/10.1371/journal.pone.0227807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935277	Green Published, gold			2022-12-26	WOS:000534354100055
J	Matias-Garcia, PR; Wilson, R; Mussack, V; Reischl, E; Waldenberger, M; Gieger, C; Anton, G; Peters, A; Kuehn-Steven, A				Matias-Garcia, Pamela R.; Wilson, Rory; Mussack, Veronika; Reischl, Eva; Waldenberger, Melanie; Gieger, Christian; Anton, Gabriele; Peters, Annette; Kuehn-Steven, Andrea			Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples	PLOS ONE			English	Article							PCR DATA; SERUM; CANCER; MIRNA; TIME; BIOMARKERS; QUANTIFICATION; POPULATION; BIOGENESIS; STABILITY	Sample collection, processing, storage and isolation methods constitute pre-analytic factors that can influence the quality of samples used in research and clinical practice. With regard to biobanking practices, a critical point in the sample's life chain is storage, particularly long-term storage. Since most studies examine the influence of different temperatures (4 degrees C, room temperature) or delays in sample processing on sample quality, there is only little information on the effects of long-term storage at ultra-low (vapor phase of liquid nitrogen) temperatures on biomarker levels. Among these biomarkers, circulating miRNAs hold great potential for diagnosis or prognosis for a variety of diseases, like cancer, infections and chronic diseases, and are thus of high interest in several scientific questions. We therefore investigated the influence of long-term storage on levels of eight circulating miRNAs (miR-103a-3p, miR-191-5p, miR-124-3p, miR-30c-5p, miR-451a, miR-23a-3p, miR-93-5p, miR-24-3p, and miR-33b-5p) from 10 participants from the population-based cohort study KORA. Sample collection took place during the baseline survey S4 and the follow-up surveys F4 and FF4, over a time period spanning from 1999 to 2014. The influence of freezethaw (f/t) cycles on miRNA stability was also investigated using samples from volunteers (n = 6). Obtained plasma samples were profiled using Exiqon's miRCURYTM real-time PCR profiling system, and repeated measures ANOVA was used to check for storage or f/t effects. Our results show that detected levels of most of the studied miRNAs showed no statistically significant changes due to storage at ultra-low temperatures for up to 17 years; miR-451a levels were altered due to contamination during sampling. Freeze-thawing of one to four cycles showed an effect only on miR-30c-5p. Our results highlight the robustness of this set of circulating miRNAs for decades of storage at ultra-low temperatures and several freeze-thaw cycles, which makes our findings increasingly relevant for research conducted with biobanked samples.	[Matias-Garcia, Pamela R.; Wilson, Rory; Reischl, Eva; Waldenberger, Melanie; Gieger, Christian; Anton, Gabriele; Kuehn-Steven, Andrea] German Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Matias-Garcia, Pamela R.; Wilson, Rory; Reischl, Eva; Waldenberger, Melanie; Gieger, Christian; Anton, Gabriele; Peters, Annette; Kuehn-Steven, Andrea] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol, Neuherberg, Germany; [Matias-Garcia, Pamela R.] Tech Univ Munich, TUM Sch Med, Munich, Germany; [Mussack, Veronika] Tech Univ Munich TUM, TUM Sch Life Sci Weihenstephan, Dept Anim Physiol & Immunol, Freising Weihenstephan, Germany; [Waldenberger, Melanie; Peters, Annette] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Anton, Gabriele; Kuehn-Steven, Andrea] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Gieger, Christian; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, KORA Study Grp, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; German Center for Infection Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kuehn-Steven, A (corresponding author), German Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Res Unit Mol Epidemiol, Neuherberg, Germany.; Kuehn-Steven, A (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Epidemiol, Neuherberg, Germany.; Kuehn-Steven, A (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.	andrea.kuehn@helmholtz-muenchen.de	Peters, Annette/A-6117-2011	Peters, Annette/0000-0001-6645-0985; Matias Garcia, Pamela Raquel/0000-0002-3906-5405	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-MaximiliansUniversitat, as part of LMUinnovativ	Helmholtz Zentrum Munchen - German Research Center for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-MaximiliansUniversitat, as part of LMUinnovativ	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-MaximiliansUniversitat, as part of LMUinnovativ.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameling S, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0136-7; Ammerlaan W, 2016, BIOPRESERV BIOBANK, V14, P390, DOI 10.1089/bio.2015.0125; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andreu Z, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.31655; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Balzano F, 2015, MOLECULES, V20, P19030, DOI 10.3390/molecules201019030; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Binderup Helle Glud, 2016, Biochem Biophys Rep, V7, P195, DOI 10.1016/j.bbrep.2016.06.005; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chakraborty C, 2017, MOL THER-NUCL ACIDS, V8, P132, DOI 10.1016/j.omtn.2017.06.005; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Computing RFfS, 2016, R LANG ENV STAT COMP; Cuhadar S, 2013, BIOCHEM MEDICA, V23, P70, DOI 10.11613/BM.2013.009; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Ellervik C, 2015, CLIN CHEM, V61, P914, DOI 10.1373/clinchem.2014.228783; Farina NH, 2014, J CELL BIOCHEM, V115, P805, DOI 10.1002/jcb.24745; Finnegan EF, 2013, CRIT REV BIOCHEM MOL, V48, P51, DOI 10.3109/10409238.2012.738643; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glinge C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167969; Grasedieck S, 2012, LEUKEMIA, V26, P2414, DOI 10.1038/leu.2012.106; Hastings ML, 2012, METHODS, V58, P144, DOI 10.1016/j.ymeth.2012.07.026; Hebels DGAJ, 2013, ENVIRON HEALTH PERSP, V121, P480, DOI 10.1289/ehp.1205657; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Kim DJ, 2012, J MOL DIAGN, V14, P71, DOI 10.1016/j.jmoldx.2011.09.002; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kuner R, 2013, METHODS, V59, P132, DOI 10.1016/j.ymeth.2012.05.004; Lee JE, 2017, OMICS, V21, P499, DOI 10.1089/omi.2017.0109; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moore HM, 2011, CANCER EPIDEM BIOMAR, V20, P729, DOI 10.1158/1055-9965.EPI-11-0021; Morata-Tarifa C, 2017, SCI REP-UK, V7, DOI 10.1038/srep39782; Mraz M, 2009, BIOCHEM BIOPH RES CO, V390, P1, DOI 10.1016/j.bbrc.2009.09.061; Muth Dillon C, 2018, BMC Res Notes, V11, P273, DOI 10.1186/s13104-018-3378-6; Nair VS, 2014, AM J EPIDEMIOL, V180, P140, DOI 10.1093/aje/kwu135; Paltiel L, 2008, CELL PRESERV TECHNOL, V6, P223, DOI 10.1089/cpt.2008.0012; Peng F., 2017, VIROL REP, V7, P1, DOI [DOI 10.1016/J.VIREP.2016.11.001, DOI 10.1016/j.virep.2016.11.001]; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Pizzamiglio S, 2017, ONCOL LETT, V13, P315, DOI 10.3892/ol.2016.5452; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simeon-Dubach D, 2012, J PATHOL, V228, P431, DOI 10.1002/path.4117; Sourvinou IS, 2013, J MOL DIAGN, V15, P827, DOI 10.1016/j.jmoldx.2013.07.005; Vandesompele, 2009, REAL TIME PCR CURREN; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Zhang Z, 2018, WEBPOWER R PACKAGE B; Zhang Z, 2018, PRACTICAL STAT POWER	66	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227648	10.1371/journal.pone.0227648	http://dx.doi.org/10.1371/journal.pone.0227648			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935258	gold, Green Published			2022-12-26	WOS:000534354100040
J	Cheng, YY; Chang, ST; Kao, CL; Chen, YH; Lin, CH				Cheng, Yuan-Yang; Chang, Shin-Tsu; Kao, Chung-Lan; Chen, Yi-Huei; Lin, Ching-Heng			The impact of rehabilitation frequency on the risk of stroke in patients with rheumatoid arthritis	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; SEVERITY; EXERCISE; DISEASE	Background Patients with rheumatoid arthritis are at higher risk of developing stroke due to augmented systemic inflammation. While regular exercise has been shown to reduce inflammation in human subjects, the purpose of our study is to determine whether increased frequency of rehabilitation is protective against stroke or not. Methods A total of 16,224 rheumatoid arthritis patients with a catastrophic illness certificate were identified in our database from 2000 to 2006, and 663 of them developed stroke before the end of 2013. After statistically matching for age, sex, and the time interval between the diagnosis of rheumatoid arthritis and stroke, 642 patients without stroke were identified as the control group. Analyses with Student's t test and Chi-square test were done to compare the clinical characteristics of patients with and without stroke, and logistic regression analysis was then performed to evaluate the odds ratio of stroke. Results Higher odds ratio of stroke was revealed in patients with hypertension, diabetes mellitus, and moderate degree of rheumatoid arthritis disease severity. Furthermore, more than 40 rehabilitation sessions per year reduced the risk of developing stroke in patients with moderate disease severity. Conclusions Physical activities brought by more rehabilitation sessions are beneficial and should be encouraged in patients with rheumatoid arthritis, particularly for those with higher disease activity but not taking biologic agents.	[Cheng, Yuan-Yang; Chang, Shin-Tsu] Taichung Vet Gen Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Cheng, Yuan-Yang; Kao, Chung-Lan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chang, Shin-Tsu] Triserv Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chang, Shin-Tsu] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chang, Shin-Tsu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Kao, Chung-Lan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taipei Vet Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Tri-Service General Hospital; National Defense Medical Center; Chung Shan Medical University; Taichung Veterans General Hospital; Taipei Veterans General Hospital	Lin, CH (corresponding author), Taipei Vet Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	epid@vghtc.gov.tw	Chang, Shin-Tsu/AAF-8506-2020	Chang, Shin-Tsu/0000-0003-4005-2094	Taichung Veterans General Hospital, Taiwan [TCVGH-1087322D]	Taichung Veterans General Hospital, Taiwan	CHL received grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1087322D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2019, Diabetes Care, V42, pS46, DOI 10.2337/dc19-S005; [Anonymous], 2016, NAT BIOTECHNOL, V34, pvii, DOI 10.1038/nbt.3732; [Anonymous], EP REP DEM PAT TAIW; Cabral D, 2005, ARTHRIT RHEUM-ARTHR, V53, P61, DOI 10.1002/art.20925; Chen YR, 2018, J NEUROL, V265, P1810, DOI 10.1007/s00415-018-8885-9; Das S, 2017, J PHARMACOL PHARMACO, V8, P81, DOI 10.4103/jpp.JPP_194_16; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Kerekes G, 2011, ISR MED ASSOC J, V13, P147; Kerekes G, 2009, CLIN RHEUMATOL, V28, P705, DOI 10.1007/s10067-009-1095-1; Medicine ACoS, 2017, ACSMS GUID EX TEST P, P321; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Metsios GS, 2015, EXPERT REV CLIN IMMU, V11, P1121, DOI 10.1586/1744666X.2015.1067606; Meune C, 2010, ARCH CARDIOVASC DIS, V103, P253, DOI 10.1016/j.acvd.2010.03.007; Pedersen BK, 2017, EUR J CLIN INVEST, V47, P600, DOI 10.1111/eci.12781; Rongen-van Dartel SAA, 2015, ARTHRIT CARE RES, V67, P1054, DOI 10.1002/acr.22561; Scott David L, 2010, Lancet, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Semb AG, 2010, ANN RHEUM DIS, V69, P1996, DOI 10.1136/ard.2009.126128; Shekhar S, 2018, EUR J PHARMACOL, V833, P531, DOI 10.1016/j.ejphar.2018.06.028; Silvagni E, 2019, CLIN EXP RHEUMATOL, V37, P519; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Swardh E, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095793; Tang KT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33104; Tang KT, 2016, SCI REP-UK, V6, DOI 10.1038/srep22387; Ting G, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2482; Tiosano S, 2017, NEUROEPIDEMIOLOGY, V49, P99, DOI 10.1159/000481992; Toledano E, 2019, REUMATOL CLIN, V15, P146, DOI 10.1016/j.reuma.2017.07.004; Turesson C, 2007, CURR OPIN RHEUMATOL, V19, P190, DOI 10.1097/BOR.0b013e3280147107; Vinet E, 2011, J RHEUMATOL, V38, P2318, DOI 10.3899/jrheum.110587; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Wiseman SJ, 2016, STROKE, V47, P943, DOI 10.1161/STROKEAHA.115.012052; Wolfe F, 2006, J RHEUMATOL, V33, P1952; Wu MH, 2016, MOL NEUROBIOL, V53, P4961, DOI 10.1007/s12035-015-9418-5	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227514	10.1371/journal.pone.0227514	http://dx.doi.org/10.1371/journal.pone.0227514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KD9ML	31929568	gold, Green Published			2022-12-26	WOS:000508185400001
J	Goetzl, EJ; Yaffe, K; Peltz, CB; Ledreux, A; Gorgens, K; Davidson, B; Granholm, AC; Mustapic, M; Kapogiannis, D; Tweedie, D; Greig, NH				Goetzl, Edward J.; Yaffe, Kristine; Peltz, Carrie B.; Ledreux, Aurelie; Gorgens, Kim; Davidson, Bradley; Granholm, Ann-Charlotte; Mustapic, Maja; Kapogiannis, Dimitrios; Tweedie, David; Greig, Nigel H.			Traumatic brain injury increases plasma astrocyte-derived exosome levels of neurotoxic complement proteins	FASEB JOURNAL			English	Article						extracellular vesicles; neurodegeneration; neuroinflammation	IDENTIFICATION; ATTACK	Possible involvement of complement (C) systems in the pathogenesis of traumatic brain injury (TBI) was investigated by quantifying Cproteins in plasma astrocyte-derived exosomes (ADEs) of subjects with sports-related TBI (sTBI) and TBI in military veterans (mtTBI) without cognitive impairment. All sTBI subjects (n = 24) had mild injuries, whereas eight of the mtTBI subjects had moderate, and 17 had mild injuries. Plasma levels of ADEs were decreased after acute sTBI and returned to normal within months. Cprotein levels in ADEs were from 12- to 35-fold higher than the corresponding levels in neuron-derived exosomes. CD81 exosome marker-normalized ADE levels of classical pathway C4b, alternative pathway factor D and Bb, lectin pathway mannose-binding lectin (MBL), and shared neurotoxic effectors C3b and C5b-9 terminal C complex were significantly higher and those of C regulatory proteins CR1 and CD59 were lower in the first week of acute sTBI (n = 12) than in controls (n = 12). Most C abnormalities were no longer detected in chronic sTBI at 3-12 months after acute sTBI, except for elevated levels of factor D, Bb, and MBL. In contrast, significant elevations of ADE levels of C4b, factor D, Bb, MBL, C3b and C5b-9 terminal C complex, and depressions of CR1 and CD59 relative to those of controls were observed after 1-4 years in early chronic mtTBI (n = 10) and persisted for decades except for normalization of Bb, MBL, and CD59 in late chronic mtTBI (n = 15). Complement inhibitors may be useful therapeutically in acute TBI and post-concussion syndrome.	[Goetzl, Edward J.] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Med Ctr, Neurol Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine; Peltz, Carrie B.] San Francisco VA Med Ctr, Dept Psychiat, San Francisco, CA USA; [Peltz, Carrie B.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO USA; [Gorgens, Kim] Univ Denver, Grad Sch Profess Psychol, Denver, CO USA; [Davidson, Bradley] Univ Denver, Dept Mech & Mat Engn, Denver, CO USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Lab Clin Invest, Baltimore, MD 21224 USA; [Tweedie, David; Greig, Nigel H.] NIA, Translat Gerontol Branch, Baltimore, MD 21224 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Northern California Institute for Research & Education; University of Denver; University of Denver; University of Denver; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Goetzl, EJ (corresponding author), UCSF, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Kapogiannis, Dimitrios/AAW-4934-2020; Ledreux, Aurelie/M-3967-2018	Kapogiannis, Dimitrios/0000-0003-2181-3118; Gorgens, Kim/0000-0003-4413-0600; Ledreux, Aurelie/0000-0001-6232-7672; Mustapic, Maja/0000-0003-0511-2047	U.S. Department of Defense (DOD) [WB1XWH-14-2-0137]; University of Denver (DU) [999]; HHS \ NIH \ National Institute on Aging (NIA)	U.S. Department of Defense (DOD)(United States Department of Defense); University of Denver (DU); HHS \ NIH \ National Institute on Aging (NIA)	U.S. Department of Defense (DOD), Grant/Award Number: WB1XWH-14-2-0137; University of Denver (DU), Grant/Award Number: 999; HHS vertical bar NIH vertical bar National Institute on Aging (NIA)	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Carpanini SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00362; Ceyzeriat K, 2016, NEUROSCIENCE, V330, P205, DOI 10.1016/j.neuroscience.2016.05.043; Choi SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097093; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; De Blasio D, 2019, J CEREBR BLOOD F MET, V39, DOI 10.1177/0271678X18758881; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Goetzl EJ, 2017, FASEB J, V31, P1792, DOI 10.1096/fj.201601221R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harris ME, 2002, J CLIN EXP NEUROPSYC, V24, P214, DOI 10.1076/jcen.24.2.214.995; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Winston CN, 2019, ALZH DEMENT-DADM, V11, P61, DOI 10.1016/j.dadm.2018.11.002; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	33	30	31	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3359	3366		10.1096/fj.201902842R	http://dx.doi.org/10.1096/fj.201902842R		JAN 2020	8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916313	hybrid, Green Accepted			2022-12-26	WOS:000506440100001
J	Kim, L; Kwon, DH; Heo, J; Park, MR; Song, HK				Kim, Leehyeon; Kwon, Do Hoon; Heo, Jiwon; Park, Mi Rae; Song, Hyun Kyu			Use of the LC3B-fusion technique for biochemical and structural studies of proteins involved in the N-degron pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein crystallization; ubiquitylation (ubiquitination); protein degradation; autophagy; p62 (sequestosome 1(SQSTM1)); LC3B; N-end rule; NTAQ1; PRT1; UBR box	END RULE PATHWAY; SUMO FUSION TECHNOLOGY; TERMINAL AMIDASE; SUBSTRATE RECOGNITION; UBIQUITIN LIGASE; EXPRESSION; COMPONENT; SPECIFICITY; PHOSPHORYLATION; AUTOPHAGY	The N-degron pathway, formerly the N-end rule pathway, is a protein degradation process that determines the half-life of proteins based on their N-terminal residues. In contrast to the well-established in vivo studies over decades, in vitro studies of this pathway, including biochemical characterization and high-resolution structures, are relatively limited. In this study, we have developed a unique fusion technique using microtubule-associated protein 1A/1B light chain 3B, a key marker protein of autophagy, to tag the N terminus of the proteins involved in the N-degron pathway, which enables high yield of homogeneous target proteins with variable N-terminal residues for diverse biochemical studies including enzymatic and binding assays and substrate identification. Intriguingly, crystallization showed a markedly enhanced probability, even for the N-degron complexes. To validate our results, we determined the structures of select proteins in the N-degron pathway and compared them with the Protein Data Bank?deposited proteins. Furthermore, several biochemical applications of this technique were introduced. Therefore, this technique can be used as a general tool for the in vitro study of the N-degron pathway.	[Kim, Leehyeon; Kwon, Do Hoon; Heo, Jiwon; Park, Mi Rae; Song, Hyun Kyu] Korea Univ, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea	Korea University	Song, HK (corresponding author), Korea Univ, Dept Life Sci, 145 Anam Ro, Seoul 02841, South Korea.	hksong@korea.ac.kr	Sood, Anoop Kumar/A-7344-2013; Song, Hyun Kyu/D-6763-2016	Sood, Anoop Kumar/0000-0001-5702-4108; Song, Hyun Kyu/0000-0001-5684-4059; Kim, Leehyeon/0000-0002-1266-7828	International Collaborative Research Program of the Institute for Protein Research, Osaka University [ICR-17-05]	International Collaborative Research Program of the Institute for Protein Research, Osaka University	We thank the staff at Beamlines 5C and 11C, Pohang Accelerator Laboratory, Republic of Korea and Beamline BL-17A, Photon Factory, Japan, for help with X-ray data collection. This work was performed in part under the International Collaborative Research Program of the Institute for Protein Research, Osaka University Grant ICR-17-05. Diffraction data were collected at the Osaka University Beamline BL44XU at SPring-8 (Harima, Japan) under Proposal 2019A6973.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1995, J BIOL CHEM, V270, P12065, DOI 10.1074/jbc.270.20.12065; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Dong C, 2018, NAT CHEM BIOL, V14, P466, DOI 10.1038/s41589-018-0036-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Grigoryev S, 1996, J BIOL CHEM, V271, P28521, DOI 10.1074/jbc.271.45.28521; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Hondred D, 1999, PLANT PHYSIOL, V119, P713, DOI 10.1104/pp.119.2.713; Hwang CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024925; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim JM, 2018, SCIENCE, V362, P1019, DOI 10.1126/science.aat0174; Kim MK, 2016, P NATL ACAD SCI USA, V113, P12438, DOI 10.1073/pnas.1612620113; Kobe B, 2015, ACTA CRYSTALLOGR F, V71, P861, DOI 10.1107/S2053230X15011061; Kwon DH, 2019, AUTOPHAGY, V15, P180, DOI 10.1080/15548627.2018.1532264; Kwon DH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05825-x; Kwon DH, 2017, BIOCHEM BIOPH RES CO, V490, P1093, DOI 10.1016/j.bbrc.2017.06.173; Kwon DH, 2017, AUTOPHAGY, V13, P70, DOI 10.1080/15548627.2016.1243199; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Munoz-Escobar J, 2017, STRUCTURE, V25, P719, DOI 10.1016/j.str.2017.03.004; Nishimura K, 2013, PLANT CELL, V25, P2276, DOI 10.1105/tpc.113.112557; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Park MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111142; Potuschak T, 1998, P NATL ACAD SCI USA, V95, P7904, DOI 10.1073/pnas.95.14.7904; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Satakarni M, 2011, PROTEIN EXPRES PURIF, V78, P113, DOI 10.1016/j.pep.2011.04.015; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; UHLEN M, 1990, METHOD ENZYMOL, V185, P129; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang XH, 2016, PROTEIN J, V35, P115, DOI 10.1007/s10930-016-9654-1; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	57	8	8	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2590	2600		10.1074/jbc.RA119.010912	http://dx.doi.org/10.1074/jbc.RA119.010912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31919097	hybrid, Green Published			2022-12-26	WOS:000519969100006
J	Cope, NJ; Novak, B; Liu, ZW; Cavallo, M; Gunderwala, AY; Connolly, M; Wang, ZH				Cope, Nicholas J.; Novak, Borna; Liu, Zhiwei; Cavallo, Maria; Gunderwala, Amber Y.; Connolly, Matthew; Wang, Zhihong			Analyses of the oncogenic BRAF(D594G) variant reveal a kinase-independent function of BRAF in activating MAPK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphorylation; protein kinase; Raf kinase; dimerization; ATP; allosteric inhibitor; ATP-competitive inhibitor; P-loop; paradoxical activation; DFG motif; autophosphorylation; molecular dynamics; 14?3-3 protein; peptide inhibitor; allosteric activation; cancer; kinase signaling	RAF INHIBITORS; PATHWAY; MUTATIONS; MECHANISM; DOMAIN; CRAF; MUTANTS; SIDE	Class 3 mutations in B-Raf proto-oncogene, Ser/Thr kinase (BRAF), that result in kinase-impaired or kinase-dead BRAF have the highest mutation frequency in BRAF gene in lung adenocarcinoma. Several studies have reported that kinase-dead BRAF variants amplify mitogen-activated protein kinase (MAPK) signaling by dimerizing with and activating WT C-Raf proto-oncogene, Ser/Thr kinase (CRAF). However, the structural and functional principles underlying their activation remain elusive. Herein, using cell biology and various biochemical approaches, we established that variant BRAF(D594G), a kinase-dead representative of class 3 mutation-derived BRAF variants, has a higher dimerization potential as compared with WT BRAF. Molecular dynamics simulations uncovered that the D594G substitution orients the ?C-helix toward the IN position and extends the activation loop within the kinase domain, shifting the equilibrium toward the active, dimeric conformation, thus priming BRAF(D594G) as an effective allosteric activator of CRAF. We found that B/CRAF heterodimers are the most thermodynamically stable RAF dimers, suggesting that RAF heterodimers, and not homodimers, are the major players in determining the amplitude of MAPK signaling in cells. Additionally, we show that BRAF(D594G):CRAF heterodimers bypass autoinhibitory P-loop phosphorylation, which might contribute to longer duration of MAPK pathway signaling in cancer cells. Last, we propose that the dimer interface of the BRAF(D594G):CRAF heterodimer may represent a promising target in the design of novel anticancer therapeutics.	[Cope, Nicholas J.; Novak, Borna; Liu, Zhiwei; Cavallo, Maria; Gunderwala, Amber Y.; Connolly, Matthew; Wang, Zhihong] Univ Sci, Dept Chem & Biochem, Philadelphia, PA 19104 USA		Wang, ZH (corresponding author), Univ Sci, Dept Chem & Biochem, Philadelphia, PA 19104 USA.	z.wang@usciences.edu	Zhiwei, Liu/HGC-1226-2022		W. W. Smith Charitable Fund; NIGMS, National Institutes of Health [1R15GM128099-01]; Spiers Fellowship	W. W. Smith Charitable Fund; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spiers Fellowship	This work was supported by the W. W. Smith Charitable Fund and NIGMS, National Institutes of Health, Grant 1R15GM128099-01 (to Z. W.) and the Spiers Fellowship (to N. J. C. and A. Y. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Carter J, 2015, AM J CLIN PATHOL, V144, P620, DOI 10.1309/AJCP85ATMJOZOUDJ; Case D.A., 2016, AMBER 2016, DOI DOI 10.13140/RG.2.2.27958.70729; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Cope N, 2019, CHEMBIOCHEM, V20, P2850, DOI 10.1002/cbic.201900266; Cope N, 2018, CHEMBIOCHEM, V19, P1988, DOI 10.1002/cbic.201800359; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Grasso M, 2018, J MED CHEM, V61, P5034, DOI 10.1021/acs.jmedchem.8b00499; Grasso M, 2016, ACS CHEM BIOL, V11, P2876, DOI 10.1021/acschembio.6b00529; Gunderwala AY, 2019, ACS CHEM BIOL, V14, P1471, DOI 10.1021/acschembio.9b00191; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2013, CANCER CELL, V23, P594, DOI 10.1016/j.ccr.2013.03.033; Hu JC, 2013, CELL, V154, P1036, DOI 10.1016/j.cell.2013.07.046; Hu JC, 2011, P NATL ACAD SCI USA, V108, P6067, DOI 10.1073/pnas.1102554108; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Karoulia Z, 2016, CANCER CELL, V30, P485, DOI 10.1016/j.ccell.2016.06.024; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; Kondo Y, 2019, SCIENCE, V366, P109, DOI 10.1126/science.aay0543; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nieto P, 2017, NATURE, V548, P239, DOI 10.1038/nature23297; Noeparast Amir, 2018, Oncotarget, V9, P16110, DOI 10.18632/oncotarget.24576; Park E, 2019, NATURE, V575, P545, DOI 10.1038/s41586-019-1660-y; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qjn J, 2012, J MED CHEM, V55, P5220, DOI 10.1021/jm3004416; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Thevakumaran N, 2015, NAT STRUCT MOL BIOL, V22, P37, DOI 10.1038/nsmb.2924; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZL, 2019, AGING-US, V11, P7187, DOI 10.18632/aging.102244; Weber CK, 2001, CANCER RES, V61, P3595; Yao Z, 2017, NATURE, V548, P234, DOI 10.1038/nature23291; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yuan JM, 2018, J BIOL CHEM, V293, P14276, DOI 10.1074/jbc.RA118.004597; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	44	12	12	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2407	2420		10.1074/jbc.RA119.011536	http://dx.doi.org/10.1074/jbc.RA119.011536			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31929109	Green Published, hybrid			2022-12-26	WOS:000517330200022
J	Koeller, CM; Tiengwe, C; Schwartz, KJ; Bangs, JD				Koeller, Carolina M.; Tiengwe, Calvin; Schwartz, Kevin J.; Bangs, James D.			Steric constraints control processing of glycosylphosphatidylinositol anchors in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; transferrin; glycosylphosphatidylinositol (GPI anchor); trypanosome; N-linked glycosylation; glycosylphosphatidylinositol processing; kinetoplastid protozoa; N-glycan processing; transferrin receptor; trypanosome	VARIANT SURFACE GLYCOPROTEIN; POLY-N-ACETYLLACTOSAMINE; TRANSFERRIN RECEPTOR; MEMBRANE ANCHOR; LINKED OLIGOSACCHARIDES; GENE-EXPRESSION; PROTEIN P67; GLYCOSYLATION; BIOSYNTHESIS; TRAFFICKING	The transferrin receptor (TfR) of the bloodstream form (BSF) of Trypanosoma brucei is a heterodimer comprising glycosylphosphatidylinositol (GPI)-anchored expression site?associated gene 6 (ESAG6 or E6) and soluble ESAG7. Mature E6 has five N-glycans, consisting of three oligomannose and two unprocessed paucimannose structures. Its GPI anchor is modified by the addition of 4?6 ?-galactose residues. TfR binds tomato lectin (TL), specific for N-acetyllactosamine (LacNAc) repeats, and previous studies have shown transport-dependent increases in E6 size consistent with post-glycan processing in the endoplasmic reticulum. Using pulse-chase radiolabeling, peptide-N-glycosidase F treatment, lectin pulldowns, and exoglycosidase treatment, we have now investigated TfR N-glycan and GPI processing. E6 increased ?5 kDa during maturation, becoming reactive with both TL and Erythrina cristagalli lectin (ECL, terminal LacNAc), indicating synthesis of poly-LacNAc on paucimannose N-glycans. This processing was lost after exoglycosidase treatment and after RNAi-based silencing of TbSTT3A, the oligosaccharyltransferase that transfers paucimannose structures to nascent secretory polypeptides. These results contradict previous structural studies. Minor GPI processing was also observed, consistent with ?-galactose addition. However, increasing the spacing between E6 protein and the GPI ?-site (aa 4?7) resulted in extensive post-translational processing of the GPI anchor to a form that was TL/ECL-reactive, suggesting the addition of LacNAc structures, confirmed by identical assays with BiPNHP, a non-N-glycosylated GPI-anchored reporter. We conclude that BSF trypanosomes can modify GPIs by generating structures reminiscent of those present in insect-stage trypanosomes and that steric constraints, not stage-specific expression of glycosyltransferases, regulate GPI processing.	[Koeller, Carolina M.; Tiengwe, Calvin; Bangs, James D.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Schwartz, Kevin J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Tiengwe, Calvin] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Wisconsin System; University of Wisconsin Madison; Imperial College London	Bangs, JD (corresponding author), SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA.	jdbangs@buffalo.edu	Tiengwe, Calvin/AAH-6658-2020; Koeller, Carolina/ABB-1968-2021	Tiengwe, Calvin/0000-0002-3742-6502; Koeller, Carolina/0000-0002-1919-7582; Bangs, James/0000-0001-7903-6521	NIAID, National Institutes of Health [R01 AI035739]; Jacobs School of Medicine and Biomedical Sciences	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Jacobs School of Medicine and Biomedical Sciences	This work was supported by NIAID, National Institutes of Health, Grant R01 AI035739 and funds from the Jacobs School of Medicine and Biomedical Sciences (to J. D. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander DL, 2002, J CELL SCI, V115, P3253; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; BANGS JD, 1988, J BIOL CHEM, V263, P17697; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; CLAYTON CE, 1989, J BIOL CHEM, V264, P15088; Damerow M, 2016, J BIOL CHEM, V291, P13834, DOI 10.1074/jbc.M116.733246; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 2017, ESSENTIALS GLYCOBIOL, P2015, DOI DOI 10.1101/GLYC0BIOLOGY.3E.012; Haanstra JR, 2016, BBA-MOL CELL RES, V1863, P1038, DOI 10.1016/j.bbamcr.2015.09.015; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Itakura Y, 2007, J BIOCHEM, V142, P459, DOI 10.1093/jb/mvm153; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelley RJ, 1995, MOL BIOCHEM PARASIT, V74, P167, DOI 10.1016/0166-6851(95)02493-X; LIGTENBERG MJL, 1994, EMBO J, V13, P2565, DOI 10.1002/j.1460-2075.1994.tb06546.x; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Maier A, 1996, FEBS LETT, V396, P87, DOI 10.1016/0014-5793(96)01073-3; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; MAYOR S, 1992, J BIOL CHEM, V267, P754; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2007, MOL BIOCHEM PARASIT, V151, P220, DOI 10.1016/j.molbiopara.2006.11.001; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; MERKLE RK, 1987, J BIOL CHEM, V262, P8179; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; Mussmann R, 2004, J BIOL CHEM, V279, P40690, DOI 10.1074/jbc.M404697200; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Oguri S, 2005, GLYCOCONJUGATE J, V22, P453, DOI 10.1007/s10719-005-5329-4; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; PaturiauxHanocq F, 1997, BIOCHEM J, V324, P885, DOI 10.1042/bj3240885; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Read LK, 2016, WIRES RNA, V7, P33, DOI 10.1002/wrna.1313; SALMON D, 1994, CELL, V78, P75, DOI 10.1016/0092-8674(94)90574-6; Salmon D, 1997, EMBO J, V16, P7272, DOI 10.1093/emboj/16.24.7272; Schwartz KJ, 2013, EUKARYOT CELL, V12, P132, DOI 10.1128/EC.00293-12; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Silverman JS, 2011, MOL MICROBIOL, V82, P664, DOI 10.1111/j.1365-2958.2011.07842.x; STEVERDING D, 1994, EUR J CELL BIOL, V64, P78; STEVERDING D, 1995, J CELL BIOL, V131, P1173, DOI 10.1083/jcb.131.5.1173; Tiengwe C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006366; Tiengwe C, 2016, CELL MICROBIOL, V18, P1673, DOI 10.1111/cmi.12605; Umaer K, 2018, TRAFFIC, V19, P406, DOI 10.1111/tra.12565; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Welburn SC, 2016, TRENDS PARASITOL, V32, P230, DOI 10.1016/j.pt.2015.11.008; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zitzmann N, 2000, GLYCOBIOLOGY, V10, P243, DOI 10.1093/glycob/10.3.243	53	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2227	2238		10.1074/jbc.RA119.010847	http://dx.doi.org/10.1074/jbc.RA119.010847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31932305	Green Published, hybrid			2022-12-26	WOS:000517330200007
J	Yoshida, H; Aoki, M; Komiya, A; Endo, Y; Kawabata, K; Nakamura, T; Sakai, S; Sayo, T; Okada, Y; Takahashi, Y				Yoshida, Hiroyuki; Aoki, Mika; Komiya, Aya; Endo, Yoko; Kawabata, Keigo; Nakamura, Tomomi; Sakai, Shingo; Sayo, Tetsuya; Okada, Yasunori; Takahashi, Yoshito			HYBID (alias KIAA1199/CEMIP) and hyaluronan synthase coordinately regulate hyaluronan metabolism in histamine-stimulated skin fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; skin; hyaluronan; mast cell; histamine; cell signaling; catabolism; hyaluronan synthase; KIAA1199; HYBID; photoaging	EXPRESSION; INFLAMMATION; RECEPTORS; DEGRADATION; TRYPTASE; GENE	The immune-regulatory compound histamine is involved in the metabolism of the essential skin component hyaluronan (HA). We previously reported that histamine up-regulates the expression of HYBID (hyaluronan-binding protein involved in hyaluronan depolymerization, also called CEMIP or KIAA1199), which plays a key role in HA degradation. However, no information is available about histamine's effects on HA synthase (HAS) expression, the molecular sizes of HA species produced, and histamine receptors and their signaling pathways in skin fibroblasts. Moreover, histamine's effects on photoaged skin remain elusive. Here, we show that histamine increases HA degradation by up-regulating HYBID and down-regulating HAS2 in human skin fibroblasts in a dose- and time-dependent manner and thereby decreases the total amounts and sizes of newly produced HA. Histamine H1 blocker abrogated the histamine effects on HYBID up-regulation, HAS2 suppression, and HA degradation. Histamine H1 agonist exhibited effects on HA levels, composition, and breakdown similar to those of histamine. Of note, blockade of protein kinase C? or PI3K?Akt signaling abolished histamine-mediated HYBID stimulation and HAS2 suppression, respectively. Immunohistochemical experiments revealed a significant ?2-fold increase in tryptase-positive mast cells in photoaged skin, where HYBID and HAS2 expression levels were increased and decreased, respectively, compared with photoprotected skin. These results indicate that histamine controls HA metabolism by up-regulating HYBID and down-regulating HAS2 via distinct signaling pathways downstream of histamine receptor H1. They further suggest that histamine may contribute to photoaged skin damage by skewing HA metabolism toward degradation.	[Yoshida, Hiroyuki; Aoki, Mika; Komiya, Aya; Endo, Yoko; Kawabata, Keigo; Nakamura, Tomomi; Sayo, Tetsuya; Takahashi, Yoshito] Kao Corp, Dept Biol Sci Res, 3-28,5 Chome,Kotobuki Cho, Odawara, Kanagawa 2500002, Japan; [Sakai, Shingo] Kao Corp, Dept Hlth Beauty Prod Res, Odawara, Kanagawa 2500002, Japan; [Okada, Yasunori] Juntendo Univ, Grad Sch Med, Dept Pathophysiol Locomot & Neoplast Dis, Tokyo 1138421, Japan	KAO Corporation; KAO Corporation; Juntendo University	Yoshida, H (corresponding author), Kao Corp, Dept Biol Sci Res, 3-28,5 Chome,Kotobuki Cho, Odawara, Kanagawa 2500002, Japan.; Okada, Y (corresponding author), Juntendo Univ, Grad Sch Med, Dept Pathophysiol Locomot & Neoplast Dis, Tokyo 1138421, Japan.	yoshida.hiroyuki2@kao.com; ya-okada@juntendo.ac.jp						BHAWAN J, 1992, AM J DERMATOPATH, V14, P224, DOI 10.1097/00000372-199206000-00008; BHAWAN J, 1995, J CUTAN PATHOL, V22, P154, DOI 10.1111/j.1600-0560.1995.tb01399.x; Bosset S, 2003, BRIT J DERMATOL, V149, P826, DOI 10.1046/j.1365-2133.2003.05456.x; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; Dong HQ, 2014, MOL NEUROBIOL, V49, P1487, DOI 10.1007/s12035-014-8697-6; Gebhardt C, 2010, J INVEST DERMATOL, V130, P141, DOI 10.1038/jid.2009.210; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; JOHNSON CL, 1990, AM J PHYSIOL, V258, pC533, DOI 10.1152/ajpcell.1990.258.3.C533; Kim MS, 2009, BRIT J DERMATOL, V160, P393, DOI 10.1111/j.1365-2133.2008.08838.x; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LAVKER RM, 1988, J INVEST DERMATOL, V90, P325, DOI 10.1111/1523-1747.ep12456193; Li HG, 2003, CIRCULATION, V107, P2348, DOI 10.1161/01.CIR.0000066697.19571.AF; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mettler SE, 2007, AM J PHYSIOL-GASTR L, V293, pG532, DOI 10.1152/ajpgi.00138.2007; Nagaoka A, 2015, J BIOL CHEM, V290, P30910, DOI 10.1074/jbc.M115.673566; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Rojas IG, 2004, J ORAL PATHOL MED, V33, P567, DOI 10.1111/j.1600-0714.2004.00242.x; ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511; Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Toyoda M, 2005, BRIT J DERMATOL, V153, P13, DOI 10.1111/j.1365-2133.2005.06965.x; Toyoda M, 2001, J DERMATOL SCI, V27, pS32; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Yamamoto H, 2017, J BIOL CHEM, V292, P7304, DOI 10.1074/jbc.M116.770149; Yoshida H, 2018, BRIT J DERMATOL, V179, P136, DOI 10.1111/bjd.16335; Yoshida H, 2018, SKIN RES TECHNOL, V24, P562, DOI 10.1111/srt.12467; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110	30	8	8	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2483	2494		10.1074/jbc.RA119.010457	http://dx.doi.org/10.1074/jbc.RA119.010457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31949043	Green Published, hybrid			2022-12-26	WOS:000517330200028
J	Qu, BQ; Li, X; Cardona, CJ; Xing, Z				Qu, Bingqian; Li, Xue; Cardona, Carol J.; Xing, Zheng			Reassortment and adaptive mutations of an emerging avian influenza virus H7N4 subtype in China	PLOS ONE			English	Article							A VIRUS; OUTBREAK	Human infections with avian influenza viruses including H5, H7 and H9 hemagglutinin subtypes occur at a low rate. Among human infections with H7 viruses, regional outbreaks with H7N2, H7N3, H7N7 and H7N9 have been documented. Early in 2018, a human infection with a novel H7N4 avian influenza virus was reported in Jiangsu, China. This study is aimed at understanding the probable origin and molecular features of this emerging H7N4 virus. Genomic segments encoding hemagglutinin (HA) and neuraminidase (NA) of H7Nx and HxN4 viruses were compared with this H7N4 strain by alignment and phylogenetic tree analysis. Phylogenetic analysis indicated that the human H7N4 virus probably originated from multiple reassortments of avian H7N7 and H8N4 viruses for its HA and NA, respectively, and likely a regional uncharacterized virus for its internal segments. Our data excluded that circulating avian H9N2 viruses were the origin of the H7N4 internal segments, unlike the human H5N1 and H7N9 viruses that both had H9N2 backbones. This index case provided a unique opportunity to examine viral mutations by directly comparing the human isolate with its closest viral relatives isolated from avian species from the patient's farm, which may suggest critical mutations required for viral adaptation in humans. Whole-genome scanning was performed and the sequences of the human and related avian H7N4 isolates were compared. Mutations in PB2 (E627K), PB2 (K683T), PB1-F2 (N47S), HA (N283D), HA(K321E), NA(A137V), NA(K296R) and M2 (C19Y) were identified in the human isolate while no mutations were found in PB1, NP, NS1, and NS2 of the human H7N4 compared to the avian H7N4 viruses. Our data in this report provide further evidence for the genesis of this novel H7N4 virus with a multi-reassortment model and show molecular changes that might be responsible for the transmission of this virus from chickens or ducks to and subsequent replication in humans.	[Qu, Bingqian; Li, Xue; Xing, Zheng] Nanjing Univ, Med Sch, Nanjing, Peoples R China; [Qu, Bingqian; Li, Xue; Xing, Zheng] Nanjing Univ, Jiangsu Prov Key Lab Mol Med, Nanjing, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55455 USA; [Qu, Bingqian; Li, Xue] Univ Hosp Heidelberg, Heidelberg, Germany	Nanjing University; Nanjing University; University of Minnesota System; University of Minnesota Twin Cities; Ruprecht Karls University Heidelberg	Xing, Z (corresponding author), Nanjing Univ, Med Sch, Nanjing, Peoples R China.; Xing, Z (corresponding author), Nanjing Univ, Jiangsu Prov Key Lab Mol Med, Nanjing, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55455 USA.	zxing@umn.edu	Qu, Bingqian/AAD-1728-2020; Xing, Zheng/O-3137-2015	Qu, Bingqian/0000-0002-7330-2929; Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China [81571993]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	ZX; National Natural Science Foundation of China; Grant No. 81571993; www.nsfc.gov.cn/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hayashi T, 2015, J VIROL, V89, P8042, DOI 10.1128/JVI.00901-15; HUO X, 2018, SCI B, P1049, DOI DOI 10.1109/ICDM.2018.00133; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Li X, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/7375294; Selleck PW, 2003, AVIAN DIS, V47, P806, DOI 10.1637/0005-2086-47.s3.806; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Sutton TC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090461; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong XC, 2018, J INFECTION, V77, P255, DOI 10.1016/j.jinf.2018.06.002; Vijaykrishna D, 2019, EMERG INFECT DIS, V25; Wang HM, 2016, INFECT GENET EVOL, V39, P325, DOI 10.1016/j.meegid.2016.02.013; Yamayoshi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08039; Yen HL, 2013, MBIO, V16, P4, DOI DOI 10.1128/MBI0.00396-13; ZHAO SY, 2017, EUROSURVEILLANCE, V22, DOI DOI 10.3390/MOLECULES22101721	19	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227597	10.1371/journal.pone.0227597	http://dx.doi.org/10.1371/journal.pone.0227597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951605	Green Published, gold			2022-12-26	WOS:000534370500023
J	Cordaro, M; Scuto, M; Siracusa, R; D'amico, R; Peritore, AF; Gugliandolo, E; Fusco, R; Crupi, R; Impellizzeri, D; Pozzebon, M; Alfonsi, D; Mattei, N; Marcolongo, G; Evangelista, M; Cuzzocrea, S; Di Paola, R				Cordaro, Marika; Scuto, Maria; Siracusa, Rosalba; D'amico, Ramona; Peritore, Alessio Filippo; Gugliandolo, Enrico; Fusco, Roberta; Crupi, Rosalia; Impellizzeri, Daniela; Pozzebon, Michele; Alfonsi, Daniele; Mattei, Nicolo; Marcolongo, Gabriele; Evangelista, Maurizio; Cuzzocrea, Salvatore; Di Paola, Rosanna			Effect of N-palmitoylethanolamine-oxazoline on comorbid neuropsychiatric disturbance associated with inflammatory bowel disease	FASEB JOURNAL			English	Article						comorbidity; DSS; gut-brain-axis; N-palmitoylethanolamine-oxazoline	DEXTRAN SULFATE SODIUM; INDUCED COLITIS; MAST-CELLS; GASTROINTESTINAL TRANSIT; ULCERATIVE-COLITIS; TIGHT JUNCTION; RAT MODEL; BRAIN; GUT; STRESS	Inflammatory bowel disease (IBD) is a chronic disorder characterized by inflammation of the gastrointestinal (GI) tract, and it is associated with different neurological disorders. Recent evidence has demonstrated that the gut-brain-axis has a central function in the perpetuation of IBS, and for this reason, it can be considered a possible therapeutic target. N-Palmitoylethanolamine-oxazoline (PEA-OXA) possesses anti-inflammatory and potent neuroprotective effects. Although recent studies have explained the neuroprotective properties of PEA-OXA, nothing is known about its effects on the gut-brain axis during colitis. The aim of this study is to explore the mechanism and the effect of PEA-OXA on the gut-brain axis in rats subjected to experimental colitis induced by intracolonic administration of dextran sulfate sodium (DSS). Daily oral administration of PEA-OXA (10 mg/kg daily o.s.) was able to decrease the body weight loss, macroscopic damage, colon length, histological alteration, and inflammation after DSS induction. Additionally, PEA-OXA administration enhanced neurotrophic growth factor release and decreased the astroglial and microglial activation induced by DSS. Moreover, PEA-OXA restored intestinal permeability and tight junctions (TJs) as well as reduced apoptosis in the colon and brain. In our work, we demonstrated, for the first time, the action of PEA-OXA on the gut-brain axis in a model of DSS-induced colitis and its implication on the "secondary" effects associated with colonic disturbance.	[Cordaro, Marika; Siracusa, Rosalba; D'amico, Ramona; Peritore, Alessio Filippo; Gugliandolo, Enrico; Fusco, Roberta; Crupi, Rosalia; Impellizzeri, Daniela; Cuzzocrea, Salvatore; Di Paola, Rosanna] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Scuto, Maria] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Pozzebon, Michele] dtoLABS Srl Analyt Excellence Ctr, Resana, Italy; [Alfonsi, Daniele; Mattei, Nicolo; Marcolongo, Gabriele] Epitech Grp SpA, Milan, Italy; [Evangelista, Maurizio] Univ Cattolica Sacro Cuore, Inst Anaesthesiol & Reanimat, Rome, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; University of Catania; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Saint Louis University	Cuzzocrea, S; Di Paola, R (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	salvator@unime.it; dipaolar@unime.it	Peritore, Alessio/HGB-1327-2022; Siracusa, Rosalba/AAC-3110-2022; Gugliandolo, Enrico/AAB-9972-2019; evangelista, maurizio/G-6820-2012; FUSCO, Roberta/AAC-1745-2019; Cordaro, Marika/K-7329-2016; di paola, rosanna/U-4356-2019; D'Amico, Ramona/AAC-9061-2019	Siracusa, Rosalba/0000-0001-7868-2505; Gugliandolo, Enrico/0000-0001-6840-3154; FUSCO, Roberta/0000-0003-0223-1403; Cordaro, Marika/0000-0002-3980-0043; di paola, rosanna/0000-0001-6725-8581; Crupi, Rosalia/0000-0002-7629-3132; D'Amico, Ramona/0000-0003-0389-3871; Impellizzeri, Daniela/0000-0001-9492-3161; peritore, alessio filippo/0000-0001-8545-990X				Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Balaha M, 2016, LIFE SCI, V146, P40, DOI 10.1016/j.lfs.2016.01.012; Bassotti G, 2014, WORLD J GASTROENTERO, V20, P37, DOI 10.3748/wjg.v20.i1.37; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; BJARNASON I, 1994, GUT, V35, pS18, DOI 10.1136/gut.35.1_Suppl.S18; Cordaro M, 2018, MOL NEUROBIOL, V55, P9251, DOI 10.1007/s12035-018-1064-2; Cordaro M, 2016, MOL PHARMACOL, V90, P549, DOI 10.1124/mol.116.105668; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Dalziel JE, 2017, AM J PHYSIOL-GASTR L, V313, pG62, DOI 10.1152/ajpgi.00008.2017; Dalziel JE, 2016, NEUROGASTROENT MOTIL, V28, P1241, DOI 10.1111/nmo.12824; Dalziel JE, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121351; De Winter BY, 2012, BBA-MOL BASIS DIS, V1822, P66, DOI 10.1016/j.bbadis.2011.03.016; Do J, 2018, CLIN PSYCHOPHARM NEU, V16, P422, DOI 10.9758/cpn.2018.16.4.422; Elsheikh W, 2012, J PHYSIOL PHARMACOL, V63, P463; Emge JR, 2016, AM J PHYSIOL-GASTR L, V310, pG989, DOI 10.1152/ajpgi.00086.2016; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Goodhand JR, 2012, INFLAMM BOWEL DIS, V18, P2301, DOI 10.1002/ibd.22916; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Halpin SJ, 2012, AM J GASTROENTEROL, V107, P1474, DOI 10.1038/ajg.2012.260; Han Y, 2018, NEUROSCI BULL, V34, P1058, DOI 10.1007/s12264-018-0288-5; Hathaway CA, 1999, AM J PHYSIOL-GASTR L, V276, pG1174, DOI 10.1152/ajpgi.1999.276.5.G1174; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Iba Y, 2003, INT IMMUNOPHARMACOL, V3, P485, DOI 10.1016/S1567-5769(02)00299-0; Impellizzeri D, 2019, NEUROBIOL DIS, V125, P77, DOI 10.1016/j.nbd.2019.01.007; Impellizzeri D, 2017, J NEUROTRAUM, V34, P2609, DOI 10.1089/neu.2016.4808; Impellizzeri D, 2016, PHARMACOL RES, V108, P23, DOI 10.1016/j.phrs.2016.04.007; Jain P, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00177; Khan Waliul I, 2013, Gastroenterol Hepatol (N Y), V9, P259; Kim MW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072025; Kim YR, 2017, J CELL MOL MED, V21, P3565, DOI 10.1111/jcmm.13267; Kishimoto Y, 2019, NEUROMOL MED, V21, P239, DOI 10.1007/s12017-019-08539-5; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li YH, 2018, INT IMMUNOPHARMACOL, V60, P194, DOI 10.1016/j.intimp.2018.05.001; Liu JT., 2015, NEUROL-NEUROIMMUNOL, V2, P131, DOI DOI 10.4103/2347-8659.156980; Mawdsley JE, 2006, NEUROIMMUNOMODULAT, V13, P327, DOI 10.1159/000104861; Painsipp E, 2011, BRIT J PHARMACOL, V163, P1302, DOI 10.1111/j.1476-5381.2011.01326.x; Park Yo Han, 2015, J Cancer Prev, V20, P260, DOI 10.15430/JCP.2015.20.4.260; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Petrosino S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00308; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Sanchez-Fidalgo S, 2015, MOL NUTR FOOD RES, V59, P284, DOI 10.1002/mnfr.201400518; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Shalev Hadar, 2009, Cardiovasc Psychiatry Neurol, V2009, P278531, DOI 10.1155/2009/278531; Taniguchi T, 1998, J GASTROEN HEPATOL, V13, P945, DOI 10.1111/j.1440-1746.1998.tb00766.x; Tyagi A, 2012, BRIT J NUTR, V108, P1612, DOI 10.1017/S0007114511007197; Vidal A, 2008, INFLAMM BOWEL DIS, V14, P977, DOI 10.1002/ibd.20388; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wan MX, 2002, BRIT J PHARMACOL, V135, P1749, DOI 10.1038/sj.bjp.0704638; Wei L, 2018, NEUROMOL MED, V20, P252, DOI 10.1007/s12017-018-8489-7; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Xia XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027282; Zhao L, 2017, MOLECULES, V22, DOI 10.3390/molecules22071218; Zhao Q, 2018, INFLAMM RES, V67, P663, DOI 10.1007/s00011-018-1155-6; Zhong F, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00776; Zhu CH, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0252-y; Zhu CZ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00442	61	15	15	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					4085	4106		10.1096/fj.201901584RR	http://dx.doi.org/10.1096/fj.201901584RR		JAN 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950563	Bronze			2022-12-26	WOS:000507916300001
J	Vitkin, E; Gillis, A; Polikovsky, M; Bender, B; Golberg, A; Yakhini, Z				Vitkin, Edward; Gillis, Amichai; Polikovsky, Mark; Bender, Barak; Golberg, Alexander; Yakhini, Zohar			Distributed flux balance analysis simulations of serial biomass fermentation by two organisms	PLOS ONE			English	Article							KNOCKOUT STRATEGIES; ESCHERICHIA-COLI; DESIGN; BIOREFINERIES; TECHNOLOGY; BIOETHANOL; SYSTEMS; GROWTH	Intelligent biorefinery design that addresses both the composition of the biomass feedstock as well as fermentation microorganisms could benefit from dedicated tools for computational simulation and computer-assisted optimization. Here we present the BioLego Vn2.0 framework, based on Microsoft Azure Cloud, which supports large-scale simulations of biomass serial fermentation processes by two different organisms. BioLego enables the simultaneous analysis of multiple fermentation scenarios and the comparison of fermentation potential of multiple feedstock compositions. Thanks to the effective use of cloud computing it further allows resource intensive analysis and exploration of media and organism modifications. We use BioLego to obtain biological and validation results, including (1) exploratory search for the optimal utilization of corn biomasses-corn cobs, corn fiber and corn stoverin fermentation biorefineries; (2) analysis of the possible effects of changes in the composition of K. alvarezi biomass on the ethanol production yield in an anaerobic two-step process (S. cerevisiae followed by E. coli); (3) analysis of the impact, on the estimated ethanol production yield, of knocking out single organism reactions either in one or in both organisms in an anaerobic two-step fermentation process of Ulva sp. into ethanol (S. cerevisiae followed by E. coli); and (4) comparison of several experimentally measured ethanol fermentation rates with the predictions of BioLego.	[Vitkin, Edward; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel; [Vitkin, Edward] IBM Watson Hlth, Haifa, Israel; [Gillis, Amichai; Polikovsky, Mark; Bender, Barak; Golberg, Alexander] Tel Aviv Univ, Porter Sch Environm & Earth Sci, Tel Aviv, Israel; [Yakhini, Zohar] Interdisciplinary Ctr, Sch Comp Sci, Herzliyya, Israel	Technion Israel Institute of Technology; Tel Aviv University; Reichman University	Vitkin, E; Yakhini, Z (corresponding author), Technion Israel Inst Technol, Dept Comp Sci, Haifa, Israel.; Vitkin, E (corresponding author), IBM Watson Hlth, Haifa, Israel.; Yakhini, Z (corresponding author), Interdisciplinary Ctr, Sch Comp Sci, Herzliyya, Israel.	edward.vitkin@gmail.com; zohar.yakhini@idc.ac.il	Polikovsky, Mark/AAA-5289-2022	Polikovsky, Mark/0000-0001-9699-0966; Vitkin, Edward/0000-0003-4055-4772; Yakhini, Zohar/0000-0002-0420-5412	Azure for Research grant from Microsoft; Israel Ministry of Energy [215-11-032]; Technion - Israel Institute of Technology; Technion-Israel Institute of Technology	Azure for Research grant from Microsoft(Microsoft); Israel Ministry of Energy; Technion - Israel Institute of Technology; Technion-Israel Institute of Technology	This work was generously supported by an Azure for Research grant from Microsoft to EV and ZY. AlG work was founded by Israel Ministry of Energy (grants #215-11-032). Work of MP was founded by the Israeli Ministry of Science, Technology, and Space. The generous financial help of the Technion - Israel Institute of Technology is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was generously supported by an Azure for Research grant from Microsoft. The generous financial help of the Technion-Israel Institute of Technology is gratefully acknowledged. We thank all members of Zohar Yakhini's research group for important discussions.	ANDERSEN KB, 1980, J BACTERIOL, V144, P114, DOI 10.1128/JB.144.1.114-123.1980; [Anonymous], 2017, COLD SPRING HARB PRO, V2017; [Anonymous], 2006, COLD SPRING HARB PRO, V2006; BALDWIN AR, 1951, J AM OIL CHEM SOC, V28, P24, DOI 10.1007/BF02639745; Bataille C, 2018, J CLEAN PROD, V187, P960, DOI 10.1016/j.jclepro.2018.03.107; Bond-Watts BB, 2011, NAT CHEM BIOL, V7, P222, DOI 10.1038/NCHEMBIO.537; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Chemodanov A, 2017, ENERG CONVERS MANAGE, V148, P1497, DOI 10.1016/j.enconman.2017.06.066; DEINDOERFER FH, 1959, IND ENG CHEM, V51, P809, DOI 10.1021/ie50595a023; Demirbas MF, 2009, APPL ENERG, V86, pS151, DOI 10.1016/j.apenergy.2009.04.043; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Golberg A, 2015, P ECOS 2015 28 INT C, P1; Golberg A, 2014, BIOFUEL BIOPROD BIOR, V8, P67, DOI 10.1002/bbb.1438; Hagman A, 2014, FEBS J, V281, P4805, DOI 10.1111/febs.13019; Heavner BD, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-55; Ingle K, 2018, BIOENERG RES, V11, P22, DOI 10.1007/s12155-017-9874-z; Jia XQ, 2016, SYN SYST BIOTECHNO, V1, P109, DOI 10.1016/j.synbio.2016.02.001; Jiang R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27761; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Korzen L, 2015, RSC ADV, V5, P16223, DOI 10.1039/c4ra14880k; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Masuo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25764; McAloon A, 2000, DETERMINING COST PRO; McAnulty MJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-42; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Raman K, 2009, BRIEF BIOINFORM, V10, P435, DOI 10.1093/bib/bbp011; Shefer S, 2017, BOT MAR, V60, P219, DOI 10.1515/bot-2016-0039; Sorek N, 2014, BIOSCIENCE, V64, P192, DOI 10.1093/biosci/bit037; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Sy CL, 2018, J CLEAN PROD, V170, P496, DOI 10.1016/j.jclepro.2017.09.140; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Trivedi N, 2013, BIORESOURCE TECHNOL, V150, P106, DOI 10.1016/j.biortech.2013.09.103; Van Eylen D, 2011, BIORESOURCE TECHNOL, V102, P5995, DOI 10.1016/j.biortech.2011.02.049; van Iersel MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-5; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; Vitkin E, 2018, COMPUTATIONAL ASPECT; Vitkin E, 2015, TECHNOLOGY, V3, P89, DOI 10.1142/S2339547815400038; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Wang EX, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0418-6; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45; Wu WJ, 2017, BIORESOUR BIOPROCESS, V4, DOI 10.1186/s40643-017-0138-8; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363	47	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227363	10.1371/journal.pone.0227363	http://dx.doi.org/10.1371/journal.pone.0227363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945096	Green Published, gold			2022-12-26	WOS:000534370100034
J	Khoe, LC; Wangge, G; Soewondo, P; Tahapary, DL; Widyahening, IS				Khoe, Levina Chandra; Wangge, Grace; Soewondo, Pradana; Tahapary, Dicky L.; Widyahening, Indah Suci			The implementation of community-based diabetes and hypertension management care program in Indonesia	PLOS ONE			English	Article								Since 2010, Indonesian government has initiated a chronic disease management program, Prolanis (Program Pengendalian Penyakit Kronis) targeted for diabetes and hypertension. The program is continued at the commencement of universal health coverage (UHC) in 2014. "This study aimed to report the utilization and cost of the implementation of Prolanis in Indonesia from 2014 to 2016, or two years since the commencement of Indonesian universal health coverage." Secondary data analysis was performed using publicly available data and data obtained from the national health insurance agency (BPJS); while data on disease prevalence were collected from basic national health survey. There was an increase trend of Prolanis participants, from around 11,000 participants in 2014 to more than 250,000 in 2016. More than 70% of participants were adults living in Java, however, the acceptance rate was very low in other area. Across different activities in Prolanis, physical activity was the most participated ones. In comparison to other regions, regions in Java were the most active area. The total expenditure for Prolanis program in 2016 increased almost triple from the annual cost in 2014. However, the cost per person was actually decreased more than 50%. Within two years of UHC implementation, there were increase covered participants and total costs, but cost per individual was decreased and there was significant difference in of cost between Java and outside Java. Further study and routine monitoring-evaluation process by health authority is needed to assess whether the cost difference would affect the service quality.	[Khoe, Levina Chandra; Widyahening, Indah Suci] Univ Indonesia, Fac Med, Dept Community Med, Jakarta, Indonesia; [Wangge, Grace] Univ Indonesia, Southeast Asian Ministers Educ Org, Reg Ctr Food & Nutr SEAMEO RECFON, Pusat Kajian Gizi Reg PKGR, Jakarta, Indonesia; [Soewondo, Pradana; Tahapary, Dicky L.] Univ Indonesia, Facuty Med, Dept Internal Med, Div Metab Endocrine, Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia	Wangge, G (corresponding author), Univ Indonesia, Southeast Asian Ministers Educ Org, Reg Ctr Food & Nutr SEAMEO RECFON, Pusat Kajian Gizi Reg PKGR, Jakarta, Indonesia.	g.wangge@seameo-recfon.org	Widyahening, Indah/ABB-9058-2021; Widyahening, Indah/GNP-8450-2022; Wangge, Grace/AAS-5241-2020	Widyahening, Indah/0000-0002-7952-2893; Wangge, Grace/0000-0002-5416-273X; Khoe, Levina/0000-0002-2050-392X	Directorate of Research and Community Engagement, Universitas Indonesia [5282/UN2, R3.1/HKP05.00/2018]	Directorate of Research and Community Engagement, Universitas Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	We received publication funding for this project from Directorate of Research and Community Engagement, Universitas Indonesia under grant number 5282/UN2.R3.1/HKP05.00/2018. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assupina M, 2013, J ILMU KESEHAT MASY, V4, P254; BPJS Kesehatan, PROLANIS PROGR PENG; Dyanneza F., 2017, Indonesian Journal of Medicine, V2, P52, DOI 10.26911/theijmed.2016.01.03.06; Indonesia Central Statistic Agency, 2017, IND POP PROJ 2010 20; Indonesian Ministry of Health, 2018, RISET KESEHATAN DASA; Ministry of Health Republic of Indonesia, 2013, RISET KESEHATAN DASA; WHO, 2010, WHO INT CHRON DIS PR	7	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227806	10.1371/journal.pone.0227806	http://dx.doi.org/10.1371/journal.pone.0227806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935256	Green Published, gold			2022-12-26	WOS:000534354100054
J	Steinbach, RJ; Haese, NN; Smith, JL; Colgin, LMA; MacAllister, RP; Greene, JM; Parkins, CJ; Kempton, JB; Porsov, E; Wang, XJ; Renner, LM; McGill, TJ; Dozier, BL; Kreklywich, CN; Andoh, TF; Grafe, MR; Pecoraro, HL; Hodge, T; Friedman, RM; Houser, LA; Morgan, TK; Stenzel, P; Lindner, JR; Schelonka, RL; Sacha, JB; Roberts, VHJ; Neuringer, M; Brigande, JV; Kroenke, CD; Frias, AE; Lewis, AD; Kelleher, MA; Hirsch, AJ; Streblow, DN				Steinbach, Rosemary J.; Haese, Nicole N.; Smith, Jessica L.; Colgin, Lois M. A.; MacAllister, Rhonda P.; Greene, Justin M.; Parkins, Christopher J.; Kempton, J. Beth; Porsov, Edward; Wang, Xiaojie; Renner, Lauren M.; McGill, Trevor J.; Dozier, Brandy L.; Kreklywich, Craig N.; Andoh, Takeshi F.; Grafe, Marjorie R.; Pecoraro, Heidi L.; Hodge, Travis; Friedman, Robert M.; Houser, Lisa A.; Morgan, Terry K.; Stenzel, Peter; Lindner, Jonathan R.; Schelonka, Robert L.; Sacha, Jonah B.; Roberts, Victoria H. J.; Neuringer, Martha; Brigande, John V.; Kroenke, Christopher D.; Frias, Antonio E.; Lewis, Anne D.; Kelleher, Meredith A.; Hirsch, Alec J.; Streblow, Daniel Neal			A neonatal nonhuman primate model of gestational Zika virus infection with evidence of microencephaly, seizures and cardiomyopathy	PLOS ONE			English	Article							DILATED CARDIOMYOPATHY; CARDIOTHORACIC RATIO; BIRTH-WEIGHT; FETAL; GROWTH; REGISTRATION; INFANTS; ROBUST; BRAZIL; COMPLICATIONS	Zika virus infection during pregnancy is associated with miscarriage and with a broad spectrum of fetal and neonatal developmental abnormalities collectively known as congenital Zika syndrome (CZS). Symptomology of CZS includes malformations of the brain and skull, neurodevelopmental delay, seizures, joint contractures, hearing loss and visual impairment. Previous studies of Zika virus in pregnant rhesus macaques (Macaca mulatta) have described injury to the developing fetus and pregnancy loss, but neonatal outcomes following fetal Zika virus exposure have yet to be characterized in nonhuman primates. Herein we describe the presentation of rhesus macaque neonates with a spectrum of clinical outcomes, including one infant with CZS-like symptoms including cardiomyopathy, motor delay and seizure activity following maternal infection with Zika virus during the first trimester of pregnancy. Further characterization of this neonatal nonhuman primate model of gestational Zika virus infection will provide opportunities to evaluate the efficacy of pre- and postnatal therapeutics for gestational Zika virus infection and CZS.	[Steinbach, Rosemary J.; Roberts, Victoria H. J.; Frias, Antonio E.; Kelleher, Meredith A.] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA; [Haese, Nicole N.; Smith, Jessica L.; Greene, Justin M.; Parkins, Christopher J.; Kreklywich, Craig N.; Andoh, Takeshi F.; Sacha, Jonah B.; Hirsch, Alec J.; Streblow, Daniel Neal] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Haese, Nicole N.; Greene, Justin M.; Sacha, Jonah B.; Hirsch, Alec J.; Streblow, Daniel Neal] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA; [Colgin, Lois M. A.; Lewis, Anne D.] Oregon Natl Primate Res Ctr, Div Comparat Med, Pathol Serv Unit, Beaverton, OR USA; [MacAllister, Rhonda P.; Dozier, Brandy L.] Oregon Natl Primate Res Ctr, Div Comparat Med, Clin Med Unit, Beaverton, OR USA; [Kempton, J. Beth; Porsov, Edward; Brigande, John V.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Wang, Xiaojie; Kroenke, Christopher D.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Renner, Lauren M.; McGill, Trevor J.; Friedman, Robert M.; Neuringer, Martha] Oregon Natl Primate Res Ctr, Dept Neurosci, Beaverton, OR USA; [McGill, Trevor J.; Neuringer, Martha] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA; [Grafe, Marjorie R.; Morgan, Terry K.; Stenzel, Peter] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Pecoraro, Heidi L.] North Dakota State Univ, Vet Diagnost Serv Dept, Fargo, ND USA; [Hodge, Travis] Oregon Natl Primate Res Ctr, Div Comparat Med, Time Mated Breeding Serv Unit, Beaverton, OR USA; [Houser, Lisa A.] Oregon Natl Primate Res Ctr, Div Comparat Med, Behav Serv Unit, Beaverton, OR USA; [Morgan, Terry K.; Frias, Antonio E.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Lindner, Jonathan R.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Schelonka, Robert L.] Oregon Hlth & Sci Univ, Dept Pediat, Div Neonatol, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; North Dakota State University Fargo; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Streblow, DN (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA.; Streblow, DN (corresponding author), Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR 97006 USA.	streblow@ohsu.edu	Kelleher, Meredith Anne/L-2317-2019; de Lima, Antonio Marcos Oliveira/AAT-2148-2021	Kelleher, Meredith Anne/0000-0002-5313-004X; Wang, Xiaojie/0000-0001-5557-6048; Steinbach, Rosemary/0000-0003-0257-7308	Bill and Melinda Gates Foundation [OPP1131710]; Oregon National Primate Research Center (ONPRC) [P51-ODO11092]; National Institutes of Health [K01-OD026561, R21-HD091032, R01-HD096741-01]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Oregon National Primate Research Center (ONPRC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work presented in this manuscript was supported by the Bill and Melinda Gates Foundation (OPP1131710) the Pilot Program and Base grant support from the Oregon National Primate Research Center (ONPRC) P51-ODO11092 as well as K01-OD026561, R21-HD091032 and R01-HD096741-01 awarded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abend NS, 2018, VOLPES NEUROLOGY NEW; Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702; Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802; Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304; Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656; Attaway DF, 2017, J INFECT PUBLIC HEAL, V10, P120, DOI 10.1016/j.jiph.2016.09.008; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cakirer Sinan, 2003, Curr Probl Diagn Radiol, V32, P194, DOI 10.1016/S0363-0188(03)00026-4; Carta KG, 2019, J AM COLL CARDIOL, V73, P719, DOI 10.1016/S0735-1097(19)31327-0; Centers for Disease Control and Prevention, 2018, OUTC PREGN LAB EV PO; Centers for Disease Control and Prevention, 2019, ZIK TRANSM 2019; Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w; Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6; Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004; Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029; Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Di Cavalcanti D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175065; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5; EDWARDS DK, 1981, AM J ROENTGENOL, V136, P907, DOI 10.2214/ajr.136.5.907; Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098; Esposito DL, 2017, ABORTION RATE IS MUC; da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Goldberger AL, 2018, GOLDBERGERS CLIN ELE, P50; Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479; Greene JM, 2017, MUCOSAL IMMUNOL, V10, P802, DOI 10.1038/mi.2016.91; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9; Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219; Hopper KJ, 2008, COMPARATIVE MED, V58, P597; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x; Kattwinkel J, 2011, TXB NEONATAL RESUSCI; Kearney MT, 2001, POSTGRAD MED J, V77, P4, DOI 10.1136/pmj.77.903.4; Kelleher MA, 2017, PEDIATR RES, V82, P244, DOI 10.1038/pr.2017.57; KERR GR, 1969, GROWTH, V33, P201; Knutsen AK, 2013, CEREB CORTEX, V23, P488, DOI 10.1093/cercor/bhs042; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Liu Z, 2019, NEUROIMAGE, V184, P372, DOI 10.1016/j.neuroimage.2018.09.015; Lo JO, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.016; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4; Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004; Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001; Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2; Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019; Maslen CL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00735; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399; Mirvis D, 2018, BRAUNWALDS HEART DIS, V11th; Mitchell C, 2019, J AM SOC ECHOCARDIOG, V32, P1, DOI 10.1016/j.echo.2018.06.004; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617; da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956; van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI [10.1523/jneurosci.3124-16.2017, 10.1523/JNEUROSCI.3124-16.2017]; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004; O'Connor M, 2008, AM J EMERG MED, V26, P506, DOI 10.1016/j.ajem.2008.03.030; Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583; Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020; Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362; Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0; Peloggia A, 2018, INT J GYNECOL OBSTET, V143, P277, DOI 10.1002/ijgo.12663; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704; Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289; Resiere D, 2018, J CLIN VIROL, V98, P8, DOI 10.1016/j.jcv.2017.11.002; Rohlfing T, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00027; Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA; RUPPENTHAL GC, 1992, RES PROTOCOL TECHNIC; Sackett G, 2006, DEV PSYCHOBIOL, V48, P243, DOI 10.1002/dev.20132; Santana MB, 2019, CLIN MICROBIOL INFEC, V25, P1043, DOI 10.1016/j.cmi.2019.03.020; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041; Schreur PJW, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0044-y; Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]; Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Slotkin TA, 2011, NEUROTOXICOL TERATOL, V33, P431, DOI 10.1016/j.ntt.2011.02.001; Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019; Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580; Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; Tarantal AF, 1995, GROWTH REGULAT, V5, P190; Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9; Trevathan E, 2016, BIRTH DEFECTS RES A, V106, P869, DOI 10.1002/bdra.23582; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009; Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wang XJ, 2017, J NEUROSCI, V37, P1971, DOI 10.1523/JNEUROSCI.3157-16.2017; Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117; Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495; Wozniak LJ, 2006, J PERINATOL, V26, P769, DOI 10.1038/sj.jp.7211605; Ohki CMY, 2019, EXPERT OPIN DRUG DIS, V14, P577, DOI 10.1080/17460441.2019.1597050; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448	102	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227676	10.1371/journal.pone.0227676	http://dx.doi.org/10.1371/journal.pone.0227676			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935257	gold, Green Published			2022-12-26	WOS:000534354100041
J	Wang, ZY; Huang, C; Lv, HB; Zhang, MZ; Li, XM				Wang, Zhenyu; Huang, Chen; Lv, Huibin; Zhang, Mingzhou; Li, Xuemin			In silico analysis and high-risk pathogenic phenotype predictions of non-synonymous single nucleotide polymorphisms in human Crystallin beta A4 gene associated with congenital cataract	PLOS ONE			English	Article							STABILITY CHANGES; WEB SERVER; SEQUENCE; MUTATION; VARIANTS; DATABASE; CRYBA4	In order to provide a cost-effective method to narrow down the number of pathogenic Crystallin beta A4 (CRYBA4) non-synonymous single nucleotide polymorphisms (nsSNPs), we collected nsSNP information of the CRYBA4 gene from SNP databases and literature, predicting the pathogenicity and possible changes of protein properties and structures using multiple bioinformatics tools. The nsSNP data of the CRYBA4 gene were collected from 4 databases and published literature. According to 12 criteria, six bioinformatics tools were chosen to predict the pathogenicity. I-Mutant 2.0, Mupro and INPS online tools were used to analyze the effects of amino acid substitution on protein stability by calculating the value of Delta Delta G. ConSurf, SOPMA, GETAREA and HOPE online tools were used to predict the evolutionary conservation of amino acids, solvent accessible surface areas, and the physical and chemical properties and changes of protein structure. All 157 CRYBA4 nsSNPs were analyzed. Forty-four CRYBA4 high-risk pathogenic nsSNPs (predicted to be pathogenic by all six software tools) were detected out of the 157 CRYBA4 nsSNPs, four of which (c.283C>T, p.R95W; c.449T>A, p.V150D; c.475G>A, p.G159R; c.575G>C, p.R192P) should be focused on because of their high potential pathogenicity and possibility of changing protein properties. Thirty high-risk nsSNPs were predicted to cause a decrease of protein stability. Twenty-nine high-risk nsSNPs occurred in evolutionary conserved positions. Twenty-two high-risk nsSNPs occurred in the core of the protein. It is predicted that these high-risk pathogenic nsSNPs can cause changes in the physical and chemical properties of amino acids, resulting in structural changes of proteins and changes in the interactions between domains and other molecules, thus affecting the function of proteins. This study provides important reference value when narrowing down the number of pathogenic CRYBA4 nsSNPs and studying the pathogenesis of congenital cataracts. By using this method, we can easily find 44 high-risk pathogenic nsSNPs out of 157 CRYBA4 nsSNPs.	[Wang, Zhenyu; Huang, Chen; Lv, Huibin; Zhang, Mingzhou; Li, Xuemin] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China; [Wang, Zhenyu; Huang, Chen; Lv, Huibin; Zhang, Mingzhou; Li, Xuemin] Peking Univ, Hosp 3, Beijing Key Lab Restorat Damaged Ocular Nerve, Beijing, Peoples R China; [Huang, Chen] Peking Univ, Hosp 3, Med Res Ctr, Beijing, Peoples R China	Peking University; Peking University; Peking University	Li, XM (corresponding author), Peking Univ, Hosp 3, Dept Ophthalmol, Beijing, Peoples R China.; Li, XM (corresponding author), Peking Univ, Hosp 3, Beijing Key Lab Restorat Damaged Ocular Nerve, Beijing, Peoples R China.	lxmlxm66@sina.com		Li, Xuemin/0000-0001-7822-4694; Wang, Zhenyu/0000-0001-6458-3944; Li, Xuemin/0000-0002-4018-9974	National Science and Technology Major Project [2018ZX10101004]	National Science and Technology Major Project	This research was funded by National Science and Technology Major Project, grant number 2018ZX10101004. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguayo-Ortiz R, 2019, J PHYS CHEM B, V123, P5671, DOI 10.1021/acs.jpcb.9b01818; Arcanjo C, 2018, AQUAT TOXICOL, V200, P114, DOI 10.1016/j.aquatox.2018.04.012; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chen JJ, 2017, INVEST OPHTH VIS SCI, V58, P2207, DOI 10.1167/iovs.17-21469; Chen X, 2003, PHARMACOGENOMICS J, V3, P77, DOI 10.1038/sj.tpj.6500167; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Gill D, 2000, INVEST OPHTH VIS SCI, V41, P159; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Huang BY, 2010, EUR J MED GENET, V53, P347, DOI 10.1016/j.ejmg.2010.07.001; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kumar M, 2013, MOL VIS, V19, P2436; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Li JC, 2018, NUCLEIC ACIDS RES, V46, P7793, DOI 10.1093/nar/gky678; Li JY, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0828-0; Li WQ, 2019, EXP EYE RES, V186, DOI 10.1016/j.exer.2019.107712; Luxembourg B, 2015, THROMB RES, V135, P404, DOI 10.1016/j.thromres.2014.11.022; MORITZ C, 1987, P NATL ACAD SCI USA, V84, P7183, DOI 10.1073/pnas.84.20.7183; PEJAVER V, MUTPRED2 INFERRING M; Pichi F, 2016, DEV OPHTHALMOL, V57, P1, DOI 10.1159/000442495; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Santana A, 2011, ARQ BRAS OFTALMOL, V74, P136, DOI 10.1590/S0004-27492011000200016; Savojardo C, 2016, BIOINFORMATICS, V32, P2542, DOI 10.1093/bioinformatics/btw192; Sheeladevi S, 2016, EYE, V30, P1160, DOI 10.1038/eye.2016.156; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shiels A, 2017, EXP EYE RES, V156, P95, DOI 10.1016/j.exer.2016.06.011; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Sun WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100455; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Yi J, 2011, INT J OPHTHALMOL-CHI, V4, P422, DOI 10.3980/j.issn.2222-3959.2011.04.20; Zhai Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01182-9; Zhou GK, 2010, MOL VIS, V16, P1019	45	7	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227859	10.1371/journal.pone.0227859	http://dx.doi.org/10.1371/journal.pone.0227859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935276	Green Published, gold			2022-12-26	WOS:000534354100059
J	Brown, M; Zhang, WB; Yan, DY; Kenath, R; Le, L; Wang, H; Delitto, D; Ostrov, D; Robertson, K; Liu, C; Pham, K				Brown, Matthew; Zhang, Wanbin; Yan, Deyue; Kenath, Rajath; Le, Le; Wang, He; Delitto, Daniel; Ostrov, David; Robertson, Keith; Liu, Chen; Pham, Kien			The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC	PLOS ONE			English	Article							DOWN-REGULATION; CELL-DIVISION; CANCER CELLS; APOPTOSIS; EXPRESSION; PROTEIN; PHOSPHORYLATION; YM155; PROLIFERATION; IMMUNOTHERAPY	Treating pancreatic ductal adenocarcinoma (PDAC) remains a major hurdle in the field of oncology. Less than half of patients respond to frontline chemotherapy and the pancreatic tumor microenvironment limits the efficacy of immunotherapeutic approaches. Targeted therapies could serve as effective treatments to enhance the clinical response rate. One potential therapeutic target is survivin, a protein that is normally expressed during embryonic and fetal development and has a critical impact on cell cycle control and apoptosis. In adulthood, survivin is not present in most normal adult cells, but is significantly re-expressed in tumor tissues. In PDAC, elevated survivin expression is correlated with treatment resistance and lower patient survival, although the underlying mechanisms of survivin's action in this type of cancer is poorly understood. Using patient derived xenografts of PDAC and their corresponding primary pancreatic cancer lines (PPCL-46 and PPCL-LM1) possessing increased expression of survivin, we aimed to evaluate the therapeutic response of a novel survivin inhibitor, UFSHR, with respect to survivin expression and the tumorigenic characteristics of PDAC. Cell viability and apoptosis analyses revealed that repressing survivin expression by UFSHR or YM155, a well-known inhibitor of survivin, in PPCLs effectively reduces cell proliferation by inducing apoptosis. Tumor cell migration was also hindered following treatment with YM155 and UFSHR. In addition, both survivin inhibitors, particularly UFSHR, effectively reduced progression of PPCL-46 and PPCL-LM1 tumors, when compared to the untreated cohort. Overall, this study provides solid evidence to support the critical role of survivin in PDAC progression and proposes a novel survivin inhibitor UFSHR that can become an alternative strategy for this type of cancer.	[Brown, Matthew] Rutgers State Univ, Sch Arts & Sci, Dept Cell Biol & Neurosci, Piscataway, NJ USA; [Zhang, Wanbin; Yan, Deyue] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Shanghai, Peoples R China; [Kenath, Rajath; Le, Le; Wang, He; Liu, Chen; Pham, Kien] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ 08854 USA; [Wang, He; Liu, Chen; Pham, Kien] Rutgers State Univ, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07102 USA; [Delitto, Daniel] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Ostrov, David] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Robertson, Keith] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Robertson, Keith] Mayo Clin, Ctr Individualized Med, Rochester, MN USA	Rutgers State University New Brunswick; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; State University System of Florida; University of Florida; Mayo Clinic; Mayo Clinic	Liu, C; Pham, K (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ 08854 USA.; Liu, C; Pham, K (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07102 USA.	chen.liu@rutgers.edu; kien.pham@rutgers.edu	Zhang, Wanbin/I-1208-2013; le, le/AFS-7417-2022	Le, Le Thi Thu/0000-0002-1013-2328; Kenath, Rajath/0000-0003-3350-7484; Brown, Matthew/0000-0001-5832-4073; Wang, He/0000-0001-9736-8028; Delitto, Daniel/0000-0002-2838-5841				Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Danielpour D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47573-y; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Emens LA, 2015, CANCER IMMUNOL RES, V3, P436, DOI 10.1158/2326-6066.CIR-15-0064; Garg H, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0326-1; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; Gordon-Dseagu VL, 2018, INT J EPIDEMIOL, V47, P427, DOI 10.1093/ije/dyx232; Guo SC, 2017, WORLD J CLIN ONCOL, V8, P230, DOI 10.5306/wjco.v8.i3.230; Hansen JB, 2008, MOL CANCER THER, V7, P2736, DOI 10.1158/1535-7163.MCT-08-0161; Hattori M, 2001, CANCER LETT, V169, P155, DOI 10.1016/S0304-3835(01)00499-2; Huang JC, 2015, CANCER LETT, V366, P160, DOI 10.1016/j.canlet.2015.05.033; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kami K, 2005, SURGERY, V138, P299, DOI 10.1016/j.surg.2005.05.009; Kappler M, 2001, INT J CANCER, V95, P360, DOI 10.1002/1097-0215(20011120)95:6<360::AID-IJC1063>3.0.CO;2-1; Konduri S, 2009, MOL CANCER THER, V8, P533, DOI 10.1158/1535-7163.MCT-08-0405; Kreger BT, 2016, CANCERS, V8, DOI 10.3390/cancers8120111; Li DY, 2018, BIOMED REP, V8, P399, DOI 10.3892/br.2018.1077; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li YD, 2015, INT J CLIN EXP PATHO, V8, P1731; Lopez RA, 2007, ANTI-CANCER DRUG, V18, P933; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pavlidou A, 2014, WORLD J CLIN ONCOL, V5, P883, DOI 10.5306/wjco.v5.i5.883; Pham K, 2016, AM J PATHOL, V186, P1537, DOI 10.1016/j.ajpath.2016.02.009; Raj D, 2008, CARCINOGENESIS, V29, P194, DOI 10.1093/carcin/bgm219; Rauch A, 2014, BBA-REV CANCER, V1845, P202, DOI 10.1016/j.bbcan.2014.01.003; Retzer-Lidl M, 2007, INT J CANCER, V121, P66, DOI 10.1002/ijc.22619; Roy K, 2016, RECENT PAT ANTI-CANC, V11, P152, DOI 10.2174/1574892811666160229121815; Satoh K, 2001, CANCER, V92, P271, DOI 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Shima H, 2019, CANCER SCI, V110, P2378, DOI 10.1111/cas.14106; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Stebbing J, 2014, CANCER-AM CANCER SOC, V120, P2006, DOI 10.1002/cncr.28696; Tanioka M, 2011, CANCER CHEMOTH PHARM, V68, P505, DOI 10.1007/s00280-010-1506-7; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Wang HW, 2002, EMBO J, V21, P2602, DOI 10.1093/emboj/21.11.2602; Warsame R, 2012, EXPERT REV ANTICANC, V12, P1327, DOI [10.1586/ERA.12.115, 10.1586/era.12.115]; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Ye JQ, 2019, ONCOL REP, V41, P1169, DOI 10.3892/or.2018.6854; Zhang T, 2001, CANCER RES, V61, P8664	45	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226917	10.1371/journal.pone.0226917	http://dx.doi.org/10.1371/journal.pone.0226917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929540	gold, Green Published, Green Submitted			2022-12-26	WOS:000534352500022
J	Du, B; Xu, YM; Dong, HL; Li, Y; Wangid, J				Du, Bin; Xu, Yumei; Dong, Hailong; Li, Yan; Wangid, Jianming			Phanerochaete chrysosporium strain B-22, a nematophagous fungus parasitizing Meloidogyne incognita	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; BIOLOGICAL-CONTROL; TOXIC POLLUTANTS; TRICHODERMA; JAVANICA; SEQUENCE; PROTEASE; ENZYMES; INOCULA; CHITIN	The root-knot nematode Meloidogyne incognita has a wide host range and it is one of the most economically important crop parasites worldwide. Biological control has been a good approach for reducing M. incognita infection, for which many nematophagous fungi are reportedly applicable. However, the controlling effects of Phanerochaete chrysosporium strain B-22 are still unclear. In the present study we characterized the parasitism of this strain on M. incognita eggs, second-stage juveniles (J2), and adult females. The highest corrected mortality was 71.9% at 3 x 10(8) colony forming units (CFU) mL(-1) and the estimated median lethal concentration of the fungus was 0.96 x 10(8) CFU mL(-1). Two days after treatment with Phanerochaete chrysosporium strain B-22 eggshells were dissolved. A strong lethal effect was noted against J2, as the fungal spores developed in their body walls, germinated, and the resulting hyphae crossed the juvenile cuticle to dissolve it, thereby causing shrinkage and deformation of the juvenile body wall. The spores and hyphae also attacked adult females, causing the shrinkage and dissolution of their bodies and leakage of contents after five days. Greenhouse experiments revealed that different concentrations of the fungal spores effectively controlled M. incognita. In the roots, the highest inhibition rate for adult females, juveniles, egg mass, and gall index was 84.61%, 78.91%, 84.25%, and 79.48%, respectively. The highest juvenile inhibition rate was 89.18% in the soil. Phanerochaete chrysosporium strain B-22 also improved tomato plant growth, therefore being safe for tomato plants while effectively parasitizing M. incognita. This strain is thus a promising biocontrol agent against M. incognita.	[Du, Bin; Xu, Yumei; Dong, Hailong; Wangid, Jianming] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China; [Du, Bin; Li, Yan] Taiyuan Univ, Dept Hort, Taiyuan, Shanxi, Peoples R China	Shanxi Agricultural University; Taiyuan University	Wangid, J (corresponding author), Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China.	jm8wang@163.com		bin, du/0000-0001-9516-8049; Wang, Jianming/0000-0001-9923-1789	Shanxi Provincial Science and Technology Planning Project [20120311019-3, 20133054]; Key Research and Development Program Projects in Shanxi Province [201803D221004-2]; Basic Research Program of Shanxi Province [201801D221321]	Shanxi Provincial Science and Technology Planning Project; Key Research and Development Program Projects in Shanxi Province; Basic Research Program of Shanxi Province	This work was supported by the Shanxi Provincial Science and Technology Planning Project (Grant Nos. 20120311019-3, 20133054), The Key Research and Development Program Projects in Shanxi Province (Grant Nos. 201803D221004-2), and the Basic Research Program of Shanxi Province (Grant Nos. 201801D221321).	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Abo-Korah MS, 2017, EGYPT J BIOL PEST CO, V27, P111; Affokpon A, 2011, SOIL BIOL BIOCHEM, V43, P600, DOI 10.1016/j.soilbio.2010.11.029; Anastasiadis IA, 2008, CROP PROT, V27, P352, DOI 10.1016/j.cropro.2007.06.008; Ashraf Mohd. Shaikhul, 2005, Archives of Phytopathology and Plant Protection, V38, P227, DOI 10.1080/03235400500094498; BARRON GL, 1987, CAN J BOT, V65, P774, DOI 10.1139/b87-103; Bird DM, 2003, PHYSIOL MOL PLANT P, V62, P115, DOI 10.1016/S0885-5765(03)00045-6; BURDSALL H H JR, 1974, Mycotaxon, V1, P123; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; Castillo P, 2006, PLANT PATHOL, V55, P705, DOI 10.1111/j.1365-3059.2006.01400.x; Chen J, 1999, J NEMATOL, V31, P719; Ding X, 2000, INT J PARASITOL, V30, P77, DOI 10.1016/S0020-7519(99)00165-4; Dong HL, 2015, BIOL CONTROL, V83, P7, DOI 10.1016/j.biocontrol.2014.12.016; Eisenback J. D., 1985, An advanced treatise on Meloidogyne. Volume 1: Biology and control., P95; Goswami J, 2008, J ENVIRON SCI HEAL B, V43, P237, DOI 10.1080/03601230701771164; Herve V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147100; Hu L, 2016, J HAZARD MATER, V301, P106, DOI 10.1016/j.jhazmat.2015.08.060; Huang WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089717; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Iijima N, 2002, BIOSCI BIOTECH BIOCH, V66, P2083, DOI 10.1271/bbb.66.2083; Ismail A.E., 2014, INT J SUSTAIN AGR RE, V1, P39; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kadri T, 2017, J ENVIRON SCI, V51, P52, DOI 10.1016/j.jes.2016.08.023; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; KWOK OCH, 1992, J CHEM ECOL, V18, P127, DOI 10.1007/BF00993748; Li J, 2015, ANNU REV PHYTOPATHOL, V53, P67, DOI 10.1146/annurev-phyto-080614-120336; Li P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16125-7; Mantelin S, 2017, MOL PLANT PATHOL, V18, P3, DOI 10.1111/mpp.12394; Marin MV, 2017, CHIL J AGR RES, V77, P58, DOI 10.4067/S0718-58392017000100007; Marlin M, 2019, FORESTS, V10, DOI 10.3390/f10050404; Mittal N, 1995, CROP PROT, V14, P647, DOI 10.1016/0261-2194(95)00045-3; Okada H, 2005, NEMATOLOGY, V7, P843, DOI 10.1163/156854105776186424; Ray A, 2012, APPL MICROBIOL BIOT, V93, P2075, DOI 10.1007/s00253-012-3907-5; SASSER JN, 1983, ANNU REV PHYTOPATHOL, V21, P271, DOI 10.1146/annurev.py.21.090183.001415; Satou T, 2008, BIOL PHARM BULL, V31, P574, DOI 10.1248/bpb.31.574; Schwartz HT, 2007, NAT PROTOC, V2, P705, DOI 10.1038/nprot.2007.93; Sharon E, 2007, EUR J PLANT PATHOL, V118, P247, DOI 10.1007/s10658-007-9140-x; Shu-xia Xu, 2008, Yingyong Shengtai Xuebao, V19, P2480; Siddiqui ZA, 2009, J GEN PLANT PATHOL, V75, P144, DOI 10.1007/s10327-009-0154-4; Su YL, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0311-8; Tan Q, 2015, CHEMOSPHERE, V128, P21, DOI 10.1016/j.chemosphere.2014.12.088; Thorn Greg, 1993, Transactions of the Mycological Society of Japan, V34, P449; THORN RG, 1984, SCIENCE, V224, P76, DOI 10.1126/science.224.4644.76; Trifonova Zlatka, 2009, Estonian Journal of Ecology, V58, P47, DOI 10.3176/eco.2009.1.05; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Verdejo-Lucas S, 2002, J NEMATOL, V34, P405; Viaene NM, 2000, J NEMATOL, V32, P85; Wei BQ, 2009, BIOCONTROL SCI TECHN, V19, P859, DOI 10.1080/09583150903165636; Yan XN, 2011, J ZHEJIANG UNIV-SC B, V12, P219, DOI 10.1631/jzus.B1000165; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Zeng GM, 2012, ENVIRON SCI TECHNOL, V46, P7818, DOI 10.1021/es301006j; Zeng GM, 2007, BIORESOURCE TECHNOL, V98, P320, DOI 10.1016/j.biortech.2006.01.001; Zhang Shu-wu, 2013, Yingyong Shengtai Xuebao, V24, P2955	53	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0216688	10.1371/journal.pone.0216688	http://dx.doi.org/10.1371/journal.pone.0216688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LL9OC	31931510	gold, Green Published			2022-12-26	WOS:000531883400001
J	Moon, I; Lee, SY; Kim, HK; Han, KD; Kwak, S; Kim, M; Lee, HJ; Hwang, IC; Lee, H; Park, JB; Yoon, YE; Kim, YJ; Cho, GY				Moon, Inki; Lee, Seo-Young; Kim, Hyung-Kwan; Han, Kyung-Do; Kwak, Soongu; Kim, Minkwan; Lee, Hyun-Jung; Hwang, In-Chang; Lee, Heesun; Park, Jun-Bean; Yoon, Yeonyee E.; Kim, Yong-Jin; Cho, Goo-Yeong			Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study	PLOS ONE			English	Article							TASK-FORCE; DIAGNOSIS; MANAGEMENT	Temporal trends of the prevalence and incidence of hypertrophic cardiomyopathy (HCM) have not been well established in Asian populations. Using the Korean National Health Insurance Services database, we identified patients with a confirmed diagnosis of HCM between 2010 and 2016. The annual prevalence and incidence of HCM, and their clinical characteristics were investigated. The prevalence of HCM has increased from 0.016% (n = 6313) in 2010 to 0.031% (n = 13,035) in 2016. During a 7-year period, 13,229 patients were newly diagnosed with HCM. The incidence rate increased from 4.15 (per 100,000 personyears) in 2010 to 5.6 in 2016. The prevalence and incidence of HCM increased with age and peaked during the 70s, with male predominance in all age groups. Chest pain is the most frequent clinical presentation followed by shortness of breath and syncope. Hypertension and dyslipidemia were the two most common comorbidities. Heart failure and atrial fibrillation was diagnosed in about 1/3 and 1/4 of patients with HCM, respectively. The prevalence and incidence of HCM gradually increased from 2010 to 2016, possibly due to heightened recognition of the disease. Given the progressively high incidence of HCM with age and high prevalence of coexisting modifiable risk factors, continued efforts are required to increase awareness regarding HCM-related symptoms and potential complications.	[Moon, Inki; Lee, Seo-Young; Kim, Hyung-Kwan; Kwak, Soongu; Kim, Minkwan; Lee, Hyun-Jung; Park, Jun-Bean; Kim, Yong-Jin] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Han, Kyung-Do] Catholic Univ Korea, Dept Med Stat, Coll Med, Seoul, South Korea; [Hwang, In-Chang; Yoon, Yeonyee E.; Cho, Goo-Yeong] Seoul Natl Univ, Dept Cardiol, Cardiovasc Ctr, Bundang Hosp, Seongnam, Gyeonggi, South Korea; [Lee, Heesun] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, HK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	cardiman73@gmail.com	Moon, Inki/AAD-3163-2019; Hwang, In-Chang/K-8562-2012; Kim, Minkwan/AAD-4036-2022; Park, Jun-Bean/AAN-3026-2021	Moon, Inki/0000-0002-3404-3012; Hwang, In-Chang/0000-0003-4966-3924; Kim, Minkwan/0000-0002-4079-8219; Park, Jun-Bean/0000-0003-4053-8713; Kim, Hyung-Kwan/0000-0001-7950-2131; Kwak, Soongu/0000-0002-1798-7441	Actelion; GSK; Handok Pharm; Dae-Woong Pharm; Yuhan; Hanmi; ChongKunDang Pharm; Norvatis	Actelion; GSK(GlaxoSmithKline); Handok Pharm; Dae-Woong Pharm; Yuhan; Hanmi; ChongKunDang Pharm; Norvatis	Prof. Hyung-Kwan Kim (HK-K) reports research grants from Actelion, GSK, Handok Pharm, Dae-Woong Pharm, Yuhan, Hanmi, ChongKunDang Pharm and Norvatis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adabag AS, 2006, AM J CARDIOL, V98, P1507, DOI 10.1016/j.amjcard.2006.07.029; Cardim N, 2018, REV PORT CARDIOL, V37, P1, DOI 10.1016/j.repc.2017.08.005; Choi YJ, 2019, EUR HEART J, V40, P724, DOI 10.1093/eurheartj/ehy801; Choi YJ, 2018, INT J CARDIOL, V273, P130, DOI 10.1016/j.ijcard.2018.08.038; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Gersh BJ, 2011, CIRCULATION, V124, pE783, DOI 10.1161/CIR.0b013e318223e2bd; Geske JB, 2017, EUR HEART J, V38, P3434, DOI 10.1093/eurheartj/ehx527; Husser D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196612; Ingles J, 2017, CIRC CARDIOVASC GENE, V0; Kubo T, 2010, J CARDIOL, V56, P314, DOI 10.1016/j.jjcc.2010.07.004; Maron BJ, 2016, AM J CARDIOL, V117, P434, DOI 10.1016/j.amjcard.2015.11.013; Maron BJ, 2015, J AM COLL CARDIOL, V65, P1915, DOI 10.1016/j.jacc.2015.02.061; Maron BJ, 2014, J AM COLL CARDIOL, V64, P83, DOI 10.1016/j.jacc.2014.05.003; Maron BJ, 2012, AM J CARDIOL, V109, P1341, DOI 10.1016/j.amjcard.2011.12.027; Maron BJ, 2004, AM J CARDIOL, V93, P1510, DOI 10.1016/j.amjcard.2004.03.007; Maron BJ, 2003, J AM COLL CARDIOL, V42, P882, DOI 10.1016/S0735-1097(03)00855-6; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1999, J AM COLL CARDIOL, V33, P1590, DOI 10.1016/S0735-1097(99)00039-X; Maron MS, 2016, AM J CARDIOL, V117, P1651, DOI 10.1016/j.amjcard.2016.02.044; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Perez-Sanchez I, 2018, REV ESP CARDIOL, V71, P146, DOI [10.1016/j.rec.2017.06.002, 10.1016/j.recesp.2017.05.026]; Wu CS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001568	22	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227012	10.1371/journal.pone.0227012	http://dx.doi.org/10.1371/journal.pone.0227012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929538	Green Published, gold			2022-12-26	WOS:000534352500024
J	Saraiva, CWC; Cardoso, SC; Groppo, DP; De Salles, AAF; de Avila, LF; da Rosa, LAR				Chagas Saraiva, Crystian Wilian; Cardoso, Simone Coutinho; Groppo, Daniela Piai; Ferreira De Salles, Antonio Afonso; de Avila, Luiz Fernando; Ribeiro da Rosa, Luiz Antonio			Gamma Knife radiosurgery for vestibular schwannomas: Evaluation of planning using the sphericity degree of the target volume	PLOS ONE			English	Article								Introduction This study explores the possibility of a relationship between the sphericity degree of a target volume with the dose distribution. This relationship is evaluated based on the ratio isodose volume / target volume (IV/TV) and the metrics coverage, i.e., selectivity, gradient index, conformity index and mean dose when planning radiosurgery for vestibular schwannoma. Methods Sphericity degree (phi) was calculated for each target volume (TV) of 64 patients who underwent stereotactic radiosurgery (SRS) for vestibular schwannoma. The calculation of this parameter was developed using the theoretical definition for operational sphericity phi = V-P/V-CS. The values found are evaluated considering the following metrics:-Coverage (C), selectivity (S), gradient index (GI), Paddick conformity index (CIPaddick) and dose distribution (IV/TV). The planning was also carried out considering a spherical target volume defined in a spherical phantom. The spherical volume is the same as the target used in the treatment plan. The planning of the spherical target was considered as a reference plan to evaluate the dose distribution inside and outside the volume. Results It was possible to observe that the majority of target volumes has (phi) around 0,66-0,77, corresponding to 54,7% of the total. Considering the mean values for metrics, the results are: C = 0,98, S = 0,78, GI = 3,11 and CI = 0,81. The dose distribution was equivalent for treatment plans and reference plans. Quantitative analysis for IV/TV shows that these values are higher than 30% for treatment plans where shot density is large. Conclusion This study demonstrates that de sphericity degree (phi) can be related to the dose distribution (IV/TV). Therefore the sphericity degree is a good parameter to evaluate the dose distribution of a plan for vestibular schwannoma treatment, considering the reference plan as being a spherical target using a leksell gamma knife (R) perfexion (LGKP). This study shows that the sphericity degree offers important information of the dose distribution outside and inside the target volume. This is not evaluated by the other parameters already implemented as metric to analyzing the GKP plans.	[Chagas Saraiva, Crystian Wilian; Ribeiro da Rosa, Luiz Antonio] CNEN, Inst Radioprotec & Dosimetria, IRD, Comissao Nacl Energia Nucl, Rio De Janeiro, Brazil; [Chagas Saraiva, Crystian Wilian; Ferreira De Salles, Antonio Afonso] HCor, Hosp Coracao, Associac Sanat Sfrio, Sao Paulo, Brazil; [Cardoso, Simone Coutinho] Univ Fed Rio de Janeiro, UFRJ, Inst Fis, Rio De Janeiro, Brazil; [Groppo, Daniela Piai] CNEN, Inst Pesquisa Energet & Nucl, IPEN, Sao Paulo, Brazil; [de Avila, Luiz Fernando] Univ Estadual Campinas, Fac Tecnol, UNICAMP, Limeira, Brazil	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; Hospital do Coracao - HCor; Universidade Federal do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade Estadual de Campinas	Saraiva, CWC (corresponding author), CNEN, Inst Radioprotec & Dosimetria, IRD, Comissao Nacl Energia Nucl, Rio De Janeiro, Brazil.; Saraiva, CWC (corresponding author), HCor, Hosp Coracao, Associac Sanat Sfrio, Sao Paulo, Brazil.	crystian.saraiva@gmail.com	Cardoso, Simone/AAH-4274-2021; de Avila, Luis/AAI-6279-2021	de Avila, Luis/0000-0002-5763-8078; cardoso, simone/0000-0001-6216-202X				[Anonymous], 2011, ELEKTA           SEP; [Anonymous], 2011, ELEKTA           JUL; Johnson PB, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0919-4; Liscak R, 2000, RADIOSURG, V3, P205; NOREN G, 1993, ACTA NEUROCHIR, P104; Novotny J, 2009, MED PHYS, V36, P1768, DOI 10.1118/1.3113904; Osmancikova P, 2018, J APPL CLIN MED PHYS, V19, P138, DOI 10.1002/acm2.12238; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Paddick I, 2006, J NEUROSURG, V105, P194, DOI 10.3171/sup.2006.105.7.194; Rykaczewski B, 2014, WSPOLCZESNA ONKOL, V18, P60, DOI 10.5114/wo.2014.39840; SHAW E, 1993, INT J RADIAT ONCOL, V27, P1231, DOI 10.1016/0360-3016(93)90548-A; Wadell H, 1933, J GEOL, V41, P310, DOI 10.1086/624040; Wu A, 1992, Neurosurg Clin N Am, V3, P35; Wu QJ, 2004, RADIOSURG, V5, P260, DOI 10.1159/000078126	14	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0225638	10.1371/journal.pone.0225638	http://dx.doi.org/10.1371/journal.pone.0225638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923229	Green Submitted, Green Published, gold			2022-12-26	WOS:000534350000008
J	Epstein, D; Steinfeld, Y; Marcusohn, E; Ammouri, H; Miller, A				Epstein, Danny; Steinfeld, Yaniv; Marcusohn, Erez; Ammouri, Hanna; Miller, Asaf			Health care professionals' knowledge of commonly used sedative, analgesic and neuromuscular drugs: A single center (Rambam Health Care Campus), prospective, observational survey	PLOS ONE			English	Article							PAIN; VENTILATION; MANAGEMENT	Background Pain management and sedation are important aspects in the treatment of hospitalized patients, especially those mechanically ventilated. In many hospitals, such patients are treated not only in intensive care units, but also in other wards. In the nineteen eighties, numerous studies demonstrated a wide array of misconceptions and inadequate knowledge related to commonly used sedative, analgesics and muscle relaxants which may prevent appropriate treatment. Since these publications, multiple studies have shown that appropriate sedation and analgesia are associated with improved clinical outcomes, educational programs were developed and guidelines published. Whether the personnel's knowledge kept up with these changes is unknown. The aim of this study was to determine the current rate of misconceptions and knowledge gaps regarding commonly used sedative, analgesic and neuromuscular drugs. Methods In this prospective, observational, cross-sectional survey, a questionnaire was e-mailed to physicians and nurses routinely treating mechanically ventilated patients in Rambam Health Care Campus (Haifa, Israel). Results 355 questionnaires were returned. 82.54% knew that midazolam has no analgesic effect. 71-72% were familiar with the sedative effect of opiates. 27% believed that propofol has analgesic properties and 30.52% thought that rocuronium has a sedative effect. Conclusion Our findings demonstrate that although a lot has been done during the last decades in order to improve the treatment of critically ill patients, the rate of misconceptions regarding pharmacological characteristics of commonly used drugs is unacceptably high. We call for performance of similar surveys in other institutes and for immediate action to improve patients' care.	[Epstein, Danny; Marcusohn, Erez] Rambam Hlth Care Campus, Dept Internal Med B, Haifa, Israel; [Steinfeld, Yaniv] Rambam Hlth Care Campus, Orthoped Surg Div, Haifa, Israel; [Ammouri, Hanna; Miller, Asaf] Rambam Hlth Care Campus, Med Intens Care Unit, Haifa, Israel	Rambam Health Care Campus; Rambam Health Care Campus; Rambam Health Care Campus	Epstein, D (corresponding author), Rambam Hlth Care Campus, Dept Internal Med B, Haifa, Israel.	d_epstein@rambam.health.gov.il	steinfeld, yaniv/ABC-7911-2020	steinfeld, yaniv/0000-0001-5257-3087; Marcusohn, Erez/0000-0003-1004-0826				[Anonymous], 1981, Lancet, V1, P427; Braun AR, 2010, ANAESTH INTENS CARE, V38, P935, DOI 10.1177/0310057X1003800520; Brown TB, 2005, AM FAM PHYSICIAN, V71, P85; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Draugalis JR, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720111; Du Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182432; Hersch M, 2007, J CRIT CARE, V22, P13, DOI 10.1016/j.jcrc.2006.06.004; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Keon-Cohen Z, 2017, ANAESTH INTENS CARE, V45, P396, DOI 10.1177/0310057X1704500316; Kress JP, 2002, AM J RESP CRIT CARE, V166, P1024, DOI 10.1164/rccm.200204-270CC; LOPER KA, 1989, PAIN, V37, P315, DOI 10.1016/0304-3959(89)90196-6; Marino P.L., 2014, ICU BOOK; Martyn JAJ, 2019, NEW ENGL J MED, V380, P365, DOI 10.1056/NEJMra1800222; MILLERJONES CMH, 1980, ANAESTHESIA, V35, P1104, DOI 10.1111/j.1365-2044.1980.tb05052.x; Mohammadi E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197265; PAIEMENT B, 1979, CAN ANAESTH SOC J, V26, P173, DOI 10.1007/BF03006977; Patel SB, 2012, AM J RESP CRIT CARE, V185, P486, DOI 10.1164/rccm.201102-0273CI; Peterson RA., 2000, CONSTRUCTING EFFECTI, DOI 10.4135/9781483349022; Rockett M, 2017, ANAESTHESIA, V72, P1237, DOI 10.1111/anae.14007; Rowley P, 2017, BRIT J ANAESTH, V118, P486, DOI 10.1093/bja/aex040; Shehabi Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12679; Sigakis MJG, 2015, CRIT CARE MED, V43, P2468, DOI 10.1097/CCM.0000000000001256; Story DA, 2019, ANESTHESIOLOGY, V130, P192, DOI 10.1097/ALN.0000000000002436; Williams Cydni N, 2013, World J Crit Care Med, V2, P21, DOI 10.5492/wjccm.v2.i4.21	24	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227499	10.1371/journal.pone.0227499	http://dx.doi.org/10.1371/journal.pone.0227499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923236	Green Published, gold			2022-12-26	WOS:000534350000086
J	Liu, S; Fu, R; Li, GW				Liu, Shu; Fu, Rao; Li, Guangwu			Exploring the mechanism of olfactory recognition in the initial stage by modeling the emission spectrum of electron transfer	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THERMOCHEMISTRY; ENERGY DECOMPOSITION ANALYSIS; MOLECULAR-ORBITAL METHODS; VIBRATIONAL THEORY; CHARGE-TRANSPORT; MIDWAY MOLECULE; SUPEREXCHANGE; PHOTOSYNTHESIS; BACTERIORHODOPSIN; DYNAMICS	Olfactory sense remains elusive regarding the primary reception mechanism. Some studies suggest that olfaction is a spectral sense, the olfactory event is triggered by electron transfer (ET) across the odorants at the active sites of odorant receptors (ORs). Herein we present a Donor-Bridge-Acceptor model, proposing that the ET process can be viewed as an electron hopping from the donor molecule to the odorant molecule (Bridge), then hopping off to the acceptor molecule, making the electronic state of the odorant molecule change along with vibrations (vibronic transition). The odorant specific parameter, Huang-Rhys factor can be derived from ab initio calculations, which make the simulation of ET spectra achievable. In this study, we revealed that the emission spectra (after Gaussian convolution) can be acted as odor characteristic spectra. Using the emission spectrum of ET, we were able to reasonably interpret the similar bitter-almond odors among hydrogen cyanide, benzaldehyde and nitrobenzene. In terms of isotope effects, we succeeded in explaining why subjects can easily distinguish cyclopentadecanone from its fully deuterated analogue cyclopentadecanoned-28 but not distinguishing acetophenone from acetophenone-d8.	[Liu, Shu; Li, Guangwu] Anhui Med Univ, Dept Anat, Hefei, Anhui, Peoples R China; [Fu, Rao] Sun Yat Sen Univ, Sch Med, Dept Anat, Guangzhou, Guangdong, Peoples R China	Anhui Medical University; Sun Yat Sen University	Liu, S (corresponding author), Anhui Med Univ, Dept Anat, Hefei, Anhui, Peoples R China.	liushu@mail.sysu.edu.cn		Liu, Shu/0000-0002-6072-6036	Doctoral Scientific Research Foundation of Anhui medical university [0103028101]	Doctoral Scientific Research Foundation of Anhui medical university	This work was supported by Doctoral Scientific Research Foundation of Anhui medical university 0103028101 (Shu Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOORE JE, 1964, ANN NY ACAD SCI, V116, P457, DOI 10.1111/j.1749-6632.1964.tb45075.x; AMOORE JE, 1964, SCI AM, V210, P42, DOI 10.1038/scientificamerican0264-42; Becke AD, 1997, J CHEM PHYS, V107, P8554, DOI 10.1063/1.475007; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bittner ER, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767067; Bixon M, 1999, ADV CHEM PHYS, V106, P35, DOI 10.1002/9780470141656.ch3; Bixon M, 1997, J CHEM PHYS, V107, P5154, DOI 10.1063/1.474878; BIXON M, 1995, CHEM PHYS, V197, P389, DOI 10.1016/0301-0104(95)00168-N; Block E, 2015, P NATL ACAD SCI USA, V112, pE2766, DOI 10.1073/pnas.1503054112; Brookes JC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.038101; Brookes JC, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2016.0822; Brookes JC, 2012, SENSORS-BASEL, V12, P15709, DOI 10.3390/s121115709; Christophorou LG, 1984, ELECT MOL INTERACTIO; Drimyli E, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0152-15.2016; Duschinsky F, 1937, ACTA PHYSICOCHIM URS, V7, P551; Dykstra CE, 2005, THEORY APPL COMPUTIN; Dyson G. M., 1937, PERFUM ESSENT OIL RE, V28, P13; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Fedorov DG, 2018, J PHYS CHEM A, V122, P1781, DOI 10.1021/acs.jpca.7b12000; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Franco MI, 2011, P NATL ACAD SCI USA, V108, P3797, DOI 10.1073/pnas.1012293108; Frisch G. W., 2013, GAUSSIAN 09; Fukuzumi S, 2003, ORG BIOMOL CHEM, V1, P609, DOI 10.1039/b300053b; FULLMAN B, 1963, NATURE, V199, P912, DOI 10.1038/199912a0; Gane S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055780; Gm D., 1928, PERFUMERY ESSENT, V19, P456; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Green MC, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790616; Gronenberg W, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3089; Haffenden AM, 2001, CURR BIOL, V11, P177, DOI 10.1016/S0960-9822(01)00023-9; HAGLER TW, 1991, PHYS REV B, V44, P8652, DOI 10.1103/PhysRevB.44.8652; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Heifetz A, 2016, J CHEM INF MODEL, V56, P159, DOI 10.1021/acs.jcim.5b00644; Hettinger TP, 2011, P NATL ACAD SCI USA, V108, pE349, DOI 10.1073/pnas.1103992108; Hoehn RD, 2018, FRONT PHYS-LAUSANNE, V6, DOI 10.3389/fphy.2018.00025; Hoehn RD, 2017, P NATL ACAD SCI USA, V114, P5595, DOI 10.1073/pnas.1618422114; Hoehn RD, 2015, SCI REP-UK, V5, DOI 10.1038/srep09990; Horsfield AP, 2017, ADV PHYS-X, V2, P937, DOI 10.1080/23746149.2017.1378594; Illenberger E., 1992, GASEOUS MOL IONS; Iversen G, 1998, J BIOL INORG CHEM, V3, P229, DOI 10.1007/s007750050226; Jiang J, 2005, NANO LETT, V5, P1551, DOI 10.1021/nl050789h; JORTNER J, 1976, J CHEM PHYS, V64, P4860, DOI 10.1063/1.432142; Kanemoto K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235203; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keller A, 2004, NAT NEUROSCI, V7, P337, DOI 10.1038/nn1215; Kim Y, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.196804; KROGER A, 1978, FORTSCHR MED, V96, P2362; Kushmerick JG, 2004, NANO LETT, V4, P639, DOI 10.1021/nl049871n; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liu GK, 2003, MOL PHYS, V101, P1029, DOI 10.1080/0026897021000046889; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Malagoli M, 2000, CHEM PHYS LETT, V327, P13, DOI 10.1016/S0009-2614(00)00757-0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; May V., 2011, CHARGE ENERGY TRANSF; Mebel AM, 1999, J PHYS CHEM A, V103, P10674, DOI 10.1021/jp992429m; Mok DKW, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4811671; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; Moya PR, 2007, J PHARMACOL EXP THER, V321, P1054, DOI 10.1124/jpet.106.117507; Paoli M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21893; Paulson BP, 2005, J AM CHEM SOC, V127, P4860, DOI 10.1021/ja044946a; Paulsson M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.226604; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Petrov EG, 2001, J CHEM PHYS, V115, P7107, DOI 10.1063/1.1404389; Phipps MJS, 2015, CHEM SOC REV, V44, P3177, DOI 10.1039/c4cs00375f; Pope M., 1999, ELECT PROCESSES ORGA; Pshenichnyuk SA, 2018, J PHYS CHEM LETT, V9, P2320, DOI 10.1021/acs.jpclett.8b00704; Ray TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009019; Reese A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152345; Reimers JR, 2001, J CHEM PHYS, V115, P9103, DOI 10.1063/1.1412875; Saidani MA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.165315; Sando GM, 2001, J PHYS CHEM A, V105, P5326, DOI 10.1021/jp004230b; Schenkl S, 2006, P NATL ACAD SCI USA, V103, P4101, DOI 10.1073/pnas.0506303103; Schenkl S, 2005, SCIENCE, V309, P917, DOI 10.1126/science.1111482; Schumm S, 2000, J PHYS CHEM A, V104, P10648, DOI 10.1021/jp000187g; Sell CS, 2006, ANGEW CHEM INT EDIT, V45, P6254, DOI 10.1002/anie.200600782; Sell C, 2009, CHEM SENSES, V34, P181, DOI 10.1093/chemse/bjn069; Shreve AP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.037405; SLEIGH AK, 1986, J PHYS C SOLID STATE, V19, P6645, DOI 10.1088/0022-3719/19/33/013; Solov'yov IA, 2012, PHYS CHEM CHEM PHYS, V14, P13861, DOI 10.1039/c2cp41436h; SONG L, 1993, SCIENCE, V261, P891, DOI 10.1126/science.261.5123.891; Sumi H, 1996, CHEM PHYS LETT, V252, P85, DOI 10.1016/S0009-2614(96)00142-X; Sumi H, 1997, J ELECTROANAL CHEM, V438, P11, DOI 10.1016/S0022-0728(97)00023-5; Thijssen JM, 2008, PHYS STATUS SOLIDI B, V245, P1455, DOI 10.1002/pssb.200743470; Triller A, 2008, CHEM BIODIVERS, V5, P862, DOI 10.1002/cbdv.200890101; Troisi A, 2007, P NATL ACAD SCI USA, V104, P14255, DOI 10.1073/pnas.0704208104; Turin L, 2002, J THEOR BIOL, V216, P367, DOI 10.1006/jtbi.2001.2504; Turin L, 1996, CHEM SENSES, V21, P773, DOI 10.1093/chemse/21.6.773; Turin L, 2015, P NATL ACAD SCI USA, V112, pE3154, DOI 10.1073/pnas.1508035112; WAGNER M, 1964, J CHEM PHYS, V41, P3939, DOI 10.1063/1.1725839; WRIGHT RH, 1954, J APPL CHEM, V4, P615; WRIGHT RH, 1954, J APPL CHEM, V4, P611; Wright RH, 1956, CHEM IND, V37, P973; ZAKARYA D, 1993, J PHYS ORG CHEM, V6, P627, DOI 10.1002/poc.610061106; Zusman LD, 1999, J CHEM PHYS, V110, P10468, DOI 10.1063/1.478976	96	0	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0217665	10.1371/journal.pone.0217665	http://dx.doi.org/10.1371/journal.pone.0217665			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923248	Green Submitted, Green Published, gold			2022-12-26	WOS:000534350000003
J	Park, EJ; Jung, HJ; Choi, HJ; Jang, HJ; Park, HJ; Nejsum, LN; Kwon, TH				Park, Eui-Jung; Jung, Hyun Jun; Choi, Hyo-Jung; Jang, Hyo-Ju; Park, Hye-Jeong; Nejsum, Lene N.; Kwon, Tae-Hwan			Exosomes co-expressing AQP5-targeting miRNAs and IL-4 receptor-binding peptide inhibit the migration of human breast cancer cells	FASEB JOURNAL			English	Article						aquaporin-5; breast cancer; cell migration; exosome; miRNA	INTERLEUKIN-4 RECEPTOR; TARGETED DELIVERY; AQUAPORIN-5; KIDNEY; SUPPRESSION; BIOGENESIS; SURVIVAL; GROWTH; SIRNA; AQP5	Aquaporin-5 (AQP5) plays a role in breast cancer cell migration. This study aimed to identify AQP5-targeting miRNAs and examine their effects on breast cancer cell migration through exosome-mediated delivery. Bioinformatic analyses identified miR-1226-3p, miR-19a-3p, and miR-19b-3p as putative regulators of AQP5 mRNA. Immunoblotting revealed a decrease of AQP5 protein abundance when each of these miRNAs was transfected into human breast cancer MDA-MB-231 cells. Quantitative real-time PCR demonstrated the reduction of AQP5 mRNA expression by the transfection of miR-1226-3p and a luciferase reporter assay revealed the reduction of AQP5 translation after the transfection of miR-19b-3p in MDA-MB-231 cells. Consistently, the transfection of each miRNA impeded cell migration. Pathway enrichment analyses showed that these three miRNAs regulate target genes, which were predominantly enriched in the gap junction pathway. For the efficient delivery of AQP5-targeting miRNAs to breast cancer cells, exosomes expressing both miRNAs and a peptide targeting interleukin-4 receptor, which is highly expressed in breast cancer cells, were bioengineered and their inhibitory effects on AQP5 protein expression and cell migration were demonstrated in MDA-MB-231 cells. Taken together, AQP5-regulating miRNAs are identified, which could be exploited for the inhibition of breast cancer cell migration via the exosome-mediated delivery.	[Park, Eui-Jung; Choi, Hyo-Jung; Jang, Hyo-Ju; Park, Hye-Jeong; Kwon, Tae-Hwan] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Dongin Dong 101, Taegu 41944, South Korea; [Park, Eui-Jung; Jang, Hyo-Ju; Park, Hye-Jeong; Kwon, Tae-Hwan] Kyungpook Natl Univ, BK21 Plus KNU Biomed Convergence Program, Dept Biomed Sci, Sch Med, Taegu, South Korea; [Jung, Hyun Jun] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Nejsum, Lene N.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark	Kyungpook National University; Kyungpook National University; Johns Hopkins University; Aarhus University	Kwon, TH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Dongin Dong 101, Taegu 41944, South Korea.	thkwon@knu.ac.kr	Kwon, Tae-Hwan/ABA-1981-2020	Nejsum, Lene Niemann/0000-0003-4368-8821; Jung, Hyun Jun/0000-0003-0519-5858	National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology, Korea [2014R1A5A2009242, 2017R1D1A3B03036044]	National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology, Korea	This study was supported by the grant from the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, Information and Communication Technology, Korea (2014R1A5A2009242 and 2017R1D1A3B03036044).	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Benovic JL, 2004, CANCER CELL, V6, P429, DOI 10.1016/j.ccr.2004.10.017; Burt BM, 2012, CLIN CANCER RES, V18, P1568, DOI 10.1158/1078-0432.CCR-11-1808; Conlan RS, 2017, TRENDS MOL MED, V23, P636, DOI 10.1016/j.molmed.2017.05.003; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Delporte Christine, 2009, Handb Exp Pharmacol, P185, DOI 10.1007/978-3-540-79885-9_9; Donnarumma E, 2017, ONCOTARGET, V8, P19592, DOI 10.18632/oncotarget.14752; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Eitan E, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26373; Garcia-Manrique P, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2017.1422676; Guruprasath P, 2017, BIOMATERIALS, V142, P101, DOI 10.1016/j.biomaterials.2017.07.024; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Jensen HH, 2017, BIOCHEM BIOPH RES CO, V493, P1210, DOI 10.1016/j.bbrc.2017.09.125; Jensen HH, 2016, INT J BIOCHEM CELL B, V79, P271, DOI 10.1016/j.biocel.2016.09.005; Jiang BF, 2014, J GASTROENTEROL, V49, P1011, DOI 10.1007/s00535-013-0851-9; Jin CN, 2010, INT J ONCOL, V37, P61, DOI 10.3892/ijo_00000653; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028492; Kang SK, 2008, AM J PATHOL, V173, P518, DOI 10.2353/ajpath.2008.071198; Kawakami K, 2002, CANCER RES, V62, P3575; Kawakami M, 2002, CLIN CANCER RES, V8, P3503; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Kim JE, 2015, AM J PHYSIOL-RENAL, V308, pF749, DOI 10.1152/ajprenal.00334.2014; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Kooijmans SAA, 2012, INT J NANOMED, V7, P1525, DOI 10.2147/IJN.S29661; Kowal EJK, 2017, METHODS MOL BIOL, V1660, P143, DOI 10.1007/978-1-4939-7253-1_12; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lee SJ, 2014, ANN SURG ONCOL, V21, P375, DOI 10.1245/s10434-013-3317-7; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu Y, 2016, CANCER LETT, V370, P125, DOI 10.1016/j.canlet.2015.10.011; Login FH, 2019, FASEB J, V33, P6980, DOI 10.1096/fj.201802068RR; Marlar S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102106; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; Meldolesi J, 2018, CURR BIOL, V28, pR435, DOI 10.1016/j.cub.2018.01.059; Momen-Heravi F, 2014, NANOMED-NANOTECHNOL, V10, P1517, DOI 10.1016/j.nano.2014.03.014; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; OBIRI NI, 1994, CLIN EXP IMMUNOL, V95, P148; OBIRI NI, 1993, J CLIN INVEST, V91, P88, DOI 10.1172/JCI116205; Oh SH, 2019, FASEB J, V33, P7301, DOI 10.1096/fj.201802415RR; Ohno S, 2016, METHODS MOL BIOL, V1448, P261, DOI 10.1007/978-1-4939-3753-0_19; Oklinski MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122050; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Park EJ, 2018, AM J PHYSIOL-RENAL, V314, pF329, DOI 10.1152/ajprenal.00358.2017; Promeneur D, 2000, AM J PHYSIOL-RENAL, V279, pF370, DOI 10.1152/ajprenal.2000.279.2.F370; Ribatti D, 2014, BBA-GEN SUBJECTS, V1840, P1550, DOI 10.1016/j.bbagen.2013.09.025; Rodriguez GV, 2017, CANCER IMMUNOL RES, V5, P234, DOI 10.1158/2326-6066.CIR-16-0150; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Ruan K, 2009, CANCER LETT, V285, P116, DOI 10.1016/j.canlet.2009.04.031; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shahabipour F, 2017, J CELL PHYSIOL, V232, P1660, DOI 10.1002/jcp.25766; Skandalis SS, 2014, MATRIX BIOL, V35, P182, DOI 10.1016/j.matbio.2013.09.002; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Thomson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055214; Vadevoo MP, 2017, MOL CANCER THER, V16, P2803, DOI 10.1158/1535-7163.MCT-17-0339; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang H, 2016, ONCOL REP, V36, P2079, DOI 10.3892/or.2016.5029; Yin RT, 2018, INT J BIOCHEM CELL B, V97, P43, DOI 10.1016/j.biocel.2018.02.005; Yu G, 2013, MOL CELL BIOCHEM, V380, P239, DOI 10.1007/s11010-013-1679-6; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhu ZC, 2018, ONCOL LETT, V16, P2661, DOI 10.3892/ol.2018.8955	63	27	27	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3379	3398		10.1096/fj.201902434R	http://dx.doi.org/10.1096/fj.201902434R		JAN 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31922312				2022-12-26	WOS:000506612000001
J	Kim, JH; Ahn, JB; Kim, DH; Kim, S; Ma, HW; Che, X; Seo, DH; Kim, TI; Kim, WH; Cheon, JH; Kim, SW				Kim, Jae Hyeon; Ahn, Jae Bum; Kim, Da Hye; Kim, Soochan; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Kim, Tae Il; Kim, Won Ho; Cheon, Jae Hee; Kim, Seung Won			Glutathione S-transferase theta 1 protects against colitis through goblet cell differentiation via interleukin-22	FASEB JOURNAL			English	Article						dimerization; glutathione S-transferase theta 1; goblet cell; inflammatory bowel disease; interleukin 22	INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE STRESS; NULL GENOTYPE; GSTT1; POLYMORPHISMS; METAANALYSIS; HOMEOSTASIS; GSTM1; STAT3; SUSCEPTIBILITY	The enzyme glutathione S-transferase theta 1 (GSTT1) is involved in detoxifying chemicals, including reactive oxygen species (ROS). Here, we provide a significant insight into the role of GSTT1 in inflammatory bowel disease (IBD). We identified decreased expression of GSTT1 in inflamed colons from IBD patients compared to controls. We intrarectally or intraperitoneally delivered Gstt1 gene to mice with dextran sodium sulfate (DSS)-induced colitis and noted attenuation of colitis through gene transfer of Gstt1 via an IL-22 dependent pathway. Downregulation of GSTT1 by pathogen-associated molecular patterns (PAMPs) of microbes reduced innate defense responses and goblet cell differentiation. The GSTT1 mutation in intestinal epithelial cells (IECs) and IBD patients decreased its dimerization, which was connected to insufficient phosphorylation of signal transducer and activator of transcription-3 and p38/mitogen-activated protein kinase by their common activator, IL-22. GSTT1 ameliorated colitis and contributed as a modulator of goblet cells through sensing pathogens and host immune responses. Its mutations are linked to chronic intestinal inflammation due to its insufficient dimerization. Our results provide new insights into GSTT1 mutations that are linked to chronic intestinal inflammation due to its insufficient dimerization and their functional consequences in IBDs.	[Kim, Jae Hyeon; Kim, Da Hye; Kim, Soochan; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Kim, Tae Il; Kim, Won Ho; Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Kim, Jae Hyeon; Kim, Da Hye; Kim, Soochan; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Kim, Tae Il; Kim, Won Ho; Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Jae Hyeon; Ma, Hyun Woo; Che, Xiumei; Seo, Dong Hyuk; Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea; [Ahn, Jae Bum] Yonsei Univ, Coll Med, Dept Med, Seoul, South Korea; [Cheon, Jae Hee; Kim, Seung Won] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Cheon, JH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.; Kim, SW (corresponding author), Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, 50-1 Yonsei Ro, Seoul 03722, South Korea.	GENIUSHEE@yuhs.ac; swk21c@hanmail.net	Cheon, Jae Hee/B-4523-2015	Cheon, Jae Hee/0000-0002-2282-8904; Kim, Seung Won/0000-0002-1692-1192; Kim, Soochan/0000-0002-2577-2969; Kim, Won Ho/0000-0002-5682-9972; Kim, Tae Il/0000-0003-4807-890X; KIM, JAEHYEON/0000-0003-0064-6656	Ministry of Sicence, ICT, amp; Future Planning [NRF-2014R1A1A1008096, NRF-2017R1A1A1A05001011]; Korean government (MSIP) [NRF-2017R1A2B4001848]	Ministry of Sicence, ICT, amp; Future Planning; Korean government (MSIP)	The Ministry of Sicence, ICT, & Future Planning, Grant/Award Number: NRF-2014R1A1A1008096 and NRF-2017R1A1A1A05001011; the Korean government (MSIP), Grant/Award Number: NRF-2017R1A2B4001848	Ardesjo B, 2008, J AUTOIMMUN, V30, P273, DOI 10.1016/j.jaut.2007.11.008; ARNOLD JW, 1993, CELL IMMUNOL, V151, P336, DOI 10.1006/cimm.1993.1243; Aviello G, 2017, BRIT J PHARMACOL, V174, P1704, DOI 10.1111/bph.13428; Booth C., 2002, CULTURE EPITHELIAL C, P303, DOI DOI 10.1002/0471221201.CH10; Boutouja F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010018; Broekman MMTJ, 2014, J HUM GENET, V59, P575, DOI 10.1038/jhg.2014.77; BURDON RH, 1989, FREE RADICAL RES COM, V7, P149, DOI 10.3109/10715768909087937; Butturini E, 2014, ACS CHEM BIOL, V9, P1885, DOI 10.1021/cb500407d; Butturini E, 2013, FREE RADICAL BIO MED, V65, P1322, DOI 10.1016/j.freeradbiomed.2013.09.015; Cobo ER, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00905-16; Deakin M, 1996, CARCINOGENESIS, V17, P881, DOI 10.1093/carcin/17.4.881; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Ebert MN, 2001, NUTR CANCER, V41, P156, DOI 10.1207/S15327914NC41-1&amp;2_22; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Garama DJ, 2015, MOL CELL BIOL, V35, P3646, DOI 10.1128/MCB.00541-15; Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hu SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159758; Ito M, 2011, AGING-US, V3, P1213, DOI 10.18632/aging.100418; Juronen E, 1996, BIOCHEM MOL BIOL INT, V39, P21; Keshavarzian A, 2003, GUT, V52, P720, DOI 10.1136/gut.52.5.720; King SJ, 2019, INTEST RES, V17, P177, DOI 10.5217/ir.2018.00170; Liang SQ, 2013, RESPIROLOGY, V18, P774, DOI 10.1111/resp.12097; Luo Z, 2019, AM J PHYSIOL-CELL PH, V316, pC198, DOI 10.1152/ajpcell.00256.2018; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Marcos M, 2011, ALIMENT PHARM THER, V34, P1159, DOI 10.1111/j.1365-2036.2011.04862.x; Masoodi TA, 2012, GENOMICS, V99, P330, DOI 10.1016/j.ygeno.2012.04.006; Menon D, 2014, FREE RADICAL BIO MED, V73, P318, DOI 10.1016/j.freeradbiomed.2014.05.020; Miner-Williams WM, 2016, NUTR RES REV, V29, P40, DOI 10.1017/S0954422416000019; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Qian J, 2017, CELL PHYSIOL BIOCHEM, V41, P2545, DOI 10.1159/000475978; Ren HT, 2018, J SURG RES, V222, P39, DOI 10.1016/j.jss.2017.09.041; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Turner JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003698; Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003; Wells JM, 2017, AM J PHYSIOL-GASTR L, V312, pG171, DOI 10.1152/ajpgi.00048.2015; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089302; Yang YC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087749, 10.1371/journal.pone.0100677, 10.1371/journal.pone.0085863, 10.1371/journal.pone.0102942]; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.588	51	9	9	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3289	3304		10.1096/fj.201902421R	http://dx.doi.org/10.1096/fj.201902421R		JAN 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916636				2022-12-26	WOS:000506442800001
J	Muto, Y; Miyoshi, H; Kaneko, H				Muto, Yumiko; Miyoshi, Hideka; Kaneko, Hirohiko			Eye-gaze information input based on pupillary response to visual stimulus with luminance modulation	PLOS ONE			English	Article							LIGHT; SIZE; REFLEX	This study develops an information-input interface in which a visual stimulus targeted by a user's eye gaze is identified based on the pupillary light reflex to periodic luminance modulations of the object. Experiment 1 examines how pupil size changes in response to periodic luminance modulation of visual stimuli, and the results are used to develop an algorithm for information input. Experiment 2a examines the effectiveness of interfaces with two objects. The results demonstrate that 98% accurate identification of the gaze targeted object is possible if the luminance modulation frequencies of two objects differ by at least 0.12 Hz. Experiment 2b examines the accuracy of a gaze directed information input method based on a keyboard configuration with twelve responses. The results reveal that keyboard input is possible with an average accuracy of 85% for luminance modulation frequencies from 0.75 to 2.75 Hz. The proposed pupillometry based information-input interface offers several advantages, such as low burden on users, minimal invasiveness, no need for training or experience, high theoretical validity, and no need for calibration. Thus, the pupillometry method presented herein has advantages for practical use without requiring the eye's position to be calibrated. Additionally, this method has a potential for the design of interfaces that allow patients with severely limited motor function to communicate with others.	[Muto, Yumiko; Miyoshi, Hideka; Kaneko, Hirohiko] Tokyo Inst Technol, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan; [Muto, Yumiko] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan	Tokyo Institute of Technology	Muto, Y; Kaneko, H (corresponding author), Tokyo Inst Technol, Dept Informat & Commun Engn, Yokohama, Kanagawa, Japan.; Muto, Y (corresponding author), Tamagawa Univ, Brain Sci Inst, Tokyo, Japan.	muto@lab.tamagawa.ac.jp; kaneko.h.ab@m.titech.ac.jp			Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST)	Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST)	This research was supported by Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP) from Japan Science and Technology Agency (JST).	Ahlstrom U, 2006, INT J IND ERGONOM, V36, P623, DOI 10.1016/j.ergon.2006.04.002; ALEXANDRIDIS E, 1977, A GRAEF ARCH KLIN EX, V202, P175, DOI 10.1007/BF00407866; Barbur JL, 2004, CLIN NEUROPHYSIOL, V115, P2650, DOI 10.1016/j.clinph.2004.05.022; Barbur JL, 1995, BASIC AND CLINICAL PERSPECTIVES IN VISION RESEARCH, P3; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; BOUMA H, 1962, NATURE, V193, P690, DOI 10.1038/193690a0; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Calcagnini G, 1997, COMPUT CARDIOL, V24, P133, DOI 10.1109/CIC.1997.647848; Crawford BH, 1936, PROC R SOC SER B-BIO, V121, P376, DOI 10.1098/rspb.1936.0072; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; HASEGAWA S, 1989, Nippon Ganka Gakkai Zasshi, V93, P955; KAY SM, 1981, P IEEE, V69, P1380, DOI 10.1109/PROC.1981.12184; LOEWENFELD I. E., 1958, DOCUMENTA OPHTHALMOL, V12, P185, DOI 10.1007/BF00913471; Loewenfeld I.E., 1993, PUPIL ANATOMY PHYSL; Mathot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148805; Mathot S, 2015, CURR DIR PSYCHOL SCI, V24, P374, DOI 10.1177/0963721415593725; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; Matsuda K., 2017, INT C HUMAN COMPUTER, P593; Moro S, 2004, THESIS; Muto Y, 2018, HUM INT S HI2018 D, V25; MYERS GA, 1993, BIOL CYBERN, V68, P235, DOI 10.1007/BF00224857; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; Oliva M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23265-x; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Reeves P, 1920, J OPT SOC AM, V4, P35, DOI 10.1364/JOSA.4.000035; Silva B, 2016, J OPT SOC AM A, V33, P1546, DOI 10.1364/JOSAA.33.001546; Stoll J, 2013, CURR BIOL, V23, pR647, DOI 10.1016/j.cub.2013.06.011; Teukolsky SA, 1992, NUMERICAL RECIPES C; Van Orden KF, 2001, HUM FACTORS, V43, P111, DOI 10.1518/001872001775992570; WOODHOUSE JM, 1975, VISION RES, V15, P649, DOI 10.1016/0042-6989(75)90279-5; WOODHOUSE JM, 1975, VISION RES, V15, P645, DOI 10.1016/0042-6989(75)90278-3; YOSHIDA H, 1994, METHOD INFORM MED, V33, P46; Yoshida H., 1995, IEEE 17 ANN C ENG ME, V1, P165; Zangemeister WH, 2009, NEUROL INT, V1, P65, DOI 10.4081/ni.2009.e19	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0226991	10.1371/journal.pone.0226991	http://dx.doi.org/10.1371/journal.pone.0226991			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5ER	31917794	Green Published, gold			2022-12-26	WOS:000534341100011
J	Sescleifer, AM; Francoisse, CA; Webber, JC; Rector, JD; Lin, AY				Sescleifer, Anne M.; Francoisse, Caitlin A.; Webber, Janna C.; Rector, Jeffrey D.; Lin, Alexander Y.			Transforming assessment of speech in children with cleft palate via online crowdsourcing	PLOS ONE			English	Article							RATINGS; PATHOLOGISTS; SURGERY	Objective Speech intelligibility is fundamental to social interactions and a critical surgical outcome in patients with cleft palate. Online crowdsourcing is a burgeoning technology, with potential to mitigate the burden of limited accessibility to speech-language-pathologists (SLPs). This pilot study investigates the concordance of online crowdsourced evaluations of hypernasality with SLP ratings of children with cleft palate. Methods Six audio-phrases each from children with cleft palate were assessed by online crowdsourcing using Amazon Mechanical Turk (MTurk), and compared to SLP's gold-standard hypernasality score on the Pittsburgh Weighted Speech Score (PWSS). Phrases were presented to MTurk crowdsourced lay-raters to assess hypernasality on a Likert scale analogous to the PWSS. The survey included clickable reference audio samples for different levels of hypernasality. Results 1,088 unique online crowdsourced speech ratings were collected on 16 sentences of 3 children with cleft palate aged 4-8 years, with audio averaging 6.5 years follow-up after cleft palate surgery. Patient 1 crowd-mean was 2.62 (SLP rated 2-3); Patient 2 crowd-mean 2.66 (SLP rated 3); and Patient 3 crowd-mean 1.76 (SLP rated 2). Rounded for consistency with PWSS scale, all patients matched SLP ratings. Different sentences had different accuracies compared to the SLP gold standard scores. Conclusion Online crowdsourced ratings of hypernasal speech in children with cleft palate were concordant with SLP ratings, predicting SLP scores in all 3 patients. This novel technology has potential for translation in clinical speech assessments, and may serve as a valuable screening tool for non-experts to identify children requiring further assessment and intervention by a qualified speech language pathology expert.	[Sescleifer, Anne M.; Francoisse, Caitlin A.; Lin, Alexander Y.] St Louis Univ, Sch Med, Div Plast Surg, St Louis, MO 63103 USA; [Webber, Janna C.; Lin, Alexander Y.] SLU, SSM Hlth Cardinal Glennon Childrens Hosp, St Louis Cleft Craniofacial Ctr, Div Pediat Plast Surg, St Louis, MO 63103 USA; [Rector, Jeffrey D.] Rector Consulting, San Francisco, CA USA	Saint Louis University; Saint Louis University	Lin, AY (corresponding author), St Louis Univ, Sch Med, Div Plast Surg, St Louis, MO 63103 USA.; Lin, AY (corresponding author), SLU, SSM Hlth Cardinal Glennon Childrens Hosp, St Louis Cleft Craniofacial Ctr, Div Pediat Plast Surg, St Louis, MO 63103 USA.	Alexander.Lin@Health.SLU.edu		Lin, Alexander/0000-0003-4599-7230	Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship	Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship	This work was supported in part by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship. There was no additional external funding received for this study.	Abbott MA, 2014, PEDIATR REV, V35, P177, DOI 10.1542/pir.35-5-177; [Anonymous], 2016, 12 AM CLETT PAL CRA; BAGNALL AD, 1988, BRIT J PLAST SURG, V41, P488, DOI 10.1016/0007-1226(88)90005-7; Brunnegard K, 2009, INT J LANG COMM DIS, V44, P656, DOI 10.1080/13682820802295203; Lewis KE, 2003, J COMMUN DISORD, V36, P49, DOI 10.1016/S0021-9924(02)00134-X; Lohmander A, 2004, CLEFT PALATE-CRAN J, V41, P64, DOI 10.1597/02-136; McNaney R OM, 2016, CHI C HUM FACT COMP; McWilliams BJ, 1979, VELOPHARYNGEAL INCOM; Naran S, 2017, PLAST RECONSTR SURG, V139, p1343E, DOI 10.1097/PRS.0000000000003335; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Reilly S, 2016, J PAEDIATR CHILD H, V52, P1057, DOI 10.1111/jpc.13318; Sescleifer AM, 2018, J SURG RES, V232, P351, DOI 10.1016/j.jss.2018.06.032; STARR CD, 1984, CLEFT PALATE J, V21, P286; Tonz M, 2002, FOLIA PHONIATR LOGO, V54, P288, DOI 10.1159/000066153; Witt PD, 1996, PLAST RECONSTR SURG, V98, P958, DOI 10.1097/00006534-199611000-00005	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227686	10.1371/journal.pone.0227686	http://dx.doi.org/10.1371/journal.pone.0227686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917818	Green Published, gold			2022-12-26	WOS:000534341100033
J	Zhang, CF; Huang, H; Chen, Z; Zhang, ZY; Lu, WW; Qiu, MS				Zhang, Chengfu; Huang, Hao; Chen, Zhen; Zhang, Zunyi; Lu, Wenwen; Qiu, Mengsheng			The transcription factor NKX2-2 regulates oligodendrocyte differentiation through domain-specific interactions with transcriptional corepressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oligodendrocyte; neurobiology; neurodifferentiation; neurodevelopment; genetics; chicken; differentiation; electroporation; oligodendrocyte; spinal cord	SPINAL-CORD; NK-2 HOMEODOMAIN; GENERATION; ORIGIN; MYELIN; DNA; PROGENITORS; EXPRESSION; REPRESSION; BINDING	The homeodomain protein NK2 homeobox 2 (NKX2-2) is a transcription factor that plays a critical role in the control of cell fate specification and differentiation in many tissues. In the developing central nervous system, this developmentally important transcription factor functions as a transcriptional repressor that governs oligodendrocyte (OL) differentiation and myelin gene expression, but the roles of various NKX2-2 structural domains in this process are unclear. In this study, using in situ hybridization, immunofluorescence, and coimmunoprecipitation, we determined the structural domains that mediate the repressive functions of murine NKX2-2 and identified the transcriptional corepressors that interact with it in OL cells. Through in ovo electroporation in embryonic chicken spinal cords, we demonstrate that the N-terminal Tinman domain and C-terminal domain synergistically promote OL differentiation by recruiting distinct transcriptional corepressors, including enhancer of split Groucho 3 (GRG3), histone deacetylase 1 (HDAC1), and DNA methyltransferase 3 ? (DNMT3A). We also observed that the NK2-specific domain suppresses the function of the C-terminal domain in OL differentiation. These findings delineate the distinct NKX2-2 domains and their roles in OL differentiation and suggest that NKX2-2 regulates differentiation by repressing gene expression via multiple cofactors and molecular mechanisms.	[Zhang, Chengfu; Qiu, Mengsheng] Zhejiang Univ, Coll Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China; [Zhang, Chengfu; Huang, Hao; Chen, Zhen; Zhang, Zunyi; Lu, Wenwen; Qiu, Mengsheng] Hangzhou Normal Univ, Inst Life Sci, Key Lab Organ Dev & Regenerat Zhejiang Prov, 16 Xuelin St, Hangzhou 311121, Peoples R China	Zhejiang University; Hangzhou Normal University	Qiu, MS (corresponding author), Zhejiang Univ, Coll Life Sci, 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China.; Qiu, MS (corresponding author), Hangzhou Normal Univ, Inst Life Sci, Key Lab Organ Dev & Regenerat Zhejiang Prov, 16 Xuelin St, Hangzhou 311121, Peoples R China.	m0qiu001@yahoo.com			National Natural Science Foundation of China [31572224, 31771621, 31900703]; Natural Science Founda-tion of Zhejiang Province [LQ15C070001, LQ19C090001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Founda-tion of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grants 31572224, 31771621, and 31900703 and Natural Science Founda-tion of Zhejiang Province Grants LQ15C070001 and LQ19C090001. The authors declare that they have no conflicts of interest with the contents of this article.	Bercury KK, 2015, DEV CELL, V32, P447, DOI 10.1016/j.devcel.2015.01.016; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Chandran S, 1998, GLIA, V24, P382, DOI 10.1002/(SICI)1098-1136(199812)24:4<382::AID-GLIA3>3.0.CO;2-5; CHEN CY, 1995, J BIOL CHEM, V270, P15628, DOI 10.1074/jbc.270.26.15628; Chen HM, 2018, J CANCER, V9, P3067, DOI 10.7150/jca.26382; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Egawa N, 2019, GLIA, V67, P718, DOI 10.1002/glia.23567; Fu H, 2002, DEVELOPMENT, V129, P681; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; He L, 2013, NEUROSCI BULL, V29, P129, DOI 10.1007/s12264-013-1318-y; Hervouet E, 2009, EPIGENETICS-US, V4, P487, DOI 10.4161/epi.4.7.9883; Hessabi B, 2000, BIOCHEM BIOPH RES CO, V270, P695, DOI 10.1006/bbrc.2000.2491; Huang H, 2018, J NEUROSCI, V38, P9829, DOI 10.1523/JNEUROSCI.0154-18.2018; Huang H, 2013, NEUROSCI BULL, V29, P155, DOI 10.1007/s12264-013-1314-2; Ishii A, 2014, J NEUROSCI, V34, P16031, DOI 10.1523/JNEUROSCI.3360-14.2014; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Moyon S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0336-16.2017; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; Qi YC, 2001, DEVELOPMENT, V128, P2723; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Soula C, 2001, DEVELOPMENT, V128, P1369; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; TSAO DHH, 1994, BIOCHEMISTRY-US, V33, P15053, DOI 10.1021/bi00254a014; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Wei Q, 2005, J BIOL CHEM, V280, P16284, DOI 10.1074/jbc.M500491200; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhu Q, 2014, DEVELOPMENT, V141, P548, DOI 10.1242/dev.095323	34	9	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1879	1888		10.1074/jbc.RA119.011163	http://dx.doi.org/10.1074/jbc.RA119.011163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31932307	hybrid, Green Published			2022-12-26	WOS:000517128200009
J	Cordovilla-Guardia, S; Molina, TB; Franco-Antonio, C; Santano-Mogena, E; Vilar-Lopez, R				Cordovilla-Guardia, Sergio; Bautista Molina, Tania; Franco-Antonio, Cristina; Santano-Mogena, Esperanza; Vilar-Lopez, Raquel			Association of benzodiazepines, opioids and tricyclic antidepressants use and falls in trauma patients: Conditional effect of age	PLOS ONE			English	Article							PSYCHOTROPIC-DRUGS; ELDERLY-PEOPLE; OLDER-PEOPLE; INJURY; HEALTH; RISK; MEDICATION; FRACTURES; OBESITY; BURDEN	Introduction The relationship between benzodiazepines, opioids and tricyclic antidepressants and trauma is of great importance because of increased consumption and the growing evidence of a positive association among older adults. The objective of this study was to determine the effect size of the association between the consumption of psychotropic medications/opioids and falls in patients who have suffered trauma by studying the role of other variables in this relationship. Method From 2011 to 2016, the presence of benzodiazepines, opioids and tricyclic antidepressants and other drugs in 1060 patients admitted for trauma at a level I trauma hospital was analysed. Multivariate models were used to measure the adjusted effect size of the association between consumption of benzodiazepines, opioids and tricyclic antidepressants and falls, and the effect of age on this association was studied. Results A total of 192 patients tested positive for benzodiazepines, opioids and tricyclic antidepressants, with same-level falls being the most frequent mechanism of injury in this group (40.1%), with an odds ratio of 1.96 (1.40-2.75), p < 0.001. Once other covariates were introduced, this association was not observed, leaving only age, gender (woman) and, to a lesser extent, sensory conditions as variables associated with falls. Age acted as an effect modifier between benzodiazepines, opioids and tricyclic antidepressants and falls, with significant effect sizes starting at 51.9 years of age. Conclusions The association between the consumption of benzodiazepines, opioids and tricyclic antidepressants and falls in patients admitted for trauma is conditioned by other confounding variables, with age being the most influential confounding variable.	[Cordovilla-Guardia, Sergio; Franco-Antonio, Cristina; Santano-Mogena, Esperanza] Univ Extremadura, Nursing & Occupat Therapy Coll, Nursing Dept, Caceres, Spain; [Cordovilla-Guardia, Sergio; Franco-Antonio, Cristina; Santano-Mogena, Esperanza] Univ Extremadura, Hlth & Care Res Grp GISyC, Caceres, Spain; [Bautista Molina, Tania] Hosp Univ Virgen de las Nieves, Granada, Spain; [Vilar-Lopez, Raquel] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Vilar-Lopez, Raquel] Andalusian Observ Drugs & Addict, Granada, Spain	Universidad de Extremadura; Universidad de Extremadura; Hospital Universitario Virgen de las Nieves; University of Granada	Cordovilla-Guardia, S (corresponding author), Univ Extremadura, Nursing & Occupat Therapy Coll, Nursing Dept, Caceres, Spain.; Cordovilla-Guardia, S (corresponding author), Univ Extremadura, Hlth & Care Res Grp GISyC, Caceres, Spain.	cordovilla@unex.es	Antonio, Cristina Franco/AAL-1752-2020; Alser, Osaid/P-5509-2017; Sergio, Cordovilla-Guardia/I-7268-2019; Mogena, Santano/AAD-9756-2022; Vilar Lopez, Raquel/I-7847-2016	Antonio, Cristina Franco/0000-0001-8427-2836; Alser, Osaid/0000-0001-6743-803X; Sergio, Cordovilla-Guardia/0000-0001-7651-5017; Vilar Lopez, Raquel/0000-0001-9639-0143	Programa Operativo FEDER Extremadura (2014-2020) y Fondo Europeo Desarrollo Regional (FEDER) Grant [GR18146]; 4IE+ project - Interreg V-A Espana-Portugal (POCTEP) 20142020 program [0499_4IE_PLUS_4_E]	Programa Operativo FEDER Extremadura (2014-2020) y Fondo Europeo Desarrollo Regional (FEDER) Grant; 4IE+ project - Interreg V-A Espana-Portugal (POCTEP) 20142020 program	The members of the GISyC group (SCG, CFA and ESM) are funded by "Programa Operativo FEDER Extremadura (2014-2020) y Fondo Europeo Desarrollo Regional (FEDER) Grant number: GR18146. This work was supported by 4IE+ project (0499_4IE_PLUS_4_E) funded by the Interreg V-A Espana-Portugal (POCTEP) 20142020 program.; This work was supported by 4IE+ project (0499_4IE_PLUS_4_E) funded by the Interreg V-A Espana-Portugal (POCTEP) 2014-2020 program.	Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Athanasopoulos C, 2013, BASIC CLIN PHARMACOL, V112, P55, DOI 10.1111/j.1742-7843.2012.00920.x; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Romero FB, 2008, ATEN PRIM, V40, P617, DOI 10.1016/S0212-6567(08)75695-6; Berlowitz DR, 2014, J GEN INTERN MED, V29, P1577, DOI 10.1007/s11606-014-3016-5; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Boeuf-Cazou O, 2010, PHARMACOEPIDEM DR S, V19, P296, DOI 10.1002/pds.1911; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Cordovilla-Guardia S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203963; Curkovic M, 2016, PSYCHIAT DANUB, V28, P13; Dowrick C, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7140; Drummer OH, 2012, FORENSIC SCI INT, V215, P14, DOI 10.1016/j.forsciint.2011.01.040; Du Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182432; Garcia MAF, 2018, J PHARM POLICY PRACT, V11, DOI 10.1186/s40545-017-0128-4; Gebara MA, 2014, J AM GERIATR SOC, V62, P1434, DOI 10.1111/jgs.12945; Gonzalez-Cocina E, 2007, REV ESPANOLA CARD SC, V7, P37, DOI DOI 10.1016/S1131-3587(07)75248-2; Griesler PC, 2019, AM J PUBLIC HEALTH, V109, P1258, DOI [10.2105/AJPH.2019.305162, 10.2105/ajph.2019.305162]; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2017, BEHAV RES THER, V98, P39, DOI 10.1016/j.brat.2016.11.001; Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000; Himes CL, 2012, J AM GERIATR SOC, V60, P124, DOI 10.1111/j.1532-5415.2011.03767.x; Ishii S, 2014, J BONE MINER RES, V29, P2561, DOI 10.1002/jbmr.2303; John A, 2015, J AFFECT DISORDERS, V183, P134, DOI 10.1016/j.jad.2015.05.002; Johnell K, 2017, INT J GERIATR PSYCH, V32, P414, DOI 10.1002/gps.4483; Klein D, 2013, BMC GERIATR BMC GERI, V13, P1, DOI [10.1186/1471-2318-13-1, DOI 10.1186/1471-2318-13-1]; Margolis KL, 2014, J GEN INTERN MED, V29, P1599, DOI 10.1007/s11606-014-2961-3; Martinez-Cengotitabengoa M, 2018, REV PSIQUIATR SALUD, V11, P12, DOI 10.1016/j.rpsm.2017.01.004; Maust DT, 2017, J CLIN PSYCHIAT, V78, pE363, DOI 10.4088/JCP.16m10713; Ministerio de Sanidad Servicios Sociales e Igualdad, 2015, ENC ALC DROG POBL GE; Moore EE, 2005, J TRAUMA, V59, pS53, DOI 10.1097/01.ta.0000174868.13616.67; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Novak SP, 2016, BMC PSYCHIATRY, P1, DOI [10.1186/s12888-015-0706-4, DOI 10.1186/S12888-015-0706-4]; Palmer KT, 2014, OCCUP ENVIRON MED, V71, P308, DOI 10.1136/oemed-2013-101948; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; Pratt NL, 2014, DRUG SAFETY, V37, P529, DOI 10.1007/s40264-014-0179-2; Escamez FR, 2013, ACTAS ESP PSIQUIATRI, V41, P232; Sheehan KJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-132; Smink BE, 2010, CNS DRUGS, V24, P639, DOI 10.2165/11533170-000000000-00000; Sorock GS, 2006, ALCOHOL, V40, P193, DOI 10.1016/j.alcohol.2007.01.002; Suelves JM, 2010, REV PANAM SALUD PUBL, V27, P37, DOI 10.1590/S1020-49892010000100006; Wofford Marion R, 2006, J Clin Hypertens (Greenwich), V8, P114, DOI 10.1111/j.1524-6175.2006.04751.x; Xing D, 2014, OSTEOPOROSIS INT, V25, P105, DOI 10.1007/s00198-013-2446-y	43	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227696	10.1371/journal.pone.0227696	http://dx.doi.org/10.1371/journal.pone.0227696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940406	Green Published, gold			2022-12-26	WOS:000534368000094
J	Crailsheim, D; Stuger, HP; Kalcher-Sommersguter, E; Llorente, M				Crailsheim, Dietmar; Stueger, Hans Peter; Kalcher-Sommersguter, Elfriede; Llorente, Miquel			Early life experience and alterations of group composition shape the social grooming networks of former pet and entertainment chimpanzees (Pan troglodytes)	PLOS ONE			English	Article							CAPTIVE CHIMPANZEES; WILD CHIMPANZEES; NONHUMAN-PRIMATES; EARLY DEPRIVATION; NATIONAL-PARK; BEHAVIOR; INFANT; REDUCTION; PATTERNS; FISSION	The long-term effects of early life adversities on social capacities have been documented in humans and wild-caught former laboratory chimpanzees (Pan troglodytes). However, former pet and entertainment chimpanzees have received little attention to date. This study aimed to investigate the long-term effects of early life experience on 18 former pet and entertainment chimpanzees, based on social grooming data collected at a primate rescue centre over a 12-year period. Moreover, we also focused on the possible short-term effects that alterations to group composition might have on grooming patterns. For this purpose, we compared stable and unstable periods (i.e. where alterations to group composition occurred). We used two individual social network measures to analyse the grooming activity and the distribution of grooming among group mates for each individual. We could show that wild-caught chimpanzees were significantly more selective regarding their grooming partners and spent less time grooming when compared to their captive born companions. We also found that individuals who were predominantly housed without conspecifics during infancy spent less time grooming compared to those who were predominantly housed with conspecifics during infancy. Furthermore, we found that alterations to the group composition had short-term effects on the distribution of social grooming from a more equal distribution during periods with a stable group composition towards a more unequal and selective distribution during unstable periods. Thus, we conclude that the social grooming networks of former pet and entertainment chimpanzees are shaped not only by long-term effects such as early life experience, but also by short-term effects such as alterations to group composition. Remarkably, we found not only captive born chimpanzees but also wild-caught individuals to adjust their grooming to socially challenging situations by modifying their grooming distribution in a similar way.	[Crailsheim, Dietmar; Llorente, Miquel] Fundacio MONA, Unitat Recerca & Etol, Riudellots De La Selva, Spain; [Crailsheim, Dietmar; Llorente, Miquel] Univ Girona, Fac Educ & Psicol, Girona, Spain; [Stueger, Hans Peter] AGES Austrian Agcy Hlth & Food Safety, Dept Stat & Analyt Epidemiol, Graz, Austria; [Kalcher-Sommersguter, Elfriede] Karl Franzens Univ Graz, Inst Biol, Graz, Austria; [Llorente, Miquel] IPRIM Inst Recerca & Estudis Primatol, Girona, Spain	Universitat de Girona; University of Graz	Crailsheim, D (corresponding author), Fundacio MONA, Unitat Recerca & Etol, Riudellots De La Selva, Spain.; Crailsheim, D (corresponding author), Univ Girona, Fac Educ & Psicol, Girona, Spain.	d.crailsheim@gmail.com	Llorente, Miquel/N-1594-2013	Llorente, Miquel/0000-0001-9003-1983; Crailsheim, Dietmar/0000-0001-6869-1256	Spanish Ministerio de Ciencia e Innovacion [HAR2009-07223/HIST]; Ministerio de Economia y Competividad [HAR2012-32548]; Generalitat de Catalunya [2009 SGR-188, 2014 SGR-899, 2017 SGR-1040]; Fundacao para a Ciencia e a Tecnologia [PTDC/PSI-PCO/104170/2008]; Universitat Rovirai Virgili [2009AIRE-05, 2005ACCES-13]; "la Caixa" Foundation (EMCOBA Project) [LCF/PR/PR17/11120020]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Universitat Rovirai Virgili; "la Caixa" Foundation (EMCOBA Project)	This research has been funded by: (1) the Spanish Ministerio de Ciencia e Innovacion (HAR2009-07223/HIST) http://www.ciencia.gob.es (2) Ministerio de Economia y Competividad (HAR2012-32548), http://www.mineco.gob.es/(3) Generalitat de Catalunya (2009 SGR-188; 2014 SGR-899; 2017 SGR-1040) https://web.gencat.cat (4) Fundacao para a Ciencia e a Tecnologia (PTDC/PSI-PCO/104170/2008) https://www.fct.pt/(5) Universitat Rovirai Virgili (2009AIRE-05; 2005ACCES-13) http://www.urv.cat/es/(6) The project leading to these results has received funding from "la Caixa" Foundation (EMCOBA Project), under agreement LCF/PR/PR17/11120020 to ML and DC. https://obrasociallacaixa.org/es/home Funding 1-5 were all granted to Fundacion MONA (NGO) with Miquel Llorente (ML) being head of research at that time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2010, MIND CHIMPANZEE ECOL; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Bard K.A, 1995, HDB PARENTING BIOL E, V2, P27; Barton K., 2016, MUMIN MULTIMODEL INF; Bashaw MJ, 2010, PRIMATES, V51, P139, DOI 10.1007/s10329-009-0176-8; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beck Benjamin B., 2010, P332; Beisner Brianne A., 2014, P111; Birkett LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020101; Bloomsmith M.A., 2006, NURSERY REARING NONH, P289; Boesch C, 2000, CHIMPANZEES TAI FORE; Bos K, 2011, HARVARD REV PSYCHIAT, V19, P15, DOI 10.3109/10673229.2011.549773; Bradshaw GA, 2008, J TRAUMA DISSOCIATIO, V9, P9, DOI 10.1080/15299730802073619; Bradshaw GA, 2009, DEV PSYCHOL, V45, P1376, DOI 10.1037/a0015860; Brando S, 2018, BEHAV PROCESS, V156, P83, DOI 10.1016/j.beproc.2017.09.010; Brent L., 2001, CARE MANAGEMENT CAPT; Cano R, 2014, USE NATURAL RESOURCE; Carne C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095039; Caws C, 2003, INT J PRIMATOL, V24, P1077, DOI 10.1023/A:1026280329544; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Clark FE, 2011, AM J PRIMATOL, V73, P748, DOI 10.1002/ajp.20903; Clay AW, 2015, J COMP PSYCHOL, V129, P145, DOI 10.1037/a0038901; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Waal F. B. M., 1996, CHIMPANZEE CULTURES, P243; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL FBM, 1989, ZOO BIOL, P141, DOI 10.1002/zoo.1430080514; Dufour V, 2011, AM J PRIMATOL, V73, P802, DOI 10.1002/ajp.20943; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Ferdowsian HR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019855; Fox J., 2018, R COMPANION APPL REG, VThird; Freeman HD, 2016, DEV PSYCHOBIOL, V58, P519, DOI 10.1002/dev.21395; Freeman HD, 2014, PEERJ, V2, DOI 10.7717/peerj.579; Funkhouser JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191898; Gilby IC, 2013, BEHAV ECOL SOCIOBIOL, V67, P373, DOI 10.1007/s00265-012-1457-6; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goodall J, 1996, GREAT APE SOC; Grueter CC, 2013, EVOL HUM BEHAV, V34, P61, DOI 10.1016/j.evolhumbehav.2012.09.004; HEMELRIJK CK, 1994, ANIM BEHAV, V48, P479, DOI 10.1006/anbe.1994.1264; Hicks Thurston C., 2010, African Primates, V7, P1; Itani J., 1967, Primates, V8, P355, DOI 10.1007/BF01792020; Jacobs A, 2011, AM J PRIMATOL, V73, P741, DOI 10.1002/ajp.20932; Jacobson SL, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170932; Kabasawa A, 2011, PRIMATOL MONOGR, P45, DOI 10.1007/978-4-431-53921-6_6; Kalcher E, 2008, DEV PSYCHOBIOL, V50, P777, DOI 10.1002/dev.20330; Kalcher-Sommersguter E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16439; Kalcher-Sommersguter E, 2011, DEV PSYCHOL, V47, P77, DOI 10.1037/a0020783; Kano F, 2012, PSYCHOLOGIA, V55, P9, DOI 10.2117/psysoc.2012.9; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; KERR GR, 1969, J PEDIATR, V75, P833, DOI 10.1016/S0022-3476(69)80307-0; Koene Paul, 2014, Animals, V4, P93, DOI 10.3390/ani4010093; Kormos R., 2003, W AFRICAN CHIMPANZEE; Koski SE, 2012, INT J PRIMATOL, V33, P905, DOI 10.1007/s10764-012-9623-2; Koyama NF, 2019, PRIMATES, V60, P203, DOI 10.1007/s10329-018-0675-6; Kreppner JM, 2001, J ABNORM CHILD PSYCH, V29, P513; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Lehmann J, 2007, ANIM BEHAV, V74, P1617, DOI 10.1016/j.anbehav.2006.10.025; Lehmann J, 2004, BEHAV ECOL SOCIOBIOL, V56, P207, DOI 10.1007/s00265-004-0781-x; Lehmann J, 2008, INT J PRIMATOL, V29, P65, DOI 10.1007/s10764-007-9230-9; Lehmann J, 2007, EVOL ECOL, V21, P613, DOI 10.1007/s10682-006-9141-9; Leve M, 2016, PRIMATES, V57, P73, DOI 10.1007/s10329-015-0494-y; Llorente M, 2015, INT J PRIMATOL, V36, P605, DOI 10.1007/s10764-015-9842-4; Llorente Miquel, 2012, Animals, V2, P363, DOI 10.3390/ani2030363; Lopresti-Goodman SM, 2015, J TRAUMA DISSOCIATIO, V16, P349, DOI 10.1080/15299732.2014.1003673; Lopresti-Goodman SM, 2013, BEHAV SCI-BASEL, V3, P1, DOI 10.3390/bs3010001; Martin P., 1993, MEASURING BEHAV INTR; Matsumoto-Oda A, 1998, AM J PRIMATOL, V46, P157, DOI 10.1002/(SICI)1098-2345(1998)46:2<157::AID-AJP5>3.0.CO;2-V; Matsuzawa T., 2009, PRIMATE ORIGINS HUMA; Matsuzawa T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P3, DOI 10.1007/4-431-30248-4_1; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; McFarland D., 2010, SOCIAL NETWORK ANAL; McGoron L, 2012, J AM ACAD CHILD PSY, V51, P683, DOI 10.1016/j.jaac.2012.05.004; NISHIDA T, 1988, FOLIA PRIMATOL, V50, P109, DOI 10.1159/000156335; Nishida T., 1990, CHIMPANZEES MAHALE M; Ortin S, 2019, DEV PSYCHOBIOL, V61, P874, DOI 10.1002/dev.21853; Pasquaretta C, 2014, SCI REP-UK, V4, DOI 10.1038/srep07600; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; PERKINS LA, 1992, ZOO BIOL, V11, P177, DOI 10.1002/zoo.1430110306; Peterson D., 2000, HEARTSBLOOD HUNTING; Plooij FX., 1984, BEHAV DEV FREE LIVIN; Pruetz JDE, 2001, CARE MANAGEMENT CAPT, V2; R Core Team, 2021, R LANGUAGE ENV STAT; Redshaw M.E., 1991, P217; Reimers M, 2007, HORM BEHAV, V51, P428, DOI 10.1016/j.yhbeh.2006.12.011; Rennie AE, 2006, ANIM WELFARE, V15, P215; Rushmore J, 2013, J ANIM ECOL, V82, P976, DOI 10.1111/1365-2656.12088; Samuni L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1643; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; Shimada M, 2014, AM J PRIMATOL, V76, P1025, DOI 10.1002/ajp.22289; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; Spinelli S, 2009, ARCH GEN PSYCHIAT, V66, P658, DOI 10.1001/archgenpsychiatry.2009.52; Stiles D., 2013, STOLEN APES ILLICIT; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; TERRY RL, 1970, J PSYCHOL, V76, P129, DOI 10.1080/00223980.1970.9916830; Thunstrom M, 2013, PRIMATES, V54, P13, DOI 10.1007/s10329-012-0319-1; TUTIN C E G, 1983, Primates, V24, P154, DOI 10.1007/BF02381079; van Leeuwen EJC, 2018, P NATL ACAD SCI USA, V115, P11393, DOI 10.1073/pnas.1722614115; van Leeuwen EJC, 2014, ANIM COGN, V17, P407, DOI 10.1007/s10071-013-0672-5; Watts DP, 2000, INT J PRIMATOL, V21, P189, DOI 10.1023/A:1005469302911; WHITE FJ, 1994, FOLIA PRIMATOL, V63, P181, DOI 10.1159/000156818; WHITE FJ, 1992, AM J PRIMATOL, V26, P215, DOI 10.1002/ajp.1350260307; Wooddell LJ, 2017, PSYCHONEUROENDOCRINO, V84, P109, DOI 10.1016/j.psyneuen.2017.06.018; Wrangham R.W., 1977, PRIMATE ECOLOGY STUD, P503, DOI DOI 10.1016/B978-0-12-176850-8.50022-6; Wrangham RW, 1975, BEHAV ECOLOGY CHIMPA; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O; Ziegler TE, 2017, HORM BEHAV, V91, P107, DOI 10.1016/j.yhbeh.2017.03.004	111	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226947	10.1371/journal.pone.0226947	http://dx.doi.org/10.1371/journal.pone.0226947			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KF6OM	31940322	Green Published, gold			2022-12-26	WOS:000509359100001
J	Kuwajima, M; Ostrovskaya, OI; Cao, G; Weisberg, SA; Harris, KM; Zemelman, BV				Kuwajima, Masaaki; Ostrovskaya, Olga, I; Cao, Guan; Weisberg, Seth A.; Harris, Kristen M.; Zemelman, Boris, V			Ultrastructure of light-activated axons following optogenetic stimulation to produce late-phase long-term potentiation	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; AREA CA1; ASCORBATE PEROXIDASE; SYNAPTIC PLASTICITY; DENTATE GYRUS; IN-VIVO; LTP; SYNAPSES; TRANSMISSION; PROTEIN	Analysis of neuronal compartments has revealed many state-dependent changes in geometry but establishing synapse-specific mechanisms at the nanoscale has proven elusive. We co-expressed channelrhodopsin2-GFP and mAPEX2 in a subset of hippocampal CA3 neurons and used trains of light to induce late-phase long-term potentiation (L-LTP) in area CA1. L-LTP was shown to be specific to the labeled axons by severing CA3 inputs, which prevented back-propagating recruitment of unlabeled axons. Membrane-associated mAPEX2 tolerated microwave-enhanced chemical fixation and drove tyramide signal amplification to deposit Alexa Fluor dyes in the light-activated axons. Subsequent post-embedding immunogold labeling resulted in outstanding ultrastructure and clear distinctions between labeled (activated), and unlabeled axons without obscuring subcellular organelles. The gold-labeled axons in potentiated slices were reconstructed through serial section electron microscopy; presynaptic vesicles and other constituents could be quantified unambiguously. The genetic specification, reliable physiology, and compatibility with established methods for ultrastructural preservation make this an ideal approach to link synapse ultrastructure and function in intact circuits.	[Kuwajima, Masaaki; Ostrovskaya, Olga, I; Cao, Guan; Harris, Kristen M.; Zemelman, Boris, V] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Weisberg, Seth A.; Harris, Kristen M.; Zemelman, Boris, V] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Harris, KM; Zemelman, BV (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA.; Harris, KM; Zemelman, BV (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.	kharris@mail.clm.utexas.edu; zemelmanb@mail.lm.utexas.edu		Kuwajima, Masaaki/0000-0002-1478-3726	Brain Research Foundation Scientific Innovations Award; National Institutes of Health [MH104319, NS074644, EY026446, EY026442, NS094330]; National Science Foundation [1707356]; Human Frontier Science Program [RGP0041]; University of Texas System UT BRAIN Seed Grants [NNRI 365222, 365289]	Brain Research Foundation Scientific Innovations Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); University of Texas System UT BRAIN Seed Grants	Funded by Brain Research Foundation Scientific Innovations Award (to KMH; https://www.thebrf.org/).National Institutes of Health Grants (MH104319 and NS074644 to KMH; EY026446, EY026442, and NS094330 to BVZ; https://www.nih.gov/).National Science Foundation Grant (1707356 to KMH; https://www.nsf.gov/).Human Frontier Science Program (RGP0041 to BVZ; https://www.hfsp.org/).The University of Texas System UT BRAIN Seed Grants (NNRI 365222 and 365289 to BVZ; https://www.utsystem.edu/sites/neuroscience/ut-brain-0).Human Frontier Science Program (RGP0041 to BVZ; https://www.hfsp.org/).The University of Texas System UT BRAIN Seed Grants (NNRI 365222 and 365289 to BVZ; https://www.utsystem.edu/sites/neuroscience/ut-brain-0).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurnhammer C, 2012, HUM GENE THER METHOD, V23, P18, DOI 10.1089/hgtb.2011.034; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; BLISS TVP, 1983, J PHYSIOL-LONDON, V341, P617, DOI 10.1113/jphysiol.1983.sp014828; Borghuis BG, 2011, J NEUROSCI, V31, P2855, DOI 10.1523/JNEUROSCI.6064-10.2011; BORTOLOTTO ZA, 1993, NEUROPHARMACOLOGY, V32, P1, DOI 10.1016/0028-3908(93)90123-K; Bourne JN, 2007, NEUROPHARMACOLOGY, V52, P55, DOI 10.1016/j.neuropharm.2006.06.020; Bourne JN, 2013, J COMP NEUROL, V521, P3898, DOI 10.1002/cne.23384; Bourne JN, 2012, CURR OPIN NEUROBIOL, V22, P372, DOI 10.1016/j.conb.2011.10.019; Bourne JN, 2011, HIPPOCAMPUS, V21, P354, DOI 10.1002/hipo.20768; Cao G, 2012, J NEUROPHYSIOL, V107, P902, DOI 10.1152/jn.00780.2011; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Coleman RA, 2006, J HISTOCHEM CYTOCHEM, V54, P817, DOI 10.1369/jhc.6A6929.2006; Fiala JC, 2001, J MICROSC-OXFORD, V202, P468, DOI 10.1046/j.1365-2818.2001.00926.x; Fiala JC, 2001, J AM MED INFORM ASSN, V8, P1; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Habib D, 2010, HIPPOCAMPUS, V20, P29, DOI 10.1002/hipo.20611; Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404; HARRIS KM, 1984, J PHYSIOL-LONDON, V346, P27, DOI 10.1113/jphysiol.1984.sp015005; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hashimotodani Y, 2017, NEURON, V95, P928, DOI 10.1016/j.neuron.2017.07.028; Isomura Y, 2002, J NEUROPHYSIOL, V87, P1169, DOI 10.1152/jn.00536.2001; Jackman SL, 2014, J NEUROSCI, V34, P7704, DOI 10.1523/JNEUROSCI.4694-13.2014; JENSEN FE, 1989, J NEUROSCI METH, V29, P217, DOI 10.1016/0165-0270(89)90146-5; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kloosterman F, 2001, J NEUROPHYSIOL, V86, P2435, DOI 10.1152/jn.2001.86.5.2435; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Kuwajima M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059573; Kuwajima Masaaki, 2013, Methods Mol Biol, V950, P253, DOI 10.1007/978-1-62703-137-0_15; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee J, 2015, CHEM COMMUN, V51, P10945, DOI 10.1039/c5cc02409a; LEUNG LS, 1979, J NEUROPHYSIOL, V42, P1557, DOI 10.1152/jn.1979.42.6.1557; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Martin SJ, 2019, NEUROSCIENCE, V397, P147, DOI 10.1016/j.neuroscience.2018.11.044; MITTLER R, 1991, FEBS LETT, V289, P257, DOI 10.1016/0014-5793(91)81083-K; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; O'Riordan KJ, 2018, CELL REP, V22, P2053, DOI 10.1016/j.celrep.2018.01.085; Oberti D, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00024; Oishi N, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-018-0424-1; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Popov VI, 2004, NEUROSCIENCE, V128, P251, DOI 10.1016/j.neuroscience.2004.06.029; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Smith HL, 2016, ELIFE, V5, DOI 10.7554/eLife.15275; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; WHEAL HV, 1983, BRAIN RES, V272, P247, DOI 10.1016/0006-8993(83)90570-X; Yuste R, 2000, METHOD ENZYMOL, V327, P522, DOI 10.1016/S0076-6879(00)27300-X; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	57	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							0226797	10.1371/journal.pone.0226797	http://dx.doi.org/10.1371/journal.pone.0226797			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940316	Green Submitted, gold, Green Published			2022-12-26	WOS:000534368000044
J	Colombet, I; Rigal, L; Urtizberea, M; Vinant, P; Rouquette, A				Colombet, Isabelle; Rigal, Laurent; Urtizberea, Miren; Vinant, Pascale; Rouquette, Alexandra			Validity of the French version of the Autonomy Preference Index and its adaptation for patients with advanced cancer	PLOS ONE			English	Article							SHARED DECISION-MAKING; END-OF-LIFE; FIT INDEXES; INTERNATIONAL CONSENSUS; CULTURAL-ADAPTATION; NEAR-DEATH; INFORMATION; CARE; HEALTH; RECOMMENDATIONS	Background While patient-centered care is recommended as a key dimension for quality improvement, in case of serious illness, patients may have different expectations regarding information and participation in medical decision-making. In oncology, anticipation of disease worsening remains difficult, especially when patient's preferences towards prognosis medical information are unclear. Valid tools to explore patients' preferences could help targeting end-of-life discussions, which have been shown to decrease aggressiveness of end-of-life care. Our aim was to establish the validity and reliability of the French version of the Autonomy Preference Index (API) among patients with incurable cancer and in primary care setting. Three supplementary items were specifically developed to evaluate preparedness to anticipate disease deterioration among patients with incurable cancer. Methods The psychometric properties of the API translated into French were assessed among patients consecutively recruited from January to March 2017 in the waiting rooms of 19 general practitioners (N = 391) and in an oncology (N = 187) clinic in Paris. Relationships between the newly-developed items and the API subscale scores were studied. Results A three correlated factors confirmatory model (two factors related to decision-making and a factor related to information-seeking preferences) showed an acceptable fit on the whole sample and no measurement invariance issue was found across settings, age, sex and educational level. Internal consistency and test-retest reliability were acceptable for the information-seeking and decision-making subscales. One of the newly-developed items on patients' ability to anticipate a decision on the use of artificial respiration if a sudden deterioration of their illness occurred was not related to the API subscale scores. Conclusion The French version of the API was found valid and reliable for use in general practice and oncology settings. The additional items on patient preparedness to anticipate disease deterioration can be of interest to ensure that patient values guide all end-of-life clinical decisions.	[Colombet, Isabelle; Urtizberea, Miren] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Colombet, Isabelle; Vinant, Pascale] Cochin Hosp, AP HP, Palliat Med, Paris, France; [Rigal, Laurent; Rouquette, Alexandra] Univ Paris Saclay, UVSQ, Inserm, CESP, Paris, France; [Rigal, Laurent] Univ Paris Saclay, Dept Gen Practice, Le Kremlin Bicetre, France; [Rouquette, Alexandra] Bicetre Hosp, AP HP, Publ Hlth & Epidemiol Dept, Le Kremlin Bicetre, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Rouquette, A (corresponding author), Univ Paris Saclay, UVSQ, Inserm, CESP, Paris, France.; Rouquette, A (corresponding author), Bicetre Hosp, AP HP, Publ Hlth & Epidemiol Dept, Le Kremlin Bicetre, France.	alex.rouquette@gmail.com	Rouquette, Alexandra/AGY-2116-2022; Colombet, Isabelle/J-8186-2017	Rouquette, Alexandra/0000-0002-2473-1719; Colombet, Isabelle/0000-0002-8721-1526	Fonds pour les Soins Palliatifs [Convention with Paris Descartes University] [J17P99CONV11]	Fonds pour les Soins Palliatifs [Convention with Paris Descartes University]	This work (IC) was supported by the Fonds pour les Soins Palliatifs [Convention with Paris Descartes University no J17P99CONV11]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the participants in the study, Lamisse Bouti (MSc) from the Research Center in Epidemiology and Population Health, INSERM U1018 and Paris-Sud University for her work in the data management and exploratory analyses processes, Lotfi Dahmane from the Public Health and Epidemiology Department of Paris-Sud University Hospitals for his help for data collection and regulatory procedures, Marie-Yvonne Guillard from the palliative care team for her help in the identification of patients eligible for the ONCO sample, Pr Francois Goldwasser head of the oncology department of the Cochin Hospital and all the staff members for their help in recruitment in the ONCO sample, and the general practitioners and Aude Benichou from the General Practice Department of the Paris-Sud University for their help in recruitment and data collection in the GP sample.	American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; Anagnostou D, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015277; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Belanger E, 2011, PALLIATIVE MED, V25, P242, DOI 10.1177/0269216310389348; Bonfils KA, 2015, PSYCHIAT RES, V228, P526, DOI 10.1016/j.psychres.2015.06.004; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Davis MA, 1999, ACAD EMERG MED, V6, P781, DOI 10.1111/j.1553-2712.1999.tb01206.x; de Vet HW, 2011, MEASUREMENT MED PRAC; El-Jawahri A, 2019, ONCOLOGIST, V24, P247, DOI 10.1634/theoncologist.2018-0317; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Epstein J, 2015, J CLIN EPIDEMIOL, V68, P435, DOI 10.1016/j.jclinepi.2014.11.021; Epstein J, 2015, J CLIN EPIDEMIOL, V68, P360, DOI 10.1016/j.jclinepi.2013.07.013; Gaston CM, 2005, SOC SCI MED, V61, P2252, DOI 10.1016/j.socscimed.2005.04.015; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; GIBSON PG, 1995, CHEST, V107, P1003, DOI 10.1378/chest.107.4.1003; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Hagerty RG, 2005, J CLIN ONCOL, V23, P1278, DOI 10.1200/JCO.2005.11.138; Hill SA, 2006, J MENTAL HLTH, V15, P75, DOI DOI 10.1080/09638230500512250; Hoerger M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-188; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jenkins V, 2011, J CLIN ONCOL, V29, P61, DOI 10.1200/JCO.2010.30.0814; Kline R.B., 2006, PRINCIPLES PRACTICE, V2nd; KRANTZ DS, 1980, J PERS SOC PSYCHOL, V39, P977, DOI 10.1037/0022-3514.39.5.977; Legare F, 2014, PATIENT EDUC COUNS, V96, P281, DOI 10.1016/j.pec.2014.06.014; Maciejewski PK, 2013, J PAIN SYMPTOM MANAG, V45, P841, DOI 10.1016/j.jpainsymman.2012.04.003; Mack JW, 2012, J CLIN ONCOL, V30, P4387, DOI 10.1200/JCO.2012.43.6055; Marsh HW, 2013, DEV PSYCHOL, V49, P1194, DOI 10.1037/a0026913; Millsap RE, 2011, STAT APPROACHES MEAS; Mokkink LB, 2018, QUAL LIFE RES, V27, P1171, DOI 10.1007/s11136-017-1765-4; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Morandi S, 2017, PSYCHOL ASSESSMENT, V29, P110, DOI 10.1037/pas0000327; Muthen L.K., 2010, MPLUS USERS GUIDE; Muthn LK, 2012, MPLUS STAT ANAL LATE; Pennec S, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-25; Rietjens JAC, 2017, LANCET ONCOL, V18, pE543, DOI 10.1016/S1470-2045(17)30582-X; Rouquette A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215073; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simon D, 2010, HEALTH EXPECT, V13, P234, DOI 10.1111/j.1369-7625.2009.00584.x; Solomon R, 2017, PATIENT, V10, P489, DOI 10.1007/s40271-017-0226-z; Spies CD, 2006, ACTA ANAESTH SCAND, V50, P1019, DOI 10.1111/j.1399-6576.2006.01097.x; StataCorp, 2012, STAT STAT SOFTW REL; Stein RA, 2013, J CLIN ONCOL, V31, P3403, DOI 10.1200/JCO.2011.40.8872; Vinant P, 2015, B CANCER, V102, P234, DOI 10.1016/j.bulcan.2015.01.009; Washington KT, 2016, PALLIATIVE MED, V30, P270, DOI 10.1177/0269216315601545; Watkins MW, 2017, CLIN NEUROPSYCHOL, V31, P1113, DOI 10.1080/13854046.2017.1317364; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227802	10.1371/journal.pone.0227802	http://dx.doi.org/10.1371/journal.pone.0227802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935263	Green Published, gold			2022-12-26	WOS:000534354100053
J	Gregory, A; Denis, M; Bayat, M; Kumar, V; Kim, BH; Webb, J; Nayak, R; Adabi, S; Meixner, DD; Polley, EC; Fazzio, RT; Fatemi, M; Alizad, A				Gregory, Adriana; Denis, Max; Bayat, Mahdi; Kumar, Viksit; Kim, Bae Hyung; Webb, Jeremy; Nayak, Rohit; Adabi, Saba; Meixner, Duane D.; Polley, Eric C.; Fazzio, Robert T.; Fatemi, Mostafa; Alizad, Azra			Predictive value of comb-push ultrasound shear elastography for the differentiation of reactive and metastatic axillary lymph nodes: A preliminary investigation	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BREAST-CANCER PATIENTS; NONINVASIVE EVALUATION; ACCURACY; LYMPHADENOPATHY; SONOGRAPHY; CYTOLOGY; BENIGN; BIOPSY; WOMEN	Objectives To evaluate the predictive performance of comb-push ultrasound shear elastography for the differentiation of reactive and metastatic axillary lymph nodes. Methods From June 2014 through September 2018, 114 female volunteers (mean age 58.1 +/- 13.3 years; range 28-88 years) with enlarged axillary lymph nodes identified by palpation or clinical imaging were prospectively enrolled in the study. Mean, standard deviation and maximum shear wave elastography parameters from 117 lymph nodes were obtained and compared to fine needle aspiration biopsy results. Mann-Whitney U test and ROC curve analysis were performed. Results The axillary lymph nodes were classified as reactive or metastatic based on the fine needle aspiration outcomes. A statistically significant difference between reactive and metastatic axillary lymph nodes was observed based on comb-push ultrasound shear elastography (CUSE) results (p<0.0001) from mean and maximum elasticity values. Mean elasticity showed the best separation with a ROC analysis resulting in 90.5% sensitivity, 94.4% specificity, 0.97 area under the curve, 95% positive predictive value, and 89.5% negative predictive value with a 30.2-kPa threshold. Conclusions CUSE provided a quantifiable parameter that can be used for the assessment of enlarged axillary lymph nodes to differentiate between reactive and metastatic processes.	[Gregory, Adriana; Denis, Max; Webb, Jeremy; Nayak, Rohit; Adabi, Saba; Meixner, Duane D.; Fazzio, Robert T.; Alizad, Azra] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA; [Bayat, Mahdi; Kumar, Viksit; Kim, Bae Hyung; Fatemi, Mostafa] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Polley, Eric C.] Mayo Clin, Coll Med, Biomed Stat & Informat, Rochester, MN USA; [Denis, Max] Univ Dist Columbia, Dept Mech Engn, Washington, DC USA; [Bayat, Mahdi] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA; [Kim, Bae Hyung] Vave Hlth Inc, Redwood City, CA USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of the District of Columbia; Case Western Reserve University	Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55905 USA.	Alizad.Azra@mayo.edu		Kim, Baehyung/0000-0001-9725-5592; Fatemi, Mostafa/0000-0002-6603-9077	National Institute of Health (NIH) [R01CA148994, R01CA168575, R01CA195527, R01CA174723]; Mayo Clinic	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic	The study was supported by National Institute of Health (NIH) Grants R01CA148994: AA, R01CA168575: MF, R01CA195527: MF and AA, and R01CA174723: MF. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. The funders of this study include National Institutes of Health (NIH) and Mayo Clinic, which funded the study and provided the salaries for the authors. The NIH and Mayo Clinic did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aikuwari E, 2008, CANCER CYTOPATHOL, V114, P89, DOI 10.1002/cncr.23344; Alam F, 2015, J SCI FOUND, V13, P36; Alvarez S, 2006, AM J ROENTGENOL, V186, P1342, DOI 10.2214/AJR.05.0936; Aristizabal S, 2014, PHYS MED BIOL, V59, P7735, DOI 10.1088/0031-9155/59/24/7735; Bazemore AW, 2002, AM FAM PHYSICIAN, V66, P2103; Bedi DG, 2008, AM J ROENTGENOL, V191, P646, DOI 10.2214/AJR.07.2460; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Carlson GW, 2011, JAMA-J AM MED ASSOC, V305, P606, DOI 10.1001/jama.2011.131; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chen SQ, 2016, J ULTRAS MED, V35, P571, DOI 10.7863/ultra.15.05053; Ciatto S, 2007, BREAST CANCER RES TR, V103, P85, DOI 10.1007/s10549-006-9355-0; Evans A, 2014, BREAST CANCER RES TR, V143, P153, DOI 10.1007/s10549-013-2747-z; Fein DA, 1997, J SURG ONCOL, V65, P34, DOI 10.1002/(SICI)1096-9098(199705)65:1<34::AID-JSO7>3.0.CO;2-P; Harlow, 1999, Breast Cancer, V6, P159, DOI 10.1007/BF02966925; Kilic F, 2016, J ULTRAS MED, V35, P271, DOI 10.7863/ultra.15.03039; Koelliker SL, 2008, RADIOLOGY, V246, P81, DOI 10.1148/radiol.2463061463; Kwansa AL, 2016, BIOPHYS CHEM, V214, P1, DOI 10.1016/j.bpc.2016.04.001; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; McGee JM, 1996, AM J SURG, V172, P501; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Rautiainen S, 2013, RADIOLOGY, V269, P54, DOI 10.1148/radiol.13122637; Rizwan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10002; Rocha Rafael Dahmer, 2015, Radiol Bras, V48, P345, DOI 10.1590/0100-3984.2014.0121; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; Tamaki K, 2013, TOHOKU J EXP MED, V231, P211, DOI 10.1620/tjem.231.211; Tan S, 2017, J ULTRAS MED, V36, P189, DOI 10.7863/ultra.16.01014; Tanis PJ, 2001, J AM COLL SURGEONS, V192, P399, DOI 10.1016/S1072-7515(00)00776-6; Tourasse C, 2012, EUR J RADIOL, V81, P3154, DOI 10.1016/j.ejrad.2012.04.031; Youk JH, 2017, ULTRASOUND MED BIOL, V43, P1581, DOI 10.1016/j.ultrasmedbio.2017.03.016	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226994	10.1371/journal.pone.0226994	http://dx.doi.org/10.1371/journal.pone.0226994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929558	gold, Green Published			2022-12-26	WOS:000534352500023
J	Wada, K; Koike, H; Fujii, T; Morita, T				Wada, Keisuke; Koike, Hideaki; Fujii, Tatsuya; Morita, Tomotake			Targeted transcriptomic study of the implication of central metabolic pathways in mannosylerythritol lipids biosynthesis in Pseudozyma antarctica T-34	PLOS ONE			English	Article							GLYCOLIPID BIOSURFACTANTS; CANDIDA-ANTARCTICA; CONVERSION	Pseudozyma antarctica is a nonpathogenic phyllosphere yeast known as an excellent producer of industrial lipases and mannosylerythritol lipids (MELs), which are multi-functional glycolipids. The fungus produces a much higher amount of MELs from vegetable oil than from glucose, whereas its close relative, Ustilago maydis UM521, produces a lower amount of MELs from vegetable oil. In the present study, we used previous gene expression profiles measured by DNA microarray analyses after culturing on two carbon sources, glucose and soybean oil, to further characterize MEL biosynthesis in P. antarctica T-34. A total of 264 genes were found with induction ratios and expression intensities under oily conditions with similar tendencies to those of MEL cluster genes. Of these, 93 were categorized as metabolic genes using the Eukaryotic Orthologous Groups classification. Within this metabolic category, amino acids, carbohydrates, inorganic ions, and secondary metabolite metabolism, as well as energy production and conversion, but not lipid metabolism, were enriched. Furthermore, genes involved in central metabolic pathways, such as glycolysis and the tricarboxylic acid cycle, were highly induced in P. antarctica T-34 under oily conditions, whereas they were suppressed in U. maydis UM521. These results suggest that the central metabolism of P. antarctica T-34 under oily conditions contributes to its excellent oil utilization and extracellular glycolipid production.	[Wada, Keisuke; Fujii, Tatsuya] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem, Higashihiroshima, Hiroshima, Japan; [Koike, Hideaki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Morita, Tomotake] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Morita, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki, Japan.	morita-tomotake@aist.go.jp	Wada, Keisuke/AAW-7752-2021; Wada, Keisuke/J-1522-2018; Morita, Tomotake/L-7073-2018	Wada, Keisuke/0000-0002-1454-6093; Wada, Keisuke/0000-0002-1454-6093; Morita, Tomotake/0000-0001-6956-3096				BOEKHOUT T, 1995, J GEN APPL MICROBIOL, V41, P359, DOI 10.2323/jgam.41.359; CARR DB, 1987, J AM STAT ASSOC, V82, P424, DOI 10.2307/2289444; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Imura T, 2007, LANGMUIR, V23, P1659, DOI 10.1021/la0620814; Ito S, 2007, COLLOID SURFACE B, V58, P165, DOI 10.1016/j.colsurfb.2007.03.003; Kitamoto D, 1998, BIOTECHNOL LETT, V20, P813, DOI 10.1023/A:1005347022247; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; KITAMOTO D, 1990, AGR BIOL CHEM TOKYO, V54, P37, DOI 10.1080/00021369.1990.10869919; Kitamoto D, 2001, BIOTECHNOL LETT, V23, P1709, DOI 10.1023/A:1012464717259; Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; Liu N, 2016, METAB ENG, V38, P86, DOI 10.1016/j.ymben.2016.06.006; Liu YB, 2011, BIORESOURCE TECHNOL, V102, P3927, DOI 10.1016/j.biortech.2010.11.115; Lorenz S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00053-14; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; Morita T, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00064-13, DOI 10.1128/GENOMEA.00064-13]; Morita T, 2007, APPL MICROBIOL BIOT, V74, P307, DOI 10.1007/s00253-006-0672-3; Morita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086490; Morita T, 2013, APPL MICROBIOL BIOT, V97, P4691, DOI 10.1007/s00253-013-4858-1; Morita T, 2010, APPL MICROBIOL BIOT, V88, P679, DOI 10.1007/s00253-010-2762-5; Morita T, 2009, BIOTECHNOL APPL BIOC, V53, P39, DOI 10.1042/BA20090033; *R DEV COR TEAM, 2009, R LANG ENV STAT; Rau U, 2005, APPL MICROBIOL BIOT, V68, P607, DOI 10.1007/s00253-005-1906-5; Renilla S, 2012, APPL MICROBIOL BIOT, V93, P2109, DOI 10.1007/s00253-011-3536-4; Saika A, 2017, APPL MICROBIOL BIOT, V101, P8345, DOI 10.1007/s00253-017-8589-6; Spoeckner S, 1999, APPL MICROBIOL BIOT, V51, P33, DOI 10.1007/s002530051359; Ueda H, 2015, APPL MICROBIOL BIOT, V99, P6405, DOI 10.1007/s00253-015-6523-3; Yang YH, 2005, STAT BIOL HEALTH, P49	29	5	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227295	10.1371/journal.pone.0227295	http://dx.doi.org/10.1371/journal.pone.0227295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923270	Green Published, gold			2022-12-26	WOS:000534350000063
J	Choi, EJ; Lee, YJ; Lee, JM; Kim, YJ; Choi, JH; Ahn, B; Kim, K; Han, MG				Choi, Eun-Ji; Lee, Young Jae; Lee, Jin-Moo; Kim, Yeon-Jung; Choi, Jang-Hoon; Ahn, Byeongwoo; Kim, Kisoon; Han, Myung Guk			The effect of mutations derived from mouse-adapted H3N2 seasonal influenza A virus to pathogenicity and host adaptation	PLOS ONE			English	Article							INCREASED VIRULENCE; UNITED-STATES; HEMAGGLUTININ; PATHOGENESIS; DETERMINANTS; LUNG; MICE; IDENTIFICATION; TRANSMISSION; GENOME	Elucidating the genetic basis of influenza A viruses (IAVs) is important to understand which mutations will determine the virulence and the host range of mammals. Here, seasonal H3N2 influenza was adapted in mice by serial passage and four mutants, each carrying amino acid substitutions related to mouse adaptation in either the PB2, HA, NP, or NA protein, were generated. To confirm the contribution of each gene to enhanced pathogenicity and mouse adaptation, mice were inoculated with the respective variants, and virulence, replication, histopathology, and infectivity were examined. The virus harboring HA mutations displayed increased infection efficiency and replication competence, resulting in higher mortality in mice relative to those infected with wild-type virus. By contrast, the NP D34N mutation caused rapid and widespread infection in multiple organs without presenting virulent symptoms. Additionally, the PB2 F323L mutation presented delayed but elevated replication competence in the respiratory tract, whereas the S331R mutation in NA showed no considerable effects on mouse adaptation. These results suggested that mouse-adapted changes in HA are major factors in increased pathogenicity and that mutations in NP and PB2 also contribute to cross-species adaptability. Our findings offer a better understanding of the molecular basis for IAV pathogenicity and adaptation in a new host.	[Choi, Eun-Ji; Lee, Young Jae; Lee, Jin-Moo; Kim, Yeon-Jung; Choi, Jang-Hoon; Kim, Kisoon; Han, Myung Guk] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Infect Dis Res, Div Viral Dis Res, Osong, South Korea; [Ahn, Byeongwoo] Chungbuk Natl Univ, Coll Vet Med, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea CDC Center for Disease Prevention; Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Chungbuk National University	Han, MG (corresponding author), Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Ctr Infect Dis Res, Div Viral Dis Res, Osong, South Korea.	mghan@korea.kr		Lee, Young Jae/0000-0002-4902-2281	National Institute of Health, Korea [2017-NI43001, 2014-ER4301-02]	National Institute of Health, Korea	This work was supported by grants of the National Institute of Health, Korea (2017-NI43001 and 2014-ER4301-02). The funder provided experiment resources, equipment, reagents and space, and helped to complete manuscript by pay the cost for English proofreading service, http://www.cdc.go.kr/index.es?sid=a5.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Prof. Robert G. Webster at St. Jude Children's Research Hospital, at Memphis, for the plasmid vector pHW2000.	Andrewes CH, 1934, LANCET, V2, P859; Broberg E, 2015, EUROSURVEILLANCE, V20, P2; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Chambers BS, 2015, CELL REP, V12, P1, DOI 10.1016/j.celrep.2015.06.005; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; D'Mello T, 2015, MMWR-MORBID MORTAL W, V64, P206; de Jong RMC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-276; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Eisfeld AJ, 2014, NAT PROTOC, V9, P2663, DOI 10.1038/nprot.2014.180; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; HIRST GK, 1947, J EXP MED, V86, P357, DOI 10.1084/jem.86.5.357; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Kamal RP, 2014, CURR TOP MICROBIOL, V385, P243, DOI 10.1007/82_2014_388; Kamiki H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110653; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kim HM, 2015, VIROLOGY, V481, P136, DOI 10.1016/j.virol.2015.02.042; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; MONONEN I, 1984, BIOCHIM BIOPHYS ACTA, V788, P364, DOI 10.1016/0167-4838(84)90050-5; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pebody RG, 2015, EUROSURVEILLANCE, V20, P6, DOI [10.2807/1560-7917.ES2015.20.5.21025, 10.2807/1560-7917.ES.2015.20.36.30013]; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Ping JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9148; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Prokopyeva EA, 2016, INFECT GENET EVOL, V39, P265, DOI 10.1016/j.meegid.2016.01.022; Pu ZQ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00414; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; REED L. J., 1938, AMER JOUR HYG, V27, P493; RUDNEVA IA, 1986, ARCH VIROL, V90, P237, DOI 10.1007/BF01317373; SHILOV AA, 1994, VOP VIRUSOL+, V39, P153; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thangavel RR, 2014, J IMMUNOL METHODS, V410, P60, DOI 10.1016/j.jim.2014.03.023; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040752; Webster RG, 1997, FEMS IMMUNOL MED MIC, V18, P275, DOI 10.1016/S0928-8244(97)00058-8	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227516	10.1371/journal.pone.0227516	http://dx.doi.org/10.1371/journal.pone.0227516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917822	Green Submitted, Green Published, gold			2022-12-26	WOS:000534341100022
J	Elsayed, R; Kurago, Z; Cutler, CW; Arce, R; Gerber, J; Celis, E; Sultan, H; Elashiry, M; Meghil, M; Sun, C; Auersvald, CM; Elsayed, R; Elshikh, MEM; Isales, C; Elsalanty, ME; Zeitoun, R; Awad, ME				Elsayed, Ranya; Kurago, Zoya; Cutler, Christopher W.; Arce, Roger; Gerber, Jennifer; Celis, Esteban; Sultan, Hussein; Elashiry, Mahmoud; Meghil, Mohamed; Sun, Christina; Auersvald, Caroline M.; Elsayed, Riham; Elshikh, Mohey Eldin M.; Isales, Carlos; Elsalanty, Mohammed E.; Zeitoun, Rana; Awad, Mohamed E.			Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw	FASEB JOURNAL			English	Article						alveolar bone healing; dendritic cells; osteonecrosis	MEDICATION-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; PROGENITOR CELLS; POSITION PAPER; BONE; BISPHOSPHONATES; MONOCYTES; ASSOCIATION; REMOVAL; LIGAND	Dendritic cells are an important link between innate and adaptive immune response. The role of dendritic cells in bone homeostasis, however, is not understood. Osteoporosis medications that inhibit osteoclasts have been associated with osteonecrosis, a condition limited to the jawbone, thus called medication-related osteonecrosis of the jaw. We propose that disruption of the local immune response renders the oral microenvironment conducive to osteonecrosis. We tested whether zoledronate (Zol) treatment impaired dendritic cell (DC) functions and increased bacterial load in alveolar bone in vivo and whether DC inhibition alone predisposed the animals to osteonecrosis. We also analyzed the role of Zol in impairment of differentiation and function of migratory and tissue-resident DCs, promoting disruption of T-cell activation in vitro. Results demonstrated a Zol induced impairment in DC functions and an increased bacterial load in the oral cavity. DC-deficient mice were predisposed to osteonecrosis following dental extraction. Zol treatment of DCs in vitro caused an impairment in immune functions including differentiation, maturation, migration, antigen presentation, and T-cell activation. We conclude that the mechanism of Zol-induced osteonecrosis of the jaw involves disruption of DC immune functions required to clear bacterial infection and activate T cell effector response.	[Elsayed, Ranya; Kurago, Zoya; Gerber, Jennifer; Elashiry, Mahmoud; Meghil, Mohamed; Sun, Christina; Auersvald, Caroline M.; Elsalanty, Mohammed E.; Zeitoun, Rana; Awad, Mohamed E.] Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Augusta, GA 30904 USA; [Kurago, Zoya; Celis, Esteban] Augusta Univ, Med Coll Georgia, Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA USA; [Cutler, Christopher W.; Arce, Roger; Elashiry, Mahmoud; Meghil, Mohamed] Augusta Univ, Dent Coll Georgia, Dept Periodont, Augusta, GA 30904 USA; [Sultan, Hussein] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Elsayed, Riham; Elshikh, Mohey Eldin M.] Barts & London Queen Marys Sch Med & Dent, Ctr Expt Med & Rheumatol, William Harvey Res Inst, London, England; [Isales, Carlos] Augusta Univ, Dept Neurosci & Regenerat Med, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Washington University (WUSTL); University of London; Queen Mary University London; University System of Georgia; Augusta University	Elsalanty, ME (corresponding author), Augusta Univ, Dent Coll Georgia, Dept Oral Biol & Diagnost Sci, Augusta, GA 30904 USA.	melsalanty@augusta.edu	Meghil, Mohamed M./I-4851-2019; Awad, Mohamed E./ABC-8407-2020; Sultan, Hussein/AAQ-5261-2020; Isales, Carlos/J-9902-2013; Arce, Roger M./E-6768-2011	Meghil, Mohamed M./0000-0003-2344-3579; Isales, Carlos/0000-0002-4480-3484; El Sayed, Riham/0000-0002-8634-5872; Arce, Roger M./0000-0002-4721-4722; Celis, Esteban/0000-0001-8299-4480	National Institute of Dental and Craniofacial Research [2R15DE025134-02]; National Institute of Health [1-S10 OD025177-01]; National Institute of Aging [2P01AG036675-06A1]	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by the National Institute of Dental and Craniofacial Research award number 2R15DE025134-02, National Institute of Health award number 1-S10 OD025177-01, and the National Institute of Aging award number 2P01AG036675-06A1	Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P2464, DOI 10.1001/jama.2018.7097; Alnaeeli M, 2007, J BONE MINER RES, V22, P775, DOI 10.1359/JBMR.070314; Arizon M, 2012, P NATL ACAD SCI USA, V109, P7043, DOI 10.1073/pnas.1116770109; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bringmann A, 2007, LEUKEMIA, V21, P732, DOI 10.1038/sj.leu.2404556; Cheng ML, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00329; Cutler CW, 2006, J DENT RES, V85, P678, DOI 10.1177/154405910608500801; Cutler CW, 2007, PERIODONTOL 2000, V45, P35, DOI 10.1111/j.1600-0757.2007.00222.x; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Elsayed R, 2018, BONE, V110, P141, DOI 10.1016/j.bone.2018.01.030; Failli A, 2014, HUM VACC IMMUNOTHER, V10, P3375, DOI 10.4161/hv.29416; Ferrari-Lacraz S, 2011, OSTEOPOROSIS INT, V22, P435, DOI 10.1007/s00198-010-1326-y; Howie RN, 2015, ARCH ORAL BIOL, V60, P1699, DOI 10.1016/j.archoralbio.2015.09.001; Howie RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132520; Kalyan S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0568-z; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Kozloff KM, 2010, J BONE MINER RES, V25, P1748, DOI 10.1002/jbmr.66; Kyrgidis A, 2017, OSTEOPOROSIS INT, V28, P991, DOI 10.1007/s00198-016-3807-0; Lam-Ubol A, 2010, INFLAMMATION, V33, P207, DOI 10.1007/s10753-009-9175-6; Liu ZF, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.701:300319, 10.3389/fmicb.2015.00319]; Lombard T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/8768162; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Moutsopoulos NM, 2018, TRENDS IMMUNOL, V39, P276, DOI 10.1016/j.it.2017.08.005; Muccioli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2785; Muratsu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067906; Nudel I, 2011, J IMMUNOL, V186, P891, DOI 10.4049/jimmunol.1002943; Orsini G, 2011, EXP BIOL MED, V236, P1420, DOI 10.1258/ebm.2011.011168; Palani Chithra Devi, 2018, Oncotarget, V9, P6814, DOI 10.18632/oncotarget.23784; Papapoulos SE, 2007, NEW ENGL J MED, V356, P1075, DOI 10.1056/NEJMc062792; Pazianas M, 2011, JNCI-J NATL CANCER I, V103, P232, DOI 10.1093/jnci/djq516; Pushalkar S, 2014, INT J ORAL SCI, V6, P219, DOI 10.1038/ijos.2014.46; Rocha-Perugini V, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00202-17; Roelofs AJ, 2010, CURR PHARM DESIGN, V16, P2950; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Rosella D, 2016, J INT SOC PREV COMMU, V6, P97, DOI 10.4103/2231-0762.178742; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Santiago-Schwarz F, 2001, J IMMUNOL, V167, P1758, DOI 10.4049/jimmunol.167.3.1758; Santini D, 2009, CANCER IMMUNOL IMMUN, V58, P31, DOI 10.1007/s00262-008-0521-6; Sedghizadeh PP, 2008, J ORAL MAXIL SURG, V66, P767, DOI 10.1016/j.joms.2007.11.035; Siegert I, 2014, METHODS MOL BIOL, V1121, P111, DOI 10.1007/978-1-4614-9632-8_9; Stadler AF, 2017, J IMMUNOL METHODS, V449, P7, DOI 10.1016/j.jim.2017.06.007; Svejda B, 2016, WIEN MED WOCHENSCHR, V166, P68, DOI 10.1007/s10354-016-0437-2; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; van Blijswijk J, 2013, EUR J IMMUNOL, V43, P22, DOI 10.1002/eji.201243022; Wilensky A, 2014, ORAL DIS, V20, P119, DOI 10.1111/odi.12122; Wolf AM, 2006, HAEMATOLOGICA, V91, P1165; Wu RQ, 2014, INT J ORAL SCI, V6, P125, DOI 10.1038/ijos.2014.48	49	14	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2595	2608		10.1096/fj.201901819RR	http://dx.doi.org/10.1096/fj.201901819RR		JAN 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31919918	Green Accepted			2022-12-26	WOS:000506587800001
J	Pawlik, G; Renne, MF; Kol, MA; de Kroon, AIPM				Pawlik, Grzegorz; Renne, Mike F.; Kol, Matthijs A.; de Kroon, Anton I. P. M.			The topology of the ER-resident phospholipid methyltransferase Opi3 of Saccharomyces cerevisiae is consistent with in trans catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid metabolism; cysteine-mediated cross-linking; membrane enzyme; yeast; S-adenosylmethionine (SAM); cysteine scanning; in trans catalysis; membrane topology; phosphatidylethanolamine N-methyltransferase (PEMT); phospholipid N-methyltransferase (PLMT)	CROSS-PATHWAY REGULATION; N-METHYLTRANSFERASES; MEMBRANE-PROTEINS; CONTACT SITES; PHOSPHATIDYLCHOLINE; METHYLATION; MECHANISM; MEMBER; GENE; WEB	Phospholipid N-methyltransferases (PLMTs) synthesize phosphatidylcholine by methylating phosphatidylethanolamine using S-adenosylmethionine as a methyl donor. Eukaryotic PLMTs are integral membrane enzymes located in the endoplasmic reticulum (ER). Recently Opi3, a PLMT of the yeast Saccharomyces cerevisiae was proposed to perform in trans catalysis, i.e. while localized in the ER, Opi3 would methylate lipid substrates located in the plasma membrane at membrane contact sites. Here, we tested whether the Opi3 active site is located at the cytosolic side of the ER membrane, which is a prerequisite for in trans catalysis. The membrane topology of Opi3 (and its human counterpart, phosphatidylethanolamine N-methyltransferase, expressed in yeast) was addressed by topology prediction algorithms and by the substituted cysteine accessibility method. The results of these analyses indicated that Opi3 (as well as phosphatidylethanolamine N-methyltransferase) has an N-out C-in topology and contains four transmembrane domains, with the fourth forming a re-entrant loop. On the basis of the sequence conservation between the C-terminal half of Opi3 and isoprenyl cysteine carboxyl methyltransferases with a solved crystal structure, we identified amino acids critical for Opi3 activity by site-directed mutagenesis. Modeling of the structure of the C-terminal part of Opi3 was consistent with the topology obtained by the substituted cysteine accessibility method and revealed that the active site faces the cytosol. In conclusion, the location of the Opi3 active site identified here is consistent with the proposed mechanism of in trans catalysis, as well as with conventional catalysis in cis.	[Pawlik, Grzegorz; Renne, Mike F.; Kol, Matthijs A.; de Kroon, Anton I. P. M.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Membrane Biochem & Biophys, NL-3584 CH Utrecht, Netherlands; [Pawlik, Grzegorz; Renne, Mike F.; Kol, Matthijs A.; de Kroon, Anton I. P. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Pawlik, Grzegorz] Liposoma BV, Sci Pk 408, NL-1098 XH Amsterdam, Netherlands; [Renne, Mike F.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kol, Matthijs A.] Univ Osnabruck, Dept Biol Chem, Mol Cell Biol Div, D-49076 Osnabruck, Germany	Utrecht University; Utrecht University; University of Oxford; University Osnabruck	de Kroon, AIPM (corresponding author), Univ Utrecht, Dept Membrane Biochem & Biophys, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.i.p.m.dekroon@uu.nl		de Kroon, Anton/0000-0003-1209-756X; Renne, Mike/0000-0003-0508-2298	Focus en Massa Program Membrane proteins of Utrecht University	Focus en Massa Program Membrane proteins of Utrecht University	This work was supported by the Focus en Massa Program Membrane proteins of Utrecht University. The authors declare that they have no conflicts of interest with the contents of this article.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boumann HA, 2004, J BIOL CHEM, V279, P40314, DOI 10.1074/jbc.M406517200; Brooks CL, 2013, PROTEIN SCI, V22, P425, DOI 10.1002/pro.2223; Danne L, 2015, MOL MICROBIOL, V95, P313, DOI 10.1111/mmi.12870; DAUM G, 1982, J BIOL CHEM, V257, P3028; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Diver MM, 2018, NATURE, V553, P526, DOI 10.1038/nature25439; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gietz RD, 2014, METHODS MOL BIOL, V1205, P1, DOI 10.1007/978-1-4939-1363-3_1; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Henrich E, 2018, BIOCHEMISTRY-US, V57, P5780, DOI 10.1021/acs.biochem.8b00807; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Holzl G, 2019, ANNU REV PLANT BIOL, V70, P51, DOI 10.1146/annurev-arplant-050718-100202; Hoffmann PC, 2017, BIOL CELL, V109, P400, DOI 10.1111/boc.201700031; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Janssen MJFW, 2002, FEBS LETT, V513, P197, DOI 10.1016/S0014-5793(02)02298-6; Kanipes MI, 1997, BBA-LIPID LIPID MET, V1348, P134, DOI 10.1016/S0005-2760(97)00121-5; Keogh MR, 2009, J BIOL CHEM, V284, P15439, DOI 10.1074/jbc.M109.005991; Kim H, 2003, J BIOL CHEM, V278, P10208, DOI 10.1074/jbc.M300163200; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; MCGRAW P, 1989, GENETICS, V122, P317; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Morita S, 2010, BIOCHEM J, V432, P387, DOI 10.1042/BJ20100490; Pagac M, 2012, MOL MICROBIOL, V86, P1156, DOI 10.1111/mmi.12047; Pagac M, 2011, J BIOL CHEM, V286, P36438, DOI 10.1074/jbc.M111.256511; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Pundir Sangya, 2016, Curr Protoc Bioinformatics, V53, DOI 10.1002/0471250953.bi0129s53; Quon E, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003864; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16864; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sadhua MJ, 2014, MOL BIOL CELL, V25, P1653, DOI 10.1091/mbc.E13-12-0755; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; SUMMERS EF, 1988, GENETICS, V120, P909; Tavassoli S, 2013, EMBO REP, V14, P434, DOI 10.1038/embor.2013.36; Vance DE, 2013, BBA-MOL CELL BIOL L, V1831, P626, DOI 10.1016/j.bbalip.2012.07.017; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020; Ye CQ, 2017, MOL CELL, V66, P180, DOI 10.1016/j.molcel.2017.02.026	51	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2473	2482		10.1074/jbc.RA119.011102	http://dx.doi.org/10.1074/jbc.RA119.011102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31932304	Green Published, hybrid			2022-12-26	WOS:000517330200027
J	Durand, L; Duval, S; Evagelidis, A; Guillemot, J; Dianati, V; Sikorska, E; Schu, P; Day, R; Seidah, NG				Durand, Lorelei; Duval, Stephanie; Evagelidis, Alexandra; Guillemot, Johann; Dianati, Vahid; Sikorska, Emilia; Schu, Peter; Day, Robert; Seidah, Nabil G.			The motif EXEXXXL in the cytosolic tail of the secretory human proprotein convertase PC7 regulates its trafficking and cleavage activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						shedding; trafficking; protease; protein dynamic; convertase; adaptor protein 2 (AP-2); cell sorting; cytosolic tail (CT); proprotein convertase type 7; transferrin receptor 1(TfR1)	FURIN; MEMBRANE; BINDING; AP-1; COMPLEMENTARY; INHIBITION; EXPRESSION; BIOLOGY; GROWTH; CELLS	Many secretory proteins are activated by cleavage at specific sites. The proprotein convertases (PCs) form a family of nine secretory subtilisin-like serine proteases, seven of which cleave at specific basic residues within the trans-Golgi network, granules, or at the cell surface/endosomes. The seventh member, PC7, is a type-I transmembrane (TM) protein with a 97-residue?long cytosolic tail (CT). PC7 sheds human transferrin receptor 1 (hTfR1) into soluble shTfR1 in endosomes. To better understand the physiological roles of PC7, here we focused on the relationship between the CT-regulated trafficking of PC7 and its ability to shed hTfR1. Deletion of the TMCT resulted in soluble PC7 and loss of its hTfR1 shedding activity. Extensive CT deletions and mutagenesis analyses helped us zoom in on three residues in the CT, namely Glu-719, Glu-721, and Leu-725, that are part of a novel motif, EXEXXXL725, critical for PC7 activity on hTfR1. NMR studies of two 14-mer peptides mimicking this region of the CT and its Ala variants revealed that the three exposed residues are on the same side of the molecule. This led to the identification of adaptor protein 2 (AP-2) as a protein that recognizes the EXEXXXL725 motif, thus representing a potentially new regulator of PC7 trafficking and cleavage activity. Immunocytochemistry of the subcellular localization of PC7 and its Ala variants of Leu-725 and Glu-719 and Glu-721 revealed that Leu-725 enhances PC7 localization to early endosomes and that, together with Glu-719 and Glu-721, it increases the endosomal activity of PC7 on hTfR1.	[Durand, Lorelei; Duval, Stephanie; Evagelidis, Alexandra; Seidah, Nabil G.] Univ Montreal, Clin Res Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Guillemot, Johann] Univ Lyon, Univ Claude Bernard Lyon 1, Ecole Normale Super Lyon, CIRI,INSERM,U1111,CNRS,UMR5308,Team Pathogenesis, F-69100 Villeurbanne, France; [Dianati, Vahid; Day, Robert] Inst Pharmacol Sherbrooke, Dept Surg, Div Urol, Sherbrooke, PQ J1H 5N4, Canada; [Dianati, Vahid; Day, Robert] Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada; [Sikorska, Emilia] Univ Gdansk, Fac Chem, PL-80233 Gdansk, Poland; [Schu, Peter] Univ Med Ctr, Dept Cellular Biochem, Humboldtallee 23, D-37073 Gottingen, Germany	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Fahrenheit Universities; University of Gdansk; University of Gottingen	Seidah, NG (corresponding author), Clin Res Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Guillemot, Johann/O-1066-2013; Seidah, Nabil/I-3596-2013	Guillemot, Johann/0000-0002-5902-9188; Seidah, Nabil/0000-0001-6503-9342; Sikorska, Emilia/0000-0001-7851-6371; Dianati, Vahid/0000-0001-6883-6574; Schu, Peter/0000-0001-7169-1097	Canadian Institutes of Health Research Foundation Scheme [148363]; Canada Research Chair [950-231335]	Canadian Institutes of Health Research Foundation Scheme(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institutes of Health Research Foundation Scheme 148363 and Canada Research Chair 950-231335. The authors declare that they have no conflicts of interest with the contents of this article.	Ashraf Y, 2018, ATHEROSCLEROSIS SUPP, V32, P56, DOI 10.1016/j.atherosclerosissup.2018.04.169; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Baltes J, 2014, J CELL SCI, V127, P3477, DOI 10.1242/jcs.146886; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chamberland JP, 2016, J CELL SCI, V129, P2625, DOI 10.1242/jcs.173708; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Dacks JB, 2017, CURR OPIN CELL BIOL, V47, P108, DOI 10.1016/j.ceb.2017.04.001; Declercq J, 2017, EUR J CELL BIOL, V96, P432, DOI 10.1016/j.ejcb.2017.03.010; Declercq J, 2012, J BIOL CHEM, V287, P9052, DOI 10.1074/jbc.M111.306407; Dongiovanni P, 2019, J LIPID RES, V60, P1144, DOI 10.1194/jlr.P090449; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Gavenonis J, 2014, NAT CHEM BIOL, V10, P716, DOI [10.1038/NCHEMBIO.1580, 10.1038/nchembio.1580]; Ginefra P, 2018, CELL REP, V22, P2176, DOI 10.1016/j.celrep.2018.02.005; Gu JS, 2010, EXP CELL RES, V316, P1946, DOI 10.1016/j.yexcr.2010.03.026; Guardia CM, 2018, CURR OPIN NEUROBIOL, V51, P103, DOI 10.1016/j.conb.2018.02.021; Guillemot J, 2014, FEBS OPEN BIO, V4, P741, DOI 10.1016/j.fob.2014.08.004; Guillemot J, 2013, HEPATOLOGY, V57, P2514, DOI 10.1002/hep.26297; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medigeshi GR, 2008, TRAFFIC, V9, P121, DOI 10.1111/j.1600-0854.2007.00672.x; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Rajan SG, 2018, GENESIS, V56, DOI 10.1002/dvg.23214; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Rousselet E, 2011, J BIOL CHEM, V286, P9185, DOI 10.1074/jbc.M110.189936; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Seidah Nabil G, 2017, Glob Cardiol Sci Pract, V2017, pe201702, DOI 10.21542/gcsp.2017.2; Seidah NG, 2014, CIRC RES, V114, P1022, DOI 10.1161/CIRCRESAHA.114.301621; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Senturker S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039380; Sergeeva OA, 2019, P NATL ACAD SCI USA, V116, P1279, DOI 10.1073/pnas.1812588116; Shi X, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00559; Susan-Resiga D, 2017, J BIOL CHEM, V292, P1573, DOI 10.1074/jbc.M116.769430; Tie HC, 2017, JOVE-J VIS EXP, DOI 10.3791/55996; Turpeinen H, 2013, J BIOL CHEM, V288, P36610, DOI 10.1074/jbc.M113.453183; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Voelz VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000281; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	51	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2068	2083		10.1074/jbc.RA119.011775	http://dx.doi.org/10.1074/jbc.RA119.011775			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915245	hybrid, Green Published			2022-12-26	WOS:000517128200024
J	Edward, A; Hoffmann, L; Manase, F; Matsushita, K; Pariyo, GW; Brady, TM; Appel, LJ				Edward, Anbrasi; Hoffmann, Lisa; Manase, Frank; Matsushita, Kunihiro; Pariyo, George William; Brady, Tammy M.; Appel, Lawrence J.			An exploratory study on the quality of patient screening and counseling for hypertension management in Tanzania	PLOS ONE			English	Article								Background The global burden of hypertension, currently estimated at 1 billion, is a leading Non-Communicable Disease (NCD) in Sub Saharan Africa. In Tanzania, the reported prevalence of hypertension is 25%. Inherent limitations of the healthcare system to control hypertension include inadequate provider knowledge, system capacity, medication access, and patient awareness, all of which hinder effective screening and disease management. To assess the quality of hypertension screening and patient counseling, we conducted a study in an ambulatory setting in Tanzania. Methods Observations of patient screening were conducted on 69 adult patients during routine outpatient care and screening camps. In addition, 33 healthcare providers participated in a prepost knowledge assessment after observing instructional training videos. Results Patient observations indicated that blood pressure (BP) measurement was explained to 65% of patients, and 77% of the measurements were made with mercury sphygmomanometers. For several aspects of BP measurement, nurses performed better than doctors: patient's arm supported on a flat surface (doctors, 58% vs nurses 67%, p<0.05), and patient's back was supported (doctors, 50% vs nurses 88%, p<0.01). Among those diagnosed with hypertension, 7% were prescribed medications, 14% were advised on reduced salt during cooking, 29% on reduced salt consumption, 21% on reduced consumption of sodium rich foods, 21% on reducing caloric intake, 21% on increasing physical activity, and 43% were informed about follow up appointments. Provider knowledge assessments showed critical gaps in consequences of hypertension, 1st line medicines, and awareness of guidelines at baseline. Following the instructional videos there were improvements in some aspects: diagnostic criteria for hypertension (pre 45% vs post 91%, p<0.001) and counseling for controlling hypertension (pre 30% vs post 58%, p<0.01). Conclusion Enhancing knowledge and performance competencies of health providers at the primary care level is a critical prerequisite for effective hypertension management in low resource settings.	[Edward, Anbrasi; Pariyo, George William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Hoffmann, Lisa] WHO, Patient Safety & Risk Management Unit, Geneva, Switzerland; [Manase, Frank] Community Ctr Prevent Med, Dar Es Salaam, Tanzania; [Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Sch Med, Dept Epidemiol, Div Cardiol, Baltimore, MD USA; [Brady, Tammy M.] Johns Hopkins Sch Med, Div Pediat Nephrol, Baltimore, MD USA; [Appel, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Sch Med, Dept Epidemiol, Baltimore, MD USA; [Appel, Lawrence J.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Sch Med, Dept Int Hlth, Baltimore, MD USA; [Appel, Lawrence J.] Johns Hopkins Sch Nursing, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Johns Hopkins University	Edward, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	aedward1@jhu.edu	Appel, Larry/GLT-2608-2022; Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X	Johns Hopkins Bloomberg School of Public Health; Resolve to Save Lives - Bloomberg Philanthropies; Bill and Melinda Gates Foundation; Gates Philanthropy Partners; Chan Zuckerberg Foundation [69577]; MPH travel award; Resolve to Save Lives project at Johns Hopkins	Johns Hopkins Bloomberg School of Public Health(Johns Hopkins University); Resolve to Save Lives - Bloomberg Philanthropies; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gates Philanthropy Partners; Chan Zuckerberg Foundation; MPH travel award; Resolve to Save Lives project at Johns Hopkins	The study was conducted with support from an MPH travel award from the Johns Hopkins Bloomberg School of Public Health. Partial financial support for the video testing component was provided by Resolve to Save Lives, which is funded by Bloomberg Philanthropies, the Bill and Melinda Gates Foundation, and Gates Philanthropy Partners, funded with support from the Chan Zuckerberg Foundation; Grant #69577. LH was funded by the MPH travel award, and AE, KM, LA, GP and TB were partially funded by the Resolve to Save Lives project at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diagnostic Corporation, TAK BLOOD PRESS; [Anonymous], 2015, CARD DIS CVDS; Bintabara D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192942; Galson SW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018829; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Mbuya FE, 2014, TANZAN J HLTH RES, V16, P98, DOI [10.4314/thrb.v16i2.5, DOI 10.4314/THRB.V16I2.5]; Mosha NR, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1321279; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Peck RN, 2013, J HYPERTENS, V31, P1806, DOI 10.1097/HJH.0b013e328362bad7; United Republic of Tanzania Ministry of Health and Social Welfare, 2008, NAT NONC DIS STRAT; World Health Organization, 2018, NONC DIS NCD COUNTR; World Health Organization, 2009, GLOB HLTH RISKS MORT, P16; World Health Organization, 2018, GLOB HLTH OBS GHO DA; World Health Organization, 2018, GLOB HTLH OBS GHO DA	14	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227439	10.1371/journal.pone.0227439	http://dx.doi.org/10.1371/journal.pone.0227439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945075	Green Published, gold			2022-12-26	WOS:000534370100039
J	Yang, YC; Tao, J; Zong, SX				Yang, Yuchao; Tao, Jing; Zong, Shixiang			Identification of putative Type-I sex pheromone biosynthesis-related genes expressed in the female pheromone gland of Streltzoviella insularis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ACTIVATING NEUROPEPTIDE RECEPTOR; FATTY-ACID BIOSYNTHESIS; RAT-LIVER MITOCHONDRIA; HELICOVERPA-ZEA; BOMBYX-MORI; DIFFERENTIAL EXPRESSION; MAMESTRA-BRASSICAE; LEAFROLLER MOTH; BETA-OXIDATION	Species-specific sex pheromones play key roles in moth sexual communication. Although the general pathway of Type-I sex pheromone biosynthesis is well established, only a handful of genes encoding enzymes involved in this pathway have been characterized. Streltzoviella insularis is a destructive wood-boring pest of many street trees in China, and the female sex pheromone of this species comprises a blend of (Z)-3-tetradecenyl acetate, (E)-3-tetradecenyl acetate, and (Z)-5-dodecenyl acetate. This organism therefore provides an excellent model for research on the diversity of genes and molecular mechanisms involved in pheromone production. Herein, we assembled the pheromone gland transcriptome of S. insularis by next-generation sequencing and identified 74 genes encoding candidate key enzymes involved in the fatty acid biosynthesis, beta-oxidation, and functional group modification. In addition, tissue expression patterns further showed that an acetyl-CoA carboxylase and two desaturases were highly expressed in the pheromone glands compared with the other tissues, indicating possible roles in S. insularis sex pheromone biosynthesis. Finally, we proposed putative S. insularis biosynthetic pathways for sex pheromone components and highlighted candidate genes. Our findings lay a solid foundation for understanding the molecular mechanisms underpinning S. insularis sex pheromone biosynthesis, and provide potential targets for disrupting chemical communication that could assist the development of novel pest control methods.	[Yang, Yuchao; Tao, Jing; Zong, Shixiang] Beijing Forestry Univ, Sch Forestry, Beijing Key Lab Forest Pest Control, Beijing, Peoples R China	Beijing Forestry University	Tao, J; Zong, SX (corresponding author), Beijing Forestry Univ, Sch Forestry, Beijing Key Lab Forest Pest Control, Beijing, Peoples R China.	taojing1029@hotmail.com; zongsx@126.com			Fundamental Research Funds for the Central Universities [2018ZY24]; Beijing's Science and Technology Planning Project [Z171100001417005]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing's Science and Technology Planning Project	This research was funded by Fundamental Research Funds for the Central Universities (2018ZY24) and Beijing's Science and Technology Planning Project (Z171100001417005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; BESTMANN HJ, 1987, EXPERIENTIA, V43, P1033; BJOSTAD LB, 1984, J CHEM ECOL, V10, P681, DOI 10.1007/BF00994228; BJOSTAD LB, 1981, J BIOL CHEM, V256, P7936; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; Chen DS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16518-8; Choi MY, 2006, ANN ENTOMOL SOC AM, V99, P905, DOI 10.1603/0013-8746(2006)99[905:ROECAC]2.0.CO;2; Choi MY, 2003, P NATL ACAD SCI USA, V100, P9721, DOI 10.1073/pnas.1632485100; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding BJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1909-2; Eliyahu D, 2003, PESTIC BIOCHEM PHYS, V77, P75, DOI 10.1016/S0048-3575(03)00101-9; FANG NB, 1995, ARCH INSECT BIOCHEM, V30, P321, DOI 10.1002/arch.940300403; Fodor J, 2018, GEN COMP ENDOCR, V258, P60, DOI 10.1016/j.ygcen.2017.05.024; Foster SP, 1996, ARCH INSECT BIOCHEM, V33, P135, DOI 10.1002/(SICI)1520-6327(1996)33:2&lt;135::AID-ARCH4&gt;3.0.CO;2-X; FOSTER SP, 1988, ARCH INSECT BIOCHEM, V8, P1, DOI 10.1002/arch.940080102; Gao R. T., 1983, FOR PEST DIS, V1, P3; GOLZ A, 1994, J PLANT PHYSIOL, V143, P426, DOI 10.1016/S0176-1617(11)81802-X; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu SH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-636; HARWOOD JL, 1988, ANNU REV PLANT PHYS, V39, P101, DOI 10.1146/annurev.arplant.39.1.101; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hull JJ, 2005, BIOCHEM BIOPH RES CO, V334, P69, DOI 10.1016/j.bbrc.2005.06.050; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; Jurenka R, 2004, TOP CURR CHEM, V239, P97, DOI 10.1007/b95450; JURENKA RA, 1989, INSECT BIOCHEM, V19, P639, DOI 10.1016/0020-1790(89)90098-X; JURENKA RA, 1991, INSECT BIOCHEM, V21, P81, DOI 10.1016/0020-1790(91)90067-O; JURENKA RA, 1991, P NATL ACAD SCI USA, V88, P8621, DOI 10.1073/pnas.88.19.8621; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; Knipple DC, 2002, GENETICS, V162, P1737; Kozlov MV, 1996, J CHEM ECOL, V22, P431, DOI 10.1007/BF02033647; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Liu HX, 2018, ORIENT INSECTS, V52, P420, DOI 10.1080/00305316.2018.1437088; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOFSTEDT C, 1994, J CHEM ECOL, V20, P153, DOI 10.1007/BF02065998; LOFSTEDT C, 1988, J CHEM ECOL, V14, P903, DOI 10.1007/BF01018782; Lofstedt C, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P43; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Matsumoto S, 2010, BIOSCI BIOTECH BIOCH, V74, P223, DOI 10.1271/bbb.90756; MCNEIL JN, 1991, ANNU REV ENTOMOL, V36, P407, DOI 10.1146/annurev.en.36.010191.002203; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MORSE D, 1987, INSECT BIOCHEM, V17, P53, DOI 10.1016/0020-1790(87)90143-0; Moto K, 2004, P NATL ACAD SCI USA, V101, P8631, DOI 10.1073/pnas.0402056101; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Nusawardani T, 2013, INSECT MOL BIOL, V22, P331, DOI 10.1111/imb.12025; PAPE ME, 1988, ARCH BIOCHEM BIOPHYS, V267, P104, DOI 10.1016/0003-9861(88)90013-6; Park HY, 2008, INSECT BIOCHEM MOLEC, V38, P581, DOI 10.1016/j.ibmb.2008.02.001; Rafaeli A, 2007, INSECT MOL BIOL, V16, P287, DOI 10.1111/j.1365-2583.2007.00725.x; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; RAINA AK, 1989, SCIENCE, V244, P796, DOI 10.1126/science.244.4906.796; Rambaut A, 2014, FIGTREE 1 4 2 SOFTWA; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; SOFER W, 1987, ANNU REV GENET, V21, P203, DOI 10.1146/annurev.genet.21.1.203; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANG JD, 1989, P NATL ACAD SCI USA, V86, P1806, DOI 10.1073/pnas.86.6.1806; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TEAL PEA, 1987, ARCH INSECT BIOCHEM, V4, P261, DOI 10.1002/arch.940040404; TEAL PEA, 1988, J CHEM ECOL, V14, P2131, DOI 10.1007/BF01014254; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOLPE JJ, 1973, ANNU REV BIOCHEM, V42, P21, DOI 10.1146/annurev.bi.42.070173.000321; Wang HL, 2010, INSECT BIOCHEM MOLEC, V40, P742, DOI 10.1016/j.ibmb.2010.07.009; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Xu LL, 2017, CAN J ZOOL, V95, P611, DOI 10.1139/cjz-2016-0225; Zhang Jintong, 2001, Scientia Silvae Sinicae, V37, P71; Zhang Jintong, 2000, Scientia Silvae Sinicae, V36, P123; Zhang YN, 2017, MOL GENET GENOMICS, V292, P795, DOI 10.1007/s00438-017-1307-3; Zhang YN, 2014, J CHEM ECOL, V40, P439, DOI 10.1007/s10886-014-0433-1; ZHAO CH, 1990, ARCH INSECT BIOCHEM, V15, P57, DOI 10.1002/arch.940150106; Zhu JW, 1996, INSECT BIOCHEM MOLEC, V26, P171, DOI 10.1016/0965-1748(95)00079-8	76	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227666	10.1371/journal.pone.0227666	http://dx.doi.org/10.1371/journal.pone.0227666			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945099	Green Published, gold			2022-12-26	WOS:000534370100051
J	Zoulias, N; Brown, J; Rowe, J; Casson, SA				Zoulias, Nicholas; Brown, Jordan; Rowe, James; Casson, Stuart A.			HY5 is not integral to light mediated stomatal development in Arabidopsis	PLOS ONE			English	Article							GENE-EXPRESSION; ABSCISIC-ACID; COP1; TRANSFORMATION; PROMOTERS; RESPONSES; BINDING; SWITCH; PCR	Light is a crucial signal that regulates many aspects of plant physiology and growth including the development of stomata, the pores in the epidermal surface of the leaf. Light signals positively regulate stomatal development leading to changes in stomatal density and stomatal index (SI; the proportion of cells in the epidermis that are stomata). Both phytochrome and cryptochrome photoreceptors are required to regulate stomatal development in response to light. The transcription factor ELONGATED HYPOCOTYL 5 (HY5) is a key regulator of light signalling, acting downstream of photoreceptors. We hypothesised that HY5 could regulate stomatal development in response to light signals due to the putative presence of HY5 binding sites in the promoter of the STOMAGEN (STOM) gene, which encodes a peptide regulator of stomatal development. Our analysis shows that HY5 does have the potential to regulate the STOM promoter in vitro and that HY5 is expressed in both the epidermis and mesophyll. However, analysis of hy5 and hy5 hyh double mutants (HYH; HY5-HOMOLOG), found that they had normal stomatal development under different light conditions and the expression of stomatal developmental genes was not perturbed following light shift experiments. Analysis of stable lines overexpressing HY5 also showed no change in stomatal development or the expression of stomatal developmental genes. We therefore conclude that whilst HY5 has the potential to regulate the expression of STOM, it does not have a major role in regulating stomatal development in response to light signals.	[Zoulias, Nicholas; Brown, Jordan; Casson, Stuart A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [Rowe, James] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Brown, Jordan] Chameleon Commun Int, Wilmslow, Cheshire, England	University of Sheffield; University of Cambridge; Chameleon Communications International	Casson, SA (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England.	s.casson@sheffield.ac.uk		Rowe, Jim/0000-0002-3523-4347; Casson, Stuart/0000-0001-5702-6947	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N002393/1]; Departmental PhD studentship; BBSRC [BB/N002393/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Departmental PhD studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) grant (BB/N002393/1) and a Departmental PhD studentship (JB) to SAC. https://bbsrc.ukri.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; Assmann SM, 2016, CURR OPIN PLANT BIOL, V33, P157, DOI 10.1016/j.pbi.2016.07.003; Binkert M, 2014, PLANT CELL, V26, P4200, DOI 10.1105/tpc.114.130716; Casson SA, 2009, CURR BIOL, V19, P229, DOI 10.1016/j.cub.2008.12.046; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; Chen XB, 2016, CURR BIOL, V26, P640, DOI 10.1016/j.cub.2015.12.066; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Geldner N, 2009, PLANT J, V59, P169, DOI 10.1111/j.1365-313X.2009.03851.x; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Hunt L, 2010, NEW PHYTOL, V186, P609, DOI 10.1111/j.1469-8137.2010.03200.x; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kang CY, 2009, PLANT CELL, V21, P2624, DOI 10.1105/tpc.109.069765; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; Lee JH, 2017, PLANT CELL, V29, P2817, DOI 10.1105/tpc.17.00371; Lee JS, 2015, NATURE, V522, P435, DOI 10.1038/nature14561; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Meng XZ, 2015, CURR BIOL, V25, P2361, DOI 10.1016/j.cub.2015.07.068; Ohashi-Ito K, 2006, PLANT CELL, V18, P2493, DOI 10.1105/tpc.106.046136; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Putarjunan A, 2019, NAT PLANTS, V5, P742, DOI 10.1038/s41477-019-0440-x; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Yadav V, 2002, PLANT J, V31, P741, DOI 10.1046/j.1365-313X.2002.01395.x; Zhang JH, 2014, ADV INTEL SYS RES, V111, P29; Zhang YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180449; Zhong SL, 2008, TRANSGENIC RES, V17, P985, DOI 10.1007/s11248-008-9199-y; Zoulias N, 2018, BIOCHEM J, V475, P441, DOI 10.1042/BCJ20170413	35	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0222480	10.1371/journal.pone.0222480	http://dx.doi.org/10.1371/journal.pone.0222480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945058	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000534370100006
J	Hirahara, N; Nakamura, HM; Sasaki, S; Matsushita, A; Ohba, K; Kuroda, G; Sakai, Y; Shinkai, S; Haeno, H; Nishio, T; Yoshida, S; Oki, Y; Suda, T				Hirahara, Naoko; Nakamura, Hiroko Misawa; Sasaki, Shigekazu; Matsushita, Akio; Ohba, Kenji; Kuroda, Go; Sakai, Yuki; Shinkai, Shinsuke; Haeno, Hiroshi; Nishio, Takuhiro; Yoshida, Shuichi; Oki, Yutaka; Suda, Takafumi			Liganded T3 receptor beta 2 inhibits the positive feedback autoregulation of the gene for GATA2, a transcription factor critical for thyrotropin production	PLOS ONE			English	Article							PITUITARY-THYROID AXIS; ALPHA-SUBUNIT GENE; PROTEIN-KINASE-C; NEGATIVE REGULATION; ALTERNATIVE PROMOTERS; HORMONE RECEPTORS; MOLECULAR-BIOLOGY; EXPRESSION; GONADOTROPE; THYROXINE	The serum concentration of thyrotropin (thyroid stimulating hormone, TSH) is drastically reduced by small increase in the levels of thyroid hormones (T3 and its prohormone, T4); however, the mechanism underlying this relationship is unknown. TSH consists of the chorionic gonadotropin a (CGA) and the beta chain (TSH beta). The expression of both peptides is induced by the transcription factor GATA2, a determinant of the thyrotroph and gonadotroph differentiation in the pituitary. We previously reported that the liganded T3 receptor (TR) inhibits transactivation activity of GATA2 via a tethering mechanism and proposed that this mechanism, but not binding of TR with a negative T3-responsive element, is the basis for the T3-dependent inhibition of the TSH beta and CGA genes. Multiple GATA-responsive elements (GATA-REs) also exist within the GATA2 gene itself and mediate the positive feedback autoregulation of this gene. To elucidate the effect of T3 on this non-linear regulation, we fused the GATA-REs at -3.9 kb or +9.5 kb of the GATA2 gene with the chloramphenicol acetyltransferase reporter gene harbored in its 1S-promoter. These constructs were co-transfected with the expression plasmids for GATA2 and the pituitary specific TR, TR beta 2, into kidney-derived CV1 cells. We found that liganded TR beta 2 represses the GATA2-induced transactivation of these reporter genes. Multi-dimensional input function theory revealed that liganded TR beta 2 functions as a classical transcriptional repressor. Then, we investigated the effect of T3 on the endogenous expression of GATA2 protein and mRNA in the gonadotroph-derived L beta T2 cells. In this cell line, T3 reduced GATA2 protein independently of the ubiquitin proteasome system. GATA2 mRNA was drastically suppressed by T3, the concentration of which corresponds to moderate hypothyroidism and euthyroidism. These results suggest that liganded TR beta 2 inhibits the positive feedback autoregulation of the GATA2 gene; moreover this mechanism plays an important role in the potent reduction of TSH production by T3.	[Hirahara, Naoko] Japanese Red Cross Shizuoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Shizuoka, Shizuoka, Japan; [Nakamura, Hiroko Misawa; Sasaki, Shigekazu; Matsushita, Akio; Kuroda, Go; Sakai, Yuki; Shinkai, Shinsuke; Suda, Takafumi] Hamamatsu Univ, Dept Internal Med, Div 2, Sch Med, Hamamatsu, Shizuoka, Japan; [Ohba, Kenji] Hamamatsu Univ, Med Educ Ctr, Sch Med, Hamamatsu, Shizuoka, Japan; [Haeno, Hiroshi] Univ Tokyo Kashiwa, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Nishio, Takuhiro; Yoshida, Shuichi] Hamamatsu Univ, Dept Integrated Human Sci, Sch Med, Hamamatsu, Shizuoka, Japan; [Oki, Yutaka] Hamamatsu Univ, Dept Family & Community Med, Sch Med, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Sasaki, S (corresponding author), Hamamatsu Univ, Dept Internal Med, Div 2, Sch Med, Hamamatsu, Shizuoka, Japan.	sasakis@hama-med.ac.jp	Ohba, Kenji/AAU-5180-2021	Ohba, Kenji/0000-0001-8538-8742	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590689]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in Aid for Scientific Research to S. S. from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 24590689). The sponsors or funders play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.jsps.go.jp/j-grantsinaid/	Abel ED, 1999, J CLIN INVEST, V104, P291, DOI 10.1172/JCI6397; Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Alon U., 2006, INTRO SYSTEMS BIOL D, P253; ASHIZAWA K, 1992, P NATL ACAD SCI USA, V89, P9277, DOI 10.1073/pnas.89.19.9277; Bai H, 2013, J REPROD DEVELOP, V59, P1, DOI 10.1262/jrd.2012-100; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366, DOI 10.1210/me.2005-0378; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Christoffolete MA, 2006, ENDOCRINOLOGY, V147, P1735, DOI 10.1210/en.2005-1300; Cohen RN, 2012, WERNER INGBARS THYRO, P149; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P5049, DOI 10.1210/en.2012-1504; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; De Sousa SMC, 2015, ENDOCRINOL DIABETES, V2015, DOI [DOI 10.1530/EDM-15-0017, 10.1530/EDM-15-0017]; DELEAN A, 1977, ENDOCRINOLOGY, V100, P1496, DOI 10.1210/endo-100-6-1496; Dietrich JW, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00287; Donadieu J, 2018, HAEMATOLOGICA, V103, P1278, DOI 10.3324/haematol.2017.181909; Fekete C, 2014, ENDOCR REV, V35, P159, DOI 10.1210/er.2013-1087; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Fowkes RC, 2002, BIOL REPROD, V67, P725, DOI 10.1095/biolreprod67.3.725; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Gergics P, 2016, ENDOCRINOLOGY, V157, P3631, DOI 10.1210/en.2016-1183; Gordon DF, 1997, J BIOL CHEM, V272, P24339, DOI 10.1074/jbc.272.39.24339; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Hadlow NC, 2013, J CLIN ENDOCR METAB, V98, P2936, DOI 10.1210/jc.2012-4223; Hoermann R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187232; Hoermann R, 2010, EUR J ENDOCRINOL, V162, P1123, DOI 10.1530/EJE-10-0106; Home P, 2017, DEVELOPMENT, V144, P876, DOI 10.1242/dev.145318; Ingley E, 2001, J BIOL CHEM, V276, P43428, DOI 10.1074/jbc.M106645200; Iwaki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088610; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Kashiwabara Y, 2009, J MOL ENDOCRINOL, V42, P225, DOI 10.1677/JME-08-0099; Katsumura KR, 2017, BLOOD, V129, P2092, DOI 10.1182/blood-2016-09-687871; Kilby MD, 2005, PLACENTA, V26, P105, DOI 10.1016/j.placenta.2004.08.004; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; KOHLER PO, 1971, J CLIN ENDOCR METAB, V32, P683, DOI 10.1210/jcem-32-5-683; KRANE IM, 1991, MOL ENDOCRINOL, V5, P469, DOI 10.1210/mend-5-4-469; Larsen PR, 2015, WILLIAMS TXB ENDOCRI, P334; Laverriere JN, 2016, MOL CELL ENDOCRINOL, V434, P250, DOI 10.1016/j.mce.2016.07.010; Leow MKS, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-35; Liu CQ, 2003, J BIOL CHEM, V278, P44857, DOI 10.1074/jbc.M304489200; Lo A, 2011, J MOL ENDOCRINOL, V47, P45, DOI 10.1530/JME-10-0137; Matsunaga H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142400; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Medici M, 2015, ENDOCR REV, V36, P214, DOI 10.1210/er.2014-1081; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minegishi N, 2005, GENES CELLS, V10, P693, DOI 10.1111/j.1365-2443.2005.00864.x; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Minegishi N, 1999, BLOOD, V93, P4196, DOI 10.1182/blood.V93.12.4196.412k23_4196_4207; Misawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028916; Nakajima T, 2015, J BIOL CHEM, V290, P10368, DOI 10.1074/jbc.M114.613018; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Nakata Y, 2010, BLOOD, V116, P1280, DOI 10.1182/blood-2009-05-223255; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Nolan LA, 2004, J ENDOCRINOL, V180, P35, DOI 10.1677/joe.0.1800035; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; Park S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006991; Paul S, 2017, PLACENTA, V60, pS61, DOI 10.1016/j.placenta.2017.05.005; Perello M, 2006, ENDOCRINOLOGY, V147, P2705, DOI 10.1210/en.2005-1609; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; REICHLIN S, 1967, J CLIN ENDOCR METAB, V27, P251, DOI 10.1210/jcem-27-2-251; Rizzoti K, 2015, J MOL ENDOCRINOL, V54, pR55, DOI 10.1530/JME-14-0237; SANCHEZPACHECO A, 1995, MOL CELL BIOL, V15, P6322; Sasaki S, 2018, VITAM HORM, V106, P97, DOI 10.1016/bs.vh.2017.06.006; SCHOMBURG L, 1995, ENDOCRINOLOGY, V136, P3480, DOI 10.1210/en.136.8.3480; SHUPNIK MA, 1989, ENDOCR REV, V10, P459, DOI 10.1210/edrv-10-4-459; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; Spinner MA, 2014, BLOOD, V123, P809, DOI 10.1182/blood-2013-07-515528; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; Sugrue ML, 2010, ENDOCRINOLOGY, V151, P793, DOI 10.1210/en.2009-0976; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; van Mullem AA, 2014, EUR THYROID J, V3, P17, DOI 10.1159/000360637; WEHMANN RE, 1984, CRC CR REV CL LAB SC, V20, P243, DOI 10.3109/10408368409165776; Weiss RE, 1997, ENDOCRINOLOGY, V138, P3624, DOI 10.1210/en.138.9.3624; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; Wood WM, 2002, ENDOCRINOLOGY, V143, P347, DOI 10.1210/en.143.2.347; Wozniak RJ, 2007, J BIOL CHEM, V282, P14665, DOI 10.1074/jbc.M700792200; Yusta B, 1998, ENDOCRINOLOGY, V139, P4476, DOI 10.1210/en.139.11.4476	89	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227646	10.1371/journal.pone.0227646	http://dx.doi.org/10.1371/journal.pone.0227646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940421	Green Submitted, gold, Green Published			2022-12-26	WOS:000534368000087
J	Sambah, F; Baatiema, L; Appiah, F; Ameyaw, EK; Budu, E; Ahinkorah, BO; Oduro, JK; Seidu, AA				Sambah, Francis; Baatiema, Linus; Appiah, Francis; Ameyaw, Edward Kwabena; Budu, Eugene; Ahinkorah, Bright Opoku; Oduro, Joseph Kojo; Seidu, Abdul-Aziz			Educational attainment and HIV testing and counselling service utilisation during antenatal care in Ghana: Analysis of Demographic and Health Surveys	PLOS ONE			English	Article								Introduction Receiving results for Human Immunodeficiency Virus (HIV) testing and counselling during antenatal care (ANC) is critical for eliminating mother-to-child transmission. We investigated the educational attainment of women and receiving results for HIV testing and counselling (HTC) during ANC in Ghana. Materials and methods We extracted data from the women's files of the 2008 and 2014 Ghana Demographic and Health Surveys. The study sampled 2,660 women aged 15-49 with complete data on receiving HIV testing results during ANC. We computed the highest educational attainment and receipt of HTC results for each of the surveys and presented it with a dot plot. Two Binary Logistic Regression Models were fitted to determine the likelihood of receiving HTC results by the educational attainment of the women. Results We found that receiving HTC results was highest among women with secondary or higher education (87.4% in 2008 and 89.5% in 2014) and least among those with no education (69.9% in 2008 and 76.8 in 2014). From the regression analysis, women with secondary or higher level of education [AOR = 1.535; CI = 1.044, 2.258], richest women [AOR = 5.565; CI = 2.560, 12.10], and women aged 30-34 years [AOR = 1.693; CI = 1.171, 2.952], were more likely to receive HTC results. However, those who did not know that a healthy-looking person can have HIV or not [AOR = 0.322; CI = 0.161, 0.646] were less likely to receive HTC results. Conclusion Despite the relatively high receipt of HTC results at ANC observed between 2008 and 2014, our findings revealed disparities driven by educational attainment, wealth status, age, ANC visits and residence. This indicates that women with no education, those from rural areas, younger and poor women are missing out on the full continuum of HTC service at ANC. The Health Promotion Unit of Ghana Health Service through Community Health Nurses and the Community-Based Health Planning and Services, should intensify their education programs on HIV and make full utilisation of HIV testing and counselling service appealing to women during ANC. This is particularly to be prioritised among the least educated, younger women and rural dwellers.	[Sambah, Francis] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana; [Baatiema, Linus; Appiah, Francis; Budu, Eugene; Oduro, Joseph Kojo; Seidu, Abdul-Aziz] Univ Cape Coast, Coll Humanities & Legal Studies, Dept Populat & Hlth, Cape Coast, Ghana; [Ameyaw, Edward Kwabena; Ahinkorah, Bright Opoku] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia	University of Cape Coast; University of Cape Coast; University of Technology Sydney	Oduro, JK (corresponding author), Univ Cape Coast, Coll Humanities & Legal Studies, Dept Populat & Hlth, Cape Coast, Ghana.	joseph.oduro@ucc.edu.gh	Seidu, Abdul-Aziz/S-2521-2019; Sambah, Francis/AFD-4475-2022; Ameyaw, Edward/AAF-2526-2020	Seidu, Abdul-Aziz/0000-0001-9734-9054; Sambah, Francis/0000-0003-4245-7028; Ameyaw, Edward/0000-0002-6617-237X; Oduro, Joseph/0000-0002-1347-7102	Measure DHS	Measure DHS	We are grateful to Measure DHS for granting us access to the data used for this study.	Avert, 2019, PREV MOTH CHILD TRAN; Ejigu Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201886; Ghana AIDS commission, 2017, NAT SUBN HIV AIDS ES; Ghana AIDS commission, 2018, HIV FACT SHEET 2018; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF Macro, 2009, GHAN DEM HLTH SURV; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; Karamagi CAS, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-284; Kowalczyk J, 2002, JAIDS, V31, P408, DOI 10.1097/00126334-200212010-00007; Kuhnt J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017122; Mahande MJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0180-3; Muyunda B, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00192; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Nwachukwu C. E., 2011, AFRICAN J REPROD HLT, V15; Sambah F, 2019, DETERMINANTS HIV TES; Sambah F, 2018, J HEALTH SCI, V6, P449; Strecher VJ., 1997, CAMBRIDGE HDB PSYCHO, V113, P117; Udoh EE, 2020, J BIOSOC SCI, V52, P473, DOI 10.1017/S0021932019000555; UNAIDS, 2017, START FREE STAY FREE; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2019, MOTH CHILD TRANSM HI	21	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227576	10.1371/journal.pone.0227576	http://dx.doi.org/10.1371/journal.pone.0227576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940331	Green Published, gold			2022-12-26	WOS:000534368000082
J	Terry, JP; Akrobotu, PD; Negre, CFA; Mniszewski, SM				Terry, Jason P.; Akrobotu, Prosper D.; Negre, Christian F. A.; Mniszewski, Susan M.			Quantum isomer search	PLOS ONE			English	Article							AUTOMATED STRUCTURE ELUCIDATION; ARTIFICIAL-INTELLIGENCE; EXHAUSTIVE GENERATION; CHEMICAL INFERENCE; EXPERT-SYSTEM; STOCHASTIC GENERATOR; STRUCTURAL ISOMERS; ORGANIC ISOMERS; PROGRAM	Isomer search or molecule enumeration refers to the problem of finding all the isomers for a given molecule. Many classical search methods have been developed in order to tackle this problem. However, the availability of quantum computing architectures has given us the opportunity to address this problem with new (quantum) techniques. This paper describes a quantum isomer search procedure for determining all the structural isomers of alkanes. We first formulate the structural isomer search problem as a quadratic unconstrained binary optimization (QUBO) problem. The QUBO formulation is for general use on either annealing or gate-based quantum computers. We use the D-Wave quantum annealer to enumerate all structural isomers of all alkanes with fewer carbon atoms (n < 10) than Decane (C10H22)The number of isomer solutions increases with the number of carbon atoms. We find that the sampling time needed to identify all solutions scales linearly with the number of carbon atoms in the alkane. We probe the problem further by employing reverse annealing as well as a perturbed QUBO Hamiltonian and find that the combination of these two methods significantly reduces the number of samples required to find all isomers.	[Terry, Jason P.] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Terry, Jason P.] Brown Univ, Data Sci Initiat, Providence, RI 02912 USA; [Terry, Jason P.] Los Alamos Natl Lab, Theoret Div, Ctr Nonlinear Studies T CNLS, Los Alamos, NM USA; [Akrobotu, Prosper D.] Univ Texas Dallas, Dept Math Sci, Richardson, TX 75083 USA; [Akrobotu, Prosper D.; Negre, Christian F. A.] Los Alamos Natl Lab, Phys & Chem Mat T 1, Theoret Div, Los Alamos, NM 87545 USA; [Mniszewski, Susan M.] Los Alamos Natl Lab, Informat Sci Comp Computat & Stat Sci Div CCS 3, Los Alamos, NM 87545 USA	University System of Georgia; University of Georgia; Brown University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Texas System; University of Texas Dallas; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Negre, CFA (corresponding author), Los Alamos Natl Lab, Phys & Chem Mat T 1, Theoret Div, Los Alamos, NM 87545 USA.; Mniszewski, SM (corresponding author), Los Alamos Natl Lab, Informat Sci Comp Computat & Stat Sci Div CCS 3, Los Alamos, NM 87545 USA.	cnegre@lanl.gov; smm@lanl.gov	Mniszewski, Susan/AAX-2025-2020	Terry, Jason/0000-0002-8590-7271	Los Alamos National Laboratory (LANL) Information Science and Technology Institute (ISTI); Laboratory Directed Research and Development (LDRD); Los Alamos National Laboratory Quantum Computing Summer School 2019; National Science Foundation (NSF) Mathematical Sciences Graduate Internship (MSGI) Program - NSF Division of Mathematical Sciences	Los Alamos National Laboratory (LANL) Information Science and Technology Institute (ISTI); Laboratory Directed Research and Development (LDRD); Los Alamos National Laboratory Quantum Computing Summer School 2019; National Science Foundation (NSF) Mathematical Sciences Graduate Internship (MSGI) Program - NSF Division of Mathematical Sciences(National Science Foundation (NSF))	SMM and CFAN were funded by Los Alamos National Laboratory (LANL) Information Science and Technology Institute (ISTI) and Laboratory Directed Research and Development (LDRD). JPT was funded by the Los Alamos National Laboratory Quantum Computing Summer School 2019. PDA was funded by the National Science Foundation (NSF) Mathematical Sciences Graduate Internship (MSGI) Program sponsored by the NSF Division of Mathematical Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TOPOLOGY MOLECULES N; [Anonymous], 2019, QPU ARCH CHIM; Badertscher M, 2000, CHEMOMETR INTELL LAB, V51, P73, DOI 10.1016/S0169-7439(00)00056-3; Barone R, 1995, MATCH-COMMUN MATH CO, P19; Bian Z., 2010, D WAVE SYST, V2; BOHANEC S, 1992, MATCH-COMMUN MAT OCT, P49; Bondy J. A., 2008, GTM, V244; Boothby K, 2019, D WAVE TECHNICAL REP; CARABEDIAN M, 1988, ANAL CHEM, V60, P2186, DOI 10.1021/ac00171a005; CARHART RE, 1981, J ORG CHEM, V46, P1708, DOI 10.1021/jo00321a037; CARHART RE, 1977, COMPUT CHEM, V1, P79, DOI 10.1016/0097-8485(77)80003-X; Cervera-Lierta A, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-12-21-114; CHRISTIE BD, 1991, J AM CHEM SOC, V113, P3750, DOI 10.1021/ja00010a018; CHRISTIE BD, 1988, J CHEM INF COMP SCI, V28, P87, DOI 10.1021/ci00058a009; CONTRERAS ML, 1992, J CHEM INF COMP SCI, V32, P323, DOI 10.1021/ci00008a011; D-Wave, 2019, LOS AL NATL LAB UPGR; D-Wave, 2019, TYP POSTPR; D-Wave, 2019, SOLV PROBL QPU; D-Wave, D WAV 2000Q SYST; D-Wave, 2019, BREAKD QPU ACC TIM; D-Wave, 2019, D WAV MAK NEW LOW NO; D-Wave, 2019, SAMPL TESTS RES; Denchev V, 2016, ARXIV151202206; Elyashberg ME, 1997, ANAL CHIM ACTA, V337, P265, DOI 10.1016/S0003-2670(96)00391-1; Elyashberg ME, 2002, J NAT PROD, V65, P693, DOI 10.1021/np0103315; FAULON JL, 1994, J CHEM INF COMP SCI, V34, P1204, DOI 10.1021/ci00021a031; Faulon JL, 2005, REV COMP CH, V21, P209, DOI 10.1002/0471720895.ch3; Faulon JL, 1996, J CHEM INF COMP SCI, V36, P731, DOI 10.1021/ci950179a; FUNATSU K, 1988, J CHEM INF COMP SCI, V28, P18, DOI 10.1021/ci00057a003; Glover FW, ABS181111538 CORR; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hao J, 2000, EXPERT SYSTEM ELUCID, V43; HENDRICKSON JB, 1991, J CHEM INF COMP SCI, V31, P101, DOI 10.1021/ci00001a018; Hu C, 1992, CHINESE J ANAL CHEM, V20, P643; Kelley J., 2018, PREVIEW BRISTLECONE; KERBER A, 1990, ANAL CHIM ACTA, V235, P221, DOI 10.1016/S0003-2670(00)82078-4; King J, 2019, ARXIV190700707; Le Bret C, 2000, MATCH-COMMUN MATH CO, P79; LEDERBERG J, 1969, J AM CHEM SOC, V91, P2973, DOI 10.1021/ja01039a025; Lindel T, 1997, J MOL MODEL, V3, P364, DOI 10.1007/s008940050052; Lindsay R.K., 1980, APPL ARTIF INTELL, V1st ed.; Lucas A, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00005; LUINGE HJ, 1992, MATCH-COMMUN MAT OCT, P175; Maki-Arvela P, 2018, CATALYSTS, V8, DOI 10.3390/catal8110534; Minkin VI, 1999, PURE APPL CHEM, V71, P1919, DOI 10.1351/pac199971101919; Moss GP, 1996, PURE APPL CHEM, V68, P2193, DOI 10.1351/pac199668122193; Nakanishi K, 2019, ARXIV181009434; Negre C. F. A., 2019, ARXIV190109756; PENG C, 1994, J CHEM INF COMP SCI, V34, P814, DOI 10.1021/ci00020a014; Peruzzo A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5213; Pudenz KL, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.042302; Ranzi E, 2015, CHEM ENGINEER TRANS, V43, P871, DOI 10.3303/CET1543146; Reading E, 2016, ANAL CHEM, V88, P2273, DOI 10.1021/acs.analchem.5b04068; Steinbeck C, 2001, J CHEM INF COMP SCI, V41, P1500, DOI 10.1021/ci000407n; Ushijima-Mwesigwa H, 2017, PROCEEDINGS OF 2ND INTERNATIONAL WORKSHOP ON POST MOORE'S ERA SUPERCOMPUTING (PMES 2017), P22, DOI 10.1145/3149526.3149531; Will M, 1996, J CHEM INF COMP SCI, V36, P221, DOI 10.1021/ci950092p; ZHU SY, 1982, J CHEM INF COMP SCI, V22, P34, DOI 10.1021/ci00033a007	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226787	10.1371/journal.pone.0226787	http://dx.doi.org/10.1371/journal.pone.0226787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940317	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000043
J	Zhou, JR; Wang, Y; Fan, QJ; Liu, YH; Liu, H; Yan, JY; Li, M; Dong, WJ; Li, WZ				Zhou, Jiaorui; Wang, Yue; Fan, Qingjie; Liu, Yinhui; Liu, He; Yan, Jingyu; Li, Ming; Dong, Weijie; Li, Wenzhe			High levels of fucosylation and sialylation of milk N-glycans from mothers with gestational diabetes mellitus alter the offspring gut microbiome and immune balance in mice	FASEB JOURNAL			English	Article						Bacteroides; gestational diabetes mellitus; gut microbiome; immune balance; milk N-glycans	REGULATORY T-CELLS; ORAL TOLERANCE; OLIGOSACCHARIDES; CHILDREN; DISEASE; WOMEN; ASSOCIATION; BACTEROIDES; IMBALANCE; MECHANISM	Gestational diabetes mellitus (GDM) is significantly associated with allergen sensitization in early childhood, and this may influence the gut microbiome and immune system of the children. In addition to mother-to-child transmission of microbes, milk glycans play a pivotal role in shaping the gut microbiome of infants. A previous study has demonstrated alterations in the major milk N-glycans of mothers with GDM. However, the impact of these changes on the gut microbiome and immune response of the neonates has yet to be studied. Here, we aimed to compare the glycosylation levels of various milk glycans between normal and GDM mice, and to characterize the intestinal microbiome and immune responses of the offspring after weaning. We found that GDM mouse milk contained significantly higher concentrations of fucosylated and sialylated N-glycans than control mice, but there was no difference in the concentration of milk oligosaccharides between the groups. The differences in milk N-glycans had direct effects on the intestinal microbiome of the offspring, which in turn affected their immune response upon challenge with ovalbumin (OVA), with disruptions in the Th1/Th2 and Th17/Treg cell balances. This study lays the foundation for further research and development of specific nutritional care for the offspring of GDM mothers.	[Zhou, Jiaorui; Fan, Qingjie; Liu, Yinhui; Liu, He; Li, Ming] Dalian Med Univ, Coll Basic Med Sci, Dept Microecol, Dalian 116044, Peoples R China; [Wang, Yue; Dong, Weijie; Li, Wenzhe] Dalian Med Univ, Coll Basic Med Sci, Dept Biochem, Dalian 116044, Peoples R China; [Yan, Jingyu] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Li, M (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Microecol, Dalian 116044, Peoples R China.; Dong, WJ; Li, WZ (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Biochem, Dalian 116044, Peoples R China.	vivianmarat@163.com; wjdong@dlmedu.edu.cn; liwenzhe@dlmedu.edu.cn	fan, qingjie/AAB-8624-2022	fan, qingjie/0000-0001-8281-1218	National Nature Science Fundation of China [31770859, 31900920]; Guangzhou Biostime Institute of Nutrition Care [2018BINCMCF39, 2016BINCMCF1102, 2019BINCMCF02]	National Nature Science Fundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Biostime Institute of Nutrition Care	National Nature Science Fundation of China, Grant/Award Number: 31770859 and 31900920; Guangzhou Biostime Institute of Nutrition & Care, Grant/Award Number: 2018BINCMCF39, 2016BINCMCF1102 and 2019BINCMCF02	ADLERBERTH I, 1991, ACTA PAEDIATR SCAND, V80, P602, DOI 10.1111/j.1651-2227.1991.tb11917.x; Allhorn M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001413; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Boerschmann H, 2010, DIABETES CARE, V33, P1845, DOI 10.2337/dc10-0139; Briliute J, 2019, NAT MICROBIOL, V4, P1571, DOI 10.1038/s41564-019-0466-x; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cregan, 2007, BREASTFEEDING REV, V15, P5; Damm P, 2015, NAT REV ENDOCRINOL, V11, DOI 10.1038/nrendo.2015.54; Eisenstein EM, 2009, PEDIATR RES, V65, p26R, DOI 10.1203/PDR.0b013e31819e76c7; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Garrido D, 2012, MOL CELL PROTEOMICS, V11, P775, DOI 10.1074/mcp.M112.018119; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Hadar E, 2009, NUTR METAB CARDIOVAS, V19, P75, DOI 10.1016/j.numecd.2008.11.007; Huang CJ, 2018, MOL MED REP, V17, P6293, DOI 10.3892/mmr.2018.8683; Ji XL, 2019, INT J BIOL MACROMOL, V131, P1067, DOI 10.1016/j.ijbiomac.2019.03.175; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Johnson CC, 2016, EXPERT REV CLIN IMMU, V12, P379, DOI 10.1586/1744666X.2016.1139452; Kim SY, 2012, CURR OPIN OBSTET GYN, V24, P376, DOI 10.1097/GCO.0b013e328359f0f4; Kim WG, 2019, BENEF MICROBES, V10, P55, DOI 10.3920/BM2017.0146; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kumar R, 2009, J ALLERGY CLIN IMMUN, V124, P1031, DOI 10.1016/j.jaci.2009.06.052; Kwon MS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01905; Li CC, 2018, J ASTHMA, V55, P1, DOI 10.1080/02770903.2016.1266494; Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x; Li M, 2019, MBIO, V10, DOI [10.1128/mBio.00128-19, 10.1128/mbio.00128-19]; Madan JC, 2016, JAMA PEDIATR, V170, P212, DOI 10.1001/jamapediatrics.2015.3732; Meng SS, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0430-8; Nakayama J, 2011, FEMS IMMUNOL MED MIC, V63, P397, DOI 10.1111/j.1574-695X.2011.00872.x; Ravcheev DA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00111; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Sakaguchi S, 2011, J IMMUNOL, V186, P3808; SALYERS AA, 1984, ANNU REV MICROBIOL, V38, P293, DOI 10.1146/annurev.mi.38.100184.001453; Shah BR, 2008, DIABETES CARE, V31, P1668, DOI 10.2337/dc08-0706; Sifnaios E, 2019, IN VIVO, V33, P31, DOI 10.21873/invivo.11435; Smilowitz JT, 2013, J NUTR, V143, P1906, DOI 10.3945/jn.113.180695; Sofi MH, 2019, DIABETES, V68, P1975, DOI 10.2337/db19-0211; Su ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205695; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Tao BH, 2015, IRAN J ALLERGY ASTHM, V14, P273; TESTI R, 1990, J EXP MED, V172, P701, DOI 10.1084/jem.172.3.701; Thurl S, 2017, NUTR REV, V75, P920, DOI 10.1093/nutrit/nux044; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; Wang J, 2014, J ETHNOPHARMACOL, V154, P131, DOI 10.1016/j.jep.2014.03.041; Wang JF, 2018, GUT, V67, P1614, DOI 10.1136/gutjnl-2018-315988; Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011; Warner BB, 2016, LANCET, V387, P1928, DOI 10.1016/S0140-6736(16)00081-7; Wu LC, 2014, NAT REV IMMUNOL, V14, P247, DOI 10.1038/nri3632; Wu SY, 2018, EUR J PHARMACOL, V831, P38, DOI 10.1016/j.ejphar.2018.04.028; Xu J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43039-3; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033; Ye GY, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/6081248; Yu ZT, 2013, GLYCOBIOLOGY, V23, P169, DOI 10.1093/glycob/cws138; Zhang YB, 2004, AM J MED GENET B, V129B, P16, DOI 10.1002/ajmg.b.30076; Zhu WW, 2013, DIABETES CARE, V36, P586, DOI 10.2337/dc12-1157; Zimmermann P, 2019, J ALLERGY CLIN IMMUN, V143, P467, DOI 10.1016/j.jaci.2018.09.025; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	65	11	12	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3715	3731		10.1096/fj.201901674R	http://dx.doi.org/10.1096/fj.201901674R		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944389	Bronze			2022-12-26	WOS:000507592900001
J	Maleki, S; Rahwan, T; Ghosh, S; Malibari, A; Alghazzawi, D; Rogers, A; Beigy, H; Jennings, NR				Maleki, Sasan; Rahwan, Talal; Ghosh, Siddhartha; Malibari, Areej; Alghazzawi, Daniyal; Rogers, Alex; Beigy, Hamid; Jennings, Nicholas R.			The Shapley value for a fair division of group discounts for coordinating cooling loads	PLOS ONE			English	Article							COOPERATIVE GAME	We consider a demand response program in which a block of apartments receive a discount from their electricity supplier if they ensure that their aggregate load from air conditioning does not exceed a predetermined threshold. The goal of the participants is to obtain the discount, while ensuring that their individual temperature preferences are also satisfied. As such, the apartments need to collectively optimise their use of air conditioning so as to satisfy these constraints and minimise their costs. Given an optimal cooling profile that secures the discount, the problem that the apartments face then is to divide the total discounted cost in a fair way. To achieve this, we take a coalitional game approach and propose the use of the Shapley value from cooperative game theory, which is the normative payoff division mechanism that offers a unique set of desirable fairness properties. However, applying the Shapley value in this setting presents a novel computational challenge. This is because its calculation requires, as input, the cost of every subset of apartments, which means solving an exponential number of collective optimisations, each of which is a computationally intensive problem. To address this, we propose solving the optimisation problem of each subset suboptimally, to allow for acceptable solutions that require less computation. We show that, due to the linearity property of the Shapley value, if suboptimal costs are used rather than optimal ones, the division of the discount will be fair in the following sense: each apartment is fairly "rewarded" for its contribution to the optimal cost and, at the same time, is fairly "penalised" for its contribution to the discrepancy between the suboptimal and the optimal costs. Importantly, this is achieved without requiring the optimal solutions.	[Maleki, Sasan; Beigy, Hamid] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Rahwan, Talal] New York Univ Abu Dhabi, Comp Sci, Abu Dhabi, U Arab Emirates; [Ghosh, Siddhartha] Univ Southampton, Elect & Comp Sci, Southampton, Hants, England; [Malibari, Areej] King Abdulaziz Univ, Dept Comp Sci, Jeddah, Saudi Arabia; [Alghazzawi, Daniyal] King Abdulaziz Univ, Dept Informat Syst, Jeddah, Saudi Arabia; [Rogers, Alex] Univ Oxford, Dept Comp Sci, Oxford, England; [Jennings, Nicholas R.] Imperial Coll London, Dept Comp, Oxford, England	Sharif University of Technology; University of Southampton; King Abdulaziz University; King Abdulaziz University; University of Oxford; Imperial College London	Maleki, S (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.	smaleki@ce.sharif.edu	Beigy, Hamid/ABF-7542-2020; Jennings, Nick/HGU-8308-2022; Alghazzawi, Daniyal M/I-1656-2012	Beigy, Hamid/0000-0003-1679-2092; Jennings, Nick/0000-0003-0166-248X; Alghazzawi, Daniyal M/0000-0002-5533-3203; Maleki, Sasan/0000-0003-2945-0737	National Elites Foundation of Iran; EPSRC in the United Kingdom through "Intelligent Agents for Home Energy Management" project [EP/I000143/1]; EPSRC in the United Kingdom through ORCHID programme grant [EP/I011587/1]; Deanship of Scientific Research at King Abdulaziz University [9-15-1432-HiCi]; Deanship of Scientific Research (DSR), King Abdulaziz University (KAU) [9-15-1432-HiCi]; KAU; National Elites Foundation; 'Intelligent Agents for Home Energy Management' project [EP/I000143/1]; ORCHID programme grant [EP/I011587/1]	National Elites Foundation of Iran; EPSRC in the United Kingdom through "Intelligent Agents for Home Energy Management" project(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC in the United Kingdom through ORCHID programme grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Deanship of Scientific Research at King Abdulaziz University; Deanship of Scientific Research (DSR), King Abdulaziz University (KAU); KAU; National Elites Foundation; 'Intelligent Agents for Home Energy Management' project; ORCHID programme grant	SM received a post-doctoral fellowship from the National Elites Foundation of Iran. TR, SG, AR and NJ were supported by the EPSRC in the United Kingdom through "Intelligent Agents for Home Energy Management" project (EP/I000143/1) and ORCHID programme grant (EP/I011587/1). AM, DA and NJ were supported by the Deanship of Scientific Research at King Abdulaziz University (9-15-1432-HiCi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), under grant No. (9-15-1432-HiCi). The authors, therefore, acknowledge technical and financial support of KAU. This work was also supported in Iran by the National Elites Foundation, and in the United Kingdom by the 'Intelligent Agents for Home Energy Management' project (EP/I000143/1) and ORCHID programme grant (EP/I011587/1). The authors are also grateful for the useful feedback received from the anonymous reviewers.	Aghajani S, 2017, ENERGY, V137, P129, DOI 10.1016/j.energy.2017.07.006; Airiau S, 2013, KNOWL ENG REV, V28, P381, DOI 10.1017/S0269888913000106; Alam M, 2013, P 2013 INT C AUT AG, P731; Andersen KK, 2000, ENERG BUILDINGS, V31, P13, DOI 10.1016/S0378-7788(98)00069-3; Aswani A, 2012, P IEEE, V100, P240, DOI 10.1109/JPROC.2011.2161242; Aziz H., 2016, J ARTIFICIAL INTELLI, V56, P573; Bacher P, 2011, ENERG BUILDINGS, V43, P1511, DOI 10.1016/j.enbuild.2011.02.005; Bachrach Y, 2010, AUTON AGENT MULTI-AG, V20, P105, DOI 10.1007/s10458-009-9078-9; Battaglini M, 2016, AM ECON J-MICROECON, V8, P268, DOI 10.1257/mic.20150126; Chakraborty P, 2019, IEEE T SMART GRID, V10, P4379, DOI 10.1109/TSG.2018.2858206; Chakraborty P, 2018, IEEE T POWER SYST, V33, P70, DOI 10.1109/TPWRS.2017.2690404; Chakraborty P, 2016, IEEE DECIS CONTR P, P5805, DOI 10.1109/CDC.2016.7799162; Dong L, 2019, GAME ECON BEHAV, V115, P209, DOI 10.1016/j.geb.2019.02.016; Dutta G, 2017, J OPER RES SOC, V68, P1131, DOI 10.1057/s41274-016-0149-4; Fang Q, 2016, COMPLEXITY CORE, P372; Fatima SS, 2008, ARTIF INTELL, V172, P1673, DOI 10.1016/j.artint.2008.05.003; Greco G, 2011, ARTIF INTELL, V175, P1877, DOI 10.1016/j.artint.2011.06.002; Guo Y, 2008, SASO 2008: Second IEEE International Conference on Self-Adaptive and Self-Organizing Systems, Proceedings, P64, DOI 10.1109/SASO.2008.71; HSU YY, 1991, IEEE T POWER SYST, V6, P1056, DOI 10.1109/59.119246; Maleki S, 2014, 5 WORKSH COOP GAM MU; Mann I., 1962, RM3158PR RAND CORP; Maschler M, 2013, BARGAINING SET, P782; McNeil MA, 2008, FUTURE AIR CONDITION; OWEN G, 1972, MANAGE SCI B-APPL, V18, pP64; Quillinan JD, 2011, J REVENUE PRICING MA, V10, P545, DOI 10.1057/rpm.2011.22; Ramchurn SD, 2012, COMMUN ACM, V55, P86, DOI 10.1145/2133806.2133825; Rogers A, 2011, 2 INT WORKSH AG TECH; Sandholm TW, 1997, ARTIF INTELL, V94, P99, DOI 10.1016/S0004-3702(97)00030-1; Shapley LS, 2016, 17 VALUE N PERSON GA, V17, P307, DOI [10.1515/9781400881970-018, DOI 10.1515/9781400881970-018]; Simon D, 2006, OPTIMAL STATE ESTIMA; Simshauser P, 2016, ENERG J, V37, P199, DOI 10.5547/01956574.37.3.psim; Thrall R.M., 1963, NAVAL RES LOGIST Q, V10, P281, DOI [10.1002/nav.3800100126, DOI 10.1002/NAV.3800100126]; US Department of Energy, 2008, GRID 2030 NAT VIS EL; Zhou Q, 2019, IEEE T SMART GRID, V10, P6355, DOI 10.1109/TSG.2019.2903686	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227049	10.1371/journal.pone.0227049	http://dx.doi.org/10.1371/journal.pone.0227049			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923244	Green Published, gold			2022-12-26	WOS:000534350000039
J	Melmer, DJ; O'Sullivan, TL; Greer, AL; Poljak, Z				Melmer, Dylan John; O'Sullivan, Terri L.; Greer, Amy L.; Poljak, Zvonimir			An investigation of transportation practices in an Ontario swine system using descriptive network analysis	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MOUTH-DISEASE; PORCINE; SPREAD; MOVEMENTS; CANADA; TRANSMISSION; SHIPMENTS; VEHICLES; REGIONS	The objectives of this research were to describe the contact structure of transportation vehicles and swine facilities in an Ontario swine production system, and to assess their potential contribution to possible disease transmission over different time periods. A years' worth of data (2015) was obtained from a large swine production and data management company located in Ontario, Canada. There was a total of 155 different transportation vehicles, and 220 different farms within the study population. Two-mode networks were constructed for 1-,3-, and 7-day time periods over the entire year and were analyzed. Trends in the size of the maximum weak component and outgoing contact chain over discrete time periods were investigated using linear regression. Additionally, the number of different types of facilities with betweenness >0 and in/out degree>0 were analyzed using Poisson regression. Maximum weekly outgoing contact chain (MOCCw) contained between 2.1% and 7.1% of the study population. This suggests a potential maximum of disease spread within this population if the disease was detected within one week. Frequency of node types within MOCCw showed considerable variability; although nursery sites were relatively most frequent. The regression analysis of several node and network level statistics indicated a potential peak time of connectivity during the summer months and warrants further confirmation and investigation. The inclusion of transportation vehicles contributed to the linear increase in the maximum weekly weak component (MWCw) size over time. This finding in combination with constant population dynamics, may have been driven by the differential utilization of trucks over time. Despite known limitations of maximum weak components as an estimator of possible outbreaks, this finding suggests that transportation vehicles should be included, when possible and relevant, in the evaluation of contacts between farms.	[Melmer, Dylan John; O'Sullivan, Terri L.; Greer, Amy L.; Poljak, Zvonimir] Univ Guelph, Dept Populat Med, Guelph, ON, Canada	University of Guelph	Melmer, DJ (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON, Canada.	dmelmer@uoguelph.ca		Melmer, Dylan/0000-0001-9215-0441	Ontario Ministry of Agriculture Food and Rural Affairs, part of the University of Guelph; OMAFRA partnership [UofG2014-1932]	Ontario Ministry of Agriculture Food and Rural Affairs, part of the University of Guelph; OMAFRA partnership	Funding for this study was provided by Ontario Ministry of Agriculture Food and Rural Affairs, part of the University of Guelph and OMAFRA partnership. Zvonimir Poljak, UofG2014-1932, http://www.omafra.gov.on.ca/english/.	Ajayi T, 2018, TRANSBOUND EMERG DIS, V65, P1197, DOI 10.1111/tbed.12858; [Anonymous], 2012, OSHAB TRANSPORT BIOS, P1; Arruda AG, 2016, PREV VET MED, V128, P41, DOI 10.1016/j.prevetmed.2016.03.010; Arruda AG, 2015, CAN J VET RES, V79, P268; Bottoms K, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-217; Csardi G, 2006, INTERJOURNAL; Dee S, 2005, CAN J VET RES, V69, P64; Dee S, 2004, P 18 IPVS C HAMB; Dee SA, 2004, CAN J VET RES, V68, P128; Dorjee S, 2013, PREV VET MED, V112, P118, DOI 10.1016/j.prevetmed.2013.06.008; Dube C, 2008, TRANSBOUND EMERG DIS, V55, P382, DOI 10.1111/j.1865-1682.2008.01053.x; Dube C, 2009, TRANSBOUND EMERG DIS, V56, P73, DOI 10.1111/j.1865-1682.2008.01064.x; Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4; Grolemond G, 2011, J STAT SOFTW, V40, P1; Guinat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28429; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Kinsley AC, 2019, PREV VET MED, V164, P1, DOI 10.1016/j.prevetmed.2019.01.001; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; Lee K, 2017, PREV VET MED, V138, P113, DOI 10.1016/j.prevetmed.2017.02.001; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Mateost Poumian A, 1995, Rev Sci Tech, V14, P165; Melmer DJ, 2018, PREV VET MED, V159, P211, DOI 10.1016/j.prevetmed.2018.09.021; Noremark M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-71; Perri AM, 2019, PREV VET MED, V162, P18, DOI 10.1016/j.prevetmed.2018.11.001; Porphyre T, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-140; R Core Team, 2013, R LANG ENV STAT COMP; Rautureau S, 2012, ANIMAL, V6, P1152, DOI 10.1017/S1751731111002631; Smith RP, 2013, PREV VET MED, V108, P167, DOI 10.1016/j.prevetmed.2012.08.011; Spence KL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219771; Thakur KK, 2016, TRANSBOUND EMERG DIS, V63, pE14, DOI 10.1111/tbed.12225; Thakur KK, 2015, PREV VET MED, V118, P413, DOI 10.1016/j.prevetmed.2015.01.006; Valdes-Donoso P, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00002	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226813	10.1371/journal.pone.0226813	http://dx.doi.org/10.1371/journal.pone.0226813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923199	gold, Green Published			2022-12-26	WOS:000534350000026
J	Tan, MSY; Davison, D; Sanchez, MI; Anderson, BM; Howell, S; Snijders, A; Edgington-Mitchell, LE; Deu, E				Tan, Michele S. Y.; Davison, Dara; Sanchez, Mateo I.; Anderson, Bethany M.; Howell, Stephen; Snijders, Ambrosius; Edgington-Mitchell, Laura E.; Deu, Edgar			Novel broad-spectrum activity-based probes to profile malarial cysteine proteases	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RESISTANCE	Clan CA cysteine proteases, also known as papain-like proteases, play important roles throughout the malaria parasite life cycle and are therefore potential drug targets to treat this disease and prevent its transmission. In order to study the biological function of these proteases and to chemically validate some of them as viable drug targets, highly specific inhibitors need to be developed. This is especially challenging given the large number of clan CA proteases present in Plasmodium species (ten in Plasmodium falciparum), and the difficulty of designing selective inhibitors that do not cross-react with other members of the same family. Additionally, any efforts to develop antimalarial drugs targeting these proteases will also have to take into account potential off-target effects against the 11 human cysteine cathepsins. Activity-based protein profiling has been a very useful tool to determine the specificity of inhibitors against all members of an enzyme family. However, current clan CA proteases broad-spectrum activity-based probes either target endopeptidases or dipeptidyl aminopeptidases, but not both subfamilies efficiently. In this study, we present a new series of dipeptydic vinyl sulfone probes containing a free N-terminal tryptophan and a fluorophore at the P1 position that are able to label both subfamilies efficiently, both in Plasmodium falciparum and in mammalian cells, thus making them better broad-spectrum activity-based probes. We also show that some of these probes are cell permeable and can therefore be used to determine the specificity of inhibitors in living cells. Interestingly, we show that the choice of fluorophore greatly influences the specificity of the probes as well as their cell permeability.	[Tan, Michele S. Y.; Davison, Dara; Howell, Stephen; Snijders, Ambrosius; Deu, Edgar] Francis Crick Inst, London, England; [Sanchez, Mateo I.] Stanford Sch Med, Dept Genet, Stanford, CA USA; [Anderson, Bethany M.; Edgington-Mitchell, Laura E.] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Edgington-Mitchell, Laura E.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Edgington-Mitchell, Laura E.] New York Univ, Dept Maxillofacial Surg, Coll Dent, New York, NY USA	Francis Crick Institute; Stanford University; University of Melbourne; Monash University; New York University	Deu, E (corresponding author), Francis Crick Inst, London, England.	edgar.deu@crick.ac.uk	Sanchez, Mateo/AAB-2434-2020	Sanchez, Mateo/0000-0003-1359-6969; Anderson, Bethany/0000-0002-1663-1099; Tan, Michele Ser Ying/0000-0002-3747-2365; Edgington-Mitchell, Laura/0000-0002-6810-6149; Deu, Edgar/0000-0002-1852-4828	Welcome Trust [099950]; Royal Society Sir Henry Dale Fellowship [099950]; Marie Curie Career Integration Grant [PCIG14-GA-2013-631809]; National Health and Medical Research Council of Australia (NHMRC) [GNT1091636]; Russell and Mab Grimwade Miegunyah Fund at the University of Melbourne; Medical Research Council through the National Institute for Medical Research student placement program	Welcome Trust(Wellcome Trust); Royal Society Sir Henry Dale Fellowship; Marie Curie Career Integration Grant; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Russell and Mab Grimwade Miegunyah Fund at the University of Melbourne; Medical Research Council through the National Institute for Medical Research student placement program	This work was funded by the Welcome Trust and Royal Society Sir Henry Dale Fellowship 099950 and the Marie Curie Career Integration Grant PCIG14-GA-2013-631809, both awarded to E.D. LEM was supported by an Early Career Fellowship from the National Health and Medical Research Council of Australia (NHMRC, GNT1091636) and a Grimwade Fellowship sponsored by the Russell and Mab Grimwade Miegunyah Fund at the University of Melbourne. Finally, we would also like to thank the Medical Research Council for funding SYT through the National Institute for Medical Research student placement program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Deu E, 2018, PREPRINT, P1, DOI DOI 10.1101/246124; Deu E, 2017, FEBS J, V284, P2604, DOI 10.1111/febs.14130; Deu E, 2010, CHEM BIOL, V17, P808, DOI 10.1016/j.chembiol.2010.06.007; Drag M, 2010, NAT REV DRUG DISCOV, V9, P690, DOI 10.1038/nrd3053; Drake MT, 2017, ENDOCR REV, V38, P325, DOI 10.1210/er.2015-1114; Edgington-Mitchell LE, 2017, METHODS MOL BIOL, V1491, P145, DOI 10.1007/978-1-4939-6439-0_11; Ferreira LG, 2017, PHARMACOL THERAPEUT, V180, P49, DOI 10.1016/j.pharmthera.2017.06.004; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; Hopp CS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006586; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Korkmaz B, 2018, PHARMACOL THERAPEUT, V190, P202, DOI 10.1016/j.pharmthera.2018.05.011; Kramer L, 2017, TRENDS PHARMACOL SCI, V38, P873, DOI 10.1016/j.tips.2017.06.003; Lehmann C, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007031; Miller BE, 2017, BRIT J CLIN PHARMACO, V83, P2813, DOI 10.1111/bcp.13398; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Olson OC, 2015, NAT REV CANCER, V15, P712, DOI 10.1038/nrc4027; Palmer R, 2018, CLIN PHARMACOL THER, V104, P1155, DOI 10.1002/cpt.1053; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P8721, DOI 10.1073/pnas.0402738101; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Singh N, 2006, EXP PARASITOL, V112, P187, DOI 10.1016/j.exppara.2005.10.007; Suarez-Cortes P, 2016, MOL CELL PROTEOMICS, V15, P3243, DOI 10.1074/mcp.M116.060681; Tanaka TQ, 2013, ANTIMICROB AGENTS CH, V57, P4645, DOI 10.1128/AAC.02495-12; Thomas JA, 2018, NAT MICROBIOL, V3, P447, DOI 10.1038/s41564-018-0111-0; Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yuan F, 2006, J AM CHEM SOC, V128, P5616, DOI 10.1021/ja060835v	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227341	10.1371/journal.pone.0227341	http://dx.doi.org/10.1371/journal.pone.0227341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923258	Green Submitted, Green Published, gold			2022-12-26	WOS:000534350000068
J	Antonelli, F; Esposito, A; Calvo, L; Licursi, V; Tisseyre, P; Ricci, S; Romagnoli, M; Piazza, S; Guerrieri, F				Antonelli, Federica; Esposito, Alfonso; Calvo, Ludovica; Licursi, Valerio; Tisseyre, Philippe; Ricci, Sandra; Romagnoli, Manuela; Piazza, Silvano; Guerrieri, Francesca			Characterization of black patina from the Tiber River embankments using Next-Generation Sequencing	PLOS ONE			English	Article							ENDOLITHIC BACTERIAL COMMUNITIES; GUIZHOU KARST AREA; SP NOV.; MICROCOLONIAL FUNGI; LIMESTONE ROCKS; GEN. NOV.; MICROBIAL DETERIORATION; SPATIAL-DISTRIBUTION; EMENDED DESCRIPTION; NANJIANG CANYON	Black patinas are very common biological deterioration phenomena on lapideous artworks in outdoor environments. These substrates, exposed to sunlight, and atmospheric and environmental agents (i.e. wind and temperature changes), represent extreme environments that can only be colonized by highly versatile and adaptable microorganisms. Black patinas comprise a wide variety of microorganisms, but the morphological plasticity of most of these microorganisms hinders their identification by optical microscopy. This study used Next-Generation Sequencing (NGS) (including shotgun and amplicon sequencing) to characterize the black patina of the travertine embankments (muraglioni) of the Tiber River in Rome (Italy). Overall, the sequencing highlighted the rich diversity of bacterial and fungal communities and allowed the identification of more than one hundred taxa. NGS confirmed the relevance of coccoid and filamentous cyanobacteria observed by optical microscopy and revealed an informative landscape of the fungal community underlining the presence of microcolonial fungi and phylloplane yeasts. For the first time high-throughput sequencing allowed the exploration of the expansive diversity of bacteria in black patina, which has so far been overlooked in routine analyses. Furthermore, the identification of euendolithic microorganisms and weathering agents underlines the biodegradative role of black patina, which has often been underestimated. Therefore, the use of NGS to characterize black patinas could be useful in choosing appropriate conservation treatments and in the monitoring of stone colonization after the restoration interventions.	[Antonelli, Federica; Romagnoli, Manuela] Tuscia Univ, Dept Innovat Biol Syst Food & Forestry DIBAF, Viterbo, Italy; [Esposito, Alfonso; Piazza, Silvano] Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Trento, Italy; [Calvo, Ludovica; Guerrieri, Francesca] Ist Italiano Tecnol, Ctr Life NanoSci Sapienza, Rome, Italy; [Licursi, Valerio] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Tisseyre, Philippe] Soprintendenza Mare, Palermo, Regione Sicilia, Italy; [Ricci, Sandra] ISCR, Biol Lab, Rome, Italy; [Guerrieri, Francesca] CRCL, Epigenet & Epigen Hepatocellular Carcinoma, U1052, Lyon, France	Tuscia University; University of Trento; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL)	Antonelli, F (corresponding author), Tuscia Univ, Dept Innovat Biol Syst Food & Forestry DIBAF, Viterbo, Italy.; Guerrieri, F (corresponding author), Ist Italiano Tecnol, Ctr Life NanoSci Sapienza, Rome, Italy.; Guerrieri, F (corresponding author), CRCL, Epigenet & Epigen Hepatocellular Carcinoma, U1052, Lyon, France.	fedantonelli@gmail.com; fraguerrieri@gmail.com	Romagnoli, Manuela/D-9955-2011; Esposito, Alfonso/GYU-1260-2022; Antonelli, Federica/AAI-5786-2021; guerrieri, francesca/G-3908-2013	Romagnoli, Manuela/0000-0002-2568-6411; Esposito, Alfonso/0000-0003-0726-5290; Piazza, Silvano/0000-0002-7156-5434; Guerrieri, Francesca/0000-0002-2021-4394; Licursi, Valerio/0000-0002-8172-1437; Antonelli, Federica/0000-0002-6830-7477				Al-Thani RF, 2012, ECOLOGY CYANOBACTERI, P427, DOI [10.1007/978-94-007-3855-3_16, DOI 10.1007/978-94-007-3855-3_16]; Albertano P., 2012, ECOLOGY CYANOBACTERI, P317, DOI [DOI 10.1007/978-94-007-3855-3_11, 10.1007/978-94-007-3855-3_11]; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/NMETH.3103, 10.1038/nmeth.3103]; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Arino X, 1997, INT BIODETER BIODEGR, V40, P233, DOI 10.1016/S0964-8305(97)00034-6; Ashkezari SJ, 2017, MYCOL PROG, V16, P247, DOI 10.1007/s11557-017-1274-4; Badalyan S. M., 2011, Diversity, V3, P136, DOI 10.3390/d3010136; Baik KS, 2014, INT J SYST EVOL MICR, V64, P4038, DOI 10.1099/ijs.0.065664-0; Baldasici O., 2012, ANN ROMAN SOC CELL B, V17, P213; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Bohr URM, 2002, HELICOBACTER, V7, P378, DOI 10.1046/j.1523-5378.2002.00113.x; Budel B, 1999, EUR J PHYCOL, V34, P361, DOI 10.1080/09670269910001736422; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caneva G, 2004, P 10 INT C DET CONS, V1, P227; Castenholz RW, 2012, ECOLOGY CYANOBACTERI, VII, P481, DOI [10.1007/978-94-007-3855-3_19, DOI 10.1007/978-94-007-3855-3_19]; Chung AP, 2010, SYST APPL MICROBIOL, V33, P436, DOI 10.1016/j.syapm.2010.09.002; Conte G, 2015, ACQUE SOTTER, V4, P33, DOI 10.7343/AS-130-15-0157; Cortese C, 1958, PERIODICO MINERAL RO, V27, P407; Crous P. W., 2018, Fungal Systematics and Evolution, V1, P169, DOI 10.3114/fuse.2018.01.08; Crous PW, 2015, SYDOWIA, V67, P81; Darienko T., 2013, TERRESTRIAL MICROALG; De Leo F, 1996, P 8 INT C DET CONS S, P625; De Leo F, 2019, FACIES, V65, DOI 10.1007/s10347-019-0564-5; Dedysh S.N., 2018, ACIDOBACTERIA ELS, P1, DOI [10.1002/9780470015902.a0027685, DOI 10.1002/9780470015902.A0027685]; Montero-Calasanz MD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/914767; Montero-Calasanz MD, 2013, INT J SYST EVOL MICR, V63, P3437, DOI 10.1099/ijs.0.051201-0; Montero-Calasanz MD, 2013, ANTON LEEUW INT J G, V103, P449, DOI 10.1007/s10482-012-9824-x; Dietrich M, 2015, MEYLANIA, V56, P5; Dillon JG, 2002, ARCH MICROBIOL, V177, P322, DOI 10.1007/s00203-001-0395-x; Dong HL, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000385; Dornieden T, 2000, OF MICROBES AND ART: THE ROLE OF MICROBIAL COMMUNITIES IN THE DEGRADATION AND PROTECTION OF CULTURAL HERITAGE, P105; Dreno B, 2018, J EUR ACAD DERMATOL, V32, P5, DOI 10.1111/jdv.15043; Erchiga VC, 2000, BRIT J DERMATOL, V143, P799, DOI 10.1046/j.1365-2133.2000.03779.x; Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319; Frank-Kamenetskaya O., 2009, STUDIA U BABES BOLYA, V54, P17, DOI [10.5038/1937-8602.54.2.4, DOI 10.5038/1937-8602.54.2.4]; Franklin LA, 2003, ADV PHOTO RESPIRAT, V14, P351; Garcia-Valles M, 2002, ENVIRON GEOL, V41, P889, DOI 10.1007/s00254-001-0466-y; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P163, DOI 10.1128/AEM.59.1.163-169.1993; Gaylarde CC, 2012, CURR MICROBIOL, V65, P183, DOI 10.1007/s00284-012-0123-6; Glaeser S.P., 2014, PROKARYOTES, V9783642301971, P641, DOI [DOI 10.1007/978-3-642-30197-1_302, 10.1007/978-3-642-30197-1_302]; Glushakova AM, 2017, MICROBIOLOGY+, V86, P128, DOI 10.1134/S0026261716060102; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; Golubic S, 2015, INT BIODETER BIODEGR, V100, P7, DOI 10.1016/j.ibiod.2015.01.019; Gomez-Cornelio S, 2016, ACTA BOT MEX, V117, P59, DOI 10.21829/abm117.2016.1168; Gorbushina A, 2003, ASTROBIOLOGY, V3, P543, DOI 10.1089/153110703322610636; GORBUSHINA AA, 1993, GEOMICROBIOL J, V11, P205, DOI 10.1080/01490459309377952; Gorbushina AA, 2007, ENVIRON MICROBIOL, V9, P1613, DOI 10.1111/j.1462-2920.2007.01301.x; Gtari M, 2012, FEMS MICROBIOL ECOL, V80, P566, DOI 10.1111/j.1574-6941.2012.01320.x; Gueidan C, 2008, STUD MYCOL, P111, DOI 10.3114/sim.2008.61.11; Han L, 2014, ANTON LEEUW INT J G, V105, P971, DOI 10.1007/s10482-014-0155-y; Hauer T, 2015, BIODIVERS CONSERV, V24, P759, DOI 10.1007/s10531-015-0890-z; Hedlund B.P., 2015, BERGEYS MANUAL SYSTE, V2nd, P1, DOI DOI 10.1002/9781118960608.FBM00257; HIRSCH P, 1995, J MICROBIOL METH, V23, P143, DOI 10.1016/0167-7012(95)00017-F; Hirsch P, 1998, SYST APPL MICROBIOL, V21, P374, DOI 10.1016/S0723-2020(98)80047-7; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Isola D, 2016, FUNGAL DIVERS, V76, P75, DOI 10.1007/s13225-015-0342-9; Jaag Otto, 1945, BEITR KRYPTO GAMENFLORA SCHWEIZ, V9, P1; Joo ES, 2015, J MICROBIOL, V53, P442, DOI 10.1007/s12275-015-5241-y; Kampfer P, 2012, INT J SYST EVOL MICR, V62, P364, DOI 10.1099/ijs.0.032441-0; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kemler M, 2017, YEASTS NATURAL ECOSY, P171, DOI [10.1007/978-3-319-62683-3_6, DOI 10.1007/978-3-319-62683-3_6]; Krumbein WE, 2003, CULT HERIT RES PAN E, V39-47; Krumbein WE, 1997, PINTA PATINA MICROBE; Lagkouvardos I, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0637-2; Lee JJ, 2015, J MICROBIOL, V53, P429, DOI 10.1007/s12275-015-5008-5; Li DH, 2016, METHODS, V102, P3, DOI 10.1016/j.ymeth.2016.02.020; Liu RY, 2014, J MICROBIOL, V52, P898, DOI 10.1007/s12275-014-4075-3; Madhour A, 2005, PHYTOCHEMISTRY, V66, P2617, DOI 10.1016/j.phytochem.2005.09.010; Malicek J, 2014, HERZOGIA, V27, P257, DOI 10.13158/heia.27.2.2014.257; Matallana-Surget S, 2009, ENVIRON MICROBIOL, V11, P2660, DOI 10.1111/j.1462-2920.2009.01992.x; McNamara C, 2011, SMITHSONIAN CONTRIBU, V2, P29; McNamara C, 2003, ART BIOL CONSERVATIO, P248; McNamara CJ, 2006, MICROB ECOL, V51, P51, DOI 10.1007/s00248-005-0200-5; McNamara CJ, 2005, FRONT ECOL ENVIRON, V3, P445, DOI 10.2307/3868661; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Montero-Calasanz MC, 2012, EXTREMOPHILES, V16, P903, DOI 10.1007/s00792-012-0486-4; Morotomi M, 2009, INT J SYST EVOL MICR, V59, P1895, DOI 10.1099/ijs.0.008169-0; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Normand P., 2015, BERGEYS MANUAL SYSTE, P1, DOI DOI 10.1002/9781118960608.GBM00054; Ogawa A, 2017, CURR MICROBIOL, V74, P848, DOI 10.1007/s00284-017-1257-3; ORTEGA-CALVO JJ, 1995, SCI TOTAL ENVIRON, V167, P329, DOI 10.1016/0048-9697(95)04593-P; Ortega-Morales BO, 2005, GEOMICROBIOL J, V22, P261, DOI 10.1080/01490450500182524; Paramo-Aguilera L, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue4-fulltext-6; Pastircakova K., 2008, Acta Phytopathologica et Entomologica Hungarica, V43, P31, DOI 10.1556/APhyt.43.2008.1.4; PENTECOST A, 1992, ARCH HYDROBIOL, V124, P167; Pentecost A., 2012, ECOLOGY CYANOBACTERI, P291, DOI DOI 10.1007/978-94-007-3855-3_10; Portillo MC, 2011, BIOCOLONIZATION STON, P19; Potts M, 1999, EUR J PHYCOL, V34, P319, DOI 10.1017/S0967026299002267; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Prior R, 2017, SYDOWIA, V69, P183, DOI 10.12905/0380.sydowia69-2017-0483; Pujalte M.J., 2014, PROKARYOTES, P439; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RAJ HD, 1990, CRIT REV MICROBIOL, V17, P329, DOI 10.3109/10408419009114761; Ricci S, 2018, DIALOGUES CULTURAL H, P277; Rosenberg E., 2014, PROKARYOTES, DOI DOI 10.1007/978-3-642-38954-2_137; Ruibal C, 2009, STUD MYCOL, P123, DOI 10.3114/sim.2009.64.06; Ruibal C, 2008, PERSOONIA, V21, P93, DOI 10.3767/003158508X371379; Sanchez-Moral S, 2018, J CULT HERIT, V34, P185, DOI 10.1016/j.culher.2018.02.019; Schabereiter-Gurtner C, 2002, ENVIRON MICROBIOL, V4, P392, DOI 10.1046/j.1462-2920.2002.00303.x; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Sert HB, 2007, ANTON LEEUW INT J G, V91, P217, DOI 10.1007/s10482-006-9111-9; Sghaier H, 2016, ISME J, V10, P21, DOI 10.1038/ismej.2015.108; Siegesmund S, 2002, GEOL SOC SPEC PUBL, V205, P1, DOI 10.1144/GSL.SP.2002.205.01.01; Sterflinger K, 1997, ANTON LEEUW INT J G, V72, P349, DOI 10.1023/A:1000570429688; Sterflinger K, 2001, ANTON LEEUW INT J G, V80, P275, DOI 10.1023/A:1013060308809; Sterflinger K, 1997, GEOMICROBIOL J, V14, P219, DOI 10.1080/01490459709378045; Sterflinger K, 1999, STUD MYCOL, P5; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tang Y, 2012, CAN J MICROBIOL, V58, P685, DOI [10.1139/W2012-042, 10.1139/w2012-042]; Tang Y, 2012, GEOMICROBIOL J, V29, P213, DOI 10.1080/01490451.2011.558560; Trouillas FP, 2010, PLANT DIS, V94, P867, DOI 10.1094/PDIS-94-7-0867; Uher B, 2009, FOTTEA, V9, P81, DOI 10.5507/fot.2009.007; Urzi C, 2001, ENVIRON MICROBIOL, V3, P471, DOI 10.1046/j.1462-2920.2001.00217.x; URZI C, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P289; Verges-Belmin V., 2008, ILLUSTRATED GLOSSARY; VILES H, 1995, GEOMORPHOLOGY, V13, P21, DOI 10.1016/0169-555X(95)00024-Y; Villa F, 2016, BIOSCIENCE, V66, P285, DOI 10.1093/biosci/biw006; Wijayawardene NN, 2014, PHYTOTAXA, V176, P192, DOI 10.11646/phytotaxa.176.1.19; WOLLENZIEN U, 1995, SCI TOTAL ENVIRON, V167, P287, DOI 10.1016/0048-9697(95)04589-S; Yoon MH, 2007, INT J SYST EVOL MICR, V57, P1834, DOI 10.1099/ijs.0.65011-0; Zhang Q, 2007, INT J SYST EVOL MICR, V57, P1752, DOI 10.1099/ijs.0.65033-0	125	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227639	10.1371/journal.pone.0227639	http://dx.doi.org/10.1371/journal.pone.0227639			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917800	gold, Green Published			2022-12-26	WOS:000534341100029
J	Tran, A; Mangeas, M; Demarchi, M; Roux, E; Degenne, P; Haramboure, M; Le Goff, G; Damiens, D; Gouagna, LC; Herbreteau, V; Dehecq, JS				Tran, Annelise; Mangeas, Morgan; Demarchi, Marie; Roux, Emmanuel; Degenne, Pascal; Haramboure, Marion; Le Goff, Gilbert; Damiens, David; Gouagna, Louis-Clement; Herbreteau, Vincent; Dehecq, Jean-Sebastien			Complementarity of empirical and process-based approaches to modelling mosquito population dynamics with Aedes albopictus as an example-Application to the development of an operational mapping tool of vector populations	PLOS ONE			English	Article							DRIVEN ABUNDANCE MODEL; REUNION ISLAND; CHIKUNGUNYA EPIDEMIC; DIPTERA-CULICIDAE; DENGUE; DISPERSAL; TEMPERATURE; AEGYPTI; SURVIVAL; REEMERGENCE	Mosquitoes are responsible for the transmission of major pathogens worldwide. Modelling their population dynamics and mapping their distribution can contribute effectively to disease surveillance and control systems. Two main approaches are classically used to understand and predict mosquito abundance in space and time, namely empirical (or statistical) and process-based models. In this work, we used both approaches to model the population dynamics in Reunion Island of the 'Tiger mosquito', Aedes albopictus, a vector of dengue and chikungunya viruses, using rainfall and temperature data. We aimed to i) evaluate and compare the two types of models, and ii) develop an operational tool that could be used by public health authorities and vector control services. Our results showed that Ae. albopictus dynamics in Reunion Island are driven by both rainfall and temperature with a non-linear relationship. The predictions of the two approaches were consistent with the observed abundances of Ae. albopictus aquatic stages. An operational tool with a user-friendly interface was developed, allowing the creation of maps of Ae. albopictus densities over the whole territory using meteorological data collected from a network of weather stations. It is now routinely used by the services in charge of vector control in Reunion Island.	[Tran, Annelise; Degenne, Pascal; Haramboure, Marion] UMR TETIS, CIRAD, St Clotilde, Reunion, France; [Tran, Annelise; Degenne, Pascal; Haramboure, Marion] Univ Montpellier, TETIS, AgroParisTech, CIRAD,CNRS,INRAE, Montpellier, France; [Tran, Annelise; Haramboure, Marion] UMR ASTRE, CIRAD, St Clotilde, Reunion, France; [Tran, Annelise; Haramboure, Marion] Univ Montpellier, INRAE, CIRAD, ASTRE, Montpellier, France; [Mangeas, Morgan; Roux, Emmanuel; Herbreteau, Vincent] UMR ESPACE DEV, IRD, Montpellier, France; [Demarchi, Marie] Maison Teledetect, Montpellier, France; [Le Goff, Gilbert; Damiens, David; Gouagna, Louis-Clement] IRD, UMR MIVEGEC, St Clotilde, Reunion, France; [Dehecq, Jean-Sebastien] Reg Hlth Agcy, St Clotilde, Reunion, France	CIRAD; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Universite de Montpellier; CIRAD; CIRAD; INRAE; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite des Antilles; University of La Reunion; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD)	Tran, A (corresponding author), UMR TETIS, CIRAD, St Clotilde, Reunion, France.; Tran, A (corresponding author), Univ Montpellier, TETIS, AgroParisTech, CIRAD,CNRS,INRAE, Montpellier, France.; Tran, A (corresponding author), UMR ASTRE, CIRAD, St Clotilde, Reunion, France.; Tran, A (corresponding author), Univ Montpellier, INRAE, CIRAD, ASTRE, Montpellier, France.	annelise.tran@cirad.fr	mangeas, morgan/AAS-7995-2020; Roux, Emmanuel/U-6942-2019; Herbreteau, Vincent/L-4411-2013	mangeas, morgan/0000-0003-4146-3784; Roux, Emmanuel/0000-0003-2266-8207; Herbreteau, Vincent/0000-0003-1762-6336; Tran, Annelise/0000-0001-5463-332X; Gouagna, Louis Clement/0000-0003-0957-4484; Le Goff, Gilbert/0000-0001-9913-8736	Regional Health Agency in Reunion Island; FEDER INTERREG TROI project (2015-2017) under the platform in partnership One Health Indian Ocean; European Research Council [682387/REVOLINC]	Regional Health Agency in Reunion Island; FEDER INTERREG TROI project (2015-2017) under the platform in partnership One Health Indian Ocean; European Research Council(European Research Council (ERC)European Commission)	This study was partially funded by the Regional Health Agency in Reunion Island (https://www.ocean-indien.ars.sante.fr/), and FEDER INTERREG TROI project (2015-2017) under the platform in partnership One Health Indian Ocean (www.onehealth-oi.org).MMreceived a grant from European Research Council (https://erc.europa.eu): ERC Consolidator grant no682387/REVOLINC project. JSD (Regional Health Agency, Reunion Island) provided part of the entomological dataset and approved the final manuscript.	Adams HD, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00438; Adde A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164685; Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646; [Anonymous], 2012, BIOMATH; [Anonymous], 2017, R LANG ENV STAT COMP; [Anonymous], 2014, GLOB BRIEF VECT BORN; Baldacchino F, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070749; Boyer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091170; Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027; Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0; Chang C.-C., LIBSVM LIB SUPPORT V; CIRE, SURV DENG REUN; D'Ortenzio E, 2011, MED MALADIES INFECT, V41, P475, DOI 10.1016/j.medmal.2010.11.021; Degenne P., 2016, SoftwareX, V5, P89, DOI 10.1016/j.softx.2016.05.002; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Dickens BL, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000801; Dieng H, 2012, INT J BIOMETEOROL, V56, P113, DOI 10.1007/s00484-011-0402-0; Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0; Dufourd C, 2013, COMPUT MATH APPL, V66, P1695, DOI 10.1016/j.camwa.2013.03.024; Dumont Y, 2016, MATH BIOSCI, V281, P9, DOI 10.1016/j.mbs.2016.08.011; Dumont Y, 2012, J MATH BIOL, V65, P809, DOI 10.1007/s00285-011-0477-6; Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313; Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282; Ezanno P, 2015, PREV VET MED, V120, P39, DOI 10.1016/j.prevetmed.2014.12.018; Fischer D, 2014, EUROSURVEILLANCE B E, V19; Gouagna LC, 2015, ACTA TROP, V143, P89, DOI 10.1016/j.actatropica.2014.12.011; Hammami P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1712-1; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163; Jung Jae-Min, 2017, Journal of Biosystems Engineering, V42, P217, DOI 10.5307/JBE.2017.42.3.217; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; KLES V, 1994, B SOC PATHOL EXOT, V87, P71; Lacour G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145311; Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008; Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519; Larrieu S, 2012, EUROSURVEILLANCE, V17, P4; Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x; Lord CC, 2007, J AM MOSQUITO CONTR, V23, P252, DOI 10.2987/8756-971X(2007)23[252:MABCOM]2.0.CO;2; Machault V, 2014, ISPRS INT J GEO-INF, V3, P1352, DOI 10.3390/ijgi3041352; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; Moiroux N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-103; Moiroux N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-71; NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P339; Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; ROSEN L, 1976, AM J TROP MED HYG, V25, P906, DOI 10.4269/ajtmh.1976.25.906; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Unlu I, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2034-7; Vapnik V., 2013, NATURE STAT LAERNING; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; Weaver Scott C, 2016, Antiviral Res, V130, P69, DOI 10.1016/j.antiviral.2016.03.010; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; WHO, 2022, MIDDLE E RESP SYNDRO	59	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227407	10.1371/journal.pone.0227407	http://dx.doi.org/10.1371/journal.pone.0227407			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951601	Green Published, gold			2022-12-26	WOS:000534370500019
J	Brown, E; Rowan, C; Strowitzki, MJ; Fagundes, RR; Faber, KN; Guntsch, A; Halligan, DN; Kugler, J; Jones, F; Lee, CT; Doherty, G; Taylor, CT				Brown, Eric; Rowan, Catherine; Strowitzki, Moritz J.; Fagundes, Raphael R.; Faber, Klaas Nico; Guentsch, Annemarie; Halligan, Doug N.; Kugler, Julia; Jones, Fiona; Lee, Chee T.; Doherty, Glen; Taylor, Cormac T.			Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1 alpha response in ulcerative colitis patients	FASEB JOURNAL			English	Article						colitis; epithelium; hypoxia; inflammation; PHD1	BINDING-PROTEIN ISOFORMS; GENE-EXPRESSION; HYPOXIA; ACTIVATION; PATHWAY; MODEL	The HIF hydroxylase enzymes (PHD1-3 and FIH) are cellular oxygen-sensors which confer hypoxic-sensitivity upon the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha. Microenvironmental hypoxia has a strong influence on the epithelial and immune cell function through HIF-dependent gene expression and consequently impacts upon the course of disease progression in ulcerative colitis (UC), with HIF-1 alpha being protective while HIF-2 alpha promotes disease. However, little is known about how inflammation regulates hypoxia-responsive pathways in UC patients. Here we demonstrate that hypoxia is a prominent microenvironmental feature of the mucosa in UC patients with active inflammatory disease. Furthermore, we found that inflammation drives transcriptional programming of the HIF pathway including downregulation of PHD1 thereby increasing the tissue responsiveness to hypoxia and skewing this response toward protective HIF-1 over detrimental HIF-2 activation. We identified CEBP alpha as a transcriptional regulator of PHD1 mRNA expression which is downregulated in both inflamed tissue derived from patients and in cultured intestinal epithelial cells treated with inflammatory cytokines. In summary, we propose that PHD1 downregulation skews the hypoxic response toward enhanced protective HIF-1 alpha stabilization in the inflamed mucosa of UC patients.	[Brown, Eric; Strowitzki, Moritz J.; Fagundes, Raphael R.; Guentsch, Annemarie; Halligan, Doug N.; Kugler, Julia; Lee, Chee T.; Doherty, Glen; Taylor, Cormac T.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Brown, Eric; Strowitzki, Moritz J.; Fagundes, Raphael R.; Guentsch, Annemarie; Halligan, Doug N.; Kugler, Julia; Lee, Chee T.; Doherty, Glen; Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin, Ireland; [Rowan, Catherine; Jones, Fiona; Doherty, Glen] St Vincents Univ Hosp, Ctr Colorectal Dis, Elm Pk, Dublin, Ireland; [Fagundes, Raphael R.; Faber, Klaas Nico] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatol & Gastroenterol, Groningen, Netherlands	University College Dublin; University College Dublin; University College Dublin; Saint Vincent's University Hospital; University of Groningen	Taylor, CT (corresponding author), Univ Coll Dublin, UCD Conway Inst, Dublin 4, Ireland.	cormac.taylor@ucd.ie		Doherty, Glen/0000-0003-4384-5049; Lee, Chee Teik/0000-0002-9769-9422; Fagundes, Raphael/0000-0003-1571-0374; Strowitzki, Moritz J./0000-0001-6967-9283	European Commission (EC) [15/ERA-CSM/32/67]; Science Foundation Ireland	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	European Commission (EC), Grant/Award Number: 15/ERA-CSM/32/67; Science Foundation Ireland	Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2017, MICROBES INFECT, V19, P210, DOI 10.1016/j.micinf.2016.09.004; Evans SM, 2000, CANCER RES, V60, P2018; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Higashiyama M, 2012, J LEUKOCYTE BIOL, V91, P901, DOI 10.1189/jlb.1011518; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Jain R, 1999, BIOCHEM J, V338, P737, DOI 10.1042/0264-6021:3380737; Kalra J, 2018, N-S ARCH PHARMACOL, V391, P285, DOI 10.1007/s00210-017-1455-3; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Lin X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-48; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal-Bressenot A, 2017, GUT, V66, P43, DOI 10.1136/gutjnl-2015-310187; McDonnell M, SINGLE ASCENDING DOS; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Palmieri O, 2015, INFLAMM BOWEL DIS, V21, P1260, DOI 10.1097/MIB.0000000000000370; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Scholz CC, 2013, CURR OPIN PHARMACOL, V13, P646, DOI 10.1016/j.coph.2013.04.009; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Taylor CT, 2017, NAT REV IMMUNOL, V17, P774, DOI 10.1038/nri.2017.103; Tengku-Muhammad TS, 2000, CYTOKINE, V12, P1430, DOI 10.1006/cyto.2000.0711; Thompson AAR, 2014, BLOOD, V123, P366, DOI 10.1182/blood-2013-05-500207; Van Welden S, 2017, NAT REV GASTRO HEPAT, V14, P596, DOI 10.1038/nrgastro.2017.101; Xu CM, 2016, EXP THER MED, V11, P1330, DOI 10.3892/etm.2016.3030; Xue X, 2014, AM J PHYSIOL-GASTR L, V307, pG187, DOI 10.1152/ajpgi.00112.2014; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yin M, 1996, J BIOL CHEM, V271, P17974, DOI 10.1074/jbc.271.30.17974; Zhou KR, 2017, NUCLEIC ACIDS RES, V45, pD43, DOI 10.1093/nar/gkw965	34	10	11	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3732	3742		10.1096/fj.201902103R	http://dx.doi.org/10.1096/fj.201902103R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944416	Bronze, Green Published			2022-12-26	WOS:000507596600001
J	Castro, JT; Oliveira, GS; Nishigasako, MA; Debrie, AS; Miyaji, EN; Soares-Schanoski, A; Akamatsu, MA; Locht, C; Ho, PL; Mielcarek, N; Oliveira, MLS				Castro, Julia T.; Oliveira, Giuliana S.; Nishigasako, Melissa A.; Debrie, Anne-Sophie; Miyaji, Eliane N.; Soares-Schanoski, Alessandra; Akamatsu, Milena A.; Locht, Camille; Ho, Paulo L.; Mielcarek, Nathalie; Oliveira, Maria Leonor S.			Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; PROTEIN-A; FILAMENTOUS HEMAGGLUTININ; IMMUNE-RESPONSES; COMPLEMENT DEPOSITION; PROTECTION; PSPA; ANTIBODIES; DISEASE; INDUCTION	Pneumococcal Surface Protein A (PspA) has been successfully tested as vaccine candidate against Streptococcus pneumoniae infections. Vaccines able to induce PspA-specific antibodies and Th1 cytokines usually provide protection in mice. We have shown that the whole cell pertussis vaccine (wP) or components from acellular pertussis vaccines, such as Pertussis Toxin or Filamentous Hemagglutinin (FHA), are good adjuvants to PspA, suggesting that combined pertussis-PspA vaccines would be interesting strategies against the two infections. Here, we evaluated the potential of wP as a delivery vector to PspA. Bordetella pertussis strains producing a PspA from clade 4 (PspA4Pro) fused to the N-terminal region of FHA (Fha44) were constructed and inactivated with formaldehyde for the production of wP(PspA4Pro). Subcutaneous immunization of mice with wP(PspA4Pro) induced low levels of anti-PspA4 IgG, even after 3 doses, and did not protect against a lethal pneumococcal challenge. Prime-boost strategies using wP(PspA4Pro) and PspA4Pro showed that there was no advantage in using the wP(PspA4Pro) vaccine. Immunization of mice with purified PspA4Pro induced higher levels of antibodies and protection against pneumococcal infection than the prime-boost strategies. Finally, purified Fha44:PspA4Pro induced high levels of anti-PspA4-Pro IgG, but no protection, suggesting that the antibodies induced by the fusion protein were not directed to protective epitopes.	[Castro, Julia T.; Oliveira, Giuliana S.; Nishigasako, Melissa A.; Miyaji, Eliane N.; Soares-Schanoski, Alessandra; Oliveira, Maria Leonor S.] Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil; [Debrie, Anne-Sophie; Locht, Camille; Mielcarek, Nathalie] Univ Lille, Inst Pasteur Lille, CIIL Ctr Infect & Immun Lille, CNRS,INSERM,CHU Lille,U1019,UMR 8204, Lille, France; [Akamatsu, Milena A.; Ho, Paulo L.] Inst Butantan, Secao Vacinas Aerob, Div Bioind, Sao Paulo, SP, Brazil	Instituto Butantan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Instituto Butantan	Oliveira, MLS (corresponding author), Inst Butantan, Lab Bacteriol, Sao Paulo, SP, Brazil.	marialeonor.oliveira@butantan.gov.br	Oliveira, Maria Leonor S/F-4988-2012; Miyaji, Eliane N/D-7642-2012; Akamatsu, Milena Apetito/V-8084-2017; Soares Schanoski, Alessandra/H-8144-2014	Miyaji, Eliane N/0000-0003-1689-5366; Akamatsu, Milena Apetito/0000-0002-8193-3448; Soares Schanoski, Alessandra/0000-0002-6514-8458; Oliveira, Maria Leonor/0000-0003-4849-3062; Mielcarek, Nathalie/0000-0002-5968-9442	FAPESP [2016/13134-3, 2016/17258-9, 2017/01992-8]; CNPq [301856/2016-8]; Fundacao Butantan; CAPES, Brasil	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan; CAPES, Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP (grant 2016/13134-3), CNPq (301856/2016-8) and Fundacao Butantan. Castro JT received a PhD fellowship and Nishigasako MA received an undergraduate fellowship (FAPESP 2016/17258-9 and 2017/01992-8); Oliveira GS received a Msc fellowship from CAPES, Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dominique Raze for the help with the construction of the pXR1Fha44: PspA4Pro plasmid. We also thank Aline Marques Cavalher, Vera Lucia de Almeida and Ricardo Alexandre de Souza Silva for the excellent technical support. This work was supported by FAPESP (grant 2016/13134-3), CNPq (301856/2016-8) and Fundacao Butantan. Castro JT received a PhD fellowship and Nishigasako MA received an undergraduate fellowship (FAPESP 2016/17258-9 and 2017/01992-8); Oliveira GS received a Msc fellowship from CAPES, Brasil).	Akamatsu MA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01570-14; Alonso S, 2002, INFECT IMMUN, V70, P4142, DOI 10.1128/IAI.70.8.4142-4147.2002; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; Campos IB, 2008, MICROBES INFECT, V10, P481, DOI 10.1016/j.micinf.2008.01.007; Coppens I, 2001, INFECT IMMUN, V69, P5440, DOI 10.1128/IAI.69.9.5440-5446.2001; Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005; Ferreira DM, 2008, CLIN VACCINE IMMUNOL, V15, P499, DOI 10.1128/CVI.00400-07; Ferreira DM, 2010, MICROB PATHOGENESIS, V48, P205, DOI 10.1016/j.micpath.2010.02.009; Figueiredo DB, 2017, APPL MICROBIOL BIOT, V101, P2305, DOI 10.1007/s00253-016-7983-9; Hanniffy SB, 2007, J INFECT DIS, V195, P185, DOI 10.1086/509807; Kammoun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059198; Li R, 2011, VACCINE, V29, P5502, DOI 10.1016/j.vaccine.2011.05.052; Mielcarek N, 1998, NAT BIOTECHNOL, V16, P454, DOI 10.1038/nbt0598-454; Miyaji EN, 2013, CELL MOL LIFE SCI, V70, P3303, DOI 10.1007/s00018-012-1234-8; Moreno AT, 2010, CLIN VACCINE IMMUNOL, V17, P439, DOI 10.1128/CVI.00430-09; Oliveira MLS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010863; Poulain-Godefroy O, 2003, SCAND J IMMUNOL, V58, P503, DOI 10.1046/j.1365-3083.2003.01336.x; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren B, 2012, CLIN VACCINE IMMUNOL, V19, P1574, DOI 10.1128/CVI.00393-12; RenauldMongenie G, 1996, P NATL ACAD SCI USA, V93, P7944, DOI 10.1073/pnas.93.15.7944; Salcedo-Rivillas C, 2014, CLIN VACCINE IMMUNOL, V21, P972, DOI 10.1128/CVI.00134-14; Shaper M, 2004, INFECT IMMUN, V72, P5031, DOI 10.1128/IAI.72.9.5031-5040.2004; Tostes RO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170157; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; Wang SF, 2010, INFECT IMMUN, V78, P3258, DOI 10.1128/IAI.00176-10; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Yildirim I, 2015, INFECT DIS CLIN N AM, V29, P679, DOI 10.1016/j.idc.2015.07.009	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0228055	10.1371/journal.pone.0228055	http://dx.doi.org/10.1371/journal.pone.0228055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945121	Green Published, gold			2022-12-26	WOS:000534370100082
J	Chen, GL; Kamat, PK; Ahmad, AS; Dore, S				Chen, Gangling; Kamat, Pradip Kumar; Ahmad, Abdullah Shafique; Dore, Sylvain			Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; IN-VITRO MODEL; BRAIN-INJURY; REPERFUSION INJURY; ARTERY OCCLUSION; KETAMINE; PROTECTION; RECEPTOR; NEUROPROTECTION; SEVOFLURANE	Limb remote ischemic postconditioning (LRIP) has been reported as an effective method to reduce the induced experimental stroke damage after ischemic reperfusion (IR) injury. Studies suggest that anesthetics used during induction of ischemic stroke can reduce IR injury, which could affect the actual mechanisms of neuroprotection by LRIP. This study focuses on the comparative effects of anesthetics such as isoflurane and ketamine-xylazine on ischemic injury when used during LRIP. Adult C57BL/6 mice were anesthetized by isoflurane or halothane, and transient middle cerebral artery occlusion (MCAO) was induced through insertion of the filament. Under isoflurane or ketamine-xylazine anesthesia, LRIP was performed after 90 min of reperfusion by carrying out three cycles of 5 min ischemia/5 min reperfusion of the bilateral hind limbs for one session per day for a total of 3 days. Results showed that the use of different anesthetics-isoflurane or ketamine-xylazine-during LRIP had no effects on body weight. However, LRIP was able to improve neurological function as observed by the neurological deficit score in ischemic mice. Interestingly, the neurological deficit in the group where ketamine-xylazine was used was better than the group where isoflurane was used during LRIP. Furthermore, the LRIP was able to prolong the period of the ischemic mice on the rotarod and this effect was more significant in the groups where ketamine-xylazine was used during LRIP. Moreover, LRIP significantly attenuated the infarction volume; however, this effect was independent of the anesthetic used during LRIP. From these results, we conclude that ischemic mice that were subjected to LRIP under ketamine-xylazine anesthesia had better neurological deficit outcomes after stroke.	[Chen, Gangling; Kamat, Pradip Kumar; Ahmad, Abdullah Shafique; Dore, Sylvain] Univ Florida, Dept Anesthesiol, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32611 USA; [Chen, Gangling] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Dept Pharmacol Chinese Mat Med, Nanjing, Peoples R China; [Dore, Sylvain] Univ Florida, Dept Neurol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Pharmaceut, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; China Pharmaceutical University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Dore, S (corresponding author), Univ Florida, Dept Anesthesiol, Ctr Translat Res Neurodegenerat Dis, McKnight Brain Inst, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Dept Neurol, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Dept Pharmaceut, Gainesville, FL 32611 USA.; Dore, S (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109	McKnight Brain Research Institute, Brain and Spinal Cord Injury Research Trust Fund; National Natural Science Foundation of China [81503284]	McKnight Brain Research Institute, Brain and Spinal Cord Injury Research Trust Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the McKnight Brain Research Institute, Brain and Spinal Cord Injury Research Trust Fund (SD, ASA), and the National Natural Science Foundation of China (No. 81503284, GC). The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the McKnight Brain Research Institute, Brain and Spinal Cord Injury Research Trust Fund (SD, ASA), and the National Natural Science Foundation of China (No. 81503284, GC). The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Ahmad AS, 2014, NEUROSCIENCE, V279, P260, DOI 10.1016/j.neuroscience.2014.08.050; Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Ahmad M, 2006, EUR J NEUROSCI, V23, P35, DOI 10.1111/j.1460-9568.2005.04540.x; Andreka G, 2007, HEART, V93, P749, DOI 10.1136/hrt.2006.114504; Baumert JH, 2009, J CARDIOTHOR VASC AN, V23, P614, DOI 10.1053/j.jvca.2009.01.028; Chen GL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121971; Chen GL, 2014, INDIAN J EXP BIOL, V52, P597; Cruz FF, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1645-x; Dirnagl U, 2009, BRIT J PHARMACOL, V157, P1154, DOI 10.1111/j.1476-5381.2009.00211.x; do Vale EM, 2016, BASIC CLIN PHARMACOL, V119, P562, DOI 10.1111/bcpt.12637; Frankowski JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17956; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Guler L, 2014, ADV CLIN EXP MED, V23, P683, DOI 10.17219/acem/37214; Kapinya KJ, 2002, NEUROREPORT, V13, P1431, DOI 10.1097/00001756-200208070-00017; Khatibi NH, 2011, ANESTH ANALG, V113, P343, DOI 10.1213/ANE.0b013e31821f9524; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Leclerc JL, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0182-2; Lee HT, 2006, AM J PHYSIOL-RENAL, V291, pF67, DOI 10.1152/ajprenal.00412.2005; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li J, 2016, INT J IMMUNOPATH PH, V29, P300, DOI 10.1177/0394632016638346; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Liman S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/380403; Liu J, 2016, AM J TRANSL RES, V8, P2597; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mathews KS, 2001, NEUROCHEM INT, V38, P367, DOI 10.1016/S0197-0186(00)00125-X; Pi ZB, 2018, MOL MED REP, V17, P6497, DOI 10.3892/mmr.2018.8642; Qi ZF, 2012, CNS NEUROSCI THER, V18, P965, DOI 10.1111/cns.12016; Ramagiri S, 2017, BRAIN RES, V1669, P44, DOI 10.1016/j.brainres.2017.05.016; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; RIDENOUR TR, 1991, BRAIN RES, V565, P116, DOI 10.1016/0006-8993(91)91742-J; Sakai H, 2007, ANESTHESIOLOGY, V106, P92, DOI 10.1097/00000542-200701000-00017; Schlattmann P, 2010, J CEREBR BLOOD F MET, V30, P1558, DOI 10.1038/jcbfm.2010.95; Sehmidt R, 2007, ANN SURG, V245, P931, DOI 10.1097/01.sla.0000256891.45790.4d; Sloan RC, 2011, J AM ASSOC LAB ANIM, V50, P349; Sunyer B, 2007, BEHAV BRAIN RES, V181, P64, DOI 10.1016/j.bbr.2007.03.025; Toner CC, 2002, BRAIN RES, V958, P390, DOI 10.1016/S0006-8993(02)03696-X; Tsubota H, 2010, EUR J VASC ENDOVASC, V40, P804, DOI 10.1016/j.ejvs.2010.08.014; WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267; Xiao F, 2012, NEURAL REGEN RES, V7, P833, DOI 10.3969/j.issn.1673-5374.2012.11.006; Xiong LZ, 2003, ANESTH ANALG, V96, P233, DOI 10.1097/00000539-200301000-00047; Xu DJ, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0323-x; Xue QS, 2004, ACTA PHARMACOL SIN, V25, P115; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; ZHANG L, 2017, J IMMUNOTHER CANC S2, V5; Zheng SQ, 2004, MOL PHARMACOL, V65, P1172, DOI 10.1124/mol.65.5.1172	46	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227624	10.1371/journal.pone.0227624	http://dx.doi.org/10.1371/journal.pone.0227624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945776	Green Published, gold			2022-12-26	WOS:000534370100047
J	Engel, CEA; Vorlander, D; Biedendieck, R; Krull, R; Dohnt, K				Engel, Christina Elisabeth Anna; Vorlaender, David; Biedendieck, Rebekka; Krull, Rainer; Dohnt, Katrin			Quantification of microaerobic growth of Geobacter sulfurreducens	PLOS ONE			English	Article							EXTRACELLULAR ELECTRON-TRANSFER; DI-GMP; PURE CULTURE; REDUCTION; ACETATE; OXYGEN; OXIDATION; HYDROGEN; FE(III); MICROARRAY	Geobacter sulfurreducens was originally considered a strict anaerobe. However, this bacterium was later shown to not only tolerate exposure to oxygen but also to use it as terminal electron acceptor. Research performed has so far only revealed the general ability of G. sulfurreducens to reduce oxygen, but the oxygen uptake rate has not been quantified yet, nor has evidence been provided as to how the bacterium achieves oxygen reduction. Therefore, microaerobic growth of G. sulfurreducens was investigated here with better defined operating conditions as previously performed and a transcriptome analysis was performed to elucidate possible metabolic mechanisms important for oxygen reduction in G. sulfurreducens. The investigations revealed that cell growth with oxygen is possible to the same extent as with fumarate if the maximum specific oxygen uptake rate (sOUR) of 95 mg(O2) g(CDW)(-1) h(-1) is not surpassed. Hereby, the entire amount of introduced oxygen is reduced. When oxygen concentrations are too high, cell growth is completely inhibited and there is no partial oxygen consumption. Transcriptome analysis suggests a menaquinol oxidase to be the enzyme responsible for oxygen reduction. Transcriptome analysis has further revealed three different survival strategies, depending on the oxygen concentration present. When prompted with small amounts of oxygen, G. sulfurreducens will try to escape the microaerobic area; if oxygen concentrations are higher, cells will focus on rapid and complete oxygen reduction coupled to cell growth; and ultimately cells will form protective layers if a complete reduction becomes impossible. The results presented here have important implications for understanding how G. sulfurreducens survives exposure to oxygen.	[Engel, Christina Elisabeth Anna; Vorlaender, David; Biedendieck, Rebekka; Krull, Rainer; Dohnt, Katrin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, Braunschweig, Germany; [Engel, Christina Elisabeth Anna; Vorlaender, David; Krull, Rainer; Dohnt, Katrin] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Ctr Syst Biol BRICS, Braunschweig, Germany; [Biedendieck, Rebekka] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology	Dohnt, K (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, Braunschweig, Germany.; Dohnt, K (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Ctr Syst Biol BRICS, Braunschweig, Germany.	k.dohnt@tu-braunschweig.de		Biedendieck, Rebekka/0000-0002-3567-6196; Krull, Rainer/0000-0003-2821-8610	NTH-Research Unit ElektroBak -Innovative materials and concepts for microbial electrochemical systems within the Braunschweig Integrated Centre of Systems Biology (BRICS) at the Technische Universitat Braunschweig, Germany; German Research Foundation; Open Access Publication Funds of the Technische Universitat Braunschweig	NTH-Research Unit ElektroBak -Innovative materials and concepts for microbial electrochemical systems within the Braunschweig Integrated Centre of Systems Biology (BRICS) at the Technische Universitat Braunschweig, Germany; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Technische Universitat Braunschweig	The authors gratefully acknowledge financial support provided by the NTH-Research Unit ElektroBak -Innovative materials and concepts for microbial electrochemical systems within the Braunschweig Integrated Centre of Systems Biology (BRICS) at the Technische Universitat Braunschweig, Germany. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Technische Universitat Braunschweig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge financial support provided by the NTH-Research Unit ElektroBak-Innovative materials and concepts for microbial electrochemical systems within the Braunschweig Integrated Centre of Systems Biology (BRICS) at the Technische Universitat Braunschweig, Germany. Special thanks go to Annika Michel of the Institute of Microbiology at the Technische Universitat Braunschweig for help with performing RNA purification and microarray preparation.	Altschul S.F., 1997, NUCLEIC ACIDS RES, V25, P3389, DOI DOI 10.1093/NAR/25.17; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; Biedendieck R, 2011, METHOD ENZYMOL, V500, P165, DOI 10.1016/B978-0-12-385118-5.00010-4; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Borgmeier C, 2011, APPL MICROBIOL BIOT, V92, P583, DOI 10.1007/s00253-011-3575-x; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Brown DG, 2005, ENVIRON SCI TECHNOL, V39, P3069, DOI 10.1021/es048613p; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Butler JE, 2006, J BACTERIOL, V188, P450, DOI 10.1128/JB.188.2.450-455.2006; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Call DF, 2011, APPL ENVIRON MICROB, V77, P8791, DOI 10.1128/AEM.06434-11; Daum B, 2018, BIOL CHEM, V399, P799, DOI 10.1515/hsz-2018-0157; DiDonato LN, 2006, J BACTERIOL, V188, P8469, DOI 10.1128/JB.01278-06; Engel C, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00060; Galushko AS, 2000, ARCH MICROBIOL, V174, P314, DOI 10.1007/s002030000208; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Kabashima Y, 2009, J BIOCHEM, V146, P845, DOI 10.1093/jb/mvp140; Kim JR, 2005, APPL MICROBIOL BIOT, V68, P23, DOI 10.1007/s00253-004-1845-6; Lin WC, 2004, APPL ENVIRON MICROB, V70, P2525, DOI 10.1128/AEM.70.4.2525-2528.2004; Lombard M, 2000, J BIOL CHEM, V275, P115, DOI 10.1074/jbc.275.1.115; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5; Mahadevan R, 2006, APPL ENVIRON MICROB, V72, P1558, DOI 10.1128/AEM.72.2.1558-1568.2006; Mehta T, 2005, APPL ENVIRON MICROB, V71, P8634, DOI 10.1128/AEM.71.12.8634-8641.2005; Methe BA, 2003, SCIENCE, P302; Mouser PJ, 2009, ISME J, V3, P454, DOI 10.1038/ismej.2008.126; Nunez C, 2006, J BACTERIOL, V188, P2792, DOI 10.1128/JB.188.8.2792-2800.2006; Ramel F, 2013, MICROBIOL-SGM, V159, P2663, DOI 10.1099/mic.0.071282-0; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy086; Richter LV, 2012, J BACTERIOL, V194, P2551, DOI 10.1128/JB.06366-11; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Shelobolina ES, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-16; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Speers AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01578; Stein R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11148; Tran HT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-471; Tremblay PL, 2012, J BACTERIOL, V194, P2248, DOI 10.1128/JB.00044-12; Weisenberger S, 1996, AICHE J, V42, P298, DOI 10.1002/aic.690420130; Williams KH, 2011, GEOMICROBIOL J, V28, P519, DOI 10.1080/01490451.2010.520074; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Yang K, 2008, FEBS LETT, V582, P3705, DOI 10.1016/j.febslet.2008.09.038; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	43	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0215341	10.1371/journal.pone.0215341	http://dx.doi.org/10.1371/journal.pone.0215341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945063	Green Published, gold, Green Submitted			2022-12-26	WOS:000534370100001
J	Kieser, Q; Noyce, RS; Shenouda, M; Lin, YCJ; Evans, DH				Kieser, Quinten; Noyce, Ryan S.; Shenouda, Mira; Lin, Y-C James; Evans, David H.			Cytoplasmic factories, virus assembly, and DNA replication kinetics collectively constrain the formation of poxvirus recombinants	PLOS ONE			English	Article							VACCINIA VIRUS; POLYMERASE; EXPRESSION; MORPHOGENESIS; INTERMEDIATE	Poxviruses replicate in cytoplasmic structures called factories and each factory begins as a single infecting particle. Sixty-years ago Cairns predicted that this might have effects on vaccinia virus (VACV) recombination because the factories would have to collide and mix their contents to permit recombination. We've since shown that factories collide irregularly and that even then the viroplasm mixes poorly. We've also observed that while intragenic recombination occurs frequently early in infection, intergenic recombination is less efficient and happens late in infection. Something inhibits factory fusion and viroplasm mixing but what is unclear. To study this, we've used optical and electron microscopy to track factory movement in co-infected cells and correlate these observations with virus development and recombinant formation. While the technical complexity of the experiments limited the number of cells that are amenable to extensive statistical analysis, these studies do show that intergenic recombination coincides with virion assembly and when VACV replication has declined to <= 10% of earlier levels. Along the boundaries between colliding factories, one sees ER membrane remnants and other cell constituents like mitochondria. These collisions don't always cause factory fusion, but when factories do fuse, they still entrain cell constituents like mitochondria and ER-wrapped microtubules. However, these materials wouldn't seem to pose much of a further barrier to DNA mixing and so it's likely that the viroplasm also presents an omnipresent impediment to DNA mixing. Late packaging reactions might help to disrupt the viroplasm, but packaging would sequester the DNA just as the replication and recombination machinery goes into decline and further reduce recombinant yields. Many factors thus appear to conspire to limit recombination between co-infecting poxviruses.	[Kieser, Quinten; Noyce, Ryan S.; Shenouda, Mira; Lin, Y-C James; Evans, David H.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Kieser, Quinten; Noyce, Ryan S.; Shenouda, Mira; Lin, Y-C James; Evans, David H.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Evans, DH (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Evans, DH (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	devans@ualberta.ca	; Evans, David/M-1912-2016	Lin, Yi-Chan James/0000-0003-0867-220X; Evans, David/0000-0001-5871-299X	Canadian Institutes for Health Research [PS 159614]; Natural Sciences & Engineering Research Council [RGPIN 05201]; Canada Foundation for Innovation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by operating grants to DHE from the Canadian Institutes for Health Research (PS 159614; http://cihr-irsc.gc.ca/), the Natural Sciences & Engineering Research Council (RGPIN 05201; https://www.nserc-crsng.gc.ca/), and by Infrastructure awards from the Canada Foundation for Innovation (https://www.innovation.ca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAIRNS J, 1960, VIROLOGY, V11, P603, DOI 10.1016/0042-6822(60)90103-3; Cepeda V, 2014, VIRUS RES, V183, P23, DOI 10.1016/j.virusres.2014.01.016; Czarnecki MW, 2017, VIRUS RES, V234, P193, DOI 10.1016/j.virusres.2017.01.027; DALES S, 1961, J BIOPHYS BIOCHEM CY, V10, P475, DOI 10.1083/jcb.10.4.475; De Silva FS, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-23; DELANGE AM, 1986, P NATL ACAD SCI USA, V83, P614, DOI 10.1073/pnas.83.3.614; Elde NC, 2012, CELL, V150, P831, DOI 10.1016/j.cell.2012.05.049; Esposito JJ, 2006, SCIENCE, V313, P807, DOI 10.1126/science.1125134; EVANS DH, 1988, J VIROL, V62, P367, DOI 10.1128/JVI.62.2.367-375.1988; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Gammon DB, 2009, J VIROL, V83, P4236, DOI 10.1128/JVI.02255-08; Harrison K, 2016, J VIROL, V90, P10120, DOI 10.1128/JVI.01464-16; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Kieser Q, 2019, METHODS MOL BIOL, V2023, P221, DOI 10.1007/978-1-4939-9593-6_14; Kobiler O, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007714; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LEE C, 1989, J CELL BIOL, V109, P2045, DOI 10.1083/jcb.109.5.2045; Lin YCJ, 2010, J VIROL, V84, P2432, DOI 10.1128/JVI.01998-09; Liu B, 2018, J VIROL, V92; Magee WC, 2009, J VIROL METHODS, V161, P44, DOI 10.1016/j.jviromet.2009.05.012; MCDONALD WF, 1992, J VIROL, V66, P534, DOI 10.1128/JVI.66.1.534-547.1992; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Moss B, 2015, VIROLOGY, V479, P619, DOI 10.1016/j.virol.2015.02.003; PARKS RJ, 1991, J VIROL, V65, P1263, DOI 10.1128/JVI.65.3.1263-1272.1991; Paszkowski P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005824; Qin L, 2014, J VIROL, V88, P5277, DOI 10.1128/JVI.00022-14; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Rochester SC, 1998, J VIROL, V72, P2917, DOI 10.1128/JVI.72.4.2917-2926.1998; Schepis A, 2006, TRAFFIC, V7, P308, DOI 10.1111/j.1600-0854.2005.00381.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Tolonen N, 2001, MOL BIOL CELL, V12, P2031, DOI 10.1091/mbc.12.7.2031; Weisse AY, 2015, P NATL ACAD SCI USA, V112, pE1038, DOI 10.1073/pnas.1416533112; Welsch S, 2003, J VIROL, V77, P6014, DOI 10.1128/JVI.77.10.6014-6028.2003; Willer DO, 1999, VIROLOGY, V257, P511, DOI 10.1006/viro.1999.9705; Willer DO, 2000, VIROLOGY, V278, P562, DOI 10.1006/viro.2000.0686; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Yang ZL, 2015, J VIROL, V89, P6874, DOI 10.1128/JVI.00528-15; Yang ZL, 2011, J VIROL, V85, P9899, DOI 10.1128/JVI.05446-11; Yao XD, 2003, VIROLOGY, V308, P147, DOI 10.1016/S0042-6822(02)00089-2	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0228028	10.1371/journal.pone.0228028	http://dx.doi.org/10.1371/journal.pone.0228028			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945138	Green Published, gold			2022-12-26	WOS:000534370100080
J	Yitayih, Y; Soboka, M; Tesfaye, E; Abera, M; Mamaru, A; Adorjan, K				Yitayih, Yimenu; Soboka, Matiwos; Tesfaye, Elias; Abera, Mubarek; Mamaru, Almaz; Adorjan, Kristina			A cross-sectional study of psychopathy and khat abuse among prisoners in the correctional institution in Jimma, Ethiopia	PLOS ONE			English	Article							ANTISOCIAL-BEHAVIOR; ALCOHOL-USE	Background Khat abuse and psychopathy are both strongly related to criminal activity. Higher rates of substance use in people with psychopathy are hypothesized to be related to psychopathic personality traits, which include high sensation seeking, low conscientiousness and neuroticism, impulsivity, and irresponsibility. Little is known, however, about the association between psychopathy and khat abuse among prisoners in Ethiopia. Therefore, we evaluated the presence of these two factors in prisoners in the correctional institution in Jimma, Southwest Ethiopia. Materials and methods We used a cross-sectional study design to collect data from 336 prisoners from June 5 to July 5, 2017. Study participants were selected by a systematic random sampling technique. Khat abuse was assessed with the Drug Abuse Screening Tool and psychopathy with the Psychopathy Checklist: Screening Version. We also assessed nicotine dependence with the Fagerstrom Test for Nicotine Dependence; alcohol use disorder, with the alcohol use disorder identification test; adverse traumatic life events, with the Life Events Checklist; and social support, with the Oslo 3-Item Social Support Scale. Data were entered into EpiData version 3.1 and analyzed in bivariate and multivariable logistic regression models. Variables with a P value < 0.05 in the final fitted model were declared to be significantly associated with the outcome variable. Results The overall prevalence of lifetime khat use was 59.9%, and the prevalence of khat abuse in prisoners with psychopathy was 78.0%. Prisoners with psychopathy had a three times higher odds ratio of abusing khat than those without psychopathy (AOR = 3.00 [1.17-7.67]). Among the confounders, a family history of substance use (AOR = 2.50 [1.45-4.31]), poor support (AOR = 2.28 [1.11-4.67]), alcohol use disorder (AOR = 7.78 [4.16-14.53]), and suicidal ideation and suicide attempts (AOR = 2.26 [1.45-4.31]) were also positively associated with khat abuse. Conclusions The prevalence of khat abuse was higher in prisoners with possible or probable psychopathy.	[Yitayih, Yimenu; Soboka, Matiwos; Tesfaye, Elias; Abera, Mubarek; Mamaru, Almaz] Jimma Univ, Fac Med Sci, Dept Psychiat, Jimma, Ethiopia; [Adorjan, Kristina] Univ Munich, Dept Psychiat & Psychotherapy, Med Ctr, Munich, Germany; [Adorjan, Kristina] Univ Munich, Inst Psychiat Phen & Genom IPPG, Med Ctr, Munich, Germany; [Adorjan, Kristina] Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany	Jimma University; University of Munich; University of Munich; University of Munich	Yitayih, Y (corresponding author), Jimma Univ, Fac Med Sci, Dept Psychiat, Jimma, Ethiopia.	yemenu2007@gmail.com	Soboka, matiwos/AAF-2163-2020	Soboka, Matiwos/0000-0003-2820-0947	Jimma University	Jimma University	We would like to thank Jimma University for granting ethical approval. Our deep thanks go to all study participants, who spent their valuable time responding to the questions in this study.	Babor T. F., 2001, ALCOHOL USE DISORDER, V2; Boen H, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-20; Central statistical agency-CSA/Ethiopia ICF, 2017, ETH DEM HLTH SURV 20; Coid J, 2009, INT J LAW PSYCHIAT, V32, P134, DOI 10.1016/j.ijlp.2009.02.008; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; Harris GT., 2006, HDB PSYCHOPATHY, P555; Hart S.D., 1995, MANUAL HARE PSYCHOPA; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hemphill J., 1998, LEGAL CRIMINOL PSYCH, V3, P139, DOI DOI 10.1111/J.2044-8333.1998.TB00355.X; Lam LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep11420; Leistico AMR, 2008, LAW HUMAN BEHAV, V32, P28, DOI 10.1007/s10979-007-9096-6; Lejuez CW, 2010, ALCOHOL CLIN EXP RES, V34, P1334, DOI 10.1111/j.1530-0277.2010.01217.x; Lykken D. T., 2018, HDB PSYCHOPATHY; National Drug Intelligence Center, 2003, INT B KHAT; Naugle DK, 2008, REORDERED LIVES LEAR; Reardon ML, 2002, ALCOHOL CLIN EXP RES, V26, P1188, DOI 10.1097/01.ALC.0000023988.43694.FE; Steadman HJ, 2000, LAW HUMAN BEHAV, V24, P83, DOI 10.1023/A:1005478820425; Taylor J., 2006, HDB PSYCHOPATHY, P495; Toennes SW, 2003, BRIT J CLIN PHARMACO, V56, P125, DOI 10.1046/j.1365-2125.2003.01834.x; Van Stelle KR, 2004, BEHAV SCI LAW, V22, P585, DOI 10.1002/bsl.602; Walsh Z, 2007, J PERS DISORD, V21, P273, DOI 10.1521/pedi.2007.21.3.273; Widiger TA, 1998, PSYCHOPATHY, P171; Yitayih Y, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1901-x; Young R, 2008, ALCOHOL ALCOHOLISM, V43, P204, DOI 10.1093/alcalc/agm147	25	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227405	10.1371/journal.pone.0227405	http://dx.doi.org/10.1371/journal.pone.0227405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945093	gold, Green Published			2022-12-26	WOS:000534370100037
J	McAlister, FA; Mian, R; Oldgren, J; Wallentin, L; Ezekowitz, M; Yusuf, S; Connolly, SJ; Healey, JS				McAlister, Finlay A.; Mian, Rajibul; Oldgren, Jonas; Wallentin, Lars; Ezekowitz, Michael; Yusuf, Salim; Connolly, Stuart J.; Healey, Jeff S.		RE-LY Atrial Fibrillation Registry	Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; EMERGENCY-DEPARTMENT; ORAL ANTICOAGULANT; MANAGEMENT; MORTALITY; COUNTRIES; PROFILES; STROKE; CANADA	Background Although hypertension is the most common risk factor for atrial fibrillation (AF), whether blood pressure (BP) control varies across the spectrum of stroke risk in patients with AF or by adequacy of their thromboprophylaxis management is unclear. Methods We examined data from the RE-LY AF registry conducted at 164 emergency departments (EDs) in 47 countries between December 2007 and October 2011. Results Of the 15,400 patients in the registry, we analyzed the 9929 (mean age 67.5 years, 51.9% men) with a prior history of AF and complete BP data. While 6508 (66.5%) AF patients had hypertension, the prevalence varied widely depending on comorbidity profiles: from 45.4% in those without other cardiovascular risk factors to 82.5% in those with AF and diabetes. Although 93.9% of AF patients with hypertension were on at least one antihypertensive agent, fewer than half had BP levels <= 140/90 with no difference across risk profiles: 45.9% of those with NVAF and CHADS(2) scores of 1 and 45.6% of those with NVAF and CHADS(2) scores of 2 or more (46.9% and 45.3% for CHA(2)DS(2)-VASc scores of 1 versus 2 or more). BP control rates were not significantly better in those NVAF patients receiving guideline concordant thromboprophylaxis management (47.2%, aOR 1.03, 95%CI 0.89-1.20) than in those not receiving guideline-concordant antithrombotic therapy (45.3%). Conclusions Hypertension was common in patients with AF but BP control rates were sub-optimal and varied little across the spectrum of stroke risk or by adequacy of thromboprophylaxis. This highlights the need for an increased focus on total atherosclerotic risk rather than just thromboprophylaxis management in AF patients.	[McAlister, Finlay A.] Univ Alberta, Fac Med & Dent, Div Gen Internal Med, Edmonton, AB, Canada; [Mian, Rajibul; Yusuf, Salim; Connolly, Stuart J.; Healey, Jeff S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Oldgren, Jonas; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Oldgren, Jonas; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ezekowitz, Michael] Lankenau Inst Med Res, Wynnewood, PA USA	University of Alberta; McMaster University; Population Health Research Institute; Uppsala University; Uppsala University; Lankenau Medical Center; Lankenau Institute for Medical Research	McAlister, FA (corresponding author), Univ Alberta, Fac Med & Dent, Div Gen Internal Med, Edmonton, AB, Canada.	Finlay.McAlister@ualberta.ca	Ezekowitz, Michael/AAJ-2543-2021; McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341; Yusuf, Salim/0000-0003-4776-5601	Boehringer Ingelheim; Alberta Health Services Chair in Cardiovascular Outcomes Research	Boehringer Ingelheim(Boehringer Ingelheim); Alberta Health Services Chair in Cardiovascular Outcomes Research	The RE-LY AF registry cohort study was funded by Boehringer Ingelheim but all data management and analyses were undertaken at the Population Health Research Institute in Hamilton, Canada. FAM is supported by the Alberta Health Services Chair in Cardiovascular Outcomes Research. The funders had no input into study design, data collection and analysis, generation of this research question, the preparation of this manuscript, or the decision to publish.	Andersson OK, 1998, BMJ-BRIT MED J, V317, P167, DOI 10.1136/bmj.317.7152.167; Backer HD, 2003, ANN EMERG MED, V41, P507, DOI 10.1067/mem.2003.151; Belletti DA, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-7; Benetos A, 2003, J HYPERTENS, V21, P1635, DOI 10.1097/00004872-200309000-00011; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Birkett NJ, 1997, J HYPERTENS, V15, P237, DOI 10.1097/00004872-199715030-00004; CHERNOW SM, 1987, ANN EMERG MED, V16, P180, DOI 10.1016/S0196-0644(87)80012-4; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Decker WW, 2006, ANN EMERG MED, V47, P237, DOI 10.1016/j.annemergmed.2005.10.003; Freedman B, 2016, JAMA CARDIOL, V1, P366, DOI 10.1001/jamacardio.2016.0393; Gu QP, 2008, ANN EPIDEMIOL, V18, P302, DOI 10.1016/j.annepidem.2007.11.013; Gudmundsson LS, 2004, J HUM HYPERTENS, V18, P615, DOI 10.1038/sj.jhh.1001725; Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0; Lee S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191738; McAlister FA, 2001, CAN MED ASSOC J, V164, P517; McAlister FA, 2001, BMJ-BRIT MED J, V322, P908, DOI 10.1136/bmj.322.7291.908; McAlister FA, 2018, INT J CARDIOL, V269, P145, DOI 10.1016/j.ijcard.2018.07.128; McAlister FA, 2013, CAN J CARDIOL, V29, P598, DOI 10.1016/j.cjca.2012.12.004; Odutayo A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4482; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Pagidipati NJ, 2017, CIRCULATION, V136, P1193, DOI 10.1161/CIRCULATIONAHA.117.027252; Petersen LA, 2009, CIRCULATION, V119, P2978, DOI 10.1161/CIRCULATIONAHA.108.836544; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; White P, 2007, EDUCATION AND CAREER CHOICE: A NEW MODEL OF DECISION MAKING, P167; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226259	10.1371/journal.pone.0226259	http://dx.doi.org/10.1371/journal.pone.0226259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940361	Green Published, gold			2022-12-26	WOS:000534368000024
J	Nance, DJ; Satterwhite, ER; Bhaskar, B; Misra, S; Carraway, KR; Mansfield, KD				Nance, Daniel J.; Satterwhite, Emily R.; Bhaskar, Brinda; Misra, Sway; Carraway, Kristen R.; Mansfield, Kyle D.			Characterization of METTL16 as a cytoplasmic RNA binding protein	PLOS ONE			English	Article							M(6)A METHYLTRANSFERASE; U6 SNRNA; ESSENTIAL GENES; N-6-METHYLADENOSINE; METHYLATION; TRANSLATION; PLURIPOTENCY; CANCER	mRNA modification by N6-methyladenosine (m6A) is involved in many post-transcriptional regulation processes including mRNA stability, splicing and promotion of translation. Accordingly, the recently identified mRNA methylation complex containing METTL3, METTL14, and WTAP has been the subject of intense study. However, METTL16 (METT10D) has also been identified as an RNA m6A methyltransferase that can methylate both coding and noncoding RNAs, but its biological role remains unclear. While global studies have identified many potential RNA targets of METTL16, only a handful, including the long noncoding RNA MALAT1, the snRNA U6, as well as the mRNA MAT2A have been verified and/or studied to any great extent. In this study we identified/verified METTL16 targets by immunoprecipitation of both endogenous as well as exogenous FLAG-tagged protein. Interestingly, exogenously overexpressed METTL16 differed from the endogenous protein in its relative affinity for RNA targets which prompted us to investigate METTL16's localization within the cell. Surprisingly, biochemical fractionation revealed that a majority of METTL16 protein resides in the cytoplasm of a number of cells. Furthermore, siRNA knockdown of METTL16 resulted in expression changes of a few mRNA targets suggesting that METTL16 may play a role in regulating gene expression. Thus, while METTL16 has been reported to be a nuclear protein, our findings suggest that METTL16 is also a cytoplasmic methyltransferase that may alter its RNA binding preferences depending on its cellular localization. Future studies will seek to confirm differences between cytoplasmic and nuclear RNA targets in addition to exploring the physiological role of METTL16 through long-term knockdown.	[Nance, Daniel J.; Satterwhite, Emily R.; Bhaskar, Brinda; Misra, Sway; Carraway, Kristen R.; Mansfield, Kyle D.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA; [Bhaskar, Brinda] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Misra, Sway] Univ Georgia, Athens, GA 30602 USA	University of North Carolina; East Carolina University; Wake Forest University; University System of Georgia; University of Georgia	Mansfield, KD (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA.	mansfieldk@ecu.edu		Mansfield, Kyle/0000-0002-5498-9876	East Carolina University Start up Funds; Brody School of Medicine Dean's Award; Research Scholar Grant, from the American Cancer Society [RSG-19-044-01-RMC]; East Carolina University	East Carolina University Start up Funds; Brody School of Medicine Dean's Award; Research Scholar Grant, from the American Cancer Society(American Cancer Society); East Carolina University	This work was supported by East Carolina University Start up Funds (KDM), Brody School of Medicine Dean's Award (KDM) and a Research Scholar Grant, RSG-19-044-01-RMC, from the American Cancer Society (KDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank past and present members of the lab including Nate Fry and Mohammed Dorgham for helpful discussions and advice during the course of this project. We would also like to thank the East Carolina University Vice Chairs for Diversity Summer Biomedical Research Program for supporting students (BB and SM) working on this project.	Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Bertomeu T, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00302-17; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Brown JA, 2016, P NATL ACAD SCI USA, V113, P14013, DOI 10.1073/pnas.1614759113; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dawson PJ, 1996, AM J PATHOL, V148, P313; Dorsett M, 2009, MOL CELL BIOL, V29, P6128, DOI 10.1128/MCB.00815-09; Doxtader KA, 2018, MOL CELL, V71, P1001, DOI 10.1016/j.molcel.2018.07.025; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Fry Nate J, 2018, Oncotarget, V9, P31231, DOI 10.18632/oncotarget.25782; Fry NJ, 2017, RNA, V23, P1444, DOI 10.1261/rna.061044.117; Fury MG, 1996, EXP CELL RES, V228, P160, DOI 10.1006/excr.1996.0311; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Jaffrey SR, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0395-8; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu K, 2016, CURR PROTEIN PEPT SC, V17, P306, DOI 10.2174/1389203716666150901113553; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Ma HH, 2019, NAT CHEM BIOL, V15, P88, DOI 10.1038/s41589-018-0184-3; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; Mendel M, 2018, MOL CELL, V71, P986, DOI 10.1016/j.molcel.2018.08.004; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Tran NV, 2019, NUCLEIC ACIDS RES, V47, P7719, DOI 10.1093/nar/gkz619; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pauley R J, 1993, Eur J Cancer Prev, V2 Suppl 3, P67; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roundtree IA, 2016, TRENDS GENET, V32, P320, DOI 10.1016/j.tig.2016.03.006; Ruszkowska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23608-8; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Wu YS, 2016, STEM CELLS DEV, V25, P1050, DOI 10.1089/scd.2016.0062; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang C, 2016, P NATL ACAD SCI USA, V113, DOI [10.1073/pnas.1618558114, DOI 10.1073/PNAS.1618558114]; Zhang CZ, 2016, ONCOTARGET, V7, P64527, DOI 10.18632/oncotarget.11743; Zhang Xiao, 2016, Yichuan, V38, P275, DOI 10.16288/j.yczz.16-049; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao BS, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0609-1; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	47	24	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227647	10.1371/journal.pone.0227647	http://dx.doi.org/10.1371/journal.pone.0227647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940410	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000088
J	Palanca, M; Ruspi, ML; Cristofolini, L; Liebsch, C; Villa, T; Brayda-Bruno, M; Galbusera, F; Wilke, HJ; La Barbera, L				Palanca, Marco; Ruspi, Maria Luisa; Cristofolini, Luca; Liebsch, Christian; Villa, Tomaso; Brayda-Bruno, Marco; Galbusera, Fabio; Wilke, Hans-Joachim; La Barbera, Luigi			The strain distribution in the lumbar anterior longitudinal ligament is affected by the loading condition and bony features: An in vitro full-field analysis	PLOS ONE			English	Article							SPINAL LIGAMENTS; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; STEPWISE REDUCTION; DISC DEGENERATION; MOTION; BEHAVIOR; STIFFNESS; HYDRATION	The role of the ligaments is fundamental in determining the spine biomechanics in physiological and pathological conditions. The anterior longitudinal ligament (ALL) is fundamental in constraining motions especially in the sagittal plane. The ALL also confines the intervertebral discs, preventing herniation. The specific contribution of the ALL has indirectly been investigated in the past as a part of whole spine segments where the structural flexibility was measured. The mechanical properties of isolated ALL have been measured as well. The strain distribution in the ALL has never been measured under pseudo-physiological conditions, as part of multi-vertebra spine segments. This would help elucidate the biomechanical function of the ALL. The aim of this study was to investigate in depth the biomechanical function of the ALL in front of the lumbar vertebrae and of the intervertebral disc. Five lumbar cadaveric spine specimens were subjected to different loading scenarios (flexion-extension, lateral bending, axial torsion) using a state-of-the-art spine tester. The full-field strain distribution on the anterior surface was measured using digital image correlation (DIC) adapted and validated for application to spine segments. The measured strain maps were highly inhomogeneous: the ALL was generally more strained in front of the discs than in front of the vertebrae, with some locally higher strains both imputable to ligament fibers and related to local bony defects. The strain distributions were significantly different among the loading configurations, but also between opposite directions of loading (flexion vs. extension, right vs. left lateral bending, clockwise vs. counterclockwise torsion). This study allowed for the first time to assess the biomechanical behaviour of the anterior longitudinal ligament for the different loading of the spine. We were able to identify both the average trends, and the local effects related to osteophytes, a key feature indicative of spine degeneration.	[Palanca, Marco; Ruspi, Maria Luisa; Cristofolini, Luca] Alma Mater Studiorum Univ Bologna, Sch Engn & Architecture, Dept Ind Engn, Bologna, Italy; [Liebsch, Christian; Wilke, Hans-Joachim] Univ Hosp Ulm, Trauma Res Ctr Ulm ZTF, Inst Orthopaed Res & Biomech, Ulm, Germany; [Villa, Tomaso; La Barbera, Luigi] Politecn Milan, Lab Biol Struct Mech, Dept Chem Mat & Chem Engn G Natta, Milan, Italy; [Villa, Tomaso; Galbusera, Fabio] IRCCS Ist Ortoped Galeazzi, Milan, Italy; [Brayda-Bruno, Marco] IRCCS Ist Ortoped Galeazzi, Dept Spine Surg 3, Milan, Italy	University of Bologna; Ulm University; Polytechnic University of Milan; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi	Palanca, M (corresponding author), Alma Mater Studiorum Univ Bologna, Sch Engn & Architecture, Dept Ind Engn, Bologna, Italy.	marco.palanca@unibo.it	Wilke, Hans-Joachim/M-6440-2014; La Barbera, Luigi/E-6663-2018; Liebsch, Christian/AAY-9918-2020; Cristofolini, Luca/C-4402-2013	Wilke, Hans-Joachim/0000-0001-6007-8844; La Barbera, Luigi/0000-0002-9822-2116; Liebsch, Christian/0000-0003-1543-4728; Palanca, Marco/0000-0002-1231-2728; Cristofolini, Luca/0000-0002-7473-6868; VILLA, TOMASO MARIA TOBIA/0000-0003-2663-6755	SRS-Globus NI (New Investigator Grant); Scoliosis Research Society; Fondazione CARISBO Cassa di Risparmio di Bologna [380/2018]	SRS-Globus NI (New Investigator Grant); Scoliosis Research Society; Fondazione CARISBO Cassa di Risparmio di Bologna	LLB: SRS-Globus NI (New Investigator Grant), Scoliosis Research Society (URL: https://www.srs.org/newsletter/issues/september-2016/research-grants-committee/full-article).MP, MLR, LC: Fondazione CARISBO Cassa di Risparmio di Bologna (grant 380/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawahi M, 2010, SPINE PHILA PA 1976, V30; Brandolini N, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414300026; Busscher I, 2009, SPINE, V34, P2858, DOI 10.1097/BRS.0b013e3181b4c75d; CHAZAL J, 1985, J BIOMECH, V18, P167, DOI 10.1016/0021-9290(85)90202-7; Costi JJ, 2002, CLIN BIOMECH, V17, P446, DOI 10.1016/S0268-0033(02)00035-9; Dall'Ara E, 2010, J BIOMECH, V43, P2374, DOI 10.1016/j.jbiomech.2010.04.023; Gardner-Morse MG, 2004, J BIOMECH, V37, P205, DOI 10.1016/j.jbiomech.2003.10.003; Gray H, 2004, GRAYS ANATOMY ANATOM; Heuer F, 2008, J BIOMECH, V41, P2402, DOI 10.1016/j.jbiomech.2008.05.031; Heuer F, 2008, J BIOMECH, V41, P1953, DOI 10.1016/j.jbiomech.2008.03.023; Heuer F, 2008, J BIOMECH, V41, P1086, DOI 10.1016/j.jbiomech.2007.11.019; Heuer F, 2007, J BIOMECH, V40, P795, DOI 10.1016/j.jbiomech.2006.03.016; Kettler A, 2000, SPINE, V25, P543, DOI 10.1097/00007632-200003010-00003; La Barbera L, 2018, EUR SPINE J, V27, P2357, DOI 10.1007/s00586-018-5623-z; LIN HS, 1978, J BONE JOINT SURG AM, V60, P41, DOI 10.2106/00004623-197860010-00006; Lionello G, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/10/107001; Lysack JT, 2000, J BIOMECH, V33, P765, DOI 10.1016/S0021-9290(00)00021-X; Mercer S, 1999, SPINE, V24, P619, DOI 10.1097/00007632-199904010-00002; NEUMANN P, 1992, J BIOMECH, V25, P1185, DOI 10.1016/0021-9290(92)90074-B; NEUMANN P, 1994, J ORTHOPAED RES, V12, P103, DOI 10.1002/jor.1100120113; Oxland TR, 2016, J BIOMECH, V49, P817, DOI 10.1016/j.jbiomech.2015.10.035; Palanca M., 2016, INT BIOMECH, V3, P1, DOI [10.1080/23335432.2015.1117395, DOI 10.1080/23335432.2015.1117395]; Palanca M, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040587; Palanca M, 2018, MED ENG PHYS, V52, P76, DOI 10.1016/j.medengphy.2017.11.003; Palanca M, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415400047; PANJABI MM, 1982, SPINE, V7, P192, DOI 10.1097/00007632-198205000-00003; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; PINTAR FA, 1992, J BIOMECH, V25, P1351, DOI 10.1016/0021-9290(92)90290-H; Race A, 2000, SPINE, V25, P662, DOI 10.1097/00007632-200003150-00003; RHALMI S, 1993, SPINE, V18, P264, DOI 10.1097/00007632-199302000-00015; Robertson DJ, 2013, J MECH BEHAV BIOMED, V23, P44, DOI 10.1016/j.jmbbm.2013.04.004; Schmidt R, 2010, EUR SPINE J, V19, P1534, DOI 10.1007/s00586-010-1432-8; Sis HL, 2016, J BIOMECH, V49, P3252, DOI 10.1016/j.jbiomech.2016.08.003; Sutton MA, 2009, IMAGE CORRELATION FOR SHAPE, MOTION AND DEFORMATION MEASUREMENTS: BASIC CONCEPTS, THEORY AND APPLICATIONS, P1, DOI [10.1007/978-0-387-78747-3, 10.1007/978-0-387-78747-3_5]; Tanaka N, 2001, Spine J, V1, P47, DOI 10.1016/S1529-9430(01)00006-7; TKACZUK H, 1968, ACTA ORTHOP SCAND, VS, P8; Volkheimer D, 2015, EUR SPINE J, V24, P1882, DOI 10.1007/s00586-015-4040-9; White A.A., 1990, CLIN BIOMECH; Wilke H J, 1997, Eur Spine J, V6, P129, DOI 10.1007/BF01358746; Wilke H J, 1994, Eur Spine J, V3, P91, DOI 10.1007/BF02221446; Wilke H J, 1998, Eur Spine J, V7, P148, DOI 10.1007/s005860050045; Wilke HJ, 2006, EUR SPINE J, V15, P720, DOI 10.1007/s00586-005-1029-9; Wilke HJ, 2011, EUR SPINE J, V20, P1859, DOI 10.1007/s00586-011-1822-6; Wilke HJ, 1998, ANAT REC, V251, P15, DOI 10.1002/(SICI)1097-0185(199805)251:1<15::AID-AR4>3.0.CO;2-D; Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014	46	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227210	10.1371/journal.pone.0227210	http://dx.doi.org/10.1371/journal.pone.0227210			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935225	Green Submitted, gold, Green Published			2022-12-26	WOS:000534354100014
J	van der Velden, JL; Alcorn, JF; Chapman, DG; Lundblad, LKA; Irvin, CG; Davis, RJ; Butnor, K; Janssen-Heininger, YMW				van der Velden, Jos L.; Alcorn, John F.; Chapman, David G.; Lundblad, Lennart K. A.; Irvin, Charles G.; Davis, Roger J.; Butnor, Kelly; Janssen-Heininger, Yvonne M. W.			Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; STEM-CELLS; IN-VIVO; TISSUE; APOPTOSIS; FAS; ACTIVATION; EXPRESSION; INDUCTION	The stress-induced kinase, c-Jun-N-terminal kinase 1 (JNK1) has previously been implicated in the pathogenesis of lung fibrosis. However, the exact cell type(s) wherein JNK1 exerts its pro-fibrotic role(s) remained enigmatic. Herein we demonstrate prominent activation of JNK in bronchial epithelia using the mouse models of bleomycin- or AdTGF beta 1-induced fibrosis. Furthermore, in lung tissues of patients with idiopathic pulmonary fibrosis (IPF), active JNK was observed in various regions including type I and type II pneumocytes and fibroblasts. No JNK activity was observed in adjacent normal tissue or in normal control tissue. To address the role of epithelial JNK1, we ablated Jnk1 form bronchiolar and alveolar type II epithelial cells using CCSP-directed Cre recombinase-mediated ablation of LoxP-flanked Jnk1 alleles. Our results demonstrate that ablation of Jnk1 from airway epithelia resulted in a strong protection from bleomycin- or adenovirus expressing active transforming growth factor beta-1 (AdTGF beta 1)-induced fibrosis. Ablation of the Jnk1 allele at a time when collagen increases were already present showed a reversal of existing increases in collagen content. Epithelial Jnk1 ablation resulted in attenuation of mesenchymal genes and proteins in lung tissue and preserved expression of epithelial genes. Collectively, these data suggest that epithelial JNK1 contributes to the pathogenesis of pulmonary fibrosis. Given the presence of active JNK in lungs from patients with IPF, targeting JNK1 in airway epithelia may represent a potential treatment strategy to combat this devastating disease.	[van der Velden, Jos L.; Butnor, Kelly; Janssen-Heininger, Yvonne M. W.] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA; [Alcorn, John F.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Chapman, David G.; Lundblad, Lennart K. A.; Irvin, Charles G.] Univ Vermont, Dept Med, Burlington, VT USA; [Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Janssen-Heininger, YMW (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Burlington, VT USA.	yvonne.janssen@uvm.edu		van der Velden, Jos/0000-0002-2451-3180; Davis, Roger/0000-0002-0130-1652; Lundblad, Lennart/0000-0002-1749-8242; Chapman, David/0000-0002-8211-1817	NIH [R01 HL079331, R01 HL060014, R35 HL135828];  [R03 HL095404]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was funded by NIH R01 HL079331, R01 HL060014, and R35 HL135828 (Y J-H). Analysis of biological specimens provided by the Lung Tissue Research Consortium (LTRC) was supported by R03 HL095404 (Y J-H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Anathy V, 2012, MOL CELL BIOL, V32, P3464, DOI 10.1128/MCB.00125-12; Borok Zea, 2011, Proc Am Thorac Soc, V8, P215, DOI 10.1513/pats.201012-067CB; Burman A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99543; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Dolhnikoff M, 1999, AM J RESP CRIT CARE, V160, P1750, DOI 10.1164/ajrccm.160.5.9812040; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Krenitsky VP, 2012, BIOORG MED CHEM LETT, V22, P1433, DOI 10.1016/j.bmcl.2011.12.027; Li S, 2014, AM J PHYSIOL-LUNG C, V306, pL196, DOI 10.1152/ajplung.00055.2013; Liang M, 2017, J AM SOC NEPHROL, V28, P3277, DOI 10.1681/ASN.2015121354; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Nureki SI, 2018, J CLIN INVEST, V128, P4008, DOI 10.1172/JCI99287; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Reich N, 2012, ANN RHEUM DIS, V71, P737, DOI 10.1136/annrheumdis-2011-200412; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Tomioka S, 2002, J APPL PHYSIOL, V93, P263, DOI 10.1152/japplphysiol.01129.2001; van der Velden JL, 2018, AM J PHYSIOL-LUNG C, V314, pL984, DOI 10.1152/ajplung.00053.2017; van der Velden JLJ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0117-2; van der Velden JLJ, 2012, AM J RESP CELL MOL, V47, P306, DOI 10.1165/rcmb.2011-0297OC; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Velden J L AJ, 2011, AM J RESP CELL MOL B, V44, P571, DOI DOI 10.1165/RCMB.2009-02820C; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wygrecka M, 2012, AM J RESP CELL MOL, V47, P614, DOI 10.1165/rcmb.2012-0097OC; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yang J, 2013, AM J PATHOL, V183, P1559, DOI 10.1016/j.ajpath.2013.07.016; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yoshida K, 2002, J PATHOL, V198, P388, DOI 10.1002/path.1208; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zent J, 2018, CELL PHYSIOL BIOCHEM, V49, P848, DOI 10.1159/000493217; Zhong Q, 2011, AM J RESP CELL MOL, V45, P498, DOI 10.1165/rcmb.2010-0347OC; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0226904	10.1371/journal.pone.0226904	http://dx.doi.org/10.1371/journal.pone.0226904			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935227	Green Published, gold			2022-12-26	WOS:000534354100009
J	Amariei, G; Boltes, K; Rosal, R; Leton, P				Amariei, Georgiana; Boltes, Karina; Rosal, Roberto; Leton, Pedro			Enzyme response of activated sludge to a mixture of emerging contaminants in continuous exposure	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; WASTE-WATER TREATMENT; MICROBIAL COMMUNITY; PHARMACEUTICAL COMPOUNDS; OXIDATIVE STRESS; RESISTANCE GENES; REMOVAL; TRICLOSAN; TOXICITY; TETRACYCLINE	The relevant information about the impacts caused by presence of emerging pollutants in mixtures on the ecological environment, especially on the more vulnerable compartments such as activated sludge (AS) is relatively limited. This study investigated the effect of ibuprofen (IBU) and triclosan (TCS), alone and in combination to the performance and enzymatic activity of AS bacterial community. The assays were carried out in a pilot AS reactor operating for two-weeks under continuous dosage of pollutants. The microbial activity was tracked by measuring oxygen uptake rate, esterase activity, oxidative stress and antioxidant enzyme activities. It was found that IBU and TCS had no acute toxic effects on reactor biomass concentration. TCS led to significant decrease of COD removal efficiency, which dropped from 90% to 35%. Continuous exposure to IBU, TCS and their mixtures increased the activities of glutathione s-transferase (GST) and esterase as a response to oxidative damage. A high increase in GST activity was associated with non-reversible toxic damage while peaks of esterase activity combined with moderate GST increase were attributed to an adaptive response.	[Amariei, Georgiana; Boltes, Karina; Rosal, Roberto; Leton, Pedro] Univ Alcala, Dept Chem Engn, Madrid, Spain	Universidad de Alcala	Amariei, G (corresponding author), Univ Alcala, Dept Chem Engn, Madrid, Spain.	georgiana.amariei@uah.es	Rosal, Roberto/N-1231-2014; BOLTES, KARINA/ABF-7916-2021; Amariei, Georgiana/S-5536-2018; Leton, Pedro/I-2802-2015	Rosal, Roberto/0000-0003-0816-8775; Amariei, Georgiana/0000-0002-5412-6325; BOLTES, KARINA/0000-0001-9686-7730; Leton, Pedro/0000-0002-0384-6189	Madrid Regional Government Grant [P2018/EMT4341]	Madrid Regional Government Grant	This research was supported by the Madrid Regional Government Grant P2018/EMT4341 (REMTAVARES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarino T, 2014, BIORESOURCE TECHNOL, V152, P477, DOI 10.1016/j.biortech.2013.10.107; Amariei G, 2017, J HAZARD MATER, V334, P193, DOI 10.1016/j.jhazmat.2017.04.018; Amorim CL, 2014, WATER RES, V50, P101, DOI 10.1016/j.watres.2013.10.043; Arriaga S, 2016, WATER RES, V107, P37, DOI 10.1016/j.watres.2016.10.046; Ashfaq M, 2019, SCI TOTAL ENVIRON, V688, P653, DOI 10.1016/j.scitotenv.2019.06.285; Bedoux G, 2012, ENVIRON SCI POLLUT R, V19, P1044, DOI 10.1007/s11356-011-0632-z; Behera SK, 2010, J HAZARD MATER, V179, P684, DOI 10.1016/j.jhazmat.2010.03.056; Boczar BA, 2001, WATER RES, V35, P4208, DOI 10.1016/S0043-1354(01)00150-6; Borgman O, 2013, WATER RES, V47, P3431, DOI 10.1016/j.watres.2013.03.045; Boxall ABA, 2012, ENVIRON HEALTH PERSP, V120, P1221, DOI 10.1289/ehp.1104477; BREEUWER P, 1995, APPL ENVIRON MICROB, V61, P6; Cavanagh JAE, 2018, TOXICOL IN VITRO, V48, P342, DOI 10.1016/j.tiv.2018.02.003; Collado N, 2014, ENVIRON POLLUT, V185, P202, DOI 10.1016/j.envpol.2013.10.040; Collado NBG, 2013, CHEMOSPHERE; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Drury B, 2013, ENVIRON SCI TECHNOL, V47, P8923, DOI 10.1021/es401919k; Ebele Anekwe Jennifer, 2017, Emerging Contaminants, V3, P1, DOI 10.1016/j.emcon.2016.12.004; Geret F, 2002, BIOMARKERS, V7, P242, DOI 10.1080/13547500210125040; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Grandclement C, 2017, WATER RES, V111, P297, DOI 10.1016/j.watres.2017.01.005; Gros M, 2006, ANAL BIOANAL CHEM, V386, P941, DOI 10.1007/s00216-006-0586-z; He HJ, 2017, INT BIODETER BIODEGR, V119, P520, DOI 10.1016/j.ibiod.2016.10.007; Jiang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178006; Klatt CG, 2003, BIOTECHNOL BIOENG, V82, P313, DOI 10.1002/bit.10572; Krah D, 2016, WATER RES, V95, P348, DOI 10.1016/j.watres.2016.03.037; Kraigher B, 2008, WATER RES, V42, P4578, DOI 10.1016/j.watres.2008.08.006; Li ZH, 2018, BIORESOURCE TECHNOL, V248, P171, DOI 10.1016/j.biortech.2017.06.166; Liu JL, 2013, ENVIRON INT, V59, P208, DOI 10.1016/j.envint.2013.06.012; Liu XT, 2017, BIORESOURCE TECHNOL, V238, P407, DOI 10.1016/j.biortech.2017.04.045; Lu ZM, 2009, ECOTOX ENVIRON SAFE, V72, P136, DOI 10.1016/j.ecoenv.2008.01.009; Martin J, 2012, J HAZARD MATER, V239, P40, DOI 10.1016/j.jhazmat.2012.04.068; Martinez-Martinez M, 2014, MICROB BIOTECHNOL, V7, P184, DOI 10.1111/1751-7915.12107; McNamara PJ, 2014, ENVIRON SCI TECHNOL, V48, P7393, DOI 10.1021/es501388v; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Nauen R, 2002, ANAL BIOCHEM, V303, P194, DOI 10.1006/abio.2002.5578; Nguyen LN, 2019, SCI TOTAL ENVIRON, V657, P739, DOI 10.1016/j.scitotenv.2018.12.094; OECD, 2010, TEST NO 209 ACT SLUD; Paiga P, 2019, SCI TOTAL ENVIRON, V648, P582, DOI 10.1016/j.scitotenv.2018.08.129; Palli L, 2019, INT J HYG ENVIR HEAL, V222, P717, DOI 10.1016/j.ijheh.2019.05.006; Patel M, 2019, CHEM REV, V119, P3510, DOI 10.1021/acs.chemrev.8b00299; Petrie B, 2014, WATER RES, V62, P180, DOI 10.1016/j.watres.2014.05.036; Ren SJ, 2004, ENVIRON INT, V30, P1151, DOI 10.1016/j.envint.2004.06.003; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rosal R, 2010, WATER RES, V44, P578, DOI 10.1016/j.watres.2009.07.004; Stasinakis AS, 2008, ECOTOX ENVIRON SAFE, V70, P199, DOI 10.1016/j.ecoenv.2007.12.011; Suarez S, 2010, WATER RES, V44, P3214, DOI 10.1016/j.watres.2010.02.040; Sui Q, 2011, ENVIRON SCI TECHNOL, V45, P3341, DOI 10.1021/es200248d; Thiebault T, 2017, J ENVIRON CHEM ENG, V5, P2894, DOI 10.1016/j.jece.2017.05.039; Wilkinson JL, 2016, CRIT REV ENV SCI TEC, V46, P336, DOI 10.1080/10643389.2015.1096876; Yazdanbakhsh AR, 2019, J HAZARD MATER, V366, P114, DOI 10.1016/j.jhazmat.2018.11.098; Yu XL, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3760-y; Zhang W, 2013, BIORESOURCE TECHNOL, V150, P9, DOI 10.1016/j.biortech.2013.09.081; Zhang Y, 2012, FEMS MICROBIOL LETT, V334, P95, DOI 10.1111/j.1574-6968.2012.02625.x; Zhang YY, 2016, SCI TOTAL ENVIRON, V571, P479, DOI 10.1016/j.scitotenv.2016.07.014	55	8	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227267	10.1371/journal.pone.0227267	http://dx.doi.org/10.1371/journal.pone.0227267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931513	Green Published, gold			2022-12-26	WOS:000534352500031
J	Day, NK; Schmidt, TS; Roberts, JJ; Osmundson, BC; Willacker, JJ; Eagles-Smith, CA				Day, Natalie K.; Schmidt, Travis S.; Roberts, James J.; Osmundson, Barbara C.; Willacker, James J.; Eagles-Smith, Collin A.			Mercury and selenium concentrations in fishes of the Upper Colorado River Basin, southwestern United States: A retrospective assessment	PLOS ONE			English	Article							PIKEMINNOW PTYCHOCHEILUS-LUCIUS; SUCKER XYRAUCHEN-TEXANUS; FRESH-WATER; RAZORBACK SUCKER; LIFE-HISTORY; GREEN RIVER; SPORT FISH; TOXICITY; BIOACCUMULATION; METHYLMERCURY	Mercury (Hg) and selenium (Se) are contaminants of concern for fish in the Upper Colorado River Basin (UCRB). We explored Hg and Se in fish tissues (2,324 individuals) collected over 50 years (1962-2011) from the UCRB. Samples include native and non-native fish collected from lotic waterbodies spanning 7 major tributaries to the Colorado River. There was little variation of total mercury (THg) in fish assemblages basin-wide and only 13% (272/1959) of individual fish samples exceeded the fish health benchmark (0.27 mu g THg/g ww). Most THg exceedances were observed in the White-Yampa tributary whereas the San Juan had the lowest mean THg concentration. Risks associated with THg are species specific with exceedances dominated by Colorado Pikeminnow (mean = 0.38 and standard error +/- 0.08 mu g THg/g ww) and Roundtail Chub (0.24 +/- 0.06 mu g THg/g ww). For Se, 48% (827/1720) of all individuals exceeded the fish health benchmark (5.1 mu g Se/g dw). The Gunnison river had the most individual exceedances of the Se benchmark (74%) whereas the Dirty Devil had the fewest. We identified that species of management concern accumulate THg and Se to levels above risk thresholds and that fishes of the White-Yampa (THg) and Gunnison (Se) rivers are at the greatest risk in the UCRB.	[Day, Natalie K.] US Geol Survey, Southwest Biol Sci Ctr, Moab, UT USA; [Schmidt, Travis S.; Roberts, James J.] US Geol Survey, Colorado Water Sci Ctr, Ft Collins, CO 80526 USA; [Osmundson, Barbara C.] US Fish & Wildlife Serv, Grand Junction, CO USA; [Willacker, James J.; Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Schmidt, TS (corresponding author), US Geol Survey, Colorado Water Sci Ctr, Ft Collins, CO 80526 USA.	tschmidt@usgs.gov		Day, Natalie/0000-0002-8768-5705; Willacker, James/0000-0002-6286-5224	Bureau of Land Management; Environmental Health Mission Area of the USGS; commercial company, Trapper Mine Inc.	Bureau of Land Management; Environmental Health Mission Area of the USGS; commercial company, Trapper Mine Inc.	Funding was provided by the Bureau of Land Management to TSS, the Environmental Health Mission Area of the USGS to TSS, and the commercial company, Trapper Mine Inc. offered funding to the Colorado Water Science Center. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alpers CN, 2016, SCI TOTAL ENVIRON, V571, P364, DOI 10.1016/j.scitotenv.2016.05.088; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baldwin DH, 2009, ECOL APPL, V19, P2004, DOI 10.1890/08-1891.1; Barton K., 2016, MUMIN MULTIMODEL INF; Beckvar N, 2005, ENVIRON TOXICOL CHEM, V24, P2094, DOI 10.1897/04-284R.1; Bestgen KR, 2007, T AM FISH SOC, V136, P1356, DOI 10.1577/T05-303.1; Bestgen KR, 2007, POPULATION STATUS TR; Bevelhimer M.S., 1997, ESERTM202 OAK RIDG N; Boalt E, 2014, MAR POLLUT BULL, V78, P130, DOI 10.1016/j.marpolbul.2013.10.051; Buhl KJ, 1996, ARCH ENVIRON CON TOX, V30, P84; Buhl KJ, 2000, CHRONIC TOXICITY DIE; Burger J, 2012, SCI TOTAL ENVIRON, V431, P46, DOI 10.1016/j.scitotenv.2012.05.024; Burger J, 2011, SCI TOTAL ENVIRON, V409, P1418, DOI 10.1016/j.scitotenv.2010.12.034; CARLSON C A, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P220; CFR, 1994, DET CRIT HAB COL RIV; Chen CY, 2006, ENVIRON HEALTH PERSP, V114, P297, DOI 10.1289/ehp.7861; Bueno PC, 2009, ENVIRON GEOL, V56, P815, DOI 10.1007/s00254-007-1182-z; Dang F, 2011, ENVIRON SCI TECHNOL, V45, P3116, DOI 10.1021/es103705a; Das K, 2016, MAR POLLUT BULL, V108, P70, DOI 10.1016/j.marpolbul.2016.04.060; Day NK, 2019, FISH TISSUE MERCURY, DOI [10.5066/F71N802D, DOI 10.5066/F71N802D]; Driscoll CT, 2013, ENVIRON SCI TECHNOL, V47, P4967, DOI 10.1021/es305071v; Eagles-Smith CA, 2014, 20141051 US DEP INT; Eagles-Smith CA, 2018, AMBIO, V47, P170, DOI 10.1007/s13280-017-1011-x; Eagles-Smith CA, 2016, SCI TOTAL ENVIRON, V568, P1213, DOI 10.1016/j.scitotenv.2016.05.094; Eagles-Smith CA, 2016, SCI TOTAL ENVIRON, V568, P1171, DOI 10.1016/j.scitotenv.2016.03.229; Eisler R, 2000, HDB CHEM RISK ASSESS; Elrashidi MA, 2018, COMMUN SOIL SCI PLAN, V49, P1083, DOI 10.1080/00103624.2018.1448858; Evers DC, 2007, BIOSCIENCE, V57, P29, DOI 10.1641/B570107; Frouin H, 2012, AQUAT TOXICOL, V109, P185, DOI 10.1016/j.aquatox.2011.09.021; GANTHER HE, 1972, SCIENCE, V175, P1122, DOI 10.1126/science.175.4026.1122; Golden ME, RETENTION GROWTH HAB; Hamilton SJ, 2005, ECOTOX ENVIRON SAFE, V61, P7, DOI 10.1016/j.ecoenv.2004.07.002; Hamilton SJ, 2004, WATER AIR SOIL POLL, V159, P2, DOI 10.1023/B:WATE.0000049143.55199.76; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hamilton SJ, 2004, ENVIRON TOXICOL, V19, P51, DOI 10.1002/tox.10151; Hamilton SJ, 2003, ECOTOX ENVIRON SAFE, V56, P201, DOI 10.1016/S0147-6513(02)00091-X; Hamilton SJ, 2002, AQUAT TOXICOL, V59, P253, DOI 10.1016/S0166-445X(01)00257-0; Hamilton SJ, 1998, BOOK SOIL P, V64, P297; HAMILTON SJ, 1994, ARCH ENVIRON CON TOX, V27, P195; Hamilton SJ, 1999, HUM ECOL RISK ASSESS, V5, P1153, DOI 10.1080/10807039.1999.10518884; Hamilton SJ, 1998, SELENIUM OTHER TRACE; Heinz GH, 2012, ARCH ENVIRON CON TOX, V62, P141, DOI 10.1007/s00244-011-9680-0; Karbassi AR, 2014, ENVIRON ENG MANAG J, V13, P115; Khan MAK, 2009, ENVIRON TOXICOL CHEM, V28, P1567, DOI 10.1897/08-375.1; Lamborg CH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001847; Lemly AD, 2004, ECOTOX ENVIRON SAFE, V59, P44, DOI 10.1016/S0147-6513(03)00095-2; Lemly AD, 2002, AQUAT TOXICOL, V57, P39, DOI 10.1016/S0166-445X(01)00264-8; LEMLY AD, 1993, ENVIRON MONIT ASSESS, V28, P83, DOI 10.1007/BF00547213; Lemly AD, 1996, ENV CONTAMINANTS WIL; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lepak JM, 2012, CAN J FISH AQUAT SCI, V69, P122, DOI [10.1139/F2011-136, 10.1139/f2011-136]; Lepak JM, 2009, BIOSCIENCE, V59, P174, DOI 10.1525/bio.2009.59.2.10; Miller PS, 2014, POPULATION VIABILITY; Minckley W. L, 1973, FISHES ARIZONA; Minckley WL., 1991, BATTLE EXTINCTION NA; Morel FMM, 1998, ANNU REV ECOL SYST, V29, P543, DOI 10.1146/annurev.ecolsys.29.1.543; Mulder PJ, 2012, ENVIRON SCI TECHNOL, V46, P9027, DOI 10.1021/es301216b; Muscatello JR, 2008, ENVIRON POLLUT, V156, P387, DOI 10.1016/j.envpol.2008.01.039; OGLE R S, 1988, Lake and Reservoir Management, V4, P165; Olden JD, 2006, ECOL MONOGR, V76, P25, DOI 10.1890/05-0330; Olden JD, 2007, GLOBAL ECOL BIOGEOGR, V16, P694, DOI 10.1111/j.1466-8238.2007.00337.x; Osmundson BC, 2019, ARCH ENVIRON CON TOX, V76, P17, DOI 10.1007/s00244-018-0566-2; Osmundson BC, 2000, ARCH ENVIRON CON TOX, V38, P479, DOI 10.1007/s002449910063; Osmundson BC, 2011, CO SELENIUM FISH TIS; Osmundson BC, 2016, FIELD ASSESSMENT COL; Osmundson D, POPULATION STRUCTURE; Osmundson DB, 1998, T AM FISH SOC, V127, P943, DOI 10.1577/1548-8659(1998)127<0943:DPOSAA>2.0.CO;2; Osmundson DB, 2009, POPULATION STATUS TR; Osmundson DB, 2017, ENDANGER SPECIES RES, V34, P131, DOI 10.3354/esr00842; Penglase S, 2014, AQUAT TOXICOL, V149, P16, DOI 10.1016/j.aquatox.2014.01.020; Peterson SA, 2007, ENVIRON SCI TECHNOL, V41, P58, DOI 10.1021/es061070u; Peterson SA, 2009, ENVIRON SCI TECHNOL, V43, P3919, DOI 10.1021/es803203g; Presser Theresa S., 2010, Integrated Environmental Assessment and Management, V6, P685, DOI 10.1002/ieam.101; Reash RJ, 2015, INTEGR ENVIRON ASSES, V11, P474, DOI 10.1002/ieam.1618; Martin JAR, 2016, J HAZARD MATER, V308, P131, DOI 10.1016/j.jhazmat.2016.01.026; SAIKI MK, 1993, ARCH ENVIRON CON TOX, V24, P307, DOI 10.1007/BF01128729; Sandheinrich M., 2011, ENV CONTAM BIOTA INT, V2, P169; Schuster PF, 2002, ENVIRON SCI TECHNOL, V36, P2303, DOI 10.1021/es0157503; Scudder BC, 2009, 20095109 US GEOL SUR; Seiler R, 2003, IRRIGATION INDUCED C, P1655; Seixas TG, 2012, B ENVIRON CONTAM TOX, V89, P434, DOI 10.1007/s00128-012-0680-1; Sormo EG, 2011, ENVIRON SCI TECHNOL, V45, P6561, DOI 10.1021/es200478b; Tyus H. M., 1996, NONNATIVE FISHES UPP; USEPA, 2016, EPA822R16006 USEPA; USFWS, 2011, COL PIK PTYCH LUC 5; USFWS (U.S. Fish and Wildlife Service), 2002, COL PIK PTYCH LUC RE; Van Dyke JU, 2013, ENVIRON POLLUT, V182, P45, DOI 10.1016/j.envpol.2013.06.025; VANICEK CD, 1969, T AM FISH SOC, V98, P193, DOI 10.1577/1548-8659(1969)98[193:LHOTCS]2.0.CO;2; WADDELL B, 1995, ARCH ENVIRON CON TOX, V28, P321, DOI 10.1007/BF00213109; Walters DM, 2015, ENVIRON TOXICOL CHEM, V34, P2385, DOI 10.1002/etc.3077; Weiss-Penzias PS, 2016, SCI TOTAL ENVIRON, V568, P546, DOI 10.1016/j.scitotenv.2016.01.061; Wiener J.G., 2003, HDB ECOTOXICOLOGY, V2, P409; Willacker JJ, 2016, SCI TOTAL ENVIRON, V568, P739, DOI 10.1016/j.scitotenv.2016.03.050; Yackulic CB, 2014, ECOL EVOL, V4, P1006, DOI 10.1002/ece3.990; Zhang X, 2013, SCI TOTAL ENVIRON, V443, P218, DOI 10.1016/j.scitotenv.2012.10.090	95	4	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226824	10.1371/journal.pone.0226824	http://dx.doi.org/10.1371/journal.pone.0226824			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929573	Green Published, gold			2022-12-26	WOS:000534352500020
J	Spong, G; Gould, NP; Sahlen, E; Cromsigt, JPGM; Kindberg, J; DePerno, CS				Spong, Goran; Gould, Nicholas P.; Sahlen, Ellinor; Cromsigt, Joris P. G. M.; Kindberg, Jonas; DePerno, Christopher S.			Large-scale spatial variation of chronic stress signals in moose	PLOS ONE			English	Article							HAIR CORTISOL CONCENTRATION; LONG-TERM STRESS; HORMONE; RESPONSES; UNGULATE; GLUCOCORTICOIDS; TEMPERATURE; POPULATION; PREDATION; BIOMARKER	The physiological effects of short-term stress responses typically lead to increased individual survival as it prepares the body for fight or flight through catabolic reactions in the body. These physiological effects trade off against growth, immunocompetence, reproduction, and even long-term survival. Chronic stress may thus reduce individual and population performance, with direct implications for the management and conservation of wildlife populations. Yet, relatively little is known about how chronic stress levels vary across wild populations and factors contributing to increased chronic stress levels. One method to measure long-term stress in mammals is to quantify slowly incorporated stress hormone (cortisol) in hair, which most likely reflect a long-term average of the stress responses. In this study, we sampled 237 harvested moose Alces alces across Sweden to determine the relative effect of landscape variables and disturbances on moose hair cortisol levels. We used linear model combinations and Akaike's Information Criterion (corrected for small sample sizes), and included variables related to human disturbance, ungulate competition, large carnivore density, and ambient temperature to estimate the covariates that best explained the variance in stress levels in moose. The most important variables explaining the variation in hair cortisol levels in moose were the long-term average temperature sum in the area moose lived and the distance to occupied wolf territory; higher hair cortisol levels were detected where temperatures were higher and closer to occupied wolf territories, respectively.	[Spong, Goran; Sahlen, Ellinor; Cromsigt, Joris P. G. M.; Kindberg, Jonas] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Spong, Goran; Gould, Nicholas P.; Sahlen, Ellinor; DePerno, Christopher S.] Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC USA; [Cromsigt, Joris P. G. M.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Kindberg, Jonas] Norwegian Inst Nat Res, Trondheim, Norway	Swedish University of Agricultural Sciences; Nelson Mandela University; Norwegian Institute Nature Research	Spong, G (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden.; Spong, G (corresponding author), Dept Forestry & Environm Resources, Fisheries Wildlife & Conservat Biol Program, Raleigh, NC USA.	goran.spong@slu.se	Kindberg, Jonas/AAA-5058-2020	Kindberg, Jonas/0000-0003-1445-4524; Spong, Goran/0000-0002-1246-5046; Cromsigt, Joris/0000-0002-8632-9469	Nicholson Foundation; Swedish Environmental Protection Agency [NV-01337-15]; FORMAS [2008-997]	Nicholson Foundation; Swedish Environmental Protection Agency; FORMAS(Swedish Research Council Formas)	ES was supported by a full PhD grant from the Nicholson Foundation. JC was funded by the Swedish Environmental Protection Agency (NV-01337-15), and GS received funding from FORMAS (2008-997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1524; [Anonymous], 2012, VILTOLYCKSSTATISTIK; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Bechshoft TO, 2013, POLAR BIOL, V36, P1525, DOI 10.1007/s00300-013-1364-y; Blas J, 2007, P NATL ACAD SCI USA, V104, P8880, DOI 10.1073/pnas.0700232104; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Bourbonnais ML, 2013, PLOS ONE, V8, DOI [10.1371/journal.po, 10.1371/journal.pone.0083768]; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cook NJ, 2012, CAN J ANIM SCI, V92, P227, DOI 10.4141/CJAS2012-045; Corlatti L, 2018, ECOL INDIC, V95, P775, DOI 10.1016/j.ecolind.2018.08.028; Corlatti L, 2012, ANIM BEHAV, V84, P1061, DOI 10.1016/j.anbehav.2012.08.005; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Ericsson G, 2015, EUR J WILDLIFE RES, V61, P919, DOI 10.1007/s10344-015-0968-7; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fey K, 2008, BEHAV ECOL SOCIOBIOL, V62, P321, DOI 10.1007/s00265-007-0419-x; Frey SJK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501392; IPCC. Climate Change, 2008, IMP AD VULN WORK GRO; KHANSARI DN, 1990, IMMUNOL TODAY, V11, P170, DOI 10.1016/0167-5699(90)90069-L; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lenarz MS, 2010, J WILDLIFE MANAGE, V74, P1013, DOI 10.2193/2009-493; Lenarz MS, 2009, J WILDLIFE MANAGE, V73, P503, DOI 10.2193/2008-265; Li Y, 2015, NATURE COMMUNICATION, V6; Lundmark C, 2008, ARCT ANTARCT ALP RES, V40, P111, DOI 10.1657/1523-0430(06-103)[LUNDMARK]2.0.CO;2; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Macbeth BJ, 2012, WILDLIFE SOC B, V36, P747, DOI 10.1002/wsb.219; Malmsten J., 2014, THESIS; McCann NP, 2013, CAN J ZOOL, V91, P893, DOI 10.1139/cjz-2013-0175; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Mooring MS, 2006, HORM BEHAV, V49, P369, DOI 10.1016/j.yhbeh.2005.08.008; Murray DL, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)166[1:PNDACI]2.0.CO;2; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Nichols RV, 2014, SCAND J FOREST RES, V29, P650, DOI 10.1080/02827581.2014.960895; Olsson O, 1997, WILDLIFE BIOL, V3, P13, DOI 10.2981/wlb.1997.003; RENECKER LA, 1986, CAN J ZOOL, V64, P322, DOI 10.1139/z86-052; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; SMHI, 2014, KLIM NR 9 REP; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Vachon-Presseau E, 2013, BRAIN, V136, P815, DOI 10.1093/brain/aws371; Valimaki P, 2010, PARASITOL RES, V107, P117, DOI 10.1007/s00436-010-1845-7; WARD JR, 1992, DOMEST ANIM ENDOCRIN, V9, P97, DOI 10.1016/0739-7240(92)90023-Q; Weed JL, 2012, AM J PRIMATOL, V74, P76; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	51	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0225990	10.1371/journal.pone.0225990	http://dx.doi.org/10.1371/journal.pone.0225990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929559	Green Published, gold			2022-12-26	WOS:000534352500005
J	Weitzel, T; Rodriguez, F; Noriega, LM; Marcotti, A; Duran, L; Palavecino, C; Porte, L; Aguilera, X; Wolff, M; Cortes, CP				Weitzel, Thomas; Rodriguez, Fernanda; Miguel Noriega, Luis; Marcotti, Alejandra; Duran, Luisa; Palavecino, Carla; Porte, Lorena; Aguilera, Ximena; Wolff, Marcelo; Cortes, Claudia P.			Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; EXPANDED ACCESS PROGRAM; VIRAL-HEPATITIS; RISK-FACTORS; COINFECTION; IMPACT; EPIDEMIOLOGY; PREVALENCE; MORTALITY; VACCINE	Background Coinfections of HIV patients with hepatitis B virus (HBV) and hepatitis C virus (HCV) are mayor public health problems, contributing to the emerging burden of HIV-associated hepatic mortality. Coinfection rates vary geographically, depending on various factors such as predominant transmission modes, HBV vaccination rates, and prevalence of HBV and HCV in the general population. In South America, the epidemiology of coinfections is uncertain, since systematic studies are scarce. Our study aimed to analyze rates of HBV and HCV infection in people living with HIV attending centers of the public and private health system in Chile. Methods We performed a cross-sectional study including a public university hospital and a private health center in Santiago, Metropolitan Region in Chile. Serum samples were used to determine serological markers of hepatitis B (HBsAg, anti-HBs, anti-HBc total, HBeAg, anti-HBe) and anti-HCV. Demographic, clinical and laboratory data were obtained from medical records. Results 399 patients were included (353 from public, 46 from private health center). Most (92.8%) were male, with a median age of 38.3 years; 99.4% acquired HIV through sexual contact (75.0% MSM); 25.7% had AIDS and 90.4% were on ART. In 78.9%, viral loads were <40 cps/mL; the median CD4 cell count was 468 cells/mm(3). According to their serological status, 37.6% of patients were HBV naive (susceptible), 6.5% were vaccinated, 43.6% had resolved HBV infection, and 5.8% were chronically infected. The rate of vaccination was 4.5% in the public and 21.7% in the private system. HCV coinfection was found in 1.0% of all patients. Conclusion HBV coinfection rate was within the range of other South American countries, but lower than in non-industrialized regions in Asia and Africa. A low percentage of patients were HBV vaccinated, especially within the public system. HCV coinfection rate was very low, most probably due to the rareness of injecting drug use.	[Weitzel, Thomas; Porte, Lorena] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Lab Clin, Santiago, Chile; [Weitzel, Thomas] Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias & Innovac Med ICIM, Santiago, Chile; [Rodriguez, Fernanda; Wolff, Marcelo; Cortes, Claudia P.] Fdn Arriaran, Santiago, Chile; [Miguel Noriega, Luis; Marcotti, Alejandra; Duran, Luisa] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Dept Med Interne, Santiago, Chile; [Palavecino, Carla; Wolff, Marcelo; Cortes, Claudia P.] Univ Chile, Fac Med, Dept Med, Santiago, Chile; [Aguilera, Ximena] Univ Desarrollo, Fac Med Clin Alemana, Ctr Epidemiol & Polit Salud, Santiago, Chile; [Duran, Luisa] Hosp Mil, Serv lnfectol, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; Universidad del Desarrollo; Clinica Alemana; Universidad del Desarrollo; Universidad de Chile; Universidad del Desarrollo; Universidad de Chile	Weitzel, T (corresponding author), Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Lab Clin, Santiago, Chile.; Weitzel, T (corresponding author), Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias & Innovac Med ICIM, Santiago, Chile.	thomas.weitzel@gmail.com	aguilera, ximena/P-7682-2019; Duran, Luisa/AAV-5556-2021; Aguilera, Ximena Paz/D-9861-2014; Cortes, Claudia P/AAF-7326-2020	aguilera, ximena/0000-0002-8153-6733; Aguilera, Ximena Paz/0000-0002-8153-6733; Cortes, Claudia P/0000-0001-9101-9783; Weitzel, Thomas/0000-0002-9804-2123; Duran Graeff, Luisa/0000-0001-5110-6356	Clinica Alemana, Universidad del Desarrollo, in Santiago, Chile	Clinica Alemana, Universidad del Desarrollo, in Santiago, Chile	The study was supported by research grant of T.W., provided by Clinica Alemana, Universidad del Desarrollo, in Santiago, Chile (www.alemana.cl).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera X, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001676; Alarcon AM, 2018, REV CHIL INFECTOL, V35, P276, DOI 10.4067/s0716-10182018000300276; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 1977, Am J Public Health, V67, P31; [Anonymous], 1993, JAMA, V269, P729; [Anonymous], 2019, GUIDELINES PREVENTIO; [Anonymous], 2019, WHO VACC PREV DIS MO; Bailey CL, 2008, INT J INFECT DIS, V12, pE77, DOI 10.1016/j.ijid.2008.05.1226; Beltran C, 2016, REV CHIL INFECTOL, V33, pS2, DOI 10.4067/S0716-10182016000700001; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Burton KC, 2019, REV CHIL INFECTOL, V36, P221, DOI 10.4067/S0716-10182019000200221; Castillo-Laborde C, 2017, MEDICC REV, V19, P57, DOI 10.37757/MR2017.V19.N2-3.10; Centers for Disease Control and Prevention, EP PREV HIV VIR HEP; Chang JJ, 2018, CURR HIV-AIDS REP, V15, P172, DOI 10.1007/s11904-018-0379-y; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Cortes CP, 2018, REV MED CHILE, V146, P290, DOI 10.4067/s0034-98872018000300290; Crowell TA, 2015, JAIDS-J ACQ IMM DEF, V68, P425, DOI 10.1097/QAI.0000000000000490; Ceballos ME, 2016, REV CHIL INFECTOL, V33, P531, DOI 10.4067/S0716-10182016000500007; European AIDS Clinical Society, 2021, EACS GUID; European Centre for Disease Prevention and Control, 2018, PUBL HLTH GUID HIV H; Fainboim H, 1999, J VIRAL HEPATITIS, V6, P53, DOI 10.1046/j.1365-2893.1999.t01-1-6120135.x; Goic A, 2015, REV MED CHILE, V143, P774, DOI 10.4067/S0034-98872015000600011; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Ibarra H, 2007, REV MED CHILE, V135, P229; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Vargas JI, 2016, J MED VIROL, V88, P639, DOI 10.1002/jmv.24384; Isapres de Chile, 2018, INFORM VIH SIDA COBE; Jansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142515; Kang W, 2014, EXPERT REV GASTROENT, V8, P247, DOI 10.1586/17474124.2014.876357; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Kourtis AP, 2012, NEW ENGL J MED, V366, P1749, DOI 10.1056/NEJMp1201796; Liang SH, 2010, JAIDS-J ACQ IMM DEF, V54, P122, DOI 10.1097/QAI.0b013e3181daafd5; Martins S, 2014, REV SOC BRAS MED TRO, V47, P552, DOI 10.1590/0037-8682-0109-2014; McFaul K, 2015, J VIRAL HEPATITIS, V22, P535, DOI 10.1111/jvh.12366; Ministerio de Desarrollo Social y Familia, ENC CASEN 2017; Ministerio de Salud. Chile MdSd, 2016, LIST PREST ESP; Ministerio de Salud de Chile Organizacion Panamericana de la Salud, 2015, VIG MON HEP VIR B C; MINSAL SGC, 2013, GUIA CLIN AUGE INF R; Miro JM, 2019, INTENS CARE MED, V45, P398, DOI 10.1007/s00134-019-05524-1; Morlat P, 2014, AIDS, V28, P1181, DOI 10.1097/QAD.0000000000000222; O'Hara GA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005842; Omland LH, 2008, HIV MED, V9, P300, DOI 10.1111/j.1468-1293.2008.00564.x; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Otto-Knapp R, 2013, INT J INFECT DIS, V17, pE919, DOI 10.1016/j.ijid.2013.05.009; Perez C, 2009, REV MED CHILE, V137, P641, DOI /S0034-98872009000500007; Peters L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S6-S13; Nunez JAP, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000012238, 10.1097/md.0000000000012238]; Ramirez CA, 2009, REV CHIL INFECTOL, V26, P26, DOI /S0716-10182009000100004; Rock C, 2013, J INFECT PUBLIC HEAL, V6, P173, DOI 10.1016/j.jiph.2012.11.001; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Sampaio AS, 2009, ACTUALIZADIONES SID, V17, P12; Servicio Nacional para la Prevencio  y Rehabilitacio  del Consumo de Drogas y Alcohol (SENDA), 2003, QUINT EST NAC DROG P; Singh KP, 2017, AIDS, V31, P2035, DOI 10.1097/QAD.0000000000001574; Soriano V, 2010, ANTIVIR RES, V85, P303, DOI 10.1016/j.antiviral.2009.10.021; Soza A, 2006, REV MED CHILE, V134, P777; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Tedaldi EM, 2004, CLIN INFECT DIS, V38, P1483; Tengan FM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2695-z; Tengan FM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1988-y; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; UNAIDS, COUNTR FACTSH CHIL 2; Vasquez F, 2013, REV PANAM SALUD PUBL, V33, P98, DOI 10.1590/S1020-49892013000200004; Weis N, 2006, CLIN INFECT DIS, V42, P1481, DOI 10.1086/503569; WHO, 2017, WHO PUBLISHES LIST B; WHO, 2002, HEP B; Witt MD, 2013, CLIN INFECT DIS, V56, P606, DOI 10.1093/cid/cis908; Wolff MJ, 2010, JAIDS-J ACQ IMM DEF, V55, P368, DOI 10.1097/QAI.0b013e3181eb4fb9; Wolff WJ, 2005, JAIDS-J ACQ IMM DEF, V40, P551; World Health Organization, FACTSH HEP B; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; ZUNINO M. ENNA, 2002, Rev. chil. infectol., V19, P140	72	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0227776	10.1371/journal.pone.0227776	http://dx.doi.org/10.1371/journal.pone.0227776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917810	gold, Green Published			2022-12-26	WOS:000534341100036
J	Jung, E; Choi, TI; Lee, JE; Kim, CH; Kim, J				Jung, Eunji; Choi, Tae-Ik; Lee, Ji-Eun; Kim, Cheol-Hee; Kim, Joon			ESCRT subunit CHMP4B localizes to primary cilia and is required for the structural integrity of the ciliary membrane	FASEB JOURNAL			English	Article						ciliopathy phenotype; endosomal sorting complex; membrane curvature	CILIOGENESIS; COMPLEX; MACHINERY; PATHWAYS; REVEALS; TUBULIN; CP110	Proteins specialized in the detection, generation, or stabilization of membrane curvature play important roles in establishing various morphologies of cells and cellular organelles. Primary cilia are cellular organelles that protrude from the cell surface using a microtubule-based cytoskeleton called the axoneme as a structural support. It is unclear whether the integrity of the high curvature of the ciliary membrane depends on membrane curvature-related proteins. Charged Multivesicular Body Protein 4B (CHMP4B), a subunit of the endosomal sorting complexes required for transport (ESCRT), can stabilize membrane curvature. Here we show that CHMP4B is involved in the assembly and maintenance of primary cilia. CHMP4B was localized to primary cilia in mammalian cells. Knockdown of CHMP4B interfered with cilium assembly and also caused fragmentation of preexisting cilia. By contrast, cilium formation was unaffected by the interruption of the ESCRT-dependent endocytic degradation pathway. Morpholino (MO)-mediated CHMP4B depletion in zebrafish embryos induced characteristic phenotypes of ciliary defects such as curved body axis, hydrocephalus, otolith malformation, and kidney cyst. Our study reveals a new role for the multifunctional protein CHMP4B as a key factor in maintaining the structural integrity of primary cilia.	[Jung, Eunji; Kim, Joon] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon, South Korea; [Choi, Tae-Ik; Kim, Cheol-Hee] Chungnam Natl Univ, Dept Biol, 99 Daehak Ro, Daejeon 34134, South Korea; [Lee, Ji-Eun] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, Joon] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University; Sungkyunkwan University (SKKU); Korea Advanced Institute of Science & Technology (KAIST)	Kim, CH (corresponding author), Chungnam Natl Univ, Dept Biol, 99 Daehak Ro, Daejeon 34134, South Korea.; Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	zebrakim@cnu.ac.kr; joonkim@kaist.ac.kr	Kim, Joon/C-1833-2011		Korean Ministry of Science and ICT [2017R1A2B3005208, 2018M3A9B8021980]; Korean Ministry of Health Welfare [HI18C0013]	Korean Ministry of Science and ICT(Ministry of Science, ICT & Future Planning, Republic of Korea); Korean Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	Korean Ministry of Science and ICT, Grant/Award Number: 2017R1A2B3005208 and 2018M3A9B8021980; Korean Ministry of Health & Welfare, Grant/Award Number: HI18C0013	Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Carter SP, 2019, CURR OPIN CELL BIOL, V59, P133, DOI 10.1016/j.ceb.2019.04.007; Christ L, 2016, J CELL BIOL, V212, P499, DOI 10.1083/jcb.201507009; Dema A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.209080; Diener DR, 2015, CURR BIOL, V25, P379, DOI 10.1016/j.cub.2014.11.066; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fremont S, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14528; Garcia G, 2018, CURR BIOL, V28, pR421, DOI 10.1016/j.cub.2018.03.010; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Insinna C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08192-9; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kuhns S, 2013, J CELL BIOL, V200, P505, DOI 10.1083/jcb.201206013; Lee IH, 2015, P NATL ACAD SCI USA, V112, P15892, DOI 10.1073/pnas.1518765113; Lee SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27284; Lee S, 2018, J CELL BIOL, V217, P2831, DOI 10.1083/jcb.201711104; Long H, 2016, CURR BIOL, V26, P3327, DOI 10.1016/j.cub.2016.09.055; MacDonald E, 2018, J CELL BIOL, V217, P2549, DOI 10.1083/jcb.201710051; Madhivanan K, 2016, RES REP BIOL, V7, P15, DOI 10.2147/RRB.S62510; Mamiska A., 2016, SCI SIGNAL, V9, pra8, DOI 10.1126/scisignal.aad0848; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Mirvis M, 2018, BIOCHEM J, V475, P2329, DOI 10.1042/BCJ20170453; Molla-Herman A, 2010, J CELL SCI, V123, P1785, DOI 10.1242/jcs.059519; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Nachury MV, 2019, NAT REV MOL CELL BIO, V20, P389, DOI 10.1038/s41580-019-0116-4; Omori Y, 2008, NAT CELL BIOL, V10, P437, DOI 10.1038/ncb1706; Ott C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21491-x; Phua SC, 2017, CELL, V168, P264, DOI 10.1016/j.cell.2016.12.032; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Roosing S, 2015, ELIFE, V4, DOI 10.7554/eLife.06602; Saito M, 2017, EMBO REP, V18, P1460, DOI 10.15252/embr.201744204; Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028; Shiels A, 2007, AM J HUM GENET, V81, P596, DOI 10.1086/519980; Shin N, 2008, J CELL SCI, V121, P1252, DOI 10.1242/jcs.016709; Smith KP, 2011, CYTOSKELETON, V68, P112, DOI 10.1002/cm.20498; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Szymanska Katarzyna, 2012, Cilia, V1, P10, DOI 10.1186/2046-2530-1-10; Tang SG, 2016, ELIFE, V5, DOI 10.7554/eLife.15507; Tang SG, 2015, ELIFE, V4, DOI 10.7554/eLife.12548; Tanos BE, 2013, GENE DEV, V27, P163, DOI 10.1101/gad.207043.112; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Waters AM, 2011, PEDIATR NEPHROL, V26, P1039, DOI 10.1007/s00467-010-1731-7; Wenzel EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05345-8; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073	55	7	7	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					1331	1344		10.1096/fj.201901778R	http://dx.doi.org/10.1096/fj.201901778R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914703				2022-12-26	WOS:000507308900089
J	Wei, L; Surma, M; Yang, Y; Tersey, S; Shi, JJ				Wei, Lei; Surma, Michelle; Yang, Yang; Tersey, Sarah; Shi, Jianjian			ROCK2 inhibition enhances the thermogenic program in white and brown fat tissue in mice	FASEB JOURNAL			English	Article						beige adipogenesis; energy expenditure; obesity; ROCK2; ROCK2-selective inhibitor	RHO-ASSOCIATED-KINASE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; TARGETED DISRUPTION; MOUSE; BEIGE; CELL; DELETION; OBESITY; ACTIVATION	The RhoA/ROCK-mediated actin cytoskeleton dynamics have been implicated in adipogenesis. The two ROCK isoforms, ROCK1 and ROCK2, are highly homologous. The contribution of ROCK2 to adipogenesis in vivo has not been elucidated. The present study aimed at the in vivo and in vitro roles of ROCK2 in the regulation of adipogenesis and the development of obesity. We performed molecular, histological, and metabolic analyses in ROCK2(+/-) and ROCK2(+/KD) mouse models, the latter harboring an allele with a kinase-dead (KD) mutation. Both ROCK2(+/-) and ROCK2(+/KD) mouse models showed a lean body mass phenotype during aging, associated with increased amounts of beige cells in subcutaneous white adipose tissue (sWAT) and increased thermogenic gene expression in all fat depots. ROCK2(+/-) mice on a high-fat diet showed increased energy expenditure accompanying by reduced obesity, and improved insulin sensitivity. In vitro differentiated ROCK2(+/-) stromal-vascular (SV) cells revealed increased beige adipogenesis associated with increased thermogenic gene expressions. Treatment with a selective ROCK2 inhibitor, KD025, to inhibit ROCK2 activity in differentiated SV cells reproduced the pro-beige phenotype of ROCK2(+/-) SV cells. In conclusion, ROCK2 activity-mediated actin cytoskeleton dynamics contribute to the inhibition of beige adipogenesis in WAT, and also promotes age-related and diet-induced fat mass gain and insulin resistance.	[Wei, Lei; Surma, Michelle; Yang, Yang; Tersey, Sarah; Shi, Jianjian] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, 1044 West Walnut St,R4-240, Indianapolis, IN 46202 USA; [Wei, Lei; Tersey, Sarah] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Wei, Lei] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wei, L; Shi, JJ (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, 1044 West Walnut St,R4-240, Indianapolis, IN 46202 USA.	lewei@iu.edu; jishi@iu.edu		Tersey, Sarah/0000-0003-0667-2361	School of Medicine, Indiana University (IUSM) [2286128, 2286118]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL107537, HL134599]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK097512]	School of Medicine, Indiana University (IUSM); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	School of Medicine, Indiana University (IUSM), Grant/Award Number: 2286128; School of Medicine, Indiana University (IUSM), Grant/Award Number: 2286118; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL107537; HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: P30 DK097512; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL134599	Akhter M, 2018, ANN CLIN TRANSL NEUR, V5, P769, DOI 10.1002/acn3.569; [Anonymous], 2019, FACT SHEET OB OV; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Berry DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10184; Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Boerma M, 2008, BLOOD COAGUL FIBRIN, V19, P709, DOI 10.1097/MBC.0b013e32830b2891; Chang YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06011; Chun KH, 2012, ENDOCRINOLOGY, V153, P1649, DOI 10.1210/en.2011-1036; Chun KH, 2011, AM J PHYSIOL-ENDOC M, V300, pE536, DOI 10.1152/ajpendo.00538.2010; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Defert O, 2017, EXPERT OPIN THER PAT, V27, P507, DOI 10.1080/13543776.2017.1272579; Dorn T, 2018, EMBO J, V37, DOI 10.15252/embj.201798133; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Diep DTV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20821-3; Feng YB, 2016, J MED CHEM, V59, P2269, DOI 10.1021/acs.jmedchem.5b00683; Flynn R, 2016, BLOOD, V127, P2144, DOI 10.1182/blood-2015-10-678706; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Hara Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001227; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Huang H, 2018, J CLIN INVEST, V128, P5335, DOI 10.1172/JCI63562; Inoue Y, 2018, CURR OBES REP, V7, P276, DOI 10.1007/s13679-018-0317-8; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jahani V, 2018, BIOMED PHARMACOTHER, V106, P1024, DOI 10.1016/j.biopha.2018.07.060; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Lee DH, 2009, J BIOL CHEM, V284, P11776, DOI 10.1074/jbc.C900014200; Lee JH, 2014, ANN CLIN TRANSL NEUR, V1, P2, DOI 10.1002/acn3.19; Lee SH, 2014, AM J PHYSIOL-ENDOC M, V306, pE332, DOI 10.1152/ajpendo.00619.2013; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JZ, 2016, ADIPOCYTE, V5, P130, DOI 10.1080/21623945.2016.1140708; Liu L, 2016, CLIN CHIM ACTA, V462, P107, DOI 10.1016/j.cca.2016.09.003; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Munoz VR, 2018, J GERONTOL A-BIOL, P1, DOI [10.1093/gerona/gly293, DOI 10.1093/GER0NA/GLY293]; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nedergaard J, 2005, EMBO REP, V6, P917, DOI 10.1038/sj.embor.7400532; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Noda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110446; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Sadeghian H, 2018, ANN NEUROL, V84, P409, DOI 10.1002/ana.25298; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shi JJ, 2008, J MOL CELL CARDIOL, V44, P551, DOI 10.1016/j.yjmcc.2007.11.018; Shi JJ, 2019, FASEB J, V33, P7348, DOI 10.1096/fj.201802510R; Shi Jianjian, 2018, Oncotarget, V9, P12995, DOI 10.18632/oncotarget.24457; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Shi JJ, 2012, AM J PHYSIOL-HEART C, V302, pH1603, DOI 10.1152/ajpheart.00844.2011; Shi JJ, 2010, J MOL CELL CARDIOL, V49, P819, DOI 10.1016/j.yjmcc.2010.08.008; Sim CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174761; Soliman H, 2016, INT J OBESITY, V40, P1435, DOI 10.1038/ijo.2016.89; Soliman H, 2015, AM J PHYSIOL-HEART C, V309, pH70, DOI 10.1152/ajpheart.00664.2014; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Surma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090758; Thumkeo D, 2005, GENES CELLS, V10, P825, DOI 10.1111/j.1365-2443.2005.00882.x; Thumkeo D, 2003, MOL CELL BIOL, V23, P5043, DOI 10.1128/MCB.23.14.5043-5055.2003; Weiss JM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8953; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zanin-Zhorov A, 2017, J IMMUNOL, V198, P3809, DOI 10.4049/jimmunol.1602142; Zanin-Zhorov Alexandra, 2016, Small GTPases, V7, P173, DOI 10.1080/21541248.2016.1181698; Zanin-Zhorov A, 2014, P NATL ACAD SCI USA, V111, P16814, DOI 10.1073/pnas.1414189111; Zhou XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29669	67	7	7	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2020	34	1					474	493		10.1096/fj.201901174RR	http://dx.doi.org/10.1096/fj.201901174RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC6TY	31914704	Green Accepted, Green Submitted			2022-12-26	WOS:000507308900033
J	Marivin, A; Maziarz, M; Zhao, JY; DiGiacomo, V; Calvo, IO; Mann, EA; Ear, J; Blanco-Canosa, JB; Ross, EM; Ghosh, P; Garcia-Marcos, M				Marivin, Arthur; Maziarz, Marcin; Zhao, Jingyi; DiGiacomo, Vincent; Olmos Calvo, Isabel; Mann, Emily A.; Ear, Jason; Blanco-Canosa, Juan B.; Ross, Elliott M.; Ghosh, Pradipta; Garcia-Marcos, Mikel			DAPLE protein inhibits nucleotide exchange on G?(s) and G?(q) via the same motif that activates G?i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; G-protein?coupled receptor (GPCR); guanine nucleotide?exchange factor (GEF); G protein; protein?protein interaction; cell signaling; G?-binding and -activating (GBA); guanine nucleotide dissociation inhibitor (GDI)	G-ALPHA-S; HETEROTRIMERIC G-PROTEINS; DISSOCIATION INHIBITOR; COUPLED RECEPTORS; REGULATORY MOTIF; DRUG DISCOVERY; GOLOCO MOTIF; SUBUNIT; STATE; RGS	Besides being regulated by G-protein?coupled receptors, the activity of heterotrimeric G proteins is modulated by many cytoplasmic proteins. GIV/Girdin and DAPLE (Dvl-associating protein with a high frequency of leucine) are the best-characterized members of a group of cytoplasmic regulators that contain a G?-binding and -activating (GBA) motif and whose dysregulation underlies human diseases, including cancer and birth defects. GBA motif?containing proteins were originally reported to modulate G proteins by binding G? subunits of the G(i/o) family (G?(i)) over other families (such as G(s), G(q/11), or G(12/13)), and promoting nucleotide exchange in vitro. However, some evidence suggests that this is not always the case, as phosphorylation of the GBA motif of GIV promotes its binding to G?(s) and inhibits nucleotide exchange. The G-protein specificity of DAPLE and how it might affect nucleotide exchange on G proteins besides G?(i) remain to be investigated. Here, we show that DAPLE's GBA motif, in addition to G?(i), binds efficiently to members of the G(s) and G(q/11) families (G?(s) and G?(q), respectively), but not of the G(12/13) family (G?(12)) in the absence of post-translational phosphorylation. We pinpointed Met-1669 as the residue in the GBA motif of DAPLE that diverges from that in GIV and enables better binding to G?(s) and G?(q). Unlike the nucleotide-exchange acceleration observed for G?(i), DAPLE inhibited nucleotide exchange on G?(s) and G?(q). These findings indicate that GBA motifs have versatility in their G-protein?modulating effect, i.e. they can bind to G? subunits of different classes and either stimulate or inhibit nucleotide exchange depending on the G-protein subtype.	[Marivin, Arthur; Maziarz, Marcin; Zhao, Jingyi; DiGiacomo, Vincent; Olmos Calvo, Isabel; Mann, Emily A.; Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA; [Ear, Jason; Ghosh, Pradipta] Univ Calif San Diego, Dept Med & Cellular & Mol Med, La Jolla, CA 92093 USA; [Blanco-Canosa, Juan B.] CSIC, Inst Adv Chem Catalonia IQAC, Dept Biol Chem, ES-08034 Barcelona, Spain; [Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Dallas, TX 75390 USA; [DiGiacomo, Vincent] DeepBiome Therapeut, Cambridge, MA 02139 USA; [Olmos Calvo, Isabel] Med Univ Vienna, Div Rheumatol, A-1090 Vienna, Austria	Boston University; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of Vienna	Garcia-Marcos, M (corresponding author), Boston Univ, Sch Med, Dept Biochem, 72 E Concord St,Silvio Conte Bldg K, Boston, MA 02118 USA.	mgm1@bu.edu	Zhao, Jingyi/AAG-3799-2019; Blanco-Canosa, Juan B./H-4544-2015	Zhao, Jingyi/0000-0002-3125-2716; Blanco-Canosa, Juan B./0000-0001-5738-6993	National Institutes of Health [CA100768, CA160911, R01GM108733, R01GM136132, R01GM030355]; American Cancer Society-Funding Hope Postdoctoral Fellowship [PF-19-084-01-CDD]; Hartwell Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-Funding Hope Postdoctoral Fellowship; Hartwell Foundation	This work was supported by National Institutes of Health Grants R01GM108733 and R01GM136132 (to M. G.-M.), American Cancer Society-Funding Hope Postdoctoral Fellowship PF-19-084-01-CDD (to M. M.), a postdoctoral fellowship from the Hartwell Foundation (to V. D.), National Institutes of Health Grant R01GM030355 (to E. M. R.), and National Institutes of Health Grants CA100768 and CA160911 (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Acharya BR, 2018, DEV CELL, V47, P439, DOI 10.1016/j.devcel.2018.09.016; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Aznar N, 2015, ELIFE, V4, DOI 10.7554/eLife.07091; Beas AO, 2012, MOL BIOL CELL, V23, P4623, DOI 10.1091/mbc.E12-02-0133; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2006, EUR J CELL BIOL, V85, P1233, DOI 10.1016/j.ejcb.2006.08.002; Blumer JB, 2014, MOL PHARMACOL, V85, P388, DOI 10.1124/mol.113.090068; BRANDT DR, 1985, J BIOL CHEM, V260, P266; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chan P, 2011, J BIOL CHEM, V286, P19932, DOI 10.1074/jbc.M110.163675; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Coleman BD, 2016, MOL BIOL EVOL, V33, P820, DOI 10.1093/molbev/msv336; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; DiGiacomo V, 2018, BIOCHEMISTRY-US, V57, P255, DOI 10.1021/acs.biochem.7b00845; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Ear J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48420-w; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gotta M, 2003, CURR BIOL, V13, P1029, DOI 10.1016/S0960-9822(03)00371-3; Gupta V, 2016, P NATL ACAD SCI USA, V113, pE5721, DOI 10.1073/pnas.1609502113; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; de Opakua AI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15163; Johnston CA, 2005, FEBS LETT, V579, P5746, DOI 10.1016/j.febslet.2005.09.059; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kalogriopoulos NA, 2019, P NATL ACAD SCI USA, V116, P16394, DOI 10.1073/pnas.1906658116; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Leyme A, 2017, P NATL ACAD SCI USA, V114, pE10319, DOI 10.1073/pnas.1707992114; Leyme A, 2015, J CELL BIOL, V210, P1165, DOI 10.1083/jcb.201506041; Leyme A, 2014, J BIOL CHEM, V289, P21818, DOI 10.1074/jbc.M114.549790; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Marivin A, 2019, MOL BIOL CELL, V30, P1900, DOI 10.1091/mbc.E19-02-0091; Marivin A, 2019, J CELL BIOL, V218, P1743, DOI 10.1083/jcb.201811174; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Maziarz M, 2018, J BIOL CHEM, V293, P16964, DOI 10.1074/jbc.RA118.003580; Meyer TN, 2002, J BIOL CHEM, V277, P24855, DOI 10.1074/jbc.C200240200; Midde KK, 2015, P NATL ACAD SCI USA, V112, pE937, DOI 10.1073/pnas.1420140112; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Natochin M, 1998, BIOCHEMISTRY-US, V37, P13776, DOI 10.1021/bi981155a; Navaratnarajah P, 2017, J BIOL CHEM, V292, P16788, DOI 10.1074/jbc.M117.809673; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Parag-Sharma K, 2016, J BIOL CHEM, V291, P27098, DOI 10.1074/jbc.M116.764431; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Ritchie Benjamin J, 2013, J Mol Signal, V8, P3, DOI 10.1186/1750-2187-8-3; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Ross EM, 2002, METHOD ENZYMOL, V344, P601; Saha C, 2001, BIOCHEM BIOPH RES CO, V285, P250, DOI 10.1006/bbrc.2001.5154; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; UEDA N, 1994, J BIOL CHEM, V269, P4388; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756	85	6	6	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2270	2284		10.1074/jbc.RA119.011648	http://dx.doi.org/10.1074/jbc.RA119.011648			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	31949046	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000517330200011
J	Katwal, TB; Bazile, D				Katwal, Tirtha Bdr; Bazile, Didier			First adaptation of quinoa in the Bhutanese mountain agriculture systems	PLOS ONE			English	Article							CHENOPODIUM-QUINOA; WILLD.	Bhutan represents typical mountain agriculture farming systems with unique challenges. The agriculture production systems under environmental constraints are typical of small-scale agricultural subsistence systems related to family farming in the Himalayan Mountains with very low level of mechanization, numerous abiotic stresses influenced by climate and other socio-economic constraints. Quinoa was first introduced in 2015 through FAO's support to Bhutan as a new crop to enhance the food and nutritional security of the Bhutanese people. The main objective was to adapt this versatile crop to the local mountain agriculture conditions as a climate resilient crop for diversifying the farmer's traditional potato and maize based cropping systems. Ten quinoa varieties were evaluated at two different sites representing contrasted mountain agroecologies in Bhutan and were tested during the two agricultural campaigns 2016 and 2017. Yusipang (2600 masl) represents the cool temperate agroecological zone, and Lingmethang (640 masl) the dry subtropical agroecological zone. The sowing time differed depending on the growing season and elevation of the sites. Results indicate that quinoa can be successfully grown in Bhutan for the two different agroecological zones. The grain yields varied from 0.61 to 2.68 t.ha(-1) in the high altitude areas where quinoa was seeded in spring and harvested in autumn season. The grain yield in the lower elevation ranged from 1.59 to 2.98 t.ha(-1) where the crop was sown in autumn and harvested in winter season. Depending on genotypes' characteristics and agroecological zones, crop maturity significantly varied from 92 to 197 days with all genotypes maturing much earlier in the lower elevations where mean minimum and maximum temperatures during the growing season were higher. Quinoa is rapidly promoted across different agroecological contexts in the country as a new climate resilient and nutrient dense pseudo cereal to diversify the traditional existing cropping system with some necessary adjustments in sowing time, suitable varieties and crop management practices. To fast track the rapid promotion of this new crop in Bhutan, four varieties have been released in 2018. In just over three years, the cultivation of quinoa as a new cereal has been demonstrated and partially adapted to the maize and potato based traditional cropping systems under the Himalayan mountain agriculture. Quinoa is also being adapted to the rice based cropping system and rapidly promoted as an alternative food security crop in the current 12th Five Year national development plan of Bhutan. To rapidly promote quinoa cultivation, the Royal Government of Bhutan is supporting the supply of free quinoa seeds, cultivation technologies and milling machines to the rural communities. To promote the consumption and utilization of quinoa at national level, consumer awareness are created by preparing and serving local Bhutanese dishes from quinoa during local food fairs and farmer's field days. In addition, the Royal Government of Bhutan has included quinoa in the school feeding programme recognizing the high nutrient value of the crop for enhancing and securing the nutritional needs of the young children.	[Katwal, Tirtha Bdr] Minist Agr & Forests, Dept Agr, Agr Res & Dev Ctr Yusipang, Thimphu, Bhutan; [Bazile, Didier] CIRAD, UPR Green, Montpellier, France; [Bazile, Didier] Univ Montpellier, CIRAD, GREEN, Montpellier, France; [Bazile, Didier] CIRAD, DGDRS, Montpellier, France	CIRAD; CIRAD; Universite de Montpellier; CIRAD	Katwal, TB (corresponding author), Minist Agr & Forests, Dept Agr, Agr Res & Dev Ctr Yusipang, Thimphu, Bhutan.; Bazile, D (corresponding author), CIRAD, UPR Green, Montpellier, France.; Bazile, D (corresponding author), Univ Montpellier, CIRAD, GREEN, Montpellier, France.; Bazile, D (corresponding author), CIRAD, DGDRS, Montpellier, France.	tirthakatwal@gmail.com; didier.bazile@cirad.fr	BAZILE, Didier/C-6120-2016; BAZILE, Didier/L-3859-2019	BAZILE, Didier/0000-0001-5617-9319; BAZILE, Didier/0000-0001-5617-9319				Al-Ejeh F, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P6-10-06; [Anonymous], 1993, INHE, V19, P2; Apaza V., 2013, CATALOGO VARIEDADES; ARDC, 2018, 12 5 YEAR PLAN STRAT; Bazile D., 2016, Farming Matters, V32, P36; Bazile D., 2015, STATE ART REPORT QUI; Bazile D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00850; Bazile D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00622; Bazile D, 2013, QUINOA: BOTANY, PRODUCTION AND USES, P16, DOI 10.1079/9781780642260.0016; Bertero HD, 2008, EUR J AGRON, V28, P186, DOI 10.1016/j.eja.2007.07.002; Bhargava A, 2015, STATE ART REPORT QUI, P511; Bhargava A, 2007, FIELD CROP RES, V101, P104, DOI 10.1016/j.fcr.2006.10.001; BIONDI S, 2015, STATE ART REPORT QUI, P143; Chevarria-Lazo M., 2015, STATE ART REPORT QUI, P83; Choukr-Allah R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00346; De Ron AM, 2017, CHALLENGE PROTEIN CR, DOI [10.3389/978-2-88945-162-3, DOI 10.3389/978-2-88945-162-3]; Didier Bazile, 2015, STATE ART REPORT QUI, P586; DoA, 2018, FLAGSH PROGR UP SCAL; DoA, 2016, AGR STAT 2016; Gongbu T, 1998, SW CHINA J AGR SCI, P37; Gongbu T., 1997, NW CHINA J AGR SCI, P25; Gross National Happiness Commission (GNHC), 2013, 11 5 YEAR PLAN; Hooker J.D., 1885, FLORA BRIT INDIA, V4, P644; Hooker JD, 1952, HIMALAYAN J, V1, P386; Jacobsen SE, 2012, FIELD CROP RES, V128, P34, DOI 10.1016/j.fcr.2011.12.001; Jacobsen SE, 2003, FOOD REV INT, V19, P167, DOI 10.1081/FRI-120018883; Jacobsen SE, 2005, EUR J AGRON, V22, P131, DOI 10.1016/j.eja.2004.01.003; Jacobsen SE, 1997, EUPHYTICA, V96, P41, DOI 10.1023/A:1002992718009; Jacobsen SE, 2003, FOOD REV INT, V19, P99, DOI 10.1081/FRI-120018872; Jankovic S, 2016, ROMANIAN AGR RES, V33; Katwal TB, 2013, POPULARIZING MULTIPL; Katwal TB, 2018, BHUTAN J AGR, VI; Katwal TB, 2018, QUINOA GEN INFORM PA; Katwal TB, 2015, AGRICULTURE-BASEL, V5, P2, DOI 10.3390/agriculture5010002; LCMP. National Soil Service Center and the Policy and Planning Division, 2010, LAND COV ASS REP; Man SL, 2010, FITOTERAPIA, V81, P703, DOI 10.1016/j.fitote.2010.06.004; Martinez EA, 2015, WORLD AGRIC SER, P19; MOAF, 2011, BHUT CLIM SUMM 2011; NEC, 2016, BHUT STAT ENV REP; NSB. National Statistical Bureau, 2018, KEY IND; NSSC, 2003, 4202SS18 NSSC MIN AG; NSSC, 1998, 1A NSSC MIN AGR RES; Parker L, 2017, 191 CGIAR CCAFS; PARTAP T, 1985, AGR ECOSYST ENVIRON, V14, P185, DOI 10.1016/0167-8809(85)90035-0; PHCB, 2017, NATL REPORT; PROINPA, 2011, QUIN ANC CROP CONTR; Pulvento C, 2010, J AGRONOMY CROP SCI; RNR Statistics, 2015, BHUT REN NAT RES STA; Ruiz KB, 2014, AGRON SUSTAIN DEV, V34, P349, DOI 10.1007/s13593-013-0195-0; Troisi J., 2015, STATE ART REPORT QUI, P267; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Yazar A, INT QUIN C DUB UAE 1	52	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0219804	10.1371/journal.pone.0219804	http://dx.doi.org/10.1371/journal.pone.0219804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945062	Green Published, Green Submitted, gold			2022-12-26	WOS:000534370100003
J	Salvage, SC; Rees, JS; McStea, A; Hirsch, M; Wang, L; Tynan, CJ; Reed, MW; Irons, JR; Butler, R; Thompson, AJ; Martin-Fernandez, ML; Huang, CLH; Jackson, AP				Salvage, Samantha C.; Rees, Johanna S.; McStea, Alexandra; Hirsch, Michael; Wang, Lin; Tynan, Christopher J.; Reed, Matthew W.; Irons, Jennifer R.; Butler, Richard; Thompson, Andrew J.; Martin-Fernandez, Marisa L.; Huang, Christopher L-H; Jackson, Antony P.			Supramolecular clustering of the cardiac sodium channel Nav1.5 in HEK293F cells, with and without the auxiliary beta 3-subunit	FASEB JOURNAL			English	Article						beta 3-subunit; Hodgkin Huxley kinetics; super-resolution imaging; voltage-gated sodium channel Nav1; 5	NA+ CHANNEL; KINETICS; MUTATION; SCN5A; INACTIVATION; TRAFFICKING; NA(V)1.5; DOMAINS; COMPLEX	Voltage-gated sodium channels comprise an ion-selective alpha-subunit and one or more associated beta-subunits. The beta 3-subunit (encoded by the SCN3B gene) is an important physiological regulator of the heart-specific sodium channel, Nav1.5. We have previously shown that when expressed alone in HEK293F cells, the full-length beta 3-subunit forms trimers in the plasma membrane. We extend this result with biochemical assays and use the proximity ligation assay (PLA) to identify oligomeric beta 3-subunits, not just at the plasma membrane, but throughout the secretory pathway. We then investigate the corresponding clustering properties of the alpha-subunit and the effects upon these of the beta 3-subunits. The oligomeric status of the Nav1.5 alpha-subunit in vivo, with or without the beta 3-subunit, has not been previously investigated. Using super-resolution fluorescence imaging, we show that under conditions typically used in electrophysiological studies, the Nav1.5 alpha-subunit assembles on the plasma membrane of HEK293F cells into spatially localized clusters rather than individual and randomly dispersed molecules. Quantitative analysis indicates that the beta 3-subunit is not required for this clustering but beta 3 does significantly change the distribution of cluster sizes and nearest-neighbor distances between Nav1.5 alpha-subunits. However, when assayed by PLA, the beta 3-subunit increases the number of PLA-positive signals generated by anti-(Nav1.5 alpha-subunit) antibodies, mainly at the plasma membrane. Since PLA can be sensitive to the orientation of proteins within a cluster, we suggest that the beta 3-subunit introduces a significant change in the relative alignment of individual Nav1.5 alpha-subunits, but the clustering itself depends on other factors. We also show that these structural and higher-order changes induced by the beta 3-subunit do not alter the degree of electrophysiological gating cooperativity between Nav1.5 alpha-subunits. Our data provide new insights into the role of the beta 3-subunit and the supramolecular organization of sodium channels, in an important model cell system that is widely used to study Nav channel behavior.	[Salvage, Samantha C.; Rees, Johanna S.; Irons, Jennifer R.; Huang, Christopher L-H; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [McStea, Alexandra; Hirsch, Michael; Wang, Lin; Tynan, Christopher J.; Martin-Fernandez, Marisa L.] Rutherford Appleton Lab, Sci & Technol Facil Council, Cent Laser Facil, Res Complex Harwell, Oxford, England; [Reed, Matthew W.] Australian Natl Univ, Res Sch Phys & Engn, Dept Nucl Phys, Canberrra, ACT, Australia; [Butler, Richard] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge, England; [Thompson, Andrew J.] Univ Cambridge, Dept Pharmacol, Cambridge, England; [Huang, Christopher L-H] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Australian National University; University of Cambridge; University of Cambridge; University of Cambridge	Salvage, SC; Jackson, AP (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England.	ss2148@cam.ac.uk; apj10@cam.ac.uk		martin-fernandez, marisa/0000-0001-5496-6300; Tynan, Christopher/0000-0002-4553-7018; Hirsch, Michael/0000-0001-6183-6256; Salvage, Samantha/0000-0002-5793-2349; Thompson, Andrew/0000-0002-7046-6792	British Heart Foundation [PG/14/79/31102]; Wellcome Trust [105727/Z/14/Z]; Medical Research Council (UK) [MR/K015591/1]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	British Heart Foundation, Grant/Award Number: PG/14/79/31102; Wellcome Trust, Grant/Award Number: 105727/Z/14/Z; Medical Research Council (UK), Grant/Award Number: MR/K015591/1	ADRIAN RH, 1969, J PHYSIOL-LONDON, V204, P207, DOI 10.1113/jphysiol.1969.sp008909; ADRIAN RH, 1978, ANNU REV BIOPHYS BIO, V7, P85, DOI 10.1146/annurev.bb.07.060178.000505; Ahern CA, 2016, J GEN PHYSIOL, V147, P1, DOI 10.1085/jgp.201511492; Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Alsemarz A., 2018, LTD SIGNIFICANCE SIT, DOI [10.1101/411355, DOI 10.1101/411355]; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Balse E, 2018, HANDB EXP PHARMACOL, V246, P73, DOI 10.1007/164_2017_45; CATTERALL WA, 1978, P NATL ACAD SCI USA, V75, P218, DOI 10.1073/pnas.75.1.218; Clatot J, 2018, AM J PHYSIOL-HEART C, V315, pH1250, DOI 10.1152/ajpheart.00721.2017; Clatot J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02262-0; Clatot J, 2012, CARDIOVASC RES, V96, P53, DOI 10.1093/cvr/cvs211; Corder G., 2014, NONPARAMETRIC STAT S, Vsecond; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Durisic N, 2014, CURR OPIN CHEM BIOL, V20, P22, DOI 10.1016/j.cbpa.2014.04.005; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Hakim P, 2010, ACTA PHYSIOL, V198, P47, DOI 10.1111/j.1748-1716.2009.02048.x; Hakim P, 2008, PROG BIOPHYS MOL BIO, V98, P251, DOI 10.1016/j.pbiomolbio.2009.01.005; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Ishikawa T, 2013, CIRC J, V77, P959, DOI 10.1253/circj.CJ-12-0995; Ko SH, 2005, PFLUG ARCH EUR J PHY, V449, P403, DOI 10.1007/s00424-004-1348-4; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Namadurai S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140192; Namadurai S, 2014, J BIOL CHEM, V289, P10797, DOI 10.1074/jbc.M113.527994; Pan XJ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2486; Poelzing S, 2006, CIRCULATION, V114, P368, DOI 10.1161/CIRCULATIONAHA.105.601294; Printsev I, 2017, J MEMBRANE BIOL, V250, P379, DOI 10.1007/s00232-016-9931-0; Roberts SK, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3096; Ruhlmann AH, 2019, UNCOUPLING SODIUM CH, DOI [10.1101/716654, DOI 10.1101/716654]; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5509; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shen HZ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2596; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Shimizu H, 2017, J BIOL CHEM, V292, P13428, DOI 10.1074/jbc.M117.786509; Shimizu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26618; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yereddi NR, 2013, FASEB J, V27, P568, DOI 10.1096/fj.12-209445; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Zanetti-Domingues LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06632-0; Zhu WD, 2017, J GEN PHYSIOL, V149, P813, DOI 10.1085/jgp.201711802	43	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3537	3553		10.1096/fj.201701473RR	http://dx.doi.org/10.1096/fj.201701473RR		JAN 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31950564	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000507917000001
J	Wang, YX; Wang, CN; Gu, YZ; Wang, PZ; Song, WT; Ma, JH; Yang, XF				Wang, Yuxin; Wang, Chaonan; Gu, Yizhu; Wang, Pingzhi; Song, Weitang; Ma, Jinhai; Yang, Xiaofei			The variability of bacterial communities in both the endosphere and ectosphere of different niches in Chinese chives (Allium tuberosum)	PLOS ONE			English	Article							DIVERSITY; SOIL; MICROBIOME; PLANTS	Deciphering the various types of interactions between plants and their microbiomes is a hot topic for research in ecology as well as in plant sciences and agronomy. To analyse and compare the differences in microbial communities in different compartments of Chinese chives, high-throughput sequencing technology was employed to amplify and sequence the V5-V6 region of the 16S rDNA of microorganisms in the leaves, phylloplanes, stems, roots and rhizospheres of Chinese chives. The sequences were clustered by operational taxonomic units (OTUs), and the community composition of bacteria between the endosphere (inner tissues) and ectosphere (outer surfaces) of Chinese chives was analysed based on the OTU. Overall, the results indicated that the endophytic bacteria in Chinese chives mainly include Proteobacteria, Actinobacteria, and Actinomycetes. Alpha diversity index analysis and OTU number analysis showed that the bacterial diversity and richness of the underground plant compartments were higher than those of the above-ground parts. PCoA based on the OTU level showed that the vertical stratification structure of plants and compartments had significant effects on the bacterial community structure. The richness of endophytic bacteria also varied greatly among the different varieties of Chinese chive. A considerable number of endophytic bacteria form symbiotic and mutually beneficial relationships with host plants, which play an important role in regulating host growth, metabolism and stress resistance. Further investigations are needed to uncover the evolution of interactions between plants and endophytes.	[Wang, Yuxin; Wang, Chaonan; Gu, Yizhu; Wang, Pingzhi; Song, Weitang] China Agr Univ, Coll Water Resources & Civil Engn, Beijing, Peoples R China; [Ma, Jinhai; Yang, Xiaofei] Henan Jiuxing Inst Biotechnol, Pingdingshan, Henan, Peoples R China	China Agricultural University	Wang, YX (corresponding author), China Agr Univ, Coll Water Resources & Civil Engn, Beijing, Peoples R China.	wangyuxin@cau.edu.cn	Wang, Chao/GXF-8353-2022	Wang, Yuxin/0000-0003-0291-495X	earmarked fund for Modern Agro-industry Technology Research System [CARS-23-C02]	earmarked fund for Modern Agro-industry Technology Research System	This research was financially supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-23-C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao YL, 2019, J PETROL SCI ENG, V174, P776, DOI 10.1016/j.petrol.2018.11.067; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Beckers B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00650; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Dong M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00267; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Galbally IE, 2002, J ATMOS CHEM, V43, P195, DOI 10.1023/A:1020684815474; Gladieux P, 2018, MOL ECOL, V27, P3037, DOI 10.1111/mec.14775; Gong XW, 2019, SOIL TILL RES, V195, DOI 10.1016/j.still.2019.104355; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Liu HW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02552; Liu KH, 2014, ANTON LEEUW INT J G, V105, P871, DOI 10.1007/s10482-014-0141-4; Lopez-Velasco G, 2013, FEMS MICROBIOL LETT, V346, P146, DOI 10.1111/1574-6968.12216; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maida I, 2016, ENVIRON MICROBIOL, V18, P2357, DOI 10.1111/1462-2920.12911; Qin S, 2011, APPL MICROBIOL BIOT, V89, P457, DOI 10.1007/s00253-010-2923-6; RILEY D, 1969, SOIL SCI SOC AM PRO, V33, P905, DOI 10.2136/sssaj1969.03615995003300060031x; Suarez-Moreno ZR, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00290; Schlatter D, 2017, PHYTOPATHOLOGY, V107, P1284, DOI 10.1094/PHYTO-03-17-0111-RVW; Shakya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076382; Sickel W, 2016, MICROB ECOL, V71, P938, DOI 10.1007/s00248-015-0723-3; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Tahtamouni ME, 2016, J ARID LAND, V8, P241, DOI 10.1007/s40333-015-0061-9; Tang XL, 2017, FOOD RES INT, V102, P681, DOI 10.1016/j.foodres.2017.08.034; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; [姚领爱 Yao Lingai], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P1750	34	6	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227671	10.1371/journal.pone.0227671	http://dx.doi.org/10.1371/journal.pone.0227671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945106	Green Published, gold			2022-12-26	WOS:000534370100052
J	Mahneva, O; Risley, MG; John, C; Milton, SL; Dawson-Scully, K; Ja, WW				Mahneva, Olena; Risley, Monica G.; John, Ciny; Milton, Sarah L.; Dawson-Scully, Ken; Ja, William W.			In vivo expression of peptidylarginine deiminase in Drosophila melanogaster	PLOS ONE			English	Article							PROTEIN ARGININE DEIMINASE-4; MYELIN BASIC-PROTEIN; PAD2 OVEREXPRESSION; MULTIPLE-SCLEROSIS; PRION PROTEIN; CITRULLINATION; CALCIUM; MODEL; DEMYELINATION; ACCUMULATION	Peptidylarginine deiminase (PAD) modifies peptidylarginine and converts it to peptidylcitrulline in the presence of elevated calcium. Protein modification can lead to severe changes in protein structure and function, and aberrant PAD activity is linked to human pathologies. While PAD homologs have been discovered in vertebrates-as well as in protozoa, fungi, and bacteria-none have been identified in Drosophila melanogaster, a simple and widely used animal model for human diseases. Here, we describe the development of a human PAD overexpression model in Drosophila. We established fly lines harboring human PAD2 or PAD4 transgenes for ectopic expression under control of the GAL4/UAS system. We show that ubiquitous or nervous system expression of PAD2 or PAD4 have minimal impact on fly lifespan, fecundity, and the response to acute heat stress. Although we did not detect citrullinated proteins in fly homogenates, fly-expressed PAD4-but not PAD2-was active in vitro upon Ca2+ supplementation. The transgenic fly lines may be valuable in future efforts to develop animal models of PAD-related disorders and for investigating the biochemistry and regulation of PAD function.	[Mahneva, Olena; Risley, Monica G.; John, Ciny; Milton, Sarah L.; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Risley, Monica G.] Int Max Planck Res Sch IMPRS Brain & Behav, Boca Raton, FL USA; [Ja, William W.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Ja, William W.] Scripps Res Inst, Ctr Aging, Jupiter, FL 33458 USA	State University System of Florida; Florida Atlantic University; Scripps Research Institute; Scripps Research Institute	Ja, WW (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.; Ja, WW (corresponding author), Scripps Res Inst, Ctr Aging, Jupiter, FL 33458 USA.	wja@scripps.edu		John, Ciny/0000-0003-3688-0751	National Institutes of Health [R01AG045036, R56AG065986]; Florida Atlantic University (FAU) Foundation; FAU Brain Institute; FAU Jupiter Life Science Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Atlantic University (FAU) Foundation; FAU Brain Institute; FAU Jupiter Life Science Initiative	This work was supported by the National Institutes of Health (R01AG045036 and R56AG065986, to WWJ), the Florida Atlantic University (FAU) Foundation, the FAU Brain Institute, and the FAU Jupiter Life Science Initiative. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya NK, 2012, J AUTOIMMUN, V38, P369, DOI 10.1016/j.jaut.2012.03.004; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Beret G, 2019, PROTEIN SCI, V28, P478, DOI 10.1002/pro.3571; Bhattacharya SK, 2008, AGING CELL, V7, P441, DOI 10.1111/j.1474-9726.2008.00376.x; Bielecka E, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.C114.617142; BRAND AH, 1993, DEVELOPMENT, V118, P401; Touz MC, 2008, J CELL SCI, V121, P2930, DOI 10.1242/jcs.026963; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Cherrington BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041242; Choi EK, 2014, PROTEIN DEIMINATION, P219; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Coudane F, 2011, EUR J DERMATOL, V21, P376, DOI 10.1684/ejd.2011.1394; Criscitiello MF, 2019, FISH SHELLFISH IMMUN, V92, P249, DOI 10.1016/j.fsi.2019.06.012; Darrah E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005370; Deleault NR, 2003, J NEUROCHEM, V85, P1614, DOI 10.1046/j.1471-4159.2003.01819.x; Ding D, 2019, MOL NEUROBIOL, V56, P2618, DOI 10.1007/s12035-018-1262-y; El-Sayed ASA, 2019, ENZYME MICROB TECH, V124, P41, DOI 10.1016/j.enzmictec.2019.02.004; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; FUJISAKI M, 1981, J BIOCHEM, V89, P257, DOI 10.1093/oxfordjournals.jbchem.a133189; Gavin BA, 2006, J NEUROSCI, V26, P12408, DOI 10.1523/JNEUROSCI.3372-06.2006; Gavinho B., 2019, PEPTIDYLARGININE DEI, V2019, DOI [10.1101/586438, DOI 10.1101/586438]; Guo Q, 2011, J BIOL CHEM, V286, P17069, DOI 10.1074/jbc.M111.230961; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Ishigami A, 2005, J NEUROSCI RES, V80, P120, DOI 10.1002/jnr.20431; Ja WW, 2009, P NATL ACAD SCI USA, V106, P18633, DOI 10.1073/pnas.0908016106; Jang B, 2018, MOL NEUROBIOL, V55, P3172, DOI 10.1007/s12035-017-0560-0; Jang B, 2013, PRION, V7, P42, DOI 10.4161/pri.22380; Jang B, 2010, ACTA NEUROPATHOL, V119, P199, DOI 10.1007/s00401-009-0625-x; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Kan R, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-19; Kearney PL, 2005, BIOCHEMISTRY-US, V44, P10570, DOI 10.1021/bi050292m; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kholia S, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26192; Klose MK, 2008, J NEUROPHYSIOL, V99, P2420, DOI 10.1152/jn.01251.2007; Kosgodage US, 2019, FRONT CELL INFECT MI, V9; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Liu YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021314; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Magnadottir B, 2019, DEV COMP IMMUNOL, V92, P1, DOI 10.1016/j.dci.2018.10.016; Magnadottir B, 2018, DEV COMP IMMUNOL, V87, P157, DOI 10.1016/j.dci.2018.06.006; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; McElwee JL, 2014, CANCER RES, V74, P6306, DOI 10.1158/0008-5472.CAN-14-0749; Mohanan S, 2017, CELL TISSUE RES, V370, P275, DOI 10.1007/s00441-017-2669-x; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; Rebl A, 2010, MOL BIOL REP, V37, P2333, DOI 10.1007/s11033-009-9738-5; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; Shimizu A, 2014, COMP BIOCHEM PHYS B, V167, P65, DOI 10.1016/j.cbpb.2013.10.003; Slade DJ, 2015, ACS CHEM BIOL, V10, P1043, DOI 10.1021/cb500933j; TAKAHARA H, 1986, AGR BIOL CHEM TOKYO, V50, P2899, DOI 10.1080/00021369.1986.10867830; Vranych CV, 2014, BBA-MOL CELL RES, V1843, P1805, DOI 10.1016/j.bbamcr.2014.04.014; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400	56	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227822	10.1371/journal.pone.0227822	http://dx.doi.org/10.1371/journal.pone.0227822			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940417	Green Submitted, Green Published, gold			2022-12-26	WOS:000534368000101
J	Fekad, GA; Omigbodun, AO; Roberts, OA; Yalew, AW				Fekad, Gedefaw Abeje; Omigbodun, Akinyinka O.; Roberts, Olumuyiwa A.; Yalew, Alemayehu Worku			Determinants of change in long-acting or permanent contraceptives use in Ethiopia; A multivariate decomposition analysis of data from the Ethiopian demographic and health survey	PLOS ONE			English	Article							DEMAND; WOMEN	Background There has been an increase in the uptake of long-acting or permanent contraceptive methods (LAPMs) in Ethiopia. Identifying the factors associated with this change is important for designing interventions that will further accelerate the uptake. This study was done to identify components of, and factors associated with, changes in the use of LAPMs in Ethiopia. Methods Information about 16,336 married or in-union reproductive-age women were extracted from the 2005 and 2016 Ethiopian Demographic and Health Surveys (EDHS). Normalized weighting was used to compensate for disproportionate sampling and non-response in the survey. The two data sets were merged and analyzed using multivariate decomposition analysis. Result From 2005 to 2016, the use of LAPMs increased by 12.0 percentage points. Changes in the characteristics of women (compositional factors) were responsible for nearly 7.0% of the observed difference. Most of the change (92.0%) was attributable to differences in the effects of characteristics. Age, working status, woman's occupation, concordance on the desired number of children between women and their partners, and a visit by health workers in the 12 months before the survey were all significantly associated with the change. Conclusion The contribution of variation in the survey population structure was not significant for the observed change. The change in the use of LAPMs was mainly due to behavioral changes among older, educated and working women, and women visited by health workers.	[Fekad, Gedefaw Abeje] Univ Ibadan, Pan African Univ, Inst Life & Earth Sci Including Hlth & Agr, Ibadan, Nigeria; [Fekad, Gedefaw Abeje] Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Omigbodun, Akinyinka O.; Roberts, Olumuyiwa A.] Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Obstet & Gynecol, Ibadan, Nigeria; [Yalew, Alemayehu Worku] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	University of Ibadan; Bahir Dar University; University of Ibadan; University College Hospital, Ibadan; Addis Ababa University	Fekad, GA (corresponding author), Univ Ibadan, Pan African Univ, Inst Life & Earth Sci Including Hlth & Agr, Ibadan, Nigeria.; Fekad, GA (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	abejegedefaw@gmail.com	Abeje, Gedefaw/AAL-1098-2021	Fekadu, Gedefaw Abeje/0000-0002-9912-8332; Omigbodun, Akinyinka/0000-0002-6377-9299				Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; Adedini SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217574; Agha N, 2018, PAKISTAN J WOMENS ST, V25; Ameyaw EK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220970; [Anonymous], 2015, TRENDS CONTR US WORL; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Bosomprah S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0415-x; Bulto G, 2018, GYNECOL OBSTET, V8, P2161; Bulto GA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-46; Castro Martin T, 1994, Popul Bull UN, P81; Central Statistical Agency (CSA) and ORC Macro, 2005, ETH DEM HLTH SURV 20; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2011, ETH DEM HLTH SURV AD; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Edoka I, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0661-4; Fruhauf T, 2018, HEALTH POLICY PLANN, V33, P828, DOI 10.1093/heapol/czy058; Hancock NL, 2015, TEMPORAL TRENDS PRED, V2015; Hayter M, 2016, PRIM HEALTH CARE RES, V17, P287, DOI 10.1017/S1463423615000432; Hubacher D, 2017, AM J OBSTET GYNECOL, V216, P101, DOI 10.1016/j.ajog.2016.08.033; Joshi R, 2015, INT J GYNECOL OBSTET, V131, pS60, DOI 10.1016/j.ijgo.2015.04.024; Mekonnen G, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.98.3421; Mesfin YM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0194-0; Meskele M, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-109; Minstry of Health Ethiopia, 2016, COST IMPL PLAN FAM P; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Olson DJ, 2013, STUD FAMILY PLANN, V44, P445, DOI 10.1111/j.1728-4465.2013.00369.x; Ontiri S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091543; Powers DA, 2011, STATA J, V11, P556, DOI 10.1177/1536867X1101100404; Radulovic O, 2006, FACTA U, V13, P58; Rutayisire PC, 2014, INT J POPULATION RES, V2014; Stoddard A, 2011, DRUGS, V71, P969, DOI 10.2165/11591290-000000000-00000; Melka AS, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.246.5835; Tsakos G, 2017, J EPIDEMIOL COMMUN H, V71, P1203, DOI 10.1136/jech-2017-209696; Tsui AO, 2017, POPUL DEV REV, V43, P166, DOI 10.1111/padr.12051; Umar AS, 2017, AFR HEALTH SCI, V17, P391, DOI 10.4314/ahs.v17i2.13; USAID, 2012, 3 SUCC SUBS AFR FAM; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855; Worku AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116525; Yalew Saleamlak Adbaru, 2015, BMC Res Notes, V8, P29, DOI 10.1186/s13104-015-0974-6; Zenebe CB, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0432-9	40	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227218	10.1371/journal.pone.0227218	http://dx.doi.org/10.1371/journal.pone.0227218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935224	gold, Green Published			2022-12-26	WOS:000534354100015
J	Ortiz-Peregrina, S; Ortiz, C; Salas, C; Casares-Lopez, M; Soler, M; Anera, RG				Ortiz-Peregrina, Sonia; Ortiz, Carolina; Salas, Carlos; Casares-Lopez, Miriam; Soler, Margarita; Anera, Rosario G.			Intraocular scattering as a predictor of driving performance in older adults with cataracts	PLOS ONE			English	Article							VISUAL INTERVENTION INFLUENCE; CONTRAST SENSITIVITY; RUTTING MITIGATION; OPTICAL-QUALITY; DRIVERS; IMPAIRMENT; AGE; ACUITY; LIGHT; GLARE	Cataracts can limit a person's ability to perform vision-dependent tasks safely, affecting the quality of life of older people. This study examines the relationship between visual function and driving, by studying which visual parameters might be important for predicting driving performance in older drivers with and without cataracts, ascertaining whether the objective measurement of intraocular scattering should be considered in assessment procedures for older drivers. This cross-sectional study involved a total of 20 older drivers (10 patients with bilateral cataracts and 10 control subjects). All participants were examined for visual acuity, contrast sensitivity, visual discrimination capacity, and intraocular scattering. Driving performance was also tested using a driving simulator. To study the relationship between visual parameters and driving performance, a correlation analysis and regression model were used. Drivers with cataracts showed a significantly impaired (p<0.05) visual function, with an Objective Scattering Index (OSI) 3.5 times greater than the control group. Driving performance was also significantly worse (p<0.05) in drivers with cataracts, reflected by a notable deterioration in lane keeping. The correlation analysis showed significant associations between driving performance and all the visual parameters studied. Finally, the regression model revealed that the OSI was the best predictor of driving performance, accounting for 51.3% of its variance. Visual function and driving performance are markedly deteriorated when cataracts are present. Our results demonstrate that the objective scattering index (OSI) has a high predictive power when it comes to simulated driving performance in older drivers, both with and without cataracts, suggesting that scatter measurements could be important in helping better understand visual limitations in older drivers.	[Ortiz-Peregrina, Sonia; Ortiz, Carolina; Salas, Carlos; Casares-Lopez, Miriam; Soler, Margarita; Anera, Rosario G.] Univ Granada, Dept Opt, Lab Vis Sci & Applicat, Granada, Spain	University of Granada	Ortiz, C (corresponding author), Univ Granada, Dept Opt, Lab Vis Sci & Applicat, Granada, Spain.	ortizh@ugr.es	Ortiz, Carolina/ABE-8963-2020; Salas, Carlos/ABG-9023-2020; Anera, Rosario G./L-4692-2017; Hita, Carlos María Salas/ABG-8082-2020; Casares-Lopez, Miriam/B-9979-2017; Ortiz-Peregrina, Sonia/C-2156-2017	Ortiz, Carolina/0000-0003-0248-1699; Anera, Rosario G./0000-0003-3614-2142; Hita, Carlos María Salas/0000-0003-4526-3843; Casares-Lopez, Miriam/0000-0003-2767-4913; Ortiz-Peregrina, Sonia/0000-0001-6353-9511	Ministry of Economy and Competitiveness (Spain); European Regional Development Fund (ERDF) [FIS2017-85058-R]; Ministry of Science, Innovation and Universities (Spain) [FPU15/05571]	Ministry of Economy and Competitiveness (Spain)(Spanish Government); European Regional Development Fund (ERDF)(European Commission); Ministry of Science, Innovation and Universities (Spain)(Spanish Government)	This work was supported by the Ministry of Economy and Competitiveness (Spain) and the European Regional Development Fund (ERDF) (FIS2017-85058-R), as well as by the Ministry of Science, Innovation and Universities (Spain) (Grant FPU15/05571). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Babizhayev MA, 2009, APPL ERGON, V40, P545, DOI 10.1016/j.apergo.2007.09.003; Bal T, 2011, OPHTHALMOLOGICA, V225, P105, DOI 10.1159/000317076; BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Bedard M, 2010, AM J OCCUP THER, V64, P336, DOI 10.5014/ajot.64.2.336; Brooks JO, 2010, ACCIDENT ANAL PREV, V42, P788, DOI 10.1016/j.aap.2009.04.013; Castro JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3526702; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; DEWAARD PWT, 1992, INVEST OPHTH VIS SCI, V33, P618; Elliott DB, 1998, VISION RES, V38, P2047, DOI 10.1016/S0042-6989(97)00382-9; Fernandez J, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/4318405; Fraser ML, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-45; Freeman EE, 2006, INVEST OPHTH VIS SCI, V47, P514, DOI 10.1167/iovs.05-0934; Galliot F, 2016, J REFRACT SURG, V32, P96, DOI 10.3928/1081597X-20151222-02; Higgins KE, 2005, OPTOMETRY VISION SCI, V82, P647, DOI 10.1097/01.opx.0000174725.32907.86; Hills B.L, 1977, 768 LR TRANSP ROAD R; Hwang JS, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0904-1; Keay L, 2016, CLIN EXP OPTOM, V99, P449, DOI 10.1111/cxo.12414; Kimlin JA, 2017, INVEST OPHTH VIS SCI, V58, P2796, DOI 10.1167/iovs.16-21219; Laitinen A, 2010, ACTA OPHTHALMOL, V88, P463, DOI 10.1111/j.1755-3768.2009.01566.x; Martinez-Roda JA, 2016, CLIN EXP OPTOM, V99, P518, DOI 10.1111/cxo.12369; Martinez-Roda JA, 2011, CLIN EXP OPTOM, V94, P223, DOI 10.1111/j.1444-0938.2010.00535.x; Martinez-Roda JA, 2016, J CATARACT REFR SURG, V42, P1461, DOI 10.1016/j.jcrs.2016.08.015; Monestam E, 2005, BRIT J OPHTHALMOL, V89, P459, DOI 10.1136/bjo.2004.051151; Nischler C, 2010, EUR J OPHTHALMOL, V20, P892, DOI 10.1177/112067211002000513; Ortiz C, 2018, ACCIDENT ANAL PREV, V117, P239, DOI 10.1016/j.aap.2018.04.018; Ortiz C, 2013, APPL ERGON, V44, P523, DOI 10.1016/j.apergo.2012.11.006; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Owsley C, 2001, ARCH OPHTHALMOL-CHIC, V119, P881; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; POMERANCE GN, 1994, INVEST OPHTH VIS SCI, V35, P3357; Preusser DF, 1998, ACCIDENT ANAL PREV, V30, P151, DOI 10.1016/S0001-4575(97)00090-0; Rosenbloom S, 2001, TRANSPORTATION, V28, P375, DOI 10.1023/A:1011802707259; RUBIN GS, 1993, ARCH OPHTHALMOL-CHIC, V111, P56, DOI 10.1001/archopht.1993.01090010060027; van den Berg T.J.T.P., 2009, J OPTOM, V2, P112, DOI 10.3921/joptom.2009.112; van den Berg TJTP, 2017, OPHTHAL PHYSL OPT, V37, P333, DOI 10.1111/opo.12368; van Rijn LJ, 2011, ACTA OPHTHALMOL, V89, P124, DOI 10.1111/j.1755-3768.2009.01640.x; van Rijn LJ, 2005, BRIT J OPHTHALMOL, V89, P345, DOI 10.1136/bjo.2004.044990; Wood JM, 2006, BRIT J OPHTHALMOL, V90, P1277, DOI 10.1136/bjo.2006.096057; Wood JM, 2004, TRANSPORT RES REC, P7; Wood JM, 2005, OPTOMETRY VISION SCI, V82, P698, DOI 10.1097/01.opx.0000175562.27101.51; Wood JM, 2002, HUM FACTORS, V44, P482, DOI 10.1518/0018720024497664; WOOD JM, 1994, HUM FACTORS, V36, P476, DOI 10.1177/001872089403600305; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Zhu XY, 2019, INT J PAVEMENT ENG, V20, P573, DOI 10.1080/10298436.2017.1316646	46	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227892	10.1371/journal.pone.0227892	http://dx.doi.org/10.1371/journal.pone.0227892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935273	Green Published, gold, Green Submitted			2022-12-26	WOS:000534354100063
J	Janda, T; Lejmel, MA; Molnar, AB; Majlath, I; Pal, M; Nguyen, QT; Nguyen, NT; Le, VN; Szalai, G				Janda, Tibor; Lejmel, Magdalena Anna; Molnar, Anna Borbala; Majlath, Imre; Pal, Magda; Quang Trung Nguyen; Ngoc Tung Nguyen; Van Nhan Le; Szalai, Gabriella			Interaction between elevated temperature and different types of Na-salicylate treatment in Brachypodium dystachion	PLOS ONE			English	Article							INDUCED THERMOTOLERANCE; GLUTATHIONE-REDUCTASE; STRESS TOLERANCE; GENE-EXPRESSION; ACID DECREASES; CADMIUM; PHOTOSYNTHESIS; PLANTS; HEAT; ANTIOXIDANTS	Salicylic acid (SA) plays a role in several physiological processes in plants. Exogenously applied SA is a promising tool to reduce stress sensitivity. However, the mode of action may depend on how the treatment was performed and environmental conditions may alter the effects of SA. In the present study the physiological and biochemical effects of different modes of application (soaking seeds prior sowing; spraying leaves with 0.5 mM NaSA) were compared at normal and moderately elevated temperatures (4 h; 35 degrees C) in Brachypodium distachyon (L.) P. Beauv. plants. While soaking the seeds stimulated plant growth, spraying caused mild stress, as indicated by the chlorophyll-a fluorescence induction parameters and changes in certain protective compounds, such as glutathione, flavonoids or antioxidant enzymes. Elevated temperature also caused an increase in the glutathione-S-transferase activity, and this increase was more pronounced in plants pre-treated with NaSA. Both seed soaking or spraying with NaSA and exposure to heat treatment at 35 degrees C reduced the abscisic acid levels in the leaves. In contrast to abscisic acid, the jasmonic acid level in the leaves were increased by both spraying and heat treatment. The present results suggest that different modes of application may induce different physiological processes, after which plants respond differently to heat treatment. Since these results were obtained with a model plants, further experiments are required to clarify how these changes occur in crop plants, especially in cereals.	[Janda, Tibor; Lejmel, Magdalena Anna; Molnar, Anna Borbala; Majlath, Imre; Pal, Magda; Szalai, Gabriella] Hungarian Acad Sci, Agr Inst, Ctr Agr Res, Martonvasar, Hungary; [Quang Trung Nguyen; Ngoc Tung Nguyen; Van Nhan Le] Vietnam Acad Sci & Technol, Ctr Res & Technol Transfer, Hanoi, Vietnam; [Van Nhan Le] Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Duy Tan University	Szalai, G (corresponding author), Hungarian Acad Sci, Agr Inst, Ctr Agr Res, Martonvasar, Hungary.	szalai.gabriella@agrar.mta.hu	Pál, Magda/I-5039-2019; Quang Trung, Nguyen/GXG-4868-2022	Pál, Magda/0000-0003-3468-962X; Majlath, Imre/0000-0003-3887-008X	Nemzeti Kutatasi Fejlesztesies Innovacios Hivatal [K124430]; Vietnam Academy of Science and Technology grant [QTHU01.02/18-19]; Magyar Tudomanyos Akademia	Nemzeti Kutatasi Fejlesztesies Innovacios Hivatal(National Research, Development & Innovation Office (NRDIO) - Hungary); Vietnam Academy of Science and Technology grant; Magyar Tudomanyos Akademia	This work was supported by Nemzeti Kutatasi Fejlesztesies Innovacios Hivatal grant K124430, Vietnam Academy of Science and Technology grant QTHU01.02/18-19, and Magyar Tudomanyos Akademia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Chai JY, 2014, J EXP BOT, V65, P6513, DOI 10.1093/jxb/eru369; Dat JF, 1998, PLANT PHYSIOL, V118, P1455, DOI 10.1104/pp.118.4.1455; Dobra J, 2015, PLANT SCI, V231, P52, DOI 10.1016/j.plantsci.2014.11.005; Ghanta S, 2014, J PLANT PHYSIOL, V171, P940, DOI 10.1016/j.jplph.2014.03.002; Ghazijahani N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00573; Gondor OK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01447; Gondor OK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160157; Gulyas Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-91; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; Huang CP, 2016, PLANT GROWTH REGUL, V79, P199, DOI 10.1007/s10725-015-0125-z; Janda K, 2012, J PLANT PHYSIOL, V169, P971, DOI 10.1016/j.jplph.2012.02.020; Janda T, 1999, PLANTA, V208, P175, DOI 10.1007/s004250050547; Janda T, 2000, MAYDICA, V45, P29; Janda T, 2014, ACTA PHYSIOL PLANT, V36, P2537, DOI 10.1007/s11738-014-1620-y; Jesus C, 2015, ENVIRON EXP BOT, V118, P56, DOI 10.1016/j.envexpbot.2015.06.004; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Khan MIR, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26374; Klessig DF, 2018, MOL PLANT MICROBE IN, V31, P871, DOI [10.1094/MPMI-03-18-0067-CR, 10.1094/mpmi-03-18-0067-cr]; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Krantev A, 2008, J PLANT PHYSIOL, V165, P920, DOI 10.1016/j.jplph.2006.11.014; Li GZ, 2013, GENE, V529, P321, DOI 10.1016/j.gene.2013.07.093; Liu HT, 2006, J EXP BOT, V57, P3337, DOI 10.1093/jxb/erl098; Mannervik B, 1981, Methods Enzymol, V77, P231; Martinez V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00838; Maruri-Lopez I, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00423; MEUWLY P, 1993, ANAL BIOCHEM, V214, P500, DOI 10.1006/abio.1993.1529; Mishra B, 2019, PLANT GROWTH REGUL, V87, P403, DOI 10.1007/s10725-019-00480-8; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Ohashi Y., 2004, PLANT BIOTECHNOL, V21, P95, DOI DOI 10.5511/PLANTBIOTECHNOLOGY.21.95; Pal M, 2005, PHYSIOL PLANTARUM, V125, P356, DOI 10.1111/j.1399-3054.2005.00545.x; Popova LP, 2009, PLANT PHYSIOL BIOCH, V47, P224, DOI 10.1016/j.plaphy.2008.11.007; Rehman HU, 2015, J INTEGR AGR, V14, P1745, DOI 10.1016/S2095-3119(14)61000-5; SANCHEZCASAS P, 1994, PLANT PHYSIOL, V106, P1675, DOI 10.1104/pp.106.4.1675; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Serrano M, 2013, PLANT PHYSIOL, V162, P1815, DOI 10.1104/pp.113.218156; Shakirova F. M., 2007, Salicylic acid: a plant hormone, P69, DOI 10.1007/1-4020-5184-0_4; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; Soliman MH, 2018, BOT STUD, V59, DOI 10.1186/s40529-018-0222-1; Szalai G, 2016, CEREAL RES COMMUN, V44, P537, DOI 10.1556/0806.44.2016.038; Szalai G, 2011, J PLANT PHYSIOL, V168, P213, DOI 10.1016/j.jplph.2010.07.029; Thomas JC, 2004, PLANT SCI, V167, P259, DOI 10.1016/j.plantsci.2004.03.022; Vaca E, 2017, PHYSIOL PLANTARUM, V161, P322, DOI 10.1111/ppl.12602; Wang LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-34; Wang LB, 2018, PLANT GROWTH REGUL, V86, P211, DOI 10.1007/s10725-018-0422-4; Wang LJ, 2006, PLANT SCI, V170, P685, DOI 10.1016/j.plantsci.2005.09.005; Xu YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21843; Zanella L, 2019, J NAT PROD, V82, P2379, DOI 10.1021/acs.jnatprod.8b00801; Zhu F, 2011, PLANT SIGNAL BEHAV, V6, P1402, DOI 10.4161/psb.6.9.16538	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227608	10.1371/journal.pone.0227608	http://dx.doi.org/10.1371/journal.pone.0227608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31931519	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000534352500052
J	de Sousa, C; Fatoyinbo, L; Neigh, C; Boucka, F; Angoue, V; Larsen, T				de Sousa, Celio; Fatoyinbo, Lola; Neigh, Christopher; Boucka, Farrel; Angoue, Vanessa; Larsen, Trond			Cloud-computing and machine learning in support of country-level land cover and ecosystem extent mapping in Liberia and Gabon	PLOS ONE			English	Article							GOOGLE EARTH ENGINE; FOREST COVER; AREA; MAP; CLASSIFIER; SOUTHEAST; SERVICES; IMAGERY; AFRICA; INDEX	Liberia and Gabon joined the Gaborone Declaration for Sustainability in Africa (GDSA), established in 2012, with the goal of incorporating the value of nature into national decision making by estimating the multiple services obtained from ecosystems using the natural capital accounting framework. In this study, we produced 30-m resolution 10 classes land cover maps for the 2015 epoch for Liberia and Gabon using the Google Earth Engine (GEE) cloud platform to support the ongoing natural capital accounting efforts in these nations. We propose an integrated method of pixel-based classification using Landsat 8 data, the Random Forest (RF) classifier and ancillary data to produce high quality land cover products to fit a broad range of applications, including natural capital accounting. Our approach focuses on a pre-classification filtering (Masking Phase) based on spectral signature and ancillary data to reduce the number of pixels prone to be misclassified; therefore, increasing the quality of the final product. The proposed approach yields an overall accuracy of 83% and 81% for Liberia and Gabon, respectively, outperforming prior land cover products for these countries in both thematic content and accuracy. Our approach, while relatively simple and highly replicable, was able to produce high quality land cover products to fill an observational gap in up to date land cover data at national scale for Liberia and Gabon.	[de Sousa, Celio] Univ Space Res Assoc, GESTAR, Columbia, MD 21046 USA; [de Sousa, Celio; Fatoyinbo, Lola; Neigh, Christopher] NASA, Earth Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Boucka, Farrel; Angoue, Vanessa] Agence Gabonaise Etud & Observat Spatiales AGEOS, Libreville, Gabon; [Larsen, Trond] Conservat Int, Arlington, VA USA	Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Conservation International	de Sousa, C (corresponding author), Univ Space Res Assoc, GESTAR, Columbia, MD 21046 USA.; de Sousa, C (corresponding author), NASA, Earth Sci Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	celio.h.resendedesousa@nasa.gov	Neigh, Christopher/AAR-8780-2020	Neigh, Christopher/0000-0002-5322-6340	NASA Earth Science Division Partnerships Program	NASA Earth Science Division Partnerships Program	Supported by NASA Earth Science Division Partnerships Program. There was no additional external funding received for this study.	Arino O, 2000, PROCESSING, P2412; Azzari G, 2017, REMOTE SENS ENVIRON, V202, P64, DOI 10.1016/j.rse.2017.05.025; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bontemps S., 2011, GLOBCOVER 2009 PRODU; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunting P, 2018, REMOTE SENS; Bwangoy JRB, 2010, REMOTE SENS ENVIRON, V114, P73, DOI 10.1016/j.rse.2009.08.004; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chen BQ, 2017, ISPRS J PHOTOGRAMM, V131, P104, DOI 10.1016/j.isprsjprs.2017.07.011; Christie T, 2007, ORYX, V41, P539, DOI 10.1017/S0030605307000609; Claverie M, 2018, REMOTE SENS ENVIRON, V219, P145, DOI 10.1016/j.rse.2018.09.002; Daily G, 2009, FRONT ECOL ENV; Dinh N, 2012, REMOTE SENS ENVIRON, V127, P60, DOI [10.1016/j.rse.2012.08.022, DOI 10.1016/J.RSE.2012.08.022]; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Fritz S, 2003, HARMONISATION MOSAIC, P41; Geoville Metria, 2016, LIBERIA LAND COVER F; Gessner U, 2015, REMOTE SENS ENVIRON, V164, P282, DOI 10.1016/j.rse.2015.03.029; Giri C, 2011, STATUS DISTRIBUTION, P154, DOI DOI 10.1111/J.1466-8238.2010.00584.X; Giri C, 2015, J ENVIRON MANAGE, V148, P101, DOI 10.1016/j.jenvman.2014.01.020; Gitelson AA, 2003, GEOPHYS RES LETT; Goldblatt R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080634; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hayha T, 2014, ECOL MODEL, V289, P124, DOI 10.1016/j.ecolmodel.2014.07.002; Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012; Henderson FM, 2008, INT J REMOTE SENS, V1161; HESS LL, 1995, IEEE T GEOSCI REMOTE, V33, P896, DOI 10.1109/36.406675; Hess LL, 2015, HYDROBIOLOGIA; Jawarneh RN, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-017-3266-8; Jin ZN, 2019, REMOTE SENS ENVIRON, V228, P115, DOI 10.1016/j.rse.2019.04.016; JOHANSEN K, 2015, REMOTE SENS APPL SOC, V1, P36, DOI DOI 10.1016/j.rsase.2015.06.002; Johnson BA, 2016, APPL GEOGR, V67, P140, DOI 10.1016/j.apgeog.2015.12.006; Jordan C, 1969, ECOLOGY, V50, P1; Kastner T, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034015; Kawamura M, 1996, INT ARCH PHOTOGRAMM; Laurin GV, 2013, INT J APPL EARTH OBS, V21, P7, DOI 10.1016/j.jag.2012.08.002; Lohou F, 2014, ATMOS CHEM PHYS, V14, P3883, DOI 10.5194/acp-14-3883-2014; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Mahdianpari M, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071119; Malhi Y, 2013, PHILOS T R SOC B; Mayaux P, 2004, J BIOGEOGR, V31, P861, DOI 10.1111/j.1365-2699.2004.01073.x; Midekisa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184926; Miettinen J, 2016, REMOTE SENS LETT, V7, P701, DOI 10.1080/2150704X.2016.1182659; Mittermeier Russell A., 2004, P1; Oliphant AJ, 2019, INT J APPL EARTH OBS, V81, P110, DOI 10.1016/j.jag.2018.11.014; Olofsson P, 2014, REMOTE SENS ENVIRON, V148, P42, DOI 10.1016/j.rse.2014.02.015; Ordway EM, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6509; Parente L, 2017, INT J APPL EARTH OBS, V62, P135, DOI 10.1016/j.jag.2017.06.003; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Rikimaru A, 1997, P 18 AS C REM SENS; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sannier C, 2014, REMOTE SENS ENVIRON, V151, P138, DOI 10.1016/j.rse.2013.09.015; Shi TZ, 2016, REMOTE SENS LETT, V7, P885, DOI 10.1080/2150704X.2016.1195935; Sidhu N, 2018, EUR J REMOTE SENS, V51, P486, DOI 10.1080/22797254.2018.1451782; Simonetti D, 2015, IEEE GEOSCI REMOTE S, V12, P1496, DOI 10.1109/LGRS.2015.2409982; Townsend PA, 1998, GEOMORPHOLOGY, V21, P295, DOI 10.1016/S0169-555X(97)00069-X; Townsend PA, 1995, PHOTOGRAMM ENG REMOT; Trianni G, 2014, INT GEOSCI REMOTE SE, P1473, DOI 10.1109/IGARSS.2014.6946715; Tsyganskaya V, 2018, INT J REMOTE SENS, V39, P2255, DOI 10.1080/01431161.2017.1420938; Vittek M, 2014, REMOTE SENS-BASEL, V6, P658, DOI 10.3390/rs6010658; Wang Y, 1995, REMOTE SENS ENV, V4257; Wang ZQ, 2015, INT J REMOTE SENS, V36, P1055, DOI 10.1080/01431161.2015.1007250; Wickham J, 2014, REMOTE SENS-BASEL, V6, P7424, DOI 10.3390/rs6087424; Wingate VR, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8080681; Xiong J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9101065; Xu H, 2007, INT J REMOTE SENS, V1161; Zha Y, 2003, INT J REMOTE SENS, V24, P583, DOI 10.1080/01431160304987; Zhao HM, 2005, INT GEOSCI REMOTE SE, P1666	70	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227438	10.1371/journal.pone.0227438	http://dx.doi.org/10.1371/journal.pone.0227438			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923284	gold, Green Published			2022-12-26	WOS:000534350000077
J	Ma, ZB; Wang, LL; Zhao, MZ; Gu, S; Wang, CH; Zhao, JM; Tang, ZQ; Gao, H; Zhang, LY; Fu, L; Yin, YG; He, N; Zheng, WJ; Xu, ZJ				Ma, Zuobin; Wang, Lili; Zhao, Mingzhu; Gu, Shuang; Wang, Changhua; Zhao, Jiaming; Tang, Zhiqiang; Gao, Hong; Zhang, Liying; Fu, Liang; Yin, Yongan; He, Na; Zheng, Wenjing; Xu, Zhengjin			iTRAQ proteomics reveals the regulatory response to Magnaporthe oryzae in durable resistant vs. susceptible rice genotypes	PLOS ONE			English	Article							DEFENSE RESPONSES; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; INNATE IMMUNITY; CELL-DEATH; RECEPTOR; PATHOGEN; IDENTIFICATION; PROTEINS; PERCEPTION	Rice blast disease caused by Magnaporthe oryzae (M. oryzae) is one of the most serious diseases. Although previous research using two-dimensional gel-based proteomics to assess the proteins related to the rice blast resistance had been done, few proteins were identified. Here, we used the iTRAQ method to detect the differentially expressed proteins (DEPs) in the durable resistant rice variety Gangyuan8 (GY8) and the susceptible rice variety Lijiangxintuanheigu (LTH) in response to M. oryzae invasion, and then transcriptome sequencing was used to assist analysis A total of 193 and 672 DEPs were specifically identified in GY8 and LTH, respectively, with only 46 similarly expressed DEPs being shared by GY8 and LTH.39 DEPs involved in plant-pathogen interaction, plant hormone signal transduction, fatty acid metabolism and peroxisome biosynthesis were significantly different between compatible interaction (LTH) and incompatible interaction (GY8). Some proteins participated in peroxide signal transduction and biosynthesis was down-regulated in GY8 but up-regulated in LTH. A lot of genes encoding pathogenesis-related gene (PR), such as chitinase and glucanase, were significantly up-regulated at both the transcriptome and proteome levels at 24 hours post-inoculation in GY8, but up-regulated at the transcriptome level and down-regulated at the proteome level in LTH. Our study reveals that the pathogen-associated molecular pattern (PAMP)-triggered immunity defense system may be activated at the transcriptome level but was inhibited at the protein level in susceptible rice varieties after inoculation. The results may facilitate future studies of the molecular mechanisms of rice blast resistance.	[Ma, Zuobin; Wang, Lili; Zhao, Mingzhu; Gu, Shuang; Xu, Zhengjin] Shenyang Agr Univ, Rice Res Inst, Shenyang, Peoples R China; [Ma, Zuobin; Zhao, Mingzhu; Wang, Changhua; Tang, Zhiqiang; Gao, Hong; Zhang, Liying; Fu, Liang; He, Na; Zheng, Wenjing] Liaoning Acad Agr Sci, Rice Res Inst Liaoning Prov, Shenyang, Peoples R China; [Zhao, Jiaming] Liaoning Acad Agr Sci, Sorghum Res Inst Liaoning Prov, Shenyang, Peoples R China; [Yin, Yongan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China	Shenyang Agricultural University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Xu, ZJ (corresponding author), Shenyang Agr Univ, Rice Res Inst, Shenyang, Peoples R China.; Zheng, WJ (corresponding author), Liaoning Acad Agr Sci, Rice Res Inst Liaoning Prov, Shenyang, Peoples R China.	zwj27@126.com; xuzhengjin@126.com	wang, lili/HDL-7210-2022; Zheng, Wenjing/ABD-2105-2020		National Natural Science Foundation of China [31772107, 31571993]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31772107 and 31571993)	Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Bagnaresi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051609; Chen XW, 2011, TRENDS PLANT SCI, V16, P451, DOI 10.1016/j.tplants.2011.04.003; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Desaki Y, 2006, PLANT CELL PHYSIOL, V47, P1530, DOI 10.1093/pcp/pcl019; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; [窦世娟 Dou ShiJuan], 2014, [科学通报, Chinese Science Bulletin], V59, P245; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kawano Y, 2013, CURR OPIN PLANT BIOL, V16, P496, DOI 10.1016/j.pbi.2013.07.004; Kim JY, 2009, INT J MOL SCI, V10, P2860, DOI 10.3390/ijms10062860; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2009, PROTEOMICS, V9, P1302, DOI 10.1002/pmic.200800589; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Li WT, 2016, MOL PLANT PATHOL, V17, P354, DOI 10.1111/mpp.12286; Li YF, 2014, PROTEOMICS, V14, P1088, DOI 10.1002/pmic.201300104; Lin ZM, 2017, PLANT CELL PHYSIOL, V58, P560, DOI 10.1093/pcp/pcx001; Liu B, 2012, PLANT CELL, V24, P3406, DOI 10.1105/tpc.112.102475; Liu WD, 2013, MOL PLANT, V6, P605, DOI 10.1093/mp/sst015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Peng XY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00351; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Shanti ML, 2001, PLANT DIS, V85, P506, DOI 10.1094/PDIS.2001.85.5.506; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Shinya T, 2010, PLANT CELL PHYSIOL, V51, P262, DOI 10.1093/pcp/pcp185; Skamnioti P, 2009, TRENDS BIOTECHNOL, V27, P141, DOI 10.1016/j.tibtech.2008.12.002; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Vijayati J, 2013, INDIAN J GENET PL BR, V73, P233, DOI 10.5958/j.0975-6906.73.3.035; [王世维 Wang Shiwei], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P462; Wang YM, 2014, PLANT PATHOLOGY J, V30, P343, DOI 10.5423/PPJ.OA.06.2014.0055; Wei T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059720; Yamaguchi K, 2013, CELL HOST MICROBE, V13, P347, DOI 10.1016/j.chom.2013.02.007; Yan X, 2016, CURR OPIN MICROBIOL, V34, P147, DOI 10.1016/j.mib.2016.10.001; You CC, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1050-2; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang F, 2004, J PLANT PHYSIOL, V161, P53, DOI 10.1078/0176-1617-01179; Zhang HY, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600365; Zhang M, 2017, J PROTEOMICS, V152, P226, DOI 10.1016/j.jprot.2016.11.011; Zhang Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01834; Zheng WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082126; Zhong XT, 2017, J PROTEOMICS, V152, P88, DOI 10.1016/j.jprot.2016.10.015	45	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227470	10.1371/journal.pone.0227470	http://dx.doi.org/10.1371/journal.pone.0227470			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923921	gold, Green Published			2022-12-26	WOS:000534350000082
J	Shang, Y; Mishra, A; Wang, T; Wang, YW; Desai, M; Chen, SH; Mao, ZS; Do, L; Bernstein, AS; Trouard, TP; Brinton, RD				Shang, Yuan; Mishra, Aarti; Wang, Tian; Wang, Yiwei; Desai, Maunil; Chen, Shuhua; Mao, Zisu; Do, Loi; Bernstein, Adam S.; Trouard, Theodore P.; Brinton, Roberta D.			Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; GLUCOSE-METABOLISM; LIPID-METABOLISM; GENE-EXPRESSION; MITOCHONDRIAL; ALLELE; RISK; DEFICIENCY	Late onset Alzheimer's disease (LOAD) is a progressive neurodegenerative disease with four well-established risk factors: age, APOE4 genotype, female chromosomal sex, and maternal history of AD. Each risk factor impacts multiple systems, making LOAD a complex systems biology challenge. To investigate interactions between LOAD risk factors, we performed multiple scale analyses, including metabolomics, transcriptomics, brain magnetic resonance imaging (MRI), and beta-amyloid assessment, in 16 months old male and female mice with humanized human APOE3 (hAPOE3) or APOE4 (hAPOE4) genes. Metabolomic analyses indicated a sex difference in plasma profile whereas APOE genotype determined brain metabolic profile. Consistent with the brain metabolome, gene and pathway-based RNA-Seq analyses of the hippocampus indicated increased expression of fatty acid/lipid metabolism related genes and pathways in both hAPOE4 males and females. Further, female transcription of fatty acid and amino acids pathways were significantly different from males. MRI based imaging analyses indicated that in multiple white matter tracts, hAPOE4 males and females exhibited lower fractional anisotropy than their hAPOE3 counterparts, suggesting a lower level of white matter integrity in hAPOE4 mice. Consistent with the brain metabolomic and transcriptomic profile of hAPOE4 carriers, beta-amyloid generation was detectable in 16-month-old male and female brains. These data provide therapeutic targets based on chromosomal sex and APOE genotype. Collectively, these data provide a framework for developing precision medicine interventions during the prodromal phase of LOAD, when the potential to reverse, prevent and delay LOAD progression is greatest.	[Shang, Yuan; Mishra, Aarti; Wang, Tian; Wang, Yiwei; Chen, Shuhua; Mao, Zisu; Brinton, Roberta D.] Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ 85721 USA; [Desai, Maunil] Univ Southern Calif, Sch Pharm, Los Angeles, CA 90007 USA; [Do, Loi; Trouard, Theodore P.] Univ Arizona, Biomed Engn, Tucson, AZ USA; [Bernstein, Adam S.] Univ Arizona, Coll Med, Tucson, AZ USA	University of Arizona; University of Southern California; University of Arizona; University of Arizona	Brinton, RD (corresponding author), Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ 85721 USA.	rbrinton@email.arizona.edu	Mishra, Aarti/AAI-4038-2021; SHANG, Raymond Yuan/AAV-3446-2020	Mishra, Aarti/0000-0002-7845-6759; Wang, Yiwei/0000-0003-1836-9909; SHANG, Yuan/0000-0002-7093-4234; Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [P01AG026572, R01AG057931, RF1AG059093]; Alzheimer's Association [SAGA-17-419459]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association)	This work was supported by National Institute on Aging grants P01AG026572, R01AG057931, and RF1AG059093 to RDB, and Alzheimer's Association SAGA-17-419459 to RDB.	Aksenov MY, 1999, NEUROCHEM RES, V24, P767, DOI 10.1023/A:1020783614031; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087; Brinton RD., 2017, ALZHEIMERS DEMENT, V13, pP882; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Carrieri G, 2001, HUM GENET, V108, P194, DOI 10.1007/s004390100463; CHANDRASEKARAN K, 1994, MOL BRAIN RES, V24, P336, DOI 10.1016/0169-328X(94)90147-3; Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084; Chen NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195952; Chong J, 2019, METABOLITES, V9, DOI 10.3390/metabo9030057; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coto E, 2011, NEUROGENETICS, V12, P345, DOI 10.1007/s10048-011-0295-4; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; De Santi S, 2001, NEUROBIOL AGING, V22, P529, DOI 10.1016/S0197-4580(01)00230-5; Drzezga A, 2005, NEUROLOGY, V64, P102, DOI 10.1212/01.WNL.0000148478.39691.D3; Edland SD, 2002, ALZ DIS ASSOC DIS, V16, P1, DOI 10.1097/00002093-200201000-00001; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Ishii K, 1997, J NUCL MED, V38, P925; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kang JH, 2012, ENDOCR REV, V33, P715, DOI 10.1210/er.2011-1049; Kish SJ, 1999, J NEUROCHEM, V72, P700, DOI 10.1046/j.1471-4159.1999.0720700.x; Klavins Kristaps, 2015, Alzheimers Dement (Amst), V1, P295; Klosinski LP, 2015, EBIOMEDICINE, V2, P1888, DOI 10.1016/j.ebiom.2015.11.002; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Law SH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051149; Liu Q, 2014, NEUROSCI BULL, V30, P331, DOI 10.1007/s12264-013-1410-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maruszak A, 2011, J ALZHEIMERS DIS, V27, P197, DOI 10.3233/JAD-2011-110710; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; Mishra A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00312; Montine TJ, 2005, AM J PATHOL, V166, P1283, DOI 10.1016/S0002-9440(10)62347-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mosconi L, 2005, J NEUROL NEUROSUR PS, V76, P15, DOI 10.1136/jnnp.2003.030882; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mosconi L, 2004, PSYCHIAT RES-NEUROIM, V130, P141, DOI 10.1016/j.pscychresns.2003.12.005; Mosconi L, 2004, J NEUROL NEUROSUR PS, V75, P370, DOI 10.1136/jnnp.2003.014993; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Mosconi L, 2008, BIOL PSYCHIAT, V63, P609, DOI 10.1016/j.biopsych.2007.05.030; Mosconi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185926; Mosconi L, 2017, NEUROLOGY, V89, P1382, DOI 10.1212/WNL.0000000000004425; Mosconi L, 2013, CLIN TRANSL IMAGING, V1, P217, DOI 10.1007/s40336-013-0026-y; Mosconi Lisa, 2010, Human Genomics, V4, P170; Operto G, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0375-x; PAGANINIHILL A, 1994, AM J EPIDEMIOL, V140, P256, DOI 10.1093/oxfordjournals.aje.a117244; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; REBECK GW, 1993, NEURON, V11, P575; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Riedel BC, 2016, J STEROID BIOCHEM, V160, P134, DOI 10.1016/j.jsbmb.2016.03.012; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Seshadri S, 2006, STROKE, V37, P345, DOI 10.1161/01.STR.0000199613.38911.b2; Shi L, 2014, INT J NEUROPSYCHOPH, V17, P1863, DOI 10.1017/S1461145714000601; Smith DS, 2015, PEERJ, V3, DOI 10.7717/peerj.909; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; St John-Williams L, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.140; Steadman PE, 2014, AUTISM RES, V7, P124, DOI 10.1002/aur.1344; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toledo JB, 2017, ALZHEIMERS DEMENT, V13, P965, DOI 10.1016/j.jalz.2017.01.020; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Wolf AB, 2013, NEUROBIOL AGING, V34, P1007, DOI 10.1016/j.neurobiolaging.2012.10.011; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Xu PT, 2006, NEUROBIOL DIS, V21, P256, DOI 10.1016/j.nbd.2005.07.004; Xu PT, 2007, MOL CELL NEUROSCI, V36, P313, DOI 10.1016/j.mcn.2007.06.009; Yao J, 2011, MOL ASPECTS MED, V32, P247, DOI 10.1016/j.mam.2011.10.005; Yin F, 2015, NEUROBIOL AGING, V36, P2282, DOI 10.1016/j.neurobiolaging.2015.03.013; Zhao LQ, 2016, NEUROBIOL AGING, V42, P69, DOI 10.1016/j.neurobiolaging.2016.02.011	85	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0225392	10.1371/journal.pone.0225392	http://dx.doi.org/10.1371/journal.pone.0225392			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917799	Green Published, gold			2022-12-26	WOS:000534341100006
J	Timmons, JJ; Densmore, D				Timmons, Joshua J.; Densmore, Doug			Repository-based plasmid design	PLOS ONE			English	Article							DNA; STANDARDS; LIBRARY	There was an explosion in the amount of commercially available DNA in sequence repositories over the last decade. The number of such plasmids increased from 12,000 to over 300,000 among three of the largest repositories: iGEM, Addgene, and DNASU. A challenge in biodesign remains how to use these and other repository-based sequences effectively, correctly, and seamlessly. This work describes an approach to plasmid design where a plasmid is specified as simply a DNA sequence or list of features. The proposed software then finds the most cost-effective combination of synthetic and PCR-prepared repository fragments to build the plasmid via Gibson assembly (R). It finds existing DNA sequences in both user-specified and public DNA databases: iGEM, Addgene, and DNASU. Such a software application is introduced and characterized against all post-2005 iGEM composite parts and all Addgene vectors submitted in 2018 and found to reduce costs by 34% versus a purely synthetic plasmid design approach. The described software will improve current plasmid assembly workflows by shortening design times, improving build quality, and reducing costs.	[Timmons, Joshua J.; Densmore, Doug] Lattice Automat Inc, Boston, MA 02111 USA; [Densmore, Doug] Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Densmore, Doug] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA	Boston University; Boston University	Densmore, D (corresponding author), Lattice Automat Inc, Boston, MA 02111 USA.; Densmore, D (corresponding author), Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA.; Densmore, D (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.	dougd@bu.edu						Adames NR, 2015, NUCLEIC ACIDS RES, V43, P4823, DOI 10.1093/nar/gkv272; [Anonymous], 2018, APPENDICES; [Anonymous], 2008, BUILD BLAST DAT LOC; Apt K. R., 1990, HDB THEORETICAL COMP, P493; Benchling, LIFE SCI R D CLOUD; Biomatters, 2020, GEN BIOINF SOFTW SEQ; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Brown J, 2007, IET SYNTH BIOL, V1, P4; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Christen M, 2015, ACS SYNTH BIOL, V4, P927, DOI 10.1021/acssynbio.5b00087; Densmore D, 2012, IEEE DES TEST COMPUT, V29, P7, DOI 10.1109/MDT.2012.2193370; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Engler C, 2014, METHODS MOL BIOL, V1116, P119, DOI 10.1007/978-1-62703-764-8_9; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Herscovitch M, 2012, NAT BIOTECHNOL, V30, P316, DOI 10.1038/nbt.2177; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Iverson SV, 2016, ACS SYNTH BIOL, V5, P99, DOI 10.1021/acssynbio.5b00124; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kahl L, 2018, NAT BIOTECHNOL, V36, P923, DOI 10.1038/nbt.4263; Kamens J, 2015, NUCLEIC ACIDS RES, V43, pD1152, DOI 10.1093/nar/gku893; Kamens J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001991; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lodish H, 2000, MOL CELL BIOL; McLaughlin JA, 2018, ACS SYNTH BIOL, V7, P682, DOI 10.1021/acssynbio.7b00403; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Oberortner E, 2017, ACS SYNTH BIOL, V6, P485, DOI 10.1021/acssynbio.6b00200; Peccoud J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002671; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Smolke CD, 2009, NAT BIOTECHNOL, V27, P1099, DOI 10.1038/nbt1209-1099; SnapGene, SOFTW EV MOL BIOL; Timmons J, 2019, REPP; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wan XY, 2019, NAT CHEM BIOL, V15, P540, DOI 10.1038/s41589-019-0244-3; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zuo DM, 2007, NUCLEIC ACIDS RES, V35, pD680, DOI 10.1093/nar/gkl898	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2020	15	1							e0223935	10.1371/journal.pone.0223935	http://dx.doi.org/10.1371/journal.pone.0223935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5ER	31917791	gold, Green Published, Green Submitted			2022-12-26	WOS:000534341100004
J	Zhou, XD; Xia, N; Lv, BJ; Tang, TT; Nie, SF; Zhang, M; Jiao, J; Liu, JF; Xu, CJ; Hou, GF; Yang, XP; Hu, Y; Liao, YH; Cheng, X				Zhou, Xingdi; Xia, Ni; Lv, Bingjie; Tang, Tingting; Nie, Shaofang; Zhang, Min; Jiao, Jiao; Liu, Jianfeng; Xu, Chanjuan; Hou, Guofei; Yang, Xiangping; Hu, Yu; Liao, Yuhua; Cheng, Xiang			Interleukin 35 ameliorates myocardial ischemia-reperfusion injury by activating the gp130-STAT3 axis	FASEB JOURNAL			English	Article						apoptosis; cardiomyocyte; cytokine; heart	PANCREATIC DUCTAL ADENOCARCINOMA; HEART-FAILURE; IL-12 FAMILY; GROWTH-FACTORS; INFARCT SIZE; CYTOKINES; IL-35; MECHANISMS; RECEPTOR; COMMUNICATION	Myocardial ischemia-reperfusion injury (MIRI) is common clinical complication, which represents significant challenge in the treatment of acute myocardial infarction (AMI) diseases. Interleukin 35 (IL-35) exhibits anti-inflammatory properties via the engagement of the gp130, IL-12R beta 2 and IL-27R alpha receptors. However, whether IL-35 plays a beneficial role in the treatment of MIRI and potential underling mechanism are unclear. We showed that IL-35 conferred protection from MIRI as demonstrated by reduced infarct size and cardiac troponin T, improved cardiac function and decreased cardiomyocyte apoptosis in a mouse model. Despite activation of both STAT3 and STAT5 phosphorylation in the heart by IL-35, signal transducers and activators of transcription 3 (STAT3) was essential for mediating the IL-35-mediated protective effect on MIRI using cardiomyocyte-specific STAT3 deficient mice. Furthermore, gp130 was required for the STAT3 activation and cardio-protection induced by IL-35. Interestingly, IL-35 induced gp130 homodimer and gp130/IL-12R beta 2 heterodimers in cardiomyocyte. Our results indicate that IL-35 can execute a protective role against MIRI through a novel signaling pathway, IL-35-gp130-STAT3 pathway, in cardiomyocytes, which may be beneficial for the development of novel and effective therapeutic approaches to treat the MIRI.	[Zhou, Xingdi; Xia, Ni; Lv, Bingjie; Tang, Tingting; Nie, Shaofang; Zhang, Min; Jiao, Jiao; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Union Hosp, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Zhou, Xingdi; Xia, Ni; Lv, Bingjie; Tang, Tingting; Nie, Shaofang; Zhang, Min; Jiao, Jiao; Hu, Yu; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Educ Minist & Hubei Prov, Key Lab Biol Targeted Therapy,Union Hosp, Wuhan, Peoples R China; [Liu, Jianfeng; Xu, Chanjuan; Hou, Guofei] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Sino France Lab Cellular Signaling, Key Lab Mol Biophys,Minist Educ, Wuhan, Hubei, Peoples R China; [Liu, Jianfeng; Xu, Chanjuan; Hou, Guofei] Huazhong Univ Sci & Technol, Collaborat Innovat Ctr Genet & Dev, Wuhan, Hubei, Peoples R China; [Yang, Xiangping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Wuhan, Peoples R China; [Hu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Hematol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Cheng, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Union Hosp, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	nathancx@hust.edu.cn	饭, 蔡/AAI-5850-2020	Yang, Xiang-Ping/0000-0001-9003-1772	National Natural Science Fund for Distinguished Young Scholars [81525003]; National Natural Science Foundation of China [81720108005, 91639301, 81770503, 81670361, 81500186, 81600187]	National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Fund for Distinguished Young Scholars, Grant/Award Number: 81525003; National Natural Science Foundation of China, Grant/Award Number: 81720108005, 91639301, 81770503, 81670361, 81500186 and 81600187	Bar-Natan M, 2012, LEUKEMIA, V26, P1407, DOI 10.1038/leu.2011.338; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barry SP, 2007, TRENDS MOL MED, V13, P82, DOI 10.1016/j.molmed.2006.12.002; Behzadi P, 2016, ACTA MICROBIOL IMM H, V63, P1, DOI 10.1556/030.63.2016.1.1; Boag SE, 2017, ANTIOXID REDOX SIGN, V26, P660, DOI 10.1089/ars.2016.6940; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Bulluck H, 2016, HEART, V102, P341, DOI 10.1136/heartjnl-2015-307855; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Eefting F, 2004, CARDIOVASC RES, V61, P414, DOI 10.1016/j.cardiores.2003.12.023; Egwuagu CE, 2015, CYTOKINE GROWTH F R, V26, P587, DOI 10.1016/j.cytogfr.2015.07.013; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fischer P, 2008, BRIT J PHARMACOL, V153, pS414, DOI 10.1038/bjp.2008.1; Fischer P, 2007, BASIC RES CARDIOL, V102, P279, DOI 10.1007/s00395-007-0658-z; Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hu YD, 2014, ARCH VIROL, V159, P2411, DOI 10.1007/s00705-014-2098-z; Huang CB, 2018, GASTROENTEROLOGY, V154, P675, DOI 10.1053/j.gastro.2017.09.039; Huang CB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14035; Ibanez B, 2015, J AM COLL CARDIOL, V65, P1455, DOI 10.1016/j.jacc.2015.02.032; Jia DL, 2019, CIRC RES, V124, P1323, DOI 10.1161/CIRCRESAHA.118.314569; Kempe S, 2009, AM J PATHOL, V175, P440, DOI 10.2353/ajpath.2009.080752; Kim SC, 2012, JOVE-J VIS EXP, DOI 10.3791/3896; Li X, 2017, CYTOKINE, VS1043-4666; Li YB, 2007, ULTRASOUND MED BIOL, V33, P894, DOI 10.1016/j.ultrasmedbio.2006.12.008; Liu H, 2015, IMMUNOL INVEST, V44, P566, DOI 10.3109/08820139.2015.1043671; Metzler B, 2001, CARDIOVASC RES, V49, P399, DOI 10.1016/S0008-6363(00)00261-3; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Pulkki KJ, 1997, ANN MED, V29, P339, DOI 10.3109/07853899708999358; Rondard P, 2008, EMBO J, V27, P1321, DOI 10.1038/emboj.2008.64; Roubille F, 2011, CIRCULATION, V124, P1330, DOI 10.1161/CIRCULATIONAHA.111.031864; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Shewchuk LJ, 2010, CAN J PHYSIOL PHARM, V88, P324, DOI 10.1139/Y09-131; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; van der Heijden T, 2017, CYTOKINE; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wang RX, 2014, NAT MED, V20, P633, DOI 10.1038/nm.3554; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Xu C, 2018, NEUROCHEM RES, V43, P1454, DOI 10.1007/s11064-018-2560-5; Yang ZQ, 2008, AM J PHYSIOL-HEART C, V295, pH2328, DOI 10.1152/ajpheart.00091.2008; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	52	9	13	8	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					3224	3238		10.1096/fj.201901718RR	http://dx.doi.org/10.1096/fj.201901718RR		JAN 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31917470				2022-12-26	WOS:000506443100001
J	Xu, XL; Tian, SC				Xu, Xingliang; Tian, Suchuan			Load transfer mechanism and critical length of anchorage zone for anchor bolt	PLOS ONE			English	Article							GROUTED ROCK BOLTS; FAILURE; STRESS; DESIGN; MODELS; SLIP	The length of anchorage zone of an anchor bolt affects the distribution of axial force and shear stress therein. Based on a shear-displacement model, the load distribution of anchor bolts in the elastic deformation stage was analysed. Moreover, the mechanical response of threaded steel anchor bolts with different anchorage lengths was explored through pull-out test and numerical simulation. The results showed that axial force and shear stress were negatively exponentially distributed within the anchorage zone of anchor bolts in which there were the maximum axial force and shear stress at the beginning of the anchorage zone. In the elastic deformation stage of the anchorage, the longer the anchorage length, the more uniformly the shear stress was distributed within the anchorage zone and the larger the ultimate shear stress; however, there was a critical anchorage length, which, when exceeded, the ultimate shear stress remained unchanged. The calculation formula for the critical anchorage length was deduced and a reasonable anchorage length determined. The research result provides an important theoretical basis for rapid design of support parameters for anchor bolts.	[Xu, Xingliang; Tian, Suchuan] China Univ Min & Technol, Key Lab Deep Coal Resource Min, Minist Educ China, Xuzhou, Jiangsu, Peoples R China; [Xu, Xingliang] Xinjiang Inst Engn, Min Dept, Urumqi, Xinjiang Uygur, Peoples R China	China University of Mining & Technology; Ministry of Education, China; Xinjiang Institute of Engineering	Tian, SC (corresponding author), China Univ Min & Technol, Key Lab Deep Coal Resource Min, Minist Educ China, Xuzhou, Jiangsu, Peoples R China.	tiansc@cumt.edu.cn			General Program of the National Natural Science Foundation of China [51864044]	General Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported, and financed, by the General Program of the National Natural Science Foundation of China (51864044).; This work was supported, and financed, by the General Program of the National Natural Science Foundation of China (51864044). The authors would like to thank the Editor and the Reviewers for their helpful and constructive comments.	Akisanya AR, 2014, ENG STRUCT, V74, P23, DOI 10.1016/j.engstruct.2014.05.013; Assaad JJ, 2019, TUNN UNDERGR SP TECH, V84, P317, DOI 10.1016/j.tust.2018.11.035; BENMOKRANE B, 1995, INT J ROCK MECH MIN, V32, P633, DOI 10.1016/0148-9062(95)00021-8; Cai Y, 2004, TUNN UNDERGR SP TECH, V19, P607, DOI 10.1016/j.tust.2004.02.129; Hsiao FY, 2009, TUNN UNDERGR SP TECH, V24, P14, DOI 10.1016/j.tust.2008.01.003; Huang MH, 2018, ROCK SOIL MECH, V39, P4033, DOI 10.16285/j.rsm.2017.0475; Ito F, 2001, CONSTR BUILD MATER, V15, P263, DOI 10.1016/S0950-0618(00)00075-1; Ivanovic A, 2009, INT J ROCK MECH MIN, V46, P699, DOI 10.1016/j.ijrmms.2008.09.008; Jiang Z.X., 2001, J GEOTECH ENG, V23, P696, DOI [10.3321/j.issn:1000-4548.2001.06.010, DOI 10.3321/J.ISSN:1000-4548.2001.06.010]; Kaiser PK, 2012, J ROCK MECH GEOTECH, V4, P215, DOI 10.3724/SP.J.1235.2012.00215; [康红普 Kang Hongpu], 2014, [煤炭学报, Journal of China Coal Society], V39, P1; Kilic A, 2002, TUNN UNDERGR SP TECH, V17, P355, DOI 10.1016/S0886-7798(02)00038-X; Li C, 1999, INT J ROCK MECH MIN, V36, P1013, DOI 10.1016/S1365-1609(99)00064-7; Li HZ, 2017, ROCK SOIL MECH, V38, P3106, DOI 10.16285/j.rsm.2017.11.004; [刘颖浩 LIU Yinghao], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P394; Long Z, 2010, ROCK SOIL MECH, V31, P2991; Martin LB, 2011, CONSTR BUILD MATER, V25, P749, DOI 10.1016/j.conbuildmat.2010.07.011; Nemcik J, 2014, INT J ROCK MECH MIN, V71, P293, DOI 10.1016/j.ijrmms.2014.07.007; Oh BH, 2007, J STRUCT ENG, V133, P216, DOI 10.1061/(ASCE)0733-9445(2007)133:2(216); Steen M, 1998, COMPOS SCI TECHNOL, V58, P313, DOI 10.1016/S0266-3538(97)00069-9; Stefanak J, 2017, PROCEDIA ENGINEER, V172, P1129, DOI 10.1016/j.proeng.2017.02.170; Thenevin I, 2017, J ROCK MECH GEOTECH, V9, P843, DOI 10.1016/j.jrmge.2017.04.005; Tistel J, 2017, J ROCK MECH GEOTECH, V9, P1010, DOI 10.1016/j.jrmge.2017.07.005; [王洪涛 Wang Hongtao], 2015, [煤炭学报, Journal of China Coal Society], V40, P509; [尤春安 YOU Chun'an], 2009, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V28, P1976; [张洁 Zhang Jie], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P1134; [张季如 Zhang Jiru], 2002, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V24, P188; Zhen X.M., 2009, CHIN J ROCK MECH ENG, V28, P3609; Zhu XG, 2009, ROCK SOIL MECH, V30, P3386; [朱玉 Zhu Yu], 2005, [武汉理工大学学报, Journal of wuhan university of technology], V27, P60	30	6	6	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2020	15	1							e0227539	10.1371/journal.pone.0227539	http://dx.doi.org/10.1371/journal.pone.0227539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PU	31951603	Green Published, gold			2022-12-26	WOS:000534370500021
J	Anguiano, M; Morales, X; Castilla, C; Pena, AR; Ederra, C; Martinez, M; Ariz, M; Esparza, M; Amaveda, H; Mora, M; Movilla, N; Aznar, JMG; Cortes-Dominguez, I; Ortiz-de-Solorzano, C				Anguiano, Maria; Morales, Xabier; Castilla, Carlos; Pena, Alejandro Rodriguez; Ederra, Cristina; Martinez, Martin; Ariz, Mikel; Esparza, Maider; Amaveda, Hippolyte; Mora, Mario; Movilla, Nieves; Garcia Aznar, Jose Manuel; Cortes-Dominguez, Ivan; Ortiz-de-Solorzano, Carlos			The use of mixed collagen-Matrigel matrices of increasing complexity recapitulates the biphasic role of cell adhesion in cancer cell migration: ECM sensing, remodeling and forces at the leading edge of cancer invasion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CONTACT GUIDANCE; METASTASIS; TRANSITION; VINCULIN	The migration of cancer cells is highly regulated by the biomechanical properties of their local microenvironment. Using 3D scaffolds of simple composition, several aspects of cancer cell mechanosensing (signal transduction, EMC remodeling, traction forces) have been separately analyzed in the context of cell migration. However, a combined study of these factors in 3D scaffolds that more closely resemble the complex microenvironment of the cancer ECM is still missing. Here, we present a comprehensive, quantitative analysis of the role of cell-ECM interactions in cancer cell migration within a highly physiological environment consisting of mixed Matrigel-collagen hydrogel scaffolds of increasing complexity that mimic the tumor microenvironment at the leading edge of cancer invasion. We quantitatively show that the presence of Matrigel increases hydrogel stiffness, which promotes beta 1 integrin expression and metalloproteinase activity in H1299 lung cancer cells. Then, we show that ECM remodeling activity causes matrix alignment and compaction that favors higher tractions exerted by the cells. However, these traction forces do not linearly translate into increased motility due to a biphasic role of cell adhesions in cell migration: at low concentration Matrigel promotes migration-effective tractions exerted through a high number of small sized focal adhesions. However, at high Matrigel concentration, traction forces are exerted through fewer, but larger focal adhesions that favor attachment yielding lower cell motility.	[Anguiano, Maria; Morales, Xabier; Castilla, Carlos; Pena, Alejandro Rodriguez; Ederra, Cristina; Ariz, Mikel; Esparza, Maider; Cortes-Dominguez, Ivan; Ortiz-de-Solorzano, Carlos] Univ Navarra, Ciberonc, IDISNA, Pamplona, Spain; [Anguiano, Maria; Morales, Xabier; Castilla, Carlos; Pena, Alejandro Rodriguez; Ederra, Cristina; Ariz, Mikel; Esparza, Maider; Cortes-Dominguez, Ivan; Ortiz-de-Solorzano, Carlos] Univ Navarra, Solid Tumours & Biomarkers Program, Ctr Appl Med Res, Pamplona, Spain; [Martinez, Martin] Univ Navarra, Ctr Appl Med Res, Div Neurosci, Neuroimaging Lab, Pamplona, Spain; [Amaveda, Hippolyte; Mora, Mario; Movilla, Nieves; Garcia Aznar, Jose Manuel] Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Mech Engn Multiscale Mech & Biol Engn M2BE, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; University of Navarra; University of Navarra; University of Zaragoza	Ortiz-de-Solorzano, C (corresponding author), Univ Navarra, Ciberonc, IDISNA, Pamplona, Spain.; Ortiz-de-Solorzano, C (corresponding author), Univ Navarra, Solid Tumours & Biomarkers Program, Ctr Appl Med Res, Pamplona, Spain.	codesolorzano@unav.es	Ortiz-de-Solorzano, Carlos/G-3278-2010; Martinez, Martin/A-1126-2016; Ariz, Mikel/T-5502-2017; Cortes Dominguez, Ivan/T-6772-2017	Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205; Martinez, Martin/0000-0002-3053-7920; Morales, Xabier/0000-0003-0303-9958; esparza, Maider/0000-0001-7958-3154; Rodriguez Pena, Alejandro/0000-0002-0024-078X; Ariz, Mikel/0000-0002-7328-1582; Cortes Dominguez, Ivan/0000-0001-5660-7694; Amaveda Metonou, Hippolyte/0000-0003-2212-447X; Mora Alfonso, Mario Juan/0000-0003-4747-7327	Spanish Ministry of Economy and Competitiveness [DPI2015-64221-C2-2, DPI201564221-C2-1, BES-2013064996, BES-2016-076280]; Spanish Ministry of Science, Innovation and Universities [RTI2018094494-B-C22]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science, Innovation and Universities(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness under grants DPI2015-64221-C2-2 (COdS) and DPI201564221-C2-1(JMGA) and fellowships BES-2013064996 (CC) and BES-2016-076280 (ARP). It was also funded by the Spanish Ministry of Science, Innovation and Universities, under grant RTI2018094494-B-C22 (COdS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguiano M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171417; Anguiano M, 2015, IEEE ENG MED BIO, P8139, DOI 10.1109/EMBC.2015.7320283; Carey SP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42088; Chow MT, 2014, CANCER IMMUNOL RES, V2, P1125, DOI 10.1158/2326-6066.CIR-14-0160; Das A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14340-w; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Geraldo S, 2013, JOVE-J VIS EXP, DOI 10.3791/50763; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Kiss A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093431; Lee B, 2017, SCI REP-UK, V7, DOI 10.1038/srep39498; Legland D, 2016, BIOINFORMATICS, V32, P3532, DOI 10.1093/bioinformatics/btw413; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liou YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089767; Maheshwari G, 2000, J CELL SCI; Malandrino A, 2018, EXTREME MECH LETT, V21, P25, DOI 10.1016/j.eml.2018.02.003; Maska M, 2015, P INT C IM PROC ICIP, DOI [10.1109/ICIP.2015.7351109, DOI 10.1109/ICIP.2015.7351109]; Maska M, 2013, IEEE T MED IMAGING, V32, P995, DOI 10.1109/TMI.2013.2243463; Motte S, 2013, BIOPOLYMERS, V99, P35, DOI 10.1002/bip.22133; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pelaez R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181579; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sander EA, 2009, J BIOMED MATER RES A, V88A, P322, DOI 10.1002/jbm.a.31847; Sander LM, 2014, CANCER RES, V74, P4588, DOI 10.1158/0008-5472.CAN-13-3294; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; Steinwachs J, 2016, NAT METHODS, V13, P171, DOI [10.1038/NMETH.3685, 10.1038/nmeth.3685]; Thievessen I, 2015, FASEB J, V29, P4555, DOI 10.1096/fj.14-268235; Tsai KKC, 2005, CANCER RES, V65, P6734, DOI 10.1158/0008-5472.CAN-05-0703; TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1; Valero C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195820; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yeh YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14932-6; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	49	37	37	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0220019	10.1371/journal.pone.0220019	http://dx.doi.org/10.1371/journal.pone.0220019			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945053	gold, Green Published			2022-12-26	WOS:000534370100004
J	Armuzzi, A; DiBonaventura, MD; Tarallo, M; Lucas, J; Bluff, D; Hoskin, B; Bargo, D; Cappelleri, JC; Quirk, D; Salese, L				Armuzzi, Alessandro; DiBonaventura, Marco daCosta; Tarallo, Miriam; Lucas, James; Bluff, Daniel; Hoskin, Benjamin; Bargo, Danielle; Cappelleri, Joseph C.; Quirk, Daniel; Salese, Leonardo			Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MANAGEMENT; GUIDELINES; THERAPY	Objective The aim of the present study is to examine how moderate-to-severe ulcerative colitis (UC) is currently managed in real-world clinical practice across the United States (US) and European Union Five (EU5; France, Germany, Italy, Spain, and the United Kingdom). Methods Data from the 2017 Adelphi Inflammatory Bowel-Disease Specific Programme (IBD-DSP) were used. The IBD-DSP is a database of patient chart information abstracted by selected gastroenterologists across the US and EU5. Eligible gastroenterologists who agreed to participate were asked to complete patient record forms for the next seven consecutive eligible adult patients with UC. Only charts from patients with moderate-to-severe UC were included in the analysis ( defined as those with documented administration of either an immunosuppressant [IM] or a biologic). Treatment patterns were reported descriptively. Results 411 and 1191 patient charts were included in the US and EU5 (mean ages 44.2 and 39.6 years; 53.0% and 43.5% female), respectively. For those with complete treatment history, 40.7% and 52.9% used either an IM or biologic as their first treatment (with or without steroids). Usage of these therapies increased in subsequent lines. The percentage of patients treated with combination therapy (i.e., biologic therapy with a concomitant IM) in first line generally varied between 10-20% (e.g., US: adalimumab (ADA), 10.8%; infliximab (IFX), 18.2%; EU5: ADA, 12.5%; IFX, 19.9%), though increased in later lines in the EU5. Among patients currently using a biologic therapy, between 10-40% of patients used a higher than indicated dose or greater than indicated dosing frequency during maintenance (e.g., US: IFX, 37.1%; ADA, 13.4%; EU5: IFX, 39.1%; ADA, 36.1%). In both the US and EU5, the primary reason for switching therapy was efficacy-related. Conclusions In this analysis, many patients with moderate-to-severe UC use an IM or biologic as their first therapy after diagnosis. Combination therapy and dose escalation are also common, and underscore the challenges with managing this patient population.	[Armuzzi, Alessandro] Univ Cattolica Sacro Cuore, IBD Unit, Presidio Columbus Fdn Policlin Gemelli IRCCS, Rome, Italy; [DiBonaventura, Marco daCosta; Bargo, Danielle] Pfizer Inc, Patient Hlth Impact, New York, NY 10017 USA; [Tarallo, Miriam] Pfizer Inc, Patient Hlth Impact, Rome, Italy; [Lucas, James; Bluff, Daniel; Hoskin, Benjamin] Adelphi Real World, Macclesfield, Cheshire, England; [Cappelleri, Joseph C.] Pfizer Inc, Biostat, Groton, CT 06340 USA; [Quirk, Daniel; Salese, Leonardo] Pfizer Inc, Med Affairs, Collegeville, PA USA	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Pfizer; Pfizer; Adelphi Group Ltd; Pfizer; Pfizer	DiBonaventura, MD (corresponding author), Pfizer Inc, Patient Hlth Impact, New York, NY 10017 USA.	Marco.DiBonaventura@pfizer.com	Armuzzi, Alessandro/AIC-5188-2022					Anderson P, 2008, CURR MED RES OPIN, V24, P3063, DOI 10.1185/03007990802457040 ; Bressler B, 2015, GASTROENTEROLOGY, V148, P1035, DOI 10.1053/j.gastro.2015.03.001; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Casteele NV, 2017, GASTROENTEROLOGY, V153, P835, DOI 10.1053/j.gastro.2017.07.031; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Crohn's and Colitis Foundation of America, 2014, FACTS INFLAMMATORY B; Fakhoury M, 2014, J INFLAMM RES, V7, P113, DOI 10.2147/JIR.S65979; Farthing M, 2014, UNITED EUR GASTROENT, V2, P539, DOI 10.1177/2050640614554154; Harbord M, 2017, J CROHNS COLITIS, V11, P769, DOI 10.1093/ecco-jcc/jjx009; Loftus EV, 2014, INFLAMM BOWEL DIS, V20, P1361, DOI 10.1097/MIB.0000000000000089; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Patel H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175099; Rubin DT, 2014, ALIMENT PHARM THER, V39, P1143, DOI 10.1111/apt.12727; Rubin DT, 2019, AM J GASTROENTEROL, V114, P384, DOI 10.14309/ajg.0000000000000152; Smith TW, 2018, AM J GASTROENTEROL, V113, pS353; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2	17	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227914	10.1371/journal.pone.0227914	http://dx.doi.org/10.1371/journal.pone.0227914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945774	Green Published, gold			2022-12-26	WOS:000534370100072
J	Hazlewood, GS; Pokharel, G; Deardon, R; Marshall, DA; Bombardier, C; Tomlinson, G; Ma, C; Seow, CH; Panaccione, R; Kaplan, GG				Hazlewood, Glen S.; Pokharel, Gyanendra; Deardon, Robert; Marshall, Deborah A.; Bombardier, Claire; Tomlinson, George; Ma, Christopher; Seow, Cynthia H.; Panaccione, Remo; Kaplan, Gilaad G.			Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PREVALENCE; BIOLOGICS; RISK; IBD	Objective To quantify patient preferences for maintenance therapy of Crohn's disease and understand the impact on treatment selection. Methods We conducted a discrete-choice experiment in patients with Crohn's disease (n = 155) to measure the importance of attributes relevant to choosing between different medical therapies for maintenance of Crohn's disease. The attributes included efficacy and withdrawals due to adverse events, as well as dosing and other rare risks of treatment. From the discrete-choice experiment we estimated the part-worth (importance) of each attribute level, and explored preference heterogeneity through latent class analysis. We then used the part-worths to apply weights across each outcome from a prior network meta-analysis to estimate patients' preferred treatment in pairwise comparisons and for the overall group of treatments. Results The discrete-choice experiment revealed that maintaining remission was the most important attribute. Patients would accept a rare risk of infection or cancer for a 14% absolute increased chance of remission. Latent class analysis demonstrated that 45% of the cohort was risk averse, either to adverse events or requiring a course of prednisone. When these preferences were used in modelling studies to compare pairs of treatments, there was a. 78% probability that all biologic treatments were preferred to azathioprine and methotrexate, based on the balance of benefits and harms. When comparing all treatments, adalimumab was preferred by 53% of patients, who were motivated by efficacy, and vedolizumab was preferred by 30% who were driven by the preference to avoid risks. However, amongst biologic treatment options, there was considerable uncertainty regarding the preferred treatment at the individual patient level. Conclusion Patients with Crohn's disease from our population were, on average, focused on the benefits of treatment, supporting intensive treatment approaches aimed at maintaining remission. Important preference heterogeneity was identified, however, highlighting the importance of shared decision making when selecting treatments.	[Hazlewood, Glen S.; Marshall, Deborah A.; Seow, Cynthia H.; Kaplan, Gilaad G.] Univ Calgary, Cumming Sch Med, Dept Med & Community Hlth Sci, Calgary, AB, Canada; [Pokharel, Gyanendra; Deardon, Robert] Univ Calgary, Dept Math & Stat, Calgary, AB, Canada; [Deardon, Robert] Univ Calgary, Fac Vet Med, Dept Prod Anim Hlth, Calgary, AB, Canada; [Bombardier, Claire; Tomlinson, George] Univ Toronto, Dept Med, Toronto, ON, Canada; [Bombardier, Claire; Tomlinson, George] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bombardier, Claire] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Ma, Christopher; Panaccione, Remo; Kaplan, Gilaad G.] Univ Calgary, Cumming Sch Med, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Unit, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Calgary	Hazlewood, GS; Kaplan, GG (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med & Community Hlth Sci, Calgary, AB, Canada.; Kaplan, GG (corresponding author), Univ Calgary, Cumming Sch Med, Div Gastroenterol & Hepatol, Inflammatory Bowel Dis Unit, Calgary, AB, Canada.	gshazlew@ucalgary.ca; ggkaplan@ucalgary.ca	Ma, Christopher/AAH-4886-2021; Hazlewood, Glen S/N-2233-2019; Pokharel, Gyanendra/ABE-2129-2020; Panaccione, Remo/ABC-1140-2021; Kaplan, Gil/AAH-2335-2021; Tomlinson, George/L-5432-2016	Hazlewood, Glen S/0000-0001-7709-3741; Panaccione, Remo/0000-0002-5247-940X; Kaplan, Gil/0000-0003-2719-0556; Bombardier, Claire/0000-0001-5083-2137; Ma, Christopher/0000-0002-4698-9948; Tomlinson, George/0000-0002-9328-6399	Canadian Institutes for Health Research (CIHR) [MP3-139793]; SPOR grant from the Canadian Institute of Health Research; CIHR New Investigator Salary Award; Arthritis Society Young Investigator Salary Award; CIHR Canada Research Chair in Health Services and Systems Research; Arthur J.E. Child Chair Rheumatology Outcomes Research	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); SPOR grant from the Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Salary Award(Canadian Institutes of Health Research (CIHR)); Arthritis Society Young Investigator Salary Award; CIHR Canada Research Chair in Health Services and Systems Research(Canadian Institutes of Health Research (CIHR)); Arthur J.E. Child Chair Rheumatology Outcomes Research	Funding for this study was received by the Canadian Institutes for Health Research (CIHR), funding reference number MP3-139793 (GH, GK, DM, GT, CB). The IMAGINE Network, supported by a SPOR grant from the Canadian Institute of Health Research, provided partial funding for this study. Glen Hazlewood is supported by a CIHR New Investigator Salary Award and The Arthritis Society Young Investigator Salary Award. Gilaad Kaplan is a CIHR Embedded Clinician Research Chair. Deborah Marshall is supported by a CIHR Canada Research Chair in Health Services and Systems Research and the Arthur J.E. Child Chair Rheumatology Outcomes Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbvie Inc, 2019, HUM AD; Almario CV, 2018, AM J GASTROENTEROL, V113, P58, DOI 10.1038/ajg.2017.470; [Anonymous], 2016, LIGHTHOUSE STUDIO V9; Bewtra M, 2020, CLIN GASTROENTEROL H, V18, P406, DOI 10.1016/j.cgh.2019.05.010; Bewtra M, 2015, AM J GASTROENTEROL, V110, P1675, DOI 10.1038/ajg.2015.321; Bewtra M, 2013, PATIENT, V6, P241, DOI 10.1007/s40271-013-0031-2; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Casellas F, 2017, DIGEST LIVER DIS, V49, P152, DOI 10.1016/j.dld.2016.09.009; CENTOCOR INC, REM INFL; Coward S, 2019, GASTROENTEROLOGY, V156, P1345, DOI 10.1053/j.gastro.2019.01.002; Elwyn G, 2013, PATIENT EDUC COUNS, V90, P207, DOI 10.1016/j.pec.2012.06.036; Hazlewood GS, 2018, RHEUM DIS CLIN N AM, V44, P337, DOI 10.1016/j.rdc.2018.01.009; Hazlewood GS, 2018, J CLIN EPIDEMIOL, V93, P56, DOI 10.1016/j.jclinepi.2017.10.003; Hazlewood GS, 2016, RHEUMATOLOGY, V55, P1959, DOI 10.1093/rheumatology/kew280; Hazlewood GS, 2015, GASTROENTEROLOGY, V148, P344, DOI 10.1053/j.gastro.2014.10.011; Johnson FR, 2010, J MANAGE CARE PHARM, V16, P616, DOI 10.18553/jmcp.2010.16.8.616; Johnson J, 2016, PA STUD HUM RIGHTS, P157; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moran GW, 2014, CLIN GASTROENTEROL H, V12, P434, DOI 10.1016/j.cgh.2013.08.026; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Peyrin-Biroulet L, 2015, AM J GASTROENTEROL, V110, P1324, DOI 10.1038/ajg.2015.233; Quezada SM, 2018, EXPERT REV GASTROENT, V12, P1183, DOI 10.1080/17474124.2018.1545574; Scott FI, 2019, INFLAMM BOWEL DIS, V25, P925, DOI 10.1093/ibd/izy321; Singh S, 2018, ALIMENT PHARM THER, V48, P394, DOI 10.1111/apt.14852	27	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227635	10.1371/journal.pone.0227635	http://dx.doi.org/10.1371/journal.pone.0227635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945089	Green Published, gold			2022-12-26	WOS:000534370100050
J	Crumley, I; Halton, J; Greig, J; Kahunga, L; Mwanga, JP; Chua, A; Kosack, C				Crumley, Iona; Halton, Jarred; Greig, Jane; Kahunga, Lucien; Mwanga, Jean-Paul; Chua, Arlene; Kosack, Cara			The impact of computed radiography and teleradiology on patients' diagnosis and treatment in Mweso, the Democratic Republic of Congo	PLOS ONE			English	Article								Introduction High quality diagnostic imaging can provide increased diagnostic accuracy and help guide medical decision-making and management, however challenges for radiology in resource-limited settings are numerous. Diagnostic imaging and teleradiology have financial and logistical implications, so evidence of impact is crucial. We sought to test the hypothesis that the implementation of computed radiography with teleradiology consultation support will significantly change diagnoses and treatment plans in a resource limited setting. Method Paired before-after study to determine the therapeutic impact of an add-on diagnostic test. 'Preliminary Plan' and 'Final Plan' forms allowed direct comparison of diagnosis and treatment plans at initial consultation and following radiography and teleradiology. Consecutive consenting patients were included until the sample size (600) was reached. Changes in both diagnosis and treatment plan were analysed in the whole cohort, with sub-analyses of children aged <5 years, and cases of chest radiography. Results Final analysis included 536 cases. Diagnosis changed following radiography and teleradiology in 62% of cases, and treatment plans changed in 61%. In chest radiography cases, 70% of diagnoses and 62% of treatment plans changed, while in children <5 years 66% of diagnoses and 58% of treatment plans changed. Reduced final treatment plans were most common for exploratory surgery (72% decrease), surgical orthopaedic intervention (62% decrease), and TB treatment (52% decrease), allowing more conservative medical or surgical management in 61 cases. Increased final treatment plans were highest in the orthopaedic and interventional surgery and referral categories. Of 42 cases requiring interventional surgery in the final plan, 26 (62%) were identified only after radiography and teleradiology. 16 additional cases were indicated for orthopaedic surgery, 10 cases required patient transfer, and TB treatment was indicated in 45 cases. A change in the original prescription plan occurred in 41% of 536 cases, with one or more prescriptions stopped in 28% of all cases. Conclusion We found that computed radiography with teleradiology had significant clinical value in this resource-limited setting, with the potential to affect both patient outcomes and treatment costs through providing improved diagnostics and avoiding unnecessary treatments and medications.	[Crumley, Iona; Halton, Jarred; Kosack, Cara] MSF Int, Diagnost Network, Amsterdam, Netherlands; [Greig, Jane] MSF, Manson Unit, London, England; [Kahunga, Lucien; Mwanga, Jean-Paul] Hop Gen Reference, Mweso, North Kivu, Rep Congo; [Chua, Arlene] MSF Int, Diagnost Network, Geneva, Switzerland	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Crumley, I (corresponding author), MSF Int, Diagnost Network, Amsterdam, Netherlands.	iona.crumley@amsterdam.msf.org		Greig, Jane/0000-0003-2732-0023	Innovation Fund of Medecins Sans Frontieres; Ministry of Health in the Democratic Republic of Congo	Innovation Fund of Medecins Sans Frontieres; Ministry of Health in the Democratic Republic of Congo	Funding for this study was granted internally by the Innovation Fund of Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Ministry of Health in the Democratic Republic of Congo for supporting the project, the medical team and radiology department in HGR Mweso, and Judith Lindert, Jonas Koenig and Sonja Schumacher, for all their work and contribution to the study.	Coccolini F, 2018, WORLD J EMERG SURG, V13, DOI 10.1186/s13017-018-0174-5; GUYATT GH, 1986, J CHRON DIS, V39, P295, DOI 10.1016/0021-9681(86)90051-2; Halton J, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00202; Kawooya MG, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.97747; Kim YS, 2004, YONSEI MED J, V45, P761, DOI 10.3349/ymj.2004.45.5.761; Le Doare K, 2015, BRIT J CLIN PHARMACO, V79, P446, DOI 10.1111/bcp.12320; Maru DSR, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-18; Meads CA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-3; Medecins Sans Frontieres, 2019, MMRDATA 2009TO2019 2; Medecins Sans Frontieres, 2007, IT CIV STILL 1 VICT; Medecins sans Frontieres, 2009, SHATT LIV IMM MED CA; Medecins Sans Frontieres, 2006, FOOD NUTR MORT UNPUB; Medecins Sans Frontieres, 2012, ACC HEALTHC MO UNPUB; Mollura D., 2014, RADIOLOGY GLOBAL HLT; Ngoya PS, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.99.9736; Organization (WHO), 2019, DIAGNOSTIC IMAGING; Spijker S, 2014, J TELEMED TELECARE, V20, P82, DOI 10.1177/1357633X14524153; Tesfalul M, 2016, J AM MED INFORM ASSN, DOI [10.1093/JAMIA.ocv140, DOI 10.1093/JAMIA.OCV140]; WHO, 2007, IMPR DIAGN TREATM SM; World Health Organization, 2016, CHEST RAD TUB DET SU; World Health Organization, 2010, REPORT 2 GLOBAL SURV, V2; Zennaro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073939	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227773	10.1371/journal.pone.0227773	http://dx.doi.org/10.1371/journal.pone.0227773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940418	gold, Green Published			2022-12-26	WOS:000534368000099
J	Fulton, BD; Proudman, DG; Sample, HA; Gelfand, JM; Chiu, CY; DeRisi, JL; Wilson, MR				Fulton, Brent D.; Proudman, David G.; Sample, Hannah A.; Gelfand, Jeffrey M.; Chiu, Charles Y.; DeRisi, Joseph L.; Wilson, Michael R.			Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis	PLOS ONE			English	Article							UNITED-STATES; MANAGEMENT; PREDICTORS; CHILDREN; BURDEN	Objective To estimate healthcare expenditures that could be impacted by advanced diagnostic testing for patients hospitalized with meningitis or encephalitis Methods Patients hospitalized with meningitis (N = 23,933) or encephalitis (N = 7,858) in the U.S. were identified in the 2010-2014 Truven Health MarketScan Commercial Claims and Encounters Database using ICD-9-CM diagnostic codes. The database included an average of 40.8 million commercially insured enrollees under age 65 per year. Clinical, demographic and healthcare utilization criteria were used to identify patient subgroups early in their episode who were at risk to have high inpatient expenditures. Healthcare expenditures of patients within each subgroup were bifurcated: those expenditures that remained five days after the patient could be classified into the subgroup versus those that had occurred previously. Results The hospitalization episode rate per 100,000 enrollee-years for meningitis was 13.0 (95% CI: 12.9-13.2) and for encephalitis was 4.3 (95% CI: 4.2-4.4), with mean inpatient expenditures of $36,891 (SD = $92,636) and $60,181 (SD = $130,276), respectively. If advanced diagnostic testing had been administered on the day that a patient could be classified into a subgroup, then a test with a five-day turnaround time could impact the following mean inpatient expenditures that remained by subgroup for patients with meningitis or encephalitis, respectively: had a neurosurgical procedure ($83,337 and $56,020), had an ICU stay ($34,221 and $46,051), had HIV-1 infection or a previous organ transplant ($37,702 and $62,222), were age <1 year ($35,371 and $52,812), or had a hospital length of stay >2 days ($18,325 and $30,244). Discussion Inpatient expenditures for patients hospitalized with meningitis or encephalitis were substantial and varied widely. Patient subgroups who had high healthcare expenditures could be identified early in their stay, raising the potential for advanced diagnostic testing to lower these expenditures.	[Fulton, Brent D.; Proudman, David G.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Sample, Hannah A.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Gelfand, Jeffrey M.; Wilson, Michael R.] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [DeRisi, Joseph L.] Chan Zuckerberg Biohub, San Francisco, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fulton, BD (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	fultonb@berkeley.edu		Sample, Hannah/0000-0002-5398-3907; Fulton, Brent/0000-0002-8305-4711; Wilson, Michael/0000-0002-8705-5084	UCSF Center for Next-Gen Precision Diagnostics - Sandler Foundation; William K. Bowes, Jr. Foundation; Charles and Helen Schwab Foundation; Chan Zuckerberg Biohub; Mentored Clinical Scientist Development award from the National Institute of Neurological Disorders and Stroke [K08NS096117]	UCSF Center for Next-Gen Precision Diagnostics - Sandler Foundation; William K. Bowes, Jr. Foundation; Charles and Helen Schwab Foundation; Chan Zuckerberg Biohub; Mentored Clinical Scientist Development award from the National Institute of Neurological Disorders and Stroke	This study was supported by UCSF Center for Next-Gen Precision Diagnostics, https://nextgendiagnostics.ucsf.edu/, which is supported by the Sandler Foundation, https://www.sandlerfoundation.org/(BDF, DGP, HAS, JMG, CYC and MRW) the William K. Bowes, Jr. Foundation, https://www.wkbowesjrfoundation.org/(BDF, DGP, HAS, JMG, CYC, JLD and MRW), and the Charles and Helen Schwab Foundation, http://www.schwabfoundation.org/(CYC).Additional support was from the Chan Zuckerberg Biohub, https://www.czbiohub.org/(JLD) and a Mentored Clinical Scientist Development award K08NS096117 from the National Institute of Neurological Disorders and Stroke, https://www.ninds.nih.gov/(MRW).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai G, 2015, HEALTH AFFAIR, V34, P922, DOI 10.1377/hlthaff.2014.1414; Bai G, 2015, HEALTH AFFAIR, V34, P64, DOI 10.1377/hlthaff.2014.1072; Beernink T M J, 2016, Pract Neurol, V16, P136, DOI 10.1136/practneurol-2015-001166; Britton PN, 2015, INTERN MED J, V45, P563, DOI 10.1111/imj.12749; Chiu CY, 2017, EMERG INFECT DIS, V23, P1694, DOI 10.3201/eid2310.161986; Fremond ML, 2015, J PEDIAT INF DIS SOC, V4, pE53, DOI 10.1093/jpids/piv040; George BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104169; GRENINGER A, 2015, GENOME MED, V7, P1; Greninger AL, 2018, EXPERT REV MOL DIAGN, V18, P605, DOI 10.1080/14737159.2018.1487292; Hasbun R, 2017, CLIN INFECT DIS, V65, P359, DOI 10.1093/cid/cix319; Hong DK, 2018, DIAGN MICR INFEC DIS, V92, P210, DOI 10.1016/j.diagmicrobio.2018.06.009; Jouan Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1046-y; Kaiser Family Foundation, 2017, 2017 EMPL HLTH BEN S; KENNEDY CR, 1987, ARCH DIS CHILD, V62, P1156, DOI 10.1136/adc.62.11.1156; Khetsuriani N, 2002, CLIN INFECT DIS, V35, P175, DOI 10.1086/341301; Maeda J, 2017, ANAL PRIVATE SECTOR; Messacar K, 2016, DIAGN MICR INFEC DIS, V86, P118, DOI 10.1016/j.diagmicrobio.2016.05.020; Mongkolrattanothai K, 2017, J PEDIATR INFECT DIS, V6, P393, DOI 10.1093/jpids/piw066; Murkey JA, 2017, OPEN FORUM INFECT DI, P1; Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912; Nigrovic LE, 2013, PEDIATRICS, V131, P670, DOI 10.1542/peds.2012-3077; Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA; Simner PJ, 2018, CLIN INFECT DIS, V66, P778, DOI 10.1093/cid/cix881; Takhar SS, 2012, ACAD EMERG MED, V19, P632, DOI 10.1111/j.1553-2712.2012.01377.x; Thakur KT, 2013, NEUROLOGY, V81, P793, DOI 10.1212/WNL.0b013e3182a2cc6d; Truven Health Analytics, 2017, TRUV HLTH MARKETSCAN; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396; Wilson M, 2016, JAMA NEUROL, V73, P1389, DOI 10.1001/jamaneurol.2016.3617; Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Wilson MR, 2018, JAMA NEUROL, pE1	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226895	10.1371/journal.pone.0226895	http://dx.doi.org/10.1371/journal.pone.0226895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940319	Green Published, gold			2022-12-26	WOS:000534368000048
J	Jian, C; Luukkonen, P; Yki-Jarvinen, H; Salonen, A; Korpela, K				Jian, Ching; Luukkonen, Panu; Yki-Jarvinen, Hannele; Salonen, Anne; Korpela, Katri			Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling	PLOS ONE			English	Article							REAL-TIME PCR; BACTERIAL; DNA; QUANTIFICATION; PRIMERS; SAMPLES; LOAD	The use of relative abundance data from next generation sequencing (NGS) can lead to misinterpretations of microbial community structures, as the increase of one taxon leads to the concurrent decrease of the other(s) in compositional data. Although different DNA- and cell-based methods as well as statistical approaches have been developed to overcome the compositionality problem, and the biological relevance of absolute bacterial abundances has been demonstrated, the human microbiome research has not yet adopted these methods, likely due to feasibility issues. Here, we describe how quantitative PCR (qPCR) done in parallel to NGS library preparation provides an accurate estimation of absolute taxon abundances from NGS data and hence provides an attainable solution to compositionality in high-throughput microbiome analyses. The advantages and potential challenges of the method are also discussed.	[Jian, Ching; Salonen, Anne; Korpela, Katri] Univ Helsinki, Fac Med, Human Microbiome Res Program, Helsinki, Finland; [Luukkonen, Panu; Yki-Jarvinen, Hannele] Minerva Fdn, Helsinki, Finland; [Luukkonen, Panu; Yki-Jarvinen, Hannele] Univ Helsinki, Dept Med, Helsinki, Finland; [Luukkonen, Panu; Yki-Jarvinen, Hannele] Helsinki Univ Cent Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Korpela, K (corresponding author), Univ Helsinki, Fac Med, Human Microbiome Res Program, Helsinki, Finland.	katri.korpela@helsinki.fi	Jian, Ching/G-9656-2018; Salonen, Anne/AAW-1858-2020	Jian, Ching/0000-0003-0577-8834; Salonen, Anne/0000-0002-6960-7447; Luukkonen, Panu/0000-0003-2085-679X	University of Helsinki; EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EMIF) [115372]; European Union [634413]; Academy of Finland; Otto A. Malm Foundation; Sigrid Juselius Foundation; EVO Foundation; Finnish Medical Foundation; Alfred Kordelin Foundation; Paulo Foundation; Jalmari and Rauha Ahokas Foundation; Novo Nordisk Foundation; Mary and Georg C. Ehnrooth Foundation; Biocodex Microbiota Foundation	University of Helsinki; EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EMIF); European Union(European Commission); Academy of Finland(Academy of Finland); Otto A. Malm Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); EVO Foundation; Finnish Medical Foundation; Alfred Kordelin Foundation; Paulo Foundation; Jalmari and Rauha Ahokas Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Mary and Georg C. Ehnrooth Foundation; Biocodex Microbiota Foundation	The work was funded by grants from the University of Helsinki (AS, KK, PL), the EU/EFPIA Innovative Medicines Initiative Joint Undertaking (EMIF grant no. 115372, HY-J), the EPoS (Elucidating Pathways of Steatohepatitis) consortium funded by the Horizon 2020 Framework Program of the European Union under Grant Agreement 634413 (HY-J), Academy of Finland (KK, HY-J), Otto A. Malm (CJ), Sigrid Juselius (HY-J), EVO (HY-J), Finnish Medical (PL), Alfred Kordelin (PL), Paulo (AS and PL), Jalmari and Rauha Ahokas and Novo Nordisk (HY-J), Mary and Georg C. Ehnrooth (AS) as well as Biocodex Microbiota (AS) Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonk F, 2018, J MICROBIOL METH, V153, P139, DOI 10.1016/j.mimet.2018.09.015; Contijoch EJ, 2019, ELIFE, V8, DOI 10.7554/eLife.40553; Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960; Czechowska K, 2008, CURR OPIN MICROBIOL, V11, P205, DOI 10.1016/j.mib.2008.04.006; Dannemiller KC, 2014, ATMOS ENVIRON, V84, P113, DOI 10.1016/j.atmosenv.2013.11.036; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frossard A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00903; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gonzalez LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029176; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Korpela K, 2016, MARE MICROBIOTA ANAL; Korpela K, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0567-4; Korpela K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20827-x; Lewis ZT, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0071-z; Liu CM, 2015, MBIO, V6, DOI 10.1128/mBio.00589-15; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589; Luukkonen PK, 2018, DIABETES CARE, V41, P1732, DOI 10.2337/dc18-0071; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Props R, 2017, ISME J, V11, P584, DOI 10.1038/ismej.2016.117; Qi C, 2017, WORLD J GASTROENTERO, V23, P7830, DOI 10.3748/wjg.v23.i44.7830; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raju SC, 2018, J MICROBIOL METH, V147, P76, DOI 10.1016/j.mimet.2018.03.003; Reichardt N, 2018, ISME J, V12, P610, DOI 10.1038/ismej.2017.196; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stammler F, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0175-0; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Tikhonov M, 2015, ISME J, V9, P68, DOI 10.1038/ismej.2014.117; Tkacz A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0491-7; Tsilimigras MCB, 2016, ANN EPIDEMIOL, V26, P330, DOI 10.1016/j.annepidem.2016.03.002; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213	35	110	112	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227285	10.1371/journal.pone.0227285	http://dx.doi.org/10.1371/journal.pone.0227285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940382	Green Published, gold, Green Submitted			2022-12-26	WOS:000534368000061
J	Marukutira, T; Scott, N; Kelly, SL; Birungi, C; Makhema, JM; Crowe, S; Stoove, M; Hellard, M				Marukutira, Tafireyi; Scott, Nick; Kelly, Sherrie L.; Birungi, Charles; Makhema, Joseph M.; Crowe, Suzanne; Stoove, Mark; Hellard, Margaret			Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana	PLOS ONE			English	Article							AFRICA	Introduction Botswana offers publicly financed HIV treatment to citizens, but not migrants, who comprised about 7% of the population in 2016. However, HIV incidence is not declining in proportion to Botswana's HIV response. In 2018, Botswana had 86% of citizens living with HIV diagnosed, 95% of people diagnosed on treatment, and 95% viral suppression among those on treatment. We hypothesised that continued exclusion of migrants is hampering reduction of HIV incidence in Botswana. Hence, we modelled the impact of including migrants in Botswana's HIV response on achieving 90-90-90 and 95-95-95 Fast-Track targets by 2020 and 2030, respectively. Methods The Optima HIV model, with demographic, epidemiological, and behavioural inputs, was applied to citizens of and migrants to Botswana. Projections of new HIV infections and HIV-related deaths were compared for three scenarios to the end of 2030: (1) continued status quo for HIV testing and treatment coverage, and maintenance of levels of linkage to care, loss to follow-up, and viral suppression among citizens and migrants (baseline); (2) with scaled-up budget, optimised to achieve 90-90-90 and 95-95-95 Fast-Track targets by 2020 and 2030, respectively, for citizens only; and (3) scaled-up optimised budget to achieve these targets for both citizens and migrants. Results A baseline of 172,000 new HIV infections and 8,400 HIV-related deaths was projected over 2020-2030. Scaling up to achieve targets among citizens only averted an estimated 48,000 infections and 1,700 deaths. Achieving targets for both citizens and migrants averted 16,000 (34%) more infections and 442 (26%) more deaths. Scaling up for both populations reduced numbers of new HIV infections and deaths by 44% and 39% respectively compared with 2010 levels. Treating migrants when scaling up in both populations was estimated to cost USD 74 million over 2020-2030. Conclusions Providing HIV services to migrants in Botswana could lead to further reductions in HIV incidence and deaths. However, even with an increased, optimised budget that achieves 95-95-95 targets for both citizens and migrants by 2030, the 90% incidence reduction target for 2020 will be missed. Further efficiencies and innovations will be needed to meet HIV targets in Botswana.	[Marukutira, Tafireyi; Scott, Nick; Kelly, Sherrie L.; Crowe, Suzanne; Stoove, Mark; Hellard, Margaret] Burnet Inst, Melbourne, Vic, Australia; [Marukutira, Tafireyi; Crowe, Suzanne; Stoove, Mark; Hellard, Margaret] Monash Univ, Melbourne, Vic, Australia; [Birungi, Charles] UNAIDS, Gaborone, Botswana; [Birungi, Charles] UCL, London, England; [Makhema, Joseph M.] Botswana Harvard Partnership, Gaborone, Botswana	Burnet Institute; Monash University; University of London; University College London	Hellard, M (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Hellard, M (corresponding author), Monash Univ, Melbourne, Vic, Australia.	margaret.hellard@burnet.edu.au	Marukutira, Tafireyi/AAE-3518-2020	Marukutira, Tafireyi/0000-0003-1142-6114; Kelly, Sherrie/0000-0002-6232-5586; Stoove, Mark/0000-0003-2887-1409				Alvarez-del Arco D, 2017, AIDS, V31, P1979, DOI 10.1097/QAD.0000000000001571; Assefa Y, 2019, INT J INFECT DIS, V78, P57, DOI 10.1016/j.ijid.2018.10.022; Avert International, 2018, AV GLOB INF ED HIV A; Central Statistics Office (CSO) Botswana, 2014, BOTSW AIDS IMP SURV; Fakoya I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1852-9; Farahani M, 2016, AIDS, V30, P477, DOI 10.1097/QAD.0000000000000921; Gaolathe T, 2016, LANCET HIV, V3, pE221, DOI 10.1016/S2352-3018(16)00037-0; Ghys PD, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002678; International Organization for Migration (IOM), 2016, BOTSW COUNT FACTS FI; IOM (International Organization for Migration), 2018, WORLD MIGRATION REPO; Keetile M, 2014, SAHARA J-J SOC ASP H, V11, P158, DOI 10.1080/17290376.2014.960948; Kelly SL, 2018, LANCET HIV, V5, pE190, DOI 10.1016/S2352-3018(18)30024-9; Kelly SL, 2015, JAIDS-J ACQ IMM DEF, V69, P257, DOI 10.1097/QAI.0000000000000655; Kenyon C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-350; Kerr CC, 2015, JAIDS-J ACQ IMM DEF, V69, P365, DOI 10.1097/QAI.0000000000000605; Kibona I, 2018, J SCI RES REPORTS, V19, P1; Klein DJ, 2015, INT HEALTH, V7, P107, DOI 10.1093/inthealth/ihv011; Maddali MV, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011914; Marukutira T, 2017, C RETR OPP INF CROI; Marukutira T, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015994; Marukutira T, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25090; Moyo S, 2018, PLOS ONE, V13; National AIDS Coordinating Agency, 2015, PROGR REP NAT RESP 2; Olawore O, 2018, LANCET HIV, V5, pE181, DOI 10.1016/S2352-3018(18)30009-2; Optima Consortium for Decision Science, 2019, OPT HIV US GUID, VVI; Scott N, 2018, CLIN INFECT DIS, V66, P1019, DOI 10.1093/cid/cix939; Statistics Botswana, 2014, DISS SEM REP 9 12 DE; Stegman P, 2014, 20 INT AIDS C MELB A; UNAIDS, 2016, FAST TRACK COMM AIDS; UNAIDS, 2018, GLOB AIDS UPD MIL TO; UNAIDS, 2018, UNAIDS DAT 2018; UNAIDS, 2018, COUNTR FACTSH BOTSW; UNAIDS, 2017, COUTR FACTSH BOTSW 2; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2014, 90 90 90 AMB TREATM; Vearey J, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25137; Vignier N, 2018, EUR J PUBLIC HEALTH, V28, P904, DOI 10.1093/eurpub/cky118; White PJ, 2006, AIDS, V20, P1898, DOI 10.1097/01.aids.0000244213.23574.fa; Williams BG, 2017, LANCET PUBLIC HEALTH, V2, pE223, DOI 10.1016/S2468-2667(17)30066-X; Williams BG, 2016, LANCET HIV, V3, pE409, DOI 10.1016/S2352-3018(16)30116-3	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226422	10.1371/journal.pone.0226422	http://dx.doi.org/10.1371/journal.pone.0226422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940360	Green Published, gold			2022-12-26	WOS:000534368000031
J	Rhodius-Meester, HFM; van Maurik, IS; Koikkalainen, J; Tolonen, A; Frederiksen, KS; Hasselbalch, SG; Soininen, H; Herukka, SK; Remes, AM; Teunissen, CE; Barkhof, F; Pijnenburg, YAL; Scheltens, P; Lotjonen, J; van der Flier, WM				Rhodius-Meester, Hanneke F. M.; van Maurik, Ingrid S.; Koikkalainen, Juha; Tolonen, Antti; Frederiksen, Kristian S.; Hasselbalch, Steen G.; Soininen, Hilkka; Herukka, Sanna-Kaisa; Remes, Anne M.; Teunissen, Charlotte E.; Barkhof, Frederik; Pijnenburg, Yolande A. L.; Scheltens, Philip; Lotjonen, Jyrki; van der Flier, Wiesje M.			Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracy	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NIA-AA; DEMENTIA; CRITERIA; SEGMENTATION; VALIDATION; PREDICTION; ATROPHY; STATE; MRI	Introduction An accurate and timely diagnosis for Alzheimer's disease (AD) is important, both for care and research. The current diagnostic criteria allow the use of CSF biomarkers to provide pathophysiological support for the diagnosis of AD. How these criteria should be operationalized by clinicians is unclear. Tools that guide in selecting patients in which CSF biomarkers have clinical utility are needed. We evaluated computerized decision support to select patients for CSF biomarker determination. Methods We included 535 subjects (139 controls, 286 Alzheimer's disease dementia, 82 frontotemporal dementia and 28 vascular dementia) from three clinical cohorts. Positive (AD like) and negative (normal) CSF biomarker profiles were simulated to estimate whether knowledge of CSF biomarkers would impact (confidence in) diagnosis. We applied these simulated CSF values and combined them with demographic, neuropsychology and MRI data to initiate CSF testing (computerized decision support approach). We compared proportion of CSF measurements and patients diagnosed with sufficient confidence (probability of correct class >= 0.80) based on an algorithm with scenarios without CSF (only neuropsychology, MRI and APOE), CSF according to the appropriate use criteria (AUC) and CSF for all patients. Results The computerized decision support approach recommended CSF testing in 140 (26%) patients, which yielded a diagnosis with sufficient confidence in 379 (71%) of all patients. This approach was more efficient than CSF in none (0% CSF, 308 (58%) diagnosed), CSF selected based on AUC (295 (55%) CSF, 350 (65%) diagnosed) or CSF in all (100% CSF, 348 (65%) diagnosed). Conclusions We used a computerized decision support with simulated CSF results in controls and patients with different types of dementia. This approach can support clinicians in making a balanced decision in ordering additional biomarker testing. Computer-supported prediction restricts CSF testing to only 26% of cases, without compromising diagnostic accuracy.	[Rhodius-Meester, Hanneke F. M.; van Maurik, Ingrid S.; Pijnenburg, Yolande A. L.; Scheltens, Philip; van der Flier, Wiesje M.] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands; [Rhodius-Meester, Hanneke F. M.] Vrije Univ Amsterdam, Dept Internal Med, Geriatr Med Sect, Amsterdam, Netherlands; [van Maurik, Ingrid S.; van der Flier, Wiesje M.] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam Neurosci, Amsterdam UMC, Amsterdam, Netherlands; [Koikkalainen, Juha; Lotjonen, Jyrki] Combinostics Ltd, Tampere, Finland; [Tolonen, Antti] VTT Tech Res Ctr Finland Ltd, Tampere, Finland; [Frederiksen, Kristian S.; Hasselbalch, Steen G.] Univ Copenhagen, Rigshosp, Danish Dementia Res Ctr, Dept Neurol, Copenhagen, Denmark; [Soininen, Hilkka; Herukka, Sanna-Kaisa; Remes, Anne M.] Univ Eastern Finland, Inst Clin Med, Dept Neurol, Kuopio, Finland; [Remes, Anne M.] Univ Oulu, Dept Res Neurol, Unit Clin Neurosci, Oulu, Finland; [Remes, Anne M.] Oulu Univ Hosp, MRC Oulu, Oulu, Finland; [Teunissen, Charlotte E.] Amsterdam UMC, Neurochem Lab, Amsterdam Neurosci, Dept Clin Chem, Amsterdam, Netherlands; [Teunissen, Charlotte E.] Amsterdam UMC, Biobank, Amsterdam Neurosci, Dept Clin Chem, Amsterdam, Netherlands; [Barkhof, Frederik] Amsterdam UMC, Dept Radiol & Nucl Med, Amsterdam Neurosci, Amsterdam, Netherlands; [Barkhof, Frederik] UCL, Inst Neurol & Healthcare Engn, London, England	University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; VTT Technical Research Center Finland; Rigshospitalet; University of Copenhagen; University of Eastern Finland; University of Oulu; University of Oulu; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of London; University College London	Rhodius-Meester, HFM (corresponding author), Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam Neurosci,Amsterdam UMC, Amsterdam, Netherlands.; Rhodius-Meester, HFM (corresponding author), Vrije Univ Amsterdam, Dept Internal Med, Geriatr Med Sect, Amsterdam, Netherlands.	h.rhodius@amsterdamumc.nl		Teunissen, Charlotte/0000-0002-4061-0837; Barkhof, Frederik/0000-0003-3543-3706; van Maurik, Ingrid/0000-0001-6919-8340; Scheltens, Philip/0000-0002-1046-6408; frederiksen, Kristian Steen/0000-0001-5124-4417; Hasselbalch, Steen Gregers/0000-0003-4750-4911	Combinostics; European Union [601055, 224328, 611005]	Combinostics; European Union(European Commission)	This study is partly funded by Combinostics. The funder provided support in the form of salaries for authors [JK and JL], and had an additional role in the study as Juha Koikkalainen and Jyrki Lotjonen developed the method and quantitative raw data were generated using Combinostics' tools. They also reviewed the manuscript. The specific roles of these authors are articulated in the `author contributions' section. For development of the PredictAD tool, VTT Technical Research Centre of Finland has received funding from European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreements 601055 (VPH-DARE@IT), 224328 (PredictAD), and 611005 (PredictND). The latter had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.'	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bruun M, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101711; Bruun M, 2019, CURR ALZHEIMER RES, V16, P91, DOI 10.2174/1567205016666190103152425; Bruun Marie, 2018, Alzheimers Dement (Amst), V10, P509, DOI 10.1016/j.dadm.2018.07.003; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cluitmans Luc, 2013, Stud Health Technol Inform, V189, P77; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Da X, 2014, NEUROIMAGE-CLIN, V4, P164, DOI 10.1016/j.nicl.2013.11.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frisoni GB, 2017, LANCET NEUROL, V16, P661, DOI 10.1016/S1474-4422(17)30159-X; Girdler-Brown B, 2018, SO AFRICAN J PUBLIC, V2, P63, DOI DOI 10.7196/SHS; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grill JD, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0261-y; Insel Philip S, 2016, Alzheimers Dement (Amst), V4, P76; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Koikkalainen J, 2016, NEUROIMAGE-CLIN, V11, P435, DOI 10.1016/j.nicl.2016.02.019; Koikkalainen JR, 2019, EUR RADIOL, V29, P4937, DOI 10.1007/s00330-019-06067-1; Kunneman Marleen, 2017, Alzheimers Dement (N Y), V3, P314, DOI 10.1016/j.trci.2017.04.002; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Mattila J, 2011, J ALZHEIMERS DIS, V27, P163, DOI 10.3233/JAD-2011-110365; Mattsson N, 2017, NEUROBIOL AGING, V52, P196, DOI 10.1016/j.neurobiolaging.2016.02.034; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Palmqvist S, 2019, ALZHEIMERS DEMENT, V15, P194, DOI 10.1016/j.jalz.2018.08.014; Prestia A, 2015, ALZHEIMERS DEMENT, V11, P1191, DOI 10.1016/j.jalz.2014.12.001; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rhodius-Meester Hanneke F M, 2018, Alzheimers Dement (Amst), V10, P726, DOI 10.1016/j.dadm.2018.09.001; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Schmand B, 2012, NORMEN PSYCHOL TESTS; Shaw LM, 2018, ALZHEIMERS DEMENT, V14, P1505, DOI 10.1016/j.jalz.2018.07.220; Shortliffe EH, 2018, JAMA-J AM MED ASSOC, V320, P2199, DOI 10.1001/jama.2018.17163; Stiggelbout AM, 2015, PATIENT EDUC COUNS, V98, P1172, DOI 10.1016/j.pec.2015.06.022; Tolonen A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00111; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van der Flier WM, 2018, J ALZHEIMERS DIS, V62, P1091, DOI 10.3233/JAD-170850; van der Flier Wiesje M, 2017, Alzheimers Dement (N Y), V3, P301, DOI 10.1016/j.trci.2017.03.008; van der Flier WM, 2014, J ALZHEIMERS DIS, V41, P313, DOI 10.3233/JAD-132306; van Maurik IS, 2017, JAMA NEUROL, V74, P1481, DOI 10.1001/jamaneurol.2017.2712; Verberk IMW, 2020, ANN NEUROL, V87, P155, DOI 10.1002/ana.25633; Visser LNC, 2019, ALZH DEMENT-DADM, V11, P520, DOI 10.1016/j.dadm.2019.06.001; Vos SJB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100784; Wang YB, 2012, NEUROIMAGE, V60, P2379, DOI 10.1016/j.neuroimage.2012.02.034; Zekry D, 2002, J AM GERIATR SOC, V50, P1431, DOI 10.1046/j.1532-5415.2002.50367.x; Zwan M, 2014, J ALZHEIMERS DIS, V41, P801, DOI 10.3233/JAD-132561	47	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0226784	10.1371/journal.pone.0226784	http://dx.doi.org/10.1371/journal.pone.0226784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940390	Green Published, Green Submitted, gold			2022-12-26	WOS:000534368000042
J	Brown, CL; Garner, E; Jospin, G; Coil, DA; Schwake, DO; Eisen, JA; Mukhopadhyay, B; Pruden, AJ				Brown, Connor L.; Garner, Emily; Jospin, Guillaume; Coil, David A.; Schwake, David O.; Eisen, Jonathan A.; Mukhopadhyay, Biswarup; Pruden, Amy J.			Whole genome sequence analysis reveals the broad distribution of the RtxA type 1 secretion system and four novel putative type 1 secretion systems throughout the Legionella genus	PLOS ONE			English	Article							PROTEIN SECRETION; PNEUMOPHILA; IDENTIFICATION; ALIGNMENT; DATABASE; PATHWAY; TOLC	Type 1 secretion systems (T1SSs) are broadly distributed among bacteria and translocate effectors with diverse function across the bacterial cell membrane. Legionella pneumophila, the species most commonly associated with Legionellosis, encodes a T1SS at the lssXY-ZABD locus which is responsible for the secretion of the virulence factor RtxA. Many investigations have failed to detect lssD, the gene encoding the membrane fusion protein of the RtxA T1SS, in non-pneumophila Legionella, which has led to the assumption that this system is a virulence factor exclusively possessed by L. pneumophila. Here we discovered RtxA and its associated T1SS in a novel Legionella taurinensis strain, leading us to question whether this system may be more widespread than previously thought. Through a bioinformatic analysis of publicly available data, we classified and determined the distribution of four T1SSs including the RtxA T1SS and four novel T1SSs among diverse Legionella spp. The ABC transporter of the novel Legionella T1SS Legionella repeat protein secretion system shares structural similarity to those of diverse T1SS families, including the alkaline protease T1SS in Pseudomonas aeruginosa. The Legionella bacteriocin (1-3) secretion systems T1SSs are novel putative bacteriocin transporting T1SSs as their ABC transporters include C-39 peptidase domains in their N-terminal regions, with LB2SS and LB3SS likely constituting a nitrile hydratase leader peptide transport T1SSs. The LB1SS is more closely related to the colicin V T1SS in Escherichia coli. Of 45 Legionella spp. whole genomes examined, 19 (42%) were determined to possess lssB and lssD homologs. Of these 19, only 7 (37%) are known pathogens. There was no difference in the proportions of disease associated and non-disease associated species that possessed the RtxA T1SS (p = 0.4), contrary to the current consensus regarding the RtxA T1SS. These results draw into question the nature of RtxA and its T1SS as a singular virulence factor. Future studies should investigate mechanistic explanations for the association of RtxA with virulence.	[Brown, Connor L.; Garner, Emily; Pruden, Amy J.] Virginia Tech, Via Dept Civil & Environm Engn, Blacksburg, VA 24061 USA; [Brown, Connor L.; Mukhopadhyay, Biswarup] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Garner, Emily] West Virginia Univ, Dept Civil & Environm Engn, Morgantown, WV 26506 USA; [Jospin, Guillaume; Coil, David A.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Schwake, David O.] Middle Georgia State Univ, Dept Nat Sci, Macon, GA USA; [Eisen, Jonathan A.] Univ Calif Davis, Evolut & Ecol Med Microbiol & Immunol, Davis, CA 95616 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; West Virginia University; University of California System; University of California Davis; University of California System; University of California Davis	Pruden, AJ (corresponding author), Virginia Tech, Via Dept Civil & Environm Engn, Blacksburg, VA 24061 USA.	apruden@vt.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Garner, Emily/0000-0002-1579-155X; Coil, David/0000-0001-6049-8240	US National Science Foundation via RAPID Award [1556258, DGE 0822220, 1336650]; Alfred P. Sloan Foundation Microbiology of the Built Environment program; American Water Works Association Abel Wolman Fellowship; Institute for Critical Technology and Applied Science and Engineering of the Exposome Center at Virginia Polytechnic Institute	US National Science Foundation via RAPID Award(National Science Foundation (NSF)); Alfred P. Sloan Foundation Microbiology of the Built Environment program; American Water Works Association Abel Wolman Fellowship; Institute for Critical Technology and Applied Science and Engineering of the Exposome Center at Virginia Polytechnic Institute	This study was supported by the US National Science Foundation via RAPID Award no. 1556258: Recipient: A.P.; a Graduate Research Fellowship Program Grant (DGE 0822220): Recipient: E.G.; Supplementary funding associated with award #1336650: Recipient: A.P. Additional support was provided by the Alfred P. Sloan Foundation Microbiology of the Built Environment program (https://sloan.org/programs/research/microbiology-of-the-built-environment#apply): Recipient: E.G.; the American Water Works Association Abel Wolman Fellowship: Recipient: E. G.; and the Institute for Critical Technology and Applied Science and Engineering of the Exposome Center (https://ictas.vt.edu/) at Virginia Polytechnic Institute and State University: Recipient: A.P. In addition to the funding sources noted, colleague Marc A. Edwards contributed discretionary research funding to support the sequencing study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23080; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BOHACH GA, 1985, J BACTERIOL, V164, P1071, DOI 10.1128/JB.164.3.1071-1080.1985; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Chatterjee D, 2012, J BACTERIOL, V194, P4415, DOI 10.1128/JB.00640-12; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Cirillo SLG, 2001, INFECT IMMUN, V69, P508, DOI 10.1128/IAI.69.1.508-517.2001; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Fuche F, 2015, J BACTERIOL, V197, P563, DOI 10.1128/JB.02164-14; Garner E, 2019, EMERG INFECT DIS, V25, P2013, DOI 10.3201/eid2511.181032; Gimmestad M, 2006, J BACTERIOL, V188, P5551, DOI 10.1128/JB.00236-06; Ginalski K, 2004, TRENDS BIOCHEM SCI, V29, P392, DOI 10.1016/j.tibs.2004.06.001; Gomez-Valero L, 2019, P NATL ACAD SCI USA, V116, P2265, DOI 10.1073/pnas.1808016116; Guzzo J, 1991, J BACTERIOL; Haft DH, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-70; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; ISO, 117312017EN ISO; Jacobi S, 2003, INT J MED MICROBIOL, V293, P349, DOI 10.1078/1438-4221-00276; Kanonenberg K, 2013, RES MICROBIOL, V164, P596, DOI 10.1016/j.resmic.2013.03.011; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Kozlov A., 2018, BIORXIV; Lecher J, 2012, STRUCTURE, V20, P1778, DOI 10.1016/j.str.2012.08.005; Lo Presti F, 1999, INT J SYST BACTERIOL, V49, P397, DOI 10.1099/00207713-49-2-397; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qin T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00388; Shah, 2014, LEGIONNAIRES DIS SUR; Smith TJ, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00168-18; Smith TJ, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00734-17; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Whiley H, 2011, EMERG INFECT DIS, V17, P579, DOI 10.3201/eid1704.100446; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550	40	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0223033	10.1371/journal.pone.0223033	http://dx.doi.org/10.1371/journal.pone.0223033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935215	gold, Green Published, Green Submitted			2022-12-26	WOS:000534354100005
J	Chen, QK; Fu, LM				Chen, Qingke; Fu, Lingmin			Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504	PLOS ONE			English	Article							PROLIFERATION; BIOMARKERS; PATHWAY	Background Increasing evidence has suggested that multiple long non-coding RNAs (lncRNAs) act key regulatory functions in the pathogenesis of bladder cancer. This study aimed to determine the expression and clinical significance of lncRNA ROR1 antisense RNA 1 (ROR1-AS1) from patients with bladder cancer, and to explore the potential role and mechanism underlying ROR1-AS1-related cancer progression. Methods Real time quantitative PCR (RT-qPCR) was conducted to detected the expression levels of ROR1-AS1 and miR-504 in bladder cancer samples and cell lines. Chi-square test was used for correlation analysis. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) and wound scratch assays were applied to assesses the effects of ROR1-AS1 overexpression and knockdown on bladder cancer cell growth and migration in vitro, respectively. The prognosis of bladder cancer patients was evaluated by survival curves with Kaplan-Meier method. The regulatory mechanism of ROR1-AS1 on miR-504 was confirmed by bioinformatics analysis and luciferase reporter gene assay. Results ROR1-AS1 levels were obviously upregulated in bladder cancer tissues than matched normal bladder tissues. High expression of ROR1-AS1 was remarkably correlated with higher histological grade, advanced tumor stage, and positive lymph node metastasis. High ROR1-AS1 expression was markedly correlated with shorter overall survival of bladder cancer patients. Moreover, knockdown of ROR1-AS1 notably repressed T24 and 5637 cell growth and migration. ROR1-AS1 directly bound with miR-504 and act as a molecular sponge to decrease miR-504 expression. Silencing of miR-504 partly abrogated ROR1-AS1 knockdown-induced inhibitory effects on bladder cancer cell growth and migration. Conclusions Our data demonstrated that increased ROR1-AS1 promotes cell growth and migration of bladder cancer via regulation of miR-504, indicating ROR1-AS1 may be used as a prognostic biomarker and therapeutic target for bladder cancer.	[Chen, Qingke] Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China; [Fu, Lingmin] Jiangxi Hlth Vocat Coll, Nanchang, Jiangxi, Peoples R China	Nanchang University	Chen, QK (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Urol, Nanchang, Jiangxi, Peoples R China.	cqkurethral@126.com						Abdollahzadeh R, 2019, J CELL PHYSIOL, V234, P10080, DOI 10.1002/jcp.27941; Alifrangis C, 2019, NAT REV UROL, V16, P465, DOI 10.1038/s41585-019-0208-0; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Chakraborty A, 2019, AM J CANCER RES, V9, P1104; Chi YJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091015; Dinescu S, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010052; Dobruch J, 2016, EUR UROL, V69, P300, DOI 10.1016/j.eururo.2015.08.037; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Fang C, 2019, CELL CYCLE, V18, P3288, DOI 10.1080/15384101.2019.1673633; Gao RX, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1102-6; Gulia C, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110339; Hu GZ, 2017, ONCOTARGET, V8, P80223, DOI 10.18632/oncotarget.17956; Kikkawa N, 2014, INT J ONCOL, V44, P2085, DOI 10.3892/ijo.2014.2349; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Li YZ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00280; Liao TT, 2019, EUR REV MED PHARMACO, V23, P117, DOI 10.26355/eurrev_201908_18638; Liu Q, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1370-1; Maraver A, 2015, J CLIN INVEST, V125, P824, DOI 10.1172/JCI78185; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miao LY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1149-4; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Oosterlinck W, 2002, EUR UROL, V41, P105, DOI 10.1016/S0302-2838(01)00026-4; Pellucchi F, 2011, J UROLOGY, V186, P2194, DOI 10.1016/j.juro.2011.07.070; Quan H, 2018, BIOMED PHARMACOTHER, V107, P754, DOI 10.1016/j.biopha.2018.07.150; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song ZW, 2019, J CELL MOL MED, V23, P7554, DOI 10.1111/jcmm.14625; Taheri Mohammad, 2018, Biophys Rev, V10, P1205, DOI 10.1007/s12551-017-0379-y; Wang FZ, 2019, EUR REV MED PHARMACO, V23, P6899, DOI 10.26355/eurrev_201908_18729; Wang W, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191453; Yang ZZ, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.272; Ye MF, 2018, BIOMED PHARMACOTHER, V97, P1289, DOI 10.1016/j.biopha.2017.11.005; Zeng XY, 2019, CANCER MED-US, V8, P7074, DOI 10.1002/cam4.2586; Zheng YJ, 2019, FASEB J, V33, P12915, DOI 10.1096/fj.201900803R	34	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227568	10.1371/journal.pone.0227568	http://dx.doi.org/10.1371/journal.pone.0227568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929567	gold, Green Published			2022-12-26	WOS:000534352500047
J	Valli, E; Baudier, RL; Harriett, AJ; Norton, EB				Valli, Eduardo; Baudier, Robin L.; Harriett, Amanda J.; Norton, Elizabeth B.			LTA1 and dmLT enterotoxin-based proteins activate antigen-presenting cells independent of PKA and despite distinct cell entry mechanisms	PLOS ONE			English	Article							COLI HEAT-LABILE; CD4(+) T-CELLS; CHOLERA-TOXIN; TH17 RESPONSES; CYTOKINE PRODUCTION; IMMUNE-RESPONSES; VACCINE ADJUVANT; DENDRITIC CELLS; BELLS-PALSY; MUCOSAL	Enterotoxin-based proteins are powerful manipulators of mucosal immunity. The A1 domain of heat-labile enterotoxin from E. coli, or LTA1, is a newer adjuvant from this family under investigation for intranasal vaccines. Although LTA1 has been examined in mouse vaccination studies, its ability to directly stimulate immune cells compared to related adjuvant proteins has not been well explored. Here, we perform the first rigorous examination of LTA1's effect on antigen presenting cells (APC) using a human monocyte cell line THP-1. To better understand LTA1's stimulatory effects, we compared it to dmLT, or LT-R192G/L211A, a related AB5 adjuvant in clinical trials for oral or parenteral vaccines. LTA1 and dmLT both activated APCs to upregulate MHC-II (HLA-DR), CD86, cytokine secretion (e.g., IL-1 beta) and inflammasome activation. The effect of LTA1 on surface marker changes (e.g., MHC-II) was highly dose-dependent whereas dmLT exhibited high MHC-II expression regardless of dose. In contrast, cytokine secretion profiles were similar and dose-dependent after both LTA1 and dmLT treatment. Cellular activation by LTA1 was independent of ganglioside binding, as pretreatment with purified GM1 blocked the effect of dmLT but not LTA1. Unexpectedly, while activation of the inflammasome and cytokine secretion by LTA1 or dmLT was blocked by the protein kinase A inhibitor H89 (similar to previous reports), these responses were not inhibited by a more specific PKA peptide inhibitor or antagonist; thus Indicating that a novel and unknown mechanism is responsible for inflammasome activation and cytokine secretion by LT proteins. Lastly, LTA1 stimulated a similar cytokine profile in primary human monocytes as it did in THP1 cells, including IL-1 beta, IL-6, IL-8, MIP-1 alpha, MIP-1 beta, and TNF alpha. Thus, we report that LTA1 protein programs a dendritic cell-like phenotype in APCs similar to dmLT in a mechanism that is independent of PKA activation and GM1 binding and entry.	[Valli, Eduardo; Baudier, Robin L.; Harriett, Amanda J.; Norton, Elizabeth B.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University	Norton, EB (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.	enorton@tulane.edu		Harriett, Amanda/0000-0002-7858-1592; Baudier, Robin/0000-0002-3912-8891; Norton, Elizabeth/0000-0002-8426-3515	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health [R01AI114697]	National Institute Of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by a grant to E.B.N. from the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI114697. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren LC, 1997, J IMMUNOL, V158, P3936; Anosova NG, 2008, MUCOSAL IMMUNOL, V1, P59, DOI 10.1038/mi.2007.7; Arend WP, 2000, ANN RHEUM DIS, V59, P60, DOI 10.1136/ard.59.suppl_1.i60; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Bowman CC, 2001, INFECT IMMUN, V69, P1528, DOI 10.1128/IAI.69.3.1528-1535.2001; Brereton CF, 2011, J IMMUNOL, V186, P5896, DOI 10.4049/jimmunol.1003789; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Cheng E, 1999, VACCINE, V18, P38, DOI 10.1016/S0264-410X(99)00168-1; CLEMENTS JD, 1988, VACCINE, V6, P269, DOI 10.1016/0264-410X(88)90223-X; Clements JD, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00215-18; Eriksson A, 2003, VACCINE, V22, P185, DOI 10.1016/S0264-410X(03)00567-X; Fahlen-Yrlid L, 2009, J IMMUNOL, V183, P5032, DOI 10.4049/jimmunol.0803992; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Frederick DR, 2018, MUCOSAL IMMUNOL, V11, P549, DOI 10.1038/mi.2017.70; Hajishengallis G, 2004, INFECT IMMUN, V72, P6351, DOI 10.1128/IAI.72.11.6351-6358.2004; Heine SJ, 2014, J IMMUNOL, V192, P1630, DOI 10.4049/jimmunol.1302743; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Larena M, 2015, J IMMUNOL, V194, P3829, DOI 10.4049/jimmunol.1401633; Leach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051718; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Limbutara K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39116-2; Liu D, 2016, APPL MICROBIOL BIOT, V100, P5079, DOI 10.1007/s00253-016-7423-x; LOBET Y, 1991, INFECT IMMUN, V59, P2870, DOI 10.1128/IAI.59.9.2870-2879.1991; LYCKE N, 1992, EUR J IMMUNOL, V22, P2277, DOI 10.1002/eji.1830220915; Maciel M, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00460-19; Mittar D., 2011, FLOW CYTOMETRY HIGH; MOSS J, 1981, J BIOL CHEM, V256, P2861; Mudrak B, 2010, TOXINS, V2, P1445, DOI 10.3390/toxins2061445; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Negri DRM, 2009, INFECT IMMUN, V77, P1924, DOI 10.1128/IAI.01559-08; Norton EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136302; Norton EB, 2015, VACCINE, V33, P1909, DOI 10.1016/j.vaccine.2015.02.069; Norton EB, 2012, INFECT IMMUN, V80, P2426, DOI 10.1128/IAI.00181-12; Norton EB, 2011, CLIN VACCINE IMMUNOL, V18, P546, DOI 10.1128/CVI.00538-10; Novotny LA, 2011, MUCOSAL IMMUNOL, V4, P456, DOI 10.1038/mi.2011.6; Ogra PL, 2001, CLIN MICROBIOL REV, V14, P430, DOI 10.1128/CMR.14.2.430-445.2001; Okemoto K, 2006, J IMMUNOL, V176, P1203, DOI 10.4049/jimmunol.176.2.1203; Read LT, 2014, INFECT IMMUN, V82, P5308, DOI 10.1128/IAI.02496-14; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ryan EJ, 2000, J IMMUNOL, V165, P5750, DOI 10.4049/jimmunol.165.10.5750; Valli E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51356-w; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227047	10.1371/journal.pone.0227047	http://dx.doi.org/10.1371/journal.pone.0227047			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929548	gold, Green Published			2022-12-26	WOS:000534352500027
J	Veith, M; Gocmen, B; Sotiropoulos, K; Eleftherakos, K; Lotters, S; Godmann, O; Karis, M; Oguz, A; Ehl, S				Veith, Michael; Gocmen, Bayram; Sotiropoulos, Konstantinos; Eleftherakos, Karolos; Loetters, Stefan; Godmann, Olaf; Karis, Mert; Oguz, Anil; Ehl, Sarah			Phylogeographic analyses point to long-term survival on the spot in micro-endemic Lycian salamanders	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; LYCIASALAMANDRA-ATIFI BASOGLU; GENETIC DIFFERENTIATION; AMPHIBIA SALAMANDRIDAE; URODELA SALAMANDRIDAE; SPECIES DISTRIBUTIONS; POPULATION-GENETICS; DNA HAPLOTYPES; SEQUENCE; ANTALYA	Lycian salamanders (genus Lyciasalamandra) constitute an exceptional case of micro-endemism of an amphibian species on the Asian Minor mainland. These viviparous salamanders are confined to karstic limestone formations along the southern Anatolian coast and some islands. We here study the genetic differentiation within and among 118 populations of all seven Lyciasalamandra species across the entire genus' distribution. Based on circa 900 base pairs of fragments of the mitochondrial 16SrDNA and ATPase genes, we analysed the spatial haplotype distribution as well as the genetic structure and demographic history of populations. We used 253 geo-referenced populations and CHELSA climate data to infer species distribution models which we projected on climatic conditions of the Last Glacial Maximum (LGM). Within all but one species, distinct phyloclades were identified, which only in parts matched current taxonomy. Most haplotypes (78%) were private to single populations. Sometimes population genetic parameters showed contradicting results, although in several cases they indicated recent population expansion of phyloclades. Climatic suitability of localities currently inhabited by salamanders was significantly lower during the LGM compared to recent climate. All data indicated a strong degree of isolation among Lyciasalamandra populations, even within phyloclades. Given the sometimes high degree of haplotype differentiation between adjacent populations, they must have survived periods of deteriorated climates during the Quaternary on the spot. However, the alternative explanation of male biased dispersal combined with a pronounced female philopatry can only be excluded if independent nuclear data confirm this result.	[Veith, Michael; Loetters, Stefan; Ehl, Sarah] Trier Univ, Dept Biogeog, Univ Ring, Trier, Germany; [Gocmen, Bayram; Karis, Mert; Oguz, Anil] Ege Univ, Zool Sect, Dept Biol, Fac Sci, Izmir, Turkey; [Sotiropoulos, Konstantinos] Univ Ioannina, Dept Biol Applicat & Technol, Ioannina, Greece; [Eleftherakos, Karolos] Univ Athens, Sect Zool Marine Biol, Dept Biol, Athens, Greece; [Godmann, Olaf] Hauptstr, Niedernhausen, Germany	Universitat Trier; Ege University; University of Ioannina; National & Kapodistrian University of Athens	Veith, M (corresponding author), Trier Univ, Dept Biogeog, Univ Ring, Trier, Germany.	veith@uni-trier.de	OĞUZ, Mehmet Anıl/AGW-8026-2022; Sotiropoulos, Konstantinos/AAM-1860-2021; OĞUZ, Mehmet Anıl/AGW-8113-2022	OĞUZ, Mehmet Anıl/0000-0002-2539-8399; 				Akman B, 2014, SALAMANDRA, V50, P125; Alho JS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-317; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Andersen BG, 1994, ICE AGE WORLD; Avise J.C., 2000, PHYLOGEOGRAPHY; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479; Blondel J, 2010, MEDITERRANEAN REGION; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bouckaert RR, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0890-6; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COOPE GR, 1994, PHILOS T ROY SOC B, V344, P19, DOI 10.1098/rstb.1994.0046; Crottini A, 2012, J ZOOL SYST EVOL RES, V50, P305, DOI 10.1111/j.1439-0469.2012.00665.x; Dinis M, 2019, MOL PHYLOGENET EVOL, V130, P81, DOI 10.1016/j.ympev.2018.10.018; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dufresnes C, 2016, MOL ECOL, V25, P4285, DOI 10.1111/mec.13706; Ehl S, MOL PHYL EVOL; Eleftherakos K, 2007, ANN ZOOL FENN, V44, P387; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Franklin J., 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Fu YX, 1997, GENETICS, V147, P915; Gocmen B, 2018, ZOOL MIDDLE EAST, V64, P304, DOI 10.1080/09397140.2018.1511291; Gocmen B, 2012, NORTH-WEST J ZOOL, V8, P181; Gocmen B, 2011, NORTH-WEST J ZOOL, V7, P151; GOTOH O, 1993, COMPUT APPL BIOSCI, V9, P361; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Helfer V, 2012, MOL ECOL, V21, P4706, DOI 10.1111/j.1365-294X.2012.05742.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hobohm, 2014, ENDEMISM VASCULAR PL, P205; Johannesen J, 2006, J EVOLUTION BIOL, V19, P705, DOI 10.1111/j.1420-9101.2005.01064.x; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Klewen R, 1991, LANDSALAMANDER EUROP, P584; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lymberakis Petros, 2010, Diversity, V2, P233; Martinez-Solano I, 2006, MOL ECOL, V15, P3375, DOI 10.1111/j.1365-294X.2006.03013.x; Mayr E., 1942, P1; Mazza PPA, 2013, BIOSCIENCE, V63, P939, DOI 10.1525/bio.2013.63.12.7; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Muller C, 1985, GEOLOGICAL EVOLUTION, P458; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Oguz Mehmet Anti, 2016, South-Western Journal of Horticulture Biology and Environment, V7, P61; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Pons O, 1996, GENETICS, V144, P1237; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Recuero E, 2011, MOL PHYLOGENET EVOL, V60, P170, DOI 10.1016/j.ympev.2011.04.006; Rodriguez A, 2015, EVOL ECOL, V29, P765, DOI 10.1007/s10682-015-9774-7; Rodder D, 2011, ORG DIVERS EVOL, V11, P409, DOI 10.1007/s13127-011-0058-y; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Sinsch U, 2017, ZOOL ANZ, V269, P48, DOI 10.1016/j.jcz.2017.07.005; Skourtanioti E, 2016, MOL PHYLOGENET EVOL, V103, P199, DOI 10.1016/j.ympev.2016.07.005; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Teixeira J, 2018, CURR ZOOL, V64, P755, DOI 10.1093/cz/zoy010; TEMPLETON AR, 1995, GENETICS, V140, P767; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tok Cemal Varol, 2016, Ecologica Montenegrina, V9, P38; Urban MC, 2014, EVOL APPL, V7, P88, DOI 10.1111/eva.12114; van Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI 10.1111/ecog.01509; Varela S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129037; Veith M, 2003, MOL ECOL, V12, P185, DOI 10.1046/j.1365-294X.2003.01714.x; Veith Michael, 2001, Zoology in the Middle East, V22, P67; Veith M, 2016, AMPHIBIA-REPTILIA, V37, P373, DOI 10.1163/15685381-00003067; Vences M, 2017, SALAMANDRA, V53, P25; Vences M, 2013, MOL PHYLOGENET EVOL, V68, P657, DOI 10.1016/j.ympev.2013.04.014; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Warton D, 2013, J ANIM ECOL, V82, P1125, DOI 10.1111/1365-2656.12071; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Wertheim JO, 2010, SYST BIOL, V59, P1, DOI 10.1093/sysbio/syp072; Wilson RCL, 1999, GREAT ICE AGE, DOI [10.1046/J.1365-294.2003.01714.X, DOI 10.1046/J.1365-294.2003.01714.X]; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Yildiz MZ, 2015, HERPETOZOA, V28, P3; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	99	7	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226326	10.1371/journal.pone.0226326	http://dx.doi.org/10.1371/journal.pone.0226326			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929551	Green Published, gold			2022-12-26	WOS:000534352500009
J	Borges, D; Guzman-Novoa, E; Goodwin, PH				Borges, Daniel; Guzman-Novoa, Ernesto; Goodwin, Paul H.			Control of the microsporidian parasite Nosema ceranae in honey bees (Apis mellifera) using nutraceutical and immuno-stimulatory compounds	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INTESTINAL-MUCOSA; OXIDATIVE STRESS; INDUCED COLITIS; ESSENTIAL OILS; SULFORAPHANE; NARINGENIN; ANTIOXIDANT; INFECTION; CURCUMIN	Nosema ceranae is a microsporidian parasite that causes nosemosis in the honey bee (Apis mellifera). As alternatives to the antibiotic fumagillin, ten nutraceuticals (oregano oil, thymol, carvacrol, trans-cinnmaldehyde, tetrahydrocurcumin, sulforaphane, naringenin, embelin, allyl sulfide, hydroxytyrosol) and two immuno-stimulatory compounds (chitosan, poly I:C) were examined for controlling N. ceranae infections. Caged bees were inoculated with N. ceranae spores, and treatments were administered in sugar syrup. Only two compounds did not significantly reduce N. ceranae spore counts compared to the infected positive control, but the most effective were sulforaphane from cruciferous vegetables, carvacrol from oregano oil, and naringenin from citrus fruit. When tested at several concentrations, the highest sulforaphane concentration reduced spore counts by 100%, but also caused 100% bee mortality. For carvacrol, the maximum reduction in spore counts was 57% with an intermediate concentration and the maximum bee mortality was 23% with the highest concentration. For naringenin, the maximum reduction in spore counts was 64% with the highest concentration, and the maximum bee mortality was only 15% with an intermediate concentration. In the longevity experiment, naringenin-fed bees lived as long as Nosema-free control bees, both of which lived significantly longer than infected positive control bees. While its antimicrobial properties may be promising, reducing sulforaphane toxicity to bees is necessary before it can be considered as a candidate for controlling N. ceranae. Although further work on formulation is needed with naringenin, its effect on extending longevity in infected bees may give it an additional value as a potential additive for bee feed in honey bee colonies.	[Borges, Daniel; Guzman-Novoa, Ernesto; Goodwin, Paul H.] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada	University of Guelph	Guzman-Novoa, E (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON, Canada.	eguzman@uoguelph.ca		Guzman-Novoa, Ernesto/0000-0001-5632-0642	Ontario Ministry of Agriculture, Food, and Rural Affairs [200456]	Ontario Ministry of Agriculture, Food, and Rural Affairs	This study was funded by a grant from the Ontario Ministry of Agriculture, Food, and Rural Affairs to EG (Grant No. 200456). The funders did not play any role in the study. There was no additional external funding received for this study.; Paul Kelly, Nancy Bradbury, Dave Stotesbury, and a number of other volunteers at the Honey Bee Research Centre helped with sampling and feeding bees, while Pegah Valizadeh, Mariana Reyes, and Mollah Md. Hamiduzzaman helped with lab procedures. Esther Uribe-Ortega and Brenda A. Rios-Rodriguez helped greatly with all aspects of the study. Berna Emsen assisted with formatting the document. This study was funded in part by a grant from the Ontario Ministry of Agriculture, Food, and Rural Affairs to EG (Grant No. 200456).	Amaro MI, 2009, FOOD RES INT, V42, P1010, DOI 10.1016/j.foodres.2009.04.016; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aronstein KA, 2004, J APICULT RES, V43, P57, DOI 10.1080/00218839.2004.11101111; Assini JM, 2013, J LIPID RES, V54, P711, DOI 10.1194/jlr.M032631; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Bie JH, 2011, CIRCULATION, V124; BOGDAN I, 1986, Buletinul Institutului Agronomic Cluj-Napoca Seria Zootehnie si Medicina Veterinara, V40, P81; Brower V, 1998, NAT BIOTECHNOL, V16, P728, DOI 10.1038/nbt0898-728; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chattopadhyay D, 2016, BIOGERONTOLOGY, V17, P383, DOI 10.1007/s10522-015-9624-6; Chaudhari HS, 2012, PLANTA MED, V78, P651, DOI 10.1055/s-0031-1298379; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Cho S, 2012, J NUTR BIOCHEM, V23, P192, DOI 10.1016/j.jnutbio.2010.11.016; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Devi A. Girija, 2010, Uttar Pradesh Journal of Zoology, V30, P173; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Ebert TA, 2007, J APICULT RES, V46, P220, DOI 10.1080/00218839.2007.11101398; Emsen B, 2016, PARASITOL RES, V115, P175, DOI 10.1007/s00436-015-4733-3; GARY NE, 1976, ANN ENTOMOL SOC AM, V69, P287, DOI 10.1093/aesa/69.2.287; Gashout HA, 2009, J APICULT RES, V48, P263, DOI 10.3896/IBRA.1.48.4.06; Goblirsch M, 2018, APIDOLOGIE, V49, P131, DOI 10.1007/s13592-017-0535-1; Guzman-Novoa E, 2016, ONE HLTH CASE STUDIE, P204; Hamiduzzaman MM, 2010, J INVERTEBR PATHOL, V105, P151, DOI 10.1016/j.jip.2010.06.001; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P530, DOI 10.1111/1758-2229.12059; Higes M, 2011, APIDOLOGIE, V42, P364, DOI 10.1007/s13592-011-0003-2; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Huang RL, 2007, J SCI FOOD AGR, V87, P153, DOI 10.1002/jsfa.2694; Huang WF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003185; Jayaraman J, 2012, TOXICOL MECH METHOD, V22, P568, DOI 10.3109/15376516.2012.707255; Johansson NL, 2008, PLANTA MED, V74, P747, DOI 10.1055/s-2008-1074520; KATZNELSON H, 1952, SCIENCE, V115, P70, DOI 10.1126/science.115.2977.70; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kim DK, 2010, POULTRY SCI, V89, P68, DOI 10.3382/ps.2009-00275; Kollanoor-Johny A, 2012, J APPL POULTRY RES, V21, P816, DOI 10.3382/japr.2012-00540; Kubota M, 2012, NUTR CANCER, V64, P72, DOI 10.1080/01635581.2012.630554; Kumar GK, 2011, INT IMMUNOPHARMACOL, V11, P724, DOI 10.1016/j.intimp.2011.01.022; Lee SH, 2012, FOOD CHEM TOXICOL, V50, P567, DOI 10.1016/j.fct.2011.11.027; Li B, 2010, APPL ENTOMOL ZOOL, V45, P145, DOI 10.1303/aez.2010.145; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Maistrello L, 2008, APIDOLOGIE, V39, P436, DOI 10.1051/apido:2008022; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; McGowan J, 2016, J MICROBIOL METH, V131, P16, DOI 10.1016/j.mimet.2016.09.021; Mentor S, 2017, CURR NEUROVASC RES, V14, P71, DOI 10.2174/1567202613666161129113950; Nakmareong S, 2011, N-S ARCH PHARMACOL, V383, P519, DOI 10.1007/s00210-011-0624-z; Nanetti A, 2015, RES VET SCI, V102, P167, DOI 10.1016/j.rvsc.2015.08.003; Neumann P, 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.1.04, DOI 10.3896/IBRA.1.52.1.04]; Porrini MP, 2011, APIDOLOGIE, V42, P700, DOI 10.1007/s13592-011-0076-y; Parvizi P, 2012, CAN J VET RES, V76, P230; Ptaszynska AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23678-8; Qin B, 2009, HORM METAB RES, V41, P516, DOI 10.1055/s-0029-1202813; Rodriguez-Gutierrez G, 2012, MOL NUTR FOOD RES, V56, P1131, DOI 10.1002/mnfr.201100808; Roussel M, 2015, CARBOHYD POLYM, V133, P213, DOI 10.1016/j.carbpol.2015.07.022; Saltykova ES, 2016, APPL BIOCHEM MICRO+, V52, P553, DOI 10.1134/S0003683816050136; Schaffer S, 2007, J AGR FOOD CHEM, V55, P5043, DOI 10.1021/jf0703710; Sinpoo C, 2018, J INSECT PHYSIOL, V105, P1, DOI 10.1016/j.jinsphys.2017.12.010; St Paul M, 2013, VET IMMUNOL IMMUNOP, V152, P191, DOI 10.1016/j.vetimm.2012.10.013; Strachecka AJ, 2015, J APIC SCI, V59, P129, DOI 10.1515/jas-2015-0014; Tsinas A, 2011, J POULT SCI, V48, P194, DOI 10.2141/jpsa.010123; Turgis M, 2012, FOOD RES INT, V48, P696, DOI 10.1016/j.foodres.2012.06.016; van den Heever JP, 2016, APIDOLOGIE, V47, P617, DOI 10.1007/s13592-015-0409-3; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang YG, 2014, AM J PHYSIOL-ENDOC M, V307, pE14, DOI 10.1152/ajpendo.00702.2013; Williams GR, 2008, J INVERTEBR PATHOL, V99, P342, DOI 10.1016/j.jip.2008.04.005; Yanaka A, 2013, CURR PHARM DESIGN, V19, P157, DOI 10.2174/13816128130120	69	30	31	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227484	10.1371/journal.pone.0227484	http://dx.doi.org/10.1371/journal.pone.0227484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923212	Green Published, gold			2022-12-26	WOS:000534350000084
J	Mori, H; Ogura, Y; Enomoto, K; Hara, M; Maurstad, G; Stokke, BT; Kitamura, S				Mori, Hideki; Ogura, Yuko; Enomoto, Kenta; Hara, Masayuki; Maurstad, Gjertrud; Stokke, Bjorn Torger; Kitamura, Shinichi			Dense carbon-nanotube coating scaffolds stimulate osteogenic differentiation of mesenchymal stem cells	PLOS ONE			English	Article							BONE-MARROW; IN-VITRO; PROLIFERATION; TISSUE; TRANSPARENT; DNA	Carbon nanotubes (CNTs) have desirable mechanical properties for use as biomaterials in orthopedic and dental area such as bone- and tooth- substitutes. Here, we demonstrate that a glass surface densely coated with single-walled carbon nanotubes (SWNTs) stimulate the osteogenic differentiation of rat bone marrow mesenchymal stem cells (MSCs). MSCs incubated on SWNT- and multi-walled carbon nanotube (MWNT)-coated glass showed high activities of alkaline phosphatase that are markers for early stage osteogenic differentiation. Expression of Bmp2, Runx2, and Alpl of MSCs showed high level in the early stage for MSC incubation on SWNT- and MWNT-coated surfaces, but only the cells on the SWNT-coated glass showed high expression levels of Bglap (Osteocalcin). The cells on the SWNT-coated glass also contained the most calcium, and their calcium deposits had long needle-shaped crystals. SWNT coating at high density could be part of a new scaffold for bone regeneration.	[Mori, Hideki; Hara, Masayuki] Osaka Prefecture Univ, Grad Sch Sci, Sakai, Osaka, Japan; [Ogura, Yuko; Enomoto, Kenta; Kitamura, Shinichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan; [Maurstad, Gjertrud; Stokke, Bjorn Torger] NTNU Norwegian Univ Sci & Technol, Biophys & Med Technol, Dept Phys, Trondheim, Norway; [Kitamura, Shinichi] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Norwegian University of Science & Technology (NTNU); Osaka Metropolitan University	Mori, H (corresponding author), Osaka Prefecture Univ, Grad Sch Sci, Sakai, Osaka, Japan.; Kitamura, S (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan.; Kitamura, S (corresponding author), Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka, Japan.	morihide@b.s.osakafu-u.ac.jp; skita@bioinfo.osakafu-u.ac.jp	Mori, Hideki/AAI-9816-2020	Hara, Masayuki/0000-0002-3190-5908; Kitamura, Shinichi/0000-0001-7115-6561; Mori, Hideki/0000-0002-9960-9689	Joint Project for Advanced Research in Science & Technology (Osaka Prefecture University, Japan) - Graduate School of Science, Osaka Prefecture University; Osaka Prefecture University	Joint Project for Advanced Research in Science & Technology (Osaka Prefecture University, Japan) - Graduate School of Science, Osaka Prefecture University; Osaka Prefecture University	This study was funded, in part, by the Joint Project for Advanced Research in Science & Technology (Osaka Prefecture University, Japan) and the research grant for encouragement of young scientists funded by the Graduate School of Science, Osaka Prefecture University. No additional external funding was received for this study.; We thank staffs of Hitachi High-Technologies for access to instrumentation and helping the data analysis of SEM-EDX. The authors gratefully acknowledge financial support from Osaka Prefecture University.	Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118; Akasaka T, 2010, MAT SCI ENG C-MATER, V30, P391, DOI 10.1016/j.msec.2009.12.006; Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012; Ding S, 2017, BIOTECHNOL BIOENG, V114, P260, DOI 10.1002/bit.26075; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FARLEY JR, 1983, SCIENCE, V222, P330; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044; Hu L, 2004, NANO LETT, V4, P2513, DOI 10.1021/nl048435y; Infante A, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0995-x; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Kanematsu D, 2011, DIFFERENTIATION, V82, P77, DOI 10.1016/j.diff.2011.05.010; Kitamura S, Patent, Patent No. [WO2007/083771 A1, 2007083771]; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kotobuki N, 2006, J MATER SCI-MATER M, V17, P33, DOI 10.1007/s10856-006-6327-1; La Noce M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030217; Lee Ju-Ro, 2015, Biomater Res, V19, P3, DOI 10.1186/s40824-014-0024-9; Li CY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0066-5; Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045; Liberio MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112122; Liu DD, 2010, ACS NANO, V4, P2185, DOI 10.1021/nn901479w; McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794; Mooney E, 2008, NANO LETT, V8, P2137, DOI 10.1021/nl073300o; Mu QX, 2009, ACS NANO, V3, P1139, DOI 10.1021/nn900252j; Park S, 2015, J BIOMED MATER RES A, V103, P1238, DOI 10.1002/jbm.a.35236; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848; Spina A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00354; Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Takitoh T, 2015, J BIOSCI BIOENG, V119, P217, DOI 10.1016/j.jbiosc.2014.07.008; Takitoh T, 2010, J BIOSCI BIOENG, V110, P471, DOI 10.1016/j.jbiosc.2010.04.009; Tasis D, 2003, CHEM-EUR J, V9, P4001, DOI 10.1002/chem.200304800; Tran PA, 2009, ADV DRUG DELIVER REV, V61, P1097, DOI 10.1016/j.addr.2009.07.010; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670; Wong EW, 1997, SCIENCE, V277, P1971, DOI 10.1126/science.277.5334.1971; Yamakawa A, 2017, CARBOHYD POLYM, V171, P129, DOI 10.1016/j.carbpol.2017.05.012; Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e; Zhang BL, 2010, COLLOID SURFACE B, V80, P18, DOI 10.1016/j.colsurfb.2010.05.023; Zhang FY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0187-x; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	43	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0225589	10.1371/journal.pone.0225589	http://dx.doi.org/10.1371/journal.pone.0225589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923243	Green Published, gold			2022-12-26	WOS:000534350000007
J	Mousavi, S; Fotoohinasab, A; Afghah, F				Mousavi, Sajad; Fotoohinasab, Atiyeh; Afghah, Fatemeh			Single-modal and multi-modal false arrhythmia alarm reduction using attention-based convolutional and recurrent neural networks	PLOS ONE			English	Article							ICU	This study proposes a deep learning model that effectively suppresses the false alarms in the intensive care units (ICUs) without ignoring the true alarms using single- and multimodal biosignals. Most of the current work in the literature are either rule-based methods, requiring prior knowledge of arrhythmia analysis to build rules, or classical machine learning approaches, depending on hand-engineered features. In this work, we apply convolutional neural networks to automatically extract time-invariant features, an attention mechanism to put more emphasis on the important regions of the segmented input signal(s) that are more likely to contribute to an alarm, and long short-term memory units to capture the temporal information presented in the signal segments. We trained our method efficiently using a two-step training algorithm (i.e., pre-training and fine-tuning the proposed network) on the dataset provided by the PhysioNet computing in cardiology challenge 2015. The evaluation results demonstrate that the proposed method obtains better results compared to other existing algorithms for the false alarm reduction task in ICUs. The proposed method achieves a sensitivity of 93.88% and a specificity of 92.05% for the alarm classification, considering three different signals. In addition, our experiments for 5 separate alarm types leads significant results, where we just consider a single-lead ECG (e.g., a sensitivity of 90.71%, a specificity of 88.30%, an AUC of 89.51 for alarm type of Ventricular Tachycardia arrhythmia).	[Mousavi, Sajad; Fotoohinasab, Atiyeh; Afghah, Fatemeh] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA	Northern Arizona University	Mousavi, S (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.	SajadMousavi@nau.edu			National Science Foundation [1657260]; National Institute On Minority Health and Health Disparities of the National Institutes of Health [U54MD012388]	National Science Foundation(National Science Foundation (NSF)); National Institute On Minority Health and Health Disparities of the National Institutes of Health	This material is based upon work supported by the National Science Foundation under Grant Number 1657260. Research reported in this publication was also supported by the National Institute On Minority Health and Health Disparities of the National Institutes of Health under Award Number U54MD012388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelghani SA, 2016, OCHSNER J, V16, P280; Aboukhalil A, 2008, J BIOMED INFORM, V41, P442, DOI 10.1016/j.jbi.2008.03.003; Acharya UR, 2019, J MED SYST, V43, DOI 10.1007/s10916-019-1428-9; Afghah F., 2015, ARXIV151201680; Afghah F, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20030190; Ansari S, 2016, PHYSIOL MEAS, V37, P1186, DOI 10.1088/0967-3334/37/8/1186; Ansari S, 2015, COMPUT CARDIOL CONF, V42, P1181, DOI 10.1109/CIC.2015.7411127; Antink CH, 2016, PHYSIOL MEAS, V37, P1233, DOI 10.1088/0967-3334/37/8/1233; Clifford GD, 2015, COMPUT CARDIOL CONF, V42, P273, DOI 10.1109/CIC.2015.7408639; Couto P, 2015, COMPUT CARDIOL CONF, V42, P749, DOI 10.1109/CIC.2015.7411019; Drew BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110274; Fallet S, 2015, COMPUT CARDIOL CONF, V42, P277, DOI 10.1109/CIC.2015.7408640; Gajowniczek K, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19071588; He RN, 2015, COMPUT CARDIOL CONF, V42, P1189, DOI 10.1109/CIC.2015.7411129; Kalidas V, 2015, COMPUT CARDIOL CONF, V42, P733, DOI 10.1109/CIC.2015.7411015; Lai DK, 2019, IEEE ACCESS, V7, P94701, DOI 10.1109/ACCESS.2019.2925847; Lehman Eric P, 2018, Proc Mach Learn Res, V85, P571; Li AS, 2017, ARXIV170903562; Mousavi S, 2019, IEEE GEOSCI REMOTE S, P1; Mousavi S, 2019, INT CONF ACOUST SPEE, P1308, DOI [10.1109/icassp.2019.8683140, 10.1109/ICASSP.2019.8683140]; Mousavi S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216456; Mozos I, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/727401; Oroojeni MJH, 2018, EUR SIGNAL PR CONF, P1157, DOI 10.23919/EUSIPCO.2018.8552944; Plesinger F, 2015, COMPUT CARDIOL CONF, V42, P281, DOI 10.1109/CIC.2015.7408641; Shashikumar SP, 2018, KDD'18: PROCEEDINGS OF THE 24TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY & DATA MINING, P715, DOI 10.1145/3219819.3219912; Wang SJ, 2016, IEEE IJCNN, P4368, DOI 10.1109/IJCNN.2016.7727770; Zaeri-Amirani M, 2018, IEEE ENG MED BIO, P319, DOI 10.1109/EMBC.2018.8512266	27	15	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0226990	10.1371/journal.pone.0226990	http://dx.doi.org/10.1371/journal.pone.0226990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923226	gold, Green Published, Green Submitted			2022-12-26	WOS:000534350000036
J	Caon, I; Bartolini, B; Moretto, P; Parnigoni, A; Carava, E; Vitale, DL; Alaniz, L; Viola, M; Karousou, E; De Luca, G; Hascall, VC; Passi, A; Vigetti, D				Caon, Ilaria; Bartolini, Barbara; Moretto, Paola; Parnigoni, Arianna; Carava, Elena; Vitale, Daiana L.; Alaniz, Laura; Viola, Manuela; Karousou, Evgenia; De Luca, Giancarlo; Hascall, Vincent C.; Passi, Alberto; Vigetti, Davide			Sirtuin 1 reduces hyaluronan synthase 2 expression by inhibiting nuclear translocation of NF-?B and expression of the long-noncoding RNA HAS2?AS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; sirtuin 1 (SIRT1); long-noncoding RNA (long ncRNA; lncRNA); inflammation; extracellular matrix; epigenetics; metabolic regulation; glycosaminoglycan; sirtuin; HAS2; HAS2?AS1; SMC	SMOOTH-MUSCLE-CELLS; KAPPA-B; EXTRACELLULAR-MATRIX; TNF-ALPHA; POSTTRANSLATIONAL REGULATION; ATHEROSCLEROSIS; RESVERATROL; ACTIVATION; PROTEIN; TRANSCRIPTION	Hyaluronan (HA) is one of the most prevalent glycosaminoglycans of the vascular extracellular matrix (ECM). Abnormal HA accumulation within blood vessel walls is associated with tissue inflammation and is prominent in most vascular pathological conditions such as atherosclerosis and restenosis. Hyaluronan synthase 2 (HAS2) is the main hyaluronan synthase enzyme involved in HA synthesis and uses cytosolic UDP-glucuronic acid and UDP-GlcNAc as substrates. The synthesis of UDP-glucuronic acid can alter the NAD(+)/NADH ratio via the enzyme UDP-glucose dehydrogenase, which oxidizes the alcohol group at C6 to the COO? group. Here, we show that HAS2 expression can be modulated by sirtuin 1 (SIRT1), the master metabolic sensor of the cell, belonging to the class of NAD(+)-dependent deacetylases. Our results revealed the following. 1) Treatments of human aortic smooth muscle cells (AoSMCs) with SIRT1 activators (SRT1720 and resveratrol) inhibit both HAS2 expression and accumulation of pericellular HA coats. 2) Tumor necrosis factor ? (TNF?) induced HA-mediated monocyte adhesion and AoSMC migration, whereas SIRT1 activation prevented immune cell recruitment and cell motility by reducing the expression levels of the receptor for HA-mediated motility, RHAMM, and the HA-binding protein TNF-stimulated gene 6 protein (TSG6). 3) SIRT1 activation prevented nuclear translocation of NF-?B (p65), which, in turn, reduced the levels of HAS2?AS1, a long-noncoding RNA that epigenetically controls HAS2 mRNA expression. In conclusion, we demonstrate that both HAS2 expression and HA accumulation by AoSMCs are down-regulated by the metabolic sensor SIRT1.	[Caon, Ilaria; Bartolini, Barbara; Moretto, Paola; Parnigoni, Arianna; Carava, Elena; Viola, Manuela; Karousou, Evgenia; De Luca, Giancarlo; Passi, Alberto; Vigetti, Davide] Univ Insubria, Dept Med & Surg, Via JH Dunant 5, I-21100 Varese, Italy; [Vitale, Daiana L.; Alaniz, Laura] Univ Nacl Noroeste Pcia Bs As, Lab Microambiente Tumoral, CIBA, Ctr Invest & Transferencia Noroeste Pcia Bs As CI, Junin, Argentina; [Hascall, Vincent C.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA	University of Insubria; Universidad Nacional del Noroeste de la Provincia de Buenos Aires; Cleveland Clinic Foundation	Vigetti, D (corresponding author), Univ Insubria, Dept Med & Surg, Via JH Dunant 5, I-21100 Varese, Italy.	Davide.vigetti@uninsubria.it	Alaniz, Laura/AAM-2676-2020	Alaniz, Laura/0000-0002-6070-6078; Parnigoni, Arianna/0000-0002-1822-4120; Vitale, Daiana L./0000-0001-5593-9101	Universita degli Studi dell'Insubria; MIUR [PRIN 2017T8CMCY]	Universita degli Studi dell'Insubria; MIUR(Ministry of Education, Universities and Research (MIUR))	Supported by the Universita degli Studi dell'Insubria as postdoc fellows (assegno di ricerca junior).; Recipient of a fellowship supported by MIUR Grant PRIN 2017T8CMCY (to E. K.).	Badi I, 2018, ARTERIOSCL THROM VAS, V38, P2079, DOI 10.1161/ATVBAHA.118.311298; Baggenstoss BA, 2017, GLYCOBIOLOGY, V27, P154, DOI 10.1093/glycob/cww089; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caon I, 2020, SEMIN CANCER BIOL, V62, P9, DOI 10.1016/j.semcancer.2019.07.007; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chanmee T, 2016, CANCER LETT, V375, P20, DOI 10.1016/j.canlet.2016.02.031; Chen YX, 2015, BIOCHEM BIOPH RES CO, V465, P732, DOI 10.1016/j.bbrc.2015.08.066; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Davis R, 2012, CELL CYCLE, V11, P109, DOI 10.4161/cc.11.1.18473; Day AJ, 2019, MATRIX BIOL, V78-79, P60, DOI 10.1016/j.matbio.2018.01.011; de Boor S, 2015, P NATL ACAD SCI USA, V112, pE3679, DOI 10.1073/pnas.1505995112; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Filpa V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18020-7; Fischer JW, 2019, MATRIX BIOL, V78-79, P324, DOI 10.1016/j.matbio.2018.03.003; Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Heldin P, 2019, MATRIX BIOL, V78-79, P100, DOI 10.1016/j.matbio.2018.01.017; Hull RL, 2015, J HISTOCHEM CYTOCHEM, V63, P592, DOI 10.1369/0022155415576542; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jovinge S, 1997, ARTERIOSCL THROM VAS, V17, P490, DOI 10.1161/01.ATV.17.3.490; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; Karousou E, 2017, MATRIX BIOL, V59, P3, DOI 10.1016/j.matbio.2016.10.001; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kleinbongard P, 2010, PHARMACOL THERAPEUT, V127, P295, DOI 10.1016/j.pharmthera.2010.05.002; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Kolliopoulos C, 2019, MATRIX BIOL, V80, P29, DOI 10.1016/j.matbio.2018.09.002; Lauer Mark E, 2015, Int J Cell Biol, V2015, P712507, DOI 10.1155/2015/712507; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Levesque MC, 1996, J IMMUNOL, V156, P1557; Li L, 2011, CIRC RES, V108, P1180, DOI 10.1161/CIRCRESAHA.110.237875; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P103, DOI 10.1093/abbs/gmq104; Lin QQ, 2016, MED SCI MONIT BASIC, V22, P165, DOI 10.12659/MSMBR.901909; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Manou D, 2019, METHODS MOL BIOL, V1952, P1, DOI 10.1007/978-1-4939-9133-4_1; de Mera RMMF, 2019, MATRIX BIOL, V80, P85, DOI 10.1016/j.matbio.2018.10.004; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Moretto P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/167283; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Passi A, 2019, FEBS J, V286, P2937, DOI 10.1111/febs.14847; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramprasath VR, 2010, EUR J CLIN NUTR, V64, P660, DOI 10.1038/ejcn.2010.77; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Saikia P, 2017, HEPATOLOGY, V66, P602, DOI 10.1002/hep.29144; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Siiskonen H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00043; Simpson MA, 2002, J BIOL CHEM, V277, P10050, DOI 10.1074/jbc.M110069200; Sobuz SU, 2019, BBA-MOL CELL RES, V1866, P1355, DOI 10.1016/j.bbamcr.2019.05.001; Spinelli FM, 2019, FEBS J, V286, P3433, DOI 10.1111/febs.14871; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Thompson AM, 2014, AM J PHYSIOL-HEART C, V307, pH533, DOI 10.1152/ajpheart.00871.2013; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2014, FEBS J, V281, P4980, DOI 10.1111/febs.12938; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Vigetti D, 2014, ADV CANCER RES, V123, P95, DOI 10.1016/B978-0-12-800092-2.00004-6; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Vigetti D, 2014, MATRIX BIOL, V35, P8, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Viola Manuela, 2015, Int J Cell Biol, V2015, P208303, DOI 10.1155/2015/208303; Viola M, 2017, GLYCOCONJUGATE J, V34, P411, DOI 10.1007/s10719-016-9735-6; Viola M, 2016, CURR MED CHEM, V23, P2958, DOI 10.2174/0929867323666160607104602; Viola M, 2015, GLYCOCONJUGATE J, V32, P93, DOI 10.1007/s10719-015-9586-6; Viola M, 2013, J BIOL CHEM, V288, P29595, DOI 10.1074/jbc.M113.508341; Vitale Daiana L, 2018, Oncotarget, V9, P36585, DOI 10.18632/oncotarget.26379; Yamamoto H, 2017, J BIOL CHEM, V292, P7304, DOI 10.1074/jbc.M116.770149; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110; Yu X, 2015, CELL DEATH DIFFER, V22, P1170, DOI 10.1038/cdd.2014.206; Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003; Zhang P, 2016, TRANSPL P, V48, P3378, DOI 10.1016/j.transproceed.2016.10.023; Zhu GQ, 2017, MOL CARCINOGEN, V56, P2210, DOI 10.1002/mc.22674; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]	94	24	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3485	3496		10.1074/jbc.RA119.011982	http://dx.doi.org/10.1074/jbc.RA119.011982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	31932306	Green Published, hybrid			2022-12-26	WOS:000527725300010
J	Pascolutti, R; Erlandson, SC; Burri, DJ; Zheng, S; Kruse, AC				Pascolutti, Roberta; Erlandson, Sarah C.; Burri, Dominique J.; Zheng, Sanduo; Kruse, Andrew C.			Mapping and engineering the interaction between adiponectin and T-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adiponectin; crystallography; protein engineering; cadherin; adipokine	MOLECULAR-WEIGHT ADIPONECTIN; CONSERVED LYSINE RESIDUES; CELL-ADHESION MOLECULE; YEAST SURFACE DISPLAY; COLLAGENOUS DOMAIN; CRYSTAL-STRUCTURE; PROTEIN; RECEPTOR; PLASMA; ACRP30/ADIPONECTIN	Adiponectin is a highly abundant protein hormone secreted by adipose tissue. It elicits diverse biological responses, including anti-diabetic, anti-inflammatory, anti-tumor, and anti-atherosclerotic effects. Adiponectin consists of a globular domain and a collagen-like domain, and it occurs in three major oligomeric forms that self-assemble: trimers, hexamers, and high-molecular-weight oligomers. Adiponectin has been reported to bind to two seven-transmembrane domain receptors, AdipoR1 and AdipoR2, as well as to the protein T-cadherin, which is highly expressed in the cardiovascular system and binds only the high-molecular-weight form of adiponectin. The molecular mechanisms underlying this specificity remain unclear. Here we used a combination of X-ray crystallography and protein engineering to define the details of adiponectin's interaction with T-cadherin. We found that T-cadherin binds to the globular domain of adiponectin, relying on structural stabilization of this domain by bound metal ions. Moreover, we show that the adiponectin globular domain can be engineered to enhance its binding affinity for T-cadherin. These results help to define the molecular basis for the interaction between adiponectin and T-cadherin, and our engineered globular domain variants may be useful tools for further investigating adiponectin's functions.	[Pascolutti, Roberta; Erlandson, Sarah C.; Zheng, Sanduo; Kruse, Andrew C.] Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Burri, Dominique J.] Harvard Med Sch, Blavatnik Inst, Dept Microbiol, Boston, MA 02115 USA; [Zheng, Sanduo] Natl Inst Biol Sci Beijing, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing, Peoples R China	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institute of Biological Sciences, Beijing	Kruse, AC (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	andrew_kruse@hms.harvard.edu		Kruse, Andrew/0000-0002-1467-1222	National Institutes of Health [DP5OD021345]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant DP5OD021345 (to A. C. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Fukuda S, 2017, J BIOL CHEM, V292, P7840, DOI 10.1074/jbc.M117.780734; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Inoue T, 2007, AM J CARDIOL, V100, P569, DOI 10.1016/j.amjcard.2007.03.062; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kita S, 2019, ELIFE, V8, DOI 10.7554/eLife.48675; Koenen TB, 2008, BIOCHEM BIOPH RES CO, V376, P164, DOI 10.1016/j.bbrc.2008.08.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Matsuda K, 2015, ENDOCRINOLOGY, V156, P934, DOI 10.1210/en.2014-1618; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; REID KBM, 1982, BIOCHEM J, V203, P559, DOI 10.1042/bj2030559; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Richards AA, 2010, MOL ENDOCRINOL, V24, P229, DOI 10.1210/me.2009-0133; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Sjodt M, 2018, NATURE, V556, P118, DOI 10.1038/nature25985; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang Y, 2004, PROTEOMICS, V4, P3933, DOI 10.1002/pmic.200400826; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wilson D.S., 2001, CURRENT PROTOCOLS MO, DOI DOI 10.1002/0471142727.MB0803S51; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Ye J, 2019, ADIPONECTIN RELATED, V117, DOI [10.1101/776690, DOI 10.1101/776690]; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	51	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2749	2759		10.1074/jbc.RA119.010970	http://dx.doi.org/10.1074/jbc.RA119.010970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	31915248	Green Published, hybrid			2022-12-26	WOS:000519969100019
J	Kowalsky, AH; Namkoong, S; Mettetal, E; Park, HW; Kazyken, D; Fingar, DC; Lee, JH				Kowalsky, Allison Ho; Namkoong, Sim; Mettetal, Eric; Park, Hwan-Woo; Kazyken, Dubek; Fingar, Diane C.; Lee, Jun Hee			The GATOR2?mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); Akt PKB; signal transduction; liver metabolism; insulin resistance	INSULIN-RESISTANCE; INHIBIT MTORC1; SESTRINS; COMPLEX; METABOLISM; AKT/PKB; TSC2; PHOSPHORYLATION; REGULATOR; RAPAMYCIN	Sestrins represent a family of stress-inducible proteins that prevent the progression of many age- and obesity-associated disorders. Endogenous Sestrins maintain insulin-dependent AKT Ser/Thr kinase (AKT) activation during high-fat diet?induced obesity, and overexpressed Sestrins activate AKT in various cell types, including liver and skeletal muscle cells. Although Sestrin-mediated AKT activation improves metabolic parameters, the mechanistic details underlying such improvement remain elusive. Here, we investigated how Sestrin2, the Sestrin homolog highly expressed in liver, induces strong AKT activation. We found that two known targets of Sestrin2, mTOR complex (mTORC) 1 and AMP-activated protein kinase, are not required for Sestrin2-induced AKT activation. Rather, phosphoinositol 3-kinase and mTORC2, kinases upstream of AKT, were essential for Sestrin2-induced AKT activation. Among these kinases, mTORC2 catalytic activity was strongly up-regulated upon Sestrin2 overexpression in an in vitro kinase assay, indicating that mTORC2 may represent the major link between Sestrin2 and AKT. As reported previously, Sestrin2 interacted with mTORC2; however, we found here that this interaction occurs indirectly through GATOR2, a pentameric protein complex that directly interacts with Sestrin2. Deleting or silencing WDR24 (WD repeat domain 24), the GATOR2 component essential for the Sestrin2?GATOR2 interaction, or WDR59, the GATOR2 component essential for the GATOR2?mTORC2 interaction, completely ablated Sestrin2-induced AKT activation. We also noted that Sestrin2 also directly binds to the pleckstrin homology domain of AKT and induces AKT translocation to the plasma membrane. These results uncover a signaling mechanism whereby Sestrin2 activates AKT through GATOR2 and mTORC2.	[Kowalsky, Allison Ho; Namkoong, Sim; Mettetal, Eric; Park, Hwan-Woo; Lee, Jun Hee] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kazyken, Dubek; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Namkoong, Sim] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 24341, Gangwon, South Korea; [Park, Hwan-Woo] Konyang Univ, Coll Med, Dept Cell Biol, Myunggok Med Res Inst, Daejeon 35365, South Korea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kangwon National University; Konyang University	Lee, JH (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leeju@umich.edu	Park, Hwan-Woo/D-2358-2014	Park, Hwan-Woo/0000-0001-8029-2004; Lee, Jun Hee/0000-0002-2200-6011; Kazyken, Dubek/0000-0001-8530-3390	National Institutes of Health [R01DK102850, R01DK111465, T32GM008322, T32AG000114, F31DK117610, P30AG024824, P30AR069620, P30DK034933, P30DK089503, P30CA046592]; University of Michigan through the Dean's Organogenesis Fellowship; University of Michigan through Biomedical and Life Science Summer Fellowship; University of Michigan through MCubed Scholar Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan through the Dean's Organogenesis Fellowship; University of Michigan through Biomedical and Life Science Summer Fellowship; University of Michigan through MCubed Scholar Fellowship	This work was supported by National Institutes of Health Grants R01DK102850 and R01DK111465 (to J. H. L.); T32GM008322, T32AG000114, and F31DK117610 (to A. H. K.); and P30AG024824, P30AR069620, P30DK034933, P30DK089503, and P30CA046592. This work was also supported by the University of Michigan through the Dean's Organogenesis Fellowship (to S. N.) and the Biomedical and Life Science Summer Fellowship and MCubed Scholar Fellowship (to E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Dai JM, 2018, CANCER MED-US, V7, P5691, DOI 10.1002/cam4.1826; Deng WB, 2016, J CLIN INVEST, V126, P2941, DOI 10.1172/JCI87715; Ehninger D, 2014, CELL MOL LIFE SCI, V71, P4325, DOI 10.1007/s00018-014-1677-1; Eid AA, 2013, MOL CELL BIOL, V33, P3439, DOI 10.1128/MCB.00217-13; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Ho A, 2016, TRENDS BIOCHEM SCI, V41, P621, DOI 10.1016/j.tibs.2016.04.005; Horbinski C, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-2; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huang JX, 2012, METHODS MOL BIOL, V821, P75, DOI 10.1007/978-1-61779-430-8_6; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Huang MH, 2020, HEPATOLOGY, V71, P76, DOI 10.1002/hep.30820; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502; Kim MJ, 2016, AUTOPHAGY, V12, P1272, DOI 10.1080/15548627.2016.1183081; Kim M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13442-5; Kim M, 2015, INT J MOL SCI, V16, P7015, DOI 10.3390/ijms16047015; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Morrison A, 2015, FASEB J, V29, P408, DOI 10.1096/fj.14-258814; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Segales J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13832-9; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tao RY, 2015, DIABETES, V64, P1211, DOI 10.2337/db14-0539; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang Li-Ping, 2003, Methods Mol Med, V83, P127; Yang YL, 2013, EXP GERONTOL, V48, P371, DOI 10.1016/j.exger.2012.12.011; Zhao BZ, 2014, J BIOL CHEM, V289, P35806, DOI 10.1074/jbc.M114.595397	50	22	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					1769	1780		10.1074/jbc.RA119.010857	http://dx.doi.org/10.1074/jbc.RA119.010857			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	31915252	Green Published, hybrid			2022-12-26	WOS:000517128200001
J	Daniels, EC; Rodriguez, A; Zabelina, DL				Daniels, Emily C.; Rodriguez, Andrew; Zabelina, Darya L.			Severity of misophonia symptoms is associated with worse cognitive control when exposed to misophonia trigger sounds	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PHENOMENOLOGY	The present study aimed to investigate the extent to which the severity of misophonia symptoms is linked with cognitive control under misophonia symptom-provocation circumstances in the general population sample. Participants (N = 79) completed a measure of cognitive control-a Stroop color naming task, which consists of congruent and incongruent stimuli, and requires inhibition of a prepotent response (reading a word) in the service of a less predominant response (naming a color), while listening to misophonia symptom-provocation or universally unpleasant sounds. Participants' misophonia sound sensitivity, and emotional behaviors towards trigger sounds were assessed using the Misophonia Questionnaire. Stronger emotional behavioral reactions to misophonia trigger sounds were significantly associated with the larger Stroop effect when participants were exposed to the misophonia trigger sounds, but not when they were exposed to the universally unpleasant sounds. This effect held when controlling for the personality trait of Neuroticism and for baseline levels of anxiety. Both elevated misophonia sound sensitivity and emotional behaviors towards trigger sounds significantly correlated with higher self-reported anxiety when performing the Stroop task. However, only elevated emotional behaviors towards trigger sounds were linked with higher anxiety levels at baseline, suggesting that people who experience stronger emotions and behavioral reactions to misophonia trigger sounds may have higher anxiety at a trait level. Limitations and future directions are discussed.	[Daniels, Emily C.; Rodriguez, Andrew; Zabelina, Darya L.] Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Zabelina, DL (corresponding author), Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA.	dlzabeli@uark.edu	Zabelina, Darya/AAD-1985-2022	Zabelina, Darya/0000-0002-0313-7358				American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; COSTA PT, 1987, J PERS, V55, P299, DOI 10.1111/j.1467-6494.1987.tb00438.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dozier TH, 2017, AM J PSYCHOL, V130, P431, DOI 10.5406/amerjpsyc.130.4.0431; Edelstein M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00296; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Graham R, 2009, PSYCHOL MUSIC, V37, P485, DOI 10.1177/0305735608099689; Gratton G, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13016; IBM Corp, IBM SPSS STAT MAC VE; Jastreboff Margaret M., 2002, Australian and New Zealand Journal of Audiology, V24, P74, DOI 10.1375/audi.24.2.74.31105; Johnson PL, 2013, NEUROPSYCHIATRY-LOND, V3, P569, DOI 10.2217/npy.13.70; Kumar S, 2017, CURR BIOL, V27, P527, DOI 10.1016/j.cub.2016.12.048; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Rouw R, 2018, J CLIN PSYCHOL, V74, P453, DOI 10.1002/jclp.22500; Schroder A., 2013, PLOS ONE, V8; Schroder A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44084-8; Schwartz Paula, 2011, Minn Med, V94, P42; Seaborne A, 2018, APPL COGNITIVE PSYCH, V32, P264, DOI 10.1002/acp.3387; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Spielberger C. D., 1983, MIND GARDEN; Taylor S, 2017, MED HYPOTHESES, V103, P109, DOI 10.1016/j.mehy.2017.05.003; Wu MS, 2014, J CLIN PSYCHOL, V70, P994, DOI 10.1002/jclp.22098	25	23	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227118	10.1371/journal.pone.0227118	http://dx.doi.org/10.1371/journal.pone.0227118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945068	Green Submitted, Green Published, gold			2022-12-26	WOS:000534370100019
J	Owodunni, OP; Haut, ER; Shaffer, DL; Hobson, DB; Wang, JX; Yenokyan, G; Kraus, PS; Aboagye, JK; Florecki, KL; Webster, KLW; Holzmueller, CG; Streiff, MB; Lau, BD				Owodunni, Oluwafemi P.; Haut, Elliott R.; Shaffer, Dauryne L.; Hobson, Deborah B.; Wang, Jiangxia; Yenokyan, Gayane; Kraus, Peggy S.; Aboagye, Jonathan K.; Florecki, Katherine L.; Webster, Kristen L. W.; Holzmueller, Christine G.; Streiff, Michael B.; Lau, Brandyn D.			Using electronic health record system triggers to target delivery of a patient-centered intervention to improve venous thromboembolism prevention for hospitalized patients: Is there a differential effect by race?	PLOS ONE			English	Article							ETHNIC DISPARITIES; QUALITY; ASSOCIATION; PROPHYLAXIS; TRAUMA; SAFETY	Background Racial disparities are common in healthcare. Venous thromboembolism (VTE) is a leading cause of preventable harm, and disparities observed in prevention practices. We examined the impact of a patient-centered VTE education bundle on the non-administration of preventive prophylaxis by race. Methods A post-hoc, subset analysis (stratified by race) of a larger nonrandomized trial. Pre-post comparisons analysis were conducted on 16 inpatient units; study periods were October 2014 through March 2015 (baseline) and April through December 2015 (post-intervention). Patients on 4 intervention units received the patient-centered, nurse educator-led intervention if the electronic health record alerted a non-administered dose of VTE prophylaxis. Patients on 12 control units received no intervention. We compared the conditional odds of non-administered doses of VTE prophylaxis when patient refusal was a reason for non-administration, stratified by race. Results Of 272 patient interventions, 123 (45.2%) were white, 126 (46.3%) were black, and 23 (8.5%) were other races. A significant reduction was observed in the odds of non-administration of prophylaxis on intervention units compared to control units among patients who were black (OR 0.61; 95% CI, 0.46-0.81, p<0.001), white (OR 0.57; 95% CI, 0.44-0.75, p<0.001), and other races (OR 0.50; 95% CI, 0.29-0.88, p = 0.015). Conclusion Our finding suggests that the patient education materials, developed collaboratively with a diverse group of patients, improved patient's understanding and the importance of VTE prevention through prophylaxis. Quality improvement interventions should examine any differential effects by patient characteristics to ensure disparities are addressed and all patients experience the same benefits.	[Owodunni, Oluwafemi P.; Haut, Elliott R.; Shaffer, Dauryne L.; Hobson, Deborah B.; Aboagye, Jonathan K.; Florecki, Katherine L.; Webster, Kristen L. W.; Holzmueller, Christine G.] Johns Hopkins Univ, Sch Med, Dept Surg, Div Acute Care Surg, Baltimore, MD 21205 USA; [Haut, Elliott R.; Webster, Kristen L. W.; Holzmueller, Christine G.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Haut, Elliott R.; Webster, Kristen L. W.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Haut, Elliott R.; Hobson, Deborah B.; Holzmueller, Christine G.; Streiff, Michael B.; Lau, Brandyn D.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21287 USA; [Haut, Elliott R.; Lau, Brandyn D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Shaffer, Dauryne L.; Hobson, Deborah B.] Johns Hopkins Univ Hosp, Dept Nursing, Baltimore, MD USA; [Wang, Jiangxia; Yenokyan, Gayane] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Kraus, Peggy S.] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA; [Streiff, Michael B.] Johns Hopkins Univ Hosp, Dept Med, Div Hematol, Baltimore, MD 21287 USA; [Lau, Brandyn D.] Johns Hopkins Univ Hosp, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; [Lau, Brandyn D.] Johns Hopkins Univ Hosp, Div Hlth Sci Informat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Haut, ER (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Div Acute Care Surg, Baltimore, MD 21205 USA.; Haut, ER (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Haut, ER (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.; Haut, ER (corresponding author), Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21287 USA.; Haut, ER (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.	ehaut1@jhmi.edu	Webster, Kristen/AAH-9237-2021	Owodunni, Oluwafemi/0000-0003-4610-2574; Haut, Elliott/0000-0001-7075-771X	Patient Centered Outcomes Research Institute (PCORI) [CE-12-11-4489, DI-1603-34596]	Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI)	This work was supported by contracts from the Patient Centered Outcomes Research Institute (PCORI) entitled "Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology" (CE-12-11-4489) and "Preventing Venous Thromboembolism (VTE): Engaging Patients to Reduce Preventable Harm from Missed/Refused Doses of VTE Prophylaxis" (DI-1603-34596). The funders had no role in the conduct of this study. We thank our key stakeholder organizations-the National Blood Clot Alliance (NBCA), the North American Thrombosis Forum (NATF), Clot Care, and The Johns Hopkins Hospital Patient and Family Advisory Council (PFAC)."	[Anonymous], 2020, HLTH PEOPL 2020; Braveman P, 2003, J EPIDEMIOL COMMUN H, V57, P254, DOI 10.1136/jech.57.4.254; Chang VW, 2009, J HEALTH SOC BEHAV, V50, P245, DOI 10.1177/002214650905000301; Cohen MG, 2010, CIRCULATION, V121, P2294, DOI 10.1161/CIRCULATIONAHA.109.922286; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Farrow NE, 2016, JT COMM J QUAL PATIE, V42, P410, DOI 10.1016/S1553-7250(16)42082-9; Filice CE, 2017, MED CARE, V55, pE170, DOI 10.1097/MLR.0000000000000608; Finkelstein J, 2012, 206 J HOPK U EV BAS, P206; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Follmann D, 2003, BIOMETRICS, V59, P420, DOI 10.1111/1541-0420.00049; Haider AH, 2014, J TRAUMA ACUTE CARE, V77, P409, DOI 10.1097/TA.0000000000000392; Haider AH, 2012, ARCH SURG-CHICAGO, V147, P63, DOI 10.1001/archsurg.2011.254; Haut ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4741; Haut ER, 2015, JAMA SURG, V150, P912, DOI 10.1001/jamasurg.2015.1340; Haut ER, 2012, ARCH SURG-CHICAGO, V147, P901, DOI 10.1001/archsurg.2012.2024; Kawachi I, 2002, J EPIDEMIOL COMMUN H, V56, P647, DOI 10.1136/jech.56.9.647; Key NS, 2016, BLOOD, V127, P1844, DOI 10.1182/blood-2016-03-701698; Lau BD, 2018, CIRCULATION, V137, P1278, DOI 10.1161/CIRCULATIONAHA.116.026897; Lau BD, 2018, J GEN INTERN MED, V33, P19, DOI 10.1007/s11606-017-4203-y; Lau BD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181664; Lau BD, 2016, ANN SURG, V264, P1181, DOI 10.1097/SLA.0000000000001512; Lau BD, 2016, J SURG RES, V205, P179, DOI 10.1016/j.jss.2016.06.024; Lau BD, 2015, MED CARE, V53, P18, DOI 10.1097/MLR.0000000000000251; Lau BD, 2014, BMJ QUAL SAF, V23, P187, DOI 10.1136/bmjqs-2012-001782; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Margaglione M, 2011, THROMB HAEMOSTASIS, V105, P221, DOI 10.1160/TH10-08-0510; Muellner SK, 2011, THROMB HAEMOSTASIS, V105, P5, DOI 10.1160/TH10-08-0504; Narayan MC, 2017, J TRANSCULT NURS; Owodunni OP, 2018, JAMA SURG; Patient-Centered Outcomes Research Institute, RES RES; Popoola VO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152084; Rodriguez-Lainz A, 2018, PUBLIC HEALTH REP, V133, P45, DOI 10.1177/0033354917745503; Shekelle P G, 2013, Evid Rep Technol Assess (Full Rep), P1; Shekelle PG, 2013, ANN INTERN MED, V158, P365, DOI 10.7326/0003-4819-158-5-201303051-00001; Shermock KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066311; Singh Gopal K, 2017, Int J MCH AIDS, V6, P139, DOI 10.21106/ijma.236; STREIFF MB, 2012, BMJ-BRIT MED J, V344, DOI DOI 10.1136/BMJ.E3935; Streiff MB, 2016, J HOSP MED, V11, pS8, DOI 10.1002/jhm.2657; Streiff MB, 2012, HEMATOL-AM SOC HEMAT, P631, DOI 10.1182/asheducation-2012.1.631; United States Census Bureau, 2013, 2010 CENS; Weaver SJ, 2013, ANN INTERN MED, V158, P369, DOI 10.7326/0003-4819-158-5-201303051-00002; Weiss D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195447; White RH, 2009, THROMB RES, V123, pS11, DOI 10.1016/S0049-3848(09)70136-7; Wong A, 2015, J HOSP MED, V10, P108, DOI 10.1002/jhm.2282; Zaitoun A, 2017, VASC MED, V22, P498, DOI 10.1177/1358863X17733065; Zeidan AM, 2013, AM J HEMATOL, V88, P545, DOI 10.1002/ajh.23450	46	9	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227339	10.1371/journal.pone.0227339	http://dx.doi.org/10.1371/journal.pone.0227339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5PQ	31945085	gold, Green Published			2022-12-26	WOS:000534370100030
J	Patrut, A; Garg, A; Woodborne, S; Patrut, RT; Rakosy, L; Ratiu, IA; Lowy, DA				Patrut, Adrian; Garg, Arti; Woodborne, Stephan; Patrut, Roxana T.; Rakosy, Laszlo; Ratiu, Ileana Andreea; Lowy, Daniel A.			Radiocarbon dating of two old African baobabs from India	PLOS ONE			English	Article							ADANSONIA; CARBON; TREES	The article presents the radiocarbon investigation of the baobab of Jhunsi, Allahabad and the Parijaat tree at Kintoor, two old African baobabs from northern India. Several wood samples extracted from these baobabs were analysed by using AMS radiocarbon dating. The radiocarbon date of the oldest samples were 779 +/- 41 BP for the baobab of Jhunsi and 793 +/- 37 BP for the baobab of Kintoor. The corresponding calibrated ages are 770 +/- 25 and 775 +/- 25 calendar years. These values indicate that both trees are around 800 years old and become the oldest dated African baobabs outside Africa.	[Patrut, Adrian; Patrut, Roxana T.; Ratiu, Ileana Andreea] Babes Bolyai Univ, Fac Chem & Chem Engn, Cluj Napoca, Romania; [Garg, Arti] Bot Survey India, Cent Reg Ctr, Allahabad, Uttar Pradesh, India; [Woodborne, Stephan] iThemba Labs, Johannesburg, South Africa; [Patrut, Roxana T.; Rakosy, Laszlo] Babes Bolyai Univ, Fac Biol & Geol, Cluj Napoca, Romania; [Lowy, Daniel A.] Valor Hungariae, Dept Sci & Innovat, Budapest, Hungary	Babes Bolyai University from Cluj; Botanical Survey of India (BSI); National Research Foundation - South Africa; iThemba LABS; Babes Bolyai University from Cluj	Patrut, A (corresponding author), Babes Bolyai Univ, Fac Chem & Chem Engn, Cluj Napoca, Romania.	apatrut@gmail.com	Ratiu, Ileana-Andreea/C-5922-2012; Rakosy, Laszlo/K-8702-2013	Ratiu, Ileana-Andreea/0000-0003-2615-684X; Patrut, Adrian/0000-0002-9862-6735; Rakosy, Laszlo/0000-0002-7793-6996; Patrut, Roxana/0000-0002-8691-2160	Romanian Ministry of National Education CNCS-UEFISCDI [PN-III-P4-ID-PCE-2016-0776, 90/2017]	Romanian Ministry of National Education CNCS-UEFISCDI	The research was funded by the Romanian Ministry of National Education CNCS-UEFISCDI under grant PN-III-P4-ID-PCE-2016-0776, No. 90/2017 to AP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum DA, 1998, SYST BIOL, V47, P181, DOI 10.1080/106351598260879; BAUM DA, 1995, ANN MO BOT GARD, V82, P440, DOI 10.2307/2399893; Bell KL, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150370; Chapotin SM, 2006, AM J BOT, V93, P1251, DOI 10.3732/ajb.93.9.1251; Cron GV, 2016, TAXON, V65, P1037, DOI 10.12705/655.6; Loader NJ, 1997, CHEM GEOL, V136, P313, DOI 10.1016/S0009-2541(96)00133-7; Maheshwari JR, 1971, BIOL CONSERV, V4, P557; Mbele VL, 2017, PHYSCS PROC, V90, P10, DOI 10.1016/j.phpro.2017.09.009; Mishra RK, 2019, INT J UNANI INTEG ME, V3; Patrut A, 2017, AMS 14 INT C OTT CAN; Patrut A, 2007, TREE PHYSIOL, V27, P1569, DOI 10.1093/treephys/27.11.1569; Patrut A, 2018, NAT PLANTS, V4, P423, DOI 10.1038/s41477-018-0170-5; Patrut A, 2017, RADIOCARBON, V59, P435, DOI 10.1017/RDC.2016.92; Patrut A, 2016, STUD U BABES-BOL CHE, V61, P21; Patrut A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117193; Patrut A, 2013, NUCL INSTRUM METH B, V294, P622, DOI 10.1016/j.nimb.2012.04.025; Patrut A, 2011, ANN FOREST SCI, V68, P993, DOI 10.1007/s13595-011-0107-x; Patrut A, 2010, RADIOCARBON, V52, P727; Pettigrew JD, 2012, TAXON, V61, P1240, DOI 10.1002/tax.616006; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rangan H, 2015, ENVIRON HIST-UK, V21, P103, DOI 10.3197/096734015X14183179969827; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roy R. K., 2011, Chronica Horticulturae, V51, P29; Roy RK, 2013, CHRONICA HORTIC, V53, P26; Sing RK, 2016, INDIAN FOR, V143, P67; Singh M., 2003, SOC CACTI SUCC J, V111, P3; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; Tsy JMLP, 2009, MOL ECOL, V18, P1707, DOI 10.1111/j.1365-294X.2009.04144.x; Varmah J. C., 1978, Indian Forester, V104, P461; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Wickens G.E., 2008, BAOBABS PACHYCAULS A, P31, DOI [10.1007/978-1-4020-6431-9, DOI 10.1007/978-1-4020-6431-9]	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227352	10.1371/journal.pone.0227352	http://dx.doi.org/10.1371/journal.pone.0227352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	31945077	Green Published, gold			2022-12-26	WOS:000534370100032
J	Lyozin, GT; Brunelli, L				Lyozin, George T.; Brunelli, Luca			Live-cell PCR and one-step purification streamline DNA engineering	FASEB JOURNAL			English	Article						colony PCR; DNA gap repair; DNA purification; melting curve analysis	ESCHERICHIA-COLI	In vivo DNA engineering such as recombineering (recombination-mediated genetic engineering) and DNA gap repair typically involve growing Escherichia coli (E coli) containing plasmids, followed by plasmid DNA extraction and purification prior to downstream PCR-mediated DNA modifications and DNA sequencing. We previously demonstrated that crude cell lysates could be used for some limited downstream DNA applications. Here, we show how live E coli cell PCR and one-step LiCl-isopropanol purification can streamline DNA engineering. In DNA gap repair, live-cell PCR allowed the convenient elimination of clones containing background plasmids prior to DNA sequencing. Live-cell PCR also enabled the generation of specific DNA sequences for DNA engineering up to 11 kilo base pairs in length and with up to 80 base pair terminal non-homology. Using gel electrophoresis and DNA melting curve analysis, we showed that LiCl-isopropanol DNA precipitation removed primers and small, nonspecific PCR products from live-cell PCR products in only similar to 10-minutes. DNA sequencing of purified products yielded Phred quality scores values of similar to 55%. These data indicate that live-cell PCR and LiCl-isopropanol DNA precipitation are ideal to prepare DNA for sequencing and other downstream DNA applications, and might therefore accelerate high-throughput DNA engineering pipelines.	[Lyozin, George T.; Brunelli, Luca] Univ Nebraska Med Ctr, Dept Pediat, DRC 2,Rm 4034,601 S Saddle Creek Rd, Omaha, NE 68106 USA; [Lyozin, George T.; Brunelli, Luca] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68106 USA; [Brunelli, Luca] Univ Utah, Dept Pediat Neonatol, Salt Lake City, UT USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Utah System of Higher Education; University of Utah	Brunelli, L (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, DRC 2,Rm 4034,601 S Saddle Creek Rd, Omaha, NE 68106 USA.	Luca.Brunelli@hsc.utah.edu			Department of Pediatrics, University of Nebraska	Department of Pediatrics, University of Nebraska	Department of Pediatrics, University of Nebraska intramural funds	BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Flock S, 1996, BIOPHYS J, V70, P1456, DOI 10.1016/S0006-3495(96)79705-9; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Freitas SS, 2006, BIOTECHNOL PROGR, V22, P1179, DOI 10.1021/bp060052d; Gasperini M, 2016, NAT PROTOC, V11, P1782, DOI 10.1038/nprot.2016.135; Green MR, 2012, MOL CLONING LAB MANU, V1; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Lezin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023457; Lezin G, 2011, BIOTECHNOL BIOENG, V108, P1872, DOI 10.1002/bit.23116; Lyozin George T, 2017, Curr Protoc Mol Biol, V118, DOI 10.1002/cpmb.34; Lyozin GT, 2014, NAT METHODS, V11, P966, DOI [10.1038/NMETH.3030, 10.1038/nmeth.3030]; Lyozin GT, 2019, 313155 BIORXIV, P313155; MANDECKI W, 1986, P NATL ACAD SCI USA, V83, P7177, DOI 10.1073/pnas.83.19.7177; Miura M, 2013, REV INST MED TROP SP, V55, P401, DOI 10.1590/S0036-46652013000600005; SANDHU GS, 1989, BIOTECHNIQUES, V7, P689; SEMANCIK JS, 1983, ANAL BIOCHEM, V135, P275, DOI 10.1016/0003-2697(83)90683-8; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Takagi M, 1997, APPL ENVIRON MICROB, V63, P4504, DOI 10.1128/AEM.63.11.4504-4510.1997; Wei XM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004819; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zeugin JA Hartley JL., 1985, FOCUS, V7, P1, DOI DOI 10.1108/EB015969	24	2	3	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3448	3460		10.1096/fj.201902261R	http://dx.doi.org/10.1096/fj.201902261R		JAN 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	31944382	Bronze			2022-12-26	WOS:000507593300001
J	Morein-Zamir, S; Shapher, S; Gasull-Camos, J; Fineberg, NA; Robbins, TW				Morein-Zamir, Sharon; Shapher, Sonia; Gasull-Camos, Julia; Fineberg, Naomi A.; Robbins, Trevor W.			Avoid jumping to conclusions under uncertainty in Obsessive Compulsive Disorder	PLOS ONE			English	Article							DECISION-MAKING; INTOLERANCE; ANXIETY; BIAS; INVENTORY; SCALE; IMPULSIVITY; VALIDATION; DELUSIONS; ANALOG	High levels of intolerance of uncertainty (IU) could contribute to abnormal decision making in uncertain situations. Patients with Obsessive Compulsive Disorder (OCD) often report high IU, indecisiveness and the need to seek greater certainty before making decisions. The Beads task is a commonly used task assessing the degree of information gathering prior to making a decision and so would be predicted to show impairments in OCD patients. Results to date have found mixed support for this, possibility due to methodological issues. Here, a group of OCD patients (n = 50) with no comorbidities was compared with age, gender, and verbal-IQ matched controls (n = 50) on the most commonly used version of the Beads task. An independent sample of healthy volunteers with high versus low OC symptoms, and high versus low IU were also assessed (n = 125). There was no evidence that patients with OCD differed from control volunteers in the degree of information gathering prior to making a decision. Medication status and age did not appear to mediate performance. Similarly, there were no association in healthy volunteers between task performance and OC or IU characteristics. Additional measures examining the degree of certainty initially showed support for greater uncertainty in patients, but this was due to deviations from task instructions in a subset of patients. We conclude that despite the large sample size and good matching between groups, the Beads task in its most widely used form is not a useful measure of IU or of information gathering in OCD. The results argue against a robust behavioural difference in OCD when compared to controls. Recommendations for future studies employing the task are discussed.	[Morein-Zamir, Sharon] Anglia Ruskin Univ, Sch Psychol & Sports Sci, Cambridge, England; [Morein-Zamir, Sharon; Gasull-Camos, Julia; Robbins, Trevor W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England; [Morein-Zamir, Sharon; Gasull-Camos, Julia; Robbins, Trevor W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Shapher, Sonia; Fineberg, Naomi A.] Hertfordshire Partnership Univ NHS Fdn Trust, NHS, Hatfield, Herts, England; [Shapher, Sonia; Fineberg, Naomi A.] Univ Hertfordshire, Hatfield, Herts, England	Anglia Ruskin University; University of Cambridge; University of Cambridge; University of Hertfordshire	Morein-Zamir, S (corresponding author), Anglia Ruskin Univ, Sch Psychol & Sports Sci, Cambridge, England.; Morein-Zamir, S (corresponding author), Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England.; Morein-Zamir, S (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	sharon.morein@anglia.ac.uk	Fineberg, Naomi/ABI-5522-2020; Robbins, Trevor W/A-7551-2008	Gasull-Camos, Julia/0000-0003-0578-8311	Wellcome Trust [104631/Z/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported in part by a grant from the Wellcome Trust (https://wellcome.ac.uk/) to TW Robbins (104631/Z/14/Z). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch A, 2016, J BEHAV ADDICT, V5, P395, DOI 10.1556/2006.5.2016.029; Abramovitch A, 2013, CLIN PSYCHOL REV, V33, P1163, DOI 10.1016/j.cpr.2013.09.004; Abramowitz JS, 2014, CLIN PSYCHOL REV, V34, P206, DOI 10.1016/j.cpr.2014.01.004; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Balzan RP, 2014, AUST NZ J PSYCHIAT, V48, P1126, DOI 10.1177/0004867413508451; Banca P, 2016, ADDICT BIOL, V21, P504, DOI 10.1111/adb.12227; Banca P, 2015, NEUROPSYCHOPHARMACOL, V40, P1192, DOI 10.1038/npp.2014.303; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bensi L, 2007, PERS INDIV DIFFER, V43, P827, DOI 10.1016/j.paid.2007.02.007; Birrell J, 2011, CLIN PSYCHOL REV, V31, P1198, DOI 10.1016/j.cpr.2011.07.009; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Burns GL, 1996, BEHAV RES THER, V34, P163, DOI 10.1016/0005-7967(95)00035-6; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Carleton RN, 2016, J ANXIETY DISORD, V39, P30, DOI 10.1016/j.janxdis.2016.02.007; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Chamberlain SR, 2007, NEUROPSYCHOLOGIA, V45, P654, DOI 10.1016/j.neuropsychologia.2006.07.016; Chamberlain SR, 2006, PSYCHOL MED, V36, P91, DOI 10.1017/S0033291705006124; Fear CF, 1997, PSYCHOL MED, V27, P199, DOI 10.1017/S0033291796004175; Ferrari JR, 1997, J SOC BEHAV PERS, V12, P527; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; FROST RO, 1993, BEHAV RES THER, V31, P683, DOI 10.1016/0005-7967(93)90121-A; GARETY PA, 1991, J NERV MENT DIS, V179, P194, DOI 10.1097/00005053-199104000-00003; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Grassi G, 2015, J BEHAV ADDICT, V4, P263, DOI 10.1556/2006.4.2015.039; Hauser TU, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0040-3; Hauser TU, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005440; Holaway RM, 2006, J ANXIETY DISORD, V20, P158, DOI 10.1016/j.janxdis.2005.01.002; Hollander E, 2016, EUR NEUROPSYCHOPHARM, V26, P800, DOI 10.1016/j.euroneuro.2016.02.006; Hong RY, 2015, PSYCHOL ASSESSMENT, V27, P605, DOI 10.1037/pas0000074; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Jacobsen P, 2012, BRIT J CLIN PSYCHOL, V51, P84, DOI 10.1111/j.2044-8260.2011.02014.x; Jacoby RJ, 2014, J ANXIETY DISORD, V28, P495, DOI 10.1016/j.janxdis.2014.05.005; Ladouceur R, 1997, BEHAV MODIF, V21, P355, DOI 10.1177/01454455970213006; Lunt L, 2012, J NEUROPSYCHOL, V6, P65, DOI 10.1111/j.1748-6653.2011.02005.x; MILNER AD, 1971, BRIT J SOC CLIN PSYC, V10, P88, DOI 10.1111/j.2044-8260.1971.tb00719.x; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morein-Zamir S, 2018, Q J EXP PSYCHOL, V71, P2052, DOI 10.1177/1747021817737727; Nelson HE., 1982, NATL ADULT READING T; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pelissier MC, 2002, BRIT J CLIN PSYCHOL, V41, P15, DOI 10.1348/014466502163769; Pushkarskaya H, 2017, PSYCHIAT RES, V258, P305, DOI 10.1016/j.psychres.2017.08.058; Rassin E, 2007, J PSYCHOPATHOL BEHAV, V29, P61, DOI 10.1007/s10862-006-9023-z; Reese HE, 2011, J BEHAV THER EXP PSY, V42, P270, DOI 10.1016/j.jbtep.2010.11.005; Remijnse PL, 2009, PSYCHOL MED, V39, P1503, DOI 10.1017/S0033291708005072; Roma VG, 2017, COGN BEHAV THERAPY, V46, P327, DOI 10.1080/16506073.2016.1252792; Ross RM, 2016, COGN NEUROPSYCHIATRY, V21, P300, DOI 10.1080/13546805.2016.1192025; Rotge JY, 2008, ACTA PSYCHIAT SCAND, V117, P465, DOI 10.1111/j.1600-0447.2008.01173.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; So SHW, 2016, CLIN PSYCHOL REV, V46, P151, DOI 10.1016/j.cpr.2016.05.001; Sohn SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111739; Speechley WJ, 2010, J PSYCHIATR NEUROSCI, V35, P7, DOI 10.1503/jpn.090025; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sternheim L, 2011, J ANXIETY DISORD, V25, P806, DOI 10.1016/j.janxdis.2011.03.020; Tolin DF, 2003, J ANXIETY DISORD, V17, P233, DOI 10.1016/S0887-6185(02)00182-2; VOLANS PJ, 1976, BRIT J SOC CLIN PSYC, V15, P305, DOI 10.1111/j.2044-8260.1976.tb00038.x; Voon V, 2018, NEUROSCIENCE, V382, P105, DOI 10.1016/j.neuroscience.2018.03.010; Voon V, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv074; Wells A, 2004, BEHAV RES THER, V42, P385, DOI 10.1016/S0005-7967(03)00147-5	59	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0225970	10.1371/journal.pone.0225970	http://dx.doi.org/10.1371/journal.pone.0225970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5OV	31940308	Green Published, Green Accepted, gold			2022-12-26	WOS:000534368000013
J	Oder, M; Kokli, T; Umek, P; Podlipec, R; Strancar, J; Dobeic, M				Oder, Martina; Kokli, Tilen; Umek, Polona; Podlipec, Rok; Strancar, Janez; Dobeic, Martin			Photocatalytic biocidal effect of copper doped TiO2 nanotube coated surfaces under laminar flow, illuminated with UVA light on Legionella pneumophila	PLOS ONE			English	Article							WATER PLUMBING SYSTEMS; CU2+ SITES; PATHOGENS; BIOFILMS; DISINFECTION; SURVEILLANCE; REDUCTION; IMPACT; RISK	Legionella pneumophila can cause a potentially fatal form of humane pneumonia (Legionnaires' disease), which is most problematic in immunocompromised and in elderly people. Legionella species is present at low concentrations in soil, natural and artificial aquatic systems and is therefore constantly entering man-made water systems. The environment temperature for it's ideal growth range is between 32 and 42 degrees C, thus hot water pipes represent ideal environment for spread of Legionella. The bacteria are dormant below 20 degrees C and do not survive above 60 degrees C. The primary method used to control the risk from Legionella is therefore water temperature control. There are several other effective treatments to prevent growth of Legionella in water systems, however current disinfection methods can be applied only intermittently thus allowing Legionella to grow in between treatments. Here we present an alternative disinfection method based on antibacterial coatings with Cu-TiO2 nanotubes deposited on preformed surfaces. In the experiment the microbiocidal efficiency of submicron coatings on polystyrene to the bacterium of the genus Legionella pneumophila with a potential use in a water supply system was tested. The treatment thus constantly prevents growth of Legionella pneumophila in presence of water at room temperature. Here we show that 24-hour illumination with low power UVA light source (15 W/m(2) UVA illumination) of copper doped TiO2 nanotube coated surfaces is effective in preventing growth of Legionella pneumophila. Microbiocidal effects of Cu-TiO2 nanotube coatings were dependent on the flow of the medium and the intensity of UV-A light. It was determined that tested submicron coatings have microbiocidal effects specially in a non-flow or low-flow conditions, as in higher flow rates, probably to a greater possibility of Legionella pneumophila sedimentation on the coated polystyrene surfaces, meanwhile no significant differences among bacteria reduction was noted regarding to non or low flow of medium.	[Oder, Martina] Univ Ljubljana, Fac Hlth Sci, Dept Sanit Engn, Ljubljana, Slovenia; [Kokli, Tilen; Umek, Polona; Podlipec, Rok] Jozef Stefan Inst, Lab Biophys, Ljubljana, Slovenia; [Podlipec, Rok; Strancar, Janez] Helmholz Zentrum Dresden Rossendorf, Ion Beam Ctr, Dresden, Germany; [Dobeic, Martin] Univ Ljubljana, Vet Fac, Inst Food Safety Feed & Environm, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Ljubljana	Dobeic, M (corresponding author), Univ Ljubljana, Vet Fac, Inst Food Safety Feed & Environm, Ljubljana, Slovenia.	martin.dobeic@vf.uni-lj.si			Slovenian Research Agency (ARRS) [P4-0092]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	The research work was funded by Slovenian Research Agency (ARRS), Research program P4-0092. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barna Z, 2016, WATER RES, V90, P71, DOI 10.1016/j.watres.2015.12.004; Bazaka K, 2011, BIOTECHNOL J, V6, P1103, DOI 10.1002/biot.201100027; Burke AC, 2016, LANCET, P376; Correia AM, 2016, NEW ENGL J MED, V374, P497, DOI 10.1056/NEJMc1505356; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Dupuy M, 2011, WATER RES, V45, P1087, DOI 10.1016/j.watres.2010.10.025; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; Falkinham JO, 2015, PATHOGENS, V4, P373, DOI 10.3390/pathogens4020373; Farhat M, 2012, APPL ENVIRON MICROB, V78, P6850, DOI 10.1128/AEM.00831-12; Garvas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129577; Hamilton KA, 2019, ENVIRON SCI TECHNOL, V53, P4528, DOI 10.1021/acs.est.8b03000; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; International Organization for Standardization (ISO), 1998, 117311998 ISO; Koklic T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201490; Koklic T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197308; Li GH, 2008, J PHYS CHEM C, V112, P19040, DOI 10.1021/jp8068392; LI J, 1992, MATER CHEM PHYS, V32, P1, DOI 10.1016/0254-0584(92)90243-2; McCoy WF, 2015, PATHOGENS, V4, P513, DOI 10.3390/pathogens4030513; Meier T, 2016, WATER SCI TECH-W SUP, V16, P931, DOI 10.2166/ws.2016.040; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; Oder M, 2015, INT J ENVIRON HEAL R, V25, P469, DOI 10.1080/09603123.2014.963035; Park S, 2017, SCI TOTAL ENVIRON, V609, P289, DOI 10.1016/j.scitotenv.2017.07.071; Proctor CR, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0348-5; Rhoads WJ, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010029; Rodrigues PAF, 2011, 1 PORT BIOM ENG M MA; Shen Y, 2017, ENVIRON SCI TECHNOL, V51, P2087, DOI 10.1021/acs.est.6b04754; Stout JE, 2007, INFECT CONT HOSP EP, V28, P818, DOI 10.1086/518754; Szabo J, 2014, ENVIRON INT, V72, P124, DOI 10.1016/j.envint.2014.01.031; Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071; Turetgen I, 2015, WATER SA, V41, P295, DOI 10.4314/wsa.v41i3.01; U.S. Environmental Protection Agency, 2016, TECHN GUID ASS ENV J, P1; Umek P, 2008, J PHYS CHEM C, V112, P15311, DOI 10.1021/jp805005k; van der Kooij D, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02737-16, 10.1128/aem.02737-16]; Volker S, 2016, INT J HYG ENVIR HEAL, V219, P101, DOI 10.1016/j.ijheh.2015.09.007; Wang H, 2017, WATER RES, V117, P68, DOI 10.1016/j.watres.2017.03.046; Wang H, 2013, ENVIRON SCI TECHNOL, V47, P10117, DOI 10.1021/es402455r; Wang H, 2012, ENVIRON SCI TECHNOL, V46, P11566, DOI 10.1021/es303212a; Williams MM, 2013, BIOFOULING, V29, P147, DOI 10.1080/08927014.2012.757308	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0227574	10.1371/journal.pone.0227574	http://dx.doi.org/10.1371/journal.pone.0227574			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940328	Green Published, gold			2022-12-26	WOS:000534368000080
J	Siljamo, P; Ashbrook, K; Comont, RF; Skjoth, CA				Siljamo, Pilvi; Ashbrook, Kate; Comont, Richard F.; Skjoth, Carsten Ambelas			Do atmospheric events explain the arrival of an invasive ladybird (Harmonia axyridis) in the UK?	PLOS ONE			English	Article							MULTIMODEL ENSEMBLE SIMULATIONS; VESPA-VELUTINA LEPELETIER; SPIDER ARGIOPE-BRUENNICHI; BIRCH POLLEN EMISSION; COLEOPTERA-COCCINELLIDAE; BIOLOGICAL INVASIONS; HARLEQUIN LADYBIRD; NUMERICAL-MODEL; ALIEN PLANT; AIR-QUALITY	Species introduced outside their natural range threaten global biodiversity and despite greater awareness of invasive species risks at ports and airports, control measures in place only concern anthropogenic routes of dispersal. Here, we use the Harlequin ladybird, Harmonia axyridis, an invasive species which first established in the UK from continental Europe in 2004, to test whether records from 2004 and 2005 were associated with atmospheric events. We used the atmospheric-chemistry transport model SILAM to model the movement of this species from known distributions in continental Europe and tested whether the predicted atmospheric events were associated with the frequency of ladybird records in the UK. We show that the distribution of this species in the early years of its arrival does not provide substantial evidence for a purely anthropogenic introduction and show instead that atmospheric events can better explain this arrival event. Our results suggest that air flows which may assist dispersal over the English Channel are relatively frequent; ranging from once a week from Belgium and the Netherlands to 1-2 times a week from France over our study period. Given the frequency of these events, we demonstrate that atmospheric-assisted dispersal is a viable route for flying species to cross natural barriers.	[Siljamo, Pilvi] Finnish Meteorol Inst, Meteorol Res, Helsinki, Finland; [Siljamo, Pilvi; Ashbrook, Kate; Comont, Richard F.; Skjoth, Carsten Ambelas] Univ Worcester, Sch Sci & Environm, Worcester, England	Finnish Meteorological Institute; University of Worcester	Siljamo, P (corresponding author), Finnish Meteorol Inst, Meteorol Res, Helsinki, Finland.; Siljamo, P (corresponding author), Univ Worcester, Sch Sci & Environm, Worcester, England.	pilvi.siljamo@fmi.fi	Skjøth, Carsten/AAM-1002-2021; Siljamo, Pilvi/HHM-1967-2022	Skjøth, Carsten/0000-0001-5992-9568; Siljamo, Pilvi/0000-0002-2317-9125; Comont, Richard/0000-0002-9918-9813; Ashbrook, Kate/0000-0001-6555-8791	Academy of Finland [296089]	Academy of Finland(Academy of Finland)	The SAPID project (296089) of the Academy of Finland (http://www.aka.fi/en/) supported this study to PS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the volunteer recorders who have submitted records that made this paper possible, and both David and Helen Roy of the Biological Records Centre who allowed us to use the ladybird dataset. We would also like to thank the many verifiers for the UK Ladybird Survey and the technical support teams at BRC. We thank also the editor and anonymous reviewers their thorough and constructive comments for the first version of the manuscript.	Alford DV, 1998, PEDOBIOLOGIA, V42, P574; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2000, ESA BULL-EUR SPACE; Baddeley A, SPATIAL POINT PATTER; Bellard C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2454; Branch GM, 2004, J EXP MAR BIOL ECOL, V300, P189, DOI 10.1016/j.jembe.2003.12.007; Brown PMJ, 2008, BIOCONTROL, V53, P5, DOI 10.1007/s10526-007-9132-y; Brown PMJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.239; Brown PMJ, 2011, BIOCONTROL, V56, P623, DOI 10.1007/s10526-011-9379-1; CABI, 2018, INVASIVE SPECIES COM; Camacho-Cervantes Morelia, 2017, PeerJ, V5, pe3296, DOI 10.7717/peerj.3296; Carde RT, 2008, CURR BIOL, V18, pR472, DOI 10.1016/j.cub.2008.04.018; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; Comont RF, 2017, BIOCONTROL, V62, P309, DOI 10.1007/s10526-016-9771-y; Comont RF, 2014, BIOL INVASIONS, V16, P1805, DOI 10.1007/s10530-013-0628-3; Diamond J.M., 1984, P191; Dick JTA, 2017, J APPL ECOL, V54, P1259, DOI 10.1111/1365-2664.12849; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Facon B, 2011, EVOL APPL, V4, P71, DOI 10.1111/j.1752-4571.2010.00134.x; Fox R., 2006, STATE BRITAINS LARGE; Gardiner Tim, 2009, Journal of Orthoptera Research, V18, P95; GREENBANK DO, 1980, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm112110fv; Grez AA, 2013, DIVERS DISTRIB, V19, P749, DOI 10.1111/ddi.12027; Grosso-Silva Jose Manuel, 2012, Arquivos Entomoloxicos, V6, P53; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Hodek I, 1996, ECOLOGY COCCINELLIDA, DOI [10.1007/978-94-017-1349-8, DOI 10.1007/978-94-017-1349-8]; Hulme M, 2009, WHY WE DISAGREE ABOUT CLIMATE CHANGE: UNDERSTANDING CONTROVERSY, INACTION AND OPPORTUNITY, P1; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2017, BIOL REV, V92, P1297, DOI 10.1111/brv.12282; Jeffries DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082278; Johnson C, 1969, MIGRATIONAND DISPERS, DOI [10.1002/qj.49709640721, DOI 10.1002/QJ.49709640721]; Juhasz L, 2017, GEO-SPAT INF SCI, V20, P241, DOI 10.1080/10095020.2017.1368200; Karl M, 2019, ATMOS CHEM PHYS, V19, P7019, DOI 10.5194/acp-19-7019-2019; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Krehenwinkel H, 2013, MOL ECOL, V22, P2232, DOI 10.1111/mec.12223; Kukkonen J, 2012, ATMOS CHEM PHYS, V12, P1, DOI 10.5194/acp-12-1-2012; Kumschick S, 2011, CLIMATIC CHANGE, V109, P319, DOI 10.1007/s10584-011-0139-0; Lacasella F, 2017, ECOL APPL, V27, P575, DOI 10.1002/eap.1467; Leskinen M, 2011, J APPL ENTOMOL, V135, P55, DOI 10.1111/j.1439-0418.2009.01480.x; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lopez S., 2011, Bulletin OEPP, V41, P439, DOI 10.1111/j.1365-2338.2011.02513.x; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Monceau K, 2014, J PEST SCI, V87, P1, DOI 10.1007/s10340-013-0537-3; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Paatero J, 2012, J ENVIRON RADIOACTIV, V114, P41, DOI 10.1016/j.jenvrad.2011.12.027; Petersen AK, 2019, GEOSCI MODEL DEV, V12, P1241, DOI 10.5194/gmd-12-1241-2019; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Raak-van den Berg CL, 2012, BIOCONTROL, V57, P71, DOI 10.1007/s10526-011-9394-2; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Robinet C, 2009, ECOL APPL, V19, P1935, DOI 10.1890/08-1971.1; Rome Quentin, 2013, Bulletin de la Societe Entomologique de France, V118, P21; Roy H., 2011, LADYBIRDS COCCINELLI; Roy H, 2018, FIELD GUIDE LADYBIRD; Roy HE, 2017, CONSERV LETT, V10, P477, DOI 10.1111/conl.12297; Roy HE, 2016, BIOL INVASIONS, V18, P997, DOI 10.1007/s10530-016-1077-6; Roy HE, 2015, ECOL ENTOMOL, V40, P336, DOI 10.1111/een.12203; Roy HE, 2014, GLOBAL CHANGE BIOL, V20, P3859, DOI 10.1111/gcb.12603; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Saarnio K, 2010, SCI TOTAL ENVIRON, V408, P2527, DOI 10.1016/j.scitotenv.2010.03.010; SHOWERS WB, 1993, ECOLOGY, V74, P2303, DOI 10.2307/1939583; Siljamo P, 2013, INT J BIOMETEOROL, V57, P125, DOI 10.1007/s00484-012-0539-5; Sofiev M, 2006, INT J BIOMETEOROL, V50, P392, DOI 10.1007/s00484-006-0027-x; Sofiev M, 2006, ATMOS ENVIRON, V40, P674, DOI 10.1016/j.atmosenv.2005.09.069; Sofiev M, 2015, GEOSCI MODEL DEV, V8, P3497, DOI 10.5194/gmd-8-3497-2015; Sofiev M, 2015, ATMOS CHEM PHYS, V15, P8115, DOI 10.5194/acp-15-8115-2015; Sofiev M, 2013, INT J BIOMETEOROL, V57, P45, DOI 10.1007/s00484-012-0532-z; Sofiev M, 2017, ATMOS CHEM PHYS, V17, P12341, DOI 10.5194/acp-17-12341-2017; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; Stohl A, 2012, ATMOS CHEM PHYS, V12, P2313, DOI 10.5194/acp-12-2313-2012; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Turbelin AJ, 2017, GLOBAL ECOL BIOGEOGR, V26, P78, DOI 10.1111/geb.12517; UKNEA, 2011, UK NAT EC ASS TECHN; van Lenteren J.C., 2007, BIOL CONTROL INVASIO, P37, DOI [10.1007/s10526-007-9132-y, DOI 10.1007/S10526-007-9132-Y]; Veriankaite L, 2010, AEROBIOLOGIA, V26, P47, DOI 10.1007/s10453-009-9142-6; Vickery V. R., 1965, Annales de la Societe Entomologique de Quebec, V10, P165; Vira J, 2017, GEOSCI MODEL DEV, V10, P1985, DOI 10.5194/gmd-10-1985-2017; Wainwright CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04503-0; Walter A, 2005, J ARACHNOL, V33, P516, DOI 10.1636/04-78.1; Williams F., 2010, EC COST INVASIVE NON; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wittenberg R, 2001, INVASIVE ALIEN SPECI; Wu QL, 2018, INSECTS, V9, DOI 10.3390/insects9030115	86	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2020	15	1							e0219335	10.1371/journal.pone.0219335	http://dx.doi.org/10.1371/journal.pone.0219335			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5OV	31940348	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000534368000002
J	Dai, SY; Chan, KCC				Dai, Siyu; Chan, Kate Ching Ching			Household environmental tobacco smoke exposure in healthy young children in Hong Kong: Prevalence and risk factors	PLOS ONE			English	Article							PASSIVE SMOKING; SOCIOECONOMIC-STATUS; PARENTAL SMOKING; 2ND-HAND SMOKE; PREGNANCY; INFANTS	Background Environmental tobacco smoke (ETS) exposure attributable respiratory illness burden is huge in paediatric population. Understanding the epidemiology of ETS exposure is important to guide health promotion planning. Therefore, we designed this study to determine the prevalence of household ETS exposure in healthy young children under 2 years of age in Hong Kong, and to explore risk factors associated with the exposure. Our secondary goal was to characterise children's exposure profile to maternal smoking. Methods A secondary analysis was performed based on the data collected from our 2013-2014 territory-wide cross-sectional pneumococcal carriage surveillance study, with a sample size of 1541. We conducted descriptive analysis for exposure prevalence, univariate and multivariate analysis for identification of risk factors. Results 1541 children (mean age: 11.2 +/- 6.4 months, male: 50.7%) were included in the analysis. The overall prevalence of current household ETS exposure was 31.5%, prevalence of prenatal and postnatal maternal smoking was 3.5% and 1.6% respectively. Independent factors associated with children's ETS exposure were: never breastfed (AOR: 1.48, 95% CI: 1.131.93, p = 0.004); prenatal maternal smoking (AOR: 7.46, 95% CI: 2.73-20.39, p< 0.001); overcrowding of household living place (AOR: 3.17, 95% CI: 2.02-4.96, P< 0.001); lower household income (AOR: 1.34, 95% CI: 1.04-1.72, p = 0.02). Interestingly, children residing in Kowloon (AOR: 1.66, 95% CI: 1.19-2.33, p = 0.003) and New Territories West (AOR: 1.54, 95% CI: 1.11-2.15, p = 0.01) were associated with exposure compared with children residing in Hong Kong Island. Conclusion Exposure to household ETS is prevalent among Hong Kong young children, particularly in children with maternal unfavourable behaviour and lower socioeconomic status. The identified risk factors should be considered while tobacco control interventions and legislations are planned.	[Dai, Siyu; Chan, Kate Ching Ching] Chinese Univ Hong Kong, Dept Paediat, Fac Med, Hong Kong, Peoples R China; [Dai, Siyu; Chan, Kate Ching Ching] Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, KCC (corresponding author), Chinese Univ Hong Kong, Dept Paediat, Fac Med, Hong Kong, Peoples R China.; Chan, KCC (corresponding author), Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China.	katechan@cuhk.edu.hk	Chan, Kate Ching-ching/P-2947-2018	Chan, Kate Ching-ching/0000-0001-7272-8285				Anderson SJ, 2005, TOB CONTROL, V14, P127, DOI 10.1136/tc.2004.009076; Anuntaseree W, 2008, PREV MED, V47, P443, DOI 10.1016/j.ypmed.2008.06.006; Arya R, 2012, INDIAN J PEDIATR, V79, P1482, DOI 10.1007/s12098-012-0763-3; Baheiraei A., 2010, TANAFFOS - Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, V9, P43; Behbod B, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001746.pub4; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Census and Statistics Department, 2021, POP HOUS STAT AN DIS; Census & Statistics Department, 2018, 64 HON KONG CENS STA; Chan KCC, 2016, VACCINE, V34, P3867, DOI 10.1016/j.vaccine.2016.05.047; COOK DG, 1994, BRIT MED J, V308, P384, DOI 10.1136/bmj.308.6925.384; Denson KWE, 2001, INT ARCH OCC ENV HEA, V74, P525, DOI 10.1007/s004200100258; Geerts CC, 2012, PEDIATRICS, V129, P45, DOI 10.1542/peds.2011-0249; Hawkins SS, 2014, CHILD CARE HLTH DEV, V40, P441, DOI 10.1111/cch.12058; Hawkins SS, 2011, PREV MED, V53, P61, DOI 10.1016/j.ypmed.2011.05.016; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Hodgkinson S., 2017, PEDIATRICS, V139, P1, DOI DOI 10.1542/peds.2015-1175; Huang KY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020161; Koletsi D, 2018, AM J ORTHOD DENTOFAC, V153, P157, DOI 10.1016/j.ajodo.2017.11.011; Kong GWS, 2008, AUST NZ J OBSTET GYN, V48, P280, DOI 10.1111/j.1479-828X.2008.00840.x; Kwok MK, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023887; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; Leung GM, 2002, PAEDIATR PERINAT EP, V16, P236, DOI 10.1046/j.1365-3016.2002.00426.x; Leung TF, 2013, PEDIATR PULM, V48, P1089, DOI 10.1002/ppul.22801; Li HCW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2326-9; Li HCW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1529-4; Mak YW, 2008, PUBLIC HEALTH, V122, P1199, DOI 10.1016/j.puhe.2008.04.004; Mak YW, 2005, ADDICT BEHAV, V30, P841, DOI 10.1016/j.addbeh.2004.08.008; Mohsin M, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-138; Nanninga S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5679-z; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Orton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112690; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Rezaeian M, 2007, J EPIDEMIOL COMMUN H, V61, P98, DOI 10.1136/jech.2005.043117; Rosen LJ, 2012, PEDIATRICS, V129, P141, DOI 10.1542/peds.2010-3209; Stead LF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub3; Thaqi A, 2005, INDOOR AIR, V15, P302, DOI 10.1111/j.1600-0668.2005.00361.x; Tong VT, 2013, MMWR SURVEILL SUMM, V62, P1; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; US Department of Health and Human Services, HLTH CONS INV EXP TO; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; World Health Organization, 2017, WHO REP GLOB TOB EP; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Yi O, 2012, NICOTINE TOB RES, V14, P607, DOI 10.1093/ntr/ntr259	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0227733	10.1371/journal.pone.0227733	http://dx.doi.org/10.1371/journal.pone.0227733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5JP	31935251	Green Published, gold			2022-12-26	WOS:000534354100047
J	Mehdizavareh, MH; Hemati, S; Soltanian-Zadeh, H				Mehdizavareh, Mohammad Hadi; Hemati, Sobhan; Soltanian-Zadeh, Hamid			Enhancing performance of subject-specific models via subject-independent information for SSVEP-based BCIs	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; VISUAL-EVOKED POTENTIALS; BRAIN; FREQUENCY; RECOGNITION	Recently, brain-computer interface (BCI) systems developed based on steady-state visual evoked potential (SSVEP) have attracted much attention due to their high information transfer rate (ITR) and increasing number of targets. However, SSVEP-based methods can be improved in terms of their accuracy and target detection time. We propose a new method based on canonical correlation analysis (CCA) to integrate subject-specific models and subject-independent information and enhance BCI performance. We propose to use training data of other subjects to optimize hyperparameters for CCA-based model of a specific subject. An ensemble version of the proposed method is also developed for a fair comparison with ensemble task-related component analysis (TRCA). The proposed method is compared with TRCA and extended CCA methods. A publicly available, 35-subject SSVEP benchmark dataset is used for comparison studies and performance is quantified by classification accuracy and ITR. The ITR of the proposed method is higher than those of TRCA and extended CCA. The proposed method outperforms extended CCA in all conditions and TRCA for time windows greater than 0.3 s. The proposed method also outperforms TRCA when there are limited training blocks and electrodes. This study illustrates that adding subject-independent information to subject-specific models can improve performance of SSVEP-based BCIs.	[Mehdizavareh, Mohammad Hadi; Hemati, Sobhan; Soltanian-Zadeh, Hamid] Univ Tehran, Coll Engn, Sch Elect & Comp Engn, CIPCE, Tehran, Iran; [Soltanian-Zadeh, Hamid] Henry Ford Hlth Syst, Dept Radiol, Med Image Anal Lab, Detroit, MI 48202 USA; [Soltanian-Zadeh, Hamid] Henry Ford Hlth Syst, Dept Res Adm, Med Image Anal Lab, Detroit, MI 48202 USA	University of Tehran; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Soltanian-Zadeh, H (corresponding author), Univ Tehran, Coll Engn, Sch Elect & Comp Engn, CIPCE, Tehran, Iran.; Soltanian-Zadeh, H (corresponding author), Henry Ford Hlth Syst, Dept Radiol, Med Image Anal Lab, Detroit, MI 48202 USA.; Soltanian-Zadeh, H (corresponding author), Henry Ford Hlth Syst, Dept Res Adm, Med Image Anal Lab, Detroit, MI 48202 USA.	hszadeh@ut.ac.ir	Soltanian-Zadeh, Hamid/AAD-7027-2022	Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Mehdizavareh, Mohammad Hadi/0000-0002-2308-8485				Ang KK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00039; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Bin GY, 2008, IEEE ENG MED BIO, P3759, DOI 10.1109/IEMBS.2008.4650026; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Chen XG, 2014, BRAIN-COMPUT INTERFA, V1, P181, DOI 10.1080/2326263X.2014.944469; Chen XG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046008; Chen XG, 2014, IEEE ENG MED BIO, P3993, DOI 10.1109/EMBC.2014.6944499; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Choi I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176674; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Fukunaga K., 2013, INTRO STAT PATTERN R; Gao S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/756347; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Jiang J, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aac605; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Nakanishi M, 2018, IEEE T BIO-MED ENG, V65, P104, DOI 10.1109/TBME.2017.2694818; Nakanishi M, 2016, LECT NOTES ARTIF INT, V9743, P253, DOI 10.1007/978-3-319-39955-3_24; Nakanishi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140703; Nakanishi M, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500191; Nuyujukian P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204566; Russo FD, 1999, VISION RES, V39, P2975, DOI DOI 10.1016/S0042-6989(99)00031-; Spuler M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172400; Tanaka H, 2013, NEUROIMAGE, V64, P308, DOI 10.1016/j.neuroimage.2012.08.044; Theodoridis S., 2010, INTRO PATTERN RECOGN; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YJ, 2017, IEEE T NEUR SYS REH, V25, P1746, DOI 10.1109/TNSRE.2016.2627556; Wang YJ, 2014, IEEE ENG MED BIO, P3037, DOI 10.1109/EMBC.2014.6944263; Webster E, UNSUPERVISED CHANNEL; Weise T, 2008, GLOBAL OPTIMIZATION; Yang C, 2018, INT J NEURAL SYST, V28, DOI 10.1142/S0129065718500284; Yao ZL, 2018, IEICE T INF SYST, VE101D, P2859, DOI 10.1587/transinf.2018EDL8122; Yuan P, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046006; Zerafa R, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaca6e; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500130; Zhang Y, 2013, IEEE T NEUR SYS REH, V21, P887, DOI 10.1109/TNSRE.2013.2279680; Zhang Y, 2011, LECT NOTES COMPUT SC, V7062, P287, DOI 10.1007/978-3-642-24955-6_35; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2020	15	1							e0226048	10.1371/journal.pone.0226048	http://dx.doi.org/10.1371/journal.pone.0226048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5JP	31935220	Green Submitted, Green Published, gold			2022-12-26	WOS:000534354100007
J	Carter, MJ; Flores, M; Ramos-Jiliberto, R				Carter, Mauricio J.; Flores, Matias; Ramos-Jiliberto, Rodrigo			Geographical origin determines responses to salinity of Mediterranean caddisflies	PLOS ONE			English	Article							AQUATIC INSECTS; MAJOR IONS; WATER; TOLERANCE; MACROINVERTEBRATES; SALINIZATION; STREAM; IONOREGULATION; PATTERNS; TRAITS	Many freshwater ecosystems worldwide, and particularly Mediterranean ones, show increasing levels of salinity. These changes in water conditions could affect abundance and distribution of inhabiting species as well as the provision of ecosystem services. In this study we conduct laboratory experiments using the macroinvertebrate Smicridea annulicornis as a model organism. Our factorial experiments were designed to evaluate the effects of geographical origin of organisms and salinity levels on survival and behavioral responses of caddisflies. The experimental organisms were captured from rivers belonging to three hydrological basins along a 450 Km latitudinal gradient in the Mediterranean region of Chile. Animals were exposed to three conductivity levels, from 180 to 1400 mu S/cm, close to the historical averages of the source rivers. We measured the behavioral responses to experimental stimuli and the survival time. Our results showed that geographical origin shaped the behavioral and survival responses to salinity. In particular, survival and activity decreased more strongly with increasing salinity in organisms coming from more dilute waters. This suggests local adaptation to be determinant for salinity responses in this benthic invertebrate species. In the current scenario of fast temporal and spatial changes in water levels and salt concentration, the conservation of geographic intra-specific variation of aquatic species is crucial for lowering the risk of salinity-driven biodiversity loss.	[Carter, Mauricio J.] Univ Andres Bello, Fac Ciencias Vida, Santiago, Chile; [Flores, Matias] Univ Chile, Fac Ciencias, Santiago, Chile; [Ramos-Jiliberto, Rodrigo] Univ Mayor, Fac Interdisciplinary Studies, GEMA Ctr Genom Ecol & Environm, Santiago, Chile	Universidad Andres Bello; Universidad de Chile; Universidad Mayor	Ramos-Jiliberto, R (corresponding author), Univ Mayor, Fac Interdisciplinary Studies, GEMA Ctr Genom Ecol & Environm, Santiago, Chile.	rodrigo.ramos@umayor.cl		Carter, Mauricio J/0000-0002-5351-8108	CONICYT/FONDECYT [1140498, 1150348, 1190173]	CONICYT/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	MCM was funded by grant CONICYT/FONDECYT 1140498. RR-J was funded by grants CONICYT/FONDECYT 1150348 and 1190173.	[Anonymous], 2017, R LANG ENV STAT COMP; Berger E, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0010; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Canedo-Arguelles M, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0002; Cespedes V, 2013, J INSECT PHYSIOL, V59, P1076, DOI 10.1016/j.jinsphys.2013.08.006; Clements WH, 2016, FRESHW SCI, V35, P126, DOI 10.1086/685085; Conti L, 2014, HYDROBIOLOGIA, V721, P297, DOI 10.1007/s10750-013-1690-7; Cormier SM, 2018, SCI TOTAL ENVIRON, V633, P1629, DOI 10.1016/j.scitotenv.2018.02.044; Dallas HF, 2013, HYDROBIOLOGIA, V719, P483, DOI 10.1007/s10750-012-1305-8; Dowse R, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160520; Dunlop J., 2015, AUSTRAL B ECOTOXICOL, P1; Dunlop JE, 2008, ENVIRON POLLUT, V151, P621, DOI 10.1016/j.envpol.2007.03.020; East JL, 2017, FRESHWATER BIOL, V62, P681, DOI 10.1111/fwb.12893; Evans D. H., 2008, OSMOTIC IONIC REGULA; Falconer D. S., 1996, INTRO QUANTITATIVE G; Figueroa R, 2007, REV CHIL HIST NAT, V80, P225; Figueroa R, 2013, HYDROBIOLOGIA, V719, P269, DOI 10.1007/s10750-013-1685-4; Griffith MB, 2017, ENVIRON TOXICOL CHEM, V36, P576, DOI 10.1002/etc.3676; Griffith MB, 2014, FRESHW SCI, V33, P1, DOI 10.1086/674704; Jannot JE, 2007, ECOL ENTOMOL, V32, P376, DOI 10.1111/j.1365-2311.2007.00876.x; Kaushal SS, 2018, P NATL ACAD SCI USA, V115, pE574, DOI 10.1073/pnas.1711234115; Kefford BJ, 2007, AQUAT ECOL, V41, P335, DOI 10.1007/s10452-006-9066-y; Kefford BJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0021; Kefford BJ, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1072; Kefford BJ, 2003, MAR FRESHWATER RES, V54, P755, DOI 10.1071/MF02081; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Koel TM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1139; Leberfinger K, 2010, HYDROBIOLOGIA, V652, P247, DOI 10.1007/s10750-010-0337-1; Lee CE, 2011, EVOLUTION, V65, P2229, DOI 10.1111/j.1558-5646.2011.01308.x; Marshall WS, 2002, J EXP ZOOL, V293, P264, DOI 10.1002/jez.10127; Mount DR, 2016, ENVIRON TOXICOL CHEM, V35, P3039, DOI 10.1002/etc.3487; Nowghani F, 2019, AQUAT TOXICOL, V211, P92, DOI 10.1016/j.aquatox.2019.03.019; Nowghani F, 2017, J EXP BIOL, V220, P3997, DOI 10.1242/jeb.166132; Olson JR, 2017, FRESHWATER BIOL, V62, P779, DOI 10.1111/fwb.12901; Peredo-Parada M, 2009, GAYANA CONCEPCION, V73; Pereira CS, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0251; Pizarro J, 2010, J HAZARD MATER, V181, P747, DOI 10.1016/j.jhazmat.2010.05.076; Pizarro J, 2010, J HAZARD MATER, V175, P608, DOI 10.1016/j.jhazmat.2009.10.048; Pond GJ, 2014, ENVIRON MANAGE, V54, P919, DOI 10.1007/s00267-014-0319-6; Raitif J, 2019, AGR ECOSYST ENVIRON, V270, P32, DOI 10.1016/j.agee.2018.10.013; Sabando MC, 2011, MAR FRESHWATER RES, V62, P1, DOI 10.1071/MF10105; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Stewart RIA, 2017, BASIC APPL ECOL, V18, P13, DOI 10.1016/j.baae.2016.09.006; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Stoks R, 2014, EVOL APPL, V7, P42, DOI 10.1111/eva.12108; Suarez ML, 2017, AQUAT SCI, V79, P1, DOI 10.1007/s00027-016-0475-2; Szocs E, 2014, SCI TOTAL ENVIRON, V468, P943, DOI 10.1016/j.scitotenv.2013.08.058; Thabet R, 2017, HYDROBIOLOGIA, V799, P1, DOI 10.1007/s10750-017-3232-1; Venancio C, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0252; Zalizniak L, 2006, MAR FRESHWATER RES, V57, P75, DOI 10.1071/MF05103	50	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0220275	10.1371/journal.pone.0220275	http://dx.doi.org/10.1371/journal.pone.0220275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929552	Green Submitted, Green Published, gold			2022-12-26	WOS:000534352500003
J	Cohen, Y				Cohen, Yigal			Root treatment with oxathiapiprolin, benthiavalicarb or their mixture provides prolonged systemic protection against oomycete foliar pathogens	PLOS ONE			English	Article							CARBOXYLIC-ACID AMIDE; BASE-LINE SENSITIVITIES; PHYTOPHTHORA-INFESTANS; DOWNY MILDEW; CAA FUNGICIDES; LIFE STAGES; RESISTANCE; EFFICACY; CAPSICI	Oxathiapiprolin is a fungicide effective against downy mildews of cucumber (Pseudoperonospora cubensis) and basil (Peronospora belbahrii) and late blight of tomato (Phytophthora infestans). To avoid fungicide resistance, it is recommended to apply oxathiapiprolin as a mixture with a partner fungicide that have a different mode of action. Here it is shown that a single application of oxathiapiprolin, benthiavalicarb, or their mixture (3+7, w/w) to the root of nursery plants grown in multi-cell trays provided prolonged systemic protection against late blight and downy mildews in growth chambers and in field tests. Soil application of 1mg active ingredient per plant provided durable protection of up to four weeks in tomato against late blight, cucumber against downy mildew and basil against downy mildew. Not only did the mixture of oxathiapiprolin and benthiavalicarb provide excellent systemic control of these diseases but also mutual protection against resistance towards both oxathiapiprolin and benthiavalicarb.	[Cohen, Yigal] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	ycohen@biu.ac.il		cohen, yigal/0000-0002-4443-1940				Andreassi I. I. J. L., 2013, International Patent, Patent No. [WO13/009971, 13009971]; Belisle RJ, 2017, PHYTOPATHOLOGY, V107, P182; Bittner RJ, 2017, CROP PROT, V93, P9, DOI 10.1016/j.cropro.2016.10.019; Blum M, 2011, PEST MANAG SCI, V67, P1211, DOI 10.1002/ps.2238; Cohen Y, 2007, PLANT PATHOL, V56, P836, DOI 10.1111/j.1365-3059.2007.01625.x; Cohen Y, 1995, PHYTOPATHOLOGY, V85, P1500, DOI 10.1094/Phyto-85-1500; Cohen Y, 2015, PLOS ONE, V10; Cohen Y, 2008, EUR J PLANT PATHOL, V122, P169, DOI 10.1007/s10658-008-9327-9; Cohen Y, 2007, PHYTOPATHOLOGY, V97, P1274, DOI 10.1094/PHYTO-97-10-1274; Cohen Y, 2018, PHYTOPARASITICA, V46, P689, DOI 10.1007/s12600-018-0702-6; Cohen Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204523; Cohen Y, 2017, PHYTOPATHOLOGY, V107, P1149, DOI [10.1094/PHYTO-01-17-0017-FI, 10.1094/PHYTO-01-17-0017-F1]; Elderfield JAD, 2018, PHYTOPATHOLOGY, V108, P803, DOI 10.1094/PHYTO-08-17-0277-R; Gisi U, 2007, PLANT PATHOL, V56, P199, DOI 10.1111/j.1365-3059.2006.01512.x; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Gray MA, 2018, PLANT DIS, V102, P734, DOI [10.1094/PDIS-08-17-1155-RE, 10.1094/pdis-08-17-1155-re]; Hao W, 2019, PLANT DIS, V103, P619, DOI 10.1094/PDIS-07-18-1152-RE; Ji P, 2015, ANN APPL BIOL, V166, P229, DOI 10.1111/aab.12176; Kosman E, 1996, PHYTOPATHOLOGY, V86, P1263; LEVY Y, 1986, Bulletin OEPP, V16, P651, DOI 10.1111/j.1365-2338.1986.tb00338.x; Lunn D, 2016, OXATHIAPIPROLIN 291; Miao JQ, 2018, PESTIC BIOCHEM PHYS, V147, P96, DOI 10.1016/j.pestbp.2018.03.009; Miao JQ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00615; Olaya G, 2016, PHYTOPATHOLOGY, V106, P76; Pasteris R. J., 2008, [No title captured], Patent No. [WO2,008,013,925, 2008013925, WO 2008013925]; Pasteris RJ, 2016, BIOORGAN MED CHEM, V24, P354, DOI 10.1016/j.bmc.2015.07.064; Reuveni M, 2003, EUR J PLANT PATHOL, V109, P243, DOI 10.1023/A:1022836105688; Rubin A, 2008, PLANT DIS, V92, P675, DOI 10.1094/PDIS-92-5-0675; Sakai J, 2010, J PESTIC SCI, V35, P488, DOI 10.1584/jpestics.J10-07; Weber-Boyvat M, 2013, BIOCHEM PHARMACOL, V86, P89, DOI 10.1016/j.bcp.2013.02.016; Yu PZ, 2017, J SCI FOOD AGR, V97, P3294, DOI 10.1002/jsfa.8178	31	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227556	10.1371/journal.pone.0227556	http://dx.doi.org/10.1371/journal.pone.0227556			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929586	Green Published, gold			2022-12-26	WOS:000534352500044
J	Heo, JE; Lee, JS; Goh, HJ; Jang, WS; Choi, YD				Heo, Ji Eun; Lee, Jong Soo; Goh, Hyeok Jun; Jang, Won Sik; Choi, Young Deuk			Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURGICAL MARGINS; SPHINCTER; CANCER; ASSOCIATION; GUIDELINES; MECHANISM; IMPACT	Purpose To evaluate early recovery of urinary continence after robot-assisted radical prostatectomy (RARP) with urethral realignment using bladder neck preservation (BNP) and maximal urethral length preservation (MULP). Methods Patients who underwent RARP between 2014 and 2017 owing to prostate cancer with a Gleason score <= 7 (3+4), <= cT2c stage, and prostate-specific antigen level < 20 ng/ml were investigated. Patients with tumors of the bladder neck or apex on magnetic resonance imaging were excluded. A total of 266 patients underwent the operation using the standard method between 2014 and 2015 (group 1), while 305 patients underwent urethral realignment between 2016 and 2017 (group 2). Continence was defined as wearing no pad or one security pad. Results The continence rates immediately after Foley catheter removal, at 2 weeks, and at 1, 3, 6, and 12 months after operation in group 2 were 46.9%, 63.0%, 73.4%, 90.1%, 94.8%, and 98.7%, respectively. The continence rate at 1 month in group 2 was significantly higher than that in group 1 (65.4% versus 73.4%, p = 0.037). The multivariate regression analysis showed that age and surgical method were factors affecting early continence recovery. The positive surgical margin rates were 18.0% and 14.8% in groups 1 and 2, respectively (p = 0.288). Biochemical recurrence occurred in 14.7% and 8.2% in groups 1 and 2, respectively (p = 0.015). Conclusion Urethral realignment using BNP and MULP resulted in rapid continence recovery and good oncological results after RARP in young patients with a Gleason score. 7 and organ-confined disease.	[Heo, Ji Eun; Lee, Jong Soo; Jang, Won Sik; Choi, Young Deuk] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; [Heo, Ji Eun; Lee, Jong Soo; Jang, Won Sik; Choi, Young Deuk] Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea; [Goh, Hyeok Jun] Dong A Univ, Dept Urol, Coll Med, Busan, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Dong A University	Choi, YD (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.; Choi, YD (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea.	youngd74@yuhs.ac		Lee, Jongsoo/0000-0002-9984-1138; Choi, Young Deuk/0000-0002-8545-5797; Jang, Won Sik/0000-0002-9082-0381; Heo, Ji Eun/0000-0002-4184-8468				Brunocilla E, 2012, INT J UROL, V19, P783, DOI 10.1111/j.1442-2042.2012.03028.x; Carroll PH, 2018, J NATL COMPR CANC NE, V16, P620, DOI 10.6004/jnccn.2018.0036; Chung JS, 2011, J ENDOUROL, V25, P787, DOI 10.1089/end.2010.0222; Chung S-Y, 2015, EUR C RAD; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Freire MP, 2009, EUR UROL, V56, P972, DOI 10.1016/j.eururo.2009.09.017; Gautam G, 2010, UROLOGY, V76, P734, DOI 10.1016/j.urology.2010.01.073; Hamada A, 2014, J ENDOUROL, V28, P930, DOI 10.1089/end.2013.0794; Hurtes X, 2012, BJU INT, V110, P875, DOI 10.1111/j.1464-410X.2011.10849.x; Jonler M, 1996, UROLOGY, V48, P433, DOI 10.1016/S0090-4295(96)00216-6; Katz R, 2003, J UROLOGY, V169, P2049, DOI 10.1097/01.ju.0000065822.15012.b7; Koo KC, 2017, JPN J CLIN ONCOL, V47, P981, DOI 10.1093/jjco/hyx101; Marcovich R, 2000, UROLOGY, V55, P904, DOI 10.1016/S0090-4295(00)00451-9; Nguyen L, 2008, J UROLOGY, V179, P1907, DOI 10.1016/j.juro.2008.01.036; Nyarangi-Dix JN, 2013, J UROLOGY, V189, P891, DOI 10.1016/j.juro.2012.09.082; Paparel P, 2009, EUR UROL, V55, P629, DOI 10.1016/j.eururo.2008.08.057; Porpiglia F, 2016, EUR UROL, V69, P485, DOI 10.1016/j.eururo.2015.08.005; Schlomm T, 2011, EUR UROL, V60, P320, DOI 10.1016/j.eururo.2011.02.040; Selli C, 2004, SCAND J UROL NEPHROL, V38, P32, DOI 10.1080/00365590310017280; Stolzenburg JU, 2010, UROL INT, V85, P135, DOI 10.1159/000314842; Tan HJ, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.01.012; Tewari AK, 2007, UROLOGY, V69, P726, DOI 10.1016/j.urology.2006.12.028; Whitson JM, 2008, J UROLOGY, V179, P1035, DOI 10.1016/j.juro.2007.10.081	24	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227744	10.1371/journal.pone.0227744	http://dx.doi.org/10.1371/journal.pone.0227744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929596	Green Published, gold			2022-12-26	WOS:000534352500067
J	Obirikorang, C; Acheampong, E; Quaye, L; Yorke, J; Amos-Abanyie, EK; Akyaw, PA; Anto, EO; Bani, SB; Asamoah, EA; Batu, EN				Obirikorang, Christian; Acheampong, Emmanuel; Quaye, Lawrence; Yorke, Joseph; Amos-Abanyie, Ernestine Kubi; Akyaw, Priscilla Abena; Anto, Enoch Odame; Bani, Simon Bannison; Asamoah, Evans Adu; Batu, Emmanuella Nsenbah			Association of single nucleotide polymorphisms with dyslipidemia in antiretroviral exposed HIV patients in a Ghanaian population: A case-control study	PLOS ONE			English	Article							LIPID-METABOLISM; CHOLESTEROL; THERAPY; DISEASE; GENES; INDIVIDUALS; GLUCOSE; IMPACT; AGENTS; RISK	Dyslipidemia is a potential complication of long-term usage of antiretroviral therapy (ART) and also known to be associated with genetic factors. The host genetic variants associated with dyslipidemia in HIV patients on ART in Ghana have not been fully explored. The study constituted a total of 289 HIV-infected patients on stable ART for at least a year. Fasting blood was collected into EDTA tube for lipids measurement. Lipid profiles were used to define dyslipidemia based on the NCEP-ATP III criteria. HIV-infected subjects were categorized into two groups; those with dyslipidemia (cases) (n = 90; 31.1%) and without dyslipidemia (controls)(n = 199; 68.9%). Four candidate single nucleotide polymorphism (SNP) genes (ABCA1-rs2066714, LDLR-rs6511720, APOA5-rs662799 and DSCAML1-rs10892151) were determined. Genotyping was performed on isolated genomic DNA of study participants using PCR followed by a multiplex ligation detection reaction (LDR). The percentage of the population who had the rare homozygote alleles for rs6511720 (T/T), rs2066714 (G/G), rs10892151 (T/T) and rs662799 (G/G) among case subjects were 5.5%, 14.4%, 6.6% and 10.0% whiles 2.0% 9.1%, 6.5% and 4.0% were observed among control subjects. There were statistically significant differences in the genotypic prevalence of APOA5 (p = 0.0357) and LDLR polymorphisms (p = 0.0387) between case and control subjects. Compared to the AA genotype of the APOA5 polymorphisms, individuals with the rare homozygote genotype [aOR = 2.38, 95%CI(1.06-6.54), p = 0.004] were significantly associated with an increased likelihood of developing dyslipidemia after controlling for age, gender, treatment duration, CD4 counts and BMI. Moreover, individuals with the rare homozygous genotype of ABCA1 (G/G) [aOR = 10.7(1.3-88.7), p = 0.0280] and LDLR (rs6511720) G>T [aOR = 61.2(7.6-493.4), p<0.0001) were more likely to have high levels of total cholesterol levels. Our data accentuate the presence of SNPs in four candidate genes and their association with dyslipidemia among HIV patients exposed to ART in the Ghanaian population, especially variants in APOA5-rs662799 and LDLR rs6511720 respectively. These findings provide baseline information that necessitates a pre-symptomatic strategy for monitoring dyslipidemia in ART-treated HIV patients. There is a need for longitudinal studies to validate a comprehensive number of SNPs and their associations with dyslipidemia.	[Obirikorang, Christian; Acheampong, Emmanuel; Anto, Enoch Odame; Asamoah, Evans Adu; Batu, Emmanuella Nsenbah] KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Acheampong, Emmanuel; Anto, Enoch Odame] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, Australia; [Quaye, Lawrence; Bani, Simon Bannison] Univ Dev Studies, Sch Allied Hlth Sci, Tamale, Ghana; [Yorke, Joseph] Komfo Anokye Teaching Hosp, Dept Surg, Kumasi, Ghana; [Amos-Abanyie, Ernestine Kubi; Akyaw, Priscilla Abena] Univ Ghana, Noguchi Mem Inst Med Res, H3Africa Kidney Dis Res Project, Accra, Ghana	Kwame Nkrumah University Science & Technology; Edith Cowan University; University for Development Studies; Kwame Nkrumah University Science & Technology; University of Ghana	Obirikorang, C (corresponding author), KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	emmanuelachea1990@yahoo.com	Acheampong, Emmanuel/I-9309-2019; Adu, Evans Asamoah/AAM-4847-2020	Acheampong, Emmanuel/0000-0002-5338-3258; Adu, Evans Asamoah/0000-0001-6374-0979				Agongo G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206326; Anastos K, 2007, JAIDS-J ACQ IMM DEF, V45, P34, DOI 10.1097/QAI.0b013e318042d5fe; Ankrah DNA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2752-7; Aragones G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-120; Asiedu GB, 2014, HEALTH CARE WOMEN IN, V35, P703, DOI 10.1080/07399332.2014.895367; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chang MH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-62; Chen SN, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-111; Chien KL, 2009, TRANSL RES, V154, P133, DOI 10.1016/j.trsl.2009.06.005; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Almeida E, 2014, J AIDS CLIN RES, V5; de Limas TG, 2014, REV SOC BRAS MED TRO, V47, P547, DOI 10.1590/0037-8682-0128-2014; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Echevarria KL, 1999, ANN PHARMACOTHER, V33, P859, DOI 10.1345/aph.18174; Echeverria P, 2015, ANTIVIR RES, V114, P48, DOI 10.1016/j.antiviral.2014.12.002; El-Sadr W, 2005, HIV MED, V6, P114, DOI 10.1111/j.1468-1293.2005.00273.x; Estrada V, 2011, AIDS REV, V13, P49; Fairoozy RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167676; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Fox J, 2006, CLIN IMPLICATIONS AN; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kc R, 2016, SCI REP-UK, V6, DOI 10.1038/srep32048; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Kodogo Vitaris, 2016, Open AIDS J, V10, P190, DOI 10.2174/1874613601610010190; Kotler DP, 2008, JAIDS-J ACQ IMM DEF, V49, pS79, DOI 10.1097/QAI.0b013e318186519c; Lai CQ, 2003, J LIPID RES, V44, P2365, DOI 10.1194/jlr.M300251-JLR200; Lazzaretti RK, 2013, GENETIC MARKERS ASS; Lazzaretti RK, 2013, SCI WORLD J, DOI 10.1155/2013/608415; Manfredi R, 2001, J INFECTION, V42, P181, DOI 10.1053/jinf.2001.0829; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Ngala R A, 2013, Afr Health Sci, V13, P1107, DOI 10.4314/ahs.v13i4.35; Nock NL, 2012, DYSLIPIDEMIA PREVENT; Obirikorang Christian, 2016, Niger Med J, V57, P86, DOI 10.4103/0300-1652.182082; Panse I, 2000, BRIT J DERMATOL, V142, P496, DOI 10.1046/j.1365-2133.2000.03363.x; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Rios-Gonzalez BE, 2013, J GENET, V92, P114; Rotger M, 2009, CIRC-CARDIOVASC GENE, V2, P621, DOI 10.1161/CIRCGENETICS.109.874412; Seda O, 2003, PHYSIOL RES, V52, P141; Tadewos A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-31; Tsai MY, 2010, MOL GENET METAB, V100, P118, DOI 10.1016/j.ymgme.2010.03.001; Umpleby AM, 2005, ANTIVIR THER, V10, P663; UNAIDS, 2017, GLOB AIDS UPD 2017; Vardarli AT, 2017, ANATOL J CARDIOL, V17, P313, DOI 10.14744/AnatolJCardiol.2016.7142; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang XP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196042; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216	53	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0227779	10.1371/journal.pone.0227779	http://dx.doi.org/10.1371/journal.pone.0227779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929604	Green Published, gold, Green Submitted			2022-12-26	WOS:000534352500074
J	Plazinska, MT; Sawicka-Gutaj, N; Czarnywojtek, A; Wolinski, K; Kobylecka, M; Karlinska, M; Prasek, K; Zgorzalewicz-Stachowiak, M; Borowska, M; Gut, P; Ruchala, M; Krolicki, L				Plazinska, Maria Teresa; Sawicka-Gutaj, Nadia; Czarnywojtek, Agata; Wolinski, Kosma; Kobylecka, Malgorzata; Karlinska, Maria; Prasek, Karolina; Zgorzalewicz-Stachowiak, Malgorzata; Borowska, Magdalena; Gut, Pawel; Ruchala, Marek; Krolicki, Leszek			Radioiodine therapy and Graves' disease - Myths and reality	PLOS ONE			English	Article							CIGARETTE-SMOKING; THYROID AUTOIMMUNITY; RADIOACTIVE IODINE; TOBACCO SMOKING; NATURAL-HISTORY; HYPERTHYROIDISM; OPHTHALMOPATHY; IMPACT; ORBITOPATHY; PREVALENCE	Introduction Autoimmune reactions in Graves' disease (GD) occur not only in the thyroid gland, but also in the orbital connective tissue, eyelids, extraocular muscles. The occurrence of orbitopathy in the course of GD is influenced by environmental factors, e.g. cigarette smoking. Objectives The aim of the study was to analyze the effect of cigarette smoking on the efficacy of activity of radioiodine(131I) therapy in patients with GD. We also studied the influence of cigarette smoking and the efficacy of prednisone prophylaxis on the risk of thyroid-associated ophthalmopathy (TAO) development after radioiodine therapy (RIT) during two years of follow-up. Patients and methods Medical records of hyperthyroid patients treated with radioiodine had been included. Patients were scheduled to visit outpatient clinics at baseline and 1, 3, 6, 9, 12, 18, and 24 months after RIT. Results The studied group consisted of 336 patients (274 women, 62 men) diagnosed with GD and treated with RIT; 130 patients received second therapeutic dose of 131I due to recurrent hyperthyroidism. Among all studied patients, 220 (65.5%) were smokers and 116 (34.5%) non-smokers. In the group of smokers 115 (52.2%) of patients received single RIT, 105 (47.8%) received second dose of RAI due to recurrent hyperthyroidism. In non-smokers 91 (78.6%) received single activity of RAI, while 25 (21.4%) patients required second RIT due to recurrent hyperthyroidism. The ophthalmic symptoms in the group of smokers after RIT were less frequent, if the patient received preventative treatment in the form of oral prednisone (P = 0.0088). Conclusions The results of our study suggest that cigarette smoking reduces the efficacy of treatment with I-131 in patients with GD. The study also confirmed the effectiveness of steroid prophylaxis against TAO development or exacerbation after RIT.	[Plazinska, Maria Teresa; Kobylecka, Malgorzata; Prasek, Karolina; Krolicki, Leszek] Warsaw Med Univ, Dept Nucl Med, Warsaw, Poland; [Sawicka-Gutaj, Nadia; Czarnywojtek, Agata; Wolinski, Kosma; Gut, Pawel; Ruchala, Marek] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland; [Borowska, Magdalena] Poznan Univ Med Sci, Dept Pharmacol, Poznan, Poland; [Karlinska, Maria] Warsaw Med Univ, Dept Med Informat & Telemed, Warsaw, Poland; [Zgorzalewicz-Stachowiak, Malgorzata] Poznan Univ Med Sci, Dept Hlth Prophylaxis, Lab Med Electrodiagnost, Poznan, Poland	Medical University of Warsaw; Poznan University of Medical Sciences; Poznan University of Medical Sciences; Medical University of Warsaw; Poznan University of Medical Sciences	Wolinski, K (corresponding author), Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland.	kosma1644@poczta.onet.pl		Czarnywojtek, Agata/0000-0003-3595-8449; Borowska, Magdalena/0000-0003-3886-873X				Acharya SH, 2008, CLIN ENDOCRINOL, V69, P943, DOI 10.1111/j.1365-2265.2008.03279.x; Alexander EK, 2002, J CLIN ENDOCR METAB, V87, P1073, DOI 10.1210/jc.87.3.1073; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Baldys-Waligorska Agata, 2009, Przegl Lek, V66, P166; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bartalena L, 2005, J CLIN ENDOCR METAB, V90, P5497, DOI 10.1210/jc.2005-1553; Bartalena L, 2016, EUR THYROID J, V5, P9, DOI 10.1159/000443828; Bartalena L, 2013, NAT REV ENDOCRINOL, V9, P724, DOI 10.1038/nrendo.2013.193; Bartalena L, 2009, NEW ENGL J MED, V360, P994, DOI 10.1056/NEJMcp0806317; Belin RM, 2004, J CLIN ENDOCR METAB, V89, P6077, DOI 10.1210/jc.2004-0431; Brand OJ, 2010, MOL CELL ENDOCRINOL, V322, P135, DOI 10.1016/j.mce.2010.01.013; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Cho NH, 2010, CLIN ENDOCRINOL, V73, P264, DOI 10.1111/j.1365-2265.2010.03790.x; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; CUNNIEN AJ, 1982, J NUCL MED, V23, P978; Czarnywojtek A, 2011, PRZEGL LEK, V68, P1010; Czarnywojtek A, 2016, POL ARCH MED WEWN, V126, P746, DOI 10.20452/pamw.3505; DEBRUIN TWA, 1994, J INTERN MED, V236, P507; Dederichs B, 2006, EXP CLIN ENDOCR DIAB, V114, P366, DOI 10.1055/s-2006-924321; Eckstein A, 2003, BRIT J OPHTHALMOL, V87, P773, DOI 10.1136/bjo.87.6.773; Haase A, 2000, EXP CLIN ENDOCR DIAB, V108, P133, DOI 10.1055/s-2000-5807; Hernandez-Jimenez S, 2007, ARCH MED RES, V38, P185, DOI 10.1016/j.arcmed.2006.09.007; Howarth D, 2001, EUR J NUCL MED, V28, P1489, DOI 10.1007/s002590100621; Jorde R, 2006, EXP CLIN ENDOCR DIAB, V114, P343, DOI 10.1055/s-2006-924264; Kamijo K, 2010, THYROID, V20, P851, DOI 10.1089/thy.2010.0059; Knudsen N, 2002, ARCH INTERN MED, V162, P439, DOI 10.1001/archinte.162.4.439; Lantz M, 2014, EXP CLIN ENDOCR DIAB, V122, P113, DOI 10.1055/s-0033-1363193; Laurberg P, 2008, EUR J ENDOCRINOL, V158, P69, DOI 10.1530/EJE-07-0450; Leslie WD, 2003, J CLIN ENDOCR METAB, V88, P978, DOI 10.1210/jc.2002-020805; Mehran L, 2012, EXP CLIN ENDOCR DIAB, V120, P80, DOI 10.1055/s-0031-1285910; Nwatsock J F, 2012, World J Nucl Med, V11, P7, DOI 10.4103/1450-1147.98731; Perros P, 2005, J CLIN ENDOCR METAB, V90, P5321, DOI 10.1210/jc.2005-0507; Piantanida E, 2013, J ENDOCRINOL INVEST, V36, P444, DOI 10.3275/8937; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Quadbeck B, 2006, EXP CLIN ENDOCR DIAB, V114, P406, DOI 10.1055/s-2006-924065; Ruchala M, 2016, EXPERT REV CLIN PHAR, V9, P981, DOI 10.1586/17512433.2016.1165606; Ruchala M, 2010, ENDOKRYNOL POL, V61, P330; Sawicka N, 2012, ENDOKRYNOL POL, V63, P10; Sawicka-Gutaj N, 2014, ENDOKRYNOL POL, V65, P54, DOI 10.5603/EP.2014.0008; Schneider DF, 2014, ANN SURG ONCOL, V21, P4174, DOI 10.1245/s10434-014-3858-4; Stokkel MPM, 2010, EUR J NUCL MED MOL I, V37, P2218, DOI 10.1007/s00259-010-1536-8; Sztal-Mazer S, 2012, THYROID, V22, P991, DOI 10.1089/thy.2011.0362; Tanda ML, 2013, J CLIN ENDOCR METAB, V98, P1443, DOI 10.1210/jc.2012-3873; Traisk F, 2009, J CLIN ENDOCR METAB, V94, P3700, DOI 10.1210/jc.2009-0747; Vaidya B, 2008, CLIN ENDOCRINOL, V68, P814, DOI 10.1111/j.1365-2265.2007.03097.x; Vejbjerg P, 2008, EUR J EPIDEMIOL, V23, P423, DOI 10.1007/s10654-008-9255-1; Vestergaard P, 2002, EUR J ENDOCRINOL, V146, P153, DOI 10.1530/eje.0.1460153; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707	49	2	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2020	15	1							e0226495	10.1371/journal.pone.0226495	http://dx.doi.org/10.1371/journal.pone.0226495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IZ	31929534	Green Published, gold			2022-12-26	WOS:000534352500015
J	Alshayban, D; Joseph, R				Alshayban, Dhfer; Joseph, Royes			Health-related quality of life among patients with type 2 diabetes mellitus in Eastern Province, Saudi Arabia: A cross-sectional study	PLOS ONE			English	Article							GLOBAL BURDEN; GLUCOSE; DISEASE; EUROQOL; PEOPLE; EQ-5D; CARE	Diabetes mellitus has reached epidemic levels, and it threatens the economy and health globally and Saudi Arabia in particular. The study assessed health-related quality of life using EuroQol instrument and its predictors among patients with Type 2 diabetes mellitus in Eastern Province, Saudi Arabia. A cross-sectional study was conducted among 378 patients with Type 2 diabetes mellitus from two major health centers in Eastern Province. The study showed moderate health-related quality of life, as reported by the median index score of 0.808 with more than a quarter of patients with severe-extreme health state in some or all domains. Multiple-regression models showed that male gender, high monthly income, having no diabetes-related complications and having random blood glucose level less than 200 mg/dl were prone to have a higher index score compared to the corresponding contrary groups. The study will help in guiding the development of effective intervention programs to improve diabetes-related health-related quality of life among the Saudi population.	[Alshayban, Dhfer; Joseph, Royes] Imam Abdulrahman Bin Faisal Univ, Coll Clin Pharm, Dept Pharm Practice, Dammam, Saudi Arabia	Imam Abdulrahman Bin Faisal University	Joseph, R (corresponding author), Imam Abdulrahman Bin Faisal Univ, Coll Clin Pharm, Dept Pharm Practice, Dammam, Saudi Arabia.	rjchacko@iau.edu.sa	Joseph, Royes/D-8507-2017	Joseph, Royes/0000-0003-4974-9963				Aburuz S, 2009, ANN SAUDI MED, V29, P304, DOI 10.4103/0256-4947.55313; Al Hayek AA, 2014, DIABETES METAB J, V38, P220, DOI 10.4093/dmj.2014.38.3.220; Al Senany S, 2015, J PHYS THER SCI, V27, P1691, DOI 10.1589/jpts.27.1691; AL-Aboudi IS, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115610129; Al-Aboudi IS, 2016, J PHARM BIOALLIED SC, V8, P195, DOI 10.4103/0975-7406.171683; Al-Maskari MY, 2011, SAUDI MED J, V32, P1285; Al-Shehri AH, 2008, ANN SAUDI MED, V28, P352; Alneami Yahya Mari, 2016, Glob J Health Sci, V8, P54089, DOI 10.5539/gjhs.v8n9p10; Bani-Issa W., 2011, Eastern Mediterranean Health Journal, V17, P825; Bekairy AM, 2018, INT J HEALTH SCI-IJH, V12, P14; Devlin NJ, 2018, HEALTH ECON, V27, P7, DOI 10.1002/hec.3564; Elazhary H., 2018, JEDDAH J ADV MED MED, V26, P1, DOI [10.9734/JAMMR/2018/40083, DOI 10.9734/JAMMR/2018/40083]; FITZPATRICK R, 1992, BRIT MED J, V305, P1074, DOI 10.1136/bmj.305.6861.1074; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Home P, 2014, DIABETES CARE, V37, P1499, DOI 10.2337/dc13-2743; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Ishii H, 2013, J DIABETES INVEST, V4, P560, DOI 10.1111/jdi.12086; Jarab AS, 2019, J PHARM HEALTH SERV, V10, P211, DOI 10.1111/jphs.12255; Kayo AR, 2012, UNIVERSA MED, V31, P131; Khoja AT, 2018, SAUDI PHARM J, V26, P292, DOI 10.1016/j.jsps.2017.11.008; Lee WJ, 2012, J KOREAN MED SCI, V27, P255, DOI 10.3346/jkms.2012.27.3.255; Mielck A, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-58; Mokdad AH, 2015, J DIABETES METAB, V6, DOI 10.4172/2155-6156.1000575; Moradi-Lakeh M, 2017, DIABETES CARE, V40, P22, DOI 10.2337/dc16-1075; Navicharern Rungrawee, 2012, Journal of the Medical Association of Thailand, V95, P156; Pan CW, 2015, QUAL LIFE RES, V24, P1767, DOI 10.1007/s11136-014-0902-6; Parsa P, 2017, DIABETES METAB SYND, V11, pS879, DOI 10.1016/j.dsx.2017.07.009; Quah JHM, 2011, ANN ACAD MED SINGAP, V40, P276; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Robert AA, 2017, CURR DIABETES REV, V13, P59, DOI 10.2174/1573399812666160126142605; Robert SA, 2009, J GERONTOL B-PSYCHOL, V64, P378, DOI 10.1093/geronb/gbp012; Safita N, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0530-7; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Scollan-Koliopoulos M, 2013, DIABETES EDUCATOR, V39, P83, DOI 10.1177/0145721712467697; Shalaby S, 2015, WORLD J DIABETES, V6, P304, DOI 10.4239/wjd.v6.i2.304; Sharara E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5472-z; Trikkalinou A, 2017, WORLD J DIABETES, V8, P120, DOI 10.4239/wjd.v8.i4.120; Unden AL, 2008, GENDER MED, V5, P162, DOI 10.1016/j.genm.2008.05.003; van der Vinne Evelien, 2009, Int J Integr Care, V9, pe89; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO, 2018, GLOB HLTH EST 2019 D; WHO, 2017, GLOBAL REPORT DIABET; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	44	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0227573	10.1371/journal.pone.0227573	http://dx.doi.org/10.1371/journal.pone.0227573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP5IB	31923232	Green Published, gold			2022-12-26	WOS:000534350000093
J	Monsalve, RI; Gutierrez, R; Hoof, I; Lombardero, M				Monsalve, Rafael I.; Gutierrez, Ruth; Hoof, Ilka; Lombardero, Manuel			Purification and molecular characterization of phospholipase, antigen 5 and hyaluronidases from the venom of the Asian hornet (Vespa velutina)	PLOS ONE			English	Article							SEQUENCE SIMILARITY; WASP VENOM; ALLERGEN; IMMUNOTHERAPY; QUANTITATION; ALIGNMENT; PROTEINS	The aim of this study was to purify potential allergenic components of Vespa velutina venom, the yellow legged Asian Hornet, and perform a preliminary characterization of the purified proteins. Starting from the whole venom of V.velutina, several chromatographic steps allowed to purify the phospholipase (named Vesp v 1), as well as the antigen 5 (Vesp v 5, the only allergenic component described as such so far). The two hyaluronidase isoforms found (Vesp v 2A and Vesp v 2B) cannot be separated from each other, but they are partially purified and characterized. Purity of the isolated proteins in shown by SDSPAGE, as well as by the results of the N-terminal sequencing. This characterization and nLC-MS/MS data provide most of the sequence for Vesp v 1 and Vesp v 5 (72 and 84% coverage, respectively), confirming that the whole sequences of the isolated natural components match with the data available in public transcriptomic databases. It is of particular interest that Vesp v 1 is a glycosylated phospholipase, a fact that had only described so far for the corresponding allergen components of Dolichovespula maculata and Solenopsis invicta. The availability of the complete sequences of Vespa velutina components permits comparison with homologous sequences from other Hymenoptera. These data demonstrate the higher similarity among the species of the genera Vespa and Vespula, in comparison to Polistes species, as it is especially observed with the hyaluronidases isoforms: the isoform Vesp v 2A only exists in the former genera, and not in Polistes; in addition, the most abundant isoform (Vesp v 2B) exhibits 93% sequence identity with the Ves v 2 isoform of Vespula vulgaris. Finally, the isolated components might be useful for improving the diagnosis of patients that could be allergic to stings of this invasive Asian hornet, as it has been the case of an improved diagnosis and treatment of other Hymenoptera-sensitized patients.	[Monsalve, Rafael I.; Gutierrez, Ruth; Lombardero, Manuel] ALK Abello SA, CMC Res & Dev, Madrid, Spain; [Hoof, Ilka] ALK Abello AS, Global Res, Horsholm, Denmark	ALK-Abello AS; ALK-Abello AS	Monsalve, RI (corresponding author), ALK Abello SA, CMC Res & Dev, Madrid, Spain.	Rafael.monsalve@alk.net		Monsalve, Rafael/0000-0002-6838-4472				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antolin-Amerigo D, 2018, ALLERGOL IMMUNOPATH, V46, P253, DOI 10.1016/j.aller.2017.05.003; Arca M, 2014, BEHAV PROCESS, V106, P122, DOI 10.1016/j.beproc.2014.05.002; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Castro L., 2010, Heteropterus Revista de Entomologia, V10, P193; Chugo S, 2015, J INVEST ALLERG CLIN, V25, P231; Erwin EA, 2005, J ALLERGY CLIN IMMUN, V115, P1029, DOI 10.1016/j.jaci.2004.12.1131; Goldberg A, 2013, INT ARCH ALLERGY IMM, V161, P174, DOI 10.1159/000345139; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HABERMANN E, 1972, ANAL BIOCHEM, V50, P163, DOI 10.1016/0003-2697(72)90495-2; Hoffman DR, 2005, J ALLERGY CLIN IMMUN, V115, P611, DOI 10.1016/j.jaci.2004.11.020; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; KING TP, 1994, INT ARCH ALLERGY IMM, V105, P224, DOI 10.1159/000236761; KING TP, 1984, ARCH BIOCHEM BIOPHYS, V230, P1, DOI 10.1016/0003-9861(84)90080-8; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; Kolarich D, 2007, PROTEOMICS, V7, P1615, DOI 10.1002/pmic.200600800; Kosnik M, 2002, CROAT MED J, V43, P25; Leza M, 2019, SCI TOTAL ENVIRON, V689, P709, DOI 10.1016/j.scitotenv.2019.06.511; Liu ZR, 2015, SCI REP-UK, V5, DOI 10.1038/srep09454; Macchia D, 2018, WORLD ALLERGY ORGAN, V11, DOI 10.1186/s40413-018-0183-6; Milanesio D, 2017, ECOL EVOL, V7, P4599, DOI 10.1002/ece3.3053; Monsalve RI, 2012, ALLERGY, V67, P528, DOI 10.1111/j.1398-9995.2011.02781.x; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; Perez-Riverol A, 2019, INSECT BIOCHEM MOLEC, V105, P10, DOI 10.1016/j.ibmb.2018.12.011; Pomes A, 2018, MOL IMMUNOL, V100, P3, DOI 10.1016/j.molimm.2018.03.003; RICHMAN PG, 1980, ANAL BIOCHEM, V109, P376, DOI 10.1016/0003-2697(80)90663-6; Schiener M, 2017, HUM VACC IMMUNOTHER, V13, P2467, DOI 10.1080/21645515.2017.1334745; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; SOLDATOVA L, 1993, FEBS LETT, V320, P145, DOI 10.1016/0014-5793(93)80080-E; Speicher KD, 2009, CURR PROTOC PROTEIN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Villemant C, 2015, PEERJ, V3, DOI 10.7717/peerj.947	32	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2020	15	1							e0225672	10.1371/journal.pone.0225672	http://dx.doi.org/10.1371/journal.pone.0225672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5IB	31923175	Green Published, Green Submitted, gold			2022-12-26	WOS:000534350000009
J	Baster, Z; Li, LQ; Kukkurainen, S; Chen, J; Pentikainen, O; Gyorffy, B; Hytonen, VP; Zhu, HN; Rajfur, Z; Huang, C				Baster, Zbigniew; Li, Liqing; Kukkurainen, Sampo; Chen, Jing; Pentikainen, Olli; Gyorffy, Balazs; Hytonen, Vesa P.; Zhu, Haining; Rajfur, Zenon; Huang, Cai			Cyanidin-3-glucoside binds to talin and modulates colon cancer cell adhesions and 3D growth	FASEB JOURNAL			English	Article						adhesion; cancer prevention; cyanidin-3-glucoside; drug discovery; molecular docking; talin1; talin2; beta-integrin	PROTEIN-LIGAND DOCKING; INTEGRIN; ANTHOCYANINS; VINCULIN; INVASION; SITES; PHOSPHORYLATION; INFLAMMATION; FIBRONECTIN; REVEALS	Cyanidin-3-glucoside (C3G) is a natural pigment, found in many colorful fruits and vegetables. It has many health benefits, including anti-inflammation, cancer prevention, and anti-diabetes. Although C3G is assumed to be an antioxidant, it has been reported to affect cell-matrix adhesions. However, the underlying molecular mechanism is unknown. Here, we show that the expression of talin1, a key regulator of integrins and cell adhesions, negatively correlated with the survival rate of colon cancer patients and that depletion of talin1 inhibited 3D spheroid growth in colon cancer cells. Interestingly, C3G bound to talin and promoted the interaction of talin with beta 1A-integrin. Molecular docking analysis shows that C3G binds to the interface of the talin-beta-integrin complex, acting as an allosteric regulator and altering the interaction between talin and integrin. Moreover, C3G promoted colon cancer cell attachment to fibronectin. While C3G had no significant effect on colon cancer cell proliferation, it significantly inhibited 3D spheroid growth in fibrin gel assays. Since C3G has no or very low toxicity, it could be potentially used for colon cancer prevention or therapy.	[Baster, Zbigniew; Li, Liqing; Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, Markey Canc Ctr, Todd Bldg,Room 551,789 South Limestone St, Lexington, KY 40536 USA; [Baster, Zbigniew; Rajfur, Zenon] Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Krakow, Poland; [Kukkurainen, Sampo; Hytonen, Vesa P.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Chen, Jing; Zhu, Haining] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Pentikainen, Olli] Univ Turku, Inst Biomed Integrat Physiol & Pharmacol, Turku, Finland; [Gyorffy, Balazs] Hungarian Acad Sci, Inst Enzymol, MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland; [Huang, Cai] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA	University of Kentucky; Jagiellonian University; Tampere University; University of Kentucky; University of Turku; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Kentucky	Huang, C (corresponding author), Univ Kentucky, Dept Pharmacol & Nutr Sci, Markey Canc Ctr, Todd Bldg,Room 551,789 South Limestone St, Lexington, KY 40536 USA.; Rajfur, Z (corresponding author), Jagiellonian Univ, Fac Phys Astron & Appl Comp Sci, Inst Phys, Krakow, Poland.	zenon.rajfur@uj.edu.pl; cai-huang@uky.edu	LI, LI/GVS-5344-2022; Hytonen, Vesa P./E-8855-2013; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020; Baster, Zbigniew/L-5174-2013; li, li/GPX-3938-2022; li, li/HII-4157-2022; Gyorffy, Balazs/AAA-9135-2021; Li, Li/AEM-3636-2022	Hytonen, Vesa P./0000-0002-9357-1480; Baster, Zbigniew/0000-0002-5987-5712; Gyorffy, Balazs/0000-0002-5772-3766; Kukkurainen, Sampo/0000-0002-0635-784X	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [R01 GM122994]; Faculty of Physics, Astronomy, and Applied Computer Science of Jagiellonian University [N17/MNS/000006]; BRATNIAK Jagiellonian University Students and Graduates Foundation	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); Faculty of Physics, Astronomy, and Applied Computer Science of Jagiellonian University; BRATNIAK Jagiellonian University Students and Graduates Foundation	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R01 GM122994; Faculty of Physics, Astronomy, and Applied Computer Science of Jagiellonian University, Grant/Award Number: N17/MNS/000006; BRATNIAK Jagiellonian University Students and Graduates Foundation	Aguilar F, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3145; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arnaout M Amin, 2016, F1000Res, V5; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bru A, 2003, BIOPHYS J, V85, P2948, DOI 10.1016/S0006-3495(03)74715-8; BURRIDGE K, 1983, CELL MOTIL CYTOSKEL, V3, P405, DOI 10.1002/cm.970030509; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chen PN, 2006, CHEM-BIOL INTERACT, V163, P218, DOI 10.1016/j.cbi.2006.08.003; Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033; Chung J, 2008, MICROSC RES TECHNIQ, V71, P380, DOI 10.1002/jemt.20566; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; Feral CC, 2008, DIABETES, V57, P1842, DOI 10.2337/db07-1751; Ferrari D, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3454023; Galvano Fabio, 2007, Ann Ist Super Sanita, V43, P382; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Guo HH, 2008, BIOCHEM PHARMACOL, V75, P1393, DOI 10.1016/j.bcp.2007.11.016; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Hemmings L, 1996, J CELL SCI, V109, P2715; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Kourtzelis I, 2017, J LEUKOCYTE BIOL, V102, P677, DOI 10.1189/jlb.3MR0117-024R; Lee JS, 2015, INT J MOL MED, V35, P405, DOI 10.3892/ijmm.2014.2013; Li LQ, 2017, ONCOTARGET, V8, P106876, DOI 10.18632/oncotarget.22449; Liu J, 2012, NAT MATER, V11, P734, DOI [10.1038/nmat3361, 10.1038/NMAT3361]; Lohachoompol V, 2004, J BIOMED BIOTECHNOL, P248; Ma X, 2019, PHYTOTHER RES, V33, P81, DOI 10.1002/ptr.6201; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Pace E, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020024; Pantan R, 2016, EXP CELL RES, V342, P104, DOI 10.1016/j.yexcr.2016.02.017; Petrovic MG, 2003, J HUM GENET, V48, P457, DOI 10.1007/s10038-003-0060-0; Prior RL, 2003, AM J CLIN NUTR, V78, p570S, DOI 10.1093/ajcn/78.3.570S; Qi L, 2018, CURR PROTEIN PEPT SC, V19, P1071, DOI 10.2174/1389203719666180809094731; Qi L, 2016, J CELL SCI, V129, P3661, DOI 10.1242/jcs.185959; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Reis JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1076-5; ROTH T, 1993, P NATL ACAD SCI USA, V90, P9640, DOI 10.1073/pnas.90.20.9640; Rozanska D, 2018, ADV CLIN EXP MED, V27, P135, DOI 10.17219/acem/64983; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; Rupasinghe HPV, 2018, J FUNCT FOODS, V44, P24, DOI 10.1016/j.jff.2018.02.023; Sztupinszki Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep37169; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; ten Brink T, 2009, J CHEM INF MODEL, V49, P1535, DOI 10.1021/ci800420z; Tsuda T, 2003, J NUTR, V133, P2125, DOI 10.1093/jn/133.7.2125; Warner EF, 2017, MOL NUTR FOOD RES, V61, DOI [10.1002/mnfr.201600053, 10.1002/mnfr.201700053]; Xu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-285; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604; You YL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700261; Yuan YX, 2017, SCI REP-UK, V7, DOI 10.1038/srep41989; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	56	9	9	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2020	34	2					2227	2237		10.1096/fj.201900945R	http://dx.doi.org/10.1096/fj.201900945R		JAN 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KN2HU	31916632				2022-12-26	WOS:000506442100001
